PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Biswas-Fiss, EE; Affet, S; Ha, M; Biswas, SB				Biswas-Fiss, Esther E.; Affet, Stephanie; Ha, Malissa; Biswas, Subhasis B.			Retinoid Binding Properties of Nucleotide Binding Domain 1 of the Stargardt Disease-associated ATP Binding Cassette (ABC) Transporter, ABCA4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; ALTERNATING ACCESS; FUNDUS FLAVIMACULATUS; BIOCHEMICAL DEFECTS; NONSENSE MUTATION; A2E ACCUMULATE; P-GLYCOPROTEIN; GENE ABCR	The retina-specific ATP binding cassette transporter, ABCA4 protein, is associated with a broad range of inherited macular degenerations, including Stargardt disease, autosomal recessive cone rod dystrophy, and fundus flavimaculatus. In order to understand its role in retinal transport in rod out segment discs, we have investigated the interactions of the soluble domains of ABCA4 with both 11-cis- and all-trans-retinal. Using fluorescence anisotropy-based binding analysis and recombinant polypeptides derived from the amino acid sequences of the four soluble domains of ABCA4, we demonstrated that the nucleotide binding domain 1 (NBD1) specifically bound 11-cis-retinal. Its affinity for all-trans-retinal was markedly reduced. Stargardt disease-associated mutations in this domain resulted in attenuation of 11-cis-retinal binding. Significant differences in 11-cis-retinal binding affinities were observed between NBD1 and other cytoplasmic and lumenal domains of ABCA4. The results suggest a possible role of ABCA4 and, in particular, the NBD1 domain in 11-cis-retinal binding. These results also correlate well with a recent report on the in vivo role of ABCA4 in 11-cis-retinal transport.	[Biswas-Fiss, Esther E.; Affet, Stephanie; Ha, Malissa] Thomas Jefferson Univ, Jefferson Sch Hlth Profess, Program Biotechnol, Dept Biosci Technol, Philadelphia, PA 19107 USA; [Biswas-Fiss, Esther E.; Biswas, Subhasis B.] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA	Jefferson University; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Biswas-Fiss, EE (corresponding author), Thomas Jefferson Univ, Jefferson Sch Hlth Profess, Program Biotechnol, Dept Biosci Technol, Edison Bldg,Suite 2124,130 S 9th St, Philadelphia, PA 19107 USA.	Esther.Biswas@jefferson.edu			National Institutes of Health, NEI [EY 013113]; NATIONAL EYE INSTITUTE [R15EY013113] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grant EY 013113 and a National Institutes of Health administrative supplement, Quantitative Physical Measurements at the Nanaoscale (to E.E.B.-F.).	Ahn J, 2000, METHOD ENZYMOL, V315, P864; Ahn JH, 2003, J BIOL CHEM, V278, P39600, DOI 10.1074/jbc.M304236200; Allikmets R, 2000, AM J HUM GENET, V67, P793, DOI 10.1086/303100; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Balan A, 2008, GENET MOL RES, V7, P117, DOI 10.4238/vol7-1gmr392; Bennett J, 2012, METHOD ENZYMOL, V507, P255, DOI 10.1016/B978-0-12-386509-0.00013-2; Birch DG, 2001, EXP EYE RES, V73, P877, DOI 10.1006/exer.2001.1093; Biswas EE, 2001, BIOCHEMISTRY-US, V40, P8181, DOI 10.1021/bi0106686; Biswas EE, 2000, BIOCHEMISTRY-US, V39, P15879, DOI 10.1021/bi0015966; Biswas-Fiss E. E., 2011, INVEST OPHTHALMOL VI, V52; Biswas-Fiss EE, 2006, BIOCHEMISTRY-US, V45, P3813, DOI 10.1021/bi052059u; Biswas-Fiss EE, 2003, BIOCHEMISTRY-US, V42, P10683, DOI 10.1021/bi034481l; Biswas-Fiss EE, 2010, J BIOL CHEM, V285, P19372, DOI 10.1074/jbc.M110.112896; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Boyer NP, 2012, PHOTOCHEM PHOTOBIOL, V88, P1373, DOI 10.1111/j.1751-1097.2012.01127.x; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs CE, 2001, INVEST OPHTH VIS SCI, V42, P2229; Brunkhorst C, 2005, RES MICROBIOL, V156, P322, DOI 10.1016/j.resmic.2004.10.016; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Cremers F P M, 2002, Ned Tijdschr Geneeskd, V146, P1581; De La Paz MA, 1999, OPHTHALMOLOGY, V106, P1531, DOI 10.1016/S0161-6420(99)90449-9; Di Pietro A, 2002, CELL MOL LIFE SCI, V59, P307, DOI 10.1007/s00018-002-8424-8; Fishman GA, 2004, ARCH OPHTHALMOL-CHIC, V122, P70, DOI 10.1001/archopht.122.1.70; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Fukui T, 2002, INVEST OPHTH VIS SCI, V43, P2819; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Ito YA, 2007, ARCH OPHTHALMOL-CHIC, V125, P128, DOI 10.1001/archopht.125.1.128; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; Katz ML, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/198042; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Klevering BJ, 2004, EUR J HUM GENET, V12, P1024, DOI 10.1038/sj.ejhg.5201258; Klevering BJ, 1999, BRIT J OPHTHALMOL, V83, P914, DOI 10.1136/bjo.83.8.914; Klevering BJ, 2005, GRAEF ARCH CLIN EXP, V243, P90, DOI 10.1007/s00417-004-1079-4; Klevering BJ, 2002, INVEST OPHTH VIS SCI, V43, P1980; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Lois N, 1999, INVEST OPHTH VIS SCI, V40, P2668; Mace PD, 2007, PROTEIN EXPRES PURIF, V52, P40, DOI 10.1016/j.pep.2006.07.025; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Molday, 2000, Am J Ophthalmol, V130, P689, DOI 10.1016/S0002-9394(00)00756-X; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Papaioannou M, 2000, INVEST OPHTH VIS SCI, V41, P16; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sambrook J., 2002, MOL CLONING LAB MANU; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simonelli F, 2004, OPHTHALMIC RES, V36, P82, DOI 10.1159/000076886; Souied EH, 1999, INVEST OPHTH VIS SCI, V40, P2740; Stankiewicz P, 2006, GENOME DYN, V1, P1, DOI 10.1159/000092496; Suarez T, 2002, J BIOL CHEM, V277, P21759, DOI 10.1074/jbc.M202053200; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tsybovsky Y, 2010, ADV EXP MED BIOL, V703, P105, DOI 10.1007/978-1-4419-5635-4_8; van Driel MA, 1998, OPHTHALMIC GENET, V19, P117, DOI 10.1076/opge.19.3.117.2187; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang J, 2011, J BIOL CHEM, V286, P7308, DOI 10.1074/jbc.M110.210880; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Wen PC, 2011, BIOPHYS J, V101, P680, DOI 10.1016/j.bpj.2011.06.031; Winterfeld S, 2009, BIOCHEMISTRY-US, V48, P6684, DOI 10.1021/bi9003809; Yates JRW, 2000, J MED GENET, V37, P83, DOI 10.1136/jmg.37.2.83; Zernant J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/iovs.11-8182; Zhang K, 1999, GENOMICS, V60, P234, DOI 10.1006/geno.1999.5896; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051	70	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44097	44107		10.1074/jbc.M112.409623	http://dx.doi.org/10.1074/jbc.M112.409623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144455	Green Published, hybrid			2022-12-25	WOS:000312938600008
J	Engel, J; Schmalhorst, PS; Routier, FH				Engel, Jakob; Schmalhorst, Philipp S.; Routier, Francoise H.			Biosynthesis of the Fungal Cell Wall Polysaccharide Galactomannan Requires Intraluminal GDP-mannose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL MEMBRANE ANCHORS; NUCLEOTIDE-SUGAR TRANSPORTERS; ASPERGILLUS-FUMIGATUS; YEAST; GOLGI; GENE; GALACTOFURANOSE; IDENTIFICATION; MORPHOGENESIS; GLYCOSYLATION	Fungal cell walls frequently contain a polymer of mannose and galactose called galactomannan. In the pathogenic filamentous fungus Aspergillus fumigatus, this polysaccharide is made of a linear mannan backbone with side chains of galactofuran and is anchored to the plasma membrane via a glycosylphosphatidylinositol or is covalently linked to the cell wall. To date, the biosynthesis and significance of this polysaccharide are unknown. The present data demonstrate that deletion of the Golgi UDP-galactofuranose transporter GlfB or the GDP-mannose transporter GmtA leads to the absence of galactofuran or galactomannan, respectively. This indicates that the biosynthesis of galactomannan probably occurs in the lumen of the Golgi apparatus and thus contrasts with the biosynthesis of other fungal cell wall polysaccharides studied to date that takes place at the plasma membrane. Transglycosylation of galactomannan from the membrane to the cell wall is hypothesized because both the cell wall-bound and membrane-bound polysaccharide forms are affected in the generated mutants. Considering the severe growth defect of the A. fumigatus GmtA-deficient mutant, proving this paradigm might provide new targets for antifungal therapy.	[Engel, Jakob; Schmalhorst, Philipp S.; Routier, Francoise H.] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany	Hannover Medical School	Routier, FH (corresponding author), Hannover Med Sch, Dept Cellular Chem, OE 4330,Carl Neuberg Str 1, D-30625 Hannover, Germany.	Routier.Francoise@mh-hannover.de	Routier, Francoise/O-1611-2019	Schmalhorst, Philipp/0000-0002-5795-0133; Routier, Francoise/0000-0002-7163-0590	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Afroz S, 2011, FUNGAL GENET BIOL, V48, P896, DOI 10.1016/j.fgb.2011.06.001; Arakawa K, 2006, J GEN APPL MICROBIOL, V52, P137, DOI 10.2323/jgam.52.137; Atmodjo MA, 2011, P NATL ACAD SCI USA, V108, P20225, DOI 10.1073/pnas.1112816108; Baldwin TC, 2001, PLANT CELL, V13, P2283, DOI 10.1105/tpc.13.10.2283; Beauvais A, 2001, J BACTERIOL, V183, P2273, DOI 10.1128/JB.183.7.2273-2279.2001; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; Carvalho NDSP, 2011, FUNGAL BIOL-UK, V115, P253, DOI 10.1016/j.funbio.2010.12.010; Costachel C, 2005, J BIOL CHEM, V280, P39835, DOI 10.1074/jbc.M510163200; Cottrell TR, 2007, EUKARYOT CELL, V6, P776, DOI 10.1128/EC.00015-07; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471, DOI 10.1128/AAC.41.11.2471; Douglas CM, 2001, MED MYCOL, V39, P55, DOI 10.1080/mmy.39.1.55.66; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Fontaine T, 2003, GLYCOBIOLOGY, V13, P169, DOI 10.1093/glycob/cwg004; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Francois JM, 2006, NAT PROTOC, V1, P2995, DOI 10.1038/nprot.2006.457; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Jackson-Hayes L, 2008, MICROBIOL-SGM, V154, P2037, DOI 10.1099/mic.0.2008/017483-0; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015729; Kotz A, 2010, FUNGAL GENET BIOL, V47, P169, DOI 10.1016/j.fgb.2009.10.001; KRAKOW JL, 1986, J BIOL CHEM, V261, P2147; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Krappmann S, 2005, EUKARYOT CELL, V4, P1298, DOI 10.1128/EC.4.7.1298-1307.2005; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Nishikawa A, 2002, J BACTERIOL, V184, P29, DOI 10.1128/JB.184.1.29-42.2002; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Sandhu APS, 2009, MOL PLANT, V2, P840, DOI 10.1093/mp/ssp056; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schneider P, 1996, BIOCHEM J, V313, P963, DOI 10.1042/bj3130963; SHEMATEK EM, 1980, J BIOL CHEM, V255, P888; Simenel C, 2008, GLYCOBIOLOGY, V18, P84, DOI 10.1093/glycob/cwm122; Stepan H, 2011, ANAL BIOCHEM, V418, P24, DOI 10.1016/j.ab.2011.07.005; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; Takahashi HK, 2009, AN ACAD BRAS CIENC, V81, P477, DOI 10.1590/S0001-37652009000300012; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Toledo MS, 2007, J LIPID RES, V48, P1801, DOI 10.1194/jlr.M700149-JLR200; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Weidner G, 1998, CURR GENET, V33, P378, DOI 10.1007/s002940050350; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701	60	36	39	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44418	44424		10.1074/jbc.M112.398321	http://dx.doi.org/10.1074/jbc.M112.398321			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23139423	Green Published, hybrid			2022-12-25	WOS:000312938600038
J	Schiller, B; Makrypidi, G; Razzazi-Fazeli, E; Paschinger, K; Walochnik, J; Wilson, IBH				Schiller, Birgit; Makrypidi, Georgia; Razzazi-Fazeli, Ebrahim; Paschinger, Katharina; Walochnik, Julia; Wilson, Iain B. H.			Exploring the Unique N-Glycome of the Opportunistic Human Pathogen Acanthamoeba	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCEIN-CONJUGATED LECTINS; FREE-LIVING AMEBAS; LINKED OLIGOSACCHARIDES; GLYCOPROTEIN N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; TRICHOMONAS-VAGINALIS; ENTAMOEBA-HISTOLYTICA; PLASMA-MEMBRANE; SEQUENCE TYPES; GLYCANS; CASTELLANII	Glycans play key roles in host-pathogen interactions; thus, knowing the N-glycomic repertoire of a pathogen can be helpful in deciphering its methods of establishing and sustaining a disease. Therefore, we sought to elucidate the glycomic potential of the facultative amoebal parasite Acanthamoeba. This is the first study of its asparagine-linked glycans, for which we applied biochemical tools and various approaches of mass spectrometry. An initial glycomic screen of eight strains from five genotypes of this human pathogen suggested, in addition to the common eukaryotic oligomannose structures, the presence of pentose and deoxyhexose residues on their N-glycans. A more detailed analysis was performed on the N-glycans of a genotype T11 strain (4RE); fractionation by HPLC and tandem mass spectrometric analyses indicated the presence of a novel mannosylfucosyl modification of the reducing terminal core as well as phosphorylation of mannose residues, methylation of hexose and various forms of pentosylation. The largest N-glycan in the 4RE strain contained two N-acetylhexosamine, thirteen hexose, one fucose, one methyl, and two pentose residues; however, in this and most other strains analyzed, glycans with compositions of Hex(8-9)HexNAc(2)Pnt(0-1) tended to dominate in terms of abundance. Although no correlation between pathogenicity and N-glycan structure can be proposed, highly unusual structures in this facultative parasite can be found which are potential virulence factors or therapeutic targets.	[Schiller, Birgit; Paschinger, Katharina; Wilson, Iain B. H.] Univ Nat Resources & Life Sci, Univ Bodenkultur, Dept Chem, A-1190 Vienna, Austria; [Makrypidi, Georgia] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, D-20246 Hamburg, Germany; [Razzazi-Fazeli, Ebrahim] Univ Vet Med, Vetom Core Facil Res, A-1210 Vienna, Austria; [Walochnik, Julia] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Veterinary Medicine Vienna; Medical University of Vienna	Wilson, IBH (corresponding author), Univ Nat Resources & Life Sci, Univ Bodenkultur, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Walochnik, Julia/AAM-8963-2020; Wilson, Iain/B-3326-2009	Walochnik, Julia/0000-0003-0356-2853; Wilson, Iain/0000-0001-8996-1518; Paschinger, Katharina/0000-0002-3594-7136; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301	Austrian Fonds zur Forderung der wissenschaftlichen Forschung Grant [P20565]	Austrian Fonds zur Forderung der wissenschaftlichen Forschung Grant(Austrian Science Fund (FWF))	This work was supported in part by Austrian Fonds zur Forderung der wissenschaftlichen Forschung Grant P20565 (to I. B. H. W.).	Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BOSE K, 1989, INT J PARASITOL, V19, P737, DOI 10.1016/0020-7519(89)90060-X; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; Corsaro D, 2010, PARASITOL RES, V107, P233, DOI 10.1007/s00436-010-1870-6; Dudley R, 2009, EXP PARASITOL, V122, P338, DOI 10.1016/j.exppara.2009.04.009; Elloway EAG, 2004, J APPL MICROBIOL, V97, P1319, DOI 10.1111/j.1365-2672.2004.02430.x; Garate M, 2005, INFECT IMMUN, V73, P5775, DOI 10.1128/IAI.73.9.5775-5781.2005; Gast RJ, 1996, J EUKARYOT MICROBIOL, V43, P498, DOI 10.1111/j.1550-7408.1996.tb04510.x; ISHIHARA H, 1979, J BIOL CHEM, V254, P715; KETCHAM CM, 1992, J BIOL CHEM, V267, P11654; Khan NA, 2002, CURR MICROBIOL, V45, P197, DOI 10.1007/s00284-001-0108-3; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kong HH, 2009, KOREAN J PARASITOL, V47, pS21, DOI 10.3347/kjp.2009.47.S.S21; KORN ED, 1974, J BIOL CHEM, V249, P3335; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; LANG L, 1986, J BIOL CHEM, V261, P6320; Lehr T, 2007, GLYCOBIOLOGY, V17, P82, DOI 10.1093/glycob/cwl048; Leitsch D, 2010, EUKARYOT CELL, V9, P611, DOI 10.1128/EC.00300-09; Levy-Ontman O, 2011, J BIOL CHEM, V286, P21340, DOI 10.1074/jbc.M110.175042; Magliano ACM, 2012, PARASITOLOGY, V139, P45, DOI 10.1017/S0031182011001648; Magnelli P, 2008, J BIOL CHEM, V283, P18355, DOI 10.1074/jbc.M800725200; Makrypidi G, 2012, MOL CELL BIOL, V32, P774, DOI 10.1128/MCB.06195-11; Michel R, 2004, ACTA PROTOZOOL, V43, P37; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; NEFF RJ, 1957, J PROTOZOOL, V4, P176, DOI 10.1111/j.1550-7408.1957.tb02505.x; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; PAATERO GIL, 1988, EXP CELL RES, V179, P253, DOI 10.1016/0014-4827(88)90364-3; Park JN, 2012, J BIOL CHEM, V287, P19501, DOI 10.1074/jbc.M112.354209; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; Paschinger K, 2011, J MASS SPECTROM, V46, P561, DOI 10.1002/jms.1925; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; PUANGLARP N, 1995, EUR J BIOCHEM, V232, P873; Pumidonming W, 2010, PARASITOL RES, V106, P553, DOI 10.1007/s00436-009-1694-4; ROBIN JB, 1988, ARCH OPHTHALMOL-CHIC, V106, P1273, DOI 10.1001/archopht.1988.01060140433047; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Schiller B, 2009, BIOCHEM J, V423, P41, DOI 10.1042/BJ20090786; Schuster FL, 2004, INT J PARASITOL, V34, P1001, DOI 10.1016/j.ijpara.2004.06.004; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Stothard DR, 1998, J EUKARYOT MICROBIOL, V45, P45, DOI 10.1111/j.1550-7408.1998.tb05068.x; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; VISVESVARA GS, 1975, J PROTOZOOL, V22, P245, DOI 10.1111/j.1550-7408.1975.tb05860.x; Walochnik J, 2000, APPL ENVIRON MICROB, V66, P4408, DOI 10.1128/AEM.66.10.4408-4413.2000; Walochnik J, 2000, J CLIN MICROBIOL, V38, P3932, DOI 10.1128/JCM.38.11.3932-3936.2000; Wilson IBH, 2012, GLYCOCONJUGATE J, V29, P173, DOI 10.1007/s10719-012-9378-1; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; Wuhrer M, 2011, MASS SPECTROM REV, V30, P664, DOI 10.1002/mas.20337; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153	53	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43191	43204		10.1074/jbc.M112.418095	http://dx.doi.org/10.1074/jbc.M112.418095			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23139421	Green Published, hybrid			2022-12-25	WOS:000312940800001
J	Gaudio, JL; Huang, X				Gaudio, Jennifer L.; Huang, Xin			Motion Noise Changes Directional Interaction between Transparently Moving Stimuli from Repulsion to Attraction	PLOS ONE			English	Article							PERCEPTION; INTEGRATION; CONTRAST; MODEL	To interpret visual scenes, visual systems need to segment or integrate multiple moving features into distinct objects or surfaces. Previous studies have found that the perceived direction separation between two transparently moving random-dot stimuli is wider than the actual direction separation. This perceptual "direction repulsion'' is useful for segmenting overlapping motion vectors. Here we investigate the effects of motion noise on the directional interaction between overlapping moving stimuli. Human subjects viewed two overlapping random-dot patches moving in different directions and judged the direction separation between the two motion vectors. We found that the perceived direction separation progressively changed from wide to narrow as the level of motion noise in the stimuli was increased, showing a switch from direction repulsion to attraction (i.e. smaller than the veridical direction separation). We also found that direction attraction occurred at a wider range of direction separations than direction repulsion. The normalized effects of both direction repulsion and attraction were the strongest near the direction separation of similar to 25 degrees and declined as the direction separation further increased. These results support the idea that motion noise prompts motion integration to overcome stimulus ambiguity. Our findings provide new constraints on neural models of motion transparency and segmentation.	[Gaudio, Jennifer L.; Huang, Xin] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Huang, X (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA.	xhuang43@wisc.edu			University of Wisconsin-Madison; Wisconsin Alumni Research Foundation	University of Wisconsin-Madison; Wisconsin Alumni Research Foundation	This research is supported by the University of Wisconsin-Madison and Wisconsin Alumni Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Amano K, 2009, J VISION, V9, DOI 10.1167/9.3.4; Benton CP, 2003, CURR BIOL, V13, P767, DOI 10.1016/S0960-9822(03)00285-9; BLAKEMOR.C, 1970, NATURE, V228, P37, DOI 10.1038/228037a0; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Braddick OJ, 2002, VISION RES, V42, P1237, DOI 10.1016/S0042-6989(02)00018-4; Burr DC, 2009, VISION RES, V49, P1065, DOI 10.1016/j.visres.2008.10.024; Dakin SC, 2000, VISION RES, V40, P833, DOI 10.1016/S0042-6989(99)00226-6; Duncker K, 1929, SOURCE BOOK GESTALT, V12, P180; Edwards M, 2005, VISION RES, V45, P1877, DOI 10.1016/j.visres.2005.01.026; Edwards M, 1999, VISION RES, V39, P2239, DOI 10.1016/S0042-6989(98)00325-3; Grunewald A, 2004, VISION RES, V44, P959, DOI 10.1016/j.visres.2003.10.027; Hiris E, 1996, VISUAL NEUROSCI, V13, P187, DOI 10.1017/S0952523800007227; Kim J, 1996, VISION RES, V36, P1177, DOI 10.1016/0042-6989(95)00153-0; Lorenceau J, 1996, VISION RES, V36, P3415, DOI 10.1016/0042-6989(96)00086-7; MARSHAK W, 1979, SCIENCE, V205, P1399, DOI 10.1126/science.472756; MATHER G, 1980, Q J EXP PSYCHOL, V32, P325, DOI 10.1080/14640748008401168; MURAKAMI I, 1993, VISION RES, V33, P2091, DOI 10.1016/0042-6989(93)90008-K; NAWROT M, 1990, VISION RES, V30, P1439, DOI 10.1016/0042-6989(90)90025-G; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; QIAN N, 1994, J NEUROSCI, V14, P7367; RAMACHANDRAN VS, 1987, VISION RES, V27, P97, DOI 10.1016/0042-6989(87)90146-5; Rauber HJ, 1999, VISION RES, V39, P3187, DOI 10.1016/S0042-6989(99)00025-5; Raudies F, 2011, NEURAL COMPUT, V23, P2868, DOI 10.1162/NECO_a_00193; REINHARDTRUTLAND AH, 1988, PSYCHOL BULL, V103, P57, DOI 10.1037/0033-2909.103.1.57; Snowden RJ, 1999, TRENDS COGN SCI, V3, P369, DOI 10.1016/S1364-6613(99)01381-9; Takeuchi T, 1998, VISION RES, V38, P3069, DOI 10.1016/S0042-6989(98)00019-4; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; WALLACE GK, 1973, Q J EXP PSYCHOL, V25, P10, DOI 10.1080/14640747308400319; WATAMANIUK SNJ, 1992, VISION RES, V32, P2341, DOI 10.1016/0042-6989(92)90097-3; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; YUILLE AL, 1988, NATURE, V333, P71, DOI 10.1038/333071a0; ZHANG J, 1993, VISION RES, V33, P2721, DOI 10.1016/0042-6989(93)90231-K	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48649	10.1371/journal.pone.0048649	http://dx.doi.org/10.1371/journal.pone.0048649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139808	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300047
J	Khaibullina, A; Kenyon, N; Guptill, V; Quezado, MM; Wang, L; Koziol, D; Wesley, R; Moya, PR; Zhang, ZJ; Saha, A; Mukherjee, AB; Quezado, ZMN				Khaibullina, Alfia; Kenyon, Nicholas; Guptill, Virginia; Quezado, Martha M.; Wang, Li; Koziol, Deloris; Wesley, Robert; Moya, Pablo R.; Zhang, Zhongjian; Saha, Arjun; Mukherjee, Anil B.; Quezado, Zenaide M. N.			In a Model of Batten Disease, Palmitoyl Protein Thioesterase-1 Deficiency Is Associated with Brown Adipose Tissue and Thermoregulation Abnormalities	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; ENERGY-METABOLISM; NONSHIVERING THERMOGENESIS; ACTIVATION; MICE; INCL; NEURODEGENERATION; APOPTOSIS; UCP1; FAT	Infantile neuronal ceroid lipofuscinosis (INCL) is a fatal neurodegenerative disorder caused by a deficiency of palmitoyl-protein thioesterase-1 (PPT1). We have previously shown that children with INCL have increased risk of hypothermia during anesthesia and that PPT1-deficiency in mice is associated with disruption of adaptive energy metabolism, downregulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha), and mitochondrial dysfunction. Here we hypothesized that Ppt1-knockout mice, a well-studied model of INCL that shows many of the neurologic manifestations of the disease, would recapitulate the thermoregulation impairment observed in children with INCL. We also hypothesized that when exposed to cold, Ppt1-knockout mice would be unable to maintain body temperature as in mice thermogenesis requires upregulation of Pgc-1 alpha and uncoupling protein 1 (Ucp-1) in brown adipose tissue. We found that the Ppt1-KO mice had lower basal body temperature as they aged and developed hypothermia during cold exposure. Surprisingly, this inability to maintain body temperature during cold exposure in Ppt1-KO mice was associated with an adequate upregulation of Pgc-1 alpha and Ucp-1 but with lower levels of sympathetic neurotransmitters in brown adipose tissue. In addition, during baseline conditions, brown adipose tissue of Ppt1-KO mice had less vacuolization (lipid droplets) compared to wild-type animals. After cold stress, wild-type animals had significant decreases whereas Ppt1-KO had insignificant changes in lipid droplets compared with baseline measurements, thus suggesting that Ppt1-KO had less lipolysis in response to cold stress. These results uncover a previously unknown phenotype associated with PPT1 deficiency, that of altered thermoregulation, which is associated with impaired lipolysis and neurotransmitter release to brown adipose tissue during cold exposure. These findings suggest that INCL should be added to the list of neurodegenerative diseases that are linked to alterations in peripheral metabolic processes. In addition, extrapolating these findings clinically, impaired thermoregulation and hypothermia are potential risks in patients with INCL.	[Khaibullina, Alfia; Kenyon, Nicholas; Wang, Li; Quezado, Zenaide M. N.] Childrens Natl Med Ctr, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC 20010 USA; [Guptill, Virginia; Quezado, Zenaide M. N.] NIH, Dept Perioperat Med, Ctr Clin, Bethesda, MD 20892 USA; [Quezado, Martha M.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Koziol, Deloris; Wesley, Robert] NIH, Biostat & Clin Epidemiol Serv, Off Director, Ctr Clin, Bethesda, MD USA; [Moya, Pablo R.] NIMH, Clin Sci Lab, NIH, Bethesda, MD 20892 USA; [Zhang, Zhongjian; Saha, Arjun; Mukherjee, Anil B.] NICHHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Quezado, ZMN (corresponding author), Childrens Natl Med Ctr, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC 20010 USA.	zquezado@cnmc.org	Quezado, Zenaide/O-4860-2016	Quezado, Zenaide/0000-0001-9793-4368; Wang, Li/0000-0003-0036-3410; Moya, Pablo/0000-0001-6409-1544	Intramural Research Program of the National Institutes of Health, NIH Clinical Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD; Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Medical Center, Washington, DC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIH Clinical Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Medical Center, Washington, DC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the National Institutes of Health, NIH Clinical Center, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, and the The Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Medical Center, Washington, DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiainen L, 2007, NEUROBIOL DIS, V28, P52, DOI 10.1016/j.nbd.2007.06.012; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Carter EA, 2011, LIFE SCI, V89, P78, DOI 10.1016/j.lfs.2011.04.014; Cummings KJ, 2011, J PHYSIOL-LONDON, V589, P5247, DOI 10.1113/jphysiol.2011.214445; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goebel HH, 2004, BRAIN PATHOL, V14, P61, DOI 10.1111/j.1750-3639.2004.tb00499.x; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; HOFMANN SL, 2001, METABOLIC MOL BASES, P3877; Kim SJ, 2006, HUM MOL GENET, V15, P1580, DOI 10.1093/hmg/ddl078; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Madden CJ, 2010, AM J PHYSIOL-REG I, V298, pR776, DOI 10.1152/ajpregu.00614.2009; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Miao N, 2009, ANESTH ANALG, V109, P372, DOI 10.1213/ane.0b013e3181aa6e95; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nakamura K, 2008, J PHYSIOL-LONDON, V586, P2611, DOI 10.1113/jphysiol.2008.152686; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Santavuori P, 2000, Suppl Clin Neurophysiol, V53, P443, DOI 10.1016/S1567-424X(09)70193-X; Santavuori P, 2000, NEUROL SCI, V21, pS35; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; THOMSON JF, 1969, J CELL BIOL, V41, P312, DOI 10.1083/jcb.41.1.312; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wei H, 2011, HUM MOL GENET, V20, P1111, DOI 10.1093/hmg/ddq555; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200; Zhang ZJ, 2007, HUM MOL GENET, V16, P837, DOI 10.1093/hmg/ddm029; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451	41	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48733	10.1371/journal.pone.0048733	http://dx.doi.org/10.1371/journal.pone.0048733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139814	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300053
J	Robertson, KL; Mostaghim, A; Cuomo, CA; Soto, CM; Lebedev, N; Bailey, RF; Wang, Z				Robertson, Kelly L.; Mostaghim, Anahita; Cuomo, Christina A.; Soto, Carissa M.; Lebedev, Nikolai; Bailey, Robert F.; Wang, Zheng			Adaptation of the Black Yeast Wangiella dermatitidis to Ionizing Radiation: Molecular and Cellular Mechanisms	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TRANSCRIPTIONAL RESPONSE; EXOPHIALA DERMATITIDIS; GAMMA-RADIATION; DOWN-REGULATION; BLUE-LIGHT; RNA-SEQ; MELANIN; RESISTANCE	Observations of enhanced growth of melanized fungi under low-dose ionizing radiation in the laboratory and in the damaged Chernobyl nuclear reactor suggest they have adapted the ability to survive or even benefit from exposure to ionizing radiation. However, the cellular and molecular mechanism of fungal responses to such radiation remains poorly understood. Using the black yeast Wangiella dermatitidis as a model, we confirmed that ionizing radiation enhanced cell growth by increasing cell division and cell size. Using RNA-seq technology, we compared the transcriptomic profiles of the wild type and the melanin-deficient wdpks1 mutant under irradiation and non-irradiation conditions. It was found that more than 3000 genes were differentially expressed when these two strains were constantly exposed to a low dose of ionizing radiation and that half were regulated at least two fold in either direction. Functional analysis indicated that many genes for amino acid and carbohydrate metabolism and cell cycle progression were down-regulated and that a number of antioxidant genes and genes affecting membrane fluidity were up-regulated in both irradiated strains. However, the expression of ribosomal biogenesis genes was significantly up-regulated in the irradiated wild-type strain but not in the irradiated wdpks1 mutant, implying that melanin might help to contribute radiation energy for protein translation. Furthermore, we demonstrated that long-term exposure to low doses of radiation significantly increased survivability of both the wild-type and the wdpks1 mutant, which was correlated with reduced levels of reactive oxygen species (ROS), increased production of carotenoid and induced expression of genes encoding translesion DNA synthesis. Our results represent the first functional genomic study of how melanized fungal cells respond to low dose ionizing radiation and provide clues for the identification of biological processes, molecular pathways and individual genes regulated by radiation.	[Robertson, Kelly L.; Mostaghim, Anahita; Soto, Carissa M.; Lebedev, Nikolai; Wang, Zheng] USN, Ctr Bio Mol Sci & Engn, Res Lab, Washington, DC USA; [Bailey, Robert F.] USN, Hlth Phys Sect, Res Lab, Washington, DC USA; [Cuomo, Christina A.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Mostaghim, Anahita] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; George Mason University	Wang, Z (corresponding author), USN, Ctr Bio Mol Sci & Engn, Res Lab, Washington, DC USA.	zheng.wang@nrl.navy.mil	Cuomo, Christina/L-2222-2019	Cuomo, Christina/0000-0002-5778-960X	Office of Naval Research via U.S. Naval Research Laboratory core funds	Office of Naval Research via U.S. Naval Research Laboratory core funds	This work was funded by the Office of Naval Research via U.S. Naval Research Laboratory core funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ERA, 2008, CURR GENET, V53, P129, DOI 10.1007/s00294-007-0170-x; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Benton MG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-305; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Berrocal-Tito GM, 2000, PHOTOCHEM PHOTOBIOL, V71, P662, DOI 10.1562/0031-8655(2000)071<0662:COBLAD>2.0.CO;2; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bluhm BH, 2008, FUNGAL GENET BIOL, V45, P1364, DOI 10.1016/j.fgb.2008.07.005; Bryan R, 2011, FUNGAL BIOL-UK, V115, P945, DOI 10.1016/j.funbio.2011.04.003; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Company TEP, 2012, RAD DOS MEAS FUK DAI; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; DEHOOG GS, 1994, ANTON LEEUW INT J G, V65, P143, DOI 10.1007/BF00871755; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; Ermakov IV, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2139974; Feng B, 2001, INFECT IMMUN, V69, P1781, DOI 10.1128/IAI.69.3.1781-1794.2001; GEIS PA, 1984, MYCOLOGIA, V76, P268, DOI 10.2307/3793103; GEIS PA, 1984, ARCH MICROBIOL, V137, P324, DOI 10.1007/BF00410729; Gostincar C, 2008, STUD MYCOL, P51, DOI 10.3114/sim.2008.61.04; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karpichev IV, 2002, J BIOL CHEM, V277, P19609, DOI 10.1074/jbc.M202045200; Kimura S, 2006, BIOCHEM BIOPH RES CO, V346, P51, DOI 10.1016/j.bbrc.2006.05.126; Koltovaya NA, 1998, YEAST, V14, P133, DOI 10.1002/(SICI)1097-0061(19980130)14:2<133::AID-YEA206>3.0.CO;2-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehnert BE, 2002, HUM EXP TOXICOL, V21, P65, DOI 10.1191/0960327102ht212oa; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; Mal'tsev V. N., 1996, Radiatsionnaya Biologiya Radioekologiya, V36, P52; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Matias AC, 2007, FREE RADICAL BIO MED, V43, P1458, DOI 10.1016/j.freeradbiomed.2007.08.003; McDonald JP, 1997, GENETICS, V147, P1557; Mercier G, 2005, NUCLEIC ACIDS RES, V33, P6635, DOI 10.1093/nar/gki959; Mironenko NV, 2000, ECOTOX ENVIRON SAFE, V45, P177, DOI 10.1006/eesa.1999.1848; Paolo WF, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-55; Pedroso N, 2009, FREE RADICAL BIO MED, V46, P289, DOI 10.1016/j.freeradbiomed.2008.10.039; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Szaniszlo PJ, 2002, INT J MED MICROBIOL, V292, P381, DOI 10.1078/1438-4221-00221; Szaniszlo PJ, 1993, CLUES CHROMOBLASTOMY; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Upton AC, 2001, CRIT REV TOXICOL, V31, P681, DOI 10.1080/20014091111956; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Watson A, 2004, MOL BIOL CELL, V15, P851, DOI 10.1091/mbc.E03-08-0569; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; Westmoreland J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000656; Wheeler MH, 2008, EUKARYOT CELL, V7, P1699, DOI 10.1128/EC.00179-08; Zalar P, 2011, FUNGAL BIOL-UK, V115, P997, DOI 10.1016/j.funbio.2011.04.007; Zhang L, 2007, ARCH MICROBIOL, V188, P411, DOI 10.1007/s00203-007-0262-5; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966	61	59	63	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48674	10.1371/journal.pone.0048674	http://dx.doi.org/10.1371/journal.pone.0048674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139812	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300051
J	Salinas-Melgoza, A; Wright, TF				Salinas-Melgoza, Alejandro; Wright, Timothy F.			Evidence for Vocal Learning and Limited Dispersal as Dual Mechanisms for Dialect Maintenance in a Parrot	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; BUDGERIGARS MELOPSITTACUS-UNDULATUS; YELLOW-NAPED AMAZON; SONG DIALECTS; POPULATION-STRUCTURE; BIRD-SONG; CALL; EVOLUTION; CONTACT; AUROPALLIATA	Studies of avian vocal dialects commonly find evidence of geographic and acoustic stability in the face of substantial gene flow between dialects. The vocal imitation and reduced dispersal hypotheses are alternatives to explain this mismatch between vocal and genetic variation. We experimentally simulated dispersal in the yellow-naped amazon (Amazona auropalliata) by moving individuals within and across dialect boundaries in Costa Rica. One juvenile translocated across dialect boundaries altered its contact call to imitate the acoustic form of the local call six weeks post-release. In contrast, four adults translocated across dialect boundaries returned to their original capture site within 120 days, while five cross-dialect translocated adults who remained at the release site did not alter their contact calls. Translocated individuals were observed to show some segregation from resident flocks. The observation of vocal imitation by the juvenile bird supports the vocal imitation, whereas the behavior of adults is more consistent with the reduced dispersal hypotheses. Taken together, our results suggest that both post-dispersal learning by juveniles and high philopatry in adults could explain the stability of vocal dialects in the face of immigration and gene flow.	[Salinas-Melgoza, Alejandro; Wright, Timothy F.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	New Mexico State University	Salinas-Melgoza, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, San Patricio, Jalisco, Mexico.	cuixmaloso@gmail.com	Salinas-Melgoza, Alejandro/D-1789-2011	Salinas-Melgoza, Alejandro/0000-0003-2024-3061	National Science Foundation [IOS-0725032]; NMSU Arts & Sciences minigrant; World Parrot Trust; Idea Wild grant; ASNMSU research grant; Consejo Nacionalde Ciencia y Tecnologia (CONACyT)	National Science Foundation(National Science Foundation (NSF)); NMSU Arts & Sciences minigrant; World Parrot Trust; Idea Wild grant; ASNMSU research grant; Consejo Nacionalde Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Science Foundation (grant number IOS-0725032 to TFW), an NMSU Arts & Sciences minigrant (to TFW), World Parrot Trust Action grant, an Idea Wild grant, an ASNMSU research grant, and a Consejo Nacionalde Ciencia y Tecnologia (CONACyT) postgraduate scholarship to AS- M. LightHawk kindly provided support for aerial surveys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2005, AUK, V122, P803, DOI 10.1642/0004-8038(2005)122[0803:LMPBSD]2.0.CO;2; BAKER MC, 1985, BEHAV BRAIN SCI, V8, P85, DOI 10.1017/S0140525X00019750; BAKER MC, 1978, EVOLUTION, V32, P712, DOI 10.1111/j.1558-5646.1978.tb04624.x; BAPTISTA LF, 1982, AUK, V99, P537; Bartlett P, 1999, ETHOL ECOL EVOL, V11, P139, DOI 10.1080/08927014.1999.9522832; Blumstein DT, 2009, P ROY SOC B-BIOL SCI, V276, P3007, DOI 10.1098/rspb.2009.0703; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chilton G, 1996, CONDOR, V98, P567, DOI 10.2307/1369569; Ellers J, 2003, ANIM BEHAV, V65, P671, DOI 10.1006/anbe.2003.2081; FARABAUGH SM, 1994, J COMP PSYCHOL, V108, P81, DOI 10.1037/0735-7036.108.1.81; FEEKES F, 1982, Z TIERPSYCHOL, V58, P119; FLEISCHER RC, 1988, EVOLUTION, V42, P1146, DOI 10.1111/j.1558-5646.1988.tb04175.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Harbison H, 1999, CONDOR, V101, P133, DOI 10.2307/1370454; Hile AG, 2000, ANIM BEHAV, V59, P1209, DOI 10.1006/anbe.1999.1438; JENKINS PF, 1978, ANIM BEHAV, V26, P50, DOI 10.1016/0003-3472(78)90007-6; Lynch Alejandro, 1996, P181; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; MARLER P., 1962, CONDOR, V64, P368, DOI 10.2307/1365545; MCGREGOR P K, 1988, Bioacoustics, V1, P107; Moravec ML, 2010, ETHOLOGY, V116, P961, DOI 10.1111/j.1439-0310.2010.01809.x; MORTON ES, 1986, BEHAVIOUR, V99, P65, DOI 10.1163/156853986X00414; NOWICKI S, 1989, ANIM BEHAV, V37, P64, DOI 10.1016/0003-3472(89)90007-9; Payne R.B., 1981, P108; PEPPERBERG IM, 1994, AUK, V111, P300, DOI 10.2307/4088595; Pepperberg IM, 2004, NATURES MUSIC SCI BI, P263; PETRINOVICH L, 1981, EVOLUTION, V35, P180, DOI 10.1111/j.1558-5646.1981.tb04871.x; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Rowley Ian, 1990, BEHAV ECOLOGY GALAH; Sewall KB, 2009, ANIM BEHAV, V77, P1303, DOI 10.1016/j.anbehav.2009.01.033; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Soha JA, 2004, BEHAV ECOL, V15, P636, DOI 10.1093/beheco/arh055; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x; Wright TF, 1996, P ROY SOC B-BIOL SCI, V263, P867, DOI 10.1098/rspb.1996.0128; Wright TF, 2001, ETHOLOGY, V107, P111, DOI 10.1046/j.1439-0310.2001.00632.x; Wright TF, 2001, CONSERV BIOL, V15, P710, DOI 10.1046/j.1523-1739.2001.015003710.x; Wright TF, 2001, P ROY SOC B-BIOL SCI, V268, P609, DOI 10.1098/rspb.2000.1403; Wright TF, 2008, ANIM BEHAV, V76, P1017, DOI 10.1016/j.anbehav.2008.03.025	39	39	40	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48667	10.1371/journal.pone.0048667	http://dx.doi.org/10.1371/journal.pone.0048667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139809	Green Published, gold			2022-12-25	WOS:000311315300048
J	Freeman, DD; Choi, K; Yu, C				Freeman, Dallas D.; Choi, Kyungwho; Yu, Choongho			N-Type Thermoelectric Performance of Functionalized Carbon Nanotube-Filled Polymer Composites	PLOS ONE			English	Article							BEHAVIOR	Carbon nanotubes (CNTs) were functionalized with polyethyleneimine (PEI) and made into composites with polyvinyl acetate (PVAc). CNTs were dispersed with different amounts of sodium dodecylbenzenesulfonate (SDBS) prior to the PEI functionalization. The resulting samples exhibit air-stable n-type characteristics with electrical conductivities as great as 1500 S/m and thermopowers as large as -100 mu V/K. Electrical conductivity and thermopower were strongly affected by CNT dispersion, improving the properties with better dispersion with high concentrations of SDBS. This improvement is believed to be due to the increase in the number of tubes that are evenly coated with PEI in a better-dispersed sample. Increasing the amount of PEI relative to the other constituents positively affects thermopower but not conductivity. Air exposure reduces both thermopower and conductivity presumably due to oxygen doping (which makes CNTs p-type), but stable values were reached within seven days following sample fabrication.	[Freeman, Dallas D.; Choi, Kyungwho; Yu, Choongho] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Yu, C (corresponding author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.	chyu@tamu.edu		Choi, Kyungwho/0000-0002-4011-0402	US Air Force Office of Scientific Research under II-VI foundation [FA9550-09-1-0609]; Pioneer Research Center Program through the National Research Foundation of Korea [2011-0001645]; Ministry of Education, Science and Technology	US Air Force Office of Scientific Research under II-VI foundation(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Pioneer Research Center Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The authors gratefully acknowledge financial supports from the US Air Force Office of Scientific Research (FA9550-09-1-0609) under the auspices of Dr. Charles Lee, II-VI foundation, and the Pioneer Research Center Program through the National Research Foundation of Korea (2011-0001645) and funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins PG, 2000, SCIENCE, V287, P1801, DOI 10.1126/science.287.5459.1801; Dillon EP, 2008, ACS NANO, V2, P156, DOI 10.1021/nn7002713; DiSalvo FJ, 1999, SCIENCE, V285, P703, DOI 10.1126/science.285.5428.703; Herlem G, 2000, J ELECTROCHEM SOC, V147, P597, DOI 10.1149/1.1393239; Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u; Kaminishi D, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1886898; Kim D, 2010, ACS NANO, V4, P513, DOI 10.1021/nn9013577; Kim SM, 2009, J AM CHEM SOC, V131, P327, DOI 10.1021/ja807480g; Li ZR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3284657; Liao KS, 2010, CHEM PHYS LETT, V489, P207, DOI 10.1016/j.cplett.2010.03.010; Lin YM, 2005, IEEE T NANOTECHNOL, V4, P481, DOI 10.1109/TNANO.2005.851427; Majumdar A, 2004, SCIENCE, V303, P777, DOI 10.1126/science.1093164; Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747; Meyyappan M., 2005, CARBON NANOTUBES SCI; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Park W, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4005201; Ryu Y, 2012, J MATER CHEM, V22, P6959, DOI [10.1039/c2jm16000e, 10.1039/c2jm16000c]; Ryu Y, 2011, SOLID STATE COMMUN, V151, P1932, DOI 10.1016/j.ssc.2011.09.022; Ryu YT, 2011, CARBON, V49, P4745, DOI 10.1016/j.carbon.2011.06.082; Shim M, 2001, J AM CHEM SOC, V123, P11512, DOI 10.1021/ja0169670; Yamaguchi I, 2004, MATER LETT, V58, P598, DOI 10.1016/S0167-577X(03)00577-9; Yu CH, 2005, NANO LETT, V5, P1842, DOI 10.1021/nl051044e; Yu CH, 2012, ENERG ENVIRON SCI, V5, P9481, DOI 10.1039/c2ee22838f; Yu C, 2011, ACS NANO, V5, P7885, DOI 10.1021/nn202868a; Yu C, 2008, NANO LETT, V8, P4428, DOI 10.1021/nl802345s; Zhang ZY, 2007, NANO LETT, V7, P3603, DOI 10.1021/nl0717107	26	74	75	0	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47822	10.1371/journal.pone.0047822	http://dx.doi.org/10.1371/journal.pone.0047822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133605	Green Submitted, gold, Green Published			2022-12-25	WOS:000310702400016
J	Zhao, H; Shen, J; Wang, D; Gregory, S; Medico, L; Hu, Q; Yan, L; Odunsi, K; Lele, S; Liu, S				Zhao, Hua; Shen, Jie; Wang, Dan; Gregory, Steven; Medico, Leonardo; Hu, Qiang; Yan, Li; Odunsi, Kunle; Lele, Shashikant; Liu, Song			Associations between Gene Expression Variations and Ovarian Cancer Risk Alleles Identified from Genome Wide Association Studies	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; COLORECTAL-CANCER; MULTIPLE LOCI; 8Q24; FAMILIES; BREAST; HETEROGENEITY; POPULATION; RESOURCES; CARCINOMA	Functional genetic variations play important roles in shaping phenotypic differences among individuals through affecting gene expression, and thus, very likely to influence disease susceptibility, such as cancer susceptibility. One critical question in this era of post-genome wide association studies (GWAS) is how to assess the functional significance of the genetic variations identified from GWAS. In the current study, with lymphoblastoid cell lines (LCLs) from 74 non-related women with familial ovarian cancer and 47 unrelated controls matched on gender and race, we explored the associations between seven ovarian cancer risk variants identified from GWAS (rs3814113 on 9p22.2, rs2072590 on 2q31, rs2665390 on 3q25, rs10088218, rs1516982, rs10098821 on 8q24.21, and rs2363956 on 19p13) and whole genome mRNA expression profiles. We observed 95 significant trans-associations at a permutation level of 0.001. Compared to the other risk variants, rs10088218, rs1516982, and rs10098821 on 8q24.21 had the greatest number of significant associations (25, 16, and 38, respectively). Two possible cis-associations were observed between rs10098821 and c-Myc, and rs2072590 and HS.565379 (Permutated P = 0.0198 and 0.0399, respectively). Pathway enrichment analysis showed that several key biological pathways, such as cell cycle (P = 2.59x10(-06)), etc, were significantly overrepresented. Further characterization of significant associations between mRNAs and risk alleles might facilitate understanding the functions of GWAS discovered risk alleles in the genetic etiology of ovarian cancer.	[Zhao, Hua; Shen, Jie; Gregory, Steven; Medico, Leonardo] Roswell Pk Canc Inst, Dept Canc Prevent & Controls, Buffalo, NY 14263 USA; [Wang, Dan; Hu, Qiang; Yan, Li; Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Odunsi, Kunle; Lele, Shashikant] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Zhao, H (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Controls, Buffalo, NY 14263 USA.	hzhao2@mdanderson.org; song.liu@roswellpark.org			National Institutes of Health [5R01CA136483, P30 CA016056]; Ralph Wilson Medical Foundation; Department of Defense Ovarian Cancer Program [OC073116]; Roswell Park Alliance Foundation; NATIONAL CANCER INSTITUTE [R01CA136483, P30CA016056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph Wilson Medical Foundation; Department of Defense Ovarian Cancer Program; Roswell Park Alliance Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (5R01CA136483 to HZ and P30 CA016056 to Roswell Park Cancer Institute); Ralph Wilson Medical Foundation (to HZ); Department of Defense Ovarian Cancer Program (OC073116 to HZ), and Roswell Park Alliance Foundation (to HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; EASTON DF, 1993, AM J HUM GENET, V52, P678; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Han LP, 2011, ULTRASTRUCT PATHOL, V35, P260, DOI 10.3109/01913123.2011.608916; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; LYNCH HT, 1982, OBSTET GYNECOL, V59, P589; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; NAROD SA, 1995, AM J HUM GENET, V56, P254; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; YANCIK R, 1993, CANCER, V71, P517; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47962	10.1371/journal.pone.0047962	http://dx.doi.org/10.1371/journal.pone.0047962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133607	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400018
J	Zhang, YJ; Lin, HF; Yang, ZH; Wang, J; Li, YP				Zhang, Yijia; Lin, Hongfei; Yang, Zhihao; Wang, Jian; Li, Yanpeng			A Single Kernel-Based Approach to Extract Drug-Drug Interactions from Biomedical Literature	PLOS ONE			English	Article							INFORMATION EXTRACTION; GRAPH KERNEL; CLASSIFICATION; CORPUS	When one drug influences the level or activity of another drug this is known as a drug-drug interaction (DDI). Knowledge of such interactions is crucial for patient safety. However, the volume and content of published biomedical literature on drug interactions is expanding rapidly, making it increasingly difficult for DDIs database curators to detect and collate DDIs information manually. In this paper, we propose a single kernel-based approach to extract DDIs from biomedical literature. This novel kernel-based approach can effectively make full use of syntactic structural information of the dependency graph. In particular, our approach can efficiently represent both single subgraph topological information and the relation of two subgraphs in the dependency graph. Experimental evaluations showed that our single kernel-based approach can achieve state-of-the-art performance on the publicly available DDI corpus without exploiting multiple kernels or additional domain resources.	[Zhang, Yijia; Lin, Hongfei; Yang, Zhihao; Wang, Jian; Li, Yanpeng] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Liaoning, Peoples R China	Dalian University of Technology	Zhang, YJ (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	zhyj@dlut.edu.cn			Natural Science Foundation of China [60673039, 61070098]; National High Tech Research and Development Plan of China [2006AA01Z151]; Doctoral Program Foundation of Institutions of Higher Education of China [20090041110002]; Fundamental Research Funds for the Central Universities [DUT10JS09]; Liaoning Province Doctor Startup Fund [20091015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Plan of China(National High Technology Research and Development Program of China); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund	This work is supported by grant from the Natural Science Foundation of China (No. 60673039 and 61070098), the National High Tech Research and Development Plan of China (No. 2006AA01Z151), Doctoral Program Foundation of Institutions of Higher Education of China (20090041110002), the Fundamental Research Funds for the Central Universities (No. DUT10JS09) and Liaoning Province Doctor Startup Fund (No.20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bjorne J., 2011, P DDIEXTRACTION 2011, P35; Blaschke C, 2002, IEEE INTELL SYST, V17, P14, DOI 10.1109/MIS.2002.999215; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; Blasco SG, 2011, CEUR WORKSHOP P, V761, P51; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Bunescu RC, 2005, P C HUM LANG TECHN E, P724, DOI DOI 10.3115/1220575.1220666; Carugo O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-380; Chowdhury MFM, 2011, CHALLENGE TASK DRUG, V761, P19; Corney DPA, 2004, BIOINFORMATICS, V20, P3206, DOI 10.1093/bioinformatics/bth386; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; Gartner T, 2003, LECT NOTES ARTIF INT, V2777, P129, DOI 10.1007/978-3-540-45167-9_11; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hido S, 2009, IEEE DATA MINING, P179, DOI 10.1109/ICDM.2009.30; Kim JD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-10; Kim S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-107; Lease M, 2005, LECT NOTES ARTIF INT, V3651, P58, DOI 10.1007/11562214_6; Min Z, 2008, INFORM PROCESS MANAG, V44, P687, DOI 10.1016/j.ipm.2007.07.013; Miwa M, 2009, INT J MED INFORM, V78, pE39, DOI 10.1016/j.ijmedinf.2009.04.010; Mooney RJ, 2006, ADV NEURAL INFORM PR, P171; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Pyysalo S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-50; Pyysalo S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S6; Rodriguez-Terol A, 2009, Farm Hosp, V33, P134; Segura-Bedmar I., 2011, CHALLENGE TASK DRUG, P1; Segura-Bedmar I, 2008, DRUG DISCOV TODAY, V13, P816, DOI 10.1016/j.drudis.2008.06.001; Segura-Bedmar I, 2011, J BIOMED INFORM, V44, P789, DOI 10.1016/j.jbi.2011.04.005; Segura-Bedmar I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S1; Thomas P., 2011, P 1 CHALL TASK DRUG, P11; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yang ZH, 2011, ARTIF INTELL MED, V51, P163, DOI 10.1016/j.artmed.2010.12.002; Zelenko D, 2003, J MACH LEARN RES, V3, P1083, DOI 10.1162/153244303322533205; Zhang M, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P825; Zhang YJ, 2011, J BIOMED INFORM, V44, P1086, DOI 10.1016/j.jbi.2011.08.011; Zhou G, 2007, P 2007 JOINT C EMP M, P728; Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045	37	16	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48901	10.1371/journal.pone.0048901	http://dx.doi.org/10.1371/journal.pone.0048901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133662	Green Submitted, gold, Green Published			2022-12-25	WOS:000310601300028
J	Doka, NI; Jacob, ST; Banura, P; Moore, CC; Meya, D; Mayanja-Kizza, H; Reynolds, SJ; Scheld, WM; Yuan, W				Doka, Najah I.; Jacob, Shevin T.; Banura, Patrick; Moore, Christopher C.; Meya, David; Mayanja-Kizza, Harriet; Reynolds, Steven J.; Scheld, W. Michael; Yuan, Wen			Enrichment of HIV-1 Subtype AD Recombinants in a Ugandan Cohort of Severely Septic Patients	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; DISEASE PROGRESSION; INTENSIVE-CARE; ANTIRETROVIRAL THERAPY; RAKAI DISTRICT; SEVERE SEPSIS; TYPE-1; MANAGEMENT; PATTERNS; OUTCOMES	Background: Several population-wide HIV-1 subtype distribution studies in Uganda have evaluated relatively healthy clinic patients. Given the differences in HIV-1 disease progression based on subtype, we examined HIV-1 subtype distribution and disease outcomes among hospitalized patients with severe sepsis. Methods: Patients with severe sepsis were enrolled at two hospitals in Uganda. Data collected included demographics, Karnofsky scores, highly active antiretroviral therapy (HAART) use, HIV-1 serostatus, CD4+ T cell concentration, whole blood lactate concentration, and blood cultures. HIV-1 subtypes were determined by sequencing parts of the gag and env genes, followed by phylogenetic analysis. Results: Of the 267 patients evaluated, 228 (85.4%) were HIV infected. The predominant HIV-1 subtypes were A (46%), D (17%), and AD recombinants (30%). HIV-1 subtypes B, C, and other recombinants were uncommon. Patients infected with HIV-1 subtypes A, D and AD viruses were similar in demographics, CD4(+) T cell concentration, HAART use, Karnofsky scores, whole blood lactate concentration, and positive blood cultures. There was no difference in 30-day mortality from severe sepsis between the 3 groups (p = 0.99). Conclusion: A high proportion of HIV-1 subtypes A and AD recombinants was observed in this cohort of severely septic patients. The proportion of AD recombinants was higher in this cohort than in previous cohorts of Ugandan HIV-1 patients. No difference in baseline demographics, clinical factors or 30-day mortality was seen across HIV-subtypes.	[Doka, Najah I.; Moore, Christopher C.; Scheld, W. Michael; Yuan, Wen] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Doka, Najah I.; Yuan, Wen] Univ Virginia, Myles H Thaler Ctr AIDS & Human Retroviruses Res, Charlottesville, VA USA; [Jacob, Shevin T.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; [Jacob, Shevin T.] Univ Washington, Dept Med, Int Resp & Severe Illness Ctr INTERSECT, Seattle, WA USA; [Banura, Patrick] Masaka Reg Referral Hosp, Dept Community Hlth, Masaka, Uganda; [Meya, David; Mayanja-Kizza, Harriet] Makerere Univ, Infect Dis Inst, Dept Med, Kampala, Uganda; [Reynolds, Steven J.] NIAID, NIH, Bethesda, MD 20892 USA; [Reynolds, Steven J.] Johns Hopkins Sch Med, Baltimore, MD USA	University of Virginia; University of Virginia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine	Yuan, W (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	wy5e@virginia.edu	Jacob, Shevin/CAF-0449-2022; Meya, David/AAO-2796-2020; Mayanja-Kizza, Harriet/AAM-5372-2020	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Jacob, Shevin/0000-0003-2425-9394; , David/0000-0002-8854-0321; Meya, David/0000-0002-4138-240X; Reynolds, Steven/0000-0002-5403-2759	Pfizer Initiative in International Health at the University of Virginia [GA 9001SZ]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, ZIAAI001040] Funding Source: NIH RePORTER	Pfizer Initiative in International Health at the University of Virginia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Pfizer Initiative in International Health at the University of Virginia [GA 9001SZ]. Additional non-grant support was provided by the Rakai Health Sciences Program through the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Barugahare B, 2005, J VIROL, V79, P4132, DOI 10.1128/JVI.79.7.4132-4139.2005; Boivin MJ, 2010, AIDS, V24, P1163, DOI 10.1097/QAD.0b013e3283389dcc; Brennan CA, 1997, AIDS, V11, P1823, DOI 10.1097/00002030-199715000-00006; Collinson-Streng AN, 2009, AIDS RES HUM RETROV, V25, P1045, DOI 10.1089/aid.2009.0127; Eng SM, 2009, 5 IAS C HIV PATH TRE; Gale CV, 2006, AIDS RES HUM RETROV, V22, P985, DOI 10.1089/aid.2006.22.985; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Herbeck JT, 2007, AIDS RES HUM RETROV, V23, P755, DOI 10.1089/aid.2006.0237.A; Hu DJ, 2000, EMERG INFECT DIS, V6, P609, DOI 10.3201/eid0606.000609; Huang L, 2006, NEW ENGL J MED, V355, P173, DOI 10.1056/NEJMra050836; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Lihana RW, 2010, AIDS RES HUM RETROV, V26, P833, DOI 10.1089/aid.2009.0229; Nakanjako Damalie, 2007, Afr Health Sci, V7, P124; Nickas G, 2000, ARCH INTERN MED, V160, P541, DOI 10.1001/archinte.160.4.541; Rayfield MA, 1998, AIDS, V12, P521, DOI 10.1097/00002030-199805000-00014; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Ssali FN, 1998, J ACQ IMMUN DEF SYND, V19, P484, DOI 10.1097/00042560-199812150-00007; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; WACHTER RM, 1986, AM REV RESPIR DIS, V134, P891, DOI 10.1164/arrd.1986.134.5.891; Yang CF, 1999, J CLIN MICROBIOL, V37, P2581, DOI 10.1128/JCM.37.8.2581-2586.1999; Yirrell DL, 2004, INT J STD AIDS, V15, P103, DOI 10.1258/095646204322764299	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48356	10.1371/journal.pone.0048356	http://dx.doi.org/10.1371/journal.pone.0048356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144755	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705300065
J	Droge, J; Pande, A; Englander, EW; Makalowski, W				Droege, Jasmin; Pande, Amit; Englander, Ella W.; Makalowski, Wojciech			Comparative Genomics of Neuroglobin Reveals Its Early Origins	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NEURON-SPECIFIC EXPRESSION; FACTOR-BINDING SITES; ZINC-FINGER PROTEIN; SODIUM-CHANNEL GENE; TRANSCRIPTION FACTOR; GLOBIN GENE; IN-VIVO; REGULATORY ELEMENTS; RESPIRATORY-PROTEIN	Background: Neuroglobin (Ngb) is a hexacoordinated globin expressed mainly in the central and peripheral nervous system of vertebrates. Although several hypotheses have been put forward regarding the role of neuroglobin, its definite function remains uncertain. Ngb appears to have a neuro-protective role enhancing cell viability under hypoxia and other types of oxidative stress. Ngb is phylogenetically ancient and has a substitution rate nearly four times lower than that of other vertebrate globins, e. g. hemoglobin. Despite its high sequence conservation among vertebrates Ngb seems to be elusive in invertebrates. Principal Findings: We determined candidate orthologs in invertebrates and identified a globin of the placozoan Trichoplax adhaerens that is most likely orthologous to vertebrate Ngb and confirmed the orthologous relationship of the polymeric globin of the sea urchin Strongylocentrotus purpuratus to Ngb. The putative orthologous globin genes are located next to genes orthologous to vertebrate POMT2 similarly to localization of vertebrate Ngb. The shared syntenic position of the globins from Trichoplax, the sea urchin and of vertebrate Ngb strongly suggests that they are orthologous. A search for conserved transcription factor binding sites (TFBSs) in the promoter regions of the Ngb genes of different vertebrates via phylogenetic footprinting revealed several TFBSs, which may contribute to the specific expression of Ngb, whereas a comparative analysis with myoglobin revealed several common TFBSs, suggestive of regulatory mechanisms common to globin genes. Significance: Identification of the placozoan and echinoderm genes orthologous to vertebrate neuroglobin strongly supports the hypothesis of the early evolutionary origin of this globin, as it shows that neuroglobin was already present in the placozoan-bilaterian last common ancestor. Computational determination of the transcription factor binding sites repertoire provides on the one hand a set of transcriptional factors that are responsible for the specific expression of the Ngb genes and on the other hand a set of factors potentially controlling expression of a couple of different globin genes.	[Droege, Jasmin; Pande, Amit; Makalowski, Wojciech] Univ Munster, Inst Bioinformat, Fac Med, Munster, Germany; [Englander, Ella W.] Univ Texas Med Branch, Dept Surg, Galveston, TX USA	University of Munster; University of Texas System; University of Texas Medical Branch Galveston	Makalowski, W (corresponding author), Univ Munster, Inst Bioinformat, Fac Med, Munster, Germany.	wojmak@uni-muenster.de	Makalowski, Wojciech/I-2843-2016	Makalowski, Wojciech/0000-0003-2303-9541; Englander, Ella/0000-0002-8580-191X	Institute of Bioinformatics; Shriners Hospitals for Children [SHG8670]	Institute of Bioinformatics; Shriners Hospitals for Children	This work has been supported by the Institute of Bioinformatics funds (JD, AP, and WM) and Shriners Hospitals for Children grant SHG8670 (EWE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agatonovic-Kustrin S, 2008, MINI-REV MED CHEM, V8, P943, DOI 10.2174/138955708785132747; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailly Xavier, 2008, V9, P191; BAVISOTTO L, 1991, J EXP MED, V174, P1097, DOI 10.1084/jem.174.5.1097; Berezikov E, 2004, GENOME RES, V14, P170; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Blank M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025292; Blank M, 2011, J BIOL CHEM, V286, P26507, DOI 10.1074/jbc.M111.224634; Boron I, 2011, IUBMB LIFE, V63, P206, DOI 10.1002/iub.444; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, IUBMB LIFE, V56, P703, DOI 10.1080/15216540500037257; Burmester T, 2007, INSECT MOL BIOL, V16, P133, DOI 10.1111/j.1365-2583.2006.00706.x; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cao A, 2002, PEDIATR RES, V51, P415, DOI 10.1203/00006450-200204000-00003; Chen RL, 2010, J BIOL CHEM, V285, P10189, DOI 10.1074/jbc.M109.049130; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Diallo AB, 2010, BIOINFORMATICS, V26, P130, DOI 10.1093/bioinformatics/btp600; Dickerson R, 1983, HEMOGLOBIN STRUCTURE; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; DIXON B, 1992, TRENDS BIOCHEM SCI, V17, P486; Droge J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-54; Ebner B, 2003, MOL BIOL EVOL, V20, P1521, DOI 10.1093/molbev/msg164; Ebner B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-370; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fordel E, 2004, BIOCHEM BIOPH RES CO, V319, P342, DOI 10.1016/j.bbrc.2004.05.010; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; Fuchs C, 2004, J BIOL CHEM, V279, P24116, DOI 10.1074/jbc.M402011200; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Garry DJ, 2003, TRENDS CARDIOVAS MED, V13, P111, DOI 10.1016/S1050-1738(02)00256-6; GRAYSON J, 1995, MOL CELL BIOL, V15, P1870; Gros G, 2010, J EXP BIOL, V213, P2713, DOI 10.1242/jeb.043075; Guo X, 2007, BIOCHEM BIOPH RES CO, V364, P145, DOI 10.1016/j.bbrc.2007.09.108; Guo XM, 2006, BBA-GENE STRUCT EXPR, V1759, P208, DOI 10.1016/j.bbaexp.2006.04.002; Hankeln T, 1997, GENE, V205, P151, DOI 10.1016/S0378-1119(97)00518-0; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P1735, DOI 10.1093/molbev/mss018; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; Hoffmann FG, 2011, GENOME BIOL EVOL, V3, P588, DOI 10.1093/gbe/evr055; Hoffmann FG, 2010, P NATL ACAD SCI USA, V107, P14274, DOI 10.1073/pnas.1006756107; Huang NW, 2000, J BIOL CHEM, V275, P2852, DOI 10.1074/jbc.275.4.2852; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P183, DOI 10.1159/000135617; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P173, DOI 10.1159/000129698; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanatous SB, 2010, J EXP BIOL, V213, P2741, DOI 10.1242/jeb.041442; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; Kraus RJ, 1996, NUCLEIC ACIDS RES, V24, P1531, DOI 10.1093/nar/24.8.1531; Kugelstadt D, 2004, BIOCHEM BIOPH RES CO, V325, P719, DOI 10.1016/j.bbrc.2004.10.080; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Laufs TL, 2004, NEUROSCI LETT, V362, P83, DOI 10.1016/j.neulet.2004.02.072; Lee HM, 2011, FREE RADICAL BIO MED, V51, P2281, DOI 10.1016/j.freeradbiomed.2011.09.026; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liao DQ, 2009, MOL CANCER RES, V7, P1893, DOI 10.1158/1541-7786.MCR-09-0229; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Liu N, 2012, BIOCHEM J, V443, P153, DOI 10.1042/BJ20111856; Lloberas J, 1999, IMMUNOL TODAY, V20, P184, DOI 10.1016/S0167-5699(99)01442-5; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Makalowski W., 1995, IMPACT SHORT INTERSP, P81; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; Metzger D, 2005, PROSTAG LEUKOTR ESS, V73, P51, DOI 10.1016/j.plefa.2005.04.007; Miller M. A., 2010, CIPRES PORTALS; Myslinski E, 1998, J BIOL CHEM, V273, P21998, DOI 10.1074/jbc.273.34.21998; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Ohlsson R, 2010, CHROMOSOMA; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Plaisance V, 2005, J BIOL CHEM, V280, P401, DOI 10.1074/jbc.M411825200; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robertson KA, 1998, LEUKEMIA, V12, P690, DOI 10.1038/sj.leu.2401005; Rodda S, 2001, J BIOL CHEM, V276, P3324, DOI 10.1074/jbc.M008167200; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; SMIT AFA, REPEATMASKER OPEN 3, P1996; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Storz JF, 2011, IUBMB LIFE, V63, P313, DOI 10.1002/iub.482; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Thiagalingam A, 1996, MOL CELL BIOL, V16, P5335; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Wystub S, 2004, CYTOGENET GENOME RES, V105, P65, DOI 10.1159/000078011; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhang W, 2011, BBA-GENE REGUL MECH, V1809, P236, DOI 10.1016/j.bbagrm.2011.02.003	134	17	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47972	10.1371/journal.pone.0047972	http://dx.doi.org/10.1371/journal.pone.0047972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133533	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800025
J	Liu, T; Li, Y; Gu, H; Zhu, G; Li, JB; Cao, L; Li, F				Liu, Tong; Li, Yang; Gu, Hui; Zhu, Ge; Li, Jiabin; Cao, Liu; Li, Feng			p21-activated Kinase 6 (PAK6) Inhibits Prostate Cancer Growth via Phosphorylation of Androgen Receptor and Tumorigenic E3 Ligase Murine Double Minute-2 (Mdm2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; UBIQUITYLATION; DEGRADATION; PROGRESSION; EXPRESSION; METASTASES; CELLS	The androgen receptor (AR) signaling pathway plays a crucial role in the development and growth of prostate malignancies. Regulation of AR homeostasis in prostate tumorigenesis has not yet been fully characterized. In this study, we demonstrate that p21-activated kinase 6 (PAK6) inhibits prostate tumorigenesis by regulating AR homeostasis. First, we demonstrated that in normal prostate epithelium, AR co-localizes with PAK6 in the cytoplasm and translocates into the nucleus in malignant prostate. Furthermore, AR phosphorylation at Ser-578 by PAK6 promotes AR-E3 ligase murine double minute-2 (Mdm2) association, causing AR degradation upon androgen stimuli. We also showed that PAK6 phosphorylates Mdm2 on Thr-158 and Ser-186, which is critical for AR ubiquitin-mediated degradation. Moreover, we found that Thr-158 collaborates with Ser-186 for AR-Mdm2 association and AR ubiquitin-mediated degradation as it facilitates PAK6-mediated AR homeostasis. PAK6 knockdown promotes prostate tumor growth in vivo. Interestingly, we found a strong inverse correlation between PAK6 and AR expression in the cytoplasm of prostate cancer cells. These observations indicate that PAK6 may be important for the maintenance of androgen-induced AR signaling homeostasis and in prostate malignancy, as well as being a possible new therapeutic target for AR-positive and hormone-sensitive prostate cancer.	[Li, Feng] China Med Univ, Minist Publ Hlth, Dept Cell Biol, Key Lab Cell Biol, Shenyang 110001, Peoples R China; [Li, Feng] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Li, F (corresponding author), China Med Univ, Minist Publ Hlth, Dept Cell Biol, Key Lab Cell Biol, Shenyang 110001, Peoples R China.	fli@mail.cmu.edu.cn		Li, Feng/0000-0001-5868-7456	National Natural Science Foundation of China [30771128, 90813038, 31171360]; Ministry of Education of China Doctoral Fund [20102104110016]; Education Department of Liaoning Province Grant [LT2011011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China Doctoral Fund; Education Department of Liaoning Province Grant	This work was supported by National Natural Science Foundation of China Grants 30771128, 90813038, and 31171360, Ministry of Education of China Doctoral Fund 20102104110016, and Education Department of Liaoning Province Grant LT2011011.	Agoulnik IU, 2008, ADV EXP MED BIOL, V617, P245, DOI 10.1007/978-0-387-69080-3_23; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Faus H, 2006, BIOMED PHARMACOTHER, V60, P520, DOI 10.1016/j.biopha.2006.07.082; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Ha S, 2011, ENDOCR-RELAT CANCER, V18, P245, DOI 10.1530/ERC-10-0204; Hartel A, 2003, J STEROID BIOCHEM, V84, P231, DOI 10.1016/S0960-0760(03)00033-5; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Higano CS, 2011, UROL ONCOL-SEMIN ORI, V29, pS1, DOI 10.1016/j.urolonc.2011.08.013; Hobisch A, 1996, PROSTATE, V28, P129; HOBISCH A, 1995, CANCER RES, V55, P3068; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kaur R, 2008, PROSTATE, V68, P1510, DOI 10.1002/pros.20787; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Li XD, 2010, EXPERT OPIN THER TAR, V14, P419, DOI 10.1517/14728221003642019; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Shu SK, 2010, J BIOL CHEM, V285, P33045, DOI 10.1074/jbc.M110.121129; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wen XQ, 2009, UROLOGY, V73, P1407, DOI 10.1016/j.urology.2008.09.041; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	36	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3359	3369		10.1074/jbc.M112.384289	http://dx.doi.org/10.1074/jbc.M112.384289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23132866	hybrid, Green Published			2022-12-25	WOS:000314397900041
J	Lauer, ME; Cheng, G; Swaidani, S; Aronica, MA; Weigel, PH; Hascall, VC				Lauer, Mark E.; Cheng, Georgiana; Swaidani, Shadi; Aronica, Mark A.; Weigel, Paul H.; Hascall, Vincent C.			Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Amplifies Hyaluronan Synthesis by Airway Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; HEAVY-CHAIN; PROTEIN; SHAP; COMPLEX; SERUM; INFLAMMATION; ARTHRITIS; MATRIX; MODEL	We tested the hypothesis that the artificial addition of heavy chains from inter-alpha-inhibitor to hyaluronan (HA), by adding recombinant TSG-6 (TNF-stimulated gene-6) to the culture medium of murine airway smooth muscle (MASM) cells, would enhance leukocyte binding to HA cables produced in response to poly(I: C). As predicted, the addition of heavy chains to HA cables enhanced leukocyte adhesion to these cables, but it also had several unexpected effects. (i) It produced thicker, more pronounced HA cables. (ii) It increased the accumulation of HA in the cell-associated matrix. (iii) It decreased the amount of HA in the conditioned medium. Importantly, these effects were observed only when TSG-6 was administered in the presence of poly(I: C), and TSG-6 did not exert any effect on its own. Increased HA synthesis occurred during active, poly(I:C)-induced HA synthesis and did not occur when TSG-6 was added after poly(I:C)-induced HA synthesis was complete. MASM cells derived from TSG-6(-/-), HAS1/3(-/-), and CD44(-/-) mice amplified HA synthesis in response to poly(I: C) + TSG-6 in a manner similar to WT MASM cells, demonstrating that they are expendable in this process. We conclude that TSG-6 increases the accumulation of HA in the cell-associated matrix, partially by preventing its dissolution from the cell-associated matrix into the conditioned medium, but primarily by inducing HA synthesis.	[Lauer, Mark E.; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Cheng, Georgiana; Swaidani, Shadi; Aronica, Mark A.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Swaidani, Shadi] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; [Aronica, Mark A.] Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA; [Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lauer, ME (corresponding author), Cleveland Clin, Dept Biomed Engn, ND20, Cleveland, OH 44195 USA.	lauerm1@ccf.org			National Institutes of Health from NHLBI [P11 HL081064, P01 HL107147]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, P01HL081064, P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P11 HL081064 and P01 HL107147 from NHLBI.	Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; HUANG L, 1993, J BIOL CHEM, V268, P26725; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kida D, 1999, J RHEUMATOL, V26, P1230; Kishida T, 2008, CONNECT TISSUE RES, V49, P105, DOI 10.1080/03008200701818629; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Leigh DR, 2012, J ORTHOP RES, V30, P1725, DOI 10.1002/jor.22149; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Obayashi Y, 2008, ONCOL REP, V19, P1245; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Shen L, 2006, HEPATOL RES, V34, P178, DOI 10.1016/j.hepres.2005.12.008; Stoop R, 2001, ARTHRITIS RHEUM, V44, P2922, DOI 10.1002/1529-0131(200112)44:12<2922::AID-ART480>3.0.CO;2-7; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	31	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					423	431		10.1074/jbc.M112.389882	http://dx.doi.org/10.1074/jbc.M112.389882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23129777	Green Published, hybrid			2022-12-25	WOS:000313197200043
J	Andre, P; Wang, QY; Wang, N; Gao, B; Schilit, A; Halford, MM; Stacker, SA; Zhang, XM; Yang, YZ				Andre, Philipp; Wang, Qianyi; Wang, Na; Gao, Bo; Schilit, Arielle; Halford, Michael M.; Stacker, Steven A.; Zhang, Xuemin; Yang, Yingzi			The Wnt Coreceptor Ryk Regulates Wnt/Planar Cell Polarity by Modulating the Degradation of the Core Planar Cell Polarity Component Vangl2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; NEURAL-TUBE DEFECTS; CONVERGENT EXTENSION MOVEMENTS; RECESSIVE ROBINOW-SYNDROME; BRACHYDACTYLY TYPE-B; ZEBRAFISH GASTRULATION; AXON GUIDANCE; HAIR-CELLS; PATHWAY; ROR2	The Wnt signaling pathways control many critical developmental and adult physiological processes. In vertebrates, one fundamentally important function of Wnts is to provide directional information by regulating the evolutionarily conserved planar cell polarity (PCP) pathway during embryonic morphogenesis. However, despite the critical roles of Wnts and PCP in vertebrate development and disease, little is known about the molecular mechanisms underlying Wnt regulation of PCP. Here, we have found that the receptor-like tyrosine kinase (Ryk), a Wnt5a-binding protein required in axon guidance, regulates PCP signaling. We show that Ryk interacts with Vangl2 genetically and biochemically, and such interaction is potentiated by Wnt5a. Loss of Ryk in a Vangl2(+/-) background results in classic PCP defects, including open neural tube, misalignment of sensory hair cells in the inner ear, and shortened long bones in the limbs. Complete loss of both Ryk and Vangl2 results in more severe phenotypes that resemble the Wnt5a(-/-) mutant in many aspects such as shortened anterior-posterior body axis, limb, and frontonasal process. Our data identify the Wnt5a-binding protein Ryk as a general regulator of the mammalian Wnt/PCP signaling pathway. We show that Ryk transduces Wnt5a signaling by forming a complex with Vangl2 and that Ryk regulates PCP by at least in part promoting Vangl2 stability. As human mutations in WNT5A and VANGL2 are found to cause Robinow syndrome and neural tube defects, respectively, our results further suggest that human mutations in RYK may also be involved in these diseases.	[Andre, Philipp; Gao, Bo; Schilit, Arielle; Yang, Yingzi] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Wang, Qianyi; Wang, Na; Zhang, Xuemin] China Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing 100850, Peoples R China; [Halford, Michael M.; Stacker, Steven A.] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, Melbourne, Vic 3002, Australia; [Stacker, Steven A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Yang, YZ (corresponding author), NHGRI, Genet Dis Res Branch, 49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Stacker, Steven/0000-0003-4096-9273; Gao, Bo/0000-0002-8684-5199	intramural research program of National Human Genome Research Institute; National Health and Medical Research Council of Australia; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000187] Funding Source: NIH RePORTER	intramural research program of National Human Genome Research Institute; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the intramural research program of National Human Genome Research Institute and by the National Health and Medical Research Council of Australia.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Macheda ML, 2012, J BIOL CHEM, V287, P29312, DOI 10.1074/jbc.M112.362681; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Tada M, 2000, DEVELOPMENT, V127, P2227; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	45	83	85	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44518	44525		10.1074/jbc.M112.414441	http://dx.doi.org/10.1074/jbc.M112.414441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144463	Green Published, hybrid			2022-12-25	WOS:000312938600048
J	Elantak, L; Espeli, M; Boned, A; Bornet, O; Bonzi, J; Gauthier, L; Feracci, M; Roche, P; Guerlesquin, F; Schiff, C				Elantak, Latifa; Espeli, Marion; Boned, Annie; Bornet, Olivier; Bonzi, Jeremy; Gauthier, Laurent; Feracci, Mikael; Roche, Philippe; Guerlesquin, Francoise; Schiff, Claudine			Structural Basis for Galectin-1-dependent Pre-B Cell Receptor (Pre-BCR) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE BONE-MARROW; STROMAL CELLS; PROTEIN; BINDING; LAMBDA-5; ANGIOGENESIS; REPERTOIRE; REVEALS; ANGINEX; PEPTIDE	During B cell differentiation in the bone marrow, the expression and activation of the pre-B cell receptor (pre-BCR) constitute crucial checkpoints for B cell development. Both constitutive and ligand-dependent pre-BCR activation modes have been described. The pre-BCR constitutes an immunoglobulin heavy chain (Ig mu) and a surrogate light chain composed of the invariant lambda 5 and VpreB proteins. We previously showed that galectin-1 (GAL1), produced by bone marrow stromal cells, is a pre-BCR ligand that induces receptor clustering, leading to efficient pre-BII cell proliferation and differentiation. GAL1 interacts with the pre-BCR via the unique region of lambda 5 (lambda 5-UR). Here, we investigated the solution structure of a minimal lambda 5-UR motif that interacts with GAL1. This motif adopts a stable helical conformation that docks onto a GAL1 hydrophobic surface adjacent to its carbohydrate binding site. We identified key hydrophobic residues from the lambda 5-UR as crucial for the interaction with GAL1 and for pre-BCR clustering. These residues involved in GAL1-induced pre-BCR activation are different from those essential for autonomous receptor activation. Overall, our results indicate that constitutive and ligand-induced pre-BCR activation could occur in a complementary manner.	[Elantak, Latifa; Bonzi, Jeremy; Guerlesquin, Francoise] Aix Marseille Univ, CNRS UMR7255, Lab Ingn Syst Macromol, F-13402 Marseille 20, France; [Espeli, Marion; Boned, Annie; Schiff, Claudine] Aix Marseille Univ, UM2, INSERM U1104, Ctr Immunol Marseille Luminy,CNRS UMR7280, F-13288 Marseille 09, France; [Bornet, Olivier] Inst Microbiol Mediterranee, FR 3479, F-13402 Marseille 20, France; [Gauthier, Laurent] Innate Pharma, F-13276 Marseille, France; [Feracci, Mikael] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Roche, Philippe] Aix Marseille Univ, Inst J Paoli I Calmettes, CNRS UMR7258, Lab Integrat Struct & Chem Biol,INSERM U1068, F-13273 Marseille 09, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; University of Leicester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Guerlesquin, F (corresponding author), Aix Marseille Univ, CNRS UMR7255, Lab Ingn Syst Macromol, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	guerlesquin@imm.cnrs.fr; schiff@ciml.univ-mrs.fr	Espeli, Marion/AAH-4483-2021; ELANTAK, Latifa/S-7004-2019; ROCHE, Philippe/E-5661-2010	Espeli, Marion/0000-0001-5005-1664; ROCHE, Philippe/0000-0002-5580-0588	Agence Nationale de la Recherche [ANR-05-BLAN-0035-01]; ARC; INSERM; CNRS; Fondation pour la Recherche Medicale; WeNMR Project European FP7 e-Infrastructure grant [261572]	Agence Nationale de la Recherche(French National Research Agency (ANR)); ARC(Australian Research Council); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); WeNMR Project European FP7 e-Infrastructure grant	This work was supported by grants from the Agence Nationale de la Recherche (ANR-05-BLAN-0035-01), ARC (to M. E.), INSERM, and CNRS and the Fondation pour la Recherche Medicale (to L. E.), the WeNMR Project European FP7 e-Infrastructure grant, Contract 261572, for the use of Web portals, computing, and storage facilities.	Bankovich AJ, 2007, SCIENCE, V316, P291, DOI 10.1126/science.1139412; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Camby I, 2002, J NEUROPATH EXP NEUR, V61, P585, DOI 10.1093/jnen/61.7.585; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Dings RPM, 2012, J MED CHEM, V55, P5121, DOI 10.1021/jm300014q; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Espeli M, 2009, BLOOD, V113, P5878, DOI 10.1182/blood-2009-01-198465; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; JOUBERT R, 1992, J NEUROCHEM, V58, P200, DOI 10.1111/j.1471-4159.1992.tb09296.x; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Knoll M, 2012, J IMMUNOL, V188, P6010, DOI 10.4049/jimmunol.1200071; Lanig H, 2004, MOL IMMUNOL, V40, P1263, DOI 10.1016/j.molimm.2003.11.030; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Mourcin F, 2011, BLOOD, V117, P6552, DOI 10.1182/blood-2010-12-323113; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Nesmelova IV, 2008, BIOMOL NMR ASSIGN, V2, P203, DOI 10.1007/s12104-008-9121-9; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; PEARLMAN DA, 1995, J MOL BIOL, V248, P696, DOI 10.1006/jmbi.1995.0252; Rossi B, 2006, J IMMUNOL, V177, P796, DOI 10.4049/jimmunol.177.2.796; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; tenBoekel E, 1997, IMMUNITY, V7, P357; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; van der Schaft DWJ, 2002, FASEB J, V16, P1991, DOI 10.1096/fj.02-0509fje; Vyakarnam A, 1997, MOL CELL BIOL, V17, P4730, DOI 10.1128/MCB.17.8.4730	35	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44703	44713		10.1074/jbc.M112.395152	http://dx.doi.org/10.1074/jbc.M112.395152			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23124203	Green Published, hybrid			2022-12-25	WOS:000312938600066
J	Trujillo, CA; Negraes, PD; Schwindt, TT; Lameu, C; Carromeu, C; Muotri, AR; Pesquero, JB; Cerqueira, DM; Pillat, MM; de Souza, HDN; Turaca, LT; Abreu, JG; Ulrich, H				Trujillo, Cleber A.; Negraes, Priscilla D.; Schwindt, Telma T.; Lameu, Claudiana; Carromeu, Cassiano; Muotri, Alysson R.; Pesquero, Joao B.; Cerqueira, Debora M.; Pillat, Micheli M.; de Souza, Hellio D. N.; Turaca, Lauro T.; Abreu, Jose G.; Ulrich, Henning			Kinin-B2 Receptor Activity Determines the Differentiation Fate of Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; ISCHEMIC-STROKE; MESSENGER-RNA; BRADYKININ; ADULT; NEUROGENESIS; EXPRESSION; MIGRATION	Bradykinin is not only important for inflammation and blood pressure regulation, but also involved in neuromodulation and neuroprotection. Here we describe novel functions for bradykinin and the kinin-B2 receptor (B2BkR) in differentiation of neural stem cells. In the presence of the B2BkR antagonist HOE-140 during rat neurosphere differentiation, neuron-specific beta 3-tubulin and enolase expression was reduced together with an increase in glial protein expression, indicating that bradykinin- induced receptor activity contributes to neurogenesis. In agreement, HOE-140 affected in the same way expression levels of neural markers during neural differentiation of murine P19 and human iPS cells. Kinin-B1 receptor agonists and antagonists did not affect expression levels of neural markers, suggesting that bradykinin-mediated effects are exclusively mediated via B2BkR. Neurogenesis was augmented by bradykinin in the middle and late stages of the differentiation process. Chronic treatment with HOE-140 diminished eNOS and nNOS as well as M1-M4 muscarinic receptor expression and also affected purinergic receptor expression and activity. Neurogenesis, gliogenesis, and neural migration were altered during differentiation of neurospheres isolated from B2BkR knock-out mice. Whole mount in situ hybridization revealed the presence of B2BkR mRNA throughout the nervous system in mouse embryos, and less beta 3-tubulin and more glial proteins were expressed in developing and adult B2BkR knock-out mice brains. As a underlying transcriptional mechanism for neural fate determination, HOE-140 induced up-regulation of Notch1 and Stat3 gene expression. Because pharmacological treatments did not affect cell viability and proliferation, we conclude that bradykinin-induced signaling provides a switch for neural fate determination and specification of neurotransmitter receptor expression.	[Trujillo, Cleber A.; Negraes, Priscilla D.; Schwindt, Telma T.; Lameu, Claudiana; Pillat, Micheli M.; de Souza, Hellio D. N.; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil; [Carromeu, Cassiano; Muotri, Alysson R.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA; [Carromeu, Cassiano; Muotri, Alysson R.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Pesquero, Joao B.; Turaca, Lauro T.] Univ Fed Sao Paulo, Dept Biofis, BR-04023062 Sao Paulo, Brazil; [Cerqueira, Debora M.; Abreu, Jose G.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, Brazil	Universidade de Sao Paulo; University of California System; University of California San Diego; University of California System; University of California San Diego; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Ulrich, H (corresponding author), Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, Brazil.	henning@iq.usp.br	Pillat, Micheli/AAW-3423-2020; Ulrich, Henning/C-5245-2013; Cerqueira, Debora Malta/CAF-4323-2022; Neurociencia, Inct/I-1011-2013; Cerqueira, Debora Malta/AAB-6204-2020; Abreu, Jose G/ABB-1199-2021; Ulrich, Henning/AAX-8586-2021; Carromeu, Cassiano/B-1487-2014; Lameu, Claudiana/B-9089-2012; Abreu, Jose G/G-6159-2010	Pillat, Micheli/0000-0002-6753-6083; Ulrich, Henning/0000-0002-2114-3815; Abreu, Jose G/0000-0002-1363-1755; Ulrich, Henning/0000-0002-2114-3815; Lameu, Claudiana/0000-0002-6874-5864; Abreu, Jose G/0000-0002-9875-7786; Carromeu, Cassiano/0000-0002-7570-2213; Turaca, Lauro/0000-0001-6001-4306; Malta Cerqueira Sant'Anna Santos, Debora/0000-0001-9773-4606	National Institutes of Health [1-DP2-OD006495-01]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61285-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Provost's Office for Research of the University of Sao Paulo Programa de Incentivo a Pesquisa [2011.1.9333.1.3]; NAPNA-USP, Brazil; International Rett Syndrome Foundation [2517]; Emerald Foundation; California Institute for Regenerative Medicine Grant [TR2-01814]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Provost's Office for Research of the University of Sao Paulo Programa de Incentivo a Pesquisa; NAPNA-USP, Brazil; International Rett Syndrome Foundation; Emerald Foundation; California Institute for Regenerative Medicine Grant(California Institute for Regenerative Medicine); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovator Award Program Grant 1-DP2-OD006495-01 (to A. R. M.), research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (number 2006/61285-9), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the Provost's Office for Research of the University of Sao Paulo Programa de Incentivo a Pesquisa, Project numbers 2011.1.9333.1.3 and NAPNA-USP, Brazil (to H. U.).; Supported by a fellowship from the International Rett Syndrome Foundation, 2517.; Supported by the Emerald Foundation and the California Institute for Regenerative Medicine Grant TR2-01814.; Supported by a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).; Supported by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Bayer S.A., 1991, NEOCORTICAL DEV; Bertram CM, 2007, J LEUKOCYTE BIOL, V81, P1445, DOI 10.1189/jlb.0106055; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Bortone F, 2008, INT IMMUNOPHARMACOL, V8, P206, DOI 10.1016/j.intimp.2007.09.004; Burnstock G, 2011, CELL MOL LIFE SCI, V68, P1369, DOI 10.1007/s00018-010-0614-1; BUSH AB, 1991, J NEUROCHEM, V57, P562, DOI 10.1111/j.1471-4159.1991.tb03787.x; Buznikov GA, 1996, CELL MOL NEUROBIOL, V16, P533, DOI 10.1007/BF02152056; Calixto JB, 2000, PAIN, V87, P1, DOI 10.1016/S0304-3959(00)00335-3; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B; Campbell K, 2005, NEURON, V46, P373, DOI 10.1016/j.neuron.2005.04.014; Cardenas A, 2005, BRAIN RES REV, V50, P1, DOI 10.1016/j.brainresrev.2005.03.006; Covacu R, 2006, STEM CELLS, V24, P2792, DOI 10.1634/stemcells.2005-0640; Estrada C, 2005, NEUROSCIENTIST, V11, P294, DOI 10.1177/1073858404273850; Eurin J, 2002, NEUROPEPTIDES, V36, P257, DOI 10.1016/S0143-4179(02)00025-2; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; Franca CE, 2010, GENET MOL RES, V9, P215, DOI 10.4238/vol9-1gmr681; Gallego MJ, 2009, STEM CELLS DEV, V18, P737, DOI 10.1089/scd.2008.0190; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Gibbs SM, 2003, MOL NEUROBIOL, V27, P107, DOI 10.1385/MN:27:2:107; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hagg T, 2005, TRENDS NEUROSCI, V28, P589, DOI 10.1016/j.tins.2005.08.009; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kansui Y, 2002, HYPERTENSION, V39, P29, DOI 10.1161/hy0102.098309; KOZLOWSKI MR, 1989, PEPTIDES, V10, P1121, DOI 10.1016/0196-9781(89)90002-8; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Lameu C, 2012, J BIOL CHEM, V287, P29690, DOI 10.1074/jbc.M111.338095; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; Ling L, 2008, BRAIN RES, V1206, P89, DOI 10.1016/j.brainres.2008.01.099; LORENZON P, 1995, J CELL BIOL, V129, P797, DOI 10.1083/jcb.129.3.797; Lu DY, 2010, J CELL BIOCHEM, V110, P141, DOI 10.1002/jcb.22520; Lugo-Garcia L, 2007, EUR J PHARMACOL, V568, P54, DOI 10.1016/j.ejphar.2007.04.012; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Madeddu P, 2007, NAT CLIN PRACT NEPHR, V3, P208, DOI 10.1038/ncpneph0444; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Martins AH, 2008, CYTOM PART A, V73A, P361, DOI 10.1002/cyto.a.20519; Martins AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030755; McLaren FH, 2001, J NEUROIMMUNOL, V112, P35, DOI 10.1016/S0165-5728(00)00410-0; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nitsch RM, 1998, NEUROCHEM RES, V23, P807, DOI 10.1023/A:1022423813362; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; PURKISS J, 1991, J NEUROCHEM, V57, P1084, DOI 10.1111/j.1471-4159.1991.tb08262.x; Racchi M, 1998, BIOCHEM J, V330, P1271, DOI 10.1042/bj3301271; Raidoo DM, 1998, PHARMACOL THERAPEUT, V79, P105, DOI 10.1016/S0163-7258(98)00011-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reber BFX, 1996, PFLUG ARCH EUR J PHY, V432, P893, DOI 10.1007/s004240050213; Resende RR, 2008, INT J DEV NEUROSCI, V26, P763, DOI 10.1016/j.ijdevneu.2008.07.008; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Scemes E, 2003, J NEUROSCI, V23, P11444; Schwindt TT, 2011, J MOL NEUROSCI, V44, P141, DOI 10.1007/s12031-010-9417-y; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Ueno S, 2002, BRAIN RES PROTOC, V10, P95, DOI 10.1016/S1385-299X(02)00187-3; Ulrich H., 2011, CURR PROTOC STEM CEL, V2, p2D9; Ulrich H, 2012, STEM CELL REV REP, V8, P755, DOI 10.1007/s12015-012-9372-9; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Wang HB, 2005, J NEUROSCI, V25, P7986, DOI 10.1523/JNEUROSCI.2393-05.2005; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Yang WH, 2010, J CELL BIOCHEM, V109, P82, DOI 10.1002/jcb.22383; Zheng H, 2010, J NEUROSCI, V30, P8102, DOI 10.1523/JNEUROSCI.6069-09.2010	71	35	35	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44046	44061		10.1074/jbc.M112.407197	http://dx.doi.org/10.1074/jbc.M112.407197			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132855	hybrid, Green Published			2022-12-25	WOS:000312938600004
J	Blasco-Baque, V; Serino, M; Vergnes, JN; Riant, E; Loubieres, P; Arnal, JF; Gourdy, P; Sixou, M; Burcelin, R; Kemoun, P				Blasco-Baque, Vincent; Serino, Matteo; Vergnes, Jean-Noel; Riant, Elodie; Loubieres, Pascale; Arnal, Jean-Francois; Gourdy, Pierre; Sixou, Michel; Burcelin, Remy; Kemoun, Philippe			High-Fat Diet Induces Periodontitis in Mice through Lipopolysaccharides (LPS) Receptor Signaling: Protective Action of Estrogens	PLOS ONE			English	Article							INSULIN-RESISTANCE; GINGIVAL INFLAMMATION; METABOLIC-DISORDERS; INDUCED OBESITY; GUT MICROBIOTA; HEALTH; DISEASE; ENDOTOXEMIA; CELLS; SEX	Background: A fat-enriched diet favors the development of gram negative bacteria in the intestine which is linked to the occurrence of type 2 diabetes (T2D). Interestingly, some pathogenic gram negative bacteria are commonly associated with the development of periodontitis which, like T2D, is characterized by a chronic low-grade inflammation. Moreover, estrogens have been shown to regulate glucose homeostasis via an LPS receptor dependent immune-modulation. In this study, we evaluated whether diet-induced metabolic disease would favor the development of periodontitis in mice. In addition, the regulatory role of estrogens in this process was assessed. Methods: Four-week-old C57BL6/J WT and CD14 (part of the TLR-4 machinery for LPS-recognition) knock-out female mice were ovariectomised and subcutaneously implanted with pellets releasing either placebo or 17 beta-estradiol (E2). Mice were then fed with either a normal chow or a high-fat diet for four weeks. The development of diabetes was monitored by an intraperitoneal glucose-tolerance test and plasma insulin concentration while periodontitis was assessed by identification of pathogens, quantification of periodontal soft tissue inflammation and alveolar bone loss. Results: The fat-enriched diet increased the prevalence of periodontal pathogenic microbiota like Fusobacterium nucleatum and Prevotella intermedia, gingival inflammation and alveolar bone loss. E2 treatment prevented this effect and CD14 knockout mice resisted high-fat diet-induced periodontal defects. Conclusions/Significance: Our data show that mice fed with a diabetogenic diet developed defects and microflora of tooth supporting-tissues typically associated with periodontitis. Moreover, our results suggest a causal link between the activation of the LPS pathway on innate immunity by periodontal microbiota and HFD-induced periodontitis, a pathophysiological mechanism that could be targeted by estrogens.	[Blasco-Baque, Vincent; Serino, Matteo; Riant, Elodie; Loubieres, Pascale; Arnal, Jean-Francois; Gourdy, Pierre; Burcelin, Remy] Fac Med Toulouse, INSERM, F-31073 Toulouse, France; [Blasco-Baque, Vincent; Serino, Matteo; Riant, Elodie; Loubieres, Pascale; Arnal, Jean-Francois; Gourdy, Pierre; Burcelin, Remy] Univ Toulouse 3, UMR 1048, Inst Malad Metabol & Cardiovasc I2MC, F-31062 Toulouse, France; [Blasco-Baque, Vincent; Vergnes, Jean-Noel; Loubieres, Pascale; Sixou, Michel; Kemoun, Philippe] Univ Toulouse 3, Fac Chirurg Dent, LU 51, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Burcelin, R (corresponding author), Fac Med Toulouse, INSERM, U317, F-31073 Toulouse, France.	remy.burcelin@inserm.fr; philippe.kemoun@wanadoo.fr	ARNAL, Jean Francois/K-7004-2014; Vergnes, Jean-Noel/I-7688-2019; burcelin, remy/M-6013-2014; Blasco Baque, Vincent/AHA-9524-2022; Serino, Matteo/O-3310-2018	Vergnes, Jean-Noel/0000-0001-7322-6551; Serino, Matteo/0000-0003-4644-8532; KEMOUN, PHILIPPE/0000-0001-7373-2657; Blasco-Baque, Vincent/0000-0003-3012-8980; ARNAL, Jean Francois/0000-0003-2229-6300; Gourdy, Pierre/0000-0002-5362-3813	Societe Francaise d'Hypertension Arterielle; Societe Francophone de Diabete; European grant from the Framework program 7 [241913]	Societe Francaise d'Hypertension Arterielle; Societe Francophone de Diabete; European grant from the Framework program 7	This work was supported by grants from Societe Francaise d'Hypertension Arterielle and from the Societe Francophone de Diabete. Part of this work is supported by a European grant from the Framework program 7 (FlorinashNo 241913) to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Arnal J F, 2006, Ernst Schering Found Symp Proc, P69; Baser U, 2009, J PERIODONTOL, V80, P1983, DOI 10.1902/jop.2009.090076; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Blasco-Baque V, ANN CARDIOL ANGEIOL; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; Burcelin R, 2011, ACTA DIABETOL, V48, P257, DOI 10.1007/s00592-011-0333-6; Calippe B, 2008, J IMMUNOL, V180, P7980, DOI 10.4049/jimmunol.180.12.7980; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carrillo-de-Albornoz A, 2012, J CLIN PERIODONTOL, V39, P272, DOI 10.1111/j.1600-051X.2011.01800.x; Chan ECS, 2000, ORAL MICROBIOL IMMUN, V15, P1, DOI 10.1034/j.1399-302x.2000.150101.x; Corcoran MP, 2010, J ENDOCRINOL, V206, P217, DOI 10.1677/JOE-10-0057; Donahue RP, 1997, DIABETES CARE, V20, P1670, DOI 10.2337/diacare.20.11.1670; Feghali K, 2011, J PERIODONTAL RES, V46, P147, DOI 10.1111/j.1600-0765.2010.01311.x; Field CA, 2012, J PERIODONTAL RES, V47, P470, DOI 10.1111/j.1600-0765.2011.01455.x; Ford PJ, 2006, ORAL MICROBIOL IMMUN, V21, P206, DOI 10.1111/j.1399-302X.2006.00276.x; Gillgrass A, 2010, AM J REPROD IMMUNOL, V63, P299, DOI 10.1111/j.1600-0897.2009.00796.x; Giuca M R, 2009, Minerva Ginecol, V61, P13; GOYERT SM, 1988, SCIENCE, V239, P497, DOI 10.1126/science.2448876; Guan SM, 2011, FEMS IMMUNOL MED MIC, V62, P91, DOI 10.1111/j.1574-695X.2011.00789.x; Haas AN, 2009, J PERIODONTOL, V80, P1380, DOI 10.1902/jop.2009.090082; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Krejci CB, 2002, J AM DENT ASSOC, V133, P323, DOI 10.14219/jada.archive.2002.0171; Lakhssassi N, 2005, ORAL MICROBIOL IMMUN, V20, P244, DOI 10.1111/j.1399-302X.2005.00225.x; Lee HR, MOL ORAL MICROBIOL, V27, P109; Lenfant F, 2011, MATURITAS, V68, P165, DOI 10.1016/j.maturitas.2010.11.016; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Mascarenhas P, 2003, J CLIN PERIODONTOL, V30, P671, DOI 10.1034/j.1600-051X.2003.00055.x; Mirza BAQ, 2010, J PAK MED ASSOC, V60, P766; Munch IC, 2011, DIABETOLOGIA, V54, P757, DOI 10.1007/s00125-010-2023-2; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Oh TJ, 2002, J CLIN PERIODONTOL, V29, P400, DOI 10.1034/j.1600-051X.2002.290504.x; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Ren L, 2009, J CLIN PERIODONTOL, V36, P619, DOI 10.1111/j.1600-051X.2009.01436.x; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Robert AA, 2010, SAUDI MED J, V31, P1044; Sahingur SE, 2012, J PERIODONTOL, V83, P1069, DOI 10.1902/jop.2011.110522; Saito T, 2007, PERIODONTOL 2000, V43, P254, DOI 10.1111/j.1600-0757.2006.00186.x; Salvi GE, 1997, J PERIODONTOL, V68, P127, DOI 10.1902/jop.1997.68.2.127; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Serino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021184; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Takahashi K, 2001, J Int Acad Periodontol, V3, P104; Tarkkila L, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-10; Tew JG, 2012, J DENT RES, V91, P8, DOI 10.1177/0022034511407338; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wade-Gueye NM, 2010, ENDOCRINOLOGY, V151, P5103, DOI 10.1210/en.2010-0091; Wilensky A, 2005, J PERIODONTOL, V76, P1282, DOI 10.1902/jop.2005.76.8.1282; Willershausen B, 2004, EUR J MED RES, V9, P400	53	54	56	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48220	10.1371/journal.pone.0048220	http://dx.doi.org/10.1371/journal.pone.0048220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133617	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400026
J	Fredj, A; Pasquier, H; Demachy, I; Jonasson, G; Levy, B; Derrien, V; Bousmah, Y; Manoussaris, G; Wien, F; Ridard, J; Erard, M; Merola, F				Fredj, Asma; Pasquier, Helene; Demachy, Isabelle; Jonasson, Gabriella; Levy, Bernard; Derrien, Valerie; Bousmah, Yasmina; Manoussaris, Gallia; Wien, Frank; Ridard, Jacqueline; Erard, Marie; Merola, Fabienne			The Single T65S Mutation Generates Brighter Cyan Fluorescent Proteins with Increased Photostability and pH Insensitivity	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; CIS-TRANS PHOTOISOMERIZATION; RESONANCE ENERGY-TRANSFER; STRUCTURAL BASIS; CRYSTAL-STRUCTURES; SLOW EXCHANGE; LIVING CELLS; GREEN; CHROMOPHORE; DYNAMICS	Cyan fluorescent proteins (CFP) derived from Aequorea victoria GFP, carrying a tryptophan-based chromophore, are widely used as FRET donors in live cell fluorescence imaging experiments. Recently, several CFP variants with near-ultimate photophysical performances were obtained through a mix of site-directed and large scale random mutagenesis. To understand the structural bases of these improvements, we have studied more specifically the consequences of the single-site T65S mutation. We find that all CFP variants carrying the T65S mutation not only display an increased fluorescence quantum yield and a simpler fluorescence emission decay, but also show an improved pH stability and strongly reduced reversible photoswitching reactions. Most prominently, the Cerulean-T65S variant reaches performances nearly equivalent to those of mTurquoise, with QY = 0.84, an almost pure single exponential fluorescence decay and an outstanding stability in the acid pH range (pK(1/2) = 3.6). From the detailed examination of crystallographic structures of different CFPs and GFPs, we conclude that these improvements stem from a shift in the thermodynamic balance between two well defined configurations of the residue 65 hydroxyl. These two configurations differ in their relative stabilization of a rigid chromophore, as well as in relaying the effects of Glu222 protonation at acid pHs. Our results suggest a simple method to greatly improve numerous FRET reporters used in cell imaging, and bring novel insights into the general structure-photophysics relationships of fluorescent proteins.	[Fredj, Asma; Pasquier, Helene; Demachy, Isabelle; Jonasson, Gabriella; Levy, Bernard; Derrien, Valerie; Bousmah, Yasmina; Manoussaris, Gallia; Ridard, Jacqueline; Erard, Marie; Merola, Fabienne] Univ Paris 11, CNRS, Chim Phys Lab, F-91405 Orsay, France; [Wien, Frank] Synchrotron SOLEIL, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Merola, F (corresponding author), Univ Paris 11, CNRS, Chim Phys Lab, F-91405 Orsay, France.	fabienne.merola@u-psud.fr	ERARD, Marie/L-9089-2019; Wien, Frank/B-7846-2012; Erard, Marie/G-7478-2012; PASQUIER, HÃ©lÃne/A-3449-2013; Merola, Fabienne/A-1172-2012	ERARD, Marie/0000-0002-4063-365X; Wien, Frank/0000-0002-0752-8735; Erard, Marie/0000-0002-4063-365X; 	French Ministry of Education and Research [ED470]; Synchrotron SOLEIL [20110069]	French Ministry of Education and Research; Synchrotron SOLEIL	AF and GJ acknowledge doctoral funding from the French Ministry of Education and Research (ED470 Chimie Paris Sud). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Synchrotron SOLEIL for beamtime, under project No. 20110069, as well as Matthieu Refregiers, the DISCO beamline manager, for helpful discussions.	Abbandonato G, 2011, EUR BIOPHYS J BIOPHY, V40, P1205, DOI 10.1007/s00249-011-0742-z; Adam V, 2011, CHEM BIOL, V18, P1241, DOI 10.1016/j.chembiol.2011.08.007; Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Alvarez L, 2010, PHOTOCHEM PHOTOBIOL, V86, P55, DOI 10.1111/j.1751-1097.2009.00617.x; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Bae JH, 2003, J MOL BIOL, V328, P1071, DOI 10.1016/S0022-2836(03)00364-4; Balla T, 2009, TRENDS CELL BIOL, V19, P575, DOI 10.1016/j.tcb.2009.08.001; Bell-Upp P, 2011, BIOPHYS CHEM, V159, P217, DOI 10.1016/j.bpc.2011.06.016; Bizzarri R, 2010, J AM CHEM SOC, V132, P85, DOI 10.1021/ja9014953; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; COUPRIE ME, 1994, REV SCI INSTRUM, V65, P1485, DOI 10.1063/1.1144880; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Henderson JN, 2005, P NATL ACAD SCI USA, V102, P12712, DOI 10.1073/pnas.0502250102; Jain RK, 2004, P NATL ACAD SCI USA, V101, P111, DOI 10.1073/pnas.2534352100; Jonasson G, 2011, J CHEM THEORY COMPUT, V7, P1990, DOI 10.1021/ct200150r; Jung G, 2005, BIOPHYS J, V88, P1932, DOI 10.1529/biophysj.104.044412; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lelimousin M, 2009, BIOCHEMISTRY-US, V48, P10038, DOI 10.1021/bi901093w; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Lu SY, 2010, CLIN CANCER RES, V16, P3822, DOI 10.1158/1078-0432.CCR-10-1333; Luin S, 2009, J AM CHEM SOC, V131, P96, DOI 10.1021/ja804504b; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Meech SR, 2009, CHEM SOC REV, V38, P2922, DOI 10.1039/b820168b; MEROLA F, 1989, BIOCHEMISTRY-US, V28, P3383, DOI 10.1021/bi00434a038; Merola F, 2010, SPRINGER SER FLUORES, V8, P347, DOI 10.1007/978-3-642-04702-2_11; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson G, 2001, J CELL SCI, V114, P837; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Seifert MH, 2002, J AM CHEM SOC, V124, P7932, DOI 10.1021/ja0257725; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shinobu A, 2010, J AM CHEM SOC, V132, P11093, DOI 10.1021/ja1010652; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Tian Lin, 2008, Drug Discov Today Dis Models, V5, P27, DOI 10.1016/j.ddmod.2008.07.003; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valeur B, 2001, MOL FLUORESCENCE PRI, V2nd; Vallverdu G, 2010, PROTEINS, V78, P1040, DOI 10.1002/prot.22628; van Thor JJ, 2005, J BIOL CHEM, V280, P33652, DOI 10.1074/jbc.M505473200; van Thor JJ, 2005, J PHYS CHEM B, V109, P16099, DOI 10.1021/jp051315+; Villoing A, 2008, BIOCHEMISTRY-US, V47, P12483, DOI 10.1021/bi801400d; Voliani V, 2008, J PHYS CHEM B, V112, P10714, DOI 10.1021/jp802419h; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wien F, 2005, APPL SPECTROSC, V59, P1109, DOI 10.1366/0003702055012546; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zhang J, 2007, MOL BIOSYST, V3, P759, DOI 10.1039/b706628g	62	21	23	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e49149	10.1371/journal.pone.0049149	http://dx.doi.org/10.1371/journal.pone.0049149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133673	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400055
J	Molendijk, ML; Haffmans, JPM; Bus, BAA; Spinhoven, P; Penninx, BWJH; Prickaerts, J; Voshaar, RCO; Elzinga, BM				Molendijk, Marc L.; Haffmans, Judith P. M.; Bus, Boudewijn A. A.; Spinhoven, Philip; Penninx, Brenda W. J. H.; Prickaerts, Jos; Voshaar, Richard C. Oude; Elzinga, Bernet M.			Serum BDNF Concentrations Show Strong Seasonal Variation and Correlations with the Amount of Ambient Sunlight	PLOS ONE			English	Article							HIPPOCAMPAL DENDRITIC MORPHOLOGY; NEUROTROPHIC FACTOR; SEROTONIN TRANSPORTER; PHYSICAL-ACTIVITY; MESSENGER-RNA; BRAIN; PHOTOPERIOD; MOOD; TRANSCRIPTION; NETHERLANDS	Earlier findings show seasonality in processes and behaviors such as brain plasticity and depression that in part are regulated by Brain-Derived Neurotrophic Factor (BDNF). Based on this we investigated seasonal variation in serum BDNF concentrations in 2,851 persons who took part in the Netherlands Study of Depression and Anxiety (NESDA). Analyses by month of sampling (monthly n's >196) showed pronounced seasonal variation in serum BDNF concentrations (P<.0001) with increasing concentrations in the spring-summer period (standardized regression weight (beta) = 0.19, P<.0001) and decreasing concentrations in the autumn-winter period (beta = -0.17, P<.0001). Effect sizes [Cohen's d] ranged from 0.27 to 0.66 for monthly significant differences. We found similar seasonal variation for both sexes and for persons with a DSM-IV depression diagnosis and healthy control subjects. In explorative analyses we found that the number of sunshine hours (a major trigger to entrain seasonality) in the week of blood withdrawal and the 10 weeks prior to this event positively correlated with serum BDNF concentrations (Pearson's correlation coefficients ranged: 0.05 - 0.18) and this could partly explain the observed monthly variation. These results provide strong evidence that serum BDNF concentrations systematically vary over the year. This finding is important for our understanding of those factors that regulate BDNF expression and may provide novel avenues to understand seasonal dependent changes in behavior and illness such as depression. Finally, the findings reported here should be taken into account when designing and interpreting studies on BDNF.	[Molendijk, Marc L.; Haffmans, Judith P. M.; Spinhoven, Philip; Elzinga, Bernet M.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Molendijk, Marc L.; Spinhoven, Philip; Elzinga, Bernet M.] Leiden Univ, Med Ctr, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Haffmans, Judith P. M.] Parnassia BAVO Grp, Dept Affect Disorders, PsyQ, The Hague, Netherlands; [Bus, Boudewijn A. A.] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Spinhoven, Philip; Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W. J. H.] VU, EMGO Inst & Neurosci Campus Amsterdam, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.; Voshaar, Richard C. Oude] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands; [Prickaerts, Jos] Maastricht Univ, Dept Psychiat & Neuropsychol, Maastricht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Parnassia Psychiatric Institute; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; University of Groningen; Maastricht University	Molendijk, ML (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	molendijkml@fsw.leidenuniv.nl	Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672; Oude Voshaar, Richard/0000-0003-1501-4774	Geestkracht program of ZonMW; Dutch Scientific Organization-Medical Sciences [10.000.1002]; GGZ Buitenamstel; GGZ Drenthe; GGZ Friesland; GGZ Geestgronden; GGZ Rivierduinen; Lentis; Leiden University Medical Center; University Medical Center Groningen; VU University Medical Center; Netherlands Organisation for Scientific Research (NWO: Dutch Scientific Organization) VIDI-grant [016.085.353]; NWO [907.0023.1]	Geestkracht program of ZonMW; Dutch Scientific Organization-Medical Sciences(Netherlands Organization for Scientific Research (NWO)); GGZ Buitenamstel; GGZ Drenthe; GGZ Friesland; GGZ Geestgronden; GGZ Rivierduinen; Lentis; Leiden University Medical Center; University Medical Center Groningen; VU University Medical Center; Netherlands Organisation for Scientific Research (NWO: Dutch Scientific Organization) VIDI-grant; NWO(Netherlands Organization for Scientific Research (NWO))	The Netherlands Study of Depression and Anxiety study infrastructure is financed by the Geestkracht program of ZonMW, the Dutch Scientific Organization-Medical Sciences (Grant no. 10.000.1002) and by complementary funding from participating mental healthcare institutions (GGZ Buitenamstel, GGZ Drenthe, GGZ Friesland, GGZ Geestgronden, GGZ Rivierduinen and Lentis) and Universities (Leiden University Medical Center, University Medical Center Groningen and VU University Medical Center). Brain-Derived Neurotrophic Factor measurements were financed with Netherlands Organisation for Scientific Research (NWO: Dutch Scientific Organization) VIDI-grant no. 016.085.353 awarded to Dr. Elzinga. The contributions of Dr. Oude Voshaar and MD Bus were made possible by NWO Clinical Fellowship no. 907.0023.1 awarded to Dr. Oude Voshaar. None of the authors report potential (financial) conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; CARLSSON A, 1980, ACTA PSYCHIAT SCAND, V61, P75, DOI 10.1111/acps.1980.61.s280.75; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Conti AC, 2002, J NEUROSCI, V22, P3262, DOI 10.1523/JNEUROSCI.22-08-03262.2002; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Currie J, 2009, NEUROSCI LETT, V451, P152, DOI 10.1016/j.neulet.2008.12.043; Dawood T, 2007, MOL PSYCHIATR, V12, P981, DOI 10.1038/sj.mp.4002059; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Gonzalez MMC, 2008, P NATL ACAD SCI USA, V105, P4898, DOI 10.1073/pnas.0703615105; GORDON DJ, 1987, CIRCULATION, V76, P1224, DOI 10.1161/01.CIR.76.6.1224; Hanna GL, 1998, NEUROPSYCHOPHARMACOL, V18, P102, DOI 10.1016/S0893-133X(97)00097-3; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Karpova NN, 2010, CELL MOL NEUROBIOL, V30, P1117, DOI 10.1007/s10571-010-9544-6; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P823; Klein AB, 2010, INT J NEUROPSYCHOPH, V7, P1; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Lieverse R, 2011, ARCH GEN PSYCHIAT, V68, P61, DOI 10.1001/archgenpsychiatry.2010.183; Lu B, 2000, PROG BRAIN RES, V128, P231; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Luykx JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030497; Ma Y, 2006, EUR J CLIN NUTR, V60, P519, DOI 10.1038/sj.ejcn.1602346; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Neumeister A, 2000, BIOL PSYCHIAT, V47, P158, DOI 10.1016/S0006-3223(99)00241-3; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pillai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039358; Postolache TT, 2010, J AFFECT DISORDERS, V121, P88, DOI 10.1016/j.jad.2009.05.015; Praschak-Rieder N, 2008, ARCH GEN PSYCHIAT, V65, P1072, DOI 10.1001/archpsyc.65.9.1072; Prendergast BJ, 2008, J NEUROENDOCRINOL, V20, P261, DOI 10.1111/j.1365-2826.2007.01633.x; Pyter LM, 2006, BEHAV NEUROSCI, V120, P125, DOI 10.1037/0735-7044.120.1.125; Pyter LM, 2005, J NEUROSCI, V25, P4521, DOI 10.1523/JNEUROSCI.0795-05.2005; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; SARRIAS MJ, 1989, BIOL PSYCHIAT, V26, P695, DOI 10.1016/0006-3223(89)90104-2; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Sharp T, 2011, CURR OPIN PHARMACOL, V11, P45, DOI 10.1016/j.coph.2011.02.003; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Walton JC, 2011, FRONT NEUROENDOCRIN, V32, P303, DOI 10.1016/j.yfrne.2010.12.003; WEHR TA, 1989, AM J PSYCHIAT, V146, P829; Winthorst WH, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-198; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Workman JL, 2009, EUR J NEUROSCI, V29, P161, DOI 10.1111/j.1460-9568.2008.06570.x; World Meteorological Organization (WMO), 1996, GUID MET INSTR METH; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676	56	53	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48046	10.1371/journal.pone.0048046	http://dx.doi.org/10.1371/journal.pone.0048046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032GO	23133609	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400020
J	Zafra, O; Lamprecht-Grandio, M; de Figueras, CG; Gonzalez-Pastor, JE				Zafra, Olga; Lamprecht-Grandio, Maria; Gonzalez de Figueras, Carolina; Eduardo Gonzalez-Pastor, Jose			Extracellular DNA Release by Undomesticated Bacillus subtilis Is Regulated by Early Competence	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; NATURAL TRANSFORMATION; OLIGOPEPTIDE PERMEASE; NEISSERIA-GONORRHOEAE; BIOFILM FORMATION; QUORUM RESPONSE; CHROMOSOMAL DNA; SIGMA-FACTOR; IDENTIFICATION; SPORULATION	Extracellular DNA (eDNA) release is a widespread capacity described in many microorganisms. We identified and characterized lysis-independent eDNA production in an undomesticated strain of Bacillus subtilis. DNA fragments are released during a short time in late-exponential phase. The released eDNA corresponds to whole genome DNA, and does not harbour mutations suggesting that is not the result of error prone DNA synthesis. The absence of eDNA was linked to a spread colony morphology, which allowed a visual screening of a transposon library to search for genes involved in its production. Transposon insertions in genes related to quorum sensing and competence (oppA, oppF and comXP) and to DNA metabolism (mfd and topA) were impaired in eDNA release. Mutants in early competence genes such as comA and srfAA were also defective in eDNA while in contrast mutations in late competence genes as those for the DNA uptake machinery had no effect. A subpopulation of cells containing more DNA is present in the eDNA producing strains but absent from the eDNA defective strain. Finally, competent B. subtilis cells can be transformed by eDNA suggesting it could be used in horizontal gene transfer and providing a rationale for the molecular link between eDNA release and early-competence in B. subtilis that we report.	[Zafra, Olga; Lamprecht-Grandio, Maria; Gonzalez de Figueras, Carolina; Eduardo Gonzalez-Pastor, Jose] Ctr Astrobiol INTA CSIC, Dept Mol Evolut, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Gonzalez-Pastor, JE (corresponding author), Ctr Astrobiol INTA CSIC, Dept Mol Evolut, Madrid, Spain.	gonzalezpje@cab.inta-csic.es	Zafra, Olga/K-8110-2014; González-Pastor, José/I-2118-2015	Zafra, Olga/0000-0002-2379-3184; González-Pastor, José/0000-0002-7615-7042; Gonzalez de Figueras, Carolina/0000-0002-7867-2419	Metagenome of the Iberian Peninsula, CONSOLIDER project (Spain government funding) [CSD200700005]; Rafael Calvo Rodes fellowship from INTA	Metagenome of the Iberian Peninsula, CONSOLIDER project (Spain government funding); Rafael Calvo Rodes fellowship from INTA	Funding was provided by the Metagenome of the Iberian Peninsula, CONSOLIDER project (Spain government funding), reference: CSD200700005. M.L. was supported by a Rafael Calvo Rodes fellowship from INTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auchtung JM, 2006, J BACTERIOL, V188, P5273, DOI 10.1128/JB.00300-06; Averhoff B, 2003, ARCH MICROBIOL, V180, P385, DOI 10.1007/s00203-003-0616-6; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Bongiorni C, 2005, J BACTERIOL, V187, P4353, DOI 10.1128/JB.187.13.4353-4361.2005; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Carrolo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015678; CATLIN BW, 1960, J BACTERIOL, V79, P579, DOI 10.1128/JB.79.4.579-590.1960; Chung YS, 1998, J BACTERIOL, V180, P41, DOI 10.1128/JB.180.1.41-45.1998; Comella N, 2005, MOL MICROBIOL, V57, P1159, DOI 10.1111/j.1365-2958.2005.04749.x; Cosby WM, 1998, J BACTERIOL, V180, P1438, DOI 10.1128/JB.180.6.1438-1445.1998; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Draghi JA, 2006, MICROBIOL-SGM, V152, P2683, DOI 10.1099/mic.0.29013-0; DSOUZA C, 1994, P NATL ACAD SCI USA, V91, P9397, DOI 10.1073/pnas.91.20.9397; Gonzalez-Pastor JE, 2011, FEMS MICROBIOL REV, V35, P415, DOI 10.1111/j.1574-6976.2010.00253.x; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; FREESE E, 1979, J GEN MICROBIOL, V115, P193, DOI 10.1099/00221287-115-1-193; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hamze K, 2009, MICROBIOL-SGM, V155, P398, DOI 10.1099/mic.0.021477-0; Harwood C.R., 1990, MOL BIOL METHODS BAC; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lanigan-Gerdes S, 2007, MOL MICROBIOL, V65, P1321, DOI 10.1111/j.1365-2958.2007.05869.x; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; LORENZ MG, 1991, ARCH MICROBIOL, V156, P319, DOI 10.1007/BF00263005; Margot P, 1999, MICROBIOL-SGM, V145, P57, DOI 10.1099/13500872-145-1-57; MICHOD RE, 1988, GENETICS, V118, P31; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Ogura M, 2010, MOL MICROBIOL, V75, P1244, DOI 10.1111/j.1365-2958.2010.07047.x; PAUL JH, 1987, APPL ENVIRON MICROB, V53, P170, DOI 10.1128/AEM.53.1.170-179.1987; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; ROGGIANI M, 1990, J BACTERIOL, V172, P4056, DOI 10.1128/jb.172.7.4056-4063.1990; Sambrook J, 2001, MOL CLONING LAB MANU; Schreiber F, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-111; Shingaki R, 2003, CAN J MICROBIOL, V49, P313, DOI 10.1139/W03-041; Soler N, 2008, RES MICROBIOL, V159, P390, DOI 10.1016/j.resmic.2008.04.015; Solomon J, 2003, J BACTERIOL, V185, P6425, DOI 10.1128/JB.185.21.6425-6433.2003; SOLOMON JM, 1995, GENE DEV, V9, P547, DOI 10.1101/gad.9.5.547; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Spizizen J, 1965, ANALYSIS ASPOROGENIC; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Steinmoen H, 2003, J BACTERIOL, V185, P7176, DOI 10.1128/JB.185.24.7176-7183.2003; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; STEWART GJ, 1983, J BACTERIOL, V156, P30, DOI 10.1128/JB.156.1.30-35.1983; TAKAHASHI I, 1962, BIOCHEM BIOPH RES CO, V7, P467, DOI 10.1016/0006-291X(62)90337-6; Tani K, 2010, NUCLEIC ACIDS MOL BI, V25, P25, DOI 10.1007/978-3-642-12617-8_3; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WEINRAUCH Y, 1990, GENE DEV, V4, P860, DOI 10.1101/gad.4.5.860; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WOJCIECHOWSKI MF, 1989, GENETICS, V121, P411; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x	70	52	54	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48716	10.1371/journal.pone.0048716	http://dx.doi.org/10.1371/journal.pone.0048716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133654	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400044
J	Liu, QP				Liu, Qingpo			Mutational Bias and Translational Selection Shaping the Codon Usage Pattern of Tissue-Specific Genes in Rice	PLOS ONE			English	Article							EXPRESSION PATTERN; HOUSEKEEPING GENES; ARABIDOPSIS; ADAPTATION; EVOLUTION; GENOME	The regulatory mechanisms of determining which genes specifically expressed in which tissues are still not fully elucidated, especially in plants. Using internal correspondence analysis, I first establish that tissue-specific genes exhibit significantly different synonymous codon usage in rice, although this effect is weak. The variability of synonymous codon usage between tissues accounts for 5.62% of the total codon usage variability, which has mainly arisen from the neutral evolutionary forces, such as GC content variation among tissues. Moreover, tissue-specific genes are under differential selective constraints, inferring that natural selection also contributes to the codon usage divergence between tissues. These findings may add further evidence in understanding the differentiation and regulation of tissue-specific gene products in plants.	Zhejiang A&F Univ, Coll Agr & Food Sci, Linan, Peoples R China	Zhejiang A&F University	Liu, QP (corresponding author), Zhejiang A&F Univ, Coll Agr & Food Sci, Linan, Peoples R China.	liuqp@zafu.edu.cn	Liu, Qingpo/L-8271-2019		National Natural Science Foundation of China [31000170]; Zhejiang Provincial Natural Science Foundation of China [Y3090152]; Zhejiang A F University [2010FR060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang A F University	This work was financially supported by grants from the National Natural Science Foundation of China (31000170), Zhejiang Provincial Natural Science Foundation of China (Y3090152), and the intramural fund from Zhejiang A & F University to Q. Liu (No. 2010FR060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BULMER M, 1991, GENETICS, V129, P897; Casez P, 1988, REV STAT APPL, V36, P39; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li MN, 2007, PLANT PHYSIOL, V144, P1797, DOI 10.1104/pp.107.101600; Liu QP, 2004, PLANT SCI, V167, P101, DOI 10.1016/j.plantsci.2004.03.003; Lobry JR, 2003, J APPL GENET, V44, P235; Milnthorpe AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032966; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Mukhopadhyay P, 2008, DNA RES, V15, P347, DOI 10.1093/dnares/dsn023; Peden J, 1999, THESIS U NOTTINGHAM, P50; Perriere G, 2002, NUCLEIC ACIDS RES, V30, P4548, DOI 10.1093/nar/gkf565; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; Qiu S, 2011, MOL BIOL EVOL, V28, P771, DOI 10.1093/molbev/msq251; R Development Core Team, 2003, R LANG ENV STAT COMP; Semon M, 2006, MOL BIOL EVOL, V23, P523, DOI 10.1093/molbev/msj053; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Wang YP, 2006, NUCLEIC ACIDS RES, V34, pW492, DOI 10.1093/nar/gkl067; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	33	97	103	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48295	10.1371/journal.pone.0048295	http://dx.doi.org/10.1371/journal.pone.0048295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144748	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705300058
J	Marsh, L; Copley, JT; Huvenne, VAI; Linse, K; Reid, WDK; Rogers, AD; Sweeting, CJ; Tyler, PA				Marsh, Leigh; Copley, Jonathan T.; Huvenne, Veerle A. I.; Linse, Katrin; Reid, William D. K.; Rogers, Alex D.; Sweeting, Christopher J.; Tyler, Paul A.			Microdistribution of Faunal Assemblages at Deep-Sea Hydrothermal Vents in the Southern Ocean	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; FUCA RIDGE; COMMUNITY STRUCTURE; MUSSEL COMMUNITIES; EPIBIOTIC BACTERIA; THERMAL TOLERANCES; HABITAT SELECTION; MASSIVE SULFIDES; DECADAL-SCALE; BIOGEOGRAPHY	Chemosynthetic primary production by microbes supports abundant faunal assemblages at deep-sea hydrothermal vents, with zonation of invertebrate species typically occurring along physico-chemical gradients. Recently discovered vent fields on the East Scotia Ridge (ESR) in the Southern Ocean represent a new province of vent biogeography, but the spatial dynamics of their distinct fauna have yet to be elucidated. This study determines patterns of faunal zonation, species associations, and relationships between faunal microdistribution and hydrothermal activity in a vent field at a depth of 2,400 m on the ESR. Remotely operated vehicle (ROV) dives obtained high-definition imagery of three chimney structures with varying levels of hydrothermal activity, and a mosaic image of > 250 m(2) of seafloor co-registered with temperature measurements. Analysis of faunal microdistribution within the mosaiced seafloor reveals a consistent pattern of faunal zonation with increasing distance from vent sources and peak temperatures. Assemblages closest to vent sources are visibly dominated by a new species of anomuran crab, Kiwa n. sp. (abundance > 700 individuals m(-2)), followed by a peltospiroid gastropod (> 1,500 individuals m(-2)), eolepadid barnacle (> 1,500 individuals m(-2)), and carnivorous actinostolid anemone (> 30 individuals m(-2)). Peripheral fauna are not dominated by a single taxon, but include predatory and scavenger taxa such as stichasterid seastars, pycnogonids and octopus. Variation in faunal microdistribution on chimneys with differing levels of activity suggests a possible successional sequence for vent fauna in this new biogeographic province. An increase in delta S-34 values of primary consumers with distance from vent sources, and variation in their delta C-13 values also indicate possible zonation of nutritional modes of the vent fauna. By using ROV videography to obtain a high-resolution representation of a vent environment over a greater extent than previous studies, these results provide a baseline for determining temporal change and investigations of processes structuring faunal assemblages at Southern Ocean vents.	[Marsh, Leigh; Copley, Jonathan T.; Tyler, Paul A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Huvenne, Veerle A. I.] Natl Oceanog Ctr Southampton, Nat Environm Res Council, Southampton, Hants, England; [Linse, Katrin] British Antarctic Survey, Cambridge CB3 0ET, England; [Reid, William D. K.; Sweeting, Christopher J.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rogers, Alex D.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	NERC National Oceanography Centre; University of Southampton; NERC National Oceanography Centre; University of Southampton; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Newcastle University - UK; University of Oxford	Marsh, L (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	leigh.marsh@noc.soton.ac.uk	Copley, Jon/I-7076-2012; Marsh, Leigh/AAT-5597-2020; Marsh, Leigh/J-6068-2013; Reid, William/J-8528-2013	Copley, Jon/0000-0003-3333-4325; Marsh, Leigh/0000-0002-4613-1538; Marsh, Leigh/0000-0002-4613-1538; Linse, Katrin/0000-0003-3477-3047; Huvenne, Veerle A.I./0000-0001-7135-6360; Reid, William/0000-0003-0190-0425	Natural Environment Research Council NERC Consortium Grant [NE/DO1249X/1]; Census of Marine Life; Sloan Foundation; NERC PhD studentships [NE/D01429X/1, NE/F010664/1]; NERC [NE/D01249X/1, NE/D013437/1, bas0100026, noc010004, NE/D010470/2, noc010009, noc010011] Funding Source: UKRI; Natural Environment Research Council [NE/D010470/2, bas0100026, noc010011, NE/D013437/1, noc010009, NE/D01249X/1, noc010004] Funding Source: researchfish	Natural Environment Research Council NERC Consortium Grant; Census of Marine Life; Sloan Foundation(Alfred P. Sloan Foundation); NERC PhD studentships; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The ChEsSo research programme was funded by a Natural Environment Research Council NERC Consortium Grant (NE/DO1249X/1) and supported by the Census of Marine Life and the Sloan Foundation, all of which are gratefully acknowledged. The authors also acknowledge NERC PhD studentships NE/D01429X/1(LM) and NE/F010664/1 (WDKR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Keiji, 1998, Zoosystema, V20, P143; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Bates AE, 2005, MAR ECOL PROG SER, V305, P1, DOI 10.3354/meps305001; Bergquist DC, 2007, MAR ECOL PROG SER, V330, P49, DOI 10.3354/meps330049; CHEVALDONNE P, 1993, MAR ECOL PROG SER, V95, P251, DOI 10.3354/meps095251; Colaco A, 2002, DEEP-SEA RES PT I, V49, P395, DOI 10.1016/S0967-0637(01)00060-7; Connelly DP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1636; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P859, DOI 10.1017/S0025315407056512; Copley JTP, 1997, MAR BIOL, V129, P723, DOI 10.1007/s002270050215; Cuvelier D, 2011, LIMNOL OCEANOGR, V56, P1624, DOI 10.4319/lo.2011.56.5.1624; Cuvelier D, 2009, DEEP-SEA RES PT I, V56, P2026, DOI 10.1016/j.dsr.2009.06.006; De Busserolles F, 2009, DEEP-SEA RES PT II, V56, P1649, DOI 10.1016/j.dsr2.2009.05.011; Desbruyeres D, 2001, DEEP-SEA RES PT I, V48, P1325, DOI 10.1016/S0967-0637(00)00083-2; Desbruyeres D, 2000, HYDROBIOLOGIA, V440, P201, DOI 10.1023/A:1004175211848; Dreyer JC, 2005, MAR ECOL PROG SER, V302, P121, DOI 10.3354/meps302121; Duperron S, 2010, TOP GEOBIOL, V33, P137, DOI 10.1007/978-90-481-9572-5_6; Erickson KL, 2009, DEEP-SEA RES PT II, V56, P1577, DOI 10.1016/j.dsr2.2009.05.002; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; FISHER CR, 1988, DEEP-SEA RES, V35, P1769, DOI 10.1016/0198-0149(88)90049-0; FRY B, 1983, NATURE, V306, P51, DOI 10.1038/306051a0; Garabato ACN, 2002, DEEP-SEA RES PT II, V49, P4715, DOI 10.1016/S0967-0645(02)00156-X; Gaudron SM, 2012, MAR ENVIRON RES, V77, P129, DOI 10.1016/j.marenvres.2012.03.005; Gebruk A, 2010, CAH BIOL MAR, V51, P383; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; Govenar B, 2010, TOP GEOBIOL, V33, P403, DOI 10.1007/978-90-481-9572-5_13; Govenar BW, 2002, CAH BIOL MAR, V43, P247; Guri M, 2012, ISME J, V6, P597, DOI 10.1038/ismej.2011.133; Hall S, 2011, POLAR BIOL, V34, P363, DOI 10.1007/s00300-010-0890-0; Hashimoto J, 2001, ZOOL SCI, V18, P717, DOI 10.2108/zsj.18.717; Henry MS, 2008, DEEP-SEA RES PT I, V55, P679, DOI 10.1016/j.dsr.2008.02.001; Hessler R., 1985, B BIOL SOC WASH, V6, P411; Hessler R.R., 1983, NATO Conference Series IV Marine Sciences, V12, P735; HESSLER RR, 1988, DEEP-SEA RES, V35, P1681, DOI 10.1016/0198-0149(88)90044-1; JANNASCH HW, 1979, BIOSCIENCE, V29, P592, DOI 10.2307/1307765; JOHNSON KS, 1994, DEEP-SEA RES PT I, V41, P993, DOI 10.1016/0967-0637(94)90015-9; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1711, DOI 10.1016/0198-0149(88)90045-3; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1723, DOI 10.1016/0198-0149(88)90046-5; Lee RW, 2003, BIOL BULL-US, V205, P98, DOI 10.2307/1543230; Lenihan HS, 2008, DEEP-SEA RES PT I, V55, P1707, DOI 10.1016/j.dsr.2008.07.007; Levesque C, 2003, MAR ECOL PROG SER, V246, P173, DOI 10.3354/meps246173; Livermore R, 1997, EARTH PLANET SC LETT, V150, P261, DOI 10.1016/S0012-821X(97)00074-5; Lopez-Gonzalez P, 2006, DENSIA, V18, P65; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Lutz RA, 2008, J SHELLFISH RES, V27, P177, DOI 10.2983/0730-8000(2008)27[177:IBVFCT]2.0.CO;2; Macpherson E, 2005, ZOOSYSTEMA, V27, P709; Matabos M, 2008, J MAR BIOL ASSOC UK, V88, P995, DOI 10.1017/S002531540800163X; Micheli F, 2002, ECOL MONOGR, V72, P365, DOI 10.1890/0012-9615(2002)072[0365:PSCADS]2.0.CO;2; Mills SW, 2007, BIOL BULL-US, V212, P185, DOI 10.2307/25066601; Miyake H, 2007, MAR ECOL-EVOL PERSP, V28, P86, DOI 10.1111/j.1439-0485.2006.00115.x; Mullineaux LS, 2000, OECOLOGIA, V123, P275, DOI 10.1007/s004420051014; Mullineaux LS, 2003, ECOL MONOGR, V73, P523, DOI 10.1890/02-0674; Nakamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032965; Nye V, 2012, J MAR BIOL ASSOC UK, V92, P1057, DOI 10.1017/S0025315411002001; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Petersen J. E., 2009, P1; Podowski EL, 2010, MAR ECOL PROG SER, V418, P25, DOI 10.3354/meps08797; Podowski EL, 2009, DEEP-SEA RES PT I, V56, P2041, DOI 10.1016/j.dsr.2009.07.002; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Raso JEG, 2008, POLAR BIOL, V31, P1281, DOI 10.1007/s00300-008-0476-2; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; RONA PA, 1986, NATURE, V321, P33, DOI 10.1038/321033a0; Sarradin PM, 1998, CAH BIOL MAR, V39, P159; Sarradin PM, 1999, CAH BIOL MAR, V40, P93; Sarrazin J, 1999, MAR ECOL PROG SER, V190, P89, DOI 10.3354/meps190089; Sarrazin J, 1997, MAR ECOL PROG SER, V153, P5, DOI 10.3354/meps153005; Sarrazin J, 1999, MAR ECOL PROG SER, V185, P1, DOI 10.3354/meps185001; Sarrazin J, 2006, CAH BIOL MAR, V47, P483; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Southward AJ, 1998, CAH BIOL MAR, V39, P259; Suzuki Y, 2006, MAR ECOL PROG SER, V315, P167, DOI 10.3354/meps315167; Suzuki Y, 2009, J MAR BIOL ASSOC UK, V89, P727, DOI 10.1017/S0025315409000459; Thatje S, 2004, POLAR BIOL, V27, P195, DOI 10.1007/s00300-003-0583-z; Thurber AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026243; TIVEY MK, 1990, NATURE, V346, P51, DOI 10.1038/346051a0; Tokeshi M, 2011, J OCEANOGR, V67, P651, DOI 10.1007/s10872-011-0065-9; Tsuchida S, 2011, J MAR BIOL ASSOC UK, V91, P23, DOI 10.1017/S0025315410001827; Tsurumi M, 2003, DEEP-SEA RES PT I, V50, P611, DOI 10.1016/S0967-0637(03)00039-6; Tsurumi M, 2001, CAN J FISH AQUAT SCI, V58, P530, DOI 10.1139/cjfas-58-3-530; Tunnicliffe V, 2004, J MAR BIOL ASSOC UK, V84, P121, DOI 10.1017/S0025315404008987h; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Tyler PA, 2002, OCEANOL ACTA, V25, P227, DOI 10.1016/S0399-1784(02)01202-1; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Urcuyo IA, 2003, DEEP-SEA RES PT I, V50, P763, DOI 10.1016/S0967-0637(03)00061-X; Van Dover CL, 2011, ICES J MAR SCI, V68, P341, DOI 10.1093/icesjms/fsq086; Van Dover CL, 2000, MAR ECOL PROG SER, V195, P169, DOI 10.3354/meps195169; Van Dover CL, 2004, J EXP MAR BIOL ECOL, V300, P273, DOI 10.1016/j.jembe.2003.12.024; Van Dover CL, 2003, MAR ECOL PROG SER, V253, P55, DOI 10.3354/meps253055; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Van Dover CL, 2002, MAR BIOL, V141, P761, DOI 10.1007/s00227-002-0865-y; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Watabe H, 2002, ZOOL SCI, V19, P1167, DOI 10.2108/zsj.19.1167; Watsuji T, 2010, MICROBES ENVIRON, V25, P288, DOI 10.1264/jsme2.ME10135; Wheeler AJ, 2011, INTERRIDGE NEWSLETTE, V20, P37; Wittmann A, 2010, POLAR BIOL, V33, P919, DOI 10.1007/s00300-010-0768-1; Yoerger DR, 2000, INT J ROBOT RES, V19, P1000, DOI 10.1177/02783640022067931	102	69	71	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48348	10.1371/journal.pone.0048348	http://dx.doi.org/10.1371/journal.pone.0048348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144754	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000310705300064
J	Martinelli, N; Traglia, M; Campostrini, N; Biino, G; Corbella, M; Sala, C; Busti, F; Masciullo, C; Manna, D; Previtali, S; Castagna, A; Pistis, G; Olivieri, O; Toniolo, D; Camaschella, C; Girelli, D				Martinelli, Nicola; Traglia, Michela; Campostrini, Natascia; Biino, Ginevra; Corbella, Michela; Sala, Cinzia; Busti, Fabiana; Masciullo, Corrado; Manna, Daniele; Previtali, Sara; Castagna, Annalisa; Pistis, Giorgio; Olivieri, Oliviero; Toniolo, Daniela; Camaschella, Clara; Girelli, Domenico			Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study	PLOS ONE			English	Article							IRON OVERLOAD SYNDROME; BODY IRON; TRANSFERRIN SATURATION; INSULIN-RESISTANCE; FATTY LIVER; EXPRESSION; FERRITIN; ATHEROSCLEROSIS; ASSOCIATION; PREVALENCE	The recent discovery of hepcidin, the key iron regulatory hormone, has changed our view of iron metabolism, which in turn is long known to be linked with insulin resistant states, including type 2 diabetes mellitus and the Metabolic Syndrome (MetS). Serum ferritin levels are often elevated in MetS (Dysmetabolic hyperferritinemia - DHF), and are sometimes associated with a true mild-to-moderate hepatic iron overload (dysmetabolic iron overload syndrome - DIOS). However, the pathophysiological link between iron and MetS remains unclear. This study was aimed to investigate, for the first time, the relationship between MetS and hepcidin at population level. We measured serum hepcidin levels by Mass Spectrometry in 1,391 subjects from the Val Borbera population, and evaluated their relationship with classical MetS features. Hepcidin levels increased significantly and linearly with increasing number of MetS features, paralleling the trend of serum ferritin. In multivariate models adjusted for relevant variables including age, C-Reactive Protein, and the HFE C282Y mutation, ferritin was the only significant independent predictor of hepcidin in males, while in females MetS was also independently associated with hepcidin. Overall, these data indicate that the fundamental iron regulatory feedback is preserved in MetS, i.e. that hepcidin tends to progressively increase in response to the increase of iron stores. Due to recently discovered pleiotropic effects of hepcidin, this may worsen insulin resistance and contribute to the cardiovascular complications of MetS.	[Martinelli, Nicola; Campostrini, Natascia; Corbella, Michela; Busti, Fabiana; Manna, Daniele; Castagna, Annalisa; Olivieri, Oliviero; Girelli, Domenico] Univ Verona, Dept Med, I-37100 Verona, Italy; [Traglia, Michela; Biino, Ginevra; Sala, Cinzia; Masciullo, Corrado; Pistis, Giorgio; Toniolo, Daniela; Camaschella, Clara] San Raffaele Res Inst, Div Genet & Cell Biol, Milan, Italy; [Previtali, Sara; Camaschella, Clara] Univ Vita Salute San Raffaele, Milan, Italy	University of Verona; Vita-Salute San Raffaele University	Girelli, D (corresponding author), Univ Verona, Dept Med, I-37100 Verona, Italy.	domenico.girelli@univr.it	Girelli, Domenico/B-1183-2008; Martinelli, Nicola/J-5622-2016; Busti, Fabiana/K-8863-2019; Toniolo, Daniela/AAE-2969-2019; Traglia, Michela/AAX-5816-2020; Camaschella, Clara/A-3289-2015; Biino, Ginevra/B-5334-2013; Sala, Cinzia Felicita/AAN-1900-2020; Olivieri, Oliviero/A-9126-2008	Girelli, Domenico/0000-0001-9684-1899; Martinelli, Nicola/0000-0001-6465-5119; Busti, Fabiana/0000-0003-4642-0230; Toniolo, Daniela/0000-0001-9545-6032; Biino, Ginevra/0000-0002-9936-946X; Olivieri, Oliviero/0000-0001-8209-9056; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Italian Ministry of University and Research [200989KXFN]; Fondazione Cariverona, project Verona Nanomedicine Initiative; Telethon Fondazione onlus [GGP08089]; Regione Lombardia [17389]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariverona, project Verona Nanomedicine Initiative(Fondazione Cariverona); Telethon Fondazione onlus(Fondazione Telethon); Regione Lombardia(Regione Lombardia)	This study was supported by the Italian Ministry of University and Research (grant no. 200989KXFN) and by Fondazione Cariverona, project Verona Nanomedicine Initiative to DG and Telethon Fondazione onlus (grant no. GGP08089) and Regione Lombardia Sal-11, ID 17389 to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002498; Adams PC, 2011, J HEPATOL, V55, P453, DOI 10.1016/j.jhep.2011.02.010; Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bozzini C, 2005, DIABETES CARE, V28, P2061, DOI 10.2337/diacare.28.8.2061; Castagna A, 2010, J PROTEOMICS, V73, P527, DOI 10.1016/j.jprot.2009.08.003; Chung B, 2007, J NUTR, V137, P2366, DOI 10.1093/jn/137.11.2366; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; del Giudice EM, 2009, J CLIN ENDOCR METAB, V94, P5102, DOI 10.1210/jc.2009-1361; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Jehn ML, 2007, AM J EPIDEMIOL, V165, P1047, DOI 10.1093/aje/kwk093; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Li JJ, 2012, ARTERIOSCL THROM VAS, V32, P1158, DOI 10.1161/ATVBAHA.112.246108; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; Riva A, 2008, WORLD J GASTROENTERO, V14, P4745, DOI 10.3748/wjg.14.4745; Ruivard M, 2009, J HEPATOL, V50, P1219, DOI 10.1016/j.jhep.2009.01.029; Saeed O, 2012, ARTERIOSCL THROM VAS, V32, P299, DOI 10.1161/ATVBAHA.111.240101; Sheu WHH, 2003, CLIN ENDOCRINOL, V58, P380, DOI 10.1046/j.1365-2265.2003.01729.x; Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061; Trombini P, 2011, LIVER INT, V31, P994, DOI 10.1111/j.1478-3231.2011.02520.x; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Valenti L, 2011, ARTERIOSCL THROM VAS, V31, P683, DOI 10.1161/ATVBAHA.110.214858; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; YOKOMORI N, 1991, ENDOCRINOLOGY, V128, P1474, DOI 10.1210/endo-128-3-1474	34	54	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48250	10.1371/journal.pone.0048250	http://dx.doi.org/10.1371/journal.pone.0048250			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144745	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300055
J	Nsoesie, EO; Beckman, RJ; Marathe, MV				Nsoesie, Elaine O.; Beckman, Richard J.; Marathe, Madhav V.			Sensitivity Analysis of an Individual-Based Model for Simulation of Influenza Epidemics	PLOS ONE			English	Article							PANDEMIC INFLUENZA; NETWORK STRUCTURE; A H1N1; SCHOOLCHILDREN; HETEROGENEITY; TRANSMISSION; STRATEGIES; SPREAD; LINE	Individual-based epidemiology models are increasingly used in the study of influenza epidemics. Several studies on influenza dynamics and evaluation of intervention measures have used the same incubation and infectious period distribution parameters based on the natural history of influenza. A sensitivity analysis evaluating the influence of slight changes to these parameters (in addition to the transmissibility) would be useful for future studies and real-time modeling during an influenza pandemic. In this study, we examined individual and joint effects of parameters and ranked parameters based on their influence on the dynamics of simulated epidemics. We also compared the sensitivity of the model across synthetic social networks for Montgomery County in Virginia and New York City (and surrounding metropolitan regions) with demographic and rural-urban differences. In addition, we studied the effects of changing the mean infectious period on age-specific epidemics. The research was performed from a public health standpoint using three relevant measures: time to peak, peak infected proportion and total attack rate. We also used statistical methods in the design and analysis of the experiments. The results showed that: (i) minute changes in the transmissibility and mean infectious period significantly influenced the attack rate; (ii) the mean of the incubation period distribution appeared to be sufficient for determining its effects on the dynamics of epidemics; (iii) the infectious period distribution had the strongest influence on the structure of the epidemic curves; (iv) the sensitivity of the individual-based model was consistent across social networks investigated in this study and (v) age-specific epidemics were sensitive to changes in the mean infectious period irrespective of the susceptibility of the other age groups. These findings suggest that small changes in some of the disease model parameters can significantly influence the uncertainty observed in real-time forecasting and predicting of the characteristics of an epidemic.	[Nsoesie, Elaine O.; Beckman, Richard J.; Marathe, Madhav V.] Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA; [Marathe, Madhav V.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nsoesie, EO (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA.	onelaine@vt.edu		Nsoesie, Elaine/0000-0001-9170-8714	National Science Foundation Netse Grant [CNS-1011769]; Defense Threat Reduction Agency (DTRA) RD Grant [HDTRA1-0901-0017]; DTRA Comprehensive National Incident Management System (CNIMS) Grant [HDTRA1-07-C-0113]; National Institutes of Health Models of Infectious Disease Study (MIDAS) project [2U01GM070694-7]; DTRA Rigorous Approaches for Validation and Verification of Networked Systems Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER	National Science Foundation Netse Grant; Defense Threat Reduction Agency (DTRA) RD Grant; DTRA Comprehensive National Incident Management System (CNIMS) Grant; National Institutes of Health Models of Infectious Disease Study (MIDAS) project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA Rigorous Approaches for Validation and Verification of Networked Systems Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been partially supported by National Science Foundation Netse Grant CNS-1011769, Defense Threat Reduction Agency (DTRA) R&D Grant HDTRA1-0901-0017, DTRA Comprehensive National Incident Management System (CNIMS) Grant HDTRA1-07-C-0113, National Institutes of Health Models of Infectious Disease Study (MIDAS) project 2U01GM070694-7 and DTRA Rigorous Approaches for Validation and Verification of Networked Systems Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett C, 2004, SIAM NEWS MATH NETWO; Barrett C, 2011, EPIDEMICS-NETH, V3, P19, DOI 10.1016/j.epidem.2010.11.002; Barrett CL, 2001, TECHNICAL REPORT; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Beckman R, 2008, 07043 NDSSL VBI VIRG; Beckman RJ, 1996, TRANSPORT RES A-POL, V30, P415, DOI 10.1016/0965-8564(96)00004-3; Bisset KR, 2009, ICS'09: PROCEEDINGS OF THE 2009 ACM SIGARCH INTERNATIONAL CONFERENCE ON SUPERCOMPUTING, P430, DOI 10.1145/1542275.1542336; Bowman J, 1998, P 8 WORLD C TRANS RE; Bowman JL, 2001, TRANSPORT RES A-POL, V35, P1, DOI 10.1016/S0965-8564(99)00043-9; Box GE., 1978, STAT EXPT; Burke DS, 2006, ACAD EMERG MED, V13, P1142, DOI 10.1111/j.1553-2712.2006.tb01638.x; Cacuci D.G., 2003, SENSITIVITY UNCERTAI; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chao DL, 2011, AM J EPIDEMIOL, V173, P1121, DOI 10.1093/aje/kwq497; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Eubank S., 2010, Journal of Biological Dynamics, V4, P446, DOI 10.1080/17513751003778687; Eubank S, 2004, NATURE; Frey HC, 2002, RISK ANAL, V22, P553; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ginot V, 2006, ECOLOGICAL MODELLING, V193; Goldstein E, 2010, J R SOC INTERFACE, V7, P755, DOI 10.1098/rsif.2009.0393; Halloran ME, 2008, P NATL ACAD SCI; HAMBY DM, 1995, HEALTH PHYS, V68, P195, DOI 10.1097/00004032-199502000-00005; Heath B, 2009, JASSS-J ARTIF SOC S, V12, pA143; Helton J. C., 2008, COMPUTATIONAL METHOD, P207; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Monto AS, 1969, B WORLD HEALTH ORGAN, V41, P53742; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nsoesie Elaine O, 2011, STAT COMMUNICATIONS, V3; Ohkusa Y, 2011, J INFECT CHEMOTHERAP; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Pautasso M, 2008, ECOL COMPLEX, V5, P1, DOI 10.1016/j.ecocom.2007.07.001; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Salathe M, 2010, P NATL ACAD SCI; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Speckman P, 1997, TRANSP RES BOARD 199; Yang Y, 2010, J AM STAT ASSOC, V105, P1310, DOI 10.1198/jasa.2010.ap09581	47	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e45414	10.1371/journal.pone.0045414	http://dx.doi.org/10.1371/journal.pone.0045414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032HH	23144693	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705300004
J	Conforti, F; Yang, AL; Piro, MC; Mellone, M; Terrinoni, A; Candi, E; Tucci, P; Thomas, GJ; Knight, RA; Melino, G; Sayan, BS				Conforti, F.; Yang, Ai Li; Piro, M. Cristina; Mellone, M.; Terrinoni, A.; Candi, E.; Tucci, P.; Thomas, G. J.; Knight, R. A.; Melino, G.; Sayan, B. S.			PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63	ONCOGENE			English	Article						PIR2; Rnf144B; p63; p21(WAF1); squamous cell carcinoma (SCC); skin	SQUAMOUS-CELL CARCINOMA; E3 UBIQUITIN LIGASE; STEM-CELLS; DIFFERENTIATION; PROTEASOME; APOPTOSIS; PROTEIN; CANCER; CYCLE; EXPRESSION	Delta Np63 is a transcription factor that is critical for the development of stratified epithelia and is overexpressed or amplified in >80% of squamous cell carcinomas (SCCs). We identified the RING finger E3 ubiquitin ligase PIR2/Rnf144b as a direct transcriptional target of Delta Np63 alpha and showed that its expression parallels that of Delta Np63 alpha in keratinocytes, SCC cell lines and SCCs. We used primary keratinocytes as a model system to investigate the function of PIR2/Rnf144b in stratified epithelia. Depletion of PIR2/Rnf144b severely impaired keratinocyte proliferation and differentiation, associated with accumulation of p21(WAF1/CIP1); a known target of PIR2/Rnf144b. More importantly, we found that PIR2/Rnf144b binds and mediates proteasomal degradation of Delta Np63 alpha, generating a hitherto unknown auto-regulatory feedback loop. These findings substantiate PIR2/Rnf144b as a potentially critical component of epithelial homeostasis, acting downstream of Delta Np63 alpha to regulate cellular levels of p21(WAF1/CIP1) and Delta Np63 alpha.	[Conforti, F.; Mellone, M.; Thomas, G. J.; Sayan, B. S.] Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO16 6YD, Hants, England; [Yang, Ai Li; Tucci, P.; Knight, R. A.; Melino, G.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England; [Piro, M. Cristina; Terrinoni, A.; Candi, E.; Tucci, P.; Melino, G.] Univ Roma Tor Vergata, Dept Expt Med & Surg, IDI IRCCS, Biochem Lab, Rome, Italy	University of Southampton; University of Leicester; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Rome Tor Vergata	Sayan, BS (corresponding author), Univ Southampton, Fac Med, Canc Sci Unit, Somers Canc Res Bldg,Tremona Rd,MP824, Southampton SO16 6YD, Hants, England.	b.s.sayan@soton.ac.uk	PIRO, MARIA CRISTINA/GVT-4380-2022; TERRINONI, Alessandro/J-1533-2012	PIRO, MARIA CRISTINA/0000-0003-3004-367X; TERRINONI, Alessandro/0000-0002-7442-2252; mellone, massimiliano/0000-0002-4964-9340; TUCCI, PAOLA/0000-0002-9349-5203	University of Southampton; Medical Research Council, UK; 'Alleanza contro il Cancro' [ACC12]; MIUR/PRIN [RBIP06LCA9_0023]; AIRC [2008-2010_33-08]; Italian Human ProteomeNet RBRN07BMCT; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	University of Southampton; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 'Alleanza contro il Cancro'; MIUR/PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Human ProteomeNet RBRN07BMCT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been supported by funding from the University of Southampton to BSS and by the Medical Research Council, UK; 'Alleanza contro il Cancro' (ACC12), MIUR/PRIN (RBIP06LCA9_0023), AIRC (2008-2010_33-08), Italian Human ProteomeNet RBRN07BMCT to GM.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Huang J, 2006, FEBS LETT, V580, P940, DOI 10.1016/j.febslet.2005.09.105; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Li YC, 2009, MOL CELL BIOL, V29, P3953, DOI 10.1128/MCB.00449-09; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ng CC, 2003, ONCOGENE, V22, P4449, DOI 10.1038/sj.onc.1206586; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; Ponassi R, 2006, BIOCHEM PHARMACOL, V72, P1417, DOI 10.1016/j.bcp.2006.07.031; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Sayan AE, 2007, ANN NY ACAD SCI, V1095, P315, DOI 10.1196/annals.1397.035; Sayan AE, 2010, BIOCHEM BIOPH RES CO, V394, P824, DOI 10.1016/j.bbrc.2010.03.084; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Schavolt KL, 2007, ONCOGENE, V26, P6125, DOI 10.1038/sj.onc.1210441; Sniezek JC, 2004, LARYNGOSCOPE, V114, P2063, DOI 10.1097/01.mlg.0000149437.35855.4b; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Taebunpakul P, 2012, APOPTOSIS, V17, P762, DOI 10.1007/s10495-012-0720-7; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Westra WH, 2009, HEAD NECK PATHOL, V3, P78, DOI 10.1007/s12105-009-0100-y; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	42	18	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 3	2013	32	40					4758	4765		10.1038/onc.2012.497	http://dx.doi.org/10.1038/onc.2012.497			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23128396				2022-12-25	WOS:000325274700004
J	Lee, JO; Lee, SK; Kim, JH; Kim, N; You, GY; Moon, JW; Kim, SJ; Park, SH; Kim, HS				Lee, Jung Ok; Lee, Soo Kyung; Kim, Ji Hae; Kim, Nami; You, Ga Young; Moon, Ji Wook; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo			Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; C-CBL; POTENTIAL ROLE; FATTY-ACID; INSULIN; ADIPOCYTES; CAP; CONTRACTION; DOMAIN	Metformin is a leading oral anti-diabetes mellitus medication and is known to stimulate GLUT4 translocation. However, the mechanism by which metformin acts is still largely unknown. Here, we showed that short time treatment with metformin rapidly increased phosphorylation of Cbl in an AMP-activated protein kinase (AMPK)-dependent fashion in 3T3-L1 preadipocytes. Metformin also increased phosphorylation of Src in an AMPK-dependent manner. Src inhibition blocked metformin-mediated Cbl phosphorylation, suggesting that metformin stimulates AMPK-Src-Cbl axis pathway. In addition, long term treatment with metformin stimulated the expression of Cbl-associated protein (CAP) mRNA and protein. Long term treatment with metformin stimulated phosphorylation of c-Jun N-terminal kinase (JNK) and its downstream molecule c-Jun, which is a critical molecule for CAP transcription. Knockdown of AMPK and JNK blocked metformin-induced expression of CAP, implying that metformin stimulates AMPK-JNK-CAP axis pathway. Moreover, AMPK knockdown attenuated metformin-induced Cbl/CAP multicomplex formation, which is critical for GLUT4 translocation. A colorimetric absorbance assay demonstrated that metformin-induced translocation of GLUT4 was suppressed in CAP or Cbl knockdown cells. Furthermore, the promoter activity of CAP was increased by metformin in an AMPK/JNK-dependent fashion. In summary, these results demonstrate that metformin modulates GLUT4 translocation by regulating Cbl and CAP signals via AMPK.	[Lee, Jung Ok; Lee, Soo Kyung; Kim, Ji Hae; Kim, Nami; You, Ga Young; Moon, Ji Wook; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, HS (corresponding author), 126-1 Anam Dong 5-Ga, Seoul 136705, South Korea.	anatomykim@korea.ac.kr			National Research Foundation of Korea; Korean Government [2010-0011053]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by the National Research Foundation of Korea funded by Korean Government Grant 2010-0011053.	Ai H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1291, DOI 10.1152/ajpendo.00167.2001; Alcazar O, 2004, BIOCHEM BIOPH RES CO, V317, P285, DOI 10.1016/j.bbrc.2004.03.038; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Barnes BR, 2005, CURR MOL MED, V5, P341, DOI 10.2174/1566524053766103; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Baumann CA, 2000, J BIOL CHEM, V275, P9131, DOI 10.1074/jbc.275.13.9131; BLAKE TJ, 1991, ONCOGENE, V6, P653; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; FISCHER Y, 1995, ENDOCRINOLOGY, V136, P412, DOI 10.1210/en.136.2.412; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kumar N, 2002, BRIT J PHARMACOL, V137, P329, DOI 10.1038/sj.bjp.0704878; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Liu J, 2003, J BIOL CHEM, V278, P36754, DOI 10.1074/jbc.M300664200; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; Longnus SL, 2005, DIABETOLOGIA, V48, P2591, DOI 10.1007/s00125-005-0016-3; Makinde AO, 1997, CIRC RES, V80, P482, DOI 10.1161/01.RES.80.4.482; Meuillet EJ, 1999, EUR J PHARMACOL, V377, P241, DOI 10.1016/S0014-2999(99)00386-6; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	37	77	83	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44121	44129		10.1074/jbc.M112.361386	http://dx.doi.org/10.1074/jbc.M112.361386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135276	hybrid, Green Published			2022-12-25	WOS:000312938600011
J	Tian, N; Leshchyns'ka, I; Welch, JH; Diakowski, W; Yang, HY; Schachner, M; Sytnyk, V				Tian, Nan; Leshchyns'ka, Iryna; Welch, Jeffrey H.; Diakowski, Witold; Yang, Hongyuan; Schachner, Melitta; Sytnyk, Vladimir			Lipid Raft-dependent Endocytosis of Close Homolog of Adhesion Molecule L1 (CHL1) Promotes Neuritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-SURFACE; DENDRITE ORIENTATION; NEURITE OUTGROWTH; MICE DEFICIENT; RPTP-ALPHA; SPECTRIN; NCAM; ASSOCIATION; COMPLEX; PHOSPHORYLATION	CHL1 plays a dual role by either promoting or inhibiting neuritogenesis. We report here that neuritogenesis-promoting ligand-dependent cell surface clustering of CHL1 induces palmitoylation and lipid raft-dependent endocytosis of CHL1. We identify beta II spectrin as a binding partner of CHL1, and we show that partial disruption of the complex between CHL1 and beta II spectrin accompanies CHL1 endocytosis. Inhibition of the association of CHL1 with lipid rafts by pharmacological disruption of lipid rafts or by mutation of cysteine 1102 within the intracellular domain of CHL1 reduces endocytosis of CHL1. Endocytosis of CHL1 is also reduced by nifedipine, an inhibitor of the L-type voltage-dependent Ca2+ channels. CHL1-dependent neurite outgrowth is reduced by inhibitors of lipid raft assembly, inhibitors of voltage-dependent Ca2+ channels, and overexpression of CHL1 with mutated cysteine Cys-1102. Our results suggest that ligand-induced and lipid raft-dependent regulation of CHL1 adhesion via Ca2+-dependent remodeling of the CHL1-beta II spectrin complex and CHL1 endocytosis are required for CHL1- dependent neurite outgrowth.	[Tian, Nan; Leshchyns'ka, Iryna; Schachner, Melitta; Sytnyk, Vladimir] Univ Krankenhaus Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Tian, Nan] Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China; [Diakowski, Witold] Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-51148 Wroclaw, Poland; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Leshchyns'ka, Iryna; Welch, Jeffrey H.; Yang, Hongyuan; Sytnyk, Vladimir] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of Hamburg; University Medical Center Hamburg-Eppendorf; Dalian Medical University; University of Wroclaw; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of New South Wales Sydney	Sytnyk, V (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	v.sytnyk@unsw.edu.au	Sytnyk, Vladimir/A-3878-2010; TIan, nan/GQP-1717-2022; Yang, Hongyuan/AAR-1326-2020	Yang, Hongyuan/0000-0002-8482-6031; Sytnyk, Vladimir/0000-0003-1927-2199; Leshchyns'ka, Iryna/0000-0002-2025-5831	Deutsche Forschungsgemeinschaft; Rebecca L. Cooper Medical Research Foundation; National Health and Medical Research Council; New Jersey Commission for Spinal Cord Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rebecca L. Cooper Medical Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); New Jersey Commission for Spinal Cord Research	This work was supported by Deutsche Forschungsgemeinschaft (to M. S., I. L., and V. S.), The Rebecca L. Cooper Medical Research Foundation (to V. S. and I. L.), National Health and Medical Research Council (to V. S.), and the New Jersey Commission for Spinal Cord Research (to M. S.).	Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; Ango F, 2008, PLOS BIOL, V6, P739, DOI 10.1371/journal.pbio.0060103; BENNETT V, 1986, METHOD ENZYMOL, V134, P55; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Chernyshova Y, 2011, J NEUROSCI, V31, P3522, DOI 10.1523/JNEUROSCI.3109-10.2011; De Matteis MA, 2000, J CELL SCI, V113, P2331; Demyanenko GP, 2011, CEREB CORTEX, V21, P401, DOI 10.1093/cercor/bhq115; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Dequidt C, 2007, MOL BIOL CELL, V18, P3131, DOI 10.1091/mbc.E06-12-1101; Devanathan V, 2010, J NEUROSCI, V30, P9292, DOI 10.1523/JNEUROSCI.5657-09.2010; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; HARDY B, 1979, J CELL BIOL, V82, P654, DOI 10.1083/jcb.82.3.654; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; HINSSEN H, 1987, J CELL BIOL, V105, P1425, DOI 10.1083/jcb.105.3.1425; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Jakovcevski I, 2009, J COMP NEUROL, V513, P496, DOI 10.1002/cne.21981; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kolata S, 2008, J NEUROSCI, V28, P13505, DOI 10.1523/JNEUROSCI.2127-08.2008; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Molitoris BA, 1996, AM J PHYSIOL-RENAL, V271, pF790, DOI 10.1152/ajprenal.1996.271.4.F790; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Morellini F, 2007, MOL CELL NEUROSCI, V34, P121, DOI 10.1016/j.mcn.2006.10.006; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nishimune H, 2005, J NEUROSCI RES, V80, P593, DOI 10.1002/jnr.20517; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; Pratte M, 2009, PHYSIOL BEHAV, V97, P394, DOI 10.1016/j.physbeh.2009.03.009; Puchkov D, 2011, CEREB CORTEX, V21, P2217, DOI 10.1093/cercor/bhq283; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schrier S L, 1979, Prog Clin Biol Res, V30, P437; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; TRAVE G, 1995, EUR J BIOCHEM, V227, P35, DOI 10.1111/j.1432-1033.1995.tb20357.x; Westphal D, 2010, J BIOL CHEM, V285, P42046, DOI 10.1074/jbc.M110.177147; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939	52	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44447	44463		10.1074/jbc.M112.394973	http://dx.doi.org/10.1074/jbc.M112.394973			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144456	hybrid, Green Published			2022-12-25	WOS:000312938600041
J	Martinovic-Weigelt, D; Ekman, DR; Villeneuve, DL; James, CM; Teng, Q; Collette, TW; Ankley, GT				Martinovic-Weigelt, Dalma; Ekman, Drew R.; Villeneuve, Daniel L.; James, Channing M.; Teng, Quincy; Collette, Timothy W.; Ankley, Gerald T.			Fishy Aroma of Social Status: Urinary Chemo-Signalling of Territoriality in Male Fathead Minnows (Pimephales promelas)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; OLFACTORY SENSITIVITY; SPAWNING READINESS; CHEMICAL STIMULI; BILE-ACIDS; AGGRESSION; RECEPTORS; PHEROMONE; DOMINANCE; BEHAVIOR	Chemical structures of several urinary reproductive pheromones in fish have been identified, and their role in the chemical communication of reproductive condition is well characterized. On the contrary, the role of chemical communication in signalling of social/territorial status in fish is poorly understood. Fathead minnows are an example of a fish species whose life history traits appear conducive to evolution of chemical communication systems that confer information about social/territorial status. Male reproduction in this species is dependent upon their ability to acquire and defend a high quality nesting territory, and to attract a female to the nest. We hypothesized that fathead minnow males use visual and urine-derived chemical cues to signal territorial status. To test this hypothesis, effects of territorial acquisition on male-specific secondary sex characteristics (SSCs) and urine volumes were first assessed. Second, frequencies of male urination in varying social contexts were examined. Finally, nuclear magnetic resonance-based metabolomics was used to identify urinary metabolites that were differentially excreted in the urine of territorial versus non-territorial males. The expression of SSCs, sperm, and urine volumes increased with territory acquisition, and either remained unchanged or decreased in non-territorial males. Frequency of male urination increased significantly in the presence of females (but not males), suggesting that females are the main target of the urinary signals. Territorial and non-territorial males had distinct urinary metabolomic profiles. An unforeseen finding was that one could discern future territorial status of males, based on their initial metabolomic profiles. Bile acids and volatile amines were identified as potential chemical signals of social status in the fathead minnow. The finding that trimethylamine (a fishy smelling volatile amine) may be a social cue is particularly interesting, because it is known to bind trace amine-associated receptors, indicating that these receptors may play role in chemical signalling of social status in fish.	[Martinovic-Weigelt, Dalma; James, Channing M.] Univ St Thomas, Dept Biol, St Paul, MN USA; [Ekman, Drew R.; Teng, Quincy; Collette, Timothy W.] US EPA, Ecosyst Res Div, Athens, GA USA; [Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Mid Continent Ecol Div, Duluth, MN USA	University of St Thomas Minnesota; United States Environmental Protection Agency; United States Environmental Protection Agency	Martinovic-Weigelt, D (corresponding author), Univ St Thomas, Dept Biol, St Paul, MN USA.	dalma@stthomas.edu		Collette, Timothy/0000-0003-1946-0878; Martinovic-Weigelt, Dalma/0000-0002-9973-4965	U.S. EPA; University of Saint Thomas; National Academy of Sciences through National Research Council's Research Associate Program	U.S. EPA(United States Environmental Protection Agency); University of Saint Thomas; National Academy of Sciences through National Research Council's Research Associate Program	This work was funded by the U.S. EPA and University of Saint Thomas. DM was also funded by the National Academy of Sciences through National Research Council's Research Associate Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OG, 2005, CHEM SENSES, V30, pI309, DOI 10.1093/chemse/bjh238; ALMEIDA OG, 2003, COMP BIOCH PHYSL A, V134, pS27; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Appelt CW, 2007, ANIM BEHAV, V74, P1329, DOI 10.1016/j.anbehav.2007.02.032; Barata EN, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-54; Barata EN, 2008, J CHEM ECOL, V34, P438, DOI 10.1007/s10886-008-9458-7; Bergman DA, 2005, ANIM BEHAV, V70, P485, DOI 10.1016/j.anbehav.2004.11.021; Clotfelter ED, 2007, PHARMACOL BIOCHEM BE, V87, P222, DOI 10.1016/j.pbb.2007.04.018; COLE KS, 1992, J CHEM ECOL, V18, P1269, DOI 10.1007/BF00980079; Collette TW, 2010, ENVIRON SCI TECHNOL, V44, P6881, DOI 10.1021/es1011884; Danylchuk AJ, 2001, BEHAV ECOL, V12, P482, DOI 10.1093/beheco/12.4.482; Derby CD, 2008, J CHEM ECOL, V34, P898, DOI 10.1007/s10886-008-9489-0; DiBattista JD, 2006, PHYSIOL BIOCHEM ZOOL, V79, P675, DOI 10.1086/504612; DOVING KB, 1980, ACTA PHYSIOL SCAND, V108, P123, DOI 10.1111/j.1748-1716.1980.tb06509.x; DULKA JG, 1987, NATURE, V325, P251, DOI 10.1038/325251a0; Earley RL, 2004, P ROY SOC B-BIOL SCI, V271, P7, DOI 10.1098/rspb.2003.2558; Ekerholm M, 2005, J CHEM ECOL, V31, P1845, DOI 10.1007/s10886-005-5930-9; Ekman DR, 2007, AQUAT TOXICOL, V85, P104, DOI 10.1016/j.aquatox.2007.08.005; Faulkes CG, 2001, TRENDS ECOL EVOL, V16, P184, DOI 10.1016/S0169-5347(01)02116-4; Fine JM, 2004, J CHEM ECOL, V30, P2091, DOI 10.1023/B:JOEC.0000048776.16091.b1; Fitzpatrick JL, 2006, BEHAV ECOL, V17, P25, DOI 10.1093/beheco/ari090; Greenwood AK, 2008, P ROY SOC B-BIOL SCI, V275, P2393, DOI 10.1098/rspb.2008.0622; Hashiguchi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004083; Higuchi M, 2012, AMINO ACIDS, V43, P773, DOI 10.1007/s00726-011-1128-3; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Huertas M, 2010, J EXP BIOL, V213, P308, DOI 10.1242/jeb.033142; Hussain A, 2009, P NATL ACAD SCI USA, V106, P4313, DOI 10.1073/pnas.0803229106; Katoh E, 2008, BEHAVIOUR, V145, P1447, DOI 10.1163/156853908785765917; Kong WX, 2006, PHARMACOL BIOCHEM BE, V83, P271, DOI 10.1016/j.pbb.2006.02.007; Koyama S, 1999, PHYSIOL BEHAV, V65, P665; Kruczek M, 2009, BEHAV PROCESS, V82, P279, DOI 10.1016/j.beproc.2009.07.009; Le Francois NR, 2005, J FISH BIOL, V66, P1167, DOI 10.1111/j.0022-1112.2005.00661.x; Li WM, 2002, SCIENCE, V296, P138, DOI 10.1126/science.1067797; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Martinovic D, 2007, ENVIRON TOXICOL CHEM, V26, P271, DOI 10.1897/06-065R.1; Maruska KP, 2012, J EXP BIOL, V215, P68, DOI 10.1242/jeb.062794; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Moore AJ, 2002, AM NAT, V160, pS186, DOI 10.1086/342899; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; Mucignat-Caretta C, 2004, HORM BEHAV, V46, P11, DOI 10.1016/j.yhbeh.2004.02.004; Oliveira RF, 2002, COMP BIOCHEM PHYS B, V132, P203, DOI 10.1016/S1096-4959(01)00523-1; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Sangiao-Alvarellos S, 2006, GEN COMP ENDOCR, V149, P30, DOI 10.1016/j.ygcen.2006.05.003; Shabani S, 2009, J EXP BIOL, V212, P2464, DOI 10.1242/jeb.026492; SMITH RJF, 1978, CAN J ZOOL, V56, P2103, DOI 10.1139/z78-285; SMITH RJF, 1974, CAN J ZOOL, V52, P1031, DOI 10.1139/z74-137; Stacey N, 2001, COMP BIOCHEM PHYS C, V130, P467, DOI 10.1016/S1532-0456(01)00273-3; Stacey N.E., 2005, FISH PHYSIOL, P359; Stacey N, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 1: FISHES, P169; UNGER LM, 1983, BEHAV ECOL SOCIOBIOL, V13, P125, DOI 10.1007/BF00293802; Velez Z, 2009, J COMP PHYSIOL A, V195, P691, DOI 10.1007/s00359-009-0444-5; Winberg S, 2001, J EXP BIOL, V204, P3867; Zhang CB, 2001, J COMP PHYSIOL B, V171, P161, DOI 10.1007/s003600000170	57	20	20	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e46579	10.1371/journal.pone.0046579	http://dx.doi.org/10.1371/journal.pone.0046579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144784	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800006
J	Kindsvater, HK; Rosenthal, GG; Alonzo, SH				Kindsvater, Holly K.; Rosenthal, Gil G.; Alonzo, Suzanne H.			Maternal Size and Age Shape Offspring Size in a Live-Bearing Fish, Xiphophorus birchmanni	PLOS ONE			English	Article							EGG SIZE; LIFE-HISTORY; PERFORMANCE; SURVIVAL; DENSITY; MOTHERS; QUALITY; REPRODUCTION; ENVIRONMENT; ALLOCATION	Many studies of offspring size focus on differences in maternal investment that arise from ecological factors such as predation or competition. Classic theory predicts that these ecological factors will select for an optimal offspring size, and therefore that variation in a given environment will be minimized. Yet recent evidence suggests maternal traits such as size or age could also drive meaningful variation in offspring size. The generality of this pattern is unclear, as some studies suggest that it may represent non-adaptive variation or be an artifact of temporal or spatial differences in maternal environments. To clarify this pattern, we asked how maternal size, age and condition are related to each other in several populations of the swordtail Xiphophorus birchmanni. We then determined how these traits are related to offspring size, and whether they could resolve unexplained intra-population variation in this trait. We found that female size, age, and condition are correlated within populations; at some of these sites, older, larger females produce larger offspring than do younger females. The pattern was robust to differences among most, but not all, sites. Our results document a pattern that is consistent with recent theory predicting adaptive age-and size-dependence in maternal investment. Further work is needed to rule out non-adaptive explanations for this variation. Our results suggest that female size and age could play an under-appreciated role in population growth and evolution.	[Kindsvater, Holly K.; Alonzo, Suzanne H.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Kindsvater, Holly K.; Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico; [Rosenthal, Gil G.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Yale University; Texas A&M University System; Texas A&M University College Station	Kindsvater, HK (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	holly.kindsvater@gmail.com	Rosenthal, Gil/E-6924-2015	Rosenthal, Gil/0000-0003-0342-9024; Kindsvater, Holly/0000-0001-7580-4095	Yale University; National Science Foundation [IOS-0923825, DEB-0909843]; EPA STAR fellowship	Yale University; National Science Foundation(National Science Foundation (NSF)); EPA STAR fellowship(United States Environmental Protection Agency)	This work was supported by Yale University (SHA and HKK), the National Science Foundation (IOS-0923825 to GGR and DEB-0909843 to HKK), and an EPA STAR fellowship to HKK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashey F, 2008, OIKOS, V117, P104, DOI 10.1111/j.2007.0030-1299.16094.x; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Bernardo J, 1996, AM ZOOL, V36, P216; Bogdanova MI, 2006, FUNCT ECOL, V20, P132, DOI 10.1111/j.1365-2435.2006.01088.x; Braga Goncalves I, 2011, J FISH BIOL, V78, P1847, DOI 10.1111/j.1095-8649.2011.02984.x; Bunnell DB, 2005, T AM FISH SOC, V134, P607, DOI 10.1577/T04-094.1; Chambers RC, 1996, AM ZOOL, V36, P180; Culumber ZW, 2011, MOL ECOL, V20, P342, DOI 10.1111/j.1365-294X.2010.04949.x; EBERT D, 1993, ARCH HYDROBIOL, P453; Einum S, 2002, AM NAT, V160, P756, DOI 10.1086/343876; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; GEORGE SB, 1994, J EXP MAR BIOL ECOL, V175, P121, DOI 10.1016/0022-0981(94)90179-1; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Guinnee MA, 2007, J EVOLUTION BIOL, V20, P577, DOI 10.1111/j.1420-9101.2006.01253.x; Heath DD, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P178; Horak D, 2008, ACTA OECOL, V33, P197, DOI 10.1016/j.actao.2007.10.007; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jorgensen C, 2011, AM NAT, V177, pE119, DOI 10.1086/659622; Kindsvater HK, 2011, J EVOLUTION BIOL, V24, P2230, DOI 10.1111/j.1420-9101.2011.02351.x; Klug H, 2006, EVOLUTION, V60, P2087, DOI 10.1111/j.0014-3820.2006.tb01846.x; Leips J, 2009, EVOLUTION, V63, P1341, DOI 10.1111/j.1558-5646.2009.00631.x; Marshall DJ, 2008, AM NAT, V171, P214, DOI 10.1086/524954; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Marshall DJ, 2010, ECOLOGY, V91, P2862, DOI 10.1890/09-0156.1; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Plaistow SJ, 2006, AM NAT, V167, P206, DOI 10.1086/499380; de Leon JLP, 2011, ECOL FRESHW FISH, V20, P243, DOI 10.1111/j.1600-0633.2011.00489.x; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; R Core Team, 2022, R LANG ENV STAT COMP; Rasanen K, 2005, OECOLOGIA, V142, P546, DOI 10.1007/s00442-004-1762-5; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Roff Derek, 2002, pi; Rollinson N, 2010, EVOL ECOL RES, V12, P949; Sakai S, 2001, AM NAT, V157, P348, DOI 10.1086/319194; SINERVO B, 1990, SCIENCE, V248, P1106, DOI 10.1126/science.248.4959.1106; Skoglund H, 2011, J ANIM ECOL, V80, P365, DOI 10.1111/j.1365-2656.2010.01783.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; Turner CL, 1937, BIOL BULL-US, V72, P145, DOI 10.2307/1537249; Uller T, 2005, J ZOOL, V265, P295, DOI 10.1017/S0952836904006326; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Venturelli PA, 2010, ECOLOGY, V91, P2003, DOI 10.1890/09-1218.1	46	26	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48473	10.1371/journal.pone.0048473	http://dx.doi.org/10.1371/journal.pone.0048473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139785	Green Published, gold			2022-12-25	WOS:000311315300033
J	Takahashi, M; Eda, A; Fukushima, T; Hohjoh, H				Takahashi, Masaki; Eda, Akiko; Fukushima, Tatsunobu; Hohjoh, Hirohiko			Reduction of Type IV Collagen by Upregulated miR-29 in Normal Elderly Mouse and klotho-Deficient, Senescence-Model Mouse	PLOS ONE			English	Article							CELLULAR SENESCENCE; MICRORNA EXPRESSION; CELLS; MIRNA; SIGNALS; SYSTEM; FAMILY; GROWTH	MicroRNA (miRNA), a small non-coding RNA that functions as a mediator in gene silencing, plays important roles in gene regulation in various vital functions and activities. Here we show that the miR-29 members are upregulated in klotho-deficient [klotho(-/-)] mice, a senescence-model animal, and also in normal elderly ICR mice relative to wild-type littermates and young ICR mice. In addition, levels of type IV collagen, a major component of basement membranes and a putative target of miR-29, were lower in klotho(-/-) and elderly ICR mice than in wild-type littermates and young ICR mice. RNA degradation mediated by miR-29 may participate in the suppression of type IV collagen, both in vivo and in vitro. Taken together, our current findings suggest that the miR-29 upregulated in aging may be involved in the downregulation of type IV collagen, leading to a possible weakening of the basal membrane in senescent tissues, and miR-29 may be a useful molecular marker of senescence.	[Takahashi, Masaki; Eda, Akiko; Hohjoh, Hirohiko] NCNP, Natl Inst Neurosci, Kodaira, Tokyo, Japan; [Fukushima, Tatsunobu] Mitsubishi Rayon Co LTD, Yokohama Res Labs, Tsurumi Ku, Yokohama, Kanagawa, Japan	National Center for Neurology & Psychiatry - Japan; Mitsubishi Chemical Holdings Corporation; Mitsubishi Rayon Co., Ltd.	Hohjoh, H (corresponding author), NCNP, Natl Inst Neurosci, Kodaira, Tokyo, Japan.	hohjohh@ncnp.go.jp		Takahashi, Masaki/0000-0003-1190-2213	Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by research grants from the Ministry of Health, Labour and Welfare of Japan and by Grants-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eda A, 2011, GENE, V485, P46, DOI 10.1016/j.gene.2011.05.034; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Luna C, 2009, MOL VIS, V15, P2488; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Masselink H, 2001, CANCER LETT, V171, P87, DOI 10.1016/S0304-3835(01)00631-0; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Sakai T, 2006, CELL BIOL INT, V30, P952, DOI 10.1016/j.cellbi.2006.06.018; Takahashi M, 2010, P NATL ACAD SCI USA, V107, P21731, DOI 10.1073/pnas.1012153107; Tamura Y, 2009, MOL BIOL REP, V36, P1413, DOI 10.1007/s11033-008-9330-4; Villarreal G, 2011, INVEST OPHTH VIS SCI, V52, P3391, DOI 10.1167/iovs.10-6165; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	25	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48974	10.1371/journal.pone.0048974	http://dx.doi.org/10.1371/journal.pone.0048974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139829	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300065
J	Morimatsu, M; Togashi, Y; Nishikawa, S; Sugawa, M; Iwane, AH; Yanagida, T				Morimatsu, Masatoshi; Togashi, Yuichi; Nishikawa, So; Sugawa, Mitsuhiro; Iwane, Atsuko H.; Yanagida, Toshio			Spontaneous Structural Changes in Actin Regulate G-F Transformation	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MYOSIN; FILAMENT; DYNAMICS; FORCE; STATE; GENERATION; MOLECULES; PROTEINS; COMPLEX	Transformations between G-(monomeric) and F-actin (polymeric) are important in cellular behaviors such as migration, cytokinesis, and morphing. In order to understand these transitions, we combined single-molecule Forster resonance energy transfer with total internal reflection fluorescence microscopy to examine conformational changes of individual actin protomers. We found that the protomers can take different conformational states and that the transition interval is in the range of hundreds of seconds. The distribution of these states was dependent on the environment, suggesting that actin undergoes spontaneous structural changes that accommodate itself to polymerization.	[Morimatsu, Masatoshi; Togashi, Yuichi; Nishikawa, So; Sugawa, Mitsuhiro; Iwane, Atsuko H.; Yanagida, Toshio] Osaka Univ, Nanobiol Labs, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Togashi, Yuichi] Kobe Univ, Dept Computat Sci, Grad Sch Syst Informat, Kobe, Hyogo 657, Japan; [Togashi, Yuichi; Yanagida, Toshio] RIKEN, QBiC, Suita, Osaka, Japan	Osaka University; Kobe University; RIKEN	Yanagida, T (corresponding author), Osaka Univ, Nanobiol Labs, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	yanagida@fbs.osaka-u.ac.jp	Togashi, Yuichi/D-4163-2009	Togashi, Yuichi/0000-0003-0032-2424; SUGAWA, MITSUHIRO/0000-0002-3188-1547; Iwane, Atsuko/0000-0003-2641-2268	Japan Society for the Promotion Science (JSPS); Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT) [KAKENHI 23115007]; Grants-in-Aid for Scientific Research [23370072] Funding Source: KAKEN	Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion Science (JSPS), http://www.jsps.go.jp/english/index.html and Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT) (KAKENHI 23115007), http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; COOKE R, 1978, J MOL BIOL, V120, P361, DOI 10.1016/0022-2836(78)90424-2; Cunliffe JM, 2002, ANAL CHEM, V74, P776, DOI 10.1021/ac015627u; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dong H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000833; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Guan JQ, 2005, BIOCHEMISTRY-US, V44, P3166, DOI 10.1021/bi048021j; Guan JQ, 2003, BIOCHEMISTRY-US, V42, P11992, DOI 10.1021/bi034914k; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Iwane AH, 2009, P JPN ACAD B-PHYS, V85, P491, DOI 10.2183/pjab.85.491; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KASAI M, 1962, BIOCHIM BIOPHYS ACTA, V57, P13, DOI 10.1016/0006-3002(62)91072-7; Kim E, 1998, BIOCHEMISTRY-US, V37, P17801, DOI 10.1021/bi981286b; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Oda T, 2005, BIOPHYS J, V88, P2727, DOI 10.1529/biophysj.104.047753; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; PARDEE JD, 1982, J CELL BIOL, V93, P648, DOI 10.1083/jcb.93.3.648; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RICH SA, 1976, J MOL BIOL, V104, P777, DOI 10.1016/0022-2836(76)90181-9; Risca VI, 2012, P NATL ACAD SCI USA, V109, P2913, DOI 10.1073/pnas.1114292109; ROUAYRENC JF, 1981, EUR J BIOCHEM, V116, P73, DOI 10.1111/j.1432-1033.1981.tb05302.x; Shimozawa T, 2009, BIOPHYS J, V96, P1036, DOI 10.1016/j.bpj.2008.09.056; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e45864	10.1371/journal.pone.0045864	http://dx.doi.org/10.1371/journal.pone.0045864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144776	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400004
J	Qin, M; Huang, H; Wang, T; Hu, H; Liu, Y; Gu, YW; Cao, H; Li, HL; Huang, CX				Qin, Mu; Huang, He; Wang, Teng; Hu, He; Liu, Yu; Gu, Yongwei; Cao, Hong; Li, Hongliang; Huang, Congxin			Atrial Tachyarrhythmia in Rgs5-Null Mice	PLOS ONE			English	Article							OF-FUNCTION MUTATION; PROTEIN SIGNALING 5; ANGIOTENSIN-II; K+ CURRENTS; HEART; FIBRILLATION; MECHANISMS; CONDUCTION; REGULATOR; KINASE	Aims: The aim of this study was to elucidate the effects of regulator of G-protein signaling 5 (Rgs5), a negative regulator of G protein-mediated signaling, on atrial repolarization and tachyarrhythmia (ATA) in mice. Methods and Results: In present study, the incidence of ATA were increased in Rgs5(-/-) Langendorff-perfused mouse hearts during program electrical stimulation (PES) (46.7%, 7 of 15) and burst pacing (26.7%, 4 of 15) compared with wildtype (WT) mice (PES: 7.1%, 1 of 14; burst: 7.1%, 1 of 14) (P<0.05). And the duration of ATA also shown longer in Rgs5(-/-) heart than that in WT, 2 out of 15 hearts exhibited sustained ATA (>30s) but none of them observed in WT mice. Atrial prolonged repolarization was observed in Rgs5(-/-) hearts including widened P wave in surface ECG recording, increased action potential duration (APD) and atrial effective refractory periods (AERP), all of them showed significant difference with WT mice (P<0.05). At the cellular level, whole-cell patch clamp recorded markedly decreased densities of repolarizing K+ currents including I-Kur (at +60 mV: 14.0 +/- 2.2 pF/pA) and Ito (at + 60 mV: 16.7 +/- 1.3 pA/pF) in Rgs5(-/-) atrial cardiomyocytes, compared to those of WT mice (at +60 mV I-to: 20.4 +/- 2.0 pA/pF; Ikur: 17.9 +/- 2.0 pF/pA) (P<0.05). Conclusion: These results suggest that Rgs5 is an important regulator of arrhythmogenesis in the mouse atrium and that the enhanced susceptibility to atrial tachyarrhythmias in Rgs5(-/-) mice may contribute to abnormalities of atrial repolarization.	[Qin, Mu; Huang, He; Hu, He; Liu, Yu; Huang, Congxin] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Peoples R China; [Qin, Mu; Huang, He; Wang, Teng; Hu, He; Gu, Yongwei; Cao, Hong; Li, Hongliang; Huang, Congxin] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Huang, CX (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Peoples R China.	huangcongxing@yahoo.cn			National Key Basic Research Development Program (The "973" Program) [2012CB518604]; National Natural Science Foundation of China [81070142, 81100129]; Fundamental Research Funds for the Central Universities, China [201130202020023, 201130202020003]	National Key Basic Research Development Program (The "973" Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This research was supported by National Key Basic Research Development Program (The "973" Program) (Grant number: 2012CB518604), National Natural Science Foundation of China Grants (Grant number: 81070142 and 81100129) and Fundamental Research Funds for the Central Universities, China (grant number: 201130202020023 and 201130202020003). The funder has designed this study and decided to publish this manuscript.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Dautova Y, 2009, PFLUG ARCH EUR J PHY, V458, P443, DOI 10.1007/s00424-008-0633-z; de Boer RA, 2004, J MOL MED, V82, P678, DOI 10.1007/s00109-004-0579-3; Domenighetti AA, 2007, J MOL CELL CARDIOL, V42, P63, DOI 10.1016/j.yjmcc.2006.09.019; Fischer R, 2007, AM J PHYSIOL-HEART C, V293, pH1242, DOI 10.1152/ajpheart.01400.2006; Fu Y, 2007, AM J PHYSIOL-HEART C, V292, pH2532, DOI 10.1152/ajpheart.01391.2006; Goette A, 2002, CARDIOVASC RES, V54, P247, DOI 10.1016/S0008-6363(01)00521-1; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; Lemoine MD, 2011, CARDIOVASC RES, V92, P67, DOI 10.1093/cvr/cvr166; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Manzur M, 2009, TRENDS CARDIOVAS MED, V19, P26, DOI 10.1016/j.tcm.2009.04.002; Nattel S, 2005, PROG CARDIOVASC DIS, V48, P9, DOI 10.1016/j.pcad.2005.06.002; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Nattel S, 2009, HEART RHYTHM, V6, P85, DOI 10.1016/j.hrthm.2008.11.028; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Posokhova E, 2010, CIRC RES, V107, P00; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Rivard K, 2008, CARDIOVASC RES, V78, P53, DOI 10.1093/cvr/cvn020; Shimoni Y, 2001, J PHYSIOL-LONDON, V537, P83, DOI 10.1111/j.1469-7793.2001.0083k.x; Thilen U, 2007, EUROPACE, V9, P105, DOI 10.1093/europace/eum214; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Xiao B, 2009, CLIN CHEM LAB MED, V47, P1483, DOI 10.1515/CCLM.2009.344; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Zhang TT, 2001, CIRC RES, V88, P476, DOI 10.1161/01.RES.88.5.476	28	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e46856	10.1371/journal.pone.0046856	http://dx.doi.org/10.1371/journal.pone.0046856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144791	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400011
J	Zhang, Z; Sun, D; Hutajulu, SH; Nawaz, I; Van, DN; Huang, GW; Haryana, SM; Middeldorp, JM; Ernberg, I; Hu, LF				Zhang, Zhe; Sun, Di; Hutajulu, Susanna Hilda; Nawaz, Imran; Do Nguyen Van; Huang, Guangwu; Haryana, Sofia M.; Middeldorp, Jaap M.; Ernberg, Ingemar; Hu, Li-Fu			Development of a Non-Invasive Method, Multiplex Methylation Specific PCR (MMSP), for Early Diagnosis of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PROMOTER HYPERMETHYLATION; DNA METHYLATION; PERIPHERAL-BLOOD; HIGH-FREQUENCY; MESSENGER-RNA; LUNG-CANCER; ASSOCIATION; EXPRESSION; MANAGEMENT	Increasing evidence demonstrated that inactivation of tumor suppressor genes (TSGs) by aberrant promoter methylation is an early event during carcinogenesis. Aiming at developing early diagnostic or prognostic tools for various tumors, we took an EBV-associated tumor, nasopharyngeal carcinoma (NPC), as a model and developed a powerful assay based on "multiplex methylation specific-PCR (MMSP)". The MMSP assay was designed to detect tumor-specific methylation status of several NPC-related genes and was capable of acquiring multiplex information simultaneously through a single PCR reaction with the tiny tumor DNA derived from the direct body fluid close to the primary tumor. In this study, we collected paired nasopharyngeal (NP) swabs and NPC biopsies from 49 NPC patients and twenty noncancerous controls. A panel of markers including two EBV, and two cellular TSG markers were applied in this NPC-specific-MMSP assay. We optimized the working condition of MMSP so that it provides information equal to that from the corresponding separate PCRs. The results showed that MMSP patterns of NPC swab were largely consistent with those of corresponding biopsies and significantly distinguished themselves from those of 20 noncancerous volunteers. Among the 69 samples (49 NPCs and 20 normal controls), the sensitivity of detecting NPC from NP swabs is 98%. The specificity is as high as 100%. In conclusion, being characterized by its noninvasiveness, high reproducibility and informativeness, MMSP assay is a reliable and potential diagnostic tool for NPC. It paves the way for the development of population screening and early diagnosis approaches for various tumor types.	[Zhang, Zhe; Sun, Di; Nawaz, Imran; Do Nguyen Van; Ernberg, Ingemar; Hu, Li-Fu] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Zhang, Zhe; Sun, Di; Huang, Guangwu] Guangxi Med Univ, Dept Otolaryngol Head & Neck Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Hutajulu, Susanna Hilda; Haryana, Sofia M.] Gadjah Mada Univ, Fac Med, Yogyakarta, Indonesia; [Middeldorp, Jaap M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Do Nguyen Van] HMU, Dept Immunol & Pathophysiol, Hanoi, Vietnam	Karolinska Institutet; Guangxi Medical University; Gadjah Mada University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Hanoi Medical University	Hu, LF (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	lifu.hu@ki.se	Hutajulu, Susanna Hilda/GPP-6026-2022	Middeldorp, Jaap Michiel/0000-0002-0765-4125	Cancerfonden; Cancerforeningen; SIDA (Swedish International Development Cooperation Agency); STINT (The Swedish Foundation for International Cooperation in Research and Higher Education); SSMF(Swedish Association of Medical Research); National Basic Research Program of China [2011CB504301, 2011CB504304]; Natural Science Foundation of China [30660197]; EU-Asialink grant [ASI/B7-301/98/679-034]; Nuffic from Dutch Academy for Sciences [NFP-PhD 08/36]	Cancerfonden(Swedish Cancer Society); Cancerforeningen; SIDA (Swedish International Development Cooperation Agency); STINT (The Swedish Foundation for International Cooperation in Research and Higher Education); SSMF(Swedish Association of Medical Research); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EU-Asialink grant; Nuffic from Dutch Academy for Sciences	This study was supported by grants from Cancerfonden, Cancerforeningen, SIDA (Swedish International Development Cooperation Agency), STINT (The Swedish Foundation for International Cooperation in Research and Higher Education), SSMF(Swedish Association of Medical Research) and by grants from the National Basic Research Program of China (2011CB504301, 2011CB504304) and Natural Science Foundation of China (30660197), EU-Asialink grant (ASI/B7-301/98/679-034) and Nuffic (NFP-PhD 08/36) from the Dutch Academy for Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulnik M, 2005, BRIT J CANCER, V92, P799, DOI 10.1038/sj.bjc.6602449; Ahluwalia A, 2001, GYNECOL ONCOL, V82, P261, DOI 10.1006/gyno.2001.6291; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chang HW, 2003, INT J CANCER, V105, P851, DOI 10.1002/ijc.11162; Chi KH, 2002, INT J RADIAT ONCOL, V52, P1238, DOI 10.1016/S0360-3016(01)02781-X; Esteller M, 2001, CANCER RES, V61, P3225; FAHRAEUS R, 1988, INT J CANCER, V42, P329, DOI 10.1002/ijc.2910420305; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Gullo C, 2008, ANN ACAD MED SINGAP, V37, P769; HU LF, 1991, J VIROL, V65, P1558, DOI 10.1128/JVI.65.3.1558-1567.1991; Hutajulu SH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-48; Kantlehner M, 2011, NUCLEIC ACIDS RES, V39, pE44, DOI 10.1093/nar/gkq1357; Kim DH, 2001, ONCOGENE, V20, P1765, DOI 10.1038/sj.onc.1204302; Kwong J, 2002, CLIN CANCER RES, V8, P131; Lo KW, 2001, CANCER RES, V61, P3877; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Palmisano WA, 2000, CANCER RES, V60, P5954; Rush LJ, 2002, ANAL BIOCHEM, V307, P191, DOI 10.1016/S0003-2697(02)00033-7; Schulz W, 2005, J BIOMED BIOTECHNOL, P227, DOI 10.1155/JBB.2005.227; SHAM JST, 1990, LANCET, V335, P371, DOI 10.1016/0140-6736(90)90206-K; Stebbing J, 2006, PHARMACOGENOMICS, V7, P747, DOI 10.2217/14622416.7.5.747; Stevens SJC, 2006, INT J CANCER, V119, P608, DOI 10.1002/ijc.21914; Stevens SJC, 2005, J CLIN MICROBIOL, V43, P3066, DOI 10.1128/JCM.43.7.3066-3073.2005; TEO CG, 1987, P NATL ACAD SCI USA, V84, P8473, DOI 10.1073/pnas.84.23.8473; Tsang RKY, 2004, HEAD NECK-J SCI SPEC, V26, P598, DOI 10.1002/hed.20022; Wei WI, 2010, CLIN EXP OTORHINOLAR, V3, P1, DOI 10.3342/ceo.2010.3.1.1; Wong TS, 2002, CLIN CANCER RES, V8, P433; ZENG Y, 1985, ADV CANCER RES, V44, P121, DOI 10.1016/S0065-230X(08)60027-5	29	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e45908	10.1371/journal.pone.0045908	http://dx.doi.org/10.1371/journal.pone.0045908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144779	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400006
J	Fujita, I; Tanaka, M; Kanoh, J				Fujita, Ikumi; Tanaka, Makiko; Kanoh, Junko			Identification of the Functional Domains of the Telomere Protein Rap1 in Schizosaccharomyces pombe	PLOS ONE			English	Article							YEAST TAZ1 PROTEIN; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; LENGTH REGULATION; BINDING; COMPLEX; CHROMOSOMES; END; LOCALIZATION; CONSERVATION	The telomere at the end of a linear chromosome plays crucial roles in genome stability. In the fission yeast Schizosaccharomyces pombe, the Rap1 protein, one of the central players at the telomeres, associates with multiple proteins to regulate various telomere functions, such as the maintenance of telomere DNA length, telomere end protection, maintenance of telomere heterochromatin, and telomere clustering in meiosis. The molecular bases of the interactions between Rap1 and its partners, however, remain largely unknown. Here, we describe the identification of the interaction domains of Rap1 with its partners. The Bqt1/Bqt2 complex, which is required for normal meiotic progression, Poz1, which is required for telomere length control, and Taz1, which is required for the recruitment of Rap1 to telomeres, bind to distinct domains in the C-terminal half of Rap1. Intriguingly, analyses of a series of deletion mutants for rap1(+) have revealed that the long N-terminal region (1-456 a. a. [amino acids]) of Rap1 (full length: 693 a. a.) is not required for telomere DNA length control, telomere end protection, and telomere gene silencing, whereas the C-terminal region (457-693 a. a.) containing Poz1- and Taz1-binding domains plays important roles in those functions. Furthermore, the Bqt1/Bqt2- and Taz1-binding domains are essential for normal spore formation after meiosis. Our results suggest that the C-terminal half of Rap1 is critical for the primary telomere functions, whereas the N-terminal region containing the BRCT (BRCA1 C-terminus) and Myb domains, which are evolutionally conserved among the Rap1 family proteins, does not play a major role at the telomeres.	[Fujita, Ikumi; Tanaka, Makiko; Kanoh, Junko] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kanoh, J (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	jkanoh@protein.osaka-u.ac.jp	Kanoh, Junko/AGM-9632-2022; Fujita, Ikumi/C-9212-2017; Fujita, Ikumi/O-2342-2019	Fujita, Ikumi/0000-0002-1161-0352	Osaka University Life Science Young Independent Researcher Support Program of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Sumitomo Foundation; Novartis Foundation for the Promotion of Science	Osaka University Life Science Young Independent Researcher Support Program of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Novartis Foundation for the Promotion of Science	This work supported by the Osaka University Life Science Young Independent Researcher Support Program of the Japan Science and Technology Agency; Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Astellas Foundation for Research on Metabolic Disorders; the Takeda Science Foundation; the Sumitomo Foundation; and the Novartis Foundation for the Promotion of Science to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Chen Y, 2011, NAT STRUCT MOL BIOL, V18, P213, DOI 10.1038/nsmb.1974; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Chikashige Y, 2007, CHROMOSOMA, V116, P497, DOI 10.1007/s00412-007-0114-8; Chikashige Y, 2009, J CELL BIOL, V187, P413, DOI 10.1083/jcb.200902122; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Dehe PM, 2012, MOL CELL, V46, P797, DOI 10.1016/j.molcel.2012.04.022; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fujita I, 2012, CURR BIOL; Hansen KR, 2006, NUCLEIC ACIDS RES, V34, P78, DOI 10.1093/nar/gkj415; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Matsuura A, 1999, GENETICS, V152, P1501; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Saint-Andre CD, 2008, BIOCHIMIE, V90, P181, DOI 10.1016/j.biochi.2007.08.0; Scherthan H, 2011, CHROMOSOMA, V120, P151, DOI 10.1007/s00412-010-0295-4; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Tazumi A, 2012, GENE DEV, V26, P2050, DOI 10.1101/gad.194282.112; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748	40	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e49151	10.1371/journal.pone.0049151	http://dx.doi.org/10.1371/journal.pone.0049151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133674	Green Submitted, gold, Green Published			2022-12-25	WOS:000310702400056
J	Naito, Y; Oue, N; Hinoi, T; Sakamoto, N; Sentani, K; Ohdan, H; Yanagihara, K; Sasaki, H; Yasui, W				Naito, Yutaka; Oue, Naohide; Hinoi, Takao; Sakamoto, Naoya; Sentani, Kazuhiro; Ohdan, Hideki; Yanagihara, Kazuyoshi; Sasaki, Hiroki; Yasui, Wataru			Reg IV Is a Direct Target of Intestinal Transcriptional Factor CDX2 in Gastric Cancer	PLOS ONE			English	Article							CELL-LINES; NEUROENDOCRINE DIFFERENTIATION; PANCREATIC-CANCER; PROSTATE-CANCER; GENE-EXPRESSION; TUMOR-MARKER; CARCINOMA; PROTEIN; SERUM; ESTABLISHMENT	REG4, which encodes Reg IV protein, is a member of the calcium-dependent lectin superfamily and potent activator of the epidermal growth factor receptor/Akt/activator protein-1 signaling pathway. Several human cancers overexpress Reg IV, and Reg IV expression is associated with intestinal phenotype differentiation. However, regulation of REG4 transcription remains unclear. In the present study, we investigated whether CDX2 regulates Reg IV expression in gastric cancer (GC) cells. Expression of Reg IV and CDX2 was analyzed by Western blot and quantitative reverse transcription-polymerase chain reaction in 9 GC cell lines and 2 colon cancer cell lines. The function of the 5'-flanking region of the REG4 gene was characterized by luciferase assay. In 9 GC cell lines, endogenous Reg IV and CDX2 expression were well correlated. Using an estrogen receptor-regulated form of CDX2, rapid induction of Reg IV expression was observed in HT-29 cells. Reporter gene assays revealed an important role in transcription for consensus CDX2 DNA binding elements in the 5'-flanking region of the REG4 gene. Chromatin immunoprecipitation assays showed that CDX2 binds directly to the 5'-flanking region of REG4. These results indicate that CDX2 protein directly regulates Reg IV expression.	[Naito, Yutaka; Oue, Naohide; Sakamoto, Naoya; Sentani, Kazuhiro; Yasui, Wataru] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Pathol, Hiroshima, Japan; [Hinoi, Takao; Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Surg, Hiroshima, Japan; [Yanagihara, Kazuyoshi; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan	Hiroshima University; Hiroshima University; National Cancer Center - Japan	Yasui, W (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Pathol, Hiroshima, Japan.	wyasui@hiroshima-u.ac.jp	Hinoi, Takao/AAI-1443-2020; Ohdan, Hideki/G-4719-2019	Hinoi, Takao/0000-0003-0462-6177; Ohdan, Hideki/0000-0002-9066-1288	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [23790401, 24659163] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan, and, in part, by a Grant-in-Aid for the Third Comprehensive 10-Year Strategy for Cancer Control and for Cancer Research from the Ministry of Health, Labour and Welfare of Japan, and for the National Institute of Biomedical Innovation (Program for Promotion of Fundamental Studies in Health Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 2003, J PATHOL, V199, P36, DOI 10.1002/path.1246; Anami K, 2010, J PATHOL, V221, P275, DOI 10.1002/path.2717; Aung PP, 2006, ONCOGENE, V25, P2546, DOI 10.1038/sj.onc.1209279; Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Grignani F, 1998, CANCER RES, V58, P14; Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Hayashi T, 2009, ONCOL REP, V21, P95, DOI 10.3892/or_00000194; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heiskala K, 2010, HISTOL HISTOPATHOL, V25, P63, DOI 10.14670/HH-25.63; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Hinoi T, 2005, GASTROENTEROLOGY, V128, P946, DOI 10.1053/j.gastro.2005.01.003; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hoji H, 1977, NIIGATA IGAKUKAI ZAS, V91, P737; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Katsuno Y, 2012, J PATHOL IN PRESS; Kondo T, 2004, CANCER RES, V64, P523, DOI 10.1158/0008-5472.CAN-03-1196; Legoffic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007495; MARGALIT Y, 1993, NUCLEIC ACIDS RES, V21, P4915, DOI 10.1093/nar/21.21.4915; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Mossman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023127; Motoshita J, 2006, PATHOL INT, V56, P200, DOI 10.1111/j.1440-1827.2006.01946.x; Motoshita J, 2005, CANCER SCI, V96, P474, DOI 10.1111/j.1349-7006.2005.00074.x; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Nakata K, 2009, MODERN PATHOL, V22, P460, DOI 10.1038/modpathol.2008.205; Nanakin A, 2007, LAB INVEST, V87, P304, DOI 10.1038/labinvest.3700507; OCHIAI A, 1985, JPN J CANCER RES, V76, P1064; Ohara S, 2008, CANCER SCI, V99, P1570, DOI 10.1111/j.1349-7006.2008.00846.x; Oue N, 2005, J PATHOL, V207, P185, DOI 10.1002/path.1827; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Oue N, 2007, ONCOLOGY-BASEL, V72, P371, DOI 10.1159/000113147; PASTAN I, 1991, ANNU REV MED, V42, P277, DOI 10.1146/annurev.me.42.020191.001425; Sasahira T, 2008, HISTOPATHOLOGY, V53, P667, DOI 10.1111/j.1365-2559.2008.03188.x; SEKIGUCHI M, 1978, JPN J EXP MED, V48, P61; Sentani K, 2010, PATHOL INT, V60, P291, DOI 10.1111/j.1440-1827.2010.02519.x; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Tajima Y, 2003, J CANCER RES CLIN, V129, P683, DOI 10.1007/s00432-003-0476-0; Takakura Y, 2010, CANCER RES, V70, P6767, DOI 10.1158/0008-5472.CAN-09-4701; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Tamura H, 2009, HUM PATHOL, V40, P1686, DOI 10.1016/j.humpath.2009.06.001; Tatematsu M, 2003, CANCER SCI, V94, P135, DOI 10.1111/j.1349-7006.2003.tb01409.x; Wang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018434; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; YANAGIHARA K, 1991, CANCER RES, V51, P381; YASUI W, 1993, INT J CANCER, V53, P36, DOI 10.1002/ijc.2910530108; Yasui W, 2011, PATHOL RES PRACT, V207, P608, DOI 10.1016/j.prp.2011.09.006	46	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47545	10.1371/journal.pone.0047545	http://dx.doi.org/10.1371/journal.pone.0047545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133598	gold, Green Submitted, Green Published			2022-12-25	WOS:000310702400010
J	Yu, GH; Jiang, LM; Xu, YY; Guo, HW; Liu, HY; Zhang, Y; Yang, HY; Yuan, CG; Ma, JY				Yu, Guohua; Jiang, Liming; Xu, Yuanyuan; Guo, Hongwei; Liu, Huiyan; Zhang, Yi; Yang, Huaiyi; Yuan, Chonggang; Ma, Jiyan			Silencing Prion Protein in MDA-MB-435 Breast Cancer Cells Leads to Pleiotropic Cellular Responses to Cytotoxic Stimuli	PLOS ONE			English	Article							INDUCED APOPTOSIS; OXIDATIVE STRESS; GASTRIC-CANCER; MCF-7 CELLS; PRO-PRION; DEATH; EXPRESSION; NEURONS; PATHWAY; LINE	Prion protein (PrP) is well studied for its pathogenic role in prion disease, but its potential contribution to other pathological processes is less understood. PrP is expressed in a variety of cancers and at least in pancreatic and breast cancers, its expression appears to be associated with poor prognosis. To understand the role of PrP in breast cancer cells, we knocked down PrP expression in MDA-MB-435 breast cancer cells with small interfering RNA and subjected these cells to a series of analyses. We found that PrP knockdown in these cells does not affect cell proliferation or colony formation, but significantly influences the cellular response to cytotoxic stimuli. Compared to control cells, PrP knockdown cells exhibited an increased susceptibility to serum deprivation induced apoptosis, no change to staurosporine- or paclitaxel-induced cell deaths, and a reduced susceptibility to chemotherapy drug doxorubicin-induced cell death. To understand the mechanism of unexpected role of PrP in exacerbating doxorubicin-induced cytotoxicity, we analyzed cell death related Bcl-2 family proteins. We found that PrP knockdown alters the expression of several Bcl-2 family proteins, correlating with increased resistance to doxorubicin-induced cytotoxicity. Moreover, the enhanced doxorubicin resistance is independent of DNA damage related p53 pathway, but at least partially through the ERK1/2 pathway. Together, our study revealed that silencing PrP in MDA-MB-435 breast cancer cells results in very different responses to various cytotoxic stimuli and ERK1/2 signaling pathway is involved in PrP silencing caused resistance to doxorubicin.	[Yu, Guohua; Jiang, Liming; Xu, Yuanyuan; Guo, Hongwei; Liu, Huiyan; Zhang, Yi; Yuan, Chonggang; Ma, Jiyan] E China Normal Univ, Sch Life Sci, Key Lab Brain Funct Genom, Shanghai Key Lab Brain Funct Genom,Minist Educ, Shanghai 200062, Peoples R China; [Zhang, Yi; Ma, Jiyan] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Yang, Huaiyi] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	East China Normal University; University System of Ohio; Ohio State University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Yu, GH (corresponding author), E China Normal Univ, Sch Life Sci, Key Lab Brain Funct Genom, Shanghai Key Lab Brain Funct Genom,Minist Educ, Shanghai 200062, Peoples R China.	ghyu@bio.ecnu.edu.cn; jiangliming222@163.com; ma.131@osu.edu		Ma, Jiyan/0000-0001-7150-1898	National Natural Science Foundation of China [31172347, 30871369]; Ministry of Education of China Project 985; Fundamental Research Funds for the Central Universities [78210051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China Project 985(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding was provided by the National Natural Science Foundation of China projects 31172347 and 30871369 (http://www.nsfc.gov.cn/Portal0/default152.htm); the Ministry of Education of China Project 985 (http://www.moe.edu.cn/); and the Fundamental Research Funds for the Central Universities project 78210051 (http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Anantharam V, 2008, FREE RADICAL BIO MED, V45, P1530, DOI 10.1016/j.freeradbiomed.2008.08.028; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Li CY, 2010, J BIOL CHEM, V285, P30328, DOI 10.1074/jbc.M110.147413; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Li QQ, 2009, CELL MOL LIFE SCI, V66, P504, DOI 10.1007/s00018-008-8548-6; Liang J, 2007, FASEB J, V21, P2247, DOI 10.1096/fj.06-7799com; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Mehrpour M, 2010, CANCER LETT, V290, P1, DOI 10.1016/j.canlet.2009.07.009; Meslin F, 2007, ANN ONCOL, V18, P1793, DOI 10.1093/annonc/mdm406; Meslin F, 2007, CANCER RES, V67, P10910, DOI 10.1158/0008-5472.CAN-07-0512; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Podar K, 2008, ONCOGENE, V27, P721, DOI 10.1038/sj.onc.1210679; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Sanz E, 2008, J NEUROCHEM, V105, P2404, DOI 10.1111/j.1471-4159.2008.05326.x; Shyu WC, 2005, J NEUROSCI RES, V80, P887, DOI 10.1002/jnr.20509; Shyu WC, 2002, MOL NEUROBIOL, V26, P1, DOI 10.1385/MN:26:1:001; Singh N, 2010, ANTIOXID REDOX SIGN, V12, P1271, DOI 10.1089/ars.2009.2628; Sollazzo V, 2012, J ORTHOP RES, V30, P1004, DOI 10.1002/jor.22034; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Tampio M, 2009, TOXICOL LETT, V188, P214, DOI 10.1016/j.toxlet.2009.04.016; Thomas R, 2008, PROSTATE, V68, P1405, DOI 10.1002/pros.20808; Wang N, 2011, NEUROCHEM RES, V36, P2169, DOI 10.1007/s11064-011-0541-z; Williams WM, 2004, NEUROPATH APPL NEURO, V30, P161, DOI 10.1111/j.1365-2990.2003.00523.x	36	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48146	10.1371/journal.pone.0048146	http://dx.doi.org/10.1371/journal.pone.0048146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133614	gold, Green Published, Green Submitted			2022-12-25	WOS:000310702400024
J	Zhou, K; Zou, RY; Stephanopoulos, G; Too, HP				Zhou, Kang; Zou, Ruiyang; Stephanopoulos, Gregory; Too, Heng-Phon			Metabolite Profiling Identified Methylerythritol Cyclodiphosphate Efflux as a Limiting Step in Microbial Isoprenoid Production	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; NON-MEVALONATE PATHWAY; ESCHERICHIA-COLI; MASS-SPECTROMETRY; ISOPENTENYL DIPHOSPHATE; PRECURSOR BIOSYNTHESIS; LYCOPENE PRODUCTION; ACCUMULATION; TERPENOIDS; STRESS	Isoprenoids are natural products that are all derived from isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). These precursors are synthesized either by the mevalonate (MVA) pathway or the 1-Deoxy-D-Xylulose 5-Phosphate (DXP) pathway. Metabolic engineering of microbes has enabled overproduction of various isoprenoid products from the DXP pathway including lycopene, artemisinic acid, taxadiene and levopimaradiene. To date, there is no method to accurately measure all the DXP metabolic intermediates simultaneously so as to enable the identification of potential flux limiting steps. In this study, a solid phase extraction coupled with ultra performance liquid chromatography mass spectrometry (SPE UPLC-MS) method was developed. This method was used to measure the DXP intermediates in genetically engineered E. coli. Unexpectedly, methylerythritol cyclodiphosphate (MEC) was found to efflux when certain enzymes of the pathway were over-expressed, demonstrating the existence of a novel competing pathway branch in the DXP metabolism. Guided by these findings, ispG was overexpressed and was found to effectively reduce the efflux of MEC inside the cells, resulting in a significant increase in downstream isoprenoid production. This study demonstrated the necessity to quantify metabolites enabling the identification of a hitherto unrecognized pathway and provided useful insights into rational design in metabolic engineering.	[Zhou, Kang; Zou, Ruiyang; Stephanopoulos, Gregory; Too, Heng-Phon] Singapore MIT Alliance, Chem & Pharmaceut Engn, Singapore, Singapore; [Too, Heng-Phon] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT)	Too, HP (corresponding author), Singapore MIT Alliance, Chem & Pharmaceut Engn, Singapore, Singapore.	heng-phon_too@nuhs.edu.sg	Zhou, Kang/AAQ-5730-2021; Zhou, Kang/AAI-9969-2021	Zhou, Kang/0000-0003-0606-7030; 	Singapore-MIT Alliance (Chemical Pharmaceutical Engineering)	Singapore-MIT Alliance (Chemical Pharmaceutical Engineering)	This work was supported by a grant from Singapore-MIT Alliance (Chemical Pharmaceutical Engineering). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Artsatbanov VY, 2012, BIOCHEMISTRY-MOSCOW+, V77, P362, DOI 10.1134/S0006297912040074; Batt AL, 2008, ANAL CHEM, V80, P5021, DOI 10.1021/ac800066n; Cheng YQ, 2007, APPL ENVIRON MICROB, V73, P3460, DOI 10.1128/AEM.01751-06; Chiuminatto U, 2010, ANAL CHEM, V82, P5636, DOI 10.1021/ac100607v; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Ding DW, 2009, RIV BIOL-BIOL FORUM, V102, P385; Freedman DL, 2004, APPL ENVIRON MICROB, V70, P4629, DOI 10.1128/AEM.70.8.4629-4634.2004; Gabrielsen M, 2004, J BIOL CHEM, V279, P52753, DOI 10.1074/jbc.M408895200; Gika HG, 2010, ANAL CHEM, V82, P8226, DOI 10.1021/ac1016612; Grawert T, 2009, ANGEW CHEM INT EDIT, V48, P5756, DOI 10.1002/anie.200900548; Henneman L, 2008, ANAL BIOCHEM, V383, P18, DOI 10.1016/j.ab.2008.08.023; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Ostrovsky D, 1998, ARCH MICROBIOL, V171, P69, DOI 10.1007/s002030050680; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Qu J, 2007, ANAL CHEM, V79, P3786, DOI 10.1021/ac062184r; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Rodriguez-Villalon A, 2008, J BIOTECHNOL, V135, P78, DOI 10.1016/j.jbiotec.2008.02.023; Xiao YL, 2010, CHEM COMMUN, V46, P7220, DOI 10.1039/c0cc02594a; Xue JF, 2011, APPL ENVIRON MICROB, V77, P2399, DOI 10.1128/AEM.02341-10; Yoon SH, 2006, BIOTECHNOL BIOENG, V94, P1025, DOI 10.1002/bit.20912; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhang BC, 2011, BIOCHEMISTRY-US, V50, P3570, DOI 10.1021/bi200113y; Zhang KL, 2006, ANAL BIOCHEM, V357, P225, DOI 10.1016/j.ab.2006.07.001; Zhang YL, 2011, J BIOL CHEM, V286, P26576, DOI 10.1074/jbc.M111.243261; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18	32	66	72	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47513	10.1371/journal.pone.0047513	http://dx.doi.org/10.1371/journal.pone.0047513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133596	Green Submitted, Green Published, gold			2022-12-25	WOS:000310702400009
J	Grewe, B; Ehrhardt, K; Hoffmann, B; Blissenbach, M; Brandt, S; Uberla, K				Grewe, Bastian; Ehrhardt, Katrin; Hoffmann, Bianca; Blissenbach, Maik; Brandt, Sabine; Ueberla, Klaus			The HIV-1 Rev Protein Enhances Encapsidation of Unspliced and Spliced, RRE-Containing Lentiviral Vector RNA	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENOMIC RNA; GENE-EXPRESSION; VIRAL-RNA; GAG; REPLICATION; CELLS; ELEMENTS; BINDING; MECHANISMS	Background: During the RNA encapsidation process of human immunodeficiency virus (HIV) viral genomic, unspliced RNA (gRNA) is preferentially incorporated into assembling virions. However, a certain amount of spliced viral transcripts can also be detected in viral particles. Recently, we observed that nuclear export of HIV and lentiviral vector gRNA by Rev is required for efficient encapsidation. Since singly-spliced HIV transcripts also contain the Rev-response element (RRE), we investigated if the encapsidation efficiency of RRE-containing spliced HIV-vector transcripts is also increased by the viral Rev protein. Findings: Starting with a lentiviral vector imitating the splicing pattern of HIV, we constructed vectors that express an unspliced transcript either identical in sequence to the singly-spliced or the fully-spliced RNA of the parental construct. After transfection of the different lentiviral vectors cytoplasmic and virion-associated RNA levels and vector titers were determined in the presence and absence of Rev. Rev enhanced the infectious titer of vectors containing an RRE 6 to 37-fold. Furthermore, Rev strongly increased encapsidation efficiencies of all RRE-containing transcripts up to 200-fold. However, a good correlation between encapsidation efficiency and lentiviral vector titer could only be observed for the gRNA. The infectious titer of the vector encoding the fully-spliced RNA without RRE as well as the encapsidation efficiency of all transcripts lacking the RRE was not influenced by Rev. Interestingly, the splicing process itself did not seem to interfere with packaging, since the encapsidation efficiencies of the same RNA expressed either by splicing or as an unspliced transcript did not differ significantly. Conclusions: Rev-mediated nuclear export enhances the encapsidation efficiency of RRE-containing lentiviral vector RNAs independently of whether they have been spliced or not.	[Grewe, Bastian; Ehrhardt, Katrin; Hoffmann, Bianca; Blissenbach, Maik; Brandt, Sabine; Ueberla, Klaus] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany	Ruhr University Bochum	Grewe, B (corresponding author), Ruhr Univ Bochum, Dept Mol & Med Virol, Univ Str 150, Bochum, Germany.	Bastian.Grewe@rub.de		Ehrhardt, Katrin/0000-0003-0471-2008	DFG [Ue45/11-1]; DFG graduate school [1045/2]	DFG(German Research Foundation (DFG)); DFG graduate school(German Research Foundation (DFG))	This work was funded by a grant from the DFG (Ue45/11-1). BG was and BH is supported by a fellowship from the DFG graduate school 1045/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson DS, 2003, J GENE MED, V5, P829, DOI 10.1002/jgm.415; Bagnarelli P, 1996, J VIROL, V70, P7603, DOI 10.1128/JVI.70.11.7603-7613.1996; Blissenbach M, 2010, J VIROL, V84, P6598, DOI 10.1128/JVI.02264-09; Bohne J, 2005, NUCLEIC ACIDS RES, V33, P825, DOI 10.1093/nar/gki185; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; BUTERA ST, 1994, J VIROL, V68, P2726, DOI 10.1128/JVI.68.4.2726-2730.1994; Cockrell AS, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-51; Cui Y, 1999, J VIROL, V73, P6171, DOI 10.1128/JVI.73.7.6171-6176.1999; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; Didierlaurent L, 2011, NUCLEIC ACIDS RES, V39, P8915, DOI 10.1093/nar/gkr577; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Galla M, 2004, MOL CELL, V16, P309, DOI 10.1016/j.molcel.2004.09.023; Geigenmuller U, 1996, J VIROL, V70, P667; Graf M, 2000, J VIROL, V74, P10822, DOI 10.1128/JVI.74.22.10822-10826.2000; Greatorex JS, 2006, J GEN VIROL, V87, P3039, DOI 10.1099/vir.0.81658-0; Grewe B, 2010, RECENT ADV HUMAN RET, P439; Grewe B, 2012, J VIROL, V86, P2990, DOI 10.1128/JVI.06874-11; Haas DL, 2000, MOL THER, V2, P71, DOI 10.1006/mthe.2000.0094; Houzet L, 2008, NUCLEIC ACIDS RES, V36, P2311, DOI 10.1093/nar/gkn069; Houzet L, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-30; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Kim SS, 2001, VIROLOGY, V282, P154, DOI 10.1006/viro.2000.0808; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Lever AML, 1999, GENE THERAPY TECHNOL, P61; Liang C, 2004, AIDS RES HUM RETROV, V20, P203, DOI 10.1089/088922204773004923; LUBAN J, 1994, J VIROL, V68, P3784, DOI 10.1128/JVI.68.6.3784-3793.1994; Lucke S, 2005, J VIROL, V79, P9359, DOI 10.1128/JVI.79.14.9359-9362.2005; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Mautino MR, 2000, HUM GENE THER, V11, P895, DOI 10.1089/10430340050015509; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; PENG HR, 1995, VIROLOGY, V206, P16, DOI 10.1016/S0042-6822(95)80015-8; POMERANTZ RJ, 1992, J VIROL, V66, P1809, DOI 10.1128/JVI.66.3.1809-1813.1992; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Saurya S, 2005, J CLIN VIROL, V33, P324, DOI 10.1016/j.jcv.2005.05.003; Schnell T, 2000, HUM GENE THER, V11, P439, DOI 10.1089/10430340050015905; Seguin B, 1998, J VIROL, V72, P9503; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Wagner R, 2000, HUM GENE THER, V11, P2403, DOI 10.1089/104303400750038507	39	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48688	10.1371/journal.pone.0048688	http://dx.doi.org/10.1371/journal.pone.0048688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133650	Green Published, Green Submitted, gold			2022-12-25	WOS:000310601300022
J	Coetzee, V; Faerber, SJ; Greeff, JM; Lefevre, CE; Re, DE; Perrett, DI				Coetzee, Vinet; Faerber, Stella J.; Greeff, Jaco M.; Lefevre, Carmen E.; Re, Daniel E.; Perrett, David I.			African Perceptions of Female Attractiveness	PLOS ONE			English	Article							SKIN COLOR DISTRIBUTION; TO-HIP RATIO; FACIAL ATTRACTIVENESS; SEXUAL SELECTION; BODY; AGE; JUDGMENTS; HEALTH; ATTITUDES; PEOPLE	Little is known about mate choice preferences outside Western, educated, industrialised, rich and democratic societies, even though these Western populations may be particularly unrepresentative of human populations. To our knowledge, this is the first study to test which facial cues contribute to African perceptions of African female attractiveness and also the first study to test the combined role of facial adiposity, skin colour (lightness, yellowness and redness), skin homogeneity and youthfulness in the facial attractiveness preferences of any population. Results show that youthfulness, skin colour, skin homogeneity and facial adiposity significantly and independently predict attractiveness in female African faces. Younger, thinner women with a lighter, yellower skin colour and a more homogenous skin tone are considered more attractive. These findings provide a more global perspective on human mate choice and point to a universal role for these four facial cues in female facial attractiveness.	[Coetzee, Vinet; Greeff, Jaco M.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Faerber, Stella J.] Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany; [Lefevre, Carmen E.; Re, Daniel E.; Perrett, David I.] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland	University of Pretoria; Otto Friedrich University Bamberg; University of St Andrews	Coetzee, V (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	vcoetzee@tuks.co.za	Greeff, Jaco M/A-5582-2011; Coetzee, Vinet/F-2155-2011	Greeff, Jaco/0000-0003-2951-6791; Coetzee, Vinet/0000-0003-1716-0804; Perrett, David/0000-0002-6025-0939	National Research Foundation (NRF) [77256]; British Academy Wolfson Research	National Research Foundation (NRF); British Academy Wolfson Research	The authors were funded by National Research Foundation (NRF; http://www.nrf.ac.za/) Scarce Skills Postdoctoral Fellowship (VC), NRF grant 77256 (JMG) and the British Academy Wolfson Research Professorship (DP;http://www.britac.ac.uk/funding/guide/WolfsonResearchProfessorships.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaluf S, 2002, J NUTR, V132, P399, DOI 10.1093/jn/132.3.399; [Anonymous], 2007, USING MULTIVARIATE S; Ardener EW, 1954, MAN, V54, P71, DOI 10.2307/2793760; Arora MK, 2011, CLIN BIOCHEM, V44, P1035, DOI 10.1016/j.clinbiochem.2011.06.984; Burriss RP, 2011, PERS INDIV DIFFER, V50, P542, DOI 10.1016/j.paid.2010.11.022; Coetzee V, 2011, THESIS U ST ANDREWS; Coetzee V, 2011, EAT BEHAV, V12, P72, DOI 10.1016/j.eatbeh.2010.09.006; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Etcoff N., 1999, SURVIVAL PRETTIEST S; Fink B, 2008, J EUR ACAD DERMATOL, V22, P493, DOI 10.1111/j.1468-3083.2007.02512.x; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Friis H, 2001, AM J CLIN NUTR, V73, P1058; Furnham A, 2004, PERS INDIV DIFFER, V36, P1171, DOI 10.1016/S0191-8869(03)00209-5; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Glenn EN, 2008, GENDER SOC, V22, P281, DOI 10.1177/0891243208316089; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Jokela M, 2009, EVOL HUM BEHAV, V30, P342, DOI 10.1016/j.evolhumbehav.2009.03.006; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Jones BC, 2001, EVOL HUM BEHAV, V22, P417, DOI 10.1016/S1090-5138(01)00083-6; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; KENRICK DT, 1992, BEHAV BRAIN SCI, V15, P75, DOI 10.1017/S0140525X00067595; le Grange D, 1998, AM J PSYCHIAT, V155, P250; Maddox KB, 2004, PERS SOC PSYCHOL REV, V8, P383, DOI 10.1207/s15327957pspr0804_4; Matoti-Mvalo T, 2011, S AFR J CLIN NUTR, V24, P40; Matts P, 2006, J AM ACAD DERMATOL, V56, pAB26; Matts P, 2007, J AM ACAD DERMATOL, V56, pAB26; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; MENKEN J, 1986, SCIENCE, V233, P1389, DOI 10.1126/science.3755843; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Peters M, 2007, ANIM BEHAV, V73, P937, DOI 10.1016/j.anbehav.2006.07.012; Puoane T, 2010, ETHNIC DIS, V20, P29; Re DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017859; Reither EN, 2009, DEMOGRAPHY, V46, P27, DOI 10.1353/dem.0.0037; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Said CP, 2011, PSYCHOL SCI, V22, P1183, DOI 10.1177/0956797611419169; Smith KL, 2007, EVOL HUM BEHAV, V28, P48, DOI 10.1016/j.evolhumbehav.2006.05.007; Steiger JH, 1982, PSYCHOL BULL, V87, P245; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Sugiyama LS, 2004, EVOL HUM BEHAV, V25, P51, DOI 10.1016/S1090-5138(03)00083-7; SYMON D, 1995, CHIC SEX HIST SOC, P80; Symons D, 1979, EVOLUTION HUMAN SEXU; Tiddeman B, 2012, CRANIOFACIAL IDENTIFICATION, P115; Tinlin RM, 2013, BRIT J PSYCHOL, V104, P235, DOI 10.1111/j.2044-8295.2012.02117.x; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; VANDENBERGHE PL, 1986, ETHNIC RACIAL STUD, V9, P87, DOI 10.1080/01419870.1986.9993516; World Health Organization, 2012, COUNTR HLTH PROF; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484	51	47	48	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48116	10.1371/journal.pone.0048116	http://dx.doi.org/10.1371/journal.pone.0048116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032HH	23144734	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300044
J	Green, DS; Boots, B; Crowe, TP				Green, Dannielle S.; Boots, Bas; Crowe, Tasman P.			Effects of Non-Indigenous Oysters on Microbial Diversity and Ecosystem Functioning	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; COMMUNITY STRUCTURE; ORGANIC-MATTER; RIBOSOMAL-RNA; SEDIMENTS; BIODIVERSITY; POPULATIONS; NITROGEN; ECOLOGY; METHANE	Invasive ecosystem engineers can physically and chemically alter the receiving environment, thereby affecting biodiversity and ecosystem functioning. The Pacific oyster, Crassostrea gigas, invasive throughout much of the world, can establish dense populations monopolising shorelines and possibly altering ecosystem processes including decomposition and nutrient cycling. The effects of increasing cover of invasive C. gigas on ecosystem processes and associated microbial assemblages in mud-flats were tested experimentally in the field. Pore-water nutrients (NH4+ and total oxidised nitrogen), sediment chlorophyll content, microbial activity, total carbon and nitrogen, and community respiration (CO2 and CH4) were measured to assess changes in ecosystem functioning. Assemblages of bacteria and functionally important microbes, including methanogens, methylotrophs and ammonia-oxidisers were assessed in the oxic and anoxic layers of sediment using terminal restriction length polymorphism of the bacterial 16S rRNA, mxaF, amoA and archaeal mcrA genes respectively. At higher covers (40 and 80%) of oysters there was significantly greater microbial activity, increased chlorophyll content, CO2 (13 fold greater) and CH4 (6 fold greater) emission from the sediment compared to mud-flats without C. gigas. At 10% cover, C. gigas increased the concentration of total oxidised nitrogen and altered the assemblage structure of ammonia-oxidisers and methanogens. Concentrations of pore-water NH4+ were increased by C. gigas regardless of cover. Invasive species can alter ecosystem functioning not only directly, but also indirectly, by affecting microbial communities vital for the maintenance of ecosystem processes, but the nature and magnitude of these effects can be non-linear, depending on invader abundance.	[Green, Dannielle S.; Crowe, Tasman P.] Univ Coll Dublin, Sch Biol & Environm Sci, Ecol & Evolut Grp, Dublin 2, Ireland; [Boots, Bas] Univ Coll Dublin, Sch Biosyst Engn, Dublin 2, Ireland	University College Dublin; University College Dublin	Green, DS (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Ecol & Evolut Grp, Dublin 2, Ireland.	danniellesgreen@gmail.com		Green, Dannielle/0000-0002-9122-8160	project SIMBIOSYS as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme [2007-B-CD-1-S1]; Irish Government under the National Development Plan [2007-2013, R10908]	project SIMBIOSYS as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme; Irish Government under the National Development Plan	This research was funded by the project SIMBIOSYS (2007-B-CD-1-S1) as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme, financed by the Irish Government under the National Development Plan 2007-2013, administered on behalf of the Department of the Environment, Heritage and Local Government by the Irish Environmental Protection Agency (EPA). Grant code: R10908. http://www.epa.ie/researchandeducation/research/research/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alef K., 1995, METHODS APPL SOIL MI, P350; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Aminot A., 2000, STANDARD PROCEDURE D; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brune A, 2000, FEMS MICROBIOL REV, V24, P691, DOI 10.1016/S0168-6445(00)00054-1; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COCHRAN WG, 1947, BIOMETRICS, V3, P22, DOI 10.2307/3001535; Crooks J. A., 1999, Invasive species and biodiversity management. Based on papers presented at the Norway/United Nations (UN) Conference on Alien Species, 2nd Trondheim Conference on Biodiversity, Trondheim, Norway, 1-5 July 1996., P103; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Ferry JG, 2008, ANN NY ACAD SCI, V1125, P147, DOI 10.1196/annals.1419.007; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; GRIFFITHS RP, 1983, MAR ECOL PROG SER, V10, P265, DOI 10.3354/meps010265; Hahn DR, 2003, BIOL INVASIONS, V5, P45, DOI 10.1023/A:1024002908143; Hallin S, 2009, ISMEJ, V1, P1; Hansen JW, 2000, MAR ECOL PROG SER, V199, P83, DOI 10.3354/meps199083; Hopkinson C, 2004, RESP AQUATIC ECOSYST, P122; Houghton J, 2001, INTERDISCIPL SCI REV, V26, P247, DOI 10.1179/030801801679485; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Irvine IC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00090; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; KHALIL MAK, 1993, CHEMOSPHERE, V26, pR9, DOI 10.1016/0045-6535(93)90407-V; Kristensen E, 1995, LIMNOL OCEANOGR, V40, P1430, DOI 10.4319/lo.1995.40.8.1430; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Leadbetter Jr, 2005, METHOD ENZYMOL, V397, P1; Lejart M, 2012, ESTUAR COAST, V35, P622, DOI 10.1007/s12237-011-9462-y; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Lohnis F, 1926, SOIL SCI, V22, P171; Lojen S, 1999, CHEM GEOL, V159, P223, DOI 10.1016/S0009-2541(99)00032-7; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Markert A, 2010, BIOL INVASIONS, V12, P15, DOI 10.1007/s10530-009-9425-4; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; McDonald IR, 1997, APPL ENVIRON MICROB, V63, P3218, DOI 10.1128/AEM.63.8.3218-3224.1997; MCKINLEY VL, 1992, APPL ENVIRON MICROB, V58, P1554, DOI 10.1128/AEM.58.5.1554-1563.1992; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; Naeem S., 2009, BIODIVERSITY ECOSYST; Newell RIE, 2005, NATO SCI S SS IV EAR, V47, P93; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Ogrinc N, 1997, WATER AIR SOIL POLL, V99, P333, DOI 10.1007/BF02406873; Olson L. J., 2006, Agricultural and Resource Economics Review, V35, P178; OREMLAND RS, 1982, APPL ENVIRON MICROB, V44, P1270, DOI 10.1128/AEM.44.6.1270-1276.1982; Ortega-Morales BO, 2010, CURR OPIN BIOTECH, V21, P346, DOI 10.1016/j.copbio.2010.02.007; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pepper IL, 2001, CLIMATE CHANGE SCI B; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Reeburgh W. S., 1993, P1; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rowan AK, 2003, FEMS MICROBIOL ECOL, V43, P195, DOI 10.1111/j.1574-6941.2003.tb01059.x; Scallan U, 2008, MOL ECOL RESOUR, V8, P95, DOI 10.1111/j.1471-8286.2007.01901.x; Schimel JP, 1998, GLOBAL CHANGE BIOL, V4, P745, DOI 10.1046/j.1365-2486.1998.00195.x; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; SLOTH NP, 1995, MAR ECOL PROG SER, V116, P163, DOI 10.3354/meps116163; SOTOMAYOR D, 1994, ESTUARIES, V17, P140, DOI 10.2307/1352563; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; SOWERS KR, 1983, APPL ENVIRON MICROB, V45, P684, DOI 10.1128/AEM.45.2.684-690.1983; Thomsen MS, 2011, ENVIRON RES, V111, P899, DOI 10.1016/j.envres.2011.05.024; Troost K, 2010, J SEA RES, V64, P145, DOI 10.1016/j.seares.2010.02.004; Underwood AJ, 1998, OECOLOGIA, V117, P570, DOI 10.1007/s004420050694; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9	63	35	36	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48410	10.1371/journal.pone.0048410	http://dx.doi.org/10.1371/journal.pone.0048410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144762	gold, Green Submitted, Green Published			2022-12-25	WOS:000310705300072
J	Mendes-Pereira, AM; Lord, CJ; Ashworth, A				Mendes-Pereira, Ana M.; Lord, Christopher J.; Ashworth, Alan			NLK Is a Novel Therapeutic Target for PTEN Deficient Tumour Cells	PLOS ONE			English	Article							RNA INTERFERENCE; HUMAN CANCER; INHIBITORS; SCREENS	PTEN (Phosphatase and tensin homolog) is a tumour suppressor gene commonly defective in human cancer, and is thus a potentially important therapeutic target. Targeting tumour suppressor loss-of-function is possible by exploiting the genetic concept of synthetic lethality (SL). By combining the use of isogenic models of PTEN deficiency with high-throughput RNA interference (RNAi) screening, we have identified Nemo-Like Kinase (NLK) inhibition as being synthetically lethal with PTEN deficiency. This SL is likely mediated by the transcription factor FOXO1 (Forkhead box O1), an NLK substrate, as the selectivity of NLK gene silencing for PTEN deficient cells can be reversed by FOXO1 knockdown. In addition, we provide evidence that PTEN defective cells targeted by NLK gene depletion undergo senescence, suggesting that NLK function is critical for the continued proliferation of PTEN deficient cells. Taken together, these data provide new insight into the potential of targeting of NLK to treat a range of tumourigenic conditions characterised by PTEN deficiency.	[Mendes-Pereira, Ana M.; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Ashworth, Alan] Inst Canc Res, Canc Res UK Gene Funct Grp, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Lord, CJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Chris.Lord@icr.ac.uk; Alan.Ashworth@icr.ac.uk	ANA Maria, Mendes-PEREIRA/J-1735-2014; Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012	ANA Maria, Mendes-PEREIRA/0000-0002-0002-0875; Lord, Christopher J/0000-0002-3226-0515	Breakthrough Breast Cancer; National Health Service by the Royal Marsden Hospital National Institute for Health Research Biomedical Research Centre; Cancer Research UK [14276] Funding Source: researchfish	Breakthrough Breast Cancer; National Health Service by the Royal Marsden Hospital National Institute for Health Research Biomedical Research Centre; Cancer Research UK(Cancer Research UK)	This work was supported by Breakthrough Breast Cancer. The authors acknowledge National Health Service funding by the Royal Marsden Hospital National Institute for Health Research Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Haynes JM, 2002, BIOCHEM PHARMACOL, V64, P385, DOI 10.1016/S0006-2952(02)01211-X; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Kim S, 2010, J BIOL CHEM, V285, P8122, DOI 10.1074/jbc.M110.101824; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Lee C, 2007, CELL CYCLE, V6, P394, DOI 10.4161/cc.6.4.3810; Lord CJ, 2008, DNA REPAIR, V7, P2010, DOI 10.1016/j.dnarep.2008.08.014; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Smukste I, 2003, CANCER CELL, V4, P419, DOI 10.1016/S1535-6108(03)00307-6; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809	16	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47249	10.1371/journal.pone.0047249	http://dx.doi.org/10.1371/journal.pone.0047249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144700	gold, Green Submitted, Green Published			2022-12-25	WOS:000310705300011
J	Adamberg, K; Seiman, A; Vilu, R				Adamberg, Kaarel; Seiman, Andrus; Vilu, Raivo			Increased Biomass Yield of Lactococcus lactis by Reduced Overconsumption of Amino Acids and Increased Catalytic Activities of Enzymes	PLOS ONE			English	Article							GROWTH; METABOLISM; CATABOLISM; BACTERIUM	Steady state cultivation and multidimensional data analysis (metabolic fluxes, absolute proteome, and transcriptome) are used to identify parameters that control the increase in biomass yield of Lactococcus lactis from 0.10 to 0.12 C-mol C-mol(-1) with an increase in specific growth rate by 5 times from 0.1 to 0.5 h(-1). Reorganization of amino acid consumption was expressed by the inactivation of the arginine deiminase pathway at a specific growth rate of 0.35 h(-1) followed by reduced over-consumption of pyruvate directed amino acids (asparagine, serine, threonine, alanine and cysteine) until almost all consumed amino acids were used only for protein synthesis at maximal specific growth rate. This balanced growth was characterized by a high glycolytic flux carrying up to 87% of the carbon flow and only amino acids that relate to nucleotide synthesis (glutamine, serine and asparagine) were consumed in higher amounts than required for cellular protein synthesis. Changes in the proteome were minor (mainly increase in the translation apparatus). Instead, the apparent catalytic activities of enzymes and ribosomes increased by 3.5 times (0.1 vs 0.5 h(-1)). The apparent catalytic activities of glycolytic enzymes and ribosomal proteins were seen to follow this regulation pattern while those of enzymes involved in nucleotide metabolism increased more than the specific growth rate (over 5.5 times). Nucleotide synthesis formed the most abundant biomonomer synthetic pathway in the cells with an expenditure of 6% from the total ATP required for biosynthesis. Due to the increase in apparent catalytic activity, ribosome translation was more efficient at higher growth rates as evidenced by a decrease of protein to mRNA ratios. All these effects resulted in a 30% decrease of calculated ATP spilling (0.1 vs 0.5 h(-1)). Our results show that bioprocesses can be made more efficient (using a balanced metabolism) by varying the growth conditions.	[Adamberg, Kaarel; Vilu, Raivo] Tallinn Univ Technol, Dept Chem, Tallinn, Estonia; [Adamberg, Kaarel; Seiman, Andrus; Vilu, Raivo] Competence Ctr Food & Fermentat Technol, Tallinn, Estonia; [Adamberg, Kaarel] Tallinn Univ Technol, Food Proc Dept, Tallinn, Estonia	Tallinn University of Technology; Tallinn University of Technology	Adamberg, K (corresponding author), Tallinn Univ Technol, Dept Chem, Tallinn, Estonia.	kaarel@tftak.eu	Adamberg, Kaarel/AAE-3295-2019; Adamberg, Kaarel/D-1084-2013; Vilu, Raivo/AAY-9780-2020	Adamberg, Kaarel/0000-0002-7203-925X; Adamberg, Kaarel/0000-0002-7203-925X; 	European Regional Development Fund [EU29994]; SA Archimedes [26.23-2/679]; Ministry of Education, Estonia [SF0140090s08]	European Regional Development Fund(European Commission); SA Archimedes; Ministry of Education, Estonia(Ministry of Education and Research, Estonia)	The financial support for this research was provided by the European Regional Development Fund project EU29994, SA Archimedes through the project 26.23-2/679 and Ministry of Education, Estonia, through the grant SF0140090s08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardo Y, 2006, BIOTECHNOL ADV, V24, P238, DOI 10.1016/j.biotechadv.2005.11.005; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Chambellon E, 2009, J BACTERIOL, V191, P873, DOI 10.1128/JB.01114-08; Christensen JE, 1999, ANTON LEEUW INT J G, V76, P217, DOI 10.1023/A:1002001919720; COCAIGNBOUSQUET M, 1995, J APPL BACTERIOL, V79, P108, DOI 10.1111/j.1365-2672.1995.tb03131.x; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dressaire C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000606; Even S, 2001, J BACTERIOL, V183, P3817, DOI 10.1128/JB.183.13.3817-3824.2001; Goel A, 2012, APPL ENVIRON MICROB, V78, P134, DOI 10.1128/AEM.05276-11; Hugenholtz J, 2008, INT DAIRY J, V18, P466, DOI 10.1016/j.idairyj.2007.11.015; Lahtvee PJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-12; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Marreddy RKR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010317; Medina M, 2008, INFECT IMMUN, V76, P2696, DOI 10.1128/IAI.00119-08; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Novak L, 1997, APPL ENVIRON MICROB, V63, P2665, DOI 10.1128/AEM.63.7.2665-2670.1997; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; POOLMAN B, 1988, J BACTERIOL, V170, P700, DOI 10.1128/jb.170.2.700-707.1988; Russell JB, 2007, J MOL MICROB BIOTECH, V13, P1, DOI 10.1159/000103591; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Spitsmeister M, 2010, J MICROBIOL METH, V82, P288, DOI 10.1016/j.mimet.2010.07.006; Wessely F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.46; Zhang GY, 2009, APPL ENVIRON MICROB, V75, P1080, DOI 10.1128/AEM.01416-08	23	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48223	10.1371/journal.pone.0048223	http://dx.doi.org/10.1371/journal.pone.0048223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133574	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800064
J	Hood-Nowotny, R; Schwarzinger, B; Schwarzinger, C; Soliban, S; Madakacherry, O; Aigner, M; Watzka, M; Gilles, J				Hood-Nowotny, Rebecca; Schwarzinger, Bettina; Schwarzinger, Clemens; Soliban, Sharon; Madakacherry, Odessa; Aigner, Martina; Watzka, Margarete; Gilles, Jeremie			An Analysis of Diet Quality, How It Controls Fatty Acid Profiles, Isotope Signatures and Stoichiometry in the Malaria Mosquito Anopheles arabiensis	PLOS ONE			English	Article							CULEX-PIPIENS; NUTRITIONAL REQUIREMENTS; PRIMARY PRODUCTIVITY; BODY-SIZE; NITROGEN; DIPTERA; CARBON; TERRESTRIAL; ECOSYSTEMS; CULICIDAE	Background: Knowing the underlying mechanisms of mosquito ecology will ensure effective vector management and contribute to the overall goal of malaria control. Mosquito populations show a high degree of population plasticity in response to environmental variability. However, the principle factors controlling population size and fecundity are for the most part unknown. Larval habitat and diet play a crucial role in subsequent mosquito fitness. Developing the most competitive insects for sterile insect technique programmes requires a "production" orientated perspective, to deduce the most effective larval diet formulation; the information gained from this process offers us some insight into the mechanisms and processes taking place in natural native mosquito habitats. Methodology/Principal Findings: Fatty acid profiles and de-novo or direct assimilation pathways, of whole-individual mosquitoes reared on a range of larval diets were determined using pyrolysis gas chromatograph/mass spectrometry. We used elemental analysis and isotope ratio mass spectrometry to measure individual-whole-body carbon, nitrogen and phosphorous values and to assess the impact of dietary quality on subsequent population stoichiometry, size, quality and isotopic signature. Diet had the greatest impact on fatty acid (FA) profiles of the mosquitoes, which exhibited a high degree of dietary routing, characteristic of generalist feeders. De-novo synthesis of a number of important FAs was observed. Mosquito C:N stoichiometry was fixed in the teneral stage. Dietary N content had significant influence on mosquito size, and P was shown to be a flexible pool which limited overall population size. Conclusions/Significance: Direct routing of FAs was evident but there was ubiquitous de-novo synthesis suggesting mosquito larvae are competent generalist feeders capable of survival on diet with varying characteristics. It was concluded that nitrogen availability in the larval diet controlled teneral mosquito size and that teneral CN ratio is a sex-and species-specific fixed parameter. This finding has significant implications for overall mosquito competitiveness and environmental management.	[Hood-Nowotny, Rebecca; Watzka, Margarete] Univ Vienna, Dept Terr Ecosyst Res, Vienna, Austria; [Schwarzinger, Bettina; Schwarzinger, Clemens] Johannes Kepler Univ Linz, Insitute Chem Technol Organ Mat, A-4040 Linz, Austria; [Soliban, Sharon; Madakacherry, Odessa; Aigner, Martina; Gilles, Jeremie] IAEA, Joint Food & Agr Org, Insect Pest Control Lab, Div Nucl Tech Food & Agr,Agcy Labs Seibersdorf, A-1400 Vienna, Austria	University of Vienna; Johannes Kepler University Linz; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Hood-Nowotny, R (corresponding author), Univ Vienna, Dept Terr Ecosyst Res, Vienna, Austria.	Rebecca.Clare.Hood-Nowotny@univie.ac.at	Schwarzinger, Clemens/AAA-4193-2022; Schwarzinger, Bettina/ABI-1039-2020; Watzka, Margarete/C-3843-2014	Watzka, Margarete/0000-0003-0334-1823; Hood-Nowotny, Rebecca/0000-0002-4398-3233; Schwarzinger, Clemens/0000-0002-8421-9063; Schwarzinger, Bettina/0000-0002-8273-8679	Elise Richter Program [V138]; Austrian Science Fund (FWF) [V 138] Funding Source: researchfish	Elise Richter Program(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Elise Richter Program V138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOV S, 1962, J INSECT PHYSIOL, V8, P319, DOI 10.1016/0022-1910(62)90035-5; Benedict MQ, 2009, J INSECT PHYSIOL, V55, P197, DOI 10.1016/j.jinsphys.2008.11.003; Bigogno C, 2002, PHYTOCHEMISTRY, V60, P497, DOI 10.1016/S0031-9422(02)00100-0; BOWMAN RA, 1989, COMMUN SOIL SCI PLAN, V20, P539, DOI 10.1080/00103628909368099; Briffa M, 2008, ANIM BEHAV, V75, P1053, DOI 10.1016/j.anbehav.2007.08.016; Burger Joep M S, 2004, Sci Aging Knowledge Environ, V2004, ppe30, DOI 10.1126/sageke.2004.28.pe30; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clements A. N., 1992, BIOL MOSQUITOES, V1; D'Angelo E, 2001, J ENVIRON QUAL, V30, P2206, DOI 10.2134/jeq2001.2206; DADD RH, 1980, J NUTR, V110, P1152, DOI 10.1093/jn/110.6.1152; DADD RH, 1979, J INSECT PHYSIOL, V25, P495, DOI 10.1016/S0022-1910(79)80008-6; DADD RH, 1987, INSECT BIOCHEM, V17, P7, DOI 10.1016/0020-1790(87)90137-5; DADD RH, 1988, J INSECT PHYSIOL, V34, P779, DOI 10.1016/0022-1910(88)90152-7; DADD RH, 1988, ENVIRON ENTOMOL, V17, P172, DOI 10.1093/ee/17.2.172; Dadd RH, 1988, EICOSAPENTAENOIC ACI; Damiens D, 2012, MED VET ENT IN PRESS; Demmelmair H, 1997, EUR J PEDIATR, V156, pS70, DOI 10.1007/PL00014276; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dyckmans J, 2002, PLANT CELL ENVIRON, V25, P469, DOI 10.1046/j.1365-3040.2002.00826.x; Elias DO, 2008, ANIM BEHAV, V76, P901, DOI 10.1016/j.anbehav.2008.01.032; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fougeron AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026899; Freeman EA, 2008, J STAT SOFTWARE, V23; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; Getz WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014539; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; GOLBERG L, 1948, BIOCHEM J, V43, P379, DOI 10.1042/bj0430379; Gr?ning M., 2004, INT STABLE ISOTOPE R; Hassett RP, 1997, LIMNOL OCEANOGR, V42, P648, DOI 10.4319/lo.1997.42.4.0648; Haubert D, 2011, SOIL BIOL BIOCHEM, V43, P490, DOI 10.1016/j.soilbio.2010.10.008; HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389; Helinski Michelle E.H., 2008, Parasites & Vectors, V1, P1; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; KLEINJAN JE, 1977, ANN ENTOMOL SOC AM, V70, P541, DOI 10.1093/aesa/70.4.541; Kurkiewicz S, 2003, J AM SOC MASS SPECTR, V14, P58, DOI 10.1016/S1044-0305(02)00817-6; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Markow TA, 1999, FUNCT ECOL, V13, P78, DOI 10.1046/j.1365-2435.1999.00285.x; Mayzaud P, 2007, MAR CHEM, V107, P202, DOI 10.1016/j.marchem.2007.07.001; Moribayashi Atsuko, 2004, Medical Entomology and Zoology, V55, P59; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; NASCI RS, 1986, ENVIRON ENTOMOL, V15, P874, DOI 10.1093/ee/15.4.874; Ng'habi KR, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-49; Nielsen SL, 1996, FUNCT ECOL, V10, P167, DOI 10.2307/2389840; Nikolic N, 2008, EUR FOOD RES TECHNOL, V227, P1543, DOI 10.1007/s00217-008-0877-z; Okanda F.M., 2002, Malaria Journal, pUnpaginated, DOI 10.1186/1475-2875-1-10; Okech BA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-50; Pomfret JC, 2006, ANIM BEHAV, V71, P567, DOI 10.1016/j.anbehav.2005.05.023; RATNAYAKE WMN, 1993, J AM COLL NUTR, V12, P651; REDFIELD AC, 1958, AM SCI, V46, P205; Robert V, 1998, J MED ENTOMOL, V35, P948, DOI 10.1093/jmedent/35.6.948; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Schindler DE, 1997, ECOLOGY, V78, P1816; SINGH KRP, 1957, J INSECT PHYSIOL, V1, P199, DOI 10.1016/0022-1910(57)90036-7; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; STANLEYSAMUELSON DW, 1981, J INSECT PHYSIOL, V27, P571, DOI 10.1016/0022-1910(81)90103-7; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Teal PEA, 2011, J APPL ENTOMOLOGY; Teng H-J, 1998, ENVIRON ENTOMOL, V27, P342; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Ul Haq I, 2010, J INSECT PHYSIOL, V56, P1807, DOI 10.1016/j.jinsphys.2010.07.011; Visanuvimol L, 2010, ECOL ENTOMOL, V35, P386, DOI 10.1111/j.1365-2311.2010.01195.x; Vrzal EM, 2010, J INSECT PHYSIOL, V56, P1659, DOI 10.1016/j.jinsphys.2010.06.011; Woods HA, 2004, FUNCTIONAL ECOLOGY, P103; YUVAL B, 1993, J INSECT BEHAV, V6, P333, DOI 10.1007/BF01048114; YUVAL B, 1993, OECOLOGIA, V95, P65, DOI 10.1007/BF00649508	69	31	31	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e45222	10.1371/journal.pone.0045222	http://dx.doi.org/10.1371/journal.pone.0045222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133509	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800002
J	de Kreuk, BJ; Anthony, EC; Geerts, D; Hordijk, PL				de Kreuk, Bart-Jan; Anthony, Eloise C.; Geerts, Dirk; Hordijk, Peter L.			The F-BAR Protein PACSIN2 Regulates Epidermal Growth Factor Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; EGF RECEPTOR; DOWN-REGULATION; QUANTITATIVE-ANALYSIS; MEDIATED ENDOCYTOSIS; PCH PROTEINS; HER2 LEVELS; TRAFFICKING; DEGRADATION; SYNDAPIN	Signaling via growth factor receptors, including the epidermal growth factor (EGF) receptor, is key to various cellular processes, such as proliferation, cell survival, and cell migration. In a variety of human diseases such as cancer, aberrant expression and activation of growth factor receptors can lead to disturbed signaling. Intracellular trafficking is crucial for proper signaling of growth factor receptors. As a result, the level of cell surface expression of growth factor receptors is an important determinant for the outcome of downstream signaling. BAR domain-containing proteins represent an important family of proteins that regulate membrane dynamics. In this study, we identify a novel role for the F-BAR protein PACSIN2 in the regulation of EGF receptor signaling. We show that internalized EGF as well as the (activated) EGF receptor translocated to PACSIN2-positive endosomes. Furthermore, loss of PACSIN2 increased plasma membrane expression of the EGF receptor in resting cells and increased EGF-induced phosphorylation of the EGF receptor. As a consequence, EGF-induced activation of Erk and Akt as well as cell proliferation were enhanced in PACSIN2-depleted cells. In conclusion, this study identifies a novel role for the F-BAR-domain protein PACSIN2 in regulating EGF receptor surface levels and EGF-induced downstream signaling.	[Hordijk, Peter L.] Univ Amsterdam, Swammerdam Inst Life Sci, Acad Med Ctr, Dept Mol Cell Biol,Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Geerts, Dirk] Erasmus Univ, Med Ctr, Dept Pediat Oncol Hematol, NL-3015 GE Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Hordijk, PL (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Acad Med Ctr, Dept Mol Cell Biol,Sanquin Res & Landsteiner Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	p.hordijk@sanquin.nl	Geerts, Dirk/K-8260-2015	Geerts, Dirk/0000-0002-6386-8187; Hordijk, Peter/0000-0002-3348-078X	Landsteiner Stichting voor Bloedtransfusie Research (LSBR) [0731]; Netherlands Organization for Scientific Research [40-00506-98-10013]	Landsteiner Stichting voor Bloedtransfusie Research (LSBR); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by an Landsteiner Stichting voor Bloedtransfusie Research (LSBR) Grant 0731.; The NanoPro 1000 System (ProteinSimple) in the Hordijk laboratory was enabled through a "middelgroot" investment grant (40-00506-98-10013) from the Netherlands Organization for Scientific Research. We thank Dr. M. Fernandez-Borja for stimulating discussions.	Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Grant SL, 2002, ONCOGENE, V21, P460, DOI 10.1038/sj.onc.1205100; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hanafusa H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1161; Hendriks BS, 2003, CANCER RES, V63, P1130; Hendriks BS, 2003, J BIOL CHEM, V278, P23343, DOI 10.1074/jbc.M300477200; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Hu JH, 2009, CELL SIGNAL, V21, P1686, DOI 10.1016/j.cellsig.2009.07.007; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; KING AC, 1984, BIOCHEM BIOPH RES CO, V124, P585, DOI 10.1016/0006-291X(84)91594-8; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Liu H, 2006, BIOCHEM BIOPH RES CO, V342, P537, DOI 10.1016/j.bbrc.2006.01.179; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Modregger J, 2000, J CELL SCI, V113, P4511; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Prasad NK, 2008, CARCINOGENESIS, V29, P25, DOI 10.1093/carcin/bgm213; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Shimada A, 2010, FEBS LETT, V584, P1111, DOI 10.1016/j.febslet.2010.02.058; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974	47	24	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43438	43453		10.1074/jbc.M112.391078	http://dx.doi.org/10.1074/jbc.M112.391078			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129763	Green Published, hybrid			2022-12-25	WOS:000312940800025
J	Machado, CF; Beraldo, FH; Santos, TG; Bourgeon, D; Landemberger, MC; Roffe, M; Martins, VR				Machado, Cleiton F.; Beraldo, Flavio H.; Santos, Tiago G.; Bourgeon, Dominique; Landemberger, Michele C.; Roffe, Martin; Martins, Vilma R.			Disease-associated Mutations in the Prion Protein Impair Laminin-induced Process Outgrowth and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCIBLE PROTEIN-1; CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; ANTI-BAX FUNCTION; CELLULAR PRION; PATHOGENIC MUTATIONS; NEURONAL APOPTOSIS; MITOMYCIN-C; THERMODYNAMIC STABILITY; HYDROPHOBIC CORE	Prions, the agents of transmissible spongiform encephalopathies, require the expression of prion protein (PrPC) to propagate disease. PrPC is converted into an abnormal insoluble form, PrPSc, that gains neurotoxic activity. Conversely, clinical manifestations of prion disease may occur either before or in the absence of PrPSc deposits, but the loss of normal PrPC function contribution for the etiology of these diseases is still debatable. Prion disease-associated mutations in PrPC represent one of the best models to understand the impact of PrPC loss-of-function. PrPC associates with various molecules and, in particular, the interaction of PrPC with laminin (Ln) modulates neuronal plasticity and memory formation. To assess the functional alterations associated with PrPC mutations, wild-type and mutated PrPC proteins were expressed in a neural cell line derived from a PrPC-null mouse. Treatment with the laminin gamma 1 chain peptide (Ln gamma 1), which mimics the Ln binding site for PrPC, increased intracellular calcium in cells expressing wild-type PrPC, whereas a significantly lower response was observed in cells expressing mutated PrPC molecules. The Ln gamma 1 did not promote process outgrowth or protect against staurosporine-induced cell death in cells expressing mutated PrPC molecules in contrast to cells expressing wild-type PrPC. The co-expression of wild-type PrPC with mutated PrPC molecules was able to rescue the Ln protective effects, indicating the lack of negative dominance of PrPC mutated molecules. These results indicate that PrPC mutations impair process outgrowth and survival mediated by Ln gamma 1 peptide in neural cells, which may contribute to the pathogenesis of genetic prion diseases.	[Machado, Cleiton F.; Santos, Tiago G.; Bourgeon, Dominique; Landemberger, Michele C.; Roffe, Martin; Martins, Vilma R.] AC Camargo Hosp, Int Res Ctr, BR-01508010 Sao Paulo, Brazil; [Machado, Cleiton F.; Santos, Tiago G.; Bourgeon, Dominique; Landemberger, Michele C.; Roffe, Martin; Martins, Vilma R.] CNPq MCT FAPESP, Natl Inst Translat Neurosci, BR-01508010 Sao Paulo, Brazil; [Beraldo, Flavio H.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Beraldo, Flavio H.] Univ Western Ontario, Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, London, ON N6A 5K8, Canada	A.C.Camargo Cancer Center; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Western University (University of Western Ontario); Western University (University of Western Ontario)	Martins, VR (corresponding author), AC Camargo Hosp, Int Res Ctr, Rua Tagua 440, BR-01508010 Sao Paulo, Brazil.	vmartins@cipe.accamargo.org.br	Martins, Vilma R/E-2547-2012; Martins, Vilma/N-5446-2019; Santos, Tiago/F-2387-2012; Roffe, Martin/S-1124-2019; Neurociencia, Inct/I-1011-2013; dos Santos, Tiago Goss/A-1538-2019; Roffé, Martín/I-1864-2013; Machado, Cleiton/I-5907-2014; Santos, Tiago Goss/AAQ-4272-2020; Landemberger, Michele Christine/P-3014-2014	Martins, Vilma R/0000-0002-2909-8502; Santos, Tiago/0000-0001-6641-7413; Roffe, Martin/0000-0001-7247-3067; dos Santos, Tiago Goss/0000-0001-6641-7413; Roffé, Martín/0000-0001-7247-3067; Machado, Cleiton/0000-0002-3313-3868; Santos, Tiago Goss/0000-0001-6641-7413; Landemberger, Michele Christine/0000-0002-3513-3554	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/01427-2]; Howard Hughes Medical Institute; National Institute of Tanslational Neuroscience-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Ciencia e Tecnologia (INNT-CNPq/MCT); Ludwig Institute for Cancer Research; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/61251-7, 09/51653-9, 08/04776-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Tanslational Neuroscience-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Ciencia e Tecnologia (INNT-CNPq/MCT); Ludwig Institute for Cancer Research; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2009/01427-2), the Howard Hughes Medical Institute, and the National Institute of Tanslational Neuroscience-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Ciencia e Tecnologia (INNT-CNPq/MCT) and Ludwig Institute for Cancer Research. This work was also supported by the following fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 06/61251-7 (to C. F. M.); 09/51653-9 (T. G. S.); 08/04776-5 (to D. B.).	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; BLACKER KL, 1987, J INVEST DERMATOL, V89, P536, DOI 10.1111/1523-1747.ep12461169; Blake DA, 2006, J GLAUCOMA, V15, P291, DOI 10.1097/01.ijg.0000212236.96039.9c; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735; Dorandeu A, 1998, BRAIN PATHOL, V8, P531; Esch T, 1999, J NEUROSCI, V19, P6417; Faucheux BA, 2011, NEUROPATH APPL NEURO, V37, P500, DOI 10.1111/j.1365-2990.2011.01179.x; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Flechsig E, 2003, EMBO J, V22, P3095, DOI 10.1093/emboj/cdg285; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Gray F, 1999, B ACAD NAT MED PARIS, V183, P305; Gray F, 1999, J NEUROPATH EXP NEUR, V58, P321, DOI 10.1097/00005072-199904000-00002; Greil CS, 2008, VIROLOGY, V379, P284, DOI 10.1016/j.virol.2008.07.006; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Jodoin J, 2007, J NEUROSCI, V27, P5081, DOI 10.1523/JNEUROSCI.0957-07.2007; Jodoin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006647; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Linden R., 2011, UCSD NATURE MOL 0729, DOI [10.1038/mp.a003935.01, DOI 10.1038/MP.A003935.01]; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Parchi P, 1998, BRAIN PATHOL, V8, P539; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; Ponchio L, 2000, CYTOTHERAPY, V2, P281, DOI 10.1080/146532400539215; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rodriguez A, 2005, NEUROSCIENCE, V131, P825, DOI 10.1016/j.neuroscience.2004.12.023; Rodriguez A, 2006, NEUROSCI LETT, V410, P115, DOI 10.1016/j.neulet.2006.09.084; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Romano SA, 2009, FASEB J, V23, P4308, DOI 10.1096/fj.09-138974; Rossetti G, 2011, J MOL BIOL, V411, P700, DOI 10.1016/j.jmb.2011.06.008; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V328, P14, DOI 10.1016/j.bbrc.2004.12.132; Sakurai-Yamashita Y, 2005, NEUROSCIENCE, V136, P281, DOI 10.1016/j.neuroscience.2005.06.095; Schiff E, 2008, TRAFFIC, V9, P1101, DOI 10.1111/j.1600-0854.2008.00746.x; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; van der Kamp MW, 2009, PROTEIN ENG DES SEL, V22, P461, DOI 10.1093/protein/gzp039; Watanabe Y, 2008, BIOCHEM BIOPH RES CO, V366, P244, DOI 10.1016/j.bbrc.2007.11.145; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	78	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43777	43788		10.1074/jbc.M112.428235	http://dx.doi.org/10.1074/jbc.M112.428235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132868	Green Published, hybrid			2022-12-25	WOS:000312940800056
J	Rauen, T; Grammatikos, AP; Hedrich, CM; Floege, J; Tenbrock, K; Ohl, K; Kyttaris, VC; Tsokos, GC				Rauen, Thomas; Grammatikos, Alexandros P.; Hedrich, Christian M.; Floege, Juergen; Tenbrock, Klaus; Ohl, Kim; Kyttaris, Vasileios C.; Tsokos, George C.			cAMP-responsive Element Modulator alpha (CREM alpha) Contributes to Decreased Notch-1 Expression in T Cells from Patients with Active Systemic Lupus Erythematosus (SLE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; IL-2 PRODUCTION; AUTOIMMUNE; DISEASE; GENE; METHYLATION; LYMPHOCYTES; BINDING; DIFFERENTIATION; MECHANISMS	Notch signaling constitutes an evolutionarily conserved pathway that transduces signals between neighboring cells and determines major decisions in cell proliferation, survival, and differentiation. Notch signaling has been shown to play a pivotal role during T cell lineage determination. T lymphocytes from patients with systemic lupus erythematosus (SLE) display a severely altered phenotype with several molecular and functional aberrations, including defective capacities to up-regulate Notch-1 receptor expression upon T cell receptor activation. Here, we demonstrate that basal Notch-1 expression is decreased in T cells from active SLE patients at the mRNA and protein levels in various T cell subpopulations. Notch-1 transcript numbers inversely correlate with disease activity in SLE patients. We provide evidence that both enhanced histone H3 methylation and CpG DNA methylation of the human Notch-1 promoter contribute to decreased Notch-1 expression in SLE T cells. Previous data from our group identified cAMP-responsive element modulator alpha (CREM alpha), which is up-regulated in SLE T cells, as a key regulator of epigenetic patterns and gene transcription, e. g. that of IL2 and IL17 genes. In this study, we observed increased CREM alpha binding to the Notch-1 promoter, which eventually resulted in significantly reduced Notch-1 promoter activity and gene transcription. Notably, decreased Notch-1 levels were associated with elevated IL-17A levels. Our data suggest a role for Notch-1 in SLE immunopathogenesis, and for the first time, we present molecular mechanisms that mediate dysregulated Notch-1 expression in SLE T cells.	[Rauen, Thomas; Grammatikos, Alexandros P.; Hedrich, Christian M.; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Rauen, Thomas; Floege, Juergen] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany; [Tenbrock, Klaus; Ohl, Kim] Rhein Westfal TH Aachen, Dept Pediat, Div Allergol & Immunol, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University; RWTH Aachen University	Tsokos, GC (corresponding author), Beth Israel Deaconess Med Ctr CLS 937, Div Rheumatol, Dept Med, 330 Brookline Ave, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Grammatikos, Alexandros/B-2804-2008; Hedrich, Christian/AAW-3958-2020; Hedrich, Christian/AAD-6855-2019; Rauen, Thomas/GLR-8682-2022	tsokos, george C/0000-0001-9589-2360; Grammatikos, Alexandros/0000-0001-6544-8218; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [R01 AI42269, R01 AI49954, R01 AI85567]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; START Grant for Young Researchers of the Medical Faculty of RWTH University of Aachen; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Aachen [E6-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269, R01AI049954, R01AI085567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START Grant for Young Researchers of the Medical Faculty of RWTH University of Aachen; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Aachen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 and a START Grant for Young Researchers of the Medical Faculty of RWTH University of Aachen (to T. R.) and Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Aachen Grant E6-6 (to K. T.).	Ahlmann M, 2009, J IMMUNOL, V182, P4167, DOI 10.4049/jimmunol.0802976; Bailey J, 2005, J MOL ENDOCRINOL, V34, P1, DOI 10.1677/jme.1.01594; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Chatterjee M, 2012, J IMMUNOL, V188, P1206, DOI 10.4049/jimmunol.1102773; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Ghosh D, 2012, ARTHRITIS RHEUM-US, V64, P799, DOI 10.1002/art.33375; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Janson PCJ, 2008, J IMMUNOL, V181, P2878, DOI 10.4049/jimmunol.181.4.2878; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Jurynczyk M, 2008, J IMMUNOL, V180, P2634, DOI 10.4049/jimmunol.180.4.2634; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Lippe R, 2012, J MOL CELL BIOL, V4, P121, DOI 10.1093/jmcb/mjs004; Liu ZL, 2009, CANCER BIOL THER, V8, P1840, DOI 10.4161/cbt.8.19.9440; Mi XB, 2008, ACTA PHARMACOL SIN, V29, P105, DOI 10.1111/j.1745-7254.2008.00739.x; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Sodsal P, 2008, LUPUS, V17, P645, DOI 10.1177/0961203308089406; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; Tenbrock K, 2007, RHEUMATOLOGY, V46, P1525, DOI 10.1093/rheumatology/kem154; Tenbrock K, 2004, INT REV IMMUNOL, V23, P333, DOI 10.1080/08830180490452558; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Zhao M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/931018	40	31	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42525	42532		10.1074/jbc.M112.425371	http://dx.doi.org/10.1074/jbc.M112.425371			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23124208	Green Published, hybrid			2022-12-25	WOS:000312501600014
J	Blanco-Rivero, A; Shutova, T; Roman, MJ; Villarejo, A; Martinez, F				Blanco-Rivero, Amaya; Shutova, Tatiana; Jose Roman, Maria; Villarejo, Arsenio; Martinez, Flor			Phosphorylation Controls the Localization and Activation of the Lumenal Carbonic Anhydrase in Chlamydomonas reinhardtii	PLOS ONE			English	Article							GREEN-ALGA; CHLOROPLAST ENVELOPE; CONCENTRATING MECHANISM; THYLAKOID MEMBRANES; STATE TRANSITIONS; PROTEIN-KINASES; IDENTIFICATION; LIGHT; ACCLIMATION; EFFICIENCY	Background: Cah3 is the only carbonic anhydrase (CA) isoform located in the thylakoid lumen of Chlamydomonas reinhardtii. Previous studies demonstrated its association with the donor side of the photosystem II (PSII) where it is required for the optimal function of the water oxidizing complex. However this enzyme has also been frequently proposed to perform a critical function in inorganic carbon acquisition and CO2 fixation and all mutants lacking Cah3 exhibit very poor growth after transfer to low CO2 conditions. Results/Conclusions: In the present work we demonstrate that after transfer to low CO2, Cah3 is phosphorylated and that phosphorylation is correlated to changes in its localization and its increase in activity. When C. reinhardtii wild-type cells were acclimated to limiting CO2 conditions, the Cah3 activity increased about 5-6 fold. Under these conditions, there were no detectable changes in the level of the Cah3 polypeptide. The increase in activity was specifically inhibited in the presence of Staurosporine, a protein kinase inhibitor, suggesting that the Cah3 protein was post-translationally regulated via phosphorylation. Immunoprecipitation and in vitro dephosphorylation experiments confirm this hypothesis. In vivo phosphorylation analysis of thylakoid polypeptides indicates that there was a 3-fold increase in the phosphorylation signal of the Cah3 polypeptide within the first two hours after transfer to low CO2 conditions. The increase in the phosphorylation signal was correlated with changes in the intracellular localization of the Cah3 protein. Under high CO2 conditions, the Cah3 protein was only associated with the donor side of PSII in the stroma thylakoids. In contrast, in cells grown at limiting CO2 the protein was partly concentrated in the thylakoids crossing the pyrenoid, which did not contain PSII and were surrounded by Rubisco molecules. Significance: This is the first report of a CA being post-translationally regulated and describing phosphorylation events in the thylakoid lumen.	[Blanco-Rivero, Amaya; Jose Roman, Maria; Villarejo, Arsenio; Martinez, Flor] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Shutova, Tatiana; Villarejo, Arsenio] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Autonomous University of Madrid; Umea University	Martinez, F (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	flor.martinez@uam.es	Martinez, Flor/ABG-2434-2020; Martinez, Flor/L-2390-2013	Martinez, Flor/0000-0002-4657-1090; Martinez, Flor/0000-0002-4657-1090; Blanco-Rivero, Amaya/0000-0002-2954-6205; Shutova, Tatyana/0000-0002-4095-9609	Spanish Ministry of Science and Innovation (MICINN) [BFU2006-09315, BIO2009-11340]; Swedish National Research Council, Kempe Foundation (STINT Program)	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swedish National Research Council, Kempe Foundation (STINT Program)	This work was supported by research grants from the Spanish Ministry of Science and Innovation (MICINN) to F.M. and A.V. (BFU2006-09315 and BIO2009-11340) and from the Swedish National Research Council, Kempe Foundation (STINT Program) to A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 1997, PHYSIOL PLANTARUM, V100, P863, DOI 10.1034/j.1399-3054.1997.1000412.x; ALLEN KD, 1994, PLANTA, V194, P42; ARONSSON G, 1995, BIOCHEMISTRY-US, V34, P2153, DOI 10.1021/bi00007a008; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Borkhsenious ON, 1998, PLANT PHYSIOL, V116, P1585, DOI 10.1104/pp.116.4.1585; BUMANN D, 1994, BIOCHEMISTRY-US, V33, P10906, DOI 10.1021/bi00202a009; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; FALK S, 1992, PLANT PHYSIOL, V100, P685, DOI 10.1104/pp.100.2.685; Ferro M, 2002, P NATL ACAD SCI USA, V99, P11487, DOI 10.1073/pnas.172390399; Finazzi G, 2004, PHOTOSYNTH RES, V82, P327, DOI 10.1007/s11120-004-0359-5; Fulgosi H, 1998, EMBO J, V17, P1577, DOI 10.1093/emboj/17.6.1577; Gal A, 1997, PHYSIOL PLANTARUM, V100, P869, DOI 10.1034/j.1399-3054.1997.1000413.x; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gunning BES, 1999, AUST J PLANT PHYSIOL, V26, P695, DOI 10.1071/PP99076; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Hanson DT, 2003, PLANT PHYSIOL, V132, P2267, DOI 10.1104/pp.103.023481; Henk MC, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P595; HUSIC HD, 1994, PLANT PHYSIOL, V105, P133, DOI 10.1104/pp.105.1.133; Im CS, 2003, PHOTOSYNTH RES, V75, P111, DOI 10.1023/A:1022800630430; KARLSSON J, 1995, PLANT PHYSIOL, V109, P533, DOI 10.1104/pp.109.2.533; Karlsson J, 1998, EMBO J, V17, P1208, DOI 10.1093/emboj/17.5.1208; KUCHITSU K, 1988, PROTOPLASMA, V144, P17, DOI 10.1007/BF01320276; LACOSTEROYAL G, 1987, PLANT PHYSIOL, V83, P602, DOI 10.1104/pp.83.3.602; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemeille S, 2010, MOL CELL PROTEOMICS, V9, P1281, DOI 10.1074/mcp.M000020-MCP201; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; Mitra M, 2005, CAN J BOT, V83, P780, DOI 10.1139/B05-065; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Moroney JV, 2011, PHOTOSYNTH RES, V109, P133, DOI 10.1007/s11120-011-9635-3; MORONEY JV, 1986, MOL GEN GENET, V204, P199, DOI 10.1007/BF00425498; Ohad I, 2001, ADV PHOTOSYNTH, V11, P419; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RAMAZANOV Z, 1992, PHYSIOL PLANTARUM, V85, P121; RAMAZANOV Z, 1994, PLANTA, V195, P210; RAVEN JA, 1995, PHYCOLOGIA, V34, P93, DOI 10.2216/i0031-8884-34-2-93.1; Raven JA, 1997, PLANT CELL ENVIRON, V20, P147, DOI 10.1046/j.1365-3040.1997.d01-67.x; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Rintamaki E, 2001, ADV PHOTOSYNTH, V11, P395; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Seigneurin-Berny D, 1999, PLANT J, V19, P217, DOI 10.1046/j.1365-313X.1999.00511.x; Shutova T, 2008, EMBO J, V27, P782, DOI 10.1038/emboj.2008.12; Sinetova MA, 2012, BBA-BIOENERGETICS, V1817, P1248, DOI 10.1016/j.bbabio.2012.02.014; SPALDING MH, 1983, PLANT PHYSIOL, V73, P268, DOI 10.1104/pp.73.2.268; Spetea C, 2004, P NATL ACAD SCI USA, V101, P1409, DOI 10.1073/pnas.0308164100; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Suzuki T, 2003, PLANT CELL PHYSIOL, V44, P76, DOI 10.1093/pcp/pcg010; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Turkina MV, 2006, PROTEOMICS, V6, P2693, DOI 10.1002/pmic.200500461; Villarejo A, 2002, EMBO J, V21, P1930, DOI 10.1093/emboj/21.8.1930; Villarejo A, 2001, PLANTA, V213, P286, DOI 10.1007/s004250000508; WILBUR KM, 1948, J BIOL CHEM, V176, P147; Wu HY, 2011, PLANT PHYSIOL, V157, P1015, DOI 10.1104/pp.111.184739	55	48	50	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e49063	10.1371/journal.pone.0049063	http://dx.doi.org/10.1371/journal.pone.0049063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139834	Green Published, Green Submitted, gold			2022-12-25	WOS:000311315300070
J	Hampton, J; Lladser, ME				Hampton, Jerrad; Lladser, Manuel E.			Estimation of Distribution Overlap of Urn Models	PLOS ONE			English	Article							U-STATISTICS; NONPARAMETRIC-ESTIMATION; PROBABILITY; CONVERGENCE; VARIANCE; UNIFRAC; THEOREM	A classical problem in statistics is estimating the expected coverage of a sample, which has had applications in gene expression, microbial ecology, optimization, and even numismatics. Here we consider a related extension of this problem to random samples of two discrete distributions. Specifically, we estimate what we call the dissimilarity probability of a sample, i.e., the probability of a draw from one distribution not being observed in k draws from another distribution. We show our estimator of dissimilarity to be a U-statistic and a uniformly minimum variance unbiased estimator of dissimilarity over the largest appropriate range of k. Furthermore, despite the non-Markovian nature of our estimator when applied sequentially over k, we show it converges uniformly in probability to the dissimilarity parameter, and we present criteria when it is approximately normally distributed and admits a consistent jackknife estimator of its variance. As proof of concept, we analyze V35 16S rRNA data to discern between various microbial environments. Other potential applications concern any situation where dissimilarity of two discrete distributions may be of interest. For instance, in SELEX experiments, each urn could represent a random RNA pool and each draw a possible solution to a particular binding site problem over that pool. The dissimilarity of these pools is then related to the probability of finding binding site solutions in one pool that are absent in the other.	[Hampton, Jerrad; Lladser, Manuel E.] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Lladser, ME (corresponding author), Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA.	manuel.lladser@colorado.edu	Lladser, Manuel/O-7557-2019	Lladser, Manuel/0000-0001-6843-6845	National Science Foundation grant DMS [0805950]; National Institutes of Health [HG4872]; Crohns and Colitis Foundation of America; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0805950] Funding Source: National Science Foundation	National Science Foundation grant DMS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by the National Science Foundation grant DMS #0805950, the National Institutes of Health (HG4872), and the Crohns and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD IA, 1980, ANN STAT, V8, P1395, DOI 10.1214/aos/1176345212; CLAYTON MK, 1987, J AM STAT ASSOC, V82, P305, DOI 10.2307/2289168; Durrett R, 2019, PROBABILITY THEORY E, V49; EFRON B, 1981, ANN STAT, V9, P586, DOI 10.1214/aos/1176345462; ESTY WW, 1983, ANN STAT, V11, P905, DOI 10.1214/aos/1176346256; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; GRAMS WF, 1973, ANN STAT, V1, P153, DOI 10.1214/aos/1193342392; Hampton JD, 2012, THESIS U COLORADO BO; HOEFFDING W, 1948, ANN MATH STAT, V19, P293, DOI 10.1214/aoms/1177730196; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Lijoi A, 2007, BIOMETRIKA, V94, P769, DOI 10.1093/biomet/asm061; Lladser ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021105; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mao CX, 2004, J AM STAT ASSOC, V99, P1108, DOI 10.1198/016214504000001709; SEN PK, 1977, ANN PROBAB, V5, P287, DOI 10.1214/aop/1176995853; SHAO J, 1989, ANN STAT, V17, P1176, DOI 10.1214/aos/1176347263; Shevtsova IG, 2010, DOKL MATH, V82, P862, DOI 10.1134/S1064562410060062; Slutsky E, 1925, METRON, V5, P3; STARR N, 1979, ANN STAT, V7, P644, DOI 10.1214/aos/1176344684; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121	24	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e42368	10.1371/journal.pone.0042368	http://dx.doi.org/10.1371/journal.pone.0042368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139734	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300001
J	Hoehn, M; Gruber, B; Sarre, SD; Lange, R; Henle, K				Hoehn, Marion; Gruber, Bernd; Sarre, Stephen D.; Lange, Rebecca; Henle, Klaus			Can Genetic Estimators Provide Robust Estimates of the Effective Number of Breeders in Small Populations?	PLOS ONE			English	Article							GECKO OEDURA-RETICULATA; SALMON SALMO-SALAR; GEHYRA-VARIEGATA GEKKONIDAE; REPRODUCTIVE SUCCESS; EFFECTIVE SIZE; LINKAGE DISEQUILIBRIUM; NATURAL-POPULATIONS; TEMPORAL-CHANGES; SINGLE-SAMPLE; N-E/N	The effective population size (Ne) is proportional to the loss of genetic diversity and the rate of inbreeding, and its accurate estimation is crucial for the monitoring of small populations. Here, we integrate temporal studies of the gecko Oedura reticulata, to compare genetic and demographic estimators of N-e. Because geckos have overlapping generations, our goal was to demographically estimate N-bI, the inbreeding effective number of breeders and to calculate the N-bI/N-a ratio (N-a = number of adults) for four populations. Demographically estimated NbI ranged from 1 to 65 individuals. The mean reduction in the effective number of breeders relative to census size (N-bI/N-a) was 0.1 to 1.1. We identified the variance in reproductive success as the most important variable contributing to reduction of this ratio. We used four methods to estimate the genetic based inbreeding effective number of breeders N-bI(gen) and the variance effective populations size N-eV(gen) estimates from the genotype data. Two of these methods - a temporal moment-based (MBT) and a likelihood-based approach (TM3) require at least two samples in time, while the other two were single-sample estimators - the linkage disequilibrium method with bias correction LDNe and the program ONeSAMP. The genetic based estimates were fairly similar across methods and also similar to the demographic estimates excluding those estimates, in which upper confidence interval boundaries were uninformative. For example, LDNe and ONeSAMP estimates ranged from 14-55 and 24-48 individuals, respectively. However, temporal methods suffered from a large variation in confidence intervals and concerns about the prior information. We conclude that the single-sample estimators are an acceptable short-cut to estimate N-bI for species such as geckos and will be of great importance for the monitoring of species in fragmented landscapes.	[Hoehn, Marion; Gruber, Bernd; Lange, Rebecca; Henle, Klaus] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Hoehn, Marion; Gruber, Bernd; Sarre, Stephen D.] Univ Canberra, Inst Appl Ecol, Bruce, ACT, Australia	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Canberra	Hoehn, M (corresponding author), Commonwealth Sci & Ind Res Org, Acton, ACT, Australia.	marion.hoehn@csiro.au	Henle, Klaus/I-6837-2013	Henle, Klaus/0000-0002-6647-5362; Sarre, Stephen D./0000-0002-7158-2517; Thier-Lange, Rebecca/0000-0002-7654-8545; Gruber, Bernd/0000-0003-0078-8179	University of Canberra, Australia; Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany; DAAD - German Exchange Organisation; University Erlangen-Nurnberg in Germany	University of Canberra, Australia; Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany(Helmholtz Association); DAAD - German Exchange Organisation; University Erlangen-Nurnberg in Germany	DAAD - German Exchange Organisation, University Erlangen-Nurnberg in Germany and a Collaborative Industry Grant from the University of Canberra, Australia and the Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2005, MOL ECOL, V14, P4097, DOI 10.1111/j.1365-294X.2005.02689.x; Araki H, 2007, MOL ECOL, V16, P953, DOI 10.1111/j.1365-294X.2006.03206.x; Ardren WR, 2003, MOL ECOL, V12, P35, DOI 10.1046/j.1365-294X.2003.01705.x; Aspi J, 2006, MOL ECOL, V15, P1561, DOI 10.1111/j.1365-294X.2006.02877.x; Barker JSF, 2011, MOL ECOL, V20, P4452, DOI 10.1111/j.1365-294X.2011.05324.x; Beebee TJC, 2009, MOL ECOL, V18, P4790, DOI 10.1111/j.1365-294X.2009.04398.x; Berthier P, 2002, GENETICS, V160, P741; Borges-Landaez PA, 2003, J HERPETOL, V37, P592, DOI 10.1670/26-02N; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Cockburn A, 2008, J ANIM ECOL, V77, P430, DOI 10.1111/j.1365-2656.2007.01351.x; CROW JF, 1955, EVOLUTION, V9, P202, DOI 10.2307/2405589; CROW JF, 1972, AM J HUM GENET, V24, P1; Engen S, 2010, J EVOLUTION BIOL, V23, P1148, DOI 10.1111/j.1420-9101.2010.01979.x; Engen S, 2007, EVOLUTION, V61, P1873, DOI 10.1111/j.1558-5646.2007.00155.x; England PR, 2006, CONSERV GENET, V7, P303, DOI 10.1007/s10592-005-9103-8; FELSENSTEIN J, 1971, GENETICS, V68, P581; Ferner J.W., 2007, HERPETOLOGICAL CIRCU, V35; Ficetola GF, 2010, ANIM CONSERV, V13, P82, DOI 10.1111/j.1469-1795.2009.00306.x; Frankham R, 2007, GENET RES, V89, P491, DOI 10.1017/S0016672308009695; Garant D, 2003, EVOLUTION, V57, P1133; Garant D, 2001, J HERED, V92, P137, DOI 10.1093/jhered/92.2.137; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 2002, FSTAT PROGRAM ESTIMA; Gruber B, 2008, OECOLOGIA, V154, P679, DOI 10.1007/s00442-007-0866-0; Gruber Bernd, 2004, Herpetological Review, V35, P245; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hedrick P, 2005, EVOLUTION, V59, P1596; Henle K, 2004, BIODIVERS CONSERV, V13, P1, DOI 10.1023/B:BIOC.0000004311.04226.29; Henle K., 1990, Herpetological Monographs, P30; Henle Klaus, 1997, Mertensiella, V7, P133; HILL WG, 1972, THEOR POPUL BIOL, V3, P278, DOI 10.1016/0040-5809(72)90004-4; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Hoehn M, 2006, CONSERV GENET, V7, P795, DOI 10.1007/s10592-005-9070-0; Hoehn M, 2005, MOL ECOL NOTES, V5, P730, DOI 10.1111/j.1471-8286.2005.01035.x; HOW RA, 1983, AUST WILDLIFE RES, V10, P543; Hutchinson WF, 2003, P ROY SOC B-BIOL SCI, V270, P2125, DOI 10.1098/rspb.2003.2493; Johnson JA, 2004, MOL ECOL, V13, P2617, DOI 10.1111/j.1365-294X.2004.02264.x; Borrell YJ, 2008, CONSERV GENET, V9, P807, DOI 10.1007/s10592-007-9400-5; Kaeuffer R, 2004, MOL ECOL, V13, P483, DOI 10.1046/j.1365-294X.2003.02046.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KITCHENER DJ, 1988, J HERPETOL, V22, P401, DOI 10.2307/1564335; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Lande R., 1987, VIABLE POPULATIONS C, P87, DOI DOI 10.1017/CBO9780511623400.007; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McLean JE, 2008, CONSERV GENET, V9, P295, DOI 10.1007/s10592-007-9340-0; MENKENS GE, 1988, ECOLOGY, V69, P1952, DOI 10.2307/1941172; Nielsen R, 2001, GENETICS, V157, P1673; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Paulissen MA, 2000, J HERPETOL, V34, P282, DOI 10.2307/1565425; Phillipsen IC, 2011, EVOLUTION, V65, P2927, DOI 10.1111/j.1558-5646.2011.01356.x; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SACHS L, 1982, APPL STAT; SARRE S, 1995, AUST J ECOL, V20, P288, DOI 10.1111/j.1442-9993.1995.tb00541.x; SARRE S, 1995, MOL ECOL, V4, P395, DOI 10.1111/j.1365-294X.1995.tb00233.x; SARRE S, 1995, BIOL CONSERV, V71, P25, DOI 10.1016/0006-3207(94)00017-K; Sarre SD, 1998, J HERPETOL, V32, P153, DOI 10.2307/1565291; Schmeller DS, 2007, CONSERV BIOL, V21, P142, DOI 10.1111/j.1523-1739.2006.00554.x; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Skrbinsek T, 2012, MOL ECOL, V21, P862, DOI 10.1111/j.1365-294X.2011.05423.x; Stiver JR, 2008, BIOL CONSERV, V141, P472, DOI 10.1016/j.biocon.2007.10.018; Storz JF, 2002, EVOLUTION, V56, P817; Storz JF, 2001, EVOLUTION, V55, P1215; Tallmon DA, 2004, GENETICS, V167, P977, DOI 10.1534/genetics.103.026146; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tallmon DA, 2010, MOL ECOL RESOUR, V10, P684, DOI 10.1111/j.1755-0998.2010.02831.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang JL, 2010, EVOLUTION, V64, P1704, DOI 10.1111/j.1558-5646.2010.00953.x; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2007, MOL ECOL NOTES, V7, P21, DOI 10.1111/j.1471-8286.2006.01567.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2011, ECOLOGY, V92, P1513, DOI 10.1890/10-1796.1; Waples RS, 2011, MOL ECOL RESOUR, V11, P162, DOI 10.1111/j.1755-0998.2010.02942.x; Waples RS, 2010, MOL ECOL RESOUR, V10, P785, DOI 10.1111/j.1755-0998.2010.02876.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; Waples RS, 2002, MOL ECOL, V11, P1029, DOI 10.1046/j.1365-294X.2002.01504.x; WAPLES RS, 1989, GENETICS, V121, P379; Waples RS, 2002, GENETICS, V161, P783; WRIGHT S., 1938, Science (Washington), V87, P430; Wright S, 1931, GENETICS, V16, P0097; Zhdanova OL, 2008, J HERED, V99, P694, DOI 10.1093/jhered/esn061	93	20	20	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48464	10.1371/journal.pone.0048464	http://dx.doi.org/10.1371/journal.pone.0048464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139784	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300032
J	Keihaninejad, S; Ryan, NS; Malone, IB; Modat, M; Cash, D; Ridgway, GR; Zhang, H; Fox, NC; Ourselin, S				Keihaninejad, Shiva; Ryan, Natalie S.; Malone, Ian B.; Modat, Marc; Cash, David; Ridgway, Gerard R.; Zhang, Hui; Fox, Nick C.; Ourselin, Sebastien			The Importance of Group-Wise Registration in Tract Based Spatial Statistics Study of Neurodegeneration: A Simulation Study in Alzheimer's Disease	PLOS ONE			English	Article							DIFFUSION-TENSOR MRI; WHITE-MATTER CHANGES; IMAGE REGISTRATION; GREY-MATTER; BRAIN; ATROPHY; NORMALIZATION; DEGENERATION; OPTIMIZATION; INTEGRITY	Tract-based spatial statistics (TBSS) is a popular method for the analysis of diffusion tensor imaging data. TBSS focuses on differences in white matter voxels with high fractional anisotropy (FA), representing the major fibre tracts, through registering all subjects to a common reference and the creation of a FA skeleton. This work considers the effect of choice of reference in the TBSS pipeline, which can be a standard template, an individual subject from the study, a study-specific template or a group-wise average. While TBSS attempts to overcome registration error by searching the neighbourhood perpendicular to the FA skeleton for the voxel with maximum FA, this projection step may not compensate for large registration errors that might occur in the presence of pathology such as atrophy in neurodegenerative diseases. This makes registration performance and choice of reference an important issue. Substantial work in the field of computational anatomy has shown the use of group-wise averages to reduce biases while avoiding the arbitrary selection of a single individual. Here, we demonstrate the impact of the choice of reference on: (a) specificity (b) sensitivity in a simulation study and (c) a real-world comparison of Alzheimer's disease patients to controls. In (a) and (b), simulated deformations and decreases in FA were applied to control subjects to simulate changes of shape and WM integrity similar to what would be seen in AD patients, in order to provide a "ground truth" for evaluating the various methods of TBSS reference. Using a group-wise average atlas as the reference outperformed other references in the TBSS pipeline in all evaluations.	[Keihaninejad, Shiva; Ryan, Natalie S.; Malone, Ian B.; Modat, Marc; Cash, David; Ridgway, Gerard R.; Fox, Nick C.; Ourselin, Sebastien] UCL, Inst Neurol, Dementia Res Ctr, London, England; [Keihaninejad, Shiva; Modat, Marc; Cash, David; Zhang, Hui; Ourselin, Sebastien] UCL, Ctr Med Image Comp, Dept Med Phys & Bioengn, London, England; [Ridgway, Gerard R.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Keihaninejad, S (corresponding author), UCL, Inst Neurol, Dementia Res Ctr, London, England.	s.keihaninejad@ucl.ac.uk	Fox, Nick C/B-1319-2009; Fox, Nick C/AAE-1849-2021; Ridgway, Gerard/F-5145-2010; Cash, David/V-3617-2019; Ourselin, Sebastien/K-6960-2015	Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Ridgway, Gerard/0000-0002-7676-7860; Cash, David/0000-0001-7833-616X; Malone, Ian/0000-0001-7512-7856; Ourselin, Sebastien/0000-0002-5694-5340; Modat, Marc/0000-0002-5277-8530; Zhang, Hui/0000-0002-5426-2140	Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres; Alzheimer's Research UK; Medical Research Council (MRC) [G0900421, G116/143]; Wellcome Trust [079866/Z/06/Z]; Computational Biology Research Center [168]; MRC [G0801306, G116/143, G0900421] Funding Source: UKRI; Alzheimers Research UK [ART-EG2010B-1] Funding Source: researchfish; Medical Research Council [G0801306, G0900421, G116/143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish	Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres(National Institute for Health Research (NIHR)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Computational Biology Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was undertaken at University College London Hospital/University College London, who received a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme. The Dementia Research Centre is an Alzheimer's Research UK Co-ordinating Centre and has also received equipment funded by Alzheimer's Research UK. Natalie S. Ryan is supported by an Medical Research Council (MRC) Clinical Research Training Fellowship (G0900421), Gerard Ridgway is supported by core funding from the Wellcome Trust, Grant 079866/Z/06/Z, and Nick C. Fox holds an MRC Senior Clinical Fellowship (G116/143) and is an NIHR senior investigator. Marc Modat and Sebastien Ourselin were supported by Computational Biology Research Center grant 168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Andersson JLR, 2007, TECHNICAL REPORT; Arenaza-Urquijo EM, 2011, AM J GERIAT PSYCHIAT, V19, P33, DOI 10.1097/JGP.0b013e3181e448e1; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Bosch B., 2010, NEUROBIOLOGY AGING; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Cook P. A., 2006, P 14 ANN M ISMRM SEA, P2759; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Geng XJ, 2010, LECT NOTES COMPUT SC, V6361, P598; Geng XJ, 2009, NEUROIMAGE, V47, P1341, DOI 10.1016/j.neuroimage.2009.04.024; Ibanez L., 2005, ITK SOFTWARE GUIDE; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Liu Y, 2009, NEUROBIOL AGING, V32, P1558; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Park HJ, 2003, NEUROIMAGE, V20, P1995, DOI 10.1016/j.neuroimage.2003.08.008; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Shen S, 2007, MAGN RESON IMAGING, V25, P1385, DOI 10.1016/j.mri.2007.03.025; Shi L, 2009, AM J NEURORADIOL, V30, P1302, DOI 10.3174/ajnr.A1577; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wang Y, 2011, NEUROIMAGE, V55, P1577, DOI 10.1016/j.neuroimage.2011.01.038; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013; Zalesky A, 2011, MAGN RESON IMAGING, V29, P111, DOI 10.1016/j.mri.2010.06.027; Zarei M, 2009, STROKE, V40, P773, DOI 10.1161/STROKEAHA.108.530832; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	44	61	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e45996	10.1371/journal.pone.0045996	http://dx.doi.org/10.1371/journal.pone.0045996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139736	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300002
J	Puri, S; Kumar, R; Chadha, S; Tati, S; Conti, HR; Hube, B; Cullen, PJ; Edgerton, M				Puri, Sumant; Kumar, Rohitashw; Chadha, Sonia; Tati, Swetha; Conti, Heather R.; Hube, Bernhard; Cullen, Paul J.; Edgerton, Mira			Secreted Aspartic Protease Cleavage of Candida albicans Msb2 Activates Cek1 MAPK Signaling Affecting Biofilm Formation and Oropharyngeal Candidiasis	PLOS ONE			English	Article							INVASIVE GROWTH; KINASE HOMOLOG; MUCIN MSB2; CELL-WALL; PROTEINASES; GENES; TRANSDUCTION; EXPRESSION; INFECTION; VIRULENCE	Perception of external stimuli and generation of an appropriate response are crucial for host colonization by pathogens. In pathogenic fungi, mitogen activated protein kinase (MAPK) pathways regulate dimorphism, biofilm/mat formation, and virulence. Signaling mucins, characterized by a heavily glycosylated extracellular domain, a transmembrane domain, and a small cytoplasmic domain, are known to regulate various signaling pathways. In Candida albicans, the mucin Msb2 regulates the Cek1 MAPK pathway. We show here that Msb2 is localized to the yeast cell wall and is further enriched on hyphal surfaces. A msb2 Delta/Delta strain formed normal hyphae but had biofilm defects. Cek1 (but not Mkc1) phosphorylation was absent in the msb2 Delta/Delta mutant. The extracellular domain of Msb2 was shed in cells exposed to elevated temperature and carbon source limitation, concomitant with germination and Cek1 phosphorylation. Msb2 shedding occurred differentially in cells grown planktonically or on solid surfaces in the presence of cell wall and osmotic stressors. We further show that Msb2 shedding and Cek1 phosphorylation were inhibited by addition of Pepstatin A (PA), a selective inhibitor of aspartic proteases (Saps). Analysis of combinations of Sap protease mutants identified a sap8D/D mutant with reduced MAPK signaling along with defects in biofilm formation, thereby suggesting that Sap8 potentially serves as a major regulator of Msb2 processing. We further show that loss of either Msb2 (msb2 Delta/Delta) or Sap8 (sap8 Delta/Delta) resulted in higher C. albicans surface beta-glucan exposure and msb2 Delta/Delta showed attenuated virulence in a murine model of oral candidiasis. Thus, Sapmediated proteolytic cleavage of Msb2 is required for activation of the Cek1 MAPK pathway in response to environmental cues including those that induce germination. Inhibition of Msb2 processing at the level of Saps may provide a means of attenuating MAPK signaling and reducing C. albicans virulence.	[Puri, Sumant; Kumar, Rohitashw; Chadha, Sonia; Tati, Swetha; Conti, Heather R.; Edgerton, Mira] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA; [Chadha, Sonia] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India; [Conti, Heather R.] Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA; [Hube, Bernhard] Hans Knoell Inst Jena, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mechanisms, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany; [Cullen, Paul J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Bhabha Atomic Research Center (BARC); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Edgerton, M (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.	edgerto@buffalo.edu	Puri, Sumant/ABF-4209-2021; Puri, Sumant/H-4323-2012; Kumar, Rohitashw/D-1968-2014; Chadha, Sonia/AAJ-2483-2020	Kumar, Rohitashw/0000-0001-8695-3555; CHADHA, SONIA/0000-0003-2831-6907	National Institute of Dental Research, National Institutes of Health, USA [R01DE010641]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098629] Funding Source: NIH RePORTER	National Institute of Dental Research, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant R01DE010641 (ME) from the National Institute of Dental Research, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Aoki W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032513; Aoki W, 2011, J BIOCHEM, V150, P431, DOI 10.1093/jb/mvr073; Baev D, 2004, J BIOL CHEM, V279, P55060, DOI 10.1074/jbc.M411031200; Baev D, 2001, MICROBIOL-SGM, V147, P3323, DOI 10.1099/00221287-147-12-3323; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Cantero PD, 2011, MOL MICROBIOL, V80, P715, DOI 10.1111/j.1365-2958.2011.07604.x; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Ebanks RO, 2006, PROTEOMICS, V6, P2147, DOI 10.1002/pmic.200500100; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; FONZI WA, 1993, GENETICS, V134, P717; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; Karunanithi S, 2010, CURR BIOL, V20, P1389, DOI 10.1016/j.cub.2010.06.033; Kretschmar M, 2002, MICROB PATHOGENESIS, V32, P61, DOI 10.1006/mpat.2001.0478; Kruppa M, 2006, FEMS YEAST RES, V6, P149, DOI 10.1111/j.1567-1364.2006.00024.x; Kumar R, 2011, J BIOL CHEM, V286, P43748, DOI 10.1074/jbc.M111.311175; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lillehoj EP, 2003, BIOCHEM BIOPH RES CO, V307, P743, DOI 10.1016/S0006-291X(03)01260-9; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; MONOD M, 1994, MOL MICROBIOL, V13, P357, DOI 10.1111/j.1365-2958.1994.tb00429.x; Munro CA, 2002, TRENDS MICROBIOL, V10, P173, DOI 10.1016/S0966-842X(02)02330-2; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197; Newport G, 1997, J BIOL CHEM, V272, P28954, DOI 10.1074/jbc.272.46.28954; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Perez-Nadales E, 2011, PLANT CELL, V23, P1171, DOI 10.1105/tpc.110.075093; Ramage G, 2012, MYCOPATHOLOGIA, V174, P11, DOI 10.1007/s11046-012-9522-2; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Roman E, 2009, EUKARYOT CELL, V8, P1235, DOI 10.1128/EC.00081-09; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Schaller M, 2000, J INVEST DERMATOL, V114, P712, DOI 10.1046/j.1523-1747.2000.00935.x; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Silverman HS, 2003, GLYCOBIOLOGY, V13, P265, DOI 10.1093/glycob/cwg028; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Sorgo AG, 2011, EUKARYOT CELL, V10, P1071, DOI 10.1128/EC.05011-11; Sorgo AG, 2010, YEAST, V27, P661, DOI 10.1002/yea.1775; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; Szafranski-Schneider E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002501; Vadaie N, 2002, GLYCOBIOLOGY, V12, P589, DOI 10.1093/glycob/cwf074; Vadaie N, 2008, J CELL BIOL, V181, P1073, DOI 10.1083/jcb.200704079; Yi S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001117	50	61	66	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e46020	10.1371/journal.pone.0046020	http://dx.doi.org/10.1371/journal.pone.0046020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139737	gold, Green Published			2022-12-25	WOS:000311315300003
J	Weir, HJM; Murray, TK; Kehoe, PG; Love, S; Verdin, EM; O'Neill, MJ; Lane, JD; Balthasar, N				Weir, Heather J. M.; Murray, Tracey K.; Kehoe, Patrick G.; Love, Seth; Verdin, Eric M.; O'Neill, Michael J.; Lane, Jon D.; Balthasar, Nina			CNS SIRT3 Expression Is Altered by Reactive Oxygen Species and in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SIRT3-MEDIATED DEACETYLATION; MITOCHONDRIAL DYSFUNCTION; LYSINE ACETYLATION; TRANSGENIC MOUSE; OXIDATIVE DAMAGE; A-BETA; STRESS; RESTRICTION; MECHANISMS	Progressive mitochondrial dysfunction contributes to neuronal degeneration in age-mediated disease. An essential regulator of mitochondrial function is the deacetylase, sirtuin 3 (SIRT3). Here we investigate a role for CNS Sirt3 in mitochondrial responses to reactive oxygen species (ROS)- and Alzheimer's disease (AD)-mediated stress. Pharmacological augmentation of mitochondrial ROS increases Sirt3 expression in primary hippocampal culture with SIRT3 over-expression being neuroprotective. Furthermore, Sirt3 expression mirrors spatiotemporal deposition of beta-amyloid in an AD mouse model and is also upregulated in AD patient temporal neocortex. Thus, our data suggest a role for SIRT3 in mechanisms sensing and tackling ROS- and AD-mediated mitochondrial stress.	[Weir, Heather J. M.; Lane, Jon D.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Murray, Tracey K.; O'Neill, Michael J.] Eli Lilly & Co Ltd, Neurodegenerat Dis Drug Hunting Team, Windlesham, Surrey, England; [Kehoe, Patrick G.; Love, Seth] Univ Bristol, Dementia Res Grp, Inst Clin Neurosci, Bristol, Avon, England; [Verdin, Eric M.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Balthasar, Nina] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol; Eli Lilly; University of Bristol; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Bristol	Lane, JD (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	jon.lane@bristol.ac.uk; nina.balthasar@bristol.ac.uk	Lane, Jon D/A-9320-2011; Verdin, Eric/AAB-7999-2019; Kehoe, Patrick/P-8760-2018	Love, Seth/0000-0001-8683-3625; Verdin, Eric/0000-0003-3703-3183; Lane, Jon/0000-0002-6828-5888; Kehoe, Patrick/0000-0002-7542-1139	Alzheimer's Research UK; Alzheimer's Brain Bank UK; BRACE (Bristol Research into Alzheimer's and Care of the Elderly); BBSRC CASE PhD studentship; Eli Lilly Co. Ltd; Lister Institute for Preventive Medicine Prize Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-EG2005B-1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimer's Brain Bank UK; BRACE (Bristol Research into Alzheimer's and Care of the Elderly); BBSRC CASE PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eli Lilly Co. Ltd(Eli Lilly); Lister Institute for Preventive Medicine Prize Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The South West Dementia Brain Bank, under directorship of SL and PGK, is supported by grants from Alzheimer's Research UK, Alzheimer's Brain Bank UK and BRACE (Bristol Research into Alzheimer's and Care of the Elderly). HJMW was funded by a BBSRC CASE PhD studentship with support from Eli Lilly & Co. Ltd to NB and JDL. NB was funded by a Lister Institute for Preventive Medicine Prize Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GEINISMAN Y, 1986, P NATL ACAD SCI USA, V83, P3027, DOI 10.1073/pnas.83.9.3027; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hallows William C, 2008, Biochem J, V411, pe11, DOI 10.1042/BJ20080336; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Irizarry MC, 1997, J NEUROSCI, V17, P7053; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luetjens CM, 2000, J NEUROSCI, V20, P5715; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mungarro-Menchaca X, 2002, J NEUROSCI RES, V68, P89, DOI 10.1002/jnr.10193; Palmer JC, 2009, AM J PATHOL, V175, P262, DOI 10.2353/ajpath.2009.081054; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013	25	78	87	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48225	10.1371/journal.pone.0048225	http://dx.doi.org/10.1371/journal.pone.0048225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139766	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300020
J	Zhang, H; Guo, J; Voegele, RT; Zhang, JS; Duan, YH; Luo, HY; Kang, ZS				Zhang, Hong; Guo, Jun; Voegele, Ralf T.; Zhang, Jinshan; Duan, Yinghui; Luo, Huaiyong; Kang, Zhensheng			Functional Characterization of Calcineurin Homologs PsCNA1/PsCNB1 in Puccinia striiformis f. sp tritici Using a Host-Induced RNAi System	PLOS ONE			English	Article							STRIPE-MOSAIC-VIRUS; COMPATIBLE INTERACTION; NEUROSPORA-CRASSA; HYPHAL ELONGATION; LEAF RUST; GENE; WHEAT; VIRULENCE; VIGS; TOOL	Calcineurin plays a key role in morphogenesis, pathogenesis and drug resistance in most fungi. However, the function of calcineurin genes in Puccinia striiformis f. sp. tritici (Pst) is unclear. We identified and characterized the calcineurin genes PsCNA1 and PsCNB1 in Pst. Phylogenetic analyses indicate that PsCNA1 and PsCNB1 form a calcium/calmodulin regulated protein phosphatase belonging to the calcineurin heterodimers composed of subunits A and B. Quantitative RT-PCR analyses revealed that both PsCNA1 and PsCNB1 expression reached their maximum in the stage of haustorium formation, which is one day after inoculation. Using barely stripe mosaic virus (BSMV) as a transient expression vector in wheat, the expression of PsCNA1 and PsCNB1 in Pst was suppressed, leading to slower extension of fungal hyphae and reduced production of urediospores. The immune-suppressive drugs cyclosporin A and FK506 markedly reduced the germination rates of urediospores, and when germination did occur, more than two germtubes were produced. These results suggest that the calcineurin signaling pathway participates in stripe rust morphogenetic differentiation, especially the formation of haustoria during the early stage of infection and during the production of urediospores. Therefore PsCNA1 and PsCNB1 can be considered important pathogenicity genes involved in the wheat-Pst interaction.	[Zhang, Hong; Guo, Jun; Zhang, Jinshan; Duan, Yinghui; Luo, Huaiyong; Kang, Zhensheng] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Zhang, Hong; Guo, Jun; Zhang, Jinshan; Luo, Huaiyong; Kang, Zhensheng] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Voegele, Ralf T.] Univ Hohenheim, Fak Agrarwissensc, Inst Phytomed, Fachgebiet Phytopathol, D-7000 Stuttgart, Germany; [Duan, Yinghui] NW A&F Univ, Coll Plant Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; University Hohenheim; Northwest A&F University - China	Kang, ZS (corresponding author), NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	guojunwgq@nwsuaf.edu.cn; kangzs@nwsuaf.edu.cn	zhang, Hong/AAE-3848-2022	zhang, Hong/0000-0003-2230-7786; Kang, Zhensheng/0000-0001-5575-0122	National Basic Research Program of China [2013CB127700]; National Natural Science Foundation of China [30930064, 31171795]; Ministry of Education of China [B07049]; Fundamental Research Funds for the Central Universities of China [QN2009035]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was financially supported by the National Basic Research Program of China (no. 2013CB127700), the National Natural Science Foundation of China (no. 30930064 and 31171795), the 111 Project from the Ministry of Education of China (No. B07049) and the Fundamental Research Funds for the Central Universities of China (QN2009035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Il-Pyung, 2007, Journal of General Plant Pathology, V73, P113, DOI 10.1007/s10327-006-0326-4; Cervantes-Chavez JA, 2011, MOL PLANT MICROBE IN, V24, P219, DOI 10.1094/MPMI-09-10-0202; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bennypaul HS, 2012, FUNCT INTEGR GENOMIC, V12, P143, DOI 10.1007/s10142-011-0245-0; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1323, DOI 10.1094/MPMI-20-11-1323; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; dos Santos ACC, 2009, FUNGAL GENET BIOL, V46, P825, DOI 10.1016/j.fgb.2009.06.012; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cruz MC, 2001, EMBO J, V20, P1020, DOI 10.1093/emboj/20.5.1020; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Dykxhoorn DM, 2005, ANNU REV MED, V56, P401, DOI 10.1146/annurev.med.56.082103.104606; Egan JD, 2009, MOL PLANT MICROBE IN, V22, P1293, DOI 10.1094/MPMI-22-10-1293; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Guo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021895; Hameed S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018684; Harel A, 2006, MOL PLANT MICROBE IN, V19, P682, DOI 10.1094/MPMI-19-0682; HIGUCHI S, 1991, J BIOL CHEM, V266, P18104; Hiriart JB, 2003, MOL PLANT MICROBE IN, V16, P99, DOI 10.1094/MPMI.2003.16.2.99; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hu GG, 2007, MOL PLANT PATHOL, V8, P451, DOI [10.1111/j.1364-3703.2007.00406.x, 10.1111/J.1364-3703.2007.00406.X]; Jinhee C, 2009, J MICROBIOL BIOTECHN, V19, P11, DOI 10.4014/jmb.0804.268; Juvvadi PR, 2008, EUKARYOT CELL, V7, P1606, DOI 10.1128/EC.00200-08; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; KUNO T, 1991, BIOCHEM BIOPH RES CO, V180, P1159, DOI 10.1016/S0006-291X(05)81188-X; Ling P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-145; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Ma JB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-586; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Nakayashiki H, 2008, CURR OPIN MICROBIOL, V11, P494, DOI 10.1016/j.mib.2008.10.001; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Nunes CC, 2012, MOL PLANT PATHOL, V13, P519, DOI 10.1111/j.1364-3703.2011.00766.x; Rissland OS, 2011, DEVELOPMENT, V138, P3093, DOI 10.1242/dev.065284; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salame TM, 2011, APPL MICROBIOL BIOT, V89, P501, DOI 10.1007/s00253-010-2928-1; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Tinoco MLP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-27; Uppuluri P, 2008, ANTIMICROB AGENTS CH, V52, P1127, DOI 10.1128/AAC.01397-07; Viaud M, 2003, MOL MICROBIOL, V50, P1451, DOI 10.1046/j.1365-2958.2003.03798.x; Voegele RT, 2011, EUPHYTICA, V179, P41, DOI 10.1007/s10681-011-0358-5; Voegele RT, 2003, NEW PHYTOL, V159, P93, DOI 10.1046/j.1469-8137.2003.00761.x; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang XJ, 2011, MOL PLANT MICROBE IN, V24, P79, DOI 10.1094/MPMI-06-10-0131; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Yin CT, 2011, MOL PLANT MICROBE IN, V24, P554, DOI 10.1094/MPMI-10-10-0229; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203	60	11	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e49262	10.1371/journal.pone.0049262	http://dx.doi.org/10.1371/journal.pone.0049262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139840	Green Published, Green Submitted, gold			2022-12-25	WOS:000311315300073
J	Durso, LM; Miller, DN; Wienhold, BJ				Durso, Lisa M.; Miller, Daniel N.; Wienhold, Brian J.			Distribution and Quantification of Antibiotic Resistant Genes and Bacteria across Agricultural and Non-Agricultural Metagenomes	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; TRACKING; FOOD	There is concern that antibiotic resistance can potentially be transferred from animals to humans through the food chain. The relationship between specific antibiotic resistant bacteria and the genes they carry remains to be described. Few details are known about the ecology of antibiotic resistant genes and bacteria in food production systems, or how antibiotic resistance genes in food animals compare to antibiotic resistance genes in other ecosystems. Here we report the distribution of antibiotic resistant genes in publicly available agricultural and non-agricultural metagenomic samples and identify which bacteria are likely to be carrying those genes. Antibiotic resistance, as coded for in the genes used in this study, is a process that was associated with all natural, agricultural, and human-impacted ecosystems examined, with between 0.7 to 4.4% of all classified genes in each habitat coding for resistance to antibiotic and toxic compounds (RATC). Agricultural, human, and coastal-marine metagenomes have characteristic distributions of antibiotic resistance genes, and different bacteria that carry the genes. There is a larger percentage of the total genome associated with antibiotic resistance in gastrointestinal-associated and agricultural metagenomes compared to marine and Antarctic samples. Since antibiotic resistance genes are a natural part of both human-impacted and pristine habitats, presence of these resistance genes in any specific habitat is therefore not sufficient to indicate or determine impact of anthropogenic antibiotic use. We recommend that baseline studies and control samples be taken in order to determine natural background levels of antibiotic resistant bacteria and/or antibiotic resistance genes when investigating the impacts of veterinary use of antibiotics on human health. We raise questions regarding whether the underlying biology of each type of bacteria contributes to the likelihood of transfer via the food chain.	[Durso, Lisa M.; Miller, Daniel N.; Wienhold, Brian J.] USDA, ARS, Agroecosyst Management Res Unit, Lincoln, NE USA	United States Department of Agriculture (USDA)	Durso, LM (corresponding author), USDA, ARS, Agroecosyst Management Res Unit, Lincoln, NE USA.	Lisa.Durso@ars.usda.gov		Wienhold, Brian/0000-0003-3066-6965; Miller, Daniel/0000-0003-3476-487X				Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Arthur TM, 2008, J FOOD PROTECT, V71, P1752, DOI 10.4315/0362-028X-71.9.1752; Brichta-Harhay DM, 2001, APPL ENVIRON MICROB, V77, P1783; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Collignon P, 2006, J INFECT DIS, V194, P8, DOI 10.1086/504922; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Crippen TL, 2009, FOODBORNE PATHOG DIS, V6, P907, DOI 10.1089/fpd.2008.0260; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Durso LM, 2011, FOODBORNE PATHOG DIS, V8, P647, DOI 10.1089/fpd.2010.0774; Durso LM, 2011, J MICROBIOL METH, V84, P278, DOI 10.1016/j.mimet.2010.12.008; Empey WA, 1939, COMMONWEALTH AUSTR B; Haley CA, 2012, J FOOD PROTECT, V75, P428, DOI 10.4315/0362-028X.JFP-11-363; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Ng C, 2010, ISME J, V4, P1002, DOI 10.1038/ismej.2010.28; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Raphael E, 2011, APPL ENVIRON MICROB, V77, P1601, DOI 10.1128/AEM.02506-10; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schjorring Susanne, 2011, Int J Microbiol, V2011, P312956, DOI 10.1155/2011/312956; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614	31	84	86	2	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48325	10.1371/journal.pone.0048325	http://dx.doi.org/10.1371/journal.pone.0048325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133629	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400032
J	MacFarlane, AA; Orriss, G; Okun, N; Meier, M; Klonisch, T; Khajehpour, M; Stetefeld, J				MacFarlane, Ainsley A.; Orriss, George; Okun, Natalie; Meier, Markus; Klonisch, Thomas; Khajehpour, Mazdak; Stetefeld, Joerg			The Pentameric Channel of COMPcc in Complex with Different Fatty Acids	PLOS ONE			English	Article							OLIGOMERIC MATRIX PROTEIN; COILED-COIL DOMAIN; CRYSTAL-STRUCTURE; BINDING PROTEINS; CARTILAGE; TENDON; MODES	Background: COMPcc forms a pentameric left-handed coiled coil that is known to bind hydrophilic signaling molecules such as vitamin D-3, and vitamin A. Principal Findings: In an integrated approach we reveal the unique binding properties of COMPcc for saturated and unsaturated fatty acids. Our observations suggest that residues Met33 (gating pore), Thr40/Asn41 (water chamber) and Gln54 (electrostatic trap) are key elements for the binding of fatty acids by COMPcc. In addition, this work characterizes the binding of various fatty acids to COMPcc using fluorescence spectroscopy. Our findings reveal a binding trend within the hydrophobic channel of COMPcc, namely, that is driven by length of the methylene tail and incorporation of unsaturation. Conclusion/Significance: The unique binding properties imply that COMPcc may be involved in signalling functions in which hydrophilic ligands are involved. The pentameric channel is a unique carrier for lipophilic compounds. This opens the exciting possibility that COMPcc could be developed as a targeted drug delivery system.	[Stetefeld, Joerg] Univ Manitoba, Dept Chem Microbiol Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada; [MacFarlane, Ainsley A.; Orriss, George; Okun, Natalie; Meier, Markus; Khajehpour, Mazdak] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba	Stetefeld, J (corresponding author), Univ Manitoba, Dept Chem Microbiol Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada.	stetefel@cc.umanitoba.ca	Klonisch, Thomas/W-9923-2019; Stetefeld, Joerg/H-7630-2017; Krahn, Natalie/HHN-6747-2022; Meier, Markus/F-2798-2011	Stetefeld, Joerg/0000-0003-1478-3248; Krahn, Natalie/0000-0003-0696-433X; Meier, Markus/0000-0003-1068-746X	Manitoba Health Research Council; University of Manitoba Graduate Student Fellowship	Manitoba Health Research Council; University of Manitoba Graduate Student Fellowship	This work was supported by the Manitoba Health Research Council. AM received a University of Manitoba Graduate Student Fellowship. JS is a Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens T, 2002, J BIOL CHEM, V277, P19455, DOI 10.1074/jbc.M200606200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Boudko SP, 2004, J MOL BIOL, V339, P927, DOI 10.1016/j.jmb.2004.04.001; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; Efimov VP, 1996, PROTEINS, V24, P259, DOI 10.1002/(SICI)1097-0134(199602)24:2<259::AID-PROT13>3.0.CO;2-M; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Guo Y, 1998, EMBO J, V17, P5265, DOI 10.1093/emboj/17.18.5265; Guo Y, 2000, BIOPHYS CHEM, V85, P179, DOI 10.1016/S0301-4622(00)00119-8; HAMILTON JA, 1984, P NATL ACAD SCI-BIOL, V81, P3718, DOI 10.1073/pnas.81.12.3718; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Legrand P, 2010, LIPIDS, V45, P941, DOI 10.1007/s11745-010-3444-x; Leslie AGW, 1994, MOSFLM USERS GUIDE; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; McFarlane AA, 2009, EUR J PHARMACOL, V625, P101, DOI 10.1016/j.ejphar.2009.05.034; Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067; Muller G, 1998, CONNECT TISSUE RES, V39, P233, DOI 10.3109/03008209809021499; Orriss GL, 2010, FASEB J, V24, P404, DOI 10.1096/fj.09-138297; Ozbek S, 2002, EMBO J, V21, P5960, DOI 10.1093/emboj/cdf628; Rioux V, 2007, CURR OPIN CLIN NUTR, V10, P752, DOI 10.1097/MCO.0b013e3282f01a75; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Stetefeld J, 2006, P NATL ACAD SCI USA, V103, P13688, DOI 10.1073/pnas.0600306103; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x	32	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48130	10.1371/journal.pone.0048130	http://dx.doi.org/10.1371/journal.pone.0048130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133613	Green Submitted, Green Published, gold			2022-12-25	WOS:000310702400023
J	Kangaspeska, S; Hultsch, S; Edgren, H; Nicorici, D; Murumagi, A; Kallioniemi, O				Kangaspeska, Sara; Hultsch, Susanne; Edgren, Henrik; Nicorici, Daniel; Murumagi, Astrid; Kallioniemi, Olli			Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GENES; HUMAN BREAST-CANCER; GENOMIC REARRANGEMENTS; PROSTATE-CANCER; RECURRENT FUSION; IDENTIFICATION; DISCOVERY; EXPRESSION; ALIGNMENT; PATHWAY	RNA-sequencing and tailored bioinformatic methodologies have paved the way for identification of expressed fusion genes from the chaotic genomes of solid tumors. We have recently successfully exploited RNA-sequencing for the discovery of 24 novel fusion genes in breast cancer. Here, we demonstrate the importance of continuous optimization of the bioinformatic methodology for this purpose, and report the discovery and experimental validation of 13 additional fusion genes from the same samples. Integration of copy number profiling with the RNA-sequencing results revealed that the majority of the gene fusions were promoter-donating events that occurred at copy number transition points or involved high-level DNA-amplifications. Sequencing of genomic fusion break points confirmed that DNA-level rearrangements underlie selected fusion transcripts. Furthermore, a significant portion (> 60%) of the fusion genes were alternatively spliced. This illustrates the importance of reanalyzing sequencing data as gene definitions change and bioinformatic methods improve, and highlights the previously unforeseen isoform diversity among fusion transcripts.	[Kangaspeska, Sara; Hultsch, Susanne; Edgren, Henrik; Nicorici, Daniel; Murumagi, Astrid; Kallioniemi, Olli] Inst Mol Med Finland FIMM, Helsinki, Finland		Kangaspeska, S (corresponding author), Inst Mol Med Finland FIMM, Helsinki, Finland.	sara.kangaspeska@fimm.fi	Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332; Nicorici, Daniel/0000-0002-0278-8263	Academy of Finland Post-Doctoral Researcher Grant; Academy of Finland Center of Excellence Grant in Translational Genome-Scale Biology; Sigrid Juselius Foundation; Cancer Society of Finland	Academy of Finland Post-Doctoral Researcher Grant; Academy of Finland Center of Excellence Grant in Translational Genome-Scale Biology(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland	This work was supported by an Academy of Finland Post-Doctoral Researcher Grant (SK)(www.aka.fi), the Academy of Finland Center of Excellence Grant in Translational Genome-Scale Biology (www.aka.fi), the Sigrid Juselius Foundation (http://sigridjuselius.fi) and the Cancer Society of Finland (cancer.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr362; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; FUTREAL PA, 1994, CANCER RES, V54, P1791; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Karosas AO, 2010, AM J HEALTH-SYST PH, V67, P1599, DOI 10.2146/ajhp090526; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Letunic I, 2011, NUCL ACIDS RES; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Rabbitts TH, 2009, CELL, V137, P391, DOI 10.1016/j.cell.2009.04.034; Robinson DR, 2011, NAT MED; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sboner A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r104; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tabuchi Y, 2009, INT J ONCOL, V34, P313, DOI 10.3892/ijo_00000153; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang XS, 2009, NAT BIOTECHNOL, V27, P1005, DOI 10.1038/nbt.1584; Zhao Q, 2009, P NATL ACAD SCI USA, V106, P1886, DOI 10.1073/pnas.0812945106	41	49	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48745	10.1371/journal.pone.0048745	http://dx.doi.org/10.1371/journal.pone.0048745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119097	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500204
J	Fengler, VHI; Boritsch, EC; Tutz, S; Seper, A; Ebner, H; Roier, S; Schild, S; Reidl, J				Fengler, Vera H. I.; Boritsch, Eva C.; Tutz, Sarah; Seper, Andrea; Ebner, Hanna; Roier, Sandro; Schild, Stefan; Reidl, Joachim			Disulfide Bond Formation and ToxR Activity in Vibrio cholerae	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; TRANSCRIPTIONAL ACTIVATION; SIGNAL-TRANSDUCTION; DNA-BINDING; REGULATORY CASCADE; PROTEIN TOXR; DOMAIN; CONSTRUCTION; REGULON	Virulence factor production in Vibrio cholerae is complex, with ToxRS being an important part of the regulatory cascade. Additionally, ToxR is the transcriptional regulator for the genes encoding the major outer membrane porins OmpU and OmpT. ToxR is a transmembrane protein and contains two cysteine residues in the periplasmic domain. This study addresses the influence of the thiol-disulfide oxidoreductase system DsbAB, ToxR cysteine residues and ToxR/ToxS interaction on ToxR activity. The results show that porin production correlates with ToxR intrachain disulfide bond formation, which depends on DsbAB. In contrast, formation of ToxR intrachain or interchain disulfide bonds is dispensable for virulence factor production and in vivo colonization. This study further reveals that in the absence of ToxS, ToxR interchain disulfide bond formation is facilitated, whereat cysteinyl dependent homo-and oligomerization of ToxR is suppressed if ToxS is coexpressed. In summary, new insights into gene regulation by ToxR are presented, demonstrating a mechanism by which ToxR activity is linked to a DsbAB dependent intrachain disulfide bond formation.	[Fengler, Vera H. I.; Boritsch, Eva C.; Tutz, Sarah; Seper, Andrea; Ebner, Hanna; Roier, Sandro; Schild, Stefan; Reidl, Joachim] Graz Univ, Inst Mol Biosci, Graz, Austria	University of Graz	Reidl, J (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr, Graz, Austria.	joachim.reidl@uni-graz.at	Reidl, Joachim/O-2107-2016	Schild, Stefan/0000-0001-7842-0177; Reidl, Joachim/0000-0001-5798-9524; Fengler, Vera/0000-0002-5124-1491	Austrian Science Fund (FWF) [W901]; German Research Foundation (DFG) [Re1561/4-1]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) W901 (DK Molecular Enzymology) to VHIF, AS, SR, SS and JR and by the German Research Foundation (DFG) Re1561/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; Andoh A, 1998, CLIN EXP IMMUNOL, V111, P477; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; Champion GA, 1997, MOL MICROBIOL, V23, P323, DOI 10.1046/j.1365-2958.1997.2191585.x; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Correa NE, 2000, MOL MICROBIOL, V35, P743, DOI 10.1046/j.1365-2958.2000.01745.x; Crawford JA, 2003, MOL MICROBIOL, V47, P1459, DOI 10.1046/j.1365-2958.2003.03398.x; Crawford JA, 1998, MOL MICROBIOL, V29, P235, DOI 10.1046/j.1365-2958.1998.00925.x; Danese PN, 1997, GENE DEV, V11, P1183, DOI 10.1101/gad.11.9.1183; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; DiRita V J, 1994, Trends Microbiol, V2, P37, DOI 10.1016/0966-842X(94)90122-8; DIRITA VJ, 1991, CELL, V64, P29, DOI 10.1016/0092-8674(91)90206-E; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Dziejman M, 1999, MOL MICROBIOL, V31, P305, DOI 10.1046/j.1365-2958.1999.01173.x; DZIEJMAN M, 1994, MOL MICROBIOL, V13, P485, DOI 10.1111/j.1365-2958.1994.tb00443.x; Faruque SM, 2004, DNA CELL BIOL, V23, P723, DOI 10.1089/dna.2004.23.723; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Gentile F, 2002, J BIOL CHEM, V277, P44050, DOI 10.1074/jbc.M206761200; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8893, DOI 10.1093/nar/17.21.8893; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HIGGINS DE, 1994, MOL MICROBIOL, V14, P17, DOI 10.1111/j.1365-2958.1994.tb01263.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405, DOI 10.1128/JCM.22.3.405-408.1985; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; KOLMAR H, 1995, EMBO J, V14, P3895, DOI 10.1002/j.1460-2075.1995.tb00061.x; Kovach ME, 1996, MICROBIOL-SGM, V142, P2165, DOI 10.1099/13500872-142-8-2165; Krukonis ES, 2000, MOL MICROBIOL, V38, P67, DOI 10.1046/j.1365-2958.2000.02111.x; Krukonis ES, 2003, MOL CELL, V12, P157, DOI 10.1016/S1097-2765(03)00222-3; Li CYC, 2002, MOL MICROBIOL, V43, P1577, DOI 10.1046/j.1365-2958.2002.02845.x; Luders J, 2003, EMBO REP, V4, P1169, DOI 10.1038/sj.embor.7400025; Mallow EB, 1996, J BIOL CHEM, V271, P4038; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; MEKALANOS JJ, 1983, CELL, V35, P253, DOI 10.1016/0092-8674(83)90228-3; Mey AR, 2012, INFECT IMMUN, V80, P518, DOI 10.1128/IAI.05851-11; MILLER VL, 1984, P NATL ACAD SCI-BIOL, V81, P3471, DOI 10.1073/pnas.81.11.3471; MILLER VL, 1989, J BACTERIOL, V171, P1288, DOI 10.1128/jb.171.3.1288-1293.1989; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moisi M, 2009, J BACTERIOL, V191, P7027, DOI 10.1128/JB.00948-09; Morgan SJ, 2011, MOL MICROBIOL, V81, P113, DOI 10.1111/j.1365-2958.2011.07681.x; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; Osorio CR, 2000, J BACTERIOL, V182, P526, DOI 10.1128/JB.182.2.526-528.2000; OTTEMANN KM, 1995, MOL MICROBIOL, V15, P719, DOI 10.1111/j.1365-2958.1995.tb02380.x; Ottemann KM, 1996, J BACTERIOL, V178, P156, DOI 10.1128/jb.178.1.156-162.1996; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; Pfau JD, 1998, J BACTERIOL, V180, P4724, DOI 10.1128/JB.180.17.4724-4733.1998; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Quinones M, 2005, MOL CELL, V17, P291, DOI 10.1016/j.molcel.2004.11.046; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Salahpour A, 2000, TRENDS ENDOCRIN MET, V11, P163, DOI 10.1016/S1043-2760(00)00260-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; Schild S, 2007, CELL HOST MICROBE, V2, P264, DOI 10.1016/j.chom.2007.09.004; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Skorupski K, 1999, MOL MICROBIOL, V31, P763, DOI 10.1046/j.1365-2958.1999.01215.x; SVENNERHOLM AM, 1978, CURR MICROBIOL, V1, P19, DOI 10.1007/BF02601701; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Warburg O., 1942, BIOCHEM Z, V310, P384; Withey JH, 2006, MOL MICROBIOL, V59, P1779, DOI 10.1111/j.1365-2958.2006.05053.x; Xu X, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-3; YU J, 1992, MOL MICROBIOL, V6, P1949, DOI 10.1111/j.1365-2958.1992.tb01368.x	73	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47756	10.1371/journal.pone.0047756	http://dx.doi.org/10.1371/journal.pone.0047756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144706	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300017
J	Gaur, RL; Suhosk, MM; Banaei, N				Gaur, Rajiv L.; Suhosk, Megan M.; Banaei, Niaz			In Vitro Immunomodulation of a Whole Blood IFN-gamma Release Assay Enhances T Cell Responses in Subjects with Latent Tuberculosis Infection	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MYCOBACTERIUM-TUBERCULOSIS; INNATE IMMUNITY; DIAGNOSIS; RECOGNITION; RESISTANCE	Background: Activation of innate immunity via pathogen recognition receptors (PRR) modulates adaptive immune responses. PRR ligands are being exploited as vaccine adjuvants and as therapeutics, but their utility in diagnostics has not been explored. Interferon-gamma (IFN-gamma) release assays (IGRAs) are functional T cell assays used to diagnose latent tuberculosis infection (LTBI); however, novel approaches are needed to improve their sensitivity. Methods: In vitro immunomodulation of a whole blood IGRA (QuantiFERONH-TB GOLD In-Tube) with Toll-like receptor agonists poly(I:C), LPS, and imiquimod was performed on blood from subjects with LTBI and negative controls. Results: In vitro immunomodulation significantly enhanced the response of T cells stimulated with M. tuberculosis antigens from subjects with LTBI but not from uninfected controls. Immunomodulation of IGRA revealed T cell responses in subjects with LTBI whose T cells otherwise do not respond to in vitro stimulation with antigens alone. Similar to their in vivo functions, addition of poly(I: C) and LPS to whole blood induced secretion of inflammatory cytokines and IFN-alpha and enhanced the surface expression of antigen presenting and costimulatory molecules on antigen presenting cells. Conclusions: In vitro immunomodulation of whole blood IGRA may be an effective strategy for enhancing the sensitivity of T cells for diagnosis of LTBI.	[Gaur, Rajiv L.; Banaei, Niaz] Stanford Univ, Dept Pathol, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Suhosk, Megan M.; Banaei, Niaz] Stanford Univ, Dept Med, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Banaei, Niaz] Stanford Hosp & Clin, Clin Microbiol Lab, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University	Banaei, N (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.	niazbanaei@stanford.edu		Banaei, Niaz/0000-0001-8501-3000	Stanford University SPARK grant	Stanford University SPARK grant	This study was supported by a Stanford University SPARK grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Edwards L, 1998, ARCH DERMATOL, V134, P25, DOI 10.1001/archderm.134.1.25; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Huang SJ, 2009, J INVEST DERMATOL, V129, P2676, DOI 10.1038/jid.2009.151; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kauffman CA, 2007, CLIN MICROBIOL REV, V20, P115, DOI 10.1128/CMR.00027-06; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lahey T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022074; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Pappagianis D, 2001, Semin Respir Infect, V16, P242, DOI 10.1053/srin.2001.29315; Parkinson T, 2008, CURR OPIN MOL THER, V10, P21; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Vogt G, 2011, J CLIN INVEST, V121, P3889, DOI 10.1172/JCI57235; von Pirquet C, 1907, JAMA-J AM MED ASSOC, V52, P675; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; WHO, 2010, MULTIDRUG AND EXTENS; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	43	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48027	10.1371/journal.pone.0048027	http://dx.doi.org/10.1371/journal.pone.0048027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144722	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300033
J	Hsu, CW; Lin, JL; Lin-Tan, DT; Chen, KH; Yen, TH; Wu, MS; Lin, SC				Hsu, Ching-Wei; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Chen, Kuan-Hsing; Yen, Tzung-Hai; Wu, Mai-Szu; Lin, Shih-Chieh			Early Hemoperfusion May Improve Survival of Severely Paraquat-Poisoned Patients	PLOS ONE			English	Article							CONTINUOUS ARTERIOVENOUS HEMOPERFUSION; PULSE THERAPY; DEXAMETHASONE THERAPY; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PLASMA; LUNG; HEMOFILTRATION; ELIMINATION; TOXICITY	Background: Thousands of paraquat (PQ)-poisoned patients continue to die, particularly in developing countries. Although animal studies indicate that hemoperfusion (HP) within 224 h after intoxication effectively reduces mortality, the effect of early HP in humans remains unknown. Methods: We analyzed the records of all PQ-poisoned patients admitted to 2 hospitals between 2000 and 2009. Patients were grouped according to early or late HP and high-dose (oral cyclophosphamide [CP] and intravenous dexamethasone [DX]) or repeated pulse (intravenous methylprednisolone [MP] and CP, followed by DX and repeated MP and/or CP) PQ therapy. Early HP was defined as HP < 4 h, and late HP, as HP >= 4 h after PQ ingestion. We evaluated the associations between HP < 4 h, < 5 h, < 6 h, and < 7 h after PQ ingestion and the outcomes. Demographic, clinical, laboratory, and mortality data were analyzed. Results: The study included 207 severely PQ-poisoned patients. Forward stepwise multivariate Cox hazard regression analysis showed that early HP < 4 h (hazard ratio [HR] = 0.38, 95% confidence interval (CI) 0.16-0.86; P=0.020) or HP < 5 h (HR = 0.60, 95% CI: 0.39-0.92; P=0.019) significantly decreased the mortality risk. Further analysis showed that early HP reduced the mortality risk only in patients treated with repeated pulse therapy (n = 136), but not high-dose therapy (n = 71). Forward stepwise multivariate Cox hazard regression analysis showed that HP < 4.0 h (HR = 0.19, 95% CI: 0.05-0.79; P=0.022) or < 5.0 h (HR = 0.49, 95% CI: 0.24-0.98; P=0.043) after PQ ingestion significantly decreased the mortality risk in repeated pulse therapy patients, after adjustment for relevant variables. Conclusion: The results showed that early HP after PQ exposure might be effective in reducing mortality in severely poisoned patients, particularly in those treated with repeated pulse therapy.	[Hsu, Ching-Wei; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Chen, Kuan-Hsing; Yen, Tzung-Hai; Lin, Shih-Chieh] Chang Gung Mem Hosp, Dept Nephrol, Div Clin Toxicol, Lin Kou Med Ctr, Tao Yuan, Taiwan; [Hsu, Ching-Wei; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Chen, Kuan-Hsing; Yen, Tzung-Hai; Wu, Mai-Szu; Lin, Shih-Chieh] Chang Gung Univ & Sch Med, Tao Yuan, Taiwan; [Wu, Mai-Szu] Keelung Chang Gung Mem Hosp, Dept Nephrol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Lin, JL (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Div Clin Toxicol, Lin Kou Med Ctr, Tao Yuan, Taiwan.	jllin99@hotmail.com	Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505				Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BISMUTH C, 1987, HUM TOXICOL, V6, P63, DOI 10.1177/096032718700600110; Cartin-Ceba R, 2009, INTENS CARE MED, V35, P2087, DOI 10.1007/s00134-009-1635-9; Chen GH, 2002, CRIT CARE MED, V30, P2584, DOI 10.1097/00003246-200211000-00030; Dinis-Oliveira RJ, 2006, TOXICOLOGY, V227, P73, DOI 10.1016/j.tox.2006.07.025; Dinis-Oliveira RJ, 2006, FREE RADICAL BIO MED, V41, P1213, DOI 10.1016/j.freeradbiomed.2006.06.012; Editorial, 1986, LANCET, Vii, P375; Ghaffari AR, 2011, SAUDI MED J, V32, P249; HAMPSON ECGM, 1990, J PHARMACOL EXP THER, V254, P732; HART TB, 1984, LANCET, V2, P1222; HAWKSWORTH GM, 1981, TOXICOL APPL PHARM, V57, P139, DOI 10.1016/0041-008X(81)90273-8; Hong SY, 2003, TOXICOL IND HEALTH, V19, P17, DOI 10.1191/0748233703th171oa; Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880; Li LRY, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008084.pub2; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; LIN JJ, 1995, AM J KIDNEY DIS, V25, P75, DOI 10.1016/S0196-0644(95)70359-4; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; LIN JL, 1994, BLOOD PURIFICAT, V12, P121, DOI 10.1159/000170156; LIN JL, 1993, J TOXICOL-CLIN TOXIC, V31, P645, DOI 10.3109/15563659309025768; Lin NC, 2003, J TOXICOL-CLIN TOXIC, V41, P877, DOI 10.1081/CLT-120025356; MASCIETAYLOR BH, 1983, LANCET, V1, P1376; POND SM, 1987, J TOXICOL-CLIN TOXIC, V25, P305, DOI 10.3109/15563658708992634; POND SM, 1993, J TOXICOL-CLIN TOXIC, V31, P229, DOI 10.3109/15563659309000391; SCHERRMANN JM, 1987, HUM TOXICOL, V6, P91, DOI 10.1177/096032718700600116; SMITH LL, 1987, HUM TOXICOL, V6, P31, DOI 10.1177/096032718700600105; SUZUKI K, 1993, HUM EXP TOXICOL, V12, P323, DOI 10.1177/096032719301200411; Tominack RL, 2002, GOLDFRANKS TOXICOLOG, P1393; VANDEVYVER FL, 1985, J TOXICOL-CLIN TOXIC, V23, P117, DOI 10.3109/15563658508990622; Yang TS, 1997, HUM EXP TOXICOL, V16, P709, DOI 10.1177/096032719701601203	30	55	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48397	10.1371/journal.pone.0048397	http://dx.doi.org/10.1371/journal.pone.0048397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144759	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300069
J	Kawabe, Y; Hayashida, Y; Numata, K; Harada, S; Hayashida, Y; Ito, A; Kamihira, M				Kawabe, Yoshinori; Hayashida, Yuuki; Numata, Kensaku; Harada, Shota; Hayashida, Yoshifumi; Ito, Akira; Kamihira, Masamichi			Oral Immunotherapy for Pollen Allergy Using T-Cell Epitope-Containing Egg White Derived from Genetically Manipulated Chickens	PLOS ONE			English	Article							2ND MAJOR ALLERGEN; FC FUSION PROTEIN; CRY-J-II; CEDAR POLLINOSIS; EXPRESSION; TOLERANCE; RHINITIS; VACCINE; DETERMINANTS; CRY-J-1	Peptide immunotherapy using T-cell epitopes is expected to be an effective treatment for allergic diseases such as Japanese cedar (Cryptomeria japonica; Cj) pollinosis. To develop a treatment for pollen allergy by inducing oral tolerance, we generated genetically manipulated (GM) chickens by retroviral gene transduction, to produce a fusion protein of chicken egg white lysozyme and a peptide derived from seven dominant human T-cell epitopes of Japanese cedar pollen allergens (cLys-7crp). The transgene sequence was detected in all chickens transduced with the retroviral vector. Transduction efficiency in blood cells correlated to transgene expression. Western blot analysis revealed that cLys-7crp was expressed in the egg white of GM hens. Mice induced to develop allergic rhinitis by Cj pollinosis were fed with cLys-7crp-containing egg white produced by GM chickens. Total and Cj allergen (Cry j 1)-specific IgE levels were significantly decreased in allergic mice fed with cLys-7crp-containing egg white compared with allergic mice fed with normal egg white. These results suggest that oral administration of T-cell epitope-containing egg white derived from GM chickens is effective for the induction of immune tolerance as an allergy therapy.	[Kawabe, Yoshinori; Hayashida, Yuuki; Numata, Kensaku; Harada, Shota; Hayashida, Yoshifumi; Ito, Akira; Kamihira, Masamichi] Kyushu Univ, Fac Engn, Dept Chem Engn, Fukuoka 812, Japan	Kyushu University	Kamihira, M (corresponding author), Kyushu Univ, Fac Engn, Dept Chem Engn, 6-10-1 Hakozaki, Fukuoka 812, Japan.	kamihira@chem-eng.kyushu-u.ac.jp	Kamihira, Masamichi/Q-7438-2019; Ito, Akira/S-8099-2017	Kamihira, Masamichi/0000-0003-2570-5712; Ito, Akira/0000-0001-8393-0518	Japan Society for the Promotion of Science [18656245, 20360376, 23360372, 23760753]; Kieikai Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kieikai Research Foundation(Kieikai Research Foundation)	This work was supported in part by Grants-in-Aid for Scientific Research (nos. 18656245, 20360376, 23360372 and 23760753) from the Japan Society for the Promotion of Science and the Kieikai Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; du Pre MF, 2011, ALLERGY, V66, P478, DOI 10.1111/j.1398-9995.2010.02519.x; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HASHIMOTO M, 1995, CLIN EXP ALLERGY, V25, P848, DOI 10.1111/j.1365-2222.1995.tb00027.x; Hirahara K, 2001, J ALLERGY CLIN IMMUN, V108, P94, DOI 10.1067/mai.2001.115481; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hotta A, 2006, J BIOSCI BIOENG, V101, P361, DOI 10.1263/jbb.101.361; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Ishii M, 2010, INT IMMUNOPHARMACOL, V10, P1041, DOI 10.1016/j.intimp.2010.06.003; Ito A, 2009, J BIOSCI BIOENG, V108, P244, DOI 10.1016/j.jbiosc.2009.04.004; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Kamihira M, 2009, J BIOTECHNOL, V141, P18, DOI 10.1016/j.jbiotec.2009.02.022; Kawabe Y, 2006, J BIOSCI BIOENG, V102, P297, DOI 10.1263/jbb.102.297; Kodama D, 2008, BIOCHEM BIOPH RES CO, V367, P834, DOI 10.1016/j.bbrc.2008.01.020; KOMIYAMA N, 1994, BIOCHEM BIOPH RES CO, V201, P1021, DOI 10.1006/bbrc.1994.1804; Kues WA, 2011, PREV VET MED, V102, P146, DOI 10.1016/j.prevetmed.2011.04.009; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Moldaver D, 2011, ALLERGY, V66, P784, DOI 10.1111/j.1398-9995.2011.02610.x; Ohno N, 2000, IMMUNOLOGY, V99, P630, DOI 10.1046/j.1365-2567.2000.00021.x; Okamoto Yoshitaka, 2009, Allergology International, V58, P155, DOI 10.2332/allergolint.08-RAI-0074; Okuda M, 2003, ANN ALLERG ASTHMA IM, V91, P288, DOI 10.1016/S1081-1206(10)63532-6; Penno CA, 2010, TRANSGENIC RES, V19, P187, DOI 10.1007/s11248-009-9310-z; Platts-Mills TAE, 2011, IMMUNOL REV, V242, P51, DOI 10.1111/j.1600-065X.2011.01021.x; Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027; Rosenwasser LJ, 2011, CURR ALLERGY ASTHM R, V11, P178, DOI 10.1007/s11882-011-0179-6; Saito S., 2000, ANN REP SANKYO RES L, V52, P49; SAKAGUCHI M, 1990, ALLERGY, V45, P309, DOI 10.1111/j.1398-9995.1990.tb00501.x; Sakaguchi M, 2011, AURIS NASUS LARYNX, V38, P431, DOI 10.1016/j.anl.2010.12.002; Shin JH, 2010, OTOLARYNG HEAD NECK, V142, P370, DOI 10.1016/j.otohns.2009.11.025; SONE T, 1994, BIOCHEM BIOPH RES CO, V199, P619, DOI 10.1006/bbrc.1994.1273; Song G, 2011, ANN NY ACAD SCI, V1229, P69, DOI 10.1111/j.1749-6632.2011.06087.x; Stebbins KJ, 2010, EUR J PHARMACOL, V638, P142, DOI 10.1016/j.ejphar.2010.04.031; Takagi H, 2005, P NATL ACAD SCI USA, V102, P17525, DOI 10.1073/pnas.0503428102; Takagi H, 2005, PLANT BIOTECHNOL J, V3, P521, DOI 10.1111/j.1467-7652.2005.00143.x; Takagi H, 2008, VACCINE, V26, P6027, DOI 10.1016/j.vaccine.2008.09.019; Toda M, 2002, EUR J IMMUNOL, V32, P1631, DOI 10.1002/1521-4141(200206)32:6<1631::AID-IMMU1631>3.0.CO;2-O; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; Tsunematsu M, 2008, BIOMED RES-TOKYO, V29, P119, DOI 10.2220/biomedres.29.119; Tsunematsu M, 2007, LIFE SCI, V80, P1388, DOI 10.1016/j.lfs.2006.12.038; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Worm M, 2011, J ALLERGY CLIN IMMUN, V127, P89, DOI 10.1016/j.jaci.2010.11.029; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	44	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48512	10.1371/journal.pone.0048512	http://dx.doi.org/10.1371/journal.pone.0048512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144766	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300076
J	Paiva, AD; Fernandes, KM; Dias, RS; Rocha, AS; de Oliveira, LL; Neves, CA; de Paula, SO; Mantovani, HC				Paiva, Aline D.; Fernandes, Kenner M.; Dias, Roberto S.; Rocha, Alipio S.; de Oliveira, Leandro L.; Neves, Clovis A.; de Paula, Sergio O.; Mantovani, Hilario C.			Effects of the Oral Administration of Viable and Heat-Killed Streptococcus bovis HC5 Cells to Pre-Sensitized BALB/c Mice	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; GASTROINTESTINAL-TRACT; ANTIBACTERIAL ACTIVITY; INDIGENOUS BACTERIA; LACTIC-ACIDOSIS; GUT MICROBIOTA; MECHANISMS; STRAINS; GROWTH; MILK	Antimicrobial peptides have been suggested as an alternative to classical antibiotics in livestock production and bacteriocin-producing bacteria could be added to animal feeds to deliver bacteriocins in the gastrointestinal (GI) tract of ruminant and monogastric animals. In this study, viable (V) and heat-killed (HK) Streptococcus bovis HC5 cells were orally administered to pre-sensitized mice in order to assess the effects of a bacteriocin-producing bacteria on histological parameters and the immune response of the GI tract of monogastric animals. The administration of V and HK S. bovis HC5 cells during 58 days to BALB/c mice did not affect weight gain, but an increase in gut permeability was detected in animals receiving the HK cells. Viable and heat killed cells caused similar morphological alterations in the GI tract of the animals, but the most prominent effects were detected in the small intestine. The oral administration of S. bovis HC5 also influenced cytokine production in the small intestine, and the immune-mediated activity differed between V and HK cells. The relative expression of IL-12 and INF-gamma was significantly higher in the small intestine of mice treated with V cells, while an increase in IL-5, IL-13 and TNF-alpha expression was only detected in mice treated with HK cells. Considering that even under a condition of severe challenge (pre-sensitization followed by daily exposure to the same bacterial immunogen) the general health of the animals was maintained, it appears that oral administration of S. bovis HC5 cells could be a useful route to deliver bacteriocin in the GI tract of livestock animals.	[Paiva, Aline D.; Mantovani, Hilario C.] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Fernandes, Kenner M.; Dias, Roberto S.; Rocha, Alipio S.; de Oliveira, Leandro L.; Neves, Clovis A.; de Paula, Sergio O.] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Mantovani, HC (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	hcm6@ufv.br	Morais, Kenner/Z-1667-2019; De Paula, Sergio/N-2609-2018; Mantovani, Hilario C/J-5287-2012; de Oliveira, Leandro Licursi/D-3616-2009	Morais, Kenner/0000-0003-0576-8185; De Paula, Sergio/0000-0002-2275-5768; Mantovani, Hilario C/0000-0002-3481-5318; de Oliveira, Leandro Licursi/0000-0003-4353-7011	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasilia, Brazil [AUXPE/PNPD 2439/2011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [201179/2009-1]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasilia, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	A.D.P. was supported by a fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br; Grant Number AUXPE/PNPD 2439/2011, Brasilia, Brazil). This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br; Grant Number 201179/2009-1). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Balzan S, 2007, J GASTROEN HEPATOL, V22, P464, DOI 10.1111/j.1440-1746.2007.04933.x; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; Baumgart DC, 2002, CURR OPIN CLIN NUTR, V5, P685, DOI 10.1097/00075197-200211000-00012; Beecher C, 2009, J DAIRY RES, V76, P340, DOI 10.1017/S0022029909004154; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; BERG RD, 1979, INFECT IMMUN, V23, P403, DOI 10.1128/IAI.23.2.403-411.1979; BERG RD, 1986, MICROECOL THER, V16, P131; Cardoso CR, 2008, CLIN EXP ALLERGY, V38, P338; CARSON FL, 1973, AM J CLIN PATHOL, V59, P365; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; de Carvalho AAT, 2007, LETT APPL MICROBIOL, V45, P68, DOI 10.1111/j.1472-765X.2007.02150.x; de Carvalho AAT, 2007, J APPL MICROBIOL, V102, P1000, DOI 10.1111/j.1365-2672.2006.03160.x; Diez-Gonzalez Francisco, 2007, Curr Issues Intest Microbiol, V8, P15; Ganz T, 2000, NAT IMMUNOL, V1, P99, DOI 10.1038/77884; Gill HS, 2000, VACCINE, V18, P2541, DOI 10.1016/S0264-410X(00)00017-7; Gill HS, 2001, J DAIRY RES, V68, P611, DOI 10.1017/S0022029901005155; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Herrera P, 2009, ANAEROBE, V15, P44, DOI 10.1016/j.anaerobe.2008.11.003; Holt J., 1994, BERGEYS MANUAL DETER; Houlihan AJ, 2006, J APPL MICROBIOL, V100, P168, DOI 10.1111/j.1365-2672.2005.02745.x; HUNGATE RE, 1966, RUMEN ITS MICROBES; Joerger RD, 2003, POULTRY SCI, V82, P640, DOI 10.1093/ps/82.4.640; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Knippels LMJ, 1999, METHODS, V19, P78, DOI 10.1006/meth.1999.0830; Lancefield RC, 1933, J EXP MED, V57, P571, DOI 10.1084/jem.57.4.571; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; Maeda N, 2009, INT IMMUNOPHARMACOL, V9, P1122, DOI 10.1016/j.intimp.2009.04.015; Mai V, 2009, WORLD J GASTROENTERO, V15, P81, DOI 10.3748/wjg.15.81; Mantovani HC, 2003, CURR MICROBIOL, V46, P18, DOI 10.1007/s00284-002-3786-6; Mantovani HC, 2002, MICROBIOL-SGM, V148, P3347, DOI 10.1099/00221287-148-11-3347; Mantovani HC, 2001, FEMS MICROBIOL ECOL, V37, P223, DOI 10.1016/S0168-6496(01)00166-0; Masuda S, 2008, INT J FOOD MICROBIOL, V121, P245, DOI 10.1016/j.ijfoodmicro.2007.10.011; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Molina A, 2003, VET J, V165, P84, DOI 10.1016/S1090-0233(02)00173-9; Morovsky M, 1998, MICROBIOL RES, V153, P277, DOI 10.1016/S0944-5013(98)80012-8; Murosaki S, 2000, CANCER IMMUNOL IMMUN, V49, P157, DOI 10.1007/s002620050615; Nagafuchi S, 1999, BIOSCI BIOTECH BIOCH, V63, P474, DOI 10.1271/bbb.63.474; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; Neumann E, 1998, BRAZ J MED BIOL RES, V31, P1565, DOI 10.1590/S0100-879X1998001200009; Ochoa-Zarzosa A, 2008, ANTON LEEUW INT J G, V94, P199, DOI 10.1007/s10482-008-9230-6; Parra MD, 2004, J PHYSIOL BIOCHEM, V60, P85, DOI 10.1007/BF03168444; Perdigon G, 1999, J DAIRY SCI, V82, P1108, DOI 10.3168/jds.S0022-0302(99)75333-6; Perrier C, 2010, CLIN EXP ALLERGY, V40, P153, DOI 10.1111/j.1365-2222.2009.03329.x; Pochard P, 2002, J ALLERGY CLIN IMMUN, V110, P617, DOI 10.1067/mai.2002.128528; Roberton AM, 1997, CAN J GASTROENTEROL, V11, P361, DOI 10.1155/1997/642360; Russell JB, 2002, J MOL MICROB BIOTECH, V4, P347; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sashihara T, 2007, INT J FOOD MICROBIOL, V120, P274, DOI 10.1016/j.ijfoodmicro.2007.09.003; Segawa S, 2008, INT J FOOD MICROBIOL, V121, P1, DOI 10.1016/j.ijfoodmicro.2007.10.004; Sergent T, 2008, FOOD CHEM TOXICOL, V46, P813, DOI 10.1016/j.fct.2007.12.006; Shu Q, 2000, VET J, V159, P262, DOI 10.1053/tvjl.1999.0400; STEFFEN EK, 1988, J INFECT DIS, V157, P1032, DOI 10.1093/infdis/157.5.1032; Tuohy KM, 2009, CURR PHARM DESIGN, V15, P1415, DOI 10.2174/138161209788168182; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; Vitini E, 2000, BIOCELL, V24, P223; Wisselink HJ, 2002, VET MICROBIOL, V84, P155, DOI 10.1016/S0378-1135(01)00452-7; Woodcock NP, 2001, J CLIN PATHOL, V54, P619, DOI 10.1136/jcp.54.8.619; Xavier BM, 2008, FEMS MICROBIOL LETT, V283, P162, DOI 10.1111/j.1574-6968.2008.01155.x; Xavier BM, 2009, ANAEROBE, V15, P168, DOI 10.1016/j.anaerobe.2008.10.002; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	63	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48313	10.1371/journal.pone.0048313	http://dx.doi.org/10.1371/journal.pone.0048313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144752	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300062
J	Szatmari, T; Mundt, F; Heidari-Hamedani, G; Zong, F; Ferolla, E; Alexeyenko, A; Hjerpe, A; Dobra, K				Szatmari, Tunde; Mundt, Filip; Heidari-Hamedani, Ghazal; Zong, Fang; Ferolla, Elena; Alexeyenko, Andrey; Hjerpe, Anders; Dobra, Katalin			Novel Genes and Pathways Modulated by Syndecan-1: Implications for the Proliferation and Cell-Cycle Regulation of Malignant Mesothelioma Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; IN-VITRO; EXPRESSION; CANCER; SURFACE; BINDING	Malignant pleural mesothelioma is a highly malignant tumor, originating from mesothelial cells of the serous cavities. In mesothelioma the expression of syndecan-1 correlates to epithelioid morphology and inhibition of growth and migration. Our previous data suggest a complex role of syndecan-1 in mesothelioma cell proliferation although the exact underlying molecular mechanisms are not completely elucidated. The aim of this study is therefore to disclose critical genes and pathways affected by syndecan-1 in mesothelioma; in order to better understand its importance for tumor cell growth and proliferation. We modulated the expression of syndecan-1 in a human mesothelioma cell line via both overexpression and silencing, and followed the transcriptomic responses with microarray analysis. To project the transcriptome analysis on the full-dimensional picture of cellular regulation, we applied pathway analysis using Ingenuity Pathway Analysis (IPA) and a novel method of network enrichment analysis (NEA) which elucidated signaling relations between differentially expressed genes and pathways acting via various molecular mechanisms. Syndecan-1 overexpression had profound effects on genes involved in regulation of cell growth, cell cycle progression, adhesion, migration and extracellular matrix organization. In particular, expression of several growth factors, interleukins, and enzymes of importance for heparan sulfate sulfation pattern, extracellular matrix proteins and proteoglycans were significantly altered. Syndecan-1 silencing had less powerful effect on the transcriptome compared to overexpression, which can be explained by the already low initial syndecan-1 level of these cells. Nevertheless, 14 genes showed response to both up-and downregulation of syndecan-1. The "cytokine cytokine-receptor interaction", the TGF-beta, EGF, VEGF and ERK/MAPK pathways were enriched in both experimental settings. Most strikingly, nearly all analyzed pathways related to cell cycle were enriched after syndecan-1 silencing and depleted after syndecan-1 overexpression. Syndecan-1 regulates proliferation in a highly complex way, although the exact contribution of the altered pathways necessitates further functional studies.	[Szatmari, Tunde; Mundt, Filip; Heidari-Hamedani, Ghazal; Zong, Fang; Ferolla, Elena; Hjerpe, Anders; Dobra, Katalin] Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden; [Alexeyenko, Andrey] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Szatmari, T (corresponding author), Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden.	tunde.szatmari@ki.se	zong, fang/GQZ-6104-2022; Szatmári, Tünde/AAC-5808-2020; Alexeyenko, Andrey/F-1924-2016	Szatmári, Tünde/0000-0001-7727-9589; Alexeyenko, Andrey/0000-0001-8812-6481	AFA Insurance [090086]; Swedish Research Council [K2012-99x-21999-01-3]; Swedish Heart-Lung Foundation [20110450]; Swedish Society of Medicine [SLS-93621]	AFA Insurance; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society of Medicine	This study was supported by : AFA Insurance, http://www.afaforsakring.se/(090086); Swedish Research Council http://www.vr.se/(K2012-99x-21999-01-3); Swedish Heart-Lung Foundation, http://www.hjart-lungfonden.se/(20110450); and Swedish Society of Medicine http://www.sls.se/(SLS-93621). The AFA insurance company is a non-profit non-commercial company, jointly owned by the Swedish Labour Organization and the Swedish Employers Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Adachi Y, 2006, INT J CANCER, V119, P1303, DOI 10.1002/ijc.22006; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Alexeyenko A, 2011, NUCL ACIDS RES; Alexeyenko A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-226; Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Anttonen A, 2001, LUNG CANCER, V32, P297, DOI 10.1016/S0169-5002(00)00230-0; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bret C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-72; Carey DJ, 1997, BIOCHEM J, V327, P1; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dobra K, 2003, ANTICANCER RES, V23, P2435; Dobra K, 2000, EXP CELL RES, V258, P12, DOI 10.1006/excr.2000.4915; Duenas-Gonzalez A, 1998, J CELL BIOL, V141, P1407, DOI 10.1083/jcb.141.6.1407; Eiro N, 2012, WORLD J GASTRO SURG, V4, P62, DOI 10.4240/wjgs.v4.i3.62; ELENIUS K, 1994, J CELL SCI, V107, P2975; Evans C, 2006, BRIT J CANCER, V94, P1412, DOI 10.1038/sj.bjc.6603104; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fox S, 2006, FRONT BIOSCI-LANDMRK, V11, P2106, DOI 10.2741/1953; Galffy G, 1999, CANCER RES, V59, P367; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Gill S, 2010, ANAT REC, V293, P968, DOI 10.1002/ar.21094; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gotte Martin, 2003, ScientificWorldJournal, V3, P1327; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Gulyas M, 2003, J PATHOL, V199, P479, DOI 10.1002/path.1312; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He B, 2005, CANCER RES, V65, P743; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kars MD, 2010, BIOMED PHARMACOTHER, V64, P458, DOI 10.1016/j.biopha.2010.01.008; KATO M, 1994, J BIOL CHEM, V269, P18881; Katz BZ, 2010, SEMIN CANCER BIOL, V20, P186, DOI 10.1016/j.semcancer.2010.04.003; Kopp JL, 2004, J BIOL CHEM, V279, P19407, DOI 10.1074/jbc.M314115200; Kumar R, 2011, BRIT J DERMATOL, V165, P285, DOI 10.1111/j.1365-2133.2011.10324.x; Kumar-Singh S, 1998, J PATHOL, V186, P300, DOI 10.1002/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Lundin M, 2005, ONCOLOGY-BASEL, V68, P306, DOI 10.1159/000086969; Maeda T, 2004, CANCER RES, V64, P612, DOI 10.1158/0008-5472.CAN-03-2439; MALI M, 1993, J BIOL CHEM, V268, P24215; Marzo AL, 1997, CANCER RES, V57, P3200; Meng FK, 2011, ACTA PHARMACOL SIN, V32, P1159, DOI 10.1038/aps.2011.41; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Pap Z, 2009, PATHOL ONCOL RES, V15, P579, DOI 10.1007/s12253-009-9157-x; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Peterfia B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039474; Pompeo E, 2009, ANN THORAC SURG, V88, P426, DOI 10.1016/j.athoracsur.2009.04.038; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Rek A, 2009, BBA-PROTEINS PROTEOM, V1794, P577, DOI 10.1016/j.bbapap.2009.01.001; RIDLEY RC, 1993, BLOOD, V81, P767; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; Sanderson RD, 2008, CLIN EXP METASTAS, V25, P149, DOI 10.1007/s10585-007-9125-3; Schellings MWM, 2010, HYPERTENSION, V55, P249, DOI 10.1161/HYPERTENSIONAHA.109.137885; Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh AK, 2011, J BIOL CHEM, V286, P21961, DOI 10.1074/jbc.M111.238238; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Stepp MA, 2010, EXP CELL RES, V316, P2322, DOI 10.1016/j.yexcr.2010.05.020; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; TAKADA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1345, DOI 10.1006/bbrc.1994.2813; Takai N, 2000, CANCER, V89, P2059, DOI 10.1002/1097-0142(20001115)89:10<2059::AID-CNCR5>3.0.CO;2-3; Takai N, 2002, INT J MOL MED, V9, P287; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Thomas Sterling, 2010, Human Genomics, V4, P353; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Vetvicka V, 2011, ANTICANCER RES, V31, P47; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Vuoriluoto K, 2011, MATRIX BIOL, V30, P207, DOI 10.1016/j.matbio.2011.03.003; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Yang HN, 2008, CURR TREAT OPTION ON, V9, P147, DOI 10.1007/s11864-008-0067-z; Yang JD, 2011, GENE CHROMOSOME CANC, V50, P122, DOI 10.1002/gcc.20838; Yang N, 2011, AM J PATHOL, V178, P325, DOI 10.1016/j.ajpath.2010.11.039; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zhu HY, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-14; Zimmermann P, 1999, FASEB J, V13, pS91; Zong F, 2010, CELL PROLIFERAT, V43, P29, DOI 10.1111/j.1365-2184.2009.00651.x; Zong F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014816	109	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48091	10.1371/journal.pone.0048091	http://dx.doi.org/10.1371/journal.pone.0048091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144729	Green Published, gold			2022-12-25	WOS:000310705300039
J	Justice, SS; Li, BR; Downey, JS; Dabdoub, SM; Brockson, ME; Probst, GD; Ray, WC; Goodman, SD				Justice, Sheryl S.; Li, Birong; Downey, Jennifer S.; Dabdoub, Shareef M.; Brockson, M. Elizabeth; Probst, G. Duane; Ray, William C.; Goodman, Steven D.			Aberrant Community Architecture and Attenuated Persistence of Uropathogenic Escherichia coli in the Absence of Individual IHF Subunits	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; INTRACELLULAR BACTERIAL COMMUNITIES; SITE-SPECIFIC RECOMBINATION; URINARY-TRACT-INFECTION; DNA-BINDING PROTEIN; TYPE-1 FIMBRIAE; PHASE VARIATION; HIMA GENE; EXPRESSION; SURA	Uropathogenic Escherichia coli (UPEC) utilizes a complex community-based developmental pathway for growth within superficial epithelial cells of the bladder during cystitis. Extracellular DNA (eDNA) is a common matrix component of organized bacterial communities. Integration host factor (IHF) is a heterodimeric protein that binds to double-stranded DNA and produces a hairpin bend. IHF-dependent DNA architectural changes act both intrabacterially and extrabacterially to regulate gene expression and community stability, respectively. We demonstrate that both IHF subunits are required for efficient colonization of the bladder, but are dispensable for early colonization of the kidney. The community architecture of the intracellular bacterial communities (IBCs) is quantitatively different in the absence of either IhfA or IhfB in the murine model for human urinary tract infection (UTI). Restoration of Type 1 pili by ectopic production does not restore colonization in the absence of IhfA, but partially compensates in the absence of IhfB. Furthermore, we describe a binding site for IHF that is upstream of the operon that encodes for the P-pilus. Taken together, these data suggest that both IHF and its constituent subunits (independent of the heterodimer), are able to participate in multiple aspects of the UPEC pathogenic lifestyle, and may have utility as a target for treatment of bacterial cystitis.	[Justice, Sheryl S.; Li, Birong; Dabdoub, Shareef M.; Brockson, M. Elizabeth; Probst, G. Duane] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Justice, Sheryl S.] Ohio State Univ, Coll Med, Dept Pediat & Urol, Columbus, OH 43210 USA; [Downey, Jennifer S.; Goodman, Steven D.] Univ So Calif, Herman Ostrow Sch Dent, Div Biomed Sci, Los Angeles, CA USA; [Ray, William C.] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of Southern California; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Justice, SS (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA.	Sheryl.Justice@nationwidechildrens.org; sgoodman@usc.edu	Justice, Sheryl/E-3329-2011; Dabdoub, Shareef/AAD-4982-2021; Goodman, Steven/C-5732-2013; Ray, William/E-3930-2011	Justice, Sheryl/0000-0002-7059-3759; Dabdoub, Shareef/0000-0002-1374-8347; Ray, William/0000-0002-4207-250X	National Institutes of Health [1R01DC011818-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by a National Institutes of Health grant (1R01DC011818-01, to SDG). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAGA M, 1985, EMBO J, V4, P3887, DOI 10.1002/j.1460-2075.1985.tb04162.x; Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x; Barnhart MM, 2003, J BACTERIOL, V185, P2723, DOI 10.1128/JB.185.9.2723-2730.2003; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BORTOLUSSI R, 1983, INFECT IMMUN, V39, P1136, DOI 10.1128/IAI.39.3.1136-1141.1983; Chen SL, 2009, P NATL ACAD SCI USA, V106, P22439, DOI 10.1073/pnas.0902179106; Corcoran CP, 2009, MOL MICROBIOL, V74, P1071, DOI 10.1111/j.1365-2958.2009.06919.x; Crepin S, 2012, INFECT IMMUN, V80, P2802, DOI 10.1128/IAI.00162-12; Cusumano CK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003021; Dabdoub S, 2012, VISUAL ANAL IN PRESS; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; FLAMM EL, 1985, J MOL BIOL, V183, P117, DOI 10.1016/0022-2836(85)90206-2; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; GORANSSON M, 1989, MOL MICROBIOL, V3, P1557, DOI 10.1111/j.1365-2958.1989.tb00141.x; GRANSTON AE, 1993, J MOL BIOL, V234, P45, DOI 10.1006/jmbi.1993.1562; HALES LM, 1994, J BACTERIOL, V176, P2999, DOI 10.1128/JB.176.10.2999-3006.1994; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hill SA, 2002, MOL CELL PROBE, V16, P153, DOI 10.1006/mcpr.2001.0403; Horvath DJ, 2011, MICROBES INFECT, V13, P426, DOI 10.1016/j.micinf.2010.12.004; HULTGREN SJ, 1985, INFECT IMMUN, V50, P370, DOI 10.1128/IAI.50.2.370-377.1985; HULTGREN SJ, 1990, MOL MICROBIOL, V4, P1311, DOI 10.1111/j.1365-2958.1990.tb00710.x; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Hung DCI, 2011, J BACTERIOL, V193, P3642, DOI 10.1128/JB.00155-11; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Jeong HS, 2010, J BIOL CHEM, V285, P9357, DOI 10.1074/jbc.M109.089987; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kim N, 2002, J BACTERIOL, V184, P6155, DOI 10.1128/JB.184.22.6155-6162.2002; Kostakioti M, 2012, INFECT IMMUN, V80, P2826, DOI 10.1128/IAI.00283-12; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Lee AK, 1998, INFECT IMMUN, V66, P3964, DOI 10.1128/IAI.66.8.3964-3967.1998; LEE EC, 1992, EMBO J, V11, P305, DOI 10.1002/j.1460-2075.1992.tb05053.x; Li BR, 2010, MICROBES INFECT, V12, P662, DOI 10.1016/j.micinf.2010.04.009; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; Lunsford RD, 1996, CURR MICROBIOL, V32, P95, DOI 10.1007/s002849900017; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; MILLER HI, 1984, COLD SPRING HARB SYM, V49, P691, DOI 10.1101/SQB.1984.049.01.078; MILLER HI, 1979, COLD SPRING HARB SYM, V43, P1121, DOI 10.1101/SQB.1979.043.01.125; MILLER HI, 1981, P NATL ACAD SCI-BIOL, V78, P6754, DOI 10.1073/pnas.78.11.6754; MIZUSAWA H, 1981, MUTAT RES, V82, P47, DOI 10.1016/0027-5107(81)90137-8; Morash MG, 2009, APPL ENVIRON MICROB, V75, P1826, DOI 10.1128/AEM.02756-08; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; NASH HA, 1987, J BACTERIOL, V169, P4124, DOI 10.1128/jb.169.9.4124-4127.1987; Nicholson TF, 2009, INFECT IMMUN, V77, P5245, DOI 10.1128/IAI.00670-09; Rosen DA, 2008, INFECT IMMUN, V76, P3337, DOI 10.1128/IAI.00090-08; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; ROUVIEREYANIV J, 1975, P NATL ACAD SCI USA, V72, P3428, DOI 10.1073/pnas.72.9.3428; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Schwartz DJ, 2011, INFECT IMMUN, V79, P4250, DOI 10.1128/IAI.05339-11; SILHAVY TJ, 1984, EXPT GENE FUSIONS, P111; Smith SGJ, 1999, MOL MICROBIOL, V34, P965, DOI 10.1046/j.1365-2958.1999.01657.x; Snyder JA, 2006, INFECT IMMUN, V74, P1387, DOI 10.1128/IAI.74.2.1387-1393.2006; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; Stonehouse E, 2008, J BACTERIOL, V190, P4736, DOI 10.1128/JB.00089-08; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; Suck D, 1997, BIOPOLYMERS, V44, P405, DOI 10.1002/(SICI)1097-0282(1997)44:4<405::AID-BIP5>3.0.CO;2-L; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; WERNER MH, 1994, CURR BIOL, V4, P477, DOI 10.1016/S0960-9822(00)00108-1; WINTERS BD, 1993, INFECT IMMUN, V61, P3259, DOI 10.1128/IAI.61.8.3259-3264.1993; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Zhang LP, 1999, INFECT IMMUN, V67, P6473; ZULIANELLO L, 1994, EMBO J, V13, P1534, DOI 10.1002/j.1460-2075.1994.tb06415.x	76	18	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48349	10.1371/journal.pone.0048349	http://dx.doi.org/10.1371/journal.pone.0048349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133584	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800072
J	Marcilla-Etxenike, A; Martin, ML; Noguera-Salva, MA; Garcia-Verdugo, JM; Soriano-Navarro, M; Dey, I; Escriba, PV; Busquets, X				Marcilla-Etxenike, Amaia; Laura Martin, Maria; Antonia Noguera-Salva, Maria; Manuel Garcia-Verdugo, Jose; Soriano-Navarro, Mario; Dey, Indranil; Escriba, Pablo V.; Busquets, Xavier			2-Hydroxyoleic Acid Induces ER Stress and Autophagy in Various Human Glioma Cell Lines	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ANTICANCER ACTIVITY; EXPRESSION; DISEASE; DEATH; DRUG; ACTIVATION; APOPTOSIS; SURVIVAL; GROWTH	Background: 2-Hydroxyoleic acid is a synthetic fatty acid with potent anti-cancer activity which does not induce undesired side effects. However, the molecular and cellular mechanisms by which this compound selectively kills human glioma cancer cells without killing normal cells is not fully understood. The present study was designed to determine the molecular bases underlying the potency against 1321N1, SF-767 and U118 human glioma cell lines growth without affecting non cancer MRC-5 cells. Methodology/Principal Findings: The cellular levels of endoplasmic reticulum (ER) stress, unfolded protein response (UPR) and autophagy markers were determined by quantitative RT-PCR and immunoblotting on 1321N1, SF-767 and U118 human glioma cells and non-tumor MRC-5 cells incubated in the presence or absence of 2OHOA or the ER stress/autophagy inducer, palmitate. The cellular response to these agents was evaluated by fluorescence microscopy, electron microscopy and flow cytometry. We have observed that 2OHOA treatments induced augments in the expression of important ER stress/UPR markers, such as phosphorylated eIF2 alpha, IRE1 alpha, CHOP, ATF4 and the spliced form of XBP1 in human glioma cells. Concomitantly, 2OHOA led to the arrest of 1321N1 cells in the G(2)/M phase of the cell cycle, with down-regulation of cyclin B1 and Cdk1/Cdc2 proteins in the three glioma cell lines studied. Finally, 2OHOA induced autophagy in 1321N1, SF-767 and U118 cells, with the appearance of autophagic vesicles and the up-regulation of LC3BI, LC3BII and ATG7 in 1321N1 cells, increases of LC3BI, LC3BII and ATG5 in SF-767 cells and up-regulation of LC3BI and LC3BII in U118 cells. Importantly, 2OHOA failed to induce such changes in non-tumor MRC-5 cells. Conclusion/Significance: The present results demonstrate that 2OHOA induces ER stress/UPR and autophagy in human glioma (1321N1, SF-767 and U118 cell lines) but not normal (MRC-5) cells, unraveling the molecular bases underlying the efficacy and lack of toxicity of this compound.	[Marcilla-Etxenike, Amaia; Laura Martin, Maria; Antonia Noguera-Salva, Maria; Escriba, Pablo V.; Busquets, Xavier] Univ Islas Baleares, Inst Univ Invest Ciencias Salud, Dept Biol, Palma de Mallorca, Spain; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles, Valencia, Spain; [Manuel Garcia-Verdugo, Jose; Soriano-Navarro, Mario] Univ Valencia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Unidad Mixta Ctr Invest Principe Felipe, Valencia, Spain; [Dey, Indranil] Lipopharma Inc, Acton, MA USA	Universitat de les Illes Balears; University of Valencia; CIBERNED; Prince Felipe Research Center; University of Valencia	Busquets, X (corresponding author), Univ Islas Baleares, Inst Univ Invest Ciencias Salud, Dept Biol, Palma de Mallorca, Spain.	xavier.busquets@uib.es	García-Verdugo, José Manuel/L-8421-2017; Busquets, Xavier/M-5574-2018	García-Verdugo, José Manuel/0000-0001-9872-6499; Busquets, Xavier/0000-0003-1157-5590; Soriano Navarro, Mario/0000-0002-7245-2095; Martin, Maria Laura/0000-0001-9359-5856; Escriba, Pablo/0000-0001-9795-182X	University of the Balearic Islands; Programa de Formacion de Profesorado Universitario (FPU), Ministerio de Educacion, Gobierno de Espana; Ministerio de Educacion y Ciencia, Spain [BFU2007-61071, BIO2010-21132]; Marathon Foundation	University of the Balearic Islands; Programa de Formacion de Profesorado Universitario (FPU), Ministerio de Educacion, Gobierno de Espana(German Research Foundation (DFG)); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Marathon Foundation	This work was supported in part by fellowships from The University of the Balearic Islands and the Programa de Formacion de Profesorado Universitario (FPU), Ministerio de Educacion, Gobierno de Espana. Grants [BFU2007-61071, BIO2010-21132] from the Ministerio de Educacion y Ciencia, Spain, and by the Marathon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2004, MOL MEMBR BIOL, V21, P261, DOI 10.1080/09687680410001716835; Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Cordomi A, 2010, J LIPID RES, V51, P1113, DOI 10.1194/jlr.M003012; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Davies MPA, 2008, INT J CANCER, V123, P85, DOI 10.1002/ijc.23479; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Han C, 2008, J MICROBIOL BIOTECHN, V18, P1197; Hansen K, 2007, J NEUROCHEM, V103, P259, DOI 10.1111/j.1471-4159.2007.04753.x; Jakobsen CH, 2008, J LIPID RES, V49, P2089, DOI 10.1194/jlr.M700389-JLR200; Jia WT, 2010, INT J BIOCHEM CELL B, V42, P2019, DOI 10.1016/j.biocel.2010.09.003; Johnson GG, 2011, CURR PHARM DESIGN, V17, P284; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Llado V, 2010, J CELL MOL MED, V13, P1; Llado V, 2009, P NATL ACAD SCI USA, V106, P13754, DOI 10.1073/pnas.0907300106; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Martinez J, 2005, J PHARMACOL EXP THER, V315, P466, DOI 10.1124/jpet.105.088716; Martinez J, 2005, MOL PHARMACOL, V67, P531, DOI 10.1124/mol.104.000778; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; Shingu T, 2010, NEURO-ONCOLOGY, V12, P1269, DOI 10.1093/neuonc/noq095; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Teres S, 2012, P NATL ACAD SCI USA, V109, P8489, DOI 10.1073/pnas.1118349109; Verfaillie Tom, 2010, Int J Cell Biol, V2010, P930509, DOI 10.1155/2010/930509; Wang GH, 2010, AM J TRANSL RES, V2, P65; Yang ZAY, 2010, ACTA BIOCH BIOPH SIN, V42, P418, DOI 10.1093/abbs/gmq037; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	40	29	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48235	10.1371/journal.pone.0048235	http://dx.doi.org/10.1371/journal.pone.0048235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133576	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800066
J	Shaffer, JA; Epel, E; Kang, MS; Ye, SQ; Schwartz, JE; Davidson, KW; Kirkland, S; Honig, LS; Shimbo, D				Shaffer, Jonathan A.; Epel, Elissa; Kang, Min Suk; Ye, Siqin; Schwartz, Joseph E.; Davidson, Karina W.; Kirkland, Susan; Honig, Lawrence S.; Shimbo, Daichi			Depressive Symptoms Are Not Associated with Leukocyte Telomere Length: Findings from the Nova Scotia Health Survey (NSHS95), a Population-Based Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CES-D; MAJOR DEPRESSION; RISK-FACTOR; MORTALITY; METAANALYSIS; STRESS; PLASMA; CANCER; BLOOD	Background: Premature shortening of leukocyte telomere length has been proposed as a novel mechanism by which depression may confer increased risk of adverse cardiovascular events. Prior studies demonstrating associations of depression and depressive symptoms with shorter leukocyte telomere length were small, included selected psychiatric outpatients, were based on convenience samples, and/or adjusted for a limited number of possible confounding factors. Methods and Findings: We examined the associations of depressive symptoms, probable depressive disorder, and specific depressive symptom clusters, as assessed by the Center for Epidemiological Studies-Depression (CES-D) scale, with leukocyte telomere length, measured by using a real-time PCR method, in 2,225 apparently healthy participants from the 1995 Nova Scotia Health Survey population-based study. The mean age was 48.2 +/- 18.9 years; 49.9% of participants were female; and the mean CES-D score was 7.4 +/- 7.9. The mean telomere length was 5,301 +/- 587 base pairs. In an unadjusted model, depressive symptoms were significantly associated with longer leukocyte telomere length (B = 27.6 base pairs per standard deviation increase in CES-D, 95% confidence interval [CI] = 3.1-52.1, p = 0.027). This association was no longer significant after adjustment for age and sex (B = 9.5, 95% CI = -14.6-33.6, p = 0.44) or after further adjustment for body mass index, Framingham risk score and previous history of ischemic heart disease (all p's >= 0.37). Neither probable depressive disorder nor specific depressive symptom clusters were independently associated with leukocyte telomere length. Conclusions: Concurrent depressive symptoms were not associated with leukocyte telomere length in a large, representative, population-based study.	[Shaffer, Jonathan A.; Ye, Siqin; Schwartz, Joseph E.; Davidson, Karina W.; Shimbo, Daichi] Columbia Univ, Ctr Behav Cardiovasc Hlth, New York, NY 10027 USA; [Epel, Elissa] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Kang, Min Suk; Honig, Lawrence S.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Schwartz, Joseph E.] SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA; [Kirkland, Susan] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Honig, Lawrence S.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Honig, Lawrence S.] Columbia Univ, Dept Neurol, New York, NY USA	Columbia University; University of California System; University of California San Francisco; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Dalhousie University; Columbia University; Columbia University	Shimbo, D (corresponding author), Columbia Univ, Ctr Behav Cardiovasc Hlth, New York, NY 10027 USA.	ds2231@columbia.edu	Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Shaffer, Jonathan A/B-2783-2013	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Kirkland, Susan/0000-0002-8182-2369; Schwartz, Joseph/0000-0002-8944-3566	National Heart, Lung, and Blood Institute, Bethesda, Maryland [HL-091099, HL-084034]; National Health and Welfare of Canada, Ottawa, Ontario; Nova Scotia Department of Health, Halifax, Nova Scotia; Heart and Stroke Foundation of New Brunswick, St. John, New Brunswick; American Heart Association [12CRP8870004]; Health Services and Research Administration [T32 HP10260]; American College of Cardiology/Merck Foundation Fellowship Award; National Institute of Health [T32HL007854-16]; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; National Institute on Aging [P50AG008702]; Henry Panasci Fund; Taub Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL084034, T32HL007854, P01HL088117, R01HL091099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Health and Welfare of Canada, Ottawa, Ontario; Nova Scotia Department of Health, Halifax, Nova Scotia; Heart and Stroke Foundation of New Brunswick, St. John, New Brunswick; American Heart Association(American Heart Association); Health Services and Research Administration; American College of Cardiology/Merck Foundation Fellowship Award; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Henry Panasci Fund; Taub Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants HL-091099 and HL-084034 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. Additional support was provided by National Health and Welfare of Canada, Ottawa, Ontario; the Nova Scotia Department of Health, Halifax, Nova Scotia; and the Heart and Stroke Foundation of New Brunswick, St. John, New Brunswick. Dr. Shaffer is supported by grants 12CRP8870004 of the American Heart Association and T32 HP10260 from the Health Services and Research Administration. Dr. Ye is supported by an American College of Cardiology/Merck Foundation Fellowship Award and by National Institute of Health Grant T32HL007854-16. Dr. Honig receives support from the Alzheimer's Association, the Alzheimer's Drug Discovery Foundation, the National Institute on Aging (grant P50AG008702), the Henry Panasci Fund, and the Taub Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bosch NM, 2009, PSYCHOSOM MED, V71, P944, DOI 10.1097/PSY.0b013e3181bc756b; BRESLAU N, 1985, PSYCHIAT RES, V15, P219, DOI 10.1016/0165-1781(85)90079-4; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; CONNELLY PW, 1992, CAN MED ASSOC J, V146, P1977; Davidson KW, 2009, AM J CARDIOL, V103, P755, DOI 10.1016/j.amjcard.2008.11.035; Dmitriev PV, 2009, ANAL TELOMERIC DNA C; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Glass Daniel, 2010, Biol Psychiatry, V68, pe21, DOI 10.1016/j.biopsych.2010.02.026; Hartmann N, 2010, DEPRESS ANXIETY, V27, P1111, DOI 10.1002/da.20749; Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23; Hoen PW, 2011, PSYCHOSOM MED, V73, P541, DOI 10.1097/PSY.0b013e31821b1f6e; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Huzen J, 2010, AGE AGEING, V39, P223, DOI 10.1093/ageing/afp256; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Lung FW, 2007, PSYCHIAT GENET, V17, P195, DOI 10.1097/YPG.0b013e32808374f6; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rowan PJ, 2002, PSYCHOL MED, V32, P903, DOI 10.1017/S0033291702005767; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Shaffer JA, 2011, PSYCHOSOM MED, V73, P370, DOI 10.1097/PSY.0b013e31821deafd; Shaffer JA, 2012, HEALTH PSYCHOL REV, V6, P165, DOI 10.1080/17437199.2010.527610; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Starr JM, 2007, EXP GERONTOL, V42, P571, DOI 10.1016/j.exger.2006.12.002; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolkowitz OM, 2012, MOL PSYCHIATR, V17, P164, DOI 10.1038/mp.2010.133; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; [No title captured]	44	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48318	10.1371/journal.pone.0048318	http://dx.doi.org/10.1371/journal.pone.0048318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026GE	23133583	Green Submitted, gold, Green Published			2022-12-25	WOS:000310261800071
J	Ji, FL; Jung, J; Koharudin, LMI; Gronenborn, AM				Ji, Fangling; Jung, Jinwon; Koharudin, Leonardus M. I.; Gronenborn, Angela M.			The Human W42R gamma D-Crystallin Mutant Structure Provides a Link between Congenital and Age-related Cataracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN FLUORESCENCE; DOMINANT CATARACT; S-CRYSTALLIN; PROTEIN; MUTATION; IDENTIFICATION; PHOTOLYSIS; MECHANISM; MOUSE; STATE	Some mutants of human gamma D-crystallin are closely linked to congenital cataracts, although the detailed molecular mechanisms of mutant-associated cataract formation are generally not known. Here we report on a recently discovered gamma D-crystallin mutant (W42R) that has been linked to autosomal dominant, congenital cataracts in a Chinese family. The mutant protein is much less soluble and stable than wild-type gamma D-crystallin. We solved the crystal structure of W42R at 1.7 angstrom resolution, which revealed only minor differences from the wild-type structure. Interestingly, the W42R variant is highly susceptible to protease digestion, suggesting the presence of a small population of partially unfolded protein. This partially unfolded species was confirmed and quantified by NMR spectroscopy. Hydrogen/deuterium exchange experiments revealed chemical exchange between the folded and unfolded species. Exposure of wild-type gamma D-crystallin to UV caused damage to the N-terminal domain of the protein, resulting in very similar proteolytic susceptibility as observed for the W42R mutant. Altogether, our combined data allowed us to propose a model for W42R pathogenesis, with the W42R mutant serving as a mimic for photodamaged gamma D-crystallin involved in age-related cataract.	[Ji, Fangling] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Peoples R China; [Ji, Fangling; Jung, Jinwon; Koharudin, Leonardus M. I.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA	Dalian University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave, Pittsburgh, PA 15261 USA.	amg100@pitt.edu		Jung, Jinwon/0000-0002-7981-3316; Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [EY021193]; China Scholarship Council; NATIONAL EYE INSTITUTE [R01EY021193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY021193 (to A. M. G). This work was also supported by a scholarship from the China Scholarship Council (to F. J.).	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004; BRYANT FD, 1975, J PHYS CHEM-US, V79, P2711, DOI 10.1021/j100592a002; Chen JJ, 2008, BIOCHEMISTRY-US, V47, P10705, DOI 10.1021/bi800499k; Chen JJ, 2006, BIOCHEMISTRY-US, V45, P11552, DOI 10.1021/bi060988v; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVERETT CA, 1994, GENOMICS, V20, P429, DOI 10.1006/geno.1994.1197; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Fu L, 2002, FEBS LETT, V513, P213, DOI 10.1016/S0014-5793(02)02313-X; Goddard T.D., 2004, SPARKY 3; Graw J, 2002, MAMM GENOME, V13, P452, DOI 10.1007/s00335-002-3021-6; Graw JC, 2004, INVEST OPHTH VIS SCI, V45, P1202, DOI 10.1167/iovs.03-0811; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji FL, 2012, BIOCHEMISTRY-US, V51, P2588, DOI 10.1021/bi300199d; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Keller B, 2007, J BIOMOL NMR, V37, P1, DOI 10.1007/s10858-006-9081-2; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lee S, 2010, J MOL BIOL, V399, P320, DOI 10.1016/j.jmb.2010.04.003; Mahler B, 2011, J MOL BIOL, V405, P840, DOI 10.1016/j.jmb.2010.11.005; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson EM, 2002, J MOL BIOL, V316, P807, DOI 10.1006/jmbi.2001.5347; Oyster CW., 1999, HUMAN EYE STRUCTURE; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, P2108; Reddy MA, 2004, HUM MOL GENET, V13, P945, DOI 10.1093/hmg/ddh110; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; Searle BC, 2005, J PROTEOME RES, V4, P546, DOI 10.1021/pr049781j; Shiels A, 2010, MOL VIS, V16, P2007; Sinha D, 1998, Mol Vis, V4, P8; Sinha D, 2001, J BIOL CHEM, V276, P9308, DOI 10.1074/jbc.M010583200; TALLMADGE DH, 1990, PHOTOCHEM PHOTOBIOL, V51, P363, DOI 10.1111/j.1751-1097.1990.tb01723.x; Vijaya R, 1997, CLIN GENET, V52, P427; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang SSS, 2010, MOL VIS, V16, P2777; WUTHRICH K, 1979, J MOL BIOL, V130, P1, DOI 10.1016/0022-2836(79)90548-5	52	37	38	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					99	109		10.1074/jbc.M112.416354	http://dx.doi.org/10.1074/jbc.M112.416354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23124202	Green Published, hybrid			2022-12-25	WOS:000313197200010
J	Ruiz, JC; Walker, SD; Anderson, SA; Eisenstein, RS; Bruick, RK				Ruiz, Julio C.; Walker, Scott D.; Anderson, Sheila A.; Eisenstein, Richard S.; Bruick, Richard K.			F-box and Leucine-rich Repeat Protein 5 (FBXL5) Is Required for Maintenance of Cellular and Systemic Iron Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMERYTHRIN-LIKE DOMAIN; REGULATORY PROTEINS; MAMMALIAN IRON; TRANSFERRIN RECEPTOR; RAT-LIVER; MITOCHONDRIAL ACONITASE; MESSENGER-RNA; IN-VIVO; METABOLISM; DEGRADATION	Maintenance of cellular iron homeostasis requires post-transcriptional regulation of iron metabolism genes by iron regulatory protein 2 (IRP2). The hemerythrin-like domain of F-box and leucine-rich repeat protein 5 (FBXL5), an E3 ubiquitin ligase subunit, senses iron and oxygen availability and facilitates IRP2 degradation in iron replete cells. Disruption of the ubiquitously expressed murine Fbxl5 gene results in a failure to sense increased cellular iron availability, accompanied by constitutive IRP2 accumulation and misexpression of IRP2 target genes. FBXL5-null mice die during embryogenesis, although viability is restored by simultaneous deletion of the IRP2, but not IRP1, gene. Mice containing a single functional Fbxl5 allele behave like their wild type littermates when fed an iron-sufficient diet. However, unlike wild type mice that manifest decreased hematocrit and hemoglobin levels when fed a low-iron diet, Fbxl5 heterozygotes maintain normal hematologic values due to increased iron absorption. The responsiveness of IRP2 to low iron is specifically enhanced in the duodena of the heterozygotes and is accompanied by increased expression of the divalent metal transporter-1. These results confirm the role of FBXL5 in the in vivo maintenance of cellular and systemic iron homeostasis and reveal a privileged role for the intestine in their regulation by virtue of its unique FBXL5 iron sensitivity.	[Ruiz, Julio C.; Walker, Scott D.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Anderson, Sheila A.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Madison	Bruick, RK (corresponding author), 5323 Harry Hines Blvd,K3-112, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu			National Center for Research Resources [C06 RR 15437-01]; National Institutes of Health [HL102481, DK66600, GM084266]; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; Robert A. Welch Foundation [I-1568]; Sara and Frank McKnight Graduate Student Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK066600, R01DK066600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); Sara and Frank McKnight Graduate Student Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sean McCormick and Paul A. Lindahl for inductively coupled plasma mass spectrometry analysis, Sandi Jo Estill, James Richardson, and the UTSW Molecular Pathology Core for assistance with the animal studies, C. Nizzi and N. Keuler for statistical analysis, and members of the Bruick lab for helpful advice. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program Grant C06 RR 15437-01 from the National Center for Research Resources.; This work was supported, in whole or in part, by National Institutes of Health Grants HL102481 (to R. K. B.), DK66600 (to R. S. E.), and GM084266 (to P. A. L.), a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (to R. K. B.), and Robert A. Welch Foundation Grant I-1568 (to R. K. B.).; HHMI Scholar and supported by a Sara and Frank McKnight Graduate Student Fellowship.	Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Camaschella C, 2011, CURR OPIN PEDIATR, V23, P14, DOI 10.1097/MOP.0b013e3283425591; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chollangi S, 2012, J BIOL CHEM, V287, P23710, DOI 10.1074/jbc.M112.360404; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; De Domenico I, 2011, SEMIN LIVER DIS, V31, P272, DOI 10.1055/s-0031-1286058; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Galy B, 2005, GENESIS, V43, P181, DOI 10.1002/gene.20169; Galy B, 2004, RNA, V10, P1019, DOI 10.1261/rna.7220704; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Grosbois B, 2005, B ACAD NAT MED PARIS, V189, P1649, DOI 10.1016/S0001-4079(19)33422-3; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; LEIBOLD EA, 1992, ANNU REV NUTR, V12, P345, DOI 10.1146/annurev.nu.12.070192.002021; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; PANTOPOULOS K, 1995, RNA, V1, P155; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Popescu BFG, 2009, CEREBELLUM, V8, P74, DOI 10.1007/s12311-008-0091-3; Ross KL, 2002, J NUTR, V132, P643, DOI 10.1093/jn/132.4.643; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, ANN NY ACAD SCI, V1177, P30, DOI 10.1111/j.1749-6632.2009.05038.x; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Shu C, 2012, CHEMBIOCHEM, V13, P788, DOI 10.1002/cbic.201200043; Smith SR, 2006, BLOOD CELL MOL DIS, V36, P283, DOI 10.1016/j.bcmd.2005.12.006; Thompson JW, 2012, BBA-MOL CELL RES, V1823, P1484, DOI 10.1016/j.bbamcr.2012.02.003; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06	41	30	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					552	560		10.1074/jbc.M112.426171	http://dx.doi.org/10.1074/jbc.M112.426171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23135277	hybrid, Green Published			2022-12-25	WOS:000313197200055
J	Basu, R; Fan, D; Kandalam, V; Lee, J; Das, SK; Wang, XH; Baldwin, TA; Oudit, GY; Kassiri, Z				Basu, Ratnadeep; Fan, Dong; Kandalam, Vijay; Lee, Jiwon; Das, Subhash K.; Wang, Xiuhua; Baldwin, Troy A.; Oudit, Gavin Y.; Kassiri, Zamaneh			Loss of Timp3 Gene Leads to Abdominal Aortic Aneurysm Formation in Response to Angiotensin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; CARDIOVASCULAR MORTALITY; RECEPTOR BLOCKERS; HEART-FAILURE; DOXYCYCLINE; EXPRESSION; GELATINASE; PROTEIN	Aortic aneurysm is dilation of the aorta primarily due to degradation of the aortic wall extracellular matrix (ECM). Tissue inhibitors of metalloproteinases (TIMPs) inhibit matrix metalloproteinases (MMPs), the proteases that degrade the ECM. Timp3 is the only ECM-bound Timp, and its levels are altered in the aorta from patients with abdominal aortic aneurysm (AAA). We investigated the causal role of Timp3 in AAA formation. Infusion of angiotensin II (Ang II) using micro-osmotic (Alzet) pumps in Timp3(-/-) male mice, but not in wild type control mice, led to adverse remodeling of the abdominal aorta, reduced collagen and elastin proteins but not mRNA, and elevated proteolytic activities, suggesting excess protein degradation within 2 weeks that led to formation of AAA by 4 weeks. Intriguingly, despite early up-regulation of MMP2 in Timp3(-/-)Ang II aortas, additional deletion of Mmp2 in these mice (Timp3(-/-)/Mmp2(-/-)) resulted in exacerbated AAA, compromised survival due to aortic rupture, and inflammation in the abdominal aorta. Reconstitution of WT bone marrow in Timp3(-/-)/Mmp2(-/-) mice reduced inflammation and prevented AAA in these animals following Ang II infusion. Treatment with a broad spectrum MMP inhibitor (PD166793) prevented the Ang II-induced AAA in Timp3(-/-) and Timp3(-/-)/Mmp2(-/-) mice. Our study demonstrates that the regulatory function of TIMP3 is critical in preventing adverse vascular remodeling and AAA. Hence, replenishing TIMP3, a physiological inhibitor of a number of metalloproteinases, could serve as a therapeutic approach in limiting AAA development or expansion.	[Basu, Ratnadeep; Fan, Dong; Kandalam, Vijay; Lee, Jiwon; Wang, Xiuhua; Kassiri, Zamaneh] Univ Alberta, Dept Physiol, Div Cardiol, Edmonton, AB T6G 2S2, Canada; [Baldwin, Troy A.] Univ Alberta, Dept Med Microbiol & Immunol, Div Cardiol, Edmonton, AB T6G 2S2, Canada; [Das, Subhash K.; Oudit, Gavin Y.] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB T6G 2S2, Canada; [Basu, Ratnadeep; Fan, Dong; Kandalam, Vijay; Lee, Jiwon; Das, Subhash K.; Wang, Xiuhua; Oudit, Gavin Y.; Kassiri, Zamaneh] Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Kassiri, Z (corresponding author), Univ Alberta, Dept Physiol, Div Cardiol, 474 HMRC, Edmonton, AB T6G 2S2, Canada.	z.kassiri@ualberta.ca	Fan, Dong/AFM-6258-2022	Fan, Dong/0000-0001-6730-0612	Canadian Institute of Health [84279]; Heart and Stroke Foundation of Canada; Alberta Innovates-Health Solutions (AI-HS) studentship	Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Innovates-Health Solutions (AI-HS) studentship	This work was supported by Canadian Institute of Health Research Grant 84279 and a Heart and Stroke Foundation of Canada grant (to Z.K.).; Supported by an Alberta Innovates-Health Solutions (AI-HS) studentship.	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Allaire E, 1998, J CLIN INVEST, V102, P1413, DOI 10.1172/JCI2909; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Baxter BT, 2002, J VASC SURG, V36, P1, DOI 10.1067/mva.2002.125018; Bohm M, 2007, AM J CARDIOL, V100, p38J, DOI 10.1016/j.amjcard.2007.05.013; Brands MW, 2010, HYPERTENSION, V56, P879, DOI 10.1161/HYPERTENSIONAHA.110.158071; Crowther M, 2000, BRIT J SURG, V87, P1391, DOI 10.1046/j.1365-2168.2000.01554.x; Cuadrado E, 2008, J LEUKOCYTE BIOL, V84, P207, DOI 10.1189/jlb.0907606; Cummins PM, 2007, AM J PHYSIOL-HEART C, V292, pH28, DOI 10.1152/ajpheart.00304.2006; Danyi P, 2011, CIRCULATION, V124, P1469, DOI 10.1161/CIRCULATIONAHA.110.006486; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Eskandari MK, 2005, J SURG RES, V123, P289, DOI 10.1016/j.jss.2004.07.247; Ferguson CD, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.016; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Forsdahl SH, 2010, INT J EPIDEMIOL, V39, P225, DOI 10.1093/ije/dyp320; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Golledge J, 2011, ATHEROSCLEROSIS, V217, P57, DOI 10.1016/j.atherosclerosis.2011.03.006; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Goodall S, 2001, CIRCULATION, V104, P304, DOI 10.1161/01.CIR.104.3.304; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1872, DOI 10.1056/NEJMoa0911056; Hackmann AE, 2008, J VASC SURG, V48, P519, DOI 10.1016/j.jvs.2008.03.064; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Ikonomidis JS, 2004, CIRCULATION, V110, pII268, DOI 10.1161/01.CIR.0000138384.68947.20; Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Javed U, 2008, CARDIOL CLIN, V26, P507, DOI 10.1016/j.ccl.2008.07.001; Kandalam V, 2011, CIRCULATION, V124, P2094, DOI 10.1161/CIRCULATIONAHA.111.030338; Kandalam V, 2010, AM J PHYSIOL-HEART C, V299, pH1012, DOI 10.1152/ajpheart.00246.2010; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Kassiri Z, 2009, J BIOL CHEM, V284, P29893, DOI 10.1074/jbc.M109.028449; Kassiri Z, 2009, J AM SOC NEPHROL, V20, P1223, DOI 10.1681/ASN.2008050492; Knox JB, 1997, CIRCULATION, V95, P205, DOI 10.1161/01.CIR.95.1.205; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Lira EB, 2006, J AM SOC ECHOCARDIOG, V19, P829, DOI 10.1016/j.echo.2005.12.023; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Moore L, 2012, HEART FAIL REV, V17, P693, DOI 10.1007/s10741-011-9266-y; Mori S, 2006, J CARD FAIL, V12, P314, DOI 10.1016/j.cardfail.2006.01.009; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Ogata T, 2005, J VASC SURG, V41, P1036, DOI 10.1016/j.jvs.2005.02.020; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Ruddy JM, 2008, J THORAC CARDIOV SUR, V136, P1123, DOI 10.1016/j.jtcvs.2008.06.027; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; SHAPIRO SD, 1991, J RHEUMATOL, V18, P95; SHAPIRO SD, 1991, ANN NY ACAD SCI, V624, P69, DOI 10.1111/j.1749-6632.1991.tb17007.x; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Suen AYW, 2012, P NATL ACAD SCI USA, V109, P893, DOI 10.1073/pnas.1114834109; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Tomaschitz A, 2011, EUR HEART J, V32, P2642, DOI 10.1093/eurheartj/ehr150; Tsarouhas K, 2010, THROMB RES, V126, P399, DOI 10.1016/j.thromres.2010.08.015; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Xiong WF, 2006, J VASC SURG, V44, P1061, DOI 10.1016/j.jvs.2006.06.036; Xiong WF, 2012, CIRC RES, V110, pE92, DOI 10.1161/CIRCRESAHA.112.268268; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zhang X, 2012, CIRC RES, V110, pE73, DOI 10.1161/CIRCRESAHA.111.253880	64	53	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44083	44096		10.1074/jbc.M112.425652	http://dx.doi.org/10.1074/jbc.M112.425652			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144462	Green Published, hybrid			2022-12-25	WOS:000312938600007
J	Kakuta, S; Yamamoto, H; Negishi, L; Kondo-Kakuta, C; Hayashi, N; Ohsumi, Y				Kakuta, Soichiro; Yamamoto, Hayashi; Negishi, Lumi; Kondo-Kakuta, Chika; Hayashi, Nobuhiro; Ohsumi, Yoshinori			Atg9 Vesicles Recruit Vesicle-tethering Proteins Trs85 and Ypt1 to the Autophagosome Formation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; TRAPP COMPLEXES; RAB GTPASES; EARLY STEPS; ORGANIZATION; CVT; CYTOPLASM; PATHWAY	Atg9 is a transmembrane protein that is essential for autophagy. In the budding yeast Saccharomyces cerevisiae, it has recently been revealed that Atg9 exists on cytoplasmic small vesicles termed Atg9 vesicles. To identify the components of Atg9 vesicles, we purified the Atg9 vesicles and subjected them to mass spectrometry. We found that their protein composition was distinct from other organellar membranes and that Atg9 and Atg27 in particular are major components of Atg9 vesicles. In addition to these two components, Trs85, a specific subunit of the transport protein particle III (TRAPPIII) complex, and the Rab GTPase Ypt1 were also identified. Trs85 directly interacts with Atg9, and the Trs85-containing TRAPPIII complex facilitates the association of Ypt1 onto Atg9 vesicles. We also showed that Trs85 and Ypt1 are localized to the preautophagosomal structure in an Atg9-dependent manner. Our data suggest that Atg9 vesicles recruit the TRAPPIII complex and Ypt1 to the preautophagosomal structure. The vesicle-tethering machinery consequently acts in the process of autophagosome formation.	[Kakuta, Soichiro; Yamamoto, Hayashi; Kondo-Kakuta, Chika; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Negishi, Lumi; Hayashi, Nobuhiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Frontier Res Ctr S2 12, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Hayashi, Nobuhiro/F-6088-2011	Ohsumi, Yoshinori/0000-0003-2384-2166; Hayashi, Nobuhiro/0000-0002-9950-094X; Negishi, Lumi/0000-0002-7297-0634	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kurosawa G, 2009, J IMMUNOL METHODS, V351, P1, DOI 10.1016/j.jim.2009.09.003; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lipatova Z, 2012, P NATL ACAD SCI USA, V109, P6981, DOI 10.1073/pnas.1121299109; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Meiling-Wesse K, 2005, J BIOL CHEM, V280, P33669, DOI 10.1074/jbc.M501701200; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nazarko TY, 2005, AUTOPHAGY, V1, P37, DOI 10.4161/auto.1.1.1512; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; van Werven FJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl003; Wang K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371591; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Yamada T, 2005, J BIOL CHEM, V280, P18283, DOI 10.1074/jbc.M413957200; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350	45	78	85	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44261	44269		10.1074/jbc.M112.411454	http://dx.doi.org/10.1074/jbc.M112.411454			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129774	Green Published, hybrid			2022-12-25	WOS:000312938600024
J	Khan, SH; Awasthi, S; Guo, CH; Goswami, D; Ling, J; Griffin, PR; Simons, SS; Kumar, R				Khan, Shagufta H.; Awasthi, Smita; Guo, Chunhua; Goswami, Devrishi; Ling, Jun; Griffin, Patrick R.; Simons, S. Stoney, Jr.; Kumar, Raj			Binding of the N-terminal Region of Coactivator TIF2 to theIntrinsically Disordered AF1 Domain of the Glucocorticoid Receptor Is Accompanied by Conformational Reorganizations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALF THYMUS DNA; TRANSCRIPTIONAL ACTIVITY; COREPRESSOR BINDING; HORMONE RECEPTORS; CHROMATIN ACCESSIBILITY; PROGESTERONE-RECEPTOR; ANTAGONIST COMPLEXES; INDUCTION PROPERTIES; SECONDARY STRUCTURE; INTRINSIC DISORDER	Control of gene transcription by glucocorticoid receptors (GRs) is important for many physiological processes. Like other steroid hormone receptors, the regulation of target genes by GR is mediated by two transactivation domains: activation function 1 (AF1) in the N-terminal domain and AF2 in the C-terminal ligand-binding domain (LBD). Full receptor activity requires both AF1 and -2 plus assorted coregulatory proteins. Crystal structures of the ligand-bound LBD have provided insight regarding how AF2 interacts with specific coactivators. However, despite its being the major activation domain of GRs, knowledge of AF1 structure/function has languished. This is mainly because of the highly disorganized structure of the GR N-terminal domain. This lack of AF1 structure is shared by all members of the steroid/nuclear receptor superfamily for which it has been examined and AF1 is thought to allow productive interactions with assorted cofactors via protein-induced changes in secondary/tertiary structures. To date, there are no reports of a classical coactivator altering the secondary/tertiary structure of the GR AF1 domain. Earlier, we reported an N-terminal fragment of the p160 coactivator TIF2, called TIF2.0, that binds the GR N-terminal domain and alters GR transcriptional activity. We therefore proposed that TIF2.0 binding to AF1 changes both its conformation and transcriptional activity. We now report that TIF2.0 interacts with the GR AF1 domain to increase the amount of alpha-helical structure in the complex. Furthermore, TIF2 coactivator activity is observed in the absence of the GR LBD in a manner that requires the AF1 domain. This contrasts with previous models where TIF2 receptor interaction domains binding to GR LBD somehow alter AF1 conformation. Our results establish for the first time that coactivators can modify the structure of the AF1 domain directly via the binding of a second region of the coactivator and suggest a molecular explanation for how coactivators increase the transcriptional activity of GR-agonist complexes.	[Khan, Shagufta H.; Ling, Jun; Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA; [Simons, S. Stoney, Jr.] NIDDK, Steroid Hormones Sect, LERB, NIH,CEB, Bethesda, MD 20892 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Geisinger Commonwealth School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Scripps Research Institute	Simons, SS (corresponding author), NIDDK, Steroid Hormones Sect, LERB, NIH,CEB, Bldg 10,Rm 8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov; rkumar@tcmedc.org	Guo, Chunhua/N-2586-2014	Awasthi, Smita/0000-0002-2065-5800	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047041, ZIADK057800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health Intramural Research Program of the NIDDK (to S. S. S., Jr.).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Busby SA, 2007, INT J MASS SPECTROM, V259, P130, DOI 10.1016/j.ijms.2006.08.006; CAVANAUGH AH, 1990, BIOCHEMISTRY-US, V29, P989, DOI 10.1021/bi00456a022; CAVANAUGH AH, 1990, BIOCHEMISTRY-US, V29, P996, DOI 10.1021/bi00456a023; Chalmers Michael J, 2007, J Biomol Tech, V18, P194; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Garza AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025875; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; KHAN SH, 2009, J BIOPHYS; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021939; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Kumar R, 2007, ARCH BIOCHEM BIOPHYS, V465, P452, DOI 10.1016/j.abb.2007.06.019; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Kumar R, 2012, ENDOCR REV, V33, P271, DOI 10.1210/er.2011-1033; Kumar R, 2009, STEROIDS, V74, P877, DOI 10.1016/j.steroids.2009.07.012; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; LEACH KL, 1979, J BIOL CHEM, V254, P1884; Lee GS, 2011, BIOCHEMISTRY-US, V50, P356, DOI 10.1021/bi101792d; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nilsson J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r65; Norris JD, 1998, J BIOL CHEM, V273, P6679, DOI 10.1074/jbc.273.12.6679; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Simons SS, 2010, CURR OPIN PHARMACOL, V10, P613, DOI 10.1016/j.coph.2010.08.001; Tao YG, 2008, BIOCHEMISTRY-US, V47, P7648, DOI 10.1021/bi800472w; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Walsh I, 2011, NUCLEIC ACIDS RES, V39, pW190, DOI 10.1093/nar/gkr411; Wang DQ, 2007, BIOCHEMISTRY-US, V46, P8036, DOI 10.1021/bi7004575; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367	71	33	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44546	44560		10.1074/jbc.M112.411330	http://dx.doi.org/10.1074/jbc.M112.411330			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132854	Green Published, hybrid			2022-12-25	WOS:000312938600051
J	Miller, C; Matic, I; Maier, KC; Schwalb, B; Roether, S; Strasser, K; Tresch, A; Mann, M; Cramer, P				Miller, Christian; Matic, Ivan; Maier, Kerstin C.; Schwalb, Bjoern; Roether, Susanne; Straesser, Katja; Tresch, Achim; Mann, Matthias; Cramer, Patrick			Mediator Phosphorylation Prevents Stress Response Transcription During Non-stress Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; MESSENGER-RNA STABILITY; GENE-EXPRESSION; IN-VIVO; MULTISTRESS RESPONSE; FUNCTIONAL-ANALYSIS; GLOBAL ANALYSIS; OSMOTIC-STRESS; CELL-CULTURE; AMINO-ACIDS	The multiprotein complex Mediator is a coactivator of RNA polymerase (Pol) II transcription that is required for the regulated expression of protein-coding genes. Mediator serves as an end point of signaling pathways and regulates Pol II transcription, but the mechanisms it uses are not well understood. Here, we used mass spectrometry and dynamic transcriptome analysis to investigate a functional role of Mediator phosphorylation in gene expression. Affinity purification and mass spectrometry revealed that Mediator from the yeast Saccharomyces cerevisiae is phosphorylated at multiple sites of 17 of its 25 subunits. Mediator phosphorylation levels change upon an external stimulus set by exposure of cells to high salt concentrations. Phosphorylated sites in the Mediator tail subunit Med15 are required for suppression of stress-induced changes in gene expression under non-stress conditions. Thus dynamic and differential Mediator phosphorylation contributes to gene regulation in eukaryotic cells.	[Miller, Christian; Maier, Kerstin C.; Schwalb, Bjoern; Roether, Susanne; Straesser, Katja; Tresch, Achim; Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Miller, Christian; Maier, Kerstin C.; Schwalb, Bjoern; Roether, Susanne; Straesser, Katja; Tresch, Achim; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, D-81377 Munich, Germany; [Matic, Ivan; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	University of Munich; University of Munich; Max Planck Society	Mann, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	Matic, Ivan/HFZ-7772-2022; Matic, Ivan/F-7284-2010; Mann, Matthias/A-3454-2013	Matic, Ivan/0000-0003-0170-7991; Matic, Ivan/0000-0003-0170-7991; Mann, Matthias/0000-0003-1292-4799; Strasser, Katja/0000-0003-3533-5516; Miller, Christian/0000-0002-7918-6869; Schwalb, Bjorn/0000-0003-2987-2622	Mann and Cramer laboratories; Center for Integrated Protein Science Munich; LMUexcellent; European Research Council; Deutsche Forschungsgemeinschaft [SFB646, TR5, FOR1068]; Nanosystems Initiative Munich; Jung-Stiftung; Vallee Foundation	Mann and Cramer laboratories; Center for Integrated Protein Science Munich; LMUexcellent; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanosystems Initiative Munich; Jung-Stiftung; Vallee Foundation	This work was supported in part by the Mann and Cramer laboratories, which are supported by the Center for Integrated Protein Science Munich.; Supported by an LMUexcellent research professorship.; Supported by SFB646 and European Research Council.; Supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, FOR1068, Nanosystems Initiative Munich, the Jung-Stiftung, and the Vallee Foundation. To whom correspondence may be addressed.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Bauer S, 2011, BIOINFORMATICS, V27, P1882, DOI 10.1093/bioinformatics/btr296; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Berti L, 2001, GENOMICS, V74, P320, DOI 10.1006/geno.2001.6566; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Enjalbert B, 2004, MOL GENET GENOMICS, V271, P697, DOI 10.1007/s00438-004-1014-8; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guidi BW, 2004, J BIOL CHEM, V279, P29114, DOI 10.1074/jbc.M404426200; Hallberg M, 2004, P NATL ACAD SCI USA, V101, P3370, DOI 10.1073/pnas.0400221101; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hirata Y, 2003, MOL BIOL CELL, V14, P302, DOI 10.1091/mbc.E02-05-0247; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jedidi I, 2010, J BIOL CHEM, V285, P2438, DOI 10.1074/jbc.M109.071589; Jeong CJ, 2001, BIOCHEMISTRY-US, V40, P9421, DOI 10.1021/bi010011k; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; Kobayashi N, 1996, BIOCHEM BIOPH RES CO, V229, P540, DOI 10.1006/bbrc.1996.1840; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Lallet S, 2006, MOL MICROBIOL, V62, P438, DOI 10.1111/j.1365-2958.2006.05363.x; Lariviere L, 2008, GENE DEV, V22, P872, DOI 10.1101/gad.465108; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Murray DB, 2011, BBA-GEN SUBJECTS, V1810, P945, DOI 10.1016/j.bbagen.2011.04.005; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sadeh A, 2012, J CELL SCI, V125, P3333, DOI 10.1242/jcs.096446; Seizl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027595; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Spaeth JM, 2011, SEMIN CELL DEV BIOL, V22, P776, DOI 10.1016/j.semcdb.2011.07.024; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Treger JM, 1998, BIOCHEM BIOPH RES CO, V243, P13, DOI 10.1006/bbrc.1997.8061; Unnikrishnan I, 2003, J BIOL CHEM, V278, P26450, DOI 10.1074/jbc.M211808200; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Zahringer H, 2000, MOL MICROBIOL, V35, P397, DOI 10.1046/j.1365-2958.2000.01706.x	85	26	26	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44017	44026		10.1074/jbc.M112.430140	http://dx.doi.org/10.1074/jbc.M112.430140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135281	hybrid, Green Published			2022-12-25	WOS:000312938600001
J	Agulleiro, JI; Fernandez, JJ				Agulleiro, Jose-Ignacio; Jesus Fernandez, Jose			Evaluation of a Multicore-Optimized Implementation for Tomographic Reconstruction	PLOS ONE			English	Article							ELECTRON TOMOGRAPHY; ITERATIVE RECONSTRUCTION; 3-DIMENSIONAL RECONSTRUCTION; CELLS; VISUALIZATION; ALGORITHMS; VIRUS; GPU	Tomography allows elucidation of the three-dimensional structure of an object from a set of projection images. In life sciences, electron microscope tomography is providing invaluable information about the cell structure at a resolution of a few nanometres. Here, large images are required to combine wide fields of view with high resolution requirements. The computational complexity of the algorithms along with the large image size then turns tomographic reconstruction into a computationally demanding problem. Traditionally, high-performance computing techniques have been applied to cope with such demands on supercomputers, distributed systems and computer clusters. In the last few years, the trend has turned towards graphics processing units (GPUs). Here we present a detailed description and a thorough evaluation of an alternative approach that relies on exploitation of the power available in modern multicore computers. The combination of single-core code optimization, vector processing, multithreading and efficient disk I/O operations succeeds in providing fast tomographic reconstructions on standard computers. The approach turns out to be competitive with the fastest GPU-based solutions thus far.	[Jesus Fernandez, Jose] Natl Res Council CNB CSIC, Natl Biotechnol Ctr, Madrid, Spain; [Agulleiro, Jose-Ignacio] Univ Almeria, Supercomp & Algorithms Grp, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidad de Almeria	Fernandez, JJ (corresponding author), Natl Res Council CNB CSIC, Natl Biotechnol Ctr, Madrid, Spain.	jj.fernandez@csic.es	Fernandez, Jose-Jesus/A-5084-2008	Fernandez, Jose-Jesus/0000-0003-2222-3355	Spanish Ministry of Science [TIN2008-01117]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding provided by the Spanish Ministry of Science, grant number TIN2008-01117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulleiro JI, 2012, ULTRAMICROSCOPY, V115, P109, DOI 10.1016/j.ultramic.2012.02.003; Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Agulleiro JI, 2010, J STRUCT BIOL, V170, P570, DOI 10.1016/j.jsb.2010.01.008; Badia-Martinez D, 2012, VIROLOGY, V430, P120, DOI 10.1016/j.virol.2012.05.001; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Beeby M, 2012, J BACTERIOL, V194, P1092, DOI 10.1128/JB.06125-11; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Castano-Diez D, 2008, J STRUCT BIOL, V164, P153, DOI 10.1016/j.jsb.2008.07.006; Fritzsche PC, 2010, INT J HIGH PERFORM C, V24, P457, DOI 10.1177/1094342010370575; Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102; Diez DC, 2007, J STRUCT BIOL, V157, P288, DOI 10.1016/j.jsb.2006.08.010; Fernandez JJ, 2008, J STRUCT BIOL, V164, P1, DOI 10.1016/j.jsb.2008.07.005; Fernandez JJ, 2002, J STRUCT BIOL, V138, P6, DOI 10.1016/S1047-8477(02)00017-5; Fernandez JJ, 2006, IEEE SIGNAL PROC MAG, V23, P84, DOI 10.1109/MSP.2006.1628881; Fernandez JJ, 2004, J PARALLEL DISTR COM, V64, P285, DOI 10.1016/j.jpdc.2003.06.005; Fernandez JJ, 2008, J PARALLEL DISTR COM, V68, P626, DOI 10.1016/j.jpdc.2007.09.003; Fernandez JJ, 2007, FUTURE GENER COMP SY, V23, P435, DOI 10.1016/j.future.2006.07.010; Fernandez JJ, 2012, MICRON, V43, P1010, DOI 10.1016/j.micron.2012.05.003; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; Gilbert P.F.C., 1972, ELECT TOMOGRAPHY MET, V182, P89; Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; Hennessy John L., 2011, COMPUTER ARCHITECTUR; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Kirk D, 2010, PROGRAMMING MASSIVEL; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lee D, 2003, PROF ENG, V16, P19; Lee VW, 2010, CONF PROC INT SYMP C, P451, DOI 10.1145/1816038.1816021; Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Murat D, 2012, MOL MICROBIOL, V85, P684, DOI 10.1111/j.1365-2958.2012.08132.x; Ounjai P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101980; Palenstijn WJ, 2011, J STRUCT BIOL, V176, P250, DOI 10.1016/j.jsb.2011.07.017; Peltier ST, 2003, J PARALLEL DISTR COM, V63, P539, DOI 10.1016/S0743-7315(03)00061-3; Perez-Berna AJ, 2012, J BIOL CHEM, V287, P31582, DOI 10.1074/jbc.M112.389957; Perkins GA, 1997, J STRUCT BIOL, V120, P219, DOI 10.1006/jsbi.1997.3920; Radermacher M., 2006, ELECT TOMOGRAPHY MET, P245, DOI DOI 10.1007/978-0-387-69008-7_9; Vazquez F, 2010, J STRUCT BIOL, V170, P146, DOI 10.1016/j.jsb.2010.01.021; Vazquez F, 2011, COMPUT J, V54, P1861, DOI 10.1093/comjnl/bxr033; Wadleigh KR, 2000, SOFTWARE OPTIMIZATIO; Wan XH, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S4; Wan XH, 2011, LECT N BIOINFORMAT, V6674, P61, DOI 10.1007/978-3-642-21260-4_10; Xiaohua Wan, 2009, Proceedings of the 2009 IEEE 15th International Conference on Parallel and Distributed Systems (ICPADS 2009), P384, DOI 10.1109/ICPADS.2009.21; Xu W, 2010, J STRUCT BIOL, V171, P142, DOI 10.1016/j.jsb.2010.03.018; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005; Zheng SQ, 2011, ULTRAMICROSCOPY, V111, P1137, DOI 10.1016/j.ultramic.2011.03.015	49	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48261	10.1371/journal.pone.0048261	http://dx.doi.org/10.1371/journal.pone.0048261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139768	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300022
J	Sarkar, SK; Dutta, M; Kumar, A; Mallik, D; Ghosh, AS				Sarkar, Sujoy K.; Dutta, Mouparna; Kumar, Akash; Mallik, Dhriti; Ghosh, Anindya S.			Sub-Inhibitory Cefsulodin Sensitization of E. coli to beta-lactams Is Mediated by PBP1b Inhibition	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-1A; ESCHERICHIA-COLI; RESISTANCE; TRANSPEPTIDASE; SHIGELLA; DELETION; SCREEN; LYSIS; SHAPE	The combination of antibiotics is one of the strategies to combat drug-resistant bacteria, though only a handful of such combinations are in use, such as the beta-lactam combinations. In the present study, the efficacy of a specific sub-inhibitory concentration of cefsulodin with other beta-lactams was evaluated against a range of Gram-negative clinical isolates. This approach increased the sensitivity of the isolates, regardless of the beta-lactamase production. The preferred target and mechanism of action of cefsulodin were identified in laboratory strains of Escherichia coli, by examining the effects of deleting the penicillin-binding protein (PBP) 1a and 1b encoding genes individually. Deletion of PBP1b was involved in sensitizing the bacteria to beta-lactam agents, irrespective of its O-antigen status. Moreover, the use of a sub-inhibitory concentration of cefsulodin in combination with a beta-lactam exerted an effect similar to that one obtained for PBP1b gene deletion. We conclude that the identified beta-lactam/cefsulodin combination works by inhibiting PBP1b ( at least partially) despite the involvement of beta-lactamases, and therefore could be extended to a broad range of Gram-negative pathogens.	[Sarkar, Sujoy K.; Dutta, Mouparna; Kumar, Akash; Mallik, Dhriti; Ghosh, Anindya S.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Ghosh, AS (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	anindyain@yahoo.com			Department of Biotechnology, Government of India [BT/215/NE/TBP/2011]; Indian council of Medical Research [5/3/3/16/2006-ECD-1]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian council of Medical Research(Indian Council of Medical Research (ICMR))	The work is funded in part by two different grants, from Department of Biotechnology, Government of India [Grant #BT/215/NE/TBP/2011: http://www.dbtindia.nic.in]; and from Indian council of Medical Research [Grant #5/3/3/16/2006-ECD-1: http://www.icmr.nic.in]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Chandrakala B, 2004, ANTIMICROB AGENTS CH, V48, P30, DOI 10.1128/AAC.48.1.30-40.2004; Chowdhury C, 2010, FEMS MICROBIOL LETT, V303, P76, DOI 10.1111/j.1574-6968.2009.01863.x; CLSI Clinical and Laboratory Standards Institute (CLSI), 2018, PERFORMANCE STANDARD, V28th, DOI DOI 10.1888/0333750888/6100; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; Ghosh AS, 2008, TRENDS MICROBIOL, V16, P309, DOI 10.1016/j.tim.2008.04.006; Ghosh AS, 1998, BIOCHEM BIOPH RES CO, V248, P669, DOI 10.1006/bbrc.1998.9042; JACOBY GH, 1991, J BACTERIOL, V173, P1; KONDO M, 1981, J ANTIBIOT, V34, P727, DOI 10.7164/antibiotics.34.727; Nilsen T, 2004, MOL MICROBIOL, V52, P1045, DOI 10.1111/j.1365-2958.2004.04050.x; Pepper ED, 2006, FEMS MICROBIOL LETT, V263, P61, DOI 10.1111/j.1574-6968.2006.00418.x; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Ramachandran V, 2006, ANTIMICROB AGENTS CH, V50, P1425, DOI 10.1128/AAC.50.4.1425-1432.2006; Sarkar SK, 2008, FEMS MICROBIOL LETT, V282, P59, DOI 10.1111/j.1574-6968.2008.01104.x; Sarkar SK, 2010, INT J ANTIMICROB AG, V35, P244, DOI 10.1016/j.ijantimicag.2009.11.004; Sarkar SK, 2011, MICROBIOL-SGM, V157, P2702, DOI 10.1099/mic.0.046227-0; Yah CS, 2010, BIOL RES, V43, P141, DOI [10.4067/S0716-97602010000200001, /S0716-97602010000200001]; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839	17	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48598	10.1371/journal.pone.0048598	http://dx.doi.org/10.1371/journal.pone.0048598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139798	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300041
J	Chhikara, N; Saraswat, M; Tomar, AK; Dey, S; Singh, S; Yadav, S				Chhikara, Nirmal; Saraswat, Mayank; Tomar, Anil Kumar; Dey, Sharmistha; Singh, Sarman; Yadav, Savita			Human Epididymis Protein-4 (HE-4): A Novel Cross-Class Protease Inhibitor	PLOS ONE			English	Article							EXPRESSION PATTERNS; SERINE PROTEINASES; OVARIAN CARCINOMAS; EPITHELIAL-CELLS; MULTIPLE TYPES; GENE FAMILY; ORAL-CAVITY; HUMAN SEMEN; CANCER; TISSUES	Epididymal proteins represent the factors necessary for maturation of sperm and play a crucial role in sperm maturation. HE-4, an epididymal protein, is a member of whey acidic protein four-disulfide core (WFDC) family with no known function. A WFDC protein has a conserved WFDC domain of 50 amino acids with eight conserved cystine residue. HE-4 is a 124 amino acid long polypeptide with two WFDC domains. Here, we show that HE-4 is secreted in the human seminal fluid as a disulfide-bonded homo-trimer and is a cross-class protease inhibitor inhibits some of the serine, aspartyl and cysteine proteases tested using hemoglobin as a substrate. Using SPR we have also observed that HE-4 shows a significant binding with all these proteases. Disulfide linkages are essential for this activity. Moreover, HE-4 is N-glycosylated and highly stable on a wide range of pH and temperature. Taken together this suggests that HE-4 is a cross-class protease inhibitor which might confer protection against microbial virulence factors of proteolytic nature.	[Chhikara, Nirmal; Saraswat, Mayank; Tomar, Anil Kumar; Dey, Sharmistha; Yadav, Savita] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Singh, Sarman] All India Inst Med Sci, Dept Lab Med, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Yadav, S (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	savita11@gmail.com	Singh, Sarman/AAR-8914-2020; Saraswat, Mayank/F-2985-2015	Singh, Sarman/0000-0002-0749-9647; Saraswat, Mayank/0000-0002-5021-8150; Tomar, Anil Kumar/0000-0002-6089-5008	Department of Science and Technology (DST), Government of India; Council of Scientific and Industrial Research (CSIR), New Delhi	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by financial grants from the Department of Science and Technology (DST), Government of India. The authors thank the Council of Scientific and Industrial Research (CSIR), New Delhi for the fellowship granted to NC. The authors also thank Department of Science and Technology (DST), Government of India, for providing fellowship to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54; Ahlgren G, 1995, J ANDROL, V16, P491; ARDELT W, 1985, BIOCHEMISTRY-US, V24, P5313, DOI 10.1021/bi00341a007; Bingle CD, 2008, TRENDS IMMUNOL, V29, P444, DOI 10.1016/j.it.2008.07.001; Bingle L, 2002, ONCOGENE, V21, P2768, DOI 10.1038/sj.onc.1205363; Bingle L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-61; Birkenmeier G, 1998, PROSTATE, V36, P219; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; Bryant MK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-168; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; DELCASTILLO I, 1992, NAT GENET, V2, P305, DOI 10.1038/ng1292-305; Devoogdt N, 2004, ANN NY ACAD SCI, V1028, P380, DOI 10.1196/annals.1322.044; Devoogdt N, 2003, P NATL ACAD SCI USA, V100, P5778, DOI 10.1073/pnas.1037154100; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; Galgano MT, 2006, MODERN PATHOL, V19, P847, DOI 10.1038/modpathol.3800612; Hassan MI, 2007, J SEP SCI, V30, P1979, DOI 10.1002/jssc.200700028; Hellstrom I, 2003, CANCER RES, V63, P3695; Hu YL, 2004, BIOCHEM J, V384, P495, DOI 10.1042/BJ20041078; Huang XW, 2004, RES MICROBIOL, V155, P811, DOI 10.1016/j.resmic.2004.07.003; Hurle B, 2007, GENOME RES, V17, P276, DOI 10.1101/gr.6004607; Israeli O, 2005, CANCER GENET CYTOGEN, V160, P35, DOI 10.1016/j.cancergencyto.2004.11.011; Jin L, 2011, NANOSCALE, V3, P4746, DOI 10.1039/c1nr11029b; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; LAEMMLI UK, 1970, J MOL BIOL, V49, P99, DOI 10.1016/0022-2836(70)90379-7; Larramendy ML, 2000, CANCER GENET CYTOGEN, V119, P132, DOI 10.1016/S0165-4608(99)00226-5; Larsen M, 2000, MAMM GENOME, V11, P767, DOI 10.1007/s003350010135; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; LEE TM, 1995, PLANT SCI, V106, P43, DOI 10.1016/0168-9452(95)04058-3; Li PP, 2002, P NATL ACAD SCI USA, V99, P1353, DOI 10.1073/pnas.032668699; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Pandhare J, 2004, PROTEIN SCI, V13, P2493, DOI 10.1110/ps.03552004; Perez-Vilar J, 1997, J BIOL CHEM, V272, P33410, DOI 10.1074/jbc.272.52.33410; Ramachandran P, 2006, J PROTEOME RES, V5, P1493, DOI 10.1021/pr050492k; Robinson PA, 1996, J ORAL PATHOL MED, V25, P135, DOI 10.1111/j.1600-0714.1996.tb00208.x; Sajid M, 2011, ADV EXP MED BIOL, V712, P100, DOI 10.1007/978-1-4419-8414-2_7; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; SCHILL WB, 1976, ANDROLOGIA, V8, P359; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; Sreedhar L, 1999, GENE, V235, P121, DOI 10.1016/S0378-1119(99)00201-2; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; STLEGER RJ, 1995, CAN J BOT, V73, pS1119, DOI 10.1139/b95-367; TANG J, 1978, NATURE, V271, P618, DOI 10.1038/271618a0; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tian XR, 2004, ONCOL REP, V12, P1001; Tokuishi K, 2012, TUMOR BIOL, V33, P103, DOI 10.1007/s13277-011-0252-8; Trexler M, 2002, BIOL CHEM, V383, P223, DOI 10.1515/BC.2002.023; Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; ZHANG M, 1995, CANCER RES, V55, P2537	58	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47672	10.1371/journal.pone.0047672	http://dx.doi.org/10.1371/journal.pone.0047672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139753	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400028
J	Eichholz, K; Beszteri, B; John, U				Eichholz, Karsten; Beszteri, Bank; John, Uwe			Putative Monofunctional Type I Polyketide Synthase Units: A Dinoflagellate-Specific Feature?	PLOS ONE			English	Article							SPLICED-LEADER; BIOSYNTHESIS; HETEROCAPSA; EXPRESSION; ALIGNMENT; DOCKING; PARVUM; GENES	Marine dinoflagellates (alveolata) are microalgae of which some cause harmful algal blooms and produce a broad variety of most likely polyketide synthesis derived phycotoxins. Recently, novel polyketide synthesase (PKS) transcripts have been described from the Florida red tide dinoflagellate Karenia brevis (gymnodiniales) which are evolutionarily related to Type I PKS but were apparently expressed as monofunctional proteins, a feature typical of Type II PKS. Here, we investigated expression units of PKS I-like sequences in Alexandrium ostenfeldii (gonyaulacales) and Heterocapsa triquetra (peridiniales) at the transcript and protein level. The five full length transcripts we obtained were all characterized by polyadenylation, a 3' UTR and the dinoflagellate specific spliced leader sequence at the 5'end. Each of the five transcripts encoded a single ketoacylsynthase (KS) domain showing high similarity to K. brevis KS sequences. The monofunctional structure was also confirmed using dinoflagellate specific KS antibodies in Western Blots. In a maximum likelihood phylogenetic analysis of KS domains from diverse PKSs, dinoflagellate KSs formed a clade placed well within the protist Type I PKS clade between apicomplexa, haptophytes and chlorophytes. These findings indicate that the atypical PKS I structure, i.e., expression as putative monofunctional units, might be a dinoflagellate specific feature. In addition, the sequenced transcripts harbored a previously unknown, apparently dinoflagellate specific conserved N-terminal domain. We discuss the implications of this novel region with regard to the putative monofunctional organization of Type I PKS in dinoflagellates.	[Eichholz, Karsten; Beszteri, Bank; John, Uwe] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	John, U (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	Uwe.John@awi.de	Beszteri, Bank M/D-1961-2010; john, uwe/S-3009-2016	Beszteri, Bank M/0000-0002-6852-1588; john, uwe/0000-0002-1297-4086; Eichholz, Karsten/0000-0001-8362-1563	PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment	PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment	Financial support was provided by the PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Broadhurst RW, 2003, CHEM BIOL, V10, P723, DOI 10.1016/S1074-5521(03)00156-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freitag M, 2011, EUR J PHYCOL, V46, P193, DOI 10.1080/09670262.2011.591438; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Jaeckisch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028012; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; John U, 2008, PROTIST, V159, P21, DOI 10.1016/j.protis.2007.08.001; John U, 2010, EUR J PHYCOL, V45, P215, DOI 10.1080/09670261003746193; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; KELLER MD, 1987, J PHYCOL, V23, P633; Kellmann R, 2010, MAR DRUGS, V8, P1011, DOI 10.3390/md8041011; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lopez-Legentil S, 2010, MAR BIOTECHNOL, V12, P32, DOI 10.1007/s10126-009-9197-y; McEwan M, 2008, J EUKARYOT MICROBIOL, V55, P530, DOI 10.1111/j.1550-7408.2008.00357.x; Monroe EA, 2008, PROTIST, V159, P471, DOI 10.1016/j.protis.2008.02.004; Monroe EA, 2010, J PHYCOL, V46, P541, DOI 10.1111/j.1529-8817.2010.00837.x; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; Richter CD, 2008, NAT CHEM BIOL, V4, P75, DOI 10.1038/nchembio.2007.61; Salcedo T, 2012, MOL BIOL EVOL, V29, P1503, DOI 10.1093/molbev/mss007; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Shimizu Y, 2003, CURR OPIN MICROBIOL, V6, P236, DOI 10.1016/S1369-5274(03)00064-X; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; von Wettstein-Knowles P, 2006, FEBS J, V273, P695, DOI 10.1111/j.1742-4658.2005.05101.x; Wright J, NATO ASI SERIES, P427; Wright Jeffrey L.C., 1998, NATO ASI Series Series G Ecological Sciences, V41, P427; Zhang H, 2008, J PHYCOL, V44, P703, DOI 10.1111/j.1529-8817.2008.00521.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004129; Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9	35	33	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48624	10.1371/journal.pone.0048624	http://dx.doi.org/10.1371/journal.pone.0048624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139807	Green Published, gold			2022-12-25	WOS:000310741400057
J	Hepponstall, M; Ignjatovic, V; Binos, S; Monagle, P; Jones, B; Cheung, MHH; d'Udekem, Y; Konstantinov, IE				Hepponstall, Michele; Ignjatovic, Vera; Binos, Steve; Monagle, Paul; Jones, Bryn; Cheung, Michael H. H.; d'Udekem, Yves; Konstantinov, Igor E.			Remote Ischemic Preconditioning (RIPC) Modifies Plasma Proteome in Humans	PLOS ONE			English	Article							COMPLEMENT GENE-EXPRESSION; HIGH-DENSITY-LIPOPROTEIN; REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; PEPTIDE B-BETA(15-42); MYOCARDIAL-INFARCTION; DEPENDENT MECHANISM; CARDIAC-SURGERY; PROTECTION; TISSUE	Remote Ischemic Preconditioning (RIPC) induced by brief episodes of ischemia of the limb protects against multi-organ damage by ischemia-reperfusion (IR). Although it has been demonstrated that RIPC affects gene expression, the proteomic response to RIPC has not been determined. This study aimed to examine RIPC induced changes in the plasma proteome. Five healthy adult volunteers had 4 cycles of 5 min ischemia alternating with 5 min reperfusion of the forearm. Blood samples were taken from the ipsilateral arm prior to first ischaemia, immediately after each episode of ischemia as well as, at 15 min and 24 h after the last episode of ischemia. Plasma samples from five individuals were analysed using two complementary techniques. Individual samples were analysed using 2Dimensional Difference in gel electrophoresis (2D DIGE) and mass spectrometry (MS). Pooled samples for each of the time-points underwent trypsin digestion and peptides generated were analysed in triplicate using Liquid Chromatography and MS (LC-MS). Six proteins changed in response to RIPC using 2D DIGE analysis, while 48 proteins were found to be differentially regulated using LC-MS. The proteins of interest were involved in acute phase response signalling, and physiological molecular and cellular functions. The RIPC stimulus modifies the plasma protein content in blood taken from the ischemic arm in a cumulative fashion and evokes a proteomic response in peripheral blood.	[Hepponstall, Michele; Ignjatovic, Vera; Monagle, Paul; Jones, Bryn; Cheung, Michael H. H.; d'Udekem, Yves; Konstantinov, Igor E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Hepponstall, Michele; Jones, Bryn; Cheung, Michael H. H.; d'Udekem, Yves; Konstantinov, Igor E.] Royal Childrens Hosp, Cardiac Surg Unit & Cardiol, Melbourne, Vic, Australia; [Hepponstall, Michele; Ignjatovic, Vera; Monagle, Paul; Cheung, Michael H. H.; Konstantinov, Igor E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Hepponstall, Michele; Binos, Steve] Dept Primary Ind, Biosci Res Div, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Konstantinov, IE (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	igor.konstantinov@rch.org.au	d'Udekem, Yves/AAS-9642-2021; Ignjatovic, Vera/F-8598-2011	Monagle, Paul/0000-0002-3970-8984; Ignjatovic, Vera/0000-0002-5548-5813; D'UDEKEM D'ACOZ, YVES/0000-0003-1851-7836	National Health and Medical Research Council (NHMRC) [628756, 1017734]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This project was funded by the National Health and Medical Research Council (NHMRC) grant (# 628756) and NHMRC postgraduate scholarship (# 1017734). Yves d'Udekem is a Career Development Fellow of The National Heart Foundation of Australia (CR 10M 5339). This study was supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Andrew SM, 1997, CURRENT PROTOCOLS IM; Ang CS, 2011, J PROTEOME RES, V10, P5059, DOI 10.1021/pr200516d; Arrell DK, 2006, CIRC RES, V99, P706, DOI 10.1161/01.RES.0000243995.74395.f8; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Cairo G, 1998, ANN NY ACAD SCI, V851, P179, DOI 10.1111/j.1749-6632.1998.tb08992.x; Calabresi L, 2006, PHARMACOL THERAPEUT, V111, P836, DOI 10.1016/j.pharmthera.2006.01.003; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Daemen MARC, 2000, CIRCULATION, V102, P1420, DOI 10.1161/01.CIR.102.12.1420; Darde Veronica M, 2007, Methods Mol Biol, V357, P351; Dickson EW, 2001, J MOL CELL CARDIOL, V33, P1751, DOI 10.1006/jmcc.2001.1436; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Gomaraschi M, 2008, J PHARMACOL EXP THER, V324, P776, DOI 10.1124/jpet.107.129411; Gu SS, 2007, LIFE SCI, V81, P702, DOI 10.1016/j.lfs.2007.06.021; Gupta N, 2007, GENOME RES, V17, P1362, DOI 10.1101/gr.6427907; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Imaizumi S, 2008, J AM COLL CARDIOL, V51, P1604, DOI 10.1016/j.jacc.2007.12.040; Kanoria S, 2007, TRANSPLANTATION, V84, P445, DOI 10.1097/01.tp.0000228235.55419.e8; Kharbanda RK, 2006, HEART, V92, P1506, DOI 10.1136/hrt.2004.042366; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Kjellberg M, 2006, J THROMB HAEMOST, V4, P168, DOI 10.1111/j.1538-7836.2005.01656.x; Konstantinov IE, 2005, J THORAC CARDIOV SUR, V130, P1326, DOI 10.1016/j.jtcvs.2005.03.050; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Konstantinov IE, 2004, J THORAC CARDIOV SUR, V127, P746, DOI 10.1016/j.jtcvs.2003.08.056; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Lang SC, 2006, BASIC RES CARDIOL, V101, P149, DOI 10.1007/s00395-005-0565-0; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Saxena P, 2011, J SURG RES, V171, P311, DOI 10.1016/j.jss.2009.11.011; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Serejo FC, 2007, J CARDIOVASC PHARM, V49, P214, DOI 10.1097/FJC.0b013e3180325ad9; Shi N, 2008, J BIOMED SCI, V15, P577, DOI 10.1007/s11373-008-9258-7; Shimizu M, 2010, J SURG RES, V158, P155, DOI 10.1016/j.jss.2008.08.010; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Stone KL, 2002, PROTEIN PROTOCOLS HD, P511; Tacchini L, 2002, HEPATOLOGY, V36, P103, DOI 10.1053/jhep.2002.33997; Tanhehco EJ, 1999, AM J PHYSIOL-HEART C, V277, pH2373, DOI 10.1152/ajpheart.1999.277.6.H2373; Tanhehco EJ, 2000, AM J PHYSIOL-HEART C, V279, pH1157, DOI 10.1152/ajpheart.2000.279.3.H1157; Warzecha Z, 2007, J PHYSIOL PHARMACOL, V58, P303; Zacharowski K, 2007, SHOCK, V27, P631, DOI 10.1097/SHK.0b013e31802fa038	42	59	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48284	10.1371/journal.pone.0048284	http://dx.doi.org/10.1371/journal.pone.0048284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139772	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400045
J	Namdari, F; Hurtado-Escobar, GA; Abed, N; Trotereau, J; Fardini, Y; Giraud, E; Velge, P; Virlogeux-Payant, I				Namdari, Fatemeh; Hurtado-Escobar, Genaro Alejandro; Abed, Nadia; Trotereau, Jerome; Fardini, Yann; Giraud, Etienne; Velge, Philippe; Virlogeux-Payant, Isabelle			Deciphering the Roles of BamB and Its Interaction with BamA in Outer Membrane Biogenesis, T3SS Expression and Virulence in Salmonella	PLOS ONE			English	Article							SECRETION SYSTEM EXPRESSION; EVOLUTIONARY CONSERVATION; CRYSTAL-STRUCTURE; YAET COMPLEX; PROTEINS; TYPHIMURIUM; LIPOPROTEIN; YFGL; IDENTIFICATION; COMPONENT	The folding and insertion of beta-barrel proteins in the outer membrane of Gram-negative bacteria is mediated by the BAM complex, which is composed of the outer membrane protein BamA and four lipoproteins BamB to BamE. In Escherichia coli and/or Salmonella, the BamB lipoprotein is involved in (i) beta-barrel protein assembly in the outer membrane, (ii) outer membrane permeability to antibiotics, (iii) the control of the expression of T3SS which are major virulence factors and (iv) the virulence of Salmonella. In E. coli, this protein has been shown to interact directly with BamA. In this study, we investigated the structure-function relationship of BamB in order to assess whether the roles of BamB in these phenotypes were inter-related and whether they require the interaction of BamB with BamA. For this purpose, recombinant plasmids harbouring point mutations in bamB were introduced in a Delta Salmonella bamB mutant. We demonstrated that the residues L173, L175 and R176 are crucial for all the roles of BamB and for the interaction of BamB with BamA. Moreover, the results obtained with a D229A BamB variant, which is unable to immunoprecipitate BamA, suggest that the interaction of BamB with BamA is not absolutely necessary for BamB function in outer-membrane protein assembly, T3SS expression and virulence. Finally, we showed that the virulence defect of the Delta bamB mutant is not related to its increased susceptibility to antimicrobials, as the D227A BamB variant fully restored the virulence of the mutant while having a similar antibiotic susceptibility to the Delta bamB strain. Overall, this study demonstrates that the different roles of BamB are not all inter-related and that L173, L175 and R176 amino-acids are privileged sites for the design of BamB inhibitors that could be used as alternative therapeutics to antibiotics, at least against Salmonella.	[Namdari, Fatemeh; Hurtado-Escobar, Genaro Alejandro; Abed, Nadia; Trotereau, Jerome; Fardini, Yann; Giraud, Etienne; Velge, Philippe; Virlogeux-Payant, Isabelle] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Namdari, Fatemeh; Hurtado-Escobar, Genaro Alejandro; Abed, Nadia; Trotereau, Jerome; Fardini, Yann; Giraud, Etienne; Velge, Philippe; Virlogeux-Payant, Isabelle] Univ Tours, Infectiol & Sante Publ UMR1282, Tours, France	INRAE; Universite de Tours	Virlogeux-Payant, I (corresponding author), INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France.	ipayant@tours.inra.fr	velge, philippe/AAK-4165-2021; Giraud, Etienne/E-9698-2011; Virlogeux-Payant, Isabelle/H-5800-2013	Giraud, Etienne/0000-0002-2534-4040; Virlogeux-Payant, Isabelle/0000-0003-4149-0168; FARDINI, Yann/0000-0002-6800-1777				AllenVercoe E, 1997, FEMS MICROBIOL LETT, V153, P33, DOI 10.1111/j.1574-6968.1997.tb10460.x; Amy M, 2004, RES MICROBIOL, V155, P543, DOI 10.1016/j.resmic.2004.03.005; Anwari K, 2012, MOL MICROBIOL, V84, P832, DOI 10.1111/j.1365-2958.2012.08059.x; Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Fardini Y, 2007, INFECT IMMUN, V75, P358, DOI 10.1128/IAI.00716-06; Fardini Y, 2009, MICROBIOL-SGM, V155, P1613, DOI 10.1099/mic.0.025155-0; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gatsos X, 2008, FEMS MICROBIOLOGY RE, V9999, P1; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Grepinet O, 2012, J BACTERIOL, V194, P2387, DOI 10.1128/JB.00256-12; Hagan CL, 2011, BIOCHEMISTRY-US, V50, P7444, DOI 10.1021/bi2010784; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehr U, 2010, MOL MICROBIOL, V78, P932, DOI 10.1111/j.1365-2958.2010.07377.x; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Palomino C, 2011, J BACTERIOL, V193, P5222, DOI 10.1128/JB.05585-11; PARDON P, 1986, ANN INST PASTEUR MIC, V137B, P47, DOI 10.1016/S0769-2609(86)80093-X; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Rolhion N, 2005, J BACTERIOL, V187, P2286, DOI 10.1128/JB.187.7.2286-2296.2005; Rossiter AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; van der Straaten T, 2001, INFECT IMMUN, V69, P7413, DOI 10.1128/IAI.69.12.7413-7418.2001; van Diepen A, 2002, INFECT IMMUN, V70, P2614, DOI 10.1128/IAI.70.5.2614-2621.2002; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	42	11	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e46050	10.1371/journal.pone.0046050	http://dx.doi.org/10.1371/journal.pone.0046050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144780	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400007
J	Phillips-Howard, PA; Odhiambo, FO; Hamel, M; Adazu, K; Ackers, M; van Eijk, AM; Orimba, V; van't Hoog, A; Beynon, C; Vulule, J; Bellis, MA; Slutsker, L; deCock, K; Breiman, R; Laserson, KF				Phillips-Howard, Penelope A.; Odhiambo, Frank O.; Hamel, Mary; Adazu, Kubaje; Ackers, Marta; van Eijk, Anne M.; Orimba, Vincent; van't Hoog, Anja; Beynon, Caryl; Vulule, John; Bellis, Mark A.; Slutsker, Laurence; deCock, Kevin; Breiman, Robert; Laserson, Kayla F.			Mortality Trends from 2003 to 2009 among Adolescents and Young Adults in Rural Western Kenya Using a Health and Demographic Surveillance System	PLOS ONE			English	Article							TREATED BED NETS; PERENNIAL MALARIA TRANSMISSION; VERBAL AUTOPSY; HIV-1 INFECTION; CHILD-MORTALITY; AIDS MORTALITY; MIDDLE-INCOME; PREVENTION; POPULATION; BURDEN	Background: Targeted global efforts to improve survival of young adults need information on mortality trends; contributions from health and demographic surveillance system (HDSS) are required. Methods and Findings: This study aimed to explore changing trends in deaths among adolescents (15-19 years) and young adults (20-24 years), using census and verbal autopsy data in rural western Kenya using a HDSS. Mid-year population estimates were used to generate all-cause mortality rates per 100,000 population by age and gender, by communicable (CD) and non-communicable disease (NCD) causes. Linear trends from 2003 to 2009 were examined. In 2003, all-cause mortality rates of adolescents and young adults were 403 and 1,613 per 100,000 population, respectively, among females; and 217 and 716 per 100,000, respectively, among males. CD mortality rates among females and males 15-24 years were 500 and 191 per 100,000 (relative risk [RR] 2.6; 95% confidence intervals [CI] 1.7-4.0; p<0.001). NCD mortality rates in same aged females and males were similar (141 and 128 per 100,000, respectively; p = 0.76). By 2009, young adult female all-cause mortality rates fell 53% (chi(2) for linear trend 30.4; p<0.001) and 61.5% among adolescent females (chi(2) for linear trend 11.9; p<0.001). No significant CD mortality reductions occurred among males or for NCD mortality in either gender. By 2009, all-cause, CD, and NCD mortality rates were not significantly different between males and females, and among males, injuries equalled HIV as the top cause of death. Conclusions: This study found significant reductions in adolescent and young adult female mortality rates, evidencing the effects of targeted public health programmes, however, all-cause and CD mortality rates among females remain alarmingly high. These data underscore the need to strengthen programmes and target strategies to reach both males and females, and to promote NCD as well as CD initiatives to reduce the mortality burden amongst both gender.	[Phillips-Howard, Penelope A.; van Eijk, Anne M.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Odhiambo, Frank O.; Adazu, Kubaje; Orimba, Vincent; van't Hoog, Anja; Vulule, John; Breiman, Robert; Laserson, Kayla F.] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Hamel, Mary; Ackers, Marta; Slutsker, Laurence; deCock, Kevin] Ctr Dis Control & Prevent, Atlanta, GA USA; [van't Hoog, Anja] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Beynon, Caryl; Bellis, Mark A.] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Breiman, Robert; Laserson, Kayla F.] Ctr Dis Control & Prevent, Nairobi, Kenya	Liverpool School of Tropical Medicine; University of Liverpool; Centers for Disease Control & Prevention - USA; University of Amsterdam; Academic Medical Center Amsterdam; Liverpool John Moores University	Phillips-Howard, PA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	pennyph@liverpool.ac.uk	van Eijk, Anna Maria/AAQ-9894-2021; Bellis, Mark A./HGA-2019-2022	Phillips-Howard, Penelope A/0000-0003-1018-116X; van Eijk, Anna Maria/0000-0003-1635-1289	The Health and Demographic Surveillance System (HDSS); Centers of Disease Control infrastructure grant; Medical Research Council [G1100677] Funding Source: researchfish; MRC [G1100677] Funding Source: UKRI	The Health and Demographic Surveillance System (HDSS); Centers of Disease Control infrastructure grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Health and Demographic Surveillance System (HDSS) and field staff support has been funded through the Centers of Disease Control infrastructure grant, with supplemental support from project-specific grants. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amare A, 2008, EPILEPSIA, V49, P600, DOI 10.1111/j.1528-1167.2008.01556.x; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Blum RW, 2007, J ADOLESCENT HEALTH, V41, P230, DOI 10.1016/j.jadohealth.2007.04.005; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Cavanaugh J, 2011, J TROP PEDIAT; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Chandramohan D, 2008, PLOS MED, V5, P169, DOI 10.1371/journal.pmed.0050057; Clark S, 2006, INT FAM PLAN PERSPEC, V32, P79, DOI 10.1363/3207906; Cohen David William, 1989, SIAYA HISTORICAL ANT; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; de Oliveira JF, 2006, REV SOC BRAS MED TRO, V39, P146, DOI 10.1590/S0037-86822006000200002; DuBois AE, 2010, INT J ENV RES PUB HE, V7, P3842, DOI 10.3390/ijerph7103842; Gargano JW, 2012, ADULT POPULATION IMP; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Karanja DMS, 2002, LANCET, V360, P592, DOI 10.1016/S0140-6736(02)09781-7; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; Kenya National Bureau of Statistics ICF Macro, 2010, 2008 09 KEN DEM HLTH; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Meltzer MI, 2003, AM J TROP MED HYG, V68, P149, DOI 10.4269/ajtmh.2003.68.149; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-18; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Ngoungou EB, 2007, REV NEUROL-FRANCE, V163, P583, DOI 10.1016/S0035-3787(07)90464-6; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Olson CK, 2011, AM J TROP MED HYG, V85, P1134, DOI 10.4269/ajtmh.2011.11-0178; Ouma PO, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-1; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P3, DOI 10.4269/ajtmh.2003.68.3; Quigley MA, 2000, TROP MED INT HEALTH, V5, P33, DOI 10.1046/j.1365-3156.2000.00517.x; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Secor WE, 2004, MEM I OSWALDO CRUZ, V99, P93, DOI 10.1590/S0074-02762004000900016; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Tensou B, 2010, TROP MED INT HEALTH, V15, P547, DOI 10.1111/j.1365-3156.2010.02484.x; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; UNAIDS, 2010, REP GLOB AIDS EP; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; van Eijk AM, 2007, TROP MED INT HEALTH, V12, P342, DOI 10.1111/j.1365-3156.2006.01787.x; van't Hoog A, 2012, INT J TB LU IN PRESS; van't Hoog AH, 2008, INT J TUBERC LUNG D, V12, pS32; van't Hoog AH, 2005, JAIDS-J ACQ IMM DEF, V40, P344, DOI 10.1097/01.qai.0000160712.86580.ff; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Zeh C, 2011, J VIROL METHODS, V176, P24, DOI 10.1016/j.jviromet.2011.05.021	65	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47017	10.1371/journal.pone.0047017	http://dx.doi.org/10.1371/journal.pone.0047017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032TG	23144796	gold, Green Accepted, Green Published			2022-12-25	WOS:000310741400014
J	Spigoni, V; Picconi, A; Cito, M; Ridolfi, V; Bonomini, S; Casali, C; Zavaroni, I; Gnudi, L; Metra, M; Dei Cas, A				Spigoni, Valentina; Picconi, Angela; Cito, Monia; Ridolfi, Valentina; Bonomini, Sabrina; Casali, Chiara; Zavaroni, Ivana; Gnudi, Luigi; Metra, Marco; Dei Cas, Alessandra			Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; EXPRESSION; AGONIST; NUMBER; ARTERY; RISK; VIVO; INFLAMMATION; MONOCYTES; DISEASE	Background: Evidence suggests that the PPAR gamma-agonist insulin sensitizer pioglitazone, may provide potential beneficial cardiovascular (CV) effects beyond its anti-hyperglycaemic function. A reduced endothelial progenitor cell (EPC) number is associated with impaired glucose tolerance (IGT) or diabetes, conditions characterised by increased CV risk. Aim: To evaluate whether pioglitazone can provide benefit in vitro in EPCs obtained from IGT subjects. Materials and Methods: Early and late-outgrowth EPCs were obtained from peripheral blood mononuclear cells of 14 IGT subjects. The in vitro effect of pioglitazone (10 mM) with/without PPAR gamma-antagonist GW9662 (1 mM) was assessed on EPC viability, apoptosis, ability to form tubular-like structures and pro-inflammatory molecule expression. Results: Pioglitazone increased early and late-outgrowth EPC viability, with negligible effects on apoptosis. The capacity of EPCs to form tubular-like structures was improved by pioglitazone in early (mean increase 28%; p = 0.005) and late-outgrowth (mean increase 30%; p = 0.037) EPCs. Pioglitazone reduced ICAM-1 and VCAM-1 adhesion molecule expression in both early (p = 0.001 and p = 0.012 respectively) and late-outgrowth (p = 0.047 and p = 0.048, respectively) EPCs. Similarly, pioglitazone reduced TNF alpha gene and protein expression in both early (p = 0.034; p = 0.022) and late-outgrowth (p = 0.026; p = 0.017) EPCs compared to control. These effects were prevented by incubation with the PPAR gamma-antagonist GW9662. Conclusion: Pioglitazone exerts beneficial effects in vitro on EPCs isolated from IGT subjects, supporting the potential implication of pioglitazone as a CV protective agents.	[Spigoni, Valentina; Metra, Marco] Univ Brescia, Dept Expt & Appl Med, Brescia, Italy; [Picconi, Angela; Cito, Monia; Ridolfi, Valentina; Bonomini, Sabrina; Casali, Chiara; Zavaroni, Ivana; Dei Cas, Alessandra] Univ Parma, Dept Internal Med & Biomed Sci, I-43100 Parma, Italy; [Gnudi, Luigi] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England	University of Brescia; University of Parma; University of London; King's College London	Spigoni, V (corresponding author), Univ Brescia, Dept Expt & Appl Med, Brescia, Italy.	alessandra.deicas@unipr.it	Metra, marco/E-7101-2010	Dei Cas, Alessandra/0000-0002-8666-4849; Metra, Marco/0000-0001-6691-8568; Spigoni, Valentina/0000-0001-5716-1671; gnudi, luigi/0000-0002-6353-630X	Centro per lo Studio del Trattamento dello Scompenso Cardiaco, Brescia University, Italy; Takeda Italia Farmaceutici	Centro per lo Studio del Trattamento dello Scompenso Cardiaco, Brescia University, Italy; Takeda Italia Farmaceutici	This work was supported by the Centro per lo Studio del Trattamento dello Scompenso Cardiaco, Brescia University, Italy, and by an unrestricted grant by Takeda Italia Farmaceutici. The funders had no role in study design, data collection and analysis.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Akhter J, 1997, DIABETES CARE, V20, P1044, DOI 10.2337/diacare.20.6.1044b; Ao CH, 2010, CELL BIOL INT, V34, P723, DOI 10.1042/CBI20090005; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Dei Cas A, 2011, NUTR METAB CARDIOVAS, V21, P512, DOI 10.1016/j.numecd.2009.11.011; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Fadini GP, 2007, DIABETOLOGIA, V50, P2156, DOI 10.1007/s00125-007-0732-y; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; FULLER JH, 1980, LANCET, V1, P1373; Gensch C, 2007, ATHEROSCLEROSIS, V192, P67, DOI 10.1016/j.atherosclerosis.2006.06.026; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ishibashi M, 2002, HYPERTENSION, V40, P687, DOI 10.1161/01.HYP.0000036396.64769.C2; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi A, 2009, EUR J CELL BIOL, V88, P731, DOI 10.1016/j.ejcb.2009.07.004; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Marx N, 2007, PROG LIPID RES, V46, P283, DOI 10.1016/j.plipres.2007.05.003; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Mizoguchi M, 2011, JACC-CARDIOVASC IMAG, V4, P1110, DOI 10.1016/j.jcmg.2011.08.007; Nakayama T, 2010, INT J CARDIOL, V138, P157, DOI 10.1016/j.ijcard.2008.08.031; Pasceri V, 2000, CIRCULATION, V101, P235, DOI 10.1161/01.CIR.101.3.235; Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676; Quinn CE, 2010, DIABETES OBES METAB, V12, P709, DOI 10.1111/j.1463-1326.2010.01224.x; Redondo S, 2007, THROMB HAEMOSTASIS, V97, P979, DOI 10.1160/TH06-10-0593; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Schernthaner G, 2009, INT J CLIN PRACT, V63, P912, DOI 10.1111/j.1742-1241.2009.02025.x; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Walcher Daniel, 2004, Diab Vasc Dis Res, V1, P76, DOI 10.3132/dvdr.2004.011; Wang CH, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.07.029; Werner C, 2007, DIABETES, V56, P2609, DOI 10.2337/db07-0069; Wu ZH, 2010, INT J CARDIOL, V138, P151, DOI 10.1016/j.ijcard.2008.08.009; Yang HB, DIABET MED IN PRESS; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yuan Z, 2005, HEART, V91, P1203, DOI 10.1136/hrt.2004.046292; Zhang WY, 2008, ARTERIOSCL THROM VAS, V28, P2312, DOI 10.1161/ATVBAHA.108.175687	49	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48283	10.1371/journal.pone.0048283	http://dx.doi.org/10.1371/journal.pone.0048283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139771	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400044
J	Selby, NM; Kolhe, NV; McIntyre, CW; Monaghan, J; Lawson, N; Elliott, D; Packington, R; Fluck, RJ				Selby, Nicholas M.; Kolhe, Nitin V.; McIntyre, Christopher W.; Monaghan, John; Lawson, Nigel; Elliott, David; Packington, Rebecca; Fluck, Richard J.			Defining the Cause of Death in Hospitalised Patients with Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; RIFLE CRITERIA; MANAGEMENT; MORTALITY; OUTCOMES; AKI	Background: The high mortality rates that follow the onset of acute kidney injury (AKI) are well recognised. However, the mode of death in patients with AKI remains relatively under-studied, particularly in general hospitalised populations who represent the majority of those affected. We sought to describe the primary cause of death in a large group of prospectively identified patients with AKI. Methods: All patients sustaining AKI at our centre between 1st October 2010 and 31st October 2011 were identified by real-time, hospital-wide, electronic AKI reporting based on the Acute Kidney Injury Network (AKIN) diagnostic criteria. Using this system we are able to generate a prospective database of all AKI cases that includes demographic, outcome and hospital coding data. For those patients that died during hospital admission, cause of death was derived from the Medical Certificate of Cause of Death. Results: During the study period there were 3,930 patients who sustained AKI; 62.0% had AKI stage 1, 20.6% had stage 2 and 17.4% stage 3. In-hospital mortality rate was 21.9% (859 patients). Cause of death could be identified in 93.4% of cases. There were three main disease categories accounting for three quarters of all mortality; sepsis (41.1%), cardiovascular disease (19.2%) and malignancy (12.9%). The major diagnosis leading to sepsis was pneumonia, whilst cardiovascular death was largely a result of heart failure and ischaemic heart disease. AKI was the primary cause of death in only 3% of cases. Conclusions: Mortality associated with AKI remains high, although cause of death is usually concurrent illness. Specific strategies to improve outcomes may therefore need to target not just the management of AKI but also the most relevant co-existing conditions.	[Selby, Nicholas M.; Kolhe, Nitin V.; McIntyre, Christopher W.; Packington, Rebecca; Fluck, Richard J.] Royal Derby Hosp, Dept Renal Med, Derby, England; [McIntyre, Christopher W.] Univ Nottingham, Sch Grad Entry Med & Hlth, Nottingham NG7 2RD, England; [Monaghan, John; Lawson, Nigel] Royal Derby Hosp, Dept Chem Pathol, Derby, England; [Elliott, David] Royal Derby Hosp, Dept Informat, Derby, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Selby, NM (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.	nick.selby@nhs.net	Selby, Nicholas/T-6759-2019; McIntyre, Christopher W/O-8927-2014	Kolhe, Nitin/0000-0003-2528-4436; Selby, Nicholas/0000-0003-0351-8326				Asim M, 2011, NEPHRON CLIN PRACT, V119, pC333, DOI 10.1159/000331071; Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Balasubramanian G, 2011, AM J KIDNEY DIS, V57, P228, DOI 10.1053/j.ajkd.2010.08.026; Barretti P, 1997, RENAL FAILURE, V19, P253, DOI 10.3109/08860229709026285; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Cruz DN, 2007, CLIN J AM SOC NEPHRO, V2, P418, DOI 10.2215/CJN.03361006; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Lines SW, 2011, INT J ARTIF ORGANS, V34, P2, DOI 10.5301/IJAO.2011.6312; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; National Confidential Enquiry into Patient Outcome & Death (NCEPOD), 2009, AC KIDN INJ ADD INS; Quoix E, 2011, LANCET, V378, P1079, DOI 10.1016/S0140-6736(11)60780-0; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Schneider AG, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.017; Schneider AG, 2012, NEPHROL DIAL TRANSPL, V27, P947, DOI 10.1093/ndt/gfr501; Selby NM, 2012, CLIN J AM SOC NEPHRO, V7, P533, DOI 10.2215/CJN.08970911; Stevens PE, 2001, QJM-INT J MED, V94, P533, DOI 10.1093/qjmed/94.10.533; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; WOODROW G, 1992, NEPHROL DIAL TRANSPL, V7, P230, DOI 10.1093/oxfordjournals.ndt.a092111	23	72	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48580	10.1371/journal.pone.0048580	http://dx.doi.org/10.1371/journal.pone.0048580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133643	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400039
J	Taslaman, L; Nilsson, B				Taslaman, Leo; Nilsson, Bjorn			A Framework for Regularized Non-Negative Matrix Factorization, with Application to the Analysis of Gene Expression Data	PLOS ONE			English	Article							MULTIPLE-MYELOMA; LEAST-SQUARES; PROFILES; LEUKEMIA	Non-negative matrix factorization (NMF) condenses high-dimensional data into lower-dimensional models subject to the requirement that data can only be added, never subtracted. However, the NMF problem does not have a unique solution, creating a need for additional constraints (regularization constraints) to promote informative solutions. Regularized NMF problems are more complicated than conventional NMF problems, creating a need for computational methods that incorporate the extra constraints in a reliable way. We developed novel methods for regularized NMF based on block-coordinate descent with proximal point modification and a fast optimization procedure over the alpha simplex. Our framework has important advantages in that it (a) accommodates for a wide range of regularization terms, including sparsity-inducing terms like the L-1 penalty, (b) guarantees that the solutions satisfy necessary conditions for optimality, ensuring that the results have well-defined numerical meaning, (c) allows the scale of the solution to be controlled exactly, and (d) is computationally efficient. We illustrate the use of our approach on in the context of gene expression microarray data analysis. The improvements described remedy key limitations of previous proposals, strengthen the theoretical basis of regularized NMF, and facilitate the use of regularized NMF in applications.	[Taslaman, Leo; Nilsson, Bjorn] Lund Univ, Dept Hematol & Transfus Med, Lund, Sweden; [Nilsson, Bjorn] Broad Inst, Cambridge, MA USA	Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Nilsson, B (corresponding author), Lund Univ, Dept Hematol & Transfus Med, Lund, Sweden.	bjorn.nilsson@med.lu.se			Swedish Foundation for Strategic Research; Swedish Children's Cancer Fund; Swedish Scientific Council; Marianne and Marcus Wallenberg's Foundation; Swedish Society of Medicine; BioCARE initiative	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Children's Cancer Fund; Swedish Scientific Council; Marianne and Marcus Wallenberg's Foundation; Swedish Society of Medicine; BioCARE initiative	This work was supported by the Swedish Foundation for Strategic Research, the Swedish Children's Cancer Fund, the Swedish Scientific Council, Marianne and Marcus Wallenberg's Foundation, the Swedish Society of Medicine, and the BioCARE initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battenberg E, 2009, 10 INT SOC MUS INF R; Berry M, 2006, PREPRINT; Bertsekas D., 1999, NONLINEAR PROGRAMMIN; Bro R, 1997, J CHEMOMETR, V11, P393, DOI 10.1002/(SICI)1099-128X(199709/10)11:5<393::AID-CEM483>3.3.CO;2-C; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chu M, 2005, SIAM J MATRIX ANAL; Cichocki A., 2006, P 6 INT C IND COMP A; Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dhillon I, 2005, P NEUR INF PROC SYST; Donoho David, 2004, DOES NONNEGATIVE MAT; Eggert J, 2004, IEEE IJCNN, P2529; Frigyesi A, 2008, CANCER INFORM, V6, P275; Gonzalez E. F., 2005, TECHNICAL REPORT; Grippo L, 2000, OPER RES LETT, V26, P127, DOI 10.1016/S0167-6377(99)00074-7; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Ho N.-D.., 2008, THESIS U CATHOLIQUE; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Hoyer PO, 2002, NEURAL NETWORKS FOR SIGNAL PROCESSING XII, PROCEEDINGS, P557, DOI 10.1109/NNSP.2002.1030067; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Kohlmann A, 2008, BRIT J HAEMATOL, V142, P802, DOI 10.1111/j.1365-2141.2008.07261.x; LAWSON CL, 1974, SOLVING LEAST SQUARE, P158; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Nilsson B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r74; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Paatero P, 1997, CHEMOMETR INTELL LAB, V37, P23, DOI 10.1016/S0169-7439(96)00044-5; Pauca V, 2005, LINEAR ALGEBRA ITS A; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Van Benthem MH, 2004, J CHEMOMETR, V18, P441, DOI 10.1002/cem.889; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Zdunek R, 2008, COMPUTATIONAL INTELL	40	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e46331	10.1371/journal.pone.0046331	http://dx.doi.org/10.1371/journal.pone.0046331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133590	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400004
J	Kalabus, JL; Cheng, QY; Blanco, JG				Kalabus, James L.; Cheng, Qiuying; Blanco, Javier G.			MicroRNAs Differentially Regulate Carbonyl Reductase 1 (CBR1) Gene Expression Dependent on the Allele Status of the Common Polymorphic Variant rs9024	PLOS ONE			English	Article							HUMAN CARBONYL-REDUCTASE-1 CBR1; INDUCED CARDIOTOXICITY; LINKING POLYMORPHISMS; POLYMIRTS DATABASE; COMPLEX TRAITS; TARGET SITES; DETERMINANTS; INDUCTION; GENOMICS; MIRBASE	MicroRNAs (miRNAs) are small RNAs responsible for the post-transcriptional regulation of a variety of human genes. To date, their involvement in the regulation of CBR1 is unknown. This study reports for the first time the identification of microRNA-574-5p (hsa-miR-574-5p) and microRNA-921 (hsa-miR-921) as two miRNAs capable of interacting with the 39-untranslated region (39-UTR) of the CBR1 gene and downregulating CBR1 expression. Furthermore, we demonstrate that a common single-nucleotide polymorphism (SNP) in the CBR1 3'-UTR (rs9024, CBR1 1096G>A) differentially impacts the regulation of CBR1 by hsa-miR-574-5p and hsa-miR-921 dependent on genotype. First, four candidate miRNAs were selected based on bioinformatic analyses, and were tested in Chinese hamster ovary (CHO) cells transfected with CBR1 39-UTR constructs harboring either the G or A allele for rs9024. We found that hsa-miR-574-5p and hsa-miR-921 significantly decreased luciferase activity in CHO cells transfected with the CBR1 39-UTR construct carrying the major rs9024 G allele by 35% and 46%, respectively. The influence of these miRNAs was different in cells transfected with a CBR1 39-UTR construct containing the minor rs9024 A allele in that only hsa-miR-574-5p had a demonstrable effect (i.e., 52% decrease in lucifersase activity). To further determine the functional effects of miRNA-mediated regulation of polymorphic CBR1, we assessed CBR1 protein expression and CBR1 enzymatic activity for the prototypical substrate menadione in human lymphoblastoid cell lines with distinct rs9024 genotypes. We found that hsa-miR-574-5p and hsa-miR-921 significantly decreased CBR1 protein (48% and 40%, respectively) and CBR1 menadione activity (54% and 18%, respectively) in lymphoblastoid cells homozygous for the major rs9024 G allele. In contrast, only hsa-miR-574-5p decreased CBR1 protein and CBR1 activity in cells homozygous for the minor rs9024 A allele, and did so by 49% and 56%, respectively. These results suggest that regulation of human CBR1 expression by hsa-miR-574-5p and hsa-miR-921 depends upon rs9024 genotype status.	[Kalabus, James L.; Cheng, Qiuying; Blanco, Javier G.] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Blanco, JG (corresponding author), SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA.	jgblanco@buffalo.edu			National Institutes of Health/National Institute of General Medical Sciences [GM73646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073646] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences grant GM73646. James L. Kalabus is a Daiichi Sankyo fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BOHREN KM, 1987, BIOCHEM J, V244, P165, DOI 10.1042/bj2440165; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Forrest GL, 2000, CANCER RES, V60, P5158; Forrest GL, 2000, CHEM-BIOL INTERACT, V129, P21, DOI 10.1016/S0009-2797(00)00196-4; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gonzalez-Covarrubias V, 2008, PHARM RES-DORDR, V25, P1730, DOI 10.1007/s11095-008-9592-5; Gonzalez-Covarrubias V, 2009, DRUG METAB DISPOS, V37, P400, DOI 10.1124/dmd.108.024547; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoffmann F, 2007, DRUG METAB REV, V39, P87, DOI 10.1080/03602530600969440; Hu ZH, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/910769; Kalabus JL, 2012, TOXICOL LETT, V211, P266, DOI 10.1016/j.toxlet.2012.04.006; Kalabus JL, 2010, DRUG METAB DISPOS, V38, P2096, DOI 10.1124/dmd.110.035550; Kassner N, 2008, DRUG METAB DISPOS, V36, P2113, DOI 10.1124/dmd.108.022251; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lakhman SS, 2005, DRUG METAB DISPOS, V33, P254, DOI 10.1124/dmd.104.002006; Lakhman SS, 2007, MOL PHARMACOL, V72, P734, DOI 10.1124/mol.107.035550; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Menna P, 2007, CARDIOVASC TOXICOL, V7, P80, DOI 10.1007/s12012-007-0011-7; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mordente A, 2009, CURR MED CHEM, V16, P1656, DOI 10.2174/092986709788186228; Rukov JL, 2011, TRENDS MOL MED, V17, P412, DOI 10.1016/j.molmed.2011.04.003; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	32	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48622	10.1371/journal.pone.0048622	http://dx.doi.org/10.1371/journal.pone.0048622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133646	Green Submitted, Green Published, gold			2022-12-25	WOS:000310601300021
J	Wang, Y; Sun, FL; Cao, H; Peng, HR; Ni, ZF; Sun, QX; Yao, YY				Wang, Yu; Sun, Fenglong; Cao, Hua; Peng, Huiru; Ni, Zhongfu; Sun, Qixin; Yao, Yingyin			TamiR159 Directed Wheat TaGAMYB Cleavage and Its Involvement in Anther Development and Heat Response	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; GAMYB-LIKE GENES; TRANSCRIPTION FACTOR; ALEURONE CELLS; TARGET GENES; ARABIDOPSIS; MICRORNA; RNA; PLANT; ARGONAUTE1	In Arabidopsis and rice, miR159-regulated GAMYB-like family transcription factors function in flower development and gibberellin (GA) signaling in cereal aleurone cells. In this study, the involvement of miR159 in the regulation of its putative target TaGAMYB and its relationship to wheat development were investigated. First, we demonstrated that cleavage of TaGAMYB1 and TaGAMYB2 was directed by miR159 using 5'-RACE and a transient expression system. Second, we overexpressed TamiR159, TaGAMYB1 and mTaGAMYB1 (impaired in the miR159 binding site) in transgenic rice, revealing that the accumulation in rice of mature miR159 derived from the precursor of wheat resulted in delayed heading time and male sterility. In addition, the number of tillers and primary branches in rice overexpressing mTaGAMYB1 increased relative to the wild type. Our previous study reported that TamiR159 was downregulated after two hours of heat stress treatment in wheat (Triticum aestivum L.). Most notably, the TamiR159 overexpression rice lines were more sensitive to heat stress relative to the wild type, indicating that the downregulation of TamiR159 in wheat after heat stress might participate in a heat stress-related signaling pathway, in turn contributing to heat stress tolerance.	[Wang, Yu; Sun, Fenglong; Cao, Hua; Peng, Huiru; Ni, Zhongfu; Sun, Qixin; Yao, Yingyin] China Agr Univ, State Key Lab Agrobiotechnol, Key Lab Crop Heterosis, Utilizat MOE, Beijing 100094, Peoples R China; [Wang, Yu; Sun, Fenglong; Cao, Hua; Peng, Huiru; Ni, Zhongfu; Sun, Qixin; Yao, Yingyin] China Agr Univ, Key Lab Crop Genom & Genet Improvement MOA, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Yao, YY (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Key Lab Crop Heterosis, Utilizat MOE, Beijing 100094, Peoples R China.	Yingyin@cau.edu.cn			863 Project of China [2012AA10A309]; National Basic Research Program of China (973 Program) [2012CB910900]; National Natural Science Foundation of China [30930058, 30600392, 30871529]	863 Project of China(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by 863 Project of China (2012AA10A309), National Basic Research Program of China (973 Program)(2012CB910900), the National Natural Science Foundation of China (30930058, 30600392, 30871529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Appleford NEJ, 1997, PHYSIOL PLANTARUM, V100, P534, DOI 10.1034/j.1399-3054.1997.1000315.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; Doyle EA, 2007, PLANT CELL ENVIRON, V30, P388, DOI 10.1111/j.1365-3040.2006.01624.x; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Gubler F, 1997, PLANT CELL PHYSIOL, V38, P362, DOI 10.1093/oxfordjournals.pcp.a029175; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Haseneyer G, 2008, THEOR APPL GENET, V117, P321, DOI 10.1007/s00122-008-0777-4; Huve K, 2012, PHYSIOL PLANTARUM, V144, P320, DOI 10.1111/j.1399-3054.2011.01562.x; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kidner CA, 2005, DEV BIOL, V280, P504, DOI 10.1016/j.ydbio.2005.01.031; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Shitsukawa N, 2007, PLANT CELL, V19, P1723, DOI 10.1105/tpc.107.051813; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Vasseur F, 2011, PLANT CELL ENVIRON, V34, P1563, DOI 10.1111/j.1365-3040.2011.02353.x; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005	40	121	135	6	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48445	10.1371/journal.pone.0048445	http://dx.doi.org/10.1371/journal.pone.0048445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133634	Green Submitted, gold, Green Published			2022-12-25	WOS:000310601300014
J	Bizzarro, V; Belvedere, R; Dal Piaz, F; Parente, L; Petrella, A				Bizzarro, Valentina; Belvedere, Raffaella; Dal Piaz, Fabrizio; Parente, Luca; Petrella, Antonello			Annexin A1 Induces Skeletal Muscle Cell Migration Acting through Formyl Peptide Receptors	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; DIFFERENTIATION; INFLAMMATION; EXPRESSION; INCREASE; FPR; PHOSPHORYLATION; GLUCOCORTICOIDS; PROLIFERATION; MODULATION	Annexin A1 (ANXA1, lipocortin-1) is a glucocorticoid-regulated 37-kDa protein, so called since its main property is to bind (i.e. to annex) to cellular membranes in a Ca2+-dependent manner. Although ANXA1 has predominantly been studied in the context of immune responses and cancer, the protein can affect a larger variety of biological phenomena, including cell proliferation and migration. Our previous results show that endogenous ANXA1 positively modulates myoblast cell differentiation by promoting migration of satellite cells and, consequently, skeletal muscle differentiation. In this work, we have evaluated the hypothesis that ANXA1 is able to exert effects on myoblast cell migration acting through formyl peptide receptors (FPRs) following changes in its subcellular localization as in other cell types and tissues. The analysis of the subcellular localization of ANXA1 in C2C12 myoblasts during myogenic differentiation showed an interesting increase of extracellular ANXA1 starting from the initial phases of skeletal muscle cell differentiation. The investigation of intracellular Ca2+ perturbation following exogenous administration of the ANXA1 N-terminal derived peptide Ac2-26 established the engagement of the FPRs which expression in C2C12 cells was assessed by qualitative PCR. Wound healing assay experiments showed that Ac2-26 peptide is able to increase migration of C2C12 skeletal muscle cells and to induce cell surface translocation and secretion of ANXA1. Our results suggest a role for ANXA1 as a highly versatile component in the signaling chains triggered by the proper calcium perturbation that takes place during active migration and differentiation or membrane repair since the protein is strongly redistributed onto the plasma membranes after an rapid increase of intracellular levels of Ca2+. These properties indicate that ANXA1 may be involved in a novel repair mechanism for skeletal muscle and may have therapeutic implications with respect to the development of ANXA1 mimetics.	[Bizzarro, Valentina; Belvedere, Raffaella; Dal Piaz, Fabrizio; Parente, Luca; Petrella, Antonello] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy	University of Salerno	Petrella, A (corresponding author), Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy.	apetrella@unisa.it	Belvedere, Raffaella/ABF-7735-2020; Dal Piaz, Fabrizio/D-1843-2010	Dal Piaz, Fabrizio/0000-0002-8643-5018; BIZZARRO, VALENTINA/0000-0002-5222-0705; PETRELLA, Antonello/0000-0002-6945-5295	University of Salerno (FARB); Banca di Credito Cooperativo, Fisciano (Salerno); Fondazione con il Sud; Regione Campania	University of Salerno (FARB); Banca di Credito Cooperativo, Fisciano (Salerno); Fondazione con il Sud; Regione Campania(Regione Campania)	The work conducted in the authors' laboratory and referred to in this paper was funded by University of Salerno (FARB 2009, 2010, 2011), from Banca di Credito Cooperativo, Fisciano (Salerno), from Fondazione con il Sud, and from Regione Campania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE MP, 1990, AM J RESP CELL MOL, V3, P349, DOI 10.1165/ajrcmb/3.4.349; Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bizzarro V, 2012, J CELL PHYSIOL, V227, P3007, DOI 10.1002/jcp.24032; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Cabane C, 2003, AM J PHYSIOL-CELL PH, V284, pC658, DOI 10.1152/ajpcell.00078.2002; Cheng TY, 2012, CANCER-AM CANCER SOC, V118, P5757, DOI 10.1002/cncr.27565; Croxtall JD, 1996, BIOCHEM PHARMACOL, V52, P351, DOI 10.1016/0006-2952(95)02442-5; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; Dalli J, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00028; De Arcangelis V, 2005, J CELL PHYSIOL, V202, P787, DOI 10.1002/jcp.20174; Dhawan J, 2004, J CELL SCI, V117, P3735, DOI 10.1242/jcs.01197; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Formigli L, 2005, J CELL SCI, V118, P1161, DOI 10.1242/jcs.01695; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Huang J, 2010, BRIT J CANCER, V102, P1052, DOI 10.1038/sj.bjc.6605591; Huang J, 2008, FRONT BIOSCI-LANDMRK, V13, P3352; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; HULLIN F, 1989, J BIOL CHEM, V264, P3506; Huo XF, 2005, BIOCHEM BIOPH RES CO, V331, P1346, DOI 10.1016/j.bbrc.2005.04.049; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Khurana A, 2003, DIFFERENTIATION, V71, P42, DOI 10.1046/j.1432-0436.2003.700604.x; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Lange C, 2007, J LEUKOCYTE BIOL, V82, P1592, DOI 10.1189/jlb.0307158; Lee KH, 1999, EXP CELL RES, V252, P401, DOI 10.1006/excr.1999.4648; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Marfella R, 2012, J CLIN ENDOCR METAB, V97, P933, DOI 10.1210/jc.2011-2037; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; Morello S, 2008, CANCER BIOL THER, V7, P278, DOI 10.4161/cbt.7.2.5301; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Rhee NJ, 2000, EUR J BIOCHEM, V267, P3220, DOI 10.1046/j.1432-1327.2000.01345.x; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Sampey AV, 2000, ARTHRITIS RHEUM, V43, P2537, DOI 10.1002/1529-0131(200011)43:11<2537::AID-ANR22>3.0.CO;2-M; Scannell M, 2006, THESCIENTIFICWORLDJO, V6, P1555, DOI 10.1100/tsw.2006.259; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Siegel AL, 2009, STEM CELLS, V27, P2527, DOI 10.1002/stem.178; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wei L, 2000, AM J PHYSIOL-HEART C, V278, pH1736, DOI 10.1152/ajpheart.2000.278.6.H1736; Williams SL, 2010, J IMMUNOL, V185, P3057, DOI 10.4049/jimmunol.1000119; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	53	39	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48246	10.1371/journal.pone.0048246	http://dx.doi.org/10.1371/journal.pone.0048246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144744	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300054
J	Brait, VH; Martin, KR; Corlett, A; Broughton, BRS; Kim, HA; Thundyil, J; Drummond, GR; Arumugam, TV; Pritchard, MA; Sobey, CG				Brait, Vanessa H.; Martin, Katherine R.; Corlett, Alicia; Broughton, Brad R. S.; Kim, Hyun Ah; Thundyil, John; Drummond, Grant R.; Arumugam, Thiruma V.; Pritchard, Melanie A.; Sobey, Christopher G.			Over-Expression of DSCR1 Protects against Post-Ischemic Neuronal Injury	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; SYNDROME CRITICAL REGION; ISCHEMIC BRAIN-INJURY; DOWN-SYNDROME; INHIBITS CALCINEURIN; EXPERIMENTAL STROKE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; T-LYMPHOCYTES; CELL-DAMAGE	Background and Purpose: The Down syndrome candidate region 1 (DSCR1) gene is located on human chromosome 21 and its protein is over-expressed in brains of Down syndrome individuals. DSCR1 can modulate the activity of calcineurin, a phosphatase abundant in the brain, but its influence on stroke outcome is not clear. We compared stroke outcome in wildtype (WT) and transgenic (DSCR1-TG) mice which over-express isoform 1 of human DSCR1. Methods: Transient cerebral ischemia was produced by occlusion of the middle cerebral artery for 0.5 h. After 23.5 h reperfusion, we assessed neurological impairment, brain infarct and edema volume, leukocyte infiltration and markers of inflammation. Intrinsic resistance to apoptosis following glucose deprivation was also assessed in primary cultures of WT and DSCR1-TG neurons. Results: In contrast to WT, DSCR1-TG mice had an improved neurological deficit score, greater grip strength, attenuated infarct volume and brain swelling, and lacked hippocampal lesions after stroke. Expression of mouse DSCR1-1, but not DSCR1-4, mRNA and protein was increased by ischemia in both WT and DSCR1-TG. Brain calcineurin activity was increased to a similar degree after ischemia in each genotype. DSCR1-TG mice had fewer infiltrating neutrophils and activated microglia compared with WT, in association with an attenuated upregulation of several pro-inflammatory genes. Neurons from DSCR1-TG mice were more resistant than WT neurons to apoptotic cell death following 24 h of glucose deprivation. Conclusions: Over-expression of DSCR1 in mice improves outcome following stroke. Mechanisms underlying this protection may involve calcineurin-independent, anti-inflammatory and anti-apoptotic effects mediated by DSCR1 in neurons.	[Martin, Katherine R.; Corlett, Alicia; Pritchard, Melanie A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Brait, Vanessa H.; Broughton, Brad R. S.; Kim, Hyun Ah; Drummond, Grant R.; Sobey, Christopher G.] Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3168, Australia; [Thundyil, John; Arumugam, Thiruma V.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	Monash University; Monash University; University of Queensland	Pritchard, MA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	melanie.pritchard@monash.edu	Arumugam, Thiruma Valavan/B-4898-2011; Arumugam, Thiruma/AAG-6958-2019; Sobey, Christopher G/A-2786-2008	Sobey, Christopher G/0000-0001-6525-9097; Kim, Hyun Ah/0000-0002-3175-9218; Arumugam, Thiruma/0000-0002-3377-0939; Drummond, Grant/0000-0001-8556-9738; Brait, Vanessa Helena/0000-0002-0911-355X; Corlett, Alicia/0000-0003-1146-2465; /0000-0001-8844-974X; Martin, Katherine/0000-0001-9453-9573	National Health and Medical Research Council (NHMRC) of Australia [606488]; NHMRC; Australian Research Council [FT100100427]; High Blood Pressure Research Council of Australia; Australian Government	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); High Blood Pressure Research Council of Australia; Australian Government(Australian GovernmentCGIAR)	This work was supported by a Project Grant from the National Health and Medical Research Council (NHMRC) of Australia [606488 to CGS and MAP]; by NHMRC Senior Research Fellowships to CGS and GRD; by a Future Fellowship from the Australian Research Council [FT100100427 to TVA]; by a Postdoctoral Fellowship from the High Blood Pressure Research Council of Australia [to BRSB]; and by Australian Postgraduate Awards from the Australian Government [to VHB and KRM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Barker-Collo S, 2012, STROKE, V43, P50, DOI 10.1161/STROKEAHA.111.627182; Basu A, 2005, J CEREBR BLOOD F MET, V25, P17, DOI 10.1038/sj.jcbfm.9600002; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Cho KO, 2008, EXP NEUROL, V212, P85, DOI 10.1016/j.expneurol.2008.03.017; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iadecola C, 1997, J NEUROSCI, V17, P9157; Jea A, 2005, PEDIATRICS, V116, pE694, DOI 10.1542/peds.2005-0568; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kim YS, 2006, J BIOL CHEM, V281, P39051, DOI 10.1074/jbc.M604659200; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sobrado M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-48; Thundyil John, 2010, Exp Transl Stroke Med, V2, P15, DOI 10.1186/2040-7378-2-15; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Yenari MA, 1998, EXP NEUROL, V153, P223, DOI 10.1006/exnr.1998.6876; ZHANG RL, 1995, STROKE, V26, P1438, DOI 10.1161/01.STR.26.8.1438; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47841	10.1371/journal.pone.0047841	http://dx.doi.org/10.1371/journal.pone.0047841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144708	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300019
J	Chen, W; Lin, H; Feng, PM; Ding, C; Zuo, YC; Chou, KC				Chen, Wei; Lin, Hao; Feng, Peng-Mian; Ding, Chen; Zuo, Yong-Chun; Chou, Kuo-Chen			iNuc-PhysChem: A Sequence-Based Predictor for Identifying Nucleosomes via Physicochemical Properties	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASS; MODIFIED MAHALANOBIS DISCRIMINANT; SUBCELLULAR LOCATION PREDICTION; HIV-1 REVERSE-TRANSCRIPTASE; HUMAN GENOME; SIGNAL PEPTIDES; ENZYME-KINETICS; HIGH-RESOLUTION; GRAPHIC RULES	Nucleosome positioning has important roles in key cellular processes. Although intensive efforts have been made in this area, the rules defining nucleosome positioning is still elusive and debated. In this study, we carried out a systematic comparison among the profiles of twelve DNA physicochemical features between the nucleosomal and linker sequences in the Saccharomyces cerevisiae genome. We found that nucleosomal sequences have some position-specific physicochemical features, which can be used for in-depth studying nucleosomes. Meanwhile, a new predictor, called iNuc-PhysChem, was developed for identification of nucleosomal sequences by incorporating these physicochemical properties into a 1788-D (dimensional) feature vector, which was further reduced to a 884-D vector via the IFS (incremental feature selection) procedure to optimize the feature set. It was observed by a cross-validation test on a benchmark dataset that the overall success rate achieved by iNuc-PhysChem was over 96% in identifying nucleosomal or linker sequences. As a web-server, iNuc-PhysChem is freely accessible to the public at http://lin.uestc.edu.cn/server/iNuc-PhysChem. For the convenience of the vast majority of experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated mathematics that were presented just for the integrity in developing the predictor. Meanwhile, for those who prefer to run predictions in their own computers, the predictor's code can be easily downloaded from the web-server. It is anticipated that iNuc-PhysChem may become a useful high throughput tool for both basic research and drug design.	[Chen, Wei] Hebei United Univ, Dept Phys, Sch Sci, Ctr Genom & Computat Biol, Tangshan, Peoples R China; [Lin, Hao; Ding, Chen] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat, Minist Educ,Ctr Bioinformat, Chengdu 610054, Peoples R China; [Feng, Peng-Mian] Hebei United Univ, Sch Publ Hlth, Tangshan, Peoples R China; [Zuo, Yong-Chun] Inner Mongolia Univ, Natl Res Ctr Anim Transgen Biotechnol, Hohhot, Peoples R China; [Chen, Wei; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	North China University of Science & Technology; University of Electronic Science & Technology of China; North China University of Science & Technology; Inner Mongolia University	Chen, W (corresponding author), Hebei United Univ, Dept Phys, Sch Sci, Ctr Genom & Computat Biol, Tangshan, Peoples R China.	wchen@gordonlifescience.org; hlin@uestc.edu.cn; kcchou@gordonlifescience.org	Feng, Pengmian/S-3089-2018; Zuo, Yongchun/J-2703-2014; Chou, Kuo-Chen/A-8340-2009; Chen, Wei/O-6774-2017; Chen, Wei/W-8311-2019; Lin, Hao/B-2066-2012	Feng, Pengmian/0000-0001-7720-1503; Zuo, Yongchun/0000-0002-6065-7835; Chen, Wei/0000-0002-6857-7696; Lin, Hao/0000-0001-6265-2862	National Nature Scientific Foundation of China [61100092]; Scientific Research Startup Foundation of North China Coal Medical University [10101115]; Foundation of Scientific and Technological Department of Hebei Province [11275532]; Scientific Research Foundation of Sichuan Province [2009JY0013]; Fundamental Research Funds for the Central Universities [ZYGX2009J081]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Startup Foundation of North China Coal Medical University; Foundation of Scientific and Technological Department of Hebei Province; Scientific Research Foundation of Sichuan Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Grants from The National Nature Scientific Foundation of China (No. 61100092), The Scientific Research Startup Foundation of North China Coal Medical University (No. 10101115), Foundation of Scientific and Technological Department of Hebei Province (No. 11275532), The Scientific Research Foundation of Sichuan Province (No. 2009JY0013) and The Fundamental Research Funds for the Central Universities (No. ZYGX2009J081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTHAUS IW, 1993, J BIOL CHEM, V268, P14875; ALTHAUS IW, 1993, J BIOL CHEM, V268, P6119; Andraos J, 2008, CAN J CHEM, V86, P342, DOI 10.1139/V08-020; Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; Blake RD, 1998, NUCLEIC ACIDS RES, V26, P3323, DOI 10.1093/nar/26.14.3323; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; BRUKNER I, 1995, J BIOMOL STRUCT DYN, V13, P309, DOI 10.1080/07391102.1995.10508842; Chen W, 2009, J MICROBIOL METH, V78, P94, DOI 10.1016/j.mimet.2009.03.013; Chen Y.-W., 2006, COMBINING SVMS VARIO; Chou K.C., 2011, NATUR SCI, V3, P862, DOI [10.4236/ns.2011.310111, DOI 10.4236/NS.2011.310111]; Chou KC, 1998, BIOCHEM BIOPH RES CO, V252, P63, DOI 10.1006/bbrc.1998.9498; CHOU KC, 1980, BIOCHEM J, V187, P829, DOI 10.1042/bj1870829; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; CHOU KC, 1989, J BIOL CHEM, V264, P12074; CHOU KC, 1990, BIOPHYS CHEM, V35, P1, DOI 10.1016/0301-4622(90)80056-D; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 1998, PROTEINS, V31, P97, DOI 10.1002/(SICI)1097-0134(19980401)31:1<97::AID-PROT8>3.0.CO;2-E; Chou KC, 2001, PROTEINS, V42, P136, DOI 10.1002/1097-0134(20010101)42:1<136::AID-PROT130>3.0.CO;2-F; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 1999, BIOCHEM BIOPH RES CO, V264, P216, DOI 10.1006/bbrc.1999.1325; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, CURR DRUG METAB, V11, P369, DOI 10.2174/138920010791514261; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Florquin K, 2005, NUCLEIC ACIDS RES, V33, P4255, DOI 10.1093/nar/gki737; Fujii S, 2007, NUCLEIC ACIDS RES, V35, P6063, DOI 10.1093/nar/gkm627; Goni JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r263; GORIN AA, 1995, J MOL BIOL, V247, P34, DOI 10.1006/jmbi.1994.0120; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Heddi B, 2010, J MOL BIOL, V395, P123, DOI 10.1016/j.jmb.2009.10.023; HO PS, 1990, BIOPOLYMERS, V30, P151, DOI 10.1002/bip.360300115; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022940; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IVANOV VI, 1994, MOL BIOL+, V28, P780; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan DL, 2010, METHODS MOL BIOL, V587, P127, DOI 10.1007/978-1-60327-355-8_9; Kurochkina N, 2011, J THEOR BIOL, V283, P92, DOI 10.1016/j.jtbi.2011.05.014; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Liu WM, 1998, J PROTEIN CHEM, V17, P209, DOI 10.1023/A:1022576400291; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Milani P, 2009, P NATL ACAD SCI USA, V106, P22257, DOI 10.1073/pnas.0909511106; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Nozaki T, 2011, GENE, V476, P10, DOI 10.1016/j.gene.2011.02.004; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; ORNSTEIN RL, 1978, BIOPOLYMERS, V17, P2341, DOI 10.1002/bip.1978.360171005; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Pillai KCS, 1985, ENCY STATISTICAL SCI, P176; Qin YF, 2012, PROTEIN PEPTIDE LETT, V19, P388, DOI 10.2174/092986612799789350; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SIVOLOB AV, 1995, J MOL BIOL, V247, P918, DOI 10.1006/jmbi.1994.0190; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Tanaka Y, 2010, CHROMOSOMA, V119, P391, DOI 10.1007/s00412-010-0264-y; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Yasuda T, 2005, DNA REPAIR, V4, P389, DOI 10.1016/j.dnarep.2004.10.008; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zhang LR, 2003, NUCLEIC ACIDS RES, V31, P6214, DOI 10.1093/nar/gkg805; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZQ, 2012, J BIOMOL STRUCT DYN, V29, P1081, DOI 10.1080/073911012010525032; Zhao XW, 2012, PROTEIN PEPTIDE LETT, V19, P492, DOI 10.2174/092986612800191080; ZHOU GP, 1984, BIOCHEM J, V222, P169, DOI 10.1042/bj2220169; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071; Zhou GP, 2011, PROTEIN PEPTIDE LETT, V18, P966, DOI 10.2174/0929866511107010966; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006	80	185	187	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47843	10.1371/journal.pone.0047843	http://dx.doi.org/10.1371/journal.pone.0047843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144709	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300020
J	Perez, ME; Pol, D				Encarnacion Perez, Maria; Pol, Diego			Major Radiations in the Evolution of Caviid Rodents: Reconciling Fossils, Ghost Lineages, and Relaxed Molecular Clocks	PLOS ONE			English	Article							SOUTHERN SOUTH-AMERICA; MIDDLE MIOCENE; CAVIOMORPH RODENTS; PHYLOGENETIC-RELATIONSHIPS; BIOGEOGRAPHIC HISTORY; PATAGONIA ARGENTINA; PINTURAS FORMATION; STRATIGRAPHIC FIT; DIVERGENCE TIME; RECORD	Background: Caviidae is a diverse group of caviomorph rodents that is broadly distributed in South America and is divided into three highly divergent extant lineages: Caviinae (cavies), Dolichotinae (maras), and Hydrochoerinae (capybaras). The fossil record of Caviidae is only abundant and diverse since the late Miocene. Caviids belongs to Cavioidea sensu stricto (Cavioidea s.s.) that also includes a diverse assemblage of extinct taxa recorded from the late Oligocene to the middle Miocene of South America ("eocardiids"). Results: A phylogenetic analysis combining morphological and molecular data is presented here, evaluating the time of diversification of selected nodes based on the calibration of phylogenetic trees with fossil taxa and the use of relaxed molecular clocks. This analysis reveals three major phases of diversification in the evolutionary history of Cavioidea s.s. The first two phases involve two successive radiations of extinct lineages that occurred during the late Oligocene and the early Miocene. The third phase consists of the diversification of Caviidae. The initial split of caviids is dated as middle Miocene by the fossil record. This date falls within the 95% higher probability distribution estimated by the relaxed Bayesian molecular clock, although the mean age estimate ages are 3.5 to 7 Myr older. The initial split of caviids is followed by an obscure period of poor fossil record (refered here as the Mayoan gap) and then by the appearance of highly differentiated modern lineages of caviids, which evidentially occurred at the late Miocene as indicated by both the fossil record and molecular clock estimates. Conclusions: The integrated approach used here allowed us identifying the agreements and discrepancies of the fossil record and molecular clock estimates on the timing of the major events in cavioid evolution, revealing evolutionary patterns that would not have been possible to gather using only molecular or paleontological data alone.	[Encarnacion Perez, Maria; Pol, Diego] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut Province, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Perez, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut Province, Argentina.	mperez@mef.org.ar; dpol@mef.org.ar	Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517	ANPCyT PICT [2613]; CONICET; American Museum of Natural History (AMNH); Yale Peabody Museum (YPM) Ostrom Fund	ANPCyT PICT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); American Museum of Natural History (AMNH); Yale Peabody Museum (YPM) Ostrom Fund	Research for this contribution was supported by ANPCyT PICT 2613 (to MEP) and the CONICET program for stays abroad for postdoctoral fellows (to MEP). Additional support that allowed the study of relevant specimens was provided to MEP by the American Museum of Natural History (AMNH) Collection Study Grant and the Yale Peabody Museum (YPM) Ostrom Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander RM, 2003, SCIENCE, V301, P1678, DOI 10.1126/science.1090964; Ameghino F, 1989, B ACAD NAC CI CORDOB; Ameghino F., 1885, B ACAD NACL CIENCIAS, V8, P5; Ameghino F., 1887, B MUSEO PLATA, V1, P1; Ameghino F, 1916, MAMIFEROS FOSILES 1, P611; Ameghino F, 1897, ARGENTINA TRAVES ULT; Ameghino F., 1888, LISTA ESPECIES MAMIF; Antoine PO, 2012, P ROY SOC B-BIOL SCI, V279, P1319, DOI 10.1098/rspb.2011.1732; ARAUJO A, 1993, MEM I OSWALDO CRUZ, V88, P577, DOI 10.1590/S0074-02761993000400014; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Bertrand OC, 2012, AM MUS NOVIT, P1; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Bondesio P., 1980, ACT 2 C ARG PAL BIOE, V3, P101; BOTTJER D J, 1988, Palaios, V3, P540, DOI 10.2307/3514444; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 2004, EVOLUTION, V58, P1375; Brochu CA, 2004, J PALEONTOL, V78, P1, DOI 10.1666/0022-3360(2004)078<0001:WCACCE>2.0.CO;2; Bromham L, 1999, TRENDS ECOL EVOL, V14, P278, DOI 10.1016/S0169-5347(99)01651-1; Bromham L, 2003, J MOL EVOL, V57, pS13, DOI 10.1007/s00239-003-0002-7; Campbell K, 2004, PALEOGENE MAMMALIAN, P1; Candela Adriana Magdalena, 2005, Instituto Superior de Correlacion Geologica (INSUGEO) Miscelanea, V14, P37; Cavin L, 2007, BIOL LETTERS, V3, P201, DOI 10.1098/rsbl.2006.0602; Chang JT, 1996, MATH BIOSCI, V137, P51, DOI 10.1016/S0025-5564(96)00075-2; Churakov G, 2010, MOL BIOL EVOL, V27, P1315, DOI 10.1093/molbev/msq019; Cione A. L., 2000, SER CORREL GEOL, V14, P191, DOI DOI 10.1007/s13358-015-0074-1; CIONE AL, 1995, J PALEONTOL, V69, P135, DOI 10.1017/S0022336000026998; Cione AL, 1996, J S AM EARTH SCI, V9, P221, DOI 10.1016/0895-9811(96)00008-9; Croft DA, 2007, PALAEONTOLOGY, V50, P277, DOI 10.1111/j.1475-4983.2006.00610.x; Dal Molin C, 1996, 13 C GEOL ARG BUEN A, V1, P473; DeBry RW, 2003, SYST BIOL, V52, P604, DOI 10.1080/10635150390235403; Deschamps CM, 2007, J VERTEBR PALEONTOL, V27, P683, DOI 10.1671/0272-4634(2007)27[683:OADOTO]2.0.CO;2; Deschamps CM, 2009, AMEGHINIANA, V46, P295; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; dos Reis SF, 1994, J MORPHOL, V220, P342; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dunnum JL, 2010, J ZOOL SYST EVOL RES, V48, P376, DOI 10.1111/j.1439-0469.2009.00561.x; Dunnum JL, 2010, J MAMMAL, V91, P243, DOI 10.1644/08-MAMM-A-214R1.1; Eisenberg JF, 2000, MAMMALS NEOTROPICS C, P1; Perez ME, 2012, AMEGHINIANA, V49, P118, DOI 10.5710/AMGH.v49i1(449); Perez ME, 2011, J MAMM EVOL, V18, P163, DOI 10.1007/s10914-011-9154-1; FIELDS ROBERT W., 1957, UNIV CALIFORNIA PUBL GEOL SCI, V32, P273; Fleagle J.G., 1995, 6 C ARG PAL BIOESTR, V2, P129; Flynn J, 1997, J VERTEBR PALEONTOL, P44; Flynn J.J., 1995, SOC SEDIMENTARY GEOL, V54, P317, DOI 10.2110/pec.95.04.0317; Flynn JJ, 2003, PALAEOGEOGR PALAEOCL, V195, P229, DOI 10.1016/S0031-0182(03)00360-2; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Frailey C.D., 1986, CONTRIBUTIONS SCI NA, V374, P1; Frailey Carl David, 2004, Natural History Museum of Los Angeles County Science Series, V40, P71; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Guerin C, 1999, PLEISTOCENE PALAEONT; Guidon N., 1993, ACT 12 C UN INT SCI, V3, P483; Vucetich MG, 2010, J MAMM EVOL, V17, P265, DOI 10.1007/s10914-010-9142-x; Guiomar Vucetich Maria, 1986, P157; Hartenberger JL, 1998, CR ACAD SCI II A, V326, P439, DOI 10.1016/S1251-8050(98)80068-2; HEDGES SB, 1994, P NATL ACAD SCI USA, V91, P9861, DOI 10.1073/pnas.91.21.9861; Hedges SB, 1998, MOL FOSSIL RECORD; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Honeycutt Rodney L., 2007, P8; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2001, MOL PHYLOGENET EVOL, V20, P238, DOI 10.1006/mpev.2001.0961; IUCN, 2022, IUCN RED LIST THREAT; Kay RF, 1999, P NATL ACAD SCI USA, V96, P13235, DOI 10.1073/pnas.96.23.13235; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Kraglievich L., 1930, AN MUS BUENOS AIRES, V36, P59; Kraglievich L., 1932, ANALES SOC CIENTIFIC, V114, P211; KRAGLIEVICH LUCAS, 1932, ANALES SOC CIENT ARGENTINA, V114, P155; Kramarz AG, 2005, J S AM EARTH SCI, V18, P199, DOI 10.1016/j.jsames.2004.10.005; Kramarz AG, 2006, J VERTEBR PALEONTOL, V26, P770, DOI 10.1671/0272-4634(2006)26[770:ERHFTP]2.0.CO;2; LANDRY STUART O., 1957, UNIV CALIFORNIA PUBL ZOOL, V56, P1; Landry Stuart O. Jr, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V75, P283; LAVOCAT R, 1974, J HUM EVOL, V3, P323, DOI 10.1016/0047-2484(74)90027-X; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Madden R, 1990, J VERTEBR PALEONTOL, V11, p44A; Madden Richard H., 2010, P423; Madden Richard H., 1997, P499; Mares M.A., 1982, Pymatuning Laboratory of Ecology Special Publications, V6, P393; Marivaux L, 2004, ZOOL J LINN SOC-LOND, V142, P105, DOI 10.1111/j.1096-3642.2004.00131.x; Marjanovic D, 2007, SYST BIOL, V56, P369, DOI 10.1080/10635150701397635; McKenna M.C., 1997, CLASSIFICATION MAMMA, P1; Montalvo C.I., 1995, 4 JORN GEOL GEOF BON, V1, P73; Montgelard C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-321; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Nasif Norma L., 2007, Acta Geologica Lilloana, V20, P99; Norell MA, 1996, PALEOBIOLOGY, V22, P453, DOI 10.1017/S0094837300016390; Norell Mark A., 1992, P89; Nowak R.M., 1999, WALKERS MAMMALS WORL, VI, P1; Nowak RM, 1999, WALKERS MAMMALS WORL, V2, P1; Opazo JC, 2005, MOL PHYLOGENET EVOL, V37, P932, DOI 10.1016/j.ympev.2005.05.002; Ortiz-Jaureguizar E, 2006, J ARID ENVIRON, V66, P498, DOI 10.1016/j.jaridenv.2006.01.007; Pascual R., 1968, Ameghiniana, V5, P237; PASCuAL R., 1961, AMEGHINIANA, V2, P61; Pascual R, 1962, AMEGHINIANA, V2, P169; Pascual R, 2006, ANN MO BOT GARD, V93, P209, DOI 10.3417/0026-6493(2006)93[209:EAGTBH]2.0.CO;2; Patterson B, 1982, B MUS COMP ZOOL HARV, V149, P370; Perez ME, 2010, J VERTEBR PALEONTOL, V30, P1848, DOI 10.1080/02724634.2010.522432; Perez-Crespo V. A., 2008, OAXACA NATURALEZA DE, V6, P5; Phillips MJ, 2009, P NATL ACAD SCI USA, V106, P17089, DOI 10.1073/pnas.0904649106; Pol D, 2004, CLADISTICS, V20, P64, DOI 10.1111/j.1096-0031.2003.00002.x; Pol D, 2006, SYST BIOL, V55, P512, DOI 10.1080/10635150600755446; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Quintana Carlos, 1997, Historia Animalium, V3, P55; Quintana Carlos A., 1998, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Biologica, V94, P125; Quintana Carlos A., 1996, Mastozoologia Neotropical, V3, P63; Rambaut A., 2007, TRACER V1 5; Re G., 2010, PALEONTOLOGY GRAN BA, P46; Reig OA, 1980, MONOGRAPHIAE NATURAE, V1, P1; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; Rinderknecht A, 2008, P ROY SOC B-BIOL SCI, V275, P923, DOI 10.1098/rspb.2007.1645; Rodriguez-Trelles F, 2002, P NATL ACAD SCI USA, V99, P8112, DOI 10.1073/pnas.122231299; Rowe DL, 2010, J BIOGEOGR, V37, P305, DOI 10.1111/j.1365-2699.2009.02190.x; Rowe DL, 2002, MOL BIOL EVOL, V19, P263, DOI 10.1093/oxfordjournals.molbev.a004080; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Sanchez-Villagra MR, 2003, SCIENCE, V301, P1708, DOI 10.1126/science.1089332; Sanchez-Villagra MR, 2010, URUMACO VENEZUELAN P, P1; Sanders KL, 2007, BIOLOGY LETT, V3, P275, DOI 10.1098/rsbl.2007.0063; Schultz PH, 2004, EARTH PLANET SC LETT, V219, P221, DOI 10.1016/S0012-821X(04)00010-X; Schultz PH, 2002, GEOL SOC AM ABSTR, V34, P401; Simpson G. G., 1945, B AM MUS NAT HIST, V85, P350; Simpson G. G., 1941, AM MUS NOVIT, V1120; SMITH AB, 1994, SYSTEMATICS FOSSIL R; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ubilla M, 1999, STUD NEOTROP FAUNA E, V34, P141, DOI 10.1076/snfe.34.3.141.8914; Ubilla Martin, 2003, Mastozoologia Neotropical, V10, P293; Ugarte F.R.E., 1956, REV ASOCIACI N GEOL, V11, P202; van Tuinen M, 2004, MOL PHYLOGENET EVOL, V30, P74, DOI 10.1016/S1055-7903(03)00164-7; Verzi DH, 2005, PALAEOGEOGR PALAEOCL, V219, P303, DOI 10.1016/j.palaeo.2005.01.003; Vucetich M.G., 1995, MONOGRAFIAS, V12, P213; Vucetich MG, 2011, J VERTEBR PALEONTOL, V31, P1382, DOI 10.1080/02724634.2011.618194; Vucetich Maria G., 1993, Ameghiniana, V30, P361; Vucetich Maria Guiomar, 2010, P193; Vucetich MG, 1999, CR ACAD SCI II A, V329, P763; Vucetich MG, ORIGINS EVOLUTION S; Vucetich MG, CAPIVARA BIOL PRODUC, P27; Wood A.E., 1959, B MUS COMP ZOOL HARV, V120, P280; WOOD ALBERT E., 1955, JOUR MAMMAL, V36, P165, DOI 10.2307/1375874; Woods C.A., 1984, P389; Woods CA., 1982, MAMMALIAN BIOL S AM, P377; Woods CA, 2005, MAMMAL SPECIES WORLD, P1538; WYSS AR, 1993, NATURE, V365, P434, DOI 10.1038/365434a0; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zarate MA, 2007, J S AM EARTH SCI, V23, P81, DOI 10.1016/j.jsames.2006.09.018	152	42	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48380	10.1371/journal.pone.0048380	http://dx.doi.org/10.1371/journal.pone.0048380			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144757	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300067
J	Helin-Salmivaara, A; Korhonen, MJ; Lehenkari, P; Junnila, SYT; Neuvonen, PJ; Ruokoniemi, P; Huupponen, R				Helin-Salmivaara, Arja; Korhonen, Maarit J.; Lehenkari, Petri; Junnila, Seppo Y. T.; Neuvonen, Pertti J.; Ruokoniemi, Paivi; Huupponen, Risto			Statins and Hip Fracture Prevention - A Population Based Cohort Study in Women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; RANDOMIZED CONTROLLED-TRIALS; POSTMENOPAUSAL WOMEN; HYDROXYMETHYLGLUTARYL-COENZYME; OSTEOBLAST DIFFERENTIATION; MC3T3-E1 CELLS; RISK; OSTEOPOROSIS; METAANALYSIS; INHIBITORS	Objective: To study the association of long-term statin use and the risk of low-energy hip fractures in middle-aged and elderly women. Design: A register-based cohort study. Setting: Finland. Participants: Women aged 45-75 years initiating statin therapy between 1996 and 2001 with adherence to statins >= 80% during the subsequent five years (n = 40 254), a respective cohort initiating hypertension drugs (n = 41 610), and women randomly selected from the population (n = 62 585). Main Outcome Measures: Incidence rate of and hazard ratio (HR) for low-energy hip fracture during the follow-up extending up to 7 years after the 5-year exposure period. Results: Altogether 199 low-energy hip fractures occurred during the 135 330 person-years (py) of follow-up in the statin cohort, giving an incidence rate of 1.5 hip fractures per 1000 py. In the hypertension and the population cohorts, the rates were 2.0 per 1000 py (312 fractures per 157 090 py) and 1.0 per 1000 py (212 fractures per 216 329 py), respectively. Adjusting for a propensity score and individual variables strongly predicting the outcome, good adherence to statins for five years was associated with a 29% decreased risk (HR 0.71; 95% CI 0.58-0.86) of a low-energy hip fracture in comparison with adherent use of hypertension drugs. The association was of the same magnitude when comparing the statin users with the population cohort, the HR being 0.69 (0.55-0.87). When women with poor (<40%), moderate (40 to 80%), and good adherence (>= 80%) to statins were compared to those with good adherence to hypertension drugs (>= 80%) or to the population cohort, the protective effect associated with statin use attenuated with the decreasing level of adherence. Conclusions: 5-year exposure to statins is associated with a reduced risk of low-energy hip fracture in women aged 50-80 years without prior hospitalizations for fractures.	[Helin-Salmivaara, Arja; Korhonen, Maarit J.; Ruokoniemi, Paivi; Huupponen, Risto] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Helin-Salmivaara, Arja] Hosp Dist Helsinki & Uusimaa, Unit Primary Hlth Care, Helsinki, Finland; [Lehenkari, Petri] Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland; [Lehenkari, Petri] Univ Oulu, Oulu Univ Hosp, Inst Clin Med, Div Surg,Dept Surg & Intens Care,Clin Res Ctr, Oulu, Finland; [Junnila, Seppo Y. T.] Salo Hlth Care Ctr, Salo, Finland; [Neuvonen, Pertti J.; Ruokoniemi, Paivi] Univ Helsinki, Dept Clin Pharmacol, SF-00250 Helsinki, Finland; [Ruokoniemi, Paivi; Huupponen, Risto] Turku Univ Hosp, Clin Pharmacol Unit, FIN-20520 Turku, Finland	University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Helsinki; University of Turku	Helin-Salmivaara, A (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	arja.helin-salmivaara@utu.fi	Neuvonen, Pertti J/G-4675-2011; Neuvonen, Pertti/Z-4818-2019; Lehenkari, Petri/O-3009-2016	Neuvonen, Pertti/0000-0003-3631-9411; Lehenkari, Petri/0000-0002-0055-5183; Korhonen, Maarit/0000-0002-2953-4757	Kela; Academy of Finland [138255]; Social Insurance Institution	Kela; Academy of Finland(Academy of Finland); Social Insurance Institution	This study was funded by Kela (www.kela.fi) (grant 10/26/2007) and the Academy of Finland (www.aka.fi, desicion number 138255). The Social Insurance Institution and the Academy of Finland had no role in the design, analyses, interpretation of data, writing the report, or in the decision to submit the manuscript.; The authors have read the journal's policy and have the following conflicts: AHS, MK, RH have been funded by the grants from the Social Insurance Institution (10/26/2007) and the Academy of Finland (number 138255). PR has received a grant from Orion Pharmos Researh Foundation. RH is a member of the Advisory Board for Social and Medical Affairs of the SII. He has conducted consultancy for Orion Corporation as an Independent External Member of a Data Monitoring and Safety Committee in a clinical trial, and assisted Santen Pharmaceutical Co in pharmacokinetic calculations. PN, PL and SYTJ declare that no competing interests exist. The authors declare no other financial or non-financial (professional or personal) conflict of interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baim S, 2012, CURR OSTEOPOROS REP, V10, P28, DOI 10.1007/s11914-011-0093-9; Bakhireva LN, 2010, PHARMACOTHERAPY, V30, P879, DOI 10.1592/phco.30.9.879; Bauer DC, 2004, ARCH INTERN MED, V164, P146, DOI 10.1001/archinte.164.2.146; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; CUMMINGS SR, 1995, AM J MED, V98, pS24, DOI 10.1016/S0002-9343(05)80041-5; de Lemos ML, 2005, CAN MED ASSOC J, V172, P613, DOI 10.1503/cmaj.1041426; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fukui T, 2012, J BONE MINER RES, V27, P1118, DOI 10.1002/jbmr.1558; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Han SL, 2012, INT J CLIN PRACT, V66, P199, DOI 10.1111/j.1742-1241.2011.02837.x; Hatzigeorgiou C, 2005, OSTEOPOROSIS INT, V16, P990, DOI 10.1007/s00198-004-1793-0; Ho ML, 2009, EUR J CLIN INVEST, V39, P296, DOI 10.1111/j.1365-2362.2009.02092.x; Horiuchi N, 2006, ORAL DIS, V12, P85, DOI 10.1111/j.1601-0825.2005.01172.x; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kijowski R, 2012, J BONE MINER RES, V27, P1494, DOI 10.1002/jbmr.1595; Leslie S.R., 2008, PHARM PROGRAMMING, V1, P13, DOI DOI 10.1179/175709208X334614; Li X, 2011, J BONE MINER METAB, V29, P396, DOI 10.1007/s00774-010-0231-y; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; Monjo M, 2010, CELL PHYSIOL BIOCHEM, V26, P647, DOI 10.1159/000322332; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; *NAT AG MED SOC IN, 2007, FINN STAT MED 2006; *NAT AG MED SOC IN, 1997, FINN STAT MED 1996; Pasco JA, 2002, ARCH INTERN MED, V162, P537, DOI 10.1001/archinte.162.5.537; Patrick AR, 2011, PHARMACOEPIDEM DR S, V20, P551, DOI 10.1002/pds.2098; Reid IR, 2001, LANCET, V357, P509, DOI 10.1016/S0140-6736(00)04042-3; REID IR, 1992, J CLIN ENDOCR METAB, V75, P45, DOI 10.1210/jc.75.1.45; Rejnmark L, 2006, CALCIFIED TISSUE INT, V79, P27, DOI 10.1007/s00223-006-0024-4; Ringe JD, 2010, RHEUMATOL INT, V30, P863, DOI 10.1007/s00296-009-1311-y; Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801; Sund R, 2007, METHOD INFORM MED, V46, P558, DOI 10.1160/ME0382; Sund Reijo, 2007, Epidemiol Perspect Innov, V4, P2, DOI 10.1186/1742-5573-4-2; Toh S, 2007, PHARMACOEPIDEM DR S, V16, P627, DOI 10.1002/pds.1363; Uzzan B, 2007, BONE, V40, P1581, DOI 10.1016/j.bone.2007.02.019; van Beek ER, 2003, BONE, V33, P805, DOI 10.1016/j.bone.2003.07.007; Virtanen JK, 2012, OSTEOPOROSIS INT, V23, P2615, DOI 10.1007/s00198-012-1903-3; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003376.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; *WHO, 2008, ATC DDD SYST; Yamashita M, 2010, REGUL PEPTIDES, V162, P99, DOI 10.1016/j.regpep.2010.03.003; Yue JR, 2010, MENOPAUSE, V17, P1071, DOI 10.1097/gme.0b013e3181d3e036	44	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48095	10.1371/journal.pone.0048095	http://dx.doi.org/10.1371/journal.pone.0048095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144731	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300041
J	Pang, S; Ran, ZJ; Liu, ZQ; Song, XY; Duan, LS; Li, XF; Wang, CJ				Pang, Sen; Ran, Zhaojin; Liu, Zhiqian; Song, Xiaoyu; Duan, Liusheng; Li, Xuefeng; Wang, Chengju			Enantioselective Induction of a Glutathione-S-Transferase, a Glutathione Transporter and an ABC Transporter in Maize by Metolachlor and Its (S)-Isomer	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; RAC-METOLACHLOR; HERBICIDE; EXPRESSION; DERIVATIVES; METABOLISM; TOXICITY; FAMILY; ENZYME	The metabolism of chiral herbicides in plants remains poorly understood. Glutathione conjugation reactions are one of the principal mechanisms that plants utilize to detoxify xenobiotics. The induction by rac- and S-metolachlor of the expression of three genes, ZmGST27, ZmGT1 and ZmMRP1, encoding respectively a glutathione-S-transferase, a glutathione transporter and an ATP-binding cassette (ABC) transporter was studied in maize. The results demonstrate that the inducing effect of rac- and S-metolachlor on the expression of ZmGST27 and ZmGT1 is comparable. However, the inducing effect of racmetolachlor on ZmMRP1 expression is more pronounced than that of S-metolachlor. Furthermore, vanadate, an ABC transporter inhibitor, could greatly reduce the difference in herbicidal activity between rac- and S-metolachlor. These results suggest that the ABC transporters may preferentially transport conjugates of rac- metolachlor, leading to a faster metabolism of the latter. Through comparing the expression of ZmGST27, ZmMRP1 and ZmGT1 after treatment by rac- and S-metolachlor, we provide novel insights into the metabolic processes of chiral herbicides in plants.	[Li, Xuefeng] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; China Agr Univ, Minist Educ, Engn Res Ctr Plant Growth Regulators, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Li, XF (corresponding author), China Agr Univ, Coll Sci, Beijing 100094, Peoples R China.	lixuefeng2007@163.com; Wangchengju@cau.edu.cn	Duan, Liusheng/F-8954-2011	Duan, Liusheng/0000-0003-0323-9378	Chinese Universities Scientific Fund [2011JS074]	Chinese Universities Scientific Fund	This study was supported by Chinese Universities Scientific Fund (Project No. 2011JS074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basantani M, 2011, PESTIC BIOCHEM PHYS, V99, P111, DOI 10.1016/j.pestbp.2010.11.007; Buser HR, 2000, ENVIRON SCI TECHNOL, V34, P2690, DOI 10.1021/es0000201; Cagnac O, 2004, PLANT PHYSIOL, V135, P1378, DOI 10.1104/pp.104.039859; Cao PY, 2008, B ENVIRON CONTAM TOX, V80, P391, DOI 10.1007/s00128-008-9359-z; Cook ME, 2008, ARCH ENVIRON CON TOX, V55, P94, DOI 10.1007/s00244-007-9088-z; Ding GW, 2002, CHEMOSPHERE, V48, P897, DOI 10.1016/S0045-6535(02)00188-1; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Falconer RL, 1997, J AGR FOOD CHEM, V45, P1946, DOI 10.1021/jf960881m; GAILLARD C, 1994, FEBS LETT, V352, P219, DOI 10.1016/0014-5793(94)00961-9; Hoekstra PF, 2006, CHEMOSPHERE, V64, P174, DOI 10.1016/j.chemosphere.2005.10.043; Jin YX, 2009, CHEMOSPHERE, V74, P1238, DOI 10.1016/j.chemosphere.2008.11.015; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kurt-Karakus PB, 2005, ENVIRON SCI TECHNOL, V39, P8671, DOI 10.1021/es051004c; Liu HJ, 2006, ECOTOX ENVIRON SAFE, V63, P451, DOI 10.1016/j.ecoenv.2005.02.002; Liu HJ, 2012, J HAZARD MATER, V217, P330, DOI 10.1016/j.jhazmat.2012.03.037; Liu HJ, 2009, AQUAT TOXICOL, V93, P100, DOI 10.1016/j.aquatox.2009.04.006; Liu W.P., 2011, ENANTIOSELECTIVE ACT; Liu WP, 2009, J AGR FOOD CHEM, V57, P2087, DOI 10.1021/jf900079y; Liu WP, 2005, P NATL ACAD SCI USA, V102, P701, DOI 10.1073/pnas.0408847102; Miyashita M, 2004, CHEMOSPHERE, V54, P1273, DOI 10.1016/j.chemosphere.2003.10.035; Muller TA, 2004, APPL MICROBIOL BIOT, V64, P300, DOI 10.1007/s00253-003-1511-4; Pang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040712; Pang S, 2012, J FOOD AGRIC ENVIRON, V10, P621; Pang S, 2010, PROG BIOCHEM BIOPHYS, V37, P1120, DOI 10.3724/SP.J.1206.2010.00188; Pereira SP, 2009, TOXICOL IN VITRO, V23, P1585, DOI 10.1016/j.tiv.2009.06.032; Qian HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019451; Qian HF, 2009, CHEMOSPHERE, V76, P885, DOI 10.1016/j.chemosphere.2009.05.009; Sekhon BS, 2009, J PESTIC SCI, V34, P1, DOI 10.1584/jpestics.R08-03; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Swarbreck D, 2003, GENE, V315, P153, DOI 10.1016/S0378-1119(03)00734-0; Theodoulou FL, 2003, PEST MANAG SCI, V59, P202, DOI 10.1002/ps.576; Vallotton N, 2008, CHEMOSPHERE, V73, P395, DOI 10.1016/j.chemosphere.2008.05.039; Wang LM, 2009, J ENVIRON SCI HEAL B, V44, P38, DOI 10.1080/03601230802519611; Xie F., 2010, J ENV SCI HLTH B, V45, P808; Xu C., 2008, CHEM RES TOXICOL, V47, P4236; Yuan JS, 2007, TRENDS PLANT SCI, V12, P6, DOI 10.1016/j.tplants.2006.11.001; Zhan XM, 2006, PESTIC BIOCHEM PHYS, V85, P133, DOI 10.1016/j.pestbp.2005.12.003; Zhang MY, 2004, PLANT PHYSIOL, V134, P482, DOI 10.1104/pp.103.030940	38	4	6	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48085	10.1371/journal.pone.0048085	http://dx.doi.org/10.1371/journal.pone.0048085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144728	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300038
J	Nikolic, N; Smole, Z; Krisko, A				Nikolic, Nela; Smole, Zlatko; Krisko, Anita			Proteomic Properties Reveal Phyloecological Clusters of Archaea	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEINS; PATTERNS; GENOME; LIFE; HYPERTHERMOPHILES; MICROORGANISMS; ADAPTATION; SIGNATURES; EVOLUTION	In this study, we propose a novel way to describe the variety of environmental adaptations of Archaea. We have clustered 57 Archaea by using a non-redundant set of proteomic features, and verified that the clusters correspond to environmental adaptations to the archaeal habitats. The first cluster consists dominantly of hyperthermophiles and hyperthermoacidophilic aerobes. The second cluster joins together halophilic and extremely halophilic Archaea, while the third cluster contains mesophilic (mostly methanogenic) Archaea together with thermoacidophiles. The non-redundant subset of proteomic features was found to consist of five features: the ratio of charged residues to uncharged, average protein size, normalized frequency of beta-sheet, normalized frequency of extended structure and number of hydrogen bond donors. We propose this clustering to be termed phyloecological clustering. This approach could give additional insights into relationships among archaeal species that may be hidden by sole phylogenetic analysis.	[Nikolic, Nela; Smole, Zlatko; Krisko, Anita] Mediterranean Inst Life Sci, Split, Croatia; [Nikolic, Nela] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Nikolic, Nela] Eawag, Dept Environm Microbiol, Dubendorf, Switzerland; [Smole, Zlatko] Swiss Fed Inst Technol, Inst Cell Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Krisko, A (corresponding author), Mediterranean Inst Life Sci, Split, Croatia.	anita.krisko@medils.hr		Nikolic, Nela/0000-0001-9068-6090	Unity Through Knowledge "Gaining experience" Grant [2A]	Unity Through Knowledge "Gaining experience" Grant	Nela Nikolic was funded by Unity Through Knowledge "Gaining experience" Grant, number 2A for her 3-month stay at The Swiss Federal Institute of Technology in Zurich (German: Eidgenossische Technische Hochschule, ETH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Carbone A, 2005, MOL BIOL EVOL, V22, P547, DOI 10.1093/molbev/msi040; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; DeLong EF, 1998, CURR OPIN GENET DEV, V8, P649, DOI 10.1016/S0959-437X(98)80032-4; Forterre P, 2002, THEOR POPUL BIOL, V61, P409, DOI 10.1006/tpbi.2002.1592; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Graham DE, 2000, P NATL ACAD SCI USA, V97, P3304, DOI 10.1073/pnas.050564797; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Gross ST, 2008, PRACTICAL HDB MICROB, P663; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Heger A, 2001, BIOINFORMATICS, V17, P272, DOI 10.1093/bioinformatics/17.3.272; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Horikoshi K, 1998, CURR OPIN MICROBIOL, V1, P291, DOI 10.1016/S1369-5274(98)80032-5; Huber R, 2000, FEMS MICROBIOL REV, V24, P615, DOI 10.1111/j.1574-6976.2000.tb00562.x; Jones D. L., 2012, FATHOM TOOLBOX MATLA; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Knight CG, 2004, P NATL ACAD SCI USA, V101, P8390, DOI 10.1073/pnas.0307270101; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Krisko A, 2010, J MOL BIOL, V402, P775, DOI 10.1016/j.jmb.2010.08.012; Kummerli R, 2007, MOL ECOL, V16, P4493, DOI 10.1111/j.1365-294X.2007.03514.x; Kunin V, 2005, NUCLEIC ACIDS RES, V33, P616, DOI 10.1093/nar/gki181; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; Lopez-Garcia P, 2008, RES MICROBIOL, V159, P67, DOI 10.1016/j.resmic.2007.11.019; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Meunier B, 2007, J PROTEOME RES, V6, P358, DOI 10.1021/pr060343h; Oren A, 2010, ELS; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Cardenas JP, 2010, APPL MICROBIOL BIOT, V88, P605, DOI 10.1007/s00253-010-2795-9; Parker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011096; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; Saeed I, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1204; Sasson O, 2003, NUCLEIC ACIDS RES, V31, P348, DOI 10.1093/nar/gkg096; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Smole Z, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-26; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suhre K, 2003, J BIOL CHEM, V278, P17198, DOI 10.1074/jbc.M301327200; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Tekaia F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-307; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Xue B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S1; Zaneveld JRR, 2011, TRENDS MICROBIOL, V19, P472, DOI 10.1016/j.tim.2011.07.006; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005	53	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48231	10.1371/journal.pone.0048231	http://dx.doi.org/10.1371/journal.pone.0048231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133575	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800065
J	Steen, HC; Nogusa, S; Thapa, RJ; Basagoudanavar, SH; Gill, AL; Merali, S; Barrero, CA; Balachandran, S; Gamero, AM				Steen, Hakan C.; Nogusa, Shoko; Thapa, Roshan J.; Basagoudanavar, Suresh H.; Gill, Amanda L.; Merali, Salim; Barrero, Carlos A.; Balachandran, Siddharth; Gamero, Ana M.			Identification of STAT2 Serine 287 as a Novel Regulatory Phosphorylation Site in Type I Interferon-induced Cellular Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; TRANSCRIPTION FACTOR; TYROSINE PHOSPHORYLATION; DNA-BINDING; STIMULATED GENES; IFN-ALPHA; ACTIVATION; PROTEIN; REQUIRES; RECEPTOR	STAT2 is a positive modulator of the transcriptional response to type I interferons (IFNs). STAT2 acquires transcriptional function by becoming tyrosine phosphorylated and imported to the nucleus following type I IFN receptor activation. Although most STAT proteins become dually phosphorylated on specific tyrosine and serine residues to acquire full transcriptional activity, no serine phosphorylation site in STAT2 has been reported. To find novel phosphorylation sites, mass spectrometry of immunoprecipitated STAT2 was used to identify several phosphorylated residues. Of these, substitution of serine 287 with alanine (S287A) generated a gain-of-function mutant that enhanced the biological effects of IFN-alpha. S287A-STAT2 increased cell growth inhibition, prolonged protection against vesicular stomatitis virus infection and enhanced transcriptional responses following exposure of cells to IFN-alpha. In contrast, a phosphomimetic STAT2 mutant (S287D) produced a loss-of-function protein that weakly activated IFN-induced ISGs. Our mechanistic studies suggest that S287A-STAT2 likely mediates its gain-of-function effects by prolonging STAT2/STAT1 dimer activation and retaining it in transcriptionally active complexes with chromatin. Altogether, we have uncovered that in response to type I IFN, STAT2 is serine phosphorylated in the coiled-coil domain that when phosphorylated can negatively regulate the biological activities of type I IFNs.	[Steen, Hakan C.; Gill, Amanda L.; Merali, Salim; Barrero, Carlos A.; Gamero, Ana M.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Nogusa, Shoko; Thapa, Roshan J.; Basagoudanavar, Suresh H.; Balachandran, Siddharth] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Basagoudanavar, Suresh H.] Indian Vet Res Inst, Bangalore 560024, Karnataka, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Gamero, AM (corresponding author), 3400 N Broad St,Kresge Hall, Philadelphia, PA 19140 USA.	gameroa@temple.edu	Basagoudanavar, Suresh/AAG-4317-2019	Basagoudanavar, Suresh/0000-0001-7714-3120; Barrero, Carlos/0000-0001-5779-6642	National Cancer Institute [RO1CA140499, K22CA095326]; ACS Research Scholar Grant [RSG-09-195-01-MPC]; Fox Chase Cancer Center institutional support via the Kidney Cancer Keystone Program; NATIONAL CANCER INSTITUTE [R01CA140499, K22CA095326] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS Research Scholar Grant; Fox Chase Cancer Center institutional support via the Kidney Cancer Keystone Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grants RO1CA140499 and K22CA095326 (to A. M. G.). This work was also supported by an ACS Research Scholar Grant (RSG-09-195-01-MPC) with additional funding provided by the Fox Chase Cancer Center institutional support via the Kidney Cancer Keystone Program.	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Cho SS, 1996, J IMMUNOL, V157, P4781; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; Gamero AM, 2004, J BIOL CHEM, V279, P12379, DOI 10.1074/jbc.M310787200; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Hasham MG, 2004, VIROLOGY, V320, P313, DOI 10.1016/j.virol.2003.11.032; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IMPROTA T, 1994, P NATL ACAD SCI USA, V91, P4776, DOI 10.1073/pnas.91.11.4776; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kadota S, 2011, J CELL SCI, V124, P892, DOI 10.1242/jcs.078253; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; LARNER AC, 1986, J BIOL CHEM, V261, P453; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Maiti NR, 2005, J INTERF CYTOK RES, V25, P553, DOI 10.1089/jir.2005.25.553; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sakamoto S, 2004, J BIOL CHEM, V279, P3245, DOI 10.1074/jbc.M309631200; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Scarzello AJ, 2007, MOL BIOL CELL, V18, P2455, DOI 10.1091/mbc.E06-09-0843; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Shirakawa T, 2011, J BIOL CHEM, V286, P4003, DOI 10.1074/jbc.M110.168435; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Testoni B, 2011, J BIOL CHEM, V286, P20217, DOI 10.1074/jbc.M111.231068; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	40	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					747	758		10.1074/jbc.M112.402529	http://dx.doi.org/10.1074/jbc.M112.402529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23139419	Green Published, hybrid			2022-12-25	WOS:000313197200074
J	Nissinen, L; Koivunen, J; Kapyla, J; Salmela, M; Nieminen, J; Jokinen, J; Sipila, K; Pihlavisto, M; Pentikainen, OT; Marjamaki, A; Heino, J				Nissinen, Liisa; Koivunen, Jarkko; Kapyla, Jarmo; Salmela, Maria; Nieminen, Jonna; Jokinen, Johanna; Sipila, Kalle; Pihlavisto, Marjo; Pentikainen, Olli T.; Marjamaki, Anne; Heino, Jyrki			Novel alpha 2 beta 1 Integrin Inhibitors Reveal That Integrin Binding to Collagen under Shear Stress Conditions Does Not Require Receptor Preactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; I-DOMAIN; CRYSTAL-STRUCTURE; ALPHA-I-2 DOMAIN; CELL-ADHESION; FIRM ADHESION; A-DOMAIN; ACTIVATION; ALPHA(2)BETA(1); SUBTYPES	The interaction between alpha 2 beta 1 integrin (GPIa/IIa, VLA-2) and vascular collagen is one of the initiating events in thrombus formation. Here, we describe two structurally similar sulfonamide derivatives, BTT-3033 and BTT-3034, and show that, under static conditions, they have an almost identical effect on alpha 2-expressing CHO cell adhesion to collagen I, but only BTT-3033 blocks platelet attachment under flow (90 dynes/cm(2)). Differential scanning fluorimetry showed that both molecules bind to the alpha 2I domain of the recombinant alpha 2 subunit. To further study integrin binding mechanism(s) of the two sulfonamides, we created an alpha 2 Y285F mutant containing a substitution near the metal ion-dependent adhesion site motif in the alpha 2I domain. The action of BTT-3033, unlike that of BTT-3034, was dependent on Tyr-285. In static conditions BTT-3034, but not BTT3033, inhibited collagen binding by an alpha 2 variant carrying a conformationally activating E318W mutation. Conversely, in under flow conditions (90 dynes/cm(2)) BTT-3033, but not BTT-3034, inhibited collagen binding by an alpha 2 variant expressing E336A loss-of-function mutation. Thus, the binding sites for BTT-3033 and BTT-3034 are differentially available in distinct integrin conformations. Therefore, these sulfonamides can be used to study the biological role of different functional stages of alpha 2 beta 1. Furthermore, only the inhibitor that recognized the nonactivated conformation of alpha 2 beta 1 integrin under shear stress conditions effectively blocked platelet adhesion, suggesting that the initial interaction between integrin and collagen takes place prior to receptor activation.	[Nissinen, Liisa; Nieminen, Jonna; Pihlavisto, Marjo; Marjamaki, Anne] BioTie Therapies, FI-20520 Turku, Finland; [Koivunen, Jarkko; Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Kapyla, Jarmo; Salmela, Maria; Jokinen, Johanna; Sipila, Kalle; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland	University of Jyvaskyla; University of Turku	Heino, J (corresponding author), Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland.	jyrki.heino@utu.fi	Pentikäinen, Olli T/E-1980-2012; Koivunen, Jarkko/AAF-8012-2020	Pentikäinen, Olli T/0000-0001-7188-4016; Koivunen, Jarkko/0000-0001-8060-555X; Kapyla, Jarmo/0000-0003-3036-713X; Nissinen, Liisa/0000-0002-6743-6736; Salmela, Maria/0000-0003-1949-7101	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Association	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Association	This work was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation, and the Finnish Cancer Association. L.N., J.N.,M.P., and A.M. are/have been employees of BioTie Therapies Corp., a biotechnology company that has developed sulfonamide compounds.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Carlsson LE, 1999, BLOOD, V93, P3583, DOI 10.1182/blood.V93.11.3583.410k34_3583_3586; Choi S, 2007, J MED CHEM, V50, P5457, DOI 10.1021/jm070252b; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; Dunne JL, 2002, BLOOD, V99, P336, DOI 10.1182/blood.V99.1.336; Ivaska J, 1999, J BIOL CHEM, V274, P3513, DOI 10.1074/jbc.274.6.3513; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; Jung SM, 2000, J BIOL CHEM, V275, P8016, DOI 10.1074/jbc.275.11.8016; Jung SM, 2001, EUR J BIOCHEM, V268, P3513, DOI 10.1046/j.1432-1327.2001.02252.x; KAMATA T, 1994, J BIOL CHEM, V269, P26006; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kapyla J, 2007, J MED CHEM, V50, P2742, DOI 10.1021/jm070063t; Koivunen JT, 2011, J AM CHEM SOC, V133, P14558, DOI 10.1021/ja206086c; Koivunen JT, 2011, MEDCHEMCOMM, V2, P764, DOI 10.1039/c1md00089f; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miller MW, 2009, P NATL ACAD SCI USA, V106, P719, DOI 10.1073/pnas.0811622106; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; NIEUWENHUIS HK, 1985, NATURE, V318, P470, DOI 10.1038/318470a0; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nissinen L, 2010, THROMB HAEMOSTASIS, V103, P387, DOI 10.1160/TH09-06-0358; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pentikainen O, 1999, J BIOL CHEM, V274, P31493, DOI 10.1074/jbc.274.44.31493; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	41	25	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44694	44702		10.1074/jbc.M111.309450	http://dx.doi.org/10.1074/jbc.M111.309450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132859	Green Published, hybrid			2022-12-25	WOS:000312938600065
J	He, M; Jenkins, P; Bennett, V				He, Meng; Jenkins, Paul; Bennett, Vann			Cysteine 70 of Ankyrin-G Is S-Palmitoylated and Is Required for Function of Ankyrin-G in Membrane Domain Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENT; BRONCHIAL EPITHELIAL-CELLS; PROTEIN PALMITOYLATION; ADHESION MOLECULE; LATERAL MEMBRANE; E-CADHERIN; L1 FAMILY; IN-VIVO; ASSOCIATION; NEUROFASCIN	Ankyrin-G (AnkG) coordinates protein composition of diverse membrane domains, including epithelial lateral membranes and neuronal axon initial segments. However, how AnkG itself localizes to these membrane domains is not understood. We report that AnkG remains on the plasma membrane in Madin-Darby canine kidney (MDCK) cells grown in low calcium, although these cells lack apical-basal polarity and exhibit loss of plasma membrane association of AnkG partners, E-cadherin and beta(2)-spectrin. We subsequently demonstrate using mutagenesis and mass spectrometry that AnkG is S-palmitoylated exclusively at Cys-70, which is located in a loop of the first ankyrin repeat and is conserved in the vertebrate ankyrin family. Moreover, C70A mutation abolishes membrane association of 190-kDa AnkG in MDCK cells grown in low calcium. C70A 190-kDa AnkG fails to restore biogenesis of epithelial lateral membranes in MDCK cells depleted of endogenous AnkG. In addition, C70A 270-kDa AnkG fails to cluster at the axon initial segment of AnkG-depleted cultured hippocampal neurons and fails to recruit neurofascin as well as voltage-gated sodium channels. These effects of C70A mutation combined with evidence for its S-palmitoylation are consistent with a requirement of palmitoylation for targeting and function of AnkG in membrane domain biogenesis at epithelial lateral membranes and neuronal axon initial segments.	[Jenkins, Paul; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [He, Meng] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Jenkins, Paul; Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Jenkins, Paul; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Jenkins, Paul; Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	vann.bennett@duke.edu	Jenkins, Paul/C-9098-2015	Jenkins, Paul/0000-0002-4207-5823	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; BENNETT V, 1980, J BIOL CHEM, V255, P2540; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Busche S, 2010, J CELL SCI, V123, P2803, DOI 10.1242/jcs.061887; Delint-Ramirez I, 2011, J BIOL CHEM, V286, P32962, DOI 10.1074/jbc.M111.243899; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Greaves J, 2010, BIOCHEM SOC T, V38, P522, DOI 10.1042/BST0380522; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kizhatil K, 2009, SCIENCE, V323, P1614, DOI 10.1126/science.1169789; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; MATTEY DL, 1986, J CELL SCI, V85, P95; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Ren Q, 1998, J NEUROCHEM, V70, P1839; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; STAUFENBIEL M, 1988, J BIOL CHEM, V263, P13615; STAUFENBIEL M, 1987, MOL CELL BIOL, V7, P2981, DOI 10.1128/MCB.7.8.2981; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	43	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43995	44005		10.1074/jbc.M112.417501	http://dx.doi.org/10.1074/jbc.M112.417501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129772	Green Published, hybrid			2022-12-25	WOS:000312940800074
J	Iwasa, M; Aihara, T; Maeda, K; Narita, A; Maeda, Y; Oda, T				Iwasa, Mitsusada; Aihara, Tomoki; Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro; Oda, Toshiro			Role of the Actin Ala-108-Pro-112 Loop in Actin Polymerization and ATPase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; F-ACTIN; FILAMENT; COMPLEX; MACROMOLECULES; HYDROLYSIS; ELONGATION; KINETICS; RELEASE; MYOSIN	Actin plays fundamental roles in a variety of cell functions in eukaryotic cells. The polymerization-depolymerization cycle, between monomeric G-actin and fibrous F-actin, drives essential cell processes. Recently, we proposed the atomic model for the F-actin structure and found that actin was in the twisted form in the monomer and in the untwisted form in the filament. To understand how the polymerization process is regulated (Caspar, D. L. (1991) Curr. Biol. 1, 30-32), we need to know further details about the transition from the twisted to the untwisted form. For this purpose, we focused our attention on the Ala-108-Pro-112 loop, which must play crucial roles in the transition, and analyzed the consequences of the amino acid replacements on the polymerization process. As compared with the wild type, the polymerization of P109A was accelerated in both the nucleation and the elongation steps, and this was attributed to an increase in the frequency factor of the Arrhenius equation. The multiple conformations allowed by the substitution presumably resulted in the effective formation of the collision complex, thus accelerating polymerization. On the other hand, the A108G mutation reduced the rates of both nucleation and elongation due to an increase in the activation energy. In the cases of polymerization acceleration and deceleration, each functional aberration is attributed to a distinct elementary process. The rigidity of the loop, which mediates neither too strong nor too weak interactions between subdomains 1 and 3, might play crucial roles in actin polymerization.	[Aihara, Tomoki; Oda, Toshiro] RIKEN SPring 8 Ctr, Xray Struct Anal Team, Sayo, Hyogo 6795148, Japan; [Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Nagoya, Aichi 4648602, Japan; [Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Iwasa, Mitsusada; Aihara, Tomoki; Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro; Oda, Toshiro] Japan Sci & Technol Agcy, RIKEN SPring Ctr 8, ERATO Actin Filament Dynam Project, Sayo, Hyogo 6795148, Japan; [Narita, Akihiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	RIKEN; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); RIKEN; Japan Science & Technology Agency (JST)	Oda, T (corresponding author), RIKEN SPring 8 Ctr, Xray Struct Anal Team, Kouto 1-1, Sayo, Hyogo 6795148, Japan.	toda@spring8.or.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23570200]; JSPS [20227008]; Takeda Science Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 23570200 (to T. O.), JSPS Grant-in-aid for Scientific Research (S) 20227008 (to Y. M. and A. N.), and a special fund from the Takeda Science Foundation (to Y. M.).	Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; CASPAR D L D, 1991, Current Biology, V1, P30, DOI 10.1016/0960-9822(91)90119-H; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W., 2006, PYMOL MOL GRAPHICS S; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KASAI M, 1969, BIOCHIM BIOPHYS ACTA, V180, P399, DOI 10.1016/0005-2728(69)90124-8; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Oosawa F., 1961, PROG THEOR PHYS SUPP, V17, P14; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pavlicek J, 2008, J BIOL CHEM, V283, P14552, DOI 10.1074/jbc.M800593200; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Sano KI, 2002, FEBS LETT, V532, P143, DOI 10.1016/S0014-5793(02)03659-1; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100	29	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43270	43276		10.1074/jbc.M112.392019	http://dx.doi.org/10.1074/jbc.M112.392019			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135274	Green Published, hybrid			2022-12-25	WOS:000312940800008
J	He, YZ; Rhodes, SD; Chen, S; Wu, XH; Yuan, J; Yang, XL; Jiang, L; Li, XQ; Takahashi, N; Xu, MJ; Mohammad, KS; Guise, TA; Yang, FC				He, Yongzheng; Rhodes, Steven D.; Chen, Shi; Wu, Xiaohua; Yuan, Jin; Yang, Xianlin; Jiang, Li; Li, Xianqi; Takahashi, Naoyuki; Xu, Mingjiang; Mohammad, Khalid S.; Guise, Theresa A.; Yang, Feng-Chun			c-Fms Signaling Mediates Neurofibromatosis Type-1 Osteoclast Gain-In-Functions	PLOS ONE			English	Article							BONE-MINERAL-DENSITY; COLONY-STIMULATING FACTOR; MURINE; DIFFERENTIATION; CHILDREN; NF1; MANIFESTATIONS; PROLIFERATION; WORTMANNIN; RESORPTION	Skeletal abnormalities including osteoporosis and osteopenia occur frequently in both pediatric and adult neurofibromatosis type 1 (NF1) patients. NF1 (Nf1) haploinsufficient osteoclasts and osteoclast progenitors derived from both NF1 patients and Nf1(+/-) mice exhibit increased differentiation, migration, and bone resorptive capacity in vitro, mediated by hyperactivation of p21(Ras) in response to limiting concentrations of macrophage-colony stimulating factor (M-CSF). Here, we show that M-CSF binding to its receptor, c-Fms, results in increased c-Fms activation in Nf1(+/-) osteoclast progenitors, mediating multiple gain-in-functions through the downstream effectors Erk1/2 and p90RSK. PLX3397, a potent and selective c-Fms inhibitor, attenuated M-CSF mediated Nf1(+/-) osteoclast migration by 50%, adhesion by 70%, and pit formation by 60%. In vivo, we administered PLX3397 to Nf1(+/-) osteoporotic mice induced by ovariectomy (OVX) and evaluated changes in bone mass and skeletal architecture. We found that PLX3397 prevented bone loss in Nf1(+/-)-OVX mice by reducing osteoclast differentiation and bone resorptive activity in vivo. Collectively, these results implicate the M-CSF/c-Fms signaling axis as a critical pathway underlying the aberrant functioning of Nf1 haploinsufficient osteoclasts and may provide a potential therapeutic target for treating NF1 associated osteoporosis and osteopenia.	[He, Yongzheng; Chen, Shi; Wu, Xiaohua; Yuan, Jin; Yang, Xianlin; Jiang, Li; Xu, Mingjiang; Yang, Feng-Chun] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Rhodes, Steven D.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Li, Xianqi; Takahashi, Naoyuki] Matsumoto Dent Univ, Div Hard Tissue Res, Shiojiri, Nagano, Japan; [Mohammad, Khalid S.; Guise, Theresa A.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Matsumoto Dental University; Indiana University System; Indiana University Bloomington	Yang, FC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA.	fyang@iupui.edu	Mohammad, Khalid/AFE-4205-2022; Mohammad, Khalid/AAE-9569-2022		Department of Defense [NF043032, NF073112]; National Institutes of Health/National Cancer Institute [5R01CA074177]; Indiana Clinical and Translational Sciences Institute Career Development Award PHS NCCR Grant [5TL1RR025759-03]; Children's Tumor Foundation Young Investigator Award [2011-01-010]; NATIONAL CANCER INSTITUTE [R01CA074177] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Indiana Clinical and Translational Sciences Institute Career Development Award PHS NCCR Grant; Children's Tumor Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Department of Defense NF043032 (FCY), NF073112 (FCY) and National Institutes of Health/National Cancer Institute/5R01CA074177 (FCY and DWC), Indiana Clinical and Translational Sciences Institute Career Development Award PHS NCCR Grant No: 5TL1RR025759-03 (SDR), and Children's Tumor Foundation Young Investigator Award 2011-01-010 (SDR). Plexxikon Inc. provided the PLX3397 compound. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanne MH, 2012, J CELL BIOCH; Anthony SP, 2011, J CLIN ONCOL S, P29; BISKOBING DM, 1995, J BONE MINER RES, V10, P1025; Brunetti-Pierri N, 2008, MOL GENET METAB, V94, P105, DOI 10.1016/j.ymgme.2007.12.004; CRAWFORD AH, 1986, J PEDIATR ORTHOPED, V6, P72, DOI 10.1097/01241398-198601000-00015; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dulai S, 2007, J PEDIATR ORTHOPED, V27, P472, DOI 10.1097/01.bpb.0000271310.87997.ae; Elefteriou F, 2009, AM J MED GENET A, V149A, P2327, DOI 10.1002/ajmg.a.33045; Friedman JM, 2002, J CHILD NEUROL, V17, P548, DOI 10.1177/088307380201700802; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; Golden LH, 2004, BONE, V34, P3, DOI 10.1016/j.bone.2003.09.005; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Heerva E, 2012, J BONE MINER RES; Heerva E, 2010, BONE, V47, P583, DOI 10.1016/j.bone.2010.06.001; Hiatt KK, 2001, J BIOL CHEM, V276, P7240, DOI 10.1074/jbc.M009202200; Illes T, 2001, OSTEOPOROSIS INT, V12, P823, DOI 10.1007/s001980170032; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jacques C, 2005, J NEURORADIOLOGY, V32, P180, DOI 10.1016/S0150-9861(05)83136-0; Kuorilehto T, 2005, OSTEOPOROSIS INT, V16, P928, DOI 10.1007/s00198-004-1801-4; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lammert M, 2005, ARCH DERMATOL, V141, P71, DOI 10.1001/archderm.141.1.71; Lammert M, 2005, OSTEOPOROSIS INT, V16, P1161, DOI 10.1007/s00198-005-1940-2; LIGGETT W, 1993, STEM CELLS, V11, P398, DOI 10.1002/stem.5530110507; Mondal R, INDIAN PEDIAT, V47, P881; NAKAMURA I, 1995, FEBS LETT, V361, P79, DOI 10.1016/0014-5793(95)00153-Z; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Palacio S, 2001, EUR J ENDOCRINOL, V144, P431, DOI 10.1530/eje.0.1440431; Pilkington MF, 1998, J BONE MINER RES, V13, P688, DOI 10.1359/jbmr.1998.13.4.688; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Seitz S, 2010, OSTEOPOROSIS INT, V21, P119, DOI 10.1007/s00198-009-0933-y; Stevenson DA, 2006, AM J HUM GENET, V79, P143, DOI 10.1086/504441; Stevenson DA, 2007, J PEDIATR-US, V150, P83, DOI 10.1016/j.jpeds.2006.10.048; Wu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024917; Yan JC, 2008, HUM MOL GENET, V17, P936, DOI 10.1093/hmg/ddm366; Yang FC, 2006, J CLIN INVEST, V116, P2880, DOI 10.1172/JCI29092; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yilmaz K, 2007, ACTA PAEDIATR, V96, P1220, DOI 10.1111/j.1651-2227.2007.00401.x; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhang W, 2011, BONE, V48, P1378, DOI 10.1016/j.bone.2011.03.760	40	14	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e46900	10.1371/journal.pone.0046900	http://dx.doi.org/10.1371/journal.pone.0046900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144792	Green Submitted, Green Published, gold			2022-12-25	WOS:000311935800010
J	Opfer, J; Gottschalk, KE				Opfer, Jan; Gottschalk, Kay-Eberhard			Identifying Discrete States of a Biological System Using a Novel Step Detection Algorithm	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; RECOGNITION EVENTS; CELL-ADHESION; SPECTROSCOPY; LOCALIZATION; DOMAINS	Identification of discrete states is a common task when studying biological systems on microscopic scales. Here, we present a novel step detection algorithm that is ideally suited to locate steplike features separating adjacent plateaus, even if they are smooth and hidden by noise. It can be adjusted to detect very low or narrow steps that cannot be recognized by conventional methods. We demonstrate the applicability of the technique on various experimental data and show strong evidence of sub-10-pN steps in atomic force spectroscopy measurements performed with living lymphocytes.	[Opfer, Jan; Gottschalk, Kay-Eberhard] Univ Ulm, Inst Expt Phys, Ulm, Germany	Ulm University	Gottschalk, KE (corresponding author), Univ Ulm, Inst Expt Phys, Ulm, Germany.	kay.gottschalk@uni-ulm.de	Gottschalk, Kay/D-6503-2012	Gottschalk, Kay/0000-0002-7951-0972	BMBF [03Z2CN11]; German Science Foundation (DFG) [GZ GO 1865/1-1]; IDK-NBT of the Ludwig Maximilians University	BMBF(Federal Ministry of Education & Research (BMBF)); German Science Foundation (DFG)(German Research Foundation (DFG)); IDK-NBT of the Ludwig Maximilians University	The work was funded by the BMBF, Grant Number 03Z2CN11 (ZIK HIKE), by the German Science Foundation (DFG; GZ GO 1865/1-1) and the IDK-NBT of the Ludwig Maximilians University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Bornschlogl T, 2011, METHODS MOL BIOL, V783, P233, DOI 10.1007/978-1-61779-282-3_13; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Brunnbauer M, 2010, P NATL ACAD SCI; Carter BC, 2008, BIOPHYS J, V94, P306, DOI 10.1529/biophysj.107.110601; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fritz J, 1998, FORCE MEDIATED KINET, P12283; Gonzalez R C, 1992, DIGITAL IMAGE PROCES; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Knight AE, 2001, PROG BIOPHYS MOL BIO, V77, P45, DOI 10.1016/S0079-6107(01)00010-4; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rosenthal-Allieri MA, 2005, J IMMUNOL, V175, P1214, DOI 10.4049/jimmunol.175.2.1214; Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0	20	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e45896	10.1371/journal.pone.0045896	http://dx.doi.org/10.1371/journal.pone.0045896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144778	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800002
J	Eitzinger, C; Ehrlenbach, S; Lindner, H; Kremser, L; Gottardi, W; Debabov, D; Anderson, M; Nagl, M; Orth, D				Eitzinger, Christian; Ehrlenbach, Silvia; Lindner, Herbert; Kremser, Leopold; Gottardi, Waldemar; Debabov, Dmitri; Anderson, Mark; Nagl, Markus; Orth, Dorothea			N-Chlorotaurine, a Long-Lived Oxidant Produced by Human Leukocytes, Inactivates Shiga Toxin of Enterohemorrhagic Escherichia coli	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; HUMAN DEFENSE SYSTEM; HUMAN-NEUTROPHILS; TAURINE; MYELOPEROXIDASE; CHLORAMINES; COMPLEMENT; SODIUM; MODEL; SHIGA-TOXIN-2	N-chlorotaurine (NCT), the main representative of long-lived oxidants produced by granulocytes and monocytes, is known to exert broad-spectrum microbicidal activity. Here we show that NCT directly inactivates Shiga toxin 2 (Stx2), used as a model toxin secreted by enterohemorrhagic Escherichia coli (EHEC). Bacterial growth and Stx2 production were both inhibited by 2 mM NCT. The cytotoxic effect of Stx2 on Vero cells was removed by >= 5.5 mM NCT. Confocal microscopy and FACS analyses showed that the binding of Stx2 to human kidney glomerular endothelial cells was inhibited, and no NCT-treated Stx2 entered the cytosol. Mass spectrometry displayed oxidation of thio groups and aromatic amino acids of Stx2 by NCT. Therefore, long-lived oxidants may act as powerful tools of innate immunity against soluble virulence factors of pathogens. Moreover, inactivation of virulence factors may contribute to therapeutic success of NCT and novel analogs, which are in development as topical antiinfectives.	[Eitzinger, Christian; Ehrlenbach, Silvia; Gottardi, Waldemar; Nagl, Markus; Orth, Dorothea] Innsbruck Med Univ, Dept Hyg Microbiol & Social Med, Div Hyg & Med Microbiol, Innsbruck, Austria; [Lindner, Herbert; Kremser, Leopold] Innsbruck Med Univ, Bioctr, Div Clin Biochem, Innsbruck, Austria; [Debabov, Dmitri; Anderson, Mark] NovaBay Pharmaceut Inc, Emeryville, CA USA	Medical University of Innsbruck; Medical University of Innsbruck	Nagl, M (corresponding author), Innsbruck Med Univ, Dept Hyg Microbiol & Social Med, Div Hyg & Med Microbiol, Innsbruck, Austria.	m.nagl@i-med.ac.at		Nagl, Markus/0000-0002-1225-9349; Orth-Holler, Dorothea/0000-0003-2904-5192	NovaBay Pharmaceuticals, Inc., Emeryville, California, United States of America	NovaBay Pharmaceuticals, Inc., Emeryville, California, United States of America	This study was supported by NovaBay Pharmaceuticals, Inc., Emeryville, California, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnitz R, 2006, PROTEOMICS, V6, P865, DOI 10.1002/pmic.200500054; Cole KD, 2008, BIOTECHNOL PROGR, V24, P784, DOI 10.1021/bp070362b; Exeni RA, 2007, THESCIENTIFICWORLDJO, V7, P1155, DOI 10.1100/tsw.2007.172; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Gottardi W, 2005, ARCH PHARM, V338, P473, DOI 10.1002/ardp.200500146; Gottardi W, 2005, ANAL BIOANAL CHEM, V382, P1328, DOI 10.1007/s00216-005-3247-8; Gottardi W, 2005, J ANTIMICROB CHEMOTH, V55, P475, DOI 10.1093/jac/dki054; Gottardi W, 2002, ARCH PHARM, V335, P411, DOI 10.1002/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D; Gottardi W, 2010, J ANTIMICROB CHEMOTH, V65, P399, DOI 10.1093/jac/dkp466; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Inward CD, 1997, PEDIATR NEPHROL, V11, P556, DOI 10.1007/s004670050337; Iovino SM, 2011, INT J CLIN EXP PATHO, V4, P587; Kanayama A, 2002, J BIOL CHEM, V277, P24049, DOI 10.1074/jbc.M110832200; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koprowski M., 2002, CENT EUR J IMMUNOL, V27, P69; Maekawa LE, 2011, J APPL ORAL SCI, V19, P106, DOI 10.1590/S1678-77572011000200005; Marcinkiewicz J, 1997, IMMUNOL TODAY, V18, P577, DOI 10.1016/S0167-5699(97)01161-4; Marcinkiewicz J, 2009, ADV EXP MED BIOL, V643, P439, DOI 10.1007/978-0-387-75681-3_46; Nagl M, 1999, J ANTIMICROB CHEMOTH, V43, P805, DOI 10.1093/jac/43.6.805; Nagl M, 2000, ANTIMICROB AGENTS CH, V44, P2507, DOI 10.1128/AAC.44.9.2507-2513.2000; Nagl M, 2002, ANTIMICROB AGENTS CH, V46, P1996, DOI 10.1128/AAC.46.6.1996-1999.2002; Olszowski S, 1996, ACTA BIOCHIM POL, V43, P661; Orth D, 2010, SEMIN THROMB HEMOST, V36, P620, DOI 10.1055/s-0030-1262883; Orth D, 2009, J IMMUNOL, V182, P6394, DOI 10.4049/jimmunol.0900151; Orth-Holler D, 2011, EMBO MOL MED, V3, P617, DOI 10.1002/emmm.201100169; Park E, 2002, CLIN IMMUNOL, V102, P179, DOI 10.1006/clim.2001.5160; PASSO SA, 1984, BLOOD, V63, P1361; Reeves EP, 2006, J MED MICROBIOL, V55, P913, DOI 10.1099/jmm.0.46405-0; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Sauter KAD, 2008, INFECT IMMUN, V76, P4469, DOI 10.1128/IAI.00592-08; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sobieszek A, 2006, ARCH BIOCHEM BIOPHYS, V454, P197, DOI 10.1016/j.abb.2006.08.004; Taylor HD, 1918, J EXP MED, V27, P375, DOI 10.1084/jem.27.3.375; Wang L, 2008, TETRAHEDRON LETT, V49, P2193, DOI 10.1016/j.tetlet.2008.02.038; Wang L, 2011, ANTIMICROB AGENTS CH, V55, P2688, DOI 10.1128/AAC.00158-11; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Witko Sarsat V, 1995, AM J RESP CRIT CARE, V152, P1910; YANG CY, 1972, APPL MICROBIOL, V24, P885, DOI 10.1128/AEM.24.6.885-890.1972; ZGLICZYNSKI JM, 1971, BIOCHIM BIOPHYS ACTA, V235, P419, DOI 10.1016/0005-2744(71)90281-6; Zhang WL, 2008, J CLIN MICROBIOL, V46, P1292, DOI 10.1128/JCM.02271-07	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47105	10.1371/journal.pone.0047105	http://dx.doi.org/10.1371/journal.pone.0047105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139739	Green Published, gold			2022-12-25	WOS:000311315300005
J	Han, XQ; Li, ZH; Chen, HJ; Wang, HY; Mei, L; Wu, SQ; Zhang, TY; Liu, BH; Lin, XM				Han, Xueqing; Li, Zhihui; Chen, Hongjun; Wang, Huiyu; Mei, Lin; Wu, Shaoqiang; Zhang, Tianyi; Liu, Bohua; Lin, Xiangmei			Influenza Virus A/Beijing/501/2009(H1N1) NS1 Interacts with beta-Tubulin and Induces Disruption of the Microtubule Network and Apoptosis on A549 Cells	PLOS ONE			English	Article							A-VIRUS; POLY(A)-BINDING PROTEIN; IN-VIVO; NUCLEI; INTERFERON; ACTIVATION; INDUCTION; IMPACT; AGENTS; BINDS	NS1 of influenza A virus is a key multifunctional protein that plays various roles in regulating viral replication mechanisms, host innate/adaptive immune responses, and cellular signalling pathways. These functions rely on its ability to participate in a multitude of protein-protein and protein-RNA interactions. To gain further insight into the role of NS1, a tandem affinity purification (TAP) method was utilized to find unknown interaction partner of NS1. The protein complexes of NS1 and its interacting partner were purified from A549 cell using TAP-tagged NS1 as bait, and co-purified cellular factors were identified by mass spectrometry (MS). We identified cellular beta-tubulin as a novel interaction partner of NS1. The RNA-binding domain of NS1 interacts with beta-tubulin through its RNA-binding domain, as judged by a glutathione S-transferase (GST) pull-down assay with the GST-fused functional domains of NS1. Immunofluorescence analysis further revealed that NS1 with beta-tubulin co-localized in the nucleus. In addition, the disruption of the microtubule network and apoptosis were also observed on NS1-transfected A549 cells. Our findings suggest that influenza A virus may utilize its NS1 protein to interact with cellular beta-tubulin to further disrupt normal cell division and induce apoptosis. Future work will illustrate whether this interaction is uniquely specific to the 2009 pandemic H1N1 virus.	[Liu, Bohua] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China; [Han, Xueqing; Li, Zhihui; Chen, Hongjun; Wang, Huiyu; Mei, Lin; Wu, Shaoqiang; Lin, Xiangmei] Chinese Acad Inspect & Quarantine, Beijing, Peoples R China; [Zhang, Tianyi] China Agr Univ, Coll Vet Med, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Inspection & Quarantine; China Agricultural University	Liu, BH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	bhliuamms@yahoo.com.cn; xiangmei8lin@yahoo.com.cn			National Basic Research Program of China (973 Program) [2011CB504704]; Fundamental Research Fund of the Chinese Academy of Inspection and Quarantine [2011JK004]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Fundamental Research Fund of the Chinese Academy of Inspection and Quarantine	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2011CB504704), http://www.973.gov.cn/AreaAppl.aspx, and the Fundamental Research Fund of the Chinese Academy of Inspection and Quarantine (Grant No. 2011JK004), http://www.caiq.gov.cn/jky/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2001, CLIN DIAGN LAB IMMUN, V8, P460, DOI 10.1128/CDLI.8.2.460-464.2001; [Anonymous], FIELDS VIROLOGY; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Falcon AM, 1999, NUCLEIC ACIDS RES, V27, P2241, DOI 10.1093/nar/27.11.2241; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Heald R, 2002, J CELL SCI, V115, P3; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Liao CH, 2005, CARCINOGENESIS, V26, P968, DOI 10.1093/carcin/bgi041; Ludwig S, 1999, VIRAL IMMUNOL, V12, P175, DOI 10.1089/vim.1999.12.175; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Murayama R, 2007, BIOCHEM BIOPH RES CO, V362, P880, DOI 10.1016/j.bbrc.2007.08.091; Nakajima N, 2012, MODERN PATHOL, V25, P1, DOI 10.1038/modpathol.2011.125; Nencioni L, 2009, J BIOL CHEM, V284, P16004, DOI 10.1074/jbc.M900146200; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Rosen DG, 2010, MODERN PATHOL, V23, P1449, DOI 10.1038/modpathol.2010.148; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Tan SL, 1998, J INTERF CYTOK RES, V18, P757, DOI 10.1089/jir.1998.18.757; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Walss C, 1999, CELL MOTIL CYTOSKEL, V42, P274, DOI 10.1002/(SICI)1097-0169(1999)42:4<274::AID-CM2>3.0.CO;2-5; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Wolff T, 1996, J VIROL, V70, P5363, DOI 10.1128/JVI.70.8.5363-5372.1996; Wolff T, 1998, J VIROL, V72, P7170, DOI 10.1128/JVI.72.9.7170-7180.1998; Yang N, 2011, J MOL CELL BIOL, V3, P221, DOI 10.1093/jmcb/mjr017; Yeh IT, 2004, CELL MOTIL CYTOSKEL, V57, P96, DOI 10.1002/cm.10157; Young LS, 1997, BRIT MED BULL, V53, P509; Zhirnov OP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P534, DOI 10.1023/A:1015542110798; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	41	39	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48340	10.1371/journal.pone.0048340	http://dx.doi.org/10.1371/journal.pone.0048340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139776	gold, Green Published, Green Submitted			2022-12-25	WOS:000311315300027
J	Irene, D; Chung, TY; Chen, BJ; Liu, TH; Li, FY; Tzen, JTC; Wang, CI; Chyan, CL				Irene, Deli; Chung, Tse-Yu; Chen, Bo-Jiun; Liu, Ting-Hang; Li, Feng-Yin; Tzen, Jason T. C.; Wang, Cheng-I; Chyan, Chia-Lin			Solution Structure of a Phytocystatin from Ananas comosus and Its Molecular Interaction with Papain	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITOR; 3-DIMENSIONAL SOLUTION STRUCTURE; SECONDARY STRUCTURE ANALYSES; RAY CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION; CYSTATIN SUPERFAMILY; PROTEASE INHIBITOR; ANIMAL CYSTATINS; OCCLUDING LOOP; CELL-DEATH	The structure of a recombinant pineapple cystatin (AcCYS) was determined by NMR with the RMSD of backbone and heavy atoms of twenty lowest energy structures of 0.56 and 1.11 angstrom, respectively. It reveals an unstructured N-terminal extension and a compact inhibitory domain comprising a four-stranded antiparallel beta-sheet wrapped around a central alpha-helix. The three structural motifs (G(45), Q(89)XVXG, and W-120) putatively responsible for the interaction with papain-like proteases are located in one side of AcCYS. Significant chemical shift perturbations in two loop regions, residues 45 to 48 (GIYD) and residues 89 to 91 (QVV), of AcCYS strongly suggest their involvement in the binding to papain, consistent with studies on other members of the cystatin family. However, the highly conserved W120 appears not to be involved in the binding with papain as no chemical shift perturbation was observed. Chemical shift index analysis further indicates that the length of the a-helix is shortened upon association with papain. Collectively, our data suggest that AcCYS undergoes local secondary structural rearrangements when papain is brought into close contact. A molecular model of AcCYS/papain complex is proposed to illustrate the interaction between AcCYS and papain, indicating a complete blockade of the catalytic triad by AcCYS.	[Irene, Deli; Chen, Bo-Jiun; Chyan, Chia-Lin] Natl Dong Hwa Univ, Dept Chem, Hualien, Taiwan; [Chung, Tse-Yu; Liu, Ting-Hang; Tzen, Jason T. C.] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Li, Feng-Yin] Natl Chung Hsing Univ, Dept Chem, Taichung 40227, Taiwan; [Wang, Cheng-I] ASTAR, Singapore Immunol Network, Inst Biomed Sci, Singapore, Singapore	National Dong Hwa University; National Chung Hsing University; National Chung Hsing University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Chyan, CL (corresponding author), Natl Dong Hwa Univ, Dept Chem, Hualien, Taiwan.	chyan@mail.ndhu.edu.tw	Li, Fengyin/AAG-9476-2019		Taiwan National Science Council [NSC-96-2113-M-259-005]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study is supported by Taiwan National Science Council grant NSC-96-2113-M-259-005 to CLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1987, J BIOL CHEM, V262, P16793; Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Arai S, 2002, J AGR FOOD CHEM, V50, P6612, DOI 10.1021/jf0201935; BARRETT AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1363; Belenghi B, 2003, EUR J BIOCHEM, V270, P2593, DOI 10.1046/j.1432-1033.2003.03630.x; Benchabane M, 2010, BIOCHIMIE, V92, P1657, DOI 10.1016/j.biochi.2010.06.006; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALLIS J, 1995, PLANT CELL, V7, P845, DOI 10.1105/tpc.7.7.845; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chu MH, 2011, PLANTA, V234, P243, DOI 10.1007/s00425-011-1398-8; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cornwall GA, 2003, MOL CELL ENDOCRINOL, V200, P1, DOI 10.1016/S0303-7207(02)00408-2; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Girard C, 2007, NEW PHYTOL, V173, P841, DOI 10.1111/j.1469-8137.2007.01968.x; Gutierrez-Campos R, 1999, NAT BIOTECHNOL, V17, P1223, DOI 10.1038/70781; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Higgins D G, 1994, Methods Mol Biol, V25, P307; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Irene D, 2012, BIOMOL NMR ASSIGN, V6, P99, DOI 10.1007/s12104-011-9334-1; Jenko S, 2003, J MOL BIOL, V326, P875, DOI 10.1016/S0022-2836(02)01432-8; Khaznadji E, 2005, INT J PARASITOL, V35, P1115, DOI 10.1016/j.ijpara.2005.05.001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kordis D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-266; Kouzuma Y, 2000, J BIOCHEM, V128, P161, DOI 10.1093/oxfordjournals.jbchem.a022736; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Ljunggren A, 2007, J MOL BIOL, V371, P137, DOI 10.1016/j.jmb.2007.05.005; Margis R, 1998, ARCH BIOCHEM BIOPHYS, V359, P24, DOI 10.1006/abbi.1998.0875; MARTIN JR, 1995, J MOL BIOL, V246, P331, DOI 10.1006/jmbi.1994.0088; Martinez M, 2007, FEBS LETT, V581, P2914, DOI 10.1016/j.febslet.2007.05.042; Nagata K, 2000, BIOCHEMISTRY-US, V39, P14753, DOI 10.1021/bi0006971; Neuteboom LW, 2009, PLANT PHYSIOL, V151, P515, DOI 10.1104/pp.109.142232; Nissen MS, 2009, PLANT CELL, V21, P861, DOI 10.1105/tpc.108.064717; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pace C N, 1986, Methods Enzymol, V131, P266; Pernas M, 2000, FEBS LETT, V467, P206, DOI 10.1016/S0014-5793(00)01157-1; Redzynia I, 2009, FEBS J, V276, P793, DOI 10.1111/j.1742-4658.2008.06824.x; Redzynia I, 2008, J BIOL CHEM, V283, P22815, DOI 10.1074/jbc.M802064200; Renko M, 2010, FEBS J, V277, P4338, DOI 10.1111/j.1742-4658.2010.07824.x; Rigden DJ, 2002, PROTEIN SCI, V11, P1971, DOI 10.1110/ps.0207202; Santos CC, 2005, J CELL SCI, V118, P901, DOI 10.1242/jcs.01677; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shyu DJH, 2004, BIOSCI BIOTECH BIOCH, V68, P1681, DOI 10.1271/bbb.68.1681; Shyu DJH, 2004, J AGR FOOD CHEM, V52, P1350, DOI 10.1021/jf034989v; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; TATE S, 1995, BIOCHEMISTRY-US, V34, P14637, DOI 10.1021/bi00045a004; Turk B, 1997, BIOL CHEM, V378, P141; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Vray B, 2002, CELL MOL LIFE SCI, V59, P1503, DOI 10.1007/s00018-002-8525-4; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Yang AH, 2005, PLANTA, V221, P493, DOI 10.1007/s00425-004-1462-8	55	17	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47865	10.1371/journal.pone.0047865	http://dx.doi.org/10.1371/journal.pone.0047865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139757	Green Published, Green Submitted, gold			2022-12-25	WOS:000311315300015
J	Arechavaleta-Velasco, ME; Alcala-Escamilla, K; Robles-Rios, C; Tsuruda, JM; Hunt, GJ				Arechavaleta-Velasco, Miguel E.; Alcala-Escamilla, Karla; Robles-Rios, Carlos; Tsuruda, Jennifer M.; Hunt, Greg J.			Fine-Scale Linkage Mapping Reveals a Small Set of Candidate Genes Influencing Honey Bee Grooming Behavior in Response to Varroa Mites	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; APIS-MELLIFERA-L.; COLONY LOSSES; POPULATION-GROWTH; NEUREXIN-I; DESTRUCTOR; RESISTANCE; JACOBSONI; HERITABILITY; REPRODUCTION	Populations of honey bees in North America have been experiencing high annual colony mortality for 15-20 years. Many apicultural researchers believe that introduced parasites called Varroa mites (V. destructor) are the most important factor in colony deaths. One important resistance mechanism that limits mite population growth in colonies is the ability of some lines of honey bees to groom mites from their bodies. To search for genes influencing this trait, we used an Illumina Bead Station genotyping array to determine the genotypes of several hundred worker bees at over a thousand single-nucleotide polymorphisms in a family that was apparently segregating for alleles influencing this behavior. Linkage analyses provided a genetic map with 1,313 markers anchored to genome sequence. Genotypes were analyzed for association with grooming behavior, measured as the time that individual bees took to initiate grooming after mites were placed on their thoraces. Quantitative-trait-locus interval mapping identified a single chromosomal region that was significant at the chromosome-wide level (p<.05) on chromosome 5 with a LOD score of 2.72. The 95% confidence interval for quantitative trait locus location contained only 27 genes (honey bee official gene annotation set 2) including Atlastin, Ataxin and Neurexin-1 (AmNrx1), which have potential neurodevelopmental and behavioral effects. Atlastin and Ataxin homologs are associated with neurological diseases in humans. AmNrx1 codes for a presynaptic protein with many alternatively spliced isoforms. Neurexin-1 influences the growth, maintenance and maturation of synapses in the brain, as well as the type of receptors most prominent within synapses. Neurexin-1 has also been associated with autism spectrum disorder and schizophrenia in humans, and self-grooming behavior in mice.	[Tsuruda, Jennifer M.; Hunt, Greg J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Arechavaleta-Velasco, Miguel E.; Robles-Rios, Carlos] Inst Nacl Invest Forestales Agr & Pecuarias, Ajuchitlan, Queretaro, Mexico; [Alcala-Escamilla, Karla] Inst Nacl Invest Forestales Agr & Pecuarias, Etla, Oaxaca, Mexico	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hunt, GJ (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	ghunt@purdue.edu	Alcala Escamilla, Karla Itzel/AAU-5146-2020	Alcala Escamilla, Karla Itzel/0000-0003-3036-1782	USDA-NRI [2008-35302-18803]; Managed Pollinator Coordinated Agricultural Project [USDA-NIFA 2009-8511805718]; CONACYT [SEP-C02-45528]; INIFAP research project [2276977P]	USDA-NRI(United States Department of Agriculture (USDA)); Managed Pollinator Coordinated Agricultural Project; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); INIFAP research project	This research was funded by a USDA-NRI award (2008-35302-18803) and the Managed Pollinator Coordinated Agricultural Project (USDA-NIFA 2009-8511805718) to GJH, and by CONACYT award (SEP-C02-45528) and the INIFAP research project (2276977P) to MEAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andino GK, 2011, APIDOLOGIE, V42, P481, DOI 10.1007/s13592-011-0004-1; Arechavaleta-Velasco ME, 2001, APIDOLOGIE, V32, P157, DOI 10.1051/apido:2001121; Arechavaleta-Velasco ME, 2000, REV VET MEX, V31, P381; Medina-Flores CA, 2011, REV MEX CIENC PECU, V2, P313; Behrens D, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.17; Biswas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009133; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Boecking O, 1999, APIDOLOGIE, V30, P141, DOI 10.1051/apido:19990205; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Currie RW, 2008, CAN J ZOOL, V86, P1059, DOI 10.1139/Z08-083; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Dahle B, 2010, J APICULT RES, V49, P124, DOI 10.3896/IBRA.1.49.1.26; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Danka RG, 2001, MITES HONEY BEE, P117; Dupuis J, 1999, GENETICS, V151, P373; Espinosa L, 2004, PROCCEDINGS OF 11 CO, P79; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Finley J, 1996, AM BEE J, V136, P805; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Guzman-Novoa E, 1999, APIDOLOGIE, V30, P173, DOI 10.1051/apido:19990207; Guzman-Novoa E, 2012, J INVERT PATHOL IN P; Guzman-Novoa E, 2011, VET MEXICO, V42, P149; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hagerman KA, 2009, GENE, V434, P29, DOI 10.1016/j.gene.2008.12.011; Harbo JR, 1999, J ECON ENTOMOL, V92, P261, DOI 10.1093/jee/92.2.261; Harbo JR, 2005, J APICULT RES, V44, P21, DOI 10.1080/00218839.2005.11101141; Harbo JR, 1999, APIDOLOGIE, V30, P183, DOI 10.1051/apido:19990208; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Hunt G. J., 1997, P21; HUNT GJ, 1995, GENETICS, V139, P1371; Hunt GJ, 1998, AM BEE J, V138, P372; Hunt GJ, 1998, GENETICS, V148, P1203; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Ibrahim A, 2006, APIDOLOGIE, V37, P31, DOI 10.1051/apido:2005052; Knight D, 2011, MOL NEUROBIOL, V44, P426, DOI 10.1007/s12035-011-8213-1; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lodesani M, 2002, J APPL ENTOMOL, V126, P130, DOI 10.1046/j.1439-0418.2002.00615.x; McMahon SA, 2011, CURR OPIN NEUROBIOL, V21, P221, DOI 10.1016/j.conb.2010.12.005; Mondragon L, 2006, APIDOLOGIE, V37, P67, DOI 10.1051/apido:2005053; Mondragon L, 2005, APIDOLOGIE, V36, P345, DOI 10.1051/apido:2005022; Moosbeckhofer R., 1997, Apidologie, V28, P193; MORETTO G, 1993, REV BRAS GENET, V16, P71; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Peterson M, 2009, J APICULT RES, V48, P145, DOI 10.3896/IBRA.1.48.2.11; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Reichelt AC, 2011, THE ROLE OF NEUREXIN, DOI 2011.02.024/Neuropharm; Rueppell O, 2004, GENETICS, V167, P1767, DOI 10.1534/genetics.103.021949; Sanford MT, 2001, MITES HONEY BEE, P149; Schafer MO, 2010, J ECON ENTOMOL, V103, P10, DOI 10.1603/EC09233; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stanimirovic Z, 2010, ACTA VET-BEOGRAD, V60, P313, DOI 10.2298/AVB1003313S; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tahmasbi G. H., 2009, Journal of Entomological Society of Iran, V28, P7; Tsuruda JM, 2012, PLOS ONE IN PRESS; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Van Ooijen JW, 2006, JOINMAP VERSION 4 0; Van Ooijen JW, 2004, MAPQTL 5 SOFTWARE FO; Vandame R, 2002, APIDOLOGIE, V33, P433, DOI 10.1051/apido:2002025; Vandame R, 2010, APIDOLOGIE, V41, P243, DOI 10.1051/apido/2010025; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068	72	50	52	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47269	10.1371/journal.pone.0047269	http://dx.doi.org/10.1371/journal.pone.0047269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133594	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400008
J	Coutant, F; Sanchez David, RY; Felix, T; Boulay, A; Caleechurn, L; Souque, P; Thouvenot, C; Bourgouin, C; Beignon, AS; Charneau, P				Coutant, Frederic; Sanchez David, Raul Yusef; Felix, Tristan; Boulay, Aude; Caleechurn, Laxmee; Souque, Philippe; Thouvenot, Catherine; Bourgouin, Catherine; Beignon, Anne-Sophie; Charneau, Pierre			A Nonintegrative Lentiviral Vector-Based Vaccine Provides Long-Term Sterile Protection against Malaria	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; CIRCUMSPOROZOITE PROTEIN; IMMUNE-RESPONSES; DENDRITIC CELLS; PLASMODIUM-BERGHEI; IN-VITRO; RECOMBINANT LENTIVECTOR; GENE-THERAPY; MOUSE MODEL	Trials testing the RTS,S candidate malaria vaccine and radiation-attenuated sporozoites (RAS) have shown that protective immunity against malaria can be induced and that an effective vaccine is not out of reach. However, longer-term protection and higher protection rates are required to eradicate malaria from the endemic regions. It implies that there is still a need to explore new vaccine strategies. Lentiviral vectors are very potent at inducing strong immunological memory. However their integrative status challenges their safety profile. Eliminating the integration step obviates the risk of insertional oncogenesis. Providing they confer sterile immunity, nonintegrative lentiviral vectors (NILV) hold promise as mass pediatric vaccine by meeting high safety standards. In this study, we have assessed the protective efficacy of NILV against malaria in a robust pre-clinical model. Mice were immunized with NILV encoding Plasmodium yoelii Circumsporozoite Protein (Py CSP) and challenged with sporozoites one month later. In two independent protective efficacy studies, 50% (37.5-62.5) of the animals were fully protected (p = 0.0072 and p = 0.0008 respectively when compared to naive mice). The remaining mice with detectable parasitized red blood cells exhibited a prolonged patency and reduced parasitemia. Moreover, protection was long-lasting with 42.8% sterile protection six months after the last immunization (p = 0.0042). Post-challenge CD8+ T cells to CSP, in contrast to anti-CSP antibodies, were associated with protection (r = -0.6615 and p = 0.0004 between the frequency of IFN-g secreting specific T cells in spleen and parasitemia). However, while NILV and RAS immunizations elicited comparable immunity to CSP, only RAS conferred 100% of sterile protection. Given that a better protection can be anticipated from a multi-antigen vaccine and an optimized vector design, NILV appear as a promising malaria vaccine.	[Coutant, Frederic; Sanchez David, Raul Yusef; Felix, Tristan; Boulay, Aude; Caleechurn, Laxmee; Souque, Philippe; Beignon, Anne-Sophie; Charneau, Pierre] Inst Pasteur, Dept Virol, Unite Virol Mol & Vaccinol, Paris, France; [Coutant, Frederic; Sanchez David, Raul Yusef; Felix, Tristan; Boulay, Aude; Caleechurn, Laxmee; Souque, Philippe; Beignon, Anne-Sophie; Charneau, Pierre] CNRS, URA3015, Paris, France; [Thouvenot, Catherine; Bourgouin, Catherine] Inst Pasteur, Dept Parasitol & Mycol, Ctr Prod & Infect Anopheles CEPIA, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Beignon, AS (corresponding author), Fac Med Paris Descartes, Paris, France.	asb@pasteur.fr; pierre.charneau@pasteur.fr	Bourgouin, Catherine/F-1253-2014; Felix, Tristan/H-9546-2017; Coutant, Frederic/P-8401-2015; Coutant, Frederic/J-6336-2019; CHARNEAU, Pierre/M-1565-2017	Bourgouin, Catherine/0000-0002-9209-845X; Felix, Tristan/0000-0002-5331-3153; Coutant, Frederic/0000-0003-2485-5284; CHARNEAU, Pierre/0000-0003-1184-5773; BEIGNON, Anne-Sophie/0000-0003-0863-983X	Institut Pasteur; Centre national de la recherche scientifique (CNRS)	Institut Pasteur(European Commission); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	The Institut Pasteur and the Centre national de la recherche scientifique (CNRS) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2010, BLOOD, V115, P3025, DOI 10.1182/blood-2009-11-253641; Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Bannister LH, 2009, PARASITOLOGY, V136, P1435, DOI 10.1017/S0031182009990734; Baumann JG, 2004, J VIROL, V78, P12537, DOI 10.1128/JVI.78.22.12537-12547.2004; Beignon AS, 2009, J VIROL, V83, P10963, DOI 10.1128/JVI.01284-09; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; Bobadilla S, 2012, GENE THER; Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10; Bruna-Romera O, 2001, P NATL ACAD SCI USA, V98, P11491, DOI 10.1073/pnas.191380898; Buffa V, 2006, VIRAL IMMUNOL, V19, P690, DOI 10.1089/vim.2006.19.690; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Casado JG, 2008, EUR J IMMUNOL, V38, P1867, DOI 10.1002/eji.200737923; Chakravarty S, 2008, INFECT IMMUN, V76, P3628, DOI 10.1128/IAI.00471-08; Chapatte L, 2006, CANCER RES, V66, P5461, DOI 10.1158/0008-5472.CAN-05-4310; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Chattopadhyay R, 2009, VACCINE, V27, P3675, DOI 10.1016/j.vaccine.2008.11.073; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Di Nunzio F, 2012, VACCINE, V30, P2499, DOI 10.1016/j.vaccine.2012.01.089; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Franke ED, 2000, INFECT IMMUN, V68, P3403, DOI 10.1128/IAI.68.6.3403-3411.2000; Furmanov K, 2010, J IMMUNOL, V184, P4889, DOI 10.4049/jimmunol.0903062; Goold HD, 2011, J IMMUNOL, V186, P4565, DOI 10.4049/jimmunol.1002529; Grasso F, 2012, INT J CANC; GRILLOT D, 1990, EUR J IMMUNOL, V20, P1215, DOI 10.1002/eji.1830200604; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Gueirard P, 2010, P NATL ACAD SCI USA, V107, P18640, DOI 10.1073/pnas.1009346107; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hatziioannou T, 2005, J VIROL, V79, P15586, DOI 10.1128/JVI.79.24.15586-15589.2005; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hu BL, 2010, VACCINE, V28, P6675, DOI 10.1016/j.vaccine.2010.08.012; Hu BL, 2009, HUM GENE THER, V20, P1652, DOI 10.1089/hum.2009.012; Iglesias MC, 2007, MOL THER, V15, P1203, DOI 10.1038/sj.mt.6300135; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Karwacz K, 2009, J VIROL, V83, P3094, DOI 10.1128/JVI.02519-08; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kumar KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004480; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Lievens M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-222; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Mauduit M, 2010, INFECT IMMUN, V78, P2182, DOI 10.1128/IAI.01415-09; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Menard R, 2008, TRENDS PARASITOL, V24, P564, DOI 10.1016/j.pt.2008.08.009; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Negri DRM, 2007, MOL THER, V15, P1716, DOI 10.1038/sj.mt.6300241; Negri DRM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/534501; Nganou-Makamdop K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036508; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; Oliveira GA, 2008, INFECT IMMUN, V76, P1200, DOI 10.1128/IAI.00566-07; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Pichlmair A, 2007, J VIROL, V81, P539, DOI 10.1128/JVI.01818-06; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; Rodrigues EG, 1998, VACCINE, V16, P1812, DOI 10.1016/S0264-410X(98)00181-9; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; Rossetti M, 2011, HUM GENE THER, V22, P177, DOI 10.1089/hum.2010.085; Rowe HM, 2006, MOL THER, V13, P310, DOI 10.1016/j.ymthe.2005.08.025; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schmidt NW, 2011, J IMMUNOL, V186, P5873, DOI 10.4049/jimmunol.1100194; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Tervo HM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-58; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; Tsurutani N, 2007, J VIROL, V81, P677, DOI 10.1128/JVI.00870-06; Vargas J, 2004, HUM GENE THER, V15, P361, DOI 10.1089/104303404322959515; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zhu R, 2011, J VIROL, V85, P10201, DOI 10.1128/JVI.00062-11	86	22	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48644	10.1371/journal.pone.0048644	http://dx.doi.org/10.1371/journal.pone.0048644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133649	gold, Green Submitted, Green Published			2022-12-25	WOS:000310702400042
J	Meng, D; Mei, AH; Liu, JX; Kang, XL; Shi, XL; Qian, RZ; Chen, SF				Meng, Dan; Mei, Aihong; Liu, Junxu; Kang, Xueling; Shi, Xianglin; Qian, Ruizhe; Chen, Sifeng			NADPH Oxidase 4 Mediates Insulin-Stimulated HIF-1 alpha and VEGF Expression, and Angiogenesis In Vitro	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; MICROVASCULAR ENDOTHELIAL-CELLS; OXYGEN SPECIES PRODUCTION; GROWTH-FACTOR EXPRESSION; NAD(P)H OXIDASE; SIGNAL-TRANSDUCTION; INDUCED ACTIVATION; FAMILY PROTEINS; NOX4; KINASE	Acute intensive insulin therapy causes a transient worsening of diabetic retinopathy in type 1 diabetes patients and is related to VEGF expression. Reactive oxygen species (ROS) have been shown to be involved in HIF-1 alpha and VEGF expression induced by insulin, but the role of specific ROS sources has not been fully elucidated. In this study we examined the role of NADPH oxidase subunit 4 (Nox4) in insulin-stimulated HIF-1 alpha and VEGF expression, and angiogenic responses in human microvascular endothelial cells (HMVECs). Here we demonstrate that knockdown of Nox4 by siRNA reduced insulin-stimulated ROS generation, the tyrosine phosphorylation of IR-beta and IRS-1, but did not change the serine phosphorylation of IRS-1. Nox4 gene silencing had a much greater inhibitory effect on insulin-induced AKT activation than ERK1/2 activation, whereas it had little effect on the expression of the phosphatases such as MKP-1 and SHIP. Inhibition of Nox4 expression inhibited the transcriptional activity of VEGF through HIF-1. Overexpression of wild-type Nox4 was sufficient to increase VEGF transcriptional activity, and further enhanced insulin-stimulated the activation of VEGF. Downregulation of Nox4 expression decreased insulin-stimulated mRNA and protein expression of HIF-1 alpha, but did not change the rate of HIF-1 alpha degradation. Inhibition of Nox4 impaired insulin-stimulated VEGF expression, cell migration, cell proliferation, and tube formation in HMVECs. Our data indicate that Nox4-derived ROS are essential for HIF-1 alpha-dependent VEGF expression, and angiogenesis in vitro induced by insulin. Nox4 may be an attractive therapeutic target for diabetic retinopathy caused by intensive insulin treatment.	[Meng, Dan; Liu, Junxu; Kang, Xueling; Qian, Ruizhe; Chen, Sifeng] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Mei, Aihong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Diag, Shanghai 200092, Peoples R China; [Shi, Xianglin] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY USA	Fudan University; Tongji University; University of Kentucky	Meng, D (corresponding author), Fudan Univ, Dept Physiol & Pathophysiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	dmeng@fudan.edu.cn	Shi, Xianglin/B-8588-2012; Meng, Dan/K-5955-2018	Chen, Sifeng/0000-0002-9504-5863; Meng, Dan/0000-0001-8588-0235	National Natural Science Foundation of China [81170298, 30600245, 30830050, 30771003]; Shanghai Municipal Health Bureau Grant [c106629]; National Basic Research Program of China [2009CB521900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau Grant; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81170298 and 30600245 to DM, 30830050 and 30771003 to SC), the Shanghai Municipal Health Bureau Grant, c106629 (DM), and the National Basic Research Program of China 2009CB521900 (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Ago T, 2011, CIRC J, V75, P1791, DOI 10.1253/circj.CJ-11-0388; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Biswas S, 2007, AM J PHYSIOL-HEART C, V292, pH758, DOI 10.1152/ajpheart.00718.2006; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Carnesecchi S, 2006, EXP CELL RES, V312, P3413, DOI 10.1016/j.yexcr.2006.07.003; Ceolotto G, 2006, FREE RADICAL BIO MED, V41, P473, DOI 10.1016/j.freeradbiomed.2006.04.015; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Flach RJR, 2010, EXPERT OPIN THER TAR, V14, P1323, DOI 10.1517/14728222.2010.528395; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Jiang ZY, 2003, J BIOL CHEM, V278, P31964, DOI 10.1074/jbc.M303314200; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Meng D, 2007, FREE RADICAL BIO MED, V42, P1651, DOI 10.1016/j.freeradbiomed.2007.01.037; Meng D, 2010, TOXICOL APPL PHARM, V244, P291, DOI 10.1016/j.taap.2010.01.004; Meng D, 2009, TOXICOL LETT, V184, P44, DOI 10.1016/j.toxlet.2008.10.016; Pan YJ, 2012, BIOMATERIALS, V33, P6570, DOI 10.1016/j.biomaterials.2012.05.062; Poulaki V, 2002, J CLIN INVEST, V109, P805, DOI 10.1172/JCI200213776; Schroder K, 2012, CIRC RES; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Tanigaki K, 2009, CIRC RES, V104, P1275, DOI 10.1161/CIRCRESAHA.108.192906; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Wu HX, 2011, GRAEF ARCH CLIN EXP, V249, P1303, DOI 10.1007/s00417-011-1677-x; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Zhou Q, 2007, CARCINOGENESIS, V28, P28, DOI 10.1093/carcin/bgl085	38	60	64	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48393	10.1371/journal.pone.0048393	http://dx.doi.org/10.1371/journal.pone.0048393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144758	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705300068
J	Mijuskovic, M; Brown, SM; Tang, ZJ; Lindsay, CR; Efstathiadis, E; Deriano, L; Roth, DB				Mijuskovic, Martina; Brown, Stuart M.; Tang, Zuojian; Lindsay, Cory R.; Efstathiadis, Efstratios; Deriano, Ludovic; Roth, David B.			A Streamlined Method for Detecting Structural Variants in Cancer Genomes by Short Read Paired-End Sequencing	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; ABL TYROSINE KINASE; C-MYC ONCOGENE; CHROMOSOME; TOOL; TRANSLOCATION; INHIBITOR; ALIGNMENT; GALAXY; DNA	Defining the architecture of a specific cancer genome, including its structural variants, is essential for understanding tumor biology, mechanisms of oncogenesis, and for designing effective personalized therapies. Short read paired-end sequencing is currently the most sensitive method for detecting somatic mutations that arise during tumor development. However, mapping structural variants using this method leads to a large number of false positive calls, mostly due to the repetitive nature of the genome and the difficulty of assigning correct mapping positions to short reads. This study describes a method to efficiently identify large tumor-specific deletions, inversions, duplications and translocations from low coverage data using SVDetect or BreakDancer software and a set of novel filtering procedures designed to reduce false positive calls. Applying our method to a spontaneous T cell lymphoma arising in a core RAG2/p53-deficient mouse, we identified 40 validated tumor-specific structural rearrangements supported by as few as 2 independent read pairs.	[Mijuskovic, Martina; Lindsay, Cory R.; Roth, David B.] Univ Penn, Dept Pathol & Lab Med, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA; [Mijuskovic, Martina; Lindsay, Cory R.; Roth, David B.] Univ Penn, Abramson Family Canc Res Inst, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA; [Brown, Stuart M.; Tang, Zuojian; Efstathiadis, Efstratios] NYU, Ctr Hlth Informat & Bioinformat, Langone Med Ctr, New York, NY USA; [Deriano, Ludovic] Inst Pasteur, Dept Immunol, F-75724 Paris, France; [Deriano, Ludovic] Ctr Natl Rech Sci, URA1961, Paris, France	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; New York University; NYU Langone Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Roth, DB (corresponding author), Univ Penn, Dept Pathol & Lab Med, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA.	David.Roth2@uphs.upenn.edu	Deriano, Ludovic/D-2048-2019	Deriano, Ludovic/0000-0002-9673-9525	National Institutes of Health Roadmap Initiative in Nanomedicine (Nanomedicine Development Center award) [PN1EY018244]; National Institutes of Health [R01CA104588]; National Institutes of Health/National Center for Research Resources [U54 RR024386-01A1]; NATIONAL CANCER INSTITUTE [R01CA104588] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER	National Institutes of Health Roadmap Initiative in Nanomedicine (Nanomedicine Development Center award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the grant PN1EY018244 from the National Institutes of Health Roadmap Initiative in Nanomedicine (Nanomedicine Development Center award) and National Institutes of Health grant R01CA104588 to DBR. SMB and ZT are partially supported by National Institutes of Health/National Center for Research Resources grant U54 RR024386-01A1 (Clinical Translation Science Award) to New York University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blankenberg D, 2010, CURRENT PROTOCOLS MO; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Deriano L, 2011, NATURE, V471, P119, DOI 10.1038/nature09755; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P7581, DOI 10.1073/pnas.80.24.7581; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Hall IM, 2012, METHODS MOL BIOL, V838, P225, DOI 10.1007/978-1-61779-507-7_11; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KONOPKA JB, 1985, P NATL ACAD SCI USA, V82, P1810, DOI 10.1073/pnas.82.6.1810; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Onishi-Seebacher M, 2011, BIOESSAYS, V33, P840, DOI 10.1002/bies.201100075; Quinlan AR, 2012, TRENDS GENET, V28, P43, DOI 10.1016/j.tig.2011.10.002; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; SCHMID CW, 1975, CELL, V6, P345, DOI 10.1016/0092-8674(75)90184-1; Smit A, 1996, REPEATMASKER OPEN 30; STRONG LC, 1981, SCIENCE, V213, P1501, DOI 10.1126/science.7280668; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	36	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48314	10.1371/journal.pone.0048314	http://dx.doi.org/10.1371/journal.pone.0048314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144753	Green Published, gold			2022-12-25	WOS:000310705300063
J	Amuasi, JH; Diap, G; Nguah, SB; Karikari, P; Boakye, I; Jambai, A; Lahai, WK; Louie, KS; Kiechel, JR				Amuasi, John H.; Diap, Graciela; Nguah, Samuel Blay; Karikari, Patrick; Boakye, Isaac; Jambai, Amara; Lahai, Wani Kumba; Louie, Karly S.; Kiechel, Jean-Rene			Access to Artemisinin-Combination Therapy (ACT) and other Anti-Malarials: National Policy and Markets in Sierra Leone	PLOS ONE			English	Article							MEDICINE RETAILER PROGRAMS; KENYA; IMPLEMENTATION; AMODIAQUINE; AFRICA	Malaria remains the leading burden of disease in post-conflict Sierra Leone. To overcome the challenge of anti-malarial drug resistance and improve effective treatment, Sierra Leone adopted artemisinin-combination therapy artesunate-amodiaquine (AS+AQ) as first-line treatment for uncomplicated P. falciparum malaria. Other national policy anti-malarials include artemether-lumefantrine (AL) as an alternative to AS+AQ, quinine and artemether for treatment of complicated malaria; and sulphadoxine-pyrimethamine (SP) for intermittent preventive treatment (IPTp). This study was conducted to evaluate access to national policy recommended anti-malarials. A cross-sectional survey of 127 medicine outlets (public, private and NGO) was conducted in urban and rural areas. The availability on the day of the survey, median prices, and affordability policy and available non-policy anti-malarials were calculated. Anti-malarials were stocked in 79% of all outlets surveyed. AS+AQ was widely available in public medicine outlets; AL was only available in the private and NGO sectors. Quinine was available in nearly two-thirds of public and NGO outlets and over one-third of private outlets. SP was widely available in all outlets. Non-policy anti-malarials were predominantly available in the private outlets. AS+AQ in the public sector was widely offered for free. Among the anti-malarials sold at a cost, the same median price of a course of AS+AQ (US$1.56), quinine tablets (US$0.63), were found in both the public and private sectors. Quinine injection had a median cost of US$0.31 in the public sector and US$0.47 in the private sector, while SP had a median cost of US$0.31 in the public sector compared to US$0.63 in the private sector. Non-policy anti-malarials were more affordable than first-line AS+AQ in all sectors. A course of AS+AQ was affordable at nearly two days' worth of wages in both the public and private sectors.	[Amuasi, John H.] Univ Minnesota, Sch Publ Hlth, PhD Program, Div Hlth Policy & Management, Minneapolis, MN 55455 USA; [Amuasi, John H.; Nguah, Samuel Blay; Karikari, Patrick; Boakye, Isaac] KATH, Kumasi, Ghana; [Diap, Graciela; Kiechel, Jean-Rene] DNDi, Geneva, Switzerland; [Jambai, Amara; Lahai, Wani Kumba] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Louie, Karly S.] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England	University of Minnesota System; University of Minnesota Twin Cities; Kwame Nkrumah University Science & Technology; Ministry of Health & Sanitation Sierra Leone; University of London; London School of Hygiene & Tropical Medicine	Amuasi, JH (corresponding author), Univ Minnesota, Sch Publ Hlth, PhD Program, Div Hlth Policy & Management, Minneapolis, MN 55455 USA.	amuas001@umn.edu	Nguah, Samuel/AAQ-9725-2020	Amuasi, John/0000-0002-8640-2662	Department for International Development (DFID; UK); Dutch Ministry of Foreign Affairs (DGIS; Netherlands); French Development Agency (AFD; France; Medecins Sans Frontieres (Doctors without Borders; International); Spanish Agency for International Development Cooperation (AECID; Spain)	Department for International Development (DFID; UK); Dutch Ministry of Foreign Affairs (DGIS; Netherlands)(Netherlands Government); French Development Agency (AFD; France; Medecins Sans Frontieres (Doctors without Borders; International); Spanish Agency for International Development Cooperation (AECID; Spain)	This work was funded by contributions from Department for International Development (DFID; UK); Dutch Ministry of Foreign Affairs (DGIS; Netherlands); French Development Agency (AFD; France; Medecins Sans Frontieres (Doctors without Borders; International); Spanish Agency for International Development Cooperation (AECID; Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S7; Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; ACTwatch, 2008, BAS OUTL SURV REP DE; Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; Amuasi JH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-34; Checchi F, 2005, TROP MED INT HEALTH, V10, P146, DOI 10.1111/j.1365-3156.2004.01367.x; Diap G, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S1-S1; Ensor T, 2008, REV FINANCING HLTH S; Gelband H, 2007, AM J TROP MED HYG, V77, P219, DOI 10.4269/ajtmh.2007.77.219; McGinnis M, 2011, MEDIA REPORTS MED QU; Medecins Sans Frontieres Holland and Belgium, 2008, FULL PRESCR BETT MAL; Ministry of Health and Sanitation Government of Sierra Leone, 2005, NAT MAL CONTR PROGR; Ministry of Health and Sanitation Government of Sierra Leone, 2007, REP SIERR LEON NAT H; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; O'Conneli K, 2009, AVAILABILITY VOLUMES; Rowa Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-93; Sabot O, 2009, DISCUSSION PAPER DIS; United Nations Development Program, 2009, HUM ENV REP 2009; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2020, REP ANT DRUG EFF RES; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; WHO Regional Office for Africa, 2009, WHO COUNTR COOP STRA; World Bank, 2009, ATLAS METHOD PURCHAS; World Health Organization, COUNTR ANT DRUG POL; World Health Organization, 2009, WORLD MAL REP 2009 A	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47733	10.1371/journal.pone.0047733	http://dx.doi.org/10.1371/journal.pone.0047733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133522	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800015
J	Koenigsknecht, MJ; Lambrecht, JA; Fenlon, LA; Downs, DM				Koenigsknecht, Mark J.; Lambrecht, Jennifer A.; Fenlon, Luke A.; Downs, Diana M.			Perturbations in Histidine Biosynthesis Uncover Robustness in the Metabolic Network of Salmonella enterica	PLOS ONE			English	Article							ESCHERICHIA-COLI; THIAMINE BIOSYNTHESIS; RIBOSE 5-PHOSPHATE; OPERON; FAMILY; PHOSPHORIBOSYLAMINE; CONSTRUCTION; MUTAGENESIS; MUTATIONS; MUTANTS	Phosphoribosylamine (PRA) is an intermediate in the biosynthetic pathway that is common to thiamine and purines. Glutamine phosphoribosyl pyrophosphate (PRPP) amidotransferase is the product of the purF gene in Salmonella enterica and catalyzes the synthesis of PRA from PRPP and glutamine. Strains lacking PurF require exogenous addition of purines for growth. However, under some growth conditions or with specific secondary mutations these strains grow in the absence of exogenous thiamine. Mutant alleles of hisA, which encodes 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino) methylideneamino] imidazole-4-carboxamide (ProFAR) isomerase, allowed PurF-independent PRA formation. The alleles of hisA that suppressed the requirement for exogenous thiamine resulted in proteins with reduced enzymatic activity. Data presented here showed that decreased activity of HisA altered metabolite pools and allowed PRA formation from ProFAR. Possible mechanisms of this conversion were proposed. The results herein emphasize the plasticity of the metabolic network and specifically highlight the potential for chemical syntheses to contribute to network robustness.	[Koenigsknecht, Mark J.; Lambrecht, Jennifer A.; Fenlon, Luke A.; Downs, Diana M.] Univ Wisconsin Madison, Dept Bacteriol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Downs, DM (corresponding author), Univ Wisconsin Madison, Dept Bacteriol, Madison, WI USA.	downs@bact.wisc.edu			National Institutes of Health [GM47296]; University of Wisconsin-Madison Department of Bacteriology; NIH [T32 GM07215]; ASM Undergraduate Research Fellowship; Department of Bacteriology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM047296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison Department of Bacteriology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASM Undergraduate Research Fellowship; Department of Bacteriology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by competitive grant GM47296 from the National Institutes of Health. MJK was partially supported by a pre-doctoral fellowship from the University of Wisconsin-Madison Department of Bacteriology. JAL was supported by NIH training grant T32 GM07215 and a pre-doctoral fellowship from the University of Wisconsin-Madison Department of Bacteriology. LAF was supported by ASM Undergraduate Research Fellowship, and an Undergraduate Research Fellowship from the Department of Bacteriology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Brenner M, 1971, HISTIDINE OPERON ITS, P349; Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; DAVISSON VJ, 1994, J ORG CHEM, V59, P137, DOI 10.1021/jo00080a022; Dougherty MJ, 2006, MICROBIOL-SGM, V152, P2345, DOI 10.1099/mic.0.28926-0; DOWNS DM, 1994, J BACTERIOL, V176, P4858, DOI 10.1128/jb.176.16.4858-4864.1994; ELY B, 1974, GENETICS, V78, P607; EnosBerlage JL, 1996, J BACTERIOL, V178, P1476, DOI 10.1128/jb.178.5.1476-1479.1996; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HARTMAN PE, 1971, ADV GENET, V16, P1, DOI 10.1016/S0065-2660(08)60352-1; Henn-Sax M, 2002, BIOCHEMISTRY-US, V41, P12032, DOI 10.1021/bi026092h; Hong M, 1998, INFECT IMMUN, V66, P4700, DOI 10.1128/IAI.66.10.4700-4710.1998; JOHNSTON HM, 1980, P NATL ACAD SCI-BIOL, V77, P508, DOI 10.1073/pnas.77.1.508; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koenigsknecht MJ, 2007, J BIOL CHEM, V282, P28379, DOI 10.1074/jbc.M704024200; Koenigsknecht MJ, 2010, TRENDS MICROBIOL, V18, P240, DOI 10.1016/j.tim.2010.03.003; Koenigsknecht MJ, 2010, MICROBIOL-SGM, V156, P950, DOI 10.1099/mic.0.033050-0; Lambrecht JA, 2012, CHEM BIOL IN PRESS; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Liao MK, 1997, MICROBIOL-UK, V143, P2903, DOI 10.1099/00221287-143-9-2903; Mac Siomoin R A, 1996, Mol Microbiol, V19, P599, DOI 10.1046/j.1365-2958.1996.405941.x; Maggio-Hall LA, 2003, ORG LETT, V5, P2211, DOI 10.1021/ol034530m; MOYED HS, 1961, J BIOL CHEM, V236, P2261; Ramos I, 2008, J BACTERIOL, V190, P815, DOI 10.1128/JB.00582-07; Roberts GP, 1978, THESIS U CALIFORNIA; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; SHEPPARD DE, 1964, GENETICS, V50, P611; Shuman HA, 2003, NAT REV GENET, V4, P419, DOI 10.1038/nrg1087; SMITH DWE, 1964, J BIOL CHEM, V239, P1848; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X	38	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48207	10.1371/journal.pone.0048207	http://dx.doi.org/10.1371/journal.pone.0048207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133571	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800061
J	Maetzler, W; Tian, YY; Baur, SM; Gauger, T; Odoj, B; Schmid, B; Schulte, C; Deuschle, C; Heck, S; Apel, A; Melms, A; Gasser, T; Berg, D				Maetzler, Walter; Tian, Youyong; Baur, Stephanie Maria; Gauger, Tina; Odoj, Bartholomaeus; Schmid, Benjamin; Schulte, Claudia; Deuschle, Christian; Heck, Susanna; Apel, Anja; Melms, Arthur; Gasser, Thomas; Berg, Daniela			Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; HUMAN APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; AMYLOID-BETA; PARKINSONS-DISEASE; CSF TRANSTHYRETIN; PREALBUMIN; BIOMARKERS; BINDING; ONSET	Parkinson's disease (PD) without (non-demented, PDND) and with dementia (PDD), and dementia with Lewy bodies (DLB) are subsumed under the umbrella term Lewy body disorders (LBD). The main component of the underlying pathologic substrate, i.e. Lewy bodies and Lewy neurites, is misfolded alpha-synuclein (Asyn), and - in particular in demented LBD patients - co-occurring misfolded amyloid-beta (Abeta). Lowered blood and cerebrospinal fluid (CSF) levels of transthyretin (TTR) - a clearance protein mainly produced in the liver and, autonomously, in the choroid plexus - are associated with Abeta accumulation in Alzheimer's disease. In addition, a recent study suggests that TTR is involved in Asyn clearance. We measured TTR protein levels in serum and cerebrospinal fluid of 131 LBD patients (77 PDND, 26 PDD, and 28 DLB) and 72 controls, and compared TTR levels with demographic and clinical data as well as neurodegenerative markers in the CSF. Five single nucleotide polymorphisms of the TTR gene which are considered to influence the ability of the protein to carry its ligands were also analyzed. CSF TTR levels were significantly higher in LBD patients compared to controls. Post-hoc analysis demonstrated that this effect was driven by PDND patients. In addition, CSF TTR levels correlated negatively with CSF Abeta(1-42), total tau and phospho-tau levels. Serum TTR levels did not significantly differ among the studied groups. There were no relevant associations between TTR levels and genetic, demographic and clinical data, respectively. These results suggest an involvement of the clearance protein TTR in LBD pathophysiology, and should motivate to elucidate TTR-related mechanisms in LBD in more detail.	[Maetzler, Walter; Tian, Youyong; Baur, Stephanie Maria; Gauger, Tina; Odoj, Bartholomaeus; Schmid, Benjamin; Schulte, Claudia; Deuschle, Christian; Heck, Susanna; Apel, Anja; Gasser, Thomas; Berg, Daniela] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany; [Maetzler, Walter; Tian, Youyong; Baur, Stephanie Maria; Gauger, Tina; Odoj, Bartholomaeus; Schmid, Benjamin; Schulte, Claudia; Deuschle, Christian; Heck, Susanna; Apel, Anja; Gasser, Thomas; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Maetzler, Walter; Tian, Youyong; Baur, Stephanie Maria; Gauger, Tina; Odoj, Bartholomaeus; Schmid, Benjamin; Schulte, Claudia; Deuschle, Christian; Heck, Susanna; Apel, Anja; Gasser, Thomas; Berg, Daniela] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Melms, Arthur] Univ Tubingen, Gen Neurol Dept, Ctr Neurol, Tubingen, Germany; [Tian, Youyong] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Nanjing Medical University	Maetzler, W (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany.	walter.maetzler@uni-tuebingen.de	Maetzler, Walter/A-6796-2011; Berg, Daniela/A-8728-2019; Gasser, Thomas/GNH-5293-2022; Maetzler, Walter/AAE-5831-2020	Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Gasser, Thomas/0000-0002-1069-1146; Maetzler, Walter/0000-0002-5945-4694; Schulte, Claudia/0000-0003-4006-1265				ARAI H, 1995, ANN NEUROL, V38, P649, DOI 10.1002/ana.410380414; Bohnen NI, 2009, NEUROLOGY, V72, P1411, DOI 10.1212/WNL.0b013e3181a187c6; Bohnen NI, 2011, BRAIN, V134, P2358, DOI 10.1093/brain/awr139; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Buchman AS, 2012, ANN NEUROL, V71, P258, DOI 10.1002/ana.22588; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Carriere I, 2008, J AM GERIATR SOC, V56, P840, DOI 10.1111/j.1532-5415.2008.01677.x; Chiang HL, 2009, CLIN CHIM ACTA, V405, P143, DOI 10.1016/j.cca.2009.04.022; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; Cuenco KT, 2011, NEUROBIOL AGING, V32, P249, DOI 10.1016/j.neurobiolaging.2009.02.014; Deleidi M., 2012, INT J ALZHEIMERS DIS, V2012, P1, DOI [10.1155/2012/391438, DOI 10.1155/2012/391438]; Du JL, 2012, PROTEIN ENG DES SEL, V25, P337, DOI 10.1093/protein/gzs026; ELOVAARA I, 1986, ACTA NEUROL SCAND, V74, P245, DOI 10.1111/j.1600-0404.1986.tb07863.x; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GIBB WRG, 1988, NEUROLOGY, V38, P1402, DOI 10.1212/WNL.38.9.1402; Gloeckner SF, 2008, J ALZHEIMERS DIS, V14, P17; Guerreiro A, 2012, AMYLOID, V19, P74, DOI 10.3109/13506129.2012.668500; Han SH, 2011, J ALZHEIMERS DIS, V25, P77, DOI 10.3233/JAD-2011-102145; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; HATTERER JA, 1993, AM J PSYCHIAT, V150, P813; HIXSON JE, 1990, J LIPID RES, V31, P545; Johnson AM, 2007, CLIN CHEM LAB MED, V45, P419, DOI 10.1515/CCLM.2007.051; Li XY, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-79; Li XY, 2011, J NEUROSCI, V31, P12483, DOI 10.1523/JNEUROSCI.2417-11.2011; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Maetzler W, 2011, J ALZHEIMERS DIS, V27, P119, DOI 10.3233/JAD-2011-110587; Maetzler W, 2011, MOVEMENT DISORD, V26, P176, DOI 10.1002/mds.23358; Maetzler W, 2010, J ALZHEIMERS DIS, V22, P933, DOI 10.3233/JAD-2010-101197; Maetzler W, 2010, J ALZHEIMERS DIS, V19, P937, DOI 10.3233/JAD-2010-1289; Maetzler W, 2009, NEUROBIOL DIS, V34, P107, DOI 10.1016/j.nbd.2008.12.008; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Natunen T, 2012, J ALZHEIMERS DIS, V28, P553, DOI 10.3233/JAD-2011-111109; Olsson M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-130; Pankratz N, 2006, MOVEMENT DISORD, V21, P45, DOI 10.1002/mds.20663; RIISOEN H, 1988, ACTA NEUROL SCAND, V78, P455, DOI 10.1111/j.1600-0404.1988.tb03687.x; Ritchie RF, 1999, J CLIN LAB ANAL, V13, P273, DOI 10.1002/(SICI)1098-2825(1999)13:6<273::AID-JCLA4>3.0.CO;2-X; Roher AE, 2009, BIOMARKERS, V14, P493, DOI 10.3109/13547500903108423; Ruano D, 2007, J PSYCHIATR RES, V41, P667, DOI 10.1016/j.jpsychires.2006.04.003; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; SCHREIBER G, 1990, AM J PHYSIOL, V258, pR338; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; SHIRAHAMA T, 1982, AM J PATHOL, V107, P41; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; TSUZUKI T, 1985, J BIOL CHEM, V260, P2224; Tumani H, 2009, J NEUROIMMUNOL, V214, P109, DOI 10.1016/j.jneuroim.2009.06.012; Velayudhan L, 2012, J ALZHEIMERS DIS, V28, P369, DOI 10.3233/JAD-2011-110611; Vicente Miranda H, 2010, J PATHOL, V221, P13, DOI 10.1002/path.2682; Zhang HL, 2012, ACTA NEUROL SCAND, V125, P129, DOI 10.1111/j.1600-0404.2011.01511.x	54	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48042	10.1371/journal.pone.0048042	http://dx.doi.org/10.1371/journal.pone.0048042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133543	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800034
J	Wang, YH; Zhu, WH; Shu, MY; Jiang, Y; Gallo, RL; Liu, YT; Huang, CM				Wang, Yanhan; Zhu, Wenhong; Shu, Muya; Jiang, Yong; Gallo, Richard L.; Liu, Yu-Tsueng; Huang, Chun-Ming			The Response of Human Skin Commensal Bacteria as a Reflection of UV Radiation: UV-B Decreases Porphyrin Production	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; PROTEIN OXIDATION; ESCHERICHIA-COLI; RELEASE FACTORS; ULTRAVIOLET; FLUORESCENCE; ACID; INACTIVATION; SUPEROXIDE; FOREHEAD	Recent global radiation fears reflect the urgent need for a new modality that can simply determine if people are in a radiation risk of developing cancer and other illnesses. Ultraviolet (UV) radiation has been thought to be the major risk factor for most skin cancers. Although various biomarkers derived from the responses of human cells have been revealed, detection of these biomarkers is cumbersome, probably requires taking live human tissues, and varies significantly depending on human immune status. Here we hypothesize that the reaction of Propionibacterium acnes (P. acnes), a human resident skin commensal, to UV radiation can serve as early surrogate markers for radiation risk because the bacteria are immediately responsive to radiation. In addition, the bacteria can be readily accessible and exposed to the same field of radiation as human body. To test our hypothesis, P. acnes was exposed to UV-B radiation. The production of porphyrins in P. acnes was significantly reduced with increasing doses of UV-B. The porphyrin reduction can be detected in both P. acnes and human skin bacterial isolates. Exposure of UV-B to P. acnes-inoculated mice led to a significant decrease in porphyrin production in a single colony of P. acnes and simultaneously induced the formation of cyclobutane pyrimidine dimers (CPD) in the epidermal layers of mouse skin. Mass spectrometric analysis via a linear trap quadrupole (LTQ)-Orbitrap XL showed that five peptides including an internal peptide (THLPTGIVVSCQNER) of a peptide chain release factor 2 (RF2) were oxidized by UV-B. Seven peptides including three internal peptides of 60 kDa chaperonin 1 were de-oxidized by UV-B. When compared to UV-B, gamma radiation also decreased the porphyrin production of P. acnes in a dose-dependent manner, but induced a different signature of protein oxidation/de-oxidation. We highlight that uncovering response of skin microbiome to radiation will facilitate the development of pre-symptomatic diagnosis of radiation risk in a battlefield exposure, nuclear accidents, terrorist attacks, or cancer imaging/therapy.	[Liu, Yu-Tsueng; Huang, Chun-Ming] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Wang, Yanhan; Shu, Muya; Gallo, Richard L.; Huang, Chun-Ming] Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA; [Zhu, Wenhong] Sanford Burnham Inst Med Res, La Jolla, CA USA; [Jiang, Yong] Surface Bioadv Inc, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Liu, YT (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	ytliu@ucsd.edu; chunming@ucsd.ed	Gallo, Richard L/A-8931-2009; , Chun-Ming/AAM-1856-2020	Gallo, Richard L/0000-0002-1401-7861; , Chun-Ming/0000-0002-3352-5394	National Institutes of Health [1R21AI088147-01, R01-AI067395-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083358, R01AI067395, R21AI088147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants (1R21AI088147-01 and R01-AI067395-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso SG, 1999, BRAZ J MED BIOL RES, V32, P255, DOI 10.1590/S0100-879X1999000300002; Ahn CY, 1996, PLAST RECONSTR SURG, V98, P1225, DOI 10.1097/00006534-199612000-00016; Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; [Anonymous], DERMATOL GENET MED; Astner S, 2004, J INVEST DERMATOL, V122, pXXX, DOI 10.1046/j.1523-1747.2003.22251.x; BROOK I, 1991, REV INFECT DIS, V13, P819; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Daly Michael J, 2007, PLoS Biol, V5, pe92; Darras-Vercambre S, 2006, PHOTODERMATOL PHOTO, V22, P153, DOI 10.1111/j.1600-0781.2006.00211.x; de Gruijl FR, 2002, EXP DERMATOL, V11, P37, DOI 10.1034/j.1600-0625.11.s.1.9.x; EVANS CA, 1975, J INVEST DERMATOL, V64, P42, DOI 10.1111/1523-1747.ep12540897; EVANS CA, 1984, J INVEST DERMATOL, V82, P294, DOI 10.1111/1523-1747.ep12260391; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; FREEMAN SE, 1986, J INVEST DERMATOL, V86, P34, DOI 10.1111/1523-1747.ep12283768; Greinert R, 2009, PATHOBIOLOGY, V76, P64, DOI 10.1159/000201675; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Guffey JS, 2006, PHOTOMED LASER SURG, V24, P684, DOI 10.1089/pho.2006.24.684; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; JACOBS NJ, 1969, J BACTERIOL, V99, P37, DOI 10.1128/JB.99.1.37-41.1969; JACOBS NJ, 1970, J BACTERIOL, V102, P398, DOI 10.1128/JB.102.2.398-403.1970; JOHNSSON A, 1987, ARCH DERMATOL RES, V279, P190, DOI 10.1007/BF00413256; KAWAKAMI K, 1990, P NATL ACAD SCI USA, V87, P8432, DOI 10.1073/pnas.87.21.8432; Kimura H, 2000, CELL BIOL INT, V24, P459, DOI 10.1006/cbir.2000.0513; KJELDSTAD B, 1987, PHOTOCHEM PHOTOBIOL, V46, P363, DOI 10.1111/j.1751-1097.1987.tb04782.x; Koenig K, 1994, J Fluoresc, V4, P17, DOI 10.1007/BF01876650; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Lee JS, 1997, J PROTEIN CHEM, V16, P283, DOI 10.1023/A:1026305025816; Leyden JJ, 1998, DERMATOLOGY, V196, P55, DOI 10.1159/000017868; LIN WS, 1987, BIOCHEM BIOPH RES CO, V147, P778, DOI 10.1016/0006-291X(87)90998-3; MCGINLEY KJ, 1980, BRIT J DERMATOL, V102, P437, DOI 10.1111/j.1365-2133.1980.tb06557.x; MCGINLEY KJ, 1978, APPL ENVIRON MICROB, V35, P62, DOI 10.1128/AEM.35.1.62-66.1978; MELO TB, 1986, Z NATURFORSCH C, V41, P867; Miura Yuriko, 2010, Journal of Medical and Dental Sciences, V57, P65; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Nakatsuji T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001551; Nakatsuji T, 2009, J INVEST DERMATOL, V129, P2480, DOI 10.1038/jid.2009.93; Nitzan Y, 2004, PHOTOCH PHOTOBIO SCI, V3, P430, DOI 10.1039/b315633h; Nitzan Y, 1999, LASER MED SCI, V14, P269, DOI 10.1007/s101030050094; PATHAK MA, 1982, J AM ACAD DERMATOL, V7, P285, DOI 10.1016/S0190-9622(82)70117-3; Ramstad S, 2006, PHOTOCH PHOTOBIO SCI, V5, P66, DOI 10.1039/b512837d; Ramstad S, 1997, J PHOTOCH PHOTOBIO B, V40, P141, DOI 10.1016/S1011-1344(97)00039-0; Romiti R, 2000, ARCH DERMATOL RES, V292, P320, DOI 10.1007/s004030000122; SADAIE Y, 1991, GENE, V98, P101; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Spickett CM, 2010, AMINO ACIDS; Tadokoro T, 2003, FASEB J, V17, P1177, DOI 10.1096/fj.02-0865fje; Talbott EO, 1995, INTRO ENV EPIDEMIOLO; Tang MS, 2010, FUTURE ONCOL, V6, P1523, DOI [10.2217/fon.10.129, 10.2217/FON.10.129]; Tsimikas S, 2002, AM J CARDIOL, V90, p22L, DOI 10.1016/S0002-9149(02)02958-2; Valcu CM, 2006, PROTEOMICS, V6, P4166, DOI 10.1002/pmic.200500660; Verdonschot E H, 2002, Ned Tijdschr Tandheelkd, V109, P122; Vink AA, 2001, J PHOTOCH PHOTOBIO B, V65, P101, DOI 10.1016/S1011-1344(01)00245-7; Wolfrum EJ, 2002, ENVIRON SCI TECHNOL, V36, P3412, DOI 10.1021/es011423j; Yamada M, 2006, ARCH DERMATOL RES, V297, P294, DOI 10.1007/s00403-005-0618-0; Youn SW, 2009, SKIN RES TECHNOL, V15, P230, DOI 10.1111/j.1600-0846.2009.00360.x	58	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47798	10.1371/journal.pone.0047798	http://dx.doi.org/10.1371/journal.pone.0047798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133525	Green Submitted, gold, Green Published			2022-12-25	WOS:000310261800018
J	Zeng, FN; Wind, N; Mcclenaghan, C; Verkuyl, JM; Watson, RP; Nash, MS				Zeng, Fanning; Wind, Nicholas; Mcclenaghan, Conor; Verkuyl, J. Martin; Watson, Robert P.; Nash, Mark S.			GPR39 Is Coupled to TMEM16A in Intestinal Fibroblast-Like Cells	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; ACTIVATED CHLORIDE CHANNEL; INTERSTITIAL-CELLS; RECEPTOR; EXPRESSION; ANOCTAMINS; INHIBITORS; SECRETION; OBESTATIN; MOTILIN	GPR39 is a GPCR implicated as a regulator of gastrointestinal motility, although the mechanism remains elusive. Here, we report that GPR39 is expressed by a specific cell population cultured from mouse small intestine muscle layers, which was subsequently identified as fibroblast-like cells (FLCs) that have recently been shown to modulate gut motility. Application of the GPR39 agonist, Zn2+, induced large currents and membrane depolarization in FLCs cultured from wild-type mice, but not Gpr39(-/-) mice. This Zn2+-induced current could be suppressed by application of a TMEM16A antagonist, CaCCinh-A01, or by silencing Tmem16a expression. These data suggest that GPR39 might modulate gut motility via regulating TMEM16A function in FLCs.	[Zeng, Fanning; Wind, Nicholas; Mcclenaghan, Conor; Verkuyl, J. Martin; Watson, Robert P.; Nash, Mark S.] Novartis Horsham Res Ctr, Gastrointestinal Dis Area, Horsham, W Sussex, England	Novartis	Zeng, FN (corresponding author), Novartis Pharma AG, Musculoskeletal Dis Area, Novartis Inst BioMed Res, Basel, Switzerland.	fanning.zeng@novartis.com		McClenaghan, Conor/0000-0002-0859-3854; Verkuyl, J. Martin/0000-0003-4115-6506				Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Feighner SD, 1999, SCIENCE, V284, P2184, DOI 10.1126/science.284.5423.2184; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huizinga JD, 2009, AM J PHYSIOL-GASTR L, V296, pG1, DOI 10.1152/ajpgi.90380.2008; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Iino S, 2009, HISTOCHEM CELL BIOL, V131, P691, DOI 10.1007/s00418-009-0580-6; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Kurahashi M, 2011, J PHYSIOL-LONDON, V589, P697, DOI 10.1113/jphysiol.2010.201129; Lauwers E, 2006, BIOCHEM BIOPH RES CO, V351, P21, DOI 10.1016/j.bbrc.2006.09.141; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; McKee KK, 1997, GENOMICS, V46, P426, DOI 10.1006/geno.1997.5069; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; PEETERS TL, 1992, GASTROENTEROLOGY, V102, P97, DOI 10.1016/0016-5085(92)91788-6; Pieri L, 2008, J CELL MOL MED, V12, P1944, DOI 10.1111/j.1582-4934.2008.00461.x; Popovics P, 2011, CELL MOL LIFE SCI, V68, P85, DOI 10.1007/s00018-010-0517-1; Sharir H, 2010, J BIOL CHEM, V285, P26097, DOI 10.1074/jbc.M110.107490; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; Tremblay F, 2009, ENDOCRINOLOGY, V150, P2586, DOI 10.1210/en.2008-1251; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Xie FJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-86; Zeng FN, 2010, GASTROENTEROLOGY, V138, P1491, DOI 10.1053/j.gastro.2009.11.048; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhu MH, 2011, J PHYSIOL-LONDON, V589, P4565, DOI 10.1113/jphysiol.2011.211094	27	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47686	10.1371/journal.pone.0047686	http://dx.doi.org/10.1371/journal.pone.0047686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133519	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800012
J	Alfadhli, A; McNett, H; Eccles, J; Tsagli, S; Noviello, C; Sloan, R; Lopez, CS; Peyton, DH; Barklis, E				Alfadhli, Ayna; McNett, Henry; Eccles, Jacob; Tsagli, Seyram; Noviello, Colleen; Sloan, Rachel; Lopez, Claudia S.; Peyton, David H.; Barklis, Eric			Analysis of Small Molecule Ligands Targeting the HIV-1 Matrix Protein-RNA Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR-LOCALIZATION SIGNAL; MEMBRANE-BINDING; ENVELOPE PROTEIN; PLASMA-MEMBRANE; BASIC DOMAIN; GAG PROTEINS; REPLICATION; ASSOCIATION; MUTATIONS	The matrix domain (MA) of the HIV-1 precursor Gag (PrGag) protein directs PrGag proteins to assembly sites at the plasma membrane by virtue of its affinity to the phospholipid, phosphatidylinositol-4,5-bisphosphate (PI(4,5)P-2). MA also binds to RNA at a site that overlaps its PI(4,5)P-2 site, suggesting that RNA binding may protect MA from associating with inappropriate cellular membranes prior to PrGag delivery to the PM. Based on this, we have developed an assay in which small molecule competitors to MA-RNA binding can be characterized, with the assumption that such compounds might interfere with essential MA functions and help elucidate additional features of MA binding. Following this approach, we have identified four compounds, including three thiadiazolanes, that compete with RNA for MA binding. We also have identified MA residues involved in thiadiazolane binding and found that they overlap the MA PI(4,5)P-2 and RNA sites. Cell culture studies demonstrated that thiadiazolanes inhibit HIV-1 replication but are associated with significant levels of toxicity. Nevertheless, these observations provide new insights into MA binding and pave the way for the development of antivirals that target the HIV-1 matrix domain.	[Alfadhli, Ayna; McNett, Henry; Eccles, Jacob; Tsagli, Seyram; Noviello, Colleen; Sloan, Rachel; Lopez, Claudia S.; Barklis, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Alfadhli, Ayna; McNett, Henry; Eccles, Jacob; Tsagli, Seyram; Noviello, Colleen; Sloan, Rachel; Lopez, Claudia S.; Barklis, Eric] Oregon Hlth & Sci Univ, Dept Microbiol, Portland, OR 97201 USA; [Peyton, David H.] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Oregon Health & Science University; Oregon Health & Science University; Portland State University	Alfadhli, A (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	alfadhli@ohsu.edu; barklis@ohsu.edu	Lopez, Claudia/GXN-1686-2022	ECCLES, Jacob/0000-0002-4202-0355; Peyton, David/0000-0001-5828-055X	National Institutes of Health [GM060170, GM101983, AI071798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101983, R01GM060170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060170, GM101983, and AI071798 (to E. B.).	Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2005, J VIROL, V79, P14498, DOI 10.1128/JVI.79.23.14498-14506.2005; Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Barklis E, 2009, J MOL BIOL, V387, P376, DOI 10.1016/j.jmb.2009.01.058; Bhatia AK, 2007, VIROLOGY, V369, P47, DOI 10.1016/j.virol.2007.06.046; Bouamr F, 2003, BIOCHEMISTRY-US, V42, P6408, DOI 10.1021/bi020692z; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Cai ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015675; Chang CY, 2008, VIROLOGY, V378, P97, DOI 10.1016/j.virol.2008.05.010; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Coffin J. M., 1997, P335; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dalton AK, 2007, J VIROL, V81, P6434, DOI 10.1128/JVI.02757-06; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ehrlich LS, 1996, BIOCHEMISTRY-US, V35, P3933, DOI 10.1021/bi952337x; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Jones CP, 2011, J VIROL, V85, P1594, DOI 10.1128/JVI.01809-10; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Lochrie MA, 1997, NUCLEIC ACIDS RES, V25, P2902, DOI 10.1093/nar/25.14.2902; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; MERVIS RJ, 1988, J VIROL, V62, P3993, DOI 10.1128/JVI.62.11.3993-4002.1988; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; MOLDT P, 1988, AGENTS ACTIONS, V24, P35, DOI 10.1007/BF01968077; Monde K, 2011, J VIROL, V85, P3584, DOI 10.1128/JVI.02266-10; Moreno S, 2010, J ANTIMICROB CHEMOTH, V65, P827, DOI 10.1093/jac/dkq061; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Noviello CM, 2011, J VIROL, V85, P4730, DOI 10.1128/JVI.00099-11; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Resh MD, 2004, P NATL ACAD SCI USA, V101, P417, DOI 10.1073/pnas.0308043101; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Scarlata S, 1998, J MOL BIOL, V277, P161, DOI 10.1006/jmbi.1997.1615; Scholz I, 2008, VIROLOGY, V371, P322, DOI 10.1016/j.virol.2007.10.010; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Smith U, 2001, INT J CLIN PRACT, P13; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Swanstrom R., 1997, P263; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; WANG CT, 1993, J VIROL, V67, P7067, DOI 10.1128/JVI.67.12.7067-7076.1993; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou J, 2005, J MOL BIOL, V349, P976, DOI 10.1016/j.jmb.2005.04.046; Zuber G, 2000, J VIROL, V74, P7431, DOI 10.1128/JVI.74.16.7431-7441.2000	73	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					666	676		10.1074/jbc.M112.399865	http://dx.doi.org/10.1074/jbc.M112.399865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23135280	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000313197200067
J	Jung, JH; Seo, PJ; Park, CM				Jung, Jae-Hoon; Seo, Pil Joon; Park, Chung-Mo			The E3 Ubiquitin Ligase HOS1 Regulates Arabidopsis Flowering by Mediating CONSTANS Degradation Under Cold Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLORAL INDUCTION; FT PROTEIN; TEMPERATURE PERCEPTION; AMBIENT-TEMPERATURE; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; GENE-EXPRESSION; DISTINCT ROLES; LOCUS-T; TIME	The timing of flowering is coordinated by a web of gene regulatory networks that integrates developmental and environmental cues in plants. Light and temperature are two major environmental determinants that regulate flowering time. Although prolonged treatment with low nonfreezing temperatures accelerates flowering by stable repression of FLOWERING LOCUS C (FLC), repeated brief cold treatments delay flowering. Here, we report that intermittent cold treatments trigger the degradation of CONSTANS (CO), a central activator of photoperiodic flowering; daily treatments caused suppression of the floral integrator FLOWERING LOCUS T (FT) and delayed flowering. Cold-induced CO degradation is mediated via a ubiquitin/proteasome pathway that involves the E3 ubiquitin ligase HIGH EXPRESSION OF OSMOTICALLY RESPONSIVE GENE 1 (HOS1). HOS1-mediated CO degradation occurs independently of the well established cold response pathways. It is also independent of the light signaling repressor CONSTITUTIVE PHOTOMORPHOGENIC 1 (COP1) E3 ligase and light wavelengths. CO has been shown to play a key role in photoperiodic flowering. Here, we demonstrated that CO served as a molecular hub, integrating photoperiodic and cold stress signals into the flowering genetic pathways. We propose that the HOS1-CO module contributes to the fine-tuning of photoperiodic flowering under short term temperature fluctuations, which often occur during local weather disturbances.	[Jung, Jae-Hoon; Park, Chung-Mo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Seo, Pil Joon] Chonbuk Natl Univ, Dept Chem, Jeonju 561756, South Korea; [Park, Chung-Mo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151742, South Korea	Seoul National University (SNU); Jeonbuk National University; Seoul National University (SNU)	Park, CM (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea.	cmpark@snu.ac.kr	Seo, Pil Joon/AAR-9426-2020; Park, Chung-Mo/B-6175-2012		National Research Foundation of Korea [20120005600]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) from the Rural Development Administration [201203013055290010200]; Agricultural R & D Promotion Center from the Korea Ministry for Food, Agriculture, Forestry and Fisheries [309017-05-4-HD140]	National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) from the Rural Development Administration; Agricultural R & D Promotion Center from the Korea Ministry for Food, Agriculture, Forestry and Fisheries	This work was supported by Leaping Research Program Grant 20120005600 from the National Research Foundation of Korea, the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center Grant 201203013055290010200) from the Rural Development Administration, and Agricultural R & D Promotion Center Grant 309017-05-4-HD140 from the Korea Ministry for Food, Agriculture, Forestry and Fisheries.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Davis SJ, 2002, CURR BIOL, V12, pR841, DOI 10.1016/S0960-9822(02)01348-9; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; Foreman J, 2011, PLANT J, V65, P441, DOI 10.1111/j.1365-313X.2010.04434.x; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hong SY, 2011, J BIOL CHEM, V286, P1659, DOI 10.1074/jbc.M110.167692; Ishitani M, 1998, PLANT CELL, V10, P1151, DOI 10.1105/tpc.10.7.1151; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Lazaro A, 2012, PLANT CELL, V24, P982, DOI 10.1105/tpc.110.081885; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Liu LJ, 2008, PLANT CELL, V20, P292, DOI 10.1105/tpc.107.057281; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Miura K, 2011, PLANT J, V67, P269, DOI 10.1111/j.1365-313X.2011.04589.x; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	51	65	75	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43277	43287		10.1074/jbc.M112.394338	http://dx.doi.org/10.1074/jbc.M112.394338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135282	hybrid, Green Published			2022-12-25	WOS:000312940800009
J	Orr, AL; Quinlan, CL; Perevoshchikova, IV; Brand, MD				Orr, Adam L.; Quinlan, Casey L.; Perevoshchikova, Irina V.; Brand, Martin D.			A Refined Analysis of Superoxide Production by Mitochondrial sn-Glycerol 3-Phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED GLYCEROL-3-PHOSPHATE DEHYDROGENASE; PIG BRAIN MITOCHONDRIA; GLYCEROPHOSPHATE DEHYDROGENASE; PHOSPHATE DEHYDROGENASE; ALPHA-GLYCEROPHOSPHATE; MAMMALIAN-CELLS; SKELETAL-MUSCLE; L-3-GLYCEROPHOSPHATE DEHYDROGENASE; DROSOPHILA MITOCHONDRIA; ELECTRON-TRANSPORT	The oxidation of sn-glycerol 3-phosphate by mitochondrial sn-glycerol 3-phosphate dehydrogenase (mGPDH) is a major pathway for transfer of cytosolic reducing equivalents to the mitochondrial electron transport chain. It is known to generate H2O2 at a range of rates and from multiple sites within the chain. The rates and sites depend upon tissue source, concentrations of glycerol 3-phosphate and calcium, and the presence of different electron transport chain inhibitors. We report a detailed examination of H2O2 production during glycerol 3-phosphate oxidation by skeletal muscle, brown fat, brain, and heart mitochondria with an emphasis on conditions under which mGPDH itself is the source of superoxide and H2O2. Importantly, we demonstrate that a substantial portion of H2O2 production commonly attributed to mGPDH originates instead from electron flow through the ubiquinone pool into complex II. When complex II is inhibited and mGPDH is the sole superoxide producer, the rate of superoxide production depends on the concentrations of glycerol 3-phosphate and calcium and correlates positively with the predicted reduction state of the ubiquinone pool. mGPDH-specific superoxide production plateaus at a rate comparable with the other major sites of superoxide production in mitochondria, the superoxide-producing center shows no sign of being overreducible, and the maximum superoxide production rate correlates with mGPDH activity in four different tissues. mGPDH produces superoxide approximately equally toward each side of the mitochondrial inner membrane, suggesting that the Q-binding pocket of mGPDH is the major site of superoxide generation. These results clarify the maximum rate and mechanism of superoxide production by mGPDH.	[Orr, Adam L.; Quinlan, Casey L.; Perevoshchikova, Irina V.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Orr, AL (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	aorr@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153	National Institutes of Health [R01 AG033542, TL1 AG032116]; Ellison Medical Foundation [AG-SS-2288-09]; NATIONAL INSTITUTE ON AGING [TL1AG032116, R01AG033542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG033542 and TL1 AG032116 (to C. L. Q.). This work was also supported by Ellison Medical Foundation Grant AG-SS-2288-09.	Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; Bruneau JM, 1998, BIOCHEM J, V336, P299, DOI 10.1042/bj3360299; Chowdhury SKR, 2007, FREE RADICAL RES, V41, P1116, DOI 10.1080/10715760701579314; COLE ES, 1978, J BIOL CHEM, V253, P7952; COTTINGHAM IR, 1980, BIOCHEM J, V192, P9, DOI 10.1042/bj1920009; Daoud H, 2009, HUM GENET, V124, P649, DOI 10.1007/s00439-008-0588-3; DAWSON AP, 1969, BIOCHEM J, V111, P27, DOI 10.1042/bj1110027; Dummler K, 1996, BIOCHEM J, V317, P913; FELLENIU.E, 1973, ACTA CHEM SCAND, V27, P2361, DOI 10.3891/acta.chem.scand.27-2361; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GARRIB A, 1986, J BIOL CHEM, V261, P8042; Gudayol M, 2001, ENDOCRINE, V16, P39, DOI 10.1385/ENDO:16:1:39; Halliwell B., 2007, FREE RADICAL BIO MED, P241; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; HUNT SM, 1970, CANCER RES, V30, P1764; Jackman MR, 1996, AM J PHYSIOL-CELL PH, V270, pC673, DOI 10.1152/ajpcell.1996.270.2.C673; JOHNSON MA, 1984, Q J EXP PHYSIOL CMS, V69, P257, DOI 10.1113/expphysiol.1984.sp002804; Kempf L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000252; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; KOPP SJ, 1984, J NEUROCHEM, V43, P1716, DOI 10.1111/j.1471-4159.1984.tb06100.x; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Linden DR, 2012, BRIT J PHARMACOL, V165, P2178, DOI 10.1111/j.1476-5381.2011.01681.x; MacDonald MJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P79, DOI 10.1006/abbi.1996.0049; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; MACDONALD MJ, 1990, CANCER RES, V50, P7203; MacDonald MJ, 2000, ARCH BIOCHEM BIOPHYS, V384, P143, DOI 10.1006/abbi.2000.2107; MEINHARDT SW, 1983, BIOCHIM BIOPHYS ACTA, V723, P219, DOI 10.1016/0005-2728(83)90121-4; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Mookerjee SA, 2011, BBA-BIOENERGETICS, V1807, P1474, DOI 10.1016/j.bbabio.2011.07.011; Mracek T, 2009, ARCH BIOCHEM BIOPHYS, V481, P30, DOI 10.1016/j.abb.2008.10.011; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nguyen NHT, 2007, J NEUROCHEM, V101, P1694, DOI 10.1111/j.1471-4159.2006.04433.x; Novials A, 1997, BIOCHEM BIOPH RES CO, V231, P570, DOI 10.1006/bbrc.1997.6147; Oelkrug R, 2010, J BIOL CHEM, V285, P21961, DOI 10.1074/jbc.M110.122861; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; PERON FG, 1974, CANCER RES, V34, P2711; Quinlan CL, 2008, AM J PHYSIOL-HEART C, V295, pH953, DOI 10.1152/ajpheart.00520.2008; Quinlan CL, 2012, FREE RADICAL BIO MED, V53, P1807, DOI 10.1016/j.freeradbiomed.2012.08.015; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; St-Pierre J, 2001, MOL GENET METAB, V72, P209, DOI 10.1006/mgme.2000.3144; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Tretter L, 2007, J NEUROSCI RES, V85, P3471, DOI 10.1002/jnr.21405; Tretter L, 2007, J NEUROCHEM, V100, P650, DOI 10.1111/j.1471-4159.2006.04223.x; URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x; Weitzel JM, 2000, BIOL CHEM, V381, P611, DOI 10.1515/BC.2000.078; Weitzel JM, 2003, BIOL REPROD, V68, P699, DOI 10.1095/biolreprod.102.008540; Weitzel JM, 2001, EUR J BIOCHEM, V268, P4095, DOI 10.1046/j.1432-1327.2001.02332.x; WERNETTE ME, 1981, J BIOL CHEM, V256, P2767; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	60	116	118	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42921	42935		10.1074/jbc.M112.397828	http://dx.doi.org/10.1074/jbc.M112.397828			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23124204	hybrid, Green Published			2022-12-25	WOS:000312501600050
J	Kajantie, E; Raikkonen, K; Henriksson, M; Leskinen, JT; Forsen, T; Heinonen, K; Pesonen, AK; Osmond, C; Barker, DJP; Eriksson, JG				Kajantie, Eero; Raikkonen, Katri; Henriksson, Markus; Leskinen, Jukka T.; Forsen, Tom; Heinonen, Kati; Pesonen, Anu-Katriina; Osmond, Clive; Barker, David J. P.; Eriksson, Johan G.			Stroke Is Predicted by Low Visuospatial in Relation to Other Intellectual Abilities and Coronary Heart Disease by Low General Intelligence	PLOS ONE			English	Article							HOSPITAL DISCHARGE REGISTER; LATE ADOLESCENCE/EARLY ADULTHOOD; POPULATION-BASED COHORT; MENTAL SURVEY 1932; RISK-FACTORS; MIDDLE-AGE; CARDIOVASCULAR-DISEASE; CHILDHOOD IQ; MORTALITY; ASSOCIATION	Background: Low intellectual ability is associated with an increased risk of coronary heart disease and stroke. Most studies have used a general intelligence score. We studied whether three different subscores of intellectual ability predict these disorders. Methods: We studied 2,786 men, born between 1934 and 1944 in Helsinki, Finland, who as conscripts at age 20 underwent an intellectual ability test comprising verbal, visuospatial (analogous to Raven's progressive matrices) and arithmetic reasoning subtests. We ascertained the later occurrence of coronary heart disease and stroke from validated national hospital discharge and death registers. Results: 281 men (10.1%) had experienced a coronary heart disease event and 131 (4.7%) a stroke event. Coronary heart disease was predicted by low scores in all subtests, hazard ratios for each standard deviation (SD) lower score ranging from 1.21 to 1.30 (confidence intervals 1.08 to 1.46). Stroke was predicted by a low visuospatial reasoning score, the corresponding hazard ratio being 1.23 (95% confidence interval 1.04 to 1.46), adjusted for year and age at testing. Adjusted in addition for the two other scores, the hazard ratio was 1.40 (1.10 to 1.79). This hazard ratio was little affected by adjustment for socioeconomic status in childhood and adult life, whereas the same adjustments attenuated the associations between intellectual ability and coronary heart disease. The associations with stroke were also unchanged when adjusted for systolic blood pressure at 20 years and reimbursement for adult antihypertensive medication. Conclusions: Stroke is predicted by low visuospatial reasoning scores in relation to scores in the two other subtests. This association may be mediated by common underlying causes such as impaired brain development, rather than by mechanisms associated with risk factors shared by stroke and coronary heart disease, such as socio-economic status, hypertension and atherosclerosis.	[Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Kajantie, Eero; Pesonen, Anu-Katriina] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; [Raikkonen, Katri; Heinonen, Kati; Pesonen, Anu-Katriina] Univ Helsinki, Dept Behav Sci, Helsinki, Finland; [Henriksson, Markus] Natl Supervisory Author Welf & Hlth, Helsinki, Finland; [Henriksson, Markus] Finnish Def Forces, Ctr Mil Med, Lahti, Finland; [Leskinen, Jukka T.] Finnish Def Forces, Natl Def Coll, Tuusula, Finland; [Forsen, Tom; Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Forsen, Tom; Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Forsen, Tom] Vasa Hlth Care Ctr, Vaasa, Finland; [Osmond, Clive; Barker, David J. P.] Univ Southampton, MRC Epidemiol Resource Ctr, Southampton, Hants, England; [Barker, David J. P.] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97201 USA; [Barker, David J. P.] King Saud Univ, Chair Fetal Programming, Riad, Saudi Arabia; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Vaasa Central Hospital; University of Helsinki; University of Southampton; Oregon Health & Science University; King Saud University; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center	Kajantie, E (corresponding author), Natl Inst Hlth & Welf, Helsinki, Finland.	eero.kajantie@helsinki.fi		Eriksson, Johan/0000-0002-2516-2060; Pesonen, Anu-Katriina/0000-0002-0662-6261; Raikkonen, Katri/0000-0003-3124-3470; Osmond, Clive/0000-0002-9054-4655; Heinonen, Kati/0000-0002-1262-5599	Academy of Finland; Paivikki and Sakari Sohlberg Foundation; Finnish Diabetes Research Foundation; Emil Aaltonen Foundation; Finnish Foundation for Cardiovascular Research; Finnish Foundation for Pediatric Research; Finnish Medical Society Duodecim; Jalmari and Rauha Ahokas Foundation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Juho Vainio Foundation; Finska Lakaresallskapet; MRC [MC_UP_A620_1017] Funding Source: UKRI; Medical Research Council [MC_UP_A620_1017] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Academy of Finland(Academy of Finland); Paivikki and Sakari Sohlberg Foundation; Finnish Diabetes Research Foundation; Emil Aaltonen Foundation; Finnish Foundation for Cardiovascular Research; Finnish Foundation for Pediatric Research; Finnish Medical Society Duodecim; Jalmari and Rauha Ahokas Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Juho Vainio Foundation; Finska Lakaresallskapet; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Academy of Finland, the Paivikki and Sakari Sohlberg Foundation, the Finnish Diabetes Research Foundation, the Emil Aaltonen Foundation, the Finnish Foundation for Cardiovascular Research, the Finnish Foundation for Pediatric Research, the Finnish Medical Society Duodecim, the Jalmari and Rauha Ahokas Foundation, the Novo Nordisk Foundation, the Signe and Ane Gyllenberg Foundation, the Sigrid Juselius Foundation, the Yrjo Jahnsson Foundation, the Juho Vainio Foundation, and Finska Lakaresallskapet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Batterham PJ, 2009, INTELLIGENCE, V37, P551, DOI 10.1016/j.intell.2008.10.004; Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Batty GD, 2008, J EPIDEMIOL COMMUN H, V62, P522, DOI 10.1136/jech.2007.064881; Batty GD, 2008, EUR J CARDIOV PREV R, V15, P359, DOI 10.1097/HJR.0b013e3282f738a6; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2009, EUR HEART J, V30, P1903, DOI 10.1093/eurheartj/ehp254; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hemmingsson T, 2007, SOC SCI MED, V65, P1410, DOI 10.1016/j.socscimed.2007.05.006; Kajantie E, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.086967; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P695, DOI 10.1007/s10654-008-9281-z; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; OTOOLE BI, 1992, PERS INDIV DIFFER, V13, P699, DOI 10.1016/0191-8869(92)90241-G; Paile-Hyvarinen M, 2009, ACTA DIABETOL, V46, P249, DOI 10.1007/s00592-009-0102-y; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Rohde TE, 2007, INTELLIGENCE, V35, P83, DOI 10.1016/j.intell.2006.05.004; Shea DL, 2001, J EDUC PSYCHOL, V93, P604, DOI 10.1037/0022-0663.93.3.604; Silventoinen K, 2007, EUR J CARDIOV PREV R, V14, P555, DOI 10.1097/HJR.0b013e328014672e; Tiihonen J, 2005, AM J PSYCHIAT, V162, P1904, DOI 10.1176/appi.ajp.162.10.1904; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; Tuovinen S, 2012, ANN MED, V44, P394, DOI 10.3109/07853890.2011.573497; Wennerstad KM, 2010, J EPIDEMIOL COMMUN H, V64, P908, DOI 10.1136/jech.2008.084020; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	36	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e46841	10.1371/journal.pone.0046841	http://dx.doi.org/10.1371/journal.pone.0046841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144789	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000311935800009
J	Ahanda, MLE; Fritz, ER; Estelle, J; Hu, ZL; Madsen, O; Groenen, MAM; Beraldi, D; Kapetanovic, R; Hume, DA; Rowland, RRR; Lunney, JK; Rogel-Gaillard, C; Reecy, JM; Giuffra, E				Ahanda, Marie-Laure Endale; Fritz, Eric R.; Estelle, Jordi; Hu, Zhi-Liang; Madsen, Ole; Groenen, Martien A. M.; Beraldi, Dario; Kapetanovic, Ronan; Hume, David A.; Rowland, Robert R. R.; Lunney, Joan K.; Rogel-Gaillard, Claire; Reecy, James M.; Giuffra, Elisabetta			Prediction of Altered 3 '-UTR miRNA-Binding Sites from RNA-Seq Data: The Swine Leukocyte Antigen Complex (SLA) as a Model Region	PLOS ONE			English	Article							MEDIATED GENE-REGULATION; TARGET RECOGNITION; MICRORNAS; ACCESSIBILITY; EXPRESSION; EVOLUTION; SEQUENCES	The SLA (swine leukocyte antigen, MHC: SLA) genes are the most important determinants of immune, infectious disease and vaccine response in pigs; several genetic associations with immunity and swine production traits have been reported. However, most of the current knowledge on SLA is limited to gene coding regions. MicroRNAs (miRNAs) are small molecules that post-transcriptionally regulate the expression of a large number of protein-coding genes in metazoans, and are suggested to play important roles in fine-tuning immune mechanisms and disease responses. Polymorphisms in either miRNAs or their gene targets may have a significant impact on gene expression by abolishing, weakening or creating miRNA target sites, possibly leading to phenotypic variation. We explored the impact of variants in the 3'-UTR miRNA target sites of genes within the whole SLA region. The combined predictions by TargetScan, PACMIT and TargetSpy, based on different biological parameters, empowered the identification of miRNA target sites and the discovery of polymorphic miRNA target sites (poly-miRTSs). Predictions for three SLA genes characterized by a different range of sequence variation provided proof of principle for the analysis of poly-miRTSs from a total of 144 M RNA-Seq reads collected from different porcine tissues. Twenty-four novel SNPs were predicted to affect miRNA-binding sites in 19 genes of the SLA region. Seven of these genes (SLA-1, SLA-6, SLA-DQA, SLA-DQB1, SLA-DOA, SLA-DOB and TAP1) are linked to antigen processing and presentation functions, which is reminiscent of associations with disease traits reported for altered miRNA binding to MHC genes in humans. An inverse correlation in expression levels was demonstrated between miRNAs and co-expressed SLA targets by exploiting a published dataset (RNA-Seq and small RNA-Seq) of three porcine tissues. Our results support the resource value of RNA-Seq collections to identify SNPs that may lead to altered miRNA regulation patterns.	[Ahanda, Marie-Laure Endale; Estelle, Jordi; Rogel-Gaillard, Claire; Giuffra, Elisabetta] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Ahanda, Marie-Laure Endale; Estelle, Jordi; Rogel-Gaillard, Claire; Giuffra, Elisabetta] CEA, DSV, IRCM, SREIT,Lab Radiobiol & Etud Genome, Jouy En Josas, France; [Ahanda, Marie-Laure Endale; Estelle, Jordi; Rogel-Gaillard, Claire; Giuffra, Elisabetta] AgroParisTech, Lab Genet Anim & Biol Integrat, Jouy En Josas, France; [Fritz, Eric R.; Hu, Zhi-Liang; Reecy, James M.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Fritz, Eric R.; Hu, Zhi-Liang; Reecy, James M.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA USA; [Madsen, Ole; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Beraldi, Dario; Kapetanovic, Ronan; Hume, David A.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Beraldi, Dario; Kapetanovic, Ronan; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [Rowland, Robert R. R.] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Lunney, Joan K.] ARS, Anim Parasit Dis Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Iowa State University; Iowa State University; Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Kansas State University; United States Department of Agriculture (USDA)	Giuffra, E (corresponding author), INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France.	elisabetta.giuffra@jouy.inra.fr	Giuffra, Elisabetta/J-8080-2014; kapetanovic, ronan/G-8322-2012; Endale Ahanda, Marie-Laure/D-1661-2012; Kapetanovic, Ronan/GRO-1748-2022; Giuffra, Elisabetta/I-3201-2013; Hume, David A/C-7695-2013; Groenen, Martien/D-8408-2012; Estellé, Jordi/A-7976-2008; Madsen, Ole/E-3730-2012	kapetanovic, ronan/0000-0002-2908-1014; Endale Ahanda, Marie-Laure/0000-0002-0861-1565; Kapetanovic, Ronan/0000-0002-2908-1014; Groenen, Martien/0000-0003-0484-4545; Estellé, Jordi/0000-0002-6241-1732; Madsen, Ole/0000-0001-8082-7881; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; Hume, David/0000-0002-2615-1478; Beraldi, Dario/0000-0003-1504-5212; Reecy, James/0000-0003-4602-0990; Giuffra, Elisabetta/0000-0001-9568-2056	'INRA Package' project of EG; U.S. National Pork Board; United States Department of Agriculture Agricultural Research Service; BBSRC [BBS/E/D/20251969, BB/G004013/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969, BB/G004013/1] Funding Source: researchfish	'INRA Package' project of EG; U.S. National Pork Board; United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MLEA and EG are supported by the 'INRA Package' project (2011-2014) of EG. ERF, RRRR, JKL, and JMR acknowledge support for the PRRS Host Genetics Consortium from the U.S. National Pork Board and from the United States Department of Agriculture Agricultural Research Service (JKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Gao Y, 2011, VET IMMUNOL IMMUNOPA; Georges M, 2006, COLD SPRING HARB SYM, V71, P343, DOI 10.1101/sqb.2006.71.056; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Groenen MAM, 2012, NATURE IN PRESS; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Harris EY, 2010, BIOINFORMATICS, V26, P572, DOI 10.1093/bioinformatics/btp706; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Hu Rui, 2011, BMC Proc, V5 Suppl 4, pS10, DOI 10.1186/1753-6561-5-S4-S10; Hu ZH, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/910769; Kapetanovic R, 2012, J IMMUNOL, V188, P3382, DOI 10.4049/jimmunol.1102649; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Lunney JK, 2009, DEV COMP IMMUNOL, V33, P362, DOI 10.1016/j.dci.2008.07.002; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Martin M, 2011, CUTADAPT REMOVES ADA; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; O'hUigin C, 2011, AM J HUM GENET, V89, P424, DOI 10.1016/j.ajhg.2011.07.024; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; R Core Team, 2022, R LANG ENV STAT COMP; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Renard C, 2006, GENOMICS, V88, P96, DOI 10.1016/j.ygeno.2006.01.004; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Tennant LM, 2007, IMMUNOGENETICS, V59, P377, DOI 10.1007/s00251-007-0206-x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zorc M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030737	58	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48607	10.1371/journal.pone.0048607	http://dx.doi.org/10.1371/journal.pone.0048607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139801	Green Published, Green Submitted, gold			2022-12-25	WOS:000311315300043
J	Huang, M; Zheng, H				Huang, Mou; Zheng, Hong			Clinical and Demographic Characteristics of Patients with Urinary Tract Hydatid Disease	PLOS ONE			English	Article							CYSTIC ECHINOCOCCOSIS; MANAGEMENT; KIDNEY; EXPERIENCE	Background: Human cystic echinococcosis (CE) is caused by flatworm larvae of Echinococcus granulosus and is endemic in many parts of the world. In humans, CE cysts primarily affect the liver and pulmonary system, but can also affect the renal system. However, the clinical manifestations of renal CE can be subtle, so healthcare professionals often overlook renal CE in differential diagnosis. In this study, we examined the clinical and demographic characteristics of patients with urinary tract CE and analyzed the diagnosis and treatment procedures for this disease. Methods: The records of 19 consecutive renal CE patients who were admitted to the First Affiliated Hospital of Xinjiang Medical University from January 1983 to April 2011 were retrospectively reviewed. In all cases, CE of the urinary tract was confirmed by pathological examination and visual inspection during surgery. Results: Fifteen patients were males and 4 were females. The most common symptoms were non-specific lower back pain and percussion tenderness on the kidney region. All patients were followed up for 9-180 months after surgery. None of the patients experienced a recurrence of renal CE, but 4 patients experienced non-renal recurrence of hydatid disease. Conclusions: Hydatid cysts from E. granulosus are structurally similar in the liver and urinary tract. Thus, the treatment regimen for liver CE developed by the World Health Organization/Informal Working Group on Echinococcosis (WHO/IWGE) could also be used for urinary tract CE. In our patients, the use of ultrasound, computed tomography, serology, and clinical characteristics provided a diagnostic accuracy of 66.7% to 92.3%.	[Zheng, Hong] Xin Jiang Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Urumqi, XinJiang, Peoples R China; [Huang, Mou] Xin Jiang Med Univ, Affiliated Hosp 1, Dept Urol, Urumqi, XinJiang, Peoples R China		Zheng, H (corresponding author), Xin Jiang Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Urumqi, XinJiang, Peoples R China.	xyzhenghong@yahoo.com.cn			National Key Clinical Specialized Construction Project for the Department of Anesthesiology; First Affiliated Hospital of Xin Jiang Medical University; Xin Jiang Medical University doctoral innovation fund [DC2010-10]; National Natural Science Foundation [30960367]; Xinjiang Uygur Autonomous Region Key Research Foundation	National Key Clinical Specialized Construction Project for the Department of Anesthesiology; First Affiliated Hospital of Xin Jiang Medical University; Xin Jiang Medical University doctoral innovation fund; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Xinjiang Uygur Autonomous Region Key Research Foundation	This research is sponsored by the National Key Clinical Specialized Construction Project for the Department of Anesthesiology, First Affiliated Hospital of Xin Jiang Medical University, Xin Jiang Medical University doctoral innovation fund (No. DC2010-10), the National Natural Science Foundation (No. 30960367), and the Xinjiang Uygur Autonomous Region Key Research Foundation #7 (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay MN, 2004, WORLD J SURG, V28, P97, DOI 10.1007/s00268-003-6901-3; Bhandarwar AH, 2009, DIGEST ENDOSC, V21, P185, DOI 10.1111/j.1443-1661.2009.00883.x; Brunetti E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001146; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Chen Xin-Hua, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P90; Cretu CM, 2012, CHIRURGIA-BUCHAREST, V107, P15; Echinococcosis WIWGo, 1996, B WORLD HEALTH ORGAN, V74, P12; El Sheikh A, 2011, HEPATO-GASTROENTEROL, V58, P336; Fekak H, 2003, ANN UROL, V37, P85, DOI 10.1016/S0003-4401(03)00026-3; Gogus C, 2003, J UROLOGY, V169, P186, DOI 10.1016/S0022-5347(05)64064-5; Horchani A, 2000, EUR UROL, V38, P461, DOI 10.1159/000020325; Ishimitsu DN, 2010, RADIOGRAPHICS, V30, P334, DOI 10.1148/rg.302095149; Junghanss T, 2008, AM J TROP MED HYG, V79, P301, DOI 10.4269/ajtmh.2008.79.301; Kalinova K, 2007, J IMAB ANN P SCI PAP; Kaya K, 2006, TROP DOCT, V36, P243, DOI 10.1258/004947506778604977; Li TY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001364; Macpherson CNL, 2003, ACTA TROP, V85, P253, DOI 10.1016/S0001-706X(02)00213-9; Motie MR, 2010, INDIAN J SURG, V72, P448, DOI 10.1007/s12262-010-0163-8; Olut Ali I., 2005, Korean Journal of Parasitology, V43, P15, DOI 10.3347/kjp.2005.43.1.15; Onur K, 2005, EUR J RADIOL EXTRA, V54, P3; Ozbey I, 2002, J INT MED RES, V30, P346; Ozbey Iss, 2001, International Urology and Nephrology, V33, P329, DOI 10.1023/A:1015209106436; Pedrosa I, 2000, RADIOGRAPHICS, V20, P795, DOI 10.1148/radiographics.20.3.g00ma06795; Shukla S, 2009, INDIAN J PATHOL MICR, V52, P213, DOI 10.4103/0377-4929.48921; Song XH, 2007, POSTGRAD MED J, V83, P536, DOI 10.1136/pgmj.2007.057166; Stamatakos M, 2008, CHIRURGIA-BUCHAREST, V103, P621; Turgut AT, 2009, AM J ROENTGENOL, V192, P462, DOI 10.2214/AJR.08.1129; Yasawy MI, 2011, WORLD J GASTROENTERO, V17, P646, DOI 10.3748/wjg.v17.i5.646; Yildirim M, 2006, ANN TROP MED PARASIT, V100, P137, DOI 10.1179/13648590678560; Zmerli S, 2001, WORLD J SURG, V25, P68, DOI 10.1007/s002680020009	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47667	10.1371/journal.pone.0047667	http://dx.doi.org/10.1371/journal.pone.0047667			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133601	gold, Green Submitted, Green Published			2022-12-25	WOS:000310702400013
J	McCaig, AM; Cosimo, E; Leach, MT; Michie, AM				McCaig, Alison M.; Cosimo, Emilio; Leach, Michael T.; Michie, Alison M.			Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; SRC-FAMILY KINASE; CHEMOKINE RECEPTORS; SURVIVAL SIGNALS; DRUG-RESISTANCE; CLL CELLS; IN-VITRO; B-CELLS; APOPTOSIS; ACTIVATION	Chemokines and their ligands play a critical role in enabling chronic lymphocytic leukaemia (CLL) cells access to protective microenvironmental niches within tissues, ultimately resulting in chemoresistance and relapse: disruption of these signaling pathways has become a novel therapeutic approach in CLL. The tyrosine kinase inhibitor dasatinib inhibits migration of several cell lines from solid-organ tumours, but effects on CLL cells have not been reported. We studied the effect of clinically achievable concentrations of dasatinib on signaling induced by the chemokine CXCL12 through its' receptor CXCR4, which is highly expressed on CLL cells. Dasatinib pre-treatment inhibited Akt and ERK phosphorylation in CLL cells upon stimulation with CXCL12. Dasatinib also significantly diminished the rapid increase in actin polymerisation observed in CLL cells following CXCL12 stimulation. Moreover, the drug significantly inhibited chemotaxis in a transwell assay, and reduced the percentage of cells able to migrate beneath a CXCL12-expressing murine stromal cell line. Dasatinib also abrogated the anti-apoptotic effect of prolonged CXCL12 stimulation on cultured CLL cells. These data suggest that dasatinib, akin to other small molecule kinase inhibitors targeting the B-cell receptor signaling pathway, may redistribute CLL cells from protective tissue niches to the peripheral blood, and support the investigation of dasatinib in combination strategies.	[McCaig, Alison M.; Cosimo, Emilio; Michie, Alison M.] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Leach, Michael T.] Gartnavel Royal Hosp, Dept Haematol, W Scotland Canc Ctr, Glasgow, Lanark, Scotland; [McCaig, Alison M.] Royal Alexandra Hosp, Dept Haematol, Paisley, Renfrew, Scotland	University of Glasgow; Beatson Oncology Centre; Gartnavel Royal Hospital	McCaig, AM (corresponding author), Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Alison.mccaig@ggc.scot.nhs.uk		Cosimo, Emilio/0000-0002-7294-222X; Michie, Alison/0000-0002-5404-475X	Medical Research Council [60013]; Tenovus Scotland [S07/14]; Medical Research Council [G0701354, G0601099] Funding Source: researchfish; Chief Scientist Office [CZB/4/748] Funding Source: researchfish; MRC [G0601099, G0701354] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. A. McCaig received a Clinical Research Training Fellowship from the Medical Research Council (http://www.mrc.ac.uk/Fundingopportunities/Fellowships/Clinicalresearchtraining/index.htm)-Grant number 60013. The work was also supported by a small research grant from Tenovus Scotland (http://www.tenovus-scotland.org.uk/ForResearchers.html) Grant number S07/14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Amrein PC, 2011, CLIN CANCER RES, V17, P2977, DOI 10.1158/1078-0432.CCR-10-2879; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Bristol-Myers-Squibb, 2006, 21986 NDA BRIST MYER, P21; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Buettner R, 2008, MOL CANCER RES, V6, P1766, DOI 10.1158/1541-7786.MCR-08-0169; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Burger M, 2005, BLOOD, V106, P1824, DOI 10.1182/blood-2004-12-4918; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Hallaert DYH, 2008, BLOOD, V112, P5141, DOI 10.1182/blood-2008-03-146704; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Hayden RE, 2009, LEUKEMIA, V23, P292, DOI 10.1038/leu.2008.283; Hochhaus A, 2007, BLOOD, V109, P2303, DOI 10.1182/blood-2006-09-047266; Hoellenriegel J, 2012, LEUKEMIA, V26, P1576, DOI 10.1038/leu.2012.24; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lopez-Guerra M, 2012, LEUKEMIA, V26, P1429, DOI 10.1038/leu.2011.364; McCaig AM, 2011, BRIT J HAEMATOL, V153, P199, DOI 10.1111/j.1365-2141.2010.08507.x; Nakata Y, 2006, BLOOD, V107, P4234, DOI 10.1182/blood-2005-08-3343; Niedermeier M, 2009, BLOOD, V113, P5549, DOI 10.1182/blood-2008-06-165068; O'Hayre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011716; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Ptasznik A, 2002, J EXP MED, V196, P667, DOI 10.1084/jem.20020519; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Song ZB, 2010, CLIN CANCER RES, V16, P587, DOI 10.1158/1078-0432.CCR-09-1519; Veldurthy A, 2008, BLOOD, V112, P1443, DOI 10.1182/blood-2007-11-123984; Willimott S, 2007, BRIT J HAEMATOL, V138, P721, DOI 10.1111/j.1365-2141.2007.06717.x	35	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48929	10.1371/journal.pone.0048929	http://dx.doi.org/10.1371/journal.pone.0048929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133664	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000310702400050
J	Heacock, M; Poltoratsky, V; Prasad, R; Wilson, SH				Heacock, Michelle; Poltoratsky, Vladimir; Prasad, Rajendra; Wilson, Samuel H.			Evidence for Abasic Site Sugar Phosphate-Mediated Cytotoxicity in Alkylating Agent Treated Saccharomyces cerevisiae	PLOS ONE			English	Article							DNA-POLYMERASE-BETA; ACTIVE-SITE; DIRECTED MUTAGENESIS; LYASE ACTIVITY; BUDDING YEAST; REPAIR; ENCODES; PURIFICATION; INHIBITORS; HOMOLOG	To better understand alkylating agent-induced cytotoxicity and the base lesion DNA repair process in Saccharomyces cerevisiae, we replaced the RAD27(FEN1) open reading frame (ORF) with the ORF of the bifunctional human repair enzyme DNA polymerase (Pol) beta. The aim was to probe the effect of removal of the incised abasic site 59-sugar phosphate group (i.e., 5'-deoxyribose phosphate or 5'-dRP) in protection against methyl methanesulfonate (MMS)-induced cytotoxicity. In S. cerevisiae, Rad27(Fen1) was suggested to protect against MMS-induced cytotoxicity by excising multinucleotide flaps generated during repair. However, we proposed that the repair intermediate with a blocked 5'-end, i.e., 5'-dRP group, is the actual cytotoxic lesion. In providing a 5'-dRP group removal function mediated by dRP lyase activity of Pol beta, the effects of the 5'-dRP group were separated from those of the multinucleotide flap itself. Human Pol beta was expressed in S. cerevisiae, and this partially rescued the MMS hypersensitivity observed with rad27(fen1) - null cells. To explore this rescue effect, altered forms of Pol beta with site-directed eliminations of either the 5'-dRP lyase or polymerase activity were expressed in rad27(fen1) null cells. The 5'-dRP lyase, but not the polymerase activity, conferred the resistance to MMS. These results suggest that after MMS exposure, the 5'-dRP group in the repair intermediate is cytotoxic and that Rad27(Fen1) protection against MMS in wild-type cells is due to elimination of the 5'-dRP group.	[Heacock, Michelle; Poltoratsky, Vladimir; Prasad, Rajendra; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01ES050159]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050159, ZIAES050158] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [project number Z01ES050159]. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2006, METHOD ENZYMOL, V408, P91, DOI 10.1016/S0076-6879(06)08007-4; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Daley JM, 2010, DNA REPAIR, V9, P690, DOI 10.1016/j.dnarep.2010.03.006; Ellisen LW, 2011, CANCER CELL, V19, P165, DOI 10.1016/j.ccr.2011.01.047; Fu D, 2012, NAT REV CANC; Gellon L, 2008, DNA REPAIR, V7, P187, DOI 10.1016/j.dnarep.2007.09.009; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; Liu Y, 2012, TRENDS BIOC IN PRESS; Ma WJ, 2008, NUCLEIC ACIDS RES, V36, P1836, DOI 10.1093/nar/gkm1148; Ma WJ, 2009, MOL CELL BIOL, V29, P1212, DOI 10.1128/MCB.01499-08; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Prasad R, 2011, MOL BIOL+, V45, P536, DOI 10.1134/S0026893311040091; Prasad R, 2003, J BIOL CHEM, V278, P29649, DOI 10.1074/jbc.M305399200; PRASAD R, 1993, NUCLEIC ACIDS RES, V21, P5301, DOI 10.1093/nar/21.23.5301; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; SHIMIZU K, 1993, J BIOL CHEM, V268, P27148; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tseng HM, 2004, J BIOL CHEM, V279, P47580, DOI 10.1074/jbc.M404492200; WANG YCJ, 1994, J BIOL CHEM, V269, P31923; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Wu XH, 1999, NUCLEIC ACIDS RES, V27, P956, DOI 10.1093/nar/27.4.956; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47945	10.1371/journal.pone.0047945	http://dx.doi.org/10.1371/journal.pone.0047945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144716	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300027
J	Kaba, SA; McCoy, ME; Doll, TAPF; Brando, C; Guo, Q; Dasgupta, D; Yang, YK; Mittelholzer, C; Spaccapelo, R; Crisanti, A; Burkhard, P; Lanar, DE				Kaba, Stephen A.; McCoy, Margaret E.; Doll, Tais A. P. F.; Brando, Clara; Guo, Qin; Dasgupta, Debleena; Yang, Yongkun; Mittelholzer, Christian; Spaccapelo, Roberta; Crisanti, Andrea; Burkhard, Peter; Lanar, David E.			Protective Antibody and CD8(+) T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine	PLOS ONE			English	Article							DENDRITIC CELLS; DNA VACCINE; MALARIA; IMMUNITY; FORMULATION; DELIVERY; GAMMA	Background: The worldwide burden of malaria remains a major public health problem due, in part, to the lack of an effective vaccine against the Plasmodium falciparum parasite. An effective vaccine will most likely require the induction of antigen specific CD8(+) and CD4(+) T-cells as well as long-lasting antibody responses all working in concert to eliminate the infection. We report here the effective modification of a self-assembling protein nanoparticle (SAPN) vaccine previously proven effective in control of a P. berghei infection in a rodent model to now present B- and T-cell epitopes of the human malaria parasite P. falciparum in a platform capable of being used in human subjects. Methodology/Principal Findings: To establish the basis for a SAPN-based vaccine, B- and CD8(+) T-cell epitopes from the P. falciparum circumsporozoite protein (PfCSP) and the universal CD4 T-helper epitope PADRE were engineered into a versatile small protein (similar to 125 amino acids) that self-assembles into a spherical nanoparticle repetitively displaying the selected epitopes. P. falciparum epitope specific immune responses were evaluated in mice using a transgenic P. berghei malaria parasite of mice expressing the human malaria full-length P. falciparum circumsporozoite protein (Tg-Pb/PfCSP). We show that SAPN constructs, delivered in saline, can induce high-titer, long-lasting (1 year) protective antibody and poly-functional (IFN gamma(+), IL-2(+)) long-lived central memory CD8(+) T-cells. Furthermore, we demonstrated that these Ab or CD8(+) T-cells can independently provide sterile protection against a lethal challenge of the transgenic parasites. Conclusion: The SAPN construct induces long-lasting antibody and cellular immune responses to epitope specific sequences of the P. falciparum circumsporozoite protein (PfCSP) and prevents infection in mice by a transgenic P. berghei parasite displaying the full length PfCSP.	[Kaba, Stephen A.; McCoy, Margaret E.; Brando, Clara; Guo, Qin; Dasgupta, Debleena; Lanar, David E.] Walter Reed Army Inst Res, Malaria Vaccine Branch, Silver Spring, MD 20910 USA; [Doll, Tais A. P. F.; Yang, Yongkun; Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT USA; [Mittelholzer, Christian] Univ Basel, ME Muller Inst Struct Biol, Basel, Switzerland; [Spaccapelo, Roberta] Univ Perugia, Dept Expt Med, Microbiol Sect, I-06100 Perugia, Italy; [Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, London, England; [Burkhard, Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Connecticut; University of Basel; University of Perugia; Imperial College London; University of Connecticut	Lanar, DE (corresponding author), Walter Reed Army Inst Res, Malaria Vaccine Branch, Silver Spring, MD 20910 USA.	david.lanar@us.army.mil	Kaba, Stephen/B-3555-2011	Kaba, Stephen/0000-0003-1509-2975; Spaccapelo, Roberta/0000-0003-2100-6172; Crisanti, Andrea/0000-0002-2406-4426	NIH [1R01AI068761-01A2]; US Military Infectious Disease Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068761] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Military Infectious Disease Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grant 1R01AI068761-01A2 (PB, DEL) and the US Military Infectious Disease Research Program (DEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2007, BIOMATERIALS, V28, P3427, DOI 10.1016/j.biomaterials.2007.04.023; Alexander J, 2002, J IMMUNOL, V168, P6189, DOI 10.4049/jimmunol.168.12.6189; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; CHAI SK, 1992, J IMMUNOL, V149, P2385; Chinchilla M, 2007, INFECT IMMUN, V75, P3769, DOI 10.1128/IAI.00356-07; Chuang I., 2013, PLOS ONE, V8, DOI 10.1371/journalpone.0055571; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; Ellis JM, 2000, HUM IMMUNOL, V61, P334, DOI 10.1016/S0198-8859(99)00155-X; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Guebre-Xabier M, 1999, FASEB J, V13, pA943; Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957; Kalkanidis M, 2006, METHODS, V40, P20, DOI 10.1016/j.ymeth.2006.05.018; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Liu J, 2004, P NATL ACAD SCI USA, V101, P16156, DOI 10.1073/pnas.0405319101; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Minigo G, 2007, VACCINE, V25, P1316, DOI 10.1016/j.vaccine.2006.09.086; Mottram PL, 2007, MOL PHARMACEUT, V4, P73, DOI 10.1021/mp060096p; Partnership TRCT, 2011, N ENGL J MED, V365; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005; Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; ROSENBERG R, 1989, SCIENCE, V245, P973, DOI 10.1126/science.2672336; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Yadava A, 2007, INFECT IMMUN, V75, P1177, DOI 10.1128/IAI.01667-06; Yang OO, 2011, HUM IMMUNOL, V72, P877, DOI 10.1016/j.humimm.2011.05.003	35	86	90	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48304	10.1371/journal.pone.0048304	http://dx.doi.org/10.1371/journal.pone.0048304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144750	gold, Green Submitted, Green Published			2022-12-25	WOS:000310705300060
J	Xue, Y; Jiang, L; Cheng, QQ; Chen, HY; Yu, YY; Lin, YD; Yang, X; Kong, N; Zhu, XX; Xu, X; Wan, WG; Zou, HJ				Xue, Yu; Jiang, Li; Cheng, Qingqing; Chen, Haiyan; Yu, Yiyun; Lin, Yinda; Yang, Xue; Kong, Ning; Zhu, Xiaoxia; Xu, Xue; Wan, Weiguo; Zou, Hejian			Adipokines in Psoriatic Arthritis Patients: The Correlations with Osteoclast Precursors and Bone Erosions	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; TNF-ALPHA; SYNOVIAL TISSUE; PLASMA-LEVELS; RESISTIN; CHEMERIN; LEPTIN; EXPRESSION; CHEMR23; CELLS	Significant bone remodeling with disordered osteoclastogenesis has been implicated in the pathogenesis of psoriatic arthritis (PsA). And there is a high prevalence of the metabolic syndrome (MS) in PsA patients. Adipokines, especially leptin and adiponectin, have recently been reported to be involved in the development and regulation of some autoimmune diseases. In this study, we examined the alternation of circulating osteoclastogenesis related cytokines [tumor necrosis factor-alpha (TNF-alpha), osteoprotegerin (OPG) and receptor activator of nuclear factor-kappa B ligand (RANKL)] and adipokines (leptin, adiponectin, resistin, chemerin, omentin) in PsA patients, and analysed the correlations between these factors and osteoclast precursors numbers, radiographic damage scores, and disease activity index. 41 PsA patients, 20 psoriasis patients, and 24 healthy controls were recruited. Blood samples were obtained for detecting the levels of TNF-alpha, OPG, RANKL and the adipokines. The numbers of osteoclast precursors (OCs) in peripheral blood were assessed. Radiographs of affected joints in PsA patients were scored for erosion, joint-space narrowing, osteolysis, and new bone formation. Compared with healthy controls, patients with PsA had higher TNF-alpha, RANKL, OCs, leptin and omentin but lower adiponectin and chemerin. Increased serum levels of TNF-alpha, RANKL, leptin, and omentin were positively correlated with OCs numbers. In contrast, serum adiponectin levels were decreased in PsA patients and negatively correlated with OCs numbers. TNF-alpha, RANKL and leptin were positively correlated with Psoriatic Arthritis Joint Activity Index (PsAJAI). Only TNF-alpha was positively correlated with radiographic damage scores. Our data demonstrated that systemic expression of soluble mediators of osteoclastogenesis and adipokines were disordered in PsA. Certain adipokines were elevated in the circulation of patients with PsA and might contribute to pathogenesis of arthritis. Prospective studies will be of interest to determine the pluripotent effects of adipokines on osteoclastogenesis in chronic inflammatory rheumatic diseases. Future studies may lead to novel therapeutic strategies.	[Xue, Yu; Jiang, Li; Cheng, Qingqing; Chen, Haiyan; Yu, Yiyun; Lin, Yinda; Yang, Xue; Kong, Ning; Zhu, Xiaoxia; Xu, Xue; Wan, Weiguo; Zou, Hejian] Fudan Univ, Dept Rheumatol, Huashan Hosp, Inst Rheumatol Immunol & Allergy, Shanghai 200433, Peoples R China; [Jiang, Li] Linyi Peoples Hosp, Dept Rheumatol, Linyi, Shandong, Peoples R China	Fudan University	Wan, WG (corresponding author), Fudan Univ, Dept Rheumatol, Huashan Hosp, Inst Rheumatol Immunol & Allergy, Shanghai 200433, Peoples R China.	wgwan1969@sina.com; hjzou@fudan.edu.cn	Chen, Haiyan/HGB-6216-2022		Program of Shanghai Subject Chief Scientist [11XD1401100]; Project 211 [211Med-XZZD03]	Program of Shanghai Subject Chief Scientist; Project 211	This work was supported by Program of Shanghai Subject Chief Scientist (NO. 11XD1401100) and Phase-3 of "Project 211" (no. 211Med-XZZD03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandarajah AP, 2008, ANN RHEUM DIS, V67, P296, DOI 10.1136/ard.2007.076091; Anandarajah AP, 2004, CURR OPIN RHEUMATOL, V16, P338, DOI 10.1097/01.bor.0000129718.13939.81<; Antoni C, 2005, ANN RHEUM DIS, V64, P1150, DOI 10.1136/ard.2004.032268; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Berg V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3215; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Calin A, 1999, J RHEUMATOL, V26, P988; Cerman AA, 2008, BRIT J DERMATOL, V159, P820, DOI 10.1111/j.1365-2133.2008.08742.x; Chi CM, 2011, ARCH DERMATOL RES, V303, P451; Colucci S, 2007, J PATHOL, V212, P47, DOI 10.1002/path.2153; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Corbetta S, 2006, EUR J ENDOCRINOL, V154, P83, DOI 10.1530/eje.1.02057; d'Elia HF, 2008, RHEUMATOLOGY, V47, P1082, DOI 10.1093/rheumatology/ken187; Dalbeth N, 2008, ARTHRITIS RHEUM-US, V58, P1854, DOI 10.1002/art.23488; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Frediani B, 2001, J RHEUMATOL, V28, P138; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Gladman DD, 2009, J RHEUMATOL, V36, P2571; Gladman DD, 2008, ANN RHEUM DIS S, V67, P526; Gonzalez-Gay MA, 2008, CLIN EXP RHEUMATOL, V26, P311; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kontny E, 2012, ANN RHEUM DIS, V71, P262, DOI 10.1136/annrheumdis-2011-200123; Lee JH, 2009, OSTEOARTHR CARTILAGE, V17, P613, DOI 10.1016/j.joca.2008.08.007; Liu L, 2008, BRIT J OPHTHALMOL, V92, P557, DOI 10.1136/bjo.2007.128769; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Mackay K, 1998, ARTHRITIS RHEUM-US, V41, P2263, DOI 10.1002/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I; Maruotti N, 2011, CLIN EXP MED, V11, P137, DOI 10.1007/s10238-010-0117-2; Mease PJ, 2004, ARTHRITIS RHEUM-US, V50, P2264, DOI 10.1002/art.20335; Mease PJ, 2005, ARTHRITIS RHEUM-US, V52, P3279, DOI 10.1002/art.21306; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Nakajima H, 2011, ARCH DERMATOL RES, V303, P451, DOI 10.1007/s00403-011-1159-3; Neumann E, 2011, ARTHRITIS RHEUM-US, V63, P1159, DOI 10.1002/art.30291; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Palmer G, 2003, ANN RHEUM DIS, V62, P913, DOI 10.1136/ard.62.10.913; Partsch G, 1997, J RHEUMATOL, V6, P1349; Ritchlin C, 1998, J RHEUMATOL, V25, P1544; Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Senolt L, 2007, ANN RHEUM DIS, V66, P458, DOI 10.1136/ard.2006.054734; Senolt L, 2010, ANN RHEUM DIS, V69, P1410, DOI 10.1136/ard.2009.119735; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Taylor WJ, 2003, J RHEUMATOL, V30, P2645; van der Heijde D, 2007, ARTHRITIS RHEUM, V56, P2698, DOI 10.1002/art.22805; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zhang ZQ, 2010, ARTHRITIS RHEUM-US, V62, P1993, DOI 10.1002/art.27473	50	69	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e46740	10.1371/journal.pone.0046740	http://dx.doi.org/10.1371/journal.pone.0046740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144698	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300009
J	Neugebauer, JM; Hawkins, DA; Beckett, L				Neugebauer, Jennifer M.; Hawkins, David A.; Beckett, Laurel			Estimating Youth Locomotion Ground Reaction Forces Using an Accelerometer-Based Activity Monitor	PLOS ONE			English	Article							IOWA BONE-DEVELOPMENT; PHYSICAL-ACTIVITY; COMPUTER-SCIENCE; HEIGHT VELOCITY; WALKING; CALIBRATION; CHILDREN; RELIABILITY; ACCURACY; VALIDITY	To address a variety of questions pertaining to the interactions between physical activity, musculoskeletal loading and musculoskeletal health/injury/adaptation, simple methods are needed to quantify, outside a laboratory setting, the forces acting on the human body during daily activities. The purpose of this study was to develop a statistically based model to estimate peak vertical ground reaction force (pVGRF) during youth gait. 20 girls (10.9 +/- 0.9 years) and 15 boys (12.5 +/- 0.6 years) wore a Biotrainer AM over their right hip. Six walking and six running trials were completed after a standard warm-up. Average AM intensity (g) and pVGRF (N) during stance were determined. Repeated measures mixed effects regression models to estimate pVGRF from Biotrainer activity monitor acceleration in youth (girls 10-12, boys 12-14 years) while walking and running were developed. Log transformed pVGRF had a statistically significant relationship with activity monitor acceleration, centered mass, sex (girl), type of locomotion (run), and locomotion type-acceleration interaction controlling for subject as a random effect. A generalized regression model without subject specific random effects was also developed. The average absolute differences between the actual and predicted pVGRF were 5.2% (1.6% standard deviation) and 9% (4.2% standard deviation) using the mixed and generalized models, respectively. The results of this study support the use of estimating pVGRF from hip acceleration using a mixed model regression equation.	[Neugebauer, Jennifer M.; Hawkins, David A.] Univ Calif Davis, Biomed Engn Grad Grp, Davis, CA 95616 USA; [Hawkins, David A.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Beckett, Laurel] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hawkins, DA (corresponding author), Univ Calif Davis, Biomed Engn Grad Grp, Davis, CA 95616 USA.	dahawkins@ucdavis.edu		Beckett, Laurel/0000-0002-2418-9843; Neugebauer, Jennifer/0000-0001-8886-7976	University of California T32 Pre-Doctoral Clinical Research Training Program; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR024146]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	University of California T32 Pre-Doctoral Clinical Research Training Program; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by funding from the University of California T32 Pre-Doctoral Clinical Research Training Program. Statistical advice was made possible by Grant Number UL1 RR024146 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Information on NCRR is available at http://www.ncrr.nih.gov/. Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett S, 2001, CLIN BIOMECH, V16, P351, DOI 10.1016/S0268-0033(01)00026-2; BERKEY CS, 1993, STAT MED, V12, P403, DOI 10.1002/sim.4780120321; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Christiansen CL, 2011, ARCH PHYS MED REHAB, V92, P1624, DOI 10.1016/j.apmr.2011.05.010; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Fox J., 2002, LINEAR MIXED MODELS; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garcia A. W., 2004, MEASURE PHYS ED EXER, V8, P119, DOI DOI 10.1207/S15327841MPEE0803_1; Janz KF, 2007, BONE, V41, P216, DOI 10.1016/j.bone.2007.05.001; Janz KF, 2003, PEDIATR EXERC SCI, V15, P34, DOI 10.1123/pes.15.1.34; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Kuczmarski R, 2000, 2000 CDC GROWTH CHAR; Low DC, 2010, GAIT POSTURE, V32, P664, DOI 10.1016/j.gaitpost.2010.08.002; Neugebauer JM, 2012, J BIOMECH, V45, P2457, DOI 10.1016/j.jbiomech.2012.06.027; Nilsson J, 1998, ACTA PHYSL SCAND, V136, P217; Philippaerts RM, 2006, J SPORT SCI, V24, P221, DOI 10.1080/02640410500189371; Rauch F, 2004, BONE, V34, P771, DOI 10.1016/j.bone.2004.01.022; Rowlands AV, 2012, J BIOMECH, V45, P448, DOI 10.1016/j.jbiomech.2011.12.006; Rowlands AV, 2005, RES Q EXERCISE SPORT, V76, P251; Stansfield BW, 2001, J PEDIATR ORTHOPED, V21, P395, DOI 10.1097/00004694-200105000-00026; THISSEN D, 1976, ANN HUM BIOL, V3, P529, DOI 10.1080/03014467600001791; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Trost SG, 2007, PEDIATR EXERC SCI, V19, P145, DOI 10.1123/pes.19.2.145; Welk GJ, 2003, MED SCI SPORT EXER, V35, P1057, DOI 10.1249/01.MSS.0000069525.56078.22; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005	28	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48182	10.1371/journal.pone.0048182	http://dx.doi.org/10.1371/journal.pone.0048182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133564	Green Submitted, gold, Green Published			2022-12-25	WOS:000310261800054
J	Hung, HI; Schwartz, JM; Maldonado, EN; Lemasters, JJ; Nieminen, AL				Hung, Hsin-I; Schwartz, Justin M.; Maldonado, Eduardo N.; Lemasters, John J.; Nieminen, Anna-Liisa			Mitoferrin-2-dependent Mitochondrial Iron Uptake Sensitizes Human Head and Neck Squamous Carcinoma Cells to Photodynamic Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PHTHALOCYANINE PHOTOSENSITIZERS; CALCIUM UNIPORTER; OXIDATIVE STRESS; CANCER; LYSOSOMES; TRANSPORT; FUSION; AUTOPHAGOSOMES; REQUIREMENT	Photodynamic therapy (PDT) is a promising approach to treat head and neck cancer cells. Here, we investigated whether mitochondrial iron uptake through mitoferrin-2 (Mfrn2) enhanced PDT-induced cell killing. Three human head and neck squamous carcinoma cell lines (UMSCC1, UMSCC14A, and UMSCC22A) were exposed to light and Pc 4, a mitochondria-targeted photosensitizer. The three cell lines responded differently: UMSCC1 and UMSCC14A cells were more resistant, whereas UMSCC22A cells were more sensitive to Pc 4-PDT-induced cell death. In non-erythroid cells, Mfrn2 is an iron transporter in the mitochondrial inner membrane. PDT-sensitive cells expressed higher Mfrn2 mRNA and protein levels compared with PDT-resistant cells. High Mfrn2-expressing cells showed higher rates of mitochondrial Fe2+ uptake compared with low Mfrn2-expressing cells. Bafilomycin, an inhibitor of the vacuolar proton pump of lysosomes and endosomes that causes lysosomal iron release to the cytosol, enhanced PDT-induced cell killing of both resistant and sensitive cells. Iron chelators and the inhibitor of the mitochondrial Ca2+ (and Fe2+) uniporter, Ru360, protected against PDT plus bafilomycin toxicity. Knockdown of Mfrn2 in UMSCC22A cells decreased the rate of mitochondrial Fe2+ uptake and delayed PDT plus bafilomycin-induced mitochondrial depolarization and cell killing. Taken together, the data suggest that lysosomal iron release and Mfrn2-dependent mitochondrial iron uptake act synergistically to induce PDT-mediated and iron-dependent mitochondrial dysfunction and subsequent cell killing. Furthermore, Mfrn2 represents a possible biomarker of sensitivity of head and neck cancers to cell killing after PDT.	[Hung, Hsin-I; Schwartz, Justin M.; Maldonado, Eduardo N.; Lemasters, John J.; Nieminen, Anna-Liisa] Med Univ S Carolina, Ctr Cell Death Injury & Regenerat, Charleston, SC 29425 USA; [Hung, Hsin-I; Schwartz, Justin M.; Maldonado, Eduardo N.; Lemasters, John J.; Nieminen, Anna-Liisa] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Maldonado, Eduardo N.; Lemasters, John J.; Nieminen, Anna-Liisa] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Nieminen, AL (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, DD505 Drug Discovery Bldg,70 President St, Charleston, SC 29425 USA.	nieminen@musc.edu		Maldonado, Eduardo/0000-0002-5285-3027	U.S. National Cancer Institute [R01 CA119079, P30 CA138313]; Abney Cancer Foundation; government of Taiwan; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA119079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073336, R56DK037034] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abney Cancer Foundation; government of Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by grants from the U.S. National Cancer Institute R01 CA119079 (A.-L. N.), P30 CA138313 (Hollings Cancer Center Cell and Molecular Imaging Shared Resource), Abney Cancer Foundation (H.-I. H.), and a scholarship from the government of Taiwan (H.-I. H.).	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Amigo JD, 2011, MOL CELL BIOL, V31, P1344, DOI 10.1128/MCB.01010-10; Baron ED, 2010, LASER SURG MED, V42, P728, DOI 10.1002/lsm.20984; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Bihan H, 2012, HEAD NECK-J SCI SPEC, V34, P493, DOI 10.1002/hed.21763; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; Carroll CB, 2011, NEUROCHEM INT, V59, P73, DOI 10.1016/j.neuint.2011.05.006; Chiu SM, 2010, PHOTOCHEM PHOTOBIOL, V86, P1161, DOI 10.1111/j.1751-1097.2010.00766.x; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duvvuri U, 2009, CURR PROB SURG, V46, P114, DOI [10.1067/j.cpsurg.2008.10.002, 10.1067/j.cpsurg.2008.10.001]; FLATMARK T, 1975, J BIOL CHEM, V250, P6433; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Jerjes W, 2011, LASER SURG MED, V43, P463, DOI 10.1002/lsm.21071; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kon K, 2010, TOXICOL SCI, V117, P101, DOI 10.1093/toxsci/kfq175; Kurz T, 2011, FREE RADICAL BIO MED, V50, P1647, DOI 10.1016/j.freeradbiomed.2011.03.014; Lam M, 2001, J BIOL CHEM, V276, P47379, DOI 10.1074/jbc.M107678200; Li Z, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-34; Liu L, 2011, FREE RADICAL BIO MED, V51, P53, DOI 10.1016/j.freeradbiomed.2011.03.042; Messner DJ, 2009, LIVER INT, V29, P63, DOI 10.1111/j.1478-3231.2008.01793.x; NIEMINEN AL, 1992, TOXICOL APPL PHARM, V115, P147, DOI 10.1016/0041-008X(92)90317-L; OLEINICK NL, 1993, PHOTOCHEM PHOTOBIOL, V57, P242, DOI 10.1111/j.1751-1097.1993.tb02282.x; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Ren YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029666; Rodriguez ME, 2009, PHOTOCHEM PHOTOBIOL, V85, P1189, DOI 10.1111/j.1751-1097.2009.00558.x; Saggu S, 2012, PHOTOCHEM PHOTOBIOL, V88, P461, DOI 10.1111/j.1751-1097.2012.01081.x; Satre M, 2007, BIOCHIMIE, V89, P1058, DOI 10.1016/j.biochi.2007.03.004; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Tan IB, 2010, HEAD NECK-J SCI SPEC, V32, P1597, DOI 10.1002/hed.21368; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	36	43	44	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					677	686		10.1074/jbc.M112.422667	http://dx.doi.org/10.1074/jbc.M112.422667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23135267	Green Published, hybrid			2022-12-25	WOS:000313197200068
J	Boudko, SP; Bachinger, HP				Boudko, Sergei P.; Baechinger, Hans Peter			The NC2 Domain of Type IX Collagen Determines the Chain Register of the Triple Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; CRYSTAL-STRUCTURE; CYSTINE-KNOT; BINDING; TRIMERIZATION; IDENTIFICATION; PEPTIDES; SEGMENT; MOTIFS; SITES	Precise mapping and unraveling the mechanism of interaction or degradation of a certain type of collagen triple helix requires the generation of short and stable collagenous fragments. This is a great challenge especially for hetero-trimeric collagens, where chain composition and register (stagger) are important factors. No system has been reported that can be efficiently used to generate a natural collagenous fragment with exact chain composition and desired chain register. The NC2 domain (only 35-50 residues) of FACIT collagens is a potent trimerization domain. In the case of type IX collagen it provides the efficient selection and hetero-trimerization of three distinct chains. The ability of the NC2 domain to determine the chain register of the triple helix is studied. We generated three possible sequence combinations (alpha 1 alpha 1 alpha 2, alpha 1 alpha 2 alpha 1, alpha 2 alpha 1 alpha 1) of a type I collagen fragment (the binding region for the von Willebrand factor A3 domain) attached to the NC2 domain. In addition, two control combinations were produced that constitute homo-trimers of (alpha 1)(3) or (alpha 2)(3). For the hetero-trimeric constructs, alpha 1 alpha 1 alpha 2 demonstrated a higher melting temperature than the other two. Binding experiments with the von Willebrand factor A3 domain revealed the homo-trimer of (alpha 1)(3) as the strongest binding construct, whereas the homo-trimer of (alpha 2)(3) showed no binding. For hetero-trimers, alpha 1 alpha 1 alpha 2 was found to be the strongest binding construct. Differences in thermal stability and binding to the A3 domain unambiguously demonstrate that the NC2 domain of type IX collagen determines not only the chain composition but also the chain register of the adjacent triple helix.	[Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Bachinger, HP (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Boudko, Sergei/0000-0003-3856-4859	Shriners Hospitals for Children	Shriners Hospitals for Children	The work was supported by a grant from Shriners Hospitals for Children.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BENDER E, 1982, J BIOL CHEM, V257, P9653; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Boudko SP, 2010, J BIOL CHEM, V285, P23721, DOI 10.1074/jbc.M110.128405; Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057; Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Brondijk THC, 2012, P NATL ACAD SCI USA, V109, P5253, DOI 10.1073/pnas.1112388109; BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CRUZ MA, 1995, J BIOL CHEM, V270, P19668; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallas JA, 2009, J BIOL CHEM, V284, P26851, DOI 10.1074/jbc.M109.014753; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005; Leo JC, 2010, INFECT IMMUN, V78, P3226, DOI 10.1128/IAI.01057-09; Li F, 2002, ANN BIOMED ENG, V30, P1107, DOI 10.1114/1.1521931; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wirz JA, 2011, MATRIX BIOL, V30, P9, DOI 10.1016/j.matbio.2010.09.005	35	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44536	44545		10.1074/jbc.M112.417543	http://dx.doi.org/10.1074/jbc.M112.417543			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132862	hybrid, Green Published			2022-12-25	WOS:000312938600050
J	Qiu, CF; Hevner, K; Enquobahrie, DA; Williams, MA				Qiu, Chunfang; Hevner, Karin; Enquobahrie, Daniel A.; Williams, Michelle A.			Maternal Serum Heme-Oxygenase-1 (HO-1) Concentrations in Early Pregnancy and Subsequent Risk of Gestational Diabetes Mellitus	PLOS ONE			English	Article							HEME OXYGENASE-1; OXIDATIVE STRESS; OVEREXPRESSION; ASSOCIATION; IRON	Background: Heme oxygenase-1 (HO-1) concentrations have been recently reported to be elevated in impaired glucose tolerance and type 2 diabetes mellitus (T2DM). However, no study has examined the association between HO-1 concentrations and gestational diabetes mellitus (GDM). Methods: In a case-control study, nested within a prospective cohort of pregnant women (186 GDM cases and 191 women who remained eu-glycemic through pregnancy), we assessed the association of maternal serum HO-1 concentrations, measured in samples collected at 16 weeks gestation, on average, with subsequent risk of GDM. Maternal serum HO-1 concentrations were determined using ELISA. We fitted multivariate logistic regression models to derive estimates of odds ratios (ORs) and 95% confidence intervals (CIs). Results: Median serum HO-1 concentrations in early pregnancy were lower in women who subsequently developed GDM compared with those who did not (1.60 vs. 1.80 ng/mL, p-value = 0.002). After adjusting for maternal age, race, family history of T2DM and pre-pregnancy body mass index, women with HO-1 >= 3.05 ng/mL (highest decile) experienced a 74% reduction of GDM risk (95% CI; 0.09-0.77) compared with women whose concentrations were < 1.23 ng/mL (lowest quartile). Conclusion: Serum HO-1 concentrations were inversely associated with subsequent GDM risk. These findings underscore the role of oxidative stress in the pathogenesis of GDM. Additional studies are warranted to confirm the clinical utility of serum HO-1 in diagnosis of GDM, particularly in the early pregnancy.	[Qiu, Chunfang; Hevner, Karin; Enquobahrie, Daniel A.; Williams, Michelle A.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA; [Enquobahrie, Daniel A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Williams, Michelle A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Swedish Medical Center; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health	Qiu, CF (corresponding author), Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA.	Chun-fang.Qiu@Swedish.org			National Institutes of Health [R01HD-32562]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by an award from the National Institutes of Health (R01HD-32562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Abraham NG, 2004, AM J PHYSIOL-HEART C, V287, pH2468, DOI 10.1152/ajpheart.01187.2003; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; American Diabetes Association, 2011, DIABETES CARE S1, V34, ps15; Bao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032223; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bowers K, 2011, DIABETES CARE, V34, P1557, DOI 10.2337/dc11-0134; Buchanan TA, 2007, DIABETES CARE, V30, pS105, DOI 10.2337/dc07-s201; Chen SF, 2005, P NATL ACAD SCI USA, V102, P7251, DOI 10.1073/pnas.0502407102; Chen XH, 2006, DIABETES CARE, V29, P1077, DOI 10.2337/dc06-0164; Damm P, 1998, DAN MED BULL, V45, P495; Di Noia MA, 2006, J BIOL CHEM, V281, P15687, DOI 10.1074/jbc.M510595200; Engeland A, 2011, EUR J EPIDEMIOL, V26, P157, DOI 10.1007/s10654-010-9527-4; Grochot-Przeczek A, 2010, THROMB HAEMOSTASIS, V104, P424, DOI 10.1160/TH09-12-0825; Hastie TJ., 1990, GEN ADDITIVE MODELS; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lyall F, 2000, FASEB J, V14, P208, DOI 10.1096/fasebj.14.1.208; Mateo I, 2010, ACTA NEUROL SCAND, V121, P136, DOI 10.1111/j.1600-0404.2009.01261.x; Miyazaki T, 2010, INT J HEMATOL, V91, P229, DOI 10.1007/s12185-010-0495-y; Mukerji G, 2012, DIABETOLOGIA, V55, P2148, DOI 10.1007/s00125-012-2549-6; National Institution of Health Office of Dietary Supplements, DIET SUPPL FACT SHEE; Pae HO, 2003, BIOCHEM BIOPH RES CO, V306, P701, DOI 10.1016/S0006-291X(03)01037-4; Paradisi G, 2002, DIABETES CARE, V25, P560, DOI 10.2337/diacare.25.3.560; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Qiu CF, 2004, OBSTET GYNECOL, V103, P519, DOI 10.1097/01.AOG.0000113621.53602.7a; Qiu CF, 2011, DIABETES CARE, V34, P1564, DOI 10.2337/dc11-0135; Qiu CF, 2011, CLIN BIOCHEM, V44, P804, DOI 10.1016/j.clinbiochem.2011.04.023; Sacerdoti D, 2005, CURR NEUROVASC RES, V2, P103, DOI 10.2174/1567202053586802; Sato T, 2006, AM J RESP CRIT CARE, V174, P906, DOI 10.1164/rccm.200508-1237OC; Suhail Mohd, 2010, J Clin Med Res, V2, P266, DOI 10.4021/jocmr454w; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Williams MA, 2004, J CLIN ENDOCR METAB, V89, P2306, DOI 10.1210/jc.2003-031201; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165	36	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48060	10.1371/journal.pone.0048060	http://dx.doi.org/10.1371/journal.pone.0048060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139759	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300017
J	Queipo-Ortuno, MI; Escote, X; Ceperuelo-Mallafre, V; Garrido-Sanchez, L; Miranda, M; Clemente-Postigo, M; Perez-Perez, R; Peral, B; Cardona, F; Fernandez-Real, JM; Tinahones, FJ; Vendrell, J				Isabel Queipo-Ortuno, Maria; Escote, Xavier; Ceperuelo-Mallafre, Victoria; Garrido-Sanchez, Lourdes; Miranda, Merce; Clemente-Postigo, Mercedes; Perez-Perez, Rafael; Peral, Belen; Cardona, Fernando; Manuel Fernandez-Real, Jose; Tinahones, Francisco J.; Vendrell, Joan			FABP4 Dynamics in Obesity: Discrepancies in Adipose Tissue and Liver Expression Regarding Circulating Plasma Levels	PLOS ONE			English	Article							ACID-BINDING PROTEIN; TYPE-2 DIABETIC-PATIENTS; METABOLIC-SYNDROME; INSULIN-RESISTANCE; FATTY-ACID-BINDING-PROTEIN-4; BIOMARKER; DISEASE; WOMEN; AP2; ATHEROSCLEROSIS	Background: FABP4 is predominantly expressed in adipose tissue, and its circulating levels are linked with obesity and a poor atherogenic profile. Objective: In patients with a wide BMI range, we analyze FABP4 expression in adipose and hepatic tissues in the settings of obesity and insulin resistance. Associations between FABP4 expression in adipose tissue and the FABP4 plasma level as well as the main adipogenic and lipolytic genes expressed in adipose tissue were also analyzed. Methods: The expression of several lipogenic, lipolytic, PPAR family and FABP family genes was analyzed by real time PCR. FABP4 protein expression in total adipose tissues and its fractions were determined by western blot. Results: In obesity FABP4 expression was down-regulated (at both mRNA and protein levels), with its levels mainly predicted by ATGL and inversely by the HOMA-IR index. The BMI appeared as the only determinant of the FABP4 variation in both adipose tissue depots. FABP4 plasma levels showed a significant progressive increase according to BMI but no association was detected between FABP4 circulating levels and SAT or VAT FABP4 gene expression. The gene expression of FABP1, FABP4 and FABP5 in hepatic tissue was significantly higher in tissue from the obese IRpatients compared to the non-IR group. Conclusion: The inverse pattern in FABP4 expression between adipose and hepatic tissue observed in morbid obese patients, regarding the IR context, suggests that both tissues may act in a balanced manner. These differences may help us to understand the discrepancies between circulating plasma levels and adipose tissue expression in obesity.	[Isabel Queipo-Ortuno, Maria; Perez-Perez, Rafael; Peral, Belen; Cardona, Fernando; Manuel Fernandez-Real, Jose; Tinahones, Francisco J.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Isabel Queipo-Ortuno, Maria; Ceperuelo-Mallafre, Victoria; Clemente-Postigo, Mercedes; Cardona, Fernando] Hosp Virgen de la Victoria, Fdn IMABIS, Lab Invest Biomed, Malaga, Spain; [Escote, Xavier; Garrido-Sanchez, Lourdes; Miranda, Merce; Vendrell, Joan] Univ Rovira & Virgili, Endocrinol & Diabet Unit, Joan Univ Hosp 23, IISPV, Tarragona, Spain; [Escote, Xavier; Ceperuelo-Mallafre, Victoria; Garrido-Sanchez, Lourdes; Miranda, Merce; Vendrell, Joan] Inst Salud Carlos III, CIBER Diabet Enfermedades Metab Asociadas CIBERDE, Madrid, Spain; [Perez-Perez, Rafael; Peral, Belen] CSIC, Inst Invest Biomed, Madrid, Spain; [Perez-Perez, Rafael; Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Manuel Fernandez-Real, Jose] Inst Invest Biomed Girona IdIBGi, Diabet Endocrinol & Nutr Serv, Girona, Spain; [Tinahones, Francisco J.] Hosp Univ Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; FIMABIS; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universidad de Malaga	Tinahones, FJ (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain.	fjtinahones@hotmail.com	Ortuño, María Isabel Queipo/AAC-1238-2021; miranda, merce/H-7467-2017; Clemente-Postigo, Mercedes/AAA-1102-2020; Peral, Belén/F-4562-2015; Ceperuelo-Mallafré, Victòria/A-4615-2017; Escote, Xavier/AAC-6335-2019; Vendrell, Joan j/V-4034-2018; Escote, Xavier/G-3440-2015; Cardona, Fernando/H-6022-2015; Escoté, Xavier/AAH-2973-2020; Tinahones, Francisco José/AAB-2882-2020; Fernández-Real, Jose Manuel/AGH-3599-2022; Cardona, Fernando/AAG-7835-2019	miranda, merce/0000-0001-6214-1042; Peral, Belén/0000-0003-4984-4020; Ceperuelo-Mallafré, Victòria/0000-0002-4460-9761; Escote, Xavier/0000-0003-1172-3995; Vendrell, Joan j/0000-0002-6994-6115; Escote, Xavier/0000-0003-1172-3995; Cardona, Fernando/0000-0003-4460-6824; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Cardona, Fernando/0000-0003-4460-6824; Tinahones, Francisco J/0000-0001-6871-4403; Perez-Perez, Rafael/0000-0001-7726-5873; QUEIPO ORTUNO, MARIA ISABEL/0000-0002-2867-0845; Clemente-Postigo, Mercedes/0000-0002-4146-6662	Fondo de Investigacion Sanitaria (FIS) from Spanish Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo [07/1024, 08/1195, CB06/03/0018, CP07/0095, PI081655, 10/00967, 11/00085]; Ministerio de Economia y Competitividad (MICINN) [SAF-2009-10461]; Servicio Andaluz de Salud [PI325/2008]; Fundacion Mutua Madrilena, Spain; Juan de la Cierva programme (JdlC) [JCI200904086, JCI-2010-06395]	Fondo de Investigacion Sanitaria (FIS) from Spanish Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo; Ministerio de Economia y Competitividad (MICINN); Servicio Andaluz de Salud; Fundacion Mutua Madrilena, Spain; Juan de la Cierva programme (JdlC)	This work was supported by Fondo de Investigacion Sanitaria (FIS) 07/1024, 08/1195, CB06/03/0018, CP07/0095 and PI081655, 10/00967, 11/00085 from the Spanish Instituto de Salud Carlos III (ISCIII), Ministerio de Sanidad y Consumo; with the participation of the European Regional Development Fund (ERDF) SAF-2009-10461 from the Ministerio de Economia y Competitividad (MICINN), the Servicio Andaluz de Salud (PI325/2008) and Fundacion Mutua Madrilena, Spain (BP). LGS and VCM are supported by fellowships from the Juan de la Cierva programme (JdlC) (JCI200904086 and JCI-2010-06395). CIBERs are an ISCIII Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri R, 2007, CIRCULATION, V116, P270; Bao Y, 2010, PLOS ONE, V6; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Cabre A, 2007, Atherosclerosis, V195, pe150; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Cabre A, 2008, CLIN CHEM, V54, P181, DOI 10.1373/clinchem.2007.094672; Cabre A, 2010, J LIPID RES, V51, P1173, DOI 10.1194/jlr.M900066; Ceperuelo-Mallafre V, 2009, J CLIN ENDOCR METAB, V94, P5062, DOI 10.1210/jc.2009-0764; Clemente-Postigo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024783; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Coll B, 2008, ATHEROSCLEROSIS, V199, P147, DOI 10.1016/j.atherosclerosis.2007.09.032; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Fisher RM, 2001, DIABETOLOGIA, V44, P1268, DOI 10.1007/s001250100643; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Garcia-Fuentes E, 2010, OBESITY, V18, P952, DOI 10.1038/oby.2009.314; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Klimcakova E, 2011, J CLIN ENDOCR METAB, V96, pE73, DOI 10.1210/jc.2010-1575; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Koh JH, 2009, DIABETES CARE, V32, P147, DOI 10.2337/dc08-1379; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Miranda M, 2010, J CLIN ENDOCR METAB, V95, P3470, DOI 10.1210/jc.2009-2655; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Pirro M, 2002, ATHEROSCLEROSIS, V160, P377, DOI 10.1016/S0021-9150(01)00588-3; Poulain-Godefroy O, 2008, AM J PHYSIOL-REG I, V295, pR1, DOI 10.1152/ajpregu.00926.2007; Roden M, 2007, CELL METAB, V6, P89, DOI 10.1016/j.cmet.2007.07.008; Shankar Sudha S, 2005, Curr Diab Rep, V5, P30, DOI 10.1007/s11892-005-0064-6; Shearer J, 2005, DIABETES, V54, P3133, DOI 10.2337/diabetes.54.11.3133; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; Terra XM, 2011, EUR J ENDOCRINOL, V164, P539, DOI 10.1530/EJE-10-1195; Tinahones FJ, 2010, OBES SURG, V20, P1559, DOI 10.1007/s11695-010-0194-z; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; World Health Organization, 2000, WHO TECHN REP SER, V894; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yang R, 2011, INT J OBESITY, V35, P217, DOI 10.1038/ijo.2010.128; Zeyda M, 2009, GERONTOLOGY, V55, P379, DOI 10.1159/000212758	43	49	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48605	10.1371/journal.pone.0048605	http://dx.doi.org/10.1371/journal.pone.0048605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139800	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400054
J	Ling, CY; Hendrickson, ML; Kalil, RE				Ling, Changying; Hendrickson, Michael L.; Kalil, Ronald E.			Morphology, Classification, and Distribution of the Projection Neurons in the Dorsal Lateral Geniculate Nucleus of the Rat	PLOS ONE			English	Article							PRIMARY OPTIC CENTERS; PRINCIPAL CELLS; RELAY CELLS; GOLGI PREPARATIONS; CEREBRAL-CORTEX; VISUAL FIELD; ALBINO-RAT; BODY; ORGANIZATION; CAT	The morphology of confirmed projection neurons in the dorsal lateral geniculate nucleus (dLGN) of the rat was examined by filling these cells retrogradely with biotinylated dextran amine (BDA) injected into the visual cortex. BDA-labeled projection neurons varied widely in the shape and size of their cell somas, with mean cross-sectional areas ranging from 60-340 mu m(2). Labeled projection neurons supported 7-55 dendrites that spanned up to 300 mu m in length and formed dendritic arbors with cross-sectional areas of up to 7.0x10(4) mu m(2). Primary dendrites emerged from cell somas in three broad patterns. In some dLGN projection neurons, primary dendrites arise from the cell soma at two poles spaced approximately 180 degrees apart. In other projection neurons, dendrites emerge principally from one side of the cell soma, while in a third group of projection neurons primary dendrites emerge from the entire perimeter of the cell soma. Based on these three distinct patterns in the distribution of primary dendrites from cell somas, we have grouped dLGN projection neurons into three classes: bipolar cells, basket cells and radial cells, respectively. The appendages seen on dendrites also can be grouped into three classes according to differences in their structure. Short "tufted" appendages arise mainly from the distal branches of dendrites; "spine-like" appendages, fine stalks with ovoid heads, typically are seen along the middle segments of dendrites; and "grape-like" appendages, short stalks that terminate in a cluster of ovoid bulbs, appear most often along the proximal segments of secondary dendrites of neurons with medium or large cell somas. While morphologically diverse dLGN projection neurons are intermingled uniformly throughout the nucleus, the caudal pole of the dLGN contains more small projection neurons of all classes than the rostral pole.	[Kalil, Ronald E.] Univ Wisconsin Madison, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA; [Ling, Changying] Univ Wisconsin Madison, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Hendrickson, Michael L.] Univ Wisconsin Madison, WM Keck Lab Biol Imaging, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kalil, RE (corresponding author), Univ Wisconsin Madison, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.	rekalil@wisc.edu		Hendrickson, Michael/0000-0002-4555-765X	NSF [IBN-9809905]	NSF(National Science Foundation (NSF))	This work was supported by a grant from the NSF (IBN-9809905) to REK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AD, 1968, Q J EXP PHYSIOL CMS, V53, P327, DOI 10.1113/expphysiol.1968.sp001974; Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; BRAUER K, 1979, EXP BRAIN RES, V36, P523; BRAUER K, 1982, Z MIKROSK ANAT FORSC, V96, P65; BURKE W, 1966, J PHYSIOL-LONDON, V187, P201, DOI 10.1113/jphysiol.1966.sp008083; BURKE W, 1966, J PHYSIOL-LONDON, V187, P231, DOI 10.1113/jphysiol.1966.sp008085; CUNNINGHAM TJ, 1971, BRAIN RES, V34, P394, DOI 10.1016/0006-8993(71)90294-0; DECOURTEN C, 1982, EXP BRAIN RES, V47, P159, DOI 10.1007/BF00239375; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; FUKUDA Y, 1974, BRAIN RES, V67, P157, DOI 10.1016/0006-8993(74)90307-2; FUKUDA Y, 1973, BRAIN RES, V57, P208, DOI 10.1016/0006-8993(73)90578-7; Fukuda Y, 1973, EXP BRAIN RES, V59, P206; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P311; GABRIEL S, 1985, EXP BRAIN RES, V61, P210; GAREY LJ, 1981, EXP BRAIN RES, V44, P117; GROSSMAN A, 1973, J COMP NEUROL, V150, P441, DOI 10.1002/cne.901500404; GUILLERY RW, 1966, J COMP NEUROL, V128, P21, DOI 10.1002/cne.901280104; HAYHOW WR, 1962, J COMP NEUROL, V118, P295, DOI 10.1002/cne.901180303; Hendrickson ML, 2012, PLOS ONE IN PRESS; HICKEY TL, 1981, J COMP NEUROL, V200, P545, DOI 10.1002/cne.902000407; HUGHES HC, 1977, J COMP NEUROL, V175, P311, DOI 10.1002/cne.901750306; KAAS JH, 1973, BRAIN BEHAV EVOLUT, V6, P253; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; KRIEBEL RM, 1975, J COMP NEUROL, V159, P45, DOI 10.1002/cne.901590105; KRIEG WJS, 1946, J COMP NEUROL, V84, P221, DOI 10.1002/cne.900840205; Lashley KS, 1934, J COMP NEUROL, V59, P341, DOI 10.1002/cne.900590302; LIEBERMAN AR, 1974, J NEUROCYTOL, V3, P677, DOI 10.1007/BF01097191; LIEBERMAN AR, 1972, BRAIN RES, V42, P196, DOI 10.1016/0006-8993(72)90053-4; Ling C, 2012, PLOS ONE IN PRESS; LUND RD, 1974, J COMP NEUROL, V158, P383, DOI 10.1002/cne.901580403; LUND RD, 1972, INVEST OPHTH VISUAL, V11, P291; MARTIN PR, 1986, EXP BRAIN RES, V62, P77; MONTERO VM, 1968, J NEUROPHYSIOL, V31, P221, DOI 10.1152/jn.1968.31.2.221; MONTERO VM, 1968, J COMP NEUROL, V134, P211, DOI 10.1002/cne.901340208; PARNAVELAS JG, 1977, J COMP NEUROL, V171, P481, DOI 10.1002/cne.901710405; PETERS A, 1976, J NEUROCYTOL, V5, P63, DOI 10.1007/BF01176183; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; REESE BE, 1983, J NEUROPHYSIOL, V49, P877, DOI 10.1152/jn.1983.49.4.877; RIBAK CE, 1975, BRAIN RES, V92, P341, DOI 10.1016/0006-8993(75)90322-4; SAINI KD, 1981, EXP BRAIN RES, V42, P235; SUMITOMO I, 1976, EXP NEUROL, V51, P110, DOI 10.1016/0014-4886(76)90056-X; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Vidal L, 2004, NEUROSCI RES, V48, P387, DOI 10.1016/j.neures.2003.12.004; WEBSTER MJ, 1984, EXP BRAIN RES, V56, P468; Williams SR, 1996, J PHYSL, V490, P120	46	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49161	10.1371/journal.pone.0049161	http://dx.doi.org/10.1371/journal.pone.0049161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139837	gold, Green Submitted, Green Published			2022-12-25	WOS:000310741400069
J	Arambourou, H; Beisel, JN; Branchu, P; Debat, V				Arambourou, Helene; Beisel, Jean-Nicolas; Branchu, Philippe; Debat, Vincent			Patterns of Fluctuating Asymmetry and Shape Variation in Chironomus riparius (Diptera, Chironomidae) Exposed to Nonylphenol or Lead	PLOS ONE			English	Article							LARVAE DIPTERA; DEVELOPMENTAL STABILITY; MOUTHPART DEFORMITIES; TENTANS LARVAE; TOXICITY; STRESS; INDICATOR; SEDIMENTS; GROWTH; BIOACCUMULATION	Deformities and fluctuating asymmetry in chironomid larvae have been proposed as sensitive indicators of biological stress and are commonly used to assess the ecological impact of human activities. In particular, they have been associated in Chironomus riparius, the most commonly used species, with heavy metal and pesticide river pollution. In this study, the effect of lead and 4-nonylphenol on mouthpart morphological variation of Chironomus riparius larvae was investigated by traditional and geometric morphometrics. For this purpose, first to fourth instar larvae were exposed to sediment spiked with lead (from 3.0 to 456.9 mg/kg dry weight) or 4-NP (from 0.1 to 198.8 mg/kg dry weight). Mentum phenotypic response to pollutants was assessed by four parameters: (1) the frequency of deformities, (2) fluctuating asymmetry of mentum length, (3) fluctuating asymmetry of mentum shape and (4) the mentum mean shape changes. Despite the bioaccumulation of pollutants in the chironomid's body, no significant differences between control and stressed groups were found for mouthpart deformities and fluctuating asymmetry of mentum length. Slight effects on mentum shape fluctuating asymmetry were observed for two stressed groups. Significant mean shape changes, consisting of tooth size increase and tooth closing, were detected for lead and 4-NP exposure respectively. Those variations, however, were negligible in comparison to mentum shape changes due to genetic effects. These results suggest that the use of mentum variation as an indicator of toxic stress in Chironomus riparius should be considered cautiously.	[Arambourou, Helene; Branchu, Philippe] IFSTTAR ERA 35, CETE France, Unite Qualite Eaux & Sols, Trappes, France; [Arambourou, Helene; Beisel, Jean-Nicolas] Univ Lorraine, Lab LIEBE, CNRS, UMR 7146, Metz, France; [Debat, Vincent] Museum Natl Hist Nat, Dept Systemat & Evolut, OSEB, UMR 5202, F-75231 Paris, France	Universite Gustave-Eiffel; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Museum National d'Histoire Naturelle (MNHN)	Arambourou, H (corresponding author), IFSTTAR ERA 35, CETE France, Unite Qualite Eaux & Sols, Trappes, France.	helene.arambourou@developpement-durable.gouv.fr	Beisel, Jean-Nicolas/H-4392-2011; Debat, Vincent/H-9610-2019	Beisel, Jean-Nicolas/0000-0002-1935-7689; Debat, Vincent/0000-0003-0040-1181	Research and Innovation Directorate (DRI) of the French Ministry of Ecology; IFSTTAR organism (French institute of science and technology for transport, development and networks); French Water Agency (AESN)	Research and Innovation Directorate (DRI) of the French Ministry of Ecology; IFSTTAR organism (French institute of science and technology for transport, development and networks); French Water Agency (AESN)	The work has been financially supported by the The Research and Innovation Directorate (DRI) of the French Ministry of Ecology, by the IFSTTAR organism (French institute of science and technology for transport, development and networks) and by the French Water Agency (AESN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal W, 2000, CHEMOSPHERE, V41, P289, DOI 10.1016/S0045-6535(99)00423-3; Al-Shami SA, 2011, WATER AIR SOIL POLL, V216, P203, DOI 10.1007/s11270-010-0528-4; Bat Levent, 2001, Turkish Journal of Zoology, V25, P87; Bervoets L, 1996, ARCH ENVIRON CON TOX, V31, P502, DOI 10.1007/BF00212434; Bettinetti R, 2002, CHEMOSPHERE, V46, P201, DOI 10.1016/S0045-6535(01)00114-X; BIRD GA, 1995, ENVIRON TOXICOL CHEM, V14, P2125, DOI [10.1897/1552-8618(1995)14[2125:TEOPAS]2.0.CO;2, 10.1002/etc.5620141216]; Bird GA, 1997, ENVIRON MONIT ASSESS, V45, P273, DOI 10.1023/A:1005782803930; Bleeker EAJ, 1999, ENVIRON TOXICOL CHEM, V18, P1829, DOI [10.1897/1551-5028(1999)018&lt;1829:EOETAO&gt;2.3.CO;2, 10.1002/etc.5620180833]; Bonada N, 2005, ARCH HYDROBIOL, V162, P167, DOI 10.1127/0003-9136/2005/0162-0167; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Borgmann U, 1999, CAN J FISH AQUAT SCI, V56, P1494, DOI 10.1139/cjfas-56-8-1494; Campero M, 2008, FUNCT ECOL, V22, P271, DOI 10.1111/j.1365-2435.2007.01381.x; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Clarke GM, 1998, HEREDITY, V80, P553, DOI 10.1046/j.1365-2540.1998.00326.x; CLARKE GM, 1993, ENVIRON POLLUT, V82, P207, DOI 10.1016/0269-7491(93)90119-9; Dahlgaard J, 2000, CONSERV BIOL, V14, P1187, DOI 10.1046/j.1523-1739.2000.99206.x; de Bisthoven LJ, 1998, ARCH ENVIRON CON TOX, V35, P249, DOI 10.1007/s002449900373; de Bisthoven LJ, 1998, CAN J FISH AQUAT SCI, V55, P688, DOI 10.1139/cjfas-55-3-688; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dias V, 2008, CHEMOSPHERE, V71, P574, DOI 10.1016/j.chemosphere.2007.09.029; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Epler J. H., 2001, IDENTIFICATION MANUA; FOWLER BA, 1987, ENVIRON HEALTH PERSP, V71, P121, DOI 10.2307/3430419; Groenendijk D, 1998, ENVIRON TOXICOL CHEM, V17, P1999, DOI [10.1002/etc.5620171016, 10.1897/1551-5028(1998)017&lt;1999:FAAMGI&gt;2.3.CO;2]; Grosell M, 2006, ENVIRON TOXICOL CHEM, V25, P97, DOI 10.1897/04-654R.1; HARE L, 1976, CAN J ZOOL, V54, P2129, DOI 10.1139/z76-246; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Hoffmann AA, 2005, AUST J ENTOMOL, V44, P233, DOI 10.1111/j.1440-6055.2005.00469.x; Hoffmann AA, 2001, ECOL LETT, V4, P97, DOI 10.1046/j.1461-0248.2001.00205.x; Hoss S, 2002, ENVIRON POLLUT, V120, P169, DOI 10.1016/S0269-7491(02)00161-6; Hudson LA, 1996, CAN J FISH AQUAT SCI, V53, P297, DOI 10.1139/cjfas-53-2-297; Hughes EM, 2004, COMP BIOCHEM PHYS C, V137, P237, DOI 10.1016/j.cca.2004.01.006; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V54, P678; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x; KRANTZBERG G, 1989, CAN J FISH AQUAT SCI, V46, P389, DOI 10.1139/f89-051; Lagrana CC, 2010, J TRENDS CHEM, V1, P8; Langer-Jaesrich M, 2010, J SOIL SEDIMENT, V10, P414, DOI 10.1007/s11368-010-0195-5; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; LeBlanc GA, 2000, ENVIRON HEALTH PERSP, V108, P1133, DOI 10.2307/3434824; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P265, DOI 10.2307/1467461; Leung Brian, 2003, P415; Maenpaa K, 2006, AQUAT TOXICOL, V77, P329, DOI 10.1016/j.aquatox.2006.01.002; Martinez EA, 2002, ARCH ENVIRON CON TOX, V42, P286, DOI 10.1007/s00244-001-0190-0; Meregalli G, 2001, ENVIRON POLLUT, V111, P241, DOI 10.1016/S0269-7491(00)00068-3; Meregalli G, 2001, SCI TOTAL ENVIRON, V269, P157, DOI 10.1016/S0048-9697(00)00824-X; Moore M, 1987, PHILOS T R SOC B, V316, P209; Nowak C, 2007, ENVIRON TOXICOL CHEM, V26, P1018, DOI 10.1897/06-349R.1; OECD, 2001, GUID 218 SED WAT CHI; Palmer A. Richard, 2003, P279; Palmer AR, 1986, ANNU REV ECOL SYST, V17, P191; Park K, 2009, CHEMOSPHERE, V77, P359, DOI 10.1016/j.chemosphere.2009.07.019; Pelabon C, 2008, EVOLUTION, V62, P2855, DOI 10.1111/j.1558-5646.2008.00495.x; PINDER LCV, 1986, ANNU REV ENTOMOL, V31, P1, DOI 10.1146/annurev.en.31.010186.000245; Piscart C, 2005, CR BIOL, V328, P912, DOI 10.1016/j.crvi.2005.09.002; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasband W, 2012, IMAGE J IMAGE PROCES; Renner R, 1997, ENVIRON SCI TECHNOL, V31, pA316, DOI 10.1021/es972366q; Rohlf F., 2010, TPS DIG; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Roulier JL, 2008, CHEMOSPHERE, V70, P925, DOI 10.1016/j.chemosphere.2007.06.061; Servia MJ, 2004, ENVIRON MONIT ASSESS, V90, P101, DOI 10.1023/B:EMAS.0000003569.22040.ac; Strenzke K., 1959, Archiv fuer Hydrobiologie Stuttgart, V56, P1; Thibaut R, 2000, ANALUSIS, V28, P793, DOI 10.1051/analusis:2000280793; Vazquez-Duhalt R., 2006, Applied Ecology and Environmental Research, V4, P1; Vermeulen AC, 1998, ARCH HYDROBIOL, V144, P103; Vermeulen AC, 2000, CHEMOSPHERE, V41, P1581, DOI 10.1016/S0045-6535(00)00033-3; WARREN LJ, 1981, ENVIRON POLLUT B, V2, P401, DOI 10.1016/0143-148X(81)90037-9; Watts MM, 2003, ECOTOX ENVIRON SAFE, V54, P207, DOI 10.1016/S0147-6513(02)00029-5; WENE GEORGE, 1940, OHIO JOUR SCI, V40, P193; WIEDERHOLM T, 1984, HYDROBIOLOGIA, V109, P243, DOI 10.1007/BF00007742; Ying GG, 2002, ENVIRON INT, V28, P215, DOI 10.1016/S0160-4120(02)00017-X; Zakharov Vladimir M., 1992, Acta Zoologica Fennica, V191, P7	74	27	28	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48844	10.1371/journal.pone.0048844	http://dx.doi.org/10.1371/journal.pone.0048844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133660	Green Published, gold			2022-12-25	WOS:000310702400048
J	Crickard, L; Babas, T; Seth, S; Silvera, P; Koriazova, L; Crotty, S				Crickard, Lindsay; Babas, Tahar; Seth, Sidharth; Silvera, Peter; Koriazova, Lilia; Crotty, Shane			Protection of Rabbits and Immunodeficient Mice against Lethal Poxvirus Infections by Human Monoclonal Antibodies	PLOS ONE			English	Article							VACCINIA IMMUNE GLOBULIN; SMALLPOX VACCINATION; NEUTRALIZING ANTIBODIES; VIRUS-INFECTION; MONKEYPOX VIRUS; GAMMA-GLOBULIN; CHALLENGE; EFFICACY; PROTEIN; THERAPY	Smallpox (variola virus) is a bioweapon concern. Monkeypox is a growing zoonotic poxvirus threat. These problems have resulted in extensive efforts to develop potential therapeutics that can prevent or treat potentially lethal poxvirus infections in humans. Monoclonal antibodies (mAbs) against smallpox are a conservative approach to this problem, as the licensed human smallpox vaccine (vaccinia virus, VACV) primarily works on the basis of protective antibody responses against smallpox. Fully human mAbs (hmAbs) against vaccinia H3 (H3L) and B5 (B5R), targeting both the mature virion (MV) and extracellular enveloped virion (EV) forms, have been developed as potential therapeutics for use in humans. Post-exposure prophylaxis was assessed in both murine and rabbit animal models. Therapeutic efficacy of the mAbs was assessed in three good laboratory practices (GLP) studies examining severe combined immunodeficiency mice (SCID) given a lethal VACV infection. Pre-exposure combination hmAb therapy provided significantly better protection against disease and death than either single hmAb or vaccinia immune globulin (VIG). Post-exposure combination mAb therapy provided significant protection against disease and death, and appeared to fully cure the VACV infection in >= 50% of SCID mice. Therapeutic efficacy was then assessed in two rabbit studies examining post-exposure hmAb prophylaxis against rabbitpox (RPXV). In the first study, rabbits were infected with RPVX and then provided hmAbs at 48 hrs post-infection, or 1 hr and 72 hrs post-infection. Rabbits in both groups receiving hmAbs were 100% protected from death. In the second rabbitpox study, 100% of animal treated with combination hmAb therapy and 100% of animals treated with anti-B5 hmAb were protected. These findings suggest that combination hmAb treatment may be effective at controlling smallpox disease in immunocompetent or immunodeficient humans.	[Crickard, Lindsay; Crotty, Shane] La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA USA; [Babas, Tahar; Silvera, Peter] So Res Inst, Infect Dis Res Dept, Frederick, MD USA; [Seth, Sidharth; Koriazova, Lilia] Kyowa Hakko Kirin Calif Inc, La Jolla, CA USA; [Crotty, Shane] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol LIAI, Div Vaccine Discovery, La Jolla, CA USA.	shane@liai.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 	NIH NIAID [AI63107, AI077953]; La Jolla Institute for Allergy and Immunology Institutional Funds; Kyowa Hakko Kirin California, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063107, U01AI077953] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); La Jolla Institute for Allergy and Immunology Institutional Funds; Kyowa Hakko Kirin California, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly funded by NIH NIAID AI63107, NIH NIAID AI077953, and La Jolla Institute for Allergy and Immunology Institutional Funds to SC. This work was partly funded by Kyowa Hakko Kirin California, Inc. internal funds to LK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Bell E, 2004, VIROLOGY, V325, P425, DOI 10.1016/j.virol.2004.05.004; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; Benhnia MREI, 2009, J VIROL, V83, P12355, DOI 10.1128/JVI.01593-09; Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Chen ZC, 2006, P NATL ACAD SCI USA, V103, P1882, DOI 10.1073/pnas.0510598103; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; Corporation BH, 1995, VACC IMM GLOB HUM PA; Couzi G., 1941, Bull. Inst. Hyg. Maroc., V1, P59; Davies DH, 2005, J VIROL, V79, P11724, DOI 10.1128/JVI.79.18.11724-11733.2005; Dynport Vaccine Company, 2005, VACC IMM GLOB INTR H; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Fenner F, 2001, SMALLPOX ITS ERADICA, P4; Fulginiti VA, 2003, JAMA-J AM MED ASSOC, V290, P1452, DOI 10.1001/jama.290.11.1452-a; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241, DOI 10.1086/375824; Goldsmith JC, 2004, VOX SANG, V86, P125, DOI 10.1111/j.0042-9007.2004.00397.x; Greenberg RN, 2008, EXPERT OPIN INV DRUG, V17, P555, DOI [10.1517/13543784.17.4.555, 10.1517/13543784.17.4.555 ]; Grosenbach DW, 2010, P NATL ACAD SCI USA, V107, P838, DOI 10.1073/pnas.0912134107; Hammarlund E, 2005, NAT MED, V11, P1005, DOI 10.1038/nm1273; He Y, 2007, J INFECT DIS, V196, P1026, DOI 10.1086/520936; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Hopkins RJ, 2004, CLIN INFECT DIS, V39, P819, DOI 10.1086/422999; Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; Karem KL, 2007, CLIN VACCINE IMMUNOL, V14, P1318, DOI 10.1128/CVI.00148-07; Kawakami Y, 2009, J EXP MED; KEMPE CH, 1960, PEDIATRICS, V26, P176; KEMPE CH, 1956, PEDIATRICS, V18, P177; Lustig S, 2005, J VIROL, V79, P13454, DOI 10.1128/JVI.79.21.13454-13462.2005; MARENNIKOVA SS, 1962, B WORLD HEALTH ORGAN, V27, P325; Marriott KA, 2008, VACCINE, V26, P581, DOI 10.1016/j.vaccine.2007.10.063; McCausland MM, 2010, ANTIVIR THER, V15, P661, DOI 10.3851/IMP1573; Moss B, 2011, IMMUNOL REV, V239, P8, DOI 10.1111/j.1600-065X.2010.00975.x; Neff JM, 2003, NEW ENGL J MED, V348, P1921; Parker S, 2008, ANTIVIR RES, V77, P39, DOI 10.1016/j.antiviral.2007.08.003; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; Shearer JD, 2005, ANTIMICROB AGENTS CH, V49, P2634, DOI 10.1128/AAC.49.7.2634-2641.2005; Talecris I., 2005, BIOTHERAPEUTICS PROL; Tomimori Y, 2011, ANTIVIR THER, V16, P67, DOI 10.3851/IMP1717; Wittek R, 2006, INT J INFECT DIS, V10, P193, DOI 10.1016/j.ijid.2005.12.001; Xu RH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002475	43	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48706	10.1371/journal.pone.0048706	http://dx.doi.org/10.1371/journal.pone.0048706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133652	gold, Green Published, Green Submitted			2022-12-25	WOS:000310702400043
J	Stockigt, F; Brixius, K; Lickfett, L; Andrie, R; Linhart, M; Nickenig, G; Schrickel, JW				Stoeckigt, Florian; Brixius, Klara; Lickfett, Lars; Andrie, Rene; Linhart, Markus; Nickenig, Georg; Schrickel, Jan Wilko			Total Beta-Adrenoceptor Knockout Slows Conduction and Reduces Inducible Arrhythmias in the Mouse Heart	PLOS ONE			English	Article							PROTEIN-KINASE-A; ADRENERGIC-RECEPTOR; CARDIAC MYOCYTES; MICE LACKING; BETA-2-ADRENERGIC RECEPTORS; METABOLIC ALTERATIONS; TARGETED DISRUPTION; UP-REGULATION; NITRIC-OXIDE; CELL-DEATH	Introduction: Beta-adrenoceptors (beta-AR) play an important role in the neurohumoral regulation of cardiac function. Three beta-AR subtypes (beta(1), beta(2), beta(3)) have been described so far. Total deficiency of these adrenoceptors (TKO) results in cardiac hypotrophy and negative inotropy. TKO represents a unique mouse model mimicking total unselective medical beta-blocker therapy in men. Electrophysiological characteristics of TKO have not yet been investigated in an animal model. Methods: In vivo electrophysiological studies using right heart catheterisation were performed in 10 TKO mice and 10 129SV wild type control mice (WT) at the age of 15 weeks. Standard surface ECG, intracardiac and electrophysiological parameters, and arrhythmia inducibility were analyzed. Results: The surface ECG of TKO mice revealed a reduced heart rate (359.2 +/- 20.9 bpm vs. 461.1 +/- 33.3 bpm; p<0.001), prolonged P wave (17.5 +/- 3.0 ms vs. 15.1 +/- 1.2 ms; p=0.019) and PQ time (40.8 +/- 2.4 ms vs. 37.3 +/- 3.0 ms; p=0.013) compared to WT. Intracardiac ECG showed a significantly prolonged infra-Hisian conductance (HV-interval: 12.9 +/- 1.4 ms vs. 6.8 +/- 1.0 ms; p<0.001). Functional testing showed prolonged atrial and ventricular refractory periods in TKO (40.5 +/- 15.5 ms vs. 21.3 +/- 5.8 ms; p=0.004; and 41.0 +/- 9.7 ms vs. 28.3 +/- 6.6 ms; p=0.004, respectively). In TKO both the probability of induction of atrial fibrillation (12% vs. 24%; p<0.001) and of ventricular tachycardias (0% vs. 26%; p<0.001) were significantly reduced. Conclusion: TKO results in significant prolongations of cardiac conduction times and refractory periods. This was accompanied by a highly significant reduction of atrial and ventricular arrhythmias. Our finding confirms the importance of beta-AR in arrhythmogenesis and the potential role of unspecific beta-receptor-blockade as therapeutic target.	[Stoeckigt, Florian; Lickfett, Lars; Andrie, Rene; Linhart, Markus; Nickenig, Georg; Schrickel, Jan Wilko] Univ Hosp Bonn, Dept Med Cardiol, Bonn, Germany; [Brixius, Klara] German Sportunivers Cologne, Cologne, Germany	University of Bonn	Stockigt, F (corresponding author), Univ Hosp Bonn, Dept Med Cardiol, Bonn, Germany.	florian.stoeckigt@ukb.uni-bonn.de		Stockigt, Florian/0000-0002-0885-679X				Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Bernstein D, 2005, AM J PHYSIOL-HEART C, V289, pH2441, DOI 10.1152/ajpheart.00005.2005; Bernstein D, 2002, TRENDS CARDIOVAS MED, V12, P287, DOI 10.1016/S1050-1738(02)00176-7; Bernstein D, 2011, PROG PEDIATR CARDIOL, V31, P35, DOI 10.1016/j.ppedcard.2010.11.007; Bisognano JD, 2000, J MOL CELL CARDIOL, V32, P817, DOI 10.1006/jmcc.2000.1123; Brixius K, 2004, BRIT J PHARMACOL, V143, P1014, DOI 10.1038/sj.bjp.0705983; Brixius K, 2006, CAN J PHYSIOL PHARM, V84, P1051, DOI 10.1139/Y06-033; BRODDE OE, 1991, PHARMACOL REV, V43, P203; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; CREAMER JE, 1986, AM J CARDIOL, V57, P1092, DOI 10.1016/0002-9149(86)90680-6; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DeSantiago J, 2008, CIRC RES, V102, P1389, DOI 10.1161/CIRCRESAHA.107.169011; DHINGRA RC, 1981, CIRCULATION, V64, P1265, DOI 10.1161/01.CIR.64.6.1265; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DUFF HJ, 1983, J AM COLL CARDIOL, V2, P1134, DOI 10.1016/S0735-1097(83)80340-4; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Ecker PM, 2006, AM J PHYSIOL-HEART C, V290, pH192, DOI 10.1152/ajpheart.00032.2005; EDVARDSSON N, 1985, EUR HEART J, V6, P163, DOI 10.1093/eurheartj/6.suppl_D.163; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; Eynon N, 2008, J CARDIOPULM REHABIL, V28, P189, DOI 10.1097/01.HCR.0000320070.81470.75; FRIEDBERG CK, 1964, ANN NY ACAD SCI, V111, P835, DOI 10.1111/j.1749-6632.1964.tb53151.x; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Gan RT, 2007, CHINESE MED J-PEKING, V120, P2250, DOI 10.1097/00029330-200712020-00018; HAFT JI, 1974, PROG CARDIOVASC DIS, V17, P73, DOI 10.1016/0033-0620(74)90039-5; Jimenez M, 2002, FEBS LETT, V530, P37, DOI 10.1016/S0014-5793(02)03387-2; Johansson B W, 1966, Acta Med Scand Suppl, V451, P1; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Kreuzberg MM, 2006, P NATL ACAD SCI USA, V103, P5959, DOI 10.1073/pnas.0508512103; Lechat P, 1999, LANCET, V353, P9; Lee S, 2010, PHYSIOL RES, V59, P679, DOI 10.33549/physiolres.931851; LEWIS RV, 1993, DRUG SAFETY, V9, P272, DOI 10.2165/00002018-199309040-00005; Miller CD, 2007, AM J MED, V120, P685, DOI 10.1016/j.amjmed.2007.04.016; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Moens AL, 2010, J MOL CELL CARDIOL, V48, P1088, DOI 10.1016/j.yjmcc.2010.02.011; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Moniotte S, 2007, EUR J HEART FAIL, V9, P1163, DOI 10.1016/j.ejheart.2007.10.006; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Morimoto A, 2004, AM J PHYSIOL-HEART C, V286, pH2425, DOI 10.1152/ajpheart.01045.2003; Myslivecek J, 2006, LIFE SCI, V79, P112, DOI 10.1016/j.lfs.2005.12.026; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Patterson AJ, 2004, CRIT CARE MED, V32, P1041, DOI 10.1097/01.CCM.0000120049.43113.90; RAINE AEG, 1981, CIRC RES, V48, P804, DOI 10.1161/01.RES.48.6.804; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Rozec B, 2009, J AM COLL CARDIOL, V53, P1532, DOI 10.1016/j.jacc.2008.11.057; Sabir IN, 2007, PFLUG ARCH EUR J PHY, V454, P209, DOI 10.1007/s00424-007-0217-3; Schrickel JW, 2007, CARDIOVASC RES, V76, P257, DOI 10.1016/j.cardiores.2007.07.001; Schrickel JW, 2002, BASIC RES CARDIOL, V97, P452, DOI 10.1007/s003950200052; STRASBERG B, 1981, CIRCULATION, V63, P1043, DOI 10.1161/01.CIR.63.5.1043; Wallukat G, 2002, HERZ, V27, P683, DOI 10.1007/s00059-002-2434-z; Workman AJ, 2003, CARDIOVASC RES, V58, P518, DOI 10.1016/S0008-6363(03)00263-3; Xiao RP, 1999, CIRC RES, V84, P43; Zhan DY, 2009, CARDIOVASC RES, V84, P64, DOI 10.1093/cvr/cvp168; Zhao Q, 2007, CARDIOVASC DRUG THER, V21, P85, DOI 10.1007/s10557-007-6016-4; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	60	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e49203	10.1371/journal.pone.0049203	http://dx.doi.org/10.1371/journal.pone.0049203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133676	Green Submitted, gold, Green Published			2022-12-25	WOS:000310601300033
J	Calvani, M; Comito, G; Giannoni, E; Chiarugi, P				Calvani, Maura; Comito, Giuseppina; Giannoni, Elisa; Chiarugi, Paola			Time-Dependent Stabilization of Hypoxia Inducible Factor-1 alpha by Different Intracellular Sources of Reactive Oxygen Species	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-SURVIVAL; CANCER; ACTIVATION; HIF-1; ANGIOGENESIS; HIF-1-ALPHA; RESISTANCE; PATHWAY; OXIDASE	Intratumoral hypoxia is a major obstacle in the development of effective cancer chemotherapy, decreasing the efficacy of anti-neoplastic drugs in several solid tumours. The hypoxic environment, through its master regulator hypoxia inducible factor-1 (HIF-1), is able to maintain an anti-apoptotic potential through activation of critical genes associated with drug resistance. Besides affecting metabolism and motility of tumour cells, hypoxia also paradoxically increases production of reactive oxygen species (ROS), which contribute to stabilize HIF-1 through a redox-mediated inhibition of its proteolysis. Here we reported that 1% O-2 hypoxia increases the resistance of human metastatic melanoma cells to conventional chemotherapy with etoposide, and that the increase in chemoresistance strongly depends on ROS delivery due to hypoxia. We reported a biphasic redox-dependent role of HIF-1, involving mitochondrial complex III and NADPH oxidase as oxidants sources, synergising in enhancing survival to chemotherapy. The feed-forward loop engaged by hypoxia involves first an HIF-1-dependent vascular endothelial growth factor-A (VEGF-A) autocrine production and, in the later phase, activation of NADPH oxidase from VEGF/VEGFR2 interaction, finally leading to a further redox-dependent long lasting stabilization of HIF-1. We therefore identified a redox-dependent circuitry linking hypoxia-driven ROS to VEGF-A secretion and to enhanced melanoma cell survival to etoposide chemotherapy.	[Calvani, Maura; Comito, Giuseppina; Giannoni, Elisa; Chiarugi, Paola] Univ Florence, Dept Biochem Sci, Florence, Italy; [Chiarugi, Paola] Ist Toscano Tumouri, Florence, Italy; [Chiarugi, Paola] Ctr Res Transfer & High Educ DenoTHE, Florence, Italy	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Chiarugi, P (corresponding author), Univ Florence, Dept Biochem Sci, Florence, Italy.	paola.chiarugi@unifi.it	Giannoni, Elisa/AAE-2092-2020; Chiarugi, Paola/CDD-7988-2022	Chiarugi, Paola/0000-0001-7655-2969; Comito, Giuseppina/0000-0002-4614-067X; Giannoni, Elisa/0000-0001-7136-1098	Associazione Italiana Ricerca sul Cancro (AIRC); Istituto Toscano Tumori (ITT); Regione Toscana (TUMAR)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori (ITT); Regione Toscana (TUMAR)(Regione Toscana)	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC), by Istituto Toscano Tumori (ITT) and Regione Toscana (TUMAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Cataldi A, 2010, CURR PHARM DESIGN, V16, P1387, DOI 10.2174/138161210791033969; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Comito G, 2011, FREE RADICAL BIO MED, V51, P893, DOI 10.1016/j.freeradbiomed.2011.05.042; Davar D, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/274382; de Andrade DP, 2011, ANTI-CANCER DRUG, V22, pS15, DOI 10.1097/01.cad.0000398728.45590.11; de Gramont A, 2011, SEMIN ONCOL, V38, P521, DOI 10.1053/j.seminoncol.2011.05.006; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Di Paolo Antonello, 2007, Curr Oncol Rep, V9, P109; Du J, 2011, PLOS ONE, V6; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Flashman E, 2010, FEBS J, V4, P1742; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Giannoni E, 2012, ANTIOXID REDOX SIGN, V16, P1248, DOI 10.1089/ars.2011.4280; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Helmbach H, 2001, INT J CANCER, V93, P617, DOI 10.1002/ijc.1378; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hsieh CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023945; Jiang YY, 2011, EUR J PHARMACOL, V668, P78, DOI 10.1016/j.ejphar.2011.06.007; Kissel CK, 2006, MELANOMA RES, V16, P527, DOI 10.1097/CMR.0b013e3280103a7c; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Kuphal S, 2010, EUR J CANCER, V46, P1159, DOI 10.1016/j.ejca.2010.01.031; Lee HY, 2011, CARCINOGENESIS, V32, P703, DOI 10.1093/carcin/bgr034; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Maira F, 2011, CURR DRUG DELIV; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; Moon EJ, 2010, P NATL ACAD SCI USA, V107, P20477, DOI 10.1073/pnas.1006646107; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Piret JP, 2004, EXP CELL RES, V295, P340, DOI 10.1016/j.yexcr.2004.01.024; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Snyder CM, 2009, ANTIOXID REDOX SIGN, V11, P2673, DOI [10.1089/ars.2009.2730, 10.1089/ARS.2009.2730]; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; VAUPEL P, 1991, CANCER RES, V51, P3316; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8	44	61	64	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e38388	10.1371/journal.pone.0038388	http://dx.doi.org/10.1371/journal.pone.0038388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144690	gold, Green Published			2022-12-25	WOS:000310705300001
J	Caissard, JC; Olivier, T; Delbecque, C; Palle, S; Garry, PP; Audran, A; Valot, N; Moja, S; Nicole, F; Magnard, JL; Legrand, S; Baudino, S; Jullien, F				Caissard, Jean-Claude; Olivier, Thomas; Delbecque, Claire; Palle, Sabine; Garry, Pierre-Philippe; Audran, Arthur; Valot, Nadine; Moja, Sandrine; Nicole, Florence; Magnard, Jean-Louis; Legrand, Sylvain; Baudino, Sylvie; Jullien, Frederic			Extracellular Localization of the Diterpene Sclareol in Clary Sage (Salvia sclarea L., Lamiaceae)	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; ESSENTIAL OIL BIOSYNTHESIS; MENTHA-X-PIPERITA; GLANDULAR HAIRS; MONOTERPENE BIOSYNTHESIS; SECRETED MATERIAL; PROTEIN CRYSTALS; TRICHOMES; LEAF; RESISTANCE	Sclareol is a high-value natural product obtained by solid/liquid extraction of clary sage (Salvia sclarea L.) inflorescences. Because processes of excretion and accumulation of this labdane diterpene are unknown, the aim of this work was to gain knowledge on its sites of accumulation in planta. Samples were collected in natura or during different steps of the industrial process of extraction (steam distillation and solid/liquid extraction). Samples were then analysed with a combination of complementary analytical techniques (gas chromatography coupled to a mass spectrometer, polarized light microscopy, environmental scanning electron microscopy, two-photon fluorescence microscopy, second harmonic generation microscopy). According to the literature, it is hypothesized that sclareol is localized in oil pockets of secretory trichomes. This study demonstrates that this is not the case and that sclareol accumulates in a crystalline epicuticular form, mostly on calyces.	[Caissard, Jean-Claude; Valot, Nadine; Moja, Sandrine; Nicole, Florence; Magnard, Jean-Louis; Legrand, Sylvain; Baudino, Sylvie; Jullien, Frederic] Univ Lyon, Univ St Etienne, Lab Biotechnol Vegetales Appl Plantes Aromat & Me, St Etienne, France; [Olivier, Thomas] Univ Lyon, Univ St Etienne, Lab Hubert Curien, St Etienne, France; [Delbecque, Claire; Garry, Pierre-Philippe; Audran, Arthur] Bontoux SA, St Auban Sur Ouveze, France; [Palle, Sabine] Univ Lyon, Univ St Etienne, Ctr Microscopie Confocale Multiphoton, St Etienne, France; [Legrand, Sylvain] Univ Lille 1, Univ Lille Nord France, Lab Stress Abiot & Differenciat Vegetaux Cult, F-59655 Villeneuve Dascq, France	Universite Jean Monnet; Universite Jean Monnet; Universite Jean Monnet; Universite de Lille - ISITE; Universite de Lille	Caissard, JC (corresponding author), Univ Lyon, Univ St Etienne, Lab Biotechnol Vegetales Appl Plantes Aromat & Me, St Etienne, France.	caissard@univ-st-etienne.fr	Jullien, Frederic/AAF-5473-2020; Legrand, Sylvain/X-1576-2019	Legrand, Sylvain/0000-0002-7098-0273; MAGNARD, Jean-Louis/0000-0001-8312-2633; JULLIEN, Frederic/0000-0001-9858-729X; Baudino, Sylvie/0000-0002-3367-172X; CAISSARD, Jean-Claude/0000-0001-7938-3101; Moja, Sandrine/0000-0002-4943-3689; Florence, Nicole/0000-0002-1853-7055	Pole de Competitivite Parfums, Aromes, Senteurs, Saveurs; Direction Generale de la Competitivite, de l'Industrie et des Services; Region Rhone-Alpes; Universite Jean Monnet; CNRS; Leica Microsystem	Pole de Competitivite Parfums, Aromes, Senteurs, Saveurs; Direction Generale de la Competitivite, de l'Industrie et des Services; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Universite Jean Monnet; CNRS(Centre National de la Recherche Scientifique (CNRS)); Leica Microsystem	This work is part of the Claryssime Programme (http://www.claryssime.fr/) supervised by CD, and including a PostDoc grant to SL. Claryssime is funded by "Pole de Competitivite Parfums, Aromes, Senteurs, Saveurs", "Direction Generale de la Competitivite, de l'Industrie et des Services" and "Region Rhone-Alpes". Laser microscopy is funded by Universite Jean Monnet, CNRS and Leica Microsystem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO WR, 1992, J BIOL CHEM, V267, P7582; AMELUNXEN F, 1969, Z PFLANZENPHYSIOL, V61, P68; BAILEY JA, 1975, NATURE, V255, P328, DOI 10.1038/255328a0; Barrero AF, 1996, J ORG CHEM, V61, P2215, DOI 10.1021/jo951908o; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Bergougnoux V, 2007, PLANTA, V226, P853, DOI 10.1007/s00425-007-0531-1; Bisio A, 1999, ANN BOT-LONDON, V83, P441, DOI 10.1006/anbo.1998.0838; Bonito MC, 2011, NAT PROD COMMUN, V6, P1205; Brown RM, 2003, OPT LETT, V28, P2207, DOI 10.1364/OL.28.002207; Buschhaus C, 2011, J EXP BOT, V62, P841, DOI 10.1093/jxb/erq366; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Carver TLW, 2006, ANNU PLANT REV, V23, P368; CHANG SY, 1980, BOT GAZ, V141, P360, DOI 10.1086/337168; CHEETHAM PSJ, 1993, TRENDS BIOTECHNOL, V11, P478, DOI 10.1016/0167-7799(93)90081-J; Chen LJ, 2002, MICROSC MICROANAL, V8, P268, DOI 10.1017/S1431927602020202; Chu SW, 2002, J MICROSC-OXFORD, V208, P190, DOI 10.1046/j.1365-2818.2002.01081.x; Cisek R, 2009, PHOTOSYNTH RES, V102, P111, DOI 10.1007/s11120-009-9500-9; Colson M, 1985, PARF COSM AROMES, V66, P53; DAVID R, 1964, CR HEBD ACAD SCI, V258, P1338; ELNIR O, 1991, Flavour and Fragrance Journal, V6, P153, DOI 10.1002/ffj.2730060212; Fahn A, 2000, ADV BOT RES, V31, P37, DOI 10.1016/S0065-2296(00)31006-0; Feijo JA, 2004, PROTOPLASMA, V223, P1, DOI 10.1007/s00709-003-0026-2; FRANICH RA, 1993, FRESEN J ANAL CHEM, V347, P337, DOI 10.1007/BF00323817; GERSHENZON J, 1992, ANAL BIOCHEM, V200, P130, DOI 10.1016/0003-2697(92)90288-I; GERSHENZON J, 1989, PLANT PHYSIOL, V89, P1351, DOI 10.1104/pp.89.4.1351; Guo Z, 2004, PLANTA, V197, P627; GUO ZH, 1994, ARCH BIOCHEM BIOPHYS, V308, P103, DOI 10.1006/abbi.1994.1015; Hudaib M, 2001, FARMACO, V56, P219, DOI 10.1016/S0014-827X(01)01038-2; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Jeffree CE, 1986, INSECTS PLANT SURFAC, P23; Jeffree CE, 2006, ANNU PLANT REV, V23, P11; Jetter R, 2000, PLANT CELL ENVIRON, V23, P619, DOI 10.1046/j.1365-3040.2000.00581.x; Jetter R, 2006, ANNU PLANT REV, V23, P145; KANDRA L, 1988, ARCH BIOCHEM BIOPHYS, V265, P425, DOI 10.1016/0003-9861(88)90145-2; KEENE CK, 1985, PLANT PHYSIOL, V79, P1026, DOI 10.1104/pp.79.4.1026; Kissick DJ, 2010, ANAL CHEM, V82, P491, DOI 10.1021/ac902139w; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Lattoo SK, 2006, FLAVOUR FRAG J, V21, P817, DOI 10.1002/ffj.1733; Lawrence BM., 1994, PRODUCTION CLARY SAG; Legrand S, 2010, GENE, V450, P55, DOI 10.1016/j.gene.2009.10.004; MCCASKILL D, 1992, PLANTA, V187, P445, DOI 10.1007/BF00199962; MICHIE MJ, 1968, NATURE, V218, P578, DOI 10.1038/218578a0; Mihalik Erzsebet, 2005, Acta Biologica Szegediensis, V49, P161; Morris BD, 2005, J CHEM ECOL, V31, P89, DOI 10.1007/s10886-005-0976-2; Muller C, 2006, ANNU PLANT REV, V23, P398; Padayatti P, 2012, BIOCHEMISTRY-US, V51, P1625, DOI 10.1021/bi201682q; Proctor M., 1996, NATURAL HIST POLLINA; Riedel M, 2003, PLANTA, V218, P87, DOI 10.1007/s00425-003-1075-7; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schmiderer C, 2008, PLANT BIOLOGY, V10, P433, DOI 10.1111/j.1438-8677.2008.00053.x; SELL C, 1990, CHEM IND-LONDON, P516; SEVERSON RF, 1984, J AGR FOOD CHEM, V32, P566, DOI 10.1021/jf00123a037; Severson RF., 1985, RECENT ADV TOBACCO S, V11, P105; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Tapia L, 2004, PLANTA MED, V70, P1058, DOI 10.1055/s-2004-832647; Then M, 1998, Acta Pharm Hung, V68, P163; Turner G, 1999, PLANT PHYSIOL, V120, P879, DOI 10.1104/pp.120.3.879; Turner GW, 2000, PLANT PHYSIOL, V124, P665, DOI 10.1104/pp.124.2.665; Turner GW, 2004, PLANT PHYSIOL, V136, P4215, DOI 10.1104/pp.104.050229; ULUBELEN A, 1994, PHYTOCHEMISTRY, V36, P971, DOI 10.1016/S0031-9422(00)90474-6; van den Brule S, 2002, PLANT J, V30, P649, DOI 10.1046/j.1365-313X.2002.01321.x; Voirin B, 1996, PHYTOCHEMISTRY, V43, P573, DOI 10.1016/0031-9422(96)00285-3; WERKER E, 1985, ISRAEL J BOT, V34, P31; WERKER E, 1985, ISRAEL J BOT, V34, P239; Werker E, 1993, FLAVOUR FRAG J, V8, P249, DOI 10.1002/ffj.2730080503	66	23	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48253	10.1371/journal.pone.0048253	http://dx.doi.org/10.1371/journal.pone.0048253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133579	Green Published, gold			2022-12-25	WOS:000310261800069
J	Liu, Y; Liu, GQ; Li, QM; Liu, Y; Hou, LY; Li, GL				Liu, Yan; Liu, Guangquan; Li, Qingmei; Liu, Yong; Hou, Longyu; Li, GuoLei			Influence of Pericarp, Cotyledon and Inhibitory Substances on Sharp Tooth Oak (Quercus aliena var. acuteserrata) Germination	PLOS ONE			English	Article							SEEDLING VIGOR; ACORNS; GROWTH; MECHANISMS	In order to explore the mechanism of delayed and uneven germination in sharp tooth oak (Quercus aliena var. acuteserrata) (STO), mechanical scarification techniques were used to study STO root and shoot germination and growth. The techniques used were: removing cup scar (RS), removing the pericarp (RP), and cutting off 1/2 (HC) and 2/3 (TC) cotyledons. Germination percentage and root and shoot length for Chinese cabbage (Beassica pekinensis) seeds (CCS) were also investigated for CCS cultivated in a Sanyo growth cabinet watered by distilled water and 80% methanol extracts from the acorn embryo, cotyledon and pericarp with concentrations of 1.0 g, 0.8 g, 0.6 g and 0.4 g dry acorn weight per ml methanol. The results showed that the majority of roots and shoots from acorns with RP and HC treatment emerged two weeks earlier, more simultaneously, and their total emergences were more than 46% and 28% higher, respectively. TC accelerated root and shoot emergence time and root length, but root and shoot germination rate and shoot height had no significant difference from the control. Positive consequences were not observed on all indices of RS treatment. The germination rates of CCS watered by 1.0 g.ml(-1) methanol extracts from the embryo and cotyledon were significantly lower than those from the pericarp, and all concentrations resulted in decreased growth of root and shoot. Methanol extracts from pericarp significantly reduced root length of CCS, but presented little response in germination percentage and shoot length. The inhibitory effect was gradually increased with the increasing concentration of the methanol extract. We conclude that both the mechanical restriction of the pericarp and the presence of germination inhibitors in the embryo, cotyledon and pericarp are the causes for delayed and asynchronous germination of STO acorns.	[Li, Qingmei] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Res Inst Forestry, Beijing, Peoples R China; [Liu, Yan; Liu, Yong; Li, GuoLei] Beijing Forestry Univ, Key Lab Silviculture & Conservat, Minist Educ, Beijing, Peoples R China; [Liu, Guangquan] China Inst Water Resources & Hydropower Res, Beijing, Peoples R China; [Liu, Guangquan] NW A&F Univ, Yangling, Peoples R China; [Hou, Longyu] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Beijing Forestry University; China Institute of Water Resources & Hydropower Research; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Botany, CAS	Li, QM (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Res Inst Forestry, Beijing, Peoples R China.	liqm99@163.com		Hou, Longyu/0000-0003-1221-4586	National Basic Research Program of China (973 Program) [2010CB951301-6]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program) grant 2010CB951301-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson C, 1996, ACTA BOT NEERL, V45, P85; Blanche CA, 1981, CHANGES LEVELS GROWT, P105; BONNER FT, 1968, BOT GAZ, V129, P83, DOI 10.1086/336416; BONNER FT, 1987, SO66 USDA FOR SERV S; Branco M, 2002, FOREST ECOL MANAG, V166, P159, DOI 10.1016/S0378-1127(01)00669-7; BROWN RC, 1972, AM J BOT, V59, P311, DOI 10.2307/2441434; CROW TR, 1988, FOREST SCI, V34, P19; EVENARI M, 1949, BOT REV, V15, P153, DOI 10.1007/BF02861721; FARMER RE, 1977, FOREST SCI, V23, P329; Finch-Savage WE, 1994, SEED SCI RES, V4, P315, DOI 10.1017/S096025850000235X; Fukumoto H., 2000, J FOREST RES, V5, P31, DOI [10.1007/BF02762760, DOI 10.1007/BF02762760]; Giertych MJ, 2011, ANN FOREST SCI, V68, P433, DOI 10.1007/s13595-011-0038-6; HIRKA A, 2004, ERDESZETI KUTATASOK, V91, P97; Hopper GM, 1982, P 7 N AM FOR BIOL WO, P327; Hou X, 2010, ANN FOREST SCI, V67; Kennedy PG, 2004, OECOLOGIA, V141, P547, DOI 10.1007/s00442-004-1686-0; LEISHMAN MR, 1994, FUNCT ECOL, V8, P205, DOI 10.2307/2389903; Lombardo JA, 2009, CAN J FOREST RES, V39, P1600, DOI 10.1139/X09-079; Lorimer CG, 1993, SE84 USDA FOR SERV, P14; MCCARTHY BC, 1987, B TORREY BOT CLUB, V114, P33, DOI 10.2307/2996387; McDonald RI, 2003, J VEG SCI, V14, P441, DOI 10.1658/1100-9233(2003)014[0441:SPOQRL]2.0.CO;2; Noli E, 1999, SEED SCI TECHNOL, V27, P1; NYANDIGA CO, 1992, CAN J FOREST RES, V22, P1395, DOI 10.1139/x92-185; PETERSON JK, 1983, ANN BOT-LONDON, V52, P81, DOI 10.1093/oxfordjournals.aob.a086555; Prewein C, 2006, TREES-STRUCT FUNCT, V20, P53, DOI 10.1007/s00468-005-0012-8; Quero JL, 2007, AM J BOT, V94, P1795, DOI 10.3732/ajb.94.11.1795; Rakic S, 2006, J FOOD ENG, V74, P416, DOI 10.1016/j.jfoodeng.2005.03.057; Shi, 2005, J SW U NAT SCI, V25, P106; Shimada T, 2001, ECOL RES, V16, P803, DOI 10.1046/j.1440-1703.2001.00435.x; Shimada T, 2006, POPUL ECOL, V48, P341, DOI 10.1007/s10144-006-0012-6; Sobrino-Vesperinas E, 2000, SEED SCI RES, V10, P401, DOI 10.1017/S0960258500000441; Soria F. J., 1996, Boletin de Sanidad Vegetal, Plagas, V22, P427; Suszka B, 2006, DEBY QUERCUS ROBUR L, P305; Suszka B, 2000, NASIONA DRZEW LESNYC, P307; Suszka B., 1996, SEEDS FOREST BROADLE; Xu K, 1998, CHINESE AGR SCI B, V14, P24; Yi XF, 2008, PHOTOSYNTHETICA, V46, P139, DOI 10.1007/s11099-008-0022-z; Yi XF, 2010, PLANT ECOL, V209, P291, DOI 10.1007/s11258-010-9730-0	38	19	21	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47682	10.1371/journal.pone.0047682	http://dx.doi.org/10.1371/journal.pone.0047682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133517	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800010
J	Su, FH; Chang, SN; Chen, PC; Sung, FC; Huang, SF; Chiou, HY; Su, CT; Lin, CC; Yeh, CC				Su, Fu-Hsiung; Chang, Shih-Ni; Chen, Pei-Chun; Sung, Fung-Chang; Huang, Shiang-Fu; Chiou, Hung-Yi; Su, Chien-Tien; Lin, Cheng-Chieh; Yeh, Chih-Ching			Positive Association Between Hepatitis C Infection and Oral Cavity Cancer: A Nationwide Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; VIRUS-INFECTION; LICHEN-PLANUS; EXTRAHEPATIC MANIFESTATIONS; B-VIRUS; HEPATOCELLULAR-CARCINOMA; CIGARETTE-SMOKING; HCV RNA; RISK; PREVALENCE	Objectives: The association between viral hepatitis (B and C) and oral cavity cancer has been widely debated. This nationwide, population-based cohort study assessed the subsequent risk of oral cavity cancer among patients with chronic viral hepatitis infection. Materials and Methods: Data were retrieved from insurance claims data of 1,000,000 randomly sampled individuals covered under the Taiwan National Health Insurance system. We identified a total of 21,199 adults with chronic viral hepatitis infection (12,369 with HBV alone, 5,311 with HCV alone, and 3,519 with HBV/HCV dual infections) from 2000-2005. Comparison group comprised 84,796 sex-and age-matched subjects without viral hepatitis during the same study period. Incidence and risk of subsequent oral cavity cancer were measured until 2008. Results: The incidence of oral cavity cancers was 2.28-fold higher among patients with HCV alone than non-viral hepatitis group (6.15 versus 2.69 per 10,000 person-years). After adjusting for sociodemographic covariates, HCV alone was significantly associated with an increased risk for oral cavity cancer (hazard ratio (HR) = 1.90, 95% confidence interval (CI) = 1.20-3.02). This positive association was highest among individuals in the 40-49-year age group (HR = 2.57, 95% CI = 1.21-5.46). However, there were no significant associations between HBV alone or HBV/HCV dual infections and risk for oral cavity cancer. Conclusion: Our data suggest that HCV but not HBV infection is a risk factor for oral cavity cancer. In addition, subjects with HCV infection tend to be at early onset risk for oral cavity cancer. This finding needs to be replicated in further studies.	[Su, Fu-Hsiung; Chiou, Hung-Yi; Su, Chien-Tien; Yeh, Chih-Ching] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Chang, Shih-Ni] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Su, Fu-Hsiung; Su, Chien-Tien] Taipei Med Univ Hosp, Dept Family Med, Taipei, Taiwan; [Chang, Shih-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Shih-Ni; Chen, Pei-Chun; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Pei-Chun] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Sung, Fung-Chang; Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Huang, Shiang-Fu] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Ctr Excellence Canc Res, Taipei, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Lin, Cheng-Chieh] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan	Taipei Medical University; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Yeh, CC (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan.	ccyeh@tmu.edu.tw	Su, Fu-Hsiung/AAO-5468-2021; Lin, Cheng-Chieh/P-2564-2015	Lin, Cheng-Chieh/0000-0002-9625-6216; Chiou, Hung Yi/0000-0002-4545-9697; Su, Fu-Hsiung/0000-0002-9867-7655	National Sciences Council, Executive Yuan [DOH 97-HP-1101]; China Medical University Hospital [1MS1, DMR-94-080]; Taiwan Department of Health Clinical Trial and Research Center [DOH 100-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH100-TD-C-111-005]; Taiwan Department of Health Center of Excellence for Cancer Research in Taipei Medical University [DOH101-TD-C-111-008]	National Sciences Council, Executive Yuan; China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center; Taiwan Department of Health Cancer Research Center for Excellence; Taiwan Department of Health Center of Excellence for Cancer Research in Taipei Medical University	This study was supported by the National Sciences Council, Executive Yuan (grant numbers DOH 97-HP-1101, 2008-2010), China Medical University Hospital (grant number 1MS1, DMR-94-080), Taiwan Department of Health Clinical Trial and Research Center (grant number DOH 100-TD-B-111-004), Taiwan Department of Health Cancer Research Center for Excellence (DOH100-TD-C-111-005), and Taiwan Department of Health Center of Excellence for Cancer Research in Taipei Medical University (DOH101-TD-C-111-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 2004, J HEPATOL, V40, P341, DOI 10.1016/j.jhep.2003.10.009; BARNARD NA, 1993, J ORAL PATHOL MED, V22, P421, DOI 10.1111/j.1600-0714.1993.tb00134.x; Bokor-Bratic M, 2006, J ORAL PATHOL MED, V35, P626, DOI 10.1111/j.1600-0714.2006.00479.x; BOUQUOT JE, 1986, ORAL SURG ORAL MED O, V61, P373, DOI 10.1016/0030-4220(86)90422-6; Bureau of Health Promotion Department of Health Taiwan ROC, 1995, CANC REG ANN REP 199; Cacoub P, 2000, MEDICINE, V79, P47, DOI 10.1097/00005792-200001000-00005; Grossmann SDC, 2010, J CLIN PATHOL, V63, P1002, DOI 10.1136/jcp.2010.080036; Grossmann SDC, 2009, J PUBLIC HEALTH DENT, V69, P168, DOI 10.1111/j.1752-7325.2009.00119.x; Carrozzo M, 1997, ORAL ONCOL, V33, P220, DOI 10.1016/S0964-1955(96)00073-5; CHEN DS, 1990, J INFECT DIS, V162, P817, DOI 10.1093/infdis/162.4.817; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Cho LY, 2011, INT J CANCER, V128, P176, DOI 10.1002/ijc.25321; Chu CM, 1998, J CLIN MICROBIOL, V36, P2084, DOI 10.1128/JCM.36.7.2084-2086.1998; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; Conway DI, 2008, INT J CANCER, V122, P2811, DOI 10.1002/ijc.23430; Engels EA, 2010, LANCET ONCOL, V11, P827, DOI 10.1016/S1470-2045(10)70167-4; Fwu CW, 2011, HEPATOLOGY, V53, P1217, DOI 10.1002/hep.24150; Giordano TP, 2007, JAMA-J AM MED ASSOC, V297, P2010, DOI 10.1001/jama.297.18.2010; GUMBER SC, 1995, ANN INTERN MED, V123, P615, DOI 10.7326/0003-4819-123-8-199510150-00008; Hadziyannis SJ, 1996, DIGEST DIS SCI, V41, pS63, DOI 10.1007/BF02087878; Iloeje UH, 2010, LIVER INT, V30, P423, DOI 10.1111/j.1478-3231.2009.02147.x; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; LEE SD, 1991, HEPATOLOGY, V13, P830, DOI 10.1016/0270-9139(91)90249-U; Lin WJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/525976; Lins L, 2005, J MED VIROL, V77, P216, DOI 10.1002/jmv.20438; LIOU TC, 1992, J MED VIROL, V37, P197, DOI 10.1002/jmv.1890370309; Lodi G, 2004, BRIT J DERMATOL, V151, P1172, DOI 10.1111/j.1365-2133.2004.06257.x; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Maticic M, 2001, J PERIODONTOL, V72, P11, DOI 10.1902/jop.2001.72.1.11; NAGAO Y, 1995, J ORAL PATHOL MED, V24, P354, DOI 10.1111/j.1600-0714.1995.tb01199.x; Nagao Y, 2002, HEPATOL RES, V22, P27, DOI 10.1016/S1386-6346(01)00114-0; Nagao Y, 2000, J ORAL PATHOL MED, V29, P259, DOI 10.1034/j.1600-0714.2000.290604.x; Nobles J, 2004, LARYNGOSCOPE, V114, P2119, DOI 10.1097/01.mlg.0000149444.30017.e8; OHKAWA K, 1995, J MED VIROL, V46, P258, DOI 10.1002/jmv.1890460316; Omland Lars Haukali, 2010, Clin Epidemiol, V2, P179; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Porter SR, 1997, ORAL ONCOL, V33B, P58, DOI 10.1016/S0964-1955(96)00041-3; Sarid R, 2011, CANCER LETT, V305, P218, DOI 10.1016/j.canlet.2010.09.011; SHEEN IS, 1992, J INFECT DIS, V165, P831, DOI 10.1093/infdis/165.5.831; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Takata Y, 2002, ORAL DIS, V8, P95, DOI 10.1034/j.1601-0825.2002.1o794.x; Tsai MC, 2007, J GASTROEN HEPATOL, V22, P92, DOI 10.1111/j.1440-1746.2006.04489.x; Wen CP, 2005, TOB CONTROL, V14, pI16, DOI 10.1136/tc.2004.008003; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016/S0168-8278(98)80198-0; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008	47	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48109	10.1371/journal.pone.0048109	http://dx.doi.org/10.1371/journal.pone.0048109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133554	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800044
J	Swanberg, M; McGuigan, FE; Ivaska, KK; Gerdhem, P; Akesson, K				Swanberg, Maria; McGuigan, Fiona E.; Ivaska, Kaisa K.; Gerdhem, Paul; Akesson, Kristina			Polymorphisms in the Inflammatory Genes CIITA, CLEC16A and IFNG Influence BMD, Bone Loss and Fracture in Elderly Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CLASS-II TRANSACTIVATOR; MINERAL DENSITY; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; INTERLEUKIN-6 GENE; OSTEOPOROTIC FRACTURES; POSTMENOPAUSAL WOMEN; SEQUENCE VARIANTS; FOLLOW-UP	Osteoclast activity and the fine balance between bone formation and resorption is affected by inflammatory factors such as cytokines and T lymphocyte activity, mediated by major histocompatibility complex (MHC) molecules, in turn regulated by the MHC class II transactivator (MHC2TA). We investigated the effect of functional polymorphisms in the MHC2TA gene (CIITA), and two additional genes; C-type lectin domain 16A (CLEC16A), in linkage disequilibrium with CIITA and Interferon-gamma (IFNG), an inducer of CIITA; on bone density, bone resorption markers, bone loss and fracture risk in 75 year-old women followed for up to 10 years (OPRA n = 1003) and in young adult women (PEAK-25 n = 999). CIITA was associated with BMD at age 75 (lumbar spine p = 0.011; femoral neck (FN) p = 0.049) and age 80 (total body p = 0.015; total hip p = 0.042; FN p = 0.028). Carriers of the CIITA rs3087456(G) allele had 1.8-3.4% higher BMD and displayed increased rate of bone loss between age 75 and 80 (FN p = 0.013; total hip p = 0.030; total body p = 3.8E(-5)). Despite increasing bone loss, the rs3087456(G) allele was protective against incident fracture overall (p = 0.002), osteoporotic fracture and hip fracture. Carriers of CLEC16A and IFNG variant alleles had lower BMD (p<0.05) and ultrasound parameters and a lower risk of incident fracture (CLEC16A, p = 0.011). In 25-year old women, none of the genes were associated with BMD. In conclusion, variation in inflammatory genes CIITA, CLEC-16A and INFG appear to contribute to bone phenotypes in elderly women and suggest a role for low-grade inflammation and MHC class II expression for osteoporosis pathogenesis.	[Swanberg, Maria; McGuigan, Fiona E.; Akesson, Kristina] Lund Univ, Clin & Mol Osteoporosis Res Unit, Dept Clin Sci, S-22100 Lund, Sweden; [Swanberg, Maria] Lund Univ, Neurodegenerat & Inflammat Genet Unit, Dept Expt Med Sci, S-22100 Lund, Sweden; [Ivaska, Kaisa K.] Univ Turku, Dept Cell Biol & Anat, Inst Biomed, Turku, Finland; [Gerdhem, Paul] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Gerdhem, Paul] Karolinska Univ Hosp, Dept Orthopaed, Stockholm, Sweden; [Akesson, Kristina] Skane Univ Hosp, Dept Orthopaed, Malmo, Sweden	Lund University; Lund University; University of Turku; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital	Akesson, K (corresponding author), Lund Univ, Clin & Mol Osteoporosis Res Unit, Dept Clin Sci, S-22100 Lund, Sweden.	Kristina.Akesson@med.lu.se	Ivaska, Kaisa/G-1406-2012	Ivaska, Kaisa/0000-0001-7482-7623; Swanberg, Maria/0000-0002-1829-1008; Gerdhem, Paul/0000-0001-8061-7163	Swedish Research Council [K2009-53X-14691-07-3, K2010-77PK-21362-01-2]; FAS [2007-2125]; Greta and Johan Kock Foundation; A. Pahlsson Foundation; A. Osterlund Foundation; Knut and Alice Wallenberg Foundation; H Jarnhardt foundation; King Gustav V and Queen Victoria Foundation; Ake Wiberg Foundation; Thelma Zoegas Foundation; Malmo University Hospital Research Foundation; Research and Development Council of Region Skane, Sweden; Swedish Medical Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); FAS; Greta and Johan Kock Foundation; A. Pahlsson Foundation; A. Osterlund Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); H Jarnhardt foundation; King Gustav V and Queen Victoria Foundation; Ake Wiberg Foundation; Thelma Zoegas Foundation; Malmo University Hospital Research Foundation; Research and Development Council of Region Skane, Sweden; Swedish Medical Society	This work was supported by grants from the Swedish Research Council www.vr.se (K2009-53X-14691-07-3, K2010-77PK-21362-01-2), FAS www.fas.se (Grant 2007-2125), Greta and Johan Kock Foundation www.kockskastiftelsen.se, A. Pahlsson Foundation, A. Osterlund Foundation, Knut and Alice Wallenberg Foundation www.wallenberg.com/kaw, the H Jarnhardt foundation, King Gustav V and Queen Victoria Foundation, Ake Wiberg Foundation, Thelma Zoegas Foundation, Malmo University Hospital Research Foundation, Research and Development Council of Region Skane, Sweden, the Swedish Medical Society www.slf.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN M, 1994, HUM IMMUNOL, V39, P41, DOI 10.1016/0198-8859(94)90099-X; Awata T, 2009, J CLIN ENDOCR METAB, V94, P231, DOI 10.1210/jc.2008-0718; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; Bronson PG, 2011, GENES IMMUN; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Chung HW, 2003, J HUM GENET, V48, P243, DOI 10.1007/s10038-003-0020-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Deguchi K, 2001, MENOPAUSE, V8, P266, DOI 10.1097/00042192-200107000-00008; DEWHIRST FE, 1985, J IMMUNOL, V135, P2562; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Farber CR, 2010, J BONE MINER RES, V25, P2359, DOI 10.1002/jbmr.138; Ferrari S, 2008, BEST PRACT RES CL EN, V22, P723, DOI 10.1016/j.beem.2008.08.007; Ferrari SL, 2001, ARTHRITIS RHEUM-US, V44, P196, DOI 10.1002/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5; Ferrari SL, 2003, J CLIN ENDOCR METAB, V88, P255, DOI 10.1210/jc.2002-020092; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gerdhem P, 2007, J BONE JOINT SURG BR, V89B, P1627, DOI 10.1302/0301-620X.89B12.18946; Gerdhem P, 2004, CALCIFIED TISSUE INT, V74, P264, DOI 10.1007/s00223-002-2159-2; Grunewald J, 2010, TISSUE ANTIGENS, V76, P96, DOI 10.1111/j.1399-0039.2010.01476.x; Guo Y, 2010, J BONE MINER RES, V25, P1042, DOI 10.1359/jbmr.091040; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hofbauer LC, 2007, OSTEOPOROSIS INT, V18, P251, DOI 10.1007/s00198-006-0282-z; Holmberg AH, 2006, OSTEOPOROSIS INT, V17, P1065, DOI 10.1007/s00198-006-0137-7; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Ivaska KK, 2008, J CLIN ENDOCR METAB, V93, P2622, DOI 10.1210/jc.2007-1508; Ivaska KK, 2010, J BONE MINER RES, V25, P393, DOI 10.1359/jbmr.091006; Karasik D, 2010, J BONE MINER RES, V25, P1555, DOI 10.1002/jbmr.38; Karlsson MK, 1998, ACTA ORTHOP SCAND, V69, P189, DOI 10.3109/17453679809117626; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Kim JH, 2010, CELL SIGNAL, V22, P1341, DOI 10.1016/j.cellsig.2010.05.001; Kim K, 2010, ANN RHEUM DIS, V69, P1247, DOI 10.1136/ard.2009.117572; Koller DL, 2010, J CLIN ENDOCR METAB, V95, P1802, DOI 10.1210/jc.2009-1903; Kou I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019641; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Lenora J, 2007, OSTEOPOROSIS INT, V18, P1297, DOI 10.1007/s00198-007-0379-z; Lenora J, 2010, J CLIN DENSITOM, V13, P407, DOI 10.1016/j.jocd.2010.04.004; Lindholm E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000064; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Marquez A, 2009, EUR J HUM GENET, V17, P1304, DOI 10.1038/ejhg.2009.50; Martinez A, 2010, ANN RHEUM DIS, V69, P309, DOI 10.1136/ard.2008.098376; Martinez A, 2007, HUM IMMUNOL, V68, P685, DOI 10.1016/j.humimm.2007.05.005; McGuigan FE, 2007, CALCIFIED TISSUE INT, V81, P254, DOI 10.1007/s00223-007-9054-9; Morrison BA, 2010, AUTOIMMUNITY, V43, P690, DOI 10.3109/08916930903567492; Murray RE, 1997, BONE, V21, P89, DOI 10.1016/S8756-3282(97)00081-1; Nagarajan UM, 2002, J IMMUNOL, V169, P5078, DOI 10.4049/jimmunol.169.9.5078; Nakajima M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009723; Okabe R, 2001, CLIN CHEM, V47, P1410; Paternoster L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001217; PATTRICK M, 1989, ANN RHEUM DIS, V48, P470, DOI 10.1136/ard.48.6.470; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Seibel Markus J, 2006, Clin Biochem Rev, V27, P123; Sennerby U, 2007, OSTEOPOROSIS INT, V18, P1355, DOI 10.1007/s00198-007-0386-0; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; STASTNY P, 1976, J CLIN INVEST, V57, P1148, DOI 10.1172/JCI108382; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Swanberg M, 2010, BONE, V47, P424, DOI 10.1016/j.bone.2010.05.009; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Weitzmann MN, 2006, ANN NY ACAD SCI, V1068, P256, DOI 10.1196/annals.1346.030; WEUSTEN JJAM, 1986, ACTA ENDOCRINOL-COP, V112, P409, DOI 10.1530/acta.0.1120409; Wu XP, 2009, CLIN ENDOCRINOL, V71, P46, DOI 10.1111/j.1365-2265.2008.03437.x; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3; Zhao LJ, 2010, J BONE MINER RES, V25, P320, DOI 10.1359/jbmr.090726; Zoledziewska M, 2009, GENES IMMUN, V10, P15, DOI 10.1038/gene.2008.84; Zuvich RL, 2011, HUM MOL GENET	76	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47964	10.1371/journal.pone.0047964	http://dx.doi.org/10.1371/journal.pone.0047964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133532	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800024
J	Deole, R; Challacombe, J; Raiford, DW; Hoff, WD				Deole, Ratnakar; Challacombe, Jean; Raiford, Douglas W.; Hoff, Wouter D.			An Extremely Halophilic Proteobacterium Combines a Highly Acidic Proteome with a Low Cytoplasmic Potassium Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM SALINIBACTER-RUBER; ECTOTHIORHODOSPIRA-HALOCHLORIS; HALOBACTERIUM-SALINARUM; PHOTOTROPIC BACTERIUM; CRYSTAL-STRUCTURE; ADAPTATION; PROTEINS; SALT; DEHYDROGENASE; GENOME	Halophilic archaea accumulate molar concentrations of KCl in their cytoplasm as an osmoprotectant and have evolved highly acidic proteomes that function only at high salinity. We examined osmoprotection in the photosynthetic Proteobacteria Halorhodospira halophila and Halorhodospira halochloris. Genome sequencing and isoelectric focusing gel electrophoresis showed that the proteome of H. halophila is acidic. In line with this finding, H. halophila accumulated molar concentrations of KCl when grown in high salt medium as detected by x-ray microanalysis and plasma emission spectrometry. This result extends the taxonomic range of organisms using KCl as a main osmoprotectant to the Proteobacteria. The closely related organism H. halochloris does not exhibit an acidic proteome, matching its inability to accumulate K+. This observation indicates recent evolutionary changes in the osmoprotection strategy of these organisms. Upon growth of H. halophila in low salt medium, its cytoplasmic K+ content matches that of Escherichia coli, revealing an acidic proteome that can function in the absence of high cytoplasmic salt concentrations. These findings necessitate a reassessment of two central aspects of theories for understanding extreme halophiles. First, we conclude that proteome acidity is not driven by stabilizing interactions between K+ ions and acidic side chains but by the need for maintaining sufficient solvation and hydration of the protein surface at high salinity through strongly hydrated carboxylates. Second, we propose that obligate protein halophilicity is a non-adaptive property resulting from genetic drift in which constructive neutral evolution progressively incorporates weakly stabilizing K+-binding sites on an increasingly acidic protein surface.	[Deole, Ratnakar; Hoff, Wouter D.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Hoff, Wouter D.] Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA; [Challacombe, Jean] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Raiford, Douglas W.] Univ Montana, Dept Comp Sci, Missoula, MT 59812 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Montana System; University of Montana	Hoff, WD (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	wouter.hoff@okstate.edu	Deole, Ratnakar/AFA-6902-2022		National Science Foundation [0722410]; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; Oklahoma State University; Direct For Biological Sciences [1051590] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); Oklahoma State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Michael Kress and Terry Colberg for expert technical assistance with the plasma emission spectrometry and electron microscopy measurements. We thank all of the Joint Genome Institute personnel who participated in the sequencing, assembly, and automation of the H. halophila genome. The purchase of the FEI Quanta 600 environmental scanning electron microscope used in this work was supported by National Science Foundation Grant 0722410 to Oklahoma State University. The work conducted by the United States Department of Energy Joint Genome Institute is supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231.; This work was supported by Oklahoma State University startup funds (to W. D. H.).	Anton J, 2002, INT J SYST EVOL MICR, V52, P485, DOI 10.1099/00207713-52-2-485; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bonete MJ, 2003, FEMS MICROBIOL LETT, V226, P181, DOI 10.1016/S0378-1097(03)00592-5; Britton KL, 2006, P NATL ACAD SCI USA, V103, P4846, DOI 10.1073/pnas.0508854103; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; Coquelle N, 2010, J MOL BIOL, V404, P493, DOI 10.1016/j.jmb.2010.09.055; Elcock AH, 1998, J MOL BIOL, V280, P731, DOI 10.1006/jmbi.1998.1904; Engel MB, 2005, CELL BIOL INT, V29, P616, DOI 10.1016/j.cellbi.2005.03.024; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Frolow F, 1996, NAT STRUCT BIOL, V3, P452, DOI 10.1038/nsb0596-452; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; GALINSKI EA, 1982, FEMS MICROBIOL LETT, V13, P357, DOI 10.1016/0378-1097(82)90191-4; IMHOFF JF, 1977, ARCH MICROBIOL, V114, P115, DOI 10.1007/BF00410772; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; Madern D, 2004, BIOCHIMIE, V86, P295, DOI 10.1016/j.biochi.2004.04.004; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004192; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Oren A, 2002, EXTREMOPHILES, V6, P491, DOI 10.1007/s00792-002-0286-3; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Oren A, 1997, CAN J MICROBIOL, V43, P588, DOI 10.1139/m97-083; Ortega G, 2011, SCI REP-UK, V1, DOI 10.1038/srep00006; RAYMOND JC, 1969, ARCH MIKROBIOL, V69, P121, DOI 10.1007/BF00409756; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Strahl H, 2008, EXTREMOPHILES, V12, P741, DOI 10.1007/s00792-008-0177-3; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998; Winter JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-55; ZIMMERMANN U, 1973, BIOCHIM BIOPHYS ACTA, V311, P442, DOI 10.1016/0005-2736(73)90324-6	40	45	47	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					581	588		10.1074/jbc.M112.420505	http://dx.doi.org/10.1074/jbc.M112.420505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23144460	Green Published, hybrid			2022-12-25	WOS:000313197200058
J	Shi, ZC; Cai, ZY; Yu, JC; Zhang, TT; Zhao, S; Smeds, E; Zhang, QY; Wang, F; Zhao, CH; Fu, SB; Ghosh, S; Zhang, DK				Shi, Zhongcheng; Cai, Zhenyu; Yu, Jingcui; Zhang, Tingting; Zhao, Shu; Smeds, Emanuel; Zhang, Qingyuan; Wang, Fen; Zhao, Changhong; Fu, Songbin; Ghosh, Sankar; Zhang, Dekai			Toll-like Receptor 11 (TLR11) Prevents Salmonella Penetration into the Murine Peyer Patches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-INFECTIONS; EPITHELIAL-CELLS; INNATE IMMUNITY; III SECRETION; MOUSE MODEL; RECOGNITION; TYPHIMURIUM; HOMEOSTASIS; COMPONENTS; DEFENSE	Toll-like receptors (TLRs) are key molecular sensors used by the mammalian innate immune system to detect microorganisms. Although TLR functions in colonic immune homeostasis and tolerance to commensal bacteria have been intensively researched, the precise roles of different TLRs in response to pathogen infection in the gut remain elusive. Peyer patches are the major entrance of Salmonella infection and antigen transportation in intestine. Here, we report that, in contrast to TLR5 as a "carrier of Salmonella," TLR11 works as a "blocker of Salmonella" to prevent highly invasive Salmonella from penetrating into the murine Peyer patches and spreading systemically. TLR11 plays an important role in mediating TNF-alpha induction and systemic inflammation in response to Salmonella infection. Remarkably, in mice lacking TLR11, apparent hemorrhages at Peyer patches are induced by highly invasive Salmonella, a phenotype resembling human Salmonella infection. Therefore, our results indicate a potentially important role for TLR11 in preventing murine intestinal infection and modulating antigen transportation in the gut and imply an important role for various TLRs in cooperation with tight control of pathogens penetrating into Peyer patches. The TLR11 knock-out mouse can serve as a good animal model to study Salmonella infection.	[Shi, Zhongcheng; Cai, Zhenyu; Zhang, Tingting; Zhao, Shu; Smeds, Emanuel; Zhang, Dekai] Texas A&M Univ, Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Wang, Fen] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Zhao, Shu; Zhang, Qingyuan; Zhao, Changhong] Harbin Med Univ, Affiliated Hosp 3, Dept Med Oncol, Harbin 150081, Peoples R China; [Shi, Zhongcheng; Yu, Jingcui; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin 150081, Peoples R China; [Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Harbin Medical University; Harbin Medical University; Columbia University	Zhang, DK (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA.	dzhang@ibt.tamhsc.edu			National Institutes of Health [1R56AI085164]; Texas A&M University Health Science Center; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI085164. This work was also supported by the Texas A&M University Health Science Center.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Eckmann L, 2006, CURR OPIN GASTROEN, V22, P95, DOI 10.1097/01.mog.0000208458.38772.2a; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gerold G, 2007, SEMIN IMMUNOL, V19, P41, DOI 10.1016/j.smim.2006.12.003; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhao L, 2001, MICROBIOL IMMUNOL, V45, P149, DOI 10.1111/j.1348-0421.2001.tb01283.x	30	16	18	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43417	43423		10.1074/jbc.M112.411009	http://dx.doi.org/10.1074/jbc.M112.411009			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135279	Green Published, hybrid			2022-12-25	WOS:000312940800023
J	Inglis, HR; Greer, JM; McCombe, PA				Inglis, Hayley R.; Greer, Judith M.; McCombe, Pamela A.			Gene Expression in the Spinal Cord in Female Lewis Rats with Experimental Autoimmune Encephalomyelitis Induced with Myelin Basic Protein	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; QUANTITATIVE TRAIT LOCI; MULTIPLE-SCLEROSIS; T-CELLS; CHEMOKINE RECEPTORS; WHITE-MATTER; MICE; INFLAMMATION; MECHANISMS	Background: Experimental autoimmune encephalomyelitis (EAE), the best available model of multiple sclerosis, can be induced in different animal strains using immunization with central nervous system antigens. EAE is associated with inflammation and demyelination of the nervous system. Micro-array can be used to investigate gene expression and biological pathways that are altered during disease. There are few studies of the changes in gene expression in EAE, and these have mostly been done in a chronic mouse EAE model. EAE induced in the Lewis with myelin basic protein (MBP-EAE) is well characterised, making it an ideal candidate for the analysis of gene expression in this disease model. Methodology/Principal Findings: MBP-EAE was induced in female Lewis rats by inoculation with MBP and adjuvants. Total RNA was extracted from the spinal cords and used for micro-array analysis using AffimetrixGeneChip Rat Exon 1.0 ST Arrays. Gene expression in the spinal cords was compared between healthy female rats and female rats with MBP-EAE. Gene expression in the spinal cord of rats with MBP-EAE differed from that in the spinal cord of normal rats, and there was regulation of pathways involved with immune function and nervous system function. For selected genes the change in expression was confirmed with real-time PCR. Conclusions/Significance: EAE leads to modulation of gene expression in the spinal cord. We have identified the genes that are most significantly regulated in MBP-EAE in the Lewis rat and produced a profile of gene expression in the spinal cord at the peak of disease.	[Inglis, Hayley R.; Greer, Judith M.; McCombe, Pamela A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	University of Queensland	McCombe, PA (corresponding author), Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.	Pamela.McCombe@uq.edu.au	Greer, Judith/C-4945-2009; McCombe, Pamela/C-9692-2010	Greer, Judith/0000-0003-4440-4309; McCombe, Pamela/0000-0003-2704-8517	Multiple Sclerosis Australia	Multiple Sclerosis Australia	This study was funded by a grant from Multiple Sclerosis Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2002, AM J PATHOL, V161, P1577, DOI 10.1016/S0002-9440(10)64436-7; Almolda B, 2009, J NEUROIMMUNOL, V209, P65, DOI 10.1016/j.jneuroim.2009.01.026; Andersson A, 2008, J LEUKOCYTE BIOL, V84, P1248, DOI 10.1189/jlb.1207844; Barnum SR, 2006, BRAIN RES REV, V52, P58, DOI 10.1016/j.brainresrev.2005.12.002; Becanovic K, 2003, J IMMUNOL, V170, P1062, DOI 10.4049/jimmunol.170.2.1062; Bedoui S, 2003, J IMMUNOL, V171, P3451, DOI 10.4049/jimmunol.171.7.3451; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berard JL, 2012, GLIA; Bergsteinsdottir K, 2000, J IMMUNOL, V164, P1564, DOI 10.4049/jimmunol.164.3.1564; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Burrows GG, 1998, J IMMUNOL, V161, P5987; CHALK JB, 1994, J NEUROL SCI, V123, P154, DOI 10.1016/0022-510X(94)90218-6; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Dahlman I, 1999, HUM MOL GENET, V8, P2183, DOI 10.1093/hmg/8.12.2183; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Das A, 2008, J NEUROSCI RES, V86, P2992, DOI 10.1002/jnr.21737; de Graaf KL, 1999, INT IMMUNOL, V11, P1981, DOI 10.1093/intimm/11.12.1981; Denisov V, 2008, BIORAD B; Diez M, 2009, J NEUROIMMUNOL, V212, P82, DOI 10.1016/j.jneuroim.2009.05.004; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Du C, 2002, J IMMUNOL, V168, P3105, DOI 10.4049/jimmunol.168.6.3105; Eltayeb S, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-14; Encinas JA, 1996, J NEUROSCI RES, V45, P655; Encinas JA, 2001, INT IMMUNOL, V13, P257, DOI 10.1093/intimm/13.3.257; FREUND J, 1947, J IMMUNOL, V57, P179; Furlan R, 1999, J IMMUNOL, V163, P2403; Gheorghe CP, 2010, INT J DEV BIOL, V54, P507, DOI 10.1387/ijdb.082770cg; Greer JM, 1996, J IMMUNOL, V156, P371; Hedreul MT, 2009, J NEUROIMMUNOL, V210, P30, DOI 10.1016/j.jneuroim.2009.02.010; Herz J, 2010, EXP NEUROL, V225, P9, DOI 10.1016/j.expneurol.2009.11.019; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; Huitinga I, 1998, CLIN EXP IMMUNOL, V111, P198; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Jagodic M, 2005, J IMMUNOL, V174, P918, DOI 10.4049/jimmunol.174.2.918; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366; Jagodic M, 2001, IMMUNOGENETICS, V53, P410, DOI 10.1007/s002510100342; Jastorff AM, 2009, PROTEOM CLIN APPL, V3, P1273, DOI 10.1002/prca.200800155; Jee Y, 2001, J NEUROIMMUNOL, V114, P40, DOI 10.1016/S0165-5728(00)00446-X; Jelinsky SA, 2005, J NEUROL SCI, V239, P81, DOI 10.1016/j.jns.2005.08.008; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Liu X, 1998, GLIA, V24, P390, DOI 10.1002/(SICI)1098-1136(199812)24:4<390::AID-GLIA4>3.0.CO;2-1; Marta M, 2010, GENES IMMUN, V11, P21, DOI 10.1038/gene.2009.62; Matejuk A, 2003, ARCH IMMUNOL THER EX, V51, P185; MCCOMBE PA, 1992, J NEUROL SCI, V113, P177, DOI 10.1016/0022-510X(92)90245-G; MCCOMBE PA, 1994, J NEUROIMMUNOL, V51, P153, DOI 10.1016/0165-5728(94)90077-9; McCombe PA, 1996, J NEUROL SCI, V139, P1; Monshouwer M, 2000, NEUROIMMUNOMODULAT, V8, P142, DOI 10.1159/000054274; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Nedachi T, 2011, NEUROSCIENCE, V185, P106, DOI 10.1016/j.neuroscience.2011.04.037; Ohgoh M, 2002, J NEUROIMMUNOL, V125, P170, DOI 10.1016/S0165-5728(02)00029-2; PENDER MP, 1988, J NEUROL SCI, V86, P277, DOI 10.1016/0022-510X(88)90105-0; PENDER MP, 1989, BRAIN, V112, P393, DOI 10.1093/brain/112.2.393; PENDER MP, 1992, J AUTOIMMUN, V5, P401, DOI 10.1016/0896-8411(92)90001-7; PENDER MP, 1986, J NEUROL SCI, V75, P317, DOI 10.1016/0022-510X(86)90079-1; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Rivers TM, 1933, J EXP MED, V58, P39, DOI 10.1084/jem.58.1.39; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3; Schneider C, 2009, J NEUROIMMUNOL, V213, P84, DOI 10.1016/j.jneuroim.2009.05.015; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Smith KJ, 1999, PHILOS T R SOC B, V354, P1649, DOI 10.1098/rstb.1999.0510; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stridh P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012716; Sunnemark D, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-17; Szalai AJ, 2007, MOL IMMUNOL, V44, P3132, DOI 10.1016/j.molimm.2007.02.002; Tokuhara N, 2010, J BIOL CHEM, V285, P33294, DOI 10.1074/jbc.M109.089805; Wilson HL, 2012, BIOL-TARGETS THER, V6, P117, DOI 10.2147/BTT.S24734; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Yang S, 2006, ACTA NEUROCHIR SUPPL, V96, P203	74	8	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48555	10.1371/journal.pone.0048555	http://dx.doi.org/10.1371/journal.pone.0048555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139791	gold, Green Published, Green Submitted			2022-12-25	WOS:000311315300036
J	Langlais, KK; Brown, JL; Kassis, JA				Langlais, Kristofor K.; Brown, J. Lesley; Kassis, Judith A.			Polycomb Group Proteins Bind an engrailed PRE in Both the "ON" and "OFF" Transcriptional States of engrailed	PLOS ONE			English	Article							GROUP RESPONSE ELEMENTS; CUBITUS-INTERRUPTUS; CELLULAR MEMORY; GENOME-WIDE; DROSOPHILA; MECHANISMS; GENES; RNA; MAINTENANCE; EXPRESSION	Polycomb group (PcG) and trithorax Group (trxG) proteins maintain the "OFF" and "ON" transcriptional states of HOX genes and other targets by modulation of chromatin structure. In Drosophila, PcG proteins are bound to DNA fragments called Polycomb group response elements (PREs). The prevalent model holds that PcG proteins bind PREs only in cells where the target gene is "OFF". Another model posits that transcription through PREs disrupts associated PcG complexes, contributing to the establishment of the "ON" transcriptional state. We tested these two models at the PcG target gene engrailed. engrailed exists in a gene complex with invected, which together have 4 well-characterized PREs. Our data show that these PREs are not transcribed in embryos or larvae. We also examined whether PcG proteins are bound to an engrailed PRE in cells where engrailed is transcribed. By FLAG-tagging PcG proteins and expressing them specifically where engrailed is "ON" or "OFF", we determined that components of three major PcG protein complexes are present at an engrailed PRE in both the "ON" and "OFF" transcriptional states in larval tissues. These results show that PcG binding per se does not determine the transcriptional state of engrailed.	[Langlais, Kristofor K.; Brown, J. Lesley; Kassis, Judith A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kassis, JA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	jkassis@mail.nih.gov		Kassis, Judith/0000-0001-9268-3213	Intramural Research Program of the NIH/NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD005003] Funding Source: NIH RePORTER	Intramural Research Program of the NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the NIH/NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bender W, 2002, DEVELOPMENT, V129, P4923; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Brown JL, 2010, DEVELOPMENT, V137, P2597, DOI 10.1242/dev.047761; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chanas G, 2004, DEV BIOL, V272, P522, DOI 10.1016/j.ydbio.2004.05.020; Croker JA, 2006, DEV BIOL, V291, P368, DOI 10.1016/j.ydbio.2005.12.020; Cunningham MD, 2010, MOL CELL BIOL, V30, P820, DOI 10.1128/MCB.01287-09; DeVido SK, 2008, DEVELOPMENT, V135, P669, DOI 10.1242/dev.014779; Gustavson E, 1996, GENETICS, V142, P893; Hild M, 2004, GENOME BIOL, V5; Hogga I, 2002, DEVELOPMENT, V129, P4915; Kopczynski C, 2004, EXELIXIS FLYTAG EST; Kwon D, 2009, DEVELOPMENT, V136, P3067, DOI 10.1242/dev.036426; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Langlais KK, 2004, J EXP BIOL, V207, P2323, DOI 10.1242/jeb.01025; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Park SY, 2012, MECH DEVELOP, V128, P536, DOI 10.1016/j.mod.2012.01.004; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schmitt S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-218; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	40	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48765	10.1371/journal.pone.0048765	http://dx.doi.org/10.1371/journal.pone.0048765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139817	Green Published, gold			2022-12-25	WOS:000311315300056
J	Taleb, O; Maammar, M; Brumaru, D; Bourguignon, JJ; Schmitt, M; Klein, C; Kemmel, V; Maitre, M; Mensah-Nyagan, AG				Taleb, Omar; Maammar, Mohammed; Brumaru, Daniel; Bourguignon, Jean-Jacques; Schmitt, Martine; Klein, Christian; Kemmel, Veronique; Maitre, Michel; Mensah-Nyagan, Ayikoe Guy			Xanthurenic Acid Binds to Neuronal G-Protein-Coupled Receptors That Secondarily Activate Cationic Channels in the Cell Line NCB-20	PLOS ONE			English	Article							KYNURENINE PATHWAY; PORE DILATION; BRAIN; METABOLISM; DISORDERS; TRANSPORT; GLUTAMATE; CALCIUM; DISEASE; TRPA1	Xanthurenic acid (XA) is a metabolite of the tryptophan oxidation pathway through kynurenine and 3-hydroxykynurenine. XA was until now considered as a detoxification compound and dead-end product reducing accumulation of reactive radical species. Apart from a specific role for XA in the signaling cascade resulting in gamete maturation in mosquitoes, nothing was known about its functions in other species including mammals. Based upon XA distribution, transport, accumulation and release in the rat brain, we have recently suggested that XA may potentially be involved in neurotransmission/neuromodulation, assuming that neurons presumably express specific XA receptors. Recently, it has been shown that XA could act as a positive allosteric ligand for class II metabotropic glutamate receptors. This finding reinforces the proposed signaling role of XA in brain. Our present results provide several lines of evidence in favor of the existence of specific receptors for XA in the brain. First, binding experiments combined with autoradiography and time-course analysis led to the characterization of XA binding sites in the rat brain. Second, specific kinetic and pharmacological properties exhibited by these binding sites are in favor of G-protein-coupled receptors (GPCR). Finally, in patch-clamp and calcium imaging experiments using NCB-20 cells that do not express glutamate-induced calcium signals, XA elicited specific responses involving activation of cationic channels and increases in intracellular Ca2+ concentration. Altogether, these results suggest that XA, acting through a GPCR-induced cationic channel modulatory mechanism, may exert excitatory functions in various brain neuronal pathways.	[Taleb, Omar; Maammar, Mohammed; Brumaru, Daniel; Klein, Christian; Kemmel, Veronique; Maitre, Michel; Mensah-Nyagan, Ayikoe Guy] Univ Strasbourg, UMR S INSERM U1119, Fac Med, Strasbourg, France; [Bourguignon, Jean-Jacques; Schmitt, Martine] Univ Strasbourg, CNRS, UMR 7200, Lab Innovat Therapeut,Fac Pharm, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Taleb, O (corresponding author), Univ Strasbourg, UMR S INSERM U1119, Fac Med, Strasbourg, France.	omar@neuro-cnrs.unistra.fr	Schmitt, Martine/B-5878-2016; KLEIN, christian JP/J-9893-2016; Brumaru, Daniel/B-9600-2014; Maitre, Michel/J-9974-2016; Mensah-Nyagan, Ayikoe G/D-5951-2011; Taleb, Omar/K-1457-2016; Brumaru, Daniel/N-3073-2019; Kemmel, Veronique/O-9018-2015; Kemmel, Véronique/V-2590-2019	Schmitt, Martine/0000-0002-8723-9502; KLEIN, christian JP/0000-0002-7580-8536; Brumaru, Daniel/0000-0003-4067-9954; Maitre, Michel/0000-0003-1478-4806; Mensah-Nyagan, Ayikoe G/0000-0003-4454-511X; Taleb, Omar/0000-0003-2407-0380; Brumaru, Daniel/0000-0003-4067-9954; Kemmel, Veronique/0000-0003-4680-4293; Kemmel, Véronique/0000-0003-4680-4293	University of Strasbourg	University of Strasbourg	This work was supported by the University of Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Bhattacharyya MK, 2001, INT J PARASITOL, V31, P1129, DOI 10.1016/S0020-7519(01)00222-3; CHAN J, 1991, BRAIN RES, V539, P328, DOI 10.1016/0006-8993(91)91639-I; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Copeland CS, 2013, NEUROPHARMACOLOGY, V66, P133, DOI 10.1016/j.neuropharm.2012.03.009; Coune P, 2010, NEUROSCIENCE, V167, P49, DOI 10.1016/j.neuroscience.2010.02.009; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; FURST A, 1951, J ORG CHEM, V16, P412, DOI 10.1021/jo01143a010; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Gobaille S, 2008, J NEUROCHEM, V105, P982, DOI 10.1111/j.1471-4159.2008.05219.x; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartai Z, 2005, ACTA NEUROL SCAND, V112, P93, DOI 10.1111/j.1600-0404.2005.00442.x; Jiang H, 2003, J AM CHEM SOC, V125, P3448, DOI 10.1021/ja029887k; Kemmel V, 1998, NEUROSCIENCE, V86, P989, DOI 10.1016/S0306-4522(98)00085-2; Kemmel V, 2003, NEUROSCIENCE, V116, P1021, DOI 10.1016/S0306-4522(02)00662-0; Kolaj M, 2010, J NEUROPHYSIOL, V103, P1104, DOI 10.1152/jn.00808.2009; Lim C. K., 2007, INT C SER, V1304, P213, DOI [10.1016/j.ics.2007.07.011, DOI 10.1016/J.ICS.2007.07.011]; Malina Halina, 2002, BMC Ophthalmol, V2, P1, DOI 10.1186/1471-2415-2-1; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; MINNA JD, 1975, GENETICS, V79, P372; Nemeth H, 2006, J NEURAL TRANSM-SUPP, P285; PEET NP, 1985, J MED CHEM, V28, P298, DOI 10.1021/jm00381a007; Perez-De La Cruz Veronica, 2007, CNS & Neurological Disorders-Drug Targets, V6, P398; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; STONE TW, 1993, PHARMACOL REV, V45, P309; Stone TW, 2003, CLIN CHEM LAB MED, V41, P852, DOI 10.1515/CCLM.2003.129; Tsvetkov AV, 2002, TETRAHEDRON LETT, V43, P7267, DOI 10.1016/S0040-4039(02)01516-2; Vamos E, 2009, J NEUROL SCI, V283, P21, DOI 10.1016/j.jns.2009.02.326; Wright RA, 2013, NEUROPHARMACOLOGY, V66, P89, DOI 10.1016/j.neuropharm.2012.01.019; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Zadori D, 2009, J NEURAL TRANSM, V116, P1403, DOI 10.1007/s00702-009-0263-4	34	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48553	10.1371/journal.pone.0048553	http://dx.doi.org/10.1371/journal.pone.0048553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139790	gold, Green Published			2022-12-25	WOS:000311315300035
J	Thorsley, D; Klavins, E				Thorsley, David; Klavins, Eric			Estimation and Discrimination of Stochastic Biochemical Circuits from Time-Lapse Microscopy Data	PLOS ONE			English	Article							SIMULATION	The ability of systems and synthetic biologists to observe the dynamics of cellular behavior is hampered by the limitations of the sensors, such as fluorescent proteins, available for use in time-lapse microscopy. In this paper, we propose a generalized solution to the problem of estimating the state of a stochastic chemical reaction network from limited sensor information generated by microscopy. We mathematically derive an observer structure for cells growing under time-lapse microscopy and incorporates the effects of cell division in order to estimate the dynamically-changing state of each cell in the colony. Furthermore, the observer can be used to discrimate between models by treating model indices as states whose values do not change with time. We derive necessary and sufficient conditions that specify when stochastic chemical reaction network models, interpreted as continuous-time Markov chains, can be distinguished from each other under both continual and periodic observation. We validate the performance of the observer on the Thattai-van Oudenaarden model of transcription and translation. The observer structure is most effective when the system model is well-parameterized, suggesting potential applications in synthetic biology where standardized biological parts are available. However, further research is necessary to develop computationally tractable approximations to the exact generalized solution presented here.	[Thorsley, David] USA, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, Med Res & Mat Command, Ft Detrick, MD USA; [Klavins, Eric] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	United States Department of Defense; University of Washington; University of Washington Seattle	Thorsley, D (corresponding author), USA, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, Med Res & Mat Command, Ft Detrick, MD USA.	thorsley@u.washington.edu			AFOSR MURI (Air Force Office of Scientific Research Multidisciplinary University Research Initiative); NSF Award (National Science Foundation) [10002220]; Div Of Electrical, Commun & Cyber Sys [1002220] Funding Source: National Science Foundation	AFOSR MURI (Air Force Office of Scientific Research Multidisciplinary University Research Initiative); NSF Award (National Science Foundation); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research is partially supported by the 2006 AFOSR MURI (Air Force Office of Scientific Research Multidisciplinary University Research Initiative) award "High Confidence Design for Distributed Embedded Systems'' and NSF Award (National Science Foundation) #10002220, "Estimation and Observation of Stochastic Biochemical Networks.'' This work was performed while D. Thorsley was with the Department of Electrical Engineering, University of Washington, Seattle, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasopoulou E, 2010, IEEE T AUTOMAT CONTR, V55, P579, DOI 10.1109/TAC.2009.2039548; Ball DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026272; Boys RJ, 2008, STAT COMPUT, V18, P125, DOI 10.1007/s11222-007-9043-x; Bremaud P., 1975, MARKOV CHAINS GIBBS, V19, P91, DOI DOI 10.1007/978-1-4757-3124-8; Cassandras C. C., 1999, INTRO DISCRETE EVENT, DOI 10.1007/978-3-030-72274-6; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hayot F, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001973; Kalman RE, 1960, B SOC MAT MEX, V5, P102; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; MCQUARRI.DA, 1967, J APPL PROBAB, V4, P413, DOI 10.2307/3212214; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thorsley D, 2005, IEEE T AUTOMAT CONTR, V50, P476, DOI 10.1109/TAC.2005.844722; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Zad SH, 2005, IEEE T AUTOMAT CONTR, V50, P1010, DOI 10.1109/TAC.2005.851444	22	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47151	10.1371/journal.pone.0047151	http://dx.doi.org/10.1371/journal.pone.0047151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139740	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300006
J	Wang, J; Bai, X; Chen, YX; Zhao, YX; Liu, XY				Wang, Jing; Bai, Xue; Chen, Yongxing; Zhao, Yanxin; Liu, Xueyuan			Homocysteine Induces Apoptosis of Rat Hippocampal Neurons by Inhibiting 14-3-3 epsilon Expression and Activating Calcineurin	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BCL-2 FAMILY; RISK-FACTOR; NEUROTOXICITY; BAD; TRANSLOCATION; PATHWAYS; DEMENTIA; PROTEINS; SURVIVAL	A high level of plasma homocysteine (Hcy) increases the risk for neurodegenerative diseases. One such disorder is Alzheimer's disease, which involves marked neuronal apoptosis of unknown etiology. This study shows that Hcy inhibits expression of 14-3-3 epsilon and activates calcineurin in rat hippocampal neurons in a dose-dependent manner. Calcineurin-mediated Bad dephosphorylation, which is blocked by calcineurin inhibition and Ca2+ chelation, causes mitochondrial translocation of Bad and apoptosis; this step in the apoptotic pathway is synergistically blocked by calcineurin inhibition and overexpression of 14-3-3 epsilon. These findings demonstrated that calcineurin activation and downregulation of 14-3-3 epsilon may be one of the mechanisms of Hcy-induced apoptosis of hippocampal neurons.	[Wang, Jing; Bai, Xue; Chen, Yongxing; Zhao, Yanxin; Liu, Xueyuan] Shanghai Tongji Univ, Affiliated Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China	Tongji University	Zhao, YX (corresponding author), Shanghai Tongji Univ, Affiliated Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China.	cmmyx@126.com; liuxy@tongji.edu.cn						Bae J, 2001, APOPTOSIS, V6, P319, DOI 10.1023/A:1011319901057; Baydas G, 2005, NEUROSCIENCE, V135, P879, DOI 10.1016/j.neuroscience.2005.05.048; Biasioli S, 2000, BLOOD PURIFICAT, V18, P177, DOI 10.1159/000014416; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Ho PI, 2001, J NEUROCHEM, V78, P249, DOI 10.1046/j.1471-4159.2001.00384.x; Hu XM, 2006, J PROTEOME RES, V5, P2396, DOI 10.1021/pr060209x; Joosten E, 1997, J GERONTOL A-BIOL, V52, pM76, DOI 10.1093/gerona/52A.2.M76; Kim WK, 1999, NEUROSCI LETT, V265, P99, DOI 10.1016/S0304-3940(99)00212-8; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Maler JM, 2003, NEUROSCI LETT, V347, P85, DOI 10.1016/S0304-3940(03)00655-4; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Sachdev P, 2004, J NEUROL SCI, V226, P25, DOI 10.1016/j.jns.2004.09.006; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shou Y, 2004, BIOCHEM J, V379, P805, DOI 10.1042/BJ20031107; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x; Wu JS, 2009, CIRCULATION, V119, P1124, DOI 10.1161/CIRCULATIONAHA.108.812537; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zieminska E, 2006, NEUROCHEM INT, V48, P491, DOI 10.1016/j.neuint.2005.12.023; Zieminska E, 2003, NEUROCHEM INT, V43, P481, DOI 10.1016/S0197-0186(03)00038-X	31	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48247	10.1371/journal.pone.0048247	http://dx.doi.org/10.1371/journal.pone.0048247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139767	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300021
J	Zhuang, MQ; Yuan, ZY; Lin, LF; Hu, B; Wang, XF; Yang, YJ; Chen, XD; Jin, L; Lu, M; Ye, WM				Zhuang, Maoqiang; Yuan, Ziyu; Lin, Lanfang; Hu, Bin; Wang, Xiaofeng; Yang, Yajun; Chen, Xingdong; Jin, Li; Lu, Ming; Ye, Weimin			Reproducibility and Relative Validity of a Food Frequency Questionnaire Developed for Adults in Taizhou, China	PLOS ONE			English	Article							CORRELATION-COEFFICIENTS; VALIDATION; RELIABILITY; CHILDREN; DESIGN; HEALTH; KAPPA; FFQ	Objective: To evaluate the reproducibility and validity of a food frequency questionnaire (FFQ) developed to investigate the relationship between dietary factors and diseases in the adult Chinese population in East China. Methods: A total of 78 males and 129 females aged 30-75 years completed four inconsecutive 24-hour dietary recalls (24-HRs, served as a reference method) and two FFQs (FFQ1 and FFQ2) over a nine-month interval. The reproducibility of the FFQ was estimated with correlation coefficients, cross-classification, and weighted kappa statistic. The validity was assessed by comparing the data obtained from FFQ and 24-HRs. Results: The median nutrient intakes assessed with FFQs were higher than the average of four 24-HRs. For the food groups, Spearman, Pearson, and intraclass correlation coefficients between FFQ1 and FFQ2 ranged from 0.23 to 0.61, 0.27 to 0.64, and 0.26 to 0.65, respectively. For total energy and nutrient intakes, the corresponding coefficients ranged from 0.25 to 0.61, 0.28 to 0.64, and 0.28 to 0.62, respectively. The correlations between FFQ1 and FFQ2 for most nutrients decreased after adjustment with total energy intake. More than 70% of the subjects were classified into the same and adjacent categories by both FFQs. For food groups, the crude, energy-adjusted, and de-attenuated Spearman correlation coefficients between FFQ2 and the 24-HRs ranged from 0.17 to 0.59, 0.10 to 0.57, and 0.11 to 0.64, respectively. For total energy and nutrient intakes, the corresponding coefficients ranged from 0.20 to 0.58, 0.08 to 0.54, and 0.09 to 0.56, respectively. More than 67% of the subjects were classified into the same and adjacent categories by both instruments. Both weighted kappa statistic and Bland-Altman Plots showed reasonably acceptable agreement between the FFQ2 and 24-HRs. Conclusion: The FFQ developed for adults in the Taizhou area is reasonably reliable and valid for assessment of most food and nutrient intakes.	[Zhuang, Maoqiang; Lu, Ming] Shandong Univ, Qilu Hosp, Clin Epidemiol Unit, Jinan 250100, Shandong, Peoples R China; [Yuan, Ziyu; Wang, Xiaofeng; Yang, Yajun; Jin, Li; Ye, Weimin] CMC Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Lin, Lanfang; Hu, Bin; Wang, Xiaofeng; Yang, Yajun; Chen, Xingdong; Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Lin, Lanfang; Hu, Bin; Wang, Xiaofeng; Yang, Yajun; Chen, Xingdong; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Shandong University; Fudan University; Fudan University; Karolinska Institutet	Lu, M (corresponding author), Shandong Univ, Qilu Hosp, Clin Epidemiol Unit, Jinan 250100, Shandong, Peoples R China.	lvming@sdu.edu.cn	Jin, Li/M-5063-2019; zhuang, maoqiang/M-6562-2019; Jin, Li/C-1468-2009	zhuang, maoqiang/0000-0001-9093-2626; Jin, Li/0000-0002-4546-2415; ye, weimin/0000-0002-6859-4648	Natural Science Foundation of China [81072358]; Science and Technology Committee of Shandong Province [2012GSF11857]; scientific and technological support plans of Jiangsu Province [BE2011763]; scientific and technological support plan of the Department of Science and Technology [2011BAI09B00]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shandong Province; scientific and technological support plans of Jiangsu Province; scientific and technological support plan of the Department of Science and Technology	This work was supported by a grant from Natural Science Foundation of China (81072358), a grant from Science and Technology Committee of Shandong Province (2012GSF11857), a grant from scientific and technological support plans of Jiangsu Province (BE2011763), and a grant from scientific and technological support plan of the Department of Science and Technology (2011BAI09B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; Carithers TC, 2009, J AM DIET ASSOC, V109, P1184, DOI 10.1016/j.jada.2009.04.005; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Deschamps V, 2009, EUR J CLIN NUTR, V63, P282, DOI 10.1038/sj.ejcn.1602914; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Fraser GE, 2003, AM J CLIN NUTR, V78, p521S, DOI 10.1093/ajcn/78.3.521S; Haftenberger M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-36; Helzlsouer KJ, 2010, AM J EPIDEMIOL, V172, P4, DOI 10.1093/aje/kwq119; Ibiebele TI, 2009, PUBLIC HEALTH NUTR, V12, P2359, DOI 10.1017/S1368980009005023; Jessri M, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-137; Kesse-Guyot E, 2011, ANN NUTR METAB, V57, P153, DOI 10.1159/000321680; Kim SH, 2011, NUTR RES PRACT, V5, P260, DOI 10.4162/nrp.2011.5.3.260; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Marques-Vidal P, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.5905; Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; ROSNER B, 1988, AM J EPIDEMIOL, V127, P377, DOI 10.1093/oxfordjournals.aje.a114811; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Takachi R, 2011, J EPIDEMIOL, V21, P447, DOI 10.2188/jea.JE20100173; Vereecken CA, 2003, PUBLIC HEALTH NUTR, V6, P581, DOI 10.1079/PHN2003466; Villegas R, 2007, BRIT J NUTR, V97, P993, DOI 10.1017/S0007114507669189; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Watson JF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-62; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Xia W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019656; Yang YX, 2009, CHINA FOOD COMPOSITI; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240	34	40	44	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48341	10.1371/journal.pone.0048341	http://dx.doi.org/10.1371/journal.pone.0048341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139777	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300028
J	Dura-Bernal, S; Wennekers, T; Denham, SL				Dura-Bernal, Salvador; Wennekers, Thomas; Denham, Susan L.			Top-Down Feedback in an HMAX-Like Cortical Model of Object Perception Based on Hierarchical Bayesian Networks and Belief Propagation	PLOS ONE			English	Article							ILLUSORY CONTOURS; CAUSAL INDEPENDENCE; VISUAL RECOGNITION; ACTIVATION; INFERENCE; DEEP; DYNAMICS; VISION; CORTEX	Hierarchical generative models, such as Bayesian networks, and belief propagation have been shown to provide a theoretical framework that can account for perceptual processes, including feedforward recognition and feedback modulation. The framework explains both psychophysical and physiological experimental data and maps well onto the hierarchical distributed cortical anatomy. However, the complexity required to model cortical processes makes inference, even using approximate methods, very computationally expensive. Thus, existing object perception models based on this approach are typically limited to tree-structured networks with no loops, use small toy examples or fail to account for certain perceptual aspects such as invariance to transformations or feedback reconstruction. In this study we develop a Bayesian network with an architecture similar to that of HMAX, a biologically-inspired hierarchical model of object recognition, and use loopy belief propagation to approximate the model operations (selectivity and invariance). Crucially, the resulting Bayesian network extends the functionality of HMAX by including top-down recursive feedback. Thus, the proposed model not only achieves successful feedforward recognition invariant to noise, occlusions, and changes in position and size, but is also able to reproduce modulatory effects such as illusory contour completion and attention. Our novel and rigorous methodology covers key aspects such as learning using a layerwise greedy algorithm, combining feedback information from multiple parents and reducing the number of operations required. Overall, this work extends an established model of object recognition to include high-level feedback modulation, based on state-of-the-art probabilistic approaches. The methodology employed, consistent with evidence from the visual cortex, can be potentially generalized to build models of hierarchical perceptual organization that include top-down and bottom-up interactions, for example, in other sensory modalities.	[Dura-Bernal, Salvador] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Wennekers, Thomas; Denham, Susan L.] Univ Plymouth, Cognit Inst, Plymouth PL4 8AA, Devon, England	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Plymouth	Dura-Bernal, S (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	salvadordura@gmail.com		denham, susan/0000-0002-0988-5672; Dura-Bernal, Salvador/0000-0002-8561-5324	European Community [231168-SCANDLE]	European Community(European Commission)	This research was supported by the European Community's Seventh Framework Programme, grant no. 231168-SCANDLE:"acoustic SCene ANalysis for Detecting Living Entities" (http://www.scandle.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M., 1995, NEURAL NETWORKS PATT; Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P91; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Chen SY, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/416963; Chikkerur S, 2009, MA CBCL PAPER 278 MI; Ciresan DC, 2010, NEURAL COMPUT, V22, P3207, DOI 10.1162/NECO_a_00052; Das B, 2004, CSAI0411034 CORR; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Diez F. J., 1993, Uncertainty in Artificial Intelligence. Proceedings of the Ninth Conference (1993), P99; DiMaio F, 2006, 061 U WISC DEP COMP; Dura-Bernal S, 2011, 45 INT C INF SCI SYS, P1; Elidan G, 2006, P 22 C UNC AI; Epshtein B, 2008, P NATL ACAD SCI USA, V105, P14298, DOI 10.1073/pnas.0800968105; Felzenszwalb PF, 2006, INT J COMPUT VISION, V70, P41, DOI 10.1007/s11263-006-7899-4; Fox C, 2010, LECT NOTES COMPUT SC, V6352, P388, DOI 10.1007/978-3-642-15819-3_52; Friston KJ, 2009, NEURAL NETWORKS, V22, P1093, DOI 10.1016/j.neunet.2009.07.023; FUKUSHIMA K, 1988, NEURAL NETWORKS, V1, P119, DOI 10.1016/0893-6080(88)90014-7; Fukushima K, 2005, NEURAL NETWORKS, V18, P33, DOI 10.1016/j.neunet.2004.05.001; George D, 2005, IEEE IJCNN, P1812; George D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000532; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Grossberg S, 2007, PROG BRAIN RES, V165, P79, DOI 10.1016/S0079-6123(06)65006-1; Halgren E, 2003, NEUROIMAGE, V18, P1001, DOI 10.1016/S1053-8119(03)00045-4; Halko MA, 2008, J VISION, V8, DOI 10.1167/8.11.17; Hastie T., 2003, ELEMENTS STAT LEARNI; Heckerman D, 1996, IEEE T SYST MAN CY A, V26, P826, DOI 10.1109/3468.541341; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Huang JY, 2007, BRAIN RES, V1138, P111, DOI 10.1016/j.brainres.2006.12.081; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lakemeyer G., 2003, EXPLORING ARTIFICIAL, P239; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y, 1995, HDB BRAIN THEORY NEU, V3361, DOI DOI 10.1109/IJCNN.2004.1381049; LeCun Y., 2004, P CVPR 04; LeCun Y, 2010, IEEE INT SYMP CIRC S, P253, DOI 10.1109/ISCAS.2010.5537907; Lee H, 2011, COMMUN ACM, V54, P95, DOI 10.1145/2001269.2001295; Lee TS, 2003, J PHYSIOL-PARIS, V97, P121, DOI 10.1016/j.jphysparis.2003.09.015; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lengyel M, 2007, ADV NEURAL INFORM PR, P833; Lewicki MS, 1997, ADV NEUR IN, V9, P529; Li FF, 2007, COMPUT VIS IMAGE UND, V106, P59, DOI 10.1016/j.cviu.2005.09.012; Liang CK, 2011, IEEE T CIRC SYST VID, V21, P525, DOI 10.1109/TCSVT.2011.2125570; Litvak S, 2009, NEURAL COMPUT, V21, P3010, DOI 10.1162/neco.2009.05-08-783; Maertens M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.002.2008; Maltoni D., 2011, PATTERN RECOGNITION; Masquelier T, 2010, IEEE IJCNN, DOI 10.1109/IJCNN.2010.5596934; Murphy KP, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P467; Murray JF, 2007, NEURAL COMPUT, V19, P2301, DOI 10.1162/neco.2007.19.9.2301; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Murray SO, 2004, NEURAL NETWORKS, V17, P695, DOI 10.1016/j.neunet.2004.03.010; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Pearl J., 1988, PROBABILISTIC REASON; Pecevski D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002294; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Rao RPN, 1997, NEURAL COMPUT, V9, P721, DOI 10.1162/neco.1997.9.4.721; Rao RPN., 2007, BAYESIAN BRAIN PROBA, ppp 239; Reddy L, 2010, NEUROIMAGE, V50, P818, DOI 10.1016/j.neuroimage.2009.11.084; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Sary G, 2008, EUR J NEUROSCI, V28, P2137, DOI 10.1111/j.1460-9568.2008.06499.x; Serre T, 2004, 239AI MA CBCL MIT; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Singla P, 2010, P 24 AAAI C ART INT, P92; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Steimer A, 2009, NEURAL COMPUT, V21, P2502, DOI 10.1162/neco.2009.08-08-837; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Sutton C, 2007, C UNC ART INT UAI; Walther DB, 2007, PROG BRAIN RES, V165, P57, DOI 10.1016/S0079-6123(06)65005-X; Weiss Y, 2000, NEURAL COMPUT, V12, P1, DOI 10.1162/089976600300015880; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Yoshino A, 2006, BRAIN RES, V1071, P137, DOI 10.1016/j.brainres.2005.11.089; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002; Zagorecki A, 2006, PROBABILISTIC GRAPHI, P325; Zhang NL, 1996, J ARTIF INTELL RES, V5, P301, DOI 10.1613/jair.305	82	25	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48216	10.1371/journal.pone.0048216	http://dx.doi.org/10.1371/journal.pone.0048216			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139765	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400042
J	Overall, RW; Paszkowski-Rogacz, M; Kempermann, G				Overall, Rupert W.; Paszkowski-Rogacz, Maciej; Kempermann, Gerd			The Mammalian Adult Neurogenesis Gene Ontology (MANGO) Provides a Structural Framework for Published Information on Genes Regulating Adult Hippocampal Neurogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; DENTATE GYRUS; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; GRANULE CELLS; EXPRESSION; PROLIFERATION; MATURATION; DYNAMICS; REVEALS	Background: Adult hippocampal neurogenesis is not a single phenotype, but consists of a number of sub-processes, each of which is under complex genetic control. Interpretation of gene expression studies using existing resources often does not lead to results that address the interrelatedness of these processes. Formal structure, such as provided by ontologies, is essential in any field for comprehensive interpretation of existing knowledge but, until now, such a structure has been lacking for adult neurogenesis. Methodology/Principal Findings: We have created a resource with three components 1. A structured ontology describing the key stages in the development of adult hippocampal neural stem cells into functional granule cell neurons. 2. A comprehensive survey of the literature to annotate the results of all published reports on gene function in adult hippocampal neurogenesis (257 manuscripts covering 228 genes) to the appropriate terms in our ontology. 3. An easy-to-use searchable interface to the resulting database made freely available online. The manuscript presents an overview of the database highlighting global trends such as the current bias towards research on early proliferative stages, and an example gene set enrichment analysis. A limitation of the resource is the current scope of the literature which, however, is growing by around 100 publications per year. With the ontology and database in place, new findings can be rapidly annotated and regular updates of the database will be made publicly available. Conclusions/Significance: The resource we present allows relevant interpretation of gene expression screens in terms of defined stages of postnatal neuronal development. Annotation of genes by hand from the adult neurogenesis literature ensures the data are directly applicable to the system under study. We believe this approach could also serve as an example to other fields in a 'bottom-up' community effort complementing the already successful 'top-down' approach of the Gene Ontology.	[Overall, Rupert W.; Kempermann, Gerd] Tech Univ Dresden, CRTD, D-01062 Dresden, Germany; [Paszkowski-Rogacz, Maciej] Tech Univ Dresden, UCC, D-01062 Dresden, Germany; [Kempermann, Gerd] German Ctr Neurodegenerat Dis, DZNE, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Kempermann, G (corresponding author), Tech Univ Dresden, CRTD, D-01062 Dresden, Germany.	gerd.kempermann@crt-dresden.de	Overall, Rupert W/P-3102-2016; Kempermann, Gerd/F-5416-2010	Overall, Rupert W/0000-0002-3882-6073; Kempermann, Gerd/0000-0002-5304-4061	Helmholtz Alliance on Systems Biology (Systembiologie NW7)	Helmholtz Alliance on Systems Biology (Systembiologie NW7)	This work was supported by the Helmholtz Alliance on Systems Biology (Systembiologie NW7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardo A, 2010, CEREB CORTEX, V20, P304, DOI 10.1093/cercor/bhp100; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; Bonaguidi MA, 2012, CURR OPIN NEUROBIOL, V22, P754, DOI 10.1016/j.conb.2012.03.013; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; De Toni A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-13; Denis-Donini S, 2005, DEV BRAIN RES, V154, P81, DOI 10.1016/j.devbrainres.2004.10.010; du Plessis L, 2011, BRIEF BIOINFORM, V12, P723, DOI 10.1093/bib/bbr002; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2012, BEHAV BRAIN RES, V227, P433, DOI 10.1016/j.bbr.2011.10.010; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Forni PE, 2011, J NEUROSCI, V31, P480, DOI 10.1523/JNEUROSCI.4698-10.2011; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Lomax J, 2005, BRIEF BIOINFORM, V6, P298, DOI 10.1093/bib/6.3.298; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Markakis EA, 1999, J COMP NEUROL, V406, P449; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Noy Natalya, 2010, AMIA Annu Symp Proc, V2010, P552; Plake C, 2009, NUCLEIC ACIDS RES, V37, pW300, DOI 10.1093/nar/gkp429; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rubin DL, 2008, BRIEF BIOINFORM, V9, P75, DOI 10.1093/bib/bbm059; Sarkar SN, 2003, J NEUROCHEM, V87, P333, DOI 10.1046/j.1471-4159.2003.02006.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shapiro LA, 2005, BRAIN RES, V1040, P81, DOI 10.1016/j.brainres.2005.01.098; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; STANFIELD BB, 1988, EXP BRAIN RES, V72, P399; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; TAKAHASHI T, 1994, P NATL ACAD SCI USA, V91, P375, DOI 10.1073/pnas.91.1.375; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	47	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48527	10.1371/journal.pone.0048527	http://dx.doi.org/10.1371/journal.pone.0048527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139788	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400051
J	Ceccarini, L; Masetti, M; Cavalli, A; Recanatini, M				Ceccarini, Luisa; Masetti, Matteo; Cavalli, Andrea; Recanatini, Maurizio			Ion Conduction through the hERG Potassium Channel	PLOS ONE			English	Article							HUMAN INWARD RECTIFIER; MOLECULAR-DYNAMICS; K+ CHANNEL; SELECTIVITY FILTER; MECHANISM; INACTIVATION; KCSA; RECTIFICATION; SIMULATIONS; FLEXIBILITY	The inward rectifier voltage-gated potassium channel hERG is of primary importance for the regulation of the membrane potential of cardiomyocytes. Unlike most voltage-gated K+-channels, hERG shows a low elementary conductance at physiological voltage and potassium concentration. To investigate the molecular features underlying this unusual behavior, we simulated the ion conduction through the selectivity filter at a fully atomistic level by means of molecular dynamics-based methods, using a homology-derived model. According to our calculations, permeation of potassium ions can occur along two pathways, one involving site vacancies inside the filter (showing an energy barrier of about 6 kcal mol(-1)), and the other characterized by the presence of a knock-on intermediate (about 8 kcal mol(-1)). These barriers are indeed in accordance with a low conductance behavior, and can be explained in terms of a series of distinctive structural features displayed by the hERG ion permeation pathway.	[Ceccarini, Luisa; Masetti, Matteo; Cavalli, Andrea; Recanatini, Maurizio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Cavalli, Andrea] Italian Inst Technol, Dept Drug Discovery & Dev, Genoa, Italy	University of Bologna; Istituto Italiano di Tecnologia - IIT	Masetti, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	matteo.masetti4@unibo.it	Recanatini, Maurizio/AAU-3319-2021; Recanatini, Maurizio/GXH-1338-2022	Recanatini, Maurizio/0000-0002-0039-0518; Masetti, Matteo/0000-0002-3757-7802; CAVALLI, ANDREA/0000-0002-6370-1176	Istituto Italiano di Tecnologia, Genova, Italy; European Community [241679]; Alma Mater Studiorum - University of Bologna, Bologna, Italy	Istituto Italiano di Tecnologia, Genova, Italy; European Community(European Commission); Alma Mater Studiorum - University of Bologna, Bologna, Italy	The research leading to these results has received funding from Istituto Italiano di Tecnologia, Genova, Italy (Seed project: HERGSYM), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241679 (ARITMO project), and Alma Mater Studiorum - University of Bologna, Bologna, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 2004, J GEN PHYSIOL, V124, P679, DOI 10.1085/jgp.200409111; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; Berneche S, 2002, BIOPHYS J, V82, P772, DOI 10.1016/S0006-3495(02)75439-8; Bliznyuk AA, 2004, J PHYS CHEM B, V108, P13866, DOI 10.1021/jp0487298; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; Capener CE, 2003, BIOPHYS J, V84, P2345, DOI 10.1016/S0006-3495(03)75040-1; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan JS, 1999, BIOPHYS J, V76, P3128, DOI 10.1016/S0006-3495(99)77464-3; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Furini S, 2009, P NATL ACAD SCI USA, V106, P16074, DOI 10.1073/pnas.0903226106; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kiehn J, 1999, AM J PHYSIOL-HEART C, V277, pH199, DOI 10.1152/ajpheart.1999.277.1.H199; KOHLER HH, 1979, J THEOR BIOL, V79, P381, DOI 10.1016/0022-5193(79)90354-0; Kutteh R, 2007, J PHYS CHEM B, V111, P1090, DOI 10.1021/jp066294d; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Lees-Miller JP, 2000, CIRC RES, V86, P507, DOI 10.1161/01.RES.86.5.507; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Masetti M, 2008, J COMPUT CHEM, V29, P795, DOI 10.1002/jcc.20842; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piccinini E, 2007, J COMPUT ELECTRON, V6, P373, DOI 10.1007/s10825-006-0128-0; Raiteri P, 2006, J PHYS CHEM B, V110, P3533, DOI 10.1021/jp054359r; Rosso L, 2008, J COMPUT CHEM, V29, P24, DOI 10.1002/jcc.20675; Roux B, 2004, STRUCTURE, V12, P1343, DOI 10.1016/j.str.2004.06.013; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Tolokh IS, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011902; Treptow W, 2006, BIOPHYS J, V91, pL81, DOI 10.1529/biophysj.106.095992; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zou AR, 1997, AM J PHYSIOL-HEART C, V272, pH1309, DOI 10.1152/ajpheart.1997.272.3.H1309; Zuniga L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016141	61	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e49017	10.1371/journal.pone.0049017	http://dx.doi.org/10.1371/journal.pone.0049017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133669	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400054
J	Hsu, MK; Chen, FC				Hsu, Ming-Kung; Chen, Feng-Chi			Selective Constraint on the Upstream Open Reading Frames That Overlap with Coding Sequences in Animals	PLOS ONE			English	Article							5' UNTRANSLATED REGIONS; MESSENGER-RNA TRANSLATION; REINITIATION; INITIATION; MECHANISM; UORFS; ORFS; UAUG	Upstream open reading frames (uORFs) are translational regulatory elements located in 59 untranslated regions. They can significantly repress the translation of the downstream coding sequences (CDS), and participate in the spatio-temporal regulations of protein translation. Notwithstanding this biological significance, the selective constraint on uORFs remains underexplored. Particularly, the uORFs that partially overlap with CDS with a different reading frame (overlapping uORFs, or "VuORFs") may lead to strong translational inhibition or N-terminal truncation of the peptides encoded by the affected CDS. By analyzing VuORF-containing transcripts (designated as "VuORF transcripts") in human, mouse, and fruit fly, we demonstrate that VuORFs are in general slightly deleterious - the proportion of genes that encode at least one VuORF transcript is significantly smaller than expected in all of the three examined species. In addition, this proportion is significantly smaller in fruit fly than in mammals, indicating a higher efficiency of removing VuORFs in the former species because of its larger effective population size. Furthermore, the deleterious effect of a VuORF depends on the sequence context of its start codon (VuAUG). VuORFs with an optimal VuAUG context are more strongly disfavored than those with a suboptimal context in all of the three examined species. And the propensity to remove optimal-context VuAUGs is stronger in fruit fly than in mammals. Intriguingly, however, the currently observable optimal-context VuAUGs (but not suboptimal-context VuAUGs) are more conserved than expected. These observations suggest that the regulatory functions of VuORFs may have been gained fortuitously in organisms with a small effective population size because the slightly deleterious effect of these elements can be better tolerated in these organisms, thus allowing opportunities for the development of novel biological functions. Nevertheless, once the functions of VuORFs were established, they became subject to negative selection.	[Hsu, Ming-Kung; Chen, Feng-Chi] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan; [Chen, Feng-Chi] Natl Chiao Tung Univ, Dept Life Sci, Hsinchu, Taiwan; [Chen, Feng-Chi] China Med Univ, Dept Dent, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan	Chen, FC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan.	fcchen@nhri.org.tw	Chen, Feng-Chi/E-3841-2010		National Health Research Institutes; National Science Council of Taiwan [NSC 101-2311-B-400-003]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Feng-Chi Chen was supported by the intramural funding of National Health Research Institutes and the National Science Council of Taiwan (under contract NSC 101-2311-B-400-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bazykin GA, 2011, NUCLEIC ACIDS RES, V39, P567, DOI 10.1093/nar/gkq806; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chen CH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S3; Chen Chun-Hsi, 2011, BMC Res Notes, V4, P312, DOI 10.1186/1756-0500-4-312; Chen CH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-192; Chun-Hsi Chen, 2011, 2011 IEEE 11th International Conference on Bioinformatics & Bioengineering, P162, DOI 10.1109/BIBE.2011.32; Col B, 2007, BBA-GENE STRUCT EXPR, V1769, P532, DOI 10.1016/j.bbaexp.2007.06.003; Cvijovic M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-295; DURSTENFELD R, 1964, COMMUN ACM, V7, P420, DOI 10.1145/364520.364540; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Halligan DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000825; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Karasov T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000924; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Kochetov AV, 2005, BIOINFORMATICS, V21, P837, DOI 10.1093/bioinformatics/bti136; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; Lee HC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr645; Osada Y, 2006, GENE, V375, P80, DOI 10.1016/j.gene.2006.02.018; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Sharma V, 2011, MOL BIOL EVOL; Song KY, 2010, J CELL MOL MED, V14, P1113, DOI 10.1111/j.1582-4934.2009.00734.x; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Yun Y, 2012, GENOME RES; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48413	10.1371/journal.pone.0048413	http://dx.doi.org/10.1371/journal.pone.0048413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133632	gold, Green Submitted, Green Published			2022-12-25	WOS:000310601300012
J	Bruno, E; Borg, CMA; Kiorboe, T				Bruno, Eleonora; Borg, Christian Marc Andersen; Kiorboe, Thomas			Prey Detection and Prey Capture in Copepod Nauplii	PLOS ONE			English	Article							MARINE PLANKTONIC COPEPODS; CALANOID COPEPODS; HYDROMECHANICAL SIGNALS; FEEDING CURRENTS; OITHONA-SIMILIS; ACARTIA-TONSA; GROWTH; ZOOPLANKTON; BEHAVIOR; FOOD	Copepod nauplii are either ambush feeders that feed on motile prey or they produce a feeding current that entrains prey cells. It is unclear how ambush and feeding-current feeding nauplii perceive and capture prey. Attack jumps in ambush feeding nauplii should not be feasible at low Reynolds numbers due to the thick viscous boundary layer surrounding the attacking nauplius. We use high-speed video to describe the detection and capture of phytoplankton prey by the nauplii of two ambush feeding species (Acartia tonsa and Oithona davisae) and by the nauplii of one feeding-current feeding species (Temora longicornis). We demonstrate that the ambush feeders both detect motile prey remotely. Prey detection elicits an attack jump, but the jump is not directly towards the prey, such as has been described for adult copepods. Rather, the nauplius jumps past the prey and sets up an intermittent feeding current that pulls in the prey from behind towards the mouth. The feeding-current feeding nauplius detects prey arriving in the feeding current but only when the prey is intercepted by the setae on the feeding appendages. This elicits an altered motion pattern of the feeding appendages that draws in the prey.	[Bruno, Eleonora; Borg, Christian Marc Andersen; Kiorboe, Thomas] Tech Univ Denmark, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark	Technical University of Denmark	Bruno, E (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark.	elebr@aqua.dtu.dk	Kiørboe, Thomas/ABI-4733-2020	Kiørboe, Thomas/0000-0002-3265-336X	Swedish Research Council Formas; Danish Council for Independent Research; Villum Fonden [00007178] Funding Source: researchfish	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	This research was supported by the Swedish Research Council Formas through a postdoctoral grant to CMAB, and by a grant from the Danish Council for Independent Research to TK. The funders had no role in study design, data collection and analysis.	BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; BRETELER WCMK, 1982, NETH J SEA RES, V16, P195, DOI 10.1016/0077-7579(82)90030-8; Dalpadado P, 2000, ICES J MAR SCI, V57, P843, DOI 10.1006/jmsc.2000.0573; EMLET RB, 1985, SCIENCE, V228, P1016, DOI 10.1126/science.228.4702.1016; Fryer G., 1986, SYLLOGEUS, V58, P150; Gaard E, 2002, SARSIA, V87, P193, DOI 10.1080/00364820260294833; GAULD D. T., 1859, PROC ZOOL SOC LONDON, V132, P31; HARRIS RP, 1976, J MAR BIOL ASSOC UK, V56, P675, DOI 10.1017/S0025315400020725; HEINLE DR, 1975, MAR BIOL, V31, P235, DOI 10.1007/BF00387152; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Jakobsen HH, 2006, AQUAT MICROB ECOL, V44, P197, DOI 10.3354/ame044197; Jakobsen HH, 2001, MAR ECOL PROG SER, V214, P67, DOI 10.3354/meps214067; Jiang HS, 2008, MAR ECOL PROG SER, V373, P37, DOI 10.3354/meps07749; Jiang HS, 2002, J PLANKTON RES, V24, P191, DOI 10.1093/plankt/24.3.191; KIORBOE T, 1995, MAR ECOL PROG SER, V120, P285, DOI 10.3354/meps120285; Kiorboe T, 1999, MAR ECOL PROG SER, V179, P81, DOI 10.3354/meps179081; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Kiorboe T, 2009, P NATL ACAD SCI USA, V106, P12394, DOI 10.1073/pnas.0903350106; PAFFENHOFER GA, 1989, MAR ECOL PROG SER, V57, P129, DOI 10.3354/meps057129; Paffenhofer GA, 1996, J PLANKTON RES, V18, P1699, DOI 10.1093/plankt/18.9.1699; PAFFENHOFER GA, 1993, J PLANKTON RES, V15, P37, DOI 10.1093/plankt/15.1.37; Paffenhofer GA, 1998, MARINE ECOLOGY PROGR, V373, P37; PRICE HJ, 1983, LIMNOL OCEANOGR, V28, P116, DOI 10.4319/lo.1983.28.1.0116; SABATINI M, 1994, J PLANKTON RES, V16, P1329, DOI 10.1093/plankt/16.10.1329; SAIZ E, 1995, MAR ECOL PROG SER, V122, P147, DOI 10.3354/meps122147; STORCH OTTO, 1928, ZOOL JAHRB ABT ALLGEM ZOOL U PHYSIOL, V45, P385; STRICKLER JR, 1982, SCIENCE, V218, P158, DOI 10.1126/science.218.4568.158; Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; TISELIUS P, 1990, MAR ECOL PROG SER, V66, P23, DOI 10.3354/meps066023; Titelman J, 2003, MAR ECOL PROG SER, V247, P123, DOI 10.3354/meps247123; UCHIMA M, 1986, Bulletin of Plankton Society of Japan, V33, P21; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Visser AW, 2001, MAR ECOL PROG SER, V222, P1, DOI 10.3354/meps222001; YEN J, 1992, J PLANKTON RES, V14, P495, DOI 10.1093/plankt/14.4.495	35	28	28	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47906	10.1371/journal.pone.0047906	http://dx.doi.org/10.1371/journal.pone.0047906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144712	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300023
J	Cologna, SM; Jiang, XS; Backlund, PS; Cluzeau, CVM; Dail, MK; Yanjanin, NM; Siebel, S; Toth, CL; Jun, HS; Wassif, CA; Yergey, AL; Porter, FD				Cologna, Stephanie M.; Jiang, Xiao-Sheng; Backlund, Peter S.; Cluzeau, Celine V. M.; Dail, Michelle K.; Yanjanin, Nicole M.; Siebel, Stephan; Toth, Cynthia L.; Jun, Hyun-sik; Wassif, Christopher A.; Yergey, Alfred L.; Porter, Forbes D.			Quantitative Proteomic Analysis of Niemann-Pick Disease, Type C1 Cerebellum Identifies Protein Biomarkers and Provides Pathological Insight	PLOS ONE			English	Article							ACID-BINDING PROTEINS; LOW-DENSITY-LIPOPROTEIN; STATISTICAL-MODEL; MIGLUSTAT THERAPY; OXIDATIVE STRESS; ESCRT-III; ACTIVATION; BRAIN; NPC1; NEURODEGENERATION	Niemann-Pick disease, type C1 (NPC1) is a fatal, neurodegenerative disorder for which there is no definitive therapy. In NPC1, a pathological cascade including neuroinflammation, oxidative stress and neuronal apoptosis likely contribute to the clinical phenotype. While the genetic cause of NPC1 is known, we sought to gain a further understanding into the pathophysiology by identifying differentially expressed proteins in Npc1 mutant mouse cerebella. Using two-dimensional gel electrophoresis and mass spectrometry, 77 differentially expressed proteins were identified in Npc1 mutant mice cerebella compared to controls. These include proteins involved in glucose metabolism, detoxification/oxidative stress and Alzheimer disease-related proteins. Furthermore, members of the fatty acid binding protein family, including FABP3, FABP5 and FABP7, were found to have altered expression in the Npc1 mutant cerebellum relative to control. Translating our findings from the murine model to patients, we confirm altered expression of glutathione s-transferase alpha, superoxide dismutase, and FABP3 in cerebrospinal fluid of NPC1 patients relative to pediatric controls. A subset of NPC1 patients on miglustat, a glycosphingolipid synthesis inhibitor, showed significantly decreased levels of FABP3 compared to patients not on miglustat therapy. This study provides an initial report of dysregulated proteins in NPC1 which will assist with further investigation of NPC1 pathology and facilitate implementation of therapeutic trials.	[Cologna, Stephanie M.; Jiang, Xiao-Sheng; Cluzeau, Celine V. M.; Dail, Michelle K.; Yanjanin, Nicole M.; Siebel, Stephan; Toth, Cynthia L.; Jun, Hyun-sik; Wassif, Christopher A.; Porter, Forbes D.] NICHHD, Program Dev Endocrinol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Backlund, Peter S.; Yergey, Alfred L.] NICHHD, Biomed Mass Spectrometry Facil, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Porter, FD (corresponding author), NICHHD, Program Dev Endocrinol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA.	fdporter@mail.nih.gov	Jun, Hyun Sik/C-6799-2013; Cluzeau, Celine/E-6873-2016	Cluzeau, Celine/0000-0002-7791-6223; Wassif, Christopher/0000-0002-2524-1420	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Human Genome Research Institute; National Institutes of Health (NIH) Clinical Center; NIH Office of Rare Diseases; Ara Parsegian Medical Research Foundation; Dana Angels Research Trust; National Center for Advancement of Therapeutics; Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD [HHSN275200900011c, N01-HD-9-0011]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008824, ZICHD001421] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH) Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Rare Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parsegian Medical Research Foundation; Dana Angels Research Trust; National Center for Advancement of Therapeutics; Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Therapeutics of Rare and Neglected Disease Program of National Human Genome Research Institute, and a Bench to Bedside award from the National Institutes of Health (NIH) Clinical Center and the NIH Office of Rare Diseases. Support for NY and the collection of control CSF was provide by the Ara Parsegian Medical Research Foundation and Dana Angels Research Trust. Support has also been provided by the Therapeutics and Rare Diseases Program of the National Center for Advancement of Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Human tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD, contract HHSN275200900011c, Ref. No. N01-HD-9-0011. The authors would also like to express our gratitude to the families and patients that have participated in the clinical trial.	Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Boneva NB, 2010, NEUROSCI RES, V68, P94, DOI 10.1016/j.neures.2010.07.2028; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chiasserini D, 2010, J ALZHEIMERS DIS, V22, P1281, DOI 10.3233/JAD-2010-101293; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Fu R, 2010, MOL GENETICS METABOL; Fujita H, 2004, J CELL SCI, V117, P2997, DOI 10.1242/jcs.01170; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Jiang XS, 2010, MOL CELL PROTEOMICS, V9, P1461, DOI 10.1074/mcp.M900548-MCP200; Jiang XS, 2010, HUM MOL GENET, V19, P1347, DOI 10.1093/hmg/ddq011; Jiang XS, 2005, ELECTROPHORESIS, V26, P4540, DOI 10.1002/elps.200500286; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Jun HS, 2010, BLOOD, V116, P2783, DOI 10.1182/blood-2009-12-258491; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Klein A, 2011, NEUROBIOL DIS, V41, P209, DOI 10.1016/j.nbd.2010.09.008; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Koh CHV, 2006, J NEUROCHEM, V98, P1278, DOI 10.1111/j.1471-4159.2006.03958.x; Kumar A, 2011, PEDIATR NEUROL, V44, P57, DOI 10.1016/j.pediatrneurol.2010.08.004; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Loftus SK, 2002, HUM MOL GENET, V11, P3107, DOI 10.1093/hmg/11.24.3107; Mattsson N, 2011, NEUROLOGY, V76, P366, DOI 10.1212/WNL.0b013e318208f4ab; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ninomiya H., 2006, FUNCTIONAL STRUCTURA, P1; Nunes A, 2011, NEUROBIOL DIS, V42, P349, DOI 10.1016/j.nbd.2011.01.028; Ohsaki Y, 2006, J CELL SCI, V119, P2643, DOI 10.1242/jcs.02993; Ong WY, 2001, EXP BRAIN RES, V141, P218, DOI 10.1007/s002210100870; Ory DS, 2000, BBA-MOL CELL BIOL L, V1529, P331, DOI 10.1016/S1388-1981(00)00158-X; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2010, J CHILD NEUROL, V25, P300, DOI 10.1177/0883073809344222; PAULABARBOSA MM, 1978, J NEUROL SCI, V36, P259, DOI 10.1016/0022-510X(78)90086-2; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; Pineda M, 2010, MOL GENET METAB, V99, P358, DOI 10.1016/j.ymgme.2009.11.007; Pineda M, 2009, MOL GENET METAB, V98, P243, DOI 10.1016/j.ymgme.2009.07.003; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sawamura N, 2001, J BIOL CHEM, V276, P10314, DOI 10.1074/jbc.M009733200; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Steinacker P, 2004, NEUROSCI LETT, V370, P36, DOI 10.1016/j.neulet.2004.07.061; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Tabatabaie L, 2010, MOL GENET METAB, V99, P256, DOI 10.1016/j.ymgme.2009.10.012; TANAKA J, 1988, J NEUROPATH EXP NEUR, V47, P291, DOI 10.1097/00005072-198805000-00008; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Wu YP, 2005, MOL GENET METAB, V84, P9, DOI 10.1016/j.ymgme.2004.08.017; YAMAMOTO T, 1994, BIOCHEM BIOPH RES CO, V198, P438, DOI 10.1006/bbrc.1994.1064; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Yu T, 2011, HUM MOL GENET, V20, P4440, DOI 10.1093/hmg/ddr372; ZAMPIERI S, 2008, J CELL MOL MED; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]	69	48	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47845	10.1371/journal.pone.0047845	http://dx.doi.org/10.1371/journal.pone.0047845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144710	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705300021
J	Chisholm, KM; Wan, Y; Li, R; Montgomery, KD; Chang, HY; West, RB				Chisholm, Karen M.; Wan, Yue; Li, Rui; Montgomery, Kelli D.; Chang, Howard Y.; West, Robert B.			Detection of Long Non-Coding RNA in Archival Tissue: Correlation with Polycomb Protein Expression in Primary and Metastatic Breast Carcinoma	PLOS ONE			English	Article							PROSTATE-CANCER; EZH2; PROLIFERATION; SIGNATURE; ENHANCER; MARKER; GENE; ESTROGEN; CELLS	A major function of long non-coding RNAs (lncRNAs) is regulating gene expression through changes in chromatin state. Experimental evidence suggests that in cancer, they can influence Polycomb Repressive Complexes (PRC) to retarget to an occupancy pattern resembling that of the embryonic state. We have previously demonstrated that the expression level of lncRNA in the HOX locus, including HOTAIR, is a predictor of breast cancer metastasis. In this current project, RNA in situ hybridization of probes to three different lncRNAs (HOTAIR, ncHoxA1, and ncHoxD4), as well a immunohistochemical staining of EZH2, is undertaken in formalin-fixed paraffin-embedded breast cancer tissues in a high throughput tissue microarray format to correlate expression with clinicopathologic features. Though overall EZH2 and HOTAIR expression levels were highly correlated, the subset of cases with strong HOTAIR expression correlated with ER and PR positivity, while the subset of cases with strong EZH2 expression correlated with an increased proliferation rate, ER and PR negativity, HER2 underexpression, and triple negativity. Co-expression of HOTAIR and EZH2 trended with a worse outcome. In matched primary and metastatic cancers, both HOTAIR and EZH2 had increased expression in the metastatic carcinomas. This is the first study to show that RNA in situ hybridization of formalin fixed paraffin-embedded clinical material can be used to measure levels of long non-coding RNAs. This approach offers a method to make observations on lncRNAs that may influence the cancer epigenome in a tissue-based technique.	[Chisholm, Karen M.; Li, Rui; Montgomery, Kelli D.; West, Robert B.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Wan, Yue; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Wan, Yue; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	West, RB (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	rbwest@stanford.edu		West, Robert/0000-0002-8330-8283; Chisholm, Karen/0000-0002-1898-1252	Agency of Science, Technology and Research of Singapore; National Institutes of Health (NIH) [R01-CA118750]; Early Career Scientist of the Howard Hughes Medical Institute; NIH [R01-CA129927]; California Breast Cancer Research Program [17IB-0038]; NATIONAL CANCER INSTITUTE [R01CA129927, R01CA118750] Funding Source: NIH RePORTER	Agency of Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Career Scientist of the Howard Hughes Medical Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Y.W. is supported by Agency of Science, Technology and Research of Singapore. H.Y.C. is supported by the National Institutes of Health (NIH) (R01-CA118750) and is an Early Career Scientist of the Howard Hughes Medical Institute. R.B.W. is supported by the NIH (R01-CA129927) and the California Breast Cancer Research Program (17IB-0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Diaz LK, 2007, ADV ANAT PATHOL, V14, P419, DOI 10.1097/PAP.0b013e3181594733; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Saramaki OR, 2006, GENE CHROMOSOME CANC, V45, P639, DOI 10.1002/gcc.20327; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Webster JA, 2010, J PATHOL, V222, P158, DOI 10.1002/path.2738; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Zeidler M, 2006, J MOL HISTOL, V37, P219, DOI 10.1007/s10735-006-9042-9; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	27	115	124	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47998	10.1371/journal.pone.0047998	http://dx.doi.org/10.1371/journal.pone.0047998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133536	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800028
J	Sofrenovic, T; McEwan, K; Crowe, S; Marier, J; Davies, R; Suuronen, EJ; Kuraitis, D				Sofrenovic, Tanja; McEwan, Kimberly; Crowe, Suzanne; Marier, Jenelle; Davies, Robbie; Suuronen, Erik J.; Kuraitis, Drew			Circulating Angiogenic Cells Can Be Derived from Cryopreserved Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; UMBILICAL-CORD BLOOD; ACUTE MYOCARDIAL-INFARCTION; HUMAN CD34(+) CELLS; BONE-MARROW; THERAPEUTIC NEOVASCULARIZATION; LYMPHOCYTE IMMUNOPHENOTYPE; ADHESION MOLECULE-1; FLOW-CYTOMETRY; TOPCARE-AMI	Background: Cell transplantation for regenerative medicine has become an appealing therapeutic method; however, stem and progenitor cells are not always freshly available. Cryopreservation offers a way to freeze cells as they are generated, for storage and transport until required for therapy. This study was performed to assess the feasibility of cryopreserving peripheral blood mononuclear cells (PBMCs) for the subsequent in vitro generation of their derived therapeutic population, circulating angiogenic cells (CACs). Methods: PBMCs were isolated from healthy human donors. Freshly isolated cells were either analyzed immediately or cryopreserved in media containing 6% plasma serum and 5% dimethyl sulfoxide. PBMCs were thawed after being frozen for 1 (early thaw) or 28 (late thaw) days and analyzed, or cultured for 4 days to generate CACs. Analysis of the cells consisted of flow cytometry for viability and phenotype, as well as functional assays for their adhesion and migration potential, cytokine secretion, and in vivo angiogenic potential. Results: The viability of PBMCs and CACs as well as their adhesion and migration properties did not differ greatly after cryopreservation. Phenotypic changes did occur in PBMCs and to a lesser extent in CACs after freezing; however the potent CD34(+)VEGFR2(+)CD133(+) population remained unaffected. The derived CACs, while exhibiting changes in inflammatory cytokine secretion, showed no changes in the secretion of important regenerative and chemotactic cytokines, nor in their ability to restore perfusion in ischemic muscle. Conclusion: Overall, it appears that changes do occur in cryopreserved PBMCs and their generated CACs; however, the CD34(+)VEGFR2(+)CD133(+) progenitor population, the secretion of pro-vasculogenic factors, and the in vivo angiogenic potential of CACs remain unaffected by cryopreservation.	[Sofrenovic, Tanja; McEwan, Kimberly; Crowe, Suzanne; Marier, Jenelle; Suuronen, Erik J.; Kuraitis, Drew] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON, Canada; [Sofrenovic, Tanja; Marier, Jenelle; Suuronen, Erik J.; Kuraitis, Drew] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [McEwan, Kimberly] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada; [Davies, Robbie] Univ Ottawa, Inst Heart, Dept Stat, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Suuronen, EJ (corresponding author), Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON, Canada.	esuuronen@ottawaheart.ca; dkuraitis@ottawaheart.ca			Heart and Stroke Foundation of Ontario [T6793]; Canadian Institutes of Health Research	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant-in-Aid T6793 from the Heart and Stroke Foundation of Ontario (to ES). TS was supported by Master's studentship award from the Heart and Stroke Foundation of Ontario, DK was supported by a Canadian Graduate Scholarship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 2001, INVEST OPHTH VIS SCI, V42, P2831; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Axelsson S, 2008, CRYOBIOLOGY, V57, P201, DOI 10.1016/j.cryobiol.2008.08.001; Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Chen JZ, 2004, CLIN SCI, V107, P273, DOI 10.1042/CS20030389; Chen Y, 2010, ATHEROSCLEROSIS, V211, P638, DOI 10.1016/j.atherosclerosis.2010.03.013; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Faint JM, 2011, J IMMUNOTHER, V34, P588, DOI 10.1097/CJI.0b013e31822bc3d0; Fan CL, 2005, ACTA PHARMACOL SIN, V26, P1069, DOI 10.1111/j.1745-7254.2005.00168.x; Fan F, 2004, CANCER RES, V64, P3186, DOI 10.1158/0008-5472.CAN-03-0407; GRIFFIN JD, 1990, J IMMUNOL, V145, P576; Haack-Sorensen M, 2011, METHODS MOL BIOL, V698, P161, DOI 10.1007/978-1-60761-999-4_13; Hattori Y, 2001, EXP HEMATOL, V29, P114, DOI 10.1016/S0301-472X(00)00615-9; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Hwang ST, 1996, J EXP MED, V184, P1343, DOI 10.1084/jem.184.4.1343; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto Atsuhiko, 2002, Cardiovasc Radiat Med, V3, P221, DOI 10.1016/S1522-1865(03)00082-9; Ketheesan N, 2004, TRANSFUS APHER SCI, V30, P47, DOI 10.1016/j.transci.2003.05.002; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lanza F, 1999, HAEMATOLOGICA, V84, P969; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Lu XM, 2008, CELL TRANSPLANT, V17, P1423, DOI 10.3727/096368908787648155; Makino M, 1997, SCAND J IMMUNOL, V45, P618, DOI 10.1046/j.1365-3083.1997.d01-441.x; McHale JF, 1999, J IMMUNOL, V163, P3993; Mieno S, 2008, ANN THORAC SURG, V85, P1361, DOI 10.1016/j.athoracsur.2007.12.006; Motta JPR, 2010, CRYOBIOLOGY, V60, P301, DOI 10.1016/j.cryobiol.2010.02.002; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Reimann KA, 2000, CLIN DIAGN LAB IMMUN, V7, P352, DOI 10.1128/CDLI.7.3.352-359.2000; Ruel M, 2005, J THORAC CARDIOV SUR, V130, P633, DOI 10.1016/j.jtcvs.2005.01.013; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Scheubel RJ, 2010, INT J CARDIOL, V139, P134, DOI 10.1016/j.ijcard.2008.10.009; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Shreffler WG, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-29; Sperandio M, 2006, FEBS J, V273, P4377, DOI 10.1111/j.1742-4658.2006.05437.x; STOCKSCHLADER M, 1995, BONE MARROW TRANSPL, V15, P569; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Vanneaux V, 2010, CELL TRANSPLANT, V19, P1143, DOI 10.3727/096368910X504487; Weinberg A, 2000, CLIN DIAGN LAB IMMUN, V7, P714, DOI 10.1128/CDLI.7.4.714-716.2000; Weinberg A, 2007, CLIN VACCINE IMMUNOL, V14, P1242, DOI 10.1128/CVI.00187-07; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yoder MI, 2009, CURR OPIN HEMATOL, V16, P269, DOI 10.1097/MOH.0b013e32832bbcab; Zhou JY, 1997, J VIROL, V71, P2512, DOI 10.1128/JVI.71.3.2512-2517.1997	49	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48067	10.1371/journal.pone.0048067	http://dx.doi.org/10.1371/journal.pone.0048067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133548	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800038
J	Zhang, M; Fang, YM; Liang, ZH; Huang, LB				Zhang, Min; Fang, Yanming; Liang, Zhenhai; Huang, Libin			Enhanced Expression of Vacuolar H+-ATPase Subunit E in the Roots Is Associated with the Adaptation of Broussonetia papyrifera to Salt Stress	PLOS ONE			English	Article							PYROPHOSPHATASE ACTIVITIES; TONOPLAST VESICLES; PLASMA-MEMBRANE; NA+/H+ EXCHANGE; PROTON PUMPS; PLANT; TOLERANCE; TRANSPORT; STORAGE; TISSUE	Vacuolar H+-ATPase (V-H+-ATPase) may play a pivotal role in maintenance of ion homeostasis inside plant cells. In the present study, the expression of V-H+-ATPase genes was analyzed in the roots and leaves of a woody plant, Broussonetia papyrifera, which was stressed with 50, 100 and 150 mM NaCl. Moreover, the expression and distribution of the subunit E protein were investigated by Western blot and immunocytochemistry. These showed that treatment of B. papyrifera with NaCl distinctly changed the hydrolytic activity of V-H+-ATPase in the roots and leaves. Salinity induced a dramatic increase in V-H+-ATPase hydrolytic activity in the roots. However, only slight changes in V-H+-ATPase hydrolytic activity were observed in the leaves. In contrast, increased H+ pumping activity of V-H+-ATPase was observed in both the roots and leaves. In addition, NaCl treatment led to an increase in H+-pyrophosphatase (V-H+-PPase) activity in the roots. Moreover, NaCl treatment triggered the enhancement of mRNA levels for subunits A, E and c of V-H+-ATPase in the roots, whereas only subunit c mRNA was observed to increase in the leaves. By Western blot and immunocytological analysis, subunit E was shown to be augmented in response to salinity stress in the roots. These findings provide evidence that under salt stress, increased V-H+-ATPase activity in the roots was positively correlated with higher transcript and protein levels of V-H+-ATPase subunit E. Altogether, our results suggest an essential role for V-H+-ATPase subunit E in the response of plants to salinity stress.	[Fang, Yanming] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Zhang, Min; Liang, Zhenhai; Huang, Libin] Jiangsu Acad Forestry, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Fang, YM (corresponding author), Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China.	ymfangnfu@163.com			Scientific Research Fund in Jiangsu Province [BK2011872]; Priority Academic Program Development of Jiangsu High Education Institutions (PAPD); National Science & Technology Program in the Twelfth Five-year Plan [2011BAD38B0605]; Enterprise Doctor Assemblage Program in Jiangsu Province; Special Research Program for Public-welfare Forestry [200904001]	Scientific Research Fund in Jiangsu Province; Priority Academic Program Development of Jiangsu High Education Institutions (PAPD); National Science & Technology Program in the Twelfth Five-year Plan; Enterprise Doctor Assemblage Program in Jiangsu Province; Special Research Program for Public-welfare Forestry	This work was supported by Scientific Research Fund in Jiangsu Province (BK2011872), the Priority Academic Program Development of Jiangsu High Education Institutions (PAPD), National Science & Technology Program in the Twelfth Five-year Plan (No. 2011BAD38B0605), 2010 Enterprise Doctor Assemblage Program in Jiangsu Province, and Special Research Program for Public-welfare Forestry (200904001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Barkla BJ, 2009, PLANT CELL, V21, P4044, DOI 10.1105/tpc.109.069211; Batelli G, 2007, MOL CELL BIOL, V27, P7781, DOI 10.1128/MCB.00430-07; BETZ M, 1991, PLANT PHYSIOL, V97, P1294, DOI 10.1104/pp.97.4.1294; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Dietz KJ, 1996, BBA-BIOMEMBRANES, V1281, P134, DOI 10.1016/0005-2736(96)00044-2; GIANNINI JL, 1987, PLANT PHYSIOL, V84, P613, DOI 10.1104/pp.84.3.613; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; Hanitzsch M, 2007, MOL MEMBR BIOL, V24, P507, DOI 10.1080/09687680701447393; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kabala K, 2008, J PLANT PHYSIOL, V165, P1830, DOI 10.1016/j.jplph.2008.01.003; Kane PM, 2000, J EXP BIOL, V203, P81; Kirsch M, 1996, PLANT MOL BIOL, V32, P543, DOI 10.1007/BF00019107; Kluge C, 2003, J BIOENERG BIOMEMBR, V35, P377, DOI 10.1023/A:1025737117382; Krebs M, 2010, P NATL ACAD SCI USA, V107, P3251, DOI 10.1073/pnas.0913035107; Li MR, 2011, TREE PHYSIOL, V31, P349, DOI 10.1093/treephys/tpr003; Liang YC, 2005, ENVIRON EXP BOT, V53, P29, DOI 10.1016/j.envexpbot.2004.02.010; Lin M, 2012, EUKARYOT CELL, V11, P442, DOI 10.1128/EC.05286-11; Low R, 1996, PLANT PHYSIOL, V110, P259, DOI 10.1104/pp.110.1.259; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Muller ML, 1996, J BIOL CHEM, V271, P1916; Otoch MDL, 2001, J PLANT PHYSIOL, V158, P545, DOI 10.1078/0176-1617-00310; Parks GE, 2002, J EXP BOT, V53, P1055, DOI 10.1093/jexbot/53.371.1055; Popova OV, 2007, J PLANT PHYSIOL, V164, P1278, DOI 10.1016/j.jplph.2006.08.011; Qiu NW, 2007, PLANT SCI, V172, P1218, DOI 10.1016/j.plantsci.2007.02.013; Queiros F, 2009, J EXP BOT, V60, P1363, DOI 10.1093/jxb/erp011; Schnitzer D, 2011, PLANT CELL PHYSIOL, V52, P946, DOI 10.1093/pcp/pcr044; Senthilkumar P, 2005, CURR SCI INDIA, V89, P1386; Silva P, 2009, PLANT SIGNAL BEHAV, V4, P718, DOI 10.4161/psb.4.8.9236; Silva P, 2010, J PLANT GROWTH REGUL, V29, P23, DOI 10.1007/s00344-009-9110-y; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Tsiantis MS, 1996, PLANT J, V9, P729, DOI 10.1046/j.1365-313X.1996.9050729.x; Vera-Estrella R, 1999, PLANTA, V207, P426, DOI 10.1007/s004250050501; Wang BS, 2000, J PLANT PHYSIOL, V157, P109, DOI 10.1016/S0176-1617(00)80143-1; Yang Fan, 2009, Yingyong Shengtai Xuebao, V20, P767; YOSHIDA S, 1994, PLANT PHYSIOL, V104, P1131, DOI 10.1104/pp.104.4.1131; Zhao FG, 2005, ENVIRON EXP BOT, V53, P215, DOI 10.1016/j.envexpbot.2004.04.001	41	25	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48183	10.1371/journal.pone.0048183	http://dx.doi.org/10.1371/journal.pone.0048183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133565	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800055
J	Camacho-Vanegas, O; Till, J; Miranda-Lorenzo, I; Ozturk, B; Camacho, SC; Martignetti, JA				Camacho-Vanegas, Olga; Till, Jacob; Miranda-Lorenzo, Irene; Ozturk, Berrin; Camacho, Sandra Catalina; Martignetti, John A.			Shaking the family tree: identification of novel and biologically active alternatively spliced isoforms across the KLF family of transcription factors	FASEB JOURNAL			English	Article						Kruppel-like transcription factors; isoforms	PROGRESSION	Alternative splicing represents a unique post-transcriptional mechanism that increases the complexity of the eukaryotic proteome-generating protein isoforms whose functions can be novel, diverse, and/or even antagonistic when compared to its full-length transcript. The KLF family of genes consists of >= 17 members, which are involved in the regulation of numerous critical cellular processes, including differentiation, cell proliferation, growth-related signal transduction, angiogenesis, and apoptosis. Using a strategy based on RT-PCR, selective cloning, and promoter-based assays of cancer-relevant genes, we identify and characterize the existence of multiple biologically active KLF splice forms across the entire family of proteins. We demonstrate biological function for a number of these isoforms. Furthermore, we highlight a possible functional interaction between full-length KLF4 and one of its splice variants in up-regulating cellular proliferation. Taken together, this report identifies for the first time a more complete view of the genomic and proteomic breadth and complexity of the KLF transcription factor family, revealing the existence of highly expressed and biologically active isoforms previously uncharacterized. In essence, knowing that these KLF isoforms exist provides the first step toward understanding the roles of these genes in human health and disease.-Camacho-Vanegas, O., Till, J., Miranda-Lorenzo, I., Ozturk, B., Camacho, S. C., Martignetti, J. A. Shaking the family tree: identification of novel and biologically active alternatively spliced isoforms across the KLF family of transcription factors. FASEB J. 27, 432-436 (2013). www.fasebj.org	[Camacho-Vanegas, Olga; Till, Jacob; Miranda-Lorenzo, Irene; Ozturk, Berrin; Camacho, Sandra Catalina; Martignetti, John A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Martignetti, JA (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, 1425 Madison Ave,Box 1498, New York, NY 10029 USA.	john.martignetti@mssm.edu		Till, Jacob/0000-0002-2824-1282				Brosius J, 2005, TRENDS GENET, V21, P287, DOI 10.1016/j.tig.2005.02.014; Bryant Douglas W Jr, 2012, Methods Mol Biol, V883, P97, DOI 10.1007/978-1-61779-839-9_7; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2008, J CLIN INVEST, V118, P2711, DOI 10.1172/JCI34780; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022	10	15	21	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					432	436		10.1096/fj.12-220319	http://dx.doi.org/10.1096/fj.12-220319			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23134681				2022-12-25	WOS:000314358000004
J	Spirig, T; Malmirchegini, GR; Zhang, J; Robson, SA; Sjodt, M; Liu, MY; Kumar, KK; Dickson, CF; Gell, DA; Lei, BF; Loo, JA; Clubb, RT				Spirig, Thomas; Malmirchegini, G. Reza; Zhang, Jiang; Robson, Scott A.; Sjodt, Megan; Liu, Mengyao; Kumar, Kaavya Krishna; Dickson, Claire F.; Gell, David A.; Lei, Benfang; Loo, Joseph A.; Clubb, Robert T.			Staphylococcus aureus Uses a Novel Multidomain Receptor to Break Apart Human Hemoglobin and Steal Its Heme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE PROTEIN; STRUCTURAL BASIS; GLOBIN CHAINS; NEAT DOMAIN; IRON; BINDING; SYSTEM; ISDB; WALL; IDENTIFICATION	Staphylococcus aureus is a leading cause of life-threatening infections in the United States. It requires iron to grow, which must be actively procured from its host to successfully mount an infection. Heme-iron within hemoglobin (Hb) is the most abundant source of iron in the human body and is captured by S. aureus using two closely related receptors, IsdH and IsdB. Here we demonstrate that each receptor captures heme using two conserved near iron transporter (NEAT) domains that function synergistically. NMR studies of the 39-kDa conserved unit from IsdH (IsdH(N2N3), Ala(326)-Asp(660)) reveals that it adopts an elongated dumbbell-shaped structure in which its NEAT domains are properly positioned by a helical linker domain, whose three-dimensional structure is determined here in detail. Electrospray ionization mass spectrometry and heme transfer measurements indicate that IsdH(N2N3) extracts heme from Hb via an ordered process in which the receptor promotes heme release by inducing steric strain that dissociates the Hb tetramer. Other clinically significant Gram-positive pathogens capture Hb using receptors that contain multiple NEAT domains, suggesting that they use a conserved mechanism.	[Spirig, Thomas; Malmirchegini, G. Reza; Zhang, Jiang; Robson, Scott A.; Sjodt, Megan; Loo, Joseph A.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Spirig, Thomas; Malmirchegini, G. Reza; Zhang, Jiang; Robson, Scott A.; Sjodt, Megan; Loo, Joseph A.; Clubb, Robert T.] Univ Calif Los Angeles, UCLA Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Kumar, Kaavya Krishna; Dickson, Claire F.; Gell, David A.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Liu, Mengyao; Lei, Benfang] Montana State Univ, Dept Vet Biol, Bozeman, MT USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tasmania; Menzies Institute for Medical Research; Montana State University System; Montana State University Bozeman	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 602 Boyer Hall, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu	Zhang, Jiang/D-1136-2015	Robson, Scott/0000-0002-0529-0399; Spirig, Thomas/0000-0001-8936-238X; Sjodt, Megan/0000-0003-0234-4336; Gell, David/0000-0003-0382-1181; Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health [AI52217, GM103479, RR020004]; National Center for Research Resources for purchase of the Fourier transform ion cyclotron resonance mass spectrometer [S10RR028893]; Swiss National Science Foundation Fellowship [PBEZP3-124281]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028893, R01RR020004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM101931, R01GM103479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources for purchase of the Fourier transform ion cyclotron resonance mass spectrometer; Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI52217 (to R. T. C.), RR020004 (now reassigned as GM103479) (to J. A. L.), and S10RR028893 from the National Center for Research Resources for purchase of the Fourier transform ion cyclotron resonance mass spectrometer. This work was also supported by Swiss National Science Foundation Fellowship PBEZP3-124281 (to T. S.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Andrade MA, 2002, GENOME BIOL, V3; Ascoli F, 1981, Methods Enzymol, V76, P72; BENESCH RE, 1995, J BIOL CHEM, V270, P13785, DOI 10.1074/jbc.270.23.13785; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Bunn F. H., 1986, HEMOGLOBIN MOL GENET, P21; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Garrett Daniel S, 2011, J Magn Reson, V213, P357, DOI 10.1016/j.jmr.2011.09.007; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Goddard T. D., 2001, SPARKY NMR ANAL SOFT; GOUDA H, 1992, BIOCHEMISTRY-US, V31, P9665, DOI 10.1021/bi00155a020; Griffith WP, 2003, BIOCHEMISTRY-US, V42, P10024, DOI 10.1021/bi034035y; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu JJ, 2011, J AM SOC MASS SPECTR, V22, P408, DOI 10.1007/s13361-010-0052-1; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; Lu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037556; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Schneider JP, 1998, FOLD DES, V3, pR29, DOI 10.1016/S1359-0278(98)00011-X; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Spirig T, 2012, BIOMOL NMR ASSIGN, V6, P169, DOI 10.1007/s12104-011-9348-8; SUGITA Y, 1975, J BIOL CHEM, V250, P1251; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WAKS M, 1973, J BIOL CHEM, V248, P6462; Ward PP, 2004, BIOMETALS, V17, P203, DOI 10.1023/B:BIOM.0000027693.60932.26; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	70	43	43	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1065	1078		10.1074/jbc.M112.419119	http://dx.doi.org/10.1074/jbc.M112.419119			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23132864	hybrid, Green Published			2022-12-25	WOS:000313570300030
J	Crabtree, MJ; Brixey, R; Batchelor, H; Hale, AB; Channon, KM				Crabtree, Mark J.; Brixey, Rachel; Batchelor, Helen; Hale, Ashley B.; Channon, Keith M.			Integrated Redox Sensor and Effector Functions for Tetrahydrobiopterin- and Glutathionylation-dependent Endothelial Nitric-oxide Synthase Uncoupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-GLUTATHIONYLATION; INTRACELLULAR SUPEROXIDE; CELLS; ENOS; HPLC; EXPRESSION; OXIDATION; RATIO	Endothelial nitric-oxide synthase (eNOS) is a critical regulator of vascular homeostasis by generation of NO that is dependent on the cofactor tetrahydrobiopterin (BH4). When BH4 availability is limiting, eNOS becomes "uncoupled," resulting in superoxide production in place of NO. Recent evidence suggests that eNOS uncoupling can also be induced by S-glutathionylation, although the functional relationships between BH4 and S-glutathionylation remain unknown. To address a possible role for BH4 in S-glutathionylation-induced eNOS uncoupling, we expressed either WT or mutant eNOS rendered resistant to S-glutathionylation in cells with Tet-regulated expression of human GTP cyclohydrolase I to regulate intracellular BH4 availability. We reveal that S-glutathionylation of eNOS, by exposure to either 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or glutathione reductase-specific siRNA, results in diminished NO production and elevated eNOS-derived superoxide production, along with a concomitant reduction in BH4 levels and BH4:7,8-dihydrobiopterin ratio. In eNOS uncoupling induced by BH4 deficiency, BCNU exposure further exacerbates superoxide production, BH4 oxidation, and eNOS activity. Following mutation of C908S, BCNU-induced eNOS uncoupling and BH4 oxidation are abolished, whereas uncoupling induced by BH4 deficiency was preserved. Furthermore, BH4 deficiency alone is alone sufficient to reduce intracellular GSH:GSSG ratio and cause eNOS S-glutathionylation. These data provide the first evidence that BH4 deficiency-and S-glutathionylation-induced mechanisms of eNOS uncoupling, although mechanistically distinct, are functionally related. We propose that uncoupling of eNOS by S-glutathionylation- or by BH4-dependent mechanisms exemplifies eNOS as an integrated redox "hub" linking upstream redox-sensitive effects of BH4 and glutathione with redox-dependent targets and pathways that lie downstream of eNOS.	[Crabtree, Mark J.; Brixey, Rachel; Batchelor, Helen; Hale, Ashley B.; Channon, Keith M.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Crabtree, MJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	mark.crabtree@well.ox.ac.uk		Crabtree, Mark/0000-0003-3298-2697; channon, keith/0000-0002-1043-4342	British Heart Foundation Centre of Research Excellence [RE/08/004]; British Heart Foundation [RG/07/003/23133]; British Heart Foundation [RG/12/5/29576] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10247] Funding Source: researchfish	British Heart Foundation Centre of Research Excellence(British Heart Foundation); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by British Heart Foundation Centre of Research Excellence Intermediate Fellowship Award RE/08/004 (to M. J. C.) and British Heart Foundation Programme Grant RG/07/003/23133.	Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; Cunnington C, 2012, CIRCULATION, V125, P1356, DOI 10.1161/CIRCULATIONAHA.111.038919; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; de Bono JP, 2007, NITRIC OXIDE-BIOL CH, V16, P1, DOI 10.1016/j.niox.2006.03.008; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; McDonald DM, 2004, PHARMACOGENETICS, V14, P831, DOI 10.1097/00008571-200412000-00006; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Stroes E, 1998, FEBS LETT, V438, P161, DOI 10.1016/S0014-5793(98)01292-7; Sugiyama T, 2010, AM J PHYSIOL-HEART C, V298, pH194, DOI 10.1152/ajpheart.00767.2009; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	24	63	66	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					561	569		10.1074/jbc.M112.415992	http://dx.doi.org/10.1074/jbc.M112.415992			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23139420	Green Published, hybrid			2022-12-25	WOS:000313197200056
J	Unal, H; Jagannathan, R; Bhatnagar, A; Tirupula, K; Desnoyer, R; Karnik, SS				Unal, Hamiyet; Jagannathan, Rajaganapathi; Bhatnagar, Anushree; Tirupula, Kalyan; Desnoyer, Russell; Karnik, Sadashiva S.			Long Range Effect of Mutations on Specific Conformational Changes in the Extracellular Loop 2 of Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CYSTEINE-SCANNING MUTAGENESIS; BLOOD-PRESSURE REGULATION; 3RD TRANSMEMBRANE DOMAIN; CONSTITUTIVE ACTIVATION; AT(1) RECEPTOR; LIGAND-BINDING; ACTIVE-STATE; ACCESSIBILITY METHOD; HELIX MOVEMENT	The topology of the second extracellular loop (ECL2) and its interaction with ligands is unique in each G protein-coupled receptor. When the orthosteric ligand pocket located in the transmembrane (TM) domain is occupied, ligand-specific conformational changes occur in the ECL2. In more than 90% of G protein-coupled receptors, ECL2 is tethered to the third TM helix via a disulfide bond. Therefore, understanding the extent to which the TM domain and ECL2 conformations are coupled is useful. To investigate this, we examined conformational changes in ECL2 of the angiotensin II type 1 receptor (AT1R) by introducing mutations in distant sites that alter the activation state equilibrium of the AT1R. Differential accessibility of reporter cysteines introduced at four conformation-sensitive sites in ECL2 of these mutants was measured. Binding of the agonist angiotensin II (AngII) and inverse agonist losartan in wild-type AT1R changed the accessibility of reporter cysteines, and the pattern was consistent with ligand-specific "lid" conformations of ECL2. Without agonist stimulation, the ECL2 in the gain of function mutant N111G assumed a lid conformation similar to AngII-bound wild-type AT1R. In the presence of inverse agonists, the conformation of ECL2 in the N111G mutant was similar to the inactive state of wild-type AT1R. In contrast, AngII did not induce a lid conformation in ECL2 in the loss of function D281A mutant, which is consistent with the reduced AngII binding affinity in this mutant. However, a lid conformation was induced by [Sar(1), Gln(2), Ile(8)] AngII, a specific analog that binds to the D281A mutant with better affinity than AngII. These results provide evidence for the emerging paradigm of domain coupling facilitated by long range interactions at distant sites on the same receptor.	[Unal, Hamiyet; Jagannathan, Rajaganapathi; Bhatnagar, Anushree; Tirupula, Kalyan; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Karnik, SS (corresponding author), 9500 Euclid Ave, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	National Institutes of Health [RO1 HL57470]; National Research Service [HL007914]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007914, R01HL057470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL57470 (to S. K.). This work was also supported by National Research Service Award HL007914 (to H. U.).	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Baleanu-Gogonea C, 2006, J MOL MODEL, V12, P325, DOI 10.1007/s00894-005-0049-z; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bonde MM, 2010, BIOCHEM PHARMACOL, V80, P86, DOI 10.1016/j.bcp.2010.03.006; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; Costa-Neto CM, 2000, BRIT J PHARMACOL, V130, P1263, DOI 10.1038/sj.bjp.0703430; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Domazet I, 2009, J BIOL CHEM, V284, P31953, DOI 10.1074/jbc.M109.051839; Escano CS, 2008, J PHARMACOL EXP THER, V324, P34, DOI 10.1124/jpet.107.126300; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; Hauser M, 2007, J BIOL CHEM, V282, P10387, DOI 10.1074/jbc.M608903200; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; Hunyady L, 2003, TRENDS PHARMACOL SCI, V24, P81, DOI 10.1016/S0165-6147(02)00050-0; Hwa J, 2001, P NATL ACAD SCI USA, V98, P4872, DOI 10.1073/pnas.061632798; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JCI200420805; Lin JC, 2004, MOL CELL BIOL, V24, P2041, DOI 10.1128/MCB.24.5.2041-2051.2004; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Miura S, 1999, J BIOL CHEM, V274, P7103, DOI 10.1074/jbc.274.11.7103; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; Nikiforovich GV, 2005, J PEPT RES, V66, P236, DOI 10.1111/j.1399-3011.2005.00293.x; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Post CB, 1995, BIOCHEMISTRY-US, V34, P15881, DOI 10.1021/bi00049a001; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Rana S, 2010, J BIOL CHEM, V285, P31472, DOI 10.1074/jbc.M110.129213; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Roberts DJ, 2011, PEPTIDES, V32, P1593, DOI 10.1016/j.peptides.2011.06.009; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Stojanovic A, 2003, J BIOL CHEM, V278, P39020, DOI 10.1074/jbc.M303625200; Uddin MS, 2012, J RECEPT SIG TRANSD, V32, P65, DOI 10.3109/10799893.2011.647352; Unal H, 2012, ADV EXP MED BIOL, V749, P187, DOI 10.1007/978-1-4614-3381-1_13; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100; Yan LP, 2010, J BIOL CHEM, V285, P2227, DOI 10.1074/jbc.M109.077180	51	24	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					540	551		10.1074/jbc.M112.392514	http://dx.doi.org/10.1074/jbc.M112.392514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23139413	hybrid, Green Published			2022-12-25	WOS:000313197200054
J	Garcia-Huerta, P; Diaz-Hernandez, M; Delicado, EG; Pimentel-Santillana, M; Miras-Portugal, MT; Gomez-Villafuertes, R				Garcia-Huerta, Paula; Diaz-Hernandez, Miguel; Delicado, Esmerilda G.; Pimentel-Santillana, Maria; Teresa Miras-Portugal, Ma; Gomez-Villafuertes, Rosa			The Specificity Protein Factor Sp1 Mediates Transcriptional Regulation of P2X7 Receptors in the Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAIN-OF-FUNCTION; P2X(7) RECEPTOR; GENE-EXPRESSION; HUNTINGTON-DISEASE; POLYMORPHISM LEADS; ACTIVATION; ATP; BINDING; INHIBITION; CLONING	P2X7 receptors are involved not only in physiological functions but also in pathological brain processes. Although an increasing number of findings indicate that altered receptor expression has a causative role in neurodegenerative diseases and cancer, little is known about how expression of P2rx7 gene is controlled. Here we reported the first molecular and functional evidence that Specificity protein 1 (Sp1) transcription factor plays a pivotal role in the transcriptional regulation of P2X7 receptor. We delimited a minimal region in the murine P2rx7 promoter containing four SP1 sites, two of them being highly conserved in mammals. The functionality of these SP1 sites was confirmed by site-directed mutagenesis and Sp1 overexpression/down-regulation in neuroblastoma cells. Inhibition of Sp1-mediated transcriptional activation by mithramycin A reduced endogenous P2X7 receptor levels in primary cultures of cortical neurons and astrocytes. Using P2rx7-EGFP transgenic mice that express enhanced green fluorescent protein under the control of P2rx7 promoter, we found a high correlation between reporter expression and Sp1 levels in the brain, demonstrating that Sp1 is a key element in the transcriptional regulation of P2X7 receptor in the nervous system. Finally, we found that Sp1 mediates P2X7 receptor up-regulation in neuroblastoma cells cultured in the absence of serum, a condition that enhances chromatin accessibility and facilitates the exposure of SP1 binding sites.	[Garcia-Huerta, Paula; Diaz-Hernandez, Miguel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Ma; Gomez-Villafuertes, Rosa] Univ Complutense Madrid, Fac Vet, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; [Garcia-Huerta, Paula; Diaz-Hernandez, Miguel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Ma; Gomez-Villafuertes, Rosa] Univ Complutense Madrid, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; [Garcia-Huerta, Paula; Diaz-Hernandez, Miguel; Delicado, Esmerilda G.; Teresa Miras-Portugal, Ma; Gomez-Villafuertes, Rosa] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid 28040, Spain; [Pimentel-Santillana, Maria] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Gomez-Villafuertes, R (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Bioquim & Biol Mol, Avda Puerta de Hierro S-N, E-28040 Madrid, Spain.	marosa@vet.ucm.es	Gomez-Villafuertes, Rosa/L-7181-2014; Miras-Portugal, Maria Teresa/L-7137-2014; Pimentel-Santillana, Maria/L-9437-2014; Delicado, Esmerilda G./L-6992-2014	Gomez-Villafuertes, Rosa/0000-0002-7064-0906; Pimentel-Santillana, Maria/0000-0003-1179-4259; Diaz-Hernandez, Miguel/0000-0002-1952-4600	Ministry of Science and Innovation [BFU2008-02699, BFU2011-24743]; Spanish Ion Channel Initiative [CSD2008-00005]; Marcelino Botin Foundation; Spanish Education Ministry; Spanish Ion Channel Initiative	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ion Channel Initiative; Marcelino Botin Foundation; Spanish Education Ministry(Spanish Government); Spanish Ion Channel Initiative	This work was supported by the Ministry of Science and Innovation (BFU2008-02699 and BFU2011-24743), the Spanish Ion Channel Initiative (CSD2008-00005), and the Marcelino Botin Foundation.; Supported by a fellowship from Spanish Education Ministry.; Supported by Spanish Ion Channel Initiative. To whom correspondence should be addressed: Departamento de Bioquimica y Biologia Molecular, Facultad de Veterinaria, Universidad Complutense de Madrid, Avda. Puerta de Hierro s/n, 28040 Madrid, Spain. Tel.: 34-913943890; Fax: 34-913943909; E-mail: marosa@vet.ucm.es.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Buell GN, 1998, RECEPTOR CHANNEL, V5, P347; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Carrasquero LMG, 2010, GLIA, V58, P984, DOI 10.1002/glia.20980; Chatterjee S, 2001, ANN NEUROL, V49, P345, DOI 10.1002/ana.71.abs; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; Engel T, 2012, FASEB J, V26, P1616, DOI 10.1096/fj.11-196089; Eslick GD, 2009, INT J CARDIOL, V137, P81, DOI 10.1016/j.ijcard.2008.05.017; Ferrante RJ, 2004, J NEUROSCI, V24, P10335, DOI 10.1523/JNEUROSCI.2599-04.2004; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Gomez-Villafuertes R, 2009, FEBS J, V276, P5307, DOI 10.1111/j.1742-4658.2009.07228.x; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Gutierrez-Martin Y, 2011, J BIOL CHEM, V286, P11370, DOI 10.1074/jbc.M110.139410; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Diaz-Hernandez JI, 2012, NEUROBIOL AGING, V33, P1816, DOI 10.1016/j.neurobiolaging.2011.09.040; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jorgensen NR, 2012, EUR J HUM GENET, V20, P675, DOI 10.1038/ejhg.2011.253; KOLLER CA, 1986, NEW ENGL J MED, V315, P1433, DOI 10.1056/NEJM198612043152301; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Leon D, 2006, EUR J NEUROSCI, V23, P2999, DOI 10.1111/j.1460-9568.2006.04832.x; Leon-Otegui M, 2011, FEBS LETT, V585, P2255, DOI 10.1016/j.febslet.2011.05.048; Li CM, 2002, J INFECT DIS, V186, P1458, DOI 10.1086/344351; Li CM, 2002, FEBS LETT, V531, P127, DOI 10.1016/S0014-5793(02)03424-5; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Liu YY, 2004, GENOME RES, V14, P451, DOI 10.1101/gr.1327604; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ortega F, 2011, NEUROPHARMACOLOGY, V61, P1210, DOI 10.1016/j.neuropharm.2011.07.010; Ortega F, 2010, CELL MOL LIFE SCI, V67, P1723, DOI 10.1007/s00018-010-0278-x; Ortega F, 2009, NEUROTOX RES, V15, P193, DOI 10.1007/s12640-009-9020-6; Pan QH, 2010, BIOCHEM BIOPH RES CO, V401, P306, DOI 10.1016/j.bbrc.2010.09.058; Pankratov Y, 2009, NEUROSCIENCE, V158, P137, DOI 10.1016/j.neuroscience.2008.03.076; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Seznec J, 2011, J NEURO-ONCOL, V101, P365, DOI 10.1007/s11060-010-0266-x; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Skarratt KK, 2005, FEBS LETT, V579, P2675, DOI 10.1016/j.febslet.2005.03.091; Sperlagh B, 2007, PURINERG SIGNAL, V3, P269, DOI 10.1007/s11302-007-9080-0; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stack EC, 2007, HUM MOL GENET, V16, P1164, DOI 10.1093/hmg/ddm064; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; Sun SH, 2010, MOL NEUROBIOL, V41, P351, DOI 10.1007/s12035-010-8120-x; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Velasco M, 1997, J IMMUNOL, V158, P4437; Wang RT, 2012, J MOL NEUROSCI, V47, P311, DOI 10.1007/s12031-012-9739-z; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Yoo J, 2002, J BIOL CHEM, V277, P11904, DOI 10.1074/jbc.M111788200; Zhou LY, 2009, PURINERG SIGNAL, V5, P409, DOI 10.1007/s11302-009-9167-x	82	47	47	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44628	44644		10.1074/jbc.M112.390971	http://dx.doi.org/10.1074/jbc.M112.390971			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23139414	Green Published, hybrid			2022-12-25	WOS:000312938600059
J	Li, J; Kanekiyo, T; Shinohara, M; Zhang, YW; LaDu, MJ; Xu, HX; Bu, GJ				Li, Jie; Kanekiyo, Takahisa; Shinohara, Mitsuru; Zhang, Yunwu; LaDu, Mary Jo; Xu, Huaxi; Bu, Guojun			Differential Regulation of Amyloid-beta Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC ALZHEIMERS-DISEASE; GENOME-WIDE ASSOCIATION; SOLUBLE A-BETA; IDENTIFIES VARIANTS; DEPOSITION; CLEARANCE; OLIGOMERS; LOCALIZATION; ACCUMULATION; AGGREGATION	Aggregation of amyloid-beta (A beta) peptides leads to synaptic disruption and neurodegeneration in Alzheimer disease (AD). A major A beta clearance pathway in the brain is cellular uptake and degradation. However, how A beta traffics through the endocytic pathway and how AD risk factors regulate this event is unclear. Here we show that the majority of endocytosed A beta in neurons traffics through early and late endosomes to the lysosomes for degradation. Overexpression of Rab5 or Rab7, small GTPases that function in vesicle fusion for early and late endosomes, respectively, significantly accelerates A beta endocytic trafficking to the lysosomes. We also found that a portion of endocytosed A beta traffics through Rab11-positive recycling vesicles. A blockage of this A beta recycling pathway with a constitutively active Rab11 mutant significantly accelerates cellular A beta accumulation. Inhibition of lysosomal enzymes results in A beta accumulation and aggregation. Importantly, apolipoprotein E (apoE) accelerates neuronal A beta uptake, lysosomal trafficking, and degradation in an isoform-dependent manner with apoE3 more efficiently facilitating A beta trafficking and degradation than apoE4, a risk factor for AD. Taken together, our results demonstrate that A beta endocytic trafficking to lysosomes for degradation is a major A beta clearance pathway that is differentially regulated by apoE isoforms. A disturbance of this pathway can lead to accumulation and aggregation of cellular A beta capable of causing neurotoxicity and seeding amyloid.	[Li, Jie; Zhang, Yunwu; Xu, Huaxi; Bu, Guojun] Xiamen Univ, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Inst Neurosci, Coll Med, Xiamen 361005, Fujian, Peoples R China; [Li, Jie] Xiamen Univ, Sch Pharmaceut Sci, Xiamen 361005, Fujian, Peoples R China; [Li, Jie; Kanekiyo, Takahisa; Shinohara, Mitsuru; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Xiamen University; Xiamen University; Mayo Clinic; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu	Zhang, YW/G-3999-2010; Xu, Huaxi/AAV-7177-2021	LaDu, Mary Jo/0000-0003-2141-1450	National Institutes of Health [R01AG027924, R01AG035355, P01AG030128, P01 NS074969]; National Institutes of Health Mayo Clinic Alzheimer's Disease Research Center (ADRC) Pilot Grant [P50AG16574]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574, R01AG027924, P01AG030128, R01AG038710, R01AG035355, R01AG021173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Mayo Clinic Alzheimer's Disease Research Center (ADRC) Pilot Grant; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG027924, R01AG035355, P01AG030128, and P01 NS074969 (to G.B.) and National Institutes of Health Mayo Clinic Alzheimer's Disease Research Center (ADRC) Pilot Grant P50AG16574 (to T.K.). This work was also supported by a grant from the Alzheimer's Association (to G.B.).	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2001, J ALZHEIMERS DIS, V3, P97, DOI 10.3233/JAD-2001-3114; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Peralvarez-Marin A, 2008, J MOL BIOL, V379, P589, DOI 10.1016/j.jmb.2008.04.014; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3	44	116	120	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44593	44601		10.1074/jbc.M112.420224	http://dx.doi.org/10.1074/jbc.M112.420224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132858	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000312938600056
J	Larsbrink, J; Izumi, A; Hemsworth, GR; Davies, GJ; Brumer, H				Larsbrink, Johan; Izumi, Atsushi; Hemsworth, Glyn R.; Davies, Gideon J.; Brumer, Harry			Structural Enzymology of Cellvibrio japonicus Agd31B Protein Reveals alpha-Transglucosylase Activity in Glycoside Hydrolase Family 31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOTOGA-MARITIMA MALTOSYLTRANSFERASE; HUMAN MALTASE-GLUCOAMYLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; THERMOSTABLE 4-ALPHA-GLUCANOTRANSFERASE; THERMUS-AQUATICUS; ACTION PATTERN; GLUCOSIDASE; METABOLISM; AMYLOMALTASE	The metabolism of the storage polysaccharides glycogen and starch is of vital importance to organisms from all domains of life. In bacteria, utilization of these alpha-glucans requires the concerted action of a variety of enzymes, including glycoside hydrolases, glycoside phosphorylases, and transglycosylases. In particular, transglycosylases from glycoside hydrolase family 13 (GH13) and GH77 play well established roles in alpha-glucan side chain (de) branching, regulation of oligo-and polysaccharide chain length, and formation of cyclic dextrans. Here, we present the biochemical and tertiary structural characterization of a new type of bacterial 1,4-alpha-glucan 4-alpha-glucosyltransferase from GH31. Distinct from 1,4-alpha-glucan 6-alpha-glucosyltransferases (EC 2.4.1.24) and 4-alpha-glucanotransferases (EC 2.4.1.25), this enzyme strictly transferred one glucosyl residue from alpha(1 -> 4)-glucans in disproportionation reactions. Substrate hydrolysis was undetectable for a series of malto-oligosaccharides except maltose for which transglycosylation nonetheless dominated across a range of substrate concentrations. Crystallographic analysis of the enzyme in free, acarbose-complexed, and trapped 5-fluoro-beta-glucosyl-enzyme intermediate forms revealed extended substrate interactions across one negative and up to three positive subsites, thus providing structural rationalization for the unique, single monosaccharide transferase activity of the enzyme.	[Izumi, Atsushi; Hemsworth, Glyn R.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Larsbrink, Johan; Brumer, Harry] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, Div Glycosci, S-10691 Stockholm, Sweden; [Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada	University of York - UK; Royal Institute of Technology; University of British Columbia; University of British Columbia	Davies, GJ (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	gideon.davies@york.ac.uk; brumer@msl.ubc.ca	Larsbrink, Johan/A-3053-2013; Davies, Gideon J/A-9042-2011; Hemsworth, Glyn/AAS-5473-2021	Larsbrink, Johan/0000-0001-8386-2914; Davies, Gideon J/0000-0002-7343-776X; Hemsworth, Glyn/0000-0002-8226-1380	Mizutani Foundation for Glycoscience; Swedish Research Council Formas (via the European Union WoodWisdom-Net ERA-NET); Swedish Research Council Formas (via "Carbo-Mat-the KTH Advanced Carbohydrate Materials Centre"); Biotechnology and Biological Sciences Research Council [BB/I014802/1]; BBSRC [BB/I014802/1] Funding Source: UKRI	Mizutani Foundation for Glycoscience; Swedish Research Council Formas (via the European Union WoodWisdom-Net ERA-NET)(Swedish Research Council Formas); Swedish Research Council Formas (via "Carbo-Mat-the KTH Advanced Carbohydrate Materials Centre")(Swedish Research Council Formas); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work in Stockholm was supported by the Mizutani Foundation for Glycoscience and The Swedish Research Council Formas (via the European Union WoodWisdom-Net ERA-NET project "FiberSurf: New biotechnological tools for wood fiber surface modification and analysis" and via "Carbo-Mat-the KTH Advanced Carbohydrate Materials Centre"), and work in York was supported by Biotechnology and Biological Sciences Research Council Grant BB/I014802/1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; BECKER S, 1994, J BIOL CHEM, V269, P2485; Berezina OV, 1999, MOL BIOL+, V33, P801; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Burlingham BT, 2003, J CHEM EDUC, V80, P214, DOI 10.1021/ed080p214; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Elbein AD, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Humphry DR, 2003, INT J SYST EVOL MICR, V53, P393, DOI 10.1099/ijs.0.02271-0; Janecek S, 2007, FEBS LETT, V581, P1261, DOI 10.1016/j.febslet.2007.02.036; JONES G, 1969, CARBOHYD RES, V9, P483, DOI 10.1016/S0008-6215(00)80033-6; Jung JH, 2011, PROTEINS, V79, P633, DOI 10.1002/prot.22911; Kato N, 2002, APPL ENVIRON MICROB, V68, P1250, DOI 10.1128/AEM.68.3.1250-1256.2002; Kim YK, 2003, CARBOHYD RES, V338, P2213, DOI 10.1016/S0008-6215(03)00375-6; Kim YM, 2012, FEBS J, V279, P3185, DOI 10.1111/j.1742-4658.2012.08698.x; Kim YM, 2012, J BIOL CHEM, V287, P19927, DOI 10.1074/jbc.M111.339036; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lee SS, 2003, BIOCHEMISTRY-US, V42, P13081, DOI 10.1021/bi035189g; Lee SS, 2001, BIOCHEM J, V359, P381, DOI 10.1042/0264-6021:3590381; Leemhuis H, 2010, APPL MICROBIOL BIOT, V85, P823, DOI 10.1007/s00253-009-2221-3; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; LIEBL W, 1992, EUR J BIOCHEM, V207, P81, DOI 10.1111/j.1432-1033.1992.tb17023.x; Meissner H, 1998, EUR J BIOCHEM, V258, P1050, DOI 10.1046/j.1432-1327.1998.2581050.x; Mukai K, 2004, BIOSCI BIOTECH BIOCH, V68, P2529, DOI 10.1271/bbb.68.2529; Okuyama M, 2004, PROTEIN EXPRES PURIF, V37, P170, DOI 10.1016/j.pep.2004.05.008; PALMER TN, 1976, EUR J BIOCHEM, V69, P105, DOI 10.1111/j.1432-1033.1976.tb10863.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Przylas I, 2000, J MOL BIOL, V296, P873, DOI 10.1006/jmbi.1999.3503; Ren LM, 2011, CARBOHYD RES, V346, P2688, DOI 10.1016/j.carres.2011.09.012; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Rossi EJ, 2006, FEBS J, V273, P2673, DOI 10.1111/j.1742-4658.2006.05283.x; Roujeinikova A, 2002, J MOL BIOL, V321, P149, DOI 10.1016/S0022-2836(02)00570-3; Roujeinikova A, 2001, J MOL BIOL, V312, P119, DOI 10.1006/jmbi.2001.4944; SCHWARTZ M, 1967, EUR J BIOCHEM, V2, P132, DOI 10.1111/j.1432-1033.1967.tb00117.x; Seo SH, 2011, J MOL CATAL B-ENZYM, V72, P305, DOI 10.1016/j.molcatb.2011.07.006; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Stick RV, 2009, CARBOHYDRATES: THE ESSENTIAL MOLECULES OF LIFE, 2ND EDITION, P1; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Suzuki R, 2012, BBA-PROTEINS PROTEOM, V1824, P919, DOI 10.1016/j.bbapap.2012.04.001; TAKAHA T, 1993, J BIOL CHEM, V268, P1391; Takaha T, 1999, BIOTECHNOL GENET ENG, V16, P257, DOI 10.1080/02648725.1999.10647978; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257; Terada Y, 1999, APPL ENVIRON MICROB, V65, P910; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang YH, 2009, BIOLOGIA, V64, P1053, DOI 10.2478/s11756-009-0197-1; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; Yamamoto T, 2004, BBA-PROTEINS PROTEOM, V1700, P189, DOI 10.1016/j.bbapap.2004.05.002; Zhou C, 2009, J MICROBIOL BIOTECHN, V19, P1547, DOI 10.4014/jmb.0905.05006	66	32	33	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43288	43299		10.1074/jbc.M112.416511	http://dx.doi.org/10.1074/jbc.M112.416511			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132856	Green Published, hybrid			2022-12-25	WOS:000312940800010
J	Voss, M; Fukumori, A; Kuhn, PH; Kunzel, U; Klier, B; Grammer, G; Haug-Kroper, M; Kremmer, E; Lichtenthaler, SF; Steiner, H; Schroder, B; Haass, C; Fluhrer, R				Voss, Matthias; Fukumori, Akio; Kuhn, Peer-Hendrik; Kuenzel, Ulrike; Klier, Baerbel; Grammer, Gudula; Haug-Kroeper, Martina; Kremmer, Elisabeth; Lichtenthaler, Stefan F.; Steiner, Harald; Schroeder, Bernd; Haass, Christian; Fluhrer, Regina			Foamy Virus Envelope Protein Is a Substrate for Signal Peptide Peptidase-like 3 (SPPL3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; GAMMA-SECRETASE ACTIVITY; ENV LEADER PROTEIN; ASPARTIC PROTEASE; TNF-ALPHA; CLEAVAGE; PRESENILIN; GLYCOPROTEIN; DOMAIN; IDENTIFICATION	Signal peptide peptidase (SPP), its homologs, the SPP-like proteases SPPL2a/b/c and SPPL3, as well as presenilin, the catalytic subunit of the gamma-secretase complex, are intramembrane-cleaving aspartyl proteases of the GxGD type. In this study, we identified the 18-kDa leader peptide (LP18) of the foamy virus envelope protein (FVenv) as a new substrate for intramembrane proteolysis by human SPPL3 and SPPL2a/b. In contrast to SPPL2a/b and gamma-secretase, which require substrates with an ectodomain shorter than 60 amino acids for efficient intramembrane proteolysis, SPPL3 cleaves mutant FVenv lacking the proprotein convertase cleavage site necessary for the prior shedding. Moreover, the cleavage product of FVenv generated by SPPL3 serves as a new substrate for consecutive intramembrane cleavage by SPPL2a/b. Thus, human SPPL3 is the first GxGD-type aspartyl protease shown to be capable of acting like a sheddase, similar to members of the rhomboid family, which belong to the class of intramembrane-cleaving serine proteases.	[Voss, Matthias; Fukumori, Akio; Kuenzel, Ulrike; Klier, Baerbel; Grammer, Gudula; Haug-Kroeper, Martina; Steiner, Harald; Haass, Christian; Fluhrer, Regina] Univ Munich, Adolf Butenandt Inst Biochem, D-80336 Munich, Germany; [Kuhn, Peer-Hendrik; Kremmer, Elisabeth; Lichtenthaler, Stefan F.; Steiner, Harald; Haass, Christian; Fluhrer, Regina] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Lichtenthaler, Stefan F.; Haass, Christian] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Lichtenthaler, Stefan F.] Tech Univ Munich, D-81377 Munich, Germany; [Schroeder, Bernd] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Kiel	Fluhrer, R (corresponding author), Univ Munich, Adolf Butenandt Inst Biochem, Schillerstr 44, D-80336 Munich, Germany.	regina.fluhrer@dzne.lmu.de	Schröder, Bernd/C-5504-2011; Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575; Voss, Matthias/0000-0002-4217-3175; Kuhn, Peer-Hendrik/0000-0001-7891-5102	Deutsche Forschungsgemeinschaft [HA 1737-11]; Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung; Hans und Ilse Breuer Stiftung; Elitenetwork of Bavaria within the Graduate Program "Protein Dynamics in Health and Disease"; "Forschungsprofessur" from the Ludwig-Maximilians University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung; Hans und Ilse Breuer Stiftung; Elitenetwork of Bavaria within the Graduate Program "Protein Dynamics in Health and Disease"; "Forschungsprofessur" from the Ludwig-Maximilians University	This work was supported in part by Deutsche Forschungsgemeinschaft Grant HA 1737-11 (to R. F. and C. H.) and the Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung.; Supported by a Ph.D. fellowship from the Hans und Ilse Breuer Stiftung and by the Elitenetwork of Bavaria within the Graduate Program "Protein Dynamics in Health and Disease."; Member of the Center for Integrated Protein Science Munich (CIPSM). Supported by a "Forschungsprofessur" from the Ludwig-Maximilians University.	Bansal A, 2000, J VIROL, V74, P2949, DOI 10.1128/JVI.74.6.2949-2954.2000; Chen G, 2010, PROTEIN SCI, V19, P2015, DOI 10.1002/pro.496; Duda A, 2004, J VIROL, V78, P13865, DOI 10.1128/JVI.78.24.13865-13870.2004; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fluhrer R, 2012, J BIOL CHEM, V287, P5156, DOI 10.1074/jbc.M111.328104; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Geiselhart V, 2004, J VIROL, V78, P13573, DOI 10.1128/JVI.78.24.13573-13581.2004; Geiselhart V, 2003, VIROLOGY, V310, P235, DOI 10.1016/S0042-6822(03)00125-9; GOEPFERT PA, 1995, CELL, V82, P543, DOI 10.1016/0092-8674(95)90026-8; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lindemann D, 2001, J VIROL, V75, P5762, DOI 10.1128/JVI.75.13.5762-5771.2001; Lindemann D, 2011, VIRUSES-BASEL, V3, P561, DOI 10.3390/v3050561; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Trobridge G, 2002, MOL THER, V6, P321, DOI 10.1006/mthe.2002.0672; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200	35	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43401	43409		10.1074/jbc.M112.371369	http://dx.doi.org/10.1074/jbc.M112.371369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132852	hybrid, Green Published			2022-12-25	WOS:000312940800021
J	Wang, CK; Wacklin, HP; Craik, DJ				Wang, Conan K.; Wacklin, Hanna P.; Craik, David J.			Cyclotides Insert into Lipid Bilayers to Form Membrane Pores and Destabilize the Membrane through Hydrophobic and Phosphoethanolamine-specific Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC CYSTINE KNOT; POLYPEPTIDE KALATA B1; ANTI-HIV CYCLOTIDES; PLANT CYCLOTIDES; CIRCULAR PROTEINS; ANTIMICROBIAL PEPTIDES; NEUTRON REFLECTIVITY; MACROCYCLIC PEPTIDES; OLDENLANDIA-AFFINIS; SPATIAL STRUCTURE	Cyclotides are a family of plant-derived circular proteins with potential therapeutic applications arising from their remarkable stability, broad sequence diversity, and range of bioactivities. Their membrane-binding activity is believed to be a critical component of their mechanism of action. Using isothermal titration calorimetry, we studied the binding of the prototypical cyclotides kalata B1 and kalata B2 (and various mutants) to dodecylphosphocholine micelles and phosphoethanolamine-containing lipid bilayers. Although binding is predominantly an entropy-driven process, suggesting that hydrophobic forces contribute significantly to cyclotide-lipid complex formation, specific binding to the phosphoethanolamine-lipid headgroup is also required, which is evident from the enthalpic changes in the free energy of binding. In addition, using a combination of dissipative quartz crystal microbalance measurements and neutron reflectometry, we elucidated the process by which cyclotides interact with bilayer membranes. Initially, a small number of cyclotides bind to the membrane surface and then insert first into the outer membrane leaflet followed by penetration through the membrane and pore formation. At higher concentrations of cyclotides, destabilization of membranes occurs. Our results provide significant mechanistic insight into how cyclotides exert their bioactivities.	[Wang, Conan K.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Wacklin, Hanna P.] Australian Nucl Sci & Technol Org, Natl Deuterat Facil, Sydney, NSW 2234, Australia	University of Queensland; Australian Nuclear Science & Technology Organisation	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; Wang, Conan K/D-1481-2010	Craik, David/0000-0003-0007-6796; Wang, Conan K/0000-0002-7973-7632	Australian Research Council Grant [DP0984390]; Australian Nuclear Science and Technology Organisation [04/08-N-40]	Australian Research Council Grant(Australian Research Council); Australian Nuclear Science and Technology Organisation	This work was supported in part by Australian Research Council Grant DP0984390. Travel was supported by Australian Nuclear Science and Technology Organisation Grant 04/08-N-40 for neutron reflectometry.	Armen RS, 1998, BIOPHYS J, V75, P734, DOI 10.1016/S0006-3495(98)77563-0; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Fernandez-Vidal M, 2011, J MEMBRANE BIOL, V239, P5, DOI 10.1007/s00232-010-9321-y; Goransson U, 2004, CURR PROTEIN PEPT SC, V5, P317, DOI 10.2174/1389203043379495; Goransson U, 2012, J BIOL CHEM, V287, P27001, DOI 10.1074/jbc.R111.300129; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; GRAN L, 1973, LLOYDIA, V36, P174; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Heavens O.S, 1991, OPTICAL PROPERTIES T; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Mulvenna JP, 2006, PLANT CELL, V18, P2134, DOI 10.1105/tpc.106.042812; Mulvenna JP, 2006, NUCLEIC ACIDS RES, V34, pD192, DOI 10.1093/nar/gkj005; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Nguyen GKT, 2012, J BIOL CHEM, V287, P17598, DOI 10.1074/jbc.M111.338970; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; PENFOLD J, 1991, PHYSICA B, V173, P1, DOI 10.1016/0921-4526(91)90028-D; Pinto MFS, 2012, J BIOL CHEM, V287, P134, DOI 10.1074/jbc.M111.294009; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Sando L, 2011, CHEMBIOCHEM, V12, P2456, DOI 10.1002/cbic.201100450; Schoepke T., 1993, SCI PHARM, V61, P145; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Shenkarev ZO, 2008, J INORG BIOCHEM, V102, P1246, DOI 10.1016/j.jinorgbio.2008.01.018; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; SILVIUS JR, 1986, BIOCHIM BIOPHYS ACTA, V857, P217, DOI 10.1016/0005-2736(86)90350-0; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Simonsen SM, 2004, FEBS LETT, V577, P399, DOI 10.1016/j.febslet.2004.10.034; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 1999, J AM CHEM SOC, V121, P4316, DOI 10.1021/ja984480u; Tang J, 2010, PEPTIDES, V31, P1434, DOI 10.1016/j.peptides.2010.05.004; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Vacklin HP, 2005, LANGMUIR, V21, P2827, DOI 10.1021/la047389e; Vacklin HP, 2005, BIOCHEMISTRY-US, V44, P2811, DOI 10.1021/bi047727a; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	59	51	52	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43884	43898		10.1074/jbc.M112.421198	http://dx.doi.org/10.1074/jbc.M112.421198			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129773	Green Published, hybrid			2022-12-25	WOS:000312940800065
J	Irvine, JC; Ganthavee, V; Love, JE; Alexander, AE; Horowitz, JD; Stasch, JP; Kemp-Harper, BK; Ritchie, RH				Irvine, Jennifer C.; Ganthavee, Virat; Love, Jane E.; Alexander, Amy E.; Horowitz, John D.; Stasch, Johannes-Peter; Kemp-Harper, Barbara K.; Ritchie, Rebecca H.			The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; ADULT-RAT CARDIOMYOCYTES; II-INDUCED HYPERTROPHY; NITRIC-OXIDE; CARDIAC-HYPERTROPHY; THERAPEUTIC TARGET; CYCLIC-GMP; ANTIHYPERTROPHIC ACTIONS; VENTRICULAR HYPERTROPHY; PULMONARY-HYPERTENSION	Background: Although evidence now suggests cGMP is a negative regulator of cardiac hypertrophy, the direct consequences of the soluble guanylyl cyclase (sGC) activator BAY 58-2667 on cardiac remodeling, independent of changes in hemodynamic load, has not been investigated. In the present study, we tested the hypothesis that the NO N-center dot-independent sGC activator BAY 58-2667 inhibits cardiomyocyte hypertrophy in vitro. Concomitant impact of BAY 58-2667 on cardiac fibroblast proliferation, and insights into potential mechanisms of action, were also sought. Results were compared to the sGC stimulator BAY 41-2272. Methods: Neonatal rat cardiomyocytes were incubated with endothelin-1 (ET1, 60nmol/L) in the presence and absence of BAY 41-2272 and BAY 58-2667 (0.01-0.3 mu mol/L). Hypertrophic responses and its triggers, as well as cGMP signaling, were determined. The impact of both sGC ligands on basal and stimulated cardiac fibroblast proliferation in vitro was also determined. Results: We now demonstrate that BAY 58-2667 (0.01-0.3 mu mol/L) elicited concentration-dependent antihypertrophic actions, inhibiting ET1-mediated increases in cardiomyocyte 2D area and de novo protein synthesis, as well as suppressing ET1-induced cardiomyocyte superoxide generation. This was accompanied by potent increases in cardiomyocyte cGMP accumulation and activity of its downstream signal, vasodilator-stimulated phosphoprotein (VASP), without elevating cardiomyocyte cAMP. In contrast, submicromolar concentrations of BAY 58-2667 had no effect on basal or stimulated cardiac fibroblast proliferation. Indeed, only at concentrations >= 10 mu mol/L was inhibition of cardiac fibrosis seen in vitro. The effects of BAY 58-2667 in both cell types were mimicked by BAY 41-2272. Conclusions: Our results demonstrate that BAY 58-2667 elicits protective, cardiomyocyte-selective effects in vitro. These actions are associated with sGC activation and are evident in the absence of confounding hemodynamic factors, at low (submicromolar) concentrations. Thus this distinctive sGC ligand may potentially represent an alternative therapeutic approach for limiting myocardial hypertrophy.	[Irvine, Jennifer C.; Ganthavee, Virat; Love, Jane E.; Alexander, Amy E.; Ritchie, Rebecca H.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Ganthavee, Virat; Kemp-Harper, Barbara K.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Ritchie, Rebecca H.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Horowitz, John D.] Queen Elizabeth Hosp, Cardiol Unit, Woodville, SA, Australia; [Stasch, Johannes-Peter] Bayer Schering Pharma AG, Pharma Res Ctr, Wuppertal, Germany	Baker Heart and Diabetes Institute; Monash University; Monash University; Bayer AG; Bayer Healthcare Pharmaceuticals	Ritchie, RH (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	rebecca.ritchie@bakeridi.edu.au	Ritchie, Rebecca H/E-7392-2011	Ritchie, Rebecca/0000-0002-8610-0058; Horowitz, John/0000-0001-6883-0703	National Health and Medical Research Council (NHMRC) of Australia; Victorian Government's Operational Infrastructure Support Program; Heart Foundation of Australia; Foundation for High Blood Pressure Research Council (Australia)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Heart Foundation of Australia(National Heart Foundation of Australia); Foundation for High Blood Pressure Research Council (Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (http://www.nhmrc.gov.au/), the Victorian Government's Operational Infrastructure Support Program (http://www.business.vic.gov.au/BUSVIC/STANDARD/PC_60698.html), Heart Foundation of Australia (http://www.heartfoundation.org.au), and the Foundation for High Blood Pressure Research Council (Australia) (http://www.hbprca.com.au/hbp-foundation/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Calderone A, 1998, J CLIN INVEST, V101, P812, DOI 10.1172/JCI119883; Chester M, 2009, AM J PHYSIOL-LUNG C, V297, pL318, DOI 10.1152/ajplung.00062.2009; Date M, 2002, J AM COLL CARDIOL, V39, P907, DOI 10.1016/S0735-1097(01)01826-5; Deruelle P, 2006, BIOL NEONATE, V90, P135, DOI 10.1159/000092518; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; FULLE HJ, 1994, CELL BIOCHEM FUNCT, V12, P157, DOI 10.1002/cbf.290120303; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Goh SSC, 2007, ANTIOXID REDOX SIGN, V9, P101, DOI 10.1089/ars.2007.9.101; Gupte SA, 1999, AM J PHYSIOL-LUNG C, V277, pL1124, DOI 10.1152/ajplung.1999.277.6.L1124; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Horio T, 1999, EUR J PHARMACOL, V382, P1, DOI 10.1016/S0014-2999(99)00559-2; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Irvine JC, 2007, HYPERTENSION, V49, P885, DOI 10.1161/01.HYP.0000259328.04159.90; Kalk P, 2006, BRIT J PHARMACOL, V148, P853, DOI 10.1038/sj.bjp.0706792; Krieg T, 2009, EUR HEART J, V30, P1607, DOI 10.1093/eurheartj/ehp143; Laskowski A, 2006, CARDIOVASC RES, V72, P112, DOI 10.1016/j.cardiores.2006.07.006; Lin EQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034892; Maki T, 1996, J CLIN INVEST, V97, P656, DOI 10.1172/JCI118462; Masuyama H, 2006, HYPERTENSION, V48, P972, DOI 10.1161/01.HYP.0000241087.12492.47; Masuyama H, 2009, HYPERTENS RES, V32, P597, DOI 10.1038/hr.2009.64; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Nishikimi T, 2002, EUR J PHARMACOL, V453, P175, DOI 10.1016/S0014-2999(02)02453-6; Ritchie RH, 2007, J MOL CELL CARDIOL, V42, P1119, DOI 10.1016/j.yjmcc.2007.03.900; Ritchie RH, 2009, PHARMACOL THERAPEUT, V124, P279, DOI 10.1016/j.pharmthera.2009.08.001; Ritchie RH, 2009, CURR MOL MED, V9, P814, DOI 10.2174/156652409789105499; Ritchie RH, 2004, AM J PHYSIOL-HEART C, V287, pH1179, DOI 10.1152/ajpheart.00725.2003; Ritchie RH, 1998, HYPERTENSION, V31, P39, DOI 10.1161/01.HYP.31.1.39; Ritchie RH, 1998, AM J PHYSIOL-HEART C, V275, pH1370, DOI 10.1152/ajpheart.1998.275.4.H1370; Roenicke Volker, 2002, Expert Opin Ther Targets, V6, P649, DOI 10.1517/14728222.6.6.649; Roger S, 2010, VASC PHARMACOL, V53, P281, DOI 10.1016/j.vph.2010.09.008; Roger S, 2010, BRIT J PHARMACOL, V161, P1044, DOI 10.1111/j.1476-5381.2010.00943.x; Rosenkranz AC, 2003, CARDIOVASC RES, V57, P515, DOI 10.1016/S0008-6363(02)00667-3; Rosenkranz AC, 2002, HYPERTENSION, V40, P498, DOI 10.1161/01.HYP.0000032854.74042.CF; Rosenkranz AC, 2000, J MOL CELL CARDIOL, V32, P1119, DOI 10.1006/jmcc.2000.1149; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Russell MA, 2010, ISLETS, V2, P374, DOI 10.4161/isl.2.6.13917; Sartoretto JL, 2009, AM J PHYSIOL-HEART C, V297, pH1697, DOI 10.1152/ajpheart.00595.2009; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; Schlossmann J, 2012, N-S ARCH PHARMACOL, V385, P243, DOI 10.1007/s00210-012-0730-6; Smolenski A, 2004, GENOMICS, V83, P577, DOI 10.1016/j.ygeno.2003.10.002; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Tamargo J, 2010, CURR OPIN INVEST DR, V11, P1039; Teixeira CE, 2007, J PHARMACOL EXP THER, V322, P1093, DOI 10.1124/jpet.107.124594; Thorsen LB, 2010, EUR J PHARMACOL, V647, P147, DOI 10.1016/j.ejphar.2010.08.032; Toque HA, 2010, EUR J PHARMACOL, V645, P158, DOI 10.1016/j.ejphar.2010.07.028; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; Wang YR, 2006, AM J PHYSIOL-RENAL, V290, pF167, DOI 10.1152/ajprenal.00197.2005; Zanfolin M, 2006, J CARDIOVASC PHARM, V47, P391	56	40	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e44481	10.1371/journal.pone.0044481	http://dx.doi.org/10.1371/journal.pone.0044481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144773	gold, Green Published, Green Submitted			2022-12-25	WOS:000311935800001
J	Arregui, M; Buijsse, B; Stefan, N; Corella, D; Fisher, E; di Giuseppe, R; Coltell, O; Knuppel, S; Aleksandrova, K; Joost, HG; Boeing, H; Weikert, C				Arregui, Maria; Buijsse, Brian; Stefan, Norbert; Corella, Dolores; Fisher, Eva; di Giuseppe, Romina; Coltell, Oscar; Knueppel, Sven; Aleksandrova, Krasimira; Joost, Hans-Georg; Boeing, Heiner; Weikert, Cornelia			Heterogeneity of the Stearoyl-CoA desaturase-1 (SCD1) Gene and Metabolic Risk Factors in the EPIC-Potsdam Study	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; FETUIN-A LEVELS; INSULIN-RESISTANCE; LIVER-DISEASE; PROTECTS MICE; WEIGHT-LOSS; INFLAMMATION; ASSOCIATION; POPULATION; ADIPOSITY	Background: Stearoyl-CoA desaturase-1 (SCD1) is an enzyme involved in lipid metabolism. In mice and humans its activity has been associated with traits of the metabolic syndrome, but also with the prevention of saturated fatty acids accumulation and subsequent inflammation, whereas for liver fat content inconsistent results have been reported. Thus, variants of the gene encoding SCD1 (SCD1) could potentially modify metabolic risk factors, but few human studies have addressed this question. Methods: In a sample of 2157 middle-aged men and women randomly drawn from the Potsdam cohort of the European Prospective Investigation into Cancer and Nutrition, we investigated the impact of 7 SCD1 tagging-single nucleotide polymorphisms (rs1502593, rs522951, rs11190480, rs3071, rs3793767, rs10883463 and rs508384) and 5 inferred haplotypes with frequency >5% describing 90.9% of the genotype combinations in our population, on triglycerides, body mass index (BMI), waist circumference (WC), glycated haemoglobin (HbA1c), high-sensitivity C-reactive protein (hs-CRP), gammaglutamyltransferase (GGT), alanine aminotransferase (ALT) and fetuin-A. Results: No significant associations between any of the SNPs or haplotypes and BMI, WC, fetuin-A and hs-CRP were observed. Associations of rs10883463 with triglycerides, GGT and HbA1c as well as of rs11190480 with ALT activity, were weak and became non-significant after multiple-testing correction. Also associations of the haplotype harbouring the minor allele of rs1502593 with HbA1c levels, the haplotype harbouring the minor alleles of rs11190480 and rs508384 with activity of ALT, and the haplotype harbouring the minor alleles of rs522951, rs10883463 and rs508384 with triglyceride and HbA1C levels and GGT activities did not withstand multiple-testing correction. Conclusion: These findings suggest that there are no associations between common variants of SCD1 or its inferred haplotypes and the investigated metabolic risk factors. However, given the results from animal models, heterogeneity of human SCD1 warrants further investigation, in particular with regard to rare variants.	[Arregui, Maria; Buijsse, Brian; di Giuseppe, Romina; Knueppel, Sven; Aleksandrova, Krasimira; Boeing, Heiner; Weikert, Cornelia] German Inst Human Nutr DIfE Potsdam Rehbruecke, Dept Epidemiol, Nuthetal, Germany; [Stefan, Norbert] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, D-7400 Tubingen, Germany; [Corella, Dolores] Univ Valencia, Sch Med, Dept Prevent Med, Valencia, Spain; [Corella, Dolores] Univ Valencia, Sch Med, CIBER Fisiopatol Obesidad & Nutr, Valencia, Spain; [Fisher, Eva] Robert Koch Inst, Commiss Genet Testing, Adm Off, Berlin, Germany; [Coltell, Oscar] Univ Jaume 1, Dept Comp Languages & Syst, Castellon de La Plana, Spain; [Joost, Hans-Georg] German Inst Human Nutr DIfE Potsdam Rehbruecke, Dept Pharmacol, Nuthetal, Germany; [Weikert, Cornelia] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eberhard Karls University of Tubingen; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Valencia; Robert Koch Institute; Universitat Jaume I; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Arregui, M (corresponding author), German Inst Human Nutr DIfE Potsdam Rehbruecke, Dept Epidemiol, Nuthetal, Germany.	Maria.Arregui@dife.de	Coltell, Oscar/AAA-9936-2019; Knüppel, Sven/AAI-7195-2020; Joost, Hans-Georg/J-4462-2013	Coltell, Oscar/0000-0002-4518-8495; Knüppel, Sven/0000-0001-9006-9906; Joost, Hans-Georg/0000-0002-5860-606X; Aleksandrova, Krasimira/0000-0002-1275-1827; di Giuseppe, Romina/0000-0002-5214-8897; Stefan, Norbert/0000-0002-2186-9595	German Federal Ministry of Science [01 EA 9401]; European Union [SOC 95201408 05F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98 200769 05F02]; Deutsche Forschungsgemeinschaft [STE1096/3-1]; Plan de Promocion de la Investigacion de la Universitat Jaume I (Fundacion Caixa Castello-Bancaixa) [E-2009-23]	German Federal Ministry of Science; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Plan de Promocion de la Investigacion de la Universitat Jaume I (Fundacion Caixa Castello-Bancaixa)	The recruitment phase of the EPIC-Potsdam study was funded by the German Federal Ministry of Science (01 EA 9401) and the European Union (SOC 95201408 05F02). Now EPIC-Potsdam is supported by the German Cancer Aid (70-2488-Ha I) and the European Community (SOC 98 200769 05F02). Norbert Stefan is currently funded by a Heisenberg-Professorship from the Deutsche Forschungsgemeinschaft (STE1096/3-1). Maria Arregui was funded by the Plan de Promocion de la Investigacion de la Universitat Jaume I 2009 (Fundacion Caixa Castello-Bancaixa, E-2009-23) during the genotyping work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; CONSORTIUM IH, 2005, NATURE, V437, P1299; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gong J, 2011, J NUTR, V141, P2211, DOI 10.3945/jn.111.143503; Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Haukeland JW, 2012, EUR J ENDOCRINOL, V166, P503, DOI 10.1530/EJE-11-0864; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kroke A, 1999, ANN NUTR METAB, V43, P216, DOI 10.1159/000012788; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liew CF, 2004, DIABETOLOGIA, V47, P2168, DOI 10.1007/s00125-004-1575-4; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; MacDonald MLE, 2008, J LIPID RES, V49, P217, DOI 10.1194/jlr.M700478-JLR200; MacDonald MLE, 2009, ARTERIOSCL THROM VAS, V29, P341, DOI 10.1161/ATVBAHA.108.181099; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Mussig K, 2009, EXP CLIN ENDOCR DIAB, V117, P432, DOI 10.1055/s-0028-1103299; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Peter A, 2011, AM J PHYSIOL-ENDOC M, V300, pE321, DOI 10.1152/ajpendo.00306.2010; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Petersson H, 2008, BRIT J NUTR, V99, P1186, DOI 10.1017/S0007114507871674; Petersson H, 2010, DIABETES RES CLIN PR, V87, P379, DOI 10.1016/j.diabres.2009.11.019; Petersson H, 2009, ATHEROSCLEROSIS, V203, P298, DOI 10.1016/j.atherosclerosis.2008.06.020; Reinehr T, 2008, J CLIN ENDOCR METAB, V93, P4479, DOI 10.1210/jc.2008-1505; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; Stefan N, 2008, DIABETOLOGIA, V51, P648, DOI 10.1007/s00125-008-0938-7; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Stryjecki C, 2011, MOL GENET METAB; Tomita K, 2011, DIGEST DIS SCI, V56, P3045, DOI 10.1007/s10620-011-1712-0; Warensjo E, 2007, OBESITY, V15, P1732, DOI 10.1038/oby.2007.206; Warensjo E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Yilmaz Y, 2010, ANN CLIN BIOCHEM, V47, P549, DOI 10.1258/acb.2010.010169; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhou YE, 2009, METABOLISM, V58, P158, DOI 10.1016/j.metabol.2008.09.008	51	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48338	10.1371/journal.pone.0048338	http://dx.doi.org/10.1371/journal.pone.0048338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139775	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300026
J	Bruns, AF; Yuldasheva, N; Latham, AM; Bao, LY; Pellet-Many, C; Frankel, P; Stephen, SL; Howell, GJ; Wheatcroft, SB; Kearney, MT; Zachary, IC; Ponnambalam, S				Bruns, Alexander F.; Yuldasheva, Nadira; Latham, Antony M.; Bao, Leyuan; Pellet-Many, Caroline; Frankel, Paul; Stephen, Sam L.; Howell, Gareth J.; Wheatcroft, Stephen B.; Kearney, Mark T.; Zachary, Ian C.; Ponnambalam, Sreenivasan			A Heat-Shock Protein Axis Regulates VEGFR2 Proteolysis, Blood Vessel Development and Repair	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; NITRIC-OXIDE SYNTHASE; ENDOCYTIC DOWN-REGULATION; E3 UBIQUITIN LIGASE; MOLECULAR CHAPERONE; SIGNAL-TRANSDUCTION; FACTOR RECEPTORS; CANCER CELLS; TUMOR-GROWTH	Vascular endothelial growth factor A (VEGF-A) binds to the VEGFR2 receptor tyrosine kinase, regulating endothelial function, vascular physiology and angiogenesis. However, the mechanism underlying VEGFR2 turnover and degradation in this response is unclear. Here, we tested a role for heat-shock proteins in regulating the presentation of VEGFR2 to a degradative pathway. Pharmacological inhibition of HSP90 stimulated VEGFR2 degradation in primary endothelial cells and blocked VEGF-A-stimulated intracellular signaling via VEGFR2. HSP90 inhibition stimulated the formation of a VEGFR2-HSP70 complex. Clathrin-mediated VEGFR2 endocytosis is required for this HSP-linked degradative pathway for targeting VEGFR2 to the endosome-lysosome system. HSP90 perturbation selectively inhibited VEGF-A-stimulated human endothelial cell migration in vitro. A mouse femoral artery model showed that HSP90 inhibition also blocked blood vessel repair in vivo consistent with decreased endothelial regeneration. Depletion of either HSP70 or HSP90 caused defects in blood vessel formation in a transgenic zebrafish model. We conclude that perturbation of the HSP70-HSP90 heat-shock protein axis stimulates degradation of endothelial VEGFR2 and modulates VEGF-A-stimulated intracellular signaling, endothelial cell migration, blood vessel development and repair.	[Bruns, Alexander F.; Latham, Antony M.; Bao, Leyuan; Stephen, Sam L.; Howell, Gareth J.; Ponnambalam, Sreenivasan] Univ Leeds, Endothelial Cell Biol Unit, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Yuldasheva, Nadira; Wheatcroft, Stephen B.; Kearney, Mark T.] Univ Leeds, Fac Med & Hlth, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England; [Pellet-Many, Caroline; Frankel, Paul; Zachary, Ian C.] UCL, Ctr Cardiovasc Biol & Med, London, England	University of Leeds; University of Leeds; University of London; University College London	Ponnambalam, S (corresponding author), Univ Leeds, Endothelial Cell Biol Unit, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	s.ponnambalam@leeds.ac.uk	Stephen, Sam/AAX-1293-2020; Zebrafish, UCL/A-3125-2009; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Pellet-Many, Caroline/AAE-5044-2019	Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Pellet-Many, Caroline/0000-0003-1894-3907; Ponnambalam, Sreenivasan/0000-0002-4452-7619	Wellcome Trust; British Heart Foundaton; University of Leeds ORSAS Tetley & Lupton PhD Scholarship; BBSRC-CASE PhD Studentship Award; British Heart Foundation [RG/11/11/29050] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundaton; University of Leeds ORSAS Tetley & Lupton PhD Scholarship; BBSRC-CASE PhD Studentship Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This study was funded by the Wellcome Trust (SP), the British Heart Foundaton (SP, MTK, IZ), a BBSRC-CASE PhD Studentship Award (AML) and a University of Leeds ORSAS Tetley & Lupton PhD Scholarship (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen JX, 2004, J APPL PHYSIOL, V96, P612, DOI 10.1152/japplphysiol.00728.2003; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Duval M, 2007, MOL BIOL CELL, V18, P4659, DOI 10.1091/mbc.E07-05-0467; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Herbert SP, 2009, J BIOL CHEM, V284, P5784, DOI 10.1074/jbc.M807282200; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kahn MB, 2011, DIABETES, V60, P1295, DOI 10.2337/db10-1080; Kaur G, 2004, CLIN CANCER RES, V10, P4813, DOI 10.1158/1078-0432.CCR-03-0795; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Lang SA, 2007, MOL CANCER THER, V6, P1123, DOI 10.1158/1535-7163.MCT-06-0628; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Lerdrup M, 2006, J CELL SCI, V119, P85, DOI 10.1242/jcs.02707; Lerdrup M, 2007, MOL BIOL CELL, V18, P3656, DOI 10.1091/mbc.e07-01-0025; Li JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036389; Li XL, 2011, WIRES RNA, V2, P58, DOI 10.1002/wrna.32; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Makondo K, 2008, EUR J PHARMACOL, V582, P110, DOI 10.1016/j.ejphar.2007.12.018; Masson-Gadais B, 2003, CELL STRESS CHAPERON, V8, P37, DOI 10.1379/1466-1268(2003)8<37:IVRFVA>2.0.CO;2; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; Mimnaugh Edward G., 2005, V301, P223; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Park JH, 2008, BIOCHEM BIOPH RES CO, V368, P318, DOI 10.1016/j.bbrc.2008.01.056; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Sanderson S, 2006, MOL CANCER THER, V5, P522, DOI 10.1158/1535-7163.MCT-05-0439; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shiota M, 2010, ARTERIOSCL THROM VAS, V30, P491, DOI 10.1161/ATVBAHA.109.193631; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	49	46	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48539	10.1371/journal.pone.0048539	http://dx.doi.org/10.1371/journal.pone.0048539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139789	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300034
J	Graham, JH; Robb, DT; Poe, AR				Graham, John H.; Robb, Daniel T.; Poe, Amy R.			Random Phenotypic Variation of Yeast (Saccharomyces cerevisiae) Single-Gene Knockouts Fits a Double Pareto-Lognormal Distribution	PLOS ONE			English	Article							SCALE-FREE NETWORKS; DEVELOPMENTAL STABILITY; FLUCTUATING ASYMMETRY; ROBUSTNESS; MODEL; EVOLUTION; EXPRESSION; HSP90; CELLS; CANALIZATION	Background: Distributed robustness is thought to influence the buffering of random phenotypic variation through the scale-free topology of gene regulatory, metabolic, and protein-protein interaction networks. If this hypothesis is true, then the phenotypic response to the perturbation of particular nodes in such a network should be proportional to the number of links those nodes make with neighboring nodes. This suggests a probability distribution approximating an inverse power-law of random phenotypic variation. Zero phenotypic variation, however, is impossible, because random molecular and cellular processes are essential to normal development. Consequently, a more realistic distribution should have a y-intercept close to zero in the lower tail, a mode greater than zero, and a long (fat) upper tail. The double Pareto-lognormal (DPLN) distribution is an ideal candidate distribution. It consists of a mixture of a lognormal body and upper and lower power-law tails. Objective and Methods: If our assumptions are true, the DPLN distribution should provide a better fit to random phenotypic variation in a large series of single-gene knockout lines than other skewed or symmetrical distributions. We fit a large published data set of single-gene knockout lines in Saccharomyces cerevisiae to seven different probability distributions: DPLN, right Pareto-lognormal (RPLN), left Pareto-lognormal (LPLN), normal, lognormal, exponential, and Pareto. The best model was judged by the Akaike Information Criterion (AIC). Results: Phenotypic variation among gene knockouts in S. cerevisiae fits a double Pareto-lognormal (DPLN) distribution better than any of the alternative distributions, including the right Pareto-lognormal and lognormal distributions. Conclusions and Significance: A DPLN distribution is consistent with the hypothesis that developmental stability is mediated, in part, by distributed robustness, the resilience of gene regulatory, metabolic, and protein-protein interaction networks. Alternatively, multiplicative cell growth, and the mixing of lognormal distributions having different variances, may generate a DPLN distribution.	[Graham, John H.; Poe, Amy R.] Berry Coll, Dept Biol, Mt Berry, GA USA; [Robb, Daniel T.] Berry Coll, Dept Phys Astron & Geol, Mt Berry, GA USA; [Robb, Daniel T.] Roanoke Coll, Dept Math Comp Sci & Phys, Salem, VA 24153 USA; [Poe, Amy R.] Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Graham, JH (corresponding author), Berry Coll, Dept Biol, Mt Berry, GA USA.	jgraham@berry.edu		Graham, John/0000-0003-1974-132X	School of Mathematical and Natural Sciences, Berry College, Mount Berry, Georgia, United States of America	School of Mathematical and Natural Sciences, Berry College, Mount Berry, Georgia, United States of America	This research was supported by the School of Mathematical and Natural Sciences, Berry College, Mount Berry, Georgia, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Babbitt GA, 2006, AM NAT, V167, P230, DOI 10.1086/498621; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Csermely P, 2004, TRENDS BIOCHEM SCI, V29, P331, DOI 10.1016/j.tibs.2004.05.004; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Debat V, 2006, EVOLUTION, V60, P2529, DOI 10.1554/06-045.1; DOBZHANSKY T, 1950, GENETICS, V35, P288; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Fang Z, 2012, SPRINGER SER OPTIM A, V57, P55, DOI 10.1007/978-1-4614-0754-6_3; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Freeman D. Carl, 2003, P367; FREEMAN DC, 1993, GENETICA, V89, P97, DOI 10.1007/BF02424508; Gerlee P, 2009, J R SOC INTERFACE, V6, P1233, DOI 10.1098/rsif.2008.0514; Giesen K, 2010, J URBAN ECON, V68, P129, DOI 10.1016/j.jue.2010.03.007; Graham JH, 2003, BIOL J LINN SOC, V80, P57, DOI 10.1046/j.1095-8312.2003.00220.x; GRAHAM JH, 1985, EVOLUTION, V39, P104, DOI 10.1111/j.1558-5646.1985.tb04083.x; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Graham John H., 2003, P35; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Keller EF, 2005, BIOESSAYS, V27, P1060, DOI 10.1002/bies.20294; Kelly WP, 2011, BACTERIAL MOL NETWOR, P245; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Kuznetsov VA, 2002, GENETICS, V161, P1321; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Lehner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009035; Lerner IM, 1954, GENETIC HOMEOSTASIS; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Lu C, 2009, BIOINFORMATICS, V25, P2020, DOI 10.1093/bioinformatics/btp360; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Milton CC, 2005, GENETICS, V171, P119, DOI 10.1534/genetics.104.038463; Minarikova L, 2001, EXP CELL RES, V271, P296, DOI 10.1006/excr.2001.5379; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Palkova Z, 2004, EMBO REP, V5, P470, DOI 10.1038/sj.embor.7400145; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Press W. H., 1992, ART SCI COMPUTING; Przytycka TM, 2004, COMPUT BIOL CHEM, V28, P257, DOI 10.1016/j.compbiolchem.2004.07.001; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Raz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034689; Raz S, 2011, BIOL J LINN SOC, V102, P786, DOI 10.1111/j.1095-8312.2011.01615.x; Reed WJ, 2004, COMMUN STAT-THEOR M, V33, P1733, DOI 10.1081/STA-120037438; Reed WJ, 2002, J REGIONAL SCI, V42, P1, DOI 10.1111/1467-9787.00247; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Siegal ML, 2007, GENETICA, V129, P83, DOI 10.1007/s10709-006-0035-0; Stumpf MPH, 2005, EUROPHYS LETT, V71, P152, DOI 10.1209/epl/i2004-10531-8; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Van Dongen S, 2007, BIOL J LINN SOC, V92, P197, DOI 10.1111/j.1095-8312.2007.00880.x; Waddington C., 1957, STRATEGY GENES; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; Whitacre James M., 2012, Frontiers in Genetics, V3, P5, DOI [10.3389/fgene.2012.00005, 10.3389/fgene.2012.00067]; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zakharov V.M., 1989, Soviet Scientific Reviews Section F Physiology and General Biology Reviews, V4, P1	69	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48964	10.1371/journal.pone.0048964	http://dx.doi.org/10.1371/journal.pone.0048964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139826	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300064
J	Singh, NB; Konig, N; Arampatzis, A; Heller, MO; Taylor, WR				Singh, Navrag B.; Koenig, Niklas; Arampatzis, Adamantios; Heller, Markus O.; Taylor, William R.			Extreme Levels of Noise Constitute a Key Neuromuscular Deficit in the Elderly	PLOS ONE			English	Article							MOTOR UNIT DISCHARGE; POSTURAL SWAY; FORCE FLUCTUATIONS; DYNAMIC STABILITY; GAIT VARIABILITY; HUMAN BALANCE; OLDER-ADULTS; MUSCLE; YOUNG; STEADINESS	Fluctuations during isometric force production tasks occur due to the inability of musculature to generate purely constant submaximal forces and are considered to be an estimation of neuromuscular noise. The human sensori-motor system regulates complex interactions between multiple afferent and efferent systems, which results in variability during functional task performance. Since muscles are the only active component of the motor system, it therefore seems reasonable that neuromuscular noise plays a key role in governing variability during both standing and walking. Seventy elderly women (including 34 fallers) performed multiple repetitions of isometric force production, quiet standing and walking tasks. No relationship between neuromuscular noise and functional task performance was observed in either the faller or the non-faller cohorts. When classified into groups with either nominal (group NOM, 25(th) - 75(th) percentile) or extreme (either too high or too low, group EXT) levels of neuromuscular noise, group NOM demonstrated a clear association (r(2)>0.23, p<0.05) between neuromuscular noise and variability during task performance. On the other hand, group EXT demonstrated no such relationship, but also tended to walk slower, and had lower stride lengths, as well as lower isometric strength. These results suggest that neuromuscular noise is related to the quality of both static and dynamic functional task performance, but also that extreme levels of neuromuscular noise constitute a key neuromuscular deficit in the elderly.	[Singh, Navrag B.; Koenig, Niklas; Heller, Markus O.; Taylor, William R.] Charite, Julius Wolff Inst, Ctr Sports Sci & Sports Med Berlin CSSB, D-13353 Berlin, Germany; [Arampatzis, Adamantios] Humboldt Univ, Dept Training & Movement Sci, Ctr Sports Sci & Sports Med Berlin CSSB, D-10099 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Taylor, WR (corresponding author), Charite, Julius Wolff Inst, Ctr Sports Sci & Sports Med Berlin CSSB, D-13353 Berlin, Germany.	bill.taylor@charite.de	Ignasiak, Niklas/F-8617-2014; Heller, Markus O/F-8437-2010; Singh, Navrag/F-5305-2012; Taylor, William R./F-8692-2010	Ignasiak, Niklas/0000-0001-9065-3344; Heller, Markus O/0000-0002-7879-1135; Singh, Navrag/0000-0001-8074-041X; Taylor, William R./0000-0003-4060-4098; Arampatzis, Adamantios/0000-0002-4985-0335	EU [FP7-223864]	EU(European Commission)	This research was supported by the EU framework 7 VPHOP project FP7-223864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Bruijn SM, 2009, J BIOMECH, V42, P1506, DOI 10.1016/j.jbiomech.2009.03.047; Byrne JE, 2002, PERCEPT MOTOR SKILL, V94, P265, DOI 10.2466/PMS.94.1.265-280; Cai LL, 2006, J NEUROSCI, V26, P10564, DOI 10.1523/JNEUROSCI.2266-06.2006; Christou EA, 2001, J GERONTOL A-BIOL, V56, pB524, DOI 10.1093/gerona/56.12.B524; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Day BL, 2002, ADV EXP MED BIOL, V508, P129; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Grabiner M D, 1995, Exerc Sport Sci Rev, V23, P65; Graves AE, 2000, J NEUROPHYSIOL, V83, P2030, DOI 10.1152/jn.2000.83.4.2030; Haines TP, 2007, J GERONTOL A-BIOL, V62, P664, DOI 10.1093/gerona/62.6.664; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Harbourne RT, 2009, NONLIN DYNAM PSYCHOL, V13, P123; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hortobagyi T, 2004, ARTHRIT RHEUM-ARTHR, V51, P562, DOI 10.1002/art.20545; Jaramillo F, 1998, NAT NEUROSCI, V1, P384, DOI 10.1038/1597; Jeka J, 2004, J NEUROPHYSIOL, V92, P2368, DOI 10.1152/jn.00983.2003; Kakuda N, 1999, J PHYSIOL-LONDON, V520, P929, DOI 10.1111/j.1469-7793.1999.00929.x; Karamanidis K, 2008, J ELECTROMYOGR KINES, V18, P980, DOI 10.1016/j.jelekin.2007.04.003; Kottke FJ, 1980, NEUROPHYSIOLOGIC ASP; Kouzaki M, 2010, MUSCLE NERVE, V42, P78, DOI 10.1002/mus.21599; Laidlaw DH, 2002, J APPL PHYSIOL, V93, P1400, DOI 10.1152/japplphysiol.00391.2002; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Lieber RL, 2011, PHILOS T R SOC B, V366, P1466, DOI 10.1098/rstb.2010.0316; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; Maki BE, 1944, J GERONTOL A-BIOL, V49, pM72; Neptune RR, 2011, J BIOMECH, V44, P6, DOI 10.1016/j.jbiomech.2010.08.015; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Reeves NP, 2007, CLIN BIOMECH, V22, P266, DOI 10.1016/j.clinbiomech.2006.11.011; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Rosano C, 2007, NEUROEPIDEMIOLOGY, V29, P193, DOI 10.1159/000111582; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Singh NB, 2012, J ELECTROMYOGR KINES, V22, P131, DOI 10.1016/j.jelekin.2011.10.007; Singh NB, 2010, PHILOS T R SOC A, V368, P2783, DOI 10.1098/rsta.2010.0091; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Tracy BL, 2005, MUSCLE NERVE, V32, P533, DOI 10.1002/mus.20392; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	49	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48449	10.1371/journal.pone.0048449	http://dx.doi.org/10.1371/journal.pone.0048449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040IE	23139783	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000311315300031
J	Favier, M; Bilhere, E; Lonvaud-Funel, A; Moine, V; Lucas, PM				Favier, Marion; Bilhere, Eric; Lonvaud-Funel, Aline; Moine, Virginie; Lucas, Patrick M.			Identification of pOENI-1 and Related Plasmids in Oenococcus oeni Strains Performing the Malolactic Fermentation in Wine	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; NUCLEOTIDE-SEQUENCE ANALYSIS; YELLOW-ENZYME HOMOLOGS; CRYPTIC PLASMID; EXPRESSION ANALYSIS; OXIDATIVE STRESS; GENE; MEMBRANE; DNA; SUBPOPULATIONS	Plasmids in lactic acid bacteria occasionally confer adaptive advantages improving the growth and behaviour of their host cells. They are often associated to starter cultures used in the food industry and could be a signature of their superiority. Oenococcus oeni is the main lactic acid bacteria species encountered in wine. It performs the malolactic fermentation that occurs in most wines after alcoholic fermentation and contributes to their quality and stability. Industrial O. oeni starters may be used to better control malolactic fermentation. Starters are selected empirically by virtue of their fermentation kinetics and capacity to survive in wine. This study was initiated with the aim to determine whether O. oeni contains plasmids of technological interest. Screening of 11 starters and 33 laboratory strains revealed two closely related plasmids, named pOENI-1 (18.3-kb) and pOENI-1v2 (21.9-kb). Sequence analyses indicate that they use the theta mode of replication, carry genes of maintenance and replication and two genes possibly involved in wine adaptation encoding a predicted sulphite exporter (tauE) and a NADH: flavin oxidoreductase of the old yellow enzyme family (oye). Interestingly, pOENI-1 and pOENI-1v2 were detected only in four strains, but this included three industrial starters. PCR screenings also revealed that tauE is present in six of the 11 starters, being probably inserted in the chromosome of some strains. Microvinification assays performed using strains with and without plasmids did not disclose significant differences of survival in wine or fermentation kinetics. However, analyses of 95 wines at different phases of winemaking showed that strains carrying the plasmids or the genes tauE and oye were predominant during spontaneous malolactic fermentation. Taken together, the results revealed a family of related plasmids associated with industrial starters and indigenous strains performing spontaneous malolactic fermentation that possibly contribute to the technological performance of strains in wine.	[Favier, Marion; Bilhere, Eric; Lonvaud-Funel, Aline; Lucas, Patrick M.] Univ Bordeaux, ISW, Unit Enol EA 4577, Villenave Dornon, France; [Favier, Marion] SARCO, Laffort Grp, Res Subsidiary, Bordeaux, France; [Moine, Virginie] Laffort, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux	Lucas, PM (corresponding author), Univ Bordeaux, ISW, Unit Enol EA 4577, Villenave Dornon, France.	patrick.lucas@univ-bordeauxsegalen.fr		Lucas, Patrick/0000-0002-9054-5439; Lonvaud, Aline/0000-0002-9352-3366	company SARCO; French Ministry of Higher Education and Research; SARCO, a subsidiary of the group Laffort; University Bordeaux Segalen; Laffort	company SARCO; French Ministry of Higher Education and Research; SARCO, a subsidiary of the group Laffort; University Bordeaux Segalen; Laffort	MF and EB were recipients of PhD grants from the company SARCO and the French Ministry of Higher Education and Research, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MF was a PhD student funded by SARCO, a subsidiary of the group Laffort. VM is an employee of the company Laffort. Consumables used in this work were for the largest part supported by funds from the University Bordeaux Segalen and a very minor part by Laffort. There are no patents, products in development or marketed products to declare. The authors declare no other competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alegre MT, 1999, PLASMID, V41, P128, DOI 10.1006/plas.1998.1382; Athane A, 2008, J APPL MICROBIOL, V105, P1866, DOI 10.1111/j.1365-2672.2008.03967.x; Beltramo C, 2004, J BACTERIOL, V186, P2200, DOI 10.1128/JB.186.7.2200-2205.2003; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Bilhere E, 2009, APPL ENVIRON MICROB, V75, P1291, DOI 10.1128/AEM.02563-08; Blehert DS, 1999, J BACTERIOL, V181, P6254, DOI 10.1128/JB.181.20.6254-6263.1999; Bon E, 2009, APPL ENVIRON MICROB, V75, P2079, DOI 10.1128/AEM.02194-08; Borneman AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-373; Bourdineaud JP, 2003, APPL ENVIRON MICROB, V69, P2512, DOI 10.1128/AEM.69.5.2512-2520.2003; Bourdineaud JP, 2004, INT J FOOD MICROBIOL, V92, P1, DOI 10.1016/S0168-1605(03)00162-4; Bridier J, 2010, APPL ENVIRON MICROB, V76, P7754, DOI 10.1128/AEM.01544-10; Brige A, 2006, BIOCHEM J, V394, P335, DOI 10.1042/BJ20050979; Brito L, 1999, PLASMID, V41, P260, DOI 10.1006/plas.1999.1397; Brito L, 1996, PLASMID, V36, P49, DOI 10.1006/plas.1996.0031; Carrete R, 2002, FEMS MICROBIOL LETT, V211, P155, DOI 10.1016/S0378-1097(02)00687-0; Chattoraj DK, 2000, MOL MICROBIOL, V37, P467, DOI 10.1046/j.1365-2958.2000.01986.x; Coucheney F, 2005, BBA-BIOMEMBRANES, V1720, P92, DOI 10.1016/j.bbamem.2005.11.017; DAVIS CR, 1986, APPL ENVIRON MICROB, V51, P539, DOI 10.1128/AEM.51.3.539-545.1986; DAVIS CR, 1985, AM J ENOL VITICULT, V36, P290; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Fang F, 2008, APPL ENVIRON MICROB, V74, P3216, DOI 10.1128/AEM.02631-07; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; FLEET GH, 1984, APPL ENVIRON MICROB, V48, P1034, DOI 10.1128/AEM.48.5.1034-1038.1984; FREMAUX C, 1993, PLASMID, V30, P212, DOI 10.1006/plas.1993.1053; Gagne S, 2011, J APPL MICROBIOL, V110, P218, DOI 10.1111/j.1365-2672.2010.04878.x; Garcia-Ruiz A, 2011, INT J FOOD MICROBIOL, V145, P426, DOI 10.1016/j.ijfoodmicro.2011.01.016; Grandvalet C, 2005, J BACTERIOL, V187, P5614, DOI 10.1128/JB.187.16.5614-5623.2005; Grandvalet C, 2008, MICROBIOL-SGM, V154, P2611, DOI 10.1099/mic.0.2007/016238-0; HENICKKLING T, 1989, APPL ENVIRON MICROB, V55, P2010, DOI 10.1128/AEM.55.8.2010-2016.1989; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ito Y, 2009, APPL ENVIRON MICROB, V75, P6340, DOI 10.1128/AEM.00195-09; Jobin MP, 1999, MICROBIOL-SGM, V145, P1245, DOI 10.1099/13500872-145-5-1245; Kitko RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008255; Krejcik Z, 2008, ARCH MICROBIOL, V190, P159, DOI 10.1007/s00203-008-0386-2; LAFONLAFOURCADE S, 1983, APPL ENVIRON MICROB, V46, P874, DOI 10.1128/AEM.46.4.874-880.1983; Lonvaud-Funel A, 1999, ANTON LEEUW INT J G, V76, P317, DOI 10.1023/A:1002088931106; Lucas PM, 2008, APPL ENVIRON MICROB, V74, P811, DOI 10.1128/AEM.01496-07; Lucas PM, 2005, APPL ENVIRON MICROB, V71, P1417, DOI 10.1128/AEM.71.3.1417-1424.2005; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mesas JM, 2001, PLASMID, V46, P149, DOI 10.1006/plas.2001.1537; Mills DA, 2005, FEMS MICROBIOL REV, V29, P465, DOI 10.1016/j.femsre.2005.04.011; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; Odat O, 2007, J BIOL CHEM, V282, P36010, DOI 10.1074/jbc.M704058200; Parreira R, 1999, GENE, V226, P83, DOI 10.1016/S0378-1119(98)00554-X; PREVOST H, 1995, AM J ENOL VITICULT, V46, P43; Rajewska M, 2012, FEMS MICROBIOL REV, V36, P408, DOI 10.1111/j.1574-6976.2011.00300.x; Reekmans R, 2005, FEMS YEAST RES, V5, P711, DOI 10.1016/j.femsyr.2004.12.010; Renouf V, 2010, S AFR J ENOL VITIC, V31, P75; Ruckert C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-121; Sgorbati B., 1985, Microbiologie - Aliments - Nutrition, V3, P21; Sgorbati B, 1987, MICROBIOL ALIM NUTR, V5, P295; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torriani S, 2011, ANN MICROBIOL, V61, P33, DOI 10.1007/s13213-010-0072-x; Trotter EW, 2006, APPL ENVIRON MICROB, V72, P4885, DOI 10.1128/AEM.00526-06; Ugliano M, 2005, J AGR FOOD CHEM, V53, P10134, DOI 10.1021/jf0514672; van den Hemel D, 2006, J BIOL CHEM, V281, P28152, DOI 10.1074/jbc.M603946200; Wang TT, 1997, CRIT REV BIOTECHNOL, V17, P227, DOI 10.3109/07388559709146615; Weidmann S, 2010, FEMS MICROBIOL LETT, V309, P8, DOI 10.1111/j.1574-6968.2010.01999.x; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Yin B, 2008, MOL BIOTECHNOL, V38, P241, DOI 10.1007/s12033-007-9022-7; Zhang WY, 2008, PLASMID, V60, P131, DOI 10.1016/j.plasmid.2008.06.003; Zuniga M, 1996, PLASMID, V36, P67, DOI 10.1006/plas.1996.0034	64	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49082	10.1371/journal.pone.0049082	http://dx.doi.org/10.1371/journal.pone.0049082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139835	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400068
J	Kempe, V; Thoresen, JC; Kirk, NW; Schaeffler, F; Brooks, PJ				Kempe, Vera; Thoresen, John C.; Kirk, Neil W.; Schaeffler, Felix; Brooks, Patricia J.			Individual Differences in the Discrimination of Novel Speech Sounds: Effects of Sex, Temporal Processing, Musical and Cognitive Abilities	PLOS ONE			English	Article							WORKING-MEMORY; NONSPEECH SOUNDS; CORPUS-CALLOSUM; INTELLIGENCE; INFORMATION; PERFORMANCE; PERCEPTION; ADULTS; VARIABILITY; DYSLEXIA	This study examined whether rapid temporal auditory processing, verbal working memory capacity, non-verbal intelligence, executive functioning, musical ability and prior foreign language experience predicted how well native English speakers (N = 120) discriminated Norwegian tonal and vowel contrasts as well as a non-speech analogue of the tonal contrast and a native vowel contrast presented over noise. Results confirmed a male advantage for temporal and tonal processing, and also revealed that temporal processing was associated with both non-verbal intelligence and speech processing. In contrast, effects of musical ability on non-native speech-sound processing and of inhibitory control on vowel discrimination were not mediated by temporal processing. These results suggest that individual differences in non-native speech-sound processing are to some extent determined by temporal auditory processing ability, in which males perform better, but are also determined by a host of other abilities that are deployed flexibly depending on the characteristics of the target sounds.	[Kempe, Vera; Kirk, Neil W.] Univ Abertay Dundee, Dundee, Scotland; [Thoresen, John C.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Schaeffler, Felix] Queen Margaret Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Brooks, Patricia J.] CUNY Coll Staten Isl, Staten Isl, NY USA; [Brooks, Patricia J.] CUNY, Grad Ctr, Staten Isl, NY USA	University of Abertay Dundee; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Queen Margaret University; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System	Kempe, V (corresponding author), Univ Abertay Dundee, Dundee, Scotland.	v.kempe@abertay.ac.uk	Kempe, Vera/K-6121-2012	Kempe, Vera/0000-0001-5649-4351; Schaeffler, Felix/0000-0002-2764-7635; Brooks, Patricia/0000-0001-8030-8811	School of Social and Health Sciences, University of Abertay Dundee	School of Social and Health Sciences, University of Abertay Dundee	This work was supported by a small grant from the journal Language Learning, and an institutional award and from the School of Social and Health Sciences, University of Abertay Dundee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Best CT, 2001, J ACOUST SOC AM, V109, P775, DOI 10.1121/1.1332378; Boersma P., 2020, PRAAT DOING PHONETIC; Bowles AR, 2011, 52 ANN M PSYCH SOC S; Brooks PJ, 2006, APPL PSYCHOLINGUIST, V27, P185, DOI 10.1017/S0142716406060243; Burgess GC, 2011, J EXP PSYCHOL GEN, V140, P674, DOI 10.1037/a0024695; Cattell R. B., 1973, MEASURING INTELLIGEN; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; CUTTING JE, 1974, PERCEPT PSYCHOPHYS, V16, P564, DOI 10.3758/BF03198588; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dehaene-Lambertz G, 2010, BRAIN LANG, V114, P53, DOI 10.1016/j.bandl.2009.09.003; Delogu Franco, 2006, Cogn Process, V7, P203, DOI 10.1007/s10339-006-0146-7; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Flege J. E., 2003, PHONETICS PHONOLOGY, P319; Gandour J, 2000, J COGNITIVE NEUROSCI, V12, P207, DOI 10.1162/089892900561841; Gilbert G, 2008, INT J AUDIOL, V47, P189, DOI 10.1080/14992020701829722; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; Golestani N, 2009, BRAIN LANG, V109, P55, DOI 10.1016/j.bandl.2008.01.005; Goswami U, 2002, P NATL ACAD SCI USA, V99, P10911, DOI 10.1073/pnas.122368599; Grube M, 2012, P R SOC B; Gur RC, 1999, J NEUROSCI, V19, P4065; Harris KC, 2009, J NEUROSCI, V29, P6078, DOI 10.1523/JNEUROSCI.0412-09.2009; Joanisse MF, 2003, NEUROIMAGE, V19, P64, DOI 10.1016/S1053-8119(03)00046-6; Johnson W, 2009, PERSPECT PSYCHOL SCI, V4, P598, DOI 10.1111/j.1745-6924.2009.01168.x; Kempe V, 2012, P 34 ANN C COGN SCI, P1774; Kidd GR, 2007, J ACOUST SOC AM, V122, P418, DOI 10.1121/1.2743154; Kolinsky R, 2009, MUSIC PERCEPT, V26, P235, DOI 10.1525/MP.2009.26.3.235; Liegeois-Chauvel C, 2001, ANN NY ACAD SCI, V930, P117, DOI 10.1111/j.1749-6632.2001.tb05728.x; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P2701, DOI 10.1162/jocn.2010.21585; McNichol D., 1972, PRIMER SIGNAL DETECT; MCROBERTS GW, 1992, PERCEPT PSYCHOPHYS, V51, P118, DOI 10.3758/BF03212236; Nardo D, 2009, TRENDS APPL LINGUIST; Nicholls MER, 1999, NEUROPSY NEUROPSY BE, V12, P11; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rammsayer T, 2010, PERS INDIV DIFFER, V49, P923, DOI 10.1016/j.paid.2010.07.031; Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007; Rammsayer TH, 2012, MUSIC PERCEPT, V30, P85, DOI 10.1525/MP.2012.30.1.85; Reiterer SM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00271; Roivainen E, 2011, LEARN INDIVID DIFFER, V21, P145, DOI 10.1016/j.lindif.2010.11.021; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Surprenant AM, 2001, J ACOUST SOC AM, V110, P2085, DOI 10.1121/1.1404973; Szelag E, 2011, RESTOR NEUROL NEUROS, V29, P35, DOI 10.3233/RNN-2011-0574; Talcott JB, 2000, P NATL ACAD SCI USA, V97, P2952, DOI 10.1073/pnas.040546597; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Troche SJ, 2009, INTELLIGENCE, V37, P479, DOI 10.1016/j.intell.2009.06.001; Ullen F, 2008, J NEUROSCI, V28, P4238, DOI 10.1523/JNEUROSCI.0825-08.2008; van Ravenzwaaij D, 2011, COGNITION, V119, P381, DOI 10.1016/j.cognition.2011.02.002; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; WITELSON SF, 1991, BRAIN RES, V545, P175, DOI 10.1016/0006-8993(91)91284-8; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wittmann M, 2003, PERCEPT MOTOR SKILL, V96, P105, DOI 10.2466/PMS.96.1.105-112; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	60	10	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48623	10.1371/journal.pone.0048623	http://dx.doi.org/10.1371/journal.pone.0048623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032TG	23139806	Green Published, gold			2022-12-25	WOS:000310741400056
J	Rossi, F; Giorgio, A; Battaglini, M; Stromillo, ML; Portaccio, E; Goretti, B; Federico, A; Hakiki, B; Amato, MP; De Stefano, N				Rossi, Francesca; Giorgio, Antonio; Battaglini, Marco; Stromillo, Maria Laura; Portaccio, Emilio; Goretti, Benedetta; Federico, Antonio; Hakiki, Bahia; Amato, Maria Pia; De Stefano, Nicola			Relevance of Brain Lesion Location to Cognition in Relapsing Multiple Sclerosis	PLOS ONE			English	Article							WHITE-MATTER LESIONS; CORTICAL-LESIONS; CORPUS-CALLOSUM; REMITTING MS; BENIGN MS; IMPAIRMENT; ATROPHY; MRI; DISCONNECTION; DYSFUNCTION	Objective: To assess the relationship between cognition and brain white matter (WM) lesion distribution and frequency in patients with relapsing-remitting multiple sclerosis (RR MS). Methods: MRI-based T2 lesion probability map (LPM) was used to assess the relevance of brain lesion location for cognitive impairment in a group of 142 consecutive patients with RRMS. Significance of voxelwise analyses was p<0.05, cluster-corrected for multiple comparisons. The Rao Brief Repeatable Battery was administered at the time of brain MRI to categorize the MS population into cognitively preserved (CP) and cognitively impaired (CI). Results: Out of 142 RRMS, 106 were classified as CP and 36 as CI. Although the CI group had greater WM lesion volume than the CP group (p = 0.001), T2 lesions tended to be less widespread across the WM. The peak of lesion frequency was almost twice higher in CI (61% in the forceps major) than in CP patients (37% in the posterior corona radiata). The voxelwise analysis confirmed that lesion frequency was higher in CI than in CP patients with significant bilateral clusters in the forceps major and in the splenium of the corpus callosum (p<0.05, corrected). Low scores of the Symbol Digit Modalities Test correlated with higher lesion frequency in these WM regions. Conclusions: Overall these results suggest that in MS patients, areas relevant for cognition lie mostly in the commissural fiber tracts. This supports the notion of a functional (multiple) disconnection between grey matter structures, secondary to damage located in specific WM areas, as one of the most important mechanisms leading to cognitive impairment in MS.	[Rossi, Francesca; Giorgio, Antonio; Battaglini, Marco; Stromillo, Maria Laura; Federico, Antonio; De Stefano, Nicola] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy; [Portaccio, Emilio; Goretti, Benedetta; Hakiki, Bahia; Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy	University of Siena; University of Florence	De Stefano, N (corresponding author), Univ Siena, Dept Neurol & Behav Sci, Via Laterina 8, I-53100 Siena, Italy.	destefano@unisi.it	Hakiki, Bahia/AAB-8461-2022; amato, Maria Pia/AAL-5998-2020; De Stefano, Nicola/AHE-3052-2022; Amato, Maria Pia/AAC-5940-2022; Calabrese, Massimiliano/I-6195-2012	Hakiki, Bahia/0000-0001-8540-7405; amato, Maria Pia/0000-0003-3325-3760; De Stefano, Nicola/0000-0003-4930-7639; Portaccio, Emilio/0000-0002-9662-1762; federico, antonio/0000-0002-5246-1621	Merck Serono; Biogen Idec; Bayer Schering Pharma; Sanofi-Aventis; Novartis; Sanofi-Aventis and serves; Teva Pharmaceutical Industries Ltd.; Italian MS Society	Merck Serono(Merck & Company); Biogen Idec(Biogen); Bayer Schering Pharma(Bayer AG); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Sanofi-Aventis and serves; Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Italian MS Society	The authors have read the journal's policy and have the following conflicts: Emilio Portaccio serves on a scientific advisory board for Biogen Idec and receives research support from Merck Serono, Biogen Idec, Bayer Schering Pharma, and Sanofi-Aventis. Benedetta Goretti serves on a scientific advisory board for Biogen Idec; has received speaker honoraria from Biogen Idec and Novartis; and receives research support from Biogen Idec, Merck Serono, and Novartis. Maria Pia Amato serves on scientific advisory boards for and has received speaker honoraria and research support from Biogen Idec, Merck Serono, Bayer Schering Pharma, and Sanofi-Aventis and serves on the editorial board of BMC Neurology. Nicola De Stefano serves on a scientific advisory board for Merck Serono; has received funding for travel from Teva Pharmaceutical Industries Ltd. and Merck Serono; has received speaker honoraria from Teva Pharmaceutical Industries Ltd., BioMS Medical, Biogen-Dompe AG, Bayer Schering Pharma, and Merck Serono; and receives research support from the Italian MS Society. Francesca Rossi, Antonio Giorgio, Marco Battaglini, and Maria Laura Stromillo have nothing to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amato MP, 2008, NEUROLOGY, V71, P632, DOI 10.1212/01.wnl.0000324621.58447.00; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Audoin B, 2005, MAGN RESON MATER PHY, V18, P96, DOI 10.1007/s10334-004-0098-9; Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Bodini B, 2010, J NEUROL NEUROSURG P; Ferreira MLB, 2010, ARQ NEURO-PSIQUIAT, V68, P632, DOI 10.1590/S0004-282X2010000400029; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Calabrese P, 2007, J NEUROL, V254, P18, DOI 10.1007/s00415-007-2006-5; Ceccarelli A, 2008, NEUROIMAGE, V39, P1499, DOI 10.1016/j.neuroimage.2007.11.002; Charil A, 2003, NEUROIMAGE, V19, P532, DOI 10.1016/S1053-8119(03)00117-4; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Christodoulou C, 2003, NEUROLOGY, V60, P1793, DOI 10.1212/01.WNL.0000072264.75989.B8; Dalton C, 2011, MULT SCLER; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Di Perri C, 2008, ARCH NEUROL-CHICAGO, V65, P236, DOI 10.1001/archneurol.2007.51; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Giorgio A, 2010, NEUROL SCI, V31, P245, DOI 10.1007/s10072-010-0370-x; GLOOR P, 1993, BRAIN, V116, P1249, DOI 10.1093/brain/116.5.1249; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Kincses ZT, 2011, MULT SCLER J, V17, P681, DOI 10.1177/1352458510391342; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lee MA, 1999, BRAIN, V122, P1261, DOI 10.1093/brain/122.7.1261; Lin X, 2005, J NEUROL SCI, V237, P13, DOI 10.1016/j.jns.2005.04.019; Mesaros S, 2009, HUM BRAIN MAPP, V30, P2656, DOI 10.1002/hbm.20692; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; Narayanan S, 1997, ANN NEUROL, V41, P385, DOI 10.1002/ana.410410314; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rao S, 1990, MANUAL BRIEF REPEATA; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; RAO SM, 1989, ARCH NEUROL-CHICAGO, V46, P918, DOI 10.1001/archneur.1989.00520440114028; Reuter F, 2011, MULT SCLER J, V17, P755, DOI 10.1177/1352458511398265; Rimkus Cde M, 2011, MULT SCLER INT, V2011; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; Sepulcre J, 2009, NEUROIMAGE, V47, P773, DOI 10.1016/j.neuroimage.2009.04.054; Sicotte NL, 2008, BRAIN, V131, P1134, DOI 10.1093/brain/awn030; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sombekke MH, 2011, AM J NEURORADIOL, V32, P695, DOI 10.3174/ajnr.A2352; Staff RT, 2006, NEUROIMAGE, V30, P1433, DOI 10.1016/j.neuroimage.2005.11.004; SWIRSKYSACCHETTI T, 1992, NEUROLOGY, V42, P1291, DOI 10.1212/WNL.42.7.1291; Tekok-Kilic A, 2007, NEUROIMAGE, V36, P1294, DOI 10.1016/j.neuroimage.2007.04.017; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P768, DOI 10.1002/jmri.21679; Warlop NP, 2009, BRAIN COGNITION, V71, P410, DOI 10.1016/j.bandc.2009.05.004; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053	53	64	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e44826	10.1371/journal.pone.0044826	http://dx.doi.org/10.1371/journal.pone.0044826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144775	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400003
J	Yao, ZJ; Hu, B; Liang, CJ; Zhao, LN; Jackson, M				Yao, Zhijun; Hu, Bin; Liang, Chuanjiang; Zhao, Lina; Jackson, Mike		Alzheimer's Disease Neuroimaging I	A Longitudinal Study of Atrophy in Amnestic Mild Cognitive Impairment and Normal Aging Revealed by Cortical Thickness	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SPATIAL-PATTERNS; VISUAL-SEARCH; BRAIN; DEMENTIA; DEFICIT; PROGRESSION; ASYMMETRY; INFERIOR; CORTEX	In recent years, amnestic mild cognitive impairment (aMCI) has attracted significant attention as an indicator of high risk for Alzheimer's disease. An understanding of the pathology of aMCI may benefit the development of effective clinical treatments for dementia. In this work, we measured the cortical thickness of 109 aMCI subjects and 99 normal controls (NC) twice over two years. The longitudinal changes and the cross-sectional differences between the two types of participants were explored using the vertex thickness values. The thickness of the cortex in aMCI was found significantly reduced in both longitudinal and between-group comparisons, mainly in the temporal lobe, superolateral parietal lobe and some regions of the frontal cortices. Compared to NC, the aMCI showed a significantly high atrophy rate in the left lateral temporal lobe and left parahippocampal gyrus over two years. Additionally, a significant positive correlation between brain atrophy and the decline of Mini-Mental State Examination (MMSE) scores was also found in the left superior and left middle temporal gyrus in aMCI. These findings demonstrated specific longitudinal spatial patterns of cortical atrophy in aMCI and NC. The higher atrophy rate in aMCI might be responsible for the accelerated functional decline in the aMCI progression process.	[Yao, Zhijun; Hu, Bin; Liang, Chuanjiang; Zhao, Lina] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China; [Jackson, Mike] Birmingham City Univ, Birmingham City Business Sch, Birmingham, W Midlands, England; [Hu, Bin] Birmingham City Univ, Sch Comp Telecomminicat & Networks, Birmingham, W Midlands, England	Lanzhou University; Birmingham City University; Birmingham City University	Hu, B (corresponding author), Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China.	bh@lzu.edu.cn			National Basic Research Program of China (973 Program) [2011CB711000]; National Natural Science Foundation of China [60973138, 61003240]; EU's Seventh Framework Programme OPTIMI [248544]; Study of Brain Network of The Group of Mild Cognitive Impairment [Lzujbky-2011-61]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institutes of Health [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [P30AG010129, U01AG024904, K01AG030514] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EU's Seventh Framework Programme OPTIMI; Study of Brain Network of The Group of Mild Cognitive Impairment; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Basic Research Program of China (973 Program) (No 2011CB711000), the National Natural Science Foundation of China (grant No. 60973138, grant No. 61003240), the EU's Seventh Framework Programme OPTIMI (grant No. 248544) and the Study of Brain Network of The Group of Mild Cognitive Impairment (grant no. Lzujbky-2011-61). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). This research was also supported by National Institutes of Health grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2006, BRAIN, V129, P2867, DOI 10.1093/brain/awl274; Apostolova LG, 2006, ALZ DIS ASSOC DIS, V20, P224, DOI 10.1097/01.wad.0000213857.89613.10; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Convit A, 2000, NEUROBIOL AGING, V21, P19, DOI 10.1016/S0197-4580(99)00107-4; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Filippi M, 2011, J ALZHEIMERS DIS, V24, P455, DOI 10.3233/JAD-2011-101854; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Jack CR, 2008, NEUROLOGY, V70, P1740, DOI 10.1212/01.wnl.0000281688.77598.35; Johnson MK, 2004, PSYCHOL SCI, V15, P127, DOI 10.1111/j.0963-7214.2004.01502009.x; Julkunen V, 2010, J ALZHEIMERS DIS, V21, P1141, DOI 10.3233/JAD-2010-100114; Julkunen V, 2009, DEMENT GERIATR COGN, V28, P404, DOI 10.1159/000256274; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Kim S, 2011, J CLIN NEUROSCI, V18, P916, DOI 10.1016/j.jocn.2010.12.019; Lamb K, 2007, MED SCI SPORT EXER, V39, P672, DOI 10.1249/mss.0b013e31802f04e0; Li Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.008; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mapstone M, 2003, NEUROLOGY, V60, P802, DOI 10.1212/01.WNL.0000049471.76799.DE; Masdeu JC, 2005, J NEUROL SCI, V236, P55, DOI 10.1016/j.jns.2005.05.001; McNay EC, 1998, LEARN MEMORY, V4, P411, DOI 10.1101/lm.4.5.411; Nestor PJ, 2003, BRAIN, V126, P2406, DOI 10.1093/brain/awg240; Ohnishi T, 2001, AM J NEURORADIOL, V22, P1680; PENNIELLO MJ, 1995, BRAIN, V118, P697, DOI 10.1093/brain/118.3.697; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Richards BA, 2009, NEUROBIOL AGING, V30, P1626, DOI 10.1016/j.neurobiolaging.2007.12.019; Rockwood K, 1999, AGE AGEING, V28, P551, DOI 10.1093/ageing/28.6.551; Seo SW, 2007, NEUROIMAGE, V36, P289, DOI 10.1016/j.neuroimage.2007.02.042; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spoletini I, 2008, AM J GERIAT PSYCHIAT, V16, P389, DOI 10.1097/JGP.0b013e318165dbce; Tales A, 2005, NEUROCASE, V11, P80, DOI 10.1080/13554790490896974; Trivedi Mehul A, 2006, Alzheimers Dement, V2, P296, DOI 10.1016/j.jalz.2006.06.001; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Wei GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028309; Wernicke C., 1970, ARCH NEUROL-CHICAGO, V22, P280, DOI DOI 10.1001/ARCHNEUR.1970.00480210090013; Whitwell JL, 2008, NEUROLOGY, V70, P512, DOI 10.1212/01.wnl.0000280575.77437.a2; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhijun Yao, 2011, Brain Informatics. Proceedings International Conference, BI 2011, P209, DOI 10.1007/978-3-642-23605-1_22	51	41	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48973	10.1371/journal.pone.0048973	http://dx.doi.org/10.1371/journal.pone.0048973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133666	gold, Green Published, Green Submitted			2022-12-25	WOS:000310702400051
J	Lipponen, A; Woldemichael, BT; Gurevicius, K; Tanila, H				Lipponen, Arto; Woldemichael, Bisrat T.; Gurevicius, Kestutis; Tanila, Heikki			Artificial Theta Stimulation Impairs Encoding of Contextual Fear Memory	PLOS ONE			English	Article							HIPPOCAMPAL CA1 NEURONS; DEEP BRAIN-STIMULATION; DORSAL HIPPOCAMPUS; PROTEIN-SYNTHESIS; AMYGDALA; RHYTHM; LESIONS; FORNIX; OSCILLATIONS; EXPRESSION	Several experiments have demonstrated an intimate relationship between hippocampal theta rhythm (4-12 Hz) and memory. Lesioning the medial septum or fimbria-fornix, a fiber track connecting the hippocampus and the medial septum, abolishes the theta rhythm and results in a severe impairment in declarative memory. To assess whether there is a causal relationship between hippocampal theta and memory formation we investigated whether restoration of hippocampal theta by electrical stimulation during the encoding phase also restores fimbria-fornix lesion induced memory deficit in rats in the fear conditioning paradigm. Male Wistar rats underwent sham or fimbria-fornix lesion operation. Stimulation electrodes were implanted in the ventral hippocampal commissure and recording electrodes in the septal hippocampus. Artificial theta stimulation of 8 Hz was delivered during 3-min free exploration of the test cage in half of the rats before aversive conditioning with three foot shocks during 2 min. Memory was assessed by total freezing time in the same environment 24 h and 28 h after fear conditioning, and in an intervening test session in a different context. As expected, fimbria-fornix lesion impaired fear memory and dramatically attenuated hippocampal theta power. Artificial theta stimulation produced continuous theta oscillations that were almost similar to endogenous theta rhythm in amplitude and frequency. However, contrary to our predictions, artificial theta stimulation impaired conditioned fear response in both sham and fimbria-fornix lesioned animals. These data suggest that restoration of theta oscillation per se is not sufficient to support memory encoding after fimbria-fornix lesion and that universal theta oscillation in the hippocampus with a fixed frequency may actually impair memory.	[Lipponen, Arto; Woldemichael, Bisrat T.; Gurevicius, Kestutis; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Tanila, Heikki] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Lipponen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland.	Arto.Lipponen@uef.fi		Lipponen, Arto/0000-0001-6201-6647	Emil Aaltonen Foundation	Emil Aaltonen Foundation	The study was supported by the Emil Aaltonen Foundation (personal grant AJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN CN, 1984, BRAIN RES, V322, P261, DOI 10.1016/0006-8993(84)90116-1; Bannerman DM, 2001, EXP BRAIN RES, V141, P304; Berger H, 1929, ELEKTRENKEPHALOGRAMM, P527; BLAKER SN, 1988, J COMP NEUROL, V272, P127, DOI 10.1002/cne.902720109; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN, P448; Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; Cheval H, 2011, HIPPOCAMPUS; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Freund HJ, 2009, ARCH NEUROL-CHICAGO, V66, P781, DOI 10.1001/archneurol.2009.102; GAGE FH, 1983, BRAIN RES, V268, P39, DOI 10.1016/0006-8993(83)90388-8; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Holscher C, 1997, J NEUROSCI, V17, P6470; Hu R, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0975; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Ikonen S, 2001, PHARMACOL BIOCHEM BE, V69, P165, DOI 10.1016/S0091-3057(01)00495-6; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LEUNG LS, 1994, HIPPOCAMPUS, V4, P136, DOI 10.1002/hipo.450040204; Liu L, 2002, EXP NEUROL, V177, P565, DOI 10.1006/exnr.2002.8015; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Makeig S, 1997, EEGFILT HIGH LOW BAN; Malkani S, 2000, BRAIN RES, V860, P53, DOI 10.1016/S0006-8993(00)01976-4; Malkani S, 2000, NEUROSCIENCE, V97, P693, DOI 10.1016/S0306-4522(00)00058-0; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McDonald RJ, 1997, HIPPOCAMPUS, V7, P371, DOI 10.1002/(SICI)1098-1063(1997)7:4<371::AID-HIPO3>3.0.CO;2-M; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; Munera A, 2001, J NEUROPHYSIOL, V86, P2571, DOI 10.1152/jn.2001.86.5.2571; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Pan WX, 2004, PROG NEUROBIOL, V74, P127, DOI 10.1016/j.pneurobio.2004.09.003; Pape HC, 2003, ANN NY ACAD SCI, V985, P92; PHILLIPS RG, 1995, J NEUROSCI, V15, P5308; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; RAWLINS JNP, 1979, EXP BRAIN RES, V37, P49, DOI 10.1007/BF01474253; Rosen JB, 1998, BRAIN RES, V796, P132, DOI 10.1016/S0006-8993(98)00294-7; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Shirvalkar PR, 2010, P NATL ACAD SCI USA, V107, P7054, DOI 10.1073/pnas.0911184107; STUMPF C., 1965, INT REV NEUROBIOL, V8, P77, DOI 10.1016/S0074-7742(08)60756-4; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; TURNBULL J, 1994, CAN J NEUROL SCI, V21, P100, DOI 10.1017/S0317167100049003; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Vignal JP, 2007, BRAIN, V130, P88, DOI 10.1093/brain/awl329; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	78	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48506	10.1371/journal.pone.0048506	http://dx.doi.org/10.1371/journal.pone.0048506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133638	gold, Green Published, Green Submitted			2022-12-25	WOS:000310601300016
J	Liu, PL; Wan, Q; Guo, YP; Yang, J; Rao, GY				Liu, Ping-Li; Wan, Qian; Guo, Yan-Ping; Yang, Ji; Rao, Guang-Yuan			Phylogeny of the Genus Chrysanthemum L.: Evidence from Single-Copy Nuclear Gene and Chloroplast DNA Sequences	PLOS ONE			English	Article							ALLOPOLYPLOID SPECIATION; DIPHOSPHATE SYNTHASE; ASTERACEAE; ANTHEMIDEAE; RECOMBINATION; SYSTEMATICS; ARTEMISIA; EVOLUTION; ORIGINS; UTILITY	Chrysanthemum L. (Asteraceae-Anthemideae) is a genus with rapid speciation. It comprises about 40 species, most of which are distributed in East Asia. Many of these are narrowly distributed and habitat-specific. Considerable variations in morphology and ploidy are found in this genus. Some species have been the subjects of many studies, but the relationships between Chrysanthemum and its allies and the phylogeny of this genus remain poorly understood. In the present study, 32 species/varieties from Chrysanthemum and 11 from the allied genera were analyzed using DNA sequences of the single-copy nuclear CDS gene and seven cpDNA loci (psbA-trnH, trnC-ycf6, ycf6-psbM, trnY-rpoB, rpS4-trnT, trnL-F, and rpL16). The cpDNA and nuclear CDS gene trees both suggest that 1) Chrysanthemum is not a monophyletic taxon, and the affinity between Chrysanthemum and Ajania is so close that these two genera should be incorporated taxonomically; 2) Phaeostigma is more closely related to the Chrysanthemum+Ajania than other generic allies. According to pollen morphology and to the present cpDNA and CDS data, Ajania purpurea is a member of Phaeostigma. Species differentiation in Chrysanthemum appears to be correlated with geographic and environmental conditions. The Chinese Chrysanthemum species can be divided into two groups, the C. zawadskii group and the C. indicum group. The former is distributed in northern China and the latter in southern China. Many polyploid species, such as C. argyrophyllum, may have originated from allopolyploidization involving divergent progenitors. Considering all the evidence from present and previous studies, we conclude that geographic and ecological factors as well as hybridization and polyploidy play important roles in the divergence and speciation of the genus Chrysanthemum.	[Liu, Ping-Li; Wan, Qian; Rao, Guang-Yuan] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Guo, Yan-Ping] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Yang, Ji] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Peking University; Beijing Normal University; Fudan University	Rao, GY (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	rao@pku.edu.cn	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Natural Science Foundation of China (NSFC) [30770142, 30970207]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (NSFC, grant no. 30770142 and 30970207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony NM, 2007, MOL PHYLOGENET EVOL, V43, P553, DOI 10.1016/j.ympev.2006.09.013; Bhattacharya A, 2006, SCI HORTIC-AMSTERDAM, V109, P379, DOI 10.1016/j.scienta.2006.06.004; Bremer K., 1993, B NAT HIST MUS LOND, V23, P71; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Brummitt RK, 1998, TAXON, V47, P411, DOI 10.2307/1223771; Brysting AK, 2007, SYST BIOL, V56, P467, DOI 10.1080/10635150701424553; [陈发棣 CHEN Fadi], 2008, [南京农业大学学报, Journal of Nanjing Agricultural University], V31, P118; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; da Silva JAT, 2003, BIOTECHNOL ADV, V21, P715, DOI 10.1016/S0734-9750(03)00117-4; Dai SL, 1998, ACTA BOT SIN, V40, P1053; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; DU B, 1989, J WUHAN BOT RES, V7, P293; Emshwiller E, 2002, AM J BOT, V89, P1042, DOI 10.3732/ajb.89.7.1042; EPSTEIN WW, 1973, PHYTOCHEMISTRY, V12, P737, DOI 10.1016/0031-9422(73)80670-3; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Ferguson D, 2001, P NATL ACAD SCI USA, V98, P3915, DOI 10.1073/pnas.061288698; Guo YP, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-2; Guo YP, 2004, TAXON, V53, P657, DOI 10.2307/4135441; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes CE, 2006, PHILOS T R SOC B, V361, P211, DOI 10.1098/rstb.2005.1735; Kelly LJ, 2010, MOL BIOL EVOL, V27, P781, DOI 10.1093/molbev/msp267; Kim JS, 2003, J PLANT RES, V116, P47, DOI 10.1007/s10265-002-0067-1; Kim M, 2008, SCIENCE, V322, P1116, DOI 10.1126/science.1164371; Kim ST, 2008, P NATL ACAD SCI USA, V105, P12370, DOI 10.1073/pnas.0805141105; Kitamura S, 1940, MEMOIRS COLL SCI K B, V15, P258; Kondo K, 2003, PL GE BI EV, P117; Ma JX, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-100; Martin I, 2003, PLANT BIOLOGY, V5, P85, DOI 10.1055/s-2003-37979; Masuda Y., 2009, CHROMOSOME BOT, V4, P25; MCDADE LA, 1995, MONOG SYST BOTAN, V53, P305; MULDASHEV A A, 1981, Botanicheskii Zhurnal (St. Petersburg), V66, P584; Nakata M., 1987, PLANT CHROMOSOME RES, P17; NICOLSON DH, 1999, TAXON, V48, P373; Oberprieler C., 2007, FAMILIES GENERA VASC, P342; Oberprieler Christoph, 2007, Willdenowia, V37, P89, DOI 10.3372/wi.37.37104; Pellicer J, 2009, BOT J LINN SOC, V161, P171, DOI 10.1111/j.1095-8339.2009.00998.x; Poljakov P. P., 1955, BOT MAT GERB BOT I K, V17, P418; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2014, TRACER V1 6; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rivera SB, 2001, P NATL ACAD SCI USA, V98, P4373, DOI 10.1073/pnas.071543598; Russell A, 2010, ANN BOT-LONDON, V106, P37, DOI 10.1093/aob/mcq092; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Sanz M, 2008, TAXON, V57, P66, DOI 10.2307/25065949; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shih C, 1983, FLORA REIPUBLICAE PO, V76; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Soltis DE, 2003, INT POL C 27 30 APR; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; Suda J, 2006, TAXON, V55, P447, DOI 10.2307/25065591; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Tahtiharju S, 2012, MOL BIOL EV IN PRESS; Temsch EM, 2000, GENOME, V43, P449, DOI 10.1139/gen-43-3-449; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Trehane Piers, 1995, Taxon, V44, P439, DOI 10.2307/1223427; Tsukaya H, 2002, J PLANT RES, V115, P329, DOI 10.1007/s10265-002-0041-y; Tzvelev N.N., 1961, COMPOSITAE ANTHEMIDE, P642; Wang CY, 2004, ADV ORNAMENTAL HORTI, P181; Wang J, 1993, ACTA PHYTOTAXONOMICA, V31, P140; Watson LE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-17; Yang WH, 2006, NEW PHYTOL, V171, P875, DOI 10.1111/j.1469-8137.2006.01779.x; Zhao HB, 2010, PLANT SYST EVOL, V284, P153, DOI 10.1007/s00606-009-0242-0; [Zhao Huien 赵惠恩], 2003, [分子植物育种, Molecular Plant Breeding], V1, P597; Zhmyleva AP, 2006, CHROMOSOME BOT, V1, P13; Zhou ChunLing, 2002, Journal of Beijing Forestry University, V24, P71	68	79	83	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48970	10.1371/journal.pone.0048970	http://dx.doi.org/10.1371/journal.pone.0048970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133665	Green Published, Green Submitted, gold			2022-12-25	WOS:000310601300029
J	Meplan, C; Rohrmann, S; Steinbrecher, A; Schomburg, L; Jansen, E; Linseisen, J; Hesketh, J				Meplan, Catherine; Rohrmann, Sabine; Steinbrecher, Astrid; Schomburg, Lutz; Jansen, Eugene; Linseisen, Jakob; Hesketh, John			Polymorphisms in Thioredoxin Reductase and Selenoprotein K Genes and Selenium Status Modulate Risk of Prostate Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PREVENTION; SUPPLEMENTATION; EXPRESSION; HOMEOSTASIS; BIOMARKERS; INHIBITORS; GENETICS; HEALTH; SERUM	Increased dietary intake of Selenium (Se) has been suggested to lower prostate cancer mortality, but supplementation trials have produced conflicting results. Se is incorporated into 25 selenoproteins. The aim of this work was to assess whether risk of prostate cancer is affected by genetic variants in genes coding for selenoproteins, either alone or in combination with Se status. 248 cases and 492 controls from an EPIC-Heidelberg nested case-control study were subjected to two-stage genotyping with an initial screening phase in which 384 tagging-SNPs covering 72 Se-related genes were determined in 94 cases and 94 controls using the Illumina Goldengate methodology. This analysis was followed by a second phase in which genotyping for candidate SNPs identified in the first phase was carried out in the full study using Sequenom. Risk of high-grade or advanced stage prostate cancer was modified by interactions between serum markers of Se status and genotypes for rs9880056 in SELK, rs9605030 and rs9605031 in TXNRD2, and rs7310505 in TXNRD1. No significant effects of SNPs on prostate cancer risk were observed when grade or Se status was not taken into account. In conclusion, the risk of high-grade or advanced-stage prostate cancer is significantly altered by a combination of genotype for SNPs in selenoprotein genes and Se status. The findings contribute to explaining the biological effects of selenium intake and genetic factors in prostate cancer development and highlight potential roles of thioredoxin reductases and selenoprotein K in tumour progression.	[Meplan, Catherine; Hesketh, John] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Meplan, Catherine; Hesketh, John] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rohrmann, Sabine] Univ Zurich, Inst Social & Prevent Med, Div Canc Epidemiol & Prevent, CH-8006 Zurich, Switzerland; [Rohrmann, Sabine; Steinbrecher, Astrid; Linseisen, Jakob] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Schomburg, Lutz] Charite, Inst Expt Endocrinol, D-13353 Berlin, Germany; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Linseisen, Jakob] Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany	Newcastle University - UK; Newcastle University - UK; University of Zurich; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Netherlands National Institute for Public Health & the Environment; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hesketh, J (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	j.e.hesketh@ncl.ac.uk	Linseisen, Jakob/B-5353-2014; Schomburg, Lutz/D-8096-2013; Rohrmann, Sabine/D-2113-2012	Linseisen, Jakob/0000-0002-9386-382X; Schomburg, Lutz/0000-0001-9445-1555; Rohrmann, Sabine/0000-0002-2215-1200	German Federal Ministry of Education and Research [FK 0313846A]; Environmental Cancer Risk, Nutrition and Individual Susceptibility, a Network of Excellence of the European Commission [513943]; NuGO; European Commission [FP6-505360]; German Cancer Aid; "Europe Against Cancer" Programme (European Commission, DG SANCO); Deutsche Krebshilfe [10-1792 Scho2]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Environmental Cancer Risk, Nutrition and Individual Susceptibility, a Network of Excellence of the European Commission; NuGO; European Commission(European CommissionEuropean Commission Joint Research Centre); German Cancer Aid(Deutsche Krebshilfe); "Europe Against Cancer" Programme (European Commission, DG SANCO)(European CommissionEuropean Commission Joint Research Centre); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the German Federal Ministry of Education and Research (FK 0313846A), by Environmental Cancer Risk, Nutrition and Individual Susceptibility, a Network of Excellence of the European Commission (contract no 513943) and by NuGO, the European Commission-funded Network of Excellence in Nutrigenomics (FP6-505360). Basic support of the EPIC-Heidelberg study was provided by the German Cancer Aid and the "Europe Against Cancer" Programme (European Commission, DG SANCO). CM was supported by NuGO. LS was supported by Deutsche Krebshilfe (10-1792 Scho2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Cai WQ, 2012, FREE RADICAL BIO MED, V52, P257, DOI 10.1016/j.freeradbiomed.2011.10.447; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Cooper ML, 2008, CANCER RES, V68, P10171, DOI 10.1158/0008-5472.CAN-08-1827; Dunn BK, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P297, DOI 10.1007/978-1-4614-1025-6_23; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Gonzalez-Moreno O, 2011, PROSTATE, V71, P824, DOI 10.1002/pros.21298; Hesketh J, 2008, ANNU REV NUTR, V28, P157, DOI 10.1146/annurev.nutr.28.061807.155446; Hesketh J, 2011, P NUTR SOC, V70, P365, DOI 10.1017/S0029665111000115; Hollenbach B, 2008, J TRACE ELEM MED BIO, V22, P24, DOI 10.1016/j.jtemb.2007.11.003; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Knoblauch H, 2004, HUM MOL GENET, V13, P993, DOI 10.1093/hmg/ddh119; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Meplan C, 2008, AM J CLIN NUTR, V87, P1019, DOI 10.1093/ajcn/87.4.1019; Meplan C, 2007, FASEB J, V21, P3063, DOI 10.1096/fj.07-8166com; Meplan C, 2009, ANTIOXID REDOX SIGN, V11, P2631, DOI [10.1089/ars.2009.2533, 10.1089/ARS.2009.2533]; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Penney KL, 2010, CANCER EPIDEM BIOMAR, V19, P2869, DOI 10.1158/1055-9965.EPI-10-0601; Penney KL, 2010, CANCER PREV RES, V3, P604, DOI 10.1158/1940-6207.CAPR-09-0216; Peters U, 2008, MOL NUTR FOOD RES, V52, P1261, DOI 10.1002/mnfr.200800103; Platz EA, 2010, CANCER PREV RES, V3, P576, DOI 10.1158/1940-6207.CAPR-10-0072; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Schomburg L, 2010, MOL CELL ENDOCRINOL, V322, P114, DOI 10.1016/j.mce.2010.01.011; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Sieniawska CE, 1999, J ANAL ATOM SPECTROM, V14, P109, DOI 10.1039/a806307i; Steinbrecher A, 2010, CANCER EPIDEM BIOMAR, V19, P2958, DOI 10.1158/1055-9965.EPI-10-0364; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99; Whanger PD, 2004, BRIT J NUTR, V91, P11, DOI 10.1079/BJN20031015; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Zhuo P, 2009, BBA-GEN SUBJECTS, V1790, P1546, DOI 10.1016/j.bbagen.2009.03.004	40	39	40	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48709	10.1371/journal.pone.0048709	http://dx.doi.org/10.1371/journal.pone.0048709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133653	gold, Green Published			2022-12-25	WOS:000310601300024
J	Peyraud, R; Kiefer, P; Christen, P; Portais, JC; Vorholt, JA				Peyraud, Remi; Kiefer, Patrick; Christen, Philipp; Portais, Jean-Charles; Vorholt, Julia A.			Co-Consumption of Methanol and Succinate by Methylobacterium extorquens AM1	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; SERINE CYCLE GENES; NONMETHYLOTROPHIC CONDITIONS; TRANSCRIPTIONAL REGULATOR; METHYLOTROPHIC BACTERIA; MICROBIAL-METABOLISM; MASS-SPECTROMETRY; C1 COMPOUNDS; GROWTH; PATHWAY	Methylobacterium extorquens AM1 is a facultative methylotrophic Alphaproteobacterium and has been subject to intense study under pure methylotrophic as well as pure heterotrophic growth conditions in the past. Here, we investigated the metabolism of M. extorquens AM1 under mixed substrate conditions, i.e., in the presence of methanol plus succinate. We found that both substrates were co-consumed, and the carbon conversion was two-thirds from succinate and one-third from methanol relative to mol carbon. C-13-methanol labeling and liquid chromatography mass spectrometry analyses revealed the different fates of the carbon from the two substrates. Methanol was primarily oxidized to CO2 for energy generation. However, a portion of the methanol entered biosynthetic reactions via reactions specific to the one-carbon carrier tetrahydrofolate. In contrast, succinate was primarily used to provide precursor metabolites for bulk biomass production. This work opens new perspectives on the role of methylotrophy when substrates are simultaneously available, a situation prevailing under environmental conditions.	[Peyraud, Remi; Kiefer, Patrick; Christen, Philipp; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Portais, Jean-Charles] Univ Toulouse, INSA, UPS, INP, Toulouse, France; [Portais, Jean-Charles] INRA, Ingn Syst Biol & Proc UMR792, F-31931 Toulouse, France; [Portais, Jean-Charles] CNRS, UMR5504, Toulouse, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Vorholt, JA (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	vorholt@micro.biol.ethz.ch	Vorholt, Julia/K-3514-2016; Kiefer, Patrick/G-5138-2010; Peyraud, Rémi/G-5226-2010	Vorholt, Julia/0000-0002-6011-4910; Peyraud, Rémi/0000-0002-7580-042X; Portais, Jean-Charles/0000-0002-3480-0933; Christen, Philipp/0000-0002-3139-2874	ETH Zurich [ETH-25 08-2]	ETH Zurich(ETH Zurich)	This work was supported by ETH Zurich, Research Grant ETH-25 08-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Anandham R, 2009, J MICROBIOL BIOTECHN, V19, P17, DOI 10.4014/jmb.0802.127; Anthony Christopher, 2011, Science Progress, V94, P109, DOI 10.3184/003685011X13044430633960; BECKWITH JR, 1967, SCIENCE, V156, P597, DOI 10.1126/science.156.3775.597; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2011, ENVIRON MICROBIOL, V13, P2603, DOI 10.1111/j.1462-2920.2011.02464.x; CORPE WA, 1989, FEMS MICROBIOL ECOL, V62, P243, DOI 10.1111/j.1574-6968.1989.tb03698.x; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DUNSTAN PM, 1972, BIOCHEM J, V128, P107, DOI 10.1042/bj1280107; Egli T, 1991, Biotechnology, V18, P173; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Guo XF, 2008, BIOTECHNOL BIOENG, V99, P929, DOI 10.1002/bit.21652; Guo XF, 2006, ARCH MICROBIOL, V186, P139, DOI 10.1007/s00203-006-0131-7; Hu B, 2012, J BACTERIOL, V194, P2802, DOI 10.1128/JB.00061-12; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kalyuzhnaya MG, 2005, J BACTERIOL, V187, P7511, DOI 10.1128/JB.187.21.7511-7517.2005; Kalyuzhnaya MG, 2003, J BACTERIOL, V185, P1229, DOI 10.1128/JB.185.4.1229-1235.2003; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Kleijn RJ, 2010, J BIOL CHEM, V285, P1587, DOI 10.1074/jbc.M109.061747; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knief C, 2010, MICROB ECOL, V60, P440, DOI 10.1007/s00248-010-9725-3; Kuntze K, 2011, MOL MICROBIOL, V82, P758, DOI 10.1111/j.1365-2958.2011.07856.x; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Miller WG, 2001, APPL ENVIRON MICROB, V67, P1308, DOI 10.1128/AEM.67.3.1308-1317.2001; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Peyraud R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-189; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Schneider K, 2012, J BIOL CHEM, V287, P757, DOI 10.1074/jbc.M111.305219; Skovran E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014091; Springer AL, 1998, FEMS MICROBIOL LETT, V160, P119, DOI 10.1016/S0378-1097(98)00020-2; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; TAUCHERT K, 1990, J BACTERIOL, V172, P6447, DOI 10.1128/jb.172.11.6447-6451.1990; Van Dien SJ, 2003, MICROBIOL-SGM, V149, P601, DOI 10.1099/mic.0.25955-0; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005	44	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48271	10.1371/journal.pone.0048271	http://dx.doi.org/10.1371/journal.pone.0048271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133625	Green Published, gold, Green Submitted			2022-12-25	WOS:000310601300010
J	Liu, HB; Gan, Y; Yang, B; Weng, H; Huang, CM; Yang, DF; Lei, P; Shen, GX				Liu, Hongbo; Gan, Yan; Yang, Bo; Weng, Hui; Huang, Chunmei; Yang, Daofeng; Lei, Ping; Shen, Guanxin			Performance Evaluation of the Maxwell 16 System for Extraction of Influenza Virus RNA from Diverse Samples	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; NUCLEIC-ACID EXTRACTION; SARS-CORONAVIRUS; AUTOMATED EXTRACTION; RAPID DETECTION; DIAGNOSIS; INHIBITORS	This study evaluated the performance of the Maxwell 16 System (Promega) for extraction of influenza virus (flu-v) RNA from diverse samples compared to a classical manual method (QIAamp Kit, QIAGEN). Following extraction by the two methods, all samples were analyzed by Real-time RT-PCR. Results revealed that the use of the standard Maxwell 16 protocol (Maxwell 16-S) resulted in good linearity and precision across a wide concentration range and higher sensitivity of detection from fluv stock suspensions than the manual method. Compared with the latter method, Maxwell 16-S extracted RNA more efficiently (higher RNA yield and/or fewer PCR inhibitors) from throat swabs and bronchoalveolar lavage fluids, while both methods performed comparably on fecal samples from human and poultry in terms of overall threshold cycle values and detection rates although the Maxwell 16-S co-purified more inhibitors from fecal samples. The capacity of this system to remove inhibitors from fecal matrix was improved by using a modified Maxwell 16 protocol with a reduced sample input, which eliminated all false-negatives produced by the Maxwell 16-S. These findings suggest that the Maxwell 16 System is suitable for RNA extraction from multiple-source samples for diagnosis of influenza and viral load determination and that a proper reduction in starting sample volume may improve the detection of flu-v from complex matrices such as feces. Additionally, this system allows flexible sample throughput and labor-saving sample processing with little or no risk of cross-contamination.	[Liu, Hongbo; Weng, Hui; Huang, Chunmei; Lei, Ping; Shen, Guanxin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China; [Liu, Hongbo] Zhongshan Ctr Dis Control & Prevent, Virol Lab, Zhongshan, Peoples R China; [Gan, Yan] St Josephs Hosp, Barrow Neurol Inst, Neuroimmunol Lab, Phoenix, AZ 85013 USA; [Gan, Yan] Med Ctr, Phoenix, AZ USA; [Yang, Bo] Boai Hosp Zhongshan, Dept Intens Care Unit, Zhongshan, Peoples R China; [Yang, Daofeng] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Huazhong University of Science & Technology	Shen, GX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China.	guanxin_shen@yahoo.com.cn	shen, Guanxin/F-7441-2011	Liu, Hongbo/0000-0002-7187-8115	Program for Changjiang Scholars and Innovative Research Team in University [IRT1131]; State Project on Major Infectious Diseases Prevention [2012ZX10002006-003]; International Science & Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft [SFB/Transregio TRR60]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State Project on Major Infectious Diseases Prevention; International Science & Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research work was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1131) and State Project on Major Infectious Diseases Prevention (2012ZX10002006-003), the International Science & Technology Cooperation Program of China (2011DFA31030) and Deutsche Forschungsgemeinschaft (SFB/Transregio TRR60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, US PCR SURV DIAGN IN; Baumeister AK, 1998, J CLIN MICROBIOL, V36, P1984, DOI 10.1128/JCM.36.7.1984-1988.1998; Beck ET, 2010, FUTURE MICROBIOL, V5, P901, DOI [10.2217/fmb.10.48, 10.2217/FMB.10.48]; Chiu RWK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-20; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Das A, 2006, J CLIN MICROBIOL, V44, P3065, DOI 10.1128/JCM.00639-06; Dhumpa R, 2011, DIAGN MICR INFEC DIS, V69, P258, DOI 10.1016/j.diagmicrobio.2010.09.022; Hourfar MK, 2005, CLIN CHEM, V51, P1217, DOI 10.1373/clinchem.2005.048603; Loens K, 2007, J CLIN MICROBIOL, V45, P421, DOI 10.1128/JCM.00894-06; Monteiro L, 1997, J CLIN MICROBIOL, V35, P995, DOI 10.1128/JCM.35.4.995-998.1997; Petrich A, 2006, J CLIN MICROBIOL, V44, P2681, DOI 10.1128/JCM.02460-05; Poon LLM, 2003, J CLIN VIROL, V28, P233, DOI 10.1016/j.jcv.2003.08.004; Promega Corporation, 2009, MAXW 16 VIR TOT NUCL; Radstrom P, 2004, MOL BIOTECHNOL, V26, P133, DOI 10.1385/MB:26:2:133; REZNIKOV M, 1995, EUR J CLIN MICROBIOL, V14, P58, DOI 10.1007/BF02112622; Suarez DL, 2007, AVIAN DIS, V51, P201, DOI 10.1637/7732-101006-REGR.1; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; Tewari D, 2007, J CLIN VIROL, V40, P142, DOI 10.1016/j.jcv.2007.07.011; Wang HB, 2004, CLIN CHEM, V50, P1237, DOI 10.1373/clinchem.2004.031237; Wang RXE, 2010, EXPERT REV ANTI-INFE, V8, P517, DOI [10.1586/eri.10.24, 10.1586/ERI.10.24]; World Health Organization, 2009, CDC PROT REAL TIM RT; Yoo SJ, 2010, J CLIN MICROBIOL, V48, P2314, DOI 10.1128/JCM.00325-10	23	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48094	10.1371/journal.pone.0048094	http://dx.doi.org/10.1371/journal.pone.0048094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144730	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300040
J	Bouchlaka, MN; Sckisel, GD; Wilkins, D; Maverakis, E; Monjazeb, AM; Fung, M; Welniak, L; Redelman, D; Fuchs, A; Evrensel, CA; Murphy, WJ				Bouchlaka, Myriam N.; Sckisel, Gail D.; Wilkins, Danice; Maverakis, Emanual; Monjazeb, Arta M.; Fung, Maxwell; Welniak, Lisbeth; Redelman, Doug; Fuchs, Alan; Evrensel, Cahit A.; Murphy, William J.			Mechanical Disruption of Tumors by Iron Particles and Magnetic Field Application Results in Increased Anti-Tumor Immune Responses	PLOS ONE			English	Article							RADIO-FREQUENCY ABLATION; SUPPRESSOR-CELLS; RADIOFREQUENCY ABLATION; DENDRITIC CELLS; THERMAL ABLATION; LIVER METASTASES; ANTIGENIC DRIFT; BREAST-CANCER; CLASS-II; CARCINOMA	The primary tumor represents a potential source of antigens for priming immune responses for disseminated disease. Current means of debulking tumors involves the use of cytoreductive conditioning that impairs immune cells or removal by surgery. We hypothesized that activation of the immune system could occur through the localized release of tumor antigens and induction of tumor death due to physical disruption of tumor architecture and destruction of the primary tumor in situ. This was accomplished by intratumor injection of magneto-rheological fluid (MRF) consisting of iron microparticles, in Balb/c mice bearing orthotopic 4T1 breast cancer, followed by local application of a magnetic field resulting in immediate coalescence of the particles, tumor cell death, slower growth of primary tumors as well as decreased tumor progression in distant sites and metastatic spread. This treatment was associated with increased activation of DCs in the draining lymph nodes and recruitment of both DCs and CD8(+)T cells to the tumor. The particles remained within the tumor and no toxicities were observed. The immune induction observed was significantly greater compared to cryoablation. Further anti-tumor effects were observed when MRF/magnet therapy was combined with systemic low dose immunotherapy. Thus, mechanical disruption of the primary tumor with MRF/magnetic field application represents a novel means to induce systemic immune activation in cancer.	[Murphy, William J.] Univ Calif Davis, Dept Dermatol & Internal Med, Sacramento, CA 95817 USA; [Bouchlaka, Myriam N.; Wilkins, Danice] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Sckisel, Gail D.; Welniak, Lisbeth] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Maverakis, Emanual] VA No Calif Hlth Care Syst, Sacramento, CA USA; [Monjazeb, Arta M.] Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Fung, Maxwell] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA; [Fung, Maxwell] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Redelman, Doug] Univ Nevada, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Fuchs, Alan] Univ Nevada, Dept Chem Engn, Reno, NV 89557 USA; [Evrensel, Cahit A.] Univ Nevada, Dept Biomed Engn, Reno, NV 89557 USA; [Evrensel, Cahit A.] Univ Nevada, Dept Mech Engn, Reno, NV 89557 USA; [Evrensel, Cahit A.] Univ Nevada, Grad Program Biomed Engn, Reno, NV 89557 USA	University of California System; University of California Davis; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Murphy, WJ (corresponding author), Univ Calif Davis, Dept Dermatol & Internal Med, Sacramento, CA 95817 USA.	william.murphy@ucdmc.ucdavis.edu	Maverakis, Emanual/E-1185-2013; Fung, Maxwell/AEM-2111-2022	Fung, Maxwell/0000-0003-1771-8257; Bouchlaka, Myriam/0000-0003-2865-0817; Maverakis, Emanual/0000-0002-6294-6294	Department of Defense [W81XWH-09-1-0033]	Department of Defense(United States Department of Defense)	This work was funded by the Department of Defense, grant number W81XWH-09-1-0033 (http://www.defense.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki Y, 2004, J IMMUNOL, V173, P4352, DOI 10.4049/jimmunol.173.7.4352; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; BURT DS, 1989, J EXP MED, V170, P383, DOI 10.1084/jem.170.2.383; BUTLER LD, 1989, IMMUNOPHARM IMMUNOT, V11, P445, DOI 10.3109/08923978909005379; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Curley SA, 2003, ANN SURG ONCOL, V10, P338, DOI 10.1245/ASO.2003.07.017; Danna EA, 2004, CANCER RES, V64, P2205, DOI 10.1158/0008-5472.CAN-03-2646; den Brok MHMGM, 2006, BRIT J CANCER, V95, P896, DOI 10.1038/sj.bjc.6603341; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; DEXTER DL, 1978, CANCER RES, V38, P3174; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dupre SA, 2008, EXP MOL PATHOL, V85, P174, DOI 10.1016/j.yexmp.2008.05.002; Fuchs A, 2010, J APPL POLYM SCI, V117, P934, DOI 10.1002/app.31533; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garcea G, 2003, EUR J CANCER, V39, P2150, DOI 10.1016/S0959-8049(03)00553-7; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Habibi M, 2009, BREAST CANCER RES TR, V114, P423, DOI 10.1007/s10549-008-0024-3; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hixon JA, 2002, BIOL BLOOD MARROW TR, V8, P316, DOI 10.1053/bbmt.2002.v8.pm12108917; Kaufman HL, 2002, CYTOKINE, V17, P43, DOI 10.1006/cyto.2001.0986; Laurent S, 2011, ADV COLLOID INTERFAC, V166, P8, DOI 10.1016/j.cis.2011.04.003; Lin A, 2010, IMMUNOL LETT, V127, P77, DOI 10.1016/j.imlet.2009.09.003; MILLER FR, 1983, INVAS METAST, V3, P22; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Murphy WJ, 2003, J IMMUNOL, V170, P2727, DOI 10.4049/jimmunol.170.5.2727; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Nguyen HH, 1999, VIROLOGY, V254, P50, DOI 10.1006/viro.1998.9521; Nierkens S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008368; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; OBrien MC, 1997, CYTOMETRY, V28, P81; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; Ostrand-Rosenberg S, 2000, J IMMUNOL, V165, P6015, DOI 10.4049/jimmunol.165.11.6015; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pawlik TM, 2003, ANN SURG ONCOL, V10, P1059, DOI 10.1245/ASO.2003.03.026; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Pulaski BA, 1998, CANCER RES, V58, P1486; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Raj GV, 2003, UROLOGY, V61, P23, DOI 10.1016/S0090-4295(02)01850-2; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; Ruers T, 2002, EUR J CANCER, V38, P1023, DOI 10.1016/S0959-8049(02)00059-X; Ruers TJM, 2001, BRIT J SURG, V88, P844, DOI 10.1046/j.1365-2168.2001.01766.x; Sabel MS, 2005, BREAST CANCER RES TR, V90, P97, DOI 10.1007/s10549-004-3289-1; Sanchez-Ortiz RF, 2003, J UROLOGY, V170, P178, DOI 10.1097/01.ju.0000070823.38336.7b; Scaife CL, 2003, ANN SURG ONCOL, V10, P348, DOI 10.1245/ASO.2003.08.019; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shanker A, 2009, CANCER RES, V69, P6615, DOI 10.1158/0008-5472.CAN-09-0685; Sinha P, 2005, CANCER IMMUNOL IMMUN, V54, P1137, DOI 10.1007/s00262-005-0703-4; Sinha P, 2005, CANCER RES, V65, P11743, DOI 10.1158/0008-5472.CAN-05-0045; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; STRNAT KJ, 1990, P IEEE, V78, P923, DOI 10.1109/5.56908; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; VERHOEYEN M, 1980, NATURE, V286, P771, DOI 10.1038/286771a0; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Yan TD, 2006, AM SURGEON, V72, P382; Zagoria RJ, 2001, J UROLOGY, V166, P1827, DOI 10.1016/S0022-5347(05)65687-X; Zhao Z, 2010, EJSO-EUR J SURG ONC, V36, P1149, DOI 10.1016/j.ejso.2010.09.012; Zijlstra H, 1982, PERMANENT MAGNETS TH, P37	69	23	24	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48049	10.1371/journal.pone.0048049	http://dx.doi.org/10.1371/journal.pone.0048049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133545	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800035
J	del Campo, JA; Garcia-Valdecasas, M; Rojas, L; Rojas, A; Romero-Gomez, M				del Campo, Jose A.; Garcia-Valdecasas, Marta; Rojas, Lourdes; Rojas, Angela; Romero-Gomez, Manuel			The Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BREAST-CANCER CELLS; RECEPTOR SUBSTRATE-1; MAMMALIAN TARGET; PLUS RIBAVIRIN; CORE PROTEIN; METFORMIN; MICE; PEGINTERFERON; PHOSPHATASE	Insulin is critical for controlling energy functions including glucose and lipid metabolism. Insulin resistance seems to interact with hepatitis C promoting fibrosis progression and impairing sustained virological response to peginterferon and ribavirin. The main aim was to elucidate the direct effect of hepatitis C virus (HCV) infection on insulin signaling both in vitro analyzing gene expression and protein abundance. Huh7.5 cells and JFH-1 viral particles were used for in vitro studies. Experiments were conducted by triplicate in control cells and infected cells. Genes and proteins involved in insulin signaling pathway were modified by HCV infection. Moreover, metformin treatment increased gene expression of PI3K, IRS1, MAP3K, AKT and PTEN more than >1.5 fold. PTP1B, encoding a tyrosin phosphatase, was found highly induced (>3 fold) in infected cells treated with metformin. However, PTP1B protein expression was reduced in metformin treated cells after JFH1 infection. Other proteins related to insulin pathway like Akt, PTEN and phosphorylated MTOR were also found downregulated. Viral replication was inhibited in vitro by metformin. A strong effect of HCV infection on insulin pathway-related gene and protein expression was found in vitro. These results could lead to the identification of new therapeutic targets in HCV infection and its co-morbidities.	[del Campo, Jose A.] Valme Univ Hosp, Unit Med & Surg Management Digest Dis, Seville, Spain; Valme Univ Hosp, CIBERehd, Seville, Spain	Hospital Valme; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Valme	del Campo, JA (corresponding author), Valme Univ Hosp, Unit Med & Surg Management Digest Dis, Seville, Spain.	joseantonio.delcampo@gmail.com	IBIS, DIGESTIVAS/O-1913-2015; Romero-Gomez, Manuel/L-8030-2014; García-Valdecasas, Marta/M-5095-2018	Romero-Gomez, Manuel/0000-0001-8494-8947; García-Valdecasas, Marta/0000-0001-9920-8722	Instituto de Salud Carlos III, Spanish Ministry of Economy [PI10/0611]	Instituto de Salud Carlos III, Spanish Ministry of Economy	This work was supported by grant PI10/0611 from Instituto de Salud Carlos III, Spanish Ministry of Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Chojkier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031516; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Garcia-Ruiz I, 2012, J BIOL CHEM, V287, P19564, DOI 10.1074/jbc.M112.342709; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; Harrison SA, 2012, HEPATOLOGY, V56, P464, DOI 10.1002/hep.25661; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ma YM, 2011, MOL CELL BIOCHEM, V357, P65, DOI 10.1007/s11010-011-0876-4; Machado-Neto JA, 2011, BBA-MOL CELL RES, V1813, P1404, DOI 10.1016/j.bbamcr.2011.04.002; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Nakashima K, 2011, MICROBIOL IMMUNOL, V55, P774, DOI 10.1111/j.1348-0421.2011.00382.x; Ogawa W, 1998, MOL CELL BIOCHEM, V182, P13, DOI 10.1023/A:1006862807598; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2009, HEPATOLOGY, V50, P1702, DOI 10.1002/hep.23206; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47904	10.1371/journal.pone.0047904	http://dx.doi.org/10.1371/journal.pone.0047904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133528	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800021
J	Hou, N; Mogami, H; Kubota-Murata, C; Sun, M; Takeuchi, T; Torii, S				Hou, Ni; Mogami, Hideo; Kubota-Murata, Chisato; Sun, Meng; Takeuchi, Toshiyuki; Torii, Seiji			Preferential Release of Newly Synthesized Insulin Assessed by a Multi-Label Reporter System Using Pancreatic beta-Cell Line MIN6	PLOS ONE			English	Article							SECRETORY GRANULES; STORED INSULIN; PROINSULIN; EXOCYTOSIS; PROTEINS; BIOSYNTHESIS; MECHANISMS; PHOGRIN; FUSION; ISLETS	Newly synthesized hormones have been suggested to be preferentially secreted by various neuroendocrine cells. This observation indicates that there is a distinct population of secretory granules containing new and old hormones. Recent development of fluorescent timer proteins used in bovine adrenal chromaffin cells revealed that secretory vesicles segregate into distinct age-dependent populations. Here, we verify the preferential release of newly synthesized insulin in the pancreatic beta-cell line, MIN6, using a combination of multi-labeling reporter systems with both fluorescent and biochemical procedures. This system allows hormones or granules of any age to be labeled, in contrast to the timer proteins, which require fluorescence shift time. Pulse-chase labeling with different color probes distinguishes insulin secretory granules by age, with younger granules having a predominantly intracellular localization rather than at the cell periphery.	[Hou, Ni; Kubota-Murata, Chisato; Sun, Meng; Takeuchi, Toshiyuki; Torii, Seiji] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan; [Hou, Ni] Xi An Jiao Tong Univ, Dept Genet & Mol Biol, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Mogami, Hideo] Hamamatsu Univ, Dept Hlth & Nutr Sci, Hamamatsu, Shizuoka 4312102, Japan; [Mogami, Hideo] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan	Gunma University; Xi'an Jiaotong University; Hamamatsu University School of Medicine; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Torii, S (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	storii@showa.gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Brain Research Institute, Niigata University; Grants-in-Aid for Scientific Research [24390050] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brain Research Institute, Niigata University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant in aid for Young Scientists and a challenging exploratory research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. It was also supported in part by the Collaborative Research Project of the Brain Research Institute, Niigata University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; GOLD G, 1982, SCIENCE, V218, P56, DOI 10.1126/science.6181562; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; HALBAN PA, 1982, ENDOCRINOLOGY, V110, P1183, DOI 10.1210/endo-110-4-1183; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Kubota C, 2010, J BIOL CHEM, V285, P667, DOI 10.1074/jbc.M109.053058; Michael DJ, 2007, DIABETES, V56, P1277, DOI 10.2337/db06-0367; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; RHODES CJ, 1987, J CELL BIOL, V105, P145, DOI 10.1083/jcb.105.1.145; Saito N, 2011, TRAFFIC, V12, P499, DOI 10.1111/j.1600-0854.2011.01159.x; SANDO H, 1972, J CLIN INVEST, V51, P1476, DOI 10.1172/JCI106944; Svendsen S, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-17; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Zhang B, 2003, DIABETES, V52, P2720, DOI 10.2337/diabetes.52.11.2720	21	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47921	10.1371/journal.pone.0047921	http://dx.doi.org/10.1371/journal.pone.0047921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133529	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800022
J	Sanchez-Fernandez, D; Aragon, P; Bilton, DT; Lobo, JM				Sanchez-Fernandez, David; Aragon, Pedro; Bilton, David T.; Lobo, Jorge M.			Assessing the Congruence of Thermal Niche Estimations Derived from Distribution and Physiological Data. A Test Using Diving Beetles	PLOS ONE			English	Article							SPECIES DISTRIBUTION; DISTRIBUTION MODELS; RANGE SIZE; GEOGRAPHICAL RANGE; TOLERANCE; RISK; CONSERVATISM; DIVERSITY; INVASIONS; INSECTS	A basic aim of ecology is to understand the determinants of organismal distribution, the niche concept and species distribution models providing key frameworks to approach the problem. As temperature is one of the most important factors affecting species distribution, the estimation of thermal limits is crucially important for inferring range constraints. It is expectable that thermal physiology data derived from laboratory experiments and species' occurrences may express different aspects of the species' niche. However, there is no study systematically testing this prediction in a given taxonomic group while controlling by potential phylogenetic inertia. We estimate the thermal niches of twelve Palaearctic diving beetles species using physiological data derived from experimental analyses in order to examine the extent to which these coincided with those estimated from distribution models based on observed occurrences. We found that thermal niche estimates derived from both approaches lack general congruence, and these results were similar before and after controlling by phylogeny. The congruence between potential distributions obtained from the two different procedures was also explored, and we found again that the percentage of agreement were not very high (similar to 60%). We confirm that both thermal niche estimates derived from geographical and physiological data are likely to misrepresent the true range of climatic variation that these diving beetles are able to tolerate, and so these procedures could be considered as incomplete but complementary estimations of an inaccessible reality.	[Sanchez-Fernandez, David; Aragon, Pedro; Lobo, Jorge M.] Museo Nacl Ciencias Nat CSIC, Dept Biogeog & Cambio Global, E-28006 Madrid, Spain; [Sanchez-Fernandez, David] Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain; [Sanchez-Fernandez, David] Inst Biol Evolutiva CSIC UPF, Barcelona, Spain; [Bilton, David T.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); University of Plymouth	Sanchez-Fernandez, D (corresponding author), Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain.	davidsan@um.es	Lobo, Jorge M/E-2309-2013; Sánchez-Fernández, David/J-2658-2012; Aragón, Pedro/B-2598-2009	Lobo, Jorge M/0000-0002-3152-4769; Aragón, Pedro/0000-0002-6849-7274; Bilton, David/0000-0003-1136-0848; Sanchez-Fernandez, David/0000-0003-1766-0761	Ministry of Economy and Competitiveness [CGL2011-255449]; program "Juan de la Cierva"; program "Ramon y Cajal"; Leverhulme Trust;  [CGL2011-25544]	Ministry of Economy and Competitiveness; program "Juan de la Cierva"; program "Ramon y Cajal"(Spanish Government); Leverhulme Trust(Leverhulme Trust); 	This study was partially supported by the Ministry of Economy and Competitiveness (Project Code: CGL2011-255449). D.S.-F. and P. A. were supported by the programs "Juan de la Cierva" and "Ramon y Cajal" respectively. The study was partially supported by the project CGL2011-25544. Physiological data used in this study was gathered under a project funded by the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-344; Angert AL, 2011, INTEGR COMP BIOL, V51, P733, DOI 10.1093/icb/icr048; Aragon P, 2010, J APPL ECOL, V47, P1026, DOI 10.1111/j.1365-2664.2010.01847.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Cabeza M, 2004, J APPL ECOL, V41, P252, DOI 10.1111/j.0021-8901.2004.00905.x; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; CASEY TM, 1992, AM ZOOL, V32, P225; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Colwell Robert K., 1992, P241; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Galewski K., 1971, Polskie Pismo Entomologiczne, V41, P487; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x; Krenek S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030598; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Martins EP, 2004, COMPUTER PROGRAMS ST; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson A. T., 2006, BIODIVERSITY INFORM, V3, P59, DOI DOI 10.17161/BI.V3I0.29; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Ruffo S., 2007, MEMORIE MUSEO CIVICO, P15; Rundle SD, 2007, FRESHWATER BIOL, V52, P471, DOI 10.1111/j.1365-2427.2006.01712.x; Sanchez-Fernandez D, 2008, DIVERS DISTRIB, V14, P754, DOI 10.1111/j.1472-4642.2008.00474.x; Sanchez-Fernandez D, 2012, GLOBAL ECOL BIOGEOGR, V21, P988, DOI 10.1111/j.1466-8238.2011.00743.x; Sanchez-Fernandez D, 2011, DIVERS DISTRIB, V17, P163, DOI 10.1111/j.1472-4642.2010.00716.x; Scott J.M., 2002, PREDICTING SPECIES O; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Somero George N., 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-1; Sorensen JG, 2001, FUNCT ECOL, V15, P289, DOI 10.1046/j.1365-2435.2001.00525.x; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Terblanche JS, 2006, AM J TROP MED HYG, V74, P786, DOI 10.4269/ajtmh.2006.74.786; Thompson K, 1999, J ECOL, V87, P150, DOI 10.1046/j.1365-2745.1999.00334.x; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Verdu J.R., 2008, INSECT ECOLOGY CONSE, P1; WHITTAKER RH, 1973, AM NAT, V107, P321, DOI 10.1086/282837; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4	59	28	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48163	10.1371/journal.pone.0048163	http://dx.doi.org/10.1371/journal.pone.0048163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133560	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800050
J	Carpignano, F; Silva, G; Surdo, S; Leva, V; Montecucco, A; Aredia, F; Scovassi, AI; Merlo, S; Barillaro, G; Mazzini, G				Carpignano, Francesca; Silva, Gloria; Surdo, Salvatore; Leva, Valentina; Montecucco, Alessandra; Aredia, Francesca; Scovassi, Anna Ivana; Merlo, Sabina; Barillaro, Giuseppe; Mazzini, Giuliano			A New Cell-Selective Three-Dimensional Microincubator Based on Silicon Photonic Crystals	PLOS ONE			English	Article							FIBROBLAST CELLS; CULTURE; SYSTEM; 3D	In this work, we show that vertical, high aspect-ratio (HAR) photonic crystals (PhCs), consisting of periodic arrays of 5 mu m wide gaps with depth of 50 mu m separated by 3 mu m thick silicon walls, fabricated by electrochemical micromachining, can be used as three-dimensional microincubators, allowing cell lines to be selectively grown into the gaps. Silicon micromachined dice incorporating regions with different surface profiles, namely flat silicon and deeply etched PhC, were used as microincubators for culturing adherent cell lines with different morphology and adhesion properties. We extensively investigated and compared the proliferative behavior on HAR PhCs of eight human cell models, with different origins, such as the epithelial (SW613-B3; HeLa; SW480; HCT116; HT29) and the mesenchymal (MRC-5V1; CF; HT1080). We also verified the contribution of cell sedimentation into the silicon gaps. Fluorescence microscopy analysis highlights that only cell lines that exhibit, in the tested culture condition, the behavior typical of the mesenchymal phenotype are able to penetrate into the gaps of the PhC, extending their body deeply in the narrow gaps between adjacent silicon walls, and to grow adherent to the vertical surfaces of silicon. Results reported in this work, confirmed in various experiments, strongly support our statement that such three-dimensional microstructures have selection capabilities with regard to the cell lines that can actively populate the narrow gaps. Cells with a mesenchymal phenotype could be exploited in the next future as bioreceptors, in combination with HAR PhC optical transducers, e. g., for label-free optical detection of cellular activities involving changes in cell adhesion and/or morphology (e.g., apoptosis) in a three-dimensional microenvironment.	[Carpignano, Francesca; Silva, Gloria; Merlo, Sabina] Univ Pavia, Dipartimento Ingn Ind & Informaz, I-27100 Pavia, Italy; [Surdo, Salvatore; Barillaro, Giuseppe] Univ Pisa, Dipartimento Ingn, Pisa, Italy; [Leva, Valentina; Montecucco, Alessandra; Aredia, Francesca; Scovassi, Anna Ivana; Mazzini, Giuliano] CNR, IGM, I-27100 Pavia, Italy; [Mazzini, Giuliano] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy	University of Pavia; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); University of Pavia	Merlo, S (corresponding author), Univ Pavia, Dipartimento Ingn Ind & Informaz, Via Palestro 3, I-27100 Pavia, Italy.	sabina.merlo@unipv.it	Surdo, Salvatore/P-3257-2019; Barillaro, Giuseppe/GVT-1597-2022; Barillaro, Giuseppe/B-9347-2018; Montecucco, Alessandra/B-8041-2015; Merlo, Sabina/B-2010-2017	Surdo, Salvatore/0000-0002-0779-5251; Barillaro, Giuseppe/0000-0001-6197-4851; Montecucco, Alessandra/0000-0002-9388-9149; Merlo, Sabina/0000-0003-2559-5939; Carpignano, Francesca/0000-0002-8579-2005; Scovassi, Anna Ivana/0000-0003-3484-9881	Fondazione Alma Mater Ticinensis, Pavia, Italy; Fondazione Adriano Buzzati Traverso, Italy	Fondazione Alma Mater Ticinensis, Pavia, Italy; Fondazione Adriano Buzzati Traverso, Italy	This work was supported by Fondazione Alma Mater Ticinensis, Pavia, Italy. V. Leva was supported by a postdoctoral fellowship from Fondazione Adriano Buzzati Traverso, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040293; Barillaro G, 2012, MICROFLUID NANOFLUID, V12, P545, DOI 10.1007/s10404-011-0896-0; Barillaro G, 2009, IEEE J SEL TOP QUANT, V15, P1359, DOI 10.1109/JSTQE.2009.2017278; Bassu M, 2012, ADV FUNCT MATER, V22, P1222, DOI 10.1002/adfm.201102124; Chambers KF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018796; Croce AC, 2004, BIOCHEM PHARMACOL, V67, P1035, DOI 10.1016/j.bcp.2003.10.034; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; HAWN MT, 1995, CANCER RES, V55, P3721; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hosseinkhani H, 2010, J BIOMED MATER RES A, V94A, P1, DOI 10.1002/jbm.a.32676; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; LAVIALLE C, 1988, ONCOGENE, V3, P335; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; MAZZINI G, 1983, CYTOMETRY, V3, P443, DOI 10.1002/cyto.990030610; Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0; Merlo S, 2012, J BIOPHOTONICS, V5, P785, DOI 10.1002/jbio.201100132; Merlo S, 2012, IEEE J SEL TOP QUANT, V18, P1215, DOI 10.1109/JSTQE.2011.2170662; Nikkhah M, 2010, BIOMATERIALS, V31, P4552, DOI 10.1016/j.biomaterials.2010.02.034; Nikkhah M, 2009, BIOMED MICRODEVICES, V11, P585, DOI 10.1007/s10544-008-9268-2; Nikkhah M, 2009, BIOMED MICRODEVICES, V11, P429, DOI 10.1007/s10544-008-9249-5; Ochsner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009445; Ormerod MG, 2000, FLOW CYTOMETRY PRACT, P83; Pampaloni F, 2009, BIOTECHNOL GENET ENG, V26, P129; Park TH, 2003, BIOTECHNOL PROGR, V19, P243, DOI 10.1021/bp020143k; Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Strobl JS, 2010, BIOMATERIALS, V31, P7043, DOI 10.1016/j.biomaterials.2010.05.023; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; Torisawa Y, 2005, BIOMATERIALS, V26, P2165, DOI 10.1016/j.biomaterials.2004.05.028; Valsasina B, 2012, MOL CANCER THER, V11, P1006, DOI 10.1158/1535-7163.MCT-11-0765; WILKINSON CDW, 1995, MICROELECTRON ENG, V27, P61, DOI 10.1016/0167-9317(94)00056-Z; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yeon JH, 2007, BIOCHIP J, V1, P17; ZIPPEL R, 1982, CYTOMETRY, V2, P426	36	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48556	10.1371/journal.pone.0048556	http://dx.doi.org/10.1371/journal.pone.0048556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139792	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300037
J	Seibt, J; Armant, O; Le Digarcher, A; Castro, D; Ramesh, V; Journot, L; Guillemot, F; Vanderhaeghen, P; Bouschet, T				Seibt, Julie; Armant, Olivier; Le Digarcher, Anne; Castro, Diogo; Ramesh, Vidya; Journot, Laurent; Guillemot, Francois; Vanderhaeghen, Pierre; Bouschet, Tristan			Expression at the Imprinted Dlk1-Gtl2 Locus Is Regulated by Proneural Genes in the Developing Telencephalon	PLOS ONE			English	Article							MOUSE TELENCEPHALON; PROGENITOR CELLS; STEM-CELLS; GTL2 GENE; BRAIN; SPECIFICATION; NEURONS; DIFFERENTIATION; NEUROGENESIS; NETWORK	Imprinting is an epigenetic mechanism that restrains the expression of about 100 genes to one allele depending on its parental origin. Several imprinted genes are implicated in neurodevelopmental brain disorders, such as autism, Angelman, and Prader-Willi syndromes. However, how expression of these imprinted genes is regulated during neural development is poorly understood. Here, using single and double KO animals for the transcription factors Neurogenin2 (Ngn2) and Achaete-scute homolog 1 (Ascl1), we found that the expression of a specific subset of imprinted genes is controlled by these proneural genes. Using in situ hybridization and quantitative PCR, we determined that five imprinted transcripts situated at the Dlk1-Gtl2 locus (Dlk1, Gtl2, Mirg, Rian, Rtl1) are upregulated in the dorsal telencephalon of Ngn2 KO mice. This suggests that Ngn2 influences the expression of the entire Dlk1-Gtl2 locus, independently of the parental origin of the transcripts. Interestingly 14 other imprinted genes situated at other imprinted loci were not affected by the loss of Ngn2. Finally, using Ngn2/Ascl1 double KO mice, we show that the upregulation of genes at the Dlk1-Gtl2 locus in Ngn2 KO animals requires a functional copy of Ascl1. Our data suggest a complex interplay between proneural genes in the developing forebrain that control the level of expression at the imprinted Dlk1-Gtl2 locus (but not of other imprinted genes). This raises the possibility that the transcripts of this selective locus participate in the biological effects of proneural genes in the developing telencephalon.	[Seibt, Julie; Vanderhaeghen, Pierre; Bouschet, Tristan] Univ Libre Bruxelles ULB, IRIBHM Inst Interdisciplinary Res, Brussels, Belgium; [Seibt, Julie] Campus Charite Mitte, Neurosci Res Ctr NWFZ, Berlin, Germany; [Armant, Olivier; Castro, Diogo; Ramesh, Vidya; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England; [Le Digarcher, Anne; Journot, Laurent; Bouschet, Tristan] Inst Genom Fonct, CNRS, UMR 5203, Montpellier, France; [Le Digarcher, Anne; Journot, Laurent; Bouschet, Tristan] INSERM, U661, Montpellier, France; [Le Digarcher, Anne; Journot, Laurent; Bouschet, Tristan] Univ Montpellier I, UMR 5203, Montpellier, France; [Le Digarcher, Anne; Journot, Laurent; Bouschet, Tristan] Univ Montpellier 2, UMR 5203, Montpellier, France; [Vanderhaeghen, Pierre] Univ Libre Bruxelles ULB, Welbio, Brussels, Belgium	Universite Libre de Bruxelles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite Libre de Bruxelles; WELBIO	Vanderhaeghen, P (corresponding author), Univ Libre Bruxelles ULB, IRIBHM Inst Interdisciplinary Res, Brussels, Belgium.	pvdhaegh@ulb.ac.be; Tristan.Bouschet@igf.cnrs.fr	Journot, Laurent/T-9652-2018; Bouschet, Tristan/C-8265-2019; Castro, Diogo S/I-6217-2016; Guillemot, Francois/AAV-1482-2021	Journot, Laurent/0000-0003-3499-8887; Bouschet, Tristan/0000-0002-7858-6115; Castro, Diogo S/0000-0001-8178-9565; Seibt, Julie/0000-0002-1081-9680; Vanderhaeghen, Pierre/0000-0001-7899-5720; Ramesh, Vidya/0000-0003-0375-7562; armant, olivier/0000-0001-7101-9209	Belgian Queen Elizabeth Medical Foundation; Fondation Universite Libre de Bruxelles (ULB); Fondation Pierre Clerdent; Fondation Roger de Spoelberch; Action de Recherches Concertees (ARC) Programs; Interuniversity Attraction Poles Program (IUAP), Belgian State, Federal Office for Scientific, Technical and Cultural Affairs; Belgian National Fund for Scientific Research (FNRS and FRSM); Marie Curie Fellowship; European Molecular Biology Organization (EMBO); Medical Research Council; MRC [MC_U117570528] Funding Source: UKRI; Medical Research Council [MC_U117570528] Funding Source: researchfish	Belgian Queen Elizabeth Medical Foundation; Fondation Universite Libre de Bruxelles (ULB); Fondation Pierre Clerdent; Fondation Roger de Spoelberch; Action de Recherches Concertees (ARC) Programs; Interuniversity Attraction Poles Program (IUAP), Belgian State, Federal Office for Scientific, Technical and Cultural Affairs; Belgian National Fund for Scientific Research (FNRS and FRSM)(Fonds de la Recherche Scientifique - FNRS); Marie Curie Fellowship(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the Belgian Queen Elizabeth Medical Foundation, the Fondations Universite Libre de Bruxelles (ULB), Pierre Clerdent, and Roger de Spoelberch, the Action de Recherches Concertees (ARC) Programs, the Interuniversity Attraction Poles Program (IUAP), Belgian State, Federal Office for Scientific, Technical and Cultural Affairs, the Belgian National Fund for Scientific Research (FNRS and FRSM) (to P.V), a Marie Curie Fellowship (to T.B.) and a Short-Term Fellowship from European Molecular Biology Organization (EMBO) (to J.S). The work in F.G.'s lab was supported by institutional funds from the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Casarosa S, 1999, DEVELOPMENT, V126, P525; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Chamberlain SJ, 2010, J NEUROSCI, V30, P9958, DOI 10.1523/JNEUROSCI.1728-10.2010; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dixit R, 2011, CEREB CORTEX; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Fode C, 2000, GENE DEV, V14, P67; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gordon FE, 2010, ENDOCRINOLOGY, V151, P2443, DOI 10.1210/en.2009-1151; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; GUILLEMOT F, 1993, CELL, V75, P1; Hampton DD, 2009, MAMM GENOME; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Sansom SN, 2005, DEVELOPMENT, V132, P3947, DOI 10.1242/dev.01968; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; SchusterGossler K, 1996, MAMM GENOME, V7, P20, DOI 10.1007/s003359900006; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Sha K, 2008, ANNU REV GENOM HUM G, V9, P197, DOI 10.1146/annurev.genom.122007.110031; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	38	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48675	10.1371/journal.pone.0048675	http://dx.doi.org/10.1371/journal.pone.0048675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139813	Green Published, gold			2022-12-25	WOS:000311315300052
J	Xiao, L; Joo, KI; Lim, M; Wang, P				Xiao, Liang; Joo, Kye-Il; Lim, Matthew; Wang, Pin			Dendritic Cell-Directed Vaccination with a Lentivector Encoding PSCA for Prostate Cancer in Mice	PLOS ONE			English	Article							LENTIVIRAL VECTORS; TRANSGENIC ADENOCARCINOMA; VIRAL VECTORS; POTENT CD8(+); SIPULEUCEL-T; ANTIGEN; IMMUNOTHERAPY; EXPRESSION; TRANSDUCTION; METASTASIS	Many studies have demonstrated that prostate stem cell antigen (PSCA) is an attractive target for immunotherapy based on its overexpression in prostate tumor tissue, especially in some metastatic tissues. In this study, we evaluated dendritic cell (DC)-directed lentiviral vector (DCLV) encoding murine PSCA (DCLV-PSCA) as a novel tumor vaccine for prostate cancer in mouse models. We showed that DCLV-PSCA could preferentially deliver the PSCA antigen gene to DC-SIGN-expressing 293T cells and bone marrow-derived DCs (BMDCs). Direct immunization with the DCLV-PSCA in male C57BL/6 mice elicited robust PSCA-responsive CD8(+) and CD4(+) T cells in vivo. In a transgenic adenocarcinoma mouse prostate cell line (TRAMP-C1) synergetic tumor model, we further demonstrated that DCLV-PSCA-vaccinated mice could be protected from lethal tumor challenge in a prophylactic model, whereas slower tumor growth was observed in a therapeutic model. This DCLV-PSCA vaccine also showed efficacy in inhibiting tumor metastases using a PSCA-expressing B16-F10 model. Taken together, these data suggest that DCLV is a potent vaccine carrier for PSCA in delivering anti-prostate cancer immunity.	[Xiao, Liang; Joo, Kye-Il; Lim, Matthew; Wang, Pin] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Wang, P (corresponding author), Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.	pinwang@usc.edu		Joo, Kye Il/0000-0001-8834-5561	National Institutes of Health [R01AI68978, P01CA132681]; Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE [P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (R01AI68978 and P01CA132681) and a translational acceleration grant from the Joint Center for Translational Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageichik A, 2008, MOL THER, V16, P1008, DOI 10.1038/mt.2008.95; Ahmad S, 2009, MOL THER, V17, P1101, DOI 10.1038/mt.2009.66; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Boudreau JE, 2011, MOL THER, V19, P841, DOI 10.1038/mt.2011.57; Breckpot K, 2007, GENE THER, V14, P847, DOI 10.1038/sj.gt.3302947; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Breckpot K, 2007, HUM GENE THER, V18, P536, DOI 10.1089/hum.2007.006; Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10; Brown BD, 2007, BLOOD, V109, P2797, DOI 10.1182/blood-2006-10-049312; Bruno TC, 2012, PROSTATE, V72, P514, DOI 10.1002/pros.21453; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Cui Y, 2002, BLOOD, V99, P399, DOI 10.1182/blood.V99.2.399; Dai BB, 2009, P NATL ACAD SCI USA, V106, P20382, DOI 10.1073/pnas.0911742106; Dannull J, 2000, CANCER RES, V60, P5522; Dullaers M, 2006, GENE THER, V13, P630, DOI 10.1038/sj.gt.3302697; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Foster BA, 1997, CANCER RES, V57, P3325; Garcia-Hernandez MD, 2008, CANCER RES, V68, P861, DOI 10.1158/0008-5472.CAN-07-0445; Gennari F, 2009, HUM GENE THER, V20, P554, DOI 10.1089/hum.2008.189; Goyvaerts C, 2012, GENE THER; Grabski E, 2011, MOL BIOTECHNOL, V47, P262, DOI 10.1007/s12033-010-9340-z; Graubert TA, 1996, CLIN CANCER RES, V2, P785; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Hu BL, 2010, VACCINE, V28, P6675, DOI 10.1016/j.vaccine.2010.08.012; Junco JA, 2007, VACCINE, V25, P8460, DOI 10.1016/j.vaccine.2007.09.033; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Karbach J, 2011, CLIN CANCER RES, V17, P861, DOI 10.1158/1078-0432.CCR-10-1811; Khanna R, 1998, IMMUNOL CELL BIOL, V76, P20, DOI 10.1046/j.1440-1711.1998.00717.x; Koya RC, 2007, MOL THER, V15, P971, DOI 10.1038/mt.sj.6300126; Lam JS, 2005, CLIN CANCER RES, V11, P2591, DOI 10.1158/1078-0432.CCR-04-1842; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lopes L, 2008, J VIROL, V82, P86, DOI 10.1128/JVI.01289-07; Marra E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-129; Moore ML, 2008, PROSTATE, V68, P139, DOI 10.1002/pros.20686; Morgenroth A, 2007, PROSTATE, V67, P1121, DOI 10.1002/pros.20608; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pantuck AJ, 2004, J IMMUNOTHER, V27, P240, DOI 10.1097/00002371-200405000-00009; Raff AB, 2009, CANCER LETT, V277, P126, DOI 10.1016/j.canlet.2008.08.034; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Ross S, 2002, CANCER RES, V62, P2546; Rossetti M, 2011, HUM GENE THER, V22, P177, DOI 10.1089/hum.2010.085; Saffran DC, 2001, P NATL ACAD SCI USA, V98, P2658, DOI 10.1073/pnas.051624698; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schroers R, 2000, MOL THER, V1, P171, DOI 10.1006/mthe.2000.0027; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tai A, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-1; Tan PH, 2005, BLOOD, V105, P3824, DOI 10.1182/blood-2004-10-3880; Tjoa BA, 1998, PROSTATE, V36, P39; Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x; Wei HF, 2008, CANCER RES, V68, P3854, DOI 10.1158/0008-5472.CAN-07-6051; Xiao L, 2012, VACCINE; Yang DM, 2001, CANCER RES, V61, P5857; Yang HG, 2011, CANCER GENE THER, V18, P370, DOI 10.1038/cgt.2011.13; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390; Zhigang Zhao, 2004, World J Surg Oncol, V2, P13, DOI 10.1186/1477-7819-2-13	61	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48866	10.1371/journal.pone.0048866	http://dx.doi.org/10.1371/journal.pone.0048866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139820	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300059
J	Campa, D; De Rango, F; Carrai, M; Crocco, P; Montesanto, A; Canzian, F; Rose, G; Rizzato, C; Passarino, G; Barale, R				Campa, Daniele; De Rango, Francesco; Carrai, Maura; Crocco, Paolina; Montesanto, Alberto; Canzian, Federico; Rose, Giuseppina; Rizzato, Cosmeri; Passarino, Giuseppe; Barale, Roberto			Bitter Taste Receptor Polymorphisms and Human Aging	PLOS ONE			English	Article							HUMAN LONGEVITY; GASTROINTESTINAL-TRACT; INDIVIDUAL-DIFFERENCES; GENE POLYMORPHISMS; MEDITERRANEAN DIET; CANCER PREVENTION; LIFE-SPAN; TAS2R38; PHENYLTHIOCARBAMIDE; NUTRITION	Several studies have shown that genetic factors account for 25% of the variation in human life span. On the basis of published molecular, genetic and epidemiological data, we hypothesized that genetic polymorphisms of taste receptors, which modulate food preferences but are also expressed in a number of organs and regulate food absorption processing and metabolism, could modulate the aging process. Using a tagging approach, we investigated the possible associations between longevity and the common genetic variation at the three bitter taste receptor gene clusters on chromosomes 5, 7 and 12 in a population of 941 individuals ranging in age from 20 to 106 years from the South of Italy. We found that one polymorphism, rs978739, situated 212 bp upstream of the TAS2R16 gene, shows a statistically significant association (p = 0.001) with longevity. In particular, the frequency of A/A homozygotes increases gradually from 35% in subjects aged 20 to 70 up to 55% in centenarians. These data provide suggestive evidence on the possible correlation between human longevity and taste genetics.	[Campa, Daniele; Canzian, Federico; Rizzato, Cosmeri] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [De Rango, Francesco; Crocco, Paolina; Montesanto, Alberto; Rose, Giuseppina; Passarino, Giuseppe] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; [Carrai, Maura; Barale, Roberto] Univ Pisa, Dept Biol, Pisa, Italy	Helmholtz Association; German Cancer Research Center (DKFZ); University of Calabria; University of Pisa	Campa, D (corresponding author), German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany.	d.campa@dkfz.de	Carrai, Maura/AGZ-4973-2022; Canzian, Federico/I-2804-2014; Campa, Daniele/K-1617-2016; Rizzato, Cosmeri/AAI-1261-2020; Crocco, Paolina/AAX-2695-2020; Montesanto, Alberto/J-8828-2016	Campa, Daniele/0000-0003-3220-9944; Montesanto, Alberto/0000-0002-9563-2216; crocco, paolina/0000-0001-7803-5340; Rose, Giuseppina/0000-0002-4264-4184; De Rango, Francesco/0000-0002-2328-8487; Canzian, Federico/0000-0002-4261-4583; BARALE, Roberto/0000-0003-4161-2241; Carrai, Maura/0000-0001-6663-0353	European Union's Seventh Framework Programme [259679]	European Union's Seventh Framework Programme	This research was partially funded from the European Union's Seventh Framework Programme (FP7/2007-2011) under the grant agreement 259679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; BARKER DJP, 1986, LANCET, V1, P1077; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Behrens M, 2010, RESULTS PROBL CELL D, V52, P87, DOI 10.1007/978-3-642-14426-4_8; Bell KI, 2006, AM J CLIN NUTR, V84, P245, DOI 10.1093/ajcn/84.1.245; Bhattacharya A, 2010, CARCINOGENESIS, V31, P2105, DOI 10.1093/carcin/bgq202; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Bonafe M, 2009, MOL CELL ENDOCRINOL, V299, P118, DOI 10.1016/j.mce.2008.10.038; Buckland G, 2011, BRIT J NUTR, V106, P1581, DOI 10.1017/S0007114511002078; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carrai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020464; Chang HK, 2006, BIOL PHARM BULL, V29, P1597, DOI 10.1248/bpb.29.1597; Chen Bowang, 2009, BMC Res Notes, V2, P214, DOI 10.1186/1756-0500-2-214; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Chung WH, 2010, AGEING RES REV, V9, pS67, DOI 10.1016/j.arr.2010.08.001; Cournil A, 2001, TRENDS GENET, V17, P233, DOI 10.1016/S0168-9525(01)02306-X; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Magalhaes JP, 2012, PHARMACOL REV, V64, P88, DOI 10.1124/pr.110.004499; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Feart C, 2010, CURR OPIN CLIN NUTR, V13, P14, DOI 10.1097/MCO.0b013e3283331fe4; Ferguson LR, 2008, ANNU REV NUTR, V28, P313, DOI 10.1146/annurev.nutr.28.061807.155449; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fontana L, 2009, CURR OPIN GASTROEN, V25, P144, DOI 10.1097/MOG.0b013e32831ef1ba; Ford JH, 2010, AGE, V32, P231, DOI 10.1007/s11357-009-9128-x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Garcia-Bailo B, 2009, OMICS, V13, P69, DOI 10.1089/omi.2008.0031; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gonzalez CA, 2006, NUTR CANCER, V56, P225, DOI 10.1207/s15327914nc5602_14; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Hanson MA, 2008, BASIC CLIN PHARMACOL, V102, P90, DOI 10.1111/j.1742-7843.2007.00186.x; Hausman DB, 2011, MATURITAS, V68, P203, DOI 10.1016/j.maturitas.2011.01.003; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Hayes JE, 2010, OBESITY, V18, P433, DOI 10.1038/oby.2009.351; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hinrichs AL, 2006, AM J HUM GENET, V78, P103, DOI 10.1086/499253; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Jenab M, 2009, HUM GENET, V125, P507, DOI 10.1007/s00439-009-0662-5; Keller KL, 2012, J FOOD SCI, V77, pS143, DOI 10.1111/j.1750-3841.2011.02585.x; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kerber RA, 2001, J GERONTOL A-BIOL, V56, pB130, DOI 10.1093/gerona/56.3.B130; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2005, CLIN GENET, V67, P275, DOI 10.1111/j.1399-0004.2004.00361.x; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Li F, 2012, MOL HUM REPROD; Li H, 2011, PHARMAZIE, V66, P306, DOI 10.1691/ph.2011.0785; Li H, 2011, HUM BIOL, V83, P363, DOI 10.3378/027.083.0303; Ljungquist B, 1998, J GERONTOL A-BIOL, V53, pM441, DOI 10.1093/gerona/53A.6.M441; Lumeng JC, 2008, OBESITY, V16, P1522, DOI 10.1038/oby.2008.227; Mangold JE, 2008, J MED GENET, V45, P578, DOI 10.1136/jmg.2008.057844; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Milazzo S., 2011, COCHRANE DB SYST REV, V11; Montesanto A, 2011, EUR J HUM GENET, V19, P882, DOI 10.1038/ejhg.2011.40; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Narasimhan SD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001377; Parrella E, 2010, THESCIENTIFICWORLDJO, V10, P161, DOI 10.1100/tsw.2010.8; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2000, RES PRO CEL, V29, P1; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Prodi DA, 2004, CHEM SENSES, V29, P697, DOI 10.1093/chemse/bjh074; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Slagboom PE, 2011, PHILOS T R SOC B, V366, P35, DOI 10.1098/rstb.2010.0284; Solfrizzi V, 2005, EXP GERONTOL, V40, P257, DOI 10.1016/j.exger.2005.01.001; Solfrizzi V, 2011, EXPERT REV NEUROTHER, V11, P677, DOI [10.1586/ERN.11.56, 10.1586/ern.11.56]; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Sternini C, 2007, AM J PHYSIOL-GASTR L, V292, pG457, DOI 10.1152/ajpgi.00411.2006; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2011, APPETITE, V56, P104, DOI 10.1016/j.appet.2010.11.144; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; Tognon G, 2011, AGE, V33, P439, DOI 10.1007/s11357-010-9193-1; Vlachojannis J, 2011, PHYTOTHER RES; Wang JC, 2007, ALCOHOL CLIN EXP RES, V31, P209, DOI 10.1111/j.1530-0277.2006.00297.x; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755; Willcox BJ, 2006, J GERONTOL A-BIOL, V61, P345, DOI 10.1093/gerona/61.4.345; Willcox DC, 2009, J AM COLL NUTR, V28, p500S, DOI 10.1080/07315724.2009.10718117; Wooding S, 2006, GENETICS, V172, P2015; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092	89	35	35	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e45232	10.1371/journal.pone.0045232	http://dx.doi.org/10.1371/journal.pone.0045232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133589	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400003
J	Drazen, JC; Bailey, DM; Ruhl, HA; Smith, KL				Drazen, Jeffrey C.; Bailey, David M.; Ruhl, Henry A.; Smith, Kenneth L., Jr.			The Role of Carrion Supply in the Abundance of Deep-Water Fish off California	PLOS ONE			English	Article							SEA MACROURID FISHES; PACIFIC HAKE; TIME-SERIES; CORYPHAENOIDES-ACROLEPIS; BATHYMETRIC DISTRIBUTION; EPIBENTHIC MEGAFAUNA; MERLUCCIUS-PRODUCTUS; COMMUNITY STRUCTURE; NORTHEAST ATLANTIC; FOOD LIMITATION	Few time series of deep-sea systems exist from which the factors affecting abyssal fish populations can be evaluated. Previous analysis showed an increase in grenadier abundance, in the eastern North Pacific, which lagged epibenthic megafaunal abundance, mostly echinoderms, by 9-20 months. Subsequent diet studies suggested that carrion is the grenadier's most important food. Our goal was to evaluate if changes in carrion supply might drive the temporal changes in grenadier abundance. We analyzed a unique 17 year time series of abyssal grenadier abundance and size, collected at Station M (4100 m, 220 km offshore of Pt. Conception, California), and reaffirmed the increase in abundance and also showed an increase in mean size resulting in a similar to 6 fold change in grenadier biomass. We compared this data with abundance estimates for surface living nekton (pacific hake and jack mackerel) eaten by the grenadiers as carrion. A significant positive correlation between Pacific hake (but not jack mackerel) and grenadiers was found. Hake seasonally migrate to the waters offshore of California to spawn. They are the most abundant nekton species in the region and the target of the largest commercial fishery off the west coast. The correlation to grenadier abundance was strongest when using hake abundance metrics from the area within 100 nmi of Station M. No significant correlation between grenadier abundance and hake biomass for the entire California current region was found. Given the results and grenadier longevity, migration is likely responsible for the results and the location of hake spawning probably is more important than the size of the spawning stock in understanding the dynamics of abyssal grenadier populations. Our results suggest that some abyssal fishes' population dynamics are controlled by the flux of large particles of carrion. Climate and fishing pressures affecting epipelagic fish stocks could readily modulate deep-sea fish dynamics.	[Drazen, Jeffrey C.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Bailey, David M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Ruhl, Henry A.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Smith, Kenneth L., Jr.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	University of Hawaii System; University of Glasgow; NERC National Oceanography Centre; University of Southampton; Monterey Bay Aquarium Research Institute	Drazen, JC (corresponding author), Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA.	jdrazen@hawaii.edu	Drazen, Jeffrey/C-1197-2013; Bailey, David/A-6240-2008	Drazen, Jeffrey/0000-0001-9613-3833; Bailey, David/0000-0002-0824-8823	National Science Foundation (NSF) [OCE 89-22620, OCE92-17334, OCE98-07103, OCE02-42472]; Univeristy of California, San Diego; Scripps Institution of Oceanography; David and Lucile Packard Foundation; Marie Curie fellowship (EU FP6); NSF [OCE-0727135]; NERC [noc010004, noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010004, noc010009] Funding Source: researchfish	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Univeristy of California, San Diego; Scripps Institution of Oceanography(University of California System); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Marie Curie fellowship (EU FP6); NSF(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by National Science Foundation (NSF) grants OCE 89-22620, OCE92-17334, OCE98-07103 and OCE02-42472 as well as funding from the Univeristy of California, San Diego, Scripps Institution of Oceanography and the David and Lucile Packard Foundation to K. Smith, a Marie Curie fellowship (EU FP6) to D. Bailey, and NSF grant OCE-0727135 to J. Drazen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini VN, 2006, CAN J FISH AQUAT SCI, V63, P2648, DOI 10.1139/F06-139; Anderson ME, 2005, AFR J MAR SCI, V27, P557, DOI 10.2989/18142320509504116; Andrews AH, 1999, CAN J FISH AQUAT SCI, V56, P1339, DOI 10.1139/cjfas-56-8-1339; [Anonymous], MAR FISH REV; Bailey DM, 2009, P ROY SOC B-BIOL SCI, V276, P1965, DOI 10.1098/rspb.2009.0098; Bailey DM, 2006, ECOLOGY, V87, P549, DOI 10.1890/04-1832; Bailey DM, 2003, J EXP MAR BIOL ECOL, V285, P295, DOI 10.1016/S0022-0981(02)00534-8; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beamish RJ, 2005, DEEP-SEA RES PT II, V52, P739, DOI 10.1016/j.dsr2.2004.12.016; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bjelland O, 2000, SARSIA, V85, P101, DOI 10.1080/00364827.2000.10414561; Boyle MD, 2012, J FISH BIOL, V80, P1485, DOI 10.1111/j.1095-8649.2012.03243.x; BRITTON JC, 1994, OCEANOGR MAR BIOL, V32, P369; Brodeur RD, 2005, MAR ECOL PROG SER, V298, P41, DOI 10.3354/meps298041; Brodeur RD, 2003, J OCEANOGR, V59, P515, DOI 10.1023/A:1025548801541; Catchpole TL, 2006, MAR ECOL PROG SER, V313, P215, DOI 10.3354/meps313215; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; CLARKE MR, 1972, J MAR BIOL ASSOC UK, V52, P599, DOI 10.1017/S0025315400021603; Collins MA, 1999, J MAR BIOL ASSOC UK, V79, P963, DOI 10.1017/S0025315499001198; CRABTREE RE, 1991, DEEP-SEA RES, V38, P1277, DOI 10.1016/0198-0149(91)90027-D; Drazen JC, 2002, J FISH BIOL, V60, P1280, DOI 10.1006/jfbi.2002.1943; Drazen JC, 2002, MAR BIOL, V140, P677, DOI 10.1007/s00227-001-0747-8; Drazen JC, 2001, DEEP-SEA RES PT I, V48, P909, DOI 10.1016/S0967-0637(00)00058-3; Drazen JC, 1998, DEEP-SEA RES PT II, V45, P893, DOI 10.1016/S0967-0645(98)00007-1; Drazen JC, 2012, DEEP-SEA RES PT I, V61, P34, DOI 10.1016/j.dsr.2011.11.002; Drazen JC, 2009, MAR ECOL PROG SER, V387, P1, DOI 10.3354/meps08106; Drazen JC, 2008, LIMNOL OCEANOGR, V53, P2644, DOI 10.4319/lo.2008.53.6.2644; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fleischer GW, 2005, NOAA TECH MEMO NMFS, V65, P1; Francis RICC, 2005, B MAR SCI, V76, P337; Gartner John V. Jr, 1997, P115; GUNN JS, 1989, AUST J MAR FRESH RES, V40, P97; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Horne JK, 1997, CAL COOP OCEAN FISH, V38, P90; ISAACS JD, 1975, SCI AM, V233, P85; Jamieson AJ, 2011, DEEP-SEA RES PT I, V58, P49, DOI 10.1016/j.dsr.2010.11.003; Jones EG, 2003, MAR ECOL PROG SER, V251, P75, DOI 10.3354/meps251075; Jones MRL, 2008, NEW ZEAL J MAR FRESH, V42, P73, DOI 10.1080/00288330809509937; Kaiser MJ, 2007, MAR ECOL PROG SER, V350, P267, DOI 10.3354/meps07194; King NJ, 2008, AM FISH S S, V63, P139; King NJ, 2008, J FISH BIOL, V72, P1804, DOI 10.1111/j.1095-8649.2008.01834.x; King NJ, 2006, MAR ECOL PROG SER, V319, P263, DOI 10.3354/meps319263; KOSLOW JA, 1995, MAR FRESHWATER RES, V46, P819, DOI 10.1071/MF9950819; Laptikhovsky V, 1999, FISH RES, V41, P93, DOI 10.1016/S0165-7836(98)00228-8; Lauerman LML, 1996, DEEP-SEA RES PT I, V43, P1075, DOI 10.1016/0967-0637(96)00045-3; Lorance P., 2003, Journal of Northwest Atlantic Fishery Science, V31, P387; Maccall A.D., 1983, California Cooperative Oceanic Fisheries Investigations Reports, V24, P46; MACEWICZ BJ, 1993, CAL COOP OCEAN FISH, V34, P112; Martin B, 1997, DEEP-SEA RES PT I, V44, P541, DOI 10.1016/S0967-0637(97)00008-3; MASON JC, 1986, FISH B-NOAA, V84, P209; MAUCHLINE J, 1984, J MAR BIOL ASSOC UK, V64, P657, DOI 10.1017/S0025315400030320; Mehault S, 2010, FISH RES, V104, P111, DOI 10.1016/j.fishres.2010.03.019; Murua H, 2010, FISH RES, V104, P100, DOI 10.1016/j.fishres.2009.06.007; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; PAULY D, 1988, ENVIRON BIOL FISH, V22, P261, DOI 10.1007/BF00004892; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PEARCY WG, 1974, DEEP-SEA RES, V21, P745, DOI 10.1016/0011-7471(74)90081-3; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; PRIEDE IG, 1994, LIMNOL OCEANOGR, V39, P279, DOI 10.4319/lo.1994.39.2.0279; Priede IG, 2003, J FISH BIOL, V63, P187, DOI 10.1046/j.1095-8649.2003.00142.x; Priede IG, 2000, OCEANOGR MAR BIOL, V38, P357; PRIEDE IG, 1991, NATURE, V351, P647, DOI 10.1038/351647a0; Priede IG, 2010, MAR ECOL-EVOL PERSP, V31, P247, DOI 10.1111/j.1439-0485.2009.00330.x; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Ruhl HA, 2004, SCIENCE, V305, P513, DOI 10.1126/science.1099759; Ruhl HA, 2008, P NATL ACAD SCI USA, V105, P17006, DOI 10.1073/pnas.0803898105; Ruhl HA, 2007, ECOLOGY, V88, P1250, DOI 10.1890/06-0890; Ruxton GD, 2005, DEEP-SEA RES PT I, V52, P1536, DOI 10.1016/j.dsr.2005.02.008; Ryan AW, 2005, ICES J MAR SCI, V62, P948, DOI 10.1016/j.icesjms.2005.03.006; Sakuma KM, 2006, CAL COOP OCEAN FISH, V47, P127; Seibel BA, 2005, NATURE, V438, P929, DOI 10.1038/438929a; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Smith CR, 2006, BIGGER IS BETTER ROL, P284; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Smith KL, 2008, LIMNOL OCEANOGR, V53, P2655, DOI 10.4319/lo.2008.53.6.2655; Smith KL, 1998, DEEP-SEA RES PT II, V45, P573, DOI 10.1016/S0967-0645(97)00094-5; Soltwedel T, 2003, OCEANOL ACTA, V26, P623, DOI 10.1016/S0399-1784(03)00060-4; Stewart IJ, 2011, STATUS PACIFIC HAKE; STOCKTON WL, 1982, DEEP-SEA RES, V29, P157, DOI 10.1016/0198-0149(82)90106-6; Theilacker GH, 1985, FISHERY B, V84, P1; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; WILSON RR, 1983, DEEP-SEA RES, V30, P1127, DOI 10.1016/0198-0149(83)90092-4; Witte U, 1999, MAR ECOL PROG SER, V183, P139, DOI 10.3354/meps183139; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yeh J, 2011, MAR ECOL PROG SER, V424, P145, DOI 10.3354/meps08972; Yeh J, 2009, DEEP-SEA RES PT I, V56, P251, DOI 10.1016/j.dsr.2008.08.005; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104; ZELDIS JR, 1993, B MAR SCI, V53, P864	91	27	27	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e49332	10.1371/journal.pone.0049332	http://dx.doi.org/10.1371/journal.pone.0049332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133679	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000310702400058
J	Molusky, MM; Ma, D; Buelow, K; Yin, L; Lin, JDD				Molusky, Matthew M.; Ma, Di; Buelow, Katie; Yin, Lei; Lin, Jiandie D.			Peroxisomal Localization and Circadian Regulation of Ubiquitin-Specific Protease 2	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; ENERGY-METABOLISM; HEPATIC STEATOSIS; GENE-EXPRESSION; LIVER; TRANSCRIPTION; RHYTHM; CLOCK; MOUSE; PGC-1	Temporal regulation of nutrient and energy metabolism is emerging as an important aspect of metabolic homeostasis. The regulatory network that integrates the timing cues and nutritional signals to drive diurnal metabolic rhythms remains poorly defined. The 45-kDa isoform of ubiquitin-specific protease 2 (USP2-45) is a deubiquitinase that regulates hepatic gluconeogenesis and glucose metabolism. In this study, we found that USP2-45 is localized to peroxisomes in hepatocytes through a canonical peroxisome-targeting motif at its C-terminus. Clustering analysis indicates that the expression of a subset of peroxisomal genes exhibits robust diurnal rhythm in the liver. Despite this, nuclear hormone receptor PPAR alpha, a known regulator of peroxisome gene expression, does not induce USP2-45 in hepatocytes and is dispensible for its expression during starvation. In contrast, a functional liver clock is required for the proper nutritional and circadian regulation of USP2-45 expression. At the molecular level, transcriptional coactivators PGC-1 alpha and PGC-1 beta and repressor E4BP4 exert opposing effects on USP2-45 promoter activity. These studies provide insights into the subcellular localization and transcriptional regulation of a clock-controlled deubiquitinase that regulates glucose metabolism.	[Molusky, Matthew M.; Ma, Di; Lin, Jiandie D.] Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA; [Molusky, Matthew M.; Ma, Di; Lin, Jiandie D.] Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Buelow, Katie; Yin, Lei] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, JDD (corresponding author), Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA.	jdlin@umich.edu		Buelow, Katie/0000-0002-2616-1756	United States National Institutes of Health [DK077086, HL097738]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077086, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health (DK077086 and HL097738, J.D.L.). D. M. was supported by predoctoral fellowship from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bedard N, 2011, BIOL REPROD, V85, P594, DOI 10.1095/biolreprod.110.088542; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; CELLA LK, 1995, AM J PHYSIOL-ENDOC M, V269, pE489, DOI 10.1152/ajpendo.1995.269.3.E489; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Kulozik P, 2011, CELL METAB, V13, P389, DOI 10.1016/j.cmet.2011.02.011; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Li SM, 2011, MOL ENDOCRINOL, V25, P2084, DOI 10.1210/me.2011-1227; Li SM, 2009, J APPL PHYSIOL, V107, P1959, DOI 10.1152/japplphysiol.00467.2009; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Molusky Matthew M, 2012, Diabetes, V61, P1025, DOI 10.2337/db11-0970; MUNDAY MR, 1983, BIOCHEM J, V214, P183, DOI 10.1042/bj2140183; ORTH DN, 1969, J CLIN ENDOCR METAB, V29, P479, DOI 10.1210/jcem-29-4-479; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; PHILLIPS LJ, 1970, AM J PHYSIOL, V218, P1440, DOI 10.1152/ajplegacy.1970.218.5.1440; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Scoma HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025382; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; SOLLBERGER A, 1964, ANN NY ACAD SCI, V117, P519, DOI 10.1111/j.1749-6632.1964.tb48204.x; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; UCHIYAMA Y, 1984, CELL TISSUE RES, V236, P305; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	67	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47970	10.1371/journal.pone.0047970	http://dx.doi.org/10.1371/journal.pone.0047970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133608	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400019
J	Sedykh, SE; Buneva, VN; Nevinsky, GA				Sedykh, Sergey E.; Buneva, Valentina N.; Nevinsky, Georgy A.			Human Milk sIgA Molecules Contain Various Combinations of Different Antigen-Binding Sites Resulting in a Multiple Binding Specificity of Antibodies and Enzymatic Activities of Abzymes	PLOS ONE			English	Article							NUCLEOTIDE-HYDROLYZING ANTIBODIES; SECRETORY IMMUNOGLOBULIN-A; KINASE-ACTIVITY; IGG	In the classic paradigm, immunoglobulins are monospecific molecules that have stable structures and two or more identical antigen-binding sites. However, we show here for the first time that the sIgA pool of human milk contains, depending on the donor, only 35 +/- 5% lambda-sIgAs, 48 +/- 7% kappa-sIgAs, and 17 +/- 4% of chimeric lambda-kappa-sIgAs. sIgA preparations contained no traces of canonical enzymes. However, all sIgA fractions eluted from several specific affinity sorbents under the conditions destroying even strong immune complexes demonstrated high catalytic activities in hydrolysis of ATP, DNA, and oligosaccharides, and phosphorylation of proteins, lipids, and oligosaccharides. Sequential re-chromatographies of the sIgA fractions with high affinity to one affinity sorbents on the second, third and then fourth affinity sorbents bearing other immobilized antigens led to the distribution of Abs and all catalytic activities all over the profiles of these chromatographies; in all cases some fractions eluted from affinity sorbents only under the conditions destroying strong immune complexes. In vitro, only an addition of reduced glutathione and milk plasma containing no Abs to two sIgA fractions with different affinity for DNA-cellulose led to a transition of up to 11-20% of Ab from one fraction to the other. Our data are indicative of the possibility of half-molecule exchange between different IgA and sIgA molecules. In addition, it cannot be excluded that during the penetration of IgAs through the specific milk barrier, the secretory component (S) and the join chain (J) can combine molecules of dimeric H2L2 lambda-IgAs and kappa-IgAs against different antigens forming many different variants of H(4)L(4)SJ sIgA molecules. Therefore, some chimeric molecules of sIgA can contain from two to four HL-fragments to various antigens interacting with high affinity with different sorbents and catalyzing various chemical reactions. Our data essentially expand the ideas concerning explanation of the phenomenon of polyspecificity and cross-reactivity of Abs.	[Sedykh, Sergey E.; Buneva, Valentina N.; Nevinsky, Georgy A.] Russian Acad Sci, Siberian Div, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Nevinsky, GA (corresponding author), Russian Acad Sci, Siberian Div, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.	nevinsky@niboch.nsc.ru	Nevinsky, Georgy/E-6053-2012; Sedykh, Sergey/C-9881-2013; Buneva, Valentina Nikolaevna/I-6329-2012	Sedykh, Sergey/0000-0003-0882-8171; Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Menzorova, Natalia/0000-0002-2616-7023	Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program) [6.7]; Russian Foundation for Basic Research [10-04-00281]; Siberian Division of the Russian Academy of Sciences	Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Siberian Division of the Russian Academy of Sciences(Russian Academy of Sciences)	This research was made possible in part by grants from the Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, No. 6.7), Russian Foundation for Basic Research (10-04-00281), and funds from the Siberian Division of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; AMINO N, 1982, NEW ENGL J MED, V306, P849, DOI 10.1056/NEJM198204083061405; Andryushkova AA, 2009, INT IMMUNOL, V21, P935, DOI 10.1093/intimm/dxp060; Buneva VN, 2003, BIOCHEMISTRY-MOSCOW+, V68, P890, DOI 10.1023/A:1025703132523; Buneva VN, 1998, APPL BIOCHEM BIOTECH, V75, P63, DOI 10.1007/BF02787709; David B.S., 2005, CATALYTIC ANTIBODIES, P1; Fersht AR., 1977, ENZYME STRUCTURE MEC; FEY H, 1973, VOX SANG, V25, P245, DOI 10.1111/j.1423-0410.1973.tb04369.x; Gorbunov DV, 2005, BBA-MOL CELL BIOL L, V1735, P153, DOI 10.1016/j.bbalip.2005.06.007; Hanson Lars A., 1994, Acta Paediatrica Japonica, V36, P557; IZADYAR L, 1993, P NATL ACAD SCI USA, V90, P8876, DOI 10.1073/pnas.90.19.8876; KALAGA R, 1995, J IMMUNOL, V155, P2695; Kanyshkova TG, 1997, FEBS LETT, V416, P23, DOI 10.1016/S0014-5793(97)01163-0; Karataeva NA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1207, DOI 10.1134/S000629790611006X; Karataeva NA, 2006, IMMUNOL LETT, V103, P58, DOI 10.1016/j.imlet.2005.10.009; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; MESTECKY J, 1986, CLIN IMMUNOL IMMUNOP, V40, P105, DOI 10.1016/0090-1229(86)90073-5; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Nevinsky G.A., 2010, AUTOIMMUNE DIS SYMPT, P1; Nevinsky G.A., 2011, UNDERSTANDING HIVAID, P151, DOI DOI 10.5772/22294; Nevinsky G.A., 2005, CATALYTIC ANTIBODIES, P503; Nevinsky G.A., 2003, PROTEIN STRUCTURES K, P133; Nevinsky GA, 1998, APPL BIOCHEM BIOTECH, V75, P77, DOI 10.1007/BF02787710; Nevinsky GA, 2000, APPL BIOCHEM BIOTECH, V83, P115, DOI 10.1385/ABAB:83:1-3:115; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Odintsova ES, 2011, J MOL RECOGNIT, V24, P45, DOI 10.1002/jmr.1022; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Rispens T, 2010, MOL IMMUNOL, V47, P1592, DOI 10.1016/j.molimm.2010.02.021; Savel'ev AN, 2001, CLIN CHIM ACTA, V314, P141, DOI 10.1016/S0009-8981(01)00691-X; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Sedykh SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042942; Semenov DV, 2004, MED SCI MONITOR, V10, pBR23; Tanaka A, 2000, LIVER TRANSPLANT, V6, P138, DOI 10.1002/lt.500060225; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015	35	9	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48756	10.1371/journal.pone.0048756	http://dx.doi.org/10.1371/journal.pone.0048756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133657	Green Submitted, Green Published, gold			2022-12-25	WOS:000310702400046
J	Guo, X; Huang, X; Wu, YS; Liu, DH; Lu, HL; Kim, YC; Xu, WX				Guo, Xin; Huang, Xu; Wu, Yi-song; Liu, Dong-hai; Lu, Hong-li; Kim, Yong-chul; Xu, Wen-xie			Down-Regulation of Hydrogen Sulfide Biosynthesis Accompanies Murine Interstitial Cells of Cajal Dysfunction in Partial Ileal Obstruction	PLOS ONE			English	Article							NF-KAPPA-B; SMOOTH-MUSCLE; MUSCULARIS INFLAMMATION; SMALL-INTESTINE; TNF-ALPHA; MOTILITY; RAT; EXPRESSION; NUMBER; MICE	Purpose: To investigate the role of endogenous hydrogen sulfide (H2S) in partial obstruction-induced dysfunction of the interstitial cells of Cajal (ICC) in mice ileum. Materials and Methods: Partial intestinal obstruction was induced surgically in male imprinting control region (ICR) mice. ICC networks were studied by Immunohistochemistry. Electrical activity was recorded by intracellular recording techniques. The expression of ICC phenotype marker c-kit receptor tyrosine kinase (c-kit), membrane binding stem cell factor (mSCF), the endogenous H2S biosynthesis enzymes cystathionine-beta-synthase (CBS) and cystathionine-c-lyase (CSE) was studied by Western blotting. The expression of tumor necrosis factor-alpha (TNF-alpha) mRNA was observed by using real-time polymerase chain reaction. Results: Partial intestinal obstruction resulted in ICC networks were disrupted above obstruction 14 days after the operation. The slow waves of intestinal smooth muscles in the dilated region were significantly suppressed and their amplitude and frequency were reduced, whilst the resting membrane potentials were depolarized. The expression of c-kit and mSCF was significantly decreased, also suggesting the disruption of the ICC network. The expression of TNF-alpha was significantly increased in the tunica muscularis of the obstructed intestine. Treatment of cultured intestinal smooth muscle cells with TNF-alpha caused dramatic down regulation of mSCF. The expression of CBS and CSE was significantly decreased in the tunica muscularis of the obstructed intestine. Intraperitoneal injection (i.p) of DL-propargylglycine, an irreversible inhibitor of CSE, and aminooxyacetic acid, an inhibitor of CBS, elevated the expression of TNF-alpha mRNA in the tunica muscularis of the ileum. Obstruction-induced over expression of TNF-alpha was significantly improved by supplementation of NaHS, but not the expressions of mSCF and c-kit. Conclusions: The down regulation of endogenous H2S biosynthesis is related to over expression of TNF-alpha in obstructed small intestine. TNF-alpha-mediated mSCF down-regulation is not the only reason of partial intestinal obstruction-induced loss of ICC.	[Guo, Xin; Huang, Xu; Wu, Yi-song; Liu, Dong-hai; Lu, Hong-li; Xu, Wen-xie] Shanghai Jiao Tong Univ, Dept Physiol, Sch Med, Shanghai 200030, Peoples R China; [Guo, Xin] Nantong Univ, Affiliated Hosp, Dept Urol, Nantong, Peoples R China; [Kim, Yong-chul] Chungbuk Natl Univ, Coll Med, Dept Physiol, Cheongju, South Korea	Shanghai Jiao Tong University; Nantong University; Chungbuk National University	Xu, WX (corresponding author), Shanghai Jiao Tong Univ, Dept Physiol, Sch Med, Shanghai 200030, Peoples R China.	wenxiexu@sjtu.edu.cn			National Natural Science Foundation of China [31171107, 10672103, 31071011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 31171107; 10672103; 31071011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Chitkara DK, 2006, NEUROGASTROENT MOTIL, V18, P251, DOI 10.1111/j.1365-2982.2005.00751.x; Ekblad E, 1998, GUT, V42, P836, DOI 10.1136/gut.42.6.836; GABELLA G, 1990, ANAT EMBRYOL, V182, P409; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Goto K, 2009, J PHARMACOL SCI, V110, P437, DOI 10.1254/jphs.09081FP; He CL, 2001, GASTROENTEROLOGY, V121, P427, DOI 10.1053/gast.2001.26264; Hirata I, 2011, DIGEST DIS SCI, V56, P1379, DOI 10.1007/s10620-010-1461-5; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Huizinga JD, 2009, GASTROENTEROLOGY, V137, P1548, DOI 10.1053/j.gastro.2009.09.023; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Iwasaki H, 2006, J GASTROENTEROL, V41, P1076, DOI 10.1007/s00535-006-1909-8; Jones MP, 2006, CURR OPIN GASTROEN, V22, P111, DOI 10.1097/01.mog.0000203867.33008.52; Kalayarasan S, 2008, LIFE SCI, V82, P1142, DOI 10.1016/j.lfs.2008.03.018; Kilic A, 2008, DIGEST DIS SCI, V53, P1488, DOI 10.1007/s10620-007-0053-5; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Sandgren K, 2002, DIGEST DIS SCI, V47, P1049, DOI 10.1023/A:1015085923245; Storkholm JH, 2007, DIGEST DIS SCI, V52, P336, DOI 10.1007/s10620-006-9431-7; Suzuki T, 2004, AM J PHYSIOL-GASTR L, V287, pG638, DOI 10.1152/ajpgi.00077.2004; Tan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025943; Wang XY, 2009, J CELL MOL MED, V13, P3528, DOI 10.1111/j.1582-4934.2009.00689.x; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Won KJ, 2006, NEUROGASTROENT MOTIL, V18, P53, DOI 10.1111/j.1365-2982.2005.00718.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yin JY, 2006, DIGEST DIS SCI, V51, P1818, DOI 10.1007/s10620-006-9313-z; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje	33	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48249	10.1371/journal.pone.0048249	http://dx.doi.org/10.1371/journal.pone.0048249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133623	Green Submitted, Green Published, gold			2022-12-25	WOS:000310601300009
J	Niu, N; Zhang, J; Huang, T; Sun, YG; Chen, ZS; Yi, WN; Korteweg, C; Wang, JP; Gu, J				Niu, Na; Zhang, Jie; Huang, Tao; Sun, Yingui; Chen, Zhengshan; Yi, Weining; Korteweg, Christine; Wang, Juping; Gu, Jiang			IgG Expression in Human Colorectal Cancer and Its Relationship to Cancer Cell Behaviors	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; IMMUNOLOGICAL ENHANCEMENT; POOR-PROGNOSIS; TUMOR-CELLS; GROWTH; ANTIBODY; MARKERS; ANTIGEN; LINES; PROLIFERATION	Increasing evidence indicates that various cancer cell types are capable of producing IgG. The exact function of cancer-derived IgG has, however, not been elucidated. Here we demonstrated the expression of IgG genes with V(D)J recombination in 80 cases of colorectal cancers, 4 colon cancer cell lines and a tumor bearing immune deficient mouse model. IgG expression was associated with tumor differentiation, pTNM stage, lymph node involvement and inflammatory infiltration and positively correlated with the expressions of Cyclin D1, NF-kappa B and PCNA. Furthermore, we investigated the effect of cancer-derived IgG on the malignant behaviors of colorectal cancer cells and showed that blockage of IgG resulted in increased apoptosis and negatively affected the potential for anchor-independent colony formation and cancer cell invasion. These findings suggest that IgG synthesized by colorectal cancer cells is involved in the development and growth of colorectal cancer and blockage of IgG may be a potential therapy in treating this cancer.	[Huang, Tao; Chen, Zhengshan; Korteweg, Christine; Wang, Juping; Gu, Jiang] Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China; [Niu, Na] Weifang Med Univ, Dept Pathol, Weifang, Peoples R China; [Zhang, Jie] Weifang Med Univ, Dept Human Anat, Weifang, Peoples R China; [Sun, Yingui] Weifang Med Univ, Dept Anesthesia, Weifang, Peoples R China; [Yi, Weining] Peking Univ, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China	Shantou University; Weifang Medical University; Weifang Medical University; Weifang Medical University; Peking University	Gu, J (corresponding author), Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China.	jguemailbox@gmail.com	Chen, Zhengshan/J-7499-2014; Huang, Tao/AHE-8511-2022; Niu, Na/A-2915-2016	Niu, Na/0000-0003-1016-7851; Gu, Jiang/0000-0002-0706-8329	Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province [BS2011SW051]; National Natural Science Foundation of China [81100885, 30971150]	Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Young and Middle-Aged Scientists Research Awards Fundation of Shandong Province (No. BS2011SW051), and National Natural Science Foundation of China to NN (No. 81100885). The authors also acknowledge National Natural Science Foundation of China to JG (No. 30971150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Chen ZS, 2010, CANCER-AM CANCER SOC, V116, P1953, DOI 10.1002/cncr.24892; Curran S, 2004, CLIN CANCER RES, V10, P8229, DOI 10.1158/1078-0432.CCR-04-0424; Deng R, 2008, J PATHOL, V216, P328, DOI 10.1002/path.2417; Deng Yu-qing, 2006, Zhonghua Zhongliu Zazhi, V28, P88; DOE WF, 1989, GUT, V30, P1679, DOI 10.1136/gut.30.12.1679; Flatmark K, 2004, EUR J CANCER, V40, P1593, DOI 10.1016/j.ejca.2004.02.023; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; GOUGH I, 1981, AUST NZ J SURG, V51, P440, DOI 10.1111/j.1445-2197.1981.tb05979.x; Huang J, 2008, INT J BIOCHEM CELL B, V40, P1604, DOI 10.1016/j.biocel.2007.12.004; Ioachim E, 2008, INT J CLIN PRACT, V62, P1736, DOI 10.1111/j.1742-1241.2006.01105.x; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; KVALE D, 1987, CANCER, V59, P203, DOI 10.1002/1097-0142(19870115)59:2<203::AID-CNCR2820590204>3.0.CO;2-P; Lee G, 2012, CANCER IMMUNOL IMMUN, V61, P89, DOI 10.1007/s00262-011-1088-1; Lee G, 2009, CANCER BIOL THER, V8, P161, DOI 10.4161/cbt.8.2.7117; Lee G, 2008, CANCER BIOL THER, V7, P2007, DOI 10.4161/cbt.7.12.6984; Lyall MS, 2006, CLIN CANCER RES, V12, P1184, DOI 10.1158/1078-0432.CCR-05-1864; Maloney EK, 2003, CANCER RES, V63, P5073; MANSON LA, 1994, CLIN IMMUNOL IMMUNOP, V72, P1, DOI 10.1006/clin.1994.1099; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Niu N, 2011, INT J BIOCHEM CELL B, V43, P556, DOI 10.1016/j.biocel.2010.12.012; Niu N, 2011, CELL MOL LIFE SCI, V68, P2481, DOI 10.1007/s00018-010-0572-7; Niu N, 2009, LAB INVEST, V89, P636, DOI 10.1038/labinvest.2009.28; Olubuyide I O, 1993, Afr J Med Med Sci, V22, P57; PREHN RT, 1994, CANCER RES, V54, P908; Qiu XY, 2003, CANCER RES, V63, P6488; Schreiber H, 2000, SEMIN CANCER BIOL, V10, P351, DOI 10.1006/scbi.2000.0331; SJOGREN HO, 1971, P NATL ACAD SCI USA, V68, P1372, DOI 10.1073/pnas.68.6.1372; STACH RM, 1993, J EXP MED, V178, P841, DOI 10.1084/jem.178.3.841; Sun XF, 1996, INT J CANCER, V69, P5, DOI 10.1002/(SICI)1097-0215(19960220)69:1<5::AID-IJC2>3.0.CO;2-8; Taylor DD, 1998, ONCOL REP, V5, P1519; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Webber MM, 1995, CLIN CANCER RES, V1, P1089; Zheng H, 2007, CELL BIOL INT, V31, P82, DOI 10.1016/j.cellbi.2006.09.009; Zheng S, 2001, Zhonghua Yi Xue Za Zhi, V81, P485; Zhu XH, 2008, APPL IMMUNOHISTO M M, V16, P232, DOI 10.1097/PAI.0b013e31814c915a; Zlobec I, 2008, J CLIN PATHOL, V61, P561, DOI 10.1136/jcp.2007.054858	39	62	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e47362	10.1371/journal.pone.0047362	http://dx.doi.org/10.1371/journal.pone.0047362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133595	Green Published, gold, Green Submitted			2022-12-25	WOS:000310601300001
J	Riva, S; Monti, M; Iannello, P; Antonietti, A				Riva, Silvia; Monti, Marco; Iannello, Paola; Antonietti, Alessandro			The Representation of Risk in Routine Medical Experience: What Actions for Contemporary Health Policy?	PLOS ONE			English	Article							PATIENT TRUST; PERCEPTION; BENEFITS; CHOICES; DRUGS; SAFE	Background: The comprehension of appropriate information about illnesses and treatments, can have beneficial effects on patients' satisfaction and on important health outcomes. However, it is questionable whether people are able to understand risk properly. Aim: To describe patients' representation of risk in common medical experiences by linking such a representation to the concept of trust. A further goal was to test whether the representation of risk in the medical domain is associated to the level of expertise. The third goal was to verify whether socio-demographic differences influence the representation of risk. Methods: Eighty voluntary participants from 6 health-centers in northern Italy were enrolled to conduct a semi-structured interview which included demographic questions, term-associations about risk representation, closed and open questions about attitudes and perception of risk in the medical context, as well as about medical expertise and trust. Results: The results showed that people do not have in mind a scientific definition of risk in medicine. Risk is seen as a synonym for surgery and disease and it is often confused with fear. However, general knowledge of medical matters helps people to have a better health management through risk identification and risk information, adoption of careful behaviors and tendency to have a critical view about safety and medical news. Finally, trust proved to be an important variable in risk representation and risk and trust were correlated positively. Conclusions: People must receive appropriate information about the risks and benefits of treatment, in a form that they can understand and apply to their own circumstances. Moreover, contemporary health policy should empower patients to adopt an active self-care attitude. Methodologies to enhance people's decision-making outcomes based on better risk communication should be improved in order to enable low literacy population as well elderly people to better understand their treatment and associated risk.	[Riva, Silvia; Iannello, Paola; Antonietti, Alessandro] Univ Cattolica Sacro Cuore, Dept Psychol, I-20123 Milan, Italy; [Riva, Silvia] Univ Svizzera Italiana, ICH, Lugano, Switzerland; [Monti, Marco] Max Planck Inst Human Dev Berlin, Dept Adapt Behav & Cognit, Berlin, Germany	Catholic University of the Sacred Heart; Universita della Svizzera Italiana; Max Planck Society	Riva, S (corresponding author), Univ Cattolica Sacro Cuore, Dept Psychol, I-20123 Milan, Italy.	silvia.riva@unicatt.it	Antonietti, Alessandro/K-9096-2016; Riva, Silvia/M-3163-2013; , Silvia/H-8838-2019	Antonietti, Alessandro/0000-0002-7212-8076; Riva, Silvia/0000-0003-2153-0169; Antonietti, Markus/0000-0002-8395-7558; Iannello, Paola/0000-0002-2736-2541				Agency for Healthcare Research and Quality, 2011, HLTH LIT INT OUTC UP; Bergus GR, 2002, J GEN INTERN MED, V17, P612, DOI 10.1046/j.1525-1497.2002.11001.x; Berry DC, 2006, CURR DRUG SAF, V1, P121, DOI 10.2174/157488606775252638; Brewer NT, 2009, MED DECIS MAKING, V29, P157, DOI 10.1177/0272989X08327111; Carling C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003693; Carling CLL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000140; Clark D, 2001, BMJ-BRIT MED J, V323, P706, DOI 10.1136/bmj.323.7315.706; Covington TR, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj7006137; Das TK, 2004, J BUS PSYCHOL, V19, P85, DOI 10.1023/B:JOBU.0000040274.23551.1b; Doyal L, 2001, QUAL HEALTH CARE, V10, pI29; Evans AM, 2011, J EXP SOC PSYCHOL, V47, P171, DOI 10.1016/j.jesp.2010.08.007; Gigerenzer G., 2002, RECKONING RISK LEARN; Gurm HS, 2000, ACAD MED, V75, P840, DOI 10.1097/00001888-200008000-00018; Hamilton JG, 2012, J BEHAV MED, V35, P124, DOI 10.1007/s10865-011-9342-8; Hoffrage U, 2000, SCIENCE, V290, P2261, DOI 10.1126/science.290.5500.2261; Joseph G, 2010, J GENET COUNS, V19, P447, DOI 10.1007/s10897-010-9303-3; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kugler T, 2012, J BEHAV DECIS MAKING, V25, P123, DOI 10.1002/bdm.724; Li SYW, 2009, J EVAL CLIN PRACT, V15, P993, DOI 10.1111/j.1365-2753.2009.01350.x; Marewski Julian N, 2012, Dialogues Clin Neurosci, V14, P77; Marewski JN, 2010, COGN PROCESS, V11, P103, DOI 10.1007/s10339-009-0337-0; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; Miles M.B., 1994, QUALITATIVE DATA ANA, P352; Nickel P.J., 2012, HDB RISK THEORY EPIS, P857, DOI DOI 10.1007/978-94-007-1433-5_34; Reininger B, 2003, HEALTH EDUC RES, V18, P461, DOI 10.1093/her/cyf046; Reventlow S, 2001, SCAND J PRIM HEALTH, V19, P71; Reynolds WW, 2007, SOC SCI MED, V65, P2105, DOI 10.1016/j.socscimed.2007.06.021; Riva S, 2011, ADV MED EDUC PRACT, V2, P59, DOI 10.2147/AMEP.S13004; Schulz P, 2006, STUD COMMUNIC SCI, V5, P1; See KE, 2011, ORGAN BEHAV HUM DEC, V116, P272, DOI 10.1016/j.obhdp.2011.07.006; Siegrist M, 2000, RISK ANAL, V20, P713, DOI 10.1111/0272-4332.205064; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Slovic P, 1985, REGULATORY POLICY SO, P241; Slovic P, 2007, DRUG INF J, V41, P81, DOI 10.1177/009286150704100110; Sullivan C., 2018, DOING QUALITATIVE RE; Szalay L.B., 1978, SUBJECTIVE MEANING C; T-Lab, TOOLS TEXT AN; Tarrant C, 2008, BRIT J GEN PRACT, V58, P780, DOI 10.3399/bjgp08X342615; Thaler H, 2009, NUDGE IMPROVING DECI; Thom DH, 2002, FAM PRACT, V19, P476, DOI 10.1093/fampra/19.5.476; TIMMERMANS D, 1994, MED DECIS MAKING, V14, P146, DOI 10.1177/0272989X9401400207; Unipark, ONL QUAL INT SOFTW U	43	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48297	10.1371/journal.pone.0048297	http://dx.doi.org/10.1371/journal.pone.0048297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WR	23133628	Green Published, Green Submitted, gold			2022-12-25	WOS:000310601300011
J	Chailleux, A; Desneux, N; Seguret, J; Hong, DTK; Maignet, P; Tabone, E				Chailleux, Anais; Desneux, Nicolas; Seguret, Julien; Hong Do Thi Khanh; Maignet, Pascal; Tabone, Elisabeth			Assessing European Egg Parasitoids as a Mean of Controlling the Invasive South American Tomato Pinworm Tuta absoluta	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; TRICHOGRAMMA HYMENOPTERA; LEPIDOPTERA-GELECHIIDAE; BIOCONTROL AGENTS; TEMPERATURE; PERFORMANCE; NOCTUIDAE; SELECTION; BEHAVIOR; PESTICIDES	The South American tomato pinworm (Tuta absoluta) has recently invaded Europe and is rapidly spreading in the Afro-Eurasian continent where it is becoming a major pest on tomato crops. Laboratory tests were undertaken to evaluate the potential of 29 European strains of Trichogramma parasitoids to control T. absoluta. In addition to the host itself, the host plant (tomato) was used during the laboratory tests in order to increase the chance of selecting the best parasitoid strains. Trichogramma females were placed with T. absoluta eggs on a tomato leaflet in tubes. We compared the parasitism of T. absoluta by the various Trichogramma species tested to the Trichogramma species currently commercially available for the pest control in Europe, i.e. Trichogramma achaeae. Thereafter, the more promising strains were tested on a larger scale, in mesocosm (i.e. cages in greenhouses) and in greenhouse compartments to evaluate efficiency of laboratory selected strains under cropping conditions. The most efficient strain from the laboratory screening trials did not perform as efficiently under the greenhouse conditions. We discuss differences in parasitism levels among species and strains and among the different scales tested in the experiments, as well as implications of these results for further screening for biocontrol agents.	[Chailleux, Anais; Desneux, Nicolas; Hong Do Thi Khanh; Tabone, Elisabeth] French Natl Inst Agr Res INRA, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Chailleux, Anais; Seguret, Julien; Maignet, Pascal] InVivo AgroSolut, Biotop, Valbonne, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Chailleux, A (corresponding author), French Natl Inst Agr Res INRA, Inst Sophia Agrobiotech, Sophia Antipolis, France.	chailleux.anais@gmail.com; nicolas.desneux@sophia.inra.fr	Desneux, Nicolas/J-6262-2013	Chailleux, Anais/0000-0001-5653-8019	ANRT (Association Nationale de la Recherche et de la Technologie) [167/2010]; Invivo AgroSolutions Biotop; French ministry of agriculture (CASDAR project) [10063]	ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR)); Invivo AgroSolutions Biotop; French ministry of agriculture (CASDAR project)	This work was funded by ANRT (Association Nationale de la Recherche et de la Technologie) (PhD fellowship 167/2010 to AC), Invivo AgroSolutions & Biotop and the French ministry of agriculture (CASDAR project 10063 to AC, ND and ET). The funders had no role in data analysis and preparation of the manuscript but were involved in the study design, data collection and decision to publish.	Agamy E, 2010, J PEST SCI, V83, P53, DOI 10.1007/s10340-009-0273-x; Andrade GS, 2011, J PEST SCI, V84, P313, DOI 10.1007/s10340-011-0364-3; Arno J, 2011, J PEST SCI, V84, P513, DOI 10.1007/s10340-011-0384-z; Barrientos Z. R., 1998, Ciencia e Investigacion Agraria, V25, P133; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Bourchier RS, 1996, ENTOMOL EXP APPL, V80, P461, DOI 10.1007/BF00343469; Bueno RCOF, 2009, NEOTROP ENTOMOL, V38, P389, DOI 10.1590/S1519-566X2009000300015; Cabello T., 2009, IOBC/WPRS Bulletin, V49, P225; CHASSAIN C, 1991, GENETICA, V83, P195, DOI 10.1007/BF00126225; Chau A, 2001, BIOL CONTROL, V20, P30, DOI 10.1006/bcon.2000.0881; de Medeiros MA, 2009, HORTIC BRAS, V27, P80, DOI 10.1590/S0102-05362009000100016; de Medeiros MA, 2011, BRAGANTIA, V70, P72, DOI 10.1590/S0006-87052011000100012; Desneux N, 2011, ACTA HORTIC, P31, DOI 10.17660/ActaHortic.2011.917.3; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Frandon J, 2010, PHYTOMA, V634, P9; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Kalyebi A, 2006, B ENTOMOL RES, V96, P305, DOI 10.1079/BER2006429; KASHYAP RK, 1991, J CHEM ECOL, V17, P2381, DOI 10.1007/BF00994589; KASHYAP RK, 1991, J CHEM ECOL, V17, P543, DOI 10.1007/BF00982125; KAUFFMAN WC, 1989, ENVIRON ENTOMOL, V18, P698, DOI 10.1093/ee/18.4.698; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; KRAAIJEVELD AR, 1995, FUNCT ECOL, V9, P113, DOI 10.2307/2390097; LI SY, 1994, BIOL CONTROL, V4, P244, DOI 10.1006/bcon.1994.1030; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mansour M, 2010, J PEST SCI, V83, P243, DOI 10.1007/s10340-010-0291-8; Mills N, 2010, PROG BIOL CONTROL, V9, P389, DOI 10.1007/978-1-4020-9110-0_15; Moezipour M, 2008, B INSECTOL, V61, P245; Parra JRP, 2004, NEOTROP ENTOMOL, V33, P271, DOI 10.1590/S1519-566X2004000300001; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pintureau B., 2009, LUTTE BIOL TRICHOGRA; Pizzol J, 2012, J PEST SCI, V85, P489, DOI 10.1007/s10340-012-0434-1; Pizzol J, 2010, J PEST SCI, V83, P447, DOI 10.1007/s10340-010-0327-0; Polaszek A, 2012, BIOCONTROL, V57, P21, DOI 10.1007/s10526-011-9361-y; Pratissoli D, 2005, PESQUI AGROPECU BRAS, V40, P715, DOI 10.1590/S0100-204X2005000700013; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Romeis J, 1998, ENTOMOL EXP APPL, V87, P275, DOI 10.1023/A:1003275419997; Romeis J, 1999, B ENTOMOL RES, V89, P89, DOI 10.1017/S0007485399000115; Roriz V, 2006, BIOL CONTROL, V36, P331, DOI 10.1016/j.biocontrol.2005.09.002; Smith SM, 1996, ANNU REV ENTOMOL, V41, P375, DOI 10.1146/annurev.en.41.010196.002111; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Tabone E, 2012, ACTA HORTIC, V927, P227, DOI 10.17660/ActaHortic.2012.927.25; Tabone E, 2010, J PEST SCI, V83, P251, DOI 10.1007/s10340-010-0292-7; Van Lenteren JC, 2003, BIOCONTROL, V48, P123, DOI 10.1023/A:1022645210394; Zappala L, 2012, B INSECTOL, V65, P51	51	91	96	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48068	10.1371/journal.pone.0048068	http://dx.doi.org/10.1371/journal.pone.0048068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144727	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300037
J	Manjurano, A; Clark, TG; Nadjm, B; Mtove, G; Wangai, H; Sepulveda, N; Campino, SG; Maxwell, C; Olomi, R; Rockett, KR; Jeffreys, A; Riley, EM; Reyburn, H; Drakeley, C				Manjurano, Alphaxard; Clark, Taane G.; Nadjm, Behzad; Mtove, George; Wangai, Hannah; Sepulveda, Nuno; Campino, Susana G.; Maxwell, Caroline; Olomi, Raimos; Rockett, Kirk R.; Jeffreys, Anna; Riley, Eleanor M.; Reyburn, Hugh; Drakeley, Christopher		MalariaGen Consortium	Candidate Human Genetic Polymorphisms and Severe Malaria in a Tanzanian Population	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; AFRICAN CHILDREN; IL-10 PRODUCTION; G6PD DEFICIENCY; WEST-AFRICA; SUSCEPTIBILITY; ASSOCIATION; INFECTION	Human genetic background strongly influences susceptibility to malaria infection and progression to severe disease and death. Classical genetic studies identified haemoglobinopathies and erythrocyte-associated polymorphisms, as protective against severe disease. High throughput genotyping by mass spectrometry allows multiple single nucleotide polymorphisms (SNPs) to be examined simultaneously. We compared the prevalence of 65 human SNP's, previously associated with altered risk of malaria, between Tanzanian children with and without severe malaria. Five hundred children, aged 1-10 years, with severe malaria were recruited from those admitted to hospital in Muheza, Tanzania and compared with matched controls. Genotyping was performed by Sequenom MassArray, and conventional PCR was used to detect deletions in the alpha-thalassaemia gene. SNPs in two X-linked genes were associated with altered risk of severe malaria in females but not in males: heterozygosity for one or other of two SNPs in the G6PD gene was associated with protection from all forms of severe disease whilst two SNPs in the gene encoding CD40L were associated with respiratory distress. A SNP in the adenyl cyclase 9 (ADCY9) gene was associated with protection from acidosis whilst a polymorphism in the IL-1 alpha gene (IL1A) was associated with an increased risk of acidosis. SNPs in the genes encoding IL-13 and reticulon-3 (RTN3) were associated with increased risk of cerebral malaria. This study confirms previously known genetic associations with protection from severe malaria (HbS, G6PD). It identifies two X-linked genes associated with altered risk of severe malaria in females, identifies mutations in ADCY9, IL1A and CD40L as being associated with altered risk of severe respiratory distress and acidosis, both of which are characterised by high serum lactate levels, and also identifies novel genetic associations with severe malaria (TRIM5) and cerebral malaria(IL-13 and RTN3). Further studies are required to test the generality of these associations and to understand their functional consequences.	[Manjurano, Alphaxard; Nadjm, Behzad; Mtove, George; Wangai, Hannah; Olomi, Raimos; Reyburn, Hugh; Drakeley, Christopher] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Manjurano, Alphaxard; Clark, Taane G.; Nadjm, Behzad; Maxwell, Caroline; Riley, Eleanor M.; Reyburn, Hugh; Drakeley, Christopher] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Clark, Taane G.; Sepulveda, Nuno] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Campino, Susana G.] Wellcome Trust Sanger Inst, Cambridge, England; [Rockett, Kirk R.; Jeffreys, Anna] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics	Drakeley, C (corresponding author), Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania.	Chris.Drakeley@lshtm.ac.uk	Campino, Susana/AAM-2577-2020; Sepulveda, Nuno/S-9936-2019; Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013; Clark, Taane G./AAM-2570-2020; Sepulveda, Nuno/AAA-5544-2021	Campino, Susana/0000-0003-1403-6138; Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Clark, Taane G./0000-0001-8985-9265; Nadjm, Behzad/0000-0002-7704-3629; Sepulveda, Nuno/0000-0002-8542-1706; Mtove, George/0000-0001-5173-0829	European Commission (Europaid) [SANTE/2004/078-607]; Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 087285, 096527, 075491/Z/04, 090532/Z/09/Z]; Bill and Melinda Gates Foundation through the Foundations of the National Institutes of Health, Grand Challenges in Global Health Initiative [566]; Medical Research Council [G0600718, G0600230]; National Institute for Health Research [CL-2008-20-001] Funding Source: researchfish; MRC [G0600718, G0600230] Funding Source: UKRI	European Commission (Europaid)(European Commission); Wellcome Trust(Wellcome Trust); Bill and Melinda Gates Foundation through the Foundations of the National Institutes of Health, Grand Challenges in Global Health Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Clinical data collection was part of a study funded by European Commission (Europaid) grant code SANTE/2004/078-607. The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and the Bill and Melinda Gates Foundation through the Foundations of the National Institutes of Health (566) as part of the Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). This research was supported by the Medical Research Council (G0600718; G0600230), the Wellcome Trust Biomedical Ethics Enhancement Award (087285) and Strategic Award (096527). The Wellcome Trust also provide core awards to Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z), where the majority of genotyping was performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1961, BRIT MED J, V1, P1346, DOI 10.1136/bmj.1.5236.1346; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Auburn S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010017; Auburn S, 2008, HUM GENET, V124, P499, DOI 10.1007/s00439-008-0575-8; BIENZLE U, 1972, LANCET, V1, P107; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Carpenter D, 2007, HUM IMMUNOL, V68, P165, DOI 10.1016/j.humimm.2006.12.002; Clark IA, 1996, ADV PARASIT, V37, P1, DOI 10.1016/S0065-308X(08)60218-3; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crawley J, 2010, LANCET, V375, P1468, DOI 10.1016/S0140-6736(10)60447-3; Cui L, 2012, CLIN BIOCHEM, V45, P285, DOI 10.1016/j.clinbiochem.2011.12.012; Delahaye NF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-452; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Enevold A, 2007, J INFECT DIS, V196, P451, DOI 10.1086/519390; Fowkes FJI, 2008, PLOS MED, V5, P494, DOI 10.1371/journal.pmed.0050056; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Goldberg R, 2006, J BONE MINER RES, V21, P703, DOI 10.1359/JBMR.060210; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Grant AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035863; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Heath JE, 2010, NEUROPATHOLOGY, V30, P574, DOI 10.1111/j.1440-1789.2010.01107.x; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Linke A, 1996, EXP PARASITOL, V84, P253, DOI 10.1006/expr.1996.0111; Liu YT, 2000, BRIT J HAEMATOL, V108, P295; Lukic Z, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-93; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Mtove G, 2011, CLIN INFECT DIS, V53, P548, DOI 10.1093/cid/cir471; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; Naka I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-232; Nakayama EE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00097; Ohashi J, 2003, GENES IMMUN, V4, P528, DOI 10.1038/sj.gene.6364010; Organization WH, 2010, WEEKLY EPIDEMIOLOGIC, V85, P461; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Ouma C, 2008, HUM GENET, V124, P515, DOI 10.1007/s00439-008-0578-5; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.6363877; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Teo YY, 2009, GENET EPIDEMIOL, V33, P128, DOI 10.1002/gepi.20366; Toure O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043987; Veenemans J, 2008, J INFECT DIS, V198, P401, DOI 10.1086/589884; Velavan TP, 2012, IMMUNOGENETICS, V64, P87, DOI 10.1007/s00251-011-0563-3; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, WHO MON MED PLANTS C; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; Zhang GC, 2012, INFECT IMMUN, V80, P2316, DOI 10.1128/IAI.00261-12; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	64	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47463	10.1371/journal.pone.0047463	http://dx.doi.org/10.1371/journal.pone.0047463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144702	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000310705300013
J	Valente, AXCN; Zischkau, J; Shin, JH; Gao, Y; Sarkar, A				Valente, Andre X. C. N.; Zischkau, Joseph; Shin, Joo Heon; Gao, Yuan; Sarkar, Abhijit			Genome-Wide Association Study Heterogeneous Cohort Homogenization via Subject Weight Knock-Down	PLOS ONE			English	Article							POPULATION-STRUCTURE; CRYPTIC RELATEDNESS; STRATIFICATION; REGRESSION; INFERENCE; CORRECTS; POWER; SNP	Population structure can be a source of both false-positive and false-negative findings in a genome-wide association study. This article proposes an approach that helps to reduce the false-positives. It consists of homogenizing the diseased/healthy phenotype ratio across the cohort, by decreasing the statistical weight of selected individuals. After homogenization, the cohort is statistically handled as if originating from a single well-mixed population. The method was applied to homogenize a Parkinson's disease genome-wide association study cohort.	[Valente, Andre X. C. N.] Biocant Biotechnol Innovat Ctr, Syst Biol Grp, Cantanhede, Portugal; [Valente, Andre X. C. N.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Valente, Andre X. C. N.] Virginia Commonwealth Univ, Ctr Study Biocomplex, Richmond, VA USA; [Zischkau, Joseph; Sarkar, Abhijit] Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; [Zischkau, Joseph; Sarkar, Abhijit] Catholic Univ Amer, Vitreous State Lab, Washington, DC 20064 USA; [Shin, Joo Heon; Gao, Yuan] Lieber Inst Brain Dev, Baltimore, MD USA	Universidade de Coimbra; Virginia Commonwealth University; Catholic University of America; Catholic University of America	Valente, AXCN (corresponding author), Biocant Biotechnol Innovat Ctr, Syst Biol Grp, Cantanhede, Portugal.	andre.valente@biocant.pt		X. C. N. Valente, Andre/0000-0001-6684-0596				Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; AXCN Valente, 2011, SCI ENG HIGH THROUGH, P23; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Dadd T, 2009, GENET EPIDEMIOL, V33, P290, DOI 10.1002/gepi.20379; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; EDWARDS AWF, 1963, J R STAT SOC SER A-G, V126, P109, DOI 10.2307/2982448; Edwards TL, 2012, CURR PROTOC HUM GENE, V73; Falush D, 2003, GENETICS, V164, P1567; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kimmel G, 2007, AM J HUM GENET, V81, P895, DOI 10.1086/521372; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Li MY, 2010, BIOINFORMATICS, V26, P798, DOI 10.1093/bioinformatics/btq025; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Li QZ, 2009, GENET EPIDEMIOL, V33, P432, DOI 10.1002/gepi.20396; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Miclaus K, 2009, GENET EPIDEMIOL, V33, P488, DOI 10.1002/gepi.20401; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Sillanpaa MJ, 2011, HEREDITY, V106, P511, DOI 10.1038/hdy.2010.91; Teo YY, 2008, CURR OPIN LIPIDOL, V19, P133, DOI 10.1097/MOL.0b013e3282f5dd77; Valente AXCN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00256; Wang K, 2009, GENET EPIDEMIOL, V33, P637, DOI 10.1002/gepi.20415; Witte JS, 2010, ANNU REV PUBL HEALTH, V31, P9, DOI 10.1146/annurev.publhealth.012809.103723; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007928; Zheng G, 2006, AM J HUM GENET, V78, P350, DOI 10.1086/500054; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863; Zhu XF, 2008, AM J HUM GENET, V82, P352, DOI 10.1016/j.ajhg.2007.10.009	40	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48653	10.1371/journal.pone.0048653	http://dx.doi.org/10.1371/journal.pone.0048653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144770	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300080
J	Xue, X; Li, SJ; Ahmed, MZ; De Barro, PJ; Ren, SX; Qiu, BL				Xue, Xia; Li, Shao-Jian; Ahmed, Muhammad Z.; De Barro, Paul J.; Ren, Shun-Xiang; Qiu, Bao-Li			Inactivation of Wolbachia Reveals Its Biological Roles in Whitefly Host	PLOS ONE			English	Article							TABACI HEMIPTERA ALEYRODIDAE; BEMISIA-TABACI; BACTERIAL ENDOSYMBIONTS; ACYRTHOSIPHON-PISUM; SECONDARY SYMBIONTS; INFECTION; APHIDS; POPULATIONS; RICKETTSIA; PREVALENCE	Background: The whitefly Bemisia tabaci is cryptic species complex composed of numerous species. Individual species from the complex harbor a diversity of bacterial endosymbionts including Wolbachia. However, while Wolbachia is known to have a number of different roles, its role in B. tabaci is unclear. Here, the antibiotic rifampicin is used to selectively eliminate Wolbachia from B. tabaci so as to enable its roles in whitefly development and reproduction to be explored. The indirect effects of Wolbachia elimination on the biology of Encarsia bimaculata, a dominant parasitoid of B. tabaci in South China, were also investigated. Methodology/Principal Finding: qRT-PCR and FISH were used to show that after 48 h exposure to 1.0 mg/ml rifampicin, Wolbachia was completely inactivated from B. tabaci Mediterranean (MED) without any significant impact on either the primary symbiont, Portiera aleyrodidarum or any of the other secondary endosymbionts present. For B. tabaci MED, Wolbachia was shown to be associated with decreased juvenile development time, increased likelihood that nymphs completed development, increased adult life span and increased percentage of female progeny. Inactivation was associated with a significant decrease in the body size of the 4th instar which leads us to speculate as to whether Wolbachia may have a nutrient supplementation role. The reduction in nymph body size has consequences for its parasitoid, E. bimaculata. The elimination of Wolbachia lead to a marked increase in the proportion of parasitoid eggs that completed their development, but the reduced size of the whitefly host was also associated with a significant reduction in the size of the emerging parasitoid adult and this was in turn associated with a marked reduction in adult parasitoid longevity. Conclusions/Significance: Wolbachia increases the fitness of the whitefly host and provides some protection against parasitization. These observations add to our understanding of the roles played by bacterial endosymbionts.	[Xue, Xia; Li, Shao-Jian; Ahmed, Muhammad Z.; Ren, Shun-Xiang; Qiu, Bao-Li] S China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Ahmed, Muhammad Z.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [De Barro, Paul J.] CSIRO Ecosyst Sci, Brisbane, Qld, Australia	South China Agricultural University; University of Pretoria; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ren, SX (corresponding author), S China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	rensxcn@yahoo.com.cn; baileyqiu@yahoo.com.cn	Ahmed, Muhammad Z/E-5735-2011; De Barro, Paul J/C-1724-2008	Ahmed, Muhammad Z/0000-0003-2486-157X; 	National Basic Research Program of China [2009CB119203]; Program for New Century Excellent Talents in University [NCET-0917-2011]; China National Natural Science Foundation [31071732]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was funded by the National Basic Research Program of China (2009CB119203), the Program for New Century Excellent Talents in University (NCET-0917-2011) and the China National Natural Science Foundation (31071732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2010, J ECON ENTOMOL, V103, P1848, DOI 10.1603/EC10033; Ahmed MZ, 2010, CURR MICROBIOL, V61, P322, DOI 10.1007/s00284-010-9614-5; Antony B, 2004, BIOL CONTROL, V30, P546, DOI 10.1016/j.biocontrol.2004.01.018; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Baumann P, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P403, DOI 10.1007/0-387-30741-9_16; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; BOURTZIS K, 2008, INSECT SYMBIOSIS, V3, P384; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL, P332; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Chou I, 1949, J CHIN ENTOMOL, V3, P1; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Clark EL, 2010, PROTOPLASMA, V244, P25, DOI 10.1007/s00709-010-0156-2; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dobson SL, 2002, GENETICS, V160, P1087; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gerling D, 2001, CROP PROT, V20, P779, DOI 10.1016/S0261-2194(01)00111-9; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; GUNASENA GH, 1989, ANN ENTOMOL SOC AM, V82, P187, DOI 10.1093/aesa/82.2.187; Guruprasad NM, 2011, SYMBIOSIS, V54, P151, DOI 10.1007/s13199-011-0138-y; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huxel GR, 2007, B MATH BIOL, V69, P2093, DOI 10.1007/s11538-007-9214-0; Huxel GR, 1998, AM NAT, V152, P460, DOI 10.1086/286182; Kaiser W, 2010, P ROY SOC B-BIOL SCI, V277, P2311, DOI 10.1098/rspb.2010.0214; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; KOUAME KL, 1991, OECOLOGIA, V88, P197, DOI 10.1007/BF00320811; Kuriwada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013101; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Li ZX, 2007, CURR MICROBIOL, V54, P467, DOI 10.1007/s00284-007-0011-7; MACKAUER M, 1986, J INSECT PHYSIOL, V32, P275, DOI 10.1016/0022-1910(86)90039-9; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2001, ANN MO BOT GARD, V88, P35, DOI 10.2307/2666130; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; Qiu B.-L., 2004, ENTOMOL KNOWL, V41, P18; Qiu BL, 2008, INT J PEST MANAGE, V54, P247, DOI 10.1080/09670870802044228; Qiu BL, 2009, FUNCT ECOL, V23, P496, DOI 10.1111/j.1365-2435.2008.01516.x; Qiu BL, 2009, PROG NAT SCI-MATER, V19, P713, DOI 10.1016/j.pnsc.2008.08.013; Ren SX, 2001, INSECT SCI, V8, P279, DOI DOI 10.1111/J.1744-7917.2001.TB00453.X; Ruan YM, 2006, ENTOMOL EXP APPL, V121, P159, DOI 10.1111/j.1570-8703.2006.00466.x; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; SAS Institute, 2003, SAS STAT VERS 8 2; Sasaki T, 2005, HEREDITY, V95, P389, DOI 10.1038/sj.hdy.6800737; Schmitz OJ, 2002, ECOL LETT, V5, P168, DOI 10.1046/j.1461-0248.2002.00311.x; SEQUEIRA R, 1992, EVOL ECOL, V6, P34, DOI 10.1007/BF02285332; SEQUEIRA R, 1994, ENTOMOL EXP APPL, V71, P15, DOI 10.1007/BF02380565; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Stahlhut JK, 2010, MOL ECOL, V19, P4102, DOI 10.1111/j.1365-294X.2010.04776.x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Weeks AR, 2003, CONT T ENT, P165; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	82	44	49	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48148	10.1371/journal.pone.0048148	http://dx.doi.org/10.1371/journal.pone.0048148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144739	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300049
J	Zhou, L; Liu, Y; Lu, L; Lu, XZ; Dixon, RAF				Zhou, Lei; Liu, Yu; Lu, Li; Lu, Xinzheng; Dixon, Richard A. F.			Cardiac Gene Activation Analysis in Mammalian Non-Myoblasic Cells by Nkx2-5, Tbx5, Gata4 and Myocd	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION; MYOCARDIN; DIFFERENTIATION; FIBROBLASTS; FGFR1; VASCULARIZATION; CARDIOMYOCYTES; MUTATIONS; REGULATOR	Cardiac transcription factors are master regulators during heart development. Some were shown to transdifferentiate tail tip and cardiac fibroblasts into cardiomyocytes. However, recent studies have showed that controversies exist. Potential difference in tail tip and cardiac fibroblast isolation may possibly confound the observations. Moreover, due to the use of a cardiac reporter (Myh6) selection strategy for induced cardiomyocyte enrichment, and the lack of tracking signals for each transcription factors, individual roles of each transcription factors in activating cardiac gene expression in mammalian non-myoblastic cells have never been elucidated. Answers to these questions are an important step toward cardiomyocyte regeneration. Because mouse 10T1/2 fibroblasts are non-myoblastic in nature and can be induced to express genes of all three types of muscle cells, they are an ideal model for the analysis of cardiac and non-cardiac gene activation after induction. We constructed bi-cistronic lentiviral vectors, capable of expressing cardiac transcription factors along with different fluorescent tracking signals. By infecting 10T1/2 fibroblasts with Nkx2-5, Tbx5, Gata4 or Myocd cardiac transcription factor lentivirus alone or different combinations, we found that only Tbx5+Myocd and Tbx5+Gata4+Myocd combinations induced Myh6 and Tnnt2 cardiac marker protein expression. Microarray-based gene ontology analysis revealed that Tbx5 alone activated genes involved in the Wnt receptor signaling pathway and inhibited genes involved in a number of cardiac-related processes. Myocd alone activated genes involved in a number of cardiac-related processes and inhibited genes involved in the Wnt receptor signaling pathway and non-cardiac processes. Gata4 alone inhibited genes involved in non-cardiac processes. Tbx5+Gata4+Myocd was the most effective activator of genes associated with cardiac-related processes. Unlike Tbx5, Gata4, Myocd alone or Tbx5+Myocd, Tbx5+Gata4+Myocd activated the fewest genes associated with non-cardiac processes. Conclusively, Tbx5, Gata4 and Myocd play different roles in cardiac gene activation in mammalian non-myoblastic cells. Tbx5+Gata4+Myocd activates the most cardiac and the least non-cardiac gene expression.	[Zhou, Lei; Dixon, Richard A. F.] Texas Heart Inst, Dept Mol Cardiol, Houston, TX 77025 USA; [Liu, Yu] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Lu, Li] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lu, Xinzheng] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Texas Heart Institute; University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; Nanjing Medical University	Zhou, L (corresponding author), Texas Heart Inst, Dept Mol Cardiol, Houston, TX 77025 USA.	Lzhou@heart.thi.tmc.edu; RDixon@heart.thi.tmc.edu	Liu, Yu/F-2802-2015	Liu, Yu/0000-0002-1282-4897	National Heart, Lung, and Blood Institute [RC1 HL100807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100807] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by National Heart, Lung, and Blood Institute grant RC1 HL100807. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Barbera JPM, 2002, HUM MOL GENET, V11, P283, DOI 10.1093/hmg/11.3.283; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; CONSTANTINIDES PG, 1977, NATURE, V267, P364, DOI 10.1038/267364a0; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Graf K, 2004, HYPERTENSION, V44, P809, DOI 10.1161/01.HYP.0000148459.25908.49; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hitzler JK, 1999, AM J PATHOL, V155, P53, DOI 10.1016/S0002-9440(10)65098-5; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li CL, 2005, DEVELOPMENT, V132, P4755, DOI 10.1242/dev.02065; Martino TA, 1998, VIROLOGY, V244, P302, DOI 10.1006/viro.1998.9122; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Pluta K, 2005, J GENE MED, V7, P803, DOI 10.1002/jgm.712; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Schneider Juergen E., 2004, BMC Developmental Biology, V4, P1; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Sutton RE, 1998, J VIROL, V72, P5781, DOI 10.1128/JVI.72.7.5781-5788.1998; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Wang CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024242; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Withington SL, 2006, DEV BIOL, V294, P67, DOI 10.1016/j.ydbio.2006.02.025; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	52	21	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48028	10.1371/journal.pone.0048028	http://dx.doi.org/10.1371/journal.pone.0048028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144723	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300034
J	Antal, Z; Rascle, C; Cimerman, A; Viaud, M; Billon-Grand, G; Choquer, M; Bruel, C				Antal, Zsuzsanna; Rascle, Christine; Cimerman, Agnes; Viaud, Muriel; Billon-Grand, Genevieve; Choquer, Mathias; Bruel, Christophe			The Homeobox BcHOX8 Gene in Botrytis Cinerea Regulates Vegetative Growth and Morphology	PLOS ONE			English	Article							ALPHA SUBUNIT BCG1; CRYPTOCOCCUS-NEOFORMANS; FUNCTIONAL-ANALYSIS; NEUROSPORA-CRASSA; TRANSCRIPTIONAL REGULATOR; ASPERGILLUS-NIDULANS; HYPHAL MORPHOLOGY; VIRULENCE; PROTEIN; HOMEODOMAIN	Filamentous growth and the capacity at producing conidia are two critical aspects of most fungal life cycles, including that of many plant or animal pathogens. Here, we report on the identification of a homeobox transcription factor encoding gene that plays a role in these two particular aspects of the development of the phytopathogenic fungus Botrytis cinerea. Deletion of the BcHOX8 gene in both the B. cinerea B05-10 and T4 strains causes similar phenotypes, among which a curved, arabesque-like, hyphal growth on hydrophobic surfaces; the mutants were hence named Arabesque. Expression of the BcHOX8 gene is higher in conidia and infection cushions than in developing appressorium or mycelium. In the Arabesque mutants, colony growth rate is reduced and abnormal infection cushions are produced. Asexual reproduction is also affected with abnormal conidiophore being formed, strongly reduced conidia production and dramatic changes in conidial morphology. Finally, the mutation affects the fungus ability to efficiently colonize different host plants. Analysis of the B. cinerea genome shows that BcHOX8 is one member of a nine putative homeobox genes family. Available gene expression data suggest that these genes are functional and sequence comparisons indicate that two of them would be specific to B. cinerea and its close relative Sclerotinia sclerotiorum.	[Antal, Zsuzsanna; Rascle, Christine; Billon-Grand, Genevieve; Choquer, Mathias; Bruel, Christophe] Univ Lyon 1, CNRS, Unite Mixte Rech Microbiol Adaptat & Pathogenie 5, Bayer CropSci, F-69622 Villeurbanne, France; [Cimerman, Agnes; Viaud, Muriel] INRA 1290, Thiverval Grignon, France	Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Bruel, C (corresponding author), Univ Lyon 1, CNRS, Unite Mixte Rech Microbiol Adaptat & Pathogenie 5, Bayer CropSci, F-69622 Villeurbanne, France.	christophe.bruel@univ-lyon1.fr	CHOQUER, Mathias/K-8686-2019	CHOQUER, Mathias/0000-0002-3768-160X	European Community [PIEF-GA-2008-221428]; Agence Nationale de la Recherche (ANR); Comite National des Interprofessions des Vins a Appellation d'Origine (CNIV)	European Community(European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Comite National des Interprofessions des Vins a Appellation d'Origine (CNIV)	Z. Antal and this work were funded by the European Community's Seventh Framework Programme (http://cordis.europa.eu/fp7/home_en.html) under the grant agreement no PIEF-GA-2008-221428. This study was part of the SafeGrape project financially supported by the Agence Nationale de la Recherche (ANR) and by the Comite National des Interprofessions des Vins a Appellation d'Origine (CNIV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Arbelet D, 2010, MOL PLANT MICROBE IN, V23, P1324, DOI 10.1094/MPMI-02-10-0046; Arnaise S, 2001, MOL MICROBIOL, V39, P54, DOI 10.1046/j.1365-2958.2001.02163.x; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; Billon-Grand G, 2012, MOL PLANT PATHOL, V13, P568, DOI 10.1111/j.1364-3703.2011.00772.x; Borgia PT, 1996, FUNGAL GENET BIOL, V20, P193, DOI 10.1006/fgbi.1996.0035; Brown AJ, 2001, TRENDS GENET, V17, P393, DOI 10.1016/S0168-9525(01)02343-5; Burglin TR, 2011, SUBCELL BIOCHEM, V52, P95, DOI 10.1007/978-90-481-9069-0_5; Chang YC, 2004, MOL MICROBIOL, V53, P1385, DOI 10.1111/j.1365-2958.2004.04188.x; Chang YC, 2001, P NATL ACAD SCI USA, V98, P3258, DOI 10.1073/pnas.061031998; Choquer M, 2008, FEMS MICROBIOL LETT, V289, P225, DOI 10.1111/j.1574-6968.2008.01388.x; Choquer M, 2007, FEMS MICROBIOL LETT, V277, P1, DOI 10.1111/j.1574-6968.2007.00930.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coulson RMR, 2003, NUCLEIC ACIDS RES, V31, P653, DOI 10.1093/nar/gkg156; Dalmais B, 2011, MOL PLANT PATHOL, V12, P564, DOI [10.1111/j.1364-3703.2010.00692.x, 10.1111/J.1364-3703.2010.00692.X]; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Doehlemann G, 2005, FUNGAL GENET BIOL, V42, P601, DOI 10.1016/j.fgb.2005.03.001; Doehlemann G, 2006, MICROBIOL-SGM, V152, P2625, DOI 10.1099/mic.0.29044-0; Espino JJ, 2010, PROTEOMICS, V10, P3020, DOI 10.1002/pmic.201000037; GEHRING WJ, 1993, GENE, V135, P215, DOI 10.1016/0378-1119(93)90068-E; Gioti A, 2006, J MOL BIOL, V358, P372, DOI 10.1016/j.jmb.2006.01.076; Gorovits R, 2003, EUKARYOT CELL, V2, P699, DOI 10.1128/EC.2.4.699-707.2003; GOUTTE C, 1994, EMBO J, V13, P1434, DOI 10.1002/j.1460-2075.1994.tb06397.x; Gowda M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-310; Gronover CS, 2005, MOL PLANT PATHOL, V6, P243, DOI 10.1111/j.1364-3703.2005.00278.x; Gronover CS, 2004, MOL PLANT MICROBE IN, V17, P537, DOI 10.1094/MPMI.2004.17.5.537; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Guest GM, 2004, FUNGAL GENET BIOL, V41, P13, DOI 10.1016/j.fgb.2003.08.006; Hoi JWS, 2010, EUKARYOT CELL, V9, P480, DOI 10.1128/EC.00333-09; Hull CM, 2002, GENE DEV, V16, P3046, DOI 10.1101/gad.1041402; Inoue S, 1998, J CELL SCI, V111, P1555; James TY, 2011, EUKARYOT CELL, V10, P249, DOI 10.1128/EC.00212-10; KAHMANN R, 1995, CURR OPIN GENET DEV, V5, P559, DOI 10.1016/0959-437X(95)80023-9; Kars I, 2005, MOL PLANT PATHOL, V6, P641, DOI [10.1111/j.1364-3703.2005.00312.x, 10.1111/J.1364-3703.2005.00312.X]; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Kokkelink L, 2011, FUNGAL GENET BIOL, V48, P1012, DOI 10.1016/j.fgb.2011.07.007; KUES U, 1994, PLANT CELL, V6, P1467, DOI 10.1105/tpc.6.10.1467; Kunoh T, 2000, YEAST, V16, P439, DOI 10.1002/(SICI)1097-0061(20000330)16:5<439::AID-YEA536>3.0.CO;2-M; Leroch M, 2011, APPL ENVIRON MICROB, V77, P2887, DOI 10.1128/AEM.02644-10; Liu WW, 2008, FUNGAL GENET BIOL, V45, P1062, DOI 10.1016/j.fgb.2008.04.003; Liu WD, 2010, MOL PLANT MICROBE IN, V23, P366, DOI 10.1094/MPMI-23-4-0366; Lockhart SR, 2005, GENETICS, V169, P1883, DOI 10.1534/genetics.104.038737; MARKHAM P, 1993, FEMS MICROBIOL LETT, V104, P287, DOI 10.1016/0378-1097(93)90601-W; Michielse CB, 2011, MOL PLANT MICROBE IN, V24, P1074, DOI 10.1094/MPMI-01-11-0007; Ou SH, 1985, RICE DIS; Pandey AK, 2009, MOL GENET GENOMICS, V281, P135, DOI 10.1007/s00438-008-0397-3; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Patel RM, 2008, PHYTOPATHOLOGY, V98, P1334, DOI 10.1094/PHYTO-98-12-1334; Pera LM, 1997, FOLIA MICROBIOL, V42, P551, DOI 10.1007/BF02815463; Pinedo C, 2008, ACS CHEM BIOL, V3, P791, DOI 10.1021/cb800225v; Reis H, 2005, MOL PLANT PATHOL, V6, P257, DOI 10.1111/j.1364-3703.2005.00280.x; Rispail Nicolas, 2010, Commun Integr Biol, V3, P327; ROBB MJ, 1995, MOL GEN GENET, V247, P583, DOI 10.1007/BF00290350; Rolland S, 2003, CURR GENET, V44, P164, DOI 10.1007/s00294-003-0438-8; Rolland S, 2009, MICROBIOL-SGM, V155, P2097, DOI 10.1099/mic.0.025999-0; Rolland SG, 2008, MICROBIOL-SGM, V154, P1464, DOI 10.1099/mic.0.2007/012005-0; Rui O, 2007, MICROBIOL-SGM, V153, P2791, DOI 10.1099/mic.0.2007/006338-0; Rui O, 2007, MOL PLANT PATHOL, V8, P173, DOI 10.1111/J.1364-3703.2007.00383.X; Saitoh Y, 2010, MOL GENET GENOMICS, V284, P33, DOI 10.1007/s00438-010-0545-4; Schamber A, 2010, MOL PLANT PATHOL, V11, P105, DOI [10.1111/j.1364-3703.2009.00579.X, 10.1111/j.1364-3703.2009.00579.x]; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; Schumacher J, 2008, MOL PLANT MICROBE IN, V21, P1443, DOI 10.1094/MPMI-21-11-1443; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Schumacher J, 2008, MOL MICROBIOL, V67, P1027, DOI 10.1111/j.1365-2958.2008.06105.x; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Siewers V, 2006, APPL ENVIRON MICROB, V72, P4619, DOI 10.1128/AEM.02919-05; Sone T, 1999, FUNGAL GENET BIOL, V28, P227, DOI 10.1006/fgbi.1999.1169; Soulie MC, 2006, CELL MICROBIOL, V8, P1310, DOI 10.1111/j.1462-5822.2006.00711.x; Temme N, 2012, MOL PLANT PATHOL, V13, P704, DOI 10.1111/j.1364-3703.2011.00778.x; Temme N, 2009, MOL PLANT MICROBE IN, V22, P987, DOI 10.1094/MPMI-22-8-0987; ten Have A, 2004, MICROBIOL-SGM, V150, P2475, DOI 10.1099/mic.0.27058-0; ten Have A, 2001, FUNGAL GENET BIOL, V33, P97, DOI 10.1006/fgbi.2001.1269; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; TorresGuzman JC, 1997, MOL CELL BIOL, V17, P6283, DOI 10.1128/MCB.17.11.6283; Tudzynski B, 2000, FEMS MICROBIOL LETT, V184, P9, DOI 10.1111/j.1574-6968.2000.tb08982.x; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Viaud M, 2006, MOL PLANT MICROBE IN, V19, P1042, DOI 10.1094/MPMI-19-1042; Watters MK, 2011, FUNGAL BIOL-UK, V115, P296, DOI 10.1016/j.funbio.2010.12.015; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI 10.1111/J.1364-3703.2007.00417.X; Yan Z, 2004, CURR BIOL, V14, pR743, DOI 10.1016/j.cub.2004.09.008; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang LS, 2011, FUNGAL GENET BIOL, V48, P990, DOI 10.1016/j.fgb.2011.06.002; Zheng CL, 2011, FUNGAL BIOL-UK, V115, P815, DOI 10.1016/j.funbio.2011.06.009; Ziv C, 2009, MOL MICROBIOL, V74, P974, DOI 10.1111/j.1365-2958.2009.06911.x	90	27	28	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48134	10.1371/journal.pone.0048134	http://dx.doi.org/10.1371/journal.pone.0048134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133556	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800046
J	Fang, JJ; Reichelt, M; Hidalgo, W; Agnolet, S; Schneider, B				Fang, Jingjing; Reichelt, Michael; Hidalgo, William; Agnolet, Sara; Schneider, Bernd			Tissue-Specific Distribution of Secondary Metabolites in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							ACID GLUCOSINOLATE ESTERS; ARABIDOPSIS-THALIANA; AUXIN TRANSPORT; HYDROLYSIS PRODUCTS; FLAVONOID MUTANTS; SINAPINE ESTERASE; SINAPATE ESTERS; NITRIC-OXIDE; PLANT-CELL; SEED MEAL	Four different parts, hypocotyl and radicle (HR), inner cotyledon (IC), outer cotyledon (OC), seed coat and endosperm (SE), were sampled from mature rapeseed (Brassica napus L.) by laser microdissection. Subsequently, major secondary metabolites, glucosinolates and sinapine, as well as three minor ones, a cyclic spermidine conjugate and two flavonoids, representing different compound categories, were qualified and quantified in dissected samples by high-performance liquid chromatography with diode array detection and mass spectrometry. No qualitative and quantitative difference of glucosinolates and sinapine was detected in embryo tissues (HR, IC and OC). On the other hand, the three minor compounds were observed to be distributed unevenly in different rapeseed tissues. The hypothetic biological functions of the distribution patterns of different secondary metabolites in rapeseed are discussed.	[Fang, Jingjing; Reichelt, Michael; Hidalgo, William; Agnolet, Sara; Schneider, Bernd] Max Planck Inst Chem Ecol, Jena, Germany	Max Planck Society	Schneider, B (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	schneider@ice.mpg.de	Schneider, Bernd/A-3287-2014	Schneider, Bernd/0000-0003-4788-1565; Fang, Jingjing/0000-0003-1819-5312; Hidalgo, William/0000-0002-9973-2679; Agnolet, Sara/0000-0003-4931-6711	International Max Planck Research School (IMPRS) "Exploration of Ecological Interactions with Molecular and Chemical Techniques"; Max Planck Society (MPG)	International Max Planck Research School (IMPRS) "Exploration of Ecological Interactions with Molecular and Chemical Techniques"; Max Planck Society (MPG)(Max Planck Society)	JF received a PhD scholarship by the International Max Planck Research School (IMPRS) "Exploration of Ecological Interactions with Molecular and Chemical Techniques". The research was financially supported by the Max Planck Society (MPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-106; Agerbirk N, 2012, PHYTOCHEMISTRY, V77, P16, DOI 10.1016/j.phytochem.2012.02.005; Alcazar R, 2010, PLANTA, V231, P1237, DOI 10.1007/s00425-010-1130-0; Auger B, 2010, J AGR FOOD CHEM, V58, P6246, DOI 10.1021/jf903619v; Bainard LD, 2009, WEED SCI, V57, P386, DOI 10.1614/WS-08-151.1; Baumert A, 2005, PHYTOCHEMISTRY, V66, P1334, DOI 10.1016/j.phytochem.2005.02.031; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bending GD, 2000, SOIL BIOL BIOCHEM, V32, P1261, DOI 10.1016/S0038-0717(00)00043-2; Bienz S, 2005, NAT PROD REP, V22, P647, DOI 10.1039/b413742f; Bottcher C, 2009, J MASS SPECTROM, V44, P466, DOI 10.1002/jms.1522; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; BOPP M, 1975, Z NATURFORSCH C, V30, P663; BOUCHEREAU A, 1991, PHYTOCHEMISTRY, V30, P1873, DOI 10.1016/0031-9422(91)85031-T; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Brown PD, 1996, PLANT SOIL, V181, P307, DOI 10.1007/BF00012065; BROWN PD, 1991, J CHEM ECOL, V17, P2021, DOI 10.1007/BF00992585; Burow M, 2006, J CHEM ECOL, V32, P2333, DOI 10.1007/s10886-006-9149-1; Clauss K, 2008, PLANT J, V53, P802, DOI 10.1111/j.1365-313X.2007.03374.x; Clauss K, 2011, PLANT PHYSIOL, V155, P1127, DOI 10.1104/pp.110.169821; CLOSSAISBESNARD N, 1991, J SCI FOOD AGR, V56, P25, DOI 10.1002/jsfa.2740560104; Cohen MF, 2005, SOIL BIOL BIOCHEM, V37, P1215, DOI 10.1016/j.soilbio.2004.11.027; Croteau R., 2000, NATURAL PRODUCTS SEC; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Demkura PV, 2012, MOL PLANT, V5, P642, DOI 10.1093/mp/sss025; El-Beltagi HEDS, 2010, GRASAS ACEITES, V61, P143, DOI 10.3989/gya.087009; FENWICK GR, 1982, P NUTR SOC, V41, P277, DOI 10.1079/PNS19820043; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Graser G, 2001, PHYTOCHEMISTRY, V57, P23, DOI 10.1016/S0031-9422(00)00501-X; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Hoelscher Dirk, 2008, V69, P141; Hu P, 2011, APPL SOIL ECOL, V49, P68, DOI 10.1016/j.apsoil.2011.06.014; Imai A, 2004, PLANT PHYSIOL, V135, P1565, DOI 10.1104/pp.104.041699; Imin N, 2007, J EXP BOT, V58, P439, DOI 10.1093/jxb/erl224; Ishimoto H, 2000, J CHEM ECOL, V26, P2387, DOI 10.1023/A:1005583012561; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kabouw P, 2010, PLANT SOIL, V336, P509, DOI 10.1007/s11104-010-0507-y; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kliebenstein DJ, 2005, CURR OPIN PLANT BIOL, V8, P264, DOI 10.1016/j.pbi.2005.03.002; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Lake JA, 2009, PLANT CELL ENVIRON, V32, P1377, DOI 10.1111/j.1365-3040.2009.02005.x; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Lazzeri L, 2004, J AGR FOOD CHEM, V52, P6703, DOI 10.1021/jf030776u; Lazzeri L, 2001, HORTSCIENCE, V36, P1283, DOI 10.21273/HORTSCI.36.7.1283; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Li SH, 2007, PLANTA, V225, P771, DOI 10.1007/s00425-006-0376-z; Li X, 2010, MOL PLANT, V3, P91, DOI 10.1093/mp/ssp090; Liu Q, 2012, FOOD CHEM, V135, P616, DOI 10.1016/j.foodchem.2012.04.142; Luo J, 2009, PLANT CELL, V21, P318, DOI 10.1105/tpc.108.063511; Meissner D, 2008, PLANTA, V228, P663, DOI 10.1007/s00425-008-0768-3; Milkowski C, 2010, PLANTA, V232, P19, DOI 10.1007/s00425-010-1168-z; Moco S, 2009, J PROTEOME RES, V8, P1694, DOI 10.1021/pr800973r; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Nakashima J, 2008, NEW PHYTOL, V179, P738, DOI 10.1111/j.1469-8137.2008.02502.x; Nelson T, 2008, CURR OPIN PLANT BIOL, V11, P567, DOI 10.1016/j.pbi.2008.06.006; Nesi N, 2008, CR BIOL, V331, P763, DOI 10.1016/j.crvi.2008.07.018; Obel N, 2009, MOL PLANT, V2, P922, DOI 10.1093/mp/ssp046; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Rahman L, 2011, APPL SOIL ECOL, V47, P195, DOI 10.1016/j.apsoil.2010.12.006; Reichelt M, 2002, PHYTOCHEMISTRY, V59, P663, DOI 10.1016/S0031-9422(02)00014-6; Rusak G, 2010, BIOL PLANTARUM, V54, P403, DOI 10.1007/s10535-010-0075-2; Schiebold S, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-19; Schmid MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029685; Schneider B, 2007, PLANTA, V225, P763, DOI 10.1007/s00425-006-0404-z; Sheahan JJ, 1996, AM J BOT, V83, P679, DOI 10.2307/2445845; Smolinska U, 1997, PHYTOPATHOLOGY, V87, P77, DOI 10.1094/PHYTO.1997.87.1.77; STRACK D, 1981, Z NATURFORSCH C, V36, P215; Thangstad OP, 2004, PLANT MOL BIOL, V54, P597, DOI 10.1023/B:PLAN.0000038272.99590.10; TZAGOLOFF A, 1963, PLANT PHYSIOL, V38, P202, DOI 10.1104/pp.38.2.202; Wilson KE, 1998, PHOTOCHEM PHOTOBIOL, V67, P547, DOI 10.1111/j.1751-1097.1998.tb09092.x; WILSON MI, 1993, PHOTOCHEM PHOTOBIOL, V57, P556, DOI 10.1111/j.1751-1097.1993.tb02333.x; Wimalasekera R, 2011, PLANT SCI, V181, P593, DOI 10.1016/j.plantsci.2011.04.002; Winde I, 2011, PHYTOCHEMISTRY, V72, P1566, DOI 10.1016/j.phytochem.2011.01.016; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Wolfram K, 2010, PHYTOCHEMISTRY, V71, P1076, DOI 10.1016/j.phytochem.2010.04.007; Zasada IA, 2009, J NEMATOL, V41, P221	81	39	39	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48006	10.1371/journal.pone.0048006	http://dx.doi.org/10.1371/journal.pone.0048006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133539	Green Submitted, gold, Green Published			2022-12-25	WOS:000310261800030
J	Iwanicka-Pronicka, K; Pollak, A; Skorka, A; Lechowicz, U; Pajdowska, M; Furmanek, M; Rzeski, M; Korniszewski, L; Skarzynski, H; Ploski, R				Iwanicka-Pronicka, Katarzyna; Pollak, Agnieszka; Skorka, Agata; Lechowicz, Urszula; Pajdowska, Magdalena; Furmanek, Mariusz; Rzeski, Maciej; Korniszewski, Lech; Skarzynski, Henryk; Ploski, Rafal			Postlingual Hearing Loss as a Mitochondrial 3243A > G Mutation Phenotype	PLOS ONE			English	Article							STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; GENE-MUTATIONS; DNA MUTATION; A3243G; MELAS; IMPAIRMENT; PREVALENCE; EPIDEMIOLOGY; DEAFNESS	Background: The prevalence of isolated hearing loss (HL) associated with the m.3243A>G mutation is unknown. The aim of this study was to assess the frequency and heteroplasmy level of the m.3243A>G mutation in a large group of Polish patients with postlingual bilateral sensorineural HL of unidentified cause. Methodology/Principal Findings: A molecular search was undertaken in the archival blood DNA of 1482 unrelated patients with isolated HL that had begun at ages between 5 and 40 years. Maternal relatives of the probands were subsequently investigated and all carriers underwent audiological tests. The m.3243A>G mutation was found in 16 of 1482 probands (an incidence of 1.08%) and 18 family members. Of these 34 individuals, hearing impairment was detected in 29 patients and the mean onset of HL was at 26 years. Some 42% of the identified m.3243A>G carriers did not develop multisystem symptomatology over the following 10 years. Mean heteroplasmy level of m.3243A>G was lowest in blood at a level of 14% and highest in urine at 58%. These values were independent of the manifested clinical severity of the disease. Conclusions: A single m.3243A>G carrier can usually be found among each 100 individuals who have postlingual hearing loss of unknown cause. Urine samples are best for detecting the m.3243A>G mutation and diagnosing mitochondrially inherited hearing loss.	[Iwanicka-Pronicka, Katarzyna; Pollak, Agnieszka; Lechowicz, Urszula; Furmanek, Mariusz; Rzeski, Maciej; Korniszewski, Lech; Skarzynski, Henryk] Inst Physiol & Pathol Hearing, Warsaw, Poland; [Iwanicka-Pronicka, Katarzyna; Pollak, Agnieszka; Lechowicz, Urszula; Furmanek, Mariusz; Rzeski, Maciej; Korniszewski, Lech; Skarzynski, Henryk] World Hearing Ctr, Kajetany, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Skorka, Agata] Med Univ Warsaw, Dept Paediat, Warsaw, Poland; [Pajdowska, Magdalena] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, Warsaw, Poland	Institute of Physiology & Hearing Pathology; Institute of Physiology & Hearing Pathology; Medical University of Warsaw; Medical University of Warsaw; Children's Memorial Health Institute	Iwanicka-Pronicka, K (corresponding author), Inst Physiol & Pathol Hearing, Warsaw, Poland.	k.pronicka@ifps.org.pl	Lechowicz, Urszula/ABB-9967-2020; Pajdowska, Magdalena/V-9639-2018	Pajdowska, Magdalena/0000-0002-1334-3534; Ploski, Rafal/0000-0001-6286-5526; Iwanicka-Pronicka, Katarzyna/0000-0003-2164-6663; Pollak, Agnieszka/0000-0002-2847-1782; Lechowicz, Urszula/0000-0002-2645-8779; Skarzynski, Henryk/0000-0001-7141-9851	Polish Ministry of Science and High Level Education [NN 403 130 636, NN 407 118 939]; Polish mitochondrial network MITONET.pl	Polish Ministry of Science and High Level Education; Polish mitochondrial network MITONET.pl	The study was supported by grant from the Polish Ministry of Science and High Level Education NN 403 130 636, NN 407 118 939 and Polish mitochondrial network MITONET.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82; Chinnery PF, 2006, MITOCHONDRIAL MED, P161; DAMIAN MS, 1995, ACTA NEUROL SCAND, V92, P409; Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885; Dinour D, 2004, CLIN NEPHROL, V62, P149; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Karkucinska-Wieckowska A, 2011, FOLIA NEUROPATHOL, V49, P56; Kato T, 2010, J HUM GENET, V55, P147, DOI 10.1038/jhg.2009.143; Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x; Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79; Malecki M, 2001, MED SCI MONITOR, V7, P246; Manwaring N, 2007, ARCH OTOLARYNGOL, V133, P929, DOI 10.1001/archotol.133.9.929; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Merchant S.N., 2010, SCHUKNECHTS PATHOLOG; Michaelides M, 2008, ARCH OPHTHALMOL-CHIC, V126, P320, DOI 10.1001/archopht.126.3.320; MOSEWICH RK, 1993, ARCH NEUROL-CHICAGO, V50, P275, DOI 10.1001/archneur.1993.00540030041012; Nadol JB, 2001, INT J PEDIATR OTORHI, V61, P1, DOI 10.1016/S0165-5876(01)00546-8; Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3; Narbonne H, 2001, EUR J ENDOCRINOL, V145, P541, DOI 10.1530/eje.0.1450541; Oshima T, 1999, LARYNGOSCOPE, V109, P334, DOI 10.1097/00005537-199902000-00029; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Pollak A, 2008, J MED GENET, V45, P607, DOI 10.1136/jmg.2008.059873; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Pronicki M, 2002, MED SCI MONITOR, V8, P767; Rydzanicz M, 2011, MOL GENET METAB, V104, P153, DOI 10.1016/j.ymgme.2011.05.004; Rydzanicz M, 2010, BIOCHEM BIOPH RES CO, V395, P116, DOI 10.1016/j.bbrc.2010.03.149; Sawada S, 1997, AM J OTOL, V18, P332; Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220; Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313; Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8; Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475; Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38; Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d; Wortmann SB, 2012, J INHERIT METAB DIS, V35, P13, DOI 10.1007/s10545-010-9210-7	45	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e44054	10.1371/journal.pone.0044054	http://dx.doi.org/10.1371/journal.pone.0044054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133508	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800001
J	Kim, KH; Song, K; Yoon, SH; Shehzad, O; Kim, YS; Son, JH				Kim, Kyung-Hee; Song, Karen; Yoon, Seung-Hee; Shehzad, Omer; Kim, Yeong-Shik; Son, Jin H.			Rescue of PINK1 Protein Null-specific Mitochondrial Complex IV Deficits by Ginsenoside Re Activation of Nitric Oxide Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; PARKINSONS-DISEASE; OXIDATIVE-PHOSPHORYLATION; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; DOPAMINERGIC CELLS; LEIGH-SYNDROME; BIOGENESIS; MUTATIONS; GENE	PINK1, linked to familial Parkinson's disease, is known to affect mitochondrial function. Here we identified a novel regulatory role of PINK1 in the maintenance of complex IV activity and characterized a novel mechanism by which NO signaling restored complex IV deficiency in PINK1 null dopaminergic neuronal cells. In PINK1 null cells, levels of specific chaperones, including Hsp60, leucine-rich pentatricopeptide repeat-containing (LRPPRC), and Hsp90, were severely decreased. LRP-PRC and Hsp90 were found to act upstream of Hsp60 to regulate complex IV activity. Specifically, knockdown of Hsp60 resulted in a decrease in complex IV activity, whereas antagonistic inhibition of Hsp90 by 17-(allylamino) geldanamycin decreased both Hsp60 and complex IV activity. In contrast, overexpression of the PINK1-interacting factor LRPPRC augmented complex IV activity by up-regulating Hsp60. A similar recovery of complex IV activity was also induced by coexpression of Hsp90 and Hsp60. Drug screening identified ginsenoside Re as a compound capable of reversing the deficit in complex IV activity in PINK1 null cells through specific increases of LRPPRC, Hsp90, and Hsp60 levels. The pharmacological effects of ginsenoside Re could be reversed by treatment of the pan-NOS inhibitor L-NG-Nitroarginine Methyl Ester (L-NAME) and could also be reproduced by low-level NO treatment. These results suggest that PINK1 regulates complex IV activity via interactions with upstream regulators of Hsp60, such as LRPPRC and Hsp90. Furthermore, they demonstrate that treatment with ginsenoside Re enhances functioning of the defective PINK1-Hsp90/LRPPRC-Hsp60-complex IV signaling axis in PINK1 null neurons by restoring NO levels, providing potential for new therapeutics targeting mitochondrial dysfunction in Parkinson's disease.	[Kim, Kyung-Hee; Son, Jin H.] Ewha Womans Univ, Brain Dis Res Inst, Coll Pharm, Dept Brain & Cognit Sci, Seoul 120750, South Korea; [Song, Karen; Yoon, Seung-Hee; Son, Jin H.] Ewha Womans Univ, Brain Dis Res Inst, Coll Pharm, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Shehzad, Omer; Kim, Yeong-Shik] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Son, JH (corresponding author), Ewha Womans Univ, Brain Dis Res Inst, Coll Pharm, Dept Brain & Cognit Sci, Sci Bldg C,Rm C307,11-1 Daehyun Dong, Seoul 120750, South Korea.	hjson@ewha.ac.kr	Kim, Hyung-Kwan/R-8375-2019		National Research Foundation [2010-0009233]; National Core Research Center, Republic of Korea [2012-0000952]	National Research Foundation; National Core Research Center, Republic of Korea	This work was supported in part by National Research Foundation Grant 2010-0009233 and National Core Research Center Program Grant 2012-0000952, Republic of Korea.	Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; BROWN GC, 1995, NEUROSCI LETT, V193, P201, DOI 10.1016/0304-3940(95)11703-Y; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5; Chen X, 1997, CLIN EXP PHARMACOL P, V24, P958, DOI 10.1111/j.1440-1681.1997.tb02727.x; Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; Mohanakumar KP, 2002, ANN NY ACAD SCI, V962, P389, DOI 10.1111/j.1749-6632.2002.tb04083.x; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nah SY, 2007, CNS DRUG REV, V13, P381; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Papadopoulou LC, 1999, NAT GENET, V23, P333; Pequignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Schapira AHV, 2012, ANTIOXID REDOX SIGN, V16, P965, DOI 10.1089/ars.2011.4419; Shehzad O, 2011, J SEP SCI, V34, P1116, DOI 10.1002/jssc.201000932; SHEN WQ, 1995, CIRCULATION, V92, P3505, DOI 10.1161/01.CIR.92.12.3505; Shim JH, 2011, MITOCHONDRION, V11, P707, DOI 10.1016/j.mito.2011.05.013; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Stiburek L, 2010, BBA-BIOENERGETICS, V1797, P1149, DOI 10.1016/j.bbabio.2010.04.006; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Tian JW, 2009, PHYTOTHER RES, V23, P486, DOI 10.1002/ptr.2653; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Ye R, 2011, NEUROSCIENCE, V178, P169, DOI 10.1016/j.neuroscience.2011.01.007; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang H, 2007, MOL REPROD DEV, V74, P497, DOI 10.1002/mrd.20583; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	48	28	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44109	44120		10.1074/jbc.M112.408146	http://dx.doi.org/10.1074/jbc.M112.408146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144451	Green Published, hybrid			2022-12-25	WOS:000312938600010
J	Cho, KJ; Park, JH; Piggott, AM; Salim, AA; Gorfe, AA; Parton, RG; Capon, RJ; Lacey, E; Hancock, JF				Cho, Kwang-jin; Park, Jin-Hee; Piggott, Andrew M.; Salim, Angela A.; Gorfe, Alemaheyu A.; Parton, Robert G.; Capon, Robert J.; Lacey, Ernest; Hancock, John F.			Staurosporines Disrupt Phosphatidylserine Trafficking and Mislocalize Ras Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; K-RAS; H-RAS; KINASE-C; DEPENDENT ASSOCIATION; CELLULAR MEMBRANES; LOCALIZATION; ENDOSOMES; PHOSPHOLIPIDS; MICROTUBULES	Oncogenic mutant Ras is frequently expressed in human cancers, but no anti-Ras drugs have been developed. Since membrane association is essential for Ras biological activity, we developed a high content assay for inhibitors of Ras plasma membrane localization. We discovered that staurosporine and analogs potently inhibit Ras plasma membrane binding by blocking endosomal recycling of phosphatidylserine, resulting in redistribution of phosphatidylserine from plasma membrane to endomembrane. Staurosporines are more active against K-Ras than H-Ras. K-Ras is displaced to endosomes and undergoes proteasomal-independent degradation, whereas H-Ras redistributes to the Golgi and is not degraded. K-Ras nanoclustering on the plasma membrane is also inhibited. Ras mislocalization does not correlate with protein kinase C inhibition or induction of apoptosis. Staurosporines selectively abrogate K-Ras signaling and proliferation of K-Ras-transformed cells. These results identify staurosporines as novel inhibitors of phosphatidylserine trafficking, yield new insights into the role of phosphatidylserine and electrostatics in Ras plasma membrane targeting, and validate a new target for anti-Ras therapeutics.	[Cho, Kwang-jin; Park, Jin-Hee; Gorfe, Alemaheyu A.; Hancock, John F.] Univ Texas Houston, Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, St Lucia, Qld 4072, Australia; [Piggott, Andrew M.; Salim, Angela A.; Capon, Robert J.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia; [Lacey, Ernest] Microbial Screening Technol Pty Ltd, Smithfield, NSW 2164, Australia	University of Texas System; University of Texas Health Science Center Houston; University of Queensland; University of Queensland	Hancock, JF (corresponding author), Univ Texas Houston, Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	john.f.hancock@uth.tmc.edu	Salim, Angela/J-4884-2014; Parton, Robert G/C-5673-2009; Capon, Robert/G-9238-2012; Piggott, Andrew M/G-9259-2012; Cho, Kwang-jin/AAI-4923-2020	Salim, Angela/0000-0002-8177-5689; Parton, Robert G/0000-0002-7494-5248; Capon, Robert/0000-0002-8341-7754; Piggott, Andrew M/0000-0002-5308-5314; Hancock, John/0000-0003-0542-4710	Cancer Prevention and Research Institute of Texas [RP100483]; Australian Research Council	Cancer Prevention and Research Institute of Texas; Australian Research Council(Australian Research Council)	This work was supported by the Cancer Prevention and Research Institute of Texas Grant RP100483 (to J.F.H.) and the Australian Research Council.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; COURAGE C, 1995, BRIT J CANCER, V71, P697, DOI 10.1038/bjc.1995.137; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Elad G, 1999, BBA-MOL CELL RES, V1452, P228, DOI 10.1016/S0167-4889(99)00144-5; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fong-ngern K, 2009, ANAL BIOCHEM, V395, P25, DOI 10.1016/j.ab.2009.08.007; Gorfe AA, 2008, BIOPHYS J, V95, P3269, DOI 10.1529/biophysj.108.136481; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Janosi L, 2010, BIOPHYS J, V99, P3666, DOI 10.1016/j.bpj.2010.10.031; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Okeley NM, 2004, J BIOL CHEM, V279, P21833, DOI 10.1074/jbc.M313469200; OSADA H, 1992, J ANTIBIOT, V45, P189, DOI 10.7164/antibiotics.45.189; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; SEYNAEVE CM, 1994, MOL PHARMACOL, V45, P1207; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Wang G, 2006, MOL CELL BIOL, V26, P3243, DOI 10.1128/MCB.26.8.3243-3255.2006; Weise K, 2011, J AM CHEM SOC, V133, P880, DOI 10.1021/ja107532q; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200	50	65	65	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43573	43584		10.1074/jbc.M112.424457	http://dx.doi.org/10.1074/jbc.M112.424457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23124205	Green Published, hybrid			2022-12-25	WOS:000312940800038
J	Lipari, MT; Li, W; Moran, P; Kong-Beltran, M; Sai, T; Lai, J; Lin, SJ; Kolumam, G; Zavala-Solorio, J; Izrael-Tomasevic, A; Arnott, D; Wang, JY; Peterson, AS; Kirchhofer, D				Lipari, Michael T.; Li, Wei; Moran, Paul; Kong-Beltran, Monica; Sai, Tao; Lai, Joyce; Lin, S. Jack; Kolumam, Ganesh; Zavala-Solorio, Jose; Izrael-Tomasevic, Anita; Arnott, David; Wang, Jianyong; Peterson, Andrew S.; Kirchhofer, Daniel			Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; LDL-CHOLESTEROL; NONHUMAN-PRIMATES; PROSTATE-CANCER; SECRETED PCSK9; DEGRADATION; ANTIBODY; HYPERCHOLESTEROLEMIA; MUTATIONS; BINDING	Proprotein convertase subtilisin/kexin 9 (PCSK9) regulates plasma LDL cholesterol levels by regulating the degradation of LDL receptors. Another proprotein convertase, furin, cleaves PCSK9 at Arg(218)-Gln(219) in the surface-exposed "218 loop." This cleaved form circulates in blood along with the intact form, albeit at lower concentrations. To gain a better understanding of how cleavage affects PCSK9 function, we produced recombinant furin-cleaved PCSK9 using antibody Ab-3D5, which binds the intact but not the cleaved 218 loop. Using Ab-3D5, we also produced highly purified hepsin-cleaved PCSK9. Hepsin cleaves PCSK9 at Arg(218)-Gln(219) more efficiently than furin but also cleaves at Arg(215)-Phe(216). Further analysis by size exclusion chromatography and mass spectrometry indicated that furin and hepsin produced an internal cleavage in the 218 loop without the loss of the N-terminal segment (Ser(153)-Arg(218)), which remained attached to the catalytic domain. Both furin-and hepsin-cleaved PCSK9 bound to LDL receptor with only 2-fold reduced affinity compared with intact PCSK9. Moreover, they reduced LDL receptor levels in HepG2 cells and in mouse liver with only moderately lower activity than intact PCSK9, consistent with the binding data. Single injection into mice of furin-cleaved PCSK9 resulted in significantly increased serum cholesterol levels, approaching the increase by intact PCSK9. These findings indicate that circulating furin-cleaved PCSK9 is able to regulate LDL receptor and serum cholesterol levels, although somewhat less efficiently than intact PCSK9. Therapeutic anti-PCSK9 approaches that neutralize both forms should be the most effective in preserving LDL receptors and in lowering plasma LDL cholesterol.	[Lipari, Michael T.; Li, Wei; Moran, Paul; Lin, S. Jack; Arnott, David; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Kong-Beltran, Monica; Peterson, Andrew S.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Sai, Tao; Lai, Joyce] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Kolumam, Ganesh; Zavala-Solorio, Jose] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Izrael-Tomasevic, Anita; Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Wang, Jianyong] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kirchhofer, D (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	dak@gene.com						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Duff CJ, 2011, EXPERT OPIN THER TAR, V15, P157, DOI 10.1517/14728222.2011.547480; Duff CJ, 2009, BIOCHEM J, V419, P577, DOI 10.1042/BJ20082407; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Ganesan R, 2012, PROTEIN ENG DES SEL, V25, P127, DOI 10.1093/protein/gzr067; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Magee JA, 2001, CANCER RES, V61, P5692; Malby S, 2001, BIOCHEMISTRY-US, V40, P2555, DOI 10.1021/bi002322l; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Troutt JS, 2010, J LIPID RES, V51, P345, DOI 10.1194/jlr.M000620; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	39	65	85	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43482	43491		10.1074/jbc.M112.380618	http://dx.doi.org/10.1074/jbc.M112.380618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135270	hybrid, Green Published			2022-12-25	WOS:000312940800029
J	Borgstrom, E; Andersen, P; Atterfelt, F; Julander, I; Kallenius, G; Maeurer, M; Rosenkrands, I; Widfeldt, M; Bruchfeld, J; Gaines, H				Borgstrom, Emilie; Andersen, Peter; Atterfelt, Fredrik; Julander, Inger; Kallenius, Gunilla; Maeurer, Markus; Rosenkrands, Ida; Widfeldt, Maria; Bruchfeld, Judith; Gaines, Hans			Immune Responses to ESAT-6 and CFP-10 by FASCIA and Multiplex Technology for Diagnosis of M. tuberculosis Infection; IP-10 Is a Promising Marker	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; SINGLE-CELL LEVEL; WHOLE-BLOOD; INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; CYTOKINE PROFILES; TOOLS; LYMPHOPROLIFERATION; CXCL10/IP-10; BIOMARKERS	Background: There is a need for reliable markers to diagnose active and latent tuberculosis (TB). The interferon gamma release assays (IGRAs) are compared to the tuberculin skin test (TST) more specific, but cannot discriminate between recent or remote TB infection. Here the Flow-cytometric Assay for Specific Cell-mediated Immune-response in Activated whole blood (FASCIA), which quantifies expanded T-lymphoblasts by flow-cytometric analysis after long-term antigen stimulation of whole blood, is combined with cytokine/chemokine analysis in the supernatant by multiplex technology for diagnosis of Mycobacterium tuberculosis (Mtb) infection. Methods and Findings: Consecutive patients with suspected TB (n = 85), with microbiologically verified active pulmonary TB (n = 33), extra pulmonary TB (n = 21), clinical TB (n = 11), presumed latent TB infection (LTBI) (n = 23), patients negative for TB (n = 8) and 21 healthy controls were studied. Blood samples were analyzed with FASCIA and multiplex technology to determine and correlate proliferative responses and the value of 14 cytokines for diagnosis of Mtb infection: IFN- gamma, IL-2, TNF-alpha, IP-10, IL-12, IL-6, IL-4, IL-5, IL-13, IL-17, MIP-1 beta, GM-CSF, IFN-alpha 2 and IL-10. Cytokine levels for IFN-gamma, IP-10, MIP-1 beta, IL-2, TNF-alpha, IL-6, IL-10, IL-13 and GM-CSF were significantly higher after stimulation with the Mtb specific antigens ESAT-6 and CFP-10 in patients with active TB compared to healthy controls (p<0.05) and correlated with proliferative responses. IP-10 was positive in all patients with verified TB, if using a combination of ESAT-6 and CFP-10 and was the only marker significantly more sensitive in detecting active TB then IFN-gamma (p = 0.012). Cytokine responses in patients with active TB were more frequent and detected at higher levels than in patients with LTBI. Conclusions: IP-10 seems to be an important marker for diagnosis of active and latent TB. Patients with active TB and LTBI responded with similar cytokine profiles against TB antigens but proliferative and cytokine responses were generally higher in patients with active TB. Citation: Borgstrom E, Andersen P, Atterfelt F, Julander I, Kallenius G, et al. (2012) Immune Responses to ESAT-6 and CFP-10 by FASCIA and Multiplex Technology for Diagnosis of M. tuberculosis Infection; IP-10 Is a Promising Marker. PLoS ONE 7(11): e43438. doi:10.1371/journal.pone.0043438	[Borgstrom, Emilie; Julander, Inger; Bruchfeld, Judith] Karolinska Univ Hosp, Karolinska Inst, Inst Med, Infect Dis Unit, Stockholm, Sweden; [Andersen, Peter; Rosenkrands, Ida] Statens Serum Inst, DK-2300 Copenhagen S, Denmark; [Atterfelt, Fredrik; Widfeldt, Maria; Gaines, Hans] Swedish Inst Communicable Dis Control, Stockholm, Sweden; [Kallenius, Gunilla] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, S-10064 Stockholm, Sweden; [Maeurer, Markus] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Statens Serum Institut; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet	Borgstrom, E (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Inst Med, Infect Dis Unit, Stockholm, Sweden.	emilie.wahren-borgstrom@karolinska.se	Källenius, Gunilla/AGZ-3956-2022	Andersen, Peter/0000-0002-5869-2551; Kallenius, Gunilla/0000-0002-8921-0551; Maeurer, Markus/0000-0002-8436-8077	Stockholm County Council; Karolinska Institutet through the regional agreement on medical training and clinical research (ALF); Swedish Heart-Lung Foundation	Stockholm County Council(Stockholm County Council); Karolinska Institutet through the regional agreement on medical training and clinical research (ALF); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	The FASCIA was performed at the Swedish Institute of Communicable Disease Control, in Stockholm. This work received financial support from Stockholm County Council and Karolinska Institutet through the regional agreement on medical training and clinical research (ALF) and from the Swedish Heart-Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Borgstrom E, 2011, J IMMUNOL METHODS, V370, P55, DOI 10.1016/j.jim.2011.05.008; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dlugovitzky D, 1997, FEMS IMMUNOL MED MIC, V18, P203, DOI 10.1016/S0928-8244(97)00040-0; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gaines H, 1996, J IMMUNOL METHODS, V195, P63, DOI 10.1016/0022-1759(96)00085-3; Gaines H, 2000, METH MOL B, V134, P243; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; He XY, 2010, EUR J CLIN MICROBIOL, V29, P643, DOI 10.1007/s10096-010-0908-0; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Lagrelius M, 2006, CYTOKINE, V33, P156, DOI 10.1016/j.cyto.2006.01.005; Lalor MK, 2010, VACCINE, V28, P1635, DOI 10.1016/j.vaccine.2009.11.004; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Rahman S, 2009, AM J PATHOL, V174, P2211, DOI 10.2353/ajpath.2009.080941; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Rieder HL, 1996, EUR RESPIR J, V9, P1097, DOI 10.1183/09031936.96.09051097; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Svahn A, 2003, J IMMUNOL METHODS, V277, P17, DOI 10.1016/S0022-1759(03)00111-X; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	48	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2012	7	11							e43438	10.1371/journal.pone.0043438	http://dx.doi.org/10.1371/journal.pone.0043438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053KE	23144772	Green Submitted, gold, Green Published			2022-12-25	WOS:000312269500001
J	Li, XX; Xu, K; Li, W; Qiu, XC; Ma, BA; Fan, QY; Li, Z				Li, Xiaoxiang; Xu, Kui; Li, Wei; Qiu, Xiuchun; Ma, Baoan; Fan, Qingyu; Li, Zhao			Immunologic Response to Tumor Ablation with Irreversible Electroporation	PLOS ONE			English	Article							RADIOFREQUENCY THERMAL ABLATION; SOLUBLE INTERLEUKIN-2 RECEPTOR; ANTIGEN-PRESENTING CELL; BREAST-CANCER; INFLAMMATORY RESPONSE; C6 GLIOMAS; OSTEOSARCOMA; CRYOSURGERY; METASTASES; SURVIVAL	Background: Irreversible electroporation (IRE) is a promising technique for the focal treatment of pathologic tissues, which involves placing minimally invasive electrodes within the targeted region. However, the knowledge about the therapeutic efficacy and immune reactions in response to IRE remains in its infancy. Methods: In this work, to detect whether tumor ablation with IRE could trigger the immunologic response, we developed an osteosarcoma rat model and applied IRE directly to ablate the tumor. In the experiment, 118 SD rats were randomized into 4 groups: the control, sham operation, surgical resection, and IRE groups. Another 28 rats without tumor cell implantation served as the normal non-tumor-bearing group. We analyzed the changes in T lymphocyte subsets, sIL-2R and IL-10 levels in the peripheral blood one day before operation, as well as at 1, 3, 7,14 and 21 days after the operation. Moreover, splenocytes were assayed for IFN-gamma and IL-4 production using intracellular cytokine staining one day before the operation, as well as at 7 and 21 days after operation. Results: We found that direct IRE completely ablated the tumor cells. A significant increase in peripheral lymphocytes, especially CD3(+) and CD4(+) cells, as well as an increased ratio of CD4(+)/CD8(+) were detectable 7 days after operation in both the IRE and surgical resection groups. Compared with the surgical resection group, the IRE group exhibited a stronger cellular immune response. The sIL-2R level of the peripheral blood in the IRE group decreased with time and was significantly different from that in the surgical resection group. Moreover, ablation with IRE significantly increased the percentage of IFN-gamma-positive splenocytes. Conclusion: These findings indicated that IRE could not only locally destroy the tumor but also change the status of cellular immunity in osteosarcoma-bearing rats. This provides experimental evidence for the clinical application of IRE in osteosarcoma treatment.	[Li, Xiaoxiang; Xu, Kui; Li, Wei; Qiu, Xiuchun; Ma, Baoan; Fan, Qingyu; Li, Zhao] Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Shannxi, Peoples R China	Air Force Military Medical University	Fan, QY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Shannxi, Peoples R China.	bonetm@fmmu.edu.cn; leelieber@gmail.com		Li, Zhao/0000-0002-9276-9129				Al-Sakere B, 2007, TECHNOL CANCER RES T, V6, P301, DOI 10.1177/153303460700600406; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; BRIVIO F, 1991, AM J SURG, V161, P466, DOI 10.1016/0002-9610(91)91113-W; Callstrom MR, 2006, RADIOLOGY, V241, P572, DOI 10.1148/radiol.2412051247; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Clasen S, 2008, CANCER, V113, P3121, DOI 10.1002/cncr.23882; Dromi SA, 2009, RADIOLOGY, V251, P58, DOI 10.1148/radiol.2511072175; Dupuy DE, 2011, CARDIOVASC INTER RAD, V34, P391, DOI 10.1007/s00270-010-0091-9; Fietta AM, 2009, HUM IMMUNOL, V70, P477, DOI 10.1016/j.humimm.2009.03.012; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Gazzaniga S, 2001, J INVEST DERMATOL, V116, P664, DOI 10.1046/j.0022-202x.2001.01313.x; Gillams AR, 2008, J VASC INTERV RADIOL, V19, P712, DOI 10.1016/j.jvir.2008.01.016; Goldberg SN, 2009, J VASC INTERV RADIOL, V20, pS377, DOI 10.1016/j.jvir.2009.04.011; Gravante G, 2009, LIVER INT, V29, P18, DOI 10.1111/j.1478-3231.2008.01915.x; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Hernberg M, 1996, J CLIN ONCOL, V14, P1690, DOI 10.1200/JCO.1996.14.5.1690; Hoffmann NE, 2002, UROLOGY, V60, P40, DOI 10.1016/S0090-4295(02)01683-7; Howell WM, 2006, FAM CANCER, V5, P143, DOI 10.1007/s10689-005-0072-3; Huss DJ, 2010, J IMMUNOL, V184, P5628, DOI 10.4049/jimmunol.1000288; Langsenlehner U, 2005, BREAST CANCER RES TR, V90, P113, DOI 10.1007/s10549-004-3607-7; Lee EW, 2012, J VASC INTERV RADIOL, V23, P107, DOI 10.1016/j.jvir.2011.09.020; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; Lee EW, 2010, RADIOLOGY, V255, P426, DOI 10.1148/radiol.10090337; Li M, 2011, TECHNOL CANCER RES T, V10, P95, DOI 10.7785/tcrt.2012.500183; Li M, 2010, TECHNOL CANCER RES T, V9, P87, DOI 10.1177/153303461000900110; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Liu JG, 2011, TECHNOL CANCER RES T, V10, P339, DOI 10.7785/tcrt.2012.500211; Machlenkin A, 2005, CLIN CANCER RES, V11, P4955, DOI 10.1158/1078-0432.CCR-04-2422; Mafune K, 2000, ANN SURG ONCOL, V7, P609, DOI 10.1007/BF02725341; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Maor E, 2010, J VASC INTERV RADIOL, V21, P1708, DOI 10.1016/j.jvir.2010.06.024; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Murakami S, 2002, DIGEST SURG, V19, P9, DOI 10.1159/000051999; Naumnik W, 2004, Rocz Akad Med Bialymst, V49, P246; Neal RE, 2010, BREAST CANCER RES TR, V123, P295, DOI 10.1007/s10549-010-0803-5; Nijkamp MW, 2010, J SURG ONCOL, V101, P551, DOI 10.1002/jso.21570; Pech M, 2011, CARDIOVASC INTER RAD, V34, P132, DOI 10.1007/s00270-010-9964-1; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sakata Hideto, 2002, Int J Clin Oncol, V7, P312; Sanchez-Ortiz RF, 2003, J UROLOGY, V170, P178, DOI 10.1097/01.ju.0000070823.38336.7b; Schoellnast H, 2011, RADIOLOGY, V260, P421, DOI 10.1148/radiol.11103505; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Whiteside TL, 2003, CANC MED, P221; Widenmeyer M, 2011, INT J CANCER, V128, P2653, DOI 10.1002/ijc.25601; Wissniowski TT, 2003, CANCER RES, V63, P6496; Wu F, 2004, ULTRASOUND MED BIOL, V30, P1217, DOI 10.1016/j.ultrasmedbio.2004.08.003; Wu F, 2007, ANN SURG ONCOL, V14, P1237, DOI 10.1245/s10434-006-9275-6; Yao Z, 2004, IMMUNOLOGY, P100; Yu Z, 2009, ONCOL REP, V21, P1175, DOI 10.3892/or_00000338; Zerbini A, 2006, CANCER RES, V66, P1139, DOI 10.1158/0008-5472.CAN-05-2244; Zhou L, 2010, J GASTROENTEROL, V45, P968, DOI 10.1007/s00535-010-0243-3	53	54	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48749	10.1371/journal.pone.0048749	http://dx.doi.org/10.1371/journal.pone.0048749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139816	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300055
J	Wang, HS; Wu, HM; Cheng, BH; Yen, CF; Chang, PY; Chao, A; Lee, YS; Huang, HD; Wang, TH				Wang, Hsin-Shih; Wu, Hsien-Ming; Cheng, Bi-Hwa; Yen, Chih-Feng; Chang, Pi-Yueh; Chao, Angel; Lee, Yun-Shien; Huang, Hsien-Da; Wang, Tzu-Hao			Functional Analyses of Endometriosis-Related Polymorphisms in the Estrogen Synthesis and Metabolism-Related Genes	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; SINGLE-NUCLEOTIDE POLYMORPHISMS; PHOSPHORYLATION SITES; AMNIOTIC-FLUID; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE 3; ANDROGEN RECEPTOR; OVARIAN RESPONSE; PROTEIN; RISK; ASSOCIATION	Endometriosis is determined by genetic factors, and the prevalence of genetic polymorphisms varies greatly depending on the ethnic group studied. The objective of this study was to investigate the relationship between single nucleotide polymorphisms (SNPs) of 9 genes involved in estrogen biosynthesis and metabolism and the risks of endometriosis. Three hundred patients with endometriosis and 337 non-endometriotic controls were recruited. Thirty four non-synonymous SNPs, which change amino acid residues, were analyzed using matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS). The functions of SNP-resulted amino acid changes were analyzed using multiple web-accessible databases and phosphorylation predicting algorithms. Among the 34 NCBI-listed SNPs, 22 did not exhibit polymorphism in this study of more than 600 Taiwanese Chinese women. However, homozygous and heterozygous mutants of 4 SNPs - rs6165 (genotype GG+GA, 307(Ala/Ala)+307(Ala/Thr)) of FSHR, rs 6166 (genotype GG+GA, 680(Ser/Asn)+680(Ser/Ser)) of FSHR, rs2066479 (genotype AA+AG, 289(Ser/Ser)+289(Ser/Gly)) of HSD17B3 and rs700519 (genotype TT+TC, 264(Cys/Cys)+264(Cys/Arg)) of CYP19, alone or in combination, were significantly associated with decreased risks of endometriosis. Bioinformatics results identified 307(Thr) of FSHR to be a site for O-linked glycosylation, 680(Ser) of FSHR a phosphorylated site by protein kinase B, and 289(Ser) of HSD17B3 a phosphorylated site by protein kinase B or ribosomal protein S6 kinase 1. Results of this study suggest that non-synonymous polymorphisms of FSHR, HSD17B3 and CYP19 genes may modulate the risk of endometriosis in Taiwanese Chinese women. Identification of the endometrosis-preferential non-synonymous SNPs and the conformational changes in those proteins may pave the way for the development of more disease-specific drugs.	[Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Tao Yuan, Taiwan; [Wang, Hsin-Shih; Wu, Hsien-Ming; Yen, Chih-Feng; Chao, Angel; Wang, Tzu-Hao] Chang Gung Univ, Chang Gung Mem Hosp, Dept Obstet & Gynecol, Lin Kou Med Ctr, Tao Yuan, Taiwan; [Wang, Hsin-Shih; Cheng, Bi-Hwa] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan; [Cheng, Bi-Hwa] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Chang, Pi-Yueh] Chang Gung Univ, Chang Gung Mem Hosp, Dept Lab Med, Lin Kou Med Ctr, Tao Yuan, Taiwan; [Lee, Yun-Shien; Wang, Tzu-Hao] Chang Gung Mem Hosp, Genom Med Res Core Lab, Tao Yuan, Taiwan	National Yang Ming Chiao Tung University; Ming Chuan University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, HD (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Dept Biol Sci & Technol, Hsinchu, Taiwan.	bryan@faculty.nctu.edu.tw; knoxtn@cgmh.org.tw	Yen, Chih-Feng/AAD-4023-2021; Yen, Chih-Feng/GQI-2704-2022; Huang, Hsien-Da/AAA-7376-2019	Yen, Chih-Feng/0000-0002-5419-2605; Yen, Chih-Feng/0000-0002-5419-2605; 	Chang Gung Memorial Hospital [CMRPG-340291, CMRPG-340292]; National Science Council, Taiwan [NSC100-2911-I-009-101, NSC92-2314-B-182A-054, NSC92-2314-B-182-037, NSC95-2314-B-182-061]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Chang Gung Memorial Hospital to HSW (CMRPG-340291, CMRPG-340292), as well as the National Science Council, Taiwan, to HDH (NSC100-2911-I-009-101), to THW (NSC92-2314-B-182A-054) and to HSW (NSC92-2314-B-182-037, NSC95-2314-B-182-061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; BERGQVIST IA, 1995, HUM REPROD, V10, P446, DOI 10.1093/oxfordjournals.humrep.a135960; Berkley KJ, 2005, SCIENCE, V308, P1587, DOI 10.1126/science.1111445; Bischoff FZ, 2000, HUM REPROD UPDATE, V6, P37, DOI 10.1093/humupd/6.1.37; Boehmer ALM, 1999, J CLIN ENDOCR METAB, V84, P4713, DOI 10.1210/jc.84.12.4713; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carneiro MM, 2008, BJOG-INT J OBSTET GY, V115, P113, DOI 10.1111/j.1471-0528.2007.01521.x; Chang KP, 2007, ORAL ONCOL, V43, P345, DOI 10.1016/j.oraloncology.2006.04.006; Chen JY, 2006, ARTHRITIS RHEUM-US, V54, P3908, DOI 10.1002/art.22220; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cheng YH, 2006, BIOL REPROD, V75, P605, DOI 10.1095/biolreprod.106.051912; Cho YJ, 2007, J ASSIST REPROD GEN, V24, P271, DOI 10.1007/s10815-007-9122-0; Christofolini DM, 2011, GYNECOL ENDOCRINOL, V27, P1099, DOI 10.3109/09513590.2011.569797; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daelemans C, 2004, J CLIN ENDOCR METAB, V89, P6310, DOI 10.1210/jc.2004-1044; de Castro F, 2003, FERTIL STERIL, V80, P571, DOI 10.1016/S0015-0282(03)00795-7; DMOWSKI WP, 1990, J REPROD MED, V35, P69; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Falcone T, 2010, OBSTET GYNECOL, V116, P440, DOI [10.1097/AOG.0b013e3181ea4fb6, 10.1097/AOG.0b013e3181e8b073]; Falconer H, 2007, OBSTET GYNECOL SURV, V62, P616, DOI 10.1097/01.ogx.0000279293.60436.60; Garry R, 2006, FERTIL STERIL, V86, P1307, DOI 10.1016/j.fertnstert.2006.06.045; Hanna IH, 2000, CANCER RES, V60, P3440; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang HD, 2005, J COMPUT CHEM, V26, P1032, DOI 10.1002/jcc.20235; Huber A, 2005, OBSTET GYNECOL, V106, P1025, DOI 10.1097/01.AOG.0000185259.01648.41; Juo SH, 2006, HUM REPROD, V21, P1498, DOI 10.1093/humrep/del033; Juo SHH, 2009, FERTIL STERIL, V92, P1228, DOI 10.1016/j.fertnstert.2008.08.015; Kado N, 2002, HUM REPROD, V17, P897, DOI 10.1093/humrep/17.4.897; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kim SH, 2005, HUM REPROD, V20, P2904, DOI 10.1093/humrep/dei146; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Lee TY, 2011, NUCLEIC ACIDS RES, V39, pD777, DOI 10.1093/nar/gkq970; Lee Tzong-Yi, 2009, BMC Res Notes, V2, P111, DOI 10.1186/1756-0500-2-111; Lessey BA, 2000, FERTIL STERIL, V73, P1089, DOI 10.1016/S0015-0282(00)00519-7; Lobo RA, 2005, NEW ENGL J MED, V353, P64, DOI 10.1056/NEJMra043475; Mason CW, 2006, AM J OBSTET GYNECOL, V194, P1513, DOI 10.1016/j.ajog.2005.12.044; Mayorga MP, 2000, J CLIN ENDOCR METAB, V85, P3365, DOI 10.1210/jc.85.9.3365; Mindnich R, 2005, J MOL ENDOCRINOL, V35, P305, DOI 10.1677/jme.1.01853; Moller G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010969; Moghrabi N, 1998, J CLIN ENDOCR METAB, V83, P2855, DOI 10.1210/jc.83.8.2855; Newbold RR, 2000, CANCER RES, V60, P235; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Sata F, 2010, J SEX MED, V7, P2729, DOI 10.1111/j.1743-6109.2009.01641.x; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Spadaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029252; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; TAGUCHI M, 1995, GYNECOL OBSTET INVES, V39, P192, DOI 10.1159/000292407; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Tsuchiya M, 2005, HUM REPROD, V20, P974, DOI 10.1093/humrep/deh726; Ueki K, 2004, INT J GYNECOL PATHOL, V23, P248, DOI 10.1097/01.pgp.0000130109.80359.57; Vietri MT, 2009, FERTIL STERIL, V92, P1532, DOI 10.1016/j.fertnstert.2008.07.1786; Wang CN, 2010, J CLIN ENDOCR METAB, V95, P1431, DOI 10.1210/jc.2009-1954; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025011; Wang HS, 2011, FERTIL STERIL, V95, P455, DOI 10.1016/j.fertnstert.2010.07.1092; Wang TH, 2009, FERTIL STERIL, V92, P96, DOI 10.1016/j.fertnstert.2008.05.038; Wang Z, 2004, FERTIL STERIL, V81, P1650, DOI 10.1016/j.fertnstert.2004.02.094; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; YAMASHITA S, 1994, GYNECOL OBSTET INVES, V38, P245, DOI 10.1159/000292490; Zondervan KT, 2002, HUM REPROD, V17, P1415, DOI 10.1093/humrep/17.6.1415	63	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47374	10.1371/journal.pone.0047374	http://dx.doi.org/10.1371/journal.pone.0047374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139742	gold, Green Submitted, Green Published			2022-12-25	WOS:000311315300008
J	Dib, L; Carbone, A				Dib, Linda; Carbone, Alessandra			Protein Fragments: Functional and Structural Roles of Their Coevolution Networks	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; MUTUAL INFORMATION; IN-VITRO; SEQUENCE; HELICASES; RESIDUES; PATHWAYS; MODEL; NEURODEGENERATION; IDENTIFICATION	Small protein fragments, and not just residues, can be used as basic building blocks to reconstruct networks of coevolved amino acids in proteins. Fragments often enter in physical contact one with the other and play a major biological role in the protein. The nature of these interactions might be multiple and spans beyond binding specificity, allosteric regulation and folding constraints. Indeed, coevolving fragments are indicators of important information explaining folding intermediates, peptide assembly, key mutations with known roles in genetic diseases, distinguished subfamily-dependent motifs and differentiated evolutionary pressures on protein regions. Coevolution analysis detects networks of fragments interaction and highlights a high order organization of fragments demonstrating the importance of studying at a deeper level this structure. We demonstrate that it can be applied to protein families that are highly conserved or represented by few sequences, enlarging in this manner, the class of proteins where coevolution analysis can be performed and making large-scale coevolution studies a feasible goal.	[Dib, Linda; Carbone, Alessandra] Univ Paris 06, UMR 7238, Equipe Genom Analyt, Paris, France; [Dib, Linda; Carbone, Alessandra] CNRS, UMR 7238, Lab Genom Microorganismes, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Carbone, A (corresponding author), Univ Paris 06, UMR 7238, Equipe Genom Analyt, Paris, France.	Alessandra.Carbone@lip6.fr		Carbone, Alessandra/0000-0003-2098-5743	Ministere de l'Enseignement Superieure et de la Recherche (MESR) doctoral fellowship; MESR teaching assistantship (ATER) (LD) adnd UPMC; CNRS	Ministere de l'Enseignement Superieure et de la Recherche (MESR) doctoral fellowship; MESR teaching assistantship (ATER) (LD) adnd UPMC; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a Ministere de l'Enseignement Superieure et de la Recherche (MESR) doctoral fellowship, a MESR teaching assistantship (ATER) (LD) adnd UPMC and CNRS annual funding (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bai YW, 1997, PROTEIN SCI, V6, P1449, DOI 10.1002/pro.5560060709; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Baussand J, 2007, PROTEINS, V67, P695, DOI 10.1002/prot.21319; Baussand J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000488; Bornebroek M, 2003, NEUROBIOL DIS, V14, P619, DOI 10.1016/j.nbd.2003.08.019; Bu ZM, 2007, BIOPHYS J, V92, P594, DOI 10.1529/biophysj.106.091017; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; COTMAN CW, 1995, MOL NEUROBIOL, V10, P19, DOI 10.1007/BF02740836; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Delobette S, 1996, EUR J PHARMACOL, V319, P1; Dib L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-194; Dima RI, 2006, PROTEIN SCI, V15, P258, DOI 10.1110/ps.051767306; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; Engelen S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000267; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Flood JF, 1994, P NATL ACAD SCI USA, V91, P380; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Ghiso J, 2001, J ALZHEIMERS DIS, V3, P65, DOI 10.3233/JAD-2001-3110; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hardy J, 2011, EMBO MOL MED, V3, P247, DOI 10.1002/emmm.201100139; Haspel N, 2003, PROTEIN SCI, V12, P1177, DOI 10.1110/ps.0232903; Haspel N, 2003, PROTEINS, V51, P203, DOI 10.1002/prot.10294; Innis CA, 2007, NUCLEIC ACIDS RES, V35, pW489, DOI 10.1093/nar/gkm422; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kifer I, 2008, PROTEINS, V73, P380, DOI 10.1002/prot.22073; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; Kosik KS, 1999, P NATL ACAD SCI USA, V96, P2574, DOI 10.1073/pnas.96.6.2574; Kuriyan J, 2004, CELL, V116, P354, DOI 10.1016/S0092-8674(04)00125-4; LESK AM, 1981, P NATL ACAD SCI-BIOL, V78, P4304, DOI 10.1073/pnas.78.7.4304; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Ramani AK, 2003, J MOL BIOL, V327, P273, DOI 10.1016/S0022-2836(03)00114-1; Sato S, 2006, J MOL BIOL, V360, P850, DOI 10.1016/j.jmb.2006.05.051; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Selvaraj S, 2003, BIOPHYS J, V84, P1919, DOI 10.1016/S0006-3495(03)75000-0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Tsai CJ, 2000, P NATL ACAD SCI USA, V97, P12038, DOI 10.1073/pnas.97.22.12038; Tsai CJ, 2001, PROTEIN ENG, V14, P723, DOI 10.1093/protein/14.10.723; Wang ZZ, 2000, STROKE, V31, P534, DOI 10.1161/01.STR.31.2.534; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wolynes PG, 2004, P NATL ACAD SCI USA, V101, P6837, DOI 10.1073/pnas.0402034101; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	75	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48124	10.1371/journal.pone.0048124	http://dx.doi.org/10.1371/journal.pone.0048124			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139761	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400039
J	Gao, XF; Yao, JJ; He, YL; Hu, CL; Mei, YA				Gao, Xiao-Fei; Yao, Jin-Jing; He, Yan-Lin; Hu, Changlong; Mei, Yan-Ai			Sigma-1 Receptor Agonists Directly Inhibit Na(V)1.2/1.4 Channels	PLOS ONE			English	Article							SODIUM-CHANNEL; NA+ CHANNELS; MOLECULAR DETERMINANTS; MODULATION; EXPRESSION; PHARMACOLOGY; CLONING; NOMENCLATURE; TERMINALS; CORTEX	(+)-SKF 10047 (N-allyl-normetazocine) is a prototypic and specific sigma-1 receptor agonist that has been used extensively to study the function of sigma-1 receptors. (+)-SKF 10047 inhibits K+, Na+ and Ca2+ channels via sigma-1 receptor activation. We found that (+)-SKF 10047 inhibited Na(V)1.2 and Na(V)1.4 channels independently of sigma-1 receptor activation. (+)-SKF 10047 equally inhibited Na(V)1.2/1.4 channel currents in HEK293T cells with abundant sigma-1 receptor expression and in COS-7 cells, which barely express sigma-1 receptors. The sigma-1 receptor antagonists BD 1063, BD 1047 and NE-100 did not block the inhibitory effects of (+)-SKF-10047. Blocking of the PKA, PKC and G-protein pathways did not affect (+)-SKF 10047 inhibition of Na(V)1.2 channel currents. The sigma-1 receptor agonists Dextromethorphan (DM) and 1,3-di-o-tolyl-guanidine (DTG) also inhibited Na(V)1.2 currents through a sigma-1 receptor-independent pathway. The (+)-SKF 10047 inhibition of Na(V)1.2 currents was use-and frequency-dependent. Point mutations demonstrated the importance of Phe(1764) and Tyr(1771) in the IV-segment 6 domain of the Na(V)1.2 channel and Phe(1579) in the Na(V)1.4 channel for (+)-SKF 10047 inhibition. In conclusion, our results suggest that sigma-1 receptor agonists directly inhibit Na(V)1.2/1.4 channels and that these interactions should be given special attention for future sigma-1 receptor function studies.	[Hu, Changlong] Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Hu, CL (corresponding author), Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China.	clhu@fudan.edu.cn; yamei@fudan.edu.cn	Hu, Changlong/AAQ-8348-2020	Hu, Changlong/0000-0002-8609-8947; He, Yanlin/0000-0002-5471-9016	National Basic Research Program of China [2011CB503703]; Shanghai Leading Academic Discipline Project [B111]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by a grant from the National Basic Research Program of China (2011CB503703) and the Shanghai Leading Academic Discipline Project [B111]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydar E, 2004, CANCER RES, V64, P5029, DOI 10.1158/0008-5472.CAN-03-2329; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; Castaneda-Castellanos D, 2002, MOL BRAIN RES, V99, P102, DOI 10.1016/S0169-328X(01)00340-0; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cheng ZX, 2008, EXP NEUROL, V210, P128, DOI 10.1016/j.expneurol.2007.10.004; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Fu YM, 2010, BBA-MOL CELL RES, V1803, P1396, DOI 10.1016/j.bbamcr.2010.08.005; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hongling Z, 2010, INT J PHYSL PATH PHA, V2, P1; Hu CL, 2008, J NEUROCHEM, V106, P1125, DOI 10.1111/j.1471-4159.2008.05449.x; Johannessen M, 2011, AM J PHYSIOL-CELL PH, V300, pC328, DOI 10.1152/ajpcell.00383.2010; Johannessen M, 2009, AM J PHYSIOL-CELL PH, V296, pC1049, DOI 10.1152/ajpcell.00431.2008; Jurkat-Rott K, 2010, PFLUG ARCH EUR J PHY, V460, P239, DOI 10.1007/s00424-010-0814-4; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; Lamy C, 2010, EUR J PHARMACOL, V641, P23, DOI 10.1016/j.ejphar.2010.05.008; Lee JH, 2007, EUR J PHARMACOL, V564, P7, DOI 10.1016/j.ejphar.2007.01.088; Lipkind GM, 2005, MOL PHARMACOL, V68, P1611, DOI 10.1124/mol.105.014803; Lu CW, 2012, J PHARMACOL EXP THER, V341, P532, DOI 10.1124/jpet.111.191189; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mei JF, 2001, BIOCHEM PHARMACOL, V62, P349, DOI 10.1016/S0006-2952(01)00666-9; Monnet FP, 2005, BIOL CELL, V97, P873; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Schaller KL, 2003, CEREBELLUM, V2, P2, DOI 10.1080/14734220309424; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Seth P, 1998, J NEUROCHEM, V70, P922; Smith RD, 1997, J NEUROSCI, V17, P6086; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; Zhang XJ, 2011, NEUROSCIENCE, V177, P12, DOI 10.1016/j.neuroscience.2010.12.064	43	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49384	10.1371/journal.pone.0049384	http://dx.doi.org/10.1371/journal.pone.0049384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139844	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400074
J	Kapoula, Z; Gaertner, C; Matheron, E				Kapoula, Zoi; Gaertner, Chrystal; Matheron, Eric			Spherical Lenses and Prisms Lead to Postural Instability in Both Dyslexic and Non Dyslexic Adolescents	PLOS ONE			English	Article							2-DIOPTER VERTICAL PRISM; DEVELOPMENTAL DYSLEXIA; SCHOOL-CHILDREN; PROPRIOCEPTION; AUTOMATICITY; CONVERGENCE; STABILITY; BALANCE; YOUNG; AGE	There is controversy as to whether dyslexic children present systematic postural deficiency. Clinicians use a combination of ophthalmic prisms and proprioceptive soles to improve postural performances. This study examines the effects of convergent prisms and spherical lenses on posture. Fourteen dyslexics (13-17 years-old) and 11 non dyslexics (13-16 years-old) participated in the study. Quiet stance posturography was performed with the TechnoConcept device while subjects fixated a target at eye-level from a distance of 1_m. Four conditions were run: normal viewing; viewing the target with spherical lenses of -1 diopter (ACCOM1) over each eye; viewing with -3 diopters over each eye (ACCOM3); viewing with a convergent prism of 8 diopters per eye. Relative to normal viewing, the -1 lenses increased the surface of body sway significantly whereas the -3 diopter lenses only resulted in a significant increase of antero-posterior body sway. Thus, adolescents would appear to cope more effectively with stronger conflicts rather than subtle ones. The prism condition resulted in a significant increase in both the surface and the antero-posterior body sway. Importantly, all of these effects were similar for the two groups. Wavelet analysis (time frequency domain) revealed high spectral power of antero-posterior sway for the prism condition in both groups. In the ACCOM3 condition, the spectral power of antero-posterior sway decreased for non dyslexics but increased for dyslexics suggesting that dyslexics encounter more difficulty with accommodation. The cancelling time for medium range frequency (believed to be controlled by the cerebellum), was shorter in dyslexics, suggesting fewer instances of optimal control. We conclude that dyslexics achieve similar postural performances albeit less efficiently. Prisms and lenses destabilize posture for all teenagers. Thus, contrary to adults, adolescents do not seem to use efferent, proprioceptive ocular motor signals to improve their posture, at least not immediately when confronted to convergence accommodation conflict.	[Kapoula, Zoi; Gaertner, Chrystal; Matheron, Eric] Univ Paris 05, CNRS, IRIS Grp, Ctr Etud SensoriMotrices UMR8194, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Kapoula, Z (corresponding author), Univ Paris 05, CNRS, IRIS Grp, Ctr Etud SensoriMotrices UMR8194, Paris, France.	zoi.kapoula@egp.aphp.fr			CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This study is funded by CNRS (www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Bernard-Demanze L, 2009, Curr Aging Sci, V2, P139; BERTHOZ A, 1988, PROG BRAIN RES, V76, P411; Brandt T, 1999, VERTIGO ITS MULTISEN, P503; Brautaset RL, 2006, INVEST OPHTH VIS SCI, V47, P2876, DOI 10.1167/iovs.04-1372; Brookes RL, 2007, NEUROPSYCHOLOGIA, V45, P1921, DOI 10.1016/j.neuropsychologia.2006.11.019; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Buttmer U, 2006, PROG BRAIN RES, V151, P1, DOI 10.1016/S0079-6123(05)51001-X; Chevrie-Muller C, 1977, BATTERIE LANGAGE ORA; Ciuffreda KJ, 1983, VERGENCE EYE MOVEMEN; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; Ghulyan V, 2005, ACTA OTO-LARYNGOL, V125, P607, DOI 10.1080/00016480510026908; Han Y, 1998, ACTA OPHTHALMOL SCAN, V76, P283, DOI 10.1034/j.1600-0420.1998.760306.x; Jiang BC, 2005, VISION RES, V45, P2704, DOI 10.1016/j.visres.2005.03.016; Kapoula Z, 1999, EXP BRAIN RES, V126, P175, DOI 10.1007/s002210050727; Kapoula Z, 2007, J NEUROL, V254, P1174, DOI 10.1007/s00415-006-0460-0; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Kapoula Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019272; KohenRaz R, 1996, PERCEPT MOTOR SKILL, V82, P547, DOI 10.2466/pms.1996.82.2.547; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; MARUCCHI C, 1988, Agressologie, V29, P693; Matheron E, 2008, CLIN NEUROPHYSIOL, V119, P2314, DOI 10.1016/j.clinph.2008.06.016; Matheron E, 2008, NEUROSCI LETT, V444, P176, DOI 10.1016/j.neulet.2008.08.025; Matheron E, 2007, NEUROSCI LETT, V423, P236, DOI 10.1016/j.neulet.2007.07.016; Mutti DO, 2000, INVEST OPHTH VIS SCI, V41, P2469; Nashner L M, 1979, Prog Brain Res, V50, P177; Nicolson RI, 2010, DYSLEXIA, V16, P194, DOI 10.1002/dys.408; Nicolson RI, 2005, J NEURAL TRANSM-SUPP, P19; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; Paillard T, 2002, BRIT J SPORT MED, V36, P304, DOI 10.1136/bjsm.36.4.304; Palomo-Alvarez C, 2008, GRAEF ARCH CLIN EXP, V246, P1769, DOI 10.1007/s00417-008-0921-5; Palomo-Alvarez C, 2010, GRAEF ARCH CLIN EXP, V248, P885, DOI 10.1007/s00417-009-1251-y; Patel M, 2010, DYSLEXIA, V16, P162, DOI 10.1002/dys.398; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Perennou D, 2006, EFFICIENCE DEFICIENC, P65; PESTALOZZI D, 1992, KLIN MONATSBL AUGENH, V200, P614, DOI 10.1055/s-2008-1045844; PESTALOZZI D, 1993, ANN NY ACAD SCI, V682, P397, DOI 10.1111/j.1749-6632.1993.tb23004.x; Pozzo T, 2006, NEUROSCI LETT, V403, P211, DOI 10.1016/j.neulet.2006.03.049; PREVOST G, 1988, Agressologie, V29, P697; Quercia P, 2007, J FR OPHTALMOL, V30, P380, DOI 10.1016/S0181-5512(07)89608-2; Quercia P, 2005, J FR OPHTALMOL, V28, P713, DOI 10.1016/S0181-5512(05)80983-0; Quercia P, 2011, EXP BRAIN RES, V209, P599, DOI 10.1007/s00221-011-2593-3; Ramus F, 2003, J CHILD PSYCHOL PSYC, V44, P712, DOI 10.1111/1469-7610.00157; RIDDELL PM, 1990, PERCEPT MOTOR SKILL, V70, P707, DOI 10.2466/PMS.70.3.707-718; Rochelle KSH, 2006, J CHILD PSYCHOL PSYC, V47, P1159, DOI 10.1111/j.1469-7610.2006.01641.x; Rochelle KSH, 2009, EXP BRAIN RES, V192, P627, DOI 10.1007/s00221-008-1568-5; SCHWARZ C, 1992, KLIN MONATSBL AUGENH, V200, P599, DOI 10.1055/s-2008-1045842; Stavis Monte, 2002, Binocul Vis Strabismus Q, V17, P135; STEIN JF, 1987, EYE, V1, P433, DOI 10.1038/eye.1987.66; STEIN JF, 1988, BRIT J OPHTHALMOL, V72, P162, DOI 10.1136/bjo.72.3.162; Takagi A., 1985, VESTIBULAR VISUAL CO, P74; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093; Viel S, 2009, MOTOR CONTROL, V13, P25, DOI 10.1123/mcj.13.1.25; Von Noorden GK, 2002, BINOCULAR VISION OCU, V6th; Williams HG, 1997, ARCH PHYS MED REHAB, V78, P737, DOI 10.1016/S0003-9993(97)90082-4; Zanfirescu F, 1988, AGRESSOLOGIE, V29, P661	59	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e46739	10.1371/journal.pone.0046739	http://dx.doi.org/10.1371/journal.pone.0046739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144786	gold, Green Published, Green Submitted			2022-12-25	WOS:000310741400008
J	Zhao, JJ; Li, YG; Jin, L; Zhang, SY; Fan, R; Sun, YL; Zhou, CB; Shang, QH; Li, WG; Zhang, Z; Wang, FS				Zhao, Juanjuan; Li, Yonggang; Jin, Lei; Zhang, Shuye; Fan, Rong; Sun, Yanling; Zhou, Chunbao; Shang, Qinghua; Li, Wengang; Zhang, Zheng; Wang, Fu-Sheng			Natural Killer Cells Are Characterized by the Concomitantly Increased Interferon-gamma and Cytotoxicity in Acute Resolved Hepatitis B Patients	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; CD8(+) T-CELLS; INTRAHEPATIC NK CELLS; ACUTE HBV INFECTION; C VIRUS-INFECTIONS; VIRAL CLEARANCE; LIVER; INNATE; EXPRESSION; HEPADNAVIRUS	Natural killer (NK) cells are abundant in the liver and have been implicated in inducing hepatocellular damage in patients with chronic hepatitis B virus (HBV) infection. However, the role of NK cells in acute HBV infection remains to be elucidated. We comprehensively characterized NK cells and investigated their roles in HBV clearance and liver pathology in 19 chronic hepatitis B (CHB) patients and 21 acute hepatitis B (AHB) patients as well as 16 healthy subjects. It was found that NKp46(+) NK cells were enriched in the livers of AHB and CHB patients. We further found that peripheral NK cells from AHB patients expressed higher levels of activation receptors and lower levels of inhibitory receptors than those from CHB patients and HC subjects, thus displaying the increased cytolytic activity and interferon-gamma production. NK cell activation levels were also correlated positively with serum alanine aminotransferase levels and negatively with plasma HBV DNA levels in AHB patients, which is further confirmed by the longitudinal follow-up of AHB patients. Serum pro-inflammatory cytokine and chemokine levels were also increased in AHB patients as compared with CHB and HC subjects. Thus, the concomitantly increased interferon-gamma and cytotoxicity of NK cells were associated with liver injury and viral clearance in AHB patients.	[Jin, Lei; Zhang, Shuye; Fan, Rong; Sun, Yanling; Zhou, Chunbao; Li, Wengang; Zhang, Zheng; Wang, Fu-Sheng] Beijing 302 Hosp, Inst Translat Hepatol, Res Ctr Biol Therapy, Beijing, Peoples R China; [Zhao, Juanjuan; Wang, Fu-Sheng] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China; [Li, Yonggang] Beijing 302 Hosp, Integrat Med Ctr, Beijing, Peoples R China; [Shang, Qinghua] Tai An 88 Hosp, Dept Liver Dis, Tai An, Shandong, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS; Fifth Medical Center of Chinese PLA General Hospital	Zhang, Z (corresponding author), Beijing 302 Hosp, Inst Translat Hepatol, Res Ctr Biol Therapy, Beijing, Peoples R China.	zhangzheng1975@yahoo.com.cn; fswang302@163.com	Zhang, Shuye/ABG-7815-2021	Zhang, Shuye/0000-0002-4749-6790	National Natural Science Foundation of China [30972752, 81172779]; National Key Basic Research Program of China [2012CB519005]; National Grand Program on Key Infectious Disease [2012ZX10002007-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Grand Program on Key Infectious Disease	This study was funded in full by the National Natural Science Foundation of China (30972752, 81172779), in part by the National Key Basic Research Program of China (No. 2012CB519005) and the National Grand Program on Key Infectious Disease (No. 2012ZX10002007-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Bertoletti A, 2003, HEPATOLOGY, V38, P4, DOI 10.1053/jhep.2003.50310; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Cai L, 2008, CLIN IMMUNOL, V129, P428, DOI 10.1016/j.clim.2008.08.012; Chang JJ, 2007, HEPATOLOGY, V46, P1332, DOI 10.1002/hep.21844; Das A, 2008, J EXP MED, V205, P2111, DOI 10.1084/jem.20072076; Das A, 2010, DIGEST DIS, V28, P126, DOI 10.1159/000282075; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Golden-Mason L, 2012, HEPATOLOGY, V56, P1214, DOI 10.1002/hep.25771; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Gujar SA, 2008, J VIROL, V82, P6992, DOI 10.1128/JVI.00661-08; Guy CS, 2008, J VIROL, V82, P8579, DOI 10.1128/JVI.01022-08; Heeg M, 2012, HEPATOLOGY; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Mondelli MU, 2010, EUR J CLIN INVEST, V40, P851, DOI 10.1111/j.1365-2362.2010.02332.x; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sprengers D, 2006, J HEPATOL, V45, P182, DOI 10.1016/j.jhep.2005.12.022; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Urbani S, 2002, J VIROL, V76, P12423, DOI 10.1128/JVI.76.24.12423-12434.2002; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wang Fu-Sheng, 2009, Expert Rev Gastroenterol Hepatol, V3, P499, DOI 10.1586/egh.09.50; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Zhang Z, 2008, GASTROENTEROLOGY, V134, P1938, DOI 10.1053/j.gastro.2008.03.037; Zhang Z, 2012, J GASTROEN HEPATOL, V27, P223, DOI 10.1111/j.1440-1746.2011.06940.x; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977	37	32	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e49135	10.1371/journal.pone.0049135	http://dx.doi.org/10.1371/journal.pone.0049135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133672	Green Submitted, Green Published, gold			2022-12-25	WOS:000310601300032
J	Matzek, V				Matzek, Virginia			Trait Values, Not Trait Plasticity, Best Explain Invasive Species' Performance in a Changing Environment	PLOS ONE			English	Article							FALSE DISCOVERY RATE; PHENOTYPIC PLASTICITY; NITROGEN ALLOCATION; USE EFFICIENCY; CLIMATE-CHANGE; PLANTS; PHOTOSYNTHESIS; PINUS; RESPONSES; GROWTH	The question of why some introduced species become invasive and others do not is the central puzzle of invasion biology. Two of the principal explanations for this phenomenon concern functional traits: invasive species may have higher values of competitively advantageous traits than non-invasive species, or they may have greater phenotypic plasticity in traits that permits them to survive the colonization period and spread to a broad range of environments. Although there is a large body of evidence for superiority in particular traits among invasive plants, when compared to phylogenetically related noninvasive plants, it is less clear if invasive plants are more phenotypically plastic, and whether this plasticity confers a fitness advantage. In this study, I used a model group of 10 closely related Pinus species whose invader or non-invader status has been reliably characterized to test the relative contribution of high trait values and high trait plasticity to relative growth rate, a performance measure standing in as a proxy for fitness. When grown at higher nitrogen supply, invaders had a plastic RGR response, increasing their RGR to a much greater extent than non-invaders. However, invasive species did not exhibit significantly more phenotypic plasticity than non-invasive species for any of 17 functional traits, and trait plasticity indices were generally weakly correlated with RGR. Conversely, invasive species had higher values than non-invaders for 13 of the 17 traits, including higher leaf area ratio, photosynthetic capacity, photosynthetic nutrient-use efficiency, and nutrient uptake rates, and these traits were also strongly correlated with performance. I conclude that, in responding to higher N supply, superior trait values coupled with a moderate degree of trait variation explain invasive species' superior performance better than plasticity per se.	Santa Clara Univ, Dept Environm Studies & Sci, Santa Clara, CA 95053 USA	Santa Clara University	Matzek, V (corresponding author), Santa Clara Univ, Dept Environm Studies & Sci, Santa Clara, CA 95053 USA.	vmatzek@scu.edu			NASA Earth Systems Science Fellowship	NASA Earth Systems Science Fellowship	The author was supported by a NASA Earth Systems Science Fellowship while doing this experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bossdorf O, 2008, DIVERS DISTRIB, V14, P676, DOI 10.1111/j.1472-4642.2008.00471.x; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Causton DR, 1981, BIOMETRY PLANT GROWT; Chown SL, 2007, P ROY SOC B-BIOL SCI, V274, P2531, DOI 10.1098/rspb.2007.0772; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dawson W, 2012, NEW PHYTOL, V194, P859, DOI 10.1111/j.1469-8137.2012.04104.x; Deng X, 2004, BOT BULL ACAD SINICA, V45, P213; Dukes JS, 2009, CAN J FOREST RES, V39, P231, DOI 10.1139/X08-171; EKRAMODDOULLAH AKM, 1993, TREE PHYSIOL, V12, P101, DOI 10.1093/treephys/12.1.101; Feng YL, 2008, PLANTA, V228, P383, DOI 10.1007/s00425-008-0732-2; Feng YL, 2008, BIOL INVASIONS, V10, P891, DOI 10.1007/s10530-008-9240-3; FIELD C, 1983, OECOLOGIA, V60, P384, DOI 10.1007/BF00376856; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Godoy O, 2011, FUNCT ECOL, V25, P1248, DOI 10.1111/j.1365-2435.2011.01886.x; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Hikosaka K, 2004, J PLANT RES, V117, P481, DOI 10.1007/s10265-004-0174-2; Hunt J, 2010, WHAT IS FITNESS DO W; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Leishman MR, 2010, J ECOL, V98, P28, DOI 10.1111/j.1365-2745.2009.01608.x; Lichtenthaler H.K., 1983, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Mason RAB, 2008, GLOBAL ECOL BIOGEOGR, V17, P633, DOI 10.1111/j.1466-8238.2008.00402.x; Matzek V, 2011, BIOL INVASIONS, V13, P3005, DOI 10.1007/s10530-011-9985-y; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; Muth NZ, 2006, AM J BOT, V93, P188, DOI 10.3732/ajb.93.2.188; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Palacio-Lopez K, 2011, OIKOS, V120, P1393, DOI 10.1111/j.1600-0706.2010.19114.x; Peacor SD, 2006, PLOS BIOL, V4, P2112, DOI 10.1371/journal.pbio.0040372; Poorter H, 1999, ECOLOGICAL SIGNIFICA; Pysek Petr, 2007, V193, P97; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richardson AD, 2001, ANN BOT-LONDON, V88, P1007, DOI 10.1006/anbo.2001.1538; Richardson DM, 2006, PRESLIA, V78, P375; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; Takashima T, 2004, PLANT CELL ENVIRON, V27, P1047, DOI 10.1111/j.1365-3040.2004.01209.x; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; van Kleunen M, 2011, J BIOGEOGR, V38, P1294, DOI 10.1111/j.1365-2699.2011.02495.x; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Wilson SB, 2004, HORTSCIENCE, V39, P1015, DOI 10.21273/HORTSCI.39.5.1015; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Young J., 1992, SEEDS WOODY PLANTS N	54	77	78	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48821	10.1371/journal.pone.0048821	http://dx.doi.org/10.1371/journal.pone.0048821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119098	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500205
J	Herve, V; Derr, J; Douady, S; Quinet, M; Moisan, L; Lopez, PJ				Herve, Vincent; Derr, Julien; Douady, Stephane; Quinet, Michelle; Moisan, Lionel; Lopez, Pascal Jean			Multiparametric Analyses Reveal the pH-Dependence of Silicon Biomineralization in Diatoms	PLOS ONE			English	Article							THALASSIOSIRA-PSEUDONANA BACILLARIOPHYCEAE; CYTOPLASMIC PH; BIOGENIC SILICA; MARINE DIATOM; OCEAN ACIDIFICATION; VALVE MORPHOLOGY; INTRACELLULAR PH; EXTERNAL PH; CELL-CYCLE; GROWTH	Diatoms, the major contributors of the global biogenic silica cycle in modern oceans, account for about 40% of global marine primary productivity. They are an important component of the biological pump in the ocean, and their assemblage can be used as useful climate proxies; it is therefore critical to better understand the changes induced by environmental pH on their physiology, silicification capability and morphology. Here, we show that external pH influences cell growth of the ubiquitous diatom Thalassiosira weissflogii, and modifies intracellular silicic acid and biogenic silica contents per cell. Measurements at the single-cell level reveal that extracellular pH modifications lead to intracellular acidosis. To further understand how variations of the acid-base balance affect silicon metabolism and theca formation, we developed novel imaging techniques to measure the dynamics of valve formation. We demonstrate that the kinetics of valve morphogenesis, at least in the early stages, depends on pH. Analytical modeling results suggest that acidic conditions alter the dynamics of the expansion of the vesicles within which silica polymerization occurs, and probably its internal pH. Morphological analysis of valve patterns reveals that acidification also reduces the dimension of the nanometric pores present on the valves, and concurrently overall valve porosity. Variations in the valve silica network seem to be more correlated to the dynamics and the regulation of the morphogenesis process than the silicon incorporation rate. These multiparametric analyses from single-cell to cell-population levels demonstrate that several higher-level processes are sensitive to the acid-base balance in diatoms, and its regulation is a key factor for the control of pattern formation and silicon metabolism.	[Herve, Vincent; Quinet, Michelle; Lopez, Pascal Jean] Ecole Normale Super, CNRS UMR 8189, Paris, France; [Derr, Julien; Douady, Stephane] Univ Paris Diderot, CNRS UMR 7057, Lab Mat & Syst Complexes, Paris, France; [Moisan, Lionel] Univ Paris Diderot, CNRS UMR 8145, Lab Math Appl Paris 5, Paris, France; [Lopez, Pascal Jean] UMR CNRS 7208 MNHN UPMC IRD 207, Lab Excellence CORAIL Recifs Coralliens Face Chan, Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Lopez, PJ (corresponding author), Ecole Normale Super, CNRS UMR 8189, Paris, France.	pjlopez@mnhn.fr	Lopez, Pascal Jean/P-5813-2019; DOUADY, Stephane/C-4498-2018; Moisan, Lionel/A-7400-2010	Lopez, Pascal Jean/0000-0002-9914-4252; DOUADY, Stephane/0000-0002-3416-886X; Moisan, Lionel/0000-0001-6019-2698; Herve, Vincent/0000-0002-3495-561X	CNRS; ATM from MNHN	CNRS(Centre National de la Recherche Scientifique (CNRS)); ATM from MNHN	This study was in part funded by the CNRS programs "Interface physique, biologie et chimie" and "PEPS: Projets Exploratoires", and by the ATM "Formes possibles, formes realisees" from the MNHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JT, 2005, NATURE, V437, P728, DOI 10.1038/nature03948; Alverson AJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-125; Anning T, 1996, J MARINE SYST, V9, P45, DOI 10.1016/0924-7963(96)00015-2; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Bentov S, 2009, P NATL ACAD SCI USA, V106, P21500, DOI 10.1073/pnas.0906636106; BIRKS HJB, 1990, PHILOS T R SOC B, V327, P263, DOI 10.1098/rstb.1990.0062; Blatt MR, 2007, PROTOPLASMA, V232, P131, DOI 10.1007/s00709-007-0264-9; Braun FJ, 1999, EUR J CELL BIOL, V78, P199, DOI 10.1016/S0171-9335(99)80099-5; BRZEZINSKI MA, 1994, J PHYCOL, V30, P45, DOI 10.1111/j.0022-3646.1994.00045.x; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Claquin P, 2002, J PHYCOL, V38, P922, DOI 10.1046/j.1529-8817.2002.t01-1-01220.x; Clark DR, 2000, P ROY SOC B-BIOL SCI, V267, P953, DOI 10.1098/rspb.2000.1096; Coradin T, 2003, CHEMBIOCHEM, V4, P251, DOI 10.1002/cbic.200390044; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; De La Rocha CL, 2000, MAR ECOL PROG SER, V195, P71, DOI 10.3354/meps195071; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; DEMICHELIS MI, 1979, J EXP BOT, V30, P681, DOI 10.1093/jxb/30.4.681; Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; GIMMLER H, 1988, PHYSIOL PLANTARUM, V74, P521, DOI 10.1111/j.1399-3054.1988.tb02013.x; GOYAL A, 1989, ARCH MICROBIOL, V152, P138, DOI 10.1007/BF00456091; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hazelaar S, 2003, BIOMOL ENG, V20, P163, DOI 10.1016/S1389-0344(03)00044-3; Heredia A, 2008, CHEMBIOCHEM, V9, P573, DOI 10.1002/cbic.200700313; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kohn SF, 2008, MAR BIOL, V154, P109, DOI 10.1007/s00227-008-0904-4; KUSEL AC, 1990, ARCH MICROBIOL, V153, P254, DOI 10.1007/BF00249077; LANE AE, 1981, PLANT PHYSIOL, V68, P439, DOI 10.1104/pp.68.2.439; Leblanc K, 2005, LIMNOL OCEANOGR-METH, V3, P462, DOI 10.4319/lom.2005.3.462; Leterme SC, 2010, J PHYCOL, V46, P715, DOI 10.1111/j.1529-8817.2010.00850.x; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Martin-Jezequal V, 2003, PROG MOLEC, V33, P99; Messerli MA, 2005, J EXP BIOL, V208, P2569, DOI 10.1242/jeb.01660; Milligan AJ, 2004, LIMNOL OCEANOGR, V49, P322, DOI 10.4319/lo.2004.49.2.0322; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Orij R, 2011, BBA-GEN SUBJECTS, V1810, P933, DOI 10.1016/j.bbagen.2011.03.011; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pither J, 2006, ECOL LETT, V9, pE6, DOI 10.1111/j.1461-0248.2006.00906.x; Ragueneau O, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002688; Raven JA, 2009, GEOBIOLOGY, V7, P140, DOI 10.1111/j.1472-4669.2008.00181.x; RAVEN JA, 1978, J EXP BOT, V29, P853, DOI 10.1093/jxb/29.4.853; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Smol J.P., 2010, DIATOMS APPL ENV EAR; Sorhannus U, 2007, MAR MICROPALEONTOL, V65, P1, DOI 10.1016/j.marmicro.2007.05.002; Sorhannus U, 2010, PROTIST, V161, P237, DOI 10.1016/j.protis.2009.10.003; Stanley SM, 2008, CHEM REV, V108, P4483, DOI 10.1021/cr800233u; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; Tatters AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032116; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Telford RJ, 2006, ECOL LETT, V9, pE1, DOI 10.1111/j.1461-0248.2005.00875.x; Thamatrakoln K, 2008, PLANT PHYSIOL, V146, P1397, DOI 10.1104/pp.107.107094; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Thornton D.C.O., 2009, RES LETT ECOL, V2009, P1, DOI DOI 10.1155/2009/105901; Trobajo R, 2004, NOVA HEDWIGIA, V79, P433, DOI 10.1127/0029-5035/2004/0079-0433; Trobajo R, 2011, PHYCOL RES, V59, P83, DOI 10.1111/j.1440-1835.2010.00603.x; Vartanian M, 2009, NEW PHYTOL, V182, P429, DOI 10.1111/j.1469-8137.2009.02769.x; Vrieling EG, 1999, J PHYCOL, V35, P548, DOI 10.1046/j.1529-8817.1999.3530548.x; Vrieling EG, 1999, EUR J PHYCOL, V34, P307, DOI 10.1080/09670269910001736362; Vrieling EG, 2007, P NATL ACAD SCI USA, V104, P10441, DOI 10.1073/pnas.0608980104; Watanabe T, 1999, KOENIGSTEIN, P383; Weckstrom J, 1997, HYDROBIOLOGIA, V347, P171, DOI 10.1023/A:1003091923476; Wilken S, 2011, LIMNOL OCEANOGR, V56, P1399, DOI 10.4319/lo.2011.56.4.1399; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yang WR, 2011, ANALYST, V136, P42, DOI 10.1039/c0an00602e	71	50	53	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e46722	10.1371/journal.pone.0046722	http://dx.doi.org/10.1371/journal.pone.0046722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144697	Green Published, gold			2022-12-25	WOS:000310705300008
J	Taylor, JA; Richter, CA; Suzuki, A; Watanabe, H; Iguchi, T; Coser, KR; Shioda, T; vom Saal, FS				Taylor, Julia A.; Richter, Catherine A.; Suzuki, Atsuko; Watanabe, Hajime; Iguchi, Taisen; Coser, Kathryn R.; Shioda, Toshihiro; vom Saal, Frederick S.			Dose-Related Estrogen Effects on Gene Expression in Fetal Mouse Prostate Mesenchymal Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; SIGNALING PATHWAYS; GROWTH; EXPOSURE; PROGESTERONE; EPITHELIUM; ESTRADIOL; CANCER; MICE; DIETHYLSTILBESTROL	Developmental exposure of mouse fetuses to estrogens results in dose-dependent permanent effects on prostate morphology and function. Fetal prostatic mesenchyme cells express estrogen receptor alpha (ER alpha) and androgen receptors and convert stimuli from circulating estrogens and androgens into paracrine signaling to regulate epithelial cell proliferation and differentiation. To obtain mechanistic insight into the role of different doses of estradiol (E2) in regulating mesenchymal cells, we examined E2-induced transcriptomal changes in primary cultures of fetal mouse prostate mesenchymal cells. Urogenital sinus mesenchyme cells were obtained from male mouse fetuses at gestation day 17 and exposed to 10 pM, 100 pM or 100 nM E2 in the presence of a physiological concentration of dihydrotestosterone (0.69 nM) for four days. Gene ontology studies suggested that low doses of E2 (10 pM and 100 pM) induce genes involved in morphological tissue development and sterol biosynthesis but suppress genes involved in growth factor signaling. Genes involved in cell adhesion were enriched among both up-regulated and down-regulated genes. Genes showing inverted-U-shape dose responses (enhanced by E2 at 10 pM E2 but suppressed at 100 pM) were enriched in the glycolytic pathway. At the highest dose (100 nM), E2 induced genes enriched for cell adhesion, steroid hormone signaling and metabolism, cytokines and their receptors, cell-to-cell communication, Wnt signaling, and TGF-beta signaling. These results suggest that prostate mesenchymal cells may regulate epithelial cells through direct cell contacts when estrogen level is low whereas secreted growth factors and cytokines might play significant roles when estrogen level is high.	[Taylor, Julia A.; Richter, Catherine A.; vom Saal, Frederick S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Suzuki, Atsuko; Watanabe, Hajime; Iguchi, Taisen] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Aichi, Japan; [Suzuki, Atsuko; Watanabe, Hajime; Iguchi, Taisen] Grad Univ Adv Studies SOKENDAI, Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Aichi, Japan; [Coser, Kathryn R.; Shioda, Toshihiro] Massachusetts Gen Hosp, Ctr Canc, Mol Profiling Lab, Charlestown, MA USA; [Coser, Kathryn R.; Shioda, Toshihiro] Harvard Univ, Sch Med, Charlestown, MA USA	University of Missouri System; University of Missouri Columbia; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Harvard University; Massachusetts General Hospital; Harvard University	Taylor, JA (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	taylorja@missouri.edu	Iguchi, Taisen/AAL-4225-2021; WATANABE, Hajime/AAJ-8904-2021; Watanabe, Hajime/S-8957-2019	Watanabe, Hajime/0000-0001-9657-6554; Richter, Catherine/0000-0001-7322-4206	National Institute of Environmental Health Sciences (NIEHS) [ES11283, ES018764, 1F32ES11549]; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health Labor and Welfare, Japan; Susan G. Komen for Cure [FAS0703860, KG090515]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018764, F32ES011549, R01ES011283] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Susan G. Komen for Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Institute of Environmental Health Sciences (NIEHS) (www.niehs.nih.gov/) to FVS (ES11283; ES018764) and to CR (1F32ES11549); a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (B) (http://www.mext.go.jp/english/) and a grant from the Ministry of Health Labor and Welfare, Japan (www.mhlw.go.jp/english/) to TI, and grants from Susan G. Komen for Cure (http://ww5.komen.org/researchgrants/researchandgrants.html) (FAS0703860 and KG090515) to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase S, 2011, BIOL REPROD, V84, P734, DOI 10.1095/biolreprod.110.087502; Attardi LD, 2000, GENE DEV, V14, P704; Beaudry VG, PLOS GENET, V6; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; COOKE PS, 1991, ENDOCRINOLOGY, V128, P2867, DOI 10.1210/endo-128-6-2867; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Cunha G R, 1987, Prog Clin Biol Res, V239, P251; CUNHA GR, 1983, J CELL BIOL, V96, P1662, DOI 10.1083/jcb.96.6.1662; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; DANZO BJ, 1985, ENDOCRINOLOGY, V117, P1380, DOI 10.1210/endo-117-4-1380; DEAN HJ, 1984, STEROIDS, V43, P13, DOI 10.1016/0039-128X(84)90055-2; Ellem S J, 2006, Minerva Endocrinol, V31, P1; Gupta C, 2000, P SOC EXP BIOL MED, V224, P61, DOI 10.1046/j.1525-1373.2000.22402.x; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang LW, 2004, J ANDROL, V25, P330; Huang WW, 2005, MOL ENDOCRINOL, V19, P669, DOI 10.1210/me.2004-0155; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jirasek J, 1980, MALE ACCESSORY SEX G, P3; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kokontis JM, 1999, VITAM HORM, V55, P219; Lamm MLG, 2002, DEV BIOL, V249, P349, DOI 10.1006/dbio.2002.0774; Latil A, 2001, CANCER RES, V61, P1919; Levine AC, 1998, ENDOCRINOLOGY, V139, P4672, DOI 10.1210/en.139.11.4672; Lind AJ, 2005, PROSTATE, V62, P394, DOI 10.1002/pros.20163; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Miller V., 2003, PRINCIPLES SEX BASED, P15; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nishino T, 2009, PHARMAZIE, V64, P587, DOI 10.1691/ph.2009.9583; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; NONNEMAN DJ, 1992, BIOL REPROD, V47, P723, DOI 10.1095/biolreprod47.5.723; Omoto Y, 2005, P NATL ACAD SCI USA, V102, P1484, DOI 10.1073/pnas.0409168102; Pettersson H, 2009, BBA-MOL CELL BIOL L, V1791, P1206, DOI 10.1016/j.bbalip.2009.08.010; Prins GS, 2008, DIFFERENTIATION, V76, P641, DOI 10.1111/j.1432-0436.2008.00277.x; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Prins GS, 1997, ENDOCRINOLOGY, V138, P1801, DOI 10.1210/en.138.5.1801; PRINS GS, 1991, ENDOCRINOLOGY, V129, P3187, DOI 10.1210/endo-129-6-3187; RAJFER J, 1979, INVEST UROL, V17, P3; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Richter C.A., 2005, ENDOCRINE DISRUPTORS, P379; Richter CA, 2007, ENVIRON HEALTH PERSP, V115, P902, DOI 10.1289/ehp.9804; Risbridger GP, 2001, ENDOCRINOLOGY, V142, P2443, DOI 10.1210/en.142.6.2443; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Shih SC, 2002, AM J PATHOL, V161, P35, DOI 10.1016/S0002-9440(10)64154-5; Taylor JA, 2011, J STEROID BIOCHEM, V127, P83, DOI 10.1016/j.jsbmb.2011.07.005; Thayer KA, 2001, HUM REPROD, V16, P988, DOI 10.1093/humrep/16.5.988; TIMMS BG, 1995, MICROSC RES TECHNIQ, V30, P319, DOI 10.1002/jemt.1070300407; Timms BG, 1999, J UROLOGY, V161, P1694, DOI 10.1016/S0022-5347(05)69007-6; Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102; Truica CI, 2000, CANCER RES, V60, P4709; vomSaal FS, 1997, P NATL ACAD SCI USA, V94, P2056; VOMSAAL FS, 1992, CHEM INDUCED ALTERAT, P17; WAGNER CK, 1986, HORM BEHAV, V20, P212, DOI 10.1016/0018-506X(86)90019-X; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winter SF, 2007, ONCOGENE, V26, P4897, DOI 10.1038/sj.onc.1210288; Zhang TJ, 2006, GENE EXPR PATTERNS, V6, P310, DOI 10.1016/j.modgep.2005.07.005	59	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48311	10.1371/journal.pone.0048311	http://dx.doi.org/10.1371/journal.pone.0048311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144751	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300061
J	Barabas, ME; Kossyreva, EA; Stucky, CL				Barabas, Marie E.; Kossyreva, Elena A.; Stucky, Cheryl L.			TRPA1 Is Functionally Expressed Primarily by IB4-Binding, Non-Peptidergic Mouse and Rat Sensory Neurons	PLOS ONE			English	Article							PRIMARY AFFERENT NEURONS; POTENTIAL VANILLOID 1; NEUROPATHIC PAIN; NOCICEPTIVE NEURONS; CONDUCTION-VELOCITY; OROFACIAL PAIN; ISOLECTIN B-4; DORSAL-HORN; COLD; HYPERALGESIA	Subpopulations of somatosensory neurons are characterized by functional properties and expression of receptor proteins and surface markers. CGRP expression and IB4-binding are commonly used to define peptidergic and non-peptidergic subpopulations. TRPA1 is a polymodal, plasma membrane ion channel that contributes to mechanical and cold hypersensitivity during tissue injury, making it a key target for pain therapeutics. Some studies have shown that TRPA1 is predominantly expressed by peptidergic sensory neurons, but others indicate that TRPA1 is expressed extensively within non-peptidergic, IB4-binding neurons. We used FURA-2 calcium imaging to define the functional distribution of TRPA1 among peptidergic and non-peptidergic adult mouse (C57BL/6J) DRG neurons. Approximately 80% of all small-diameter (<27 mu m) neurons from lumbar 1-6 DRGs that responded to TRPA1 agonists allyl isothiocyanate (AITC; 79%) or cinnamaldehyde (84%) were IB4-positive. Retrograde labeling via plantar hind paw injection of WGA-Alexafluor594 showed similarly that most (81%) cutaneous neurons responding to TRPA1 agonists were IB4-positive. Additionally, we cultured DRG neurons from a novel CGRP-GFP mouse where GFP expression is driven by the CGRP alpha promoter, enabling identification of CGRP- expressing live neurons. Interestingly, 78% of TRPA1-responsive neurons were CGRP- negative. Co-labeling with IB4 revealed that the majority (66%) of TRPA1 agonist responders were IB4-positive but CGRP- negative. Among TRPA1-null DRGs, few small neurons (2-4%) responded to either TRPA1 agonist, indicating that both cinnamaldehyde and AITC specifically target TRPA1. Additionally, few large neurons (>= 27 mu m diameter) responded to AITC (6%) or cinnamaldehyde (4%), confirming that most large-diameter somata lack functional TRPA1. Comparison of mouse and rat DRGs showed that the majority of TRPA1-responsive neurons in both species were IB4-positive. Together, these data demonstrate that TRPA1 is functionally expressed primarily in the IB4-positive, CGRP- negative subpopulation of small lumbar DRG neurons from rodents. Thus, IB4 binding is a better indicator than neuropeptides for TRPA1 expression.	[Barabas, Marie E.; Kossyreva, Elena A.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Stucky, CL (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	cstucky@mcw.edu	Barabas, Marie-Elizabeth/AAG-8822-2021	Barabas, Marie-Elizabeth/0000-0002-4240-6979	National Institutes of Health [NS40538, NS070711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040538, R01NS070711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grants NS40538 and NS070711 to CLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez P, 2012, EXP NEUROL, V233, P859, DOI 10.1016/j.expneurol.2011.12.019; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bennett DL, 1996, NEUROSCI LETT, V206, P33, DOI 10.1016/0304-3940(96)12418-6; BEVAN S, 1995, J NEUROSCI, V15, P4918; Bogen O, 2008, EUR J NEUROSCI, V28, P12, DOI 10.1111/j.1460-9568.2008.06308.x; Braz JM, 2005, NEURON, V47, P787, DOI 10.1016/j.neuron.2005.08.015; Caspani O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007383; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Ferrari LF, 2010, NEUROSCIENCE, V165, P896, DOI 10.1016/j.neuroscience.2009.11.029; Fullmer JM, 2004, NEUROREPORT, V15, P1705, DOI 10.1097/01.wnr.0000136037.54095.64; Gerke MB, 2001, BRAIN RES, V911, P101, DOI 10.1016/S0006-8993(01)02750-0; Hillery CA, 2011, BLOOD, V118, P3376, DOI 10.1182/blood-2010-12-327429; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Ji G, 2008, NEUROSCIENCE, V154, P1054, DOI 10.1016/j.neuroscience.2008.04.039; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Joseph EK, 2010, NEUROSCIENCE, V169, P431, DOI 10.1016/j.neuroscience.2010.04.082; Joseph EK, 2008, J PAIN, V9, P463, DOI 10.1016/j.jpain.2008.01.335; Joseph EK, 2007, PAIN, V132, P67, DOI 10.1016/j.pain.2007.01.027; Joseph EK, 2010, PAIN, V150, P17, DOI 10.1016/j.pain.2010.02.011; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kim YS, 2010, J COMP NEUROL, V518, P687, DOI 10.1002/cne.22238; KITCHENER PD, 1993, NEUROSCIENCE, V54, P545, DOI 10.1016/0306-4522(93)90274-J; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; LAWSON SN, 1993, BRAIN RES BULL, V30, P239, DOI 10.1016/0361-9230(93)90250-F; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Mizushima T, 2006, NEUROSCIENCE, V140, P1337, DOI 10.1016/j.neuroscience.2006.03.024; Munns C, 2007, CELL CALCIUM, V41, P331, DOI 10.1016/j.ceca.2006.07.008; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; OBRIEN C, 1989, NEUROSCIENCE, V32, P493, DOI 10.1016/0306-4522(89)90096-1; Perry MJ, 1998, NEUROSCIENCE, V85, P293, DOI 10.1016/S0306-4522(97)00629-5; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; PLENDERLEITH MB, 1993, NEUROSCI LETT, V159, P17, DOI 10.1016/0304-3940(93)90787-L; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 1999, J NEUROSCI, V19, P6497; Taylor AMW, 2009, J COMP NEUROL, V514, P555, DOI 10.1002/cne.22048; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Zylka MJ, 2005, NEURON, V47, P771, DOI 10.1016/j.neuron.2005.09.003	57	74	75	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47988	10.1371/journal.pone.0047988	http://dx.doi.org/10.1371/journal.pone.0047988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133534	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800026
J	Nakamura, RL; Landt, SG; Mai, E; Nejim, J; Chen, LL; Frankel, AD				Nakamura, Robert L.; Landt, Stephen G.; Mai, Emily; Nejim, Jemiel; Chen, Lily; Frankel, Alan D.			A Cell-Based Method for Screening RNA-Protein Interactions: Identification of Constitutive Transport Element-Interacting Proteins	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HNRNP-LIKE PROTEINS; MESSENGER-RNA; ARGININE METHYLATION; BINDING-PROTEIN; TAT PROTEIN; KH DOMAIN; NUCLEAR; EXPORT; SEQUENCES	We have developed a mammalian cell-based screening platform to identify proteins that assemble into RNA-protein complexes. Based on Tat-mediated activation of the HIV LTR, proteins that interact with an RNA target elicit expression of a GFP reporter and are captured by fluorescence activated cell sorting. This "Tat-hybrid" screening platform was used to identify proteins that interact with the Mason Pfizer monkey virus (MPMV) constitutive transport element (CTE), a structured RNA hairpin that mediates the transport of unspliced viral mRNAs from the nucleus to the cytoplasm. Several hnRNP-like proteins, including hnRNP A1, were identified and shown to interact with the CTE with selectivity in the reporter system comparable to Tap, a known CTE-binding protein. In vitro gel shift and pull-down assays showed that hnRNP A1 is able to form a complex with the CTE and Tap and that the RGG domain of hnRNP A1 mediates binding to Tap. These results suggest that hnRNP-like proteins may be part of larger export-competent RNA-protein complexes and that the RGG domains of these proteins play an important role in directing these binding events. The results also demonstrate the utility of the screening platform for identifying and characterizing new components of RNA-protein complexes.	[Nakamura, Robert L.; Landt, Stephen G.; Nejim, Jemiel; Frankel, Alan D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Mai, Emily; Chen, Lily] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	University of California System; University of California San Francisco; California State University System; San Francisco State University	Frankel, AD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	frankel@cgl.ucsf.edu			National Institutes of Health [AI29135, GM47478, GM20171]; National Institutes of Health Minority Biomedical Research Support - Support of Continuous Research Excellence (MBRS-SCORE); Howard Hughes Medical Institutes pre-doctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020171, R01GM047478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Minority Biomedical Research Support - Support of Continuous Research Excellence (MBRS-SCORE); Howard Hughes Medical Institutes pre-doctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (grant numbers AI29135, GM47478) to ADF, (grant number GM20171) to RLN, National Institutes of Health Minority Biomedical Research Support - Support of Continuous Research Excellence (MBRS-SCORE) to LC, and a Howard Hughes Medical Institutes pre-doctoral fellowship to SGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akindahunsi AA, 2005, COMPUT BIOL CHEM, V29, P13, DOI 10.1016/j.compbiolchem.2004.11.002; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; CHEN L, 1994, BIOCHEMISTRY-US, V33, P2708, DOI 10.1021/bi00175a046; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Corbin-Lickfett KA, 2010, J VIROL, V84, P6367, DOI 10.1128/JVI.00509-10; Coyle JH, 2003, MOL CELL BIOL, V23, P92, DOI 10.1128/MCB.23.1.92-103.2003; DANG CV, 1989, J BIOL CHEM, V264, P18019; Demczuk S, 1996, HUM MOL GENET, V5, P633, DOI 10.1093/hmg/5.5.633; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Ginisty H, 1999, J CELL SCI, V112, P761; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Gordiyenko Y, 2008, BIOCHEM SOC T, V36, P723, DOI 10.1042/BST0360723; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Harada K, 1996, NATURE, V380, P175, DOI 10.1038/380175a0; Hassfeld W, 1998, NUCLEIC ACIDS RES, V26, P439, DOI 10.1093/nar/26.2.439; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Heaton JH, 2001, J BIOL CHEM, V276, P3341, DOI 10.1074/jbc.M006538200; Hegarat N, 2008, BIOCHIMIE, V90, P1265, DOI 10.1016/j.biochi.2008.03.012; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Hung ML, 2010, NUCLEIC ACIDS RES, V38, P3351, DOI 10.1093/nar/gkq033; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; KUMAR A, 1986, J BIOL CHEM, V261, P1266; LAIRDOFFRINGA IA, 1995, P NATL ACAD SCI USA, V92, P11859, DOI 10.1073/pnas.92.25.11859; Landt SG, 2000, METHOD ENZYMOL, V318, P350; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Lindsay EA, 1997, CYTOGENET CELL GENET, V79, P243, DOI 10.1159/000134736; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Merrick WC, 1997, METHODS, V11, P333, DOI 10.1006/meth.1996.0431; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; MYER VE, 1995, RNA, V1, P171; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001; PICADOLEONARD J, 1988, J BIOL CHEM, V263, P3240; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; PUGLISI JD, 1993, P NATL ACAD SCI USA, V90, P3680, DOI 10.1073/pnas.90.8.3680; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; Sambrook J, 2001, MOL CLONING LAB MANU; SANDRIGOLDIN RM, 1981, MOL CELL BIOL, V1, P743, DOI 10.1128/MCB.1.8.743; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; SIOMI H, 1990, J VIROL, V64, P1803, DOI 10.1128/JVI.64.4.1803-1807.1990; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tan RY, 1998, P NATL ACAD SCI USA, V95, P4247, DOI 10.1073/pnas.95.8.4247; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001	73	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48194	10.1371/journal.pone.0048194	http://dx.doi.org/10.1371/journal.pone.0048194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133567	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800057
J	Trojano, M; Lucchese, G; Graziano, G; Taylor, BV; Simpson, S; Lepore, V; Grand'Maison, F; Duquette, P; Izquierdo, G; Grammond, P; Amato, MP; Bergamaschi, R; Giuliani, G; Boz, C; Hupperts, R; Van Pesch, V; Lechner-Scott, J; Cristiano, E; Fiol, M; Oreja-Guevara, C; Saladino, ML; Verheul, F; Slee, M; Paolicelli, D; Tortorella, C; D'Onghia, M; Iaffaldano, P; Direnzo, V; Butzkueven, H				Trojano, Maria; Lucchese, Guglielmo; Graziano, Giusi; Taylor, Bruce V.; Simpson, Steve, Jr.; Lepore, Vito; Grand'Maison, Francois; Duquette, Pierre; Izquierdo, Guillermo; Grammond, Pierre; Amato, Maria Pia; Bergamaschi, Roberto; Giuliani, Giorgio; Boz, Cavit; Hupperts, Raymond; Van Pesch, Vincent; Lechner-Scott, Jeannette; Cristiano, Edgardo; Fiol, Marcela; Oreja-Guevara, Celia; Laura Saladino, Maria; Verheul, Freek; Slee, Mark; Paolicelli, Damiano; Tortorella, Carla; D'Onghia, Mariangela; Iaffaldano, Pietro; Direnzo, Vita; Butzkueven, Helmut		MSBase Study Grp; New Zealand MS Prevalence Study	Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; VITAMIN-D; DIAGNOSTIC-CRITERIA; INCREASING INCIDENCE; 25-HYDROXYVITAMIN D; SUN EXPOSURE; PREVALENCE; GUIDELINES; REGISTRY; SMOKING	Background: A female/male (F/M) ratio increase over time in multiple sclerosis (MS) patients was demonstrated in many countries around the world. So far, a direct comparison of sex ratio time-trends among MS populations from different geographical areas was not carried out. Objective: In this paper we assessed and compared sex ratio trends, over a 60-year span, in MS populations belonging to different latitudinal areas. Methods: Data of a cohort of 15,996 (F = 11,290; M=4,706) definite MS with birth years ranging from 1930 to 1989 were extracted from the international MSBase registry and the New Zealand MS database. Gender ratios were calculated by six decades based on year of birth and were adjusted for the F/M born-alive ratio derived from the respective national registries of births. Results: Adjusted sex ratios showed a significant increase from the first to the last decade in the whole MS sample (from 2.35 to 2.73; p = 0.03) and in the subgroups belonging to the areas between 83 degrees N and 45 degrees N (from 1.93 to 4.55; p<0.0001) and between 45 degrees N to 35 degrees N (from 1.46 to 2.30; p<0.05) latitude, while a sex ratio stability over time was found in the subgroup from areas between 12 degrees S and 55 degrees S latitude. The sex ratio increase mainly affected relapsing-remitting (RR) MS. Conclusions: Our results confirm a general sex ratio increase over time in RRMS and also demonstrate a latitudinal gradient of this increase. These findings add useful information for planning case-control studies aimed to explore sex-related factors responsible for MS development.	[Trojano, Maria; Lucchese, Guglielmo; Paolicelli, Damiano; Tortorella, Carla; D'Onghia, Mariangela; Iaffaldano, Pietro; Direnzo, Vita] Univ Bari, Dept Neurosci & Sense Organs, Bari, Italy; [Graziano, Giusi; Lepore, Vito] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Santa Maria Imbaro, Italy; [Taylor, Bruce V.; Simpson, Steve, Jr.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Grand'Maison, Francois] Hop Charles LeMoyne, Neuro Rive S, Quebec City, PQ, Canada; [Izquierdo, Guillermo] Univ Hosp, Seville, Spain; [Duquette, Pierre] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada; [Grammond, Pierre] Hotel Dieu Levis, Quebec City, PQ, Canada; [Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy; [Bergamaschi, Roberto] Neurol Inst IRCCS Mondino, Pavia, Italy; [Giuliani, Giorgio] Osped Macerata, Macerata, Italy; [Boz, Cavit] Karadeniz Tech Univ, Trabzon, Turkey; [Hupperts, Raymond] Maaslandziekenhuis, Sittard, Netherlands; [Van Pesch, Vincent] Clin Univ St Luc, B-1200 Brussels, Belgium; [Cristiano, Edgardo] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Lechner-Scott, Jeannette] John Hunter Hosp, New Lambton Hts, NSW, Australia; [Fiol, Marcela] FLENI, Buenos Aires, DF, Argentina; [Oreja-Guevara, Celia] IdiPAZ, Univ Hosp La Paz, Madrid, Spain; [Laura Saladino, Maria] INEBA, Buenos Aires, DF, Argentina; [Verheul, Freek] Groen Hart Ziekenhuis, Gouda, Netherlands; [Slee, Mark] Flinders Univ & Med Ctr, Adelaide, SA, Australia; [Butzkueven, Helmut] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Butzkueven, Helmut] Monash Univ, Dept Neurol, Box Hill Hosp, Melbourne, Vic 3004, Australia	Universita degli Studi di Bari Aldo Moro; Consorzio Mario Negri Sud; University of Tasmania; Menzies Institute for Medical Research; University of Sherbrooke; Universite de Montreal; Laval University; University of Florence; IRCCS Fondazione Casimiro Mondino; Karadeniz Technical University; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Hospital Italiano de Buenos Aires; University of Buenos Aires; John Hunter Hospital; Hospital Universitario La Paz; Flinders University South Australia; Royal Melbourne Hospital; University of Melbourne; Box Hill Hospital; Monash University	Trojano, M (corresponding author), Univ Bari, Dept Neurosci & Sense Organs, Bari, Italy.	mtrojano@neurol.uniba.it	BOZ, Cavit/V-5127-2017; pucci, eugenio/I-1039-2014; Boz, Cavit/AAR-2268-2020; van Pesch, Vincent/AAK-9506-2020; Iaffaldano, Pietro/AFE-8061-2022; Slee, Mark/J-4731-2015; Amato, Maria Pia/AAC-5940-2022; Simpson, Steve Jr/J-2454-2013; Graziano, Giusi/J-9083-2016; Lucchese, Guglielmo/AAL-9860-2020; amato, Maria Pia/AAL-5998-2020; Lepore, Vito/ABG-4356-2020; Oreja-Guevara, Celia/N-5151-2019; Jokubaitis, Vilija G./AAD-5949-2019; tortorella, carla/J-2557-2012	pucci, eugenio/0000-0001-7606-7330; Boz, Cavit/0000-0003-0956-3304; Iaffaldano, Pietro/0000-0003-2308-1731; Slee, Mark/0000-0003-4323-2453; Simpson, Steve Jr/0000-0001-6521-3056; Graziano, Giusi/0000-0002-3347-8049; Lucchese, Guglielmo/0000-0002-1809-6376; amato, Maria Pia/0000-0003-3325-3760; Lepore, Vito/0000-0002-5466-780X; Oreja-Guevara, Celia/0000-0002-9221-5716; Jokubaitis, Vilija G./0000-0002-3942-4340; Trojano, Maria/0000-0002-6329-8946; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727; tortorella, carla/0000-0001-9037-7300; Lechner-Scott, Jeannette/0000-0002-3850-447X; van Pesch, Vincent/0000-0003-2885-9004; Cristiano, Edgardo/0000-0002-6400-8277; Sabel, Clive/0000-0001-9180-4861	Italian University and Research Ministry (MIUR); Strategic Project Apulian Region "Neurobiotech" [PS 124]; MSBase Foundation; Merck Serono; Biogen Idec; Novartis Pharma; Bayer Schering; Sanofi Aventis	Italian University and Research Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR)); Strategic Project Apulian Region "Neurobiotech"; MSBase Foundation; Merck Serono(Merck & Company); Biogen Idec(Biogen); Novartis Pharma; Bayer Schering(Bayer AG); Sanofi Aventis(Sanofi-Aventis)	This work was supported by annual research grants from the Italian University and Research Ministry (MIUR) (COFIN 2008-2009 M. T.) Strategic Project Apulian Region "Neurobiotech" PS 124, (MT, VL). The MSBase Registry is supported by the MSBase Foundation, a not-for-profit organisation. The MSBase Foundation receives financial support from Merck Serono, Biogen Idec, Novartis Pharma, Bayer Schering and Sanofi Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bentzen J, 2010, MULT SCLER J, V16, P520, DOI 10.1177/1352458510364197; Butzkueven H, 2006, MULT SCLER, V12, P769, DOI 10.1177/1352458506070775; Celius EG, 2009, ACTA NEUROL SCAND, V120, P27, DOI 10.1111/j.1600-0404.2009.01208.x; Chao MJ, 2011, NEUROLOGY, V76, P242, DOI 10.1212/WNL.0b013e318207b060; Correale J, 2010, J IMMUNOL, V185, P4948, DOI 10.4049/jimmunol.1000588; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Debouverie M, 2007, MULT SCLER J, V13, P962, DOI 10.1177/1352458507077938; El-Etr M, 2011, MATURITAS, V68, P47, DOI 10.1016/j.maturitas.2010.09.014; Glad SB, 2009, MULT SCLER J, V15, P942, DOI 10.1177/1352458509106511; Guzel R, 2001, J WOMEN HEALTH GEN-B, V10, P765, DOI 10.1089/15246090152636523; Handel AE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016149, 10.1371/journal.pone.0014606]; Handel AE, 2010, PLOS ONE, V5; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Hurwitz BJ, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e3182050225; Islam T, 2007, NEUROLOGY, V69, P381, DOI 10.1212/01.wnl.0000268266.50850.48; Kingwell E, 2012, J NEUROL NEUROSUR PS, V83, P61, DOI 10.1136/jnnp-2011-300616; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kragt JJ, 2009, MULT SCLER J, V15, P9, DOI 10.1177/1352458508095920; Maghzi AH, 2010, MULT SCLER, V16, P359, DOI 10.1177/1352458509358092; Marrie RA, 2005, NEUROLOGY, V65, P1066, DOI 10.1212/01.wnl.0000178891.20579.64; Massilamany C, 2011, J NEUROIMMUNOL, V230, P95, DOI 10.1016/j.jneuroim.2010.09.011; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McDowell TY, 2011, NEUROEPIDEMIOLOGY, V36, P39, DOI 10.1159/000322512; Moussavi M, 2005, HORM RES, V64, P144, DOI 10.1159/000088588; Nashold FE, 2009, J IMMUNOL; Orton SM, 2011, NEUROLOGY, V76, P425, DOI 10.1212/WNL.0b013e31820a0a9f; Orton SM, 2010, J NEUROL NEUROSUR PS, V81, P31, DOI 10.1136/jnnp.2008.162784; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Osoegawa M, 2009, MULT SCLER J, V15, P159, DOI 10.1177/1352458508098372; Palacios N, 2011, ANN EPIDEMIOL, V21, P536, DOI 10.1016/j.annepidem.2011.03.001; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2011, NEUROLOGY, V76, P1410, DOI 10.1212/WNL.0b013e318216715e; Ramagopalan SV, 2010, EUR J NEUROL, V17, P634, DOI 10.1111/j.1468-1331.2009.02850.x; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Sadovnick AD, 2009, J NEUROL SCI, V286, P1, DOI 10.1016/j.jns.2009.09.005; Sahraian MA, 2010, EUR NEUROL, V64, P331, DOI 10.1159/000321649; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sellner J, 2011, AUTOIMMUN REV, V10, P495, DOI 10.1016/j.autrev.2011.02.006; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P180, DOI 10.1136/jnnp.2010.215186; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Taylor BV, 2010, MULT SCLER J, V16, P1422, DOI 10.1177/1352458510379614	45	141	143	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48078	10.1371/journal.pone.0048078	http://dx.doi.org/10.1371/journal.pone.0048078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133550	Green Published, gold			2022-12-25	WOS:000310261800040
J	Zhang, YB; Dong, XL; Liu, JX; Hu, MY; Zhong, GH; Geng, P; Yi, X				Zhang, Yanbo; Dong, Xiaolin; Liu, Jinxiang; Hu, Meiying; Zhong, Guohua; Geng, Peng; Yi, Xin			Molecular Cloning, Expression and Molecular Modeling of Chemosensory Protein from Spodoptera litura and Its Binding Properties with Rhodojaponin III	PLOS ONE			English	Article							LOCUSTA-MIGRATORIA ORTHOPTERA; APIS-MELLIFERA L.; SOLUBLE-PROTEINS; ECDYSONE RECEPTOR; LIGAND-BINDING; HOMOLOGY; PATTERN; DOCKING; CDNA; IDENTIFICATION	Insects stimulate specific behaviors by the correct recognition of the chemicals in the external environment. Rhodojaponin III is a botanical grayanoid diterpenid oviposition deterrent isolated from Rhododendron molle. In this study we aimed to determine whether the CSPs involved in the recognition of Rhodojaponin III. A full-length cDNA encoding chemosensory protein was isolated from the antennae of Spodoptera litura Fabricius (CSPSlit, GenBank Accession No. DQ007458). The full-length cDNA of NlFoxA is 1789 bp and has an open reading frame (ORF) of 473 bp, encoding a protein of 126 amino acids, Northern blot analysis revealed that CSPSlit mRNA was mainly expressed in the antennae, legs, wings and female abdomens. A three-dimensional model of CSPSlit was constructed using homology modeling method, and its reliability was evaluated. The active site of CSPSlit was calculated using CDOCKER program indicated that the Tyr24, Ile45, Leu49, Thr64, Leu68, Trp79 and Leu82 were responsible ligand-binding active site on identifying Rhodojaponin III in the CSPSlit. The recombinant CSPSlit protein was expressed in Escherichia coli and purified using single-step Ni-NTA affinity chromatography. Fluorescence emission spectra revealed that the CSPSlit protein had significant affinity to rhodojaponin III. These results mean that CSPSlit is critical for insects identify the Rhodojaponin III.	[Zhang, Yanbo; Dong, Xiaolin; Liu, Jinxiang; Hu, Meiying; Zhong, Guohua; Geng, Peng; Yi, Xin] S China Agr Univ, Lab Insect Toxicol, Key Lab Pesticide & Chem Biol, Minist Educ, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Hu, MY (corresponding author), S China Agr Univ, Lab Insect Toxicol, Key Lab Pesticide & Chem Biol, Minist Educ, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn; guohuazhong@scau.edu.cn			National Natural Science Foundation [31071713]; Foundation for Young Teacher in Higher School, Fok Ying Tong Education Foundation, People's Republic of China [111027]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation for Young Teacher in Higher School, Fok Ying Tong Education Foundation, People's Republic of China	The authors gratefully acknowledge the grants from the National Natural Science Foundation (31071713) and Foundation for Young Teacher in Higher School, Fok Ying Tong Education Foundation (111027), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Baqi Y, 2011, J MED CHEM, V54, P817, DOI 10.1021/jm1012193; Bohbot J, 1998, BIOCHEM BIOPH RES CO, V253, P489, DOI 10.1006/bbrc.1998.9806; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Campanacci V, 2003, P NATL ACAD SCI USA, V100, P5069, DOI 10.1073/pnas.0836654100; Chen Qi-Jin, 2000, Entomological Knowledge, V37, P325; Danty E, 1998, CHEM SENSES, V23, P83, DOI 10.1093/chemse/23.1.83; DESJARLAIS RL, 1988, J MED CHEM, V31, P722, DOI 10.1021/jm00399a006; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Feakin SD, 1973, PEST CONTROL GROUNDN; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hu LM, 2010, ARCH INSECT BIOCHEM, V75, P174, DOI 10.1002/arch.20374; Ishida Y, 2002, NATURWISSENSCHAFTEN, V89, P505, DOI 10.1007/s00114-002-0368-1; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; Jones RT, 2010, PEST MANAG SCI, V66, P1106, DOI 10.1002/ps.1986; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Kruger N J, 1994, Methods Mol Biol, V32, P9; Kumar R, 2011, J MOL GRAPH MODEL, V29, P740, DOI 10.1016/j.jmgm.2010.12.004; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Li WH, 2008, PROTEINS, V71, P938, DOI 10.1002/prot.21778; Li XiaoDong, 1995, Journal of South China Agricultural University, V16, P80; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mameli M, 1996, INSECT BIOCHEM MOLEC, V26, P875, DOI 10.1016/S0965-1748(96)00055-0; Marchese S, 2000, INSECT BIOCHEM MOLEC, V30, P1091, DOI 10.1016/S0965-1748(00)00084-9; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Monteiro A, 2008, BIOESSAYS, V30, P358, DOI 10.1002/bies.20733; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; NISHIDA R, 1989, J CHEM ECOL, V15, P2565, DOI 10.1007/BF01014732; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Ozaki K, 2008, INSECT BIOCHEM MOLEC, V38, P969, DOI 10.1016/j.ibmb.2008.07.010; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 1999, INSECT BIOCHEM MOLEC, V29, P973, DOI 10.1016/S0965-1748(99)00073-9; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; Picone D, 2001, EUR J BIOCHEM, V268, P4794, DOI 10.1046/j.1432-1327.2001.02408.x; RAO GVR, 1993, INSECT SCI APPL, V14, P273, DOI 10.1017/S1742758400014764; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; Sambrook KJ, 1989, MOL CLONING LAB MANU; Simmonds MSJ, 2001, PHYTOCHEMISTRY, V56, P245, DOI 10.1016/S0031-9422(00)00453-2; Tohidi-Esfahani D, 2011, PEST MANAG SCI, V67, P1457, DOI 10.1002/ps.2200; Tsuchihara K, 2000, FEBS LETT, V478, P299, DOI 10.1016/S0014-5793(00)01838-X; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Tuccini A, 1996, INSECT BIOCHEM MOLEC, V26, P19, DOI 10.1016/0965-1748(95)00051-8; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Zhang X, 2008, BIOCHEM BIOPH RES CO, V370, P72, DOI 10.1016/j.bbrc.2008.03.030; Zhong GH, 2005, J NAT PROD, V68, P924, DOI 10.1021/np049645t; Zhong GH, 2006, PEST MANAG SCI, V62, P976, DOI 10.1002/ps.1267; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x; Zotti MJ, 2012, ECOTOXICOLOGY, V21, P906, DOI 10.1007/s10646-012-0852-0	61	24	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47611	10.1371/journal.pone.0047611	http://dx.doi.org/10.1371/journal.pone.0047611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133516	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800009
J	Bidkhori, G; Moeini, A; Masoudi-Nejad, A				Bidkhori, Gholamreza; Moeini, Ali; Masoudi-Nejad, Ali			Modeling of Tumor Progression in NSCLC and Intrinsic Resistance to TKI in Loss of PTEN Expression	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; NONSMALL CELL LUNG; ACTIVATED PROTEIN-KINASE; FACTOR-RECEPTOR GENE; IN-VIVO; TYROSINE PHOSPHORYLATION; DIFFERENTIAL EXPRESSION; INCREASED SENSITIVITY; SIGNALING PATHWAY; SYSTEMS BIOLOGY	EGFR signaling plays a very important role in NSCLC. It activates Ras/ERK, PI3K/Akt and STAT activation pathways. These are the main pathways for cell proliferation and survival. We have developed two mathematical models to relate to the different EGFR signaling in NSCLC and normal cells in the presence or absence of EGFR and PTEN mutations. The dynamics of downstream signaling pathways vary in the disease state and activation of some factors can be indicative of drug resistance. Our simulation denotes the effect of EGFR mutations and increased expression of certain factors in NSCLC EGFR signaling on each of the three pathways where levels of pERK, pSTAT and pAkt are increased. Over activation of ERK, Akt and STAT3 which are the main cell proliferation and survival factors act as promoting factors for tumor progression in NSCLC. In case of loss of PTEN, Akt activity level is considerably increased. Our simulation results show that in the presence of erlotinib, downstream factors i.e. pAkt, pSTAT3 and pERK are inhibited. However, in case of loss of PTEN expression in the presence of erlotinib, pAkt level would not decrease which demonstrates that these cells are resistant to erlotinib.	[Bidkhori, Gholamreza; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Moeini, Ali] Univ Tehran, Coll Engn, Dept Algorithms & Computat, Tehran, Iran	University of Tehran; University of Tehran	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Masoudi-Nejad, Ali/E-7922-2010; Masoudi-Nejad, Ali/ABH-2078-2021	Masoudi-Nejad, Ali/0000-0003-0659-5183; 				Amann J, 2005, CANCER RES, V65, P226; Babu CVS, 2006, BIOCHIMIE, V88, P277, DOI 10.1016/j.biochi.2005.08.006; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Buerger C, 2003, J BIOL CHEM, V278, P37610, DOI 10.1074/jbc.M301629200; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARPENTER G, 1983, MOL CELL ENDOCRINOL, V31, P1, DOI 10.1016/0303-7207(83)90027-8; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Cetin Z, 2010, MED ONCOL, V27, P853, DOI 10.1007/s12032-009-9296-7; Chaudhury S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012364; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Cortas T, 2007, LUNG CANCER, V55, P349, DOI 10.1016/j.lungcan.2006.11.003; DITTADI R, 1991, BRIT J CANCER, V64, P741, DOI 10.1038/bjc.1991.390; Emery IF, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-333; Endoh H, 2006, J THORAC ONCOL, V1, P629; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fujino S, 1996, EUR J CANCER, V32A, P2070, DOI 10.1016/S0959-8049(96)00243-2; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Ganti AK, 2010, CANCER INVEST, V28, P515, DOI 10.3109/07357900903476760; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Gioeli D, 1999, CANCER RES, V59, P279; Gow CH, 2005, PLOS MED, V2, P924, DOI 10.1371/journal.pmed.0020269; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Gupta A, 2009, CELL CYCLE, V8, P2198, DOI 10.4161/cc.8.14.8947; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; HELIN K, 1991, J BIOL CHEM, V266, P8363; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hsieh MY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-57; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kokubo Y, 2005, BRIT J CANCER, V92, P1711, DOI 10.1038/sj.bjc.6602559; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Lefloch R, 2009, CELL CYCLE, V8, P705, DOI 10.4161/cc.8.5.7734; Li H, 2011, ADV MED SCI-POLAND, V56, P275, DOI 10.2478/v10039-011-0043-x; Li X, 2011, CELL SIGNAL, V23, P417, DOI 10.1016/j.cellsig.2010.10.016; LUND KA, 1990, J BIOL CHEM, V265, P20517; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL M, 1995, MOL REPROD DEV, V42, P493, DOI 10.1002/mrd.1080420418; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Martelli AM, 2010, BBA-MOL CELL RES, V1803, P991, DOI 10.1016/j.bbamcr.2010.04.005; Martinez-Carpio PA, 2010, LASER MED SCI, V25, P767, DOI 10.1007/s10103-010-0790-0; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Michaelis LMM, 1913, BIOCHEM Z, V49, P36; Mukohara T, 2003, LUNG CANCER, V41, P123, DOI 10.1016/S0169-5002(03)00225-3; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Nagatomo I, 2006, DNA CELL BIOL, V25, P246, DOI 10.1089/dna.2006.25.246; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; OKA H, 1995, CANCER RES, V55, P4182; Okamoto K, 2010, CANCER RES, V70, P10402, DOI 10.1158/0008-5472.CAN-10-2438; Olaussen KA, 2003, ANTICANCER RES, V23, P4885; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Piyathilake CJ, 2002, CLIN CANCER RES, V8, P734; PORE MM, 2010, CANC LETT; Purvis J, 2008, BIOTECHNOL PROGR, V24, P540, DOI 10.1021/bp070405o; Reinmuth N, 2000, EUR RESPIR J, V16, P991, DOI 10.1183/09031936.00.16599100; RUFFJAMISON S, 1994, J BIOL CHEM, V269, P21933; RUSCH V, 1995, CANCER RES, V55, P1365; RUSCH V, 1993, CANCER RES, V53, P2379; Saito Y, 2010, BIOCHEM BIOPH RES CO, V399, P262, DOI 10.1016/j.bbrc.2010.07.066; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tsakiridis T, 2008, J THORAC ONCOL, V3, P716, DOI 10.1097/JTO.0b013e31817c6094; Ung CY, 2008, FEBS LETT, V582, P2283, DOI 10.1016/j.febslet.2008.05.026; VEALE D, 1993, BRIT J CANCER, V68, P162, DOI 10.1038/bjc.1993.306; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wakeling AE, 2005, ENDOCR-RELAT CANCER, V12, pS183, DOI 10.1677/erc.1.01014; Wakeling AE, 2002, CANCER RES, V62, P5749; WALTON GM, 1990, J BIOL CHEM, V265, P1750; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; YASUDA H, 2011, LANCET ONCOL; Yin ZJ, 2011, J SURG RES, V171, P675, DOI 10.1016/j.jss.2010.03.053; Yuan J, 2011, MOL CANCER THER, V10, P2189, DOI 10.1158/1535-7163.MCT-11-0185; Zhang JS, 2011, MOL BIOL CELL, V22, P2119, DOI 10.1091/mbc.E10-12-0969; Zhang Y, 2011, PLANTA MED; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599; Zhu JQ, 2008, CANCER LETT, V265, P307, DOI 10.1016/j.canlet.2008.02.064	112	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48004	10.1371/journal.pone.0048004	http://dx.doi.org/10.1371/journal.pone.0048004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23133538	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200134
J	Liu, YJ; Gao, LP; Liu, L; Yang, Q; Lu, ZW; Nie, ZY; Wang, YS; Xia, T				Liu, Yajun; Gao, Liping; Liu, Li; Yang, Qin; Lu, Zhongwei; Nie, Zhiyin; Wang, Yunsheng; Xia, Tao			Purification and Characterization of a Novel Galloyltransferase Involved in Catechin Galloylation in the Tea Plant (Camellia sinensis)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS SERINE CARBOXYPEPTIDASE; AUXIN TRANSPORT; PROANTHOCYANIDIN BIOSYNTHESIS; GREEN TEA; GALLOTANNIN BIOSYNTHESIS; FLAVAN-3-OL BIOSYNTHESIS; ANTHOCYANIDIN REDUCTASE; FLAVONOID BIOSYNTHESIS; BETA-GLUCOGALLIN; EXPRESSION	Catechins (flavan-3-ols), the most important secondary metabolites in the tea plant, have positive effects on human health and are crucial in defense against pathogens of the tea plant. The aim of this study was to elucidate the biosynthetic pathway of galloylated catechins in the tea plant. The results suggested that galloylated catechins were biosynthesized via 1-O-glucose ester-dependent two-step reactions by acyltransferases, which involved two enzymes, UDP-glucose:galloyl-1-O-beta-D-glucosyltransferase (UGGT) and a newly discovered enzyme, epicatechin:1-O-galloyl-beta-D-glucose O-galloyltransferase (ECGT). In the first reaction, the galloylated acyl donor beta-glucogallin was biosynthesized by UGGT from gallic acid and uridine diphosphate glucose. In the second reaction, galloylated catechins were produced by ECGT catalysis from beta-glucogallin and 2,3-cis-flavan-3-ol. 2,3-cis-Flavan-3-ol and 1-O-galloyl-beta-D-glucose were appropriate substrates of ECGT rather than 2,3-trans-flavan3-ol and 1,2,3,4,6-pentagalloylglucose. Purification by more than 1641-fold to apparent homogeneity yielded ECGT with an estimated molecular mass of 241 to 121 kDa by gel filtration. Enzyme activity and SDS-PAGE analysis indicated that the native ECGT might be a dimer, trimer, or tetramer of 60-and/or 58-kDa monomers, and these monomers represent a heterodimer consisting of pairs of 36- or 34- of and 28-kDa subunits. MALDI-TOF-TOF MS showed that the protein SCPL1199 was identified. Epigallocatechin and epicatechin exhibited higher substrate affinities than beta-glucogallin. ECGT had an optimum temperature of 30 degrees C and maximal reaction rates between pH 4.0 and 6.0. The enzyme reaction was inhibited dramatically by phenylmethylsulfonyl fluoride, HgCl2, and sodium deoxycholate.	[Liu, Yajun; Gao, Liping; Yang, Qin; Lu, Zhongwei; Nie, Zhiyin; Wang, Yunsheng] Anhui Agr Univ, Sch Life Sci, Hefei 230036, Anhui, Peoples R China; [Liu, Li; Xia, Tao] Anhui Agr Univ, Minist Educ China, Key Lab Tea Biochem & Biotechnol, Hefei 230036, Anhui, Peoples R China	Anhui Agricultural University; Anhui Agricultural University; Ministry of Education, China	Xia, T (corresponding author), Anhui Agr Univ, Minist Educ China, Key Lab Tea Biochem & Biotechnol, 130 W Changjiang Rd, Hefei 230036, Anhui, Peoples R China.	xiatao62@126.com			Natural Science Foundation of China [30972401, 31170647, 31170282]; Natural Science Foundation of Anhui Province [11040606M73]; Collegiate Natural Science Foundation of Anhui Province [KJ2012A110]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1101]; Major Project of Chinese National Programmes for Fundamental Research and Development [2012CB722903]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Collegiate Natural Science Foundation of Anhui Province; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Major Project of Chinese National Programmes for Fundamental Research and Development	This work was supported by the Natural Science Foundation of China (30972401, 31170647, and 31170282), the Natural Science Foundation of Anhui Province (11040606M73), the Collegiate Natural Science Foundation of Anhui Province (KJ2012A110), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1101), and the Major Project of Chinese National Programmes for Fundamental Research and Development (2012CB722903).	Ashihara H, 2010, PHYTOCHEMISTRY, V71, P559, DOI 10.1016/j.phytochem.2010.01.010; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Eungwanichayapant PD, 2009, PLANT PHYSIOL BIOCH, V47, P94, DOI 10.1016/j.plaphy.2008.11.002; FORREST GI, 1969, BIOCHEM J, V113, P741, DOI 10.1042/bj1130741; Fraser CM, 2007, PLANT PHYSIOL, V144, P1986, DOI 10.1104/pp.107.098970; Fraser CM, 2005, PLANT PHYSIOL, V138, P1136, DOI 10.1104/pp.104.057950; GRAWE W, 1992, PLANTA, V187, P236, DOI 10.1007/BF00201945; GROSS GG, 1983, PHYTOCHEMISTRY, V22, P2179, DOI 10.1016/S0031-9422(00)80141-7; Grotewold E., 2006, SCI FLAVONOIDS, P123; He Q, 2009, NAT PROD RES, V23, P93, DOI 10.1080/14786410801886682; Ikegami A, 2007, PLANT SCI, V172, P1037, DOI 10.1016/j.plantsci.2007.02.010; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Khater F, 2012, J EXP BOT, V63, P1201, DOI 10.1093/jxb/err340; Kuai JP, 1997, PLANT PHYSIOL, V115, P1581, DOI 10.1104/pp.115.4.1581; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li AX, 1999, PLANT PHYSIOL, V121, P453, DOI 10.1104/pp.121.2.453; Li AX, 2000, P NATL ACAD SCI USA, V97, P6902, DOI 10.1073/pnas.110154197; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Liu YJ, 2009, J AGR FOOD CHEM, V57, P10371, DOI 10.1021/jf902614n; Miketova P, 1998, J NAT PROD, V61, P461, DOI 10.1021/np9703959; Niemetz R, 2005, PHYTOCHEMISTRY, V66, P2001, DOI 10.1016/j.phytochem.2005.01.009; Niemetz R, 2001, PHYTOCHEMISTRY, V58, P657, DOI 10.1016/S0031-9422(01)00300-4; Niemetz R, 1998, PHYTOCHEMISTRY, V49, P327, DOI 10.1016/S0031-9422(98)00014-4; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; REDMOND JW, 1986, NATURE, V323, P632, DOI 10.1038/323632a0; SAIJO R, 1983, AGR BIOL CHEM TOKYO, V47, P455, DOI 10.1080/00021369.1983.10865673; Shirley AM, 2001, PLANT J, V28, P83, DOI 10.1046/j.1365-313X.2001.01123.x; STAFFORD HA, 1985, PLANT PHYSIOL, V78, P791, DOI 10.1104/pp.78.4.791; STAFFORD HA, 1984, PLANT PHYSIOL, V76, P184, DOI 10.1104/pp.76.1.184; Stafford HA, 1990, FLAVONOID METABOLISM, P63; Stehle F, 2006, FEBS LETT, V580, P6366, DOI 10.1016/j.febslet.2006.10.046; STRACK D, 1983, Z NATURFORSCH C, V38, P21; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; Teutschbein J, 2010, J BIOL CHEM, V285, P38374, DOI 10.1074/jbc.M110.171637; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; WAJANT H, 1994, PLANT MOL BIOL, V26, P735, DOI 10.1007/BF00013758; Wang R, 2008, J AGR FOOD CHEM, V56, P2694, DOI 10.1021/jf0730338; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221; Zhang XL, 2012, J SCI FOOD AGR, V92, P1533, DOI 10.1002/jsfa.4739	58	118	132	13	102	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44406	44417		10.1074/jbc.M112.403071	http://dx.doi.org/10.1074/jbc.M112.403071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132863	Green Published, hybrid			2022-12-25	WOS:000312938600037
J	Epaud, R; Aubey, F; Xu, J; Chaker, Z; Clemessy, M; Dautin, A; Ahamed, K; Bonora, M; Hoyeau, N; Flejou, JF; Mailleux, A; Clement, A; Henrion-Caude, A; Holzenberger, M				Epaud, Ralph; Aubey, Flore; Xu, Jie; Chaker, Zayna; Clemessy, Maud; Dautin, Alexandre; Ahamed, Karmene; Bonora, Monique; Hoyeau, Nadia; Flejou, Jean-Francois; Mailleux, Arnaud; Clement, Annick; Henrion-Caude, Alexandra; Holzenberger, Martin			Knockout of Insulin-Like Growth Factor-1 Receptor Impairs Distal Lung Morphogenesis	PLOS ONE			English	Article							PULMONARY HYPOPLASIA; CYSTIC-FIBROSIS; SHORT STATURE; IGF-I; MICE; GENE; DEFICIENCY; MUTATION; INTRAUTERINE; RETARDATION	Background: Insulin-like growth factors (IGF-I and -II) are pleiotropic regulators of somatic growth and development in vertebrate species. Endocrine and paracrine effects of both hormones are mediated by a common IGF type 1 receptor (IGF-1R). Lethal respiratory failure in neonatal IGF-1R knockout mice suggested a particular role for this receptor in pulmonary development, and we therefore investigated the consequences of IGF-1R inactivation in lung tissue. Methods and Findings: We first generated compound heterozygous mutant mice harboring a hypomorphic (Igf1r(neo)) and a null (Igf1r(-)) allele. These IGF-1R(neo/-) mice express only 22% of normal IGF-1R levels and are viable. In adult IGF-1R(neo/-) mice, we assessed lung morphology and respiratory physiology and found normal histomorphometric characteristics and normal breathing response to hypercapnia. We then generated homozygous IGF-1R knockout mutants (IGF-1R(-/-)) and analyzed their lung development during late gestation using histomorphometric and immunohistochemical methods. IGF-1R(-/-) embryos displayed severe lung hypoplasia and markedly underdeveloped diaphragms, leading to lethal neonatal respiratory distress. Importantly, IGF-1R(-/-) lungs from late gestation embryos were four times smaller than control lungs and showed markedly thickened intersaccular mesenchyme, indicating strongly delayed lung maturation. Cell proliferation and apoptosis were significantly increased in IGF-1R(-/-) lung tissue as compared with IGF-1R(+/+) controls. Immunohisto-chemistry using pro-SP-C, NKX2-1, CD31 and vWF as markers revealed a delay in cell differentiation and arrest in the canalicular stage of prenatal respiratory organ development in IGF-1R(-/-) mutant mice. Conclusions/ Significance: We found that low levels of IGF-1R were sufficient to ensure normal lung development in mice. In contrast, complete absence of IGF-1R significantly delayed end-gestational lung maturation. Results indicate that IGF-1R plays essential roles in cell proliferation and timing of cell differentiation during fetal lung development.	[Epaud, Ralph; Aubey, Flore; Xu, Jie; Chaker, Zayna; Clemessy, Maud; Dautin, Alexandre; Ahamed, Karmene; Bonora, Monique; Clement, Annick; Henrion-Caude, Alexandra; Holzenberger, Martin] Hop St Antoine, INSERM UMRS 938, F-75571 Paris, France; [Epaud, Ralph; Aubey, Flore; Xu, Jie; Chaker, Zayna; Clemessy, Maud; Dautin, Alexandre; Ahamed, Karmene; Bonora, Monique; Hoyeau, Nadia; Flejou, Jean-Francois; Clement, Annick; Henrion-Caude, Alexandra; Holzenberger, Martin] Univ Paris 06, Paris, France; [Epaud, Ralph] Univ Paris Est, Fac Med, INSERM U955, Creteil, France; [Hoyeau, Nadia; Flejou, Jean-Francois] Hop St Antoine, APHP, F-75571 Paris, France; [Mailleux, Arnaud] Fac Xavier Bichat, INSERM UMR 700, Paris, France; [Clement, Annick] Hop Trousseau, APHP, F-75571 Paris, France; [Henrion-Caude, Alexandra] Hop Necker Enfants Malad, INSERM UMRS 781, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Holzenberger, M (corresponding author), Hop St Antoine, INSERM UMRS 938, F-75571 Paris, France.	martin.holzenberger@inserm.fr	Holzenberger, Martin/N-9732-2018; Mailleux, Arnaud/AAH-8799-2021; Mailleux, Arnaud A/J-3576-2017; Caude, Alexandra A Henrion/I-2778-2016	Mailleux, Arnaud/0000-0003-4191-1778; Mailleux, Arnaud A/0000-0003-4191-1778; Caude, Alexandra A Henrion/0000-0002-8170-2260; Holzenberger, Martin/0000-0003-4869-725X	EU Network of Excellence LifeSpan [036894]; ANR [NT05-3 42491]	EU Network of Excellence LifeSpan; ANR(French National Research Agency (ANR))	This work was supported by EU Network of Excellence LifeSpan (036894) and ANR (NT05-3 42491). Both funders supported salary and reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-31; BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BLOTT M, 1990, EARLY HUM DEV, V21, P143, DOI 10.1016/0378-3782(90)90113-W; Bonora M, 2004, PEDIATR RES, V55, P738, DOI 10.1203/01.PDR.0000117841.81730.2B; Cottart CH, 2007, PEDIATR RES, V62, P528, DOI 10.1203/PDR.0b013e318155a61d; Fang P, 2009, J CLIN ENDOCR METAB, V94, P1740, DOI 10.1210/jc.2008-1903; Han RNN, 2003, AM J RESP CELL MOL, V28, P159, DOI 10.1165/rcmb.4764; Holzenberger M, 2001, ENDOCRINOLOGY, V142, P4469, DOI 10.1210/en.142.10.4469; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Inagaki K, 2007, J CLIN ENDOCR METAB, V92, P1542, DOI 10.1210/jc.2006-2354; Kent G, 1997, J CLIN INVEST, V100, P3060, DOI 10.1172/JCI119861; Kruis T, 2010, J CLIN ENDOCR METAB, V95, P1137, DOI 10.1210/jc.2009-1433; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Nagata K, 2007, PEDIATR SURG INT, V23, P953, DOI 10.1007/s00383-007-1977-8; Pichel JG, 2003, MECH DEVELOP, V120, P349, DOI 10.1016/S0925-4773(02)00449-5; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Raile K, 2006, J CLIN ENDOCR METAB, V91, P2264, DOI 10.1210/jc.2005-2146; ROBACK EW, 1991, AM J MED GENET, V38, P74, DOI 10.1002/ajmg.1320380117; ROBERTS AB, 1995, EARLY HUM DEV, V41, P27, DOI 10.1016/0378-3782(94)01606-P; Silva D, 2006, ENDOCRINOLOGY, V147, P5584, DOI 10.1210/en.2006-0498; Srinivasan S, 2002, AM J PHYSIOL-LUNG C, V282, pL457, DOI 10.1152/ajplung.00050.2001; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tschanz SA, 2002, EXP LUNG RES, V28, P457, DOI 10.1080/01902140290096719; Walenkamp MJE, 2006, J CLIN ENDOCR METAB, V91, P3062, DOI 10.1210/jc.2005-1597	28	48	49	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48071	10.1371/journal.pone.0048071	http://dx.doi.org/10.1371/journal.pone.0048071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139760	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300018
J	Yang, L; Huang, P; Li, F; Zhao, LY; Zhang, YL; Li, SF; Gan, ZJ; Lin, AN; Li, WJ; Liu, Y				Yang, Liu; Huang, Ping; Li, Feng; Zhao, Liyun; Zhang, Yongliang; Li, Shoufeng; Gan, Zhenji; Lin, Anning; Li, Wenjun; Liu, Yong			c-Jun Amino-Terminal Kinase-1 Mediates Glucose-Responsive Upregulation of the RNA Editing Enzyme ADAR2 in Pancreatic Beta-Cells	PLOS ONE			English	Article							ADENOSINE-DEAMINASE ADAR1; SPLICE-SITE VARIANTS; PRE-MESSENGER-RNA; SIGNAL-TRANSDUCTION; JNK; GENE; MECHANISMS; NEURONS; OBESITY; BRAIN	A-to-I RNA editing catalyzed by the two main members of the adenosine deaminase acting on RNA (ADAR) family, ADAR1 and ADAR2, represents a RNA-based recoding mechanism implicated in a variety of cellular processes. Previously we have demonstrated that the expression of ADAR2 in pancreatic islet beta-cells is responsive to the metabolic cues and ADAR2 deficiency affects regulated cellular exocytosis. To investigate the molecular mechanism by which ADAR2 is metabolically regulated, we found that in cultured beta-cells and primary islets, the stress-activated protein kinase JNK1 mediates the upregulation of ADAR2 in response to changes of the nutritional state. In parallel with glucose induction of ADAR2 expression, JNK phosphorylation was concurrently increased in insulin-secreting INS-1 beta-cells. Pharmacological inhibition of JNKs or siRNA knockdown of the expression of JNK1 prominently suppressed glucose-augmented ADAR2 expression, resulting in decreased efficiency of ADAR2 auto-editing. Consistently, the mRNA expression of Adar2 was selectively reduced in the islets from JNK1 null mice in comparison with that of wild-type littermates or JNK2 null mice, and ablation of JNK1 diminished high-fat diet-induced Adar2 expression in the islets from JNK1 null mice. Furthermore, promoter analysis of the mouse Adar2 gene identified a glucose-responsive region and revealed the transcription factor c-Jun as a driver of Adar2 transcription. Taken together, these results demonstrate that JNK1 serves as a crucial component in mediating glucose-responsive upregulation of ADAR2 expression in pancreatic beta-cells. Thus, the JNK1 pathway may be functionally linked to the nutrient-sensing actions of ADAR2-mediated RNA editing in professional secretory cells.	[Yang, Liu; Huang, Ping; Li, Feng; Zhao, Liyun; Zhang, Yongliang; Li, Shoufeng; Gan, Zhenji; Li, Wenjun; Liu, Yong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Lin, Anning] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	liuy@sibs.ac.cn		LIU, YONG/0000-0001-7771-4181; Gan, Zhenji/0000-0001-5940-207X	Ministry of Science and Technology (973 Program) [2012CB524900, 2011CB910900]; National Natural Science Foundation [81021002, 30988002, 30830033]; Chinese Academy of Sciences [KSCX2-EW-R-09, KSCX2-EW-Q-1-09]; Science and Technology Commission of Shanghai Municipality [10XD1406400]; Shanghai Institutes for Biological Sciences [2011KIP306]	Ministry of Science and Technology (973 Program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences)	This work was supported by grants from the Ministry of Science and Technology (973 Program 2012CB524900 and 2011CB910900), National Natural Science Foundation (No. 81021002, 30988002 and 30830033), Chinese Academy of Sciences (The Knowledge Innovation Programs No. KSCX2-EW-R-09 and KSCX2-EW-Q-1-09) and Science and Technology Commission of Shanghai Municipality (No. 10XD1406400) to YL and the Shanghai Institutes for Biological Sciences grant 2011KIP306 to LY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2009, DIABETOLOGIA, V52, P1871, DOI 10.1007/s00125-009-1431-7; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Czaja MJ, 2010, TRENDS ENDOCRIN MET, V21, P707, DOI 10.1016/j.tem.2010.08.010; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Gan ZJ, 2006, J BIOL CHEM, V281, P33386, DOI 10.1074/jbc.M604484200; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; George CX, 2010, J INTERFERON CYTOKIN, V31, P99; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jaeschke A, 2005, P NATL ACAD SCI USA, V102, P6931, DOI 10.1073/pnas.0502143102; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karpac J, 2009, TRENDS ENDOCRIN MET, V20, P100, DOI 10.1016/j.tem.2008.11.004; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419; Maas S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004225; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maedler K, 2008, FASEB J, V22, P1905, DOI 10.1096/fj.07-101824; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Markle D, 2003, GENE, V304, P143, DOI 10.1016/S0378-1119(02)01200-3; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Peng Z, 2012, NAT BIOTECHNOL; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Singh M, 2007, J BIOL CHEM, V282, P22448, DOI 10.1074/jbc.M700265200; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Valente L, 2005, PROG NUCLEIC ACID RE, V79, P299, DOI 10.1016/S0079-6603(04)79006-6; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Varona-Santos JL, 2008, DIABETOLOGIA, V51, P2271, DOI 10.1007/s00125-008-1169-7; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; WOODWARD GE, 1954, CANCER RES, V14, P599; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yang L, 2010, FASEB J, V24, P3720, DOI 10.1096/fj.09-152363; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	64	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48611	10.1371/journal.pone.0048611	http://dx.doi.org/10.1371/journal.pone.0048611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139803	Green Published, Green Submitted, gold			2022-12-25	WOS:000311315300045
J	Lane, BM; Lister, JA				Lane, Brandon M.; Lister, James A.			Otx but Not Mitf Transcription Factors Are Required for Zebrafish Retinal Pigment Epithelium Development	PLOS ONE			English	Article							EYE DEVELOPMENT; NEURAL RETINA; CELL; MICROPHTHALMIA; GENE; TRANSDIFFERENTIATION; SPECIFICATION; EXPRESSION; MUTATIONS; DIFFERENTIATION	Otx and Mitf transcription factors have been implicated in the development of the retinal pigmented epithelium (RPE), but the relationship between these factors and their specific roles in the development of the RPE have not been fully defined. The role of the three Otx transcription factors (Otx1a, Otx1b, and Otx2) and two Mitf transcription factors (Mitfa and Mitfb) in the development of the zebrafish RPE was explored in these experiments. The loss of Otx activity through morpholino knockdown produced variable eye defects, ranging from delayed RPE pigmentation to severe coloboma, depending on the combination of Otx factors that were targeted. Expression analysis through in situ hybridization demonstrates that otx transcription factors are necessary for the proper expression of mitfa and mitfb while Mitf transcription factors are not required for the expression of otx genes. Surprisingly, the loss of Mitf activity in mitfa, mitfb, or double mitf mutant zebrafish had no effect on RPE pigmentation or development. Moreover, histological analysis revealed that retinal lamination is unaffected in mitf mutants, as well as in otx morphants, even in regions lacking RPE. Otx and Mitf combined loss of function experiments suggest that mitfa and mitfb may still influence zebrafish RPE development. This is further supported by the ability of mitfa to induce pigmentation in the zebrafish retina when misexpressed. These findings suggest that one or more Otx targets in addition to mitfa and mitfb, possibly another mitf family member, are necessary for development of the RPE in zebrafish.	[Lane, Brandon M.; Lister, James A.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA 23284 USA	Virginia Commonwealth University	Lister, JA (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA 23284 USA.	jalister@vcu.edu			Thomas F. and Kate Miller Jeffress Memorial Trust; NIH-NINDS Center; European Commission	Thomas F. and Kate Miller Jeffress Memorial Trust; NIH-NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported in part by a grant from the Thomas F. and Kate Miller Jeffress Memorial Trust (https://www.bankofamerica.com/philanthropic/foundation.go?fnId = 124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; We thank Jesus Torres-Vazquez and Tomas Zygmunt for the gift of the alpha crystallin: DsRed Tol2 destination vector. Microscopy was performed at the VCU Department of Neurobiology and Anatomy Microscopy Facility, supported, in part, with funding from an NIH-NINDS Center core grant. Help with data analysis was provided by the Massey Cancer Center Biostatistics Shared Resource Core. Zebrafish lines and monoclonal antibodies were obtained from the Zebrafish International Resource Center (ZIRC). mitfb mutant alleles were obtained from the Hubrecht Laboratory, Utrecht, Netherlands, through ZF-MODELS-Zebrafish Models for Human Development and Disease, an Integrated Project funded by the European Commission as part of its Sixth Framework Programme.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Bumsted KM, 2000, INVEST OPHTH VIS SCI, V41, P903; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Del Rio-Tsonis K, 2003, DEV DYNAM, V226, P211, DOI 10.1002/dvdy.10224; Foucher I, 2006, DEVELOPMENT, V133, P1891, DOI 10.1242/dev.02352; Gross JV, 2008, MOL REPROD DEV, V75, P547, DOI 10.1002/mrd.20831; Hammond KL, 2006, DEVELOPMENT, V133, P1347, DOI 10.1242/dev.02306; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LARISON KD, 1990, DEVELOPMENT, V109, P567; Leger S, 2012, EUR J HUM GENET, V20, P584, DOI 10.1038/ejhg.2011.234; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lister JA, 2011, DEV DYNAM, V240, P2529, DOI 10.1002/dvdy.22743; Macdonald R, 1999, METH MOL B, V127, P77, DOI 10.1385/1-59259-678-9:77; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MERCIER P, 1995, INT J DEV BIOL, V39, P559; Mochii M, 1998, DEV BIOL, V196, P145, DOI 10.1006/dbio.1998.8864; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Okada T S, 1980, Curr Top Dev Biol, V16, P349; PITTACK C, 1991, DEVELOPMENT, V113, P577; Reinisalo M, 2012, MOL VIS, V18, P38; Rojas-Munoz A, 2005, DEV BIOL, V288, P348, DOI 10.1016/j.ydbio.2005.08.046; Rowan S, 2004, DEVELOPMENT, V131, P5139, DOI 10.1242/dev.01300; SCHOLTZ CL, 1987, DEVELOPMENT, V99, P501; Schonthaler HB, 2007, EUR J NEUROSCI, V26, P1940, DOI 10.1111/j.1460-9568.2007.05801.x; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Wyatt A, 2008, HUM MUTAT, V29, pE278, DOI 10.1002/humu.20869; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	47	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49357	10.1371/journal.pone.0049357	http://dx.doi.org/10.1371/journal.pone.0049357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139843	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400073
J	Sermeus, A; Genin, M; Maincent, A; Fransolet, M; Notte, A; Leclere, L; Riquier, H; Arnould, T; Michiels, C				Sermeus, Audrey; Genin, Marie; Maincent, Amelie; Fransolet, Maude; Notte, Annick; Leclere, Lionel; Riquier, Helene; Arnould, Thierry; Michiels, Carine			Hypoxia-Induced Modulation of Apoptosis and BCL-2 Family Proteins in Different Cancer Cell Types	PLOS ONE			English	Article							ETOPOSIDE-INDUCED APOPTOSIS; PROTECTS HEPG2 CELLS; BH3-ONLY PROTEINS; INDUCIBLE FACTOR-1-ALPHA; CISPLATIN RESISTANCE; DRUG-RESISTANCE; GENE-EXPRESSION; DEATH PATHWAYS; BREAST-CANCER; TUMOR HYPOXIA	Hypoxia plays an important role in the resistance of tumour cells to chemotherapy. However, the exact mechanisms underlying this process are not well understood. Moreover, according to the cell lines, hypoxia differently influences cell death. The study of the effects of hypoxia on the apoptosis induced by 5 chemotherapeutic drugs in 7 cancer cell types showed that hypoxia generally inhibited the drug-induced apoptosis. In most cases, the effect of hypoxia was the same for all the drugs in one cell type. The expression profile of 93 genes involved in apoptosis as well as the protein level of BCL-2 family proteins were then investigated. In HepG2 cells that are strongly protected against cell death by hypoxia, hypoxia decreased the abundance of nearly all the pro-apoptotic BCL-2 family proteins while none of them are decreased in A549 cells that are not protected against cell death by hypoxia. In HepG2 cells, hypoxia decreased NOXA and BAD abundance and modified the electrophoretic mobility of BIMEL. BIM and NOXA are important mediators of etoposide-induced cell death in HepG2 cells and the hypoxia-induced modification of these proteins abundance or post-translational modifications partly account for chemoresistance. Finally, the modulation of the abundance and/or of the post-translational modifications of most proteins of the BCL-2 family by hypoxia involves p53-dependent and -independent pathways and is cell type-dependent. A better understanding of these cell-to-cell variations is crucial in order to overcome hypoxia-induced resistance and to ameliorate cancer therapy.	[Sermeus, Audrey; Genin, Marie; Maincent, Amelie; Fransolet, Maude; Notte, Annick; Leclere, Lionel; Riquier, Helene; Arnould, Thierry; Michiels, Carine] Univ Namur FUNDP, NARILIS, Lab Biochem & Cellular Biol URBC, Namur, Belgium	University of Namur	Michiels, C (corresponding author), Univ Namur FUNDP, NARILIS, Lab Biochem & Cellular Biol URBC, Namur, Belgium.	carine.michiels@fundp.ac.be			FRIA (Fonds pour la Recherche dans l'Industrie et l'Agriculture, Belgium); FNRS-Televie grant; FRIA (FNRS, Brussels, Belgium)	FRIA (Fonds pour la Recherche dans l'Industrie et l'Agriculture, Belgium)(Fonds de la Recherche Scientifique - FNRS); FNRS-Televie grant(Fonds de la Recherche Scientifique - FNRS); FRIA (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	AS and AN are Research Fellow of FNRS (Fonds de la Recherche Scientifique, Belgium). MG and LL are supported by FRIA (Fonds pour la Recherche dans l'Industrie et l'Agriculture, Belgium). HR is recipient of a FNRS-Televie grant. This article presents results of the Belgian Program on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming. The responsibility is assumed by its authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Prof. P. Ratcliffe (Institute of Molecular Medicine, John Radcliffe Hospital, Oxford) for giving us the pGL3(PGK-HRE6)-tk-Luc plasmid. AS and AN were doctoral researchers from FNRS (National Funds for Scientific Research, Brussels, Belgium) while MG and LL are doctoral grantees from FRIA (FNRS, Brussels, Belgium). HR is a recipient from a Televie grant (FNRS, Brussels, Belgium).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; Choi YJ, 2009, J CANCER RES CLIN, V135, P1047, DOI 10.1007/s00432-009-0543-2; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; Cosse JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-61; Cosse JP, 2010, BIOCHEM PHARMACOL, V80, P1160, DOI 10.1016/j.bcp.2010.07.009; Cosse JPJ, 2009, NEOPLASIA, V11, P976, DOI 10.1593/neo.09632; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Flamant L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-191; Fletcher JI, 2008, CELL CYCLE, V7, P39, DOI 10.4161/cc.7.1.5178; Flinterman M, 2005, J BIOL CHEM, V280, P5945, DOI 10.1074/jbc.M406661200; Gilley R, 2012, CELL SIGNAL, V24, P170, DOI 10.1016/j.cellsig.2011.08.018; Girio A, 2007, CELL SIGNAL, V19, P1964, DOI 10.1016/j.cellsig.2007.05.005; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Heikkinen PT, 2010, J BIOL CHEM, V285, P3740, DOI 10.1074/jbc.M109.042978; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Humphrey RG, 2008, ENDOCRINOLOGY, V149, P2131, DOI 10.1210/en.2007-1253; Jiang P, 2007, CELL RES, V17, P283, DOI 10.1038/cr.2007.19; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kim R, 2005, ONCOL REP, V14, P595; Kinoshita M, 2001, INT J CANCER, V91, P322, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1064>3.0.CO;2-P; Knappskog S, 2012, EXPERT OPIN THER TAR, V16, pS23, DOI 10.1517/14728222.2011.640322; Kutuk O, 2008, CURR MOL MED, V8, P102; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Liu XH, 2006, J CELL BIOCHEM, V97, P755, DOI 10.1002/jcb.20683; Lozano J, 2001, J BIOL CHEM, V276, P442, DOI 10.1074/jbc.M006353200; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Merighi S, 2007, MOL PHARMACOL, V72, P162, DOI 10.1124/mol.106.031849; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Moujalled D, 2011, EMBO REP, V12, P77, DOI 10.1038/embor.2010.190; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Park SY, 2002, BIOCHEM BIOPH RES CO, V291, P150, DOI 10.1006/bbrc.2002.6421; Piret JP, 2006, EXP CELL RES, V312, P2908, DOI 10.1016/j.yexcr.2006.05.018; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Sermeus A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-27; Shroff EH, 2007, CELL CYCLE, V6, P807, DOI 10.4161/cc.6.7.4044; Truttmann AC, 2004, NEUROSCIENCE, V127, P355, DOI 10.1016/j.neuroscience.2004.05.033; Vaupel P, 2008, ONCOLOGIST, V13, P21, DOI 10.1634/theoncologist.13-S3-21; Vaupel P, 2009, ADV EXP MED BIOL, V645, P241, DOI 10.1007/978-0-387-85998-9_36; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Whelan KA, 2010, MOL BIOL CELL, V21, P3829, DOI 10.1091/mbc.E10-04-0353; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wohlkoenig C, 2011, CANCER LETT, V308, P134, DOI 10.1016/j.canlet.2011.03.014; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	70	50	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47519	10.1371/journal.pone.0047519	http://dx.doi.org/10.1371/journal.pone.0047519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139748	gold, Green Submitted, Green Published			2022-12-25	WOS:000310741400025
J	Bianco, A; Mole, A; Nobile, CGA; Di Giuseppe, G; Pileggi, C; Angelillo, IF				Bianco, Aida; Mole, Antonio; Nobile, Carmelo G. A.; Di Giuseppe, Gabriella; Pileggi, Claudia; Angelillo, Italo F.			Hospital Readmission Prevalence and Analysis of Those Potentially Avoidable in Southern Italy	PLOS ONE			English	Article							HEALTH-CARE; RATES; QUALITY; OLDER	Background: One quality indicator of hospital care, which can be used to judge the process of care, is the prevalence of hospital readmission because it reflects the impact of hospital care on the patient's condition after discharge. The purposes of the study were to measure the prevalence of hospital readmissions, to identify possible factors that influence such readmission and to measure the prevalence of readmissions potentially avoidable in Italy. Methods: A sample of 2289 medical records of patients aged 18 and over admitted for medical or surgical illness at one 502-bed community non-teaching hospital were randomly selected. Results: A total of 2252 patients were included in the final analysis, equaling a response rate of 98.4%. The overall hospital readmission prevalence within 30 days of discharge was 10.2%. Multivariate logistic regression analysis revealed that the proportion of patients readmitted within 30 days of discharge significantly increased regardless of Charlson et al. comorbidity score, among unemployed or retired patients, and in patients in general surgery. A total of 43.7% hospital readmissions were judged to be potentially avoidable. Multivariate logistic regression analysis showed that potentially avoidable readmissions were significantly higher in general surgery, in patients referred to hospital by an emergency department physician, and in those with a shortened time between discharge and readmission. Conclusion: Additional research on intervention or bundle of interventions applicable to acute inpatient populations that aim to reduce potentially avoidable readmissions is strongly needed, and health care providers are urged to implement evidence-based programs for more cost-effective delivery of health care.	[Di Giuseppe, Gabriella; Angelillo, Italo F.] Univ Naples 2, Dept Expt Med, Naples, Italy; [Bianco, Aida; Mole, Antonio; Nobile, Carmelo G. A.; Pileggi, Claudia] Univ Catanzaro Magna Graecia, Sch Med, Dept Hlth Sci, Catanzaro, Italy	Universita della Campania Vanvitelli; Magna Graecia University of Catanzaro	Angelillo, IF (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	italof.angelillo@unina2.it	PILEGGI, Claudia/AGU-6397-2022; Bianco, Aida/R-6612-2016; Angelillo, Italo Francesco/AAK-1301-2021	PILEGGI, Claudia/0000-0002-6288-5540; Angelillo, Italo Francesco/0000-0003-1213-6602; DI GIUSEPPE, Gabriella/0000-0003-4466-6683; NOBILE, Carmelo Giuseppe Angelo/0000-0002-0762-513X; BIANCO, Aida/0000-0003-4674-0306	Ministry of Health [502/92]	Ministry of Health	This study was supported by a grant from the Ministry of Health (Research Projects ex artt.12 e 12bis, Legislative decree no. 502/92). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CLARKE A, 1990, BRIT MED J, V301, P1136, DOI 10.1136/bmj.301.6761.1136; Cornette P, 2005, AGING CLIN EXP RES, V17, P322, DOI 10.1007/BF03324617; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jimenez-Puente A, 2004, INT J TECHNOL ASSESS, V20, P385, DOI 10.1017/S0266462304001230; Jones J, 1986, Health Serv J, V96, P825; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Lai JK, 2007, J AM COLL SURGEONS, V204, P193, DOI 10.1016/j.jamcollsurg.2006.11.004; Maurer PP, 2004, SWISS MED WKLY, V134, P606; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Phillips CB, 2010, MED J AUSTRALIA, V193, P602, DOI 10.5694/j.1326-5377.2010.tb04071.x; Rizza P, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-134; Rutledge Valinda, 2010, Front Health Serv Manage, V27, P13; StataCorp, 2008, STAT STAT SOFTW REL; van Walraven C, 2011, CAN MED ASSOC J, V183, pE1067, DOI 10.1503/cmaj.110400; Varkevisser M, 2010, INT J HEALTH CARE FI, V10, P43, DOI 10.1007/s10754-009-9070-6; Westert GP, 2002, HEALTH POLICY, V61, P269, DOI 10.1016/S0168-8510(01)00236-6; Witherington EMA, 2008, QUAL SAF HEALTH CARE, V17, P71, DOI 10.1136/qshc.2006.020842; Wong ELY, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-149; Yam CHK, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-311; Zamir D, 2006, EUR J INTERN MED, V17, P20, DOI 10.1016/j.ejim.2005.10.004	23	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48263	10.1371/journal.pone.0048263	http://dx.doi.org/10.1371/journal.pone.0048263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133624	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400029
J	Duan, MJ; Fan, J; Huo, SH				Duan, Mojie; Fan, Jue; Huo, Shuanghong			Conformations of Islet Amyloid Polypeptide Monomers in a Membrane Environment: Implications for Fibril Formation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS METHOD; NMR CHEMICAL-SHIFTS; PARTICLE MESH EWALD; AMYLIN GENE S20G; SECONDARY-STRUCTURE; LIPID-COMPOSITION; ALPHA-HELICES; PROTEIN; PEPTIDE; SPECTROSCOPY	The amyloid fibrils formed by islet amyloid polypeptide (IAPP) are associated with type II diabetes. One of the proposed mechanisms of the toxicity of IAPP is that it causes membrane damage. The fatal mutation of S20G human IAPP was reported to lead to early onset of type II diabetes and high tendency of amyloid formation in vitro. Characterizing the structural features of the S20G mutant in its monomeric state is experimentally difficult because of its unusually fast aggregation rate. Computational work complements experimental studies. We performed a series of molecular dynamics simulations of the monomeric state of human variants in the membrane. Our simulations are validated by extensive comparisons with experimental data. We find that a helical disruption at His18 is common to both human variants. An L-shaped motif of S20G mutant is observed in one of the conformational families. This motif that bends at His18 resembles the overall topology of IAPP fibrils. The conformational preorganization into the fibril-like topology provides a possible explanation for the fast aggregation rate of S20G IAPP.	[Duan, Mojie; Fan, Jue; Huo, Shuanghong] Clark Univ, Gustaf H Carlson Sch Chem & Biochem, Worcester, MA 01610 USA	Clark University	Huo, SH (corresponding author), Clark Univ, Gustaf H Carlson Sch Chem & Biochem, Worcester, MA 01610 USA.	shuo@clarku.edu	Fan, Jue/E-3494-2015; Huo, Shuanghong/ABG-7760-2021	Huo, Shuanghong/0000-0002-2196-0858	National Institutes of Health [1R01-GM088326]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by National Institutes of Health (1R01-GM088326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brender J.R, 2011, ACC CHEM RES; Brender JR, 2010, J AM CHEM SOC, V132, P8973, DOI 10.1021/ja1007867; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Cao P, 2012, J MOL BIOL, V421, P282, DOI 10.1016/j.jmb.2011.12.032; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; Cort JR, 2009, PROTEIN ENG DES SEL, V22, P497, DOI 10.1093/protein/gzp029; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fu L, 2011, J AM CHEM SOC, V133, P8094, DOI 10.1021/ja201575e; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; KARPLUS M, 1959, J CHEM PHYS, V30, P11, DOI 10.1063/1.1729860; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Lee CC, 2012, BIOPHYS J, V102, P1059, DOI 10.1016/j.bpj.2012.01.039; Lee SC, 2001, CLIN ENDOCRINOL, V54, P541, DOI 10.1046/j.1365-2265.2001.01244.x; Lei HX, 2006, J MOL BIOL, V356, P1049, DOI 10.1016/j.jmb.2005.11.087; Li DW, 2010, J PHYS CHEM LETT, V1, P246, DOI 10.1021/jz9001345; Ling YL, 2009, J PHYS CHEM B, V113, P2498, DOI 10.1021/jp810261x; Liu G, 2010, J AM CHEM SOC, V132, P18223, DOI 10.1021/ja1069882; Liu HZ, 2012, J PHYS CHEM B, V116, P646, DOI 10.1021/jp209791a; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Ma Z, 2001, AMYLOID, V8, P242, DOI 10.3109/13506120108993820; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polyansky AA, 2005, J PHYS CHEM B, V109, P15052, DOI 10.1021/jp0510185; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Reddy AS, 2010, BIOPHYS J, V98, P443, DOI 10.1016/j.bpj.2009.10.029; Rivera E, 2009, BIOPHYS J, V96, P4552, DOI 10.1016/j.bpj.2009.03.039; RUSTENBECK I, 1994, LIPIDS, V29, P685, DOI 10.1007/BF02538912; Sakagashira S, 2000, AM J PATHOL, V157, P2101, DOI 10.1016/S0002-9440(10)64848-1; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Sapay N, 2011, J COMPUT CHEM, V32, P1400, DOI 10.1002/jcc.21726; Shim SH, 2009, P NATL ACAD SCI USA, V106, P6614, DOI 10.1073/pnas.0805957106; Volynsky PE, 2005, BIOCHEMISTRY-US, V44, P14626, DOI 10.1021/bi0514562; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wei L, 2011, J BIOL CHEM, V286, P6291, DOI 10.1074/jbc.M110.166678; WESTERMARK P, 1972, UPSALA J MED SCI, V77, P91, DOI 10.1517/03009734000000014; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu WX, 2009, J PHYS CHEM B, V113, P7308, DOI 10.1021/jp8106827; Zhang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029519, 10.1371/journal.pone.0038191]	72	28	28	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47150	10.1371/journal.pone.0047150	http://dx.doi.org/10.1371/journal.pone.0047150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133593	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400007
J	Mercier, A; Clement, R; Harnois, T; Bourmeyster, N; Faivre, JF; Findlay, I; Chahine, M; Bois, P; Chatelier, A				Mercier, Aurelie; Clement, Romain; Harnois, Thomas; Bourmeyster, Nicolas; Faivre, Jean-Francois; Findlay, Ian; Chahine, Mohamed; Bois, Patrick; Chatelier, Aurelien			The beta(1)-Subunit of Na(v)1.5 Cardiac Sodium Channel Is Required for a Dominant Negative Effect through alpha-alpha Interaction	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; BRUGADA-SYNDROME; BETA-SUBUNITS; SCN5A MUTATIONS; MECHANISM; DISEASE; TRAFFICKING; R1432G; DEATH	Brugada syndrome (BrS) is an inherited autosomal dominant cardiac channelopathy. Several mutations on the cardiac sodium channel Na(v)1.5 which are responsible for BrS lead to misfolded proteins that do not traffic properly to the plasma membrane. In order to mimic patient heterozygosity, a trafficking defective mutant, R1432G was co-expressed with Wild Type (WT) Na-v(1).5 channels in HEK293T cells. This mutant significantly decreased the membrane Na current density when it was co-transfected with the WT channel. This dominant negative effect did not result in altered biophysical properties of Nav1.5 channels. Luminometric experiments revealed that the expression of mutant proteins induced a significant reduction in membrane expression of WT channels. Interestingly, we have found that the auxiliary Na channel beta(1)-subunit was essential for this dominant negative effect. Indeed, the absence of the beta(1)-subunit prevented the decrease in WT sodium current density and surface proteins associated with the dominant negative effect. Co-immunoprecipitation experiments demonstrated a physical interaction between Na channel alpha-subunits. This interaction occurred only when the beta 1-subunit was present. Our findings reveal a new role for beta(1)-subunits in cardiac voltage-gated sodium channels by promoting alpha-alpha subunit interaction which can lead to a dominant negative effect when one of the a-subunits shows a trafficking defective mutation.	[Mercier, Aurelie; Clement, Romain; Harnois, Thomas; Bourmeyster, Nicolas; Faivre, Jean-Francois; Findlay, Ian; Bois, Patrick; Chatelier, Aurelien] Univ Poitiers, Inst Physiol & Biol Cellulaires, FRE 3511, CNRS, Poitiers, France; [Harnois, Thomas; Bourmeyster, Nicolas] CHU Poitiers, Poitiers, France; [Findlay, Ian] Univ Tours, Lab Physiol Cellules Cardiaques & Vasc, Fac Sci, Inst Physiol & Biol Cellulaires,FRE 3511,CNRS, Tours, France; [Chahine, Mohamed] Univ Laval, Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Laval University	Chatelier, A (corresponding author), Univ Poitiers, Inst Physiol & Biol Cellulaires, FRE 3511, CNRS, Poitiers, France.	aurelien.chatelier@univ-poitiers.fr	Bois, patrick/G-2242-2014; FAIVRE, Jean-Francois/P-5097-2016; Chatelier, Aurelien/P-5056-2016; Findlay, Ian/P-5049-2016	Findlay, Ian/0000-0003-0650-2602; FAIVRE, Jean-Francois/0000-0002-8153-0171; Ferru-Clement, Romain/0000-0001-5309-0861; chatelier, aurelien/0000-0002-7441-1182; Bourmeyster, Nicolas/0000-0002-9563-5142	CNRS; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	This work was supported by CNRS and Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroudi G, 2004, CAN J CARDIOL, V20, P425; Baroudi G, 2001, CIRC RES, V88, pE78, DOI 10.1161/hh1201.093270; Bechi G, 2012, EPILEPSIA, V53, P87, DOI 10.1111/j.1528-1167.2011.03346.x; Brugada J, 1998, CIRCULATION, V97, P457; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Chahine M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00070; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Cordeiro JM, 2006, CIRCULATION, V114, P2026, DOI 10.1161/CIRCULATIONAHA.106.627489; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Isom LL, 2002, NOVART FDN SYMP, V241, P124; Keller DI, 2005, CARDIOVASC RES, V67, P510, DOI 10.1016/j.cardiores.2005.03.024; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Poelzing S, 2006, CIRCULATION, V114, P368, DOI 10.1161/CIRCULATIONAHA.105.601294; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Valdivia CR, 2004, CARDIOVASC RES, V62, P53, DOI 10.1016/j.cardiores.2004.01.022; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]	22	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48690	10.1371/journal.pone.0048690	http://dx.doi.org/10.1371/journal.pone.0048690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133651	Green Published, gold, Green Submitted			2022-12-25	WOS:000310601300023
J	Speer, AL; Al Alam, D; Sala, FG; Ford, HR; Bellusci, S; Grikscheit, TC				Speer, Allison L.; Al Alam, Denise; Sala, Frederic G.; Ford, Henri R.; Bellusci, Saverio; Grikscheit, Tracy C.			Fibroblast Growth Factor 10-Fibroblast Growth Factor Receptor 2b Mediated Signaling Is Not Required for Adult Glandular Stomach Homeostasis	PLOS ONE			English	Article							REGULATORY ROLE; MAMMARY-GLAND; EXPRESSION; CELLS; FGF10; PROLIFERATION; METAPLASIA; FIBROBLAST-GROWTH-FACTOR-10; EPITHELIUM; INDUCTION	The signaling pathways that are essential for gastric organogenesis have been studied in some detail; however, those that regulate the maintenance of the gastric epithelium during adult homeostasis remain unclear. In this study, we investigated the role of Fibroblast growth factor 10 (FGF10) and its main receptor, Fibroblast growth factor receptor 2b (FGFR2b), in adult glandular stomach homeostasis. We first showed that mouse adult glandular stomach expressed Fgf10, its receptors, Fgfr1b and Fgfr2b, and most of the other FGFR2b ligands (Fgf1, Fgf7, Fgf22) except for Fgf3 and Fgf20. Fgf10 expression was mesenchymal whereas FGFR1 and FGFR2 expression were mostly epithelial. Studying double transgenic mice that allow inducible overexpression of Fgf10 in adult mice, we showed that Fgf10 overexpression in normal adult glandular stomach increased epithelial proliferation, drove mucous neck cell differentiation, and reduced parietal and chief cell differentiation. Although a similar phenotype can be associated with the development of metaplasia, we found that Fgf10 overexpression for a short duration does not cause metaplasia. Finally, investigating double transgenic mice that allow the expression of a soluble form of Fgfr2b, FGF10's main receptor, which acts as a dominant negative, we found no significant changes in gastric epithelial proliferation or differentiation in the mutants. Our work provides evidence, for the first time, that the FGF10-FGFR2b signaling pathway is not required for epithelial proliferation and differentiation during adult glandular stomach homeostasis.	[Speer, Allison L.; Al Alam, Denise; Sala, Frederic G.; Ford, Henri R.; Bellusci, Saverio; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Dept Pediat Surg Dev Biol & Regenerat Med, Los Angeles, CA 90027 USA; [Bellusci, Saverio] Univ Giessen Lung Ctr, Dept Internal Med 2, Giessen, Germany	Children's Hospital Los Angeles	Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Dept Pediat Surg Dev Biol & Regenerat Med, Los Angeles, CA 90027 USA.	tgrikscheit@chla.usc.edu	Alam, Denise Al/AAG-9406-2019	Speer, Allison/0000-0003-4609-3778	Ethicon-Society of University Surgeons: Surgical Research Fellowship Award; National Institutes of Health [1R01HD052609-01A2, 5R01HD052609-02, 5R01HD052609-03]; California Institute for Regenerative Medicine [RN2-00946-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014032] Funding Source: NIH RePORTER	Ethicon-Society of University Surgeons: Surgical Research Fellowship Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: 1) Ethicon-Society of University Surgeons: Surgical Research Fellowship Award, Allison L. Speer, http://www.susweb.org/mc/page.do?sitePageId=93045. 2) National Institutes of Health: 1R01HD052609-01A2, 5R01HD052609-02, 5R01HD052609-03, Saverio Bellusci and Henri R. Ford, http://projectreporter.nih.gov/project_info_history.cfm?aid=7426527&icde=12717266. 3) California Institute for Regenerative Medicine: RN2-00946-1, Tracy C. Grikscheit, http://www.cirm.ca.gov/content/mechanism-tissue-engineered-small-intestine-formation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Beer HD, 2000, J BIOL CHEM, V275, P16091, DOI 10.1074/jbc.275.21.16091; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Burns RC, 2004, DEV BIOL, V265, P61, DOI 10.1016/j.ydbio.2003.09.021; Clark JC, 2001, AM J PHYSIOL-LUNG C, V280, pL705, DOI 10.1152/ajplung.2001.280.4.L705; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Fairbanks TJ, 2006, J PEDIATR SURG, V41, P132, DOI 10.1016/j.jpedsurg.2005.10.054; Fairbanks TJ, 2005, J PEDIATR SURG, V40, P390, DOI 10.1016/j.jpedsurg.2004.10.023; Fairbanks TJ, 2004, J PEDIATR SURG, V39, P872, DOI 10.1016/j.jpedsurg.2004.02.026; Fairbanks TJ, 2004, J SURG RES, V120, P201, DOI 10.1016/j.jss.2003.12.017; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goldenring JR, 2011, EXP CELL RES, V317, P2759, DOI 10.1016/j.yexcr.2011.08.017; Goldenring JR, 2010, PROG MOL BIOL TRANSL, V96, P117, DOI [10.1016/S1877-1173(10)96005-5, 10.1016/B978-0-12-381280-3.00005-1]; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hokuto I, 2003, J BIOL CHEM, V278, P415, DOI 10.1074/jbc.M208328200; Howard TA, 1996, J ANAT, V189, P303; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kanard RC, 2005, J PEDIATR SURG, V40, P313, DOI 10.1016/j.jpedsurg.2004.10.057; Karam SM, 2010, WORLD J GASTROENTERO, V16, P538, DOI 10.3748/wjg.v16.i5.538; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; Katoh Y, 2006, INT J MOL MED, V18, P1019; Keld R, 2004, BRIT J CANCER, V105, P124; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Khurana S, 2010, PROG MOL BIOL TRANSL, V96, P93, DOI 10.1016/S1877-1173(10)96004-3; Ku SK, 2003, ANAT HISTOL EMBRYOL, V32, P21, DOI 10.1046/j.1439-0264.2003.00433.x; Lennerz JKM, 2010, AM J PATHOL, V177, P1514, DOI 10.2353/ajpath.2010.100328; Lopez-Diaz L, 2006, AM J PHYSIOL-GASTR L, V290, pG970, DOI 10.1152/ajpgi.00461.2005; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Mailleux AA, 2002, DEVELOPMENT, V129, P53; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; MOULAND AJ, 1994, J BIOL CHEM, V269, P6918; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; Nozaki K, 2009, AM J PHYSIOL-GASTR L, V296, pG1211, DOI 10.1152/ajpgi.90643.2008; Nyeng P, 2007, DEV BIOL, V303, P295, DOI 10.1016/j.ydbio.2006.11.017; Ornitz DM, 2001, GENOME BIOL, V2; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Parsa S, 2010, DEVELOPMENT, V137, P3743, DOI 10.1242/dev.051672; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Sala FG, 2006, DEV BIOL, V299, P373, DOI 10.1016/j.ydbio.2006.08.001; Sala FG, 2011, DEVELOPMENT, V138, P273, DOI 10.1242/dev.051680; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shin M, 2005, GENE EXPR PATTERNS, V5, P511, DOI 10.1016/j.modgep.2004.12.004; Shin M, 2006, DEV BIOL, V294, P11, DOI 10.1016/j.ydbio.2005.12.019; Shinohara M, 2010, GASTROENTEROLOGY, V139, P2050, DOI 10.1053/j.gastro.2010.08.052; Spencer-Dene B, 2006, GASTROENTEROLOGY, V130, P1233, DOI 10.1053/j.gastro.2006.02.018; Tai CC, 2009, DEV DYNAM, V238, P294, DOI 10.1002/dvdy.21667; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394; Weis VG, 2009, GASTRIC CANCER, V12, P189, DOI 10.1007/s10120-009-0527-6; Yamamoto H, 2004, CARCINOGENESIS, V25, P325, DOI 10.1093/carcin/bgh011; Zabaleta Jovanny, 2012, Methods Mol Biol, V863, P411, DOI 10.1007/978-1-61779-612-8_26	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e49127	10.1371/journal.pone.0049127	http://dx.doi.org/10.1371/journal.pone.0049127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133671	Green Submitted, Green Published, gold			2022-12-25	WOS:000310601300031
J	Jackowska, M; Hamer, M; Carvalho, LA; Erusalimsky, JD; Butcher, L; Steptoe, A				Jackowska, Marta; Hamer, Mark; Carvalho, Livia A.; Erusalimsky, Jorge D.; Butcher, Lee; Steptoe, Andrew			Short Sleep Duration Is Associated with Shorter Telomere Length in Healthy Men: Findings from the Whitehall II Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CORTISOL SECRETION; STRESS; ALLOSTASIS; HOSTILITY; STATES	Background: Shorter telomere length and poor sleep are more prevalent at older ages, but their relationship is uncertain. This study explored associations between sleep duration and telomere length in a sample of healthy middle and early old age people. Methods: Participants were 434 men and women aged 63.3 years on average drawn from the Whitehall II cohort study. Sleep duration was measured by self-report. Results: There was a linear association between sleep duration and leukocyte telomere length in men but not in women (P = 0.035). Men reporting shorter sleep duration had shorter telomeres, independently of age, body mass index, smoking, educational attainment, current employment, cynical hostility scores and depressive symptoms. Telomeres were on average 6% shorter in men sleeping 5 hours or fewer compared with those sleeping more than 7 hours per night. Conclusion: This study adds to the growing literature relating sleep duration with biomarkers of aging, and suggests that shortening of telomeres might reflect mechanisms through which short sleep contributes to pathological conditions in older men.	[Jackowska, Marta; Hamer, Mark; Carvalho, Livia A.; Steptoe, Andrew] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Erusalimsky, Jorge D.; Butcher, Lee] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Cardiff, S Glam, Wales	University of London; University College London; Cardiff Metropolitan University; Cardiff University	Jackowska, M (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	marta.jackowska.09@ucl.ac.uk	Steptoe, Andrew/Y-2440-2019; Hamer, Mark/AAJ-6814-2021; Carvalho, Livia A/E-5681-2010; Hamer, Mark/C-1602-2008; Carvalho, Livia/Y-1032-2019; Jackowska, Marta/GWC-2556-2022	Hamer, Mark/0000-0002-8726-7992; Carvalho, Livia A/0000-0001-8862-0148; Hamer, Mark/0000-0002-8726-7992; Carvalho, Livia/0000-0001-8862-0148; Steptoe, Andrew/0000-0001-7808-4943; Erusalimsky, Jorge/0000-0002-4253-5789; Jackowska, Marta/0000-0002-2930-0483; Butcher, Lee/0000-0003-4839-6799	Medical Research Council UK [G0601647]; British Heart Foundation [RG/05/006]; Biotechnology and Biological Sciences Research Council; Unilever Discover; Medical Research Council [G0601647] Funding Source: researchfish; MRC [G0601647] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever Discover(Unilever); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Medical Research Council UK (G0601647) and by the British Heart Foundation (RG/05/006). Marta Jackowska is supported by the Biotechnology and Biological Sciences Research Council and by Unilever Discover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2006, J GERONTOL A-BIOL, V61, P871, DOI 10.1093/gerona/61.8.871; Barcelo A, 2010, RESP MED, V104, P1225, DOI 10.1016/j.rmed.2010.03.025; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Bixler EO, 2009, J SLEEP RES, V18, P221, DOI 10.1111/j.1365-2869.2008.00713.x; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Brydon L, 2012, BIOL PSYCHIAT, V71, P767, DOI 10.1016/j.biopsych.2011.08.020; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Kim J, 2010, CHEST, V138, P91, DOI 10.1378/chest.09-2832; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Krystal AD, 2008, SLEEP MED, V9, pS10, DOI 10.1016/S1389-9457(08)70011-X; Kumari M, 2009, J CLIN ENDOCR METAB, V94, P4801, DOI 10.1210/jc.2009-0555; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Liang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023462; Lusardi P, 1996, AM J HYPERTENS, V9, P503, DOI 10.1016/0895-7061(95)00389-4; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Miller MA, 2009, SLEEP, V32, P857; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Prather AA, 2011, J AGING RES IN PRESS; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; SPATHSCHWALBE E, 1992, J CLIN ENDOCR METAB, V75, P1431, DOI 10.1210/jc.75.6.1431; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van den Berg JF, 2009, SLEEP, V32, P1367, DOI 10.1093/sleep/32.10.1367; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837	40	68	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47292	10.1371/journal.pone.0047292	http://dx.doi.org/10.1371/journal.pone.0047292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144701	Green Published, gold			2022-12-25	WOS:000310705300012
J	Jin, YN; Chen, PC; Watson, JA; Walters, BJ; Phillips, SE; Green, K; Schmidt, R; Wilson, JA; Johnson, GV; Roberson, ED; Dobrunz, LE; Wilson, SM				Jin, Youngnam N.; Chen, Ping-Chung; Watson, Jennifer A.; Walters, Brandon J.; Phillips, Scott E.; Green, Karen; Schmidt, Robert; Wilson, Julie A.; Johnson, Gail V.; Roberson, Erik D.; Dobrunz, Lynn E.; Wilson, Scott M.			Usp14 Deficiency Increases Tau Phosphorylation without Altering Tau Degradation or Causing Tau-Dependent Deficits	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; MICROTUBULE-BINDING; PARKINSONS-DISEASE; TRANSGENIC MICE; ATAXIA MICE; MOUSE MODEL; KINASE	Regulated protein degradation by the proteasome plays an essential role in the enhancement and suppression of signaling pathways in the nervous system. Proteasome-associated factors are pivotal in ensuring appropriate protein degradation, and we have previously demonstrated that alterations in one of these factors, the proteasomal deubiquitinating enzyme ubiquitin-specific protease 14 (Usp14), can lead to proteasome dysfunction and neurological disease. Recent studies in cell culture have shown that Usp14 can also stabilize the expression of over-expressed, disease-associated proteins such as tau and ataxin-3. Using Usp14-deficient ax(J) mice, we investigated if loss of Usp14 results in decreased levels of endogenous tau and ataxin-3 in the nervous system of mice. Although loss of Usp14 did not alter the overall neuronal levels of tau and ataxin-3, we found increased levels of phosphorylated tau that correlated with the onset of axonal varicosities in the Usp14-deficient mice. These changes in tau phosphorylation were accompanied by increased levels of activated phospho-Akt, phosphorylated MAPKs, and inactivated phospho-GSK3 beta. However, genetic ablation of tau did not alter any of the neurological deficits in the Usp14-deficient mice, demonstrating that increased levels of phosphorylated tau do not necessarily lead to neurological disease. Due to the widespread activation of intracellular signaling pathways induced by the loss of Usp14, a better understanding of the cellular pathways regulated by the proteasome is required before effective proteasomal-based therapies can be used to treat chronic neurological diseases.	[Jin, Youngnam N.; Chen, Ping-Chung; Watson, Jennifer A.; Walters, Brandon J.; Phillips, Scott E.; Wilson, Julie A.; Dobrunz, Lynn E.; Wilson, Scott M.] Univ Alabama Birmingham, Dept Neurobiol, Civitan Int Res Ctr, Birmingham, AL 35294 USA; [Green, Karen; Schmidt, Robert] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Neuropathol, St Louis, MO USA; [Johnson, Gail V.] Univ Rochester, Dept Anesthesiol, Rochester, NY USA; [Roberson, Erik D.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of Rochester; University of Alabama System; University of Alabama Birmingham	Wilson, SM (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Civitan Int Res Ctr, Birmingham, AL 35294 USA.	wilson@nrc.uab.edu	Roberson, Erik/A-5718-2009	Roberson, Erik/0000-0002-1810-9763; PHILLIPS, SCOTT/0000-0002-5451-0984; Wilson, Scott/0000-0001-9376-9430; Dobrunz, Lynn E./0000-0002-3317-554X; Walters, Brandon/0000-0002-8073-6573	NIH/NINDS [NS047533, NS074456, NS075487]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074456, R01NS075487, R01NS047533] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH/NINDS Grants NS047533 and NS074456 (S. M. W), and NS075487 (E. D. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Asuni AA, 2010, BIOCHEM SOC T, V38, P545, DOI 10.1042/BST0380545; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Burke RE, 2004, NEUROLOGIST, V10, P75, DOI 10.1097/01.nrl.0000117822.90759.83; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Dawson HN, 2001, J CELL SCI, V114, P1179; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Gotz J, 2006, J NEUROCHEM, V98, P993, DOI 10.1111/j.1471-4159.2006.03955.x; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jantas D, 2011, NEUROTOXICOLOGY, V32, P845, DOI 10.1016/j.neuro.2011.05.013; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Ploia C, 2011, J ALZHEIMERS DIS, V26, P315, DOI 10.3233/JAD-2011-110320; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Speed HE, 2009, HIPPOCAMPUS, V19, P187, DOI 10.1002/hipo.20496; Tatebayashi Y, 2006, FASEB J, V20, P762, DOI 10.1096/fj.05-4362fje; Treiber-Held S, 2003, J PATHOL, V200, P95, DOI 10.1002/path.1345; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Um JW, 2010, J BIOL CHEM, V285, P36434, DOI 10.1074/jbc.M110.133777; Wagner U, 1996, J CELL SCI, V109, P1537; Walters BJ, 2008, MOL CELL NEUROSCI, V39, P539, DOI 10.1016/j.mcn.2008.07.028; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Yoon SY, 2010, NEUROBIOL DIS, V40, P449, DOI 10.1016/j.nbd.2010.07.005; Zhang L, 2009, J NEUROSCI RES, V87, P3231, DOI 10.1002/jnr.22147; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426; Zhu XW, 2001, MECH AGEING DEV, V123, P39, DOI 10.1016/S0047-6374(01)00342-6; ZUBENKO GS, 1989, ARCH NEUROL-CHICAGO, V46, P634, DOI 10.1001/archneur.1989.00520420054022	56	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47884	10.1371/journal.pone.0047884	http://dx.doi.org/10.1371/journal.pone.0047884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144711	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705300022
J	Courilleau, D; Bisserier, M; Jullian, JC; Lucas, A; Bouyssou, P; Fischmeister, R; Blondeau, JP; Lezoualc'h, F				Courilleau, Delphine; Bisserier, Malik; Jullian, Jean-Christophe; Lucas, Alexandre; Bouyssou, Pascal; Fischmeister, Rodolphe; Blondeau, Jean-Paul; Lezoualc'h, Frank			Identification of a Tetrahydroquinoline Analog as a Pharmacological Inhibitor of the cAMP-binding Protein Epac	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR; RAP1; ACTIVATION; MECHANISM; FAMILY	The cAMP-binding protein Epac is a therapeutic target for the treatment of various diseases such as cardiac hypertrophy and tumor invasion. This points out the importance to develop Epac inhibitors to better understand the involvement of these cAMP sensors in physiology and pathophysiology. Here, we have developed a functional fluorescence-based high-throughput assay with a Z' value around 0.7 for screening Epac-specific antagonists. We identified an Epac1 inhibitor compound named CE3F4 that blocked Epac1 guanine nucleotide exchange activity toward its effector Rap1 both in cell-free systems and in intact cells. CE3F4 is a tetrahydroquinoline analog that fails to influence protein kinase A holoenzyme activity. CE3F4 inhibited neither the interaction of Rap1 with Epac1 nor directly the GDP exchange on Rap1. The kinetics of inhibition by CE3F4 indicated that this compound did not compete for binding of agonists to Epac1 and suggested an uncompetitive inhibition mechanism with respect to Epac1 agonists. A structure-activity study showed that the formyl group on position 1 and the bromine atom on position 5 of the tetrahydroquinoline skeleton were important for CE3F4 to exert its inhibitory activity. Finally, CE3F4 inhibited Rap1 activation in living cultured cells, following Epac activation by either 8-(4-chlorophenylthio)-2'-O-methyl-cAMP, an Epac-selective agonist, or isoprenaline, a non-selective beta-adrenergic receptor agonist. Our study shows that CE3F4 and related compounds may serve as a basis for the development of new therapeutic drugs.	[Courilleau, Delphine; Fischmeister, Rodolphe; Blondeau, Jean-Paul] Univ Paris 11, Fac Pharm, CIBLOT, IFR 141, F-92296 Chatenay Malabry, France; [Bisserier, Malik; Lucas, Alexandre; Lezoualc'h, Frank] Inst Malad Metabol & Cardiovasc, UMR 1048, INSERM, F-31432 Toulouse 04, France; [Jullian, Jean-Christophe] CNRS, Fac Pharm, UMR 8076, BioCIS, F-92296 Chatenay Malabry, France; [Bisserier, Malik; Lucas, Alexandre; Lezoualc'h, Frank] Univ Toulouse 3, F-31432 Toulouse 04, France; [Bouyssou, Pascal] Univ Orleans, CNRS, UMR 7311, Inst Chim Organ & Analyt, F-45067 Orleans 2, France; [Fischmeister, Rodolphe] INSERM, UMR S 769, LabEx LERMIT, F-92296 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm)	Blondeau, JP (corresponding author), Univ Paris 11, Fac Pharm, CIBLOT, IFR 141, F-92296 Chatenay Malabry, France.	jean-paul.blondeau@u-psud.fr; frank.lezoualch@inserm.fr	Bisserier, Malik/AAI-3730-2021; Lezoualc'h, Frank/E-5031-2016; Lucas, Ana/GZA-9861-2022; Fischmeister, Rodolphe/L-6061-2018; Blondeau, Jean-Paul/AAH-6395-2019	Bisserier, Malik/0000-0001-8826-4649; Fischmeister, Rodolphe/0000-0003-2086-9865; Blondeau, Jean-Paul/0000-0003-4520-6822	Agence Nationale de la Recherche ("HyperEpac" Genopath09); Region Midi-Pyrenees; Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale (Programme Cardiovasculaire); Centre National de la Recherche Scientifique	Agence Nationale de la Recherche ("HyperEpac" Genopath09)(French National Research Agency (ANR)); Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale (Programme Cardiovasculaire)(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Agence Nationale de la Recherche ("HyperEpac" Genopath09), Region Midi-Pyrenees, and Association Francaise contre les Myopathies and Fondation pour la Recherche Medicale (Programme Cardiovasculaire) (to F.L.). This work was also supported by a grant from the Centre National de la Recherche Scientifique (Programme Interdisciplinaire de Recherche Innovation Therapeutique 2010) (to J.P.B.).	BOUYSSOU P, 1992, J HETEROCYCLIC CHEM, V29, P895, DOI 10.1002/jhet.5570290436; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Chen HJ, 2012, BIOORG MED CHEM LETT, V22, P4038, DOI 10.1016/j.bmcl.2012.04.082; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Metrich M, 2008, CIRC RES, V102, P959, DOI 10.1161/CIRCRESAHA.107.164947; Metrich M, 2010, PFLUG ARCH EUR J PHY, V459, P535, DOI 10.1007/s00424-009-0747-y; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Tsalkova T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030441; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005	22	79	82	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44192	44202		10.1074/jbc.M112.422956	http://dx.doi.org/10.1074/jbc.M112.422956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23139415	hybrid, Green Published			2022-12-25	WOS:000312938600018
J	Zhang, HS; Yan, B; Li, XB; Fan, L; Zhang, YF; Wu, GH; Li, M; Fang, J				Zhang, Hai-Sheng; Yan, Bing; Li, Xue-Bing; Fan, Li; Zhang, Yun-Fang; Wu, Guo-Hao; Li, Min; Fang, Jing			PAX2 Protein Induces Expression of Cyclin D1 through Activating AP-1 Protein and Promotes Proliferation of Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; KAPPA-B; PHOSPHORYLATION; CARCINOMA; APOPTOSIS; TARGET; GENES; TUMORIGENESIS; INHIBITION; REGULATOR	Paired box (PAX) 2, a transcription factor, plays a critical role in embryogenesis. When aberrantly expressed in adult tissues, it generally exhibits oncogenic properties. However, the underlying mechanisms remain unclear. We reported previously that the expression of PAX2 was up-regulated in human colon cancers. However, the role of PAX2 in colon cancer cells has yet to be determined. The aim of this study is to determine the function of PAX2 in colon cancer cells and to investigate the possible mechanisms underlain. We find that knockdown of PAX2 inhibits proliferation and xenograft growth of colon cancer cells. Inhibition of PAX2 results in a decreased expression of cyclin D1. Expression of cyclin D1 is found increased in human primary colon malignant tumors, and its expression is associated with that of PAX2. These data indicate that PAX2 is a positive regulator of expression of cyclin D1. We find that knockdown of PAX2 inhibits the activity of AP-1, a transcription factor that induces cyclin D1 expression, implying that PAX2 induces cyclin D1 through AP-1. PAX2 has little effect on expression of AP-1 members including c-Jun, c-Fos, and JunB. Our data show that PAX2 prevents JunB from binding c-Jun and enhances phosphorylation of c-Jun, which may elevate the activity of AP-1. Taken together, these results suggest that PAX2 promotes proliferation of colon cancer cells through AP-1.	[Zhang, Hai-Sheng; Yan, Bing; Li, Xue-Bing; Fan, Li; Fang, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Wu, Guo-Hao] Fudan Univ, Zhongshan Hosp, Sch Med, Dept Surg, Shanghai 200030, Peoples R China; [Li, Min] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; University of Texas System; University of Texas Health Science Center Houston	Fang, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	jfang@sibs.ac.cn	Yan, Binghua/ACD-0393-2022	Yan, Binghua/0000-0003-3255-6559; Wu, Guohao/0000-0001-9490-4200	Natural Science Foundation of China [30970586]; Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-09]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the Natural Science Foundation of China (Grant 30970586) and the Innovation Program of the Chinese Academy of Sciences (Grant KSCX2-EW-R-09).	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Buttiglieri S, 2004, J BIOL CHEM, V279, P4136, DOI 10.1074/jbc.M306824200; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fang J, 2007, CARCINOGENESIS, V28, P713, DOI 10.1093/carcin/bgl189; Gibson W, 2007, CANCER LETT, V248, P251, DOI 10.1016/j.canlet.2006.08.007; GNARRA JR, 1995, CANCER RES, V55, P4092; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hueber PA, 2006, KIDNEY INT, V69, P1139, DOI 10.1038/sj.ki.5000136; Hueber PA, 2008, CANCER LETT, V265, P148, DOI 10.1016/j.canlet.2008.02.016; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Li ZD, 2012, J BIOL CHEM, V287, P17737, DOI 10.1074/jbc.M111.291708; Luu VD, 2009, CLIN CANCER RES, V15, P3297, DOI 10.1158/1078-0432.CCR-08-2779; Maeda S, 2003, CANCER CELL, V3, P102, DOI 10.1016/S1535-6108(03)00025-4; Matthews CP, 2007, CURR CANCER DRUG TAR, V7, P317, DOI 10.2174/156800907780809723; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Nagata D, 2001, J BIOL CHEM, V276, P662, DOI 10.1074/jbc.M005522200; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Palmqvist R, 2000, AM J PATHOL, V157, P1947, DOI 10.1016/S0002-9440(10)64833-X; Palmqvist R, 1998, EUR J CANCER, V34, P1575, DOI 10.1016/S0959-8049(98)00162-2; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Suto R, 2004, GENE THER, V11, P187, DOI 10.1038/sj.gt.3302158; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torban E, 2000, AM J PATHOL, V157, P833, DOI 10.1016/S0002-9440(10)64597-X; Wang HLL, 2002, INT J CANCER, V101, P301, DOI 10.1002/ijc.10630; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yan B, 2011, BIOCHEM BIOPH RES CO, V409, P315, DOI 10.1016/j.bbrc.2011.05.012	41	25	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44164	44172		10.1074/jbc.M112.401521	http://dx.doi.org/10.1074/jbc.M112.401521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135283	Green Published, hybrid			2022-12-25	WOS:000312938600015
J	Gao, SY; Jack, MM; O'Neill, C				Gao, Steven Y.; Jack, Michelle M.; O'Neill, Christopher			Towards Optimising the Production of and Expression from Polycistronic Vectors in Embryonic Stem Cells	PLOS ONE			English	Article							IN-VIVO; TRANSGENE EXPRESSION; HIGHLY EFFICIENT; CLEAVAGE; GENERATION; POLYPROTEIN; PROTEINS; PROMOTER	Polycistronic vectors linked by self-processing 2A peptides have been successfully used in cellular reprogramming. The expression of these vectors has yet to be well documented in embryonic stem cells. In the present study, we generated expression cassettes containing combinatorial arrangements of 3 pancreatic transcriptions factors (Pdx1, Nkx2.2 and Ngn3) together with an eGFP reporter, all linked by self-processing 2A peptides. The study tested the utility of constructing complex expression cassettes by ligating multiple components, each flanked by unique restriction sites. This approach allowed flexible and efficient design and construction of a combinatorial array of polycistronic constructs, which were expressed after transient transfection into embryonic stem cells. The inclusion of EGFP provided for a convenient proxy measure of expression and showed that expression was similar regardless of EGFP's position within a 2A polycistronic construct. Expression of terminal EGFP was 51% and 24% more efficient when linked by T2A compared to F2A or E2A peptides, respectively. The highest level of expression was achieved when all genes in a construct were linked exclusively by T2A peptides. This effect of T2A was independent of the type of promoter used, as a similar increase in terminal EGFP expression was observed when the polycistronic constructs were under the control of a CAG promoter compared to the CMV promoter, even though the GAG promoter was more efficient in this model than the CMV promoter. The study provides guidance on design strategies and methods for the efficient generation and expression of 2A polycistronic constructs in embryonic stem cells.	[Gao, Steven Y.; Jack, Michelle M.; O'Neill, Christopher] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Ctr Dev & Regenerat Med, Sydney, NSW 2006, Australia; [Jack, Michelle M.] Royal N Shore Hosp, Dept Endocrinol, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney	O'Neill, C (corresponding author), Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Ctr Dev & Regenerat Med, Sydney, NSW 2006, Australia.	chris.oneill@sydney.edu.au			NHMRC; Favaloro bequest; Rotary Postgraduate Scholarship; Lola Douglas Paediatric Research Scholarship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Favaloro bequest; Rotary Postgraduate Scholarship; Lola Douglas Paediatric Research Scholarship	This work was supported in part by grants from the NHMRC to CO and by funds provided by the Favaloro bequest to the Department of Endocrinology. SG was supported by a Rotary Postgraduate Scholarship and a Lola Douglas Paediatric Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI [10.1186/1471-2121-1189-1182, DOI 10.1186/1471-2121-1189-1182]; Anderson RP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks027; Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Bagchi B, 2006, CELL BIOL INT, V30, P505, DOI 10.1016/j.cellbi.2006.01.008; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doronina VA, 2008, BIOCHEM SOC T, V36, P712, DOI 10.1042/BST0360712; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kim KJ, 2004, PROTEIN SCI, V13, P1698, DOI 10.1110/ps.04644504; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Radcliffe PA, 2004, GENE THER, V11, P1673, DOI 10.1038/sj.gt.3302361; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Shao LJ, 2009, CELL RES, V19, P296, DOI 10.1038/cr.2009.20; Sharma P, 2012, NUCLEIC ACIDS RES, V40, P3143, DOI 10.1093/nar/gkr1176; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P251, DOI 10.1101/pdb.prot067884; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Torres V, 2010, J BIOTECHNOL, V146, P138, DOI 10.1016/j.jbiotec.2010.01.017; Ward CM, 2002, STEM CELLS, V20, P472, DOI 10.1634/stemcells.20-5-472; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	37	11	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48668	10.1371/journal.pone.0048668	http://dx.doi.org/10.1371/journal.pone.0048668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139810	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300049
J	Jiang, XQ; Menon, A; Wang, S; Kim, J; Ohno-Machado, L				Jiang, Xiaoqian; Menon, Aditya; Wang, Shuang; Kim, Jihoon; Ohno-Machado, Lucila			Doubly Optimized Calibrated Support Vector Machine (DOC-SVM): An Algorithm for Joint Optimization of Discrimination and Calibration	PLOS ONE			English	Article							RISK-ESTIMATION; BREAST-CANCER; PREDICTION; AREA; CURVE	Historically, probabilistic models for decision support have focused on discrimination, e.g., minimizing the ranking error of predicted outcomes. Unfortunately, these models ignore another important aspect, calibration, which indicates the magnitude of correctness of model predictions. Using discrimination and calibration simultaneously can be helpful for many clinical decisions. We investigated tradeoffs between these goals, and developed a unified maximum-margin method to handle them jointly. Our approach called, Doubly Optimized Calibrated Support Vector Machine (DOC-SVM), concurrently optimizes two loss functions: the ridge regression loss and the hinge loss. Experiments using three breast cancer gene-expression datasets (i.e., GSE2034, GSE2990, and Chanrion's datasets) showed that our model generated more calibrated outputs when compared to other state-of-the-art models like Support Vector Machine (p = 0.03, p = 0.13, and p<0.001) and Logistic Regression (p = 0.006, p = 0.008, and p<0.001). DOC-SVM also demonstrated better discrimination (i.e., higher AUCs) when compared to Support Vector Machine (p = 0.38, p = 0.29, and p = 0.047) and Logistic Regression (p = 0.38, p = 0.04, and p<0.0001). DOC-SVM produced a model that was better calibrated without sacrificing discrimination, and hence may be helpful in clinical decision making.	[Jiang, Xiaoqian; Wang, Shuang; Kim, Jihoon; Ohno-Machado, Lucila] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA; [Menon, Aditya] Univ Calif San Diego, Deptartment Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Jiang, XQ (corresponding author), Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA.	x1jiang@ucsd.edu	Jiang, Xiaoqian/K-6752-2012	Ohno-Machado, Lucila/0000-0002-8005-7327; Jiang, Xiaoqian/0000-0001-9933-2205; Wang, Shuang/0000-0001-6420-983X	National Library of Medicine [1K99LM01139201, R01LM009520]; NHLBI [U54 HL108460]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL108460] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM011392, R01LM009520] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	XJ, JK and LOM were funded in part by the National Library of Medicine (1K99LM01139201, R01LM009520) and NHLBI (U54 HL108460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayer T, 2010, CANCER-AM CANCER SOC, V116, P3310, DOI 10.1002/cncr.25081; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [DOI 10.1175/1520-0493(1950)0782.0.CO;2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2]; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Chi YY, 2008, STAT MED, V27, P182, DOI 10.1002/sim.2986; DeGroot Morris H, 1981, TECHNICAL REPORT; DIAMOND GA, 1992, J CLIN EPIDEMIOL, V45, P85, DOI 10.1016/0895-4356(92)90192-P; Duda R.O., 2006, PATTERN CLASSIFICATI; Ediger Marwood N, 2009, J Diabetes Sci Technol, V3, P776; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hosmer DW, 1997, STAT MED, V16, P965; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Inza I, 2010, METHODS MOL BIOL, V593, P25, DOI 10.1007/978-1-60327-194-3_2; James AH, 1982, RADIOLOGY, P143; Jiang XQ, 2012, J AM MED INFORM ASSN, V19, pE137, DOI 10.1136/amiajnl-2011-000751; Jiang XQ, 2012, J AM MED INFORM ASSN, V19, P263, DOI 10.1136/amiajnl-2011-000291; Kotlowski W, 2011, BIPARTITE RANKING MI, P1113; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lipson Jan, 2009, J Diabetes Sci Technol, V3, P233; Murphy A. H., 1971, J APPL METEOROLOGY, V10, P155, DOI [10.1175/1520-0450(1971)010<0155:ANOTRP>2.0.CO;2, DOI 10.1175/1520-0450(1971)010<0155:ANOTRP>2.0.CO;2, DOI 10.1175/1520-0450(1971)010]; MURPHY AH, 1986, MON WEATHER REV, V114, P2671, DOI 10.1175/1520-0493(1986)114<2671:ANDOTB>2.0.CO;2; Osl M, 2010, EFFECT DATA COMBINAT, P567; Platt JC, 2000, ADV NEUR IN, P61; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P211, DOI 10.1007/BF01062525; Sanders F., 1963, J APPL METEOROL, V2, P191, DOI DOI 10.1175/1520-0450(1963)002<0191:OSPF>2.0.CO;2; Sarin P, 2012, J AM MED INFORM ASS; Sarkar IN, 2011, J AM MED INFORM ASSN, V18, P354, DOI 10.1136/amiajnl-2011-000245; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Steck H, 2007, LECT NOTES ARTIF INT, V4701, P347; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vapnik N.V., 2000, NATURE STAT LEARNING, V2nd; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang Z, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1304; Wei W, 2011, J AM MED INFORM ASSN, V18, P370, DOI 10.1136/amiajnl-2011-000101; Wu Y, 2012, J AM MED INFORM ASS; YANIV I, 1991, PSYCHOL BULL, V110, P611, DOI 10.1037/0033-2909.110.3.611; Zadrozny B., 2002, P 8 ACM SIGKDD INT C, P694, DOI [10.1145/775047.775151, DOI 10.1145/775047.775151]; Zou KH, 2011, CHAPMAN HALL CRC BIO	40	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48823	10.1371/journal.pone.0048823	http://dx.doi.org/10.1371/journal.pone.0048823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040IE	23139819	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300058
J	Ma, Y; Qin, X; Chen, RL; Li, NN; Chen, R; Hu, Z				Ma, Ying; Qin, Xia; Chen, Ruoling; Li, Niannian; Chen, Ren; Hu, Zhi			Impact of Individual-Level Social Capital on Quality of Life among AIDS Patients in China	PLOS ONE			English	Article							GROUP MEMBERSHIP; HEALTH; HIV; ASSOCIATION; HIV/AIDS; SUPPORT; ADHERENCE; OUTCOMES; RISK; SELF	Background: With growing recognition of the social determinants of health, social capital is an increasingly important construct in international health. However, the application of social capital discourse in response to HIV infection remains preliminary. The aim of this study was to assess the impact of social capital on quality of life (QoL) among adult patients with acquired immune deficiency syndrome (AIDS). Methods: A convenient sample of 283 patients receiving antiretroviral treatment (ART) was investigated in Anhui province, China. QoL data were collected using the Medical Outcomes Study HIV Survey (MOS-HIV) questionnaire. Social capital was measured using a self-developed questionnaire. Logistic regression models were used to explore associations between social capital and QoL. Results: The study sample had a mean physical health summary (PHS) score of 50.13 +/- 9.90 and a mean mental health summary (MHS) score of 41.64 +/- 11.68. Cronbach's alpha coefficients of the five multi-item scales of social capital ranged from 0.44 to 0.79. When other variables were controlled for, lower individual levels of reciprocity and trust were associated with a greater likelihood of having a poor PHS score (odds ratio [OR] = 2.02) or PHS score (OR = 6.90). Additionally, the factors of social support and social networks and ties were associated positively with MHS score (OR = 2.30, OR = 4.17, respectively). Conclusions: This is the first report to explore the effects of social capital on QoL of AIDS patients in China. The results indicate that social capital is a promising avenue for developing strategies to improve the QoL of AIDS patients in China, suggesting that the contribution of social capital should be fully exploited, especially with enhancement of QoL through social participation. Social capital development policy may be worthy of consideration.	[Ma, Ying; Qin, Xia; Chen, Ruoling; Chen, Ren; Hu, Zhi] Anhui Med Univ, Sch Hlth Serv Management, Hefei, Peoples R China; [Ma, Ying] Anhui Med Univ, Sch Publ Hlth, Hefei, Peoples R China; [Li, Niannian] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Hu, Z (corresponding author), Anhui Med Univ, Sch Hlth Serv Management, Hefei, Peoples R China.	aywghz@126.com	Chen, Ren/AAV-5572-2021; Swaibu, Ramadhani A/H-3164-2011	Chen, Ruoling/0000-0002-3033-8753	National Natural Science Foundation of China [70973001, 71103001, 71173002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Grant No. 70973001, Grant No. 71103001, and Grant No. 71173002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-499; [Anonymous], 2011, CHINAS AIDS EPIDEMIC; Bastardo YM, 2000, AIDS CARE, V12, P673, DOI 10.1080/095401200750003842; Bekele T, 2012, AIDS CARE IN PRESS; Binagwaho A, 2009, PLOS MED, V6, P10, DOI 10.1371/journal.pmed.1000018; Figuero LSB, 2011, HIV MED, V12, P22, DOI 10.1111/j.1468-1293.2010.00844.x; Calnan Michael, 2006, J Health Organ Manag, V20, P477, DOI 10.1108/14777260610701830; Campbell C, 2002, AIDS CARE, V14, P41, DOI 10.1080/09540120220097928; CAMPBELL LF, 1992, PSYCHOL REP, V70, P1075, DOI 10.2466/PR0.70.4.1075-1092; Charles B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-463; Ferguson E, 2001, J HOMOSEXUAL, V41, P119, DOI 10.1300/J082v41n02_07; Fontaine KR, 1997, J CLIN PSYCHOL, V53, P249, DOI 10.1002/(SICI)1097-4679(199704)53:3<249::AID-JCLP8>3.0.CO;2-M; Gregson S, 2004, SOC SCI MED, V58, P2119, DOI 10.1016/j.socscimed.2003.09.001; Han S, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-3; Hawe P, 2000, SOC SCI MED, V51, P871, DOI 10.1016/S0277-9536(00)00067-8; Huang ZJ, 2012, QUAL LIFE R IN PRESS; Hunter BD, 2011, HEALTH SOC CARE COMM, V19, P522, DOI 10.1111/j.1365-2524.2011.00999.x; Krause DD, 2012, AIDS CARE IN PRESS; Lau JTF, 2006, QUAL LIFE RES, V15, P1079, DOI 10.1007/s11136-005-5914-9; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Nieminen T, 2010, INT J PUBLIC HEALTH, V55, P531, DOI 10.1007/s00038-010-0138-3; Pronyk PM, 2008, SOC SCI MED, V66, P1999, DOI 10.1016/j.socscimed.2008.01.023; Roberts KJ, 2000, AIDS CARE, V12, P377, DOI 10.1080/09540120050123774; Rothon C, 2012, SOC PSYCH PSYCH EPID, V47, P697, DOI 10.1007/s00127-011-0391-7; Skevington SM, 2004, SOC PSYCH PSYCH EPID, V39, P1, DOI 10.1007/s00127-004-0700-5; Sun XJ, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-2; Takahashi K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-206; Theall KP, 2009, HEALTH PLACE, V15, P323, DOI 10.1016/j.healthplace.2008.06.001; Vimpani G, 2000, J DEV BEHAV PEDIATR, V21, P44, DOI 10.1097/00004703-200002000-00007; Vu TV, 2012, HEALTH QUAL LIFE OUT, V10, P53; Webel A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-188; Wong MD, 2007, J GEN INTERN MED, V22, P1286, DOI 10.1007/s11606-007-0265-6; Wong Y.-T., 2003, Asia Pacific Journal of Management, V20, P481, DOI 10.1023/A:1026391009543; Yadav S, 2010, QUAL LIFE RES, V19, P157, DOI 10.1007/s11136-009-9574-z; Yamaoka K, 2008, SOC SCI MED, V66, P885, DOI 10.1016/j.socscimed.2007.10.024; Yang F., 2007, CHINA PUBLIC HLTH, V23, P981; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027	37	19	23	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48888	10.1371/journal.pone.0048888	http://dx.doi.org/10.1371/journal.pone.0048888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040IE	23139823	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300062
J	Sun, CC; Wei, L; Luo, FF; Li, Y; Li, JB; Zhu, FQ; Kang, P; Xu, RS; Xiao, LL; Liu, ZL; Xu, PY				Sun, Congcong; Wei, Lei; Luo, Feifei; Li, Yi; Li, Jiaobiao; Zhu, Feiqi; Kang, Ping; Xu, Rensi; Xiao, LuLu; Liu, Zhuolin; Xu, Pingyi			HLA-DRB1 Alleles Are Associated with the Susceptibility to Sporadic Parkinson's Disease in Chinese Han Population	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; LEUKOCYTE ANTIGEN-A; HIGH-RESOLUTION HLA; GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; HAPLOTYPE FREQUENCIES; JAPANESE PATIENTS; LATE-ONSET; LINKAGE-DISEQUILIBRIUM; PULMONARY SARCOIDOSIS	Immune disorders may play an important role in the pathogenesis of Parkinson's disease (PD). Recently, polymorphisms in the HLA-DR region have been found to be associated with sporadic PD in European ancestry populations. However, polymorphisms in the HLA complex are highly variable with ethnic and geographic origin. To explore the relationships between polymorphisms of the HLA-DR region and sporadic PD in Chinese Han population, we genotyped 567 sporadic PD patients and 746 healthy controls in two independent series for the HLA-DRB1 locus with Polymerase chain reaction-sequence based typing(PCR-SBT). The chi(2) test was used to evaluate the distribution of allele frequencies between the patients and healthy controls. The impact of HLA-DRB1 alleles on PD risk was estimated by unconditional logistic regression. We found a significant higher frequency of HLA-DRB1*0301 in sporadic PD patients than in healthy controls and a positive association, which was independent of onset age, between HLA-DRB1*0301 and PD risk. Conversely, a lower frequency of HLA-DRB1*0406 was found in sporadic PD patients than in healthy controls, with a negative association between HLA-DRB1*0406 and PD risk. Furthermore, a meta-analysis involving 195205 individuals was conducted to summarize the frequencies of these two alleles in populations from various ethnic regions, we found a higher frequency of HLA-DRB1*0301, but a lower frequency of HLA-DRB1*0406 in European ancestry populations than that in Asians, this was consistent with the higher prevalence of sporadic PD in European ancestry populations. Based on these results, we speculate that HLA-DRB1 alleles are associated with the susceptibility to sporadic PD in Chinese Han population, among them HLA-DRB1*0301 is a risk allele while the effect of HLA-DRB1*0406 deserves debate.	[Sun, Congcong; Wei, Lei; Luo, Feifei; Liu, Zhuolin; Xu, Pingyi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Wei, Lei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Feifei] Third Peoples Hosp Chengdu, Dept Neurol, Chengdu, Peoples R China; [Li, Yi] Red Cross Hosp Guangzhou, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Li, Jiaobiao] HeYuan City Hosp, Dept Neurol, Heyuan, Guangdong, Peoples R China; [Zhu, Feiqi] Shantou Univ, Coll Med, Yuebei Peoples Hosp, Dept Neurol, Shantou, Guangdong, Peoples R China; [Kang, Ping] First Peoples Hosp Shaoguan, Dept Neurol, Shaoguan, Guangdong, Peoples R China; [Xu, Rensi] NanChang Univ, Affiliated Hosp 1, Dept Neurol, Nanchang, Peoples R China; [Xiao, LuLu] So Med Univ, Nanfang Hosp, Dept Tissue Typing Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Shantou University; Nanchang University; Southern Medical University - China	Xu, PY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	pingyixu@sina.com	Zhu, Feiqi/AAE-2897-2020		National High Technology Research and Development Program of China [2007AA022460]; State Key Development Program for Basic Research of China [2011CB510000]; National Natural Science Foundation of China [81071032, 81271428]; Guangzhou Foundation for scientific and technological project, China [2012J4300061]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100171110056]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Foundation for scientific and technological project, China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The trial costs were supported by research grants from the National High Technology Research and Development Program of China (grant 2007AA022460) and the State Key Development Program for Basic Research of China (grant 2011CB510000). The data collection and analysis were supported by research grants from the National Natural Science Foundation of China (grant 81071032 and 81271428). The preparation of the manuscript and publication fees were supported by research grants from the Guangzhou Foundation for scientific and technological project, China (grant 2012J4300061) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (grant 20100171110056). These funders had no role in study design, decision to publish.	Azuma H., 1999, International Urology and Nephrology, V31, P343, DOI 10.1023/A:1007126219791; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Chen PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016635; Chun-Lai T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021069; Creary LE, 2009, TRANSFUSION, V49, P57, DOI 10.1111/j.1537-2995.2008.01943.x; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de la Concha EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031018; Deng Ya-jun, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P103; Driver JA, 2009, NEUROLOGY, V72, P432, DOI 10.1212/01.wnl.0000341769.50075.bb; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Guerini FR, 2009, INT J IMMUNOPATH PH, V22, P991, DOI 10.1177/039463200902200414; Hailu E, 2012, PLOS ONE, V7; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Handunnetthi L, 2010, GENES IMMUN, V11, P99, DOI 10.1038/gene.2009.83; HASHIMOTO M, 1994, TISSUE ANTIGENS, V44, P166, DOI 10.1111/j.1399-0039.1994.tb02375.x; Hei AL, 2009, INT J IMMUNOGENET, V36, P275, DOI 10.1111/j.1744-313X.2009.00866.x; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Idali F, 2006, EUR RESPIR J, V27, P451, DOI 10.1183/09031936.06.00067105; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; KAUFMAN JF, 1984, CELL, V36, P1, DOI 10.1016/0092-8674(84)90068-0; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kitajima H, 2012, GENES IMMUN IN PRESS, P35; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Klitz W, 2009, TISSUE ANTIGENS, V74, P508, DOI 10.1111/j.1399-0039.2009.01374.x; Kojima Y, 2000, ONCOLOGY-BASEL, V59, P57, DOI 10.1159/000012138; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Lampe JB, 2003, EUR NEUROL, V50, P64, DOI 10.1159/000072500; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; LEHENY WA, 1983, TISSUE ANTIGENS, V21, P260; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Liu YZ., 2011, INT J LAB MED, V32, P728; Luo H, 2011, HUM IMMUNOL, V72, P422, DOI 10.1016/j.humimm.2011.02.017; Ma SL, 2008, DEMENT GERIATR COGN, V26, P391, DOI 10.1159/000164275; Mack SJ, 2009, TISSUE ANTIGENS, V73, P17, DOI 10.1111/j.1399-0039.2008.01151.x; Mack SJ, 2011, HUM IMMUNOL, V72, P144, DOI 10.1016/j.humimm.2010.10.017; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Manan H, 2010, HUM IMMUNOL, V71, P1238, DOI 10.1016/j.humimm.2010.09.008; Marsh SGE, 2012, TISSUE ANTIGENS, V79, P230, DOI 10.1111/j.1399-0039.2012.01841.x; MARTTILA RJ, 1981, J NEUROL SCI, V51, P217, DOI 10.1016/0022-510X(81)90100-3; McElroy JP, 2011, GENES IMMUN, V12, P523, DOI 10.1038/gene.2011.25; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meyer-Monard S, 2009, BONE MARROW TRANSPL, V43, P771, DOI 10.1038/bmt.2008.391; Middleton D, 2000, HUM IMMUNOL, V61, P1285, DOI 10.1016/S0198-8859(00)00186-5; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Mitsunaga S, 2011, HUM IMMUNOL, V72, P566, DOI 10.1016/j.humimm.2011.03.011; Miyagawa S, 1999, TISSUE ANTIGENS, V54, P333, DOI 10.1034/j.1399-0039.1999.540402.x; Monahan AJ, 2008, CELL TRANSPLANT, V17, P363; Monos DS, 1997, J INFECT DIS, V176, pS180, DOI 10.1086/513786; Murakami M, 2000, HORM RES, V54, P49, DOI 10.1159/000063437; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Neill D, 1999, NEUROSCI LETT, V275, P137, DOI 10.1016/S0304-3940(99)00761-2; Pan CF, 2009, LUPUS, V18, P698, DOI 10.1177/0961203308101955; Park MH, 1999, TISSUE ANTIGENS, V53, P386, DOI 10.1034/j.1399-0039.1999.530412.x; Qin PQ, 2011, INT J IMMUNOGENET, V38, P475, DOI 10.1111/j.1744-313X.2011.01029.x; REED E, 1983, TISSUE ANTIGENS, V21, P161; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Ros-Bernal F, 2011, P NATL ACAD SCI USA, V108, P6632, DOI 10.1073/pnas.1017820108; Saha M, 2010, J INVEST DERMATOL, V130, P311, DOI 10.1038/jid.2009.241; Saiki M, 2010, J NEUROL NEUROSUR PS, V81, P890, DOI 10.1136/jnnp.2008.162883; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schmidt AH, 2011, HUM IMMUNOL, V72, P558, DOI 10.1016/j.humimm.2011.03.010; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Song EY, 2008, HUM IMMUNOL, V69, P354, DOI 10.1016/j.humimm.2008.04.009; Song EY, 2004, HUM IMMUNOL, V65, P270, DOI 10.1016/j.humimm.2003.12.005; Tanaka T, 1999, TISSUE ANTIGENS, V54, P246, DOI 10.1034/j.1399-0039.1999.540305.x; Ueki A, 2005, J OCCUP HEALTH, V47, P61, DOI 10.1539/joh.47.61; Vidal S, 2002, EUR J IMMUNOGENET, V29, P75, DOI 10.1046/j.0960-7420.2001.00293.x; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Wang SS, 2010, BLOOD, V115, P4820, DOI 10.1182/blood-2010-01-266775; Wen SH, 2008, HUM IMMUNOL, V69, P430, DOI 10.1016/j.humimm.2008.05.012; Wiken M, 2012, J INTERN MED, V271, P90, DOI 10.1111/j.1365-2796.2011.02414.x; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Yong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016610; [张伯伟 ZHANG Bowei], 2006, [中国输血杂志, Chinese Journal of Blood Transfusion], V19, P115; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1; Zota V, 2009, J IMMUNOL, V183, P3522, DOI 10.4049/jimmunol.0900620; 李王霞, 2010, [中国输血杂志, Chinese Journal of Blood Transfusion], V23, P443	80	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48594	10.1371/journal.pone.0048594	http://dx.doi.org/10.1371/journal.pone.0048594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139797	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300040
J	Keller, KE; Sun, YY; Vranka, JA; Hayashi, L; Acott, TS				Keller, Kate E.; Sun, Ying Ying; Vranka, Janice A.; Hayashi, Lauren; Acott, Ted S.			Inhibition of Hyaluronan Synthesis Reduces Versican and Fibronectin Levels in Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; EXTRACELLULAR-MATRIX TURNOVER; AQUEOUS OUTFLOW RESISTANCE; HUMAN SKIN FIBROBLASTS; HEPARIN-II DOMAIN; ANTERIOR SEGMENTS; DOWN-REGULATION; MONKEY EYE; 4-METHYLUMBELLIFERONE; FACILITY	Hyaluronan (HA) is a major component of the extracellular matrix (ECM) and is synthesized by three HA synthases (HAS). Similarities between the HAS2 knockout mouse and the hdf mutant mouse, which has a mutation in the versican gene, suggest that HA and versican expression may be linked. In this study, the relationship between HA synthesis and levels of versican, fibronectin and several other ECM components in trabecular meshwork cells from the anterior segment of the eye was investigated. HA synthesis was inhibited using 4-methylumbelliferone (4MU), or reduced by RNAi silencing of each individual HAS gene. Quantitative RT-PCR and immunoblotting demonstrated a reduction in mRNA and protein levels of versican and fibronectin. Hyaluronidase treatment also reduced versican and fibronectin levels. These effects could not be reversed by addition of excess glucose or glucosamine or exogenous HA to the culture medium. CD44, tenascin C and fibrillin-1 mRNA levels were reduced by 4MU treatment, but SPARC and CSPG6 mRNA levels were unaffected. Immunostaining of trabecular meshwork tissue after exposure to 4MU showed an altered localization pattern of HA-binding protein, versican and fibronectin. Reduction of versican by RNAi silencing did not affect HA concentration as assessed by ELISA. Together, these data imply that HA concentration affects synthesis of certain ECM components. Since precise regulation of the trabecular meshwork ECM composition and organization is required to maintain the aqueous humor outflow resistance and intraocular pressure homeostasis in the eye, coordinated coupling of HA levels and several of its ECM binding partners should facilitate this process.	[Keller, Kate E.; Sun, Ying Ying; Vranka, Janice A.; Hayashi, Lauren; Acott, Ted S.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA	Oregon Health & Science University	Keller, KE (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	gregorka@ohsu.edu		Keller, Kate/0000-0002-1616-972X	National Institutes of Health [EY019643, EY003279, EY008247, EY010572, EY019935]; Glaucoma Research Foundation, San Francisco, CA; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R21EY019935, R01EY008247, R01EY003279, R01EY019643, P30EY010572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Research Foundation, San Francisco, CA; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY019643 (KEK), EY003279, EY008247, EY010572, EY019935 (TSA), a Shaffer Award for Innovative Research from the Glaucoma Research Foundation, San Francisco, CA (JAV), and by an unrestricted grant to the Casey Eye Institute from Research to Prevent Blindness, New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; ACOTT TS, 1985, INVEST OPHTH VIS SCI, V26, P1320; Acott TS, 2010, ENCY EYE, P170; BARANY EH, 1954, ACTA PHYSIOL SCAND, V30, P240, DOI 10.1111/j.1748-1716.1954.tb01092.x; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Boland MV, 2007, J GLAUCOMA, V16, P406, DOI 10.1097/IJG.0b013e31806540a1; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; Day JM, 2004, J BIOL CHEM, V279, P12511, DOI 10.1074/jbc.M400242200; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Faralli JA, 2009, EXP EYE RES, V88, P689, DOI 10.1016/j.exer.2008.08.019; Fuchshofer R, 2009, EXP EYE RES, V88, P683, DOI 10.1016/j.exer.2009.01.005; Funahashi M, 2009, CONNECT TISSUE RES, V50, P194, DOI 10.1080/03008200802684615; Gasiorowski JZ, 2009, EXP EYE RES, V88, P671, DOI 10.1016/j.exer.2008.08.006; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Gonzalez JM, 2009, INVEST OPHTH VIS SCI, V50, P235, DOI 10.1167/iovs.08-2143; GUM GG, 1992, AM J VET RES, V53, P767; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2008, J BIOCHEM, V144, P131, DOI 10.1093/jb/mvn046; JOHNSON DH, 1989, CURR EYE RES, V8, P1121, DOI 10.3109/02713688909000037; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Keller KE, 2008, INVEST OPHTH VIS SCI, V49, P2495, DOI 10.1167/iovs.07-0903; Keller KE, 2007, INVEST OPHTH VIS SCI, V48, P1164, DOI 10.1167/iovs.06-0875; Keller KE, 2012, INVEST OPHTH VIS SCI, V53, P4616, DOI 10.1167/iovs.12-9500; Keller KE, 2011, INVEST OPHTH VIS SCI, V52, P5049, DOI 10.1167/iovs.10-6948; Keller KE, 2009, INVEST OPHTH VIS SCI, V50, P5769, DOI 10.1167/iovs.09-3673; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P2414; KNEPPER PA, 1984, INVEST OPHTH VIS SCI, V25, P286; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Lu Z, 2008, EXP EYE RES, V86, P271, DOI 10.1016/j.exer.2007.10.018; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; McDonald JA, 2002, GLYCOCONJUGATE J, V19, P331, DOI 10.1023/A:1025369004783; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; Pelletier CC, 2005, APPL SPECTROSC, V59, P1024, DOI 10.1366/0003702054615133; PETERSON WS, 1974, AM J OPHTHALMOL, V77, P573, DOI 10.1016/0002-9394(74)90473-5; POLANSKY JR, 1984, OPHTHALMOLOGY, V91, P580; POLANSKY JR, 1979, INVEST OPHTH VIS SCI, V18, P1043; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rhee DJ, 2009, EXP EYE RES, V88, P694, DOI 10.1016/j.exer.2008.11.032; Santas AJ, 2003, INVEST OPHTH VIS SCI, V44, P4796, DOI 10.1167/iovs.02-1083; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; STAMER WD, 1995, CURR EYE RES, V14, P611, DOI 10.3109/02713689508998409; Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Viola M, 2008, CONNECT TISSUE RES, V49, P111, DOI 10.1080/03008200802148405; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Zhao XJ, 2005, MOL VIS, V11, P603	58	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48523	10.1371/journal.pone.0048523	http://dx.doi.org/10.1371/journal.pone.0048523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139787	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400050
J	Asmal, M; Whitney, JB; Luedemann, C; Carville, A; Steen, R; Letvin, NL; Geiben-Lynn, R				Asmal, Mohammed; Whitney, James B.; Luedemann, Corinne; Carville, Angela; Steen, Robert; Letvin, Norman L.; Geiben-Lynn, Ralf			In vivo Anti-HIV Activity of the Heparin-Activated Serine Protease Inhibitor Antithrombin III Encapsulated in Lymph-Targeting Immunoliposomes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STERICALLY STABILIZED LIPOSOMES; RECOMBINANT HUMAN ANTITHROMBIN; REDUCED SENSITIVITY; COMBINATION THERAPY; THROMBIN-III; DEFICIENCY; INFECTION; AIDS; CELLS	Endogenous serine protease inhibitors (serpins) are anti-inflammatory mediators with multiple biologic functions. Several serpins have been reported to modulate HIV pathogenesis, or exhibit potent anti-HIV activity in vitro, but the efficacy of serpins as therapeutic agents for HIV in vivo has not yet been demonstrated. In the present study, we show that heparin-activated antithrombin III (hep-ATIII), a member of the serpin family, significantly inhibits lentiviral replication in a nonhuman primate model. We further demonstrate greater than one log(10) reduction in plasma viremia in the nonhuman primate system by loading of hep-ATIII into anti-HLA-DR immunoliposomes, which target tissue reservoirs of viral replication. We also demonstrate the utility of hep-ATIIII as a potential salvage agent for HIV strains resistant to standard anti-retroviral treatment. Finally, we applied gene-expression arrays to analyze hep-ATIII-induced host cell interactomes and found that downstream of hep-ATIII, two independent gene networks were modulated by host factors prostaglandin synthetase-2, ERK1/2 and NF kappa B. Ultimately, understanding how serpins, such as hep-ATIII, regulate host responses during HIV infection may reveal new avenues for therapeutic intervention.	[Asmal, Mohammed; Whitney, James B.; Luedemann, Corinne; Letvin, Norman L.; Geiben-Lynn, Ralf] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Asmal, Mohammed; Whitney, James B.; Luedemann, Corinne; Carville, Angela; Steen, Robert; Letvin, Norman L.; Geiben-Lynn, Ralf] Harvard Univ, Sch Med, Boston, MA USA; [Carville, Angela] New England Primate Res Ctr, Southborough, MA USA; [Steen, Robert] Biopolymers Facil, Dept Genet, Boston, MA USA; [Geiben-Lynn, Ralf] Accelerat BioPharmaceut Inc, Woburn, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Asmal, M (corresponding author), Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	masmal@partners.org			United States National Institutes of Health [N01 AI30048, N01 AI30049, AI067854, AI060354-06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, U19AI067854, R37AI030048, R01AI030048, P30AI060354] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the United States National Institutes of Health (N01 AI30048, N01 AI30049, AI067854 and AI060354-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmal M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-226; Bahgat MM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-27; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Bestman-Smith J, 2000, BBA-BIOMEMBRANES, V1468, P161, DOI 10.1016/S0005-2736(00)00254-6; BOERMAN OC, 1995, J NUCL MED, V36, P1639; Bryan CL, 2010, CLIN INVEST MED, V33, pE384; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Chang WK, 2011, INT J NANOMED, V6, P2403, DOI 10.2147/IJN.S25646; CHENGMAYER C, 1988, ANN NEUROL, V23, pS58, DOI 10.1002/ana.410230716; Christianson SW, 1997, J IMMUNOL, V158, P3578; Chung Raymond T, 2008, Hepatology, V47, P306, DOI 10.1002/hep.22070; Cline AN, 2005, J MED PRIMATOL, V34, P303; COLLEN D, 1977, EUR J CLIN INVEST, V7, P27, DOI 10.1111/j.1365-2362.1977.tb01566.x; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; Congote LF, 2006, BIOCHEM BIOPH RES CO, V343, P617, DOI 10.1016/j.bbrc.2006.02.190; Cozzi E, 2005, TRANSPLANTATION, V80, P1501, DOI 10.1097/01.TP.0000178377.55615.8B; Desormeaux A, 1998, J DRUG TARGET, V6, P1; Desormeaux A, 2005, METHOD ENZYMOL, V391, P330, DOI 10.1016/S0076-6879(05)91019-7; Drusano GL, 1996, ANTIMICROB AGENTS CH, V40, P1143, DOI 10.1128/AAC.40.5.1143; Dufresne I, 1999, BBA-BIOMEMBRANES, V1421, P284, DOI 10.1016/S0005-2736(99)00137-6; Dunzendorfer S, 2001, BLOOD, V97, P1079, DOI 10.1182/blood.V97.4.1079; Elmaleh DR, 2005, INT J MOL MED, V16, P191; Feistritzer C, 2007, EXPERT OPIN BIOL TH, V7, P855, DOI 10.1517/14712598.7.6.855; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Geiben-Lynn R, 2002, J BIOL CHEM, V277, P42352, DOI 10.1074/jbc.M207079200; Geiben-Lynn R, 2001, J VIROL, V75, P8306, DOI 10.1128/JVI.75.17.8306-8316.2001; Hayes VM, 2003, J INFECT DIS, V188, P1205, DOI 10.1086/378641; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Ignatius R, 2000, BLOOD, V96, P3505; Kaneider NC, 2002, J CELL SCI, V115, P227; Kaneider NC, 2001, BIOCHEM BIOPH RES CO, V287, P42, DOI 10.1006/bbrc.2001.5534; Kim SE, 2012, J NEUROSCI RES; KNOT EAR, 1986, BLOOD, V67, P93; Kovochich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018270; Kramer HB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000893; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Larsson H, 2001, J BIOL CHEM, V276, P11996, DOI 10.1074/jbc.M010170200; Lederman MM, 2008, SEMIN IMMUNOL, V20, P187, DOI 10.1016/j.smim.2008.06.001; Levy JH, 2001, SEMIN THROMB HEMOST, V27, P405, DOI 10.1055/s-2001-16893; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mackewicz CE, 2003, P NATL ACAD SCI USA, V100, P3433, DOI 10.1073/pnas.0630379100; Mallipeddi R, 2010, INT J NANOMED, V5, P533; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; Minnema MC, 2000, BLOOD, V95, P1117, DOI 10.1182/blood.V95.4.1117.002k12_1117_1123; MONTEFIORI DC, 1988, J CLIN MICROBIOL, V26, P231, DOI 10.1128/JCM.26.2.231-235.1988; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; O'Reilly MS, 1999, SCIENCE, V285, P1926, DOI 10.1126/science.285.5435.1926; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Orlans FB, 1997, ETHICS BEHAV, V7, P163, DOI 10.1207/s15327019eb0702_7; OTTO MJ, 1993, P NATL ACAD SCI USA, V90, P7543, DOI 10.1073/pnas.90.16.7543; Potthoff AV, 2007, AIDS, V21, P2115, DOI 10.1097/QAD.0b013e3282f08b97; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Saber AA, 2001, AM SURGEON, V67, P645; Saif MW, 2001, AIDS PATIENT CARE ST, V15, P311, DOI 10.1089/108729101750279687; Saif MW, 2001, AIDS PATIENT CARE ST, V15, P15, DOI 10.1089/108729101460065; Schmutz G, 2006, AIDS, V20, P1951, DOI 10.1097/01.aids.0000247116.89455.5d; SCHWARTZ RS, 1989, AM J MED, V87, pS53, DOI 10.1016/0002-9343(89)80533-9; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; SHAW GM, 1984, SCIENCE, V226, P1165, DOI 10.1126/science.6095449; Shugars D C, 1997, Oral Dis, V3 Suppl 1, pS70; Siegfried NL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004535; Souter PJ, 2001, CRIT CARE MED, V29, P134, DOI 10.1097/00003246-200101000-00027; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Sun Y, 2005, J IMMUNOL, V174, P4753, DOI 10.4049/jimmunol.174.8.4753; Svarovskaia ES, 2004, J VIROL, V78, P3210, DOI 10.1128/JVI.78.7.3210-3222.2004; TENGBORN L, 1981, SCAND J CLIN LAB INV, V41, P469, DOI 10.3109/00365518109090485; Whitney JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018589; XU YH, 1994, J HISTOCHEM CYTOCHEM, V42, P1365, DOI 10.1177/42.10.7930519; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251; Zhou XY, 2011, J IMMUNOL, V186, P3148, DOI 10.4049/jimmunol.1001358	73	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48234	10.1371/journal.pone.0048234	http://dx.doi.org/10.1371/journal.pone.0048234			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133620	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400027
J	Ahmed, SA; Awosika, J; Baldwin, C; Bishop-Lilly, KA; Biswas, B; Broomall, S; Chain, PSG; Chertkov, O; Chokoshvili, O; Coyne, S; Davenport, K; Detter, JC; Dorman, W; Erkkila, TH; Folster, JP; Frey, KG; George, M; Gleasner, C; Henry, M; Hill, KK; Hubbard, K; Insalaco, J; Johnson, S; Kitzmiller, A; Krepps, M; Lo, CC; Luu, T; McNew, LA; Minogue, T; Munk, CA; Osborne, B; Patel, M; Reitenga, KG; Rosenzweig, CN; Shea, A; Shen, XH; Strockbine, N; Tarr, C; Teshima, H; van Gieson, E; Verratti, K; Wolcott, M; Xie, G; Sozhamannan, S; Gibbons, HS				Ahmed, Sanaa A.; Awosika, Joy; Baldwin, Carson; Bishop-Lilly, Kimberly A.; Biswas, Biswajit; Broomall, Stacey; Chain, Patrick S. G.; Chertkov, Olga; Chokoshvili, Otar; Coyne, Susan; Davenport, Karen; Detter, J. Chris; Dorman, William; Erkkila, Tracy H.; Folster, Jason P.; Frey, Kenneth G.; George, Matroner; Gleasner, Cheryl; Henry, Matthew; Hill, Karen K.; Hubbard, Kyle; Insalaco, Joseph; Johnson, Shannon; Kitzmiller, Aaron; Krepps, Michael; Lo, Chien-Chi; Truong Luu; McNew, Lauren A.; Minogue, Timothy; Munk, Christine A.; Osborne, Brian; Patel, Mohit; Reitenga, Krista G.; Rosenzweig, C. Nicole; Shea, April; Shen, Xiaohong; Strockbine, Nancy; Tarr, Cheryl; Teshima, Hazuki; van Gieson, Eric; Verratti, Kathleen; Wolcott, Mark; Xie, Gary; Sozhamannan, Shanmuga; Gibbons, Henry S.		Threat Characterization Consortium	Genomic Comparison of Escherichia coli O104:H4 Isolates from 2009 and 2011 Reveals Plasmid, and Prophage Heterogeneity, Including Shiga Toxin Encoding Phage stx2	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SALMONELLA-TYPHIMURIUM; AGGREGATIVE ADHERENCE; GADE YHIE; BACTERIOPHAGES; RESISTANCE; PATHOGENS; SEQUENCES; ALIGNMENT; OUTBREAK	In May of 2011, an enteroaggregative Escherichia coli O104:H4 strain that had acquired a Shiga toxin 2-converting phage caused a large outbreak of bloody diarrhea in Europe which was notable for its high prevalence of hemolytic uremic syndrome cases. Several studies have described the genomic inventory and phylogenies of strains associated with the outbreak and a collection of historical E. coli O104: H4 isolates using draft genome assemblies. We present the complete, closed genome sequences of an isolate from the 2011 outbreak (2011C-3493) and two isolates from cases of bloody diarrhea that occurred in the Republic of Georgia in 2009 (2009EL-2050 and 2009EL-2071). Comparative genome analysis indicates that, while the Georgian strains are the nearest neighbors to the 2011 outbreak isolates sequenced to date, structural and nucleotide-level differences are evident in the Stx2 phage genomes, the mer/tet antibiotic resistance island, and in the prophage and plasmid profiles of the strains, including a previously undescribed plasmid with homology to the pMT virulence plasmid of Yersinia pestis. In addition, multiphenotype analysis showed that 2009EL-2071 possessed higher resistance to polymyxin and membrane-disrupting agents. Finally, we show evidence by electron microscopy of the presence of a common phage morphotype among the European and Georgian strains and a second phage morphotype among the Georgian strains. The presence of at least two stx2 phage genotypes in host genetic backgrounds that may derive from a recent common ancestor of the 2011 outbreak isolates indicates that the emergence of stx2 phage-containing E. coli O104: H4 strains probably occurred more than once, or that the current outbreak isolates may be the result of a recent transfer of a new stx2 phage element into a pre-existing stx2-positive genetic background.	[Broomall, Stacey; Hubbard, Kyle; Insalaco, Joseph; Krepps, Michael; McNew, Lauren A.; Rosenzweig, C. Nicole; Gibbons, Henry S.] USA, Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD USA; [Ahmed, Sanaa A.; Chain, Patrick S. G.; Chertkov, Olga; Davenport, Karen; Detter, J. Chris; Erkkila, Tracy H.; Gleasner, Cheryl; Hill, Karen K.; Johnson, Shannon; Lo, Chien-Chi; Munk, Christine A.; Reitenga, Krista G.; Shen, Xiaohong; Teshima, Hazuki; Xie, Gary] Los Alamos Natl Lab, Los Alamos, NM USA; [Awosika, Joy; Bishop-Lilly, Kimberly A.; Biswas, Biswajit; Frey, Kenneth G.; George, Matroner; Henry, Matthew; Truong Luu; Patel, Mohit; Verratti, Kathleen; Sozhamannan, Shanmuga] USN, Med Res Ctr, Frederick, MD USA; [Awosika, Joy; Bishop-Lilly, Kimberly A.; Biswas, Biswajit; Frey, Kenneth G.; George, Matroner; Henry, Matthew; Truong Luu; Patel, Mohit; Verratti, Kathleen; Sozhamannan, Shanmuga] Henry M Jackson Fdn Mil Med, Frederick, MD USA; [Baldwin, Carson; Coyne, Susan; Dorman, William; Minogue, Timothy; Shea, April; Wolcott, Mark] USA, Res Inst Infect Dis, Frederick, MD USA; [Chokoshvili, Otar] Natl Ctr Dis Control & Publ Hlth, S Caucasus Field Epidemiol & Lab Training Program, Tbilisi, Georgia; [Folster, Jason P.; Strockbine, Nancy; Tarr, Cheryl] Ctr Dis Control & Prevent, Enter Dis Lab Branch, Atlanta, GA USA; [Hubbard, Kyle; Krepps, Michael] Excet Inc, Springfield, VA USA; [Insalaco, Joseph] Sci Applicat Int Corp, Abingdon, MD USA; [Kitzmiller, Aaron; Osborne, Brian] BioTeam Inc, Middleton, MA USA; [Shea, April] Team Keaki Tech, Frederick, MD USA; [van Gieson, Eric] Def Threat Reduct Agcy, Alexandria, VA USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Defense; United States Navy; United States Army Medical Research Institute of Infectious Diseases; National Center for Disease Control & Public Health - Georgia; Centers for Disease Control & Prevention - USA; Science Applications International Corporation (SAIC)	Gibbons, HS (corresponding author), USA, Edgewood Chem Biol Ctr, Aberdeen Proving Ground, MD USA.	henry.s.gibbons.civ@mail.mil	Sozhamannan, Shanmuga/AAN-7809-2020; Sozhamannan, Shanmuga/AGF-2410-2022; Chokoshvili, Otar/F-7394-2018; chain, patrick/B-9777-2013; biswas, biswajit/N-8291-2019; Johnson, Shannon Lyn/H-2799-2019; Chokoshvili, Otar/AAG-3477-2021; Chain, Patrick/O-4140-2019	Sozhamannan, Shanmuga/0000-0002-6762-7874; Chokoshvili, Otar/0000-0003-3023-1902; biswas, biswajit/0000-0002-3448-3827; Johnson, Shannon Lyn/0000-0002-3972-9208; Chokoshvili, Otar/0000-0003-3023-1902; Chain, Patrick/0000-0003-3949-3634; Lo, Chien-Chi/0000-0003-3470-1078; xie, gary/0000-0002-9176-924X; Gibbons, Henry/0000-0002-5603-8679; Bishop-Lilly, Kimberly/0000-0002-5744-8493	Defense Threat Reduction Agency [CB2847, IB06RSQ002]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	The work presented here was supported by the Defense Threat Reduction Agency (www.dtra.mil) Transformational Medical Technologies program under project numbers CB2847 to HSG and CNR; IB06RSQ002 to SS; and to JCD. The funding agency participated in the formation of the consortium but did not impact the collection of data, analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreoli SP, 2002, PEDIATR NEPHROL, V17, P293, DOI 10.1007/s00467-001-0783-0; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barlow RS, 2006, INT J FOOD MICROBIOL, V111, P1, DOI 10.1016/j.ijfoodmicro.2006.04.039; BARONDESS JJ, 1995, J BACTERIOL, V177, P1247, DOI 10.1128/jb.177.5.1247-1253.1995; BARONDESS JJ, 1990, NATURE, V346, P871, DOI 10.1038/346871a0; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Beutin L, 2012, J VIROLOGY; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Brzuszkiewicz E, 2011, ARCH MICROBIOL; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chang WLE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-109; Chen Y, 2005, PLOS BIOL, V3, P1276, DOI 10.1371/journal.pbio.0030229; Crossman L, 2011, NATURE PRECEEDINGS; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; European Food Safety Authority, 2011, TRAC SEEDS PART FEN; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Folster JP, 2010, ANTIMICROB AGENTS CH, V54, P2269, DOI 10.1128/AAC.00039-10; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Gault G, 2011, EURO SURVEILL, V16; Gibbons HS, 2005, MOL MICROBIOL, V55, P425, DOI 10.1111/j.1365-2958.2004.04409.x; Godeke J, 2011, ISME J, V5, P613, DOI 10.1038/ismej.2010.153; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRAD YH, 2012, P NATL ACAD SCI US; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Han C., 2006, P 2006 INT C BIOINF, P141; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Himathongkham S, 2001, J FOOD PROTECT, V64, P1817, DOI 10.4315/0362-028X-64.11.1817; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Jackson SA, 2011, APPL ENV MICROBIOLOG; Johansen BK, 2001, MICROBIOL-SGM, V147, P1929, DOI 10.1099/00221287-147-7-1929; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kunne C, 2012, J BACTERIOL, V194, P532, DOI 10.1128/JB.06368-11; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kus JV, 2011, J BACTERIOL, V193, P4509, DOI 10.1128/JB.00200-11; Laing CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037362; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsushiro A, 1999, J BACTERIOL, V181, P2257, DOI 10.1128/JB.181.7.2257-2260.1999; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Miquel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012714; Mootian G, 2009, J FOOD PROTECT, V72, P2308, DOI 10.4315/0362-028X-72.11.2308; Mossoro C, 2002, J CLIN MICROBIOL, V40, P3086, DOI 10.1128/JCM.40.8.3086-3088.2002; Muhldorfer I, 1996, INFECT IMMUN, V64, P495; Muniesa M, 2003, INFECT IMMUN, V71, P4554, DOI 10.1128/IAI.71.8.4554-4562.2003; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; Navarro-Garcia F, 1999, INFECT IMMUN, V67, P2184; Obrig TG, 2010, TOXINS, V2, P2769, DOI 10.3390/toxins2122769; Organization WH, 2011, OUTBR E COL O104 H4; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Picozzi C, 2012, INT J FOOD MICROBIOL, V153, P388, DOI 10.1016/j.ijfoodmicro.2011.11.031; POIREL L, 2010, ANTIMICROB AGENTS CH; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Razzaq S, 2006, AM FAM PHYSICIAN, V74, P991; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rump LV, 2011, APPL ENV MICROBIOLOG; Scheutz F, 2011, EURO SURVEILL, V16; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Smith DL, 2007, APPL ENVIRON MICROB, V73, P8032, DOI 10.1128/AEM.01278-07; Smith DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-311; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Team RDC, 2009, R LANG ENV STAT COMP; Tyler JS, 2005, PHAGES THEIR ROLE BA; United States Centers for Disease control and Prevention, 2011, BIOT AG DIS A Z; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Wagner PL, 1999, INFECT IMMUN, V67, P6710; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yew WS, 2002, J BACTERIOL, V184, P302, DOI 10.1128/JB.184.1.302-306.2002; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	90	62	65	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48228	10.1371/journal.pone.0048228	http://dx.doi.org/10.1371/journal.pone.0048228			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133618	Green Submitted, Green Published, gold			2022-12-25	WOS:000310601300006
J	Cuesta-Geijo, MA; Galindo, I; Hernaez, B; Quetglas, JI; Dalmau-Mena, I; Alonso, C				Cuesta-Geijo, Miguel A.; Galindo, Inmaculada; Hernaez, Bruno; Ignacio Quetglas, Jose; Dalmau-Mena, Inmaculada; Alonso, Covadonga			Endosomal Maturation, Rab7 GTPase and Phosphoinositides in African Swine Fever Virus Entry	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; DIRECT BINDING; PROTEIN P54; VERO CELLS; MEMBRANE; PIKFYVE; COMPARTMENT; ENDOCYTOSIS; INFECTION; SUSCEPTIBILITY	Here we analyzed the dependence of African swine fever virus (ASFV) infection on the integrity of the endosomal pathway. Using confocal immunofluorescence with antibodies against viral capsid proteins, we found colocalization of incoming viral particles with early endosomes (EE) during the first minutes of infection. Conversely, viral capsid protein was not detected in acidic late endosomal compartments, multivesicular bodies (MVBs), late endosomes (LEs) or lysosomes (LY). Using an antibody against a viral inner core protein, we found colocalization of viral cores with late compartments from 30 to 60 minutes postinfection. The absence of capsid protein staining in LEs and LYs suggested that virus desencapsidation would take place at the acid pH of these organelles. In fact, inhibitors of intraluminal acidification of endosomes caused retention of viral capsid staining virions in Rab7 expressing endosomes and more importantly, severely impaired subsequent viral protein production. Endosomal acidification in the first hour after virus entry was essential for successful infection but not thereafter. In addition, altering the balance of phosphoinositides (PIs) which are responsible of the maintenance of the endocytic pathway impaired ASFV infection. Early infection steps were dependent on the production of phosphatidylinositol 3-phosphate (PtdIns3P) which is involved in EE maturation and multivesicular body (MVB) biogenesis and on the interconversion of PtdIns3P to phosphatidylinositol 3, 5-biphosphate (PtdIns(3,5)P-2). Likewise, GTPase Rab7 activity should remain intact, as well as processes related to LE compartment physiology, which are crucial during early infection. Our data demonstrate that the EE and LE compartments and the integrity of the endosomal maturation pathway orchestrated by Rab proteins and PIs play a central role during early stages of ASFV infection.	[Cuesta-Geijo, Miguel A.; Galindo, Inmaculada; Hernaez, Bruno; Ignacio Quetglas, Jose; Dalmau-Mena, Inmaculada; Alonso, Covadonga] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Alonso, C (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain.	calonso@inia.es	Geijo, Miguel Ángel Cuesta/Q-5450-2018; Hernaez, Bruno/N-4547-2014; Alonso, Covadonga/A-8000-2011; Galindo, inmaculada/Q-6603-2018	Geijo, Miguel Ángel Cuesta/0000-0003-4694-1968; Hernaez, Bruno/0000-0002-4351-0102; Alonso, Covadonga/0000-0002-0862-6177; Galindo, inmaculada/0000-0001-8257-9797	Welcome Trust Foundation [WT075813, UE EPIZONE FOOD-CT2006-016236]; Ministerio de Economia y Competitividad of Spain Consolider [CSD2006-00007, AGL2009-09209, AGL2012-34533]	Welcome Trust Foundation(Wellcome Trust); Ministerio de Economia y Competitividad of Spain Consolider	The present work was supported by grants from the Welcome Trust Foundation WT075813, UE EPIZONE FOOD-CT2006-016236 and from the Ministerio de Economia y Competitividad of Spain Consolider CSD2006-00007, AGL2009-09209 and AGL2012-34533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI A, 1989, VIROLOGY, V171, P68, DOI 10.1016/0042-6822(89)90511-4; Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Andres G, 2001, J VIROL, V75, P6758, DOI 10.1128/JVI.75.15.6758-6768.2001; Andres G, 1997, J VIROL, V71, P2331; Andres G, 1998, J VIROL, V72, P8988; Brabec M, 2006, BIOCHEM BIOPH RES CO, V348, P741, DOI 10.1016/j.bbrc.2006.07.125; BREESE SS, 1966, VIROLOGY, V28, P420, DOI 10.1016/0042-6822(66)90054-7; CARRASCOSA AL, 1985, J VIROL, V54, P337, DOI 10.1128/JVI.54.2.337-344.1985; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Dixon L, 2000, ASFARVIRIDAE, P159; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Fuchs R, 2010, REV MED VIROL, V20, P281, DOI 10.1002/rmv.654; GRIFFITHS G, 1990, J CELL SCI, V95, P441; Gruenberg J, 2009, CURR OPIN CELL BIOL, V21, P582, DOI 10.1016/j.ceb.2009.03.008; Harbison CE, 2009, J VIROL, V83, P10504, DOI 10.1128/JVI.00295-09; Hernaez B, 2008, FEBS LETT, V582, P3275, DOI 10.1016/j.febslet.2008.08.031; Hernaez B, 2006, VIROLOGY, V350, P1, DOI 10.1016/j.virol.2006.01.021; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MCCULLOUGH KC, 1993, IMMUNOL LETT, V37, P83, DOI 10.1016/0165-2478(93)90136-P; McCullough KC, 1999, IMMUNOLOGY, V98, P203, DOI 10.1046/j.1365-2567.1999.00867.x; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Quetglas JI, 2012, J VIROL, V86, P1758, DOI 10.1128/JVI.05666-11; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rodriguez JM, 2004, J VIROL, V78, P4299, DOI 10.1128/JVI.78.8.4299-4313.2004; Rohn WM, 2000, J CELL SCI, V113, P2093; Roppenser B, 2012, METHOD CELL BIOL, V108, P173, DOI 10.1016/B978-0-12-386487-1.00009-2; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; Sanchez-Torres C, 2003, ARCH VIROL, V148, P2307, DOI 10.1007/s00705-003-0188-4; Sbrissa D, 2002, J BIOL CHEM, V277, P6073, DOI 10.1074/jbc.M110194200; Scherer J, 2011, VIRUSES-BASEL, V3, P1417, DOI 10.3390/v3081417; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stuart AD, 2006, J VIROL, V80, P7500, DOI 10.1128/JVI.02452-05; Suarez C, 2010, J VIROL, V84, P7484, DOI 10.1128/JVI.00600-10; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; UMATA T, 1990, J BIOL CHEM, V265, P21940; VALDEIRA ML, 1985, BIOL CELL, V55, P35, DOI 10.1111/j.1768-322X.1985.tb00407.x; Valdeira ML, 1998, VET MICROBIOL, V60, P131, DOI 10.1016/S0378-1135(98)00152-7; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	59	46	50	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48853	10.1371/journal.pone.0048853	http://dx.doi.org/10.1371/journal.pone.0048853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133661	Green Published, gold, Green Submitted			2022-12-25	WOS:000310601300027
J	Navarathna, DHMLP; Lionakis, MS; Lizak, MJ; Munasinghe, J; Nickerson, KW; Roberts, DD				Navarathna, Dhammika H. M. L. P.; Lionakis, Michail S.; Lizak, Martin J.; Munasinghe, Jeeva; Nickerson, Kenneth W.; Roberts, David D.			Urea Amidolyase (DUR1,2) Contributes to Virulence and Kidney Pathogenesis of Candida albicans	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; HELICOBACTER-PYLORI; MOUSE MODEL; IMMUNE-RESPONSES; EXPRESSION; AMMONIA; GENE; INDUCTION; CYTOKINES	The intracellular enzyme urea amidolyase (Dur1,2p) enables C. albicans to utilize urea as a sole nitrogen source. Because deletion of the DUR1,2 gene reduces survival of C. albicans co-cultured with a murine macrophage cell line, we investigated the role of Dur1,2p in pathogenesis using a mouse model of disseminated candidiasis. A dur1,2 Delta/dur1,2 Delta strain was significantly less virulent than the wild-type strain, showing significantly higher survival rate, better renal function, and decreased and less sustained fungal colonization in kidney and brain. Complementation of the mutant restored virulence. DUR1,2 deletion resulted in a milder host inflammatory reaction. Immunohistochemistry, flow cytometry, and magnetic resonance imaging showed decreased phagocytic infiltration into infected kidneys. Systemic cytokine levels of wild-type mice infected with the dur1,2 mutant showed a more balanced systemic pro-inflammatory cytokine response. Host gene expression and protein analysis in infected kidneys revealed parallel changes in the local immune response. Significant differences were observed in the kidney IL-1 inflammatory pathway, IL-15 signaling, MAP kinase signaling, and the alternative complement pathway. We conclude that Dur1,2p is important for kidney colonization during disseminated candidiasis and contributes to an unbalanced host inflammatory response and subsequent renal failure. Therefore, this Candida-specific enzyme may represent a useful drug target to protect the host from kidney damage associated with disseminated candidiasis.	[Navarathna, Dhammika H. M. L. P.; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lionakis, Michail S.] NIAID, Fungal Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Lizak, Martin J.; Munasinghe, Jeeva] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD USA; [Nickerson, Kenneth W.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Nebraska System; University of Nebraska Lincoln	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Nickerson, Kenneth/V-9979-2019; Roberts, David D./A-9699-2008; Lionakis, Michail/J-8840-2017; Navarathna, Dhammika/GXM-8674-2022	Roberts, David D./0000-0002-2481-2981; Lionakis, Michail/0000-0003-4994-9500; 	NIH, National Cancer Institute, Center for Cancer Research; University of Nebraska Tobacco Settlement Biomedical Research Enhancement Fund; John C. and Nettie V. David Memorial Trust Fund; University of Nebraska Foundation; NATIONAL CANCER INSTITUTE [ZIASC009173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001175] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Nebraska Tobacco Settlement Biomedical Research Enhancement Fund; John C. and Nettie V. David Memorial Trust Fund; University of Nebraska Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (DDR), the University of Nebraska Tobacco Settlement Biomedical Research Enhancement Fund (KWN), the John C. and Nettie V. David Memorial Trust Fund (KWN), Ann L. Kelsall and the Farnesol and Candida albicans Research Fund, University of Nebraska Foundation (KWN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN RB, 1995, MICROBIOL REV, V59, P646, DOI 10.1128/MMBR.59.4.646-672.1995; Ashman RB, 2008, FRONT BIOSCI-LANDMRK, V13, P3334; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Calderone AR, 2012, CANDIDA CANDIDIASIS; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; Chiozzi V, 2009, J PHYSIOL PHARMACOL, V60, P23; Cole GT, 1997, HOST-FUNGUS INTERPLAY, P247; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; COPPI M, 1989, BIOCHEM BIOPH RES CO, V165, P377, DOI 10.1016/0006-291X(89)91081-4; Corot C, 2004, INVEST RADIOL, V39, P619, DOI 10.1097/01.rli.0000135980.08491.33; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; ELBERRY HM, 1993, J BACTERIOL, V175, P4688, DOI 10.1128/JB.175.15.4688-4698.1993; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Espondaburu OR, 1996, ACTA BIOQUIM CLIN L, V30, P287; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghosh S, 2010, FEMS IMMUNOL MED MIC, V60, P63, DOI 10.1111/j.1574-695X.2010.00717.x; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Iranzo M, 2003, MED MYCOL, V41, P43, DOI 10.1080/714043897; JONES BD, 1990, INFECT IMMUN, V58, P1120, DOI 10.1128/IAI.58.4.1120-1123.1990; Kim HR, 2008, CRIT REV IMMUNOL, V28, P325, DOI 10.1615/CritRevImmunol.v28.i4.40; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Lionakis MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002865; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; MacCallum DM, 2009, FEMS YEAST RES, V9, P1111, DOI 10.1111/j.1567-1364.2009.00576.x; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; Marino G, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3124pe19; Massrieh W, 2006, BIOL REPROD, V74, P699, DOI 10.1095/biolreprod.105.045450; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Mayo K, 1997, EUR J GASTROEN HEPAT, V9, P457, DOI 10.1097/00042737-199705000-00009; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Navarathna DH, 2010, FREE RADIC BIOL MED; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P4006, DOI 10.1128/IAI.00397-07; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Navarathna DHMLP, 2010, FEMS YEAST RES, V10, P209, DOI 10.1111/j.1567-1364.2010.00602.x; Navarathna DHMLP, 2005, J ANTIMICROB CHEMOTH, V56, P1156, DOI 10.1093/jac/dki383; Navarathna DHMLP, 2010, MICROBIOLOG IN PRESS; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Netea MG, 1999, J IMMUNOL, V163, P1498; NICKERSON WJ, 1953, J INFECT DIS, V93, P43, DOI 10.1093/infdis/93.1.43; Odds FC, 1988, CANDIDA CANDIDIASIS, V2nd; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Overland G, 2005, SCAND J IMMUNOL, V62, P148, DOI 10.1111/j.1365-3083.2005.01653.x; PAPADIMITRIOU JM, 1986, J PATHOL, V150, P257, DOI 10.1002/path.1711500405; PEITSCH M C, 1991, Current Opinion in Cell Biology, V3, P710, DOI 10.1016/0955-0674(91)90045-Z; Pereno R, 2000, ONCOGENE, V19, P5153, DOI 10.1038/sj.onc.1203873; RAAB SS, 1994, MODERN PATHOL, V7, P599; RASMUSSEN LE, 1971, COMP BIOCHEM PHYSIOL, V40, P145, DOI 10.1016/0300-9629(71)90157-5; Robert R, 2000, INFECT IMMUN, V68, P570, DOI 10.1128/IAI.68.2.570-576.2000; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; ROON RJ, 1972, J BIOL CHEM, V247, P4107; Rozen S, 2000, Methods Mol Biol, V132, P365; SAS Institute Inc, 1999, SAS STAT US GUID; Sawada T, 1997, J IMMUNOL, V158, P5267; Scheurer B, 1997, IMMUNOPHARMACOLOGY, V38, P167, DOI 10.1016/S0162-3109(97)00077-5; Shawcross DI, 2008, HEPATOLOGY, V48, P1202, DOI 10.1002/hep.22474; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Subramaniam S, 2004, DEV COMP IMMUNOL, V28, P415, DOI 10.1016/j.dci.2003.09.016; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; van de Veerdonk FL, 2010, CURR OPIN CRIT CARE, V16, P453, DOI 10.1097/MCC.0b013e32833e046e; Vincent Jean-Louis, 2009, Crit Care Med, V37, pS296, DOI 10.1097/CCM.0b013e3181b6f1e1; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; Wang C H, 2001, Respirology, V6, P79; Wang CH, 2001, INT J TUBERC LUNG D, V5, P283; Zotta E, 2009, REV NEFROL DIAL TRAS, V29, P35	69	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48475	10.1371/journal.pone.0048475	http://dx.doi.org/10.1371/journal.pone.0048475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144764	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300074
J	Na, J; Lee, K; Kim, HG; Shin, JY; Na, W; Jeong, H; Lee, JW; Cho, S; Kim, WS; Ju, BG				Na, Jungtae; Lee, Kwanghyun; Kim, Hwan-Gon; Shin, Jee-Yoon; Na, Wonho; Jeong, Hayan; Lee, Jong-Woo; Cho, Sehyung; Kim, Won-Sun; Ju, Bong-Gun			Role of Type II Protein Arginine Methyltransferase 5 in the Regulation of Circadian Per1 Gene	PLOS ONE			English	Article							HUMAN PHOTOLYASE HOMOLOG; TRANSCRIPTIONAL REPRESSION; HISTONE ACETYLATION; MAMMALIAN CRY1; CLOCK FUNCTION; C-TERMINUS; PRMT5; METHYLATION; EXPRESSION; KINASE	Circadian clocks are the endogenous oscillators that regulate rhythmic physiological and behavioral changes to correspond to daily light-dark cycles. Molecular dissections have revealed that transcriptional feedback loops of the circadian clock genes drive the molecular oscillation, in which PER/CRY complexes inhibit the transcriptional activity of the CLOCK/BMAL1 heterodimer to constitute a negative feedback loop. In this study, we identified the type II protein arginine methyltransferase 5 (PRMT5) as an interacting molecule of CRY1. Although the Prmt5 gene was constitutively expressed, increased interaction of PRMT5 with CRY1 was observed when the Per1 gene was repressed both in synchronized mouse liver and NIH3T3 cells. Moreover, rhythmic recruitment of PRMT5 and CRY1 to the Per1 gene promoter was found to be associated with an increased level of histone H4R3 dimethylation and Per1 gene repression. Consistently, decreased histone H4R3 dimethylation and altered rhythmic Per1 gene expression were observed in Prmt5-depleted cells. Taken together, these findings provide an insight into the link between histone arginine methylation by PRMT5 and transcriptional regulation of the circadian Per1 gene.	[Na, Jungtae; Lee, Kwanghyun; Kim, Hwan-Gon; Shin, Jee-Yoon; Na, Wonho; Jeong, Hayan; Lee, Jong-Woo; Kim, Won-Sun; Ju, Bong-Gun] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Cho, Sehyung] Kyung Hee Univ, Dept Physiol, Sch Med, Seoul, South Korea	Sogang University; Kyung Hee University	Ju, BG (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	bgju@sogang.ac.kr			Brain Research Center of the 21st Century Frontier Research Program [2010K000824]; Basic Science Research Program through the National Research Foundation of Korea [20110000930]; Ministry of Education, Science and Technology, the Republic of Korea	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Brain Research Center of the 21st Century Frontier Research Program (2010K000824 to B.J.) and Basic Science Research Program (20110000930 to B.J.) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2000, GENE DEV, V14, P645; Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Andreu-Perez P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001936; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Blau J, 2003, NAT NEUROSCI, V6, P208, DOI 10.1038/nn0303-208; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Cesaro E, 2009, J BIOL CHEM, V284, P32321, DOI 10.1074/jbc.M109.043349; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Deng XA, 2010, P NATL ACAD SCI USA, V107, P19114, DOI 10.1073/pnas.1009669107; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Majumder S, 2010, J CELL BIOCHEM, V109, P553, DOI 10.1002/jcb.22432; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Sang Y, 2005, PLANT CELL, V17, P1569, DOI 10.1105/tpc.104.029645; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schibler U, 2005, EMBO REP, V6, pS9, DOI 10.1038/sj.embor.7400424; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; vanderSpek PJ, 1996, GENOMICS, V37, P177, DOI 10.1006/geno.1996.0539; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	55	5	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48152	10.1371/journal.pone.0048152	http://dx.doi.org/10.1371/journal.pone.0048152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133559	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800049
J	Liang, CY; Xiong, K; Szulwach, KE; Zhang, Y; Wang, ZH; Peng, JM; Fu, MG; Jin, P; Suzuki, HI; Liu, QH				Liang, Chunyang; Xiong, Ke; Szulwach, Keith E.; Zhang, Yi; Wang, Zhaohui; Peng, Junmin; Fu, Mingui; Jin, Peng; Suzuki, Hiroshi I.; Liu, Qinghua			Sjogren Syndrome Antigen B (SSB)/La Promotes Global MicroRNA Expression by Binding MicroRNA Precursors through Stem-Loop Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LA-PROTEIN; TRANSFER-RNA PRECURSORS; DROSOPHILA-MELANOGASTER; MICROPROCESSOR COMPLEX; DROSHA-DGCR8 COMPLEX; STRUCTURAL-ANALYSIS; NUCLEAR EXPORT; BREAST-CANCER; KSRP PROMOTES; SELF-RENEWAL	MicroRNAs (miRNA) control numerous physiological and pathological processes. Typically, the primary miRNA (pri-miRNA) transcripts are processed by nuclear Drosha complex into similar to 70-nucleotide stem-loop precursor miRNAs (pre-miRNA), which are further cleaved by cytoplasmic Dicer complex into similar to 21-nucleotide mature miRNAs. However, it is unclear how nascent pre-miRNAs are protected from ribonucleases, such as MCPIP1, that degrade pre-miRNAs to abort miRNA production. Here, we identify Sjogren syndrome antigen B (SSB)/La as a pre-miRNA-binding protein that regulates miRNA processing in vitro. All three RNA-binding motifs (LAM, RRM1, and RRM2) of La/SSB are required for efficient pre-miRNA binding. Intriguingly, La/SSB recognizes the characteristic stem-loop structure of pre-miRNAs, of which the majority lack a 3' UUU terminus. Moreover, La/SSB associates with endogenous pri-/pre-miRNAs and promotes miRNA biogenesis by stabilizing pre-miRNAs from nuclease (e.g. MCPIP1)-mediated decay in mammalian cells. Accordingly, we observed positive correlations between the expression status of La/SSB and Dicer in human cancer transcriptome and prognosis. These studies identify an important function of La/SSB as a global regulator of miRNA expression, and implicate stem-loop recognition as a major mechanism that mediates association between La/SSB and diverse RNA molecules.	[Liang, Chunyang; Xiong, Ke; Zhang, Yi; Wang, Zhaohui; Liu, Qinghua] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Xiong, Ke] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100094, Peoples R China; [Szulwach, Keith E.; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Fu, Mingui] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Suzuki, Hiroshi I.] Univ Tokyo, Dept Mol Pathol, Bunkyo Ku, Tokyo, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; China Agricultural University; Emory University; St Jude Children's Research Hospital; University of Missouri System; University of Missouri Kansas City; University of Tokyo	Liu, QH (corresponding author), 5323 Harry Hines Blvd,K3-219, Dallas, TX USA.	qinghua.liu@utsouthwestern.edu	Wang, Zhaohui/E-8139-2013; Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Suzuki, Hiroshi/0000-0003-4682-5086	Ministry of Education, Culture, Sports, Science and Technology of Japan [23112702, 24689018]; Welch Foundation [I-1608]; National Institute of Health; China Scholarship Council (CSC).	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Welch Foundation(The Welch Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council (CSC).(China Scholarship Council)	This work was supported in part by Grants 23112702 and 24689018 (to H. I. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant (I-1608 to Q. L.) from the Welch Foundation, and grants from the National Institute of Health awarded to M. F., P. J., and Q. L.; Supported by an award from the China Scholarship Council (CSC).	Alfano C, 2004, NAT STRUCT MOL BIOL, V11, P323, DOI 10.1038/nsmb747; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai CY, 2000, NUCLEIC ACIDS RES, V28, P1078, DOI 10.1093/nar/28.5.1078; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bousquet-Antonelli C, 2009, RNA, V15, P750, DOI 10.1261/rna.1478709; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chakshusmathi G, 2003, EMBO J, V22, P6562, DOI 10.1093/emboj/cdg625; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan H, 1998, MOL CELL BIOL, V18, P3201, DOI 10.1128/MCB.18.6.3201; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Liu X, 2007, RNA, V13, P2324, DOI 10.1261/rna.723707; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Martino L, 2012, NUCLEIC ACIDS RES, V40, P1381, DOI 10.1093/nar/gkr890; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; MATTIOLI M, 1974, ARTHRITIS RHEUM-US, V17, P421, DOI 10.1002/art.1780170413; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Merritt W. M., 2010, NEW ENGL J MED, V359, P2641; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pawlicki JM, 2008, J CELL BIOL, V182, P61, DOI 10.1083/jcb.200803111; Pruijn GJM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1987; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Trabucchi M, 2010, ADV EXP MED BIOL, V700, P36, DOI 10.1007/978-1-4419-7823-3_4; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; YOO CJ, 1994, MOL CELL BIOL, V14, P5412, DOI 10.1128/MCB.14.8.5412; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2	66	48	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					723	736		10.1074/jbc.M112.401323	http://dx.doi.org/10.1074/jbc.M112.401323			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23129761	hybrid, Green Published			2022-12-25	WOS:000313197200072
J	Bachu, M; Yalla, S; Asokan, M; Verma, A; Neogi, U; Sharma, S; Murali, RV; Mukthey, AB; Bhatt, R; Chatterjee, S; Rajan, RE; Cheedarla, N; Yadavalli, VS; Mahadevan, A; Shankar, SK; Rajagopalan, N; Shet, A; Saravanan, S; Balakrishnan, P; Solomon, S; Vajpayee, M; Satish, KS; Kundu, TK; Jeang, KT; Ranga, U				Bachu, Mahesh; Yalla, Swarupa; Asokan, Mangaiarkarasi; Verma, Anjali; Neogi, Ujjwal; Sharma, Shilpee; Murali, Rajesh V.; Mukthey, Anil Babu; Bhatt, Raghavendra; Chatterjee, Snehajyoti; Rajan, Roshan Elizabeth; Cheedarla, Narayana; Yadavalli, Venkat S.; Mahadevan, Anita; Shankar, Susarla K.; Rajagopalan, Nirmala; Shet, Anita; Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti; Vajpayee, Madhu; Satish, Kadappa Shivappa; Kundu, Tapas K.; Jeang, Kuan-Teh; Ranga, Udaykumar			Multiple NF-kappa B Sites in HIV-1 Subtype C Long Terminal Repeat Confer Superior Magnitude of Transcription and Thereby the Enhanced Viral Predominance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLADE-SPECIFIC DIFFERENCES; GENE-EXPRESSION; BINDING MOTIFS; TAT PROTEIN; WIDE-RANGE; REPLICATION; IDENTIFICATION; INFECTION; SEQUENCE	Wedemonstrate that at least three different promoter variant strains of HIV-1 subtype C have been gradually expanding and replacing the standard subtype C viruses in India, and possibly in South Africa and other global regions, over the past decade. The new viral strains contain an additional NF-kappa B, NF-kappa B-like, or RBEIII site in the viral promoter. Although the acquisition of an additional RBEIII site is a property shared by all the HIV-1 subtypes, acquiring an additional NF-kappa B site remains an exclusive property of subtype C. The acquired kappa B site is genetically distinct, binds the p50-p65 heterodimer, and strengthens the viral promoter at the levels of transcription initiation and elongation. The 4-kappa B viruses dominate the 3-kappa B "isogenic" viral strains in pairwise competition assays in T-cell lines, primary cells, and the ecotropic human immunodeficiency virus mouse model. The dominance of the 4-kappa B viral strains is also evident in the natural context when the subjects are coinfected with kappa B-variant viral strains. The mean plasma viral loads, but not CD4 counts, are significantly different in 4-kappa B infection suggesting that these newly emerging strains are probably more infectious. It is possible that higher plasma viral loads underlie selective transmission of the 4-kappa B viral strains. Several publications previously reported duplication or deletion of diverse transcription factor-binding sites in the viral promoter. Unlike previous reports, our study provides experimental evidence that the new viral strains gained a potential selective advantage as a consequence of the acquired transcription factor-binding sites and importantly that these strains have been expanding at the population level.	[Neogi, Ujjwal; Shet, Anita] St Johns Natl Acad Hlth Sci, Bengaluru 560034, India; [Bhatt, Raghavendra; Rajagopalan, Nirmala] Freedom Fdn, Bengaluru 560043, India; [Chatterjee, Snehajyoti; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bengaluru 560064, India; [Bachu, Mahesh; Yalla, Swarupa; Asokan, Mangaiarkarasi; Verma, Anjali; Sharma, Shilpee; Murali, Rajesh V.; Mukthey, Anil Babu; Rajan, Roshan Elizabeth; Cheedarla, Narayana; Ranga, Udaykumar] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, HIV AIDS Lab, Bengaluru 560064, India; [Yadavalli, Venkat S.; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Mahadevan, Anita; Shankar, Susarla K.] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bengaluru 560029, India; [Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti] YRG Ctr AIDS Res & Educ, Madras 600113, Tamil Nadu, India; [Vajpayee, Madhu] All India Inst Med Sci, Dept Microbiol, HIV & Immunol Div, New Delhi 110029, India; [Satish, Kadappa Shivappa] Seva Free Clin, Bengaluru 560010, India; [Satish, Kadappa Shivappa] Chest & Matern Ctr, Bengaluru 560010, India	St. John's National Academy of Health Sciences; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute of Mental Health & Neurosciences - India; All India Institute of Medical Sciences (AIIMS) New Delhi	Ranga, U (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, HIV AIDS Lab, Jakkur PO, Bangalore 560064, Karnataka, India.	udaykumar@jncasr.ac.in	Neogi, Ujjwal/E-4274-2012; Chatterjee, Snehajyoti/AAV-3919-2021; Verma, Anjali/HHN-5385-2022; Balakrishnan, Pachamuthu/ABV-6282-2022; Neogi, Ujjwal/ABF-1172-2021; Saravanan, Shanmugam/GOG-9024-2022; Bachu, Mahesh/I-4343-2015	Chatterjee, Snehajyoti/0000-0002-4873-9416; Balakrishnan, Pachamuthu/0000-0002-1710-9155; Neogi, Ujjwal/0000-0002-0844-3338; Saravanan, Shanmugam/0000-0002-5991-8022; Bachu, Mahesh/0000-0002-6494-6642; Kundu, Tapas/0000-0001-7790-214X; Sharma, Shilpee/0000-0003-4645-9442; Shet, Anita/0000-0002-7204-8164; Asokan, Mangaiarkarasi/0000-0001-9294-1833	Freedom Foundation were generated at the Foundation's Center for HIV/AIDS Medicine and Research at Bengaluru, India; Department of BioTechnology, Government of India [BT/01CEIB/10/III/01]; intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547] Funding Source: NIH RePORTER	Freedom Foundation were generated at the Foundation's Center for HIV/AIDS Medicine and Research at Bengaluru, India; Department of BioTechnology, Government of India(Department of Biotechnology (DBT) India); intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Several reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health. We thank Drs. Vinayaka Prasad and Brian Wigdahl for critical reading of the manuscript. The clinical samples provide by the Freedom Foundation were generated at the Foundation's Center for HIV/AIDS Medicine and Research at Bengaluru, India, funded through a unique partnership with the Institute for Molecular Medicine and Infectious Disease at the Drexel University College of Medicine in Philadelphia, PA, under the direction of Dr. Brian Wigdahl.; This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by the Department of BioTechnology, Government of India (Chromatin and Disease) Program Support Grant BT/01CEIB/10/III/01 and intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research (to T. K. K. and U. R.).	AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Bachu M, 2012, AIDS RES HUM RETROV, V28, P1362, DOI 10.1089/aid.2011.0388; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Campbell GR, 2007, J VIROL, V81, P5919, DOI 10.1128/JVI.01938-06; de Arellano ER, 2006, AIDS REV, V8, P9; De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499; ENGLUND G, 1991, VIROLOGY, V181, P150, DOI 10.1016/0042-6822(91)90479-U; Estable MC, 2007, INT J BIOL SCI, V3, P318; Estable MC, 1996, J VIROL, V70, P4053, DOI 10.1128/JVI.70.6.4053-4062.1996; Estable MC, 1998, J VIROL, V72, P6465, DOI 10.1128/JVI.72.8.6465-6474.1998; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Fusuma EE, 2005, AIDS RES HUM RETROV, V21, P965, DOI 10.1089/aid.2005.21.965; Gandhi N, 2009, AIDS RES HUM RETROV, V25, P691, DOI 10.1089/aid.2008.0299; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Hadas E, 2007, AIDS, V21, P905, DOI 10.1097/QAD.0b013e3281574549; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hunt G, 2000, AIDS RES HUM RETROV, V16, P305, DOI 10.1089/088922200309412; Hunt GM, 2001, VIRUS GENES, V23, P27, DOI 10.1023/A:1011171027134; Ilyinskii PO, 1996, J VIROL, V70, P3118, DOI 10.1128/JVI.70.5.3118-3126.1996; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; JOHANSSON B, 1995, AIDS RES HUM RETROV, V11, P761, DOI 10.1089/aid.1995.11.761; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOKEN SEC, 1992, VIROLOGY, V191, P968, DOI 10.1016/0042-6822(92)90274-S; Lemieux AM, 2004, J BIOL CHEM, V279, P52949, DOI 10.1074/jbc.M409896200; LEONARD J, 1989, J VIROL, V63, P4919, DOI 10.1128/JVI.63.11.4919-4924.1989; Locateli D, 2007, J MED VIROL, V79, P1455, DOI 10.1002/jmv.20955; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MICHAEL NL, 1994, J VIROL, V68, P3163, DOI 10.1128/JVI.68.5.3163-3174.1994; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; Munkanta M, 2005, AIDS RES HUM RETROV, V21, P901, DOI 10.1089/aid.2005.21.901; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P485, DOI 10.1089/088922299311240; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Papathanasopoulos MA, 2002, AIDS RES HUM RETROV, V18, P879, DOI 10.1089/08892220260190362; PARROTT C, 1991, J VIROL, V65, P1414, DOI 10.1128/JVI.65.3.1414-1419.1991; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pohlmann S, 1998, J VIROL, V72, P5589; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Quinones-Mateu ME, 2005, AIDS, V19, P1689, DOI 10.1097/01.aids.0000186018.39673.1c; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Ranga U., 2012, INDIAN J ME IN PRESS; Ranga U, 2010, CURR SCI INDIA, V98, P335; Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008; Roof P, 2002, VIROLOGY, V296, P77, DOI 10.1006/viro.2001.1397; ROSS EK, 1991, J VIROL, V65, P4350, DOI 10.1128/JVI.65.8.4350-4358.1991; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Saini M, 2007, VACCINE, V25, P8660, DOI 10.1016/j.vaccine.2007.10.019; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sambrook J., 2001, MOL CLONING LAB MANU; Scriba TJ, 2001, AIDS RES HUM RETROV, V17, P775, DOI 10.1089/088922201750237059; Siddappa NB, 2007, AIDS RES HUM RETROV, V23, P1268, DOI 10.1089/aid.2006.0305; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; Siddappa NB, 2004, J CLIN MICROBIOL, V42, P2742, DOI 10.1128/JCM.42.6.2742-2751.2004; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004; Verhoef K, 1999, J VIROL, V73, P1331, DOI 10.1128/JVI.73.2.1331-1340.1999; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wong JK, 2010, J BIOL CHEM, V285, P18319, DOI 10.1074/jbc.M110.120840; Zhang LQ, 1997, J VIROL, V71, P1651, DOI 10.1128/JVI.71.2.1651-1656.1997	73	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44714	44735		10.1074/jbc.M112.397158	http://dx.doi.org/10.1074/jbc.M112.397158			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23132857	Green Published, hybrid			2022-12-25	WOS:000312938600067
J	Gagne, D; Charest, LA; Morin, S; Kovrigin, EL; Doucet, N				Gagne, Donald; Charest, Laurie-Anne; Morin, Sebstien; Kovrigin, Evgenii L.; Doucet, Nicolas			Conservation of Flexible Residue Clusters among Structural and Functional Enzyme Homologues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; EOSINOPHIL CATIONIC PROTEIN; MODEL-FREE APPROACH; RIBONUCLEASE-A; CRYSTAL-STRUCTURE; CHEMICAL-EXCHANGE; BACKBONE DYNAMICS; MOTIONS; RNASE; MACROMOLECULES	Conformational flexibility between structural ensembles is an essential component of enzyme function. Although the broad dynamical landscape of proteins is known to promote a number of functional events on multiple time scales, it is yet unknown whether structural and functional enzyme homologues rely on the same concerted residue motions to perform their catalytic function. It is hypothesized that networks of contiguous and flexible residue motions occurring on the biologically relevant millisecond time scale evolved to promote and/or preserve optimal enzyme catalysis. In this study, we use a combination of NMR relaxation dispersion, model-free analysis, and ligand titration experiments to successfully capture and compare the role of conformational flexibility between two structural homologues of the pancreatic ribonuclease family: RNaseA and eosinophil cationic protein (or RNase 3). In addition to conserving the same catalytic residues and structural fold, both homologues show similar yet functionally distinct clusters of millisecond dynamics, suggesting that conformational flexibility can be conserved among analogous protein folds displaying low sequence identity. Our work shows that the reduced conformational flexibility of eosinophil cationic protein can be dynamically and functionally reproduced in the RNase A scaffold upon creation of a chimeric hybrid between the two proteins. These results support the hypothesis that conformational flexibility is partly required for catalytic function in homologous enzyme folds, further highlighting the importance of dynamic residue sectors in the structural organization of proteins.	[Gagne, Donald; Charest, Laurie-Anne; Doucet, Nicolas] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ H7V 1B7, Canada; [Morin, Sebstien] Univ Basel, Swiss Inst Bioinformat & Biozentrum, CH-4056 Basel, Switzerland; [Kovrigin, Evgenii L.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA	University of Quebec; Institut national de la recherche scientifique (INRS); Swiss Institute of Bioinformatics; University of Basel; Marquette University	Doucet, N (corresponding author), Univ Quebec, INRS Inst Armand Frappier, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.	nicolas.doucet@iaf.inrs.ca		Morin, Sebastien/0000-0003-4426-326X	Natural Sciences and Engineering Research Council of Canada [RGPIN 402623-2011]; Fonds de Recherche du Quebec Sante Research Scholar-Junior 1 career award; "Fondation Universitaire Armand-Frappier de l'INRS" Ph.D. scholarship; Fonds de Recherche du Quebec, Nature et Technologies, Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO); Fonds de Recherche du Quebec Sante (FRQS) Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec Sante Research Scholar-Junior 1 career award; "Fondation Universitaire Armand-Frappier de l'INRS" Ph.D. scholarship; Fonds de Recherche du Quebec, Nature et Technologies, Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO); Fonds de Recherche du Quebec Sante (FRQS) Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP)	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN 402623-2011 (to N. D.) and a Fonds de Recherche du Quebec Sante Research Scholar-Junior 1 career award (to N. D.).; Recipient of a "Fondation Universitaire Armand-Frappier de l'INRS" Ph.D. scholarship.; Supported by the Fonds de Recherche du Quebec, Nature et Technologies, Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction, la Structure et l'Ingenierie des Proteines" (PROTEO) and the Fonds de Recherche du Quebec Sante (FRQS) Strategic Cluster "Groupe de Recherche Axe sur la Structure des Proteines" (GRASP).	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Boix E, 1999, BIOCHEMISTRY-US, V38, P16794, DOI 10.1021/bi9919145; Boix E, 2001, METHOD ENZYMOL, V341, P287, DOI 10.1016/S0076-6879(01)41159-1; Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a; Branden C., 1999, INTRO PROTEIN STRUCT; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Carnevale V, 2006, J AM CHEM SOC, V128, P9766, DOI 10.1021/ja060896t; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Chatani E, 2002, BIOCHEMISTRY-US, V41, P4567, DOI 10.1021/bi011365e; Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m; Cuchillo CM, 2011, BIOCHEMISTRY-US, V50, P7835, DOI 10.1021/bi201075b; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; Davey JA, 2012, PROTEIN SCI, V21, P1241, DOI 10.1002/pro.2128; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doucet N, 2007, J BIOL CHEM, V282, P21448, DOI 10.1074/jbc.M609777200; Doucet N, 2011, PROTEIN PEPTIDE LETT, V18, P336, DOI 10.2174/092986611794653950; Doucet N, 2011, BIOCHEMISTRY-US, V50, P1723, DOI 10.1021/bi1018539; Doucet N, 2010, PROTEINS, V78, P2459, DOI 10.1002/prot.22754; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Dyer KD, 2006, MOL DIVERS, V10, P585, DOI 10.1007/s11030-006-9028-2; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P17386, DOI 10.1021/bi981369s; Goddard TD, 2008, SPARKY VERSION 3; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Kadonosono T, 2003, BIOCHEMISTRY-US, V42, P10651, DOI 10.1021/bi034499w; Kaplan J.I., 1980, NMR CHEM EXCHANGING; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; Kovrigin EL, 2006, BIOCHEMISTRY-US, V45, P2636, DOI 10.1021/bi0525066; Kovrigin EL, 2006, J MAGN RESON, V180, P93, DOI 10.1016/j.jmr.2006.01.010; Kovrigin EL, 2012, J BIOMOL NMR, V53, P257, DOI 10.1007/s10858-012-9636-3; Lassila JK, 2010, CURR OPIN CHEM BIOL, V14, P676, DOI 10.1016/j.cbpa.2010.08.010; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mallorqui-Fernandez G, 2000, J MOL BIOL, V300, P1297, DOI 10.1006/jmbi.2000.3939; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Marshall GR, 2008, BIOPOLYMERS, V90, P259, DOI 10.1002/bip.20845; Merlino A, 2003, PROTEINS, V53, P101, DOI 10.1002/prot.10466; Merlino A, 2002, BIOPOLYMERS, V65, P274, DOI 10.1002/bip.10225; Morin S, 2011, PROG NUCL MAG RES SP, V59, P245, DOI 10.1016/j.pnmrs.2010.12.003; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193; RAO BDN, 1989, METHOD ENZYMOL, V176, P279; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; SELA M, 1957, BIOCHIM BIOPHYS ACTA, V24, P229, DOI 10.1016/0006-3002(57)90186-5; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; Vila R, 2009, BIOPOLYMERS, V91, P1038, DOI 10.1002/bip.21204; Vitagliano L, 2002, PROTEINS, V46, P97, DOI 10.1002/prot.10033; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Watt ED, 2011, BIOPHYS J, V101, P411, DOI 10.1016/j.bpj.2011.05.039	68	29	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44289	44300		10.1074/jbc.M112.394866	http://dx.doi.org/10.1074/jbc.M112.394866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135272	hybrid, Green Published			2022-12-25	WOS:000312938600027
J	Eckert, C; Boehm, M; Carrieri, D; Yu, JP; Dubini, A; Nixon, PJ; Maness, PC				Eckert, Carrie; Boehm, Marko; Carrieri, Damian; Yu, Jianping; Dubini, Alexandra; Nixon, Peter J.; Maness, Pin-Ching			Genetic Analysis of the Hox Hydrogenase in the Cyanobacterium Synechocystis sp PCC 6803 Reveals Subunit Roles in Association, Assembly, Maturation, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; THIOCAPSA-ROSEOPERSICINA BBS; RALSTONIA-EUTROPHA H16; NOCARDIA-OPACA 1B; BIDIRECTIONAL HYDROGENASE; NIFE HYDROGENASE; REVERSIBLE HYDROGENASE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; ANACYSTIS-NIDULANS	Hydrogenases are metalloenzymes that catalyze 2H(+) + 2e(-) <-> H-2. A multisubunit, bidirectional [NiFe]-hydrogenase has been identified and characterized in a number of bacteria, including cyanobacteria, where it is hypothesized to function as an electron valve, balancing reductant in the cell. In cyanobacteria, this Hox hydrogenase consists of five proteins in two functional moieties: a hydrogenase moiety (HoxYH) with homology to heterodimeric [NiFe]-hydrogenases and a diaphorase moiety (HoxEFU) with homology to NuoEFG of respiratory Complex I, linking NAD(P)H <-> NAD(P)(+) as a source/sink for electrons. Here, we present an extensive study of Hox hydrogenase in the cyanobacterium Synechocystis sp. PCC 6803. We identify the presence of HoxEFUYH, HoxFUYH, HoxEFU, HoxFU, and HoxYH subcomplexes as well as association of the immature, unprocessed large subunit (HoxH) with other Hox subunits and unidentified factors, providing a basis for understanding Hox maturation and assembly. The analysis of mutants containing individual and combined hox gene deletions in a common parental strain reveals apparent alterations in subunit abundance and highlights an essential role for HoxF and HoxU in complex/subcomplex association. In addition, analysis of individual and combined hox mutant phenotypes in a single strain background provides a clear view of the function of each subunit in hydrogenase activity and presents evidence that its physiological function is more complicated than previously reported, with no outward defects apparent in growth or photosynthesis under various growth conditions.	[Eckert, Carrie; Boehm, Marko; Carrieri, Damian; Yu, Jianping; Dubini, Alexandra; Maness, Pin-Ching] NREL, Biosci Ctr, Golden, CO 80401 USA; [Boehm, Marko; Nixon, Peter J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Imperial College London	Eckert, C (corresponding author), NREL, Biosci Ctr, 15013 Denver W Pkwy, Golden, CO 80401 USA.	carrie.eckert@nrel.gov	dubini, alexandra/Q-6277-2019; dubini, alexandra/A-7252-2016; ECKERT, CARRIE/V-8199-2017	dubini, alexandra/0000-0001-8825-3915; dubini, alexandra/0000-0001-8825-3915; ECKERT, CARRIE/0000-0003-4201-2926; Yu, Jianping/0000-0003-0466-3197; Nixon, Peter/0000-0003-1952-6937	National Renewable Energy Laboratory's Laboratory Directed Research and Development Program; United States Department of Energy Fuel Cell Technologies Program [DE-AC36-08-GO28308]; United States Department of Energy Biological and Environmental Research Program [KP160103]; Engineering and Physical Sciences Research Council Grant [EP/F002070X/1]	National Renewable Energy Laboratory's Laboratory Directed Research and Development Program; United States Department of Energy Fuel Cell Technologies Program; United States Department of Energy Biological and Environmental Research Program; Engineering and Physical Sciences Research Council Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the National Renewable Energy Laboratory's Laboratory Directed Research and Development Program (to P. M., J. Y., C. E., and D. C.), the United States Department of Energy Fuel Cell Technologies Program (contract number DE-AC36-08-GO28308) (to P. M. and J. Y.), the United States Department of Energy Biological and Environmental Research Program (contract KP160103) (to M. B. and A. D.), and Engineering and Physical Sciences Research Council Grant (EP/F002070X/1) (to M. B. and P. N.).	Antal TK, 2006, INT J HYDROGEN ENERG, V31, P1439, DOI 10.1016/j.ijhydene.2006.06.037; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Appel J, 1996, BBA-PROTEIN STRUCT M, V1298, P141, DOI 10.1016/S0167-4838(96)00176-8; Appel J, 2012, ADV PHOTOSYNTH RESP, V33, P357, DOI 10.1007/978-94-007-1533-2_15; Aubert-Jousset E, 2011, FEBS J, V278, P4035, DOI 10.1111/j.1742-4658.2011.08308.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boehm M, 2009, J BACTERIOL, V191, P6425, DOI 10.1128/JB.00644-09; Boison G, 1998, CURR MICROBIOL, V36, P253, DOI 10.1007/s002849900305; Boison G, 1999, FEMS MICROBIOL LETT, V174, P159, DOI 10.1111/j.1574-6968.1999.tb13563.x; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Carrieri D, 2011, BIORESOURCE TECHNOL, V102, P8368, DOI 10.1016/j.biortech.2011.03.103; Casalot L, 2001, TRENDS MICROBIOL, V9, P228, DOI 10.1016/S0966-842X(01)02009-1; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Cournac L, 2002, INT J HYDROGEN ENERG, V27, P1229, DOI 10.1016/S0360-3199(02)00105-2; Dutheil J, 2012, J BACTERIOL, V194, P5423, DOI 10.1128/JB.00543-12; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gutekunst K, 2005, MOL MICROBIOL, V58, P810, DOI 10.1111/j.1365-2958.2005.04867.x; Gutthann F, 2007, BBA-BIOENERGETICS, V1767, P161, DOI 10.1016/j.bbabio.2006.12.003; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Howitt CA, 1999, PHOTOTROPHIC PROKARY, P595; Ikeuchi M, 2001, PHOTOSYNTH RES, V70, P73, DOI 10.1023/A:1013887908680; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; KENTEMICH T, 1989, Z NATURFORSCH C, V44, P384; KENTEMICH T, 1991, NATURWISSENSCHAFTEN, V78, P559, DOI 10.1007/BF01134448; Kiss E, 2009, J BIOTECHNOL, V142, P31, DOI 10.1016/j.jbiotec.2009.02.007; Kommalapati M, 2007, PHOTOSYNTH RES, V92, P315, DOI 10.1007/s11120-007-9186-9; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lagarde D, 2000, APPL ENVIRON MICROB, V66, P64, DOI 10.1128/AEM.66.1.64-72.2000; Long MN, 2007, J BIOL INORG CHEM, V12, P62, DOI 10.1007/s00775-006-0162-1; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Magalon A, 2000, FEBS LETT, V473, P254, DOI 10.1016/S0014-5793(00)01542-8; Maroti J, 2010, APPL ENVIRON MICROB, V76, P5113, DOI 10.1128/AEM.00351-10; Massanz C, 1998, J BACTERIOL, V180, P1023, DOI 10.1128/JB.180.5.1023-1029.1998; McIntosh CL, 2011, J AM CHEM SOC, V133, P11308, DOI 10.1021/ja203376y; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Oliveira P, 2005, FEMS MICROBIOL LETT, V251, P59, DOI 10.1016/j.femsle.2005.07.024; Oliveira P, 2008, J BACTERIOL, V190, P1011, DOI 10.1128/JB.01605-07; Oliveira P, 2009, DALTON T, P9990, DOI 10.1039/b908593a; Palagyi-Meszaros LS, 2009, FEBS J, V276, P164, DOI 10.1111/j.1742-4658.2008.06770.x; Pinto F, 2012, MICROBIOL-SGM, V158, P448, DOI 10.1099/mic.0.052282-0; Rakhely G, 2004, APPL ENVIRON MICROB, V70, P722, DOI 10.1128/AEM.70.2.722-728.2004; Rakhely G, 2007, BBA-BIOENERGETICS, V1767, P671, DOI 10.1016/j.bbabio.2007.02.004; Schmitz O, 1996, NATURWISSENSCHAFTEN, V83, P525; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; SCHMITZ O, 1995, EUR J BIOCHEM, V233, P266, DOI 10.1111/j.1432-1033.1995.266_1.x; SCHNEIDER K, 1984, EUR J BIOCHEM, V138, P533, DOI 10.1111/j.1432-1033.1984.tb07948.x; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; Schutz K, 2004, PLANTA, V218, P350, DOI 10.1007/s00425-003-1113-5; SEREBRIAKOVA L, 1994, ARCH MICROBIOL, V161, P140, DOI 10.1007/BF00276474; Serebryakova LT, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1370, DOI 10.1134/S0006297906120133; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wunschiers R, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-8; XU QA, 1994, J BIOL CHEM, V269, P3205	57	28	30	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43502	43515		10.1074/jbc.M112.392407	http://dx.doi.org/10.1074/jbc.M112.392407			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23139416	hybrid, Green Published			2022-12-25	WOS:000312940800031
J	Leiba, J; Hartmann, T; Cluzel, ME; Cohen-Gonsaud, M; Delolme, F; Bischoff, M; Molle, V				Leiba, Jade; Hartmann, Torsten; Cluzel, Marie-Eve; Cohen-Gonsaud, Martin; Delolme, Frederic; Bischoff, Markus; Molle, Virginie			A Novel Mode of Regulation of the Staphylococcus aureus Catabolite Control Protein A (CcpA) Mediated by Stk1 Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOLIC ACID BIOSYNTHESIS; TOXIN GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; SERINE/THREONINE KINASE; ANTIBIOTIC-RESISTANCE; SER/THR PHOSPHORYLATION; BIOFILM FORMATION; VIRULENCE; REPRESSION	The Staphylococcus aureus serine/threonine protein kinase Stk1 (also known as PknB) affects different key pathways such as cell wall metabolism, antibiotic susceptibility, and regulation of virulence. Here we report that the catabolite control protein A (CcpA), a highly conserved regulator of carbon catabolite repression and virulence in a number of Gram-positive pathogens, was efficiently phosphorylated in vitro and in vivo by Stk1 in S. aureus, whereas the CcpA homologues of Bacillus subtilis and Bacillus anthracis were not affected by the Stk1 orthologue PrkC. Mass spectrometry and mutational analyses identified Thr-18 and Thr-33 as the phosphoacceptors; both are located in the DNA binding domain of this protein. Electrophoretic mobility shift assays demonstrated that the CcpA DNA binding activity was completely abrogated for the phosphorylated CcpA. The physiological relevance of CcpA phosphorylation was assessed by generating CcpA phosphoablative (T18A/T33A) or phosphomimetic (T18D/T33D) mutants. In contrast to the wild-type and phosphoablative ccpA alleles, introduction of the phosphomimetic ccpA allele in a Delta ccpA mutant failed to restore the parental biofilm formation profile and the transcription of citZ and hla to levels seen with the wild type. The strong up regulation of ccpA transcripts and CcpA level in the ccpA mutant trans-complemented with the phosphomimetic CcpA variant suggest furthermore that CcpA acts as a negative regulator of its own expression. Together, these findings demonstrate that Stk1-driven phosphorylation of CcpA inhibits its DNA binding activity toward its regulon in S. aureus, representing a novel regulatory mechanism of CcpA activity in addition to the well known regulation via HprKP/Hpr in this clinically important pathogen.	[Hartmann, Torsten; Bischoff, Markus] Univ Saarland Hosp, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany; [Leiba, Jade; Cluzel, Marie-Eve; Molle, Virginie] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS UMR 5235, F-34095 Montpellier 05, France; [Cohen-Gonsaud, Martin] Univ Montpellier I & II, Ctr Biochim Struct, CNRS UMR 5048, INSERM U554, F-34090 Montpellier, France; [Delolme, Frederic] Univ Lyon 1, Inst Biol & Chim Prot, CNRS UMR 5086, BioSci IFR128, F-69367 Lyon, France	Universitatsklinikum des Saarlandes; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bischoff, M (corresponding author), Univ Saarland Hosp, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany.	markus.bischoff@uniklinikum-saarland.de; virginie.molle@univ-montp2.fr	MOLLE, Virginie/D-4050-2019; Bischoff, Markus/D-2130-2014	MOLLE, Virginie/0000-0002-6573-3411; Bischoff, Markus/0000-0001-6734-2732; Cohen-Gonsaud, Martin/0000-0002-0150-9912; Leiba, Jade/0000-0003-0584-9524	National Research Agency [ANR-09-MIEN-004]; Deutsche Forschungsgemeinschaft [BI 1350/1-1, 1-2]	National Research Agency(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Research Agency Grant ANR-09-MIEN-004 (to V. M.) and Deutsche Forschungsgemeinschaft Grants BI 1350/1-1 and 1-2 to (to M. B.).	Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; Cluzel ME, 2010, J BACTERIOL, V192, P6295, DOI 10.1128/JB.00853-10; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Egeter O, 1996, MOL MICROBIOL, V21, P739, DOI 10.1046/j.1365-2958.1996.301398.x; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; HUECK CJ, 1995, MOL MICROBIOL, V16, P855, DOI 10.1111/j.1365-2958.1995.tb02313.x; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MIWA Y, 1994, MICROBIOL-UK, V140, P2567, DOI 10.1099/00221287-140-10-2567; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Sadykov MR, 2011, MICROBIOL-SGM, V157, P3458, DOI 10.1099/mic.0.051243-0; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Seidel G, 2005, FEBS J, V272, P2566, DOI 10.1111/j.1742-4658.2005.04682.x; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2008, INFECT IMMUN, V76, P5093, DOI 10.1128/IAI.00724-08; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Truong-Bolduc QC, 2010, J BACTERIOL, V192, P2525, DOI 10.1128/JB.00018-10; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200	46	52	53	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43607	43619		10.1074/jbc.M112.418913	http://dx.doi.org/10.1074/jbc.M112.418913			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132867	Green Published, hybrid			2022-12-25	WOS:000312940800041
J	Mochizuki, A; Takami, M; Miyamoto, Y; Nakamaki, T; Tomoyasu, S; Kadono, Y; Tanaka, S; Inoue, T; Kamijo, R				Mochizuki, Ayako; Takami, Masamichi; Miyamoto, Yoichi; Nakamaki, Tsuyoshi; Tomoyasu, Shigeru; Kadono, Yuho; Tanaka, Sakae; Inoue, Tomio; Kamijo, Ryutaro			Cell Adhesion Signaling Regulates RANK Expression in Osteoclast Precursors	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; BONE-RESORPTION; DEFECTIVE INTERLEUKIN-1; GENE-EXPRESSION; IN-VITRO; DIFFERENTIATION; ECHISTATIN; ACTIVATOR; INHIBITION; LIGAND	Cells with monocyte/macrophage lineage expressing receptor activator of NF-kappa B (RANK) differentiate into osteoclasts following stimulation with the RANK ligand (RANKL). Cell adhesion signaling is also required for osteoclast differentiation from precursors. However, details of the mechanism by which cell adhesion signals induce osteoclast differentiation have not been fully elucidated. To investigate the participation of cell adhesion signaling in osteoclast differentiation, mouse bone marrow-derived macrophages (BMMs) were used as osteoclast precursors, and cultured on either plastic cell culture dishes (adherent condition) or the top surface of semisolid methylcellulose gel loaded in culture tubes (non-adherent condition). BMMs cultured under the adherent condition differentiated into osteoclasts in response to RANKL stimulation. However, under the non-adherent condition, the efficiency of osteoclast differentiation was markedly reduced even in the presence of RANKL. These BMMs retained macrophage characteristics including phagocytic function and gene expression profile. Lipopolysaccharide (LPS) and tumor necrosis factor -alpha TNF-alpha activated the NF-kappa B-mediated signaling pathways under both the adherent and non-adherent conditions, while RANKL activated the pathways only under the adherent condition. BMMs highly expressed RANK mRNA and protein under the adherent condition as compared to the non-adherent condition. Also, BMMs transferred from the adherent to non-adherent condition showed downregulated RANK expression within 24 hours. In contrast, transferring those from the non-adherent to adherent condition significantly increased the level of RANK expression. Moreover, interruption of cell adhesion signaling by echistatin, an RGD-containing disintegrin, decreased RANK expression in BMMs, while forced expression of either RANK or TNFR-associated factor 6 (TRAF6) in BMMs induced their differentiation into osteoclasts even under the non-adherent condition. These results suggest that cell adhesion signaling regulates RANK expression in osteoclast precursors.	[Mochizuki, Ayako; Takami, Masamichi; Miyamoto, Yoichi; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 142, Japan; [Mochizuki, Ayako; Inoue, Tomio] Showa Univ, Sch Dent, Dept Oral Physiol, Shinagawa Ku, Tokyo 142, Japan; [Nakamaki, Tsuyoshi; Tomoyasu, Shigeru] Showa Univ, Sch Med, Dept Med, Div Hematol,Shinagawa Ku, Tokyo 142, Japan; [Kadono, Yuho; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan	Showa University; Showa University; Showa University; University of Tokyo	Takami, M (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 142, Japan.	takami@dent.showa-u.ac.jp	Tanaka, Sakae/Y-3061-2019; Kadono, Yuho/AAO-2405-2020	Tanaka, Sakae/0000-0001-9210-9414; Takami, Masamichi/0000-0002-4506-3975	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science [23390426, 22791801]; Grants-in-Aid for Scientific Research [23592750, 24659830] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Project to Establish Strategic Research Center for Innovative Dentistry, from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Grants-in-Aid for Scientific Research (B) and for Young Scientists (B) from the Japan Society for the Promotion of Science (23390426 and 22791801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Costa P, 2010, INT REV CEL MOL BIO, V283, P57, DOI 10.1016/S1937-6448(10)83002-3; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; DRESNERPOLLAK R, 1994, J CELL BIOCHEM, V56, P323, DOI 10.1002/jcb.240560308; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; FISHER JE, 1993, ENDOCRINOLOGY, V132, P1411, DOI 10.1210/en.132.3.1411; HORTON MA, 1989, J BONE MINER RES, V4, P803; HULTENBY K, 1993, EUR J CELL BIOL, V62, P86; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Kadono Y, 2005, EMBO REP, V6, P171, DOI 10.1038/sj.embor.7400345; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; KURIHARA N, 1989, BLOOD, V74, P1295; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Miyamoto T, 2000, BLOOD, V96, P4335, DOI 10.1182/blood.V96.13.4335.h8004335_4335_4343; Mochizuki A, 2006, J IMMUNOL, V177, P4360, DOI 10.4049/jimmunol.177.7.4360; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nakamura I, 1998, ENDOCRINOLOGY, V139, P5182, DOI 10.1210/en.139.12.5182; RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rodan SB, 1997, J ENDOCRINOL, V154, pS47; SATO M, 1990, J CELL BIOL, V111, P1713, DOI 10.1083/jcb.111.4.1713; SATO M, 1994, J BONE MINER RES, V9, P1441; SCHEVEN BAA, 1986, NATURE, V321, P79, DOI 10.1038/321079a0; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takami M, 2000, ENDOCRINOLOGY, V141, P4711, DOI 10.1210/en.141.12.4711; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988	41	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48795	10.1371/journal.pone.0048795	http://dx.doi.org/10.1371/journal.pone.0048795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139818	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300057
J	Sammond, DW; Payne, CM; Brunecky, R; Himmel, ME; Crowley, MF; Beckham, GT				Sammond, Deanne W.; Payne, Christina M.; Brunecky, Roman; Himmel, Michael E.; Crowley, Michael F.; Beckham, Gregg T.			Cellulase Linkers Are Optimized Based on Domain Type and Function: Insights from Sequence Analysis, Biophysical Measurements, and Molecular Simulation	PLOS ONE			English	Article							X-RAY-SCATTERING; CARBOHYDRATE-BINDING MODULES; FACTORS INFLUENCING GLYCOSYLATION; TRICHODERMA-REESEI CELLULASES; CELLOBIOHYDROLASE-I; DYNAMICS SIMULATIONS; GENERALIZED BORN; DISORDERED PROTEINS; N-GLYCOSYLATION; LENGTH	Cellulase enzymes deconstruct cellulose to glucose, and are often comprised of glycosylated linkers connecting glycoside hydrolases (GHs) to carbohydrate-binding modules (CBMs). Although linker modifications can alter cellulase activity, the functional role of linkers beyond domain connectivity remains unknown. Here we investigate cellulase linkers connecting GH Family 6 or 7 catalytic domains to Family 1 or 2 CBMs, from both bacterial and eukaryotic cellulases to identify conserved characteristics potentially related to function. Sequence analysis suggests that the linker lengths between structured domains are optimized based on the GH domain and CBM type, such that linker length may be important for activity. Longer linkers are observed in eukaryotic GH Family 6 cellulases compared to GH Family 7 cellulases. Bacterial GH Family 6 cellulases are found with structured domains in either N to C terminal order, and similar linker lengths suggest there is no effect of domain order on length. O-glycosylation is uniformly distributed across linkers, suggesting that glycans are required along entire linker lengths for proteolysis protection and, as suggested by simulation, for extension. Sequence comparisons show that proline content for bacterial linkers is more than double that observed in eukaryotic linkers, but with fewer putative O-glycan sites, suggesting alternative methods for extension. Conversely, near linker termini where linkers connect to structured domains, O-glycosylation sites are observed less frequently, whereas glycines are more prevalent, suggesting the need for flexibility to achieve proper domain orientations. Putative N-glycosylation sites are quite rare in cellulase linkers, while an N-P motif, which strongly disfavors the attachment of N-glycans, is commonly observed. These results suggest that linkers exhibit features that are likely tailored for optimal function, despite possessing low sequence identity. This study suggests that cellulase linkers may exhibit function in enzyme action, and highlights the need for additional studies to elucidate cellulase linker functions.	[Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Sammond, Deanne W.; Payne, Christina M.; Brunecky, Roman; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.	gregg.beckham@nrel.gov	crowley, michael F/A-4852-2013; Payne, Christina M/C-7338-2011; Payne, Christina/ABE-8330-2020	crowley, michael F/0000-0001-5163-9398; Payne, Christina M/0000-0001-5264-0964; Payne, Christina/0000-0001-5264-0964; Brunecky, Roman/0000-0002-8352-4234	United States Department of Energy Office of the Biomass Program	United States Department of Energy Office of the Biomass Program(United States Department of Energy (DOE))	The authors thank the United States Department of Energy Office of the Biomass Program for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MJ, 2008, J CHEM THEORY COMPUT, V4, P1119, DOI 10.1021/ct800016r; ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; ABUJA PM, 1988, BIOCHEM BIOPH RES CO, V156, P180, DOI 10.1016/S0006-291X(88)80821-0; ABUJA PM, 1989, BIOCHEM BIOPH RES CO, V165, P615, DOI 10.1016/S0006-291X(89)80010-5; Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; ALFTHAN K, 1995, PROTEIN ENG, V8, P725, DOI 10.1093/protein/8.7.725; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2011, CURRENT OPINION BIOT, V23, P338; Boraston AB, 2005, BIOCHEM J, V385, P479, DOI 10.1042/BJ20041473; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boze H, 2010, BIOPHYS J, V99, P656, DOI 10.1016/j.bpj.2010.04.050; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chocholousova J, 2006, J COMPUT CHEM, V27, P719, DOI 10.1002/jcc.20387; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Crasto CJ, 2000, PROTEIN ENG, V13, P309, DOI 10.1093/protein/13.5.309; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; GILKES NR, 1988, J BIOL CHEM, V263, P10401; Godbole S, 1999, BIOTECHNOL PROGR, V15, P828, DOI 10.1021/bp9901116; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; Grassick A, 2004, EUR J BIOCHEM, V271, P4495, DOI 10.1111/j.1432-1033.2004.04409.x; Gustavsson M, 2001, PROTEIN ENG, V14, P711, DOI 10.1093/protein/14.9.711; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hui JPM, 2002, GLYCOBIOLOGY, V12, P837, DOI 10.1093/glycob/cwf089; Hui JPM, 2001, J CHROMATOGR B, V752, P349, DOI 10.1016/S0378-4347(00)00373-X; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; KNOWLES JKC, 1988, J CHEM SOC CHEM COMM, P1401, DOI 10.1039/c39880001401; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; LANGSFORD ML, 1987, FEBS LETT, V225, P163, DOI 10.1016/0014-5793(87)81150-X; Lantz SE, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-20; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Liang P, 2001, ADV APPL MICROBIOL, V50, P39, DOI 10.1016/S0065-2164(01)50003-9; Lin E, 2009, J CHEM THEORY COMPUT, V5, P2062, DOI 10.1021/ct900119n; Lin Shu-Chuan, 2007, BMC Biochemistry, V8, P9, DOI 10.1186/1471-2091-8-9; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Receveur V, 2002, J BIOL CHEM, V277, P40887, DOI 10.1074/jbc.M205404200; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ryckaert J, 1977, J COMPUT PHYS, V23; SCHMUCK M, 1986, BIOTECHNOL LETT, V8, P397, DOI 10.1007/BF01026739; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Shaw M., 2008, ANALYSTSOFTS STATPLU, P20; SHEN H, 1991, J BIOL CHEM, V266, P11335; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Sonan GK, 2007, BIOCHEM J, V407, P293, DOI 10.1042/BJ20070640; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Ting CL, 2009, J PHYS CHEM B, V113, P4970, DOI 10.1021/jp810625k; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; Uversky VN, 2012, ANAL CHEM, V84, P2096, DOI 10.1021/ac203096k; Varrot A, 2002, ACTA CRYSTALLOGR D, V58, P2201, DOI 10.1107/S0907444902017006; Varroto A, 2005, J BIOL CHEM, V280, P20181, DOI 10.1074/jbc.C500142200; Wang ML, 2011, P NATL ACAD SCI USA, V108, P11954, DOI 10.1073/pnas.1017361108; Yeh IC, 2009, J PHYS CHEM B, V113, P12382, DOI 10.1021/jp904064z; Yuzawa S, 2012, BIOCHEMISTRY-US, V51, P3708, DOI 10.1021/bi300399u; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	91	72	75	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48615	10.1371/journal.pone.0048615	http://dx.doi.org/10.1371/journal.pone.0048615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139804	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300046
J	Vascellari, S; Orru, CD; Hughson, AG; King, D; Barron, R; Wilham, JM; Baron, GS; Race, B; Pani, A; Caughey, B				Vascellari, Sarah; Orru, Christina D.; Hughson, Andrew G.; King, Declan; Barron, Rona; Wilham, Jason M.; Baron, Gerald S.; Race, Brent; Pani, Alessandra; Caughey, Byron			Prion Seeding Activities of Mouse Scrapie Strains with Divergent PrPSc Protease Sensitivities and Amyloid Plaque Content Using RT-QuIC and eQuIC	PLOS ONE			English	Article							CYCLIC AMPLIFICATION; CEREBROSPINAL-FLUID; DISEASE; TIME; BRAIN; CONVERSION; TRANSMISSION; REPLICATION; INFECTIVITY; GENERATION	Different transmissible spongiform encephalopathy (TSE)-associated forms of prion protein (e.g. PrPSc) can vary markedly in ultrastructure and biochemical characteristics, but each is propagated in the host. PrPSc propagation involves conversion from its normal isoform, PrPC, by a seeded or templated polymerization mechanism. Such a mechanism is also the basis of the RT-QuIC and eQuIC prion assays which use recombinant PrP (rPrP(Sen)) as a substrate. These ultrasensitive detection assays have been developed for TSE prions of several host species and sample tissues, but not for murine models which are central to TSE pathogenesis research. Here we have adapted RT-QuIC and eQuIC to various murine prions and evaluated how seeding activity depends on glycophosphatidylinositol (GPI) anchoring and the abundance of amyloid plaques and protease-resistant PrPSc (PrPRes). Scrapie brain dilutions up to 10(-8) and 10(-13) were detected by RT-QuIC and eQuIC, respectively. Comparisons of scrapie-affected wild-type mice and transgenic mice expressing GPI anchorless PrP showed that, although similar concentrations of seeding activity accumulated in brain, the heavily amyloid-laden anchorless mouse tissue seeded more rapid reactions. Next we compared seeding activities in the brains of mice with similar infectivity titers, but widely divergent PrPRes levels. For this purpose we compared the 263K and 139A scrapie strains in transgenic mice expressing P101L PrPC. Although the brains of 263K-affected mice had little immunoblot-detectable PrPRes, RT-QuIC indicated that seeding activity was comparable to that associated with a high-PrPRes strain, 139A. Thus, in this comparison, RT-QuIC seeding activity correlated more closely with infectivity than with PrPRes levels. We also found that eQuIC, which incorporates a PrPSc immunoprecipitation step, detected seeding activity in plasma from wild-type and anchorless PrP transgenic mice inoculated with 22L, 79A and/or RML scrapie strains. Overall, we conclude that these new mouse-adapted prion seeding assays detect diverse types of PrPSc.	[Vascellari, Sarah; Orru, Christina D.; Hughson, Andrew G.; Wilham, Jason M.; Baron, Gerald S.; Race, Brent; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Vascellari, Sarah; Orru, Christina D.; Pani, Alessandra] Univ Cagliari, Dept Biomed Sci, Monserrato, Italy; [King, Declan; Barron, Rona] Univ Edinburgh, Div Neurobiol, Roslin Inst, Roslin, Midlothian, Scotland; [King, Declan; Barron, Rona] Univ Edinburgh, R D SVS, Roslin, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cagliari; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Caughey, B (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT USA.	bcaughey@nih.gov	Pani, Alessandra/B-7831-2011; King, Declan/AAA-7145-2021; Barron, Rona/AAP-9360-2020; Barron, Rona M/C-7703-2013	Barron, Rona/0000-0003-4512-9177; King, Declan/0000-0002-2434-9317; Pani, Alessandra/0000-0002-0437-2499	National Institute for Allergy and Infectious Diseases, National Institutes of Health; Department for Environment, Food and Rural Affairs (Defra), UK [SE1790, SE2016]; Master and Back Program of the Regione Sardegna (Italy); BBSRC [BBS/E/D/05241338, BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05241338, BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000982, ZIAAI001086] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department for Environment, Food and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA)); Master and Back Program of the Regione Sardegna (Italy); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study supported by the Intramural Research Program of the National Institute for Allergy and Infectious Diseases, National Institutes of Health, as well as contracts SE1790 and SE2016 from the Department for Environment, Food and Rural Affairs (Defra), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lynne Raymond for providing bacterial expression vectors for the recombinant PrP<SUP>Sen</SUP> used as substrate in these studies. We also thank Anita Mora for graphic arts assistance, and Drs. Suzette Priola, Roger Moore and Jay Carroll for their critical evaluation of the manuscript. The 101LL knock-in transgenic line was kindly supplied by Prof Jean Manson, Roslin Institute. S.V. was partially supported by the Master and Back Program of the Regione Sardegna (Italy). We thank Drs. Franziska Kuhn, Bjorn Schroeder and Alex Raber at Prionics AG for the gift of 15B3 antibody.	Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Barria MA, 2012, METHODS MOL BIOL, V849, P199, DOI 10.1007/978-1-61779-551-0_14; Barron RM, 2003, J GEN VIROL, V84, P3165, DOI 10.1099/vir.0.19147-0; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; Bessen RA, 2012, J VIROL, V86, P1777, DOI 10.1128/JVI.06626-11; Bessen RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000837; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; DIRINGER H, 1983, BIOSCIENCE REP, V3, P563, DOI 10.1007/BF01120701; Dougherty RM., 1964, TECHNIQUES EXPT VIRO, P183; FIELD EJ, 1967, ACTA NEUROPATHOL, V8, P47, DOI 10.1007/BF00686649; Gajdusek DC, 1996, FIELDS VIROLOGY, P2851; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kim JI, 2009, FEBS LETT, V583, P3671, DOI 10.1016/j.febslet.2009.10.049; KITAMOTO T, 1986, ANN NEUROL, V20, P204, DOI 10.1002/ana.410200205; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Mahal SP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002746; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Mays CE, 2009, BIOCHEM BIOPH RES CO, V388, P306, DOI 10.1016/j.bbrc.2009.07.163; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Nishina KA, 2007, ANAL BIOCHEM, V363, P318, DOI 10.1016/j.ab.2007.01.032; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Orru CD, 2012, J CLIN MICROBIOL, V50, P1464, DOI 10.1128/JCM.06099-11; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peden AH, 2012, J GEN VIROL, V93, P438, DOI 10.1099/vir.0.033365-0; PICCARDO P, 1990, NEUROLOGY, V40, P518, DOI 10.1212/WNL.40.3_Part_1.518; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rubenstein R, 2011, J VIROL, V85, P9031, DOI 10.1128/JVI.05111-11; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217	62	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48969	10.1371/journal.pone.0048969	http://dx.doi.org/10.1371/journal.pone.0048969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139828	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400065
J	Doesch, C; Selbeck, TS; Haghi, D; Streitner, F; Schoenberg, SO; Borggrefe, M; Papavassiliu, T				Doesch, Christina; Selbeck, Tim Su; Haghi, Dariusch; Streitner, Florian; Schoenberg, Stefan O.; Borggrefe, Martin; Papavassiliu, Theano			The Relationship between the Severity of Coronary Artery Disease and Epicardial Adipose Tissue Depends on The Left Ventricular Function	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; C-REACTIVE PROTEIN; HEART-FAILURE; ADIPONECTIN EXPRESSION; METABOLIC SYNDROME; IN-VIVO; FAT; ATHEROSCLEROSIS; ECHOCARDIOGRAPHY; MARKER	Background: Epicardial adipose tissue (EAT) is an active metabolic and endocrine organ. Previous studies focusing mainly on patients with preserved left ventricular function (LVF) could show a correlation between increased amounts of EAT and the extent and activity of coronary artery disease (CAD). However, to date, there are no data available about the relationship between EAT and the severity of CAD with respect to the whole spectrum of LVF impairment. Therefore, we evaluated this relationship in patients with CAD. Methods: 250 patients with CAD and 50 healthy controls underwent CMR examination to assess EAT. The severity of CAD was defined using the angiographic Gensini score (GSS). Results: The GSS ranged from 2-364. Linear regression analysis revealed a significant correlation between EAT and GSS (r = 0.177, p = 0.01). Patients with mild (GSS <= 10) and moderate CAD (GSS>10-<= 40) showed comparable EAT to healthy controls. However, in patients with severe CAD (GSS>40) EAT was significantly reduced (p<0.0001) compared to healthy controls. Interestingly, patients with the same GSS revealed different EAT depending on the left ventricular function (LVF). Patients with preserved LVF (LVF >= 50%) showed more EAT mass compared to those with reduced LVF (LVF<50%) regardless of the GSS. In patients with preserved LVF and mild CAD, EAT was comparable to healthy controls (61.8 +/- 19.4 g vs. 62.9 +/- 14.4 g, p = 0.8). In patients with moderate CAD, EAT rose significantly to 83.1 +/- 24.9 g (p = 0.01) and started to decline to 66.4 +/- 23.6 g in patients with severe CAD (p = 0.03). Contrary, in CAD patients with reduced LVF, EAT was already significantly reduced in patients with mild CAD as compared to healthy controls (p = 0.001) and showed a stepwise decline with increasing CAD severity. Conclusion: The relationship between EAT and the severity of CAD depends on LVF. These findings emphasize the multifactorial interaction between EAT and the severity of CAD.	[Schoenberg, Stefan O.] Heidelberg Univ, Dept Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Doesch, C (corresponding author), Heidelberg Univ, Dept Med 1, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany.	Christina.Doesch@umm.de						Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Ahn SG, 2008, HEART, V94, DOI 10.1136/hrt.2007.118471; Alexopoulos N, 2010, ATHEROSCLEROSIS, V210, P150, DOI 10.1016/j.atherosclerosis.2009.11.020; Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Bettencourt N, 2012, INT J CARDIOL, V158, P26, DOI 10.1016/j.ijcard.2010.12.085; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chaldakov GN, 2001, ATHEROSCLEROSIS, V154, P237, DOI 10.1016/S0021-9150(00)00676-6; Comte A, 2004, EUR RADIOL, V14, P2182, DOI 10.1007/s00330-004-2483-1; Djaberi R, 2008, AM J CARDIOL, V102, P1602, DOI 10.1016/j.amjcard.2008.08.010; Doesch C, 2010, OBESITY, V18, P2326, DOI 10.1038/oby.2010.65; Doesch C, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-40; Eroglu S, 2009, NUTR METAB CARDIOVAS, V19, P211, DOI 10.1016/j.numecd.2008.05.002; Fluchter S, 2007, OBESITY, V15, P870, DOI 10.1038/oby.2007.591; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; HANDA K, 1989, ATHEROSCLEROSIS, V77, P209, DOI 10.1016/0021-9150(89)90083-X; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Iacobellis G, 2005, CYTOKINE, V29, P251, DOI 10.1016/j.cyto.2004.11.002; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45; Iacobellis G, 2009, HORM METAB RES, V41, P855, DOI 10.1055/s-0029-1231081; Iacobellis G, 2009, HORM METAB RES, V41, P227, DOI 10.1055/s-0028-1100412; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Iacobellis G, 2009, OBESITY, V17, P625, DOI 10.1038/oby.2008.575; Jeong JW, 2007, CIRC J, V71, P536, DOI 10.1253/circj.71.536; Khawaja T, 2011, AM J CARDIOL, V108, P397, DOI 10.1016/j.amjcard.2011.03.058; Kusunose K, 2009, JACC-CARDIOVASC IMAG, V2, P1147, DOI 10.1016/j.jcmg.2009.05.013; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; McLean DS, 2009, CLIN LIPIDOL, V4, P55, DOI 10.2217/17584299.4.1.55; Nelson AJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-15; Nesto R, 2004, DIABETIC MED, V21, P810, DOI 10.1111/j.1464-5491.2004.01296.x; Nijveldt R, 2008, EUR RADIOL, V18, P2399, DOI 10.1007/s00330-008-1017-7; Rabkin SW, 2007, OBES REV, V8, P253, DOI 10.1111/j.1467-789X.2006.00293.x; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; SHIRANI J, 1995, AM J CARDIOL, V76, P414, DOI 10.1016/S0002-9149(99)80116-7; Silaghi A, 2008, OBESITY, V16, P2424, DOI 10.1038/oby.2008.379; Silaghi A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1443, DOI 10.1152/ajpendo.00273.2007; Thanassoulis G, 2010, CIRC-CARDIOVASC IMAG, V3, P559, DOI 10.1161/CIRCIMAGING.110.956706; WOMACK HC, 1983, HUM BIOL, V55, P667; Yerramasu A, 2012, ATHEROSCLEROSIS, V220, P223, DOI 10.1016/j.atherosclerosis.2011.09.041	44	6	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48330	10.1371/journal.pone.0048330	http://dx.doi.org/10.1371/journal.pone.0048330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133630	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400033
J	Parlevliet, ET; Wang, YN; Geerling, JJ; Elst, JPSVD; Picha, K; O'Neil, K; Stojanovic-Susulic, V; Ort, T; Havekes, LM; Romijn, JA; Pijl, H; Rensen, PCN				Parlevliet, Edwin T.; Wang, Yanan; Geerling, Janine J.; Schroder-van der Elst, Janny P.; Picha, Kristen; O'Neil, Karyn; Stojanovic-Susulic, Vedrana; Ort, Tatiana; Havekes, Louis M.; Romijn, Johannes A.; Pijl, Hanno; Rensen, Patrick C. N.			GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; DE-NOVO LIPOGENESIS; BETA-CELL FUNCTION; INSULIN-RESISTANCE; TRANSGENIC MICE; LIVER-DISEASE; OB/OB MICE; LIPOPROTEINS; EXENATIDE; THERAPY	Objective: In addition to improve glucose intolerance, recent studies suggest that glucagon-like peptide-1 (GLP-1) receptor agonism also decreases triglyceride (TG) levels. The aim of this study was to evaluate the effect of GLP-1 receptor agonism on very-low-density lipoprotein (VLDL)-TG production and liver TG metabolism. Experimental Approach: The GLP-1 peptide analogues CNTO3649 and exendin-4 were continuously administered subcutaneously to high fat diet-fed APOE*3-Leiden transgenic mice. After 4 weeks, hepatic VLDL production, lipid content, and expression profiles of selected genes involved in lipid metabolism were determined. Results: CNTO3649 and exendin-4 reduced fasting plasma glucose (up to -30% and -28% respectively) and insulin (-43% and -65% respectively). In addition, these agents reduced VLDL-TG production (-36% and -54% respectively) and VLDL-apoB production (-36% and -43% respectively), indicating reduced production of VLDL particles rather than reduced lipidation of apoB. Moreover, they markedly decreased hepatic content of TG (-39% and -55% respectively), cholesterol (-30% and -55% respectively), and phospholipids (-23% and -36% respectively), accompanied by down-regulation of expression of genes involved in hepatic lipogenesis (Srebp-1c, Fasn, Dgat1) and apoB synthesis (Apob). Conclusion: GLP-1 receptor agonism reduces VLDL production and hepatic steatosis in addition to an improvement of glycemic control. These data suggest that GLP-receptor agonists could reduce hepatic steatosis and ameliorate dyslipidemia in patients with type 2 diabetes mellitus.	[Parlevliet, Edwin T.; Wang, Yanan; Geerling, Janine J.; Schroder-van der Elst, Janny P.; Havekes, Louis M.; Romijn, Johannes A.; Pijl, Hanno; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Gen Internal Med Endocrinol & Metab Dis, Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Havekes, Louis M.] Netherlands Org Appl Sci Res Metab Hlth Res, Gaubius Lab, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Rensen, PCN (corresponding author), Leiden Univ, Med Ctr, Dept Gen Internal Med Endocrinol & Metab Dis, Leiden, Netherlands.	P.C.N.Rensen@lumc.nl	Wang, Yanan/C-4143-2019; Rensen, Patrick C.N./D-7176-2018; Pijl, Hanno/W-8719-2018	Wang, Yanan/0000-0002-0327-0458; Rensen, Patrick C.N./0000-0002-8455-4988; Pijl, Hanno/0000-0002-3076-1551	Janssen Research Development; Netherlands Heart Foundation (NHS) [2007B81]; Dutch Diabetes Foundation (DFN) [2007.00.010]; Netherlands Heart Foundation [2009T038]	Janssen Research Development; Netherlands Heart Foundation (NHS)(Netherlands Heart Foundation); Dutch Diabetes Foundation (DFN); Netherlands Heart Foundation(Netherlands Heart Foundation)	This research was supported by a grant from Janssen Research & Development, the Netherlands Heart Foundation (NHS grant 2007B81 to PCNR), and the Dutch Diabetes Foundation (DFN grant 2007.00.010). PCNR is an Established Investigator of the Netherlands Heart Foundation (grant 2009T038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Adiels M, 2006, CURR OPIN LIPIDOL, V17, P238, DOI 10.1097/01.mol.0000226115.97436.c0; [Anonymous], 2005, MED LETT DRUGS THER, V47, P45; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrows BR, 2006, J CLIN ENDOCR METAB, V91, P1446, DOI 10.1210/jc.2005-1709; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Fere P, 2001, BIOCHEM SOC T, V29, P547; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Gedulin BR, 2005, DIABETOLOGIA, V48, P1380, DOI 10.1007/s00125-005-1795-2; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Green BD, 2006, J PHARMACOL EXP THER, V318, P914, DOI 10.1124/jpet.105.097824; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; HELLERSTEIN MK, 1993, AM J PHYSIOL, V265, pE814, DOI 10.1152/ajpendo.1993.265.5.E814; HOLST JJ, 1987, FEBS LETT, V211, P169, DOI 10.1016/0014-5793(87)81430-8; Hsieh J, 2010, DIABETOLOGIA, V53, P552, DOI 10.1007/s00125-009-1611-5; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; KREYMANN B, 1987, LANCET, V2, P1300; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Li XH, 1996, J LIPID RES, V37, P210; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Matikainen N, 2006, DIABETOLOGIA, V49, P2049, DOI 10.1007/s00125-006-0340-2; Mulvihill EE, 2009, DIABETES, V58, P2198, DOI 10.2337/db09-0634; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Parlevliet ET, 2010, AM J PHYSIOL-ENDOC M, V299, pE318, DOI 10.1152/ajpendo.00191.2010; Parlevliet ET, 2009, J PHARMACOL EXP THER, V328, P240, DOI 10.1124/jpet.108.144154; Picha KM, 2008, DIABETES, V57, P1926, DOI 10.2337/db07-1775; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Sathyanarayana P, 2011, OBESITY, V19, P2310, DOI 10.1038/oby.2011.152; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Tomas E, 2010, HORM METAB RES, V42, P657, DOI 10.1055/s-0030-1253421; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Viswanathan Prabhakar, 2007, Endocr Pract, V13, P444; WETTERGREN A, 1993, DIGEST DIS SCI, V38, P665, DOI 10.1007/BF01316798; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	45	64	69	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e49152	10.1371/journal.pone.0049152	http://dx.doi.org/10.1371/journal.pone.0049152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133675	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400057
J	Sun, L; Chandra, S; Sucosky, P				Sun, Ling; Chandra, Santanu; Sucosky, Philippe			Ex Vivo Evidence for the Contribution of Hemodynamic Shear Stress Abnormalities to the Early Pathogenesis of Calcific Bicuspid Aortic Valve Disease	PLOS ONE			English	Article							INTERSTITIAL-CELLS; BIOLOGICAL-PROPERTIES; MATRIX METALLOPROTEINASES; CYCLIC PRESSURE; EXPRESSION; STENOSIS; FREQUENCY; MATRIX-METALLOPROTEINASE-9; OSTEOPONTIN; PHENOTYPES	The bicuspid aortic valve (BAV) is the most common congenital cardiac anomaly and is frequently associated with calcific aortic valve disease (CAVD). The most prevalent type-I morphology, which results from left-/right-coronary cusp fusion, generates different hemodynamics than a tricuspid aortic valve (TAV). While valvular calcification has been linked to genetic and atherogenic predispositions, hemodynamic abnormalities are increasingly pointed as potential pathogenic contributors. In particular, the wall shear stress (WSS) produced by blood flow on the leaflets regulates homeostasis in the TAV. In contrast, WSS alterations cause valve dysfunction and disease. While such observations support the existence of synergies between valvular hemodynamics and biology, the role played by BAV WSS in valvular calcification remains unknown. The objective of this study was to isolate the acute effects of native BAV WSS abnormalities on CAVD pathogenesis. Porcine aortic valve leaflets were subjected ex vivo to the native WSS experienced by TAV and type-I BAV leaflets for 48 hours. Immunostaining, immunoblotting and zymography were performed to characterize endothelial activation, pro-inflammatory paracrine signaling, extracellular matrix remodeling and markers involved in valvular interstitial cell activation and osteogenesis. While TAV and non-coronary BAV leaflet WSS essentially maintained valvular homeostasis, fused BAV leaflet WSS promoted fibrosa endothelial activation, paracrine signaling (2.4-fold and 3.7-fold increase in BMP-4 and TGF-beta 1, respectively, relative to fresh controls), catabolic enzyme secretion (6.3-fold, 16.8-fold, 11.7-fold, 16.7-fold and 5.5-fold increase in MMP-2, MMP-9, cathepsin L, cathepsin S and TIMP-2, respectively) and activity (1.7-fold and 2.4-fold increase in MMP-2 and MMP-9 activity, respectively), and bone matrix synthesis (5-fold increase in osteocalcin). In contrast, BAV WSS did not significantly affect alpha-SMA and Runx2 expressions and TIMP/MMP ratio. This study demonstrates the key role played by BAV hemodynamic abnormalities in CAVD pathogenesis and suggests the dependence of BAV vulnerability to calcification on the local degree of WSS abnormality.	[Sun, Ling; Sucosky, Philippe] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA; [Sun, Ling; Sucosky, Philippe] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Sucosky, P (corresponding author), Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.	Philippe.Sucosky@nd.edu	Sucosky, Philippe/A-7052-2013	Sucosky, Philippe/0000-0003-0113-5858	National Science Foundation faculty early CAREER grant [1148558]; American Heart Association scientist development grant [11SDG7600103]; Notre Dame Eck Institute for Global Health predoctoral award; Directorate For Engineering [1148558] Funding Source: National Science Foundation	National Science Foundation faculty early CAREER grant; American Heart Association scientist development grant(American Heart Association); Notre Dame Eck Institute for Global Health predoctoral award; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work described in this article was supported in part by a National Science Foundation faculty early CAREER grant 1148558, an American Heart Association scientist development grant 11SDG7600103, and a Notre Dame Eck Institute for Global Health predoctoral award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	27Thubrikar M., 1990, AORTIC VALVE; Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Balachandran K, 2006, ANN BIOMED ENG, V34, P1655, DOI 10.1007/s10439-006-9167-8; Balachandran K, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/263870; Balachandran K, 2010, AM J PATHOL, V177, P49, DOI 10.2353/ajpath.2010.090631; Balachandran K, 2009, AM J PHYSIOL-HEART C, V296, pH756, DOI 10.1152/ajpheart.00900.2008; Barker AJ, 2010, ANN BIOMED ENG, V38, P788, DOI 10.1007/s10439-009-9854-3; Braverman AC, 2005, CURR PROB CARDIOLOGY, V30, P470, DOI 10.1016/j.cpcardiol.2005.06.002; Butcher JT, 2008, J HEART VALVE DIS, V17, P62; Butcher JT, 2006, TISSUE ENG, V12, P905, DOI 10.1089/ten.2006.12.905; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Chandra S, 2012, BIOMECH MODEL MECHAN, V11, P1085, DOI 10.1007/s10237-012-0375-x; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Edep ME, 2000, CARDIOVASC PATHOL, V9, P281, DOI 10.1016/S1054-8807(00)00043-0; Fondard O, 2005, EUR HEART J, V26, P1333, DOI 10.1093/eurheartj/ehi248; FOWLES RE, 1979, CHEST, V75, P434, DOI 10.1378/chest.75.4.434; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Goldbarg SH, 2007, J AM COLL CARDIOL, V50, P1205, DOI 10.1016/j.jacc.2007.06.024; Hakuno D, 2009, J MOL MED, V87, P17, DOI 10.1007/s00109-008-0400-9; Helske S, 2006, ARTERIOSCL THROM VAS, V26, P1791, DOI 10.1161/01.ATV.0000228824.01604.63; Hoehn D., 2010, CARDIOVASC ENG TECHN, V1, P165, DOI [10.1007/s13239-010-0015-5, DOI 10.1007/S13239-010-0015-5]; Hope MD, 2008, CIRCULATION, V117, P2818, DOI 10.1161/CIRCULATIONAHA.107.760124; Hope MD, 2010, RADIOLOGY, V255, P53, DOI 10.1148/radiol.09091437; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kaden JJ, 2005, INT J MOL MED, V16, P869; Kaden JJ, 2004, J HEART VALVE DIS, V13, P560; Kaden JJ, 2004, Z KARDIOL, V93, P124, DOI 10.1007/s00392-004-1021-0; Lewin MB, 2005, CIRCULATION, V111, P832, DOI 10.1161/01.CIR.0000157137.59691.0B; LIAN JB, 1988, CLIN ORTHOP RELAT R, P267; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Merryman WD, 2007, CARDIOVASC PATHOL, V16, P268, DOI 10.1016/j.carpath.2007.03.006; Merryman WD, 2010, J BIOMECH, V43, P87, DOI 10.1016/j.jbiomech.2009.09.013; Metzler SA, 2008, J HEART VALVE DIS, V17, P571; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; MILLS P, 1978, BRIT HEART J, V40, P951; Mohler ER, 1997, ARTERIOSCL THROM VAS, V17, P547, DOI 10.1161/01.ATV.17.3.547; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Monzack EL, 2011, J HEART VALVE DIS, V20, P449; Muller AM, 2000, J PATHOL, V191, P54, DOI 10.1002/(SICI)1096-9896(200005)191:1<54::AID-PATH568>3.0.CO;2-Y; NANDA NC, 1974, CIRCULATION, V49, P870, DOI 10.1161/01.CIR.49.5.870; O'Brien KD, 2006, ARTERIOSCL THROM VAS, V26, P1721, DOI 10.1161/01.ATV.0000227513.13697.ac; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; OLSSON M, 1994, J AM COLL CARDIOL, V23, P1162, DOI 10.1016/0735-1097(94)90606-8; Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Otto CM, 2004, VALVULAR HEART DIS; PACHULSKI RT, 1993, BRIT HEART J, V69, P237; Platt MO, 2006, J HEART VALVE DIS, V15, P622; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Rajamannan NM, 2006, CIRCULATION, V114, P2007, DOI 10.1161/CIRCULATIONAHA.106.657759; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; Robicsek F, 2004, ANN THORAC SURG, V77, P177, DOI 10.1016/S0003-4975(03)01249-9; Sabet HY, 1999, MAYO CLIN PROC, V74, P14, DOI 10.4065/74.1.14; Saikrishnan N, 2012, ANN BIOMED ENG, V40, P1760, DOI 10.1007/s10439-012-0527-2; Santibanez JF, 2002, BIOCHEM BIOPH RES CO, V296, P267; Satta J, 2003, ANN THORAC SURG, V76, P681, DOI 10.1016/S0003-4975(03)00529-0; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Smith KE, 2010, BIOMECH MODEL MECHAN, V9, P117, DOI 10.1007/s10237-009-0165-2; Soini Y, 2001, J PATHOL, V194, P225, DOI 10.1002/path.850; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Sun L, 2011, ANN BIOMED ENG, V39, P2174, DOI 10.1007/s10439-011-0305-6; Tanaka K, 2005, J AM COLL CARDIOL, V46, P134, DOI 10.1016/j.jacc.2005.03.058; Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Warnock JN, 2006, J HEART VALVE DIS, V15, P34; Weston MW, 1999, ANN BIOMED ENG, V27, P572, DOI 10.1114/1.199; Xing Y, 2004, ANN BIOMED ENG, V32, P1461, DOI 10.1114/B:ABME.0000049031.07512.11; Xing Y, 2004, ANN BIOMED ENG, V32, P555, DOI 10.1023/B:ABME.0000019175.12013.8f; Yap CH, 2012, AM J PHYSIOL-HEART C, V303, pH721, DOI 10.1152/ajpheart.00829.2011; Yap CH, 2012, BIOMECH MODEL MECHAN, V11, P231, DOI 10.1007/s10237-011-0306-2; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394	78	72	72	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48843	10.1371/journal.pone.0048843	http://dx.doi.org/10.1371/journal.pone.0048843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119099	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500206
J	Camperio, C; Caristi, S; Fanelli, G; Soligo, M; Del Porto, P; Piccolella, E				Camperio, Cristina; Caristi, Silvana; Fanelli, Giorgia; Soligo, Marzia; Del Porto, Paola; Piccolella, Enza			Forkhead Transcription Factor FOXP3 Upregulates CD25 Expression through Cooperation with RelA/NF-kappa B	PLOS ONE			English	Article							ACTIVATED T-CELLS; IMMUNE DYSREGULATION; PROMOTER OCCUPANCY; GENE-EXPRESSION; NUCLEAR-FACTOR; TARGET GENES; RECEPTOR; SIGNALS; BINDING; DNA	Considerable evidence supports the prediction that CD25 is directly regulated by the forkhead transcription factor FOXP3. However, given that CD25 is normally upregulated in activated T cells, regardless of whether they express FOXP3, this issue has still to be definitively demonstrated. Here we describe that FOXP3, induced by CD28 signals in human CD4(+)CD25(-) T lymphocytes, synergizes with RelA on a regulatory region of Cd25 promoter to mediate the transcriptional activation of Cd25 gene. We found that a striking feature of this regulatory region is the presence of a kappa B site and of two tandem copies of a non-consensus FOXP3 binding site separated at 5' ends by 19 nucleotides that allow FOXP3 and RelA binding to DNA and their physical interaction. The occupancy of the two FOXP3 binding sites in conjunction with RelA binding site occupancy allows FOXP3 to function as a positive activator of Cd25 gene. Indeed mutations of both FOXP3 binding sites such as mutation of kB site on Cd25 promoter abolished FOXP3 activatory functions. Moreover, FOXP3 mutation Delta E251, that compromises FOXP3 homotypic interactions, failed to trans activate Cd25 promoter, suggesting that both FOXP3 DNA binding and dimerization are required to trans activate Cd25 promoter. These findings identify a novel mechanism by which RelA and FOXP3 cooperate to mediate transcriptional regulation of target genes and characterize a region on Cd25 promoter where FOXP3 dimer could bridge intramolecularly two DNA sites and trans activate Cd25 gene.	[Camperio, Cristina; Caristi, Silvana; Fanelli, Giorgia; Soligo, Marzia; Del Porto, Paola; Piccolella, Enza] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy	Sapienza University Rome	Piccolella, E (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	enza.piccolella@uniroma1.it	Soligo, Marzia/AAC-1543-2019	Fanelli, Guido/0000-0002-2991-3378; caristi, silvana/0000-0002-0016-7498; Soligo, Marzia/0000-0002-1420-0914	Institute Pasteur Fondazione Cenci Bolognetti; University Sapienza of Rome; Ministry of Universities and Scientific and Technological Research (MIUR-COFIN); Italian Space Agency (ASI)	Institute Pasteur Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); University Sapienza of Rome; Ministry of Universities and Scientific and Technological Research (MIUR-COFIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI))	This work was funded by Institute Pasteur Fondazione Cenci Bolognetti, University Sapienza of Rome, Ministry of Universities and Scientific and Technological Research (MIUR-COFIN) and Italian Space Agency (ASI) grants to E. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGARTE M, 1995, EMBO J, V14, P5060, DOI 10.1002/j.1460-2075.1995.tb00188.x; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Holmes D, 2007, J BIOL CHEM, V282, P15973, DOI 10.1074/jbc.M702051200; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; KahnPerles B, 1997, J BIOL CHEM, V272, P21774, DOI 10.1074/jbc.272.35.21774; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; LIN BB, 1990, MOL CELL BIOL, V10, P850, DOI 10.1128/MCB.10.2.850; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Scotta C, 2008, J IMMUNOL, V181, P1025, DOI 10.4049/jimmunol.181.2.1025; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Soligo M, 2011, EUR J IMMUNOL, V41, P503, DOI 10.1002/eji.201040712; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Tuosto L, 2000, EUR J IMMUNOL, V30, P2445, DOI 10.1002/1521-4141(200009)30:9<2445::AID-IMMU2445>3.0.CO;2-4; van Essen D, 2009, PLOS BIOL, V7, P549, DOI 10.1371/journal.pbio.1000073; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	40	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48303	10.1371/journal.pone.0048303	http://dx.doi.org/10.1371/journal.pone.0048303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144749	gold, Green Submitted, Green Published			2022-12-25	WOS:000310705300059
J	Jorgensen, SJ; Arnoldi, NS; Estess, EE; Chapple, TK; Ruckert, M; Anderson, SD; Block, BA				Jorgensen, Salvador J.; Arnoldi, Natalie S.; Estess, Ethan E.; Chapple, Taylor K.; Rueckert, Martin; Anderson, Scot D.; Block, Barbara A.			Eating or Meeting? Cluster Analysis Reveals Intricacies of White Shark (Carcharodon carcharias) Migration and Offshore Behavior	PLOS ONE			English	Article							SOUTH-FARALLON-ISLANDS; DIVING BEHAVIOR; SWIMMING BEHAVIOR; SPAWNING BEHAVIOR; PELAGIC SHARKS; BLUEFIN TUNA; MOVEMENTS; HABITAT; LEK; PREFERENCES	Elucidating how mobile ocean predators utilize the pelagic environment is vital to understanding the dynamics of oceanic species and ecosystems. Pop-up archival transmitting (PAT) tags have emerged as an important tool to describe animal migrations in oceanic environments where direct observation is not feasible. Available PAT tag data, however, are for the most part limited to geographic position, swimming depth and environmental temperature, making effective behavioral observation challenging. However, novel analysis approaches have the potential to extend the interpretive power of these limited observations. Here we developed an approach based on clustering analysis of PAT daily time-at-depth histogram records to distinguish behavioral modes in white sharks (Carcharodon carcharias). We found four dominant and distinctive behavioral clusters matching previously described behavioral patterns, including two distinctive offshore diving modes. Once validated, we mapped behavior mode occurrence in space and time. Our results demonstrate spatial, temporal and sex-based structure in the diving behavior of white sharks in the northeastern Pacific previously unrecognized including behavioral and migratory patterns resembling those of species with lek mating systems. We discuss our findings, in combination with available life history and environmental data, and propose specific testable hypotheses to distinguish between mating and foraging in northeastern Pacific white sharks that can provide a framework for future work. Our methodology can be applied to similar datasets from other species to further define behaviors during unobservable phases.	[Jorgensen, Salvador J.] Monterey Bay Aquarium, Monterey, CA USA; [Jorgensen, Salvador J.; Arnoldi, Natalie S.; Estess, Ethan E.; Chapple, Taylor K.; Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Rueckert, Martin] Univ Paris 06, Paris, France; [Anderson, Scot D.] Point Reyes Natl Seashore, Inverness, CA USA	Monterey Bay Aquarium Research Institute; Stanford University; UDICE-French Research Universities; Sorbonne Universite	Jorgensen, SJ (corresponding author), Monterey Bay Aquarium, Monterey, CA USA.	sjorgensen@mbayaq.org		Arnoldi, Natalie/0000-0001-5576-9624	Sloan Foundation; Moore Foundation; Packard Foundation; Monterey Bay Aquarium Foundation	Sloan Foundation(Alfred P. Sloan Foundation); Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); Monterey Bay Aquarium Foundation	This project was funded by the Sloan, Moore and Packard Foundations as a part of the Tagging of Pacific Pelagics (TOPP) program of the Census of Marine Life. The Monterey Bay Aquarium Foundation also provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SD, 2003, CALIF FISH GAME, V89, P96; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson Malte, 1994; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bower JR, 2005, FISH RES, V76, P39, DOI 10.1016/j.fishres.2005.05.009; Bradbury J.W., 1981, P138; Bradford Russel W., 2012, P255; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; CAREY FG, 1984, J EXP BIOL, V109, P1; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Dewar H, 2011, FISH OCEANOGR, V20, P219, DOI 10.1111/j.1365-2419.2011.00581.x; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Domeier Michael L., 2012, P147; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Domeier ML., 2012, GLOBAL PERSPECTIVES, P133, DOI [10.1201/b11532-14, DOI 10.1201/B11532-14]; DONALDSON TJ, 1990, JPN J ICHTHYOL, V37, P292; ECKERT SA, 1989, CAN J ZOOL, V67, P2834, DOI 10.1139/z89-399; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Figenschou L, 2004, CAN J ZOOL, V82, P1278, DOI 10.1139/Z04-106; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; GLADSTONE W, 1994, ENVIRON BIOL FISH, V39, P249, DOI 10.1007/BF00005127; Gleiss AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1350; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Goldman KJ, 2008, SHARKS OPEN OCEAN BI; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hazen EL, 2010, FISH OCEANOGR, V19, P427, DOI 10.1111/j.1365-2419.2010.00561.x; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Holland Kim N., 2010, Endangered Species Research, V10, P287; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; KLIMLEY AP, 1985, Z TIERPSYCHOL, V70, P297; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Lidgard DC, 2005, BEHAV ECOL, V16, P541, DOI 10.1093/beheco/ari023; Loiselle PV., 1978, CONTRASTS BEHAV, P33; MCKAYE KR, 1983, ENVIRON BIOL FISH, V8, P81, DOI 10.1007/BF00005175; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Nasby-Lucas N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008163; Papastamatiou YP, 2012, J FISH BIOL; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Roper CFE, 1975, VERTICAL DISTRIBUTIO; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Seitz AC, 2005, ENVIRON BIOL FISH, V73, P445, DOI 10.1007/s10641-005-3216-2; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Tont S. A., 1976, CALIFORNIA COOPERATI, V18, P112, DOI DOI 10.1046/J.1365-2419.1999.00103.X.; Wedekind C, 1996, BEHAVIOUR, V133, P681, DOI 10.1163/156853996X00422; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Windle MJS, 2007, MAR BIOL, V150, P671, DOI 10.1007/s00227-006-0385-2; Winship AJ, 2012, METHODS ECOL EVOL, V3, P291, DOI 10.1111/j.2041-210X.2011.00161.x	61	51	51	0	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47819	10.1371/journal.pone.0047819	http://dx.doi.org/10.1371/journal.pone.0047819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144707	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300018
J	Kuzumaki, N; Suzuki, A; Narita, M; Hosoya, T; Nagasawa, A; Imai, S; Yamamizu, K; Morita, H; Suzuki, T; Okada, Y; Okano, HJ; Yamashita, JK; Okano, H; Narita, M				Kuzumaki, Naoko; Suzuki, Atsuo; Narita, Michiko; Hosoya, Takahiro; Nagasawa, Atsumi; Imai, Satoshi; Yamamizu, Kohei; Morita, Hiroshi; Suzuki, Tsutomu; Okada, Yohei; Okano, Hirotaka James; Yamashita, Jun K.; Okano, Hideyuki; Narita, Minoru			Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGFR MUTATIONS; TRANSACTIVATION; ACTIVATION; DOWNSTREAM; MECHANISMS; PATHWAYS; THERAPY	There is increasing evidence that functional crosstalk between GPCRs and EGFR contributes to the progression of colon, lung, breast, ovarian, prostate and head and neck tumors. In this study, we performed multiple analyses of GPCR expression in a gefitinib-resistant non-small cell lung cancer (NSCLC) cell line, H1975, which harbors an L858R/T790M mutation. To determine the expression profile of mRNAs encoding 384 GPCRs in normal human lung fibroblast (NHLF) and H1975 cells, a GPCR-specific microarray analysis was performed. A heat-map of the microarray revealed considerable differences in the expression of GPCRs between NHLF and H1975 cells. From the GPCR expression list, we selected some GPCR agonists/antagonist to investigate whether the respective ligands could affect the growth of H1975 cells. Among them, treatment with either a selective antagonist of adenosine A2a receptors, which were highly expressed in H1975 cell and another gefitinib-resistant NSCLC cells, HCC827GR cells or "small interfering RNA" (siRNA) targeting adenosine A2a receptors produced a significant decrease in cell viability of both H1975 and HCC827GR cells. Among up-regulated GPCRs in H1975 cells, Gs-, Gi- and Gq-coupled GPCRs were expressed almost equally. Among down-regulated GPCRs, Gi-coupled GPCRs were dominantly expressed in H1975 cells. The present results suggest that multilayered crosstalk between GPCRs and EGFR may play an important role in orchestrating downstream signaling molecules that are implicated in the development of gefitinib-resistant NSCLC.	[Kuzumaki, Naoko; Okada, Yohei; Okano, Hirotaka James; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Kuzumaki, Naoko; Suzuki, Atsuo; Narita, Michiko; Nagasawa, Atsumi; Imai, Satoshi; Narita, Minoru] Hoshi Univ, Dept Pharamacol, Sch Pharm & Pharmaceut Sci, Tokyo 142, Japan; [Hosoya, Takahiro] Biomed Informat Res Ctr, Biol Syst Control Team, Tokyo, Japan; [Yamamizu, Kohei; Yamashita, Jun K.] Kyoto Univ, Lab Stem Cell Differentiat, Stem Cell Res Ctr, Inst Frontier Med Sci, Kyoto, Japan; [Morita, Hiroshi] Hoshi Univ, Fac Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Tokyo 142, Japan; [Suzuki, Tsutomu] Hoshi Univ, Dept Toxicol, Sch Pharm & Pharmaceut Sci, Tokyo, Japan	Keio University; Hoshi University; Kyoto University; Hoshi University; Hoshi University	Kuzumaki, N (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan.	naokokuzumaki@gmail.com; narita@hoshi.ac.jp	Kuzumaki, Naoko/L-1287-2013; Okada, Yohei/L-1662-2013; Okano, Hideyuki/I-7584-2019	Imai, Satoshi/0000-0003-4737-8695; Okano, Hirotaka James/0000-0003-4611-7098				Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Jenner P, 2005, EXPERT OPIN INV DRUG, V14, P729, DOI 10.1517/13543784.14.6.729; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lappano R, NAT REV DRUG DISCOV, V10, P47; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Swift JL, 2011, P NATL ACAD SCI USA, V108, P7016, DOI 10.1073/pnas.1018280108; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wakeling AE, 2002, CANCER RES, V62, P5749; Zhang YH, 2009, CANCER RES, V69, P6049, DOI 10.1158/0008-5472.CAN-09-0621	21	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e44368	10.1371/journal.pone.0044368	http://dx.doi.org/10.1371/journal.pone.0044368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144692	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300003
J	Mann, MJ; Pereira, ER; Liao, N; Hendershot, LM				Mann, Melissa J.; Pereira, Ethel R.; Liao, Nan; Hendershot, Linda M.			UPR-Induced Resistance to Etoposide Is Downstream of PERK and Independent of Changes in Topoisomerase II alpha Levels	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-REGULATED STRESSES; FACTOR-KAPPA-B; ER STRESS; TRANSMEMBRANE PROTEIN; CANCER-CELLS; TRANSCRIPTIONAL INDUCTION; MESSENGER-RNAS; IRE1 REVEALS	Background: The unfolded protein response (UPR) is regulated by three ER-localized, transmembrane signal transducers that control distinct aspects of the UPR. We previously reported that both increased resistance to etoposide and a reduction in Topoisomerase II alpha protein levels were a direct response of UPR activation, and the latter occurred independent of changes in Topo IIa mRNA levels. We have now examined the contribution of each of the three up-stream transducers of the UPR, as well as some of their downstream targets in affecting decreased expression of Topo II alpha protein and increased drug resistance. Principal Findings: Our data revealed that while Ire1 activation led to Topo II alpha loss at the protein level it did not contribute to changes in sensitivity to etoposide. The decreased expression of Topo II alpha protein was not downstream of XBP-1, in keeping with the fact that Topo II alpha transcription was not affected by ER stress. Conversely, PERK activation did not contribute to changes in Topo II alpha protein levels, but it did play a significant role in the UPR-induced decreased sensitivity to etoposide. Several cellular responses downstream of PERK were examined for their potential to contribute to resistance. The ATF6 arm of the UPR did not significantly contribute to etoposide resistance within the time frame of our experiments. Conclusions and Significance: In toto, our data demonstrate that UPR-induced changes in Topo II alpha protein levels are not responsible for resistance to etoposide as has been previously hypothesized, and instead demonstrate that the PERK branch plays a Topo II alpha-independent role in altered sensitivity to this drug.	[Mann, Melissa J.; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Pereira, Ethel R.; Liao, Nan; Hendershot, Linda M.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Pereira, Ethel/0000-0003-0562-4536	National Institutes of Health grant [P01CA023099]; Cancer Center CORE grant [CA21765]; Alma and Hal Reagan Fellowship; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P01CA023099, P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE grant; Alma and Hal Reagan Fellowship; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a National Institutes of Health grant P01CA023099 (LMH), the Cancer Center CORE grant CA21765, the Alma and Hal Reagan Fellowship (ERP), and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Boelens J, 2007, IN VIVO, V21, P215; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; CAI JW, 1993, J CELL PHYSIOL, V154, P229, DOI 10.1002/jcp.1041540204; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CARLBERG M, 1993, ANTICANCER RES, V13, P167; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Davenport EL, 2008, CELL CYCLE, V7, P865, DOI 10.4161/cc.7.7.5615; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; ELBADRY OM, 1989, J CLIN INVEST, V84, P829, DOI 10.1172/JCI114243; Gao YY, 2010, J CLIN ENDOCR METAB, V95, pE319, DOI 10.1210/jc.2010-1043; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Gray MD, 2005, MOL PHARMACOL, V68, P1699, DOI 10.1124/mol.105.014753; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; HUGHES CS, 1989, CANCER RES, V49, P4452; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Levenson VV, 2000, CANCER RES, V60, P5027; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Masciarelli S, 2010, MOL IMMUNOL, V47, P1356, DOI 10.1016/j.molimm.2009.12.003; MELERO JA, 1978, J CELL PHYSIOL, V95, P295, DOI 10.1002/jcp.1040950307; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MORI K, 1993, CELL, V74, P743; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Oono K, 2004, NEUROCHEM INT, V45, P765, DOI 10.1016/j.neuint.2004.01.003; Osheroff N, 1998, BBA-GENE STRUCT EXPR, V1400, P1, DOI 10.1016/S0167-4781(98)00123-7; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sauter K, 2005, J BIOL CHEM, V280, P33566, DOI 10.1074/jbc.M503482200; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; SHEN J, 1987, P NATL ACAD SCI USA, V84, P3278, DOI 10.1073/pnas.84.10.3278; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; SHEN JW, 1989, MOL CELL BIOL, V9, P3284, DOI 10.1128/MCB.9.8.3284; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanabe M, 2003, CANCER RES, V63, P8592; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yun J, 1995, ONCOL RES, V7, P583; Yun JS, 2004, J BIOL CHEM, V279, P31296, DOI 10.1074/jbc.M401411200; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431	86	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47931	10.1371/journal.pone.0047931	http://dx.doi.org/10.1371/journal.pone.0047931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144714	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300025
J	Gromnicova, R; Romero, I; Male, D				Gromnicova, Radka; Romero, Ignacio; Male, David			Transcriptional Control of the Multi-Drug Transporter ABCB1 by Transcription Factor Sp3 in Different Human Tissues	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; EXPRESSION	The ATP-binding cassette (ABC) transporter ABCB1, encoded by the multidrug resistance gene MDR1, is expressed on brain microvascular endothelium and several types of epithelium, but not on endothelia outside the CNS. It is an essential component of the blood-brain barrier. The aim of this study was to identify cell-specific controls on the transcription of MDR1 in human brain endothelium. Reporter assays identified a region of 500 bp around the transcription start site that was optimally active in brain endothelium. Chromatin immunoprecipitation identified Sp3 and TFIID associated with this region and EMSA (electrophoretic mobility shift assays) confirmed that Sp3 binds preferentially to an Sp-target site (GC-box) on the MDR1 promoter in brain endothelium. This result contrasts with findings in other cell types and with the colon carcinoma line Caco-2, in which Sp1 preferentially associates with the MDR1 promoter. Differences in MDR1 transcriptional control between brain endothelium and Caco-2 could not be explained by the relative abundance of Sp1: Sp3 nor by the ratio of Sp3 variants, because activating variants of Sp3 were present in both cell types. However differential binding of other transcription factors was also detected in two additional upstream regions of the MDR1 promoter. Identification of cell-specific controls on the transcription of MDR1 indicates that it may be possible to modulate multi-drug resistance on tumours, while leaving the blood brain barrier intact.	[Gromnicova, Radka; Romero, Ignacio; Male, David] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Male, D (corresponding author), Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes MK7 6AA, Bucks, England.	D.K.Male@Open.ac.uk		Romero, Ignacio/0000-0002-0322-9180; Male, David/0000-0002-1242-3137; Gromnicova, Radka/0000-0001-6071-138X	Open University	Open University	The work was funded by the Open University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer B, 2004, MOL PHARMACOL, V66, P413; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chen GK, 2004, MOL PHARMACOL, V65, P906, DOI 10.1124/mol.65.4.906; Dauchy S, 2009, BIOCHEM PHARMACOL, V77, P897, DOI 10.1016/j.bcp.2008.11.001; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; Holloway K, 2007, J MOL BIOL, V365, P1271, DOI 10.1016/j.jmb.2006.10.071; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Kolell KJ, 2002, MOL BIOL EVOL, V19, P216, DOI 10.1093/oxfordjournals.molbev.a004074; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Male DK, 2009, J CEREBR BLOOD F MET, V29, P1760, DOI 10.1038/jcbfm.2009.101; Male DK, 1995, NEURAL CELL CULTURE; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Moran KM, 2004, GENE, V341, P235, DOI 10.1016/j.gene.2004.06.055; Rezaie P, 2005, CEREB CORTEX, V15, P938, DOI 10.1093/cercor/bhh194; Sade H, 2009, BBA-GENE REGUL MECH, V1789, P175, DOI 10.1016/j.bbagrm.2009.01.006; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Sundseth R, 1997, MOL PHARMACOL, V51, P963, DOI 10.1124/mol.51.6.963; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wilmer MJ, 2010, CELL TISSUE RES, V339, P449, DOI 10.1007/s00441-009-0882-y; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yu B, 2003, NUCLEIC ACIDS RES, V31, P5368, DOI 10.1093/nar/gkg706	25	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48189	10.1371/journal.pone.0048189	http://dx.doi.org/10.1371/journal.pone.0048189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133566	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800056
J	Micheletti, S; Parra, E; Routman, EJ				Micheletti, Steven; Parra, Eliseo; Routman, Eric J.			Adaptive Color Polymorphism and Unusually High Local Genetic Diversity in the Side-Blotched Lizard, Uta stansburiana	PLOS ONE			English	Article							CIMA VOLCANIC FIELD; SEQUENCE VARIATION; MOJAVE-DESERT; MC1R; EVOLUTION; FLOW; PHYLOGEOGRAPHY; PIGMENTATION; PERSPECTIVE; SELECTION	Recently, studies of adaptive color variation have become popular as models for examining the genetics of natural selection. We examined color pattern polymorphism and genetic variation in a population of side-blotched lizards (Uta stansburiana) that is found in habitats with both dark (lava) and light colored (granite) substrates. We conducted a limited experiment for adult phenotypic plasticity in laboratory conditions. We recorded both substrate and lizard color patterns in the field to determine whether lizards tended to match their substrate. Finally we examined genetic variation in a gene (melanocortin 1 receptor) that has been shown to affect lizard color in other species and in a presumably neutral gene (mitochondrial cytochrome b). Populations were sampled in the immediate area of the lava flows as well as from a more distant site to examine the role of population structure. Our captive Uta did not change color to match their background. We show that side-blotched lizards tend to match the substrate on which it was caught in the field and that variation in the melanocortin 1 receptor gene does not correlate well with color pattern in this population. Perhaps the most remarkable result is that this population of side-blotched lizards shows extremely high levels of variation at both genetic markers, in the sense of allele numbers, with relatively low levels of between-allele sequence variation. Genetic variation across this small region was as great or greater than that seen in samples of pelagic fish species collected worldwide. Statistical analysis of genetic variation suggests rapid population expansion may be responsible for the high levels of variation.	[Micheletti, Steven; Parra, Eliseo; Routman, Eric J.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	California State University System; San Francisco State University	Routman, EJ (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	routman@sfsu.edu			Sigma Xi; SFSU IRA; SFSU Center for Computing in Life Sciences	Sigma Xi; SFSU IRA; SFSU Center for Computing in Life Sciences	work was supported by Sigma Xi Grant in Aid of Research, SFSU IRA, SFSU Center for Computing in Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; BENSON SETH B., 1933, UNIV CALIFORNIA PUBL ZOOL, V40, P1; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Camargo A, 2010, MOL ECOL, V19, P3250, DOI 10.1111/j.1365-294X.2010.04722.x; Cheviron ZA, 2006, P ROY SOC B-BIOL SCI, V273, P1613, DOI 10.1098/rspb.2006.3499; Clark AM, 1999, MOL ECOL, V8, P1093, DOI 10.1046/j.1365-294x.1999.00653.x; Corso J, 2012, GENET MOL BIOL, V35, P81, DOI 10.1590/S1415-47572012005000015; Cott H.B., 1940, ADAPTIVE COLORATION; DOHRENWEND JC, 1986, GEOL SOC AM BULL, V97, P421, DOI 10.1130/0016-7606(1986)97<421:DOQCCI>2.0.CO;2; Dunbar N., 1999, NEW MEXICO GEOLOGY, V21, P25; EXCOFFIER L, 1992, GENETICS, V131, P479; Forsman A, 1995, ANN ZOOL FENN, V32, P365; HARPENDING HC, 1994, HUM BIOL, V66, P591; Herczeg G, 2010, ANN ZOOL FENN, V47, P37, DOI 10.5735/086.047.0104; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kettlewell B, 1973, EVOLUTION MELANISM S; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Luke C.A., 1989, THESIS U CALIFORNIA; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Maddison W. P., 2005, MACCLADE VER 4 08; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mulcahy DG, 2006, MOL ECOL, V15, P1807, DOI 10.1111/j.1365-294X.2006.02892.x; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nei M., 1987, MOL EVOLUTIONARY GEN; NORRIS KS, 1964, ECOLOGY, V45, P565; Norris KS, 1965, LIZARD ECOLOGY S, P162; Ore TH, 1971, CALIF GEOL SOC AM B, V82, P2553; PEARSON OP, 1977, COMP BIOCHEM PHYS A, V58, P353; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Rosenblum EB, 2005, COPEIA, P586, DOI 10.1643/CP-04-154R1; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Rosenblum EB, 2007, EVOLUTION, V61, P2971, DOI 10.1111/j.1558-5646.2007.00251.x; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; SHERBROOKE WC, 1994, PHYSIOL ZOOL, V67, P659, DOI 10.1086/physzool.67.3.30163763; Steiner CC, 2009, MOL BIOL EVOL, V26, P35, DOI 10.1093/molbev/msn218; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storfer A, 1999, EVOLUTION, V53, P889, DOI 10.1111/j.1558-5646.1999.tb05383.x; Stuart-Fox D, 2008, PLOS BIOL, V6, P22, DOI 10.1371/journal.pbio.0060025; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1983, GENETICS, V105, P437; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1306, P122, DOI 10.1016/0167-4781(96)00026-7; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Uy JAC, 2009, AM NAT, V174, P244, DOI 10.1086/600084; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WELLS SG, 1985, GEOL SOC AM BULL, V96, P1518, DOI 10.1130/0016-7606(1985)96<1518:LCLEOL>2.0.CO;2; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0	52	13	13	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47694	10.1371/journal.pone.0047694	http://dx.doi.org/10.1371/journal.pone.0047694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133520	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800013
J	Power, GA; Rice, CL; Vandervoort, AA				Power, Geoffrey A.; Rice, Charles L.; Vandervoort, Anthony A.			Increased Residual Force Enhancement in Older Adults Is Associated with a Maintenance of Eccentric Strength	PLOS ONE			English	Article							SKELETAL-MUSCLE FIBERS; HALF-SARCOMERES; VOLUNTARY CONTRACTIONS; STRETCH; YOUNG; MEN; AGE; LENGTH; ANKLE; KNEE	Despite an age-related loss of voluntary isometric and concentric strength, muscle strength is well maintained during lengthening muscle actions (i.e., eccentric strength) in old age. Additionally, in younger adults during lengthening of an activated skeletal muscle, the force level observed following the stretch is greater than the isometric force at the same muscle length. This feature is termed residual force enhancement (RFE) and is believed to be a combination of active and passive components of the contractile apparatus. The purpose of this study was to provide an initial assessment of RFE in older adults and utilize aging as a muscle model to explore RFE in a system in which isometric force production is compromised, but structural mechanisms of eccentric strength are well-maintained. Therefore, we hypothesised that older adults will experience greater RFE compared with young adults. Following a reference maximal voluntary isometric contraction (MVC) of the dorsiflexors in 10 young (26.1 +/- 2.7y) and 10 old (76.0 +/- 6.5y) men, an active stretch was performed at 15 degrees/s over a 30 degrees ankle joint excursion ending at the same muscle length as the reference MVCs (40 degrees of plantar flexion). Any additional torque compared with the reference MVC therefore represented RFE. In older men RFE was similar to 2.5 times greater compared to young. The passive component of force enhancement contributed similar to 37% and similar to 20% to total force enhancement, in old and young respectively. The positive association (R-2 = 0.57) between maintained eccentric strength in old age and RFE indicates age-related mechanisms responsible for the maintenance of eccentric strength likely contributed to the observed elevated RFE. Additionally, as indicated by the greater passive force enhancement, these mechanisms may be related to increased muscle series elastic stiffness in old age.	[Power, Geoffrey A.; Rice, Charles L.; Vandervoort, Anthony A.] Univ Western Ontario, Sch Kinesiol, Fac Hlth Sci, Canadian Ctr Activ & Aging, London, ON, Canada; [Rice, Charles L.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Vandervoort, Anthony A.] Univ Western Ontario, Fac Hlth Sci, Sch Phys Therapy, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Power, GA (corresponding author), Univ Western Ontario, Sch Kinesiol, Fac Hlth Sci, Canadian Ctr Activ & Aging, London, ON, Canada.	gpower@uwo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Queen Elizabeth II Graduate Scholarship in Science and Technology	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology	This research is supported by funding from The Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp). G.A. Power is supported by The Queen Elizabeth II Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P77; Botter A, 2011, EUR J APPL PHYSIOL, V111, P2461, DOI 10.1007/s00421-011-2093-y; Campbell Stuart G, 2011, Biophys Rev, V3, P199, DOI 10.1007/s12551-011-0059-2; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; Edman KAP, 2012, J PHYSIOL-LONDON, V590, P1339, DOI 10.1113/jphysiol.2011.222729; EDMAN KAP, 1982, J GEN PHYSIOL, V80, P769, DOI 10.1085/jgp.80.5.769; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Hasson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015953; Herzog W, 2005, J BIOMECH, V38, P409, DOI 10.1016/j.jbiomech.2004.05.001; Herzog W, 2002, J EXP BIOL, V205, P1275; Herzog W, 2012, EXERC SPORT SCI REV, V40, P50, DOI 10.1097/JES.0b013e31823cd75b; HORTOBAGYI T, 1995, J GERONTOL A-BIOL, V50, pB399, DOI 10.1093/gerona/50A.6.B399; Jakobi JM, 2002, J APPL PHYSIOL, V93, P457, DOI 10.1152/japplphysiol.00012.2002; Joumaa V, 2008, P ROY SOC B-BIOL SCI, V275, P1411, DOI 10.1098/rspb.2008.0142; JULIAN FJ, 1979, J PHYSIOL-LONDON, V293, P379, DOI 10.1113/jphysiol.1979.sp012895; Klass M, 2005, J APPL PHYSIOL, V99, P31, DOI 10.1152/japplphysiol.01426.2004; Lee HD, 2002, J PHYSIOL-LONDON, V545, P321, DOI 10.1113/jphysiol.2002.018010; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC1398, DOI 10.1152/ajpcell.00222.2010; Maganaris CN, 2001, ACTA PHYSIOL SCAND, V172, P279, DOI 10.1046/j.1365-201x.2001.00799.x; Mehta A, 2008, J BIOMECH, V41, P1611, DOI 10.1016/j.jbiomech.2008.02.010; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Narici MV, 2008, DISABIL REHABIL, V30, P1548, DOI 10.1080/09638280701831058; Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003; Ochala J, 2007, J GERONTOL A-BIOL, V62, P375, DOI 10.1093/gerona/62.4.375; Ochala J, 2006, PFLUG ARCH EUR J PHY, V452, P464, DOI 10.1007/s00424-006-0065-6; Payne AM, 2004, EXERC SPORT SCI REV, V32, P36, DOI 10.1097/00003677-200401000-00008; Pinniger GJ, 2007, J APPL PHYSIOL, V102, P18, DOI 10.1152/japplphysiol.00565.2006; Porter MM, 1997, J GERONTOL A-BIOL, V52, pB125, DOI 10.1093/gerona/52A.2.B125; POULIN MJ, 1992, CAN J SPORT SCI, V17, P3; Power GA, 2012, J BIOMECH, V45, P1835, DOI 10.1016/j.jbiomech.2012.04.006; Power GA, 2012, AGE, V34, P737, DOI 10.1007/s11357-011-9263-z; Rassier DE, 2005, J APPL PHYSIOL, V99, P1769, DOI 10.1152/japplphysiol.00010.2005; Rassier DE, 2004, J APPL PHYSIOL, V96, P419, DOI 10.1152/japplphysiol.00653.2003; Rassier DE, 2003, J BIOMECH, V36, P1309, DOI 10.1016/S0021-9290(03)00155-6; Rassier DE, 2012, P ROY SOC B-BIOL SCI, V279, P2705, DOI 10.1098/rspb.2012.0467; Rassier DE, 2012, AM J PHYSIOL-CELL PH, V302, pC240, DOI 10.1152/ajpcell.00208.2011; Roig M, 2010, EXP GERONTOL, V45, P400, DOI 10.1016/j.exger.2010.03.008; Roos MR, 1997, MUSCLE NERVE, V20, P679; Roos MR, 1999, MUSCLE NERVE, V22, P1094; Russ DW, 2012, J CACHEXIA SARCOPENI, V3, P95, DOI 10.1007/s13539-011-0054-2; Shim J, 2012, J BIOMECH, V45, P913, DOI 10.1016/j.jbiomech.2012.01.026; Telley IA, 2006, J PHYSIOL-LONDON, V573, P173, DOI 10.1113/jphysiol.2006.105809; Tilp M, 2009, EUR J APPL PHYSIOL, V106, P159, DOI 10.1007/s00421-009-1006-9; VANDERVOORT AA, 1992, J GERONTOL, V47, pM17, DOI 10.1093/geronj/47.1.M17; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; VANDERVOORT AA, 1990, J GERONTOL, V45, pB125, DOI 10.1093/geronj/45.4.B125; Winegard KJ, 1996, J GERONTOL A-BIOL, V51, pB202, DOI 10.1093/gerona/51A.3.B202	48	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e48044	10.1371/journal.pone.0048044	http://dx.doi.org/10.1371/journal.pone.0048044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23133544	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600045
J	Banerjee, A; Ghosh, A; Mills, DJ; Kahnt, J; Vonck, J; Albers, SV				Banerjee, Ankan; Ghosh, Abhrajyoti; Mills, Deryck J.; Kahnt, Joerg; Vonck, Janet; Albers, Sonja-Verena			FlaX, A Unique Component of the Crenarchaeal Archaellum, Forms Oligomeric Ring-shaped Structures and Interacts with the Motor ATPase FlaI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; FLAGELLAR FILAMENT; ROTARY MOTOR; C-RING; PROTEIN; SYMMETRY; MECHANISM; APPARATUS; EXPORT; ROTOR	Archaella are the archaeal motility structure, which are structurally similar to Gram-negative bacterial type IV pili but functionally resemble bacterial flagella. Structural and biochemical data of archaellum subunits are missing. FlaX, a conserved subunit in crenarchaeal archaella, formed high molecular weight complexes that adapted a ring-like structure with an approximate diameter of 30 nm. The C terminus of FlaX was not only involved in the oligomerization, but also essential for FlaX interaction with FlaI, the bifunctional ATPase that is involved in assembly and rotation of the archaellum. This study gives first insights in the assembly apparatus of archaella.	[Banerjee, Ankan; Ghosh, Abhrajyoti; Albers, Sonja-Verena] Max Planck Inst Terr Microbiol, Dept Mol Biol Archaea, D-35043 Marburg, Germany; [Kahnt, Joerg] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Mills, Deryck J.; Vonck, Janet] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Albers, SV (corresponding author), Max Planck Inst Terr Microbiol, Dept Mol Biol Archaea, Karl von Frisch Str 10, D-35043 Marburg, Germany.	albers@mpi-marburg.mpg.de	Albers, Sonja-Verena/H-8689-2019; Banerjee, Ankan/AAE-7382-2019; Ghosh, Abhrajyoti/H-8550-2012; Ghosh, Abhrajyoti/AAZ-8517-2020	Albers, Sonja-Verena/0000-0003-2459-2226; Banerjee, Ankan/0000-0002-1791-252X; Ghosh, Abhrajyoti/0000-0002-2469-3740; Mills, Deryck/0000-0003-0904-1119; Vonck, Janet/0000-0001-5659-8863				Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003; Bardy S, 2004, J MOL MICROB BIOTECH, V7, P41, DOI 10.1159/000077868; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; Cohen-Krausz S, 2008, J MOL BIOL, V375, P1113, DOI 10.1016/j.jmb.2007.10.048; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Ghosh A, 2011, BIOCHEM J, V437, P43, DOI 10.1042/BJ20110410; Ghosh A, 2011, BIOCHEM SOC T, V39, P64, DOI 10.1042/BST0390064; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; Henche AL, 2012, ENVIRON MICROBIOL, V14, P3188, DOI 10.1111/j.1462-2920.2012.02898.x; Henche AL, 2012, ENVIRON MICROBIOL, V14, P779, DOI 10.1111/j.1462-2920.2011.02638.x; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Lassak K, 2012, MOL MICROBIOL, V83, P110, DOI 10.1111/j.1365-2958.2011.07916.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Minamino T, 2012, MOL MICROBIOL, V83, P775, DOI 10.1111/j.1365-2958.2011.07964.x; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Pecorari F, 1996, J BIOL CHEM, V271, P5270; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Schlesner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-56; SOSINSKY GE, 1992, J MOL BIOL, V223, P171, DOI 10.1016/0022-2836(92)90724-X; Streif S, 2008, J MOL BIOL, V384, P1, DOI 10.1016/j.jmb.2008.08.057; Suzuki H, 2004, J MOL BIOL, V337, P105, DOI 10.1016/j.jmb.2004.01.034; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terradot L, 2004, MOL CELL PROTEOMICS, V3, P809, DOI 10.1074/mcp.M400048-MCP200; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Trachtenberg S, 2006, J MOL MICROB BIOTECH, V11, P208, DOI 10.1159/000094055; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Young HS, 2003, BIOPHYS J, V84, P571, DOI [10.1016/s0006-3495(03)74877-2, 10.1016/S0006-3495(03)74877-2]	36	26	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43322	43330		10.1074/jbc.M112.414383	http://dx.doi.org/10.1074/jbc.M112.414383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129770	hybrid, Green Published			2022-12-25	WOS:000312940800013
J	De Dreu, CKW; Shalvi, S; Greer, LL; Van Kleef, GA; Handgraaf, MJJ				De Dreu, Carsten K. W.; Shalvi, Shaul; Greer, Lindred L.; Van Kleef, Gerben A.; Handgraaf, Michel J. J.			Oxytocin Motivates Non-Cooperation in Intergroup Conflict to Protect Vulnerable In-Group Members	PLOS ONE			English	Article							INTRANASAL OXYTOCIN; PAROCHIAL ALTRUISM; NEURAL CIRCUITRY; VASOPRESSIN; INCREASES; TRUST; COMPETITION; AGGRESSION; BEHAVIORS; EVOLUTION	Intergroup conflict is often driven by an individual's motivation to protect oneself and fellow group members against the threat of out-group aggression, including the tendency to pre-empt out-group threat through a competitive approach. Here we link such defense-motivated competition to oxytocin, a hypothalamic neuropeptide involved in reproduction and social bonding. An intergroup conflict game was developed to disentangle whether oxytocin motivates competitive approach to protect (i) immediate self-interest, (ii) vulnerable in-group members, or (iii) both. Males self-administered oxytocin or placebo (double-blind placebo-controlled) and made decisions with financial consequences to themselves, their fellow in-group members, and a competing out-group. Game payoffs were manipulated between-subjects so that noncooperation by the out-group had high vs. low impact on personal payoff (personal vulnerability), and high vs. low impact on payoff to fellow in-group members (in-group vulnerability). When personal vulnerability was high, non-cooperation was unaffected by treatment and in-group vulnerability. When personal vulnerability was low, however, in-group vulnerability motivated non-cooperation but only when males received oxytocin. Oxytocin fuels a defense-motivated competitive approach to protect vulnerable group members, even when personal fate is not at stake.	[De Dreu, Carsten K. W.; Shalvi, Shaul; Greer, Lindred L.; Van Kleef, Gerben A.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Handgraaf, Michel J. J.] Wageningen Univ, Dept Econ, Wageningen, Netherlands	University of Amsterdam; Wageningen University & Research	De Dreu, CKW (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	c.k.w.dedreu@uva.nl	De Dreu, Carsten K.W./X-7762-2019; Greer, Lindred/J-7832-2019; Shalvi, Shaul/D-6728-2011	De Dreu, Carsten K.W./0000-0003-3692-4611; Greer, Lindred/0000-0002-8302-538X; Van Kleef, Gerben/0000-0003-0823-7654; Shalvi, Shaul/0000-0003-2225-7352				Ahn TK, 2001, PUBLIC CHOICE, V106, P137, DOI 10.1023/A:1005219123532; Axelrod R, 1984, SCIENCE, V211, P390; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bornstein G, 2003, J CONFLICT RESOLUT, V47, P326, DOI 10.1177/0022002703252367; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Cohen TR, 2008, PERSPECT PSYCHOL SCI, V3, P87, DOI 10.1111/j.1745-6916.2008.00066.x; Darwin C., 1873, DESCENT MAN; De Dreu CKW, 2012, HORM BEHAV, V61, P419, DOI 10.1016/j.yhbeh.2011.12.009; De Dreu CKW, 2012, P ROY SOC B-BIOL SCI, V279, P1150, DOI 10.1098/rspb.2011.1444; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; DEDREU CKW, 1995, J CONFLICT RESOLUT, V39, P646, DOI 10.1177/0022002795039004003; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dovidio J.F., 2010, HDB SOCIAL PSYCHOL, P1084, DOI [10.1002/9780470561119.socpsy002029, DOI 10.1002/9780470561119.SOCPSY002029]; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; Ellemers N, 2012, SCIENCE, V336, P848, DOI 10.1126/science.1220987; Fiske ST, 2002, CURR DIR PSYCHOL SCI, V11, P123, DOI 10.1111/1467-8721.00183; Gallagher L., 2005, TRENDS COGN SCI, V13, P27; Ginges J, 2011, P ROY SOC B-BIOL SCI, V278, P2930, DOI 10.1098/rspb.2010.2384; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Graw B, 2007, ANIM BEHAV, V74, P507, DOI 10.1016/j.anbehav.2006.11.021; Griesser M, 2006, P R SOC B, V273, P1881, DOI 10.1098/rspb.2006.3527; Hahn-Holbrook J, 2011, PSYCHOL SCI, V22, P1288, DOI 10.1177/0956797611420729; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Henrich N., 2007, WHY HUMANS COOPERATE; Israel S, 2012, PSYCHONEUROENDOCRINO, V37, P1341, DOI 10.1016/j.psyneuen.2012.02.001; Jervis Robert., 2017, PERCEPTION MISPERCEP; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; KOMORITA SS, 1995, ANNU REV PSYCHOL, V46, P183, DOI 10.1146/annurev.ps.46.020195.001151; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Madden JR, 2011, P ROY SOC B-BIOL SCI, V278, P1189, DOI 10.1098/rspb.2010.1675; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, PSYCHOL SCI, V21, P1072, DOI 10.1177/0956797610377343; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; Rilling JK, 2012, PSYCHONEUROENDOCRINO, V37, P447, DOI 10.1016/j.psyneuen.2011.07.013; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; van Honk J, 2011, TRENDS COGN SCI, V15, P291, DOI 10.1016/j.tics.2011.05.003; van Ijzendoorn MH, 2012, PSYCHONEUROENDOCRINO, V37, P438, DOI 10.1016/j.psyneuen.2011.07.008; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Wildschut T, 2003, PSYCHOL BULL, V129, P698, DOI 10.1037/0033-2909.129.5.698; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	55	55	56	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e46751	10.1371/journal.pone.0046751	http://dx.doi.org/10.1371/journal.pone.0046751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23144787	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800008
J	Medvetz, DA; Khabibullin, D; Hariharan, V; Ongusaha, PP; Goncharova, EA; Schlechter, T; Darling, TN; Hofmann, I; Krymskaya, VP; Liao, JK; Huang, H; Henske, EP				Medvetz, Doug A.; Khabibullin, Damir; Hariharan, Venkatesh; Ongusaha, Pat P.; Goncharova, Elena A.; Schlechter, Tanja; Darling, Thomas N.; Hofmann, Ilse; Krymskaya, Vera P.; Liao, James K.; Huang, Hayden; Henske, Elizabeth P.			Folliculin, the Product of the Birt-Hogg-Dube Tumor Suppressor Gene, Interacts with the Adherens Junction Protein p0071 to Regulate Cell-Cell Adhesion	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUBEROUS SCLEROSIS COMPLEX; SPONTANEOUS PNEUMOTHORAX; MTOR ACTIVATION; MUTATIONS; RHO; BHD; DESMOPLAKIN; FAMILY; FLCN	Birt-Hogg-Dube (BHD) is a tumor suppressor gene syndrome associated with fibrofolliculomas, cystic lung disease, and chromophobe renal cell carcinoma. In seeking to elucidate the pathogenesis of BHD, we discovered a physical interaction between folliculin (FLCN), the protein product of the BHD gene, and p0071, an armadillo repeat containing protein that localizes to the cytoplasm and to adherens junctions. Adherens junctions are one of the three cell-cell junctions that are essential to the establishment and maintenance of the cellular architecture of all epithelial tissues. Surprisingly, we found that downregulation of FLCN leads to increased cell-cell adhesion in functional cell-based assays and disruption of cell polarity in a three-dimensional lumen-forming assay, both of which are phenocopied by downregulation of p0071. These data indicate that the FLCN-p0071 protein complex is a negative regulator of cell-cell adhesion. We also found that FLCN positively regulates RhoA activity and Rho-associated kinase activity, consistent with the only known function of p0071. Finally, to examine the role of Flcn loss on cell-cell adhesion in vivo, we utilized keratin-14 cre-recombinase (K14-cre) to inactivate Flcn in the mouse epidermis. The K14-Cre-Bhd(flox/flox) mice have striking delays in eyelid opening, wavy fur, hair loss, and epidermal hyperplasia with increased levels of mammalian target of rapamycin complex 1 (mTORC1) activity. These data support a model in which dysregulation of the FLCN-p0071 interaction leads to alterations in cell adhesion, cell polarity, and RhoA signaling, with broad implications for the role of cell-cell adhesion molecules in the pathogenesis of human disease, including emphysema and renal cell carcinoma.	[Medvetz, Doug A.; Khabibullin, Damir; Henske, Elizabeth P.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Medvetz, Doug A.; Khabibullin, Damir; Ongusaha, Pat P.; Liao, James K.; Henske, Elizabeth P.] Harvard Univ, Sch Med, Boston, MA USA; [Hariharan, Venkatesh; Huang, Hayden] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Ongusaha, Pat P.; Liao, James K.] Brigham & Womens Hosp, Vasc Med Res Unit, Boston, MA 02115 USA; [Goncharova, Elena A.; Krymskaya, Vera P.] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Schlechter, Tanja; Hofmann, Ilse] Med Fac Mannheim, Joint Res Div Vasc Biol, Mannheim, Germany; [Schlechter, Tanja; Hofmann, Ilse] DKFZ ZMBH Alliance, German Canc Res Ctr, Mannheim, Germany; [Darling, Thomas N.] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Columbia University; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Uniformed Services University of the Health Sciences - USA	Henske, EP (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	ehenske@partners.org		Darling, Thomas/0000-0002-5161-1974	Myrovlytis Trust (London, UK); National Institutes of Health [DK085006]; American Heart Association [AHA-10SDG4010039]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052233, R01HL110551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070001] Funding Source: NIH RePORTER	Myrovlytis Trust (London, UK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Grants from the Myrovlytis Trust (London, UK), the National Institutes of Health (DK085006), and the American Heart Association (AHA-10SDG4010039) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Boris RS, 2011, J UROLOGY, V185, P2050, DOI 10.1016/j.juro.2011.02.051; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Calkins CC, 2003, J BIOL CHEM, V278, P1774, DOI 10.1074/jbc.M205693200; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Corso G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-8; Corso G, 2011, EUR J CANCER, V47, P631, DOI 10.1016/j.ejca.2010.10.011; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Dusek RL, 2011, NAT REV CANCER, V11, P317, DOI 10.1038/nrc3051; Felder E, 2008, AM J PHYSIOL-LUNG C, V295, pL849, DOI 10.1152/ajplung.00503.2007; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Frohlich BA, 2008, EUR RESPIR J, V32, P1316, DOI 10.1183/09031936.00132707; Gad S, 2007, BRIT J CANCER, V96, P336, DOI 10.1038/sj.bjc.6603492; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; GRIECO F, 1992, BIOTECHNIQUES, V13, P856; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hata T, 2011, ATHEROSCLEROSIS, V214, P117, DOI 10.1016/j.atherosclerosis.2010.10.005; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Hoshino D, 2011, J BIOL CHEM, V286, P3139, DOI 10.1074/jbc.M110.159715; Houweling AC, 2011, BRIT J CANCER, V105, P1912, DOI 10.1038/bjc.2011.463; Huang H, 2008, CELL MOTIL CYTOSKEL, V65, P964, DOI 10.1002/cm.20319; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Hudon V, 2009, J MED GENET; Kim G, 2005, HISTOL HISTOPATHOL, V20, P35, DOI 10.14670/HH-20.35; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Leve F, 2012, J CELL BIOCH; Liao YC, 2011, ONCOGENE; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Magie Craig R., 2002, Development (Cambridge), V129, P3771; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Naydenov NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034320; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nohria A, 2006, CIRC RES, V99, P1426, DOI 10.1161/01.RES.0000251668.39526.c7; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Ohta H, 2012, AM J PHYSIOL-LUNG C, V302, pL193, DOI 10.1152/ajplung.00349.2010; Painter JN, 2005, AM J HUM GENET, V76, P522, DOI 10.1086/428455; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Petersson F, 2010, VIRCHOWS ARCH, V456, P355, DOI 10.1007/s00428-010-0898-4; Piao X, 2009, BIOCHEM BIOPH RES CO; Preston RS, 2011, ONCOGENE, V30, P1159, DOI 10.1038/onc.2010.497; Ren HZ, 2008, CLIN GENET, V74, P178, DOI 10.1111/j.1399-0004.2008.01030.x; SACCO PA, 1995, J BIOL CHEM, V270, P20201, DOI 10.1074/jbc.270.34.20201; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Simoes-Correia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033783; Smith At, 2012, ONCOGENE; STEVENSON BR, 1989, AM J PHYSIOL, V257, pC621, DOI 10.1152/ajpcell.1989.257.4.C621; Sundaram S, 2009, EUR RESPIR J, V33, P1510, DOI 10.1183/09031936.00062608; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; TROYANOVSKY SM, 1993, CELL, V72, P561, DOI 10.1016/0092-8674(93)90075-2; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Walter B, 2010, HISTOCHEM CELL BIOL, V133, P69, DOI 10.1007/s00418-009-0645-6; Walter B, 2009, HISTOPATHOLOGY, V55, P761, DOI 10.1111/j.1365-2559.2009.03444.x; Wang L, 2010, FEBS LETT, V584, P39, DOI 10.1016/j.febslet.2009.11.033; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504; Xue GD, 2012, CANCER DISCOV, V2, P248, DOI 10.1158/2159-8290.CD-11-0270; Yang Y, 2008, CANCER GENET CYTOGEN, V180, P100, DOI 10.1016/j.cancergencyto.2007.10.010; Yu Jane, 2010, Proc Am Thorac Soc, V7, P48, DOI 10.1513/pats.200909-104JS; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhi WX, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-133	82	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47842	10.1371/journal.pone.0047842	http://dx.doi.org/10.1371/journal.pone.0047842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139756	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300014
J	Jackson, HA; Hegle, A; Nazzari, H; Jegla, T; Accili, EA				Jackson, Heather A.; Hegle, Andrew; Nazzari, Hamed; Jegla, Timothy; Accili, Eric A.			Asymmetric Divergence in Structure and Function of HCN Channel Duplicates in Ciona intestinalis	PLOS ONE			English	Article							ACTIVATED PACEMAKER CHANNELS; NUCLEOTIDE-GATED CHANNEL; PACE-MAKER CURRENT; I-H-CHANNEL; CATION CHANNEL; K+ CHANNELS; VOLTAGE; GENOME; EVOLUTION; MODEL	Hyperpolarization-activated Cyclic Nucleotide (HCN) channels are voltage-gated cation channels and are critical for regulation of membrane potential in electrically active cells. To understand the evolution of these channels at the molecular level, we cloned and examined two of three HCN homologs of the urochordate Ciona intestinalis (ciHCNa and ciHCNb). ciHCNa is like mammalian HCNs in that it possesses similar electrical function and undergoes N-glycosylation of a sequon near the pore. ciHCNb lacks the pore-associated N-glycosylation sequon and is predictably not N-glycosylated, and it also has an unusual gating phenotype in which the channel's voltage-sensitive gate appears to close incompletely. Together with previous findings, the data support an evolutionary trajectory in which an HCN ancestor underwent lineage-specific duplication in Ciona, to yield one HCN with most features that are conserved with the mammalian HCNs and another HCN that has been uniquely altered.	[Jackson, Heather A.; Hegle, Andrew; Nazzari, Hamed; Accili, Eric A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Jegla, Timothy] Penn State Univ, Eberly Coll Sci, Dept Biol, University Pk, PA 16802 USA	University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Accili, EA (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	eaaccili@interchange.ubc.ca		Jegla, Timothy/0000-0001-8616-2390	National Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada; Michael Smith Health Research Foundation; Tier II Canada Research Chair. Research	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Health Research Foundation(Michael Smith Foundation for Health Research); Tier II Canada Research Chair. Research	HJ is a recipient of a doctoral scholarship from the National Sciences and Engineering Research Council of Canada. AH is the recipient of a postdoctoral fellowship from the Heart and Stroke Foundation of Canada. HN is the recipient of doctoral scholarships from the National Sciences and Engineering Research Council of Canada and Michael Smith Health Research Foundation. EA is the recipient of a Tier II Canada Research Chair. Research in this paper was supported by a Discovery Grant from the National Sciences and Engineering Research Council of Canada (EAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Cheng L, 2007, J PHARMACOL EXP THER, V322, P931, DOI 10.1124/jpet.107.121467; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P359, DOI 10.1113/jphysiol.1981.sp013713; DIFRANCESCO D, 1982, J PHYSIOL-LONDON, V329, P485, DOI 10.1113/jphysiol.1982.sp014315; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Galindo BE, 2005, BIOCHEM BIOPH RES CO, V334, P96, DOI 10.1016/j.bbrc.2005.06.074; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Gaymard F, 1996, J BIOL CHEM, V271, P22863, DOI 10.1074/jbc.271.37.22863; Gee H, 2006, NATURE, V439, P923, DOI 10.1038/439923a; Gisselmann G, 2005, EUR J NEUROSCI, V21, P1635, DOI 10.1111/j.1460-9568.2005.03992.x; Gisselmann G, 2003, INSECT BIOCHEM MOLEC, V33, P1123, DOI 10.1016/S0965-1748(03)00132-2; Hegle AP, 2010, AM J PHYSIOL-CELL PH, V298, pC1066, DOI 10.1152/ajpcell.00389.2009; Hellbach A, 2011, J EXP ZOOL PART A, V315A, P476, DOI 10.1002/jez.695; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jackson HA, 2007, PHYSIOL GENOMICS, V29, P231, DOI 10.1152/physiolgenomics.00142.2006; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2002, J BIOL CHEM, V277, P35939, DOI 10.1074/jbc.M203485200; Marx Thomas, 1999, Invertebrate Neuroscience, V4, P55, DOI 10.1007/s101580050007; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; Ouyang Q, 2007, J NEUROPHYSIOL, V97, P3880, DOI 10.1152/jn.00246.2007; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qu Y, 2008, J PHYSIOL-LONDON, V586, P701, DOI 10.1113/jphysiol.2007.144329; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Satoh N, 2003, TRENDS GENET, V19, P376, DOI 10.1016/S0168-9525(03)00144-6; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Suzuki MM, 2005, J MOL EVOL, V61, P627, DOI 10.1007/s00239-005-0009-3; Swalla BJ, 2000, SYST BIOL, V49, P52, DOI 10.1080/10635150050207384; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang XF, 2009, BIOPHYS J, V97, P110, DOI 10.1016/j.bpj.2009.04.032	60	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47590	10.1371/journal.pone.0047590	http://dx.doi.org/10.1371/journal.pone.0047590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133599	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400011
J	Smith, BK; Martin, AD; Vandenborne, K; Darragh, BD; Davenport, PW				Smith, Barbara K.; Martin, A. Daniel; Vandenborne, Krista; Darragh, Brittany D.; Davenport, Paul W.			Chronic Intrinsic Transient Tracheal Occlusion Elicits Diaphragmatic Muscle Fiber Remodeling in Conscious Rodents	PLOS ONE			English	Article							PROLONGED MECHANICAL VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; MAXIMAL INSPIRATORY PRESSURE; MOTOR UNIT RECRUITMENT; HEAVY-CHAIN ISOFORMS; RAT DIAPHRAGM; RESPIRATORY MUSCLES; RESISTANCE EXERCISE; CANINE DIAPHRAGM; CONTRACTILE PROPERTIES	Background: Although the prevalence of inspiratory muscle strength training has increased in clinical medicine, its effect on diaphragm fiber remodeling is not well-understood and no relevant animal respiratory muscle strength training-rehabilitation experimental models exist. We tested the postulate that intrinsic transient tracheal occlusion (ITTO) conditioning in conscious animals would provide a novel experimental model of respiratory muscle strength training, and used significant increases in diaphragmatic fiber cross-sectional area (CSA) as the primary outcome measure. We hypothesized that ITTO would increase costal diaphragm fiber CSA and further hypothesized a greater duration and magnitude of occlusions would amplify remodeling. Methodology/Principal Findings: Sprague-Dawley rats underwent surgical placement of a tracheal cuff and were randomly assigned to receive daily either 10-minute sessions of ITTO, extended-duration, 20-minute ITTO (ITTO-20), partial obstruction with 50% of cuff inflation pressure (ITTO-PAR) or observation (SHAM) over two weeks. After the interventions, fiber morphology, myosin heavy chain composition and CSA were examined in the crural and ventral, medial, and dorsal costal regions. In the medial costal diaphragm, with ITTO, type IIx/b fibers were 26% larger in the medial costal diaphragm (p<0.01) and 24% larger in the crural diaphragm (p<0.05). No significant changes in fiber composition or morphology were detected. ITTO-20 sessions also yielded significant increases in medial costal fiber cross-sectional area, but the effects were not greater than those elicited by 10-minute sessions. On the other hand, ITTO-PAR resulted in partial airway obstruction and did not generate fiber hypertrophy. Conclusions/Significance: The results suggest that the magnitude of the load was more influential in altering fiber cross-sectional area than extended-duration conditioning sessions. The results also indicated that ITTO was associated with type II fiber hypertrophy in the medial costal region of the diaphragm and may be an advantageous experimental model of clinical respiratory muscle strength training.	[Smith, Barbara K.; Martin, A. Daniel; Vandenborne, Krista] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Phys Therapy, Gainesville, FL 32610 USA; [Darragh, Brittany D.] Univ S Florida, Coll Med, Tampa, FL USA; [Davenport, Paul W.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Smith, BK (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Phys Therapy, Gainesville, FL 32610 USA.	bksmith@phhp.ufl.edu		Smith, Barbara/0000-0002-3255-7036	National Institutes of Health [T32 HD043730]; Foundation for Physical Therapy; Howard Hughes Medical Institute HHMI; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Physical Therapy; Howard Hughes Medical Institute HHMI(Howard Hughes Medical Institute); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Pre-doctoral training support to BKS was provided by National Institutes of Health T32 HD043730 and The Foundation for Physical Therapy. Some supplies were provided by an Howard Hughes Medical Institute HHMI-funded mini-grant to BDD. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.; The A4.840 and SC-71 antibodies generated by Helen M. Blau were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	ADAMS N, 1983, J COMP PSYCHOL, V97, P24, DOI 10.1037/0735-7036.97.1.24; ALDRICH TK, 1989, CRIT CARE MED, V17, P143, DOI 10.1097/00003246-198902000-00008; Allen DL, 2010, AM J PHYSIOL-REG I, V299, pR889, DOI 10.1152/ajpregu.00296.2010; Bernhardt V, 2011, J APPL PHYSIOL, V111, P117, DOI 10.1152/japplphysiol.01317.2010; Bernhardt V, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00024; Bisschop A, 1997, AM J RESP CRIT CARE, V155, P1583, DOI 10.1164/ajrccm.155.5.9154861; Boriek AM, 1996, J APPL PHYSIOL, V81, P1929, DOI 10.1152/jappl.1996.81.5.1929; Boriek AM, 2005, AM J PHYSIOL-REG I, V288, pR1021, DOI 10.1152/ajpregu.00499.2003; Boriek AM, 2001, AM J PHYSIOL-REG I, V280, pR33, DOI 10.1152/ajpregu.2001.280.1.R33; Cader SA, 2010, J PHYSIOTHER, V56, P171, DOI 10.1016/S1836-9553(10)70022-9; Caiozzo VJ, 1996, J APPL PHYSIOL, V80, P1503, DOI 10.1152/jappl.1996.80.5.1503; Capdevila X, 2003, INTENS CARE MED, V29, P103, DOI 10.1007/s00134-002-1548-3; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Caruso Pedro, 2005, Clinics, V60, P479, DOI 10.1590/S1807-59322005000600009; Chang AT, 2005, PHYSIOTHER RES INT, V10, P222, DOI 10.1002/pri.14; Cox BM, 2011, BEHAV BRAIN RES, V220, P106, DOI 10.1016/j.bbr.2011.01.038; Criswell DS, 2003, CHEST, V124, P2302, DOI 10.1378/chest.124.6.2302; DANGELO E, 1988, J APPL PHYSIOL, V64, P90, DOI 10.1152/jappl.1988.64.1.90; De Troyer A, 2005, J APPL PHYSIOL, V98, P795, DOI 10.1152/japplphysiol.00632.2004; DETROYER A, 1991, J PHYSIOL-LONDON, V439, P73, DOI 10.1113/jphysiol.1991.sp018657; Drummond MJ, 2008, J APPL PHYSIOL, V104, P1452, DOI 10.1152/japplphysiol.00021.2008; Easton PA, 1999, J APPL PHYSIOL, V87, P582, DOI 10.1152/jappl.1999.87.2.582; Fauroux B, 2009, RESP MED, V103, P574, DOI 10.1016/j.rmed.2008.10.023; Fry AC, 2004, SPORTS MED, V34, P663, DOI 10.2165/00007256-200434100-00004; GANDEVIA SC, 1990, J PHYSIOL-LONDON, V428, P387, DOI 10.1113/jphysiol.1990.sp018218; Gayan-Ramirez G, 2000, J APPL PHYSIOL, V88, P26, DOI 10.1152/jappl.2000.88.1.26; Gea J, 2000, AM J RESP CRIT CARE, V161, P1274, DOI 10.1164/ajrccm.161.4.99040103; GOLDSPINK G, 1979, J PHYSIOL-LONDON, V296, P453, DOI 10.1113/jphysiol.1979.sp013016; Haddad F, 2006, J APPL PHYSIOL, V100, P1188, DOI 10.1152/japplphysiol.01227.2005; HALSETH AE, 1995, J APPL PHYSIOL, V79, P902, DOI 10.1152/jappl.1995.79.3.902; Hanke N, 2010, AM J PHYSIOL-CELL PH, V298, pC910, DOI 10.1152/ajpcell.00265.2009; Harikumar G, 2008, PEDIATR PULM, V43, P1085, DOI 10.1002/ppul.20905; Hermans G, 2010, CRIT CARE, V14, DOI 10.1186/cc9094; Hill K, 2011, RESP PHYSIOL NEUROBI, V179, P64, DOI 10.1016/j.resp.2011.04.001; Huang CH, 2011, J FORMOS MED ASSOC, V110, P518, DOI 10.1016/S0929-6646(11)60078-8; ISCOE S, 1976, RESP PHYSIOL, V26, P113, DOI 10.1016/0034-5687(76)90056-6; Jaber S, 2005, INTENS CARE MED, V31, P1427, DOI 10.1007/s00134-005-2694-1; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; JEDERLINIC P, 1984, CHEST, V86, P870, DOI 10.1378/chest.86.6.870; Jiang TX, 1998, AM J RESP CRIT CARE, V157, P230, DOI 10.1164/ajrccm.157.1.9702051; KEENS TG, 1978, J APPL PHYSIOL, V44, P905, DOI 10.1152/jappl.1978.44.6.905; Kellerman BA, 2000, MED SCI SPORT EXER, V32, P1859, DOI 10.1097/00005768-200011000-00007; Kilding AE, 2010, EUR J APPL PHYSIOL, V108, P505, DOI 10.1007/s00421-009-1228-x; Kumar V, 2009, J PHYSIOL-LONDON, V587, P211, DOI 10.1113/jphysiol.2008.164483; LARSSON L, 1990, ACTA PHYSIOL SCAND, V139, P451, DOI 10.1111/j.1748-1716.1990.tb08946.x; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Lowndes J, 2009, J STRENGTH COND RES, V23, P1915, DOI 10.1519/JSC.0b013e3181b94b35; Mantilla CB, 2010, RESP PHYSIOL NEUROBI, V173, P101, DOI 10.1016/j.resp.2010.07.001; Mantilla CB, 2011, RESP PHYSL NEUROBIOL; Martin AD, 2011, CRIT CARE, V15, DOI 10.1186/cc10081; MIYATA H, 1995, J APPL PHYSIOL, V79, P1640, DOI 10.1152/jappl.1995.79.5.1640; Montedonico S, 1999, DIGEST DIS SCI, V44, P2283, DOI 10.1023/A:1026665022685; Moodie L, 2011, J PHYSIOTHER, V57, P213, DOI 10.1016/S1836-9553(11)70051-0; Norrbrand L, 2008, EUR J APPL PHYSIOL, V102, P271, DOI 10.1007/s00421-007-0583-8; Orozco-Levi M, 2001, AM J RESP CRIT CARE, V164, P1734, DOI 10.1164/ajrccm.164.9.2011150; Park JH, 2010, YONSEI MED J, V51, P392, DOI 10.3349/ymj.2010.51.3.392; Pate KM, 2012, J APPL PHYSIOL, V112, P435, DOI 10.1152/japplphysiol.01321.2010; Pickering M, 2007, RESP PHYSIOL NEUROBI, V159, P21, DOI 10.1016/j.resp.2007.04.009; POLLARD MJ, 1985, EXP NEUROL, V90, P187, DOI 10.1016/0014-4886(85)90051-2; Poole DC, 1997, MED SCI SPORT EXER, V29, P738, DOI 10.1097/00005768-199706000-00003; POWERS SK, 1994, RESP PHYSIOL, V95, P227, DOI 10.1016/0034-5687(94)90118-X; Powers SK, 2002, J APPL PHYSIOL, V92, P1851, DOI 10.1152/japplphysiol.00881.2001; POWERS SK, 1990, J APPL PHYSIOL, V68, P2114, DOI 10.1152/jappl.1990.68.5.2114; PREZANT DJ, 1993, J APPL PHYSIOL, V74, P1212, DOI 10.1152/jappl.1993.74.3.1212; Ramirez-Sarmiento A, 2002, AM J RESP CRIT CARE, V166, P1491, DOI 10.1164/rccm.200202-075OC; REID WD, 1994, J APPL PHYSIOL, V76, P176, DOI 10.1152/jappl.1994.76.1.176; Reid WD, 1999, RESP PHYSIOL, V118, P203, DOI 10.1016/S0034-5687(99)00089-4; Rivard AL, 2006, J INVEST SURG, V19, P267, DOI 10.1080/08941930600778297; Rollier H, 1998, AM J RESP CRIT CARE, V157, P833, DOI 10.1164/ajrccm.157.3.9512103; Romer LM, 2003, MED SCI SPORT EXER, V35, P237, DOI 10.1249/01.MSS.0000048642.58419.1E; Rose L, 2011, ANAESTH INTENS CARE, V39, P623, DOI 10.1177/0310057X1103900414; Roy RR, 1996, ACTA ANAT, V155, P131; Sassoon CSH, 2002, J APPL PHYSIOL, V92, P2585, DOI 10.1152/japplphysiol.01213.2001; SIECK GC, 1994, CLIN CHEST MED, V15, P641; SIECK GC, 1989, J APPL PHYSIOL, V66, P2539, DOI 10.1152/jappl.1989.66.6.2539; Skelly JR, 2011, RESPIRATION, V82, P539, DOI 10.1159/000332348; Smith AG, 2000, MUSCLE NERVE, V23, P1569, DOI 10.1002/1097-4598(200010)23:10<1569::AID-MUS14>3.0.CO;2-M; Sprague SS, 2003, PHYS THER, V83, P171, DOI 10.1093/ptj/83.2.171; STAUBER WT, 1994, J APPL PHYSIOL, V77, P58, DOI 10.1152/jappl.1994.77.1.58; Su WL, 2010, CHEST, V137, P777, DOI 10.1378/chest.07-2808; SUGIURA T, 1992, J APPL PHYSIOL, V73, P506, DOI 10.1152/jappl.1992.73.2.506; Turgut HB, 2006, ANAT HISTOL EMBRYOL, V35, P357, DOI 10.1111/j.1439-0264.2006.00688.x; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; Vincent HK, 2000, EUR J APPL PHYSIOL, V81, P67, DOI 10.1007/PL00013799; Volianitis S, 2001, MED SCI SPORT EXER, V33, P803; WAKAI Y, 1994, J APPL PHYSIOL, V77, P2791, DOI 10.1152/jappl.1994.77.6.2791; Wilson TA, 1998, J APPL PHYSIOL, V85, P2284, DOI 10.1152/jappl.1998.85.6.2284; ZECHMAN FW, 1976, J APPL PHYSIOL, V40, P177, DOI 10.1152/jappl.1976.40.2.177; Zhu EH, 1997, AM J RESP CRIT CARE, V155, P1110, DOI 10.1164/ajrccm.155.3.9116995	89	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e49264	10.1371/journal.pone.0049264	http://dx.doi.org/10.1371/journal.pone.0049264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133678	Green Published, Green Submitted, gold			2022-12-25	WOS:000310601300035
J	Oki, M; Yamamoto, T				Oki, Mika; Yamamoto, Taro			Climate Change, Population Immunity, and Hyperendemicity in the Transmission Threshold of Dengue	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; LIFE TABLE MODEL; RIO-DE-JANEIRO; CONTROL STRATEGIES; HEMORRHAGIC-FEVER; VECTOR CONTROL; SIMULATION; EPIDEMIOLOGY; SURVEILLANCE; TEMPERATURE	Background: It has been suggested that the probability of dengue epidemics could increase because of climate change. The probability of epidemics is most commonly evaluated by the basic reproductive number (R-0), and in mosquito-borne diseases, mosquito density (the number of female mosquitoes per person [MPP]) is the critical determinant of the R-0 value. In dengue-endemic areas, 4 different serotypes of dengue virus coexist-a state known as hyperendemicity-and a certain proportion of the population is immune to one or more of these serotypes. Nevertheless, these factors are not included in the calculation of R-0. We aimed to investigate the effects of temperature change, population immunity, and hyperendemicity on the threshold MPP that triggers an epidemic. Methods and Findings: We designed a mathematical model of dengue transmission dynamics. An epidemic was defined as a 10% increase in seroprevalence in a year, and the MPP that triggered an epidemic was defined as the threshold MPP. Simulations were conducted in Singapore based on the recorded temperatures from 1980 to 2009 The threshold MPP was estimated with the effect of (1) temperature only; (2) temperature and fluctuation of population immunity; and (3) temperature, fluctuation of immunity, and hyperendemicity. When only the effect of temperature was considered, the threshold MPP was estimated to be 0.53 in the 1980s and 0.46 in the 2000s, a decrease of 13.2%. When the fluctuation of population immunity and hyperendemicity were considered in the model, the threshold MPP decreased by 38.7%, from 0.93 to 0.57, from the 1980s to the 2000s. Conclusions: The threshold MPP was underestimated if population immunity was not considered and overestimated if hyperendemicity was not included in the simulations. In addition to temperature, these factors are particularly important when quantifying the threshold MPP for the purpose of setting goals for vector control in dengue-endemic areas.	[Oki, Mika; Yamamoto, Taro] Nagasaki Univ, Dept Int Hlth, Inst Trop Med, Global Ctr Excellence, Nagasaki 852, Japan	Nagasaki University	Oki, M (corresponding author), Nagasaki Univ, Dept Int Hlth, Inst Trop Med, Global Ctr Excellence, Nagasaki 852, Japan.	mrs_southern_wind@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology; Global Center for Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [23659354] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center for Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology and the Global Center for Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantapreecha S., 2004, Dengue Bulletin, V28, P1; ANDERSON R M, 1991; Barbazan P, 2008, ANN TROP MED PARASIT, V102, P161, DOI 10.1179/136485908X252296; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170; Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x; Favier C, 2005, P ROY SOC B-BIOL SCI, V272, P1171, DOI 10.1098/rspb.2004.3020; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623; Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007; Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545; Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285; KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002; MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040; Nagao Y, 2012, EPIDEMIOL INFECT, V140, P479, DOI 10.1017/S0950268811000653; NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709; Nishiura H., 2006, Dengue Bulletin, V30, P51; Oki M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001367; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Promprou S., 2005, Dengue Bulletin, V29, P41; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94; Simmons CP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000129; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Strickman D, 2003, AM J TROP MED HYG, V68, P209, DOI 10.4269/ajtmh.2003.68.209; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Tsuzuki A, 2009, ACTA TROP, V111, P325, DOI 10.1016/j.actatropica.2009.05.010; Vaughan JA, 2009, AM J TROP MED HYG, V80, P44, DOI 10.4269/ajtmh.2009.80.44; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1179, DOI 10.1017/S0950268809002052	46	21	21	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48258	10.1371/journal.pone.0048258	http://dx.doi.org/10.1371/journal.pone.0048258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144746	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300056
J	Buonocore, F; Castro, R; Randelli, E; Lefranc, MP; Six, A; Kuhl, H; Reinhardt, R; Facchiano, A; Boudinot, P; Scapigliati, G				Buonocore, Francesco; Castro, Rosario; Randelli, Elisa; Lefranc, Marie-Paule; Six, Adrien; Kuhl, Heiner; Reinhardt, Richard; Facchiano, Angelo; Boudinot, Pierre; Scapigliati, Giuseppe			Diversity, Molecular Characterization and Expression of T Cell Receptor gamma in a Teleost Fish, the Sea Bass (Dicentrarchus labrax, L)	PLOS ONE			English	Article							BETA-CHAIN; IG SUPERFAMILY; ANTIGEN RECOGNITION; STRUCTURAL-ANALYSIS; DELTA; GENES; ALPHA; RESPONSES; CLONING; LOCUS	Two lineages of T cells, expressing either the alpha beta T cell receptor (TR) or the gamma delta TR, exist in Gnathostomes. The latter type of T cells account for 1-10 % of T cells in blood and up to 30 % in the small intestine. They may recognize unconventional antigens (phosphorylated microbial metabolites, lipid antigens) without the need of major histocompatibility class I (MH1) or class II (MH2) presentation. In this work we have described cloning and structural characterization of TR chain (TRG) from the teleost Dicentrarchus labrax. Further, by means of quantitative PCR analysis, we analyzed TRG expression levels both in poly I: C stimulated leukocytes in vitro, and following infection with betanodavirus in vivo. Two full length cDNAs relative to TRG, with the highest peptide and nucleotide identity with Japanese flounder, were identified. A multiple alignment analysis showed the conservation of peptides fundamental for TRG biological functions, and of the FGXG motif in the FR4 region, typical of most TR and immunoglobulin light chains. A 3D structure consisting of two domains mainly folded as beta strands with a sandwich architecture for each domain was also reported. TRG CDR3 of 8-18 AA in length and diversity in the TRG rearrangements expressed in thymus and intestine for a given V/C combination were evidenced by junction length spectratyping. TRG mRNA expression levels were high in basal conditions both in thymus and intestine, while in kidney and gut leukocytes they were up-regulated after in vitro stimulation by poly I: C. Finally, in juveniles the TRG expression levels were up-regulated in the head kidney and down-regulated in intestine after in vivo infection with betanodavirus. Overall, in this study the involvement of TRG-bearing T cells during viral stimulation was described for the first time, leading to new insights for the identification of T cell subsets in fish.	[Buonocore, Francesco; Randelli, Elisa; Scapigliati, Giuseppe] Largo Univ, Dept Innovat Biol Agrofood & Forest Syst, Univ Tuscia, Viterbo, Italy; [Castro, Rosario; Boudinot, Pierre] INRA, Unite Virol & Immunol Mol, Jouy En Josas, France; [Lefranc, Marie-Paule] Ctr Natl Rech Sci, Lab ImmunoGenet Mol, Inst Genet Humaine, Int ImMunoGeneT Informat Syst, Montpellier, France; [Lefranc, Marie-Paule] Univ Montpellier 2, Montpellier, France; [Six, Adrien] Univ Paris 06, Unite Mixte Rech 7211, Integrat Immunol Team, Paris, France; [Kuhl, Heiner] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Genome Ctr, Cologne, Germany; [Facchiano, Angelo] Ist Sci Alimentat, Lab Bioinformat & Computat Biol, Natl Res Council, Avellino, Italy; [Six, Adrien] Ctr Natl Rech Sci, Unite Mixte Rech, Paris, France	Tuscia University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Centre National de la Recherche Scientifique (CNRS)	Scapigliati, G (corresponding author), Largo Univ, Dept Innovat Biol Agrofood & Forest Syst, Univ Tuscia, Viterbo, Italy.	scapigg@unitus.it	Buonocore, Francesco/AAA-5236-2020; Kuhl, Heiner/L-2737-2019; Facchiano, Angelo/K-3375-2012; boudinot, pierre/L-4246-2016	Facchiano, Angelo/0000-0002-7077-4912; boudinot, pierre/0000-0002-7490-9677; Buonocore, Francesco/0000-0001-8045-5651; scapigliati, giuseppe/0000-0001-9730-9394; Six, Adrien/0000-0001-5898-555X; Reinhardt, Richard/0000-0001-9376-2132	European Commission (EC) [FOOD-CT-2005-007103]; European Community [222719 LIFECYCLE]	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); European Community(European Commission)	This work was partially supported by the European Commission within the FP6 project IMAQUANIM (EC contract number FOOD-CT-2005-007103), and the European Community's Seventh Framework Program (FP7/2007-13) under Grant Agreement 222719 LIFECYCLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelli L, 1996, FISH SHELLFISH IMMUN, V6, P493, DOI 10.1006/fsim.1996.0047; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Bernard D, 2006, J IMMUNOL, V176, P3942, DOI 10.4049/jimmunol.176.7.3942; Boschi I, 2011, FISH SHELLFISH IMMUN, V31, P655, DOI 10.1016/j.fsi.2010.10.001; Boudinot P, 2002, J IMMUNOL, V169, P6244, DOI 10.4049/jimmunol.169.11.6244; Boudinot P, 2001, J IMMUNOL, V167, P6202, DOI 10.4049/jimmunol.167.11.6202; Buonocore F, 2008, MOL IMMUNOL, V45, P3168, DOI 10.1016/j.molimm.2008.02.024; Buonocore F, 2007, FISH SHELLFISH IMMUN, V23, P853, DOI 10.1016/j.fsi.2007.03.013; Casani D, 2009, MOL IMMUNOL, V46, P943, DOI 10.1016/j.molimm.2008.09.016; Chen H, 2009, P NATL ACAD SCI USA, V106, P8591, DOI 10.1073/pnas.0811283106; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Collette A, 2002, BIOINFORMATICS, V18, P329, DOI 10.1093/bioinformatics/18.2.329; Ehrenmann Francois, 2011, Cold Spring Harb Protoc, V2011, P750, DOI 10.1101/pdb.prot5637; Ehrenmann Francois, 2011, Cold Spring Harb Protoc, V2011, P726, DOI 10.1101/pdb.prot5635; Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946; FEENEY AJ, 1993, J IMMUNOL, V151, P3094; Fischer C, 2002, GENOMICS, V79, P241, DOI 10.1006/geno.2002.6688; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hansen JD, 1998, IMMUNOL REV, V166, P199, DOI 10.1111/j.1600-065X.1998.tb01264.x; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Holtmeier Wolfgang, 2005, V86, P151, DOI 10.1159/000086659; HUCK S, 1988, EMBO J, V7, P719, DOI 10.1002/j.1460-2075.1988.tb02868.x; Huntington ND, 2011, P NATL ACAD SCI USA, V108, P6217, DOI 10.1073/pnas.1019167108; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kaas Q, 2008, IMMUNOMICS REV, P19, DOI 10.1007/978-0-387-72968-8_2; Kaas Quentin, 2005, In Silico Biology, V5, P505; Kabelitz D, 2000, INT ARCH ALLERGY IMM, V122, P1, DOI 10.1159/000024353; KOIZUMI H, 1991, J EXP MED, V173, P499, DOI 10.1084/jem.173.2.499; Kosub DA, 2008, CURR HIV RES, V6, P520, DOI 10.2174/157016208786501490; Kunzmann V, 2004, IMMUNOLOGY, V112, P369, DOI 10.1111/j.1365-2567.2004.01908.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lefranc M-P, 2001, T CELL RECEPTOR FACT, P1; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P643, DOI 10.1101/pdb.ip86; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; LEFRANC MP, 1986, CELL, V45, P237, DOI 10.1016/0092-8674(86)90388-0; Nam BH, 2003, J IMMUNOL, V170, P3081, DOI 10.4049/jimmunol.170.6.3081; NANDI D, 1991, J IMMUNOL, V147, P1773; Neville MJ, 1999, J IMMUNOL, V162, P4745; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishio J, 2004, INT IMMUNOL, V16, P423, DOI 10.1093/intimm/dxh046; Oliaro J, 2005, J LEUKOCYTE BIOL, V77, P652, DOI 10.1189/jlb.0704433; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; Ruiz M, 2002, IMMUNOGENETICS, V53, P857, DOI 10.1007/s00251-001-0408-6; Scapigliati G, 2010, FISH SHELLFISH IMMUN, V28, P303, DOI 10.1016/j.fsi.2009.11.008; Scapigliati G, 2001, FISH SHELLFISH IMMUN, V11, P711, DOI 10.1006/fsim.2001.0347; Shang N, 2008, FISH SHELLFISH IMMUN, V24, P412, DOI 10.1016/j.fsi.2007.12.007; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Yazawa R, 2008, MOL IMMUNOL, V45, P2150, DOI 10.1016/j.molimm.2007.12.007	60	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47957	10.1371/journal.pone.0047957	http://dx.doi.org/10.1371/journal.pone.0047957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133531	Green Published, gold			2022-12-25	WOS:000310261800023
J	Kim, DH; Zhang, W; Koepp, DM				Kim, Dong-Hwan; Zhang, Wei; Koepp, Deanna M.			The Hect Domain E3 Ligase Tom1 and the F-box Protein Dia2 Control Cdc6 Degradation in G(1) Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-REPLICATIVE COMPLEXES; DNA-REPLICATION; MCM PROTEINS; S-PHASE; UBIQUITIN LIGASE; CELL-CYCLE; PROTEOLYSIS; CDT1; PHOSPHORYLATION; INITIATION	The accurate replication of genetic information is critical to maintaining chromosomal integrity. Cdc6 functions in the assembly of pre-replicative complexes and is specifically required to load the Mcm2-7 replicative helicase complex at replication origins. Cdc6 is targeted for protein degradation by multiple mechanisms in Saccharomyces cerevisiae, although only a single pathway and E3 ubiquitin ligase for Cdc6 has been identified, the SCFCdc4 (Skp1/Cdc53/F-box protein) complex. Notably, Cdc6 is unstable during the G(1) phase of the cell cycle, but the ubiquitination pathway has not been previously identified. Using a genetic approach, we identified two additional E3 ubiquitin ligase components required for Cdc6 degradation, the F-box protein Dia2 and the Hect domain E3 Tom1. Both Dia2 and Tom1 control Cdc6 turnover during G1 phase of the cell cycle and act separately from SCFCdc4. Ubiquitination of Cdc6 is significantly reduced in dia2 Delta and tom1 Delta cells. Tom1 and Dia2 each independently immunoprecipitate Cdc6, binding to a C-terminal region of the protein. Tom1 and Dia2 cannot compensate for each other in Cdc6 degradation. Cdc6 and Mcm4 chromatin association is aberrant in tom1 Delta and dia2 Delta cells in G1 phase. Together, these results present evidence for a novel degradation pathway that controls Cdc6 turnover in G(1) that may regulate pre-replicative complex assembly.	[Kim, Dong-Hwan; Zhang, Wei; Koepp, Deanna M.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Koepp, DM (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 6-160 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	koepp015@umn.edu			National Institutes of Health [R01 GM076663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076663 (to D.M.K.).	Blake D, 2006, GENETICS, V174, P1709, DOI 10.1534/genetics.106.057836; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BUENO A, 1992, EMBO J, V11, P2167, DOI 10.1002/j.1460-2075.1992.tb05276.x; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Devault A, 2002, CURR BIOL, V12, P689, DOI 10.1016/S0960-9822(02)00768-6; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Hall JR, 2008, J BIOL CHEM, V283, P25356, DOI 10.1074/jbc.M802667200; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Kim DH, 2012, MOL BIOL CELL, V23, P4203, DOI 10.1091/mbc.E12-07-0548; Koepp DM, 2006, MOL BIOL CELL, V17, P1540, DOI 10.1091/mbc.E05-09-0884; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Mimura S, 2009, EMBO J, V28, P3693, DOI 10.1038/emboj.2009.320; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Saleh A, 1998, J MOL BIOL, V282, P933, DOI 10.1006/jmbi.1998.2036; Sanchez M, 1999, J BIOL CHEM, V274, P9092, DOI 10.1074/jbc.274.13.9092; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tafforeau L, 2006, EMBO J, V25, P4547, DOI 10.1038/sj.emboj.7601329; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; Yoshida Y, 2007, J BIOL CHEM, V282, P7137, DOI 10.1074/jbc.M611168200	37	11	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44212	44220		10.1074/jbc.M112.401778	http://dx.doi.org/10.1074/jbc.M112.401778			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129771	Green Published, hybrid			2022-12-25	WOS:000312938600020
J	Donegan, RK; Hill, SE; Turnage, KC; Orwig, SD; Lieberman, RL				Donegan, Rebecca K.; Hill, Shannon E.; Turnage, Katherine C.; Orwig, Susan D.; Lieberman, Raquel L.			The Glaucoma-associated Olfactomedin Domain of Myocilin Is a Novel Calcium Binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TRABECULAR MESHWORK; AQUEOUS-HUMOR; CIRCULAR-DICHROISM; CANCER CELLS; STABILITY; IDENTIFICATION; MECHANISMS; ADHESION; OUTFLOW; GROWTH	Myocilin is a protein found in the trabecular meshwork extracellular matrix tissue of the eye that plays a role in regulating intraocular pressure. Both wild-type and certain myocilin variants containing mutations in the olfactomedin (OLF) domain are linked to the optic neuropathy glaucoma. Because calcium ions are important biological cofactors that play numerous roles in extracellular matrix proteins, we examined the calcium binding properties of the myocilin OLF domain (myoc-OLF). Our study reveals an unprecedented high affinity calcium binding site within myoc-OLF. The calcium ion remains bound to wildtype OLF at neutral and acidic pH. A glaucoma-causing OLF variant, myoc-OLF(D380A), is calcium-depleted. Key differences in secondary and tertiary structure between myoc-OLF(D380A) and wild-type myoc-OLF, as well as limited access to chelators, indicate that the calcium binding site is largely buried in the interior of the protein. Analysis of six conserved aspartate or glutamate residues and an additional 18 disease-causing variants revealed two other candidate residues that may be involved in calcium coordination. Our finding expands our knowledge of calcium binding in extracellular matrix proteins; provides new clues into domain structure, function, and pathogenesis for myocilin; and offers insights into highly conserved, biomedically relevant OLF domains.	[Donegan, Rebecca K.; Hill, Shannon E.; Turnage, Katherine C.; Orwig, Susan D.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	Raquel.lieberman@chemistry.gatech.edu			National Institutes of Health [R01EY021205]; United States Department of Education Graduate Assistance in Areas of National Need Program [P200A060188]; NATIONAL EYE INSTITUTE [R01EY021205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Education Graduate Assistance in Areas of National Need Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grant R01EY021205 (to R. L. L.).; Supported in part by United States Department of Education Graduate Assistance in Areas of National Need Program P200A060188.	Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Borras T, 2009, EXP EYE RES, V88, P738, DOI 10.1016/j.exer.2008.11.027; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; BRYANT DTW, 1985, BIOCHEM J, V226, P613, DOI 10.1042/bj2260613; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Cruciani F, 2004, J TRACE ELEM MED BIO, V18, P141, DOI 10.1016/j.jtemb.2004.02.005; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Evenas J, 1998, CURR OPIN CHEM BIOL, V2, P293, DOI 10.1016/S1367-5931(98)80072-0; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Gersemann M, 2012, J CROHNS COLITIS, V6, P425, DOI 10.1016/j.crohns.2011.09.013; Goldwich A, 2009, HISTOCHEM CELL BIOL, V131, P167, DOI 10.1007/s00418-008-0518-4; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Hillier BJ, 2003, J CELL BIOL, V160, P597, DOI 10.1083/jcb.200210053; Hillier BJ, 2007, BIOCHEM CELL BIOL, V85, P552, DOI 10.1139/O07-055; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; Joe MK, 2005, BIOCHEM BIOPH RES CO, V336, P1201, DOI 10.1016/j.bbrc.2005.09.006; Kennedy KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036301; Kobayashi D, 2007, CANCER SCI, V98, P334, DOI 10.1111/j.1349-7006.2007.00397.x; Labasque M, 2011, J BIOL CHEM, V286, P42426, DOI 10.1074/jbc.M111.266353; Liu RH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-38; Maurer P, 1997, MATRIX BIOL, V15, P569, DOI 10.1016/S0945-053X(97)90033-0; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Maurer P, 1996, CURR OPIN CELL BIOL, V8, P609, DOI 10.1016/S0955-0674(96)80101-3; McLaughlin CW, 2008, AM J PHYSIOL-CELL PH, V295, pC1083, DOI 10.1152/ajpcell.340.2008; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MORRISETT JD, 1971, J AM CHEM SOC, V93, P7297, DOI 10.1021/ja00755a030; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Rigden DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021507; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; RINGVOLD A, 1988, ACTA OPHTHALMOL, V66, P153; Sanchez-Ruiz JM, 2007, BIOPHYS CHEM, V126, P43, DOI 10.1016/j.bpc.2006.05.021; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SMITH PD, 1984, ANAL BIOCHEM, V143, P188, DOI 10.1016/0003-2697(84)90575-X; Tamm ER, 1999, INVEST OPHTH VIS SCI, V40, P2577; Thompson J, 2011, PROTEINS, V79, P2380, DOI 10.1002/prot.23046; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Tumminia SJ, 1998, INVEST OPHTH VIS SCI, V39, P1361; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Yu L, 2011, NEOPLASMA, V58, P9, DOI 10.4149/neo_2011_01_9; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745	54	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43370	43377		10.1074/jbc.M112.408906	http://dx.doi.org/10.1074/jbc.M112.408906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129764	Green Published, hybrid			2022-12-25	WOS:000312940800018
J	Wang, JY; Muntean, AG; Wu, L; Hess, JL				Wang, Jingya; Muntean, Andrew G.; Wu, Laura; Hess, Jay L.			A Subset of Mixed Lineage Leukemia Proteins Has Plant Homeodomain (PHD)-mediated E3 Ligase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3K4 METHYLASES; UBIQUITIN LIGASE; COMPASS FAMILY; PHD FINGERS; CELL-CYCLE; MLL; GENE; DOMAIN; DEGRADATION; MECHANISMS	The mixed lineage leukemia protein MLL1 contains four highly conserved plant homeodomain (PHD) fingers, which are invariably deleted in oncogenic MLL1 fusion proteins in human leukemia. Here we show that the second PHD finger (PHD2) of MLL1 is an E3 ubiquitin ligase in the presence of the E2-conjugating enzyme CDC34. This activity is conserved in the second PHD finger of MLL4, the closest homolog to MLL1 but not in MLL2 or MLL3. Mutation of PHD2 leads to MLL1 stabilization, as well as increased transactivation ability and MLL1 recruitment to the target gene loci, suggesting that PHD2 negatively regulates MLL1 activity.	[Wang, Jingya; Muntean, Andrew G.; Wu, Laura; Hess, Jay L.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hess, JL (corresponding author), Univ Michigan, Sch Med, Dept Pathol, M5240 Med Sci 1,1301 Catherine Ave, Ann Arbor, MI 48109 USA.	jayhess@umich.edu		Muntean, Andrew/0000-0003-3034-0682	National Institutes of Health [K99 CA158136-01, R01 CA151425]; American Society of Hematology Scholar Award; Leukemia and Lymphoma Society Specialized Center of Research grant; NATIONAL CANCER INSTITUTE [K99CA158136, R00CA158136, R01CA151425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Scholar Award; Leukemia and Lymphoma Society Specialized Center of Research grant(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants K99 CA158136-01 (to A. G. M) and R01 CA151425 (to J. L. H.). This work was also supported by an American Society of Hematology Scholar Award (to A. G. M.) and a Leukemia and Lymphoma Society Specialized Center of Research grant (to J. L. H.).	Aplan PD, 2006, DNA REPAIR, V5, P1265, DOI 10.1016/j.dnarep.2006.05.034; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Chang PY, 2010, J MOL BIOL, V400, P137, DOI 10.1016/j.jmb.2010.05.005; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lee S, 2009, PROG MOL BIOL TRANSL, V87, P343, DOI 10.1016/S1877-1173(09)87010-5; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Muntean AG, 2008, BLOOD, V112, P4690, DOI 10.1182/blood-2008-01-134056; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Park S, 2010, BIOCHEMISTRY-US, V49, P6576, DOI 10.1021/bi1009387; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang JY, 2012, BLOOD, V119, P1151, DOI 10.1182/blood-2011-06-362079; Yokoyama A, 2011, J CELL SCI, V124, P2208, DOI 10.1242/jcs.080523	35	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43410	43416		10.1074/jbc.M112.423855	http://dx.doi.org/10.1074/jbc.M112.423855			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129768	hybrid, Green Published			2022-12-25	WOS:000312940800022
J	Yadav, PK; Banerjee, R				Yadav, Pramod Kumar; Banerjee, Ruma			Detection of Reaction Intermediates during Human Cystathionine beta-Synthase-monitored Turnover and H2S Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST CYSTATHIONINE; HYDROGEN-SULFIDE; HEME; SULFURTRANSFERASE; AMINOACRYLATE; MECHANISM; INSIGHTS	Human cystathionine beta-synthase (CBS), a novel heme-containing pyridoxal 5'-phosphate enzyme, catalyzes the condensation of homocysteine and serine or cysteine to produce cystathionine and H2O or H2S, respectively. The presence of heme in CBS has limited spectrophotometric characterization of reaction intermediates by masking the absorption of the pyridoxal 5'-phosphate cofactor. In this study, we employed difference stopped-flow spectroscopy to characterize reaction intermediates formed under catalytic turnover conditions. The reactions of L-serine and L-cysteine with CBS resulted in the formation of a common aminoacrylate intermediate (k(obs) = 0.96 +/- 0.02 and 0.38 +/- 0.01 mM(-1) s(-1), respectively, at 24 degrees C) with concomitant loss of H2O and H2S and without detectable accumulation of the external aldimine or other intermediates. Homocysteine reacted with the aminoacrylate intermediate with k(obs) = 40.6 +/- 3.8 s(-1) and re-formed the internal aldimine. In the reverse direction, CBS reacted with cystathionine, forming the aminoacrylate intermediate with k(obs) = 0.38 +/- 0.01 mM(-1) s(-1). This study provides the first insights into the pre-steady-state kinetic mechanism of human CBS and indicates that the reaction is likely to be limited by a conformational change leading to product release.	[Yadav, Pramod Kumar; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Abe K, 1996, J NEUROSCI, V16, P1066; BORCSOK E, 1982, ARCH BIOCHEM BIOPHYS, V213, P695, DOI 10.1016/0003-9861(82)90600-2; DREWE WF, 1985, BIOCHEMISTRY-US, V24, P3977, DOI 10.1021/bi00336a027; Evande R, 2004, ARCH BIOCHEM BIOPHYS, V427, P188, DOI 10.1016/j.abb.2004.04.027; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Hwang CC, 1996, BIOCHEMISTRY-US, V35, P6358, DOI 10.1021/bi9602472; Jhee KH, 2001, BIOCHEMISTRY-US, V40, P10873, DOI 10.1021/bi011087j; Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Mudd S., 2001, METABOLIC MOL BASES, P2007; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2011, BIOCHEMISTRY-US, V50, P419, DOI 10.1021/bi1010893; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 2002, J BIOL CHEM, V277, P22421, DOI 10.1074/jbc.M202513200; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w; Woehl EU, 1996, BIOCHEMISTRY-US, V35, P4776, DOI 10.1021/bi952938o; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	31	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43464	43471		10.1074/jbc.M112.414722	http://dx.doi.org/10.1074/jbc.M112.414722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23124209	hybrid, Green Published			2022-12-25	WOS:000312940800027
J	Tringali, C; Lupo, B; Silvestri, I; Papini, N; Anastasia, L; Tettamanti, G; Venerando, B				Tringali, Cristina; Lupo, Barbara; Silvestri, Ilaria; Papini, Nadia; Anastasia, Luigi; Tettamanti, Guido; Venerando, Bruno			The Plasma Membrane Sialidase NEU3 Regulates the Malignancy of Renal Carcinoma Cells by Controlling beta 1 Integrin Internalization and Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; APOPTOSIS SUPPRESSION; DOWN-REGULATION; EXPRESSION; GANGLIOSIDES; AUTOPHAGY; DIFFERENTIATION; IDENTIFICATION; INVASIVENESS; INHIBITION	The human plasma membrane sialidase NEU3 is a key enzyme in the catabolism of membrane gangliosides, is crucial in the regulation of cell surface processes, and has been demonstrated to be significantly up-regulated in renal cell carcinomas (RCCs). In this report, we show that NEU3 regulates beta 1 integrin trafficking in RCC cells by controlling beta 1 integrin recycling to the plasma membrane and controlling activation of the epidermal growth factor receptor (EGFR) and focal adhesion kinase (FAK)/protein kinase B (AKT) signaling. NEU3 silencing in RCC cells increased the membrane ganglioside content, in particular the GD1a content, and changed the expression of key regulators of the integrin recycling pathway. In addition, NEU3 silencing upregulated the Ras-related protein RAB25, which directs internalized integrins to lysosomes, and down-regulated the chloride intracellular channel protein 3 (CLIC3), which induces the recycling of internalized integrins to the plasma membrane. In this manner, NEU3 silencing enhanced the caveolar endocytosis of beta 1 integrin, blocked its recycling and reduced its levels at the plasma membrane, and, consequently, inhibited EGFR and FAK/AKT. These events had the following effects on the behavior of RCC cells: they (a) decreased drug resistance mediated by the block of autophagy and the induction of apoptosis; (b) decreased metastatic potential mediated by down-regulation of the metalloproteinases MMP1 and MMP7; and (c) decreased adhesion to collagen and fibronectin. Therefore, our data identify NEU3 as a key regulator of the beta 1 integrin-recycling pathway and FAK/AKT signaling and demonstrate its crucial role in RCC malignancy.	[Tringali, Cristina; Lupo, Barbara; Silvestri, Ilaria; Papini, Nadia; Venerando, Bruno] Univ Milan, Dept Med Biotechnol & Translat Med, I-20090 Milan, Italy; [Anastasia, Luigi] Univ Milan, Dept Biomed Sci Hlth, I-20090 Milan, Italy; [Anastasia, Luigi; Tettamanti, Guido; Venerando, Bruno] IRCCS Policlin San Donato, I-20097 Milan, Italy	University of Milan; University of Milan; IRCCS Policlinico San Donato	Venerando, B (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Via Flli Cervi 93, I-20090 Segrate, Italy.	bruno.venerando@unimi.it	Tringali, Cristina Alessandra/Q-7259-2017; papini, nadia/M-2425-2017; Anastasia, Luigi/AAN-1964-2020	Tringali, Cristina Alessandra/0000-0002-0632-6197; papini, nadia/0000-0003-4066-4955; Anastasia, Luigi/0000-0002-0712-2161; Lupo, Barbara/0000-0002-4383-6882	MIUR; Fondazione Cariplo [2010-0700]	MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by MIUR (PRIN 2008) and Fondazione Cariplo (2010-0700) (to B. V.).	Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; Aoki H, 2004, FEBS LETT, V567, P203, DOI 10.1016/j.febslet.2004.04.060; Azim H, 2010, TARGET ONCOL, V5, P269, DOI 10.1007/s11523-010-0141-x; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Biswas S, 2009, J IMMUNOL, V183, P5050, DOI 10.4049/jimmunol.0900259; Brenner W, 2008, INT J ONCOL, V32, P1125; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; Hetz C, 2008, TRENDS CELL BIOL, V18, P38, DOI 10.1016/j.tcb.2007.10.003; HOON DSB, 1993, J UROLOGY, V150, P2013, DOI 10.1016/S0022-5347(17)35956-6; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Li LJ, 2011, HEMATOL ONCOL CLIN N, V25, P667, DOI 10.1016/j.hoc.2011.04.004; Liang XY, 2012, CANCER RES, V72, P2791, DOI 10.1158/0008-5472.CAN-12-0320; Mandal C, 2010, INT J CANCER, V126, P337, DOI 10.1002/ijc.24733; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2012, GLYCOCONJUGATE J, V29, P567, DOI 10.1007/s10719-012-9394-1; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Park SY, 2012, BBA-GEN SUBJECTS, V1820, P1141, DOI 10.1016/j.bbagen.2012.04.008; Ramankulov A, 2008, CANCER SCI, V99, P1188, DOI 10.1111/j.1349-7006.2008.00802.x; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Saito S, 2000, TOHOKU J EXP MED, V190, P271, DOI 10.1620/tjem.190.271; Saito S, 1997, JPN J CANCER RES, V88, P652, DOI 10.1111/j.1349-7006.1997.tb00433.x; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Senda M, 2007, BIOCHEM J, V402, P459, DOI 10.1042/BJ20061118; Singh RD, 2010, TRAFFIC, V11, P348, DOI 10.1111/j.1600-0854.2009.01022.x; Sonnino S, 1996, GLYCOBIOLOGY, V6, P479, DOI 10.1093/glycob/6.5.479-e; Sonnino S, 2010, ADV EXP MED BIOL, V688, P165; Sonnino S, 2009, FEBS LETT, V583, P597, DOI 10.1016/j.febslet.2009.01.007; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Tringali C, 2009, CELL DEATH DIFFER, V16, P164, DOI 10.1038/cdd.2008.141; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wang FQ, 2006, CANCER LETT, V236, P292, DOI 10.1016/j.canlet.2005.05.042; Wang SY, 2011, ANTI-CANCER AGENT ME, V11, P993, DOI 10.2174/187152011797927661; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	42	49	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42835	42845		10.1074/jbc.M112.407718	http://dx.doi.org/10.1074/jbc.M112.407718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23139422	hybrid, Green Published			2022-12-25	WOS:000312501600042
J	Morin, V; Sanchez-Rubio, A; Aze, A; Iribarren, C; Fayet, C; Desdevises, Y; Garcia-Huidobro, J; Imschenetzky, M; Puchi, M; Geneviere, AM				Morin, Violeta; Sanchez-Rubio, Andrea; Aze, Antoine; Iribarren, Claudio; Fayet, Claire; Desdevises, Yves; Garcia-Huidobro, Jenaro; Imschenetzky, Maria; Puchi, Marcia; Geneviere, Anne-Marie			The Protease Degrading Sperm Histones Post-Fertilization in Sea Urchin Eggs Is a Nuclear Cathepsin L That Is Further Required for Embryo Development	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; CELL-CYCLES; BLOCKS; FERTILIZATION; SELECTION; GENE; HETEROCHROMATIN; PROTEOLYSIS	Proteolysis of sperm histones in the sea urchin male pronucleus is the consequence of the activation at fertilization of a maternal cysteine protease. We previously showed that this protein is required for male chromatin remodelling and for cell-cycle progression in the newly formed embryos. This enzyme is present in the nucleus of unfertilized eggs and is rapidly recruited to the male pronucleus after insemination. Interestingly, this cysteine-protease remains co-localized with chromatin during S phase of the first cell cycle, migrates to the mitotic spindle in M-phase and is re-located to the nuclei of daughter cells after cytokinesis. Here we identified the protease encoding cDNA and found a high sequence identity to cathepsin proteases of various organisms. A phylogenetical analysis clearly demonstrates that this sperm histone protease (SpHp) belongs to the cathepsin L sub-type. After an initial phase of ubiquitous expression throughout cleavage stages, SpHp gene transcripts become restricted to endomesodermic territories during the blastula stage. The transcripts are localized in the invaginating endoderm during gastrulation and a gut specific pattern continues through the prism and early pluteus stages. In addition, a concomitant expression of SpHp transcripts is detected in cells of the skeletogenic lineage and in accordance a pharmacological disruption of SpHp activity prevents growth of skeletal rods. These results further document the role of this nuclear cathepsin L during development.	[Aze, Antoine; Fayet, Claire; Desdevises, Yves; Geneviere, Anne-Marie] Univ Paris 06, UMR 7232, Banyuls Sur Mer, France; [Morin, Violeta; Sanchez-Rubio, Andrea; Iribarren, Claudio; Garcia-Huidobro, Jenaro; Imschenetzky, Maria; Puchi, Marcia] Univ Concepcion, Dept Biochem & Mol Biol, Concepcion, Chile; [Aze, Antoine; Fayet, Claire; Desdevises, Yves; Geneviere, Anne-Marie] CNRS, UMR 7232, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universidad de Concepcion; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Geneviere, AM (corresponding author), Univ Paris 06, UMR 7232, Banyuls Sur Mer, France.	anne-marie.geneviere@obs-banyuls.fr	Geneviere, Anne-Marie/A-3942-2013; Desdevises, Yves/D-5528-2011; Desdevises, Yves/H-5334-2019; Desdevises, Yves/AAH-2097-2019	Desdevises, Yves/0000-0001-9774-0336; Desdevises, Yves/0000-0001-9774-0336; Sanchez, Andrea/0000-0003-4452-0334; Garcia-Huidobro, Jenaro/0000-0001-5599-6800	ECOS-Sud (Evaluation-Orientation de la Cooperation Scientifique-Argentine-Chili-Uruguay) [C07B05]; ARCUS (Action en Region de Cooperation Culturelle et Scientifique); University of Concepcion [DIUC-208.037.008-1.0]; Egide program (Ministere des Affaires Etrangeres et Europeennes, France)	ECOS-Sud (Evaluation-Orientation de la Cooperation Scientifique-Argentine-Chili-Uruguay); ARCUS (Action en Region de Cooperation Culturelle et Scientifique); University of Concepcion; Egide program (Ministere des Affaires Etrangeres et Europeennes, France)	This work was supported by grants from ECOS-Sud (Evaluation-Orientation de la Cooperation Scientifique-Argentine-Chili-Uruguay, C07B05), ARCUS (Action en Region de Cooperation Culturelle et Scientifique), and University of Concepcion (DIUC-208.037.008-1.0). CI was recipient of a fellowship Eiffel from Egide program (Ministere des Affaires Etrangeres et Europeennes, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Barrett AJ, 2003, HDB PROTEOLYTIC ENZY; BRACHET J, 1963, BIOCHIM BIOPHYS ACTA, V72, P660; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Concha C, 2005, J CELL PHYSIOL, V204, P693, DOI 10.1002/jcp.20338; Concha C, 2005, J CELL PHYSIOL, V202, P602, DOI 10.1002/jcp.20157; Delalande C, 1998, EXP CELL RES, V242, P228, DOI 10.1006/excr.1998.4104; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Fei XF, 2009, BRAIN RES, V1264, P85, DOI 10.1016/j.brainres.2009.01.057; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Gourdet C, 2007, J CELL BIOCHEM, V101, P1, DOI 10.1002/jcb.21056; GROSS PR, 1964, EXP CELL RES, V33, P368, DOI 10.1016/0014-4827(64)90002-3; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Imschenetzky M, 2003, GENE, V322, P33, DOI 10.1016/j.gene.2003.08.024; Imschenetzky M, 1997, J CELL BIOCHEM, V67, P304; Iribarren C, 2008, J CELL BIOCHEM, V103, P447, DOI 10.1002/jcb.21410; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; LEPAGE T, 1992, DEV BIOL, V150, P23, DOI 10.1016/0012-1606(92)90004-Z; Morin V, 1999, BIOCHEM J, V343, P95, DOI 10.1042/0264-6021:3430095; Morin V, 2000, J CELL BIOCHEM, V76, P173, DOI 10.1002/(SICI)1097-4644(20000201)76:2<173::AID-JCB1>3.0.CO;2-7; Morin V, 2008, J CELL PHYSIOL, V216, P790, DOI 10.1002/jcp.21459; Puchi M, 2006, J CELL BIOCHEM, V98, P335, DOI 10.1002/jcb.20800; Puchi M, 2010, J CELL BIOCHEM, V111, P1099, DOI 10.1002/jcb.22712; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruszczyk A, 2008, FISH SHELLFISH IMMUN, V24, P205, DOI 10.1016/j.fsi.2007.10.015; Sambrook J, 1989, MOL CLONING; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Vogel AM, 1997, DEV GENES EVOL, V206, P477, DOI 10.1007/s004270050078	35	8	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e46850	10.1371/journal.pone.0046850	http://dx.doi.org/10.1371/journal.pone.0046850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144790	gold, Green Published, Green Submitted			2022-12-25	WOS:000310741400010
J	Neiman, M; Sundling, S; Gronberg, H; Hall, P; Czene, K; Lindberg, J; Klevebring, D				Neiman, Marten; Sundling, Simon; Gronberg, Henrik; Hall, Per; Czene, Kamila; Lindberg, Johan; Klevebring, Daniel			Library Preparation and Multiplex Capture for Massive Parallel Sequencing Applications Made Efficient and Easy	PLOS ONE			English	Article							PROSTATE-CANCER; AMPLIFICATION; CONSTRUCTION; PLATFORM; LOCI	During the recent years, rapid development of sequencing technologies and a competitive market has enabled researchers to perform massive sequencing projects at a reasonable cost. As the price for the actual sequencing reactions drops, enabling more samples to be sequenced, the relative price for preparing libraries gets larger and the practical laboratory work becomes complex and tedious. We present a cost-effective strategy for simplified library preparation compatible with both whole genome-and targeted sequencing experiments. An optimized enzyme composition and reaction buffer reduces the number of required clean-up steps and allows for usage of bulk enzymes which makes the whole process cheap, efficient and simple. We also present a two-tagging strategy, which allows for multiplex sequencing of targeted regions. To prove our concept, we have prepared libraries for low-pass sequencing from 100 ng DNA, performed 2-, 4- and 8-plex exome capture and a 96-plex capture of a 500 kb region. In all samples we see a high concordance (>99.4%) of SNP calls when comparing to commercially available SNP-chip platforms.	[Neiman, Marten; Sundling, Simon; Lindberg, Johan; Klevebring, Daniel] Karolinska Inst, Dept Med Epidemiol & Biostat, Sci Life Lab, Stockholm, Sweden; [Gronberg, Henrik; Hall, Per; Czene, Kamila] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Lindberg, J (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Sci Life Lab, Stockholm, Sweden.	johan.lindberg@ki.se; daniel.klevebring@ki.se		Klevebring, Daniel/0000-0002-9810-3838; Czene, Kamila/0000-0002-3233-5695; Lindberg, Johan/0000-0003-3610-6774	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; [Anonymous], 2011, QIAQUICK SPIN HDB, P1; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bjursell MK, 2011, AM J HUM GENET, V89, P507, DOI 10.1016/j.ajhg.2011.09.004; Depristo MA, 2011, NATURE GENETICS; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoeijmakers WAM, 2011, NAT PROTOC, V6, P1026, DOI 10.1038/nprot.2011.345; Illumina, 2010, TRUSEQ LIB PREP GUID; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Neiman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017785; QiaGen, 2011, MINELUTE HDB, P1; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rohland N, 2012, GENOME RES; Team RDC, 2010, R LANG ENV STAT COMP; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369	30	22	23	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48616	10.1371/journal.pone.0048616	http://dx.doi.org/10.1371/journal.pone.0048616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139805	gold, Green Submitted, Green Published			2022-12-25	WOS:000310741400055
J	van Gool, SA; Emons, JAM; Leijten, JCH; Decker, E; Sticht, C; van Houwelingen, JC; Goeman, JJ; Kleijburg, C; Scherjon, SA; Gretz, N; Wit, JM; Rappold, G; Post, JN; Karperien, M				van Gool, Sandy A.; Emons, Joyce A. M.; Leijten, Jeroen C. H.; Decker, Eva; Sticht, Carsten; van Houwelingen, Johannes C.; Goeman, Jelle J.; Kleijburg, Carin; Scherjon, Sicco A.; Gretz, Norbert; Wit, Jan Maarten; Rappold, Gudrun; Post, Janine N.; Karperien, Marcel			Fetal Mesenchymal Stromal Cells Differentiating towards Chondrocytes Acquire a Gene Expression Profile Resembling Human Growth Plate Cartilage	PLOS ONE			English	Article							ADULT STEM-CELLS; FACTOR XIIIA; IN-VITRO; CHONDROGENESIS; RECEPTOR; CAVEOLIN-1; BETA; TRANSGLUTAMINASE; PROLIFERATION; LOCALIZATION	We used human fetal bone marrow-derived mesenchymal stromal cells (hfMSCs) differentiating towards chondrocytes as an alternative model for the human growth plate (GP). Our aims were to study gene expression patterns associated with chondrogenic differentiation to assess whether chondrocytes derived from hfMSCs are a suitable model for studying the development and maturation of the GP. hfMSCs efficiently formed hyaline cartilage in a pellet culture in the presence of TGF beta 3 and BMP6. Microarray and principal component analysis were applied to study gene expression profiles during chondrogenic differentiation. A set of 232 genes was found to correlate with in vitro cartilage formation. Several identified genes are known to be involved in cartilage formation and validate the robustness of the differentiating hfMSC model. KEGG pathway analysis using the 232 genes revealed 9 significant signaling pathways correlated with cartilage formation. To determine the progression of growth plate cartilage formation, we compared the gene expression profile of differentiating hfMSCs with previously established expression profiles of epiphyseal GP cartilage. As differentiation towards chondrocytes proceeds, hfMSCs gradually obtain a gene expression profile resembling epiphyseal GP cartilage. We visualized the differences in gene expression profiles as protein interaction clusters and identified many protein clusters that are activated during the early chondrogenic differentiation of hfMSCs showing the potential of this system to study GP development.	[van Gool, Sandy A.; Emons, Joyce A. M.; Wit, Jan Maarten; Karperien, Marcel] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands; [Leijten, Jeroen C. H.; Post, Janine N.; Karperien, Marcel] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands; [Decker, Eva; Rappold, Gudrun] Heidelberg Univ, Dept Human Mol Genet, Heidelberg, Germany; [Sticht, Carsten; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Heidelberg, Germany; [van Houwelingen, Johannes C.; Goeman, Jelle J.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Kleijburg, Carin; Scherjon, Sicco A.] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Twente; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Karperien, M (corresponding author), Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands.	h.b.j.karperien@utwente.nl	van houwelingen, hans c/C-1872-2008; Leijten, Jeroen/G-5311-2011; Post, Janine N./E-9983-2011; Goeman, Jelle/AAT-1300-2020; Karperien, Marcel/R-3270-2018	van houwelingen, hans c/0000-0002-0494-4637; Leijten, Jeroen/0000-0002-8063-207X; Post, Janine N./0000-0002-6645-6583; Goeman, Jelle/0000-0003-4283-0259; Karperien, Marcel/0000-0003-0751-0604	European Society for Paediatric Endocrinology Research Unit; ZonMW, Netherlands Organisation for Health Research and Development [920-03-392]; Deutsche Forschungsgemeinschaft [920-03-358, Ra380/12-1]	European Society for Paediatric Endocrinology Research Unit; ZonMW, Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the European Society for Paediatric Endocrinology Research Unit and by grants from ZonMW, the Netherlands Organisation for Health Research and Development, to S. A. van Gool (grant number 920-03-392) and J.A.M. Emons (grant number 920-03-358) and a grant from the Deutsche Forschungsgemeinschaft to G. Rappold (Ra380/12-1). The authors gratefully acknowledge the TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann Daniel, 1996, Seminars in Thrombosis and Hemostasis, V22, P437; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bernardo ME, 2007, CONNECT TISSUE RES, V48, P132, DOI 10.1080/03008200701228464; Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23; Chagin Andrei S, 2007, Pediatr Endocrinol Rev, V4, P329; Chu TM, 2002, MATH BIOSCI, V176, P35, DOI 10.1016/S0025-5564(01)00107-9; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Djouad F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2153; Emons J, 2011, J ENDOCRINOL, V209, P245, DOI 10.1530/JOE-10-0219; Funaba M, 1996, ENDOCRINOLOGY, V137, P4250, DOI 10.1210/en.137.10.4250; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Grande-Garcia A, 2008, EUR J CELL BIOL, V87, P641, DOI 10.1016/j.ejcb.2008.02.001; HEINRICHS C, 1994, ENDOCRINOLOGY, V135, P1113, DOI 10.1210/en.135.3.1113; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533; Huang AH, 2010, TISSUE ENG PT A, V16, P2699, DOI [10.1089/ten.tea.2010.0042, 10.1089/ten.TEA.2010.0042]; Jasmin JF, 2006, TRENDS ENDOCRIN MET, V17, P150, DOI 10.1016/j.tem.2006.03.007; Johnson K, 2001, AM J PATHOL, V159, P149, DOI 10.1016/S0002-9440(10)61682-3; Kearns AE, 2000, J CELL BIOCHEM, V79, P80, DOI 10.1002/1097-4644(2000)79:1<80::AID-JCB80>3.0.CO;2-K; Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524; Leijten JC, GREM1 FRZB DKK UNPUB; Leijten JC, 2012, ARTHRITIS RHEUM; Ma B, PATHWAY ASSESS UNPUB; Madsen CD, 2008, EUR J CELL BIOL, V87, P617, DOI 10.1016/j.ejcb.2008.02.003; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Minina E, 2001, DEVELOPMENT, V128, P4523; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Nilsson O, 2003, J ENDOCRINOL, V177, P319, DOI 10.1677/joe.0.1770319; Nurminskaya MV, 2002, J ORTHOPAED RES, V20, P575, DOI 10.1016/S0736-0266(01)00146-2; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Sakiyama H, 1997, CELL TISSUE RES, V288, P557, DOI 10.1007/s004410050841; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Siddappa Ramakrishnaiah, 2007, Curr Stem Cell Res Ther, V2, P209, DOI 10.2174/157488807781696267; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; 't Anker PS, 2003, EXP HEMATOL, V31, P881, DOI 10.1016/S0301-472X(03)00202-9; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; WEBER KT, 1994, J MOL CELL CARDIOL, V26, P279, DOI 10.1006/jmcc.1994.1036; Wu L, 2011, TISSUE ENG PT A, V17, P1425, DOI [10.1089/ten.TEA.2010.0517, 10.1089/ten.tea.2010.0517]; Ylostalo J, 2006, STEM CELLS, V24, P642, DOI 10.1634/stemcells.2005-0270	45	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e44561	10.1371/journal.pone.0044561	http://dx.doi.org/10.1371/journal.pone.0044561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144774	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400002
J	Karali, D; Oxley, D; Runions, J; Ktistakis, N; Farmaki, T				Karali, Debora; Oxley, David; Runions, John; Ktistakis, Nicholas; Farmaki, Theodora			The Arabidopsis thaliana Immunophilin ROF1 Directly Interacts with PI(3)P and PI(3,5)P-2 and Affects Germination under Osmotic Stress	PLOS ONE			English	Article							COTTON GOSSYPIUM-HIRSUTUM; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MULTIVESICULAR BODY; SORTING NEXIN-1; BINDING-PROTEIN; ENDOSOMAL LOCALIZATION; LOW-TEMPERATURE; MEMBRANE; PLANT; ACID	A direct interaction of the Arabidopsis thaliana immunophilin ROF1 with phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate was identified using a phosphatidylinositol-phosphate affinity chromatography of cell suspension extracts, combined with a mass spectrometry (nano LC ESI-MS/MS) analysis. The first FK506 binding domain was shown sufficient to bind to both phosphatidylinositol-phosphate stereoisomers. GFP-tagged ROF1 under the control of a 35S promoter was localised in the cytoplasm and the cell periphery of Nicotiana tabacum leaf explants. Immunofluorescence microscopy of Arabidopsis thaliana root tips verified its cytoplasmic localization and membrane association and showed ROF1 localization in the elongation zone which was expanded to the meristematic zone in plants grown on high salt media. Endogenous ROF1 was shown to accumulate in response to high salt treatment in Arabidopsis thaliana young leaves as well as in seedlings germinated on high salt media (0.15 and 0.2 M NaCl) at both an mRNA and protein level. Plants over-expressing ROF1, (WSROF1OE), exhibited enhanced germination under salinity stress which was significantly reduced in the rof1(-) knock out mutants and abolished in the double mutants of ROF1 and of its interacting homologue ROF2 (WSrof1(-)/2(-)). Our results show that ROF1 plays an important role in the osmotic/salt stress responses of germinating Arabidopsis thaliana seedlings and suggest its involvement in salinity stress responses through a phosphatidylinositol-phosphate related protein quality control pathway.	[Karali, Debora; Farmaki, Theodora] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece; [Oxley, David] Babraham Inst, Mass Spectrometry Grp, Cambridge, England; [Runions, John] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England; [Ktistakis, Nicholas] Babraham Inst, Signalling Programme, Cambridge, England	Centre for Research & Technology Hellas; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Oxford Brookes University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Farmaki, T (corresponding author), Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece.	mfarmaki@certh.gr			E.U.-European Social Fund; Greek Ministry of Development-GSRT; European Molecular Biology Organization (EMBO) [ASTF 395.00-2007]; Biotechnology and Biological Sciences Research Council (BBSRC)	E.U.-European Social Fund(European Social Fund (ESF)); Greek Ministry of Development-GSRT(Greek Ministry of Development-GSRT); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research project is co-financed by the E.U.-European Social Fund (75%) and the Greek Ministry of Development-GSRT (25%) (PENED) as well as a European Molecular Biology Organization (EMBO) short term fellowship ASTF 395.00-2007 and the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviezer-Hagai K, 2007, PLANT MOL BIOL, V63, P237, DOI 10.1007/s11103-006-9085-z; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; CUNNINGHAM EB, 1995, BIOCHEM BIOPH RES CO, V215, P212, DOI 10.1006/bbrc.1995.2455; Cunningham EB, 1999, BLOOD, V94, P2778, DOI 10.1182/blood.V94.8.2778.420k10_2778_2789; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Dove SK, 2007, BIOCHEM SOC SYMP, V74, P129, DOI 10.1042/BSS2007c12; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Eugster A, 2004, MOL BIOL CELL, V15, P3031, DOI 10.1091/mbc.e03-11-0793; Farmaki T, 2007, J EXP BOT, V58, P555, DOI 10.1093/jxb/erl230; Friant S, 2003, DEV CELL, V5, P499, DOI 10.1016/S1534-5807(03)00238-7; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Gollan PJ, 2010, PLANT MOL BIOL, V72, P1, DOI 10.1007/s11103-009-9547-1; Harrell JM, 2002, BIOCHEMISTRY-US, V41, P5581, DOI 10.1021/bi020073q; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Ide Y, 2007, J EXP BOT, V58, P1173, DOI 10.1093/jxb/erl284; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Kargiotidou A, 2010, J EXP BOT, V61, P2991, DOI 10.1093/jxb/erq124; Kurek I, 1999, PLANT PHYSIOL, V119, P693, DOI 10.1104/pp.119.2.693; Kurek I, 2002, PLANT MOL BIOL, V48, P369, DOI 10.1023/A:1014023329807; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Lim ZY, 2002, J CHEM SOC PERK T 1, P1067, DOI 10.1039/b200585a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; Meijer HJG, 1999, PLANTA, V208, P294; Meijer HJG, 2001, PLANT J, V25, P541, DOI 10.1046/j.1365-313x.2001.00990.x; Meiri D, 2010, PLANT MOL BIOL, V72, P191, DOI 10.1007/s11103-009-9561-3; Meiri D, 2009, PLANT J, V59, P387, DOI 10.1111/j.1365-313X.2009.03878.x; Munnik T, 2010, PLANT CELL ENVIRON, V33, P655, DOI 10.1111/j.1365-3040.2009.02097.x; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; PANAGIOTIDIS CA, 1995, GENE, V164, P45, DOI 10.1016/0378-1119(95)00417-5; Perez-Perez JM, 2004, PLANT PHYSIOL, V134, P101, DOI 10.1104/pp.103.032524; Romano P, 2005, NEW PHYTOL, V166, P753, DOI 10.1111/j.1469-8137.2005.01373.x; Sliwinska E, 2009, J EXP BOT, V60, P3587, DOI 10.1093/jxb/erp203; Smyczynski C, 2006, J BIOL CHEM, V281, P25475, DOI 10.1074/jbc.M601815200; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Unger Tamar, 2010, Journal of Structural and Functional Genomics, V11, P113, DOI 10.1007/s10969-010-9085-8; Vucich VA, 1996, MOL GEN GENET, V252, P510, DOI 10.1007/BF02172397; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Yu YL, 2012, GENE, V498, P212, DOI 10.1016/j.gene.2012.01.094; Zhong Q, 2005, MOL BIOL CELL, V16, P2049, DOI 10.1091/mbc.e04-06-0504; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699; Zonia L, 2004, PLANT PHYSIOL, V134, P813, DOI 10.1104/pp.103.029454; Zou X, 2007, J EXP MED, V204, P3271, DOI 10.1084/jem.20071155	52	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48241	10.1371/journal.pone.0048241	http://dx.doi.org/10.1371/journal.pone.0048241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133621	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400028
J	Kirilyuk, A; Shimoji, M; Catania, J; Sahu, G; Pattabiraman, N; Giordano, A; Albanese, C; Mocchetti, I; Toretsky, JA; Uversky, VN; Avantaggiati, ML				Kirilyuk, Alexander; Shimoji, Mika; Catania, Jason; Sahu, Geetaram; Pattabiraman, Nagarajan; Giordano, Antonio; Albanese, Christopher; Mocchetti, Italo; Toretsky, Jeffrey A.; Uversky, Vladimir N.; Avantaggiati, Maria Laura			An Intrinsically Disordered Region of the Acetyltransferase p300 with Similarity to Prion-Like Domains Plays a Role in Aggregation	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; AGGRESOME FORMATION; MUTANT P53; PROTEIN; BINDING; PREDICTION; GENE; ISOFORMS; PATHWAY; ACEVIEW	Several human diseases including neurodegenerative disorders and cancer are associated with abnormal accumulation and aggregation of misfolded proteins. Proteins with high tendency to aggregate include the p53 gene product, TAU and alpha synuclein. The potential toxicity of aberrantly folded proteins is limited via their transport into intracellular sub-compartments, the aggresomes, where misfolded proteins are stored or cleared via autophagy. We have identified a region of the acetyltransferase p300 that is highly disordered and displays similarities with prion-like domains. We show that this region is encoded as an alternative spliced variant independently of the acetyltransferase domain, and provides an interaction interface for various misfolded proteins, promoting their aggregation. p300 enhances aggregation of TAU and of p53 and is a component of cellular aggregates in both tissue culture cells and in alpha-synuclein positive Lewy bodies of patients affected by Parkinson disease. Down-regulation of p300 impairs aggresome formation and enhances cytotoxicity induced by misfolded protein stress. These data unravel a novel activity of p300, offer new insights into the function of disordered domains and implicate p300 in pathological aggregation that occurs in neurodegeneration and cancer.	[Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia; [Kirilyuk, Alexander; Catania, Jason; Sahu, Geetaram; Albanese, Christopher; Toretsky, Jeffrey A.; Avantaggiati, Maria Laura] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Shimoji, Mika; Mocchetti, Italo] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Pattabiraman, Nagarajan] MolBox LLC, Silver Spring, MD USA; [Giordano, Antonio] Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Coll Sci & Technol, Philadelphia, PA 19122 USA	State University System of Florida; University of South Florida; Russian Academy of Sciences; Georgetown University; Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Uversky, VN (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA.	vuversky@health.usf.edu; ma364@georgetown.edu	Uversky, Vladimir N./F-4515-2011; Giordano, Antonio/AAU-1201-2020; Giordano, Antonio/F-1927-2010	Uversky, Vladimir N./0000-0002-4037-5857; Giordano, Antonio/0000-0002-5959-016X; Giordano, Antonio/0000-0002-5959-016X; Kirilyuk, Alexander/0000-0001-6403-8882	National Institutes of Health [R01CA102746, R01CA030716]; Programs of the Russian Academy of Sciences for the "Molecular and Cellular Biology"; Renschler foundation; Lathum foundation; NATIONAL CANCER INSTITUTE [R01CA083979, T32CA009686, R01CA030716, R01CA102746] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programs of the Russian Academy of Sciences for the "Molecular and Cellular Biology"; Renschler foundation; Lathum foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health R01CA102746 and R01CA030716 to MLA and by the Programs of the Russian Academy of Sciences for the "Molecular and Cellular Biology" to VNU; by Renschler and Lathum foundations to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avantaggiati ML, 1996, EMBO J, V15, P2236, DOI 10.1002/j.1460-2075.1996.tb00577.x; Breydo L, 2011, METALLOMICS, V3, P1163, DOI 10.1039/c1mt00106j; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Chernoff Y, 2004, CURR OPIN CHEM BIOL, V8, P665, DOI 10.1016/j.cbpa.2004.09.002; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gidalevitz T., 2011, COLD SPRING HARB PER, V3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Higashimoto Y, 2006, BIOCHEMISTRY-US, V45, P1608, DOI 10.1021/bi051192j; Hong LZ, 2010, NEUROSCI BULL, V26, P232, DOI 10.1007/s12264-010-1111-0; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kung AL, 2000, GENE DEV, V14, P272; Lee JY, 2010, AUTOPHAGY, V6, P555, DOI 10.4161/auto.6.4.11812; Liu Y, 2005, J VIROL, V79, P14004, DOI 10.1128/JVI.79.22.14004-14016.2005; Lu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-108; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Moll UM, 1996, MOL CELL BIOL, V16, P1126; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Perez RE, 2010, J CELL PHYSIOL, V225, P394, DOI 10.1002/jcp.22285; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rahman LN, 2011, AMINO ACIDS, V40, P1485, DOI 10.1007/s00726-010-0759-0; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Simms-Waldrip T, 2008, MOL GENET METAB, V94, P283, DOI 10.1016/j.ymgme.2008.03.012; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tyteca S, 2006, MOL CELL, V24, P807, DOI 10.1016/j.molcel.2006.12.005; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011	61	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48243	10.1371/journal.pone.0048243	http://dx.doi.org/10.1371/journal.pone.0048243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133622	Green Submitted, Green Published, gold			2022-12-25	WOS:000310601300008
J	McDonald, R; Schreier, HJ; Watts, JEM				McDonald, Ryan; Schreier, Harold J.; Watts, Joy E. M.			Phylogenetic Analysis of Microbial Communities in Different Regions of the Gastrointestinal Tract in Panaque nigrolineatus, a Wood-Eating Fish	PLOS ONE			English	Article							IN-SITU LOCALIZATION; INTESTINAL MICROBIOTA; MARINE FISH; DIVERSITY; GUT; CATFISHES; CELLULOSE; MICROFLORA; NITROGEN; BIAS	The Neotropical detritivorous catfish Panaque nigrolineatus imbibes large quantities of wood as part of its diet. Due to the interest in cellulose, hemi-cellulose and lignin degradation pathways, this organism provides an interesting model system for the detection of novel microbial catabolism. In this study, we characterize the microbial community present in different regions of the alimentary tract of P. nigrolineatus fed a mixed diet of date palm and palm wood in laboratory aquaria. Analysis was performed on 16S rRNA gene clone libraries derived from anterior and posterior regions of the alimentary tract and the auxiliary lobe (AL), an uncharacterized organ that is vascularly attached to the midgut. Sequence analysis and phylogenetic reconstruction revealed distinct microbial communities in each tissue region. The foregut community shared many phylotypes in common with aquarium tank water and included Legionella and Hyphomicrobium spp. As the analysis moved further into the gastrointestinal tract, phylotypes with high levels of 16S rRNA sequence similarity to nitrogen-fixing Rhizobium and Agrobacterium spp. and Clostridium xylanovorans and Clostridium saccharolyticum, dominated midgut and AL communities. However, the hindgut was dominated almost exclusively by phylotypes with the highest 16S rRNA sequence similarity to the Cytophaga-Flavobacterium-Bacteroides phylum. Species richness was highest in the foregut (Chao(1) = 26.72), decreased distally through the midgut (Chao(1) = 25.38) and hindgut (Chao(1) = 20.60), with the lowest diversity detected in the AL (Chao(1) = 18.04), indicating the presence of a specialized microbial community. Using 16S rRNA gene phylogeny, we report that the P. nigrolineatus gastrointestinal tract possesses a microbial community closely related to microorganisms capable of cellulose degradation and nitrogen fixation. Further studies are underway to determine the role of this resident microbial community in Panaque nigrolineatus.	[Watts, Joy E. M.] Univ Portsmouth, Dept Biol Sci, Portsmouth, Hants, England; [McDonald, Ryan] Towson Univ, Dept Biol Sci, Towson, MD USA; [Schreier, Harold J.] Univ Maryland Baltimore Cty, Dept Marine Biotechnol, Baltimore, MD 21228 USA; [Schreier, Harold J.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University of Portsmouth; University System of Maryland; Towson University; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Watts, JEM (corresponding author), Univ Portsmouth, Dept Biol Sci, Portsmouth, Hants, England.	joy.watts@port.ac.uk		Schreier, Harold/0000-0003-1377-3929; Watts, Joy/0000-0001-9595-0540	National Science Foundation [0801830]; Marie Curie FP7-RG [276948]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER; Direct For Biological Sciences [0801830] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Marie Curie FP7-RG; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in part, by the National Science Foundation, award 0801830 (J.E.M.W. and H.J.S.) and Marie Curie FP7-RG 276948 (J.E.M.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARAUJOLIMA CARM, 1986, SCIENCE, V234, P1256, DOI 10.1126/science.234.4781.1256; Armbruster JW, 2004, ZOOL J LINN SOC-LOND, V141, P1, DOI 10.1111/j.1096-3642.2004.00109.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Berchtold M, 1999, ARCH MICROBIOL, V172, P407, DOI 10.1007/s002030050778; Billen J, 2000, ARTHROPOD STRUCT DEV, V29, P259, DOI 10.1016/S1467-8039(00)00029-3; Brune A, 2000, CURR OPIN MICROBIOL, V3, P263, DOI 10.1016/S1369-5274(00)00087-4; CHAO A, 1984, SCAND J STAT, V11, P265; Dehn A, 2010, PHYSL HISTOLOGICAL M; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhanasiri AKS, 2011, MICROB ECOL, V61, P20, DOI 10.1007/s00248-010-9673-y; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Eddy SD, 2002, AQUACULTURE, V211, P9, DOI 10.1016/S0044-8486(01)00882-1; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Geerinckx T, 2007, J MORPHOL, V268, P805, DOI 10.1002/jmor.10547; German DP, 2009, J COMP PHYSIOL B, V179, P1025, DOI 10.1007/s00360-009-0383-z; German DP, 2009, J COMP PHYSIOL B, V179, P1011, DOI 10.1007/s00360-009-0381-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Leschine SB, 1995, ANNU REV MICROBIOL, V8, P237; Lujan NK, 2012, J MORPHOL, V273, P24, DOI 10.1002/jmor.11003; Lujan NK, 2011, FUNCT ECOL, V25, P1327, DOI 10.1111/j.1365-2435.2011.01883.x; Luyten YA, 2006, APPL ENVIRON MICROB, V72, P412, DOI 10.1128/AEM.72.1.412-417.2006; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martin-Antonio B, 2007, AQUAC RES, V38, P1213, DOI 10.1111/j.1365-2109.2007.01790.x; MATSUMOTO T, 1976, OECOLOGIA, V22, P153, DOI 10.1007/BF00344714; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Merrifield DL, 2009, AQUAC RES, V40, P1064, DOI 10.1111/j.1365-2109.2009.02200.x; Moran D, 2005, MICROB ECOL, V49, P590, DOI 10.1007/s00248-004-0097-4; MUDARRIS M, 1988, J FISH BIOL, V32, P223, DOI 10.1111/j.1095-8649.1988.tb05355.x; MURRAY WD, 1986, APPL ENVIRON MICROB, V51, P710, DOI 10.1128/AEM.51.4.710-714.1986; Nelson JA, 1999, J FISH BIOL, V54, P1069, DOI 10.1111/j.1095-8649.1999.tb00858.x; Nonogaki H, 2007, ENVIRON BIOL FISH, V78, P13, DOI 10.1007/s10641-006-9074-8; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Ringo E, 1999, AQUAC RES, V30, P73, DOI 10.1046/j.1365-2109.1999.00302.x; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Schaefer Scott A., 1993, Ichthyological Exploration of Freshwaters, V4, P309; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SERA H, 1972, B JPN SOC SCI FISH, V38, P853; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sugita H, 2005, AQUACULTURE, V243, P403, DOI 10.1016/j.aquaculture.2004.09.028; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; TSAI YL, 1992, APPL ENVIRON MICROB, V58, P2292, DOI 10.1128/AEM.58.7.2292-2295.1992; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wu SG, 2010, AQUACULTURE, V303, P1, DOI 10.1016/j.aquaculture.2009.12.025; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624	54	40	41	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48018	10.1371/journal.pone.0048018	http://dx.doi.org/10.1371/journal.pone.0048018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133540	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800031
J	McGlynn, TP; Diamond, SE; Dunn, RR				McGlynn, Terrence P.; Diamond, Sarah E.; Dunn, Robert R.			Tradeoffs in the Evolution of Caste and Body Size in the Hyperdiverse Ant Genus Pheidole	PLOS ONE			English	Article							THRESHOLD EVOLUTION; DEVELOPMENTAL MECHANISMS; SOLDIER PRODUCTION; HYMENOPTERA; ALLOCATION; HISTORY; FORMICIDAE; SPECIALIZATION; RESOURCES; PATTERNS	The efficient investment of resources is often the route to ecological success, and the adaptability of resource investment may play a critical role in promoting biodiversity. The ants of the "hyperdiverse" genus Pheidole produce two discrete sterile castes, soldiers and minor workers. Within Pheidole, there is tremendous interspecific variation in proportion of soldiers. The causes and correlates of caste ratio variation among species of Pheidole remain enigmatic. Here we test whether a body size threshold model accounts for interspecific variation in caste ratio in Pheidole, such that species with larger body sizes produce relatively fewer soldiers within their colonies. We evaluated the caste ratio of 26 species of Pheidole and found that the body size of workers accounts for interspecific variation in the production of soldiers as we predicted. Twelve species sampled from one forest in Costa Rica yielded the same relationship as found in previously published data from many localities. We conclude that production of soldiers in the most species-rich group of ants is regulated by a body size threshold mechanism, and that the great variation in body size and caste ratio in Pheidole plays a role in niche divergence in this rapidly evolving taxon.	[McGlynn, Terrence P.] Calif State Univ Dominguez Hills, Dept Biol, Carson, CA 90747 USA; [Diamond, Sarah E.; Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	California State University System; California State University Dominguez Hills; University of North Carolina; North Carolina State University	McGlynn, TP (corresponding author), Calif State Univ Dominguez Hills, Dept Biol, Carson, CA 90747 USA.	terry.mcglynn@gmail.com	Dunn, Robert/B-1360-2013; McGlynn, Terrence P/E-3405-2010; McGlynn, Terrence/ABD-3939-2020	McGlynn, Terrence P/0000-0002-4290-6156; McGlynn, Terrence/0000-0002-4290-6156; Dunn, Robert/0000-0002-6030-4837	National Science Foundation [EAR-0421178, OISE-0854259, DUE-1035131, OISE-1130156]; Sally Casanova Memorial RSCAAP Award; National Science Foundation LTREB program [DEB-0841872]; DOE-PER [DE-FG02-08ER64510]; NASA Career Grant; Office Of Internatl Science &Engineering [1130156] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Sally Casanova Memorial RSCAAP Award; National Science Foundation LTREB program(National Science Foundation (NSF)); DOE-PER(United States Department of Energy (DOE)); NASA Career Grant; Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	TPM was funded by the National Science Foundation (EAR-0421178; OISE-0854259; DUE-1035131, OISE-1130156), and a Sally Casanova Memorial RSCAAP Award. The CARBONO Project plots are funded by the National Science Foundation LTREB program (DEB-0841872). RRD was funded by DOE-PER DE-FG02-08ER64510 and a NASA Career Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bestelmeyer Brandon T., 2000, P122; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; CHARLESWORTH D, 1991, PHILOS T R SOC B, V332, P91, DOI 10.1098/rstb.1991.0036; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; DETRAIN C, 1990, INSECT SOC, V37, P315, DOI 10.1007/BF02225995; Hasegawa E, 1997, AM NAT, V149, P706, DOI 10.1086/286016; ITO F, 1990, RES POPUL ECOL, V32, P113, DOI 10.1007/BF02512593; KASPARI M, 1995, BEHAV ECOL SOCIOBIOL, V37, P255, DOI 10.1007/s002650050189; McGlynn TP, 2002, INSECT SOC, V49, P8, DOI 10.1007/s00040-002-8270-6; Mertl AL, 2010, INSECT SOC, V57, P441, DOI 10.1007/s00040-010-0102-5; Mertl AL, 2009, BEHAV ECOL SOCIOBIOL, V63, P1411, DOI 10.1007/s00265-009-0797-3; Moczek AP, 2002, EVOL ECOL RES, V4, P587; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; Moreau CS, 2008, MOL PHYLOGENET EVOL, V48, P224, DOI 10.1016/j.ympev.2008.02.020; Nijhout HF, 1996, AM NAT, V148, P40, DOI 10.1086/285910; Orme D., 2009, CAIC COMP ANAL USING; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Passera L, 1996, NATURE, V379, P630, DOI 10.1038/379630a0; PASSERA L, 1974, INSECT SOC, V21, P71, DOI 10.1007/BF02222980; Powell S, 2008, FUNCT ECOL, V22, P902, DOI 10.1111/j.1365-2435.2008.01436.x; Rajakumar R, 2012, SCIENCE, V335, P79, DOI 10.1126/science.1211451; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Tomkins JL, 2009, EVOLUTION, V63, P459, DOI 10.1111/j.1558-5646.2008.00563.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Wagner GP, 2000, AM ZOOL, V40, P819, DOI 10.1668/0003-1569(2000)040[0819:DEAAMS]2.0.CO;2; Weiser MD, 2006, ECOL ENTOMOL, V31, P131, DOI 10.1111/j.0307-6946.2006.00759.x; WHEELER DE, 1981, SCIENCE, V213, P361, DOI 10.1126/science.213.4505.361; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; WILSON EO, 1979, P AM PHILOS SOC, V123, P204; Yang AS, 2004, CURR BIOL, V14, P514, DOI 10.1016/j.cub.2004.03.005; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	31	12	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48202	10.1371/journal.pone.0048202	http://dx.doi.org/10.1371/journal.pone.0048202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133570	gold, Green Submitted, Green Published			2022-12-25	WOS:000310261800060
J	Wang, C; Wang, YX; Huang, XJ; Li, X; Zhang, T; Song, MS; Wu, LJ; Du, J; Lu, XQ; Shao, S; Zhao, FF; Ball, MA; Wu, H; Wang, W				Wang, Chao; Wang, YouXin; Huang, XiaoJie; Li, Xia; Zhang, Tong; Song, ManShu; Wu, LiJuan; Du, Juan; Lu, XiaoQin; Shao, Shuang; Zhao, FeiFei; Ball, Michele A.; Wu, Hao; Wang, Wei			Prevalence and Factors Associated with Hepatitis B Immunization and Infection among Men Who Have Sex with Men in Beijing, China	PLOS ONE			English	Article							VIRAL-HEPATITIS; VIRUS-INFECTION; YOUNG MEN; RISK; VACCINATION; HIV; EPIDEMIOLOGY; PREVENTION; SYPHILIS	Background: Among the Chinese population of 1.3 billion, there are an estimated 93 million carriers of hepatitis B virus (HBV). Men who have sex with men (MSM) are at increased risk for HBV infection; however, the prevalence of HBV immunization and infection among Chinese MSM remains undetermined. Methods: A cross-sectional survey of 1,114 eligible participants was conducted in Beijing, China. Multiple methods were used to recruit study participants. Demographic information and potential correlated factors were collected by questionnaire. Additionally, blood specimens were collected and tested for sexually transmitted infections and serologic markers of hepatitis B immunization and infection. Results: Laboratory data were available for 1,111 participants (99.7%), the prevalence of hepatitis B immunization was 38.9%, and 26.5% had serologic markers of HBV infection. Multivariate analyses indicated that higher education level, smaller number of male sex partners in the past 12 months, reported diagnosis of sexually transmitted disease (STD), and history of blood donation were independently associated with HBV immunization. Absence of steady male sex partner(s) in the past 12 months, and reported diagnosis of STD were shown to be independently associated with HBV infection. MSM positive for HBV infection were more likely to have past or current syphilis infection. Conclusions: Low prevalence of HBV immunization and high prevalence of HBV infection among Chinese MSM and a correlation between sexual risk factors and hepatitis B infection indicate that comprehensive preventative measures for HBV among MSM, including blood donor and HIV-STD clinic vaccination programs as well as targeted health education campaigns should be developed in China.	[Wang, Chao; Wang, YouXin; Li, Xia; Song, ManShu; Wu, LiJuan; Du, Juan; Lu, XiaoQin; Shao, Shuang; Zhao, FeiFei; Wang, Wei] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Huang, XiaoJie; Zhang, Tong; Wu, Hao] Capital Med Univ, Beijing YouAn Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Wang, Chao; Wang, YouXin; Li, Xia; Song, ManShu; Wu, LiJuan; Du, Juan; Lu, XiaoQin; Shao, Shuang; Zhao, FeiFei; Wu, Hao; Wang, Wei] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Ball, Michele A.] Beijing Univ Chinese Med, Acupuncture Dept, Beijing, Peoples R China; [Wang, Wei] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia	Capital Medical University; Capital Medical University; Beijing University of Chinese Medicine; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Edith Cowan University	Song, MS (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China.	songms@ccmu.edu.cn; whdoc900@hotmail.com; wei.wang@ecu.edu.au	Zhang, Tong/HGC-1090-2022; liu, li/HGC-0900-2022	Song, Manshu/0000-0003-1433-7192; wang, wei/0000-0002-1430-1360; Wang, Youxin/0000-0002-6574-6706	Major Project of Beijing Municipal Science and Technology Committee [D09050703590901]; National Science Technology Major Special Project on Major New Drug Innovation of China [2010ZX09401]; National 12th Five-Year Major Projects of China [2012ZX10001-003, 2012ZX10001-006, 2012BAI37B03]; Major State Basic Research Program-973 of China [2011CB503806]; National Natural Science Foundation of China [30901238, 31070727, 81001281]; Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality [PHR201007112]; Beijing Key Laboratory [BZ0089]	Major Project of Beijing Municipal Science and Technology Committee; National Science Technology Major Special Project on Major New Drug Innovation of China; National 12th Five-Year Major Projects of China; Major State Basic Research Program-973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality; Beijing Key Laboratory	The work was supported by Major Project of Beijing Municipal Science and Technology Committee (Grant No: D09050703590901), National Science Technology Major Special Project on Major New Drug Innovation of China (Grant No: 2010ZX09401), the National 12th Five-Year Major Projects of China (Grant No: 2012ZX10001-003, 2012ZX10001-006 and 2012BAI37B03), Major State Basic Research Program-973 of China (Grant No: 2011CB503806), National Natural Science Foundation of China (Grant No: 30901238, 31070727 and 81001281), Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (Grant No: PHR201007112) and Beijing Key Laboratory (No: BZ0089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2005, INT HEP B SER TEST R; Choi KH, 2005, SEX TRANSM DIS, V32, P44, DOI 10.1097/01.olq.0000148296.93945.53; Committee on the prevention and control of viral hepatitis infections Institute of medicine of the national academies, 2010, HEP LIV CANC NAT STR, P160; Diamond C, 2003, SEX TRANSM DIS, V30, P425, DOI 10.1097/00007435-200305000-00009; DIENSTAG JL, 1982, AM J EPIDEMIOL, V115, P26, DOI 10.1093/oxfordjournals.aje.a113277; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Lama JR, 2010, AM J TROP MED HYG, V83, P194, DOI 10.4269/ajtmh.2010.10-0003; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; LOK ASF, 1992, DIGEST DIS, V10, P46, DOI 10.1159/000171343; Lu FM, 2010, J VIRAL HEPATITIS, V17, P4, DOI 10.1111/j.1365-2893.2010.01266.x; Lu FM, 2009, CHINESE MED J-PEKING, V122, P2925, DOI 10.3760/cma.j.issn.0366-6999.2009.24.001; Ma X, 2007, J ACQ IMMUN DEF SYND, V45, P581; Ma Xiao-Yan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P851; MacKellar DA, 2001, AM J PUBLIC HEALTH, V91, P965, DOI 10.2105/AJPH.91.6.965; Pando MA, 2006, SEX TRANSM DIS, V33, P307, DOI 10.1097/01.olq.0000194578.06795.2d; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Saxton Peter J W, 2002, N Z Med J, V115, pU106; Seage GR, 1997, PUBLIC HEALTH REP, V112, P158; Urbanus AT, 2009, EURO SURVEILL, V14; van Houdt R, 2009, VACCINE, V27, P3530, DOI 10.1016/j.vaccine.2009.03.072; Weinbaum CM, 2008, AM J PUBLIC HEALTH, V98, P839, DOI 10.2105/AJPH.2006.101915; World Health Organisation (WHO), 2011, SEXUALLY TRANSMITTED; World Health Organization, 2008, HEP B; Wu Jiang, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P555; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c; Zuckerman J, 2007, LANCET INFECT DIS, V7, P410, DOI 10.1016/S1473-3099(07)70136-6	29	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48219	10.1371/journal.pone.0048219	http://dx.doi.org/10.1371/journal.pone.0048219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026GE	23133573	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800063
J	Ballarino, M; Jobert, L; Dembele, D; de la Grange, P; Auboeuf, D; Tora, L				Ballarino, M.; Jobert, L.; Dembele, D.; de la Grange, P.; Auboeuf, D.; Tora, L.			TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs	ONCOGENE			English	Article						FUS/EWS/TAF15 (FET) proteins; miRNAs; transcription; proliferation; neuronal differentiation; neuroblastoma	BINDING PROTEIN; EWS; MICRORNAS; NEUROBLASTOMA; RESOURCE; TARGETS; GROWTH; FUS	TAF15 (formerly TAFII68) is a member of the FET (FUS, EWS, TAF15) family of RNA-and DNA-binding proteins whose genes are frequently translocated in sarcomas. By performing global gene expression profiling, we found that TAF15 knockdown affects the expression of a large subset of genes, of which a significant percentage is involved in cell cycle and cell death. In agreement, TAF15 depletion had a growth-inhibitory effect and resulted in increased apoptosis. Among the TAF15-regulated genes, targets of microRNAs (miRNAs) generated from the onco-miR-17 locus were overrepresented, with CDKN1A/p21 being the top miRNAs-targeted gene. Interestingly, the levels of onco-miR-17 locus coded miRNAs (miR-17-5p and miR-20a) were decreased upon TAF15 depletion and shown to affect the post-transcriptional regulation of TAF15-dependent genes, such as CDKN1A/p21. Thus, our results demonstrate that TAF15 is required to regulate gene expression of cell cycle regulatory genes post-transcriptionally through a pathway involving miRNAs. The findings that high TAF15 levels are needed for rapid cellular proliferation and that endogenous TAF15 levels decrease during differentiation strongly suggest that TAF15 is a key regulator of maintaining a highly proliferative rate of cellular homeostasis.	[Ballarino, M.; Jobert, L.; Dembele, D.; Tora, L.] Univ Strasbourg, Dept Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire, INSERM,U964,CNRS,UMR 7104, F-67404 Illkirch Graffenstaden, Cu De Strasbour, France; [de la Grange, P.] Hop St Louis, GenoSplice Technol, Paris, France; [Auboeuf, D.] Ctr Leon Berard, INSERM, U1052, Canc Res Ctr Lyon, F-69373 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Tora, L (corresponding author), Univ Strasbourg, Dept Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire, INSERM,U964,CNRS,UMR 7104, BP 10142, F-67404 Illkirch Graffenstaden, Cu De Strasbour, France.	laszlo@igbmc.fr	Auboeuf, Didier/M-4610-2014; Dembélé, Doulaye/O-6513-2017; Tora, Laszlo/E-9999-2018; ballarino, monica/AAA-5065-2020	Dembélé, Doulaye/0000-0003-3879-6940; Tora, Laszlo/0000-0001-7398-2250; Auboeuf, Didier/0000-0002-3757-0002; Ballarino, Monica/0000-0002-8595-7105	CNRS; INSERM; AICR [09-0258]; Fondation Recherche Medicale; MRET; Association pour la Recherche sur le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AICR; Fondation Recherche Medicale; MRET; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We are very grateful to JF Caceres, VN Kim and ME Fiori for providing the Pri-17-92, Flag-DGCR8 and pGL3-p21-30UTR plasmids, respectively. We also thank N Charlet Berguerand and M Morlando for the advice in miRNA processing assay, D Devys, M Fournier, A Helmrich, P Bheda and P Laneve for critically reading the manuscript, R Contzler for the XCELLigence analysis and the IGBMC cell culture facility. This work was supported by funds from CNRS, INSERM and AICR (09-0258) grants. MB was supported by the Fondation Recherche Medicale and LJ by MRET and Association pour la Recherche sur le Cancer.	Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1999, ONCOGENE, V18, P8000, DOI 10.1038/sj.onc.1203207; Beveridge NJ, 2009, CELL SIGNAL, V21, P1837, DOI 10.1016/j.cellsig.2009.07.019; Blechingberg J, 2012, GENE, V493, P27, DOI 10.1016/j.gene.2011.11.038; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chaulk SG, 2011, RNA BIOL, V8, P1105, DOI 10.4161/rna.8.6.17410; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; De Vito C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023592; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jobert L, 2009, EMBO REP, V10, P494, DOI 10.1038/embor.2009.24; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; ROSSI A, 1992, INT J DEV NEUROSCI, V10, P527, DOI 10.1016/0736-5748(92)90053-3; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Spitzer JI, 2011, GENE CHROMOSOME CANC, V50, P338, DOI 10.1002/gcc.20858; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402	33	30	30	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2013	32	39					4646	4655		10.1038/onc.2012.490	http://dx.doi.org/10.1038/onc.2012.490			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23128393				2022-12-25	WOS:000325072200006
J	Gundelach, JH; Madhavan, AA; Wettstein, PJ; Bram, RJ				Gundelach, Justin H.; Madhavan, Ajay A.; Wettstein, Peter J.; Bram, Richard J.			The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism	FASEB JOURNAL			English	Article						CD69; chemotherapy; immune suppression; IL-2	IRON CHELATORS; ANTITUMOR-ACTIVITY; IN-VITRO; TRANSCRIPTIONAL REGULATION; SIGNALING PATHWAYS; RECEPTOR; INTERLEUKIN-2; LYMPHOCYTE; EXPRESSION; MURINE	The di-2-pyridylketone thiosemicarbazone Dp44mT is a metal-chelating compound that has been demonstrated to have potent activity as an anticancer agent. Here we report that it also has a dramatic inhibitory effect on T-cell activation in vitro. We found that 10 nM Dp44mT (IC50 3.2 nM) prevented the up-regulation of surface CD25, and completely suppressed the activation and proliferation of splenic T cells isolated from Mus musculus that were stimulated with either T-cell receptor (TCR) cross-linking antibodies or phorbol ester plus ionomycin. In contrast, Dp44mT had no adverse effects on the survival of resting T cells. In addition, T cells stimulated in the presence of Dp44mT maintained the ability to up-regulate CD69 surface expression and secrete interleukin-2. Consistent with these observations, Dp44mT did not inhibit multiple canonical signals downstream of the TCR, including the nuclear factor of activated T cells. The effects of Dp44mT were easily mitigated by addition of nontoxic copper chelators or N-acetylcysteine, indicating a role for copper and reactive oxygen species in its actions. Together, these findings suggest that Dp44mT may serve as a potent immunosuppressive agent that could complicate its use as a cancer therapeutic agent, but might have utility in the treatment of autoimmunity.-Gundelach, J. H., Madhavan, A. A., Wettstein, P. J., Bram, R. J. The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism. FASEB J. 27, 782-792 (2013). www.fasebj.org	[Gundelach, Justin H.; Madhavan, Ajay A.; Bram, Richard J.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Gundelach, Justin H.; Madhavan, Ajay A.; Bram, Richard J.] Mayo Clin, Dept Pediat & Adolescent Med, Coll Med, Rochester, MN 55905 USA; [Gundelach, Justin H.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN 55905 USA; [Wettstein, Peter J.; Bram, Richard J.] Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA; [Wettstein, Peter J.] Mayo Clin, Dept Surg, Coll Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Bram, RJ (corresponding author), Mayo Clin, 533 Guggenheim Bldg,200 1st St SW, Rochester, MN 55905 USA.	bramr@mayo.edu		Gundelach, Justin/0000-0001-7347-0511	Stanley and Belle Bestor Fund	Stanley and Belle Bestor Fund	The authors thank the laboratories of Dr. Karen Hedin and Dr. Virginia Shapiro (Department of Immunology, Mayo Clinic, Rochester, MN, USA) for kindly providing the luciferase reporter constructs used in this work. This work was supported by a grant from the Stanley and Belle Bestor Fund. The authors declare no conflicts of interest.	ABRAHAM RT, 1986, J IMMUNOPHARMACOL, V8, P165; ARRIBAS J, 1990, J BIOL CHEM, V265, P13969; Barbarulo A, 2011, J IMMUNOL, V186, P6199, DOI 10.4049/jimmunol.1002136; BISMUTH G, 1985, EUR J IMMUNOL, V15, P723, DOI 10.1002/eji.1830150716; Brewer GJ, 2008, CURR OPIN CLIN NUTR, V11, P727, DOI 10.1097/MCO.0b013e328314b678; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007048; Chen CL, 1996, J NATL CANCER I, V88, P1840, DOI 10.1093/jnci/88.24.1840; Debebe Z, 2011, MOL PHARMACOL, V79, P185, DOI 10.1124/mol.110.069062; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Emens LA, 2005, CANCER RES, V65, P8059, DOI 10.1158/0008-5472.CAN-05-1797; FIDELUS RK, 1988, CELL IMMUNOL, V113, P175, DOI 10.1016/0008-8749(88)90015-9; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Hopkins RG, 1999, J NUTR, V129, P596, DOI 10.1093/jn/129.3.596; Horvathova M, 2010, HEMATOLOGY, V15, P96, DOI 10.1179/102453310X12583347009810; Kaminski MM, 2012, BBA-MOL CELL RES, V1823, P1041, DOI 10.1016/j.bbamcr.2012.03.003; KELLY K, 1995, CURR OPIN IMMUNOL, V7, P327, DOI 10.1016/0952-7915(95)80106-5; Khwaja SS, 2010, J CLIN INVEST, V120, P2537, DOI 10.1172/JCI41277; Kovacevic Z, 2011, CURR TOP MED CHEM, V11, P483, DOI 10.2174/156802611794785190; Kuvibidila SR, 1998, J NUTR, V128, P1077, DOI 10.1093/jn/128.7.1077; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; LARSEN CS, 1989, SCAND J IMMUNOL, V30, P285, DOI 10.1111/j.1365-3083.1989.tb01213.x; Leanderson P, 1996, CARCINOGENESIS, V17, P545, DOI 10.1093/carcin/17.3.545; LIPKOWITZ S, 1984, J IMMUNOL, V132, P31; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; MacGregor HJ, 2011, CYTOKINE, V56, P669, DOI 10.1016/j.cyto.2011.08.025; Marie-Cardine A, 1999, CELL SIGNAL, V11, P705, DOI 10.1016/S0898-6568(99)00047-9; MIYAWAKI T, 1982, J IMMUNOL, V129, P2474; Norris RE, 2010, CANCER CHEMOTH PHARM, V65, P1125, DOI 10.1007/s00280-009-1120-8; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; Nowak AK, 2003, CANCER RES, V63, P4490; Patwardhan RS, 2011, BIOCHEM PHARMACOL, V82, P642, DOI 10.1016/j.bcp.2011.06.024; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; Rhee YS, 2002, CLIN EXP IMMUNOL, V127, P463, DOI 10.1046/j.1365-2249.2002.01697.x; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Siegel J N, 1991, Semin Immunol, V3, P325; Song PH, 2004, ACTA BIOCH BIOPH SIN, V36, P123, DOI 10.1093/abbs/36.2.123; Tatla S, 1999, FREE RADICAL BIO MED, V26, P14, DOI 10.1016/S0891-5849(98)00133-6; TSURUO T, 1981, CANCER RES, V41, P1967; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Xiao Y, 2008, INT J ONCOL, V33, P1073, DOI 10.3892/ijo_00000096; Xiao Y, 2010, INT J ONCOL, V37, P81, DOI 10.3892/ijo_00000655; Yu Y, 2012, CURR MED CHEM, V19, P2689, DOI 10.2174/092986712800609706; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	50	7	8	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					782	792		10.1096/fj.12-215756	http://dx.doi.org/10.1096/fj.12-215756			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23134680				2022-12-25	WOS:000314358000036
J	Gang, TB; Hammond, DJ; Singh, SK; Ferguson, DA; Mishra, VK; Agrawal, A				Gang, Toh B.; Hammond, David J., Jr.; Singh, Sanjay K.; Ferguson, Donald A., Jr.; Mishra, Vinod K.; Agrawal, Alok			The Phosphocholine-binding Pocket on C-reactive Protein Is Necessary for Initial Protection of Mice against Pneumococcal Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM AMYLOID-P; STREPTOCOCCUS-PNEUMONIAE INFECTION; SITE-DIRECTED MUTAGENESIS; PLATELET-ACTIVATING-FACTOR; FC-GAMMA-RIIA; FACTOR-H; MONOCLONAL-ANTIBODIES; COMPLEMENT ACTIVATION; COMPONENT; POLYSACCHARIDE	Human C-reactive protein (CRP) protects mice from lethal Streptococcus pneumoniae infection when injected into mice within the range of 6 h before to 2 h after the administration of pneumococci. Because CRP binds to phosphocholine-containing substances and subsequently activates the complement system, it has been proposed that the antipneumococcal function of CRP requires the binding of CRP to phosphocholine moieties present in pneumococcal cell wall C-polysaccharide. To test this proposal experimentally, in this study, we utilized a new CRP mutant incapable of binding to phosphocholine. Based on the structure of CRP-phosphocholine complexes, which showed that Phe(66), Thr(76), and Glu(81) formed the phosphocholine-binding pocket, we constructed a CRP mutant F66A/T76Y/E81A in which the pocket was blocked by substituting Tyr for Thr(76). When compared with wild-type CRP, mutant CRP bound more avidly to phosphoethanolamine and could be purified by affinity chromatography using phosphoethanolamine-conjugated Sepharose. Mutant CRP did not bind to phosphocholine, C-polysaccharide, or pneumococci. Mutant CRP was free in the mouse serum, and its rate of clearance in vivo was not faster than that of wild-type CRP. When either 25 mu g or 150 mu g of CRP was administered into mice, unlike wild-type CRP, mutant CRP did not protect mice from lethal pneumococcal infection. Mice injected with mutant CRP had higher mortality rates than mice that received wild-type CRP. Decreased survival was due to the increased bacteremia in mice treated with mutant CRP. We conclude that the phosphocholine-binding pocket on CRP is necessary for CRP-mediated initial protection of mice against lethal pneumococcal infection.	[Gang, Toh B.; Hammond, David J., Jr.; Singh, Sanjay K.; Ferguson, Donald A., Jr.; Agrawal, Alok] E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Mishra, Vinod K.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	East Tennessee State University; University of Alabama System; University of Alabama Birmingham	Agrawal, A (corresponding author), E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, POB 70577, Johnson City, TN 37614 USA.	agrawal@etsu.edu	Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512	National Institutes of Health [R01HL071233]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL071233 (to A. A.).	Abernethy TJ, 1941, J EXP MED, V73, P173, DOI 10.1084/jem.73.2.173; Agrawal A, 2002, J IMMUNOL, V169, P3217, DOI 10.4049/jimmunol.169.6.3217; Agrawal A, 1997, J IMMUNOL, V158, P345; Agrawal Alok, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P231, DOI 10.2174/187153008786848321; ANDERSON JK, 1978, FED PROC, V37, P1495; Bang R, 2005, J BIOL CHEM, V280, P25095, DOI 10.1074/jbc.M504782200; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Bitsaktsis C, 2012, INFECT IMMUN, V80, P1166, DOI 10.1128/IAI.05511-11; Black S, 2005, J IMMUNOL, V175, P1192, DOI 10.4049/jimmunol.175.2.1192; Chi M, 2002, J IMMUNOL, V168, P1413, DOI 10.4049/jimmunol.168.3.1413; CHRISTNER RB, 1994, ARCH BIOCHEM BIOPHYS, V314, P337, DOI 10.1006/abbi.1994.1451; CHUDWIN DS, 1985, INFECT IMMUN, V50, P213, DOI 10.1128/IAI.50.1.213-217.1985; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Gould JM, 2002, J INFECT DIS, V186, P361, DOI 10.1086/341658; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; HIND CRK, 1984, J EXP MED, V159, P1058, DOI 10.1084/jem.159.4.1058; HOROWITZ J, 1987, J IMMUNOL, V138, P2598; Jones NR, 2011, ARTHRITIS RHEUM-US, V63, P2641, DOI 10.1002/art.30444; KILPATRICK JM, 1982, MOL IMMUNOL, V19, P1159, DOI 10.1016/0161-5890(82)90326-1; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; Kushner Irving, 2011, Pharos Alpha Omega Alpha Honor Med Soc, V74, P14; Loeffler J.M., 2009, Q J MED, V102, P644; LOVELESS RW, 1992, EMBO J, V11, P813, DOI 10.1002/j.1460-2075.1992.tb05118.x; Malley R, 2012, P NATL ACAD SCI USA, V109, P3623, DOI 10.1073/pnas.1121383109; Mikolajek H, 2011, J MOL RECOGNIT, V24, P371, DOI 10.1002/jmr.1090; MOLD C, 1982, INFECT IMMUN, V37, P987, DOI 10.1128/IAI.37.3.987-992.1982; Mold C, 2002, J IMMUNOL, V168, P6375, DOI 10.4049/jimmunol.168.12.6375; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; MOLD C, 1982, INFECT IMMUN, V38, P392, DOI 10.1128/IAI.38.1.392-395.1982; MOLD C, 1984, J IMMUNOL, V133, P882; NAKAYAMA S, 1983, CLIN EXP IMMUNOL, V54, P319; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; OLIVEIRA EB, 1980, J IMMUNOL, V124, P1396; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; ROUX KH, 1983, J IMMUNOL, V131, P2411; Rutemark C, 2011, P NATL ACAD SCI USA, V108, pE934, DOI 10.1073/pnas.1109831108; SCHWALBE RA, 1992, BIOCHEMISTRY-US, V31, P4907, DOI 10.1021/bi00135a023; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Singh SK, 2012, J BIOL CHEM, V287, P3550, DOI 10.1074/jbc.M111.310011; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Suresh MV, 2006, J IMMUNOL, V176, P4369, DOI 10.4049/jimmunol.176.7.4369; Suresh MV, 2004, J BIOL CHEM, V279, P52552, DOI 10.1074/jbc.M409054200; SZALAI AJ, 1995, J IMMUNOL, V155, P2557; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Thomas-Rudolph D, 2007, J IMMUNOL, V178, P7283, DOI 10.4049/jimmunol.178.11.7283; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Togashi S, 1997, LAB INVEST, V77, P525; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; VOLANAKIS JE, 1982, ANN NY ACAD SCI, V389, P235, DOI 10.1111/j.1749-6632.1982.tb22140.x; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; WHITEHEAD AS, 1990, BIOCHEM J, V266, P283, DOI 10.1042/bj2660283; YING SC, 1989, J IMMUNOL, V143, P221; YOTHER J, 1982, J IMMUNOL, V128, P2374; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Zhang J, 2011, BIOCHIMIE, V93, P1710, DOI 10.1016/j.biochi.2011.06.003; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	66	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43116	43125		10.1074/jbc.M112.427310	http://dx.doi.org/10.1074/jbc.M112.427310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23139417	hybrid, Green Published			2022-12-25	WOS:000312501600067
J	Kawahara, Y; Oono, Y; Kanamori, H; Matsumoto, T; Itoh, T; Minami, E				Kawahara, Yoshihiro; Oono, Youko; Kanamori, Hiroyuki; Matsumoto, Takashi; Itoh, Takeshi; Minami, Eiichi			Simultaneous RNA-Seq Analysis of a Mixed Transcriptome of Rice and Blast Fungus Interaction	PLOS ONE			English	Article							CHITIN-TRIGGERED IMMUNITY; MAGNAPORTHE-ORYZAE; PLANT INFECTION; GENES; PROTEINS; INDUCTION; SEQUENCES; REVEALS; BIOLOGY; ROLES	A filamentous fungus, Magnaporthe oryzae, is a causal agent of rice blast disease, which is one of the most serious diseases affecting cultivated rice, Oryza sativa. However, the molecular mechanisms underlying both rice defense and fungal attack are not yet fully understood. Extensive past studies have characterized many infection-responsive genes in the pathogen and host plant, separately. To understand the plant-pathogen interaction comprehensively, it is valuable to monitor the gene expression profiles of both interacting organisms simultaneously in the same infected plant tissue. Although the host-pathogen interaction during the initial infection stage is important for the establishment of infection, the detection of fungal gene expression in infected leaves at the stage has been difficult because very few numbers of fungal cells are present. Using the emerging RNA-Seq technique, which has a wide dynamic range for expression analyses, we analyzed the mixed transcriptome of rice and blast fungus in infected leaves at 24 hours post-inoculation, which is the point when the primary infection hyphae penetrate leaf epidermal cells. We demonstrated that our method detected the gene expression of both the host plant and pathogen simultaneously in the same infected leaf blades in natural infection conditions without any artificial treatments. The upregulation of 240 fungal transcripts encoding putative secreted proteins was observed, suggesting that these candidates of fungal effector genes may play important roles in initial infection processes. The upregulation of transcripts encoding glycosyl hydrolases, cutinases and LysM domain-containing proteins were observed in the blast fungus, whereas pathogenesis-related and phytoalexin biosynthetic genes were upregulated in rice. Furthermore, more drastic changes in expression were observed in the incompatible interactions compared with the compatible ones in both rice and blast fungus at this stage. Our mixed transcriptome analysis is useful for the simultaneous elucidation of the tactics of host plant defense and pathogen attack.	[Kawahara, Yoshihiro; Oono, Youko; Kanamori, Hiroyuki; Matsumoto, Takashi; Itoh, Takeshi] Natl Inst Agrobiol Sci, Agrogenom Res Ctr, Tsukuba, Ibaraki, Japan; [Minami, Eiichi] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Itoh, T (corresponding author), Natl Inst Agrobiol Sci, Agrogenom Res Ctr, Tsukuba, Ibaraki, Japan.	taitoh@affrc.go.jp		Itoh, Takeshi/0000-0002-6291-4233	Genomics for Agricultural Innovation from the Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan [RTR0001]	Genomics for Agricultural Innovation from the Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan	This work was supported by Genomics for Agricultural Innovation (RTR0001) from the Ministry of Agriculture, Forestry and Fisheries (MAFF) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Agrawal GK, 2001, PLANT PHYSIOL BIOCH, V39, P1095, DOI 10.1016/S0981-9428(01)01333-X; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Chittoor JM, 1997, MOL PLANT MICROBE IN, V10, P861, DOI 10.1094/MPMI.1997.10.7.861; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Hasegawa M, 2010, MOL PLANT MICROBE IN, V23, P1000, DOI 10.1094/MPMI-23-8-1000; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kato T, 2009, PLANT MOL BIOL, V70, P617, DOI 10.1007/s11103-009-9495-9; Kim JY, 2009, INT J MOL SCI, V10, P2860, DOI 10.3390/ijms10062860; Kim S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-104; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Q, 2006, PHYSIOL MOL PLANT P, V68, P51, DOI 10.1016/j.pmpp.2006.06.002; Lu G, 2004, THEOR APPL GENET, V108, P525, DOI 10.1007/s00122-003-1451-5; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; McGhee JD, 2001, MOL PLANT MICROBE IN, V14, P877, DOI 10.1094/MPMI.2001.14.7.877; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Numa H, 2009, FEBS LETT, V583, P797, DOI 10.1016/j.febslet.2009.01.041; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Ohtaki S, 2006, APPL ENVIRON MICROB, V72, P2407, DOI 10.1128/AEM.72.4.2407-2413.2006; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rauyaree P, 2001, MOL PLANT PATHOL, V2, P347, DOI 10.1046/j.1464-6722.2001.00085.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shen QXJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-3; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Skamnioti P, 2007, PLANT CELL, V19, P2674, DOI 10.1105/tpc.107.051219; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Tanabe S, 2006, BIOSCI BIOTECH BIOCH, V70, P1599, DOI 10.1271/bbb.50677; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valent B, 2010, CURR OPIN PLANT BIOL, V13, P434, DOI 10.1016/j.pbi.2010.04.012; Wang Y, 2011, J PROTEOME RES, V10, P3136, DOI 10.1021/pr200202m; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilson DB, 2008, ANN NY ACAD SCI, V1125, P289, DOI 10.1196/annals.1419.026; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xue CY, 2002, PLANT CELL, V14, P2107, DOI 10.1105/tpc.003426	61	174	181	12	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e49423	10.1371/journal.pone.0049423	http://dx.doi.org/10.1371/journal.pone.0049423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139845	gold, Green Submitted, Green Published			2022-12-25	WOS:000311315300074
J	Nattier, R; Grandcolas, P; Elias, M; Desutter-Grandcolas, L; Jourdan, H; Couloux, A; Robillard, T				Nattier, Romain; Grandcolas, Philippe; Elias, Marianne; Desutter-Grandcolas, Laure; Jourdan, Herve; Couloux, Arnaud; Robillard, Tony			Secondary Sympatry Caused by Range Expansion Informs on the Dynamics of Microendemism in a Biodiversity Hotspot	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; NEW-CALEDONIA; GEOGRAPHICAL PATTERN; MOLECULAR PHYLOGENY; SPECIES RICHNESS; DIVING BEETLES; SPECIATION; DIVERSIFICATION; EVOLUTION; BIOGEOGRAPHY	Islands are bounded areas where high endemism is explained either by allopatric speciation through the fragmentation of the limited amount of space available, or by sympatric speciation and accumulation of daughter species. Most empirical evidence point out the dominant action of allopatric speciation. We evaluate this general view by looking at a case study where sympatric speciation is suspected. We analyse the mode, tempo and geography of speciation in Agnotecous, a cricket genus endemic to New Caledonia showing a generalized pattern of sympatry between species making sympatric speciation plausible. We obtained five mitochondrial and five nuclear markers (6.8 kb) from 37 taxa corresponding to 17 of the 21 known extant species of Agnotecous, and including several localities per species, and we conducted phylogenetic and dating analyses. Our results suggest that the diversification of Agnotecous occurred mostly through allopatric speciation in the last 10 Myr. Highly microendemic species are the most recent ones (<2 Myr) and current sympatry is due to secondary range expansion after allopatric speciation. Species distribution should then be viewed as a highly dynamic process and extreme microendemism only as a temporary situation. We discuss these results considering the influence of climatic changes combined with intricate soil diversity and mountain topography. A complex interplay between these factors could have permitted repeated speciation events and range expansion.	[Nattier, Romain; Grandcolas, Philippe; Elias, Marianne; Desutter-Grandcolas, Laure; Robillard, Tony] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR CNRS OSEB 7205, F-75231 Paris, France; [Jourdan, Herve] Aix Marseille Univ CNRS IRD UAPV, Inst Mediterraneen Biodiversite & Ecol Terr & Mar, IMBE, Ctr IRD Noumea,UMR IRD 237, Noumea, New Caledonia; [Couloux, Arnaud] Genoscope, Ctr Natl Sequencage, Evry, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Nattier, R (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, UMR CNRS OSEB 7205, Case Postale 50 Entomol, F-75231 Paris, France.	nattier@mnhn.fr	Nattier, Romain/C-7005-2016; Robillard, Tony/H-3523-2011; Elias, Marianne/S-6359-2016; Jourdan, Herve/D-1452-2011	Robillard, Tony/0000-0002-2177-9549; Jourdan, Herve/0000-0002-3756-4008; Grandcolas, Philippe/0000-0003-1374-1222	French Agence Nationale de la Recherche (ANR); Biodiversity research grant BIONEOCAL; Museum national d'Histoire naturelle (MNHN); Gouvernement de Nouvelle-Caledonie; Prevost Fund of the Ecole Doctorale of the Museum; Consortium National de Recherche en Genomique; MNHN [2005/67, CNRS UMS2700]	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Biodiversity research grant BIONEOCAL; Museum national d'Histoire naturelle (MNHN); Gouvernement de Nouvelle-Caledonie; Prevost Fund of the Ecole Doctorale of the Museum; Consortium National de Recherche en Genomique; MNHN	The following institutions or programs have supported the work: the French Agence Nationale de la Recherche (ANR) for funding via the Biodiversity research grant BIONEOCAL, to P. G.; the Museum national d'Histoire naturelle (MNHN); the Gouvernement de Nouvelle-Caledonie and the Prevost Fund of the Ecole Doctorale of the Museum for funding the PhD of R. N.; and the Consortium National de Recherche en Genomique, and the MNHN (CNRS UMS2700), under agreement number 2005/67 between Genoscope and the MNHN for the project 'Macrophylogeny of life' of Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Balke M, 2004, MOL PHYLOGENET EVOL, V32, P866, DOI 10.1016/j.ympev.2004.03.014; Balke M, 2007, MOL PHYLOGENET EVOL, V42, P505, DOI 10.1016/j.ympev.2006.07.019; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Bartish IV, 2005, AM J BOT, V92, P667, DOI 10.3732/ajb.92.4.667; Bauer Aaron M., 2006, Proceedings of the California Academy of Sciences, V57, P503; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; CHESSER RT, 1994, EVOLUTION, V48, P490, DOI 10.1111/j.1558-5646.1994.tb01326.x; Chevillotte V, 2006, GEOMORPHOLOGY, V81, P361, DOI 10.1016/j.geomorph.2006.04.020; Desutter-Grandcolas L, 2006, SYST ENTOMOL, V31, P65, DOI 10.1111/j.1365-3113.2005.00299.x; Desutter-Grandcolas L, 1997, MEMOIRES MUSEUM NATL, P125; Desutter-Grandcolas Laure, 1997, Memoires du Museum National d'Histoire Naturelle, V171, P165; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espeland M, 2008, MOL PHYLOGENET EVOL, V48, P904, DOI 10.1016/j.ympev.2008.06.006; Espeland M, 2010, J BIOGEOGR, V37, P879, DOI 10.1111/j.1365-2699.2009.02263.x; Fitzpatrick BM, 2006, EVOLUTION, V60, P601; Goloboff P, 2008, CLADISTICS, V24, P91; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Gorochov A.V., 1986, REV ENTOMOLOGIE URSS, V65, P692; GOROKHOV AV, 1985, PALEONTOL ZH, P59; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Grandcolas P, 2011, CLADISTICS, V27, P181, DOI 10.1111/j.1096-0031.2010.00324.x; Grant PR, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P326; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heibl C., 2011, PHYLOCLIM INTEGRATIN; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Hollingsworth PR, 2009, EVOLUTION, V63, P228, DOI 10.1111/j.1558-5646.2008.00531.x; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Jiggins CD, 2006, EVOLUTION, V60, P1454, DOI 10.1111/j.0014-3820.2006.tb01224.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Linnen CR, 2010, P ROY SOC B-BIOL SCI, V277, P3131, DOI 10.1098/rspb.2010.0577; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lowry PP, 1998, ACAD SINICA MONOGRAP, P181; Lynch J.D., 1989, P527; MOORE BR, 2004, COMPU BIOL, V4, P487; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Murienne J, 2005, CLADISTICS, V21, P2, DOI 10.1111/j.1096-0031.2004.00042.x; Murienne J, 2009, BIOL J LINN SOC, V97, P177, DOI 10.1111/j.1095-8312.2008.01184.x; Murienne Jerome, 2008, P261; Nattier R, 2011, J BIOGEOGR, V38, P2195, DOI 10.1111/j.1365-2699.2011.02563.x; Nylander JAA, 2004, MRMODELTEST VER 2; Ochoa-Ochoa LM, 2012, BIOL CONSERV, V150, P94, DOI 10.1016/j.biocon.2012.03.010; OTTE D, 1987, P ACAD NAT SCI PHILA, V139, P375; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paris J.-P., 1981, Memoire du B.R.G.M., P1; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Perret M, 2007, EVOLUTION, V61, P1641, DOI 10.1111/j.1558-5646.2007.00136.x; Phillimore AB, 2008, AM NAT, V171, P646, DOI 10.1086/587074; Pillon Y, 2009, MOL ECOL, V18, P2263, DOI 10.1111/j.1365-294X.2009.04178.x; Ponder WF, 2002, INVERTEBR SYST, V16, P571, DOI 10.1071/IT01043; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A, 2014, TRACER V1 6; Ratsoavina FM, 2010, ZOOTAXA, P62; RAXWORTHY CJ, 1995, J ZOOL, V235, P525, DOI 10.1111/j.1469-7998.1995.tb01767.x; Robillard T, 2006, MOL PHYLOGENET EVOL, V40, P643, DOI 10.1016/j.ympev.2005.10.019; Robillard T, 2010, ZOOTAXA, P17; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Maranon M, 1999, CAN J SOIL SCI, V79, P431, DOI 10.4141/S98-063; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schliewen U, 2001, MOL ECOL, V10, P1471, DOI 10.1046/j.1365-294X.2001.01276.x; Smith SA, 2007, MOL PHYLOGENET EVOL, V43, P1151, DOI 10.1016/j.ympev.2007.02.007; Swenson U, 2007, TAXON, V56, P329, DOI 10.1002/tax.562007; Trewick S, 2008, MEMOIRES MUSEUM NATL, V6, P421; Vences M, 2010, AFR J HERPETOL, V59, P133, DOI 10.1080/21564574.2010.512961; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x	78	32	34	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48047	10.1371/journal.pone.0048047	http://dx.doi.org/10.1371/journal.pone.0048047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139758	Green Published, Green Submitted, gold			2022-12-25	WOS:000311315300016
J	Rothfuchs, AG; Roffe, E; Gibson, A; Cheever, AW; Ezekowitz, RAB; Takahashi, K; Steindel, M; Sher, A; Bafica, A				Rothfuchs, Antonio Gigliotti; Roffe, Ester; Gibson, Amanda; Cheever, Allen W.; Ezekowitz, R. Alan B.; Takahashi, Kazue; Steindel, Mario; Sher, Alan; Bafica, Andre			Mannose-Binding Lectin Regulates Host Resistance and Pathology during Experimental Infection with Trypanosoma cruzi	PLOS ONE			English	Article							MICE; TISSUE; SUSCEPTIBILITY; AMASTIGOTES; RECOGNITION; ACTIVATION; EXPRESSION; INHIBITOR; SURVIVAL; PATHWAY	Mannose-binding lectin (MBL) is a humoral pattern-recognition molecule important for host defense. Although recent genetic studies suggest an involvement of MBL/MASP2-associated pathways in Chagas' disease, it is currently unknown whether MBL plays a role in host resistance to the intracellular protozoan Trypanosoma cruzi, the causative agent of Chagas' disease. In this study we employed MBL-/- mice to assess the role of MBL in resistance to experimental infection with T. cruzi. T. cruzi infection enhanced tissue expression of MBL both at the mRNA and protein level. Similarly, symptomatic acute Chagas' disease patients displayed increased serum concentrations of MBL compared to patients with indeterminate, asymptomatic forms of the disease. Furthermore, increased parasite loads in the blood and/or tissue were observed in MBL-/- mice compared to WT controls. This was associated with reduced systemic levels of IL-12/23p40 in MBL-/- mice. Importantly, MBL-/- mice infected with a cardiotropic strain of T. cruzi displayed increased myocarditis and cardiac fibrosis compared to WT controls. The latter was accompanied by elevated hydroxyproline content and mRNA levels of collagen-1 and -6 in the heart. These observations point to a previously unappreciated role for MBL in regulating host resistance and cardiac inflammation during infection with a major human pathogen.	[Rothfuchs, Antonio Gigliotti; Gibson, Amanda; Cheever, Allen W.; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Roffe, Ester] NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Cheever, Allen W.] Biomed Res Inst, Rockville, MD 20852 USA; [Ezekowitz, R. Alan B.; Takahashi, Kazue] Harvard Univ, Sch Med, Dept Pediat, Lab Dev Immunol,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Rothfuchs, Antonio Gigliotti] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Steindel, Mario; Bafica, Andre] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard Medical School; Massachusetts General Hospital; Karolinska Institutet; Universidade Federal de Santa Catarina (UFSC)	Rothfuchs, AG (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	antonio.rothfuchs@ki.se; andre.bafica@ufsc.br	Steindel, Mario/N-2040-2018; Rothfuchs, Antonio G/F-5981-2013; Bafica, Andre/ABF-5986-2020; Roffê, Ester/H-4688-2012; Steindel, Mario/H-2945-2015	Steindel, Mario/0000-0002-2768-7469; Rothfuchs, Antonio G/0000-0001-6001-7240; Bafica, Andre/0000-0002-5148-600X; Steindel, Mario/0000-0002-2768-7469	Intramural Research Program of the NIAID; EU [FP7-MC-IRG-247684]; Swedish Society for Medicine	Intramural Research Program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EU(European Commission); Swedish Society for Medicine	This work was supported by the Intramural Research Program of the NIAID. AB and MS are CNPq senior research fellows. AGR is a recipient of a Marie Curie International Reintegration grant from the EU (FP7-MC-IRG-247684) and a project grant from the Swedish Society for Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alonso DP, 2007, J INFECT DIS, V195, P1212, DOI 10.1086/512683; Amato Neto V, 1974, Rev Inst Med Trop Sao Paulo, V16, P238; Assaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034113; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; BERGMAN I, 1970, ANAL CHEM, V42, P702, DOI 10.1021/ac60289a036; Boldt ABW, 2011, CLIN IMMUNOL, V140, P63, DOI 10.1016/j.clim.2011.03.008; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711; Cestari ID, 2008, J INFECT DIS, V198, P1276, DOI 10.1086/592167; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; Ezekowitz RA, 2003, J INFECT DIS, V187, pS335, DOI 10.1086/374746; FEDERICI EE, 1964, AM J TROP MED HYG, V13, P272, DOI 10.4269/ajtmh.1964.13.272; Ferreira V, 2004, J IMMUNOL, V172, P3042, DOI 10.4049/jimmunol.172.5.3042; Gadjeva M, 2004, CLIN EXP IMMUNOL, V138, P304, DOI 10.1111/j.1365-2249.2004.02616.x; GREEN PJ, 1994, MOL BIOCHEM PARASIT, V66, P319, DOI 10.1016/0166-6851(94)90158-9; Hansen S, 2000, J IMMUNOL, V164, P2610, DOI 10.4049/jimmunol.164.5.2610; Held K, 2008, MOL IMMUNOL, V45, P3934, DOI 10.1016/j.molimm.2008.06.021; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; HUDSON L, 1984, PARASITOLOGY, V88, P283, DOI 10.1017/S0031182000054536; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Kahn SJ, 1996, INFECT IMMUN, V64, P2649, DOI 10.1128/IAI.64.7.2649-2656.1996; Keller TT, 2006, ARTERIOSCL THROM VAS, V26, P2345, DOI 10.1161/01.ATV.0000240517.69201.77; LEY V, 1988, J EXP MED, V168, P649, DOI 10.1084/jem.168.2.649; Liu H, 2001, SCAND J IMMUNOL, V53, P489, DOI 10.1046/j.1365-3083.2001.00908.x; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; Matthijsen RA, 2009, CIRCULATION, V119, P2188, DOI 10.1161/CIRCULATIONAHA.108.830661; MELO RC, 1978, J PARASITOL, V64, P475, DOI 10.2307/3279787; Moller-Kristensen M, 2006, J IMMUNOL, V176, P1769, DOI 10.4049/jimmunol.176.3.1769; Moller-Kristensen M, 2005, SCAND J IMMUNOL, V61, P426, DOI 10.1111/j.1365-3083.2005.01591.x; Monteiro AC, 2007, PLOS PATHOG, V3, P1730, DOI 10.1371/journal.ppat.0030185; NOGUEIRA N, 1976, J EXP MED, V143, P1402, DOI 10.1084/jem.143.6.1402; Rocha MOC, 2003, FRONT BIOSCI-LANDMRK, V8, pE44, DOI 10.2741/926; Rodrigues Mauricio M., 2012, Journal of Parasitology Research, P507874, DOI 10.1155/2012/507874; SASTRY K, 1991, J IMMUNOL, V147, P692; Scharfstein J, 1999, MEM I OSWALDO CRUZ, V94, P51, DOI 10.1590/S0074-02761999000700005; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; SUPER M, 1989, LANCET, V2, P1236; Takahashi K, 2002, MICROBES INFECT, V4, P773, DOI 10.1016/S1286-4579(02)01597-6; Takahashi K, 2005, INFECT IMMUN, V73, P8188, DOI 10.1128/IAI.73.12.8188-8193.2005; TAMBOURGI DV, 1993, INFECT IMMUN, V61, P3656, DOI 10.1128/IAI.61.9.3656-3663.1993; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3; Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018; Tomlinson S, 1998, PARASITOL TODAY, V14, P354, DOI 10.1016/S0169-4758(98)01295-2; Tran CT, 2007, CLIN EXP IMMUNOL, V148, P101, DOI 10.1111/j.1365-2249.2007.03324.x; Turner M W, 2000, Rev Immunogenet, V2, P305; Uemura K, 2002, J IMMUNOL, V169, P6945, DOI 10.4049/jimmunol.169.12.6945; Wagner S, 2003, J IMMUNOL, V170, P1462, DOI 10.4049/jimmunol.170.3.1462; Weitzel T, 2012, AM J TROP MED HYG, V86, P229, DOI 10.4269/ajtmh.2012.11-0539; World Health Organization, 2002, WORLD HLTH REP	54	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47835	10.1371/journal.pone.0047835	http://dx.doi.org/10.1371/journal.pone.0047835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139754	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300012
J	Tauber, S; Paulsen, K; Wolf, S; Synwoldt, P; Pahl, A; Schneider-Stock, R; Ullrich, O				Tauber, Svantje; Paulsen, Katrin; Wolf, Susanne; Synwoldt, Peggy; Pahl, Andreas; Schneider-Stock, Regine; Ullrich, Oliver			Regulation of MMP-9 by a WIN-Binding Site in the Monocyte-Macrophage System Independent from Cannabinoid Receptors	PLOS ONE			English	Article							POTENTIAL VANILLOID-1 TRPV1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OBSTRUCTIVE PULMONARY-DISEASE; CELL-SURFACE ASSOCIATION; HUMAN THP-1 MACROPHAGES; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; MATRIX METALLOPROTEINASES; MULTIPLE-SCLEROSIS; GELATINASE-B	The cannabinoid system is known to be involved in the regulation of inflammatory processes. Therefore, drugs targeting cannabinoid receptors are considered as candidates for anti-inflammatory and tissue protective therapy. We demonstrated that the prototypical cannabinoid agonist R(+) WIN55,212-2 (WIN) reduced the secretion of matrix metalloproteinase-9 (MMP-9) in a murine model of cigarette-smoke induced lung inflammation. In experiments using primary cells and cell lines of the monocyte-macrophage-system we found that binding of the cannabinoid-receptor agonist WIN to a stereo-selective, specific binding site in cells of the monocyte-macrophage-system induced a significant down-regulation of MMP-9 secretion and disturbance of intracellular processing, which subsequently down-regulated MMP-9 mRNA expression via a ERK1/2-phosphorylation-dependent pathway. Surprisingly, the anti-inflammatory effect was independent from classical cannabinoid receptors. Our experiments supposed an involvement of TRPV1, but other yet unidentified sites are also possible. We conclude that cannabinoid-induced control of MMP-9 in the monocyte-macrophage system via a cannabinoid-receptor independent pathway represents a general option for tissue protection during inflammation, such as during lung inflammation and other diseases associated with inflammatory tissue damage.	[Tauber, Svantje; Paulsen, Katrin; Wolf, Susanne; Ullrich, Oliver] Univ Zurich, Fac Med, Inst Anat, Zurich, Switzerland; [Tauber, Svantje; Paulsen, Katrin; Ullrich, Oliver] Univ Magdeburg, Inst Immunol, D-39106 Magdeburg, Germany; [Synwoldt, Peggy; Pahl, Andreas] Nycomed Germany Holding GmbH, Constance, Germany; [Schneider-Stock, Regine] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany; [Schneider-Stock, Regine] Univ Magdeburg, Inst Pathol, D-39106 Magdeburg, Germany; [Ullrich, Oliver] Univ Magdeburg, Dept Machine Design Engn Design & Prod Dev, Inst Engn Mech, D-39106 Magdeburg, Germany; [Ullrich, Oliver] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Ullrich, Oliver] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Ullrich, Oliver] ETH, Zurich, Switzerland	University of Geneva; University of Zurich; Otto von Guericke University; Nycomed GmbH; University of Erlangen Nuremberg; Otto von Guericke University; Otto von Guericke University; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ullrich, O (corresponding author), Univ Zurich, Fac Med, Inst Anat, Zurich, Switzerland.	oliver.ullrich@anatom.uzh.ch	Wolf, Susanne/AAA-6598-2022; Schneider-Stock, Regine/H-8863-2012	Wolf, Susanne/0000-0003-0922-8418	German Research Foundation; German Exzellenzinitiative; DFG (DFG Graduate School) [UL 177/6-1]	German Research Foundation(German Research Foundation (DFG)); German Exzellenzinitiative; DFG (DFG Graduate School)	Nycomed GmbH is a partner of the graduate school "Research Training Group RTG 1331'' (http://cms.uni-konstanz.de/rtg1331/introduction/general-profile-of-the-rtg-group/), funded by the German Research Foundation: The Research Training Group (RTG) is based on a collaboration between the University of Konstanz (UKN) and the research-driven pharmaceutical companies Nycomed and Boehringer-Ingelheim. The research program forges a link between basic molecular cell biology and the application and validation of model systems in biomedical research. A proven track-record in this translational approach is not only given by the partners from industry, but also by professors with a strong focus on cellular test systems in pharmacology-toxicology, and is further strengthened through a collaborative center on this topic (CAAT) together with Johns-Hopkins-University in Baltimore. The core academic groups with expertise in cell biology are also members of the new Graduate School Chemical Biology (KoRS-CB) supported by the German Exzellenzinitiative. The combined experience at the interface between basic and applied pharmaceutical research generates the profile of the graduate training program.'' Therefore, the role of Nycomed GmbH is to support the scientific goals of the research program within its field of expertise and to contribute to the teaching program of the graduate school. Nycomed GmbH has no commercial interest in the (freely available compound) tested in this study. Peggy Synwoldt and Andreas Pahl are employed by Nycomed Germany Holding GmbH. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.; This study was supported by a grant from the DFG (DFG Graduate School 1167 and FOR521 grant UL 177/6-1). ST was member of the DFG graduate school 1167 and member of the International Research Training Group "Cell-based Characterization of Disease Mechanisms in Tissue Destruction and Repair'' Konstanz/Zurich (IRTG 1331). URL: www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Alawi K, 2010, PHARMACOL THERAPEUT, V125, P181, DOI 10.1016/j.pharmthera.2009.10.005; Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Banvolgyi A, 2005, J NEUROIMMUNOL, V169, P86, DOI 10.1016/j.jneuroim.2005.08.012; Bellosta S, 1998, ARTERIOSCL THROM VAS, V18, P1671, DOI 10.1161/01.ATV.18.11.1671; Bellosta S, 2007, PHARMACOL RES, V56, P160, DOI 10.1016/j.phrs.2007.05.004; Belvisi MG, 2003, INFLAMM RES, V52, P95, DOI 10.1007/s000110300020; Berdyshev E, 1998, LIFE SCI, V63, pPL125, DOI 10.1016/S0024-3205(98)00324-5; Berdyshev EV, 1997, EUR J PHARMACOL, V330, P231, DOI 10.1016/S0014-2999(97)01007-8; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Blazquez C, 2008, CANCER RES, V68, P1945, DOI 10.1158/0008-5472.CAN-07-5176; Bolton C E, 2009, Chron Respir Dis, V6, P81, DOI 10.1177/1479972309103131; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Burstein S, 2005, LIFE SCI, V77, P1674, DOI 10.1016/j.lfs.2005.05.039; Carbonare MD, 2008, J NEUROENDOCRINOL, V20, P26, DOI 10.1111/j.1365-2826.2008.01689.x; Chandler S, 1995, NEUROSCI LETT, V201, P223, DOI 10.1016/0304-3940(95)12173-0; Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5; Corbel M, 2000, BRAZ J MED BIOL RES, V33, P749, DOI 10.1590/S0100-879X2000000700004; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; DANIELISSAKANI S, 1989, J BIOL CHEM, V264, P20240; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Engler A, 2007, BIOCHEM BIOPH RES CO, V359, P884, DOI 10.1016/j.bbrc.2007.05.178; Ermolli M, 2003, TRANSPL IMMUNOL, V11, P137, DOI 10.1016/S0966-3274(02)00150-8; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Fuller K, 2007, CLIN SCI, V112, P567, DOI 10.1042/CS20060274; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011; Gavva NR, 2007, J PHARMACOL EXP THER, V323, P128, DOI 10.1124/jpet.107.125674; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gu Y, 2010, FEMS IMMUNOL MED MIC, V58, P218, DOI 10.1111/j.1574-695X.2009.00625.x; Hao MX, 2010, J LIPID RES, V51, P2181, DOI 10.1194/jlr.M001511; Hasseldam H, 2010, NEUROIMMUNOMODULAT, V17, P252, DOI 10.1159/000290041; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Holla LI, 2006, J PERIODONTOL, V77, P1850, DOI 10.1902/jop.2006.050347; Honore P, 2005, J PHARMACOL EXP THER, V314, P410, DOI 10.1124/jpet.105.083915; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; Idris AI, 2010, CALCIFIED TISSUE INT, V87, P285, DOI 10.1007/s00223-010-9378-8; Idris AI, 2010, BONE, V46, P1089, DOI 10.1016/j.bone.2010.01.368; Ishida K, 2008, J PHARMACOL EXP THER, V324, P422, DOI 10.1124/jpet.107.131946; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Johanek LM, 2001, PAIN, V93, P303, DOI 10.1016/S0304-3959(01)00336-0; Johnson DR, 2007, J CELL BIOCHEM, V100, P184, DOI 10.1002/jcb.21046; Kang JH, 2007, J CELL BIOCHEM, V102, P506, DOI 10.1002/jcb.21312; Karabudak R, 2004, J NEUROL, V251, P279, DOI 10.1007/s00415-004-0285-7; Katsu M, 2010, J CEREBR BLOOD F MET, V30, P1939, DOI 10.1038/jcbfm.2010.45; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Klein TW, 2000, P SOC EXP BIOL MED, V225, P1, DOI 10.1046/j.1525-1373.2000.22501.x; Kurihara R, 2006, J BIOL CHEM, V281, P12908, DOI 10.1074/jbc.M510871200; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lee KJ, 2006, EXP MOL MED, V38, P364, DOI 10.1038/emm.2006.43; Liu LH, 2010, BIOCHEM BIOPH RES CO, V391, P1000, DOI 10.1016/j.bbrc.2009.12.005; Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0; Lombard C, 2007, CLIN IMMUNOL, V122, P259, DOI 10.1016/j.clim.2006.11.002; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Marchalant Y, 2009, NEUROBIOL DIS, V34, P300, DOI 10.1016/j.nbd.2009.01.014; Marom B, 2007, J LEUKOCYTE BIOL, V81, P1466, DOI 10.1189/jlb.0506328; Massa F, 2006, J MOL MED, V84, P142, DOI 10.1007/s00109-005-0016-2; Muroski ME, 2008, CURR PHARM BIOTECHNO, V9, P34; Nagase H, 1997, BIOL CHEM, V378, P151; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Oka S, 2006, EUR J PHARMACOL, V538, P154, DOI 10.1016/j.ejphar.2006.03.021; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Ou YQ, 2009, ACTA PHARMACOL SIN, V30, P435, DOI 10.1038/aps.2009.21; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Ozenci V, 2000, J NEUROIMMUNOL, V108, P236, DOI 10.1016/S0165-5728(00)00281-2; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pandey R, 2009, PHARMACOL RES, V60, P85, DOI 10.1016/j.phrs.2009.03.019; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; Pender SLF, 2006, ANN NY ACAD SCI, V1072, P386, DOI 10.1196/annals.1326.019; Pertwee RG, 2005, AAPS J, V7, pE625, DOI 10.1208/aapsj070364; Porcella A, 2001, EUR J NEUROSCI, V13, P409, DOI 10.1046/j.0953-816X.2000.01401.x; Preet A, 2011, CANCER PREV RES, V4, P65, DOI 10.1158/1940-6207.CAPR-10-0181; Price TJ, 2004, BRIT J PHARMACOL, V142, P257, DOI 10.1038/sj.bjp.0705778; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Rahat MA, 2006, J LEUKOCYTE BIOL, V79, P706, DOI 10.1189/jlb.0605302; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Reddy RC, 2004, AM J PHYSIOL-LUNG C, V286, pL613, DOI 10.1152/ajplung.00206.2003; Rival Y, 2004, DNA CELL BIOL, V23, P283, DOI 10.1089/104454904323090912; Roberts FA, 1997, INFECT IMMUN, V65, P3248, DOI 10.1128/IAI.65.8.3248-3254.1997; Rockwell CE, 2006, MOL PHARMACOL, V70, P101, DOI 10.1124/mol.105.019117; Rosch S, 2006, J PHARMACOL EXP THER, V316, P1219, DOI 10.1124/jpet.105.092858; Ross RA, 2000, EUR J PHARMACOL, V401, P121, DOI 10.1016/S0014-2999(00)00437-4; Rossi F, 2009, BONE, V44, P476, DOI 10.1016/j.bone.2008.10.056; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Salzet M, 2002, PROSTAG LEUKOTR ESS, V66, P353, DOI 10.1054/plef.2001.0347; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Sellebjerg F, 2003, BRAIN RES BULL, V61, P347, DOI 10.1016/S0361-9230(03)00097-2; Soneji ND, 2010, LIFE SCI, V87, P162, DOI 10.1016/j.lfs.2010.06.003; Song ZH, 2000, J PHARMACOL EXP THER, V294, P204; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Speidl WS, 2004, FASEB J, V18, P603, DOI 10.1096/fj.03-0454fje; Stefano GB, 1996, J BIOL CHEM, V271, P19238, DOI 10.1074/jbc.271.32.19238; Tachado SD, 2005, AM J RESP CELL MOL, V33, P610, DOI 10.1165/rcmb.2004-0341OC; Takeshita S, 1996, J IMMUNOL, V156, P2591; Teng HP, 2004, LIFE SCI, V75, P2515, DOI 10.1016/j.lfs.2004.04.037; Tollersrud OK, 1997, EUR J BIOCHEM, V246, P410, DOI 10.1111/j.1432-1033.1997.00410.x; Tomlinson ML, 2008, MECH DEVELOP, V125, P1059, DOI 10.1016/j.mod.2008.07.005; Toth M, 1997, CANCER RES, V57, P3159; Turner NA, 2005, FASEB J, V19, P804, DOI 10.1096/fj.04-2852fje; UCLA C, 1990, J CLIN INVEST, V85, P185, DOI 10.1172/JCI114411; Ullrich O, 2007, J NEUROIMMUNOL, V184, P127, DOI 10.1016/j.jneuroim.2006.11.018; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Valiveti S, 2004, INT J PHARMACEUT, V278, P173, DOI 10.1016/j.ijpharm.2004.03.009; Valleala H, 2003, LIFE SCI, V73, P2413, DOI 10.1016/S0024-3205(03)00657-X; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; WATANABE H, 1993, J CELL SCI, V104, P991; Whyte LS, 2011, BR J PHARM; Wong BM, 2001, J LEUKOCYTE BIOL, V69, P959; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Wu LH, 2000, BIOCHEM BIOPH RES CO, V269, P808, DOI 10.1006/bbrc.2000.2368; Xian XS, 2010, J CELL BIOCHEM, V110, P321, DOI 10.1002/jcb.22540; Xie ZL, 2004, J BIOL CHEM, V279, P39513, DOI 10.1074/jbc.M405844200; Xue F, 2008, HEPATOL RES, V38, P810, DOI 10.1111/j.1872-034X.2008.00333.x; Yasuda T, 2007, INFLAMM RES, V56, P246, DOI 10.1007/s00011-007-6168-5; Yu XY, 2007, J INTERF CYTOK RES, V27, P103, DOI 10.1089/jir.2006.0054; Zhao Y, 2010, EUR J PHARM; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	128	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48272	10.1371/journal.pone.0048272	http://dx.doi.org/10.1371/journal.pone.0048272			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139770	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000311315300023
J	Yoon, C; Cattamanchi, A; Davis, JL; Worodria, W; den Boon, S; Kalema, N; Katagira, W; Kaswabuli, S; Miller, C; Andama, A; Albert, H; Nabeta, P; Gray, C; Ayakaka, I; Huang, L				Yoon, Christina; Cattamanchi, Adithya; Davis, J. Lucian; Worodria, William; den Boon, Saskia; Kalema, Nelson; Katagira, Winceslaus; Kaswabuli, Sylvia; Miller, Cecily; Andama, Alfred; Albert, Heidi; Nabeta, Pamela; Gray, Christen; Ayakaka, Irene; Huang, Laurence			Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; RIFAMPIN RESISTANCE; SOUTH-AFRICA; DIAGNOSIS; DELAY; INFECTION; MORTALITY; TB	Rationale: The clinical impact of Xpert MTB/RIF for tuberculosis (TB) diagnosis in high HIV-prevalence settings is unknown. Objective: To determine the diagnostic accuracy and impact of Xpert MTB/RIF among high-risk TB suspects. Methods: We prospectively enrolled consecutive, hospitalized, Ugandan TB suspects in two phases: baseline phase in which Xpert MTB/RIF results were not reported to clinicians and an implementation phase in which results were reported. We determined the diagnostic accuracy of Xpert MTB/RIF in reference to culture (solid and liquid) and compared patient outcomes by study phase. Results: 477 patients were included (baseline phase 287, implementation phase 190). Xpert MTB/RIF had high sensitivity (187/237, 79%, 95% CI: 73-84%) and specificity (190/199, 96%, 95% CI: 92-98%) for culture-positive TB overall, but sensitivity was lower (34/81, 42%, 95% CI: 31-54%) among smear-negative TB cases. Xpert MTB/RIF reduced median days-to-TB detection for all TB cases (1 [IQR 0-26] vs. 0 [IQR 0-1], p < 0.001), and for smear-negative TB (35 [IQR 22-55] vs. 22 [IQR 0-33], p = 0.001). However, median days-to-TB treatment was similar for all TB cases (1 [IQR 0-5] vs. 0 [IQR 0-2], p = 0.06) and for smear-negative TB (7 [IQR 3-53] vs. 6 [IQR 1-61], p = 0.78). Two-month mortality was also similar between study phases among 252 TB cases (17% vs. 14%, difference +3%, 95% CI: -21% to +27%, p = 0.80), and among 87 smear-negative TB cases (28% vs. 22%, difference +6%, 95% CI: -34 to +46%, p = 0.77). Conclusions: Xpert MTB/RIF facilitated more accurate and earlier TB diagnosis, leading to a higher proportion of TB suspects with a confirmed TB diagnosis prior to hospital discharge in a high HIV/low MDR TB prevalence setting. However, our study did not detect a decrease in two-month mortality following implementation of Xpert MTB/RIF possibly because of insufficient powering, differences in empiric TB treatment rates, and disease severity between study phases.	[Yoon, Christina; Cattamanchi, Adithya; Davis, J. Lucian; Miller, Cecily; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Cattamanchi, Adithya; Davis, J. Lucian] Univ Calif San Francisco, San Francisco Gen Hosp, Curry Int TB Ctr, San Francisco, CA USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Worodria, William; Andama, Alfred] Makerere Univ, Fac Med, Dept Med, Kampala, Uganda; [Worodria, William] Uganda Minist Hlth, Kampala, Uganda; [den Boon, Saskia; Kalema, Nelson; Katagira, Winceslaus; Kaswabuli, Sylvia; Ayakaka, Irene] Makerere Univ Univ Calif San Francisco Res Collab, Kampala, Uganda; [Albert, Heidi] Fdn Innovat New Diagnost, Kampala, Uganda; [Nabeta, Pamela; Gray, Christen] Fdn Innovat New Diagnost, Geneva, Switzerland	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Makerere University; Foundation For Innovative New Diagnostics; Foundation For Innovative New Diagnostics	Cattamanchi, A (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	acattamanchi@medsfgh.ucsf.edu	Huang, Laurence/AAZ-7120-2021; Huang, Laurence/AAE-1590-2019; Davis, J. Lucian/AAC-8376-2019; Trajman, Anete/C-7679-2016; Kalema, Nelson/AAZ-5730-2020	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Trajman, Anete/0000-0002-4000-4984; Kalema, Nelson/0000-0002-7118-704X; Katagira, Winceslaus/0000-0003-4622-191X; Gray, Christen/0000-0002-9723-3032	National Institutes of Health [K23HL094141, K24HL087713, R01HL090335, K23A1080147]; Foundation for Innovative New Diagnostics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090335, K24HL087713, T32HL007185, K23HL094141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Innovative New Diagnostics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health K23HL094141 (to AC), K24HL087713 (to LH), R01HL090335 (to LH), K23A1080147 (to JLD), and Foundation for Innovative New Diagnostics (to LH). The Foundation for Innovative New Diagnostics (FIND) developed the protocol for the multi-country Xpert MTB/RIF implementation study on which this analysis is based and FIND co-authors participated in drafting the manuscript. No other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GG, 2004, INT J TUBERC LUNG D, V8, P1472; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cattamanchi A, 2011, AM J RESP CRIT CARE, V183, P547, DOI 10.1164/rccm.201008-1207OC; Chang K, 2012, J INFECT; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Greenaway C, 2002, AM J RESP CRIT CARE, V165, P927, DOI 10.1164/ajrccm.165.7.2107040; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Holtz TH, 2011, LANCET INFECT DIS, V11, P533, DOI 10.1016/S1473-3099(11)70057-3; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Kent P, 1985, PUBLIC HLTH MYCOBATE; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lin CY, 2010, J FORMOS MED ASSOC, V109, P269, DOI 10.1016/S0929-6646(10)60052-6; Liu TT, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/937013; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Millen SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001933; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Ramsay A, 2010, INT J TUBERC LUNG D, V14, P1506; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Silva DR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-57; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Perrechi MCT, 2011, J BRAS PNEUMOL, V37, P783, DOI 10.1590/S1806-37132011000600012; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; WHO, 2011, POL STAT AUT REAL TI	34	63	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48599	10.1371/journal.pone.0048599	http://dx.doi.org/10.1371/journal.pone.0048599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139799	Green Published, gold			2022-12-25	WOS:000311315300042
J	Mora, G; Scharnewski, M; Fulda, M				Mora, Gabriel; Scharnewski, Michael; Fulda, Martin			Neutral Lipid Metabolism Influences Phospholipid Synthesis and Deacylation in Saccharomyces cerevisiae	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; MITOCHONDRIAL-MEMBRANES; STERYL ESTERS; IN-VIVO; YEAST; GENE; PHOSPHATIDYLCHOLINE; ACYLTRANSFERASE; ENCODES; TRIACYLGLYCEROL	Establishment and maintenance of equilibrium in the fatty acid (FA) composition of phospholipids (PL) requires both regulation of the substrate available for PL synthesis (the acyl-CoA pool) and extensive PL turnover and acyl editing. In the present study, we utilize acyl-CoA synthetase (ACS) deficient cells, unable to recycle FA derived from lipid deacylation, to evaluate the role of several enzymatic activities in FA trafficking and PL homeostasis in Saccharomyces cerevisiae. The data presented show that phospholipases B are not contributing to constitutive PL deacylation and are therefore unlikely to be involved in PL remodeling. In contrast, the enzymes of neutral lipid (NL) synthesis and mobilization are central mediators of FA trafficking. The phospholipid: DAG acyltransferase (PDAT) Lro1p has a substantial effect on FA release and on PL equilibrium, emerging as an important mediator in PL remodeling. The acyl-CoA dependent biosynthetic activities of NL metabolism are also involved in PL homeostasis through active modulation of the substrate available for PL synthesis. In addition TAG mobilization makes an important contribution, especially in cells from stationary phase, to FA availability. Beyond its well-established role in the formation of a storage pool, NL metabolism could play a crucial role as a mechanism to uncouple the pools of PL and acyl-CoAs from each other and thereby to allow independent regulation of each one.	[Mora, Gabriel; Scharnewski, Michael; Fulda, Martin] Georg August Univ Goettingen, Albrecht von Haller Inst, Dept Plant Biochem, Gottingen, Germany	University of Gottingen	Fulda, M (corresponding author), Georg August Univ Goettingen, Albrecht von Haller Inst, Dept Plant Biochem, Gottingen, Germany.	Martin.Fulda@bio.uni-goettingen.de			Goettingen Graduate School for Neurosciences and Molecular Biosciences (GGNB) (DFG) [GSC 226/1]; international master/Ph.D.program Molecular Biology; International Max Planck Research School in Molecular Biology, Goettingen	Goettingen Graduate School for Neurosciences and Molecular Biosciences (GGNB) (DFG)(German Research Foundation (DFG)); international master/Ph.D.program Molecular Biology; International Max Planck Research School in Molecular Biology, Goettingen	This work was partly supported by the Goettingen Graduate School for Neurosciences and Molecular Biosciences (GGNB) (DFG grant GSC 226/1) (http://www.uni-goettingen.de/en/sh/56640.html) and the Georg-Christoph-Lichtenberg stipend from the international master/Ph.D.program Molecular Biology and the International Max Planck Research School in Molecular Biology, Goettingen (http://www.uni-goettingen.de/en/2293.html). The publication was supported by the open access program of the DFG and the Georg-August-University Goettingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P148, DOI 10.1016/j.bbalip.2004.09.005; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fyrst H, 1999, BIOCHEMISTRY-US, V38, P5864, DOI 10.1021/bi9824590; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Guldener U, 2002, NUCLEIC ACIDS RES, V30, P1; Ham HJ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.046946; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Jandrositz A, 2005, BBA-MOL CELL BIOL L, V1735, P50, DOI 10.1016/j.bbalip.2005.04.005; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSON DR, 1994, J CELL BIOL, V127, P751, DOI 10.1083/jcb.127.3.751; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LANDS WEM, 1958, J BIOL CHEM, V231, P883; LEE KS, 1994, J BIOL CHEM, V269, P19725; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Merkel O, 2005, BIOCHEM J, V387, P489, DOI 10.1042/BJ20041272; Michinaka Y, 2003, J BIOSCI BIOENG, V95, P435, DOI 10.1016/S1389-1723(03)80041-5; Mullner H, 2005, J BIOL CHEM, V280, P13321, DOI 10.1074/jbc.M409914200; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Scharnewski M, 2008, FEBS J, V275, P2765, DOI 10.1111/j.1742-4658.2008.06417.x; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Stalberg K, 2008, J LIPID RES, V49, P1794, DOI 10.1194/jlr.M800129-JLR200; Stumpe M, 2001, FEBS LETT, V507, P371, DOI 10.1016/S0014-5793(01)03019-8; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Tanaka K, 2008, BBA-MOL CELL BIOL L, V1781, P391, DOI 10.1016/j.bbalip.2008.06.001; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wagner A, 2009, BBA-MOL CELL BIOL L, V1791, P118, DOI 10.1016/j.bbalip.2008.11.004; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yu CJ, 1996, J BIOL CHEM, V271, P24157, DOI 10.1074/jbc.271.39.24157; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang Meng, 2009, Open Microbiol J, V3, P136, DOI 10.2174/1874285800903010136; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	72	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49269	10.1371/journal.pone.0049269	http://dx.doi.org/10.1371/journal.pone.0049269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139841	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400071
J	Ames, NJ; Sulima, P; Ngo, T; Barb, J; Munson, PJ; Paster, BJ; Hart, TC				Ames, Nancy J.; Sulima, Pawel; Ngo, Thoi; Barb, Jennifer; Munson, Peter J.; Paster, Bruce J.; Hart, Thomas C.			A Characterization of the Oral Microbiome in Allogeneic Stem Cell Transplant Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; DENTAL PLAQUE; RESPIRATORY PATHOGENS; INFECTIOUS COMPLICATIONS; NOSOCOMIAL INFECTIONS; HOST DISEASE; COLONIZATION; DIVERSITY; MORTALITY; THERAPY	Background: The mouth is a complex biological structure inhabited by diverse bacterial communities. The purpose of this study is to describe the effects of allogeneic stem cell transplantation on the oral microbiota and to examine differences among those patients who acquired respiratory complications after transplantation. Methodology/Principal Findings: All patients were consented at the National Institutes of Health, Clinical Center. Bacterial DNA was analyzed from patients' oral specimens using the Human Oral Microbe Identification Microarray. The specimens were collected from four oral sites in 45 allogeneic transplantation patients. Specimens were collected at baseline prior to transplantation, after transplantation at the nadir of the neutrophil count and after myeloid engraftment. If respiratory signs and symptoms developed, additional specimens were obtained. Patients were followed for 100 days post transplantation. Eleven patients' specimens were subjected to further statistical analysis. Many common bacterial genera, such as Streptococcus, Veillonella, Gemella, Granulicatella and Camplyobacter were identified as being present before and after transplantation. Five of 11 patients developed respiratory complications following transplantation and there was preliminary evidence that the oral microbiome changed in their oral specimens. Cluster analysis and principal component analysis revealed this change in the oral microbiota. Conclusions/Significance: After allogeneic transplantation, the oral bacterial community's response to a new immune system was not apparent and many of the most common core oral taxa remained unaffected. However, the oral microbiome was affected in patients who developed respiratory signs and symptoms after transplantation. The association related to the change in the oral microbiota and respiratory complications after transplantation will be validated by future studies using high throughput molecular methods.	[Ames, Nancy J.; Ngo, Thoi] NIH, Ctr Clin, Nursing Serv, Bethesda, MD 20892 USA; [Ames, Nancy J.; Ngo, Thoi] NIH, Ctr Clin, Patient Care Serv, Bethesda, MD 20892 USA; [Sulima, Pawel; Hart, Thomas C.] Natl Inst Dent & Craniofacial Res, Human Craniofacial Genet Sect, Craniofacial & Skeletal Dis Branch, Bethesda, MD USA; [Barb, Jennifer; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Paster, Bruce J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Ames, NJ (corresponding author), NIH, Ctr Clin, Nursing Serv, Bethesda, MD 20892 USA.	names@nih.gov	Paster, Bruce J/AAP-8559-2021; Sulima, Pawel P/H-8649-2012	Barb, Jennifer/0000-0003-3022-0154; Ngo, Thoai/0000-0001-6683-2297	National Institute of Dental and Craniofacial Research of the National Institutes of Health, Bethesda, MD; Clinical Center Nursing and Patient Care Services of the National Institutes of Health, Bethesda, MD; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL001149] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Clinical Center Nursing and Patient Care Services of the National Institutes of Health, Bethesda, MD; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); CLINICAL CENTER	The authors acknowledge support from the Intramural Program of the National Institute of Dental and Craniofacial Research and the Clinical Center Nursing and Patient Care Services of the National Institutes of Health, Bethesda, MD.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ahn J, 2011, PLOS ONE, V6, P7; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Beck S, 1979, Cancer Nurs, V2, P185; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Covington Lemuel L, 2003, J Contemp Dent Pract, V4, P36; Daly A, 2003, BIOL BLOOD MARROW TR, V9, P373, DOI 10.1016/S1083-8791(03)00100-9; De La Cochetiere MF, 2008, MICROB ECOL, V56, P395, DOI 10.1007/s00248-007-9356-5; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Didilescu AC, 2005, CLIN ORAL INVEST, V9, P141, DOI 10.1007/s00784-005-0315-6; Dye B, 2007, NATL CTR HLTH STAT V, V11, P45; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Einsele H, 2003, ANN HEMATOL, V82, pS175, DOI 10.1007/s00277-003-0772-4; El-Solh AA, 2004, CHEST, V126, P1575, DOI 10.1378/chest.126.5.1575; Fourrier F, 2005, CRIT CARE MED, V33, P1728, DOI 10.1097/01.CCM.0000171537.03493.B0; Fourrier F, 1998, CRIT CARE MED, V26, P301, DOI 10.1097/00003246-199802000-00032; Goker H, 2001, EXP HEMATOL, V29, P259, DOI 10.1016/S0301-472X(00)00677-9; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; KLEIN H., 1938, Public Health Reports, V53, P751, DOI 10.2307/4582532; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Landry RG, 2002, INT DENT J, V52, P35, DOI 10.1111/j.1875-595X.2002.tb00595.x; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Parody R, 2006, BIOL BLOOD MARROW TR, V12, P734, DOI 10.1016/j.bbmt.2006.03.007; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; Remberger M, 2001, BLOOD, V98, P1739, DOI 10.1182/blood.V98.6.1739; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Savani BN, 2005, BIOL BLOOD MARROW TR, V11, P223, DOI 10.1016/j.bbmt.2004.12.328; SCANNAPIECO FA, 1992, CRIT CARE MED, V20, P740, DOI 10.1097/00003246-199206000-00007; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sillness P Loe, 1964, ACTA ODENTOLOGICA SC, V22, P121; Sumi Y, 2007, ARCH GERONTOL GERIAT, V44, P119, DOI 10.1016/j.archger.2006.04.004; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wentzensen N, 2010, CANCER RES, V70, P8578, DOI 10.1158/0008-5472.CAN-10-1188; Wolff A, 1997, J DENT RES, V76, P1782, DOI 10.1177/00220345970760111001; World Health Organization, 1997, HDB REP RES CANC TRE, P15; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	45	16	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47628	10.1371/journal.pone.0047628	http://dx.doi.org/10.1371/journal.pone.0047628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144704	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300015
J	Higuchi, T; Seya, Y; Imanaka, K				Higuchi, Takahiro; Seya, Yasuhiro; Imanaka, Kuniyasu			Rule for Scaling Shoulder Rotation Angles while Walking through Apertures	PLOS ONE			English	Article							DYNAMIC TOUCH; SPATIAL REQUIREMENTS; RIGHTWARD COLLISIONS; LOCOMOTION; PERCEPTION; OBJECT; AFFORDANCES; INFORMATION; STRATEGIES; USERS	Background: When an individual is trying to fit into a narrow aperture, the amplitude of shoulder rotations in the yaw dimension is well proportioned to the relative aperture width to body width (referred to as the critical ratio value). Based on this fact, it is generally considered that the central nervous system (CNS) determines the amplitudes of shoulder rotations in response to the ratio value. The present study was designed to determine whether the CNS follows another rule in which a minimal spatial margin is created at the aperture passage; this rule is beneficial particularly when spatial requirements for passage (i.e., the minimum passable width) become wider than the body with an external object. Methodology/Principal Findings: Eight young participants walked through narrow apertures of three widths (ratio value = 0.9, 1.0, and 1.1) while holding one of three horizontal bars (short, 1.5 and 2.5 times the body width). The results showed that the amplitude of rotation angles became smaller for the respective ratio value as the bar increased in length. This was clearly inconsistent with the general hypothesis that predicted the same rotation angles for the same ratio value. Instead, the results were better explained with a new hypothesis which predicted that a smaller rotation angle was sufficient to produce a constant spatial margin as the bar-length increased in length. Conclusion: The results show that, at least under safe circumstances, the CNS is likely to determine the amplitudes of shoulder rotations to ensure the minimal spatial margin being created at one side of the body at the time of crossing. This was new in that the aperture width subtracted from the width of the body (plus object) was taken into account for the visuomotor control of locomotion through apertures.	[Higuchi, Takahiro; Imanaka, Kuniyasu] Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo 158, Japan; [Seya, Yasuhiro] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu, Japan	Tokyo Metropolitan University; Ritsumeikan University	Higuchi, T (corresponding author), Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo 158, Japan.	higuchit@tmu.ac.jp			Japanese Society for Promotion of Science (JSPS)	Japanese Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for young scientists from the Japanese Society for Promotion of Science (JSPS) (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARELLO C, 1992, J EXP PSYCHOL HUMAN, V18, P290, DOI 10.1037/0096-1523.18.1.290; Cinelli ME, 2008, GAIT POSTURE, V27, P595, DOI 10.1016/j.gaitpost.2007.08.002; Cowie D, 2010, NEUROPSYCHOLOGIA, V48, P2750, DOI 10.1016/j.neuropsychologia.2010.05.022; Davis TJ, 2010, PERCEPTION, V39, P1624, DOI 10.1068/p6712; Fajen BR, 2011, J EXP PSYCHOL HUMAN, V37, P1442, DOI 10.1037/a0023510; Fath AJ, 2011, PERCEPTION, V40, P887, DOI 10.1068/p6917; FITZPATRICK P, 1994, NEUROSCIENCE, V60, P551, DOI 10.1016/0306-4522(94)90264-X; Fujikake H, 2011, EXP BRAIN RES, V210, P195, DOI 10.1007/s00221-011-2621-3; Hackney AL, 2011, GAIT POSTURE; Hackney AL, 2011, GAIT POSTURE, V33, P733, DOI 10.1016/j.gaitpost.2011.02.019; Higuchi T, 2004, J EXP PSYCHOL-APPL, V10, P55, DOI 10.1037/1076-898X.10.1.55; Higuchi T, 2006, EXP BRAIN RES, V175, P50, DOI 10.1007/s00221-006-0525-4; Higuchi T, 2011, HUM MOVEMENT SCI, V30, P534, DOI 10.1016/j.humov.2010.08.003; Higuchi Takahiro, 2009, Journal of Physiological Anthropology, V28, P15, DOI 10.2114/jpa2.28.15; Lopresti-Goodman S, 2010, APPL COGNITIVE PSYCH, V24, P557, DOI 10.1002/acp.1568; Nicholls MER, 2008, BRAIN COGNITION, V68, P166, DOI 10.1016/j.bandc.2008.04.003; Nicholls MER, 2007, NEUROPSYCHOLOGIA, V45, P1122, DOI 10.1016/j.neuropsychologia.2006.07.015; Nicholls MER, 2010, ATTEN PERCEPT PSYCHO, V72, P1576, DOI 10.3758/APP.72.6.1576; PAGANO CC, 1993, PERCEPT PSYCHOPHYS, V54, P43, DOI 10.3758/BF03206936; Palatinus Z, 2011, J MOTOR BEHAV, V43, P87, DOI 10.1080/00222895.2010.538767; Stefanucci JK, 2009, PERCEPTION, V38, P1782, DOI 10.1068/p6437; Turvey MT, 1998, J EXP PSYCHOL HUMAN, V24, P35, DOI 10.1037/0096-1523.24.1.35; Turvey MT, 1996, AM PSYCHOL, V51, P1134, DOI 10.1037/0003-066X.51.11.1134; Wagman JB, 2005, ECOL PSYCHOL, V17, P105, DOI 10.1207/s15326969eco1702_3; Wagman JB, 2007, EXP PSYCHOL, V54, P54, DOI 10.1027/1618-3169.54.1.54; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371	26	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48123	10.1371/journal.pone.0048123	http://dx.doi.org/10.1371/journal.pone.0048123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032HH	23144736	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300046
J	Ivan, V; Martinez-Sanchez, E; Sima, LE; Oorschot, V; Klumperman, J; Petrescu, SM; van der Sluijs, P				Ivan, Viorica; Martinez-Sanchez, Emma; Sima, Livia E.; Oorschot, Viola; Klumperman, Judith; Petrescu, Stefana M.; van der Sluijs, Peter			AP-3 and Rabip4 ' Coordinately Regulate Spatial Distribution of Lysosomes	PLOS ONE			English	Article							MEMBRANE-PROTEINS; EARLY ENDOSOMES; SUBCELLULAR-DISTRIBUTION; MICROTUBULE MOTORS; PLASMA-MEMBRANE; RAB GTPASES; COMPLEX; EFFECTOR; ADAPTER; TRANSPORT	The RUN and FYVE domain proteins rabip4 and rabip4' are encoded by RUFY1 and differ in a 108 amino acid N-terminal extension in rabip4'. Their identical C terminus binds rab5 and rab4, but the function of rabip4s is incompletely understood. We here found that silencing RUFY1 gene products promoted outgrowth of plasma membrane protrusions, and polarized distribution and clustering of lysosomes at their tips. An interactor screen for proteins that function together with rabip4' yielded the adaptor protein complex AP-3, of which the hinge region in the beta 3 subunit bound directly to the FYVE domain of rabip4'. Rabip4' colocalized with AP-3 on a tubular subdomain of early endosomes and the extent of colocalization was increased by a dominant negative rab4 mutant. Knock-down of AP-3 had an ever more dramatic effect and caused accumulation of lysosomes in protrusions at the plasma membrane. The most peripheral lysosomes were localized beyond microtubules, within the cortical actin network. Our results uncover a novel function for AP-3 and rabip4' in regulating lysosome positioning through an interorganellar pathway.	[Ivan, Viorica; Martinez-Sanchez, Emma; Oorschot, Viola; Klumperman, Judith; van der Sluijs, Peter] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Ivan, Viorica; Sima, Livia E.; Petrescu, Stefana M.] Romanian Acad, Dept Mol Cell Biol, Inst Biochem, Bucharest, Romania	Utrecht University; Utrecht University Medical Center; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Nicolae Simionescu Institute of Cellular Biology & Pathology	van der Sluijs, P (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	p.vandersluijs@umcutrecht.nl	Petrescu, Stefana/AAJ-9505-2021; Petrescu, Stefana M/I-9240-2012; Sima, Livia/M-4389-2019; Sima, Livia E/C-2882-2011	Petrescu, Stefana/0000-0002-4047-0811; Petrescu, Stefana M/0000-0002-4047-0811; Sima, Livia/0000-0002-3404-4162; Sima, Livia E/0000-0002-3404-4162	Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI) [PNII-RU 122/2010]; Dutch Organization for Chemical Research NWO-CW; Netherlands Organization for Medical Research (ZonMW)	Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI); Dutch Organization for Chemical Research NWO-CW; Netherlands Organization for Medical Research (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI) postdoctoral research grant PNII-RU 122/2010 (VI) and a grant of the Dutch Organization for Chemical Research NWO-CW (to PvdS). Core facilities in Utrecht were partly financed by the Netherlands Organization for Medical Research (ZonMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Blumstein J, 2001, J NEUROSCI, V21, P8034, DOI 10.1523/JNEUROSCI.21-20-08034.2001; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Caviston JP, 2011, MOL BIOL CELL, V22, P478, DOI 10.1091/mbc.E10-03-0233; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703; Delevoye C, 2009, J CELL BIOL, V187, P247, DOI 10.1083/jcb.200907122; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Deneka M, 2003, EMBO J, V22, P2645, DOI 10.1093/emboj/cdg257; Elstak ED, 2011, BLOOD, V118, P1570, DOI 10.1182/blood-2011-02-339523; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Lefrancois S, 2004, DEV CELL, V7, P619, DOI 10.1016/j.devcel.2004.08.009; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Popa I, 2005, METHOD ENZYMOL, V403, P526, DOI 10.1016/S0076-6879(05)03046-6; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schmid JP, 2010, IMMUNOL REV, V235, P10, DOI 10.1111/j.0105-2896.2010.00890.x; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; van Vlijmen T, 2008, FEBS LETT, V582, P2838, DOI 10.1016/j.febslet.2008.07.012; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yamamoto H, 2010, MOL BIOL CELL, V21, P2746, DOI 10.1091/mbc.E10-01-0074; Zhen LJ, 1999, BLOOD, V94, P146, DOI 10.1182/blood.V94.1.146.413k39_146_155; Zlatic SA, 2011, MOL BIOL CELL, V22, P1699, DOI 10.1091/mbc.E10-10-0799	65	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48142	10.1371/journal.pone.0048142	http://dx.doi.org/10.1371/journal.pone.0048142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144738	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300048
J	Kim, CC; Nelson, CS; Wilson, EB; Hou, BD; DeFranco, AL; DeRisi, JL				Kim, Charles C.; Nelson, Christopher S.; Wilson, Emily B.; Hou, Baidong; DeFranco, Anthony L.; DeRisi, Joseph L.			Splenic Red Pulp Macrophages Produce Type I Interferons as Early Sentinels of Malaria Infection but Are Dispensable for Control	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE-RESPONSES; PLASMODIUM-CHABAUDI; VIRAL-INFECTIONS; T-CELLS; B-CELLS; SPLEEN; ALPHA/BETA; MOUSE; EXPRESSION	Type I interferons (T1IFNs) are among the earliest cytokines produced during infections due to their direct regulation by innate immune signaling pathways. Reports have suggested that T1IFNs are produced during malaria infection, but little is known about the in vivo cellular origins of T1IFNs or their role in protection. We have found that in addition to plasmacytoid dendritic cells, splenic red pulp macrophages (RPMs) can generate significant quantities of T1IFNs in response to P. chabaudi infection in a TLR9-, MYD88-, and IRF7-dependent manner. Furthermore, T1IFNs regulate expression of interferon-stimulated genes redundantly with Interferon-gamma (IFNG), resulting in redundancy for resistance to experimental malaria infection. Despite their role in sensing and promoting immune responses to infection, we observe that RPMs are dispensable for control of parasitemia. Our results reveal that RPMs are early sentinels of malaria infection, but that effector mechanisms previously attributed to RPMs are not essential for control.	[Nelson, Christopher S.; Wilson, Emily B.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Kim, Charles C.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Hou, Baidong; DeFranco, Anthony L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Hou, Baidong] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [DeRisi, Joseph L.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Biophysics, CAS; Howard Hughes Medical Institute; University of California System; University of California San Francisco	DeRisi, JL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	joe@derisilab.ucsf.edu		Kim, Charles/0000-0001-6474-8227; Nelson, Christopher/0000-0002-5608-2338; Hou, Baidong/0000-0002-0892-0181	Howard Hughes Medical Institute; Giannini Family Foundation; NIAID [K99 AI085035]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI085035, K99AI085035] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Giannini Family Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute (JLD), the Giannini Family Foundation (CCK), and NIAID K99 AI085035 (CCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Chimma P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000631; Ciavarra RP, 2005, VIROLOGY, V342, P177, DOI 10.1016/j.virol.2005.07.031; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; Engwerda CR, 2005, TRENDS PARASITOL, V21, P75, DOI 10.1016/j.pt.2004.11.008; Haque A, 2011, EUR J IMMUNOL, V41, P2688, DOI 10.1002/eji.201141539; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kim CC, 2008, INFECT IMMUN, V76, P5873, DOI 10.1128/IAI.00640-08; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Krucken J, 2005, INFECT IMMUN, V73, P6390, DOI 10.1128/IAI.73.10.6390-6398.2005; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; OJOAMAIZE EA, 1981, J IMMUNOL, V127, P2296; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; SCHNITZER B, 1972, SCIENCE, V177, P175, DOI 10.1126/science.177.4044.175; Seeds RE, 2009, J IMMUNOL METHODS, V350, P106, DOI 10.1016/j.jim.2009.07.016; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; STEVENSON MM, 1989, PARASITE IMMUNOL, V11, P529, DOI 10.1111/j.1365-3024.1989.tb00687.x; STEVENSON MM, 1989, EXP MOL PATHOL, V51, P80, DOI 10.1016/0014-4800(89)90009-9; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; SUSS G, 1988, INFECT IMMUN, V56, P3081; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; van der Heyde HC, 2006, INFECT IMMUN, V74, P2717, DOI 10.1128/IAI.74.5.2717-2725.2006; VANDERHEYDE HC, 1994, J IMMUNOL, V152, P4557; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; vonderWeid T, 1996, J IMMUNOL, V156, P2510; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yadava A, 1996, P NATL ACAD SCI USA, V93, P4595, DOI 10.1073/pnas.93.10.4595	44	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48126	10.1371/journal.pone.0048126	http://dx.doi.org/10.1371/journal.pone.0048126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144737	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300047
J	Publio, R; Ceballos, CC; Roque, AC				Publio, Rodrigo; Ceballos, Cesar Celis; Roque, Antonio C.			Dynamic Range of Vertebrate Retina Ganglion Cells: Importance of Active Dendrites and Coupling by Electrical Synapses	PLOS ONE			English	Article							MAMMALIAN RETINA; MECHANISMS; LECTURE	The vertebrate retina has a very high dynamic range. This is due to the concerted action of its diverse cell types. Ganglion cells, which are the output cells of the retina, have to preserve this high dynamic range to convey it to higher brain areas. Experimental evidence shows that the firing response of ganglion cells is strongly correlated with their total dendritic area and only weakly correlated with their dendritic branching complexity. On the other hand, theoretical studies with simple neuron models claim that active and large dendritic trees enhance the dynamic range of single neurons. Theoretical models also claim that electrical coupling between ganglion cells via gap junctions enhances their collective dynamic range. In this work we use morphologically reconstructed multi-compartmental ganglion cell models to perform two studies. In the first study we investigate the relationship between single ganglion cell dynamic range and number of dendritic branches/total dendritic area for both active and passive dendrites. Our results support the claim that large and active dendrites enhance the dynamic range of a single ganglion cell and show that total dendritic area has stronger correlation with dynamic range than with number of dendritic branches. In the second study we investigate the dynamic range of a square array of ganglion cells with passive or active dendritic trees coupled with each other via dendrodendritic gap junctions. Our results suggest that electrical coupling between active dendritic trees enhances the dynamic range of the ganglion cell array in comparison with both the uncoupled case and the coupled case with cells with passive dendrites. The results from our detailed computational modeling studies suggest that the key properties of the ganglion cells that endow them with a large dynamic range are large and active dendritic trees and electrical coupling via gap junctions.	[Publio, Rodrigo; Ceballos, Cesar Celis; Roque, Antonio C.] Univ Sao Paulo, Dept Phys, FFCLRP, Sao Paulo, Brazil	Universidade de Sao Paulo	Publio, R (corresponding author), Univ Sao Paulo, Dept Phys, FFCLRP, Sao Paulo, Brazil.	rpublio@me.com	Roque, Antonio C./C-2316-2011	Roque, Antonio C./0000-0003-1260-4840; Ceballos, Cesar/0000-0002-7174-5232	Fundacao de Amparo a Pesquisa do Estado de Sa Paulo (FAPESP); CNPq (Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sa Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sa Paulo (FAPESP). ACR is the recipient of a research grant from CNPq (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnevale T.N., 2006, NEURON BOOK; Copelli M, 2005, NEUROCOMPUTING, V65, P691, DOI 10.1016/j.neucom.2004.10.099; Copelli M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.060901; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Destexhe A, 2001, NEUROCOMPUTING, V38, P555, DOI 10.1016/S0925-2312(01)00348-4; Dowling J. E., 1987, RETINA APPROACHABLE; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1948, DOI 10.1152/jn.1997.78.4.1948; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1935, DOI 10.1152/jn.1997.78.4.1935; Gollo LL, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011911; Gollo LL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000402; Hidaka S, 2004, J NEUROSCI, V24, P10553, DOI 10.1523/JNEUROSCI.3319-04.2004; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Hu EH, 2010, J PHYSIOL-LONDON, V588, P4145, DOI 10.1113/jphysiol.2010.193268; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; KARSCHIN A, 1989, J PHYSIOL-LONDON, V418, P379, DOI 10.1113/jphysiol.1989.sp017847; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; KOLB H, 1994, INVEST OPHTH VIS SCI, V35, P2385; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; MARCHIAFAVA PL, 1983, VISION RES, V23, P1097, DOI 10.1016/0042-6989(83)90021-4; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Miller RF, 2006, J NEUROPHYSIOL, V95, P3171, DOI 10.1152/jn.00090.2005; Publio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006970; Robinson DW, 1998, SEMIN CELL DEV BIOL, V9, P301, DOI 10.1006/scdb.1998.0229; Rodieck R.W., 1998, 1 STEPS SEEING; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; Sheasby BW, 1999, J NEUROPHYSIOL, V81, P1685, DOI 10.1152/jn.1999.81.4.1685; Sterling P., 2004, SYNAPTIC ORG BRAIN, P217; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Wu SM, 2010, INVEST OPHTH VIS SCI, V51, P1264, DOI 10.1167/iovs.09-4396	34	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48517	10.1371/journal.pone.0048517	http://dx.doi.org/10.1371/journal.pone.0048517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144767	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300077
J	Thiltgen, G; Goldstein, RA				Thiltgen, Grant; Goldstein, Richard A.			Assessing Predictors of Changes in Protein Stability upon Mutation Using Self-Consistency	PLOS ONE			English	Article							SINGLE-POINT MUTATIONS; FREE-ENERGY CHANGES; SEQUENCE; SERVER	The ability to predict the effect of mutations on protein stability is important for a wide range of tasks, from protein engineering to assessing the impact of SNPs to understanding basic protein biophysics. A number of methods have been developed that make these predictions, but assessing the accuracy of these tools is difficult given the limitations and inconsistencies of the experimental data. We evaluate four different methods based on the ability of these methods to generate consistent results for forward and back mutations, and examine how this ability varies with the nature and location of the mutation. We find that, while one method seems to outperform the others, the ability of these methods to make accurate predictions is limited.	[Thiltgen, Grant; Goldstein, Richard A.] Natl Inst Med Res, Dept Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Goldstein, RA (corresponding author), Natl Inst Med Res, Dept Math Biol, Mill Hill, London NW7 1AA, England.	richard.goldstein@nimr.mrc.ac.uk		Goldstein, Richard/0000-0001-5148-4672	Medical Research Council, United Kingdom; MRC [MC_U117573805] Funding Source: UKRI; Medical Research Council [MC_U117573805] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Johnston MA, 2011, PROTEINS, V79, P165, DOI 10.1002/prot.22870; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Li YQ, 2012, PROTEINS, V80, P81, DOI 10.1002/prot.23163; Masso M, 2010, PROTEIN ENG DES SEL, V23, P683, DOI 10.1093/protein/gzq042; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Seeliger D, 2010, BIOPHYS J, V98, P2309, DOI 10.1016/j.bpj.2010.01.051; Tian J, 2010, BMC BIOINFORMATICS, V11, P230; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zhang Z, 2012, BIOINFORMATICS, V28, P664, DOI 10.1093/bioinformatics/bts005	22	67	67	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e46084	10.1371/journal.pone.0046084	http://dx.doi.org/10.1371/journal.pone.0046084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144695	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705300006
J	Iotti, G; Mejetta, S; Modica, L; Penkov, D; Ponzoni, M; Blasi, F				Iotti, Giorgio; Mejetta, Stefania; Modica, Livia; Penkov, Dmitry; Ponzoni, Maurilio; Blasi, Francesco			Reduction of Prep1 Levels Affects Differentiation of Normal and Malignant B Cells and Accelerates Myc Driven Lymphomagenesis	PLOS ONE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; DEFINITIVE HEMATOPOIESIS; TRANSGENIC MICE; PBX1; PROTOONCOGENE; PATHWAY; ABSENCE; PKNOX1; MEIS1; STEM	The Prep1 homeodomain transcription factor has recently been recognized as a tumor suppressor. Among other features, haploinsufficiency of Prep1 is able to strongly accelerate the B-lymphomagenesis in E mu Myc mice. Now we report that this occurs concomitantly with a change in the type of B-cell lymphomas generated by the Myc oncogene. Indeed, the tumors generated in the E mu Myc-Prep1(+/-) mice are much more immature, being mostly made up of Pro-B or Pre-B cells, while those in the E mu Myc-Prep1(+/+) mice are more differentiated being invariably IgM(+). Moreover, we show that Prep1 is in fact required for the differentiation of Pro-B and Pre-B cells into IgM(+) lymphocytes and/or their proliferation, thus showing also how a normal function of Prep1 affects E mu Myc lymphomagenesis. Finally, we show that the haploinsufficiency of Prep1 is accompanied with a major decrease of Myc-induced apoptosis and that the haploinsufficieny is sufficient for all these effects because the second allele of Prep1 is not lost even at late stages. Therefore, the tumor-suppressive activity of Prep1 is intertwined with both the interference with Myc-induced apoptosis as well as with natural developmental functions of the protein.	[Iotti, Giorgio; Mejetta, Stefania; Modica, Livia; Blasi, Francesco] IFOM Fdn Ist FIRC Oncol Mol, Lab Transcript Regulat Dev & Canc, Milan, Italy; [Penkov, Dmitry] Moscow MV Lomonosov State Univ, Dept Basic Med, Moscow, Russia; [Ponzoni, Maurilio] Ist Sci San Raffaele, Dept Pathol, I-20132 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Lomonosov Moscow State University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Blasi, F (corresponding author), IFOM Fdn Ist FIRC Oncol Mol, Lab Transcript Regulat Dev & Canc, Milan, Italy.	francesco.blasi@ifom.eu		Blasi, Francesco/0000-0001-9406-1784	AIRC (Italian Association for Cancer Research) fellowship; AIRC - (Italian Association for Cancer Research) [8929]; COST (Cooperation in the Field of Science and Technology Research) [BM 0805]; Italian Ministry of Health	AIRC (Italian Association for Cancer Research) fellowship(Fondazione AIRC per la ricerca sul cancro); AIRC - (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); COST (Cooperation in the Field of Science and Technology Research); Italian Ministry of Health(Ministry of Health, Italy)	G. Iotti was a recipient of an AIRC (Italian Association for Cancer Research) fellowship. The work was supported by AIRC - (Italian Association for Cancer Research) (Project 8929) and by COST (Cooperation in the Field of Science and Technology Research) (Project BM 0805) and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Degnan BM, 2009, CURR OPIN GENET DEV, V19, P591, DOI 10.1016/j.gde.2009.09.008; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Iotti G, 2011, P NATL ACAD SCI USA, V108, pE314, DOI 10.1073/pnas.1105216108; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Mori S, 2008, CANCER RES, V68, P8525, DOI 10.1158/0008-5472.CAN-08-1329; Nepal RM, 2009, P NATL ACAD SCI USA, V106, P18698, DOI 10.1073/pnas.0905965106; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wen RR, 2006, MOL CELL BIOL, V26, P9364, DOI 10.1128/MCB.00839-06	23	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48353	10.1371/journal.pone.0048353	http://dx.doi.org/10.1371/journal.pone.0048353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133585	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800073
J	Zhao, Q; Caballero, OL; Simpson, AJG; Strausberg, RL				Zhao, Qi; Caballero, Otavia L.; Simpson, Andrew J. G.; Strausberg, Robert L.			Differential Evolution of MAGE Genes Based on Expression Pattern and Selection Pressure	PLOS ONE			English	Article							AMINO-ACID SITES; RAPID EVOLUTION; CANCER/TESTIS ANTIGENS; POSITIVE SELECTION; DNA-SEQUENCE; METHYLATION; TESTIS; SUBSTITUTIONS; COMPLEXES; PROTEINS	Starting from publicly-accessible datasets, we have utilized comparative and phylogenetic genome analyses to characterize the evolution of the human MAGE gene family. Our characterization of genomic structures in representative genomes of primates, rodents, carnivora, and macroscelidea indicates that both Type I and Type II MAGE genes have undergone lineage-specific evolution. The restricted expression pattern in germ cells of Type I MAGE orthologs is observed throughout evolutionary history. Unlike Type II MAGEs that have conserved promoter sequences, Type I MAGEs lack promoter conservation, suggesting that epigenetic regulation is a central mechanism for controlling their expression. Codon analysis shows that Type I but not Type II MAGE genes have been under positive selection. The combination of genomic and expression analysis suggests that Type 1 MAGE promoters and genes continue to evolve in the hominin lineage, perhaps towards functional diversification or acquiring additional specific functions, and that selection pressure at codon level is associated with expression spectrum.	[Zhao, Qi; Caballero, Otavia L.; Simpson, Andrew J. G.; Strausberg, Robert L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Ludwig Collaborat Lab, Baltimore, MD 21205 USA	Johns Hopkins University	Zhao, Q (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Ludwig Collaborat Lab, Baltimore, MD 21205 USA.	qzhao1@jhmi.edu; rls@licr.org			Ludwig Institute for Cancer Research	Ludwig Institute for Cancer Research	This work is funded by the Ludwig Institute for Cancer Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Caballero OL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012773; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Chitra Chandrasekaran EB, 2008, NATURE ED, V1; Chomez P, 2001, CANCER RES, V61, P5544; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Grau E, 2009, J CANCER RES CLIN, V135, P523, DOI 10.1007/s00432-008-0484-1; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Jagadeeshan S, 2005, MOL BIOL EVOL, V22, P1793, DOI 10.1093/molbev/msi175; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kim J, 2006, INT J CANCER, V118, P2269, DOI 10.1002/ijc.21656; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 1998, GENETICS, V148, P929; OHTA T, 1994, GENETICS, V138, P1331; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Peikert T, 2006, CANCER RES, V66, P4693, DOI 10.1158/0008-5472.CAN-05-3327; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Sharma P, 2006, CLIN CANCER RES, V12, P5442, DOI 10.1158/1078-0432.CCR-06-0527; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Suyama T, 2002, LEUKEMIA RES, V26, P1113, DOI 10.1016/S0145-2126(02)00048-6; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xiao TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023747; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P267, DOI 10.1038/sj.jid.5700548; Yang ZH, 2002, CURR OPIN GENET DEV, V12, P688, DOI 10.1016/S0959-437X(02)00348-9; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yap VB, 2010, MOL BIOL EVOL, V27, P726, DOI 10.1093/molbev/msp232; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	54	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48240	10.1371/journal.pone.0048240	http://dx.doi.org/10.1371/journal.pone.0048240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133577	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800067
J	Rao, X; Evans, J; Chae, H; Pilrose, J; Kim, S; Yan, P; Huang, RL; Lai, HC; Lin, H; Liu, Y; Miller, D; Rhee, JK; Huang, YW; Gu, F; Gray, JW; Huang, THM; Nephew, KP				Rao, X.; Evans, J.; Chae, H.; Pilrose, J.; Kim, S.; Yan, P.; Huang, R-L; Lai, H-C; Lin, H.; Liu, Y.; Miller, D.; Rhee, J-K; Huang, Y-W; Gu, F.; Gray, J. W.; Huang, T. H-M; Nephew, K. P.			CpG island shore methylation regulates caveolin-1 expression in breast cancer	ONCOGENE			English	Article						Cav1; CpG island shore; DNA methylation; breast cancer	ANCHORAGE-INDEPENDENT GROWTH; ESTROGEN-RECEPTOR-ALPHA; DNA METHYLATION; CELL-LINES; GENE-EXPRESSION; BASAL-LIKE; UP-REGULATION; EGF-R; PROMOTER; PROTEIN	Caveolin-1 (Cav1) is an integral membrane, scaffolding protein found in plasma membrane invaginations (caveolae). Cav1 regulates multiple cancer-associated processes. In breast cancer, a tumor suppressive role for Cav1 has been suggested; however, Cav1 is frequently overexpressed in aggressive breast cancer subtypes, suggesting an oncogenic function in advanced-stage disease. To further delineate Cav1 function in breast cancer progression, we evaluated its expression levels among a panel of cell lines representing a spectrum of breast cancer phenotypes. In basal-like (the most aggressive BC subtype) breast cancer cells, Cav1 was consistently upregulated, and positively correlated with increased cell proliferation, anchorage-independent growth, and migration and invasion. To identify mechanisms of Cav1 gene regulation, we compared DNA methylation levels within promoter 'CpG islands' (CGIs) with 'CGI shores', recently described regions that flank CGIs with less CG-density. Integration of genome-wide DNA methylation profiles ('methylomes') with Cav1 expression in 30 breast cancer cell lines showed that differential methylation of CGI shores, but not CGIs, significantly regulated Cav1 expression. In breast cancer cell lines having low Cav1 expression (despite promoter CGI hypomethylation), we found that treatment with a DNA methyltransferase inhibitor induced Cav1 expression via CGI shore demethylation. In addition, further methylome assessments revealed that breast cancer aggressiveness associated with Cav1 CGI shore methylation levels, with shore hypermethylation in minimally aggressive, luminal breast cancer cells and shore hypomethylation in highly aggressive, basal-like cells. Cav1 CGI shore methylation was also observed in human breast tumors, and overall survival rates of breast cancer patients lacking estrogen receptor a (ER alpha) negatively correlated with Cav1 expression. Based on this first study of Cav1 (a potential oncogene) CGI shore methylation, we suggest this phenomenon may represent a new prognostic marker for ER alpha-negative, basal-like breast cancer.	[Rao, X.; Nephew, K. P.] Indiana Univ, Dept Mol & Cellular Biochem, Interdisciplinary Biochem Grad Program, Bloomington, IN USA; [Rao, X.; Pilrose, J.; Miller, D.; Nephew, K. P.] Indiana Univ, Sch Med, Med Sci Program, Bloomington, IN 47405 USA; [Evans, J.; Chae, H.; Kim, S.] Indiana Univ, Sch Informat & Comp, Bioinformat Program, Bloomington, IN USA; [Yan, P.] Ohio State Univ, Ctr Comprehens Canc, NASRIllumina Sequencing Core, Columbus, OH 43210 USA; [Huang, R-L; Lai, H-C] Natl Yang Ming Univ, Inst Biomed Informat, Dept Obstet & Gynecol, Taipei 112, Taiwan; [Lin, H.; Liu, Y.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Rhee, J-K] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Huang, Y-W] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Gu, F.; Huang, T. H-M] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Dept Mol Med, San Antonio, TX 78229 USA; [Gray, J. W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Nephew, K. P.] Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN 46202 USA; [Nephew, K. P.] Indiana Univ Sch Med, Dept Cellular Physiol, Indianapolis, IN 46202 USA; [Nephew, K. P.] Indiana Univ Sch Med, Dept Integrat Physiol, Indianapolis, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Yang Ming Chiao Tung University; Indiana University System; Indiana University Bloomington; Seoul National University (SNU); Medical College of Wisconsin; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Oregon Health & Science University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Nephew, KP (corresponding author), Indiana Univ Sch Med, 302 Jordan Hall,1001 East 3rd St, Bloomington, IN 47405 USA.	knephew@indiana.edu	Lin, Hai/N-3860-2016; Yan, Pearlly S/E-4339-2011	Lin, Hai/0000-0002-2094-758X; Yan, Pearlly S/0000-0003-1965-4920; Huang, Rui Lan/0000-0001-6458-4672	NIH [CA085289, CA113001]; Integrated Cancer Biology Program; Walther Cancer Foundation (Indianapolis, IN, USA); NATIONAL CANCER INSTITUTE [R01CA085289] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Cancer Biology Program; Walther Cancer Foundation (Indianapolis, IN, USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank Dr F Fang for pyrosequencing analysis, Dr C Balch for manuscript preparation, and the IUB light Microscopy Imaging Center for microscopy resources. This work was supported by NIH grants CA085289 and CA113001, pilot project funding from the Integrated Cancer Biology Program and the Walther Cancer Foundation (Indianapolis, IN, USA). We acknowledge the use of the ICBP45 Kit in this study.	[Anonymous], 2013, ONCOGENE, P4519; Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Bachmann N, 2008, CANCER GENET CYTOGEN, V182, P103, DOI 10.1016/j.cancergencyto.2008.01.006; Belanger MM, 2003, ANTI-CANCER DRUG, V14, P281, DOI 10.1097/00001813-200304000-00005; Chan TF, 2003, INT J ONCOL, V23, P599; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Engelman JA, 1999, FEBS LETT, V448, P221, DOI 10.1016/S0014-5793(99)00365-8; Engelman JA, 1998, FEBS LETT, V429, P330, DOI 10.1016/S0014-5793(98)00619-X; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Fang F, 2010, CANCER-AM CANCER SOC, V116, P4043, DOI 10.1002/cncr.25204; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Glait C, 2006, EXP CELL RES, V312, P3899, DOI 10.1016/j.yexcr.2006.08.016; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hurlstone AFL, 1999, ONCOGENE, V18, P1881, DOI 10.1038/sj.onc.1202491; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Lan X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022226; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lin SY, 2004, ANTICANCER RES, V24, P1645; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Nestl A, 2001, CANCER RES, V61, P1569; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Park SS, 2005, HISTOPATHOLOGY, V47, P625, DOI 10.1111/j.1365-2559.2005.02303.x; Patani N, 2012, BREAST CANCER RES TR, V131, P307, DOI 10.1007/s10549-011-1761-2; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; PINK JJ, 1995, CANCER RES, V55, P2583; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Pinilla SMR, 2006, BREAST CANCER RES TR, V99, P85, DOI 10.1007/s10549-006-9184-1; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Sagara Y, 2004, BRIT J CANCER, V91, P959, DOI 10.1038/sj.bjc.6602029; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Shatz M, 2008, INT J RADIAT BIOL, V84, P177, DOI 10.1080/09553000701745293; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Thomas NBP, 2010, BREAST CANCER RES TR, V119, P575, DOI 10.1007/s10549-009-0355-8; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tse EYT, 2012, J PATHOL, V226, P645, DOI 10.1002/path.3957; Van den Eynden GG, 2006, BREAST CANCER RES TR, V95, P219, DOI 10.1007/s10549-005-9002-1; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zschocke J, 2002, J BIOL CHEM, V277, P38772, DOI 10.1074/jbc.M205664200; Zuo T, 2011, CANCER RES, V71, P1752, DOI 10.1158/0008-5472.CAN-10-3573	61	88	92	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4519	4528		10.1038/onc.2012.474	http://dx.doi.org/10.1038/onc.2012.474			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23128390	Green Published, hybrid			2022-12-25	WOS:000324831300007
J	Goulet, A; Behnke-Parks, WM; Sindelar, CV; Major, J; Rosenfeld, SS; Moores, CA				Goulet, Adeline; Behnke-Parks, William M.; Sindelar, Charles V.; Major, Jennifer; Rosenfeld, Steven S.; Moores, Carolyn A.			The Structural Basis of Force Generation by the Mitotic Motor Kinesin-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECK-LINKER; ALLOSTERIC INHIBITION; MONASTROL INHIBITION; ELECTRON-MICROSCOPY; SMALL-MOLECULE; EG5; PROTEIN; MICROTUBULES; MECHANISM; MODEL	Kinesin-5 is required for forming the bipolar spindle during mitosis. Its motor domain, which contains nucleotide and microtubule binding sites and mechanical elements to generate force, has evolved distinct properties for its spindle-based functions. In this study, we report subnanometer resolution cryoelectron microscopy reconstructions of microtubule-bound human kinesin-5 before and after nucleotide binding and combine this information with studies of the kinetics of nucleotide-induced neck linker and cover strand movement. These studies reveal coupled, nucleotide-dependent conformational changes that explain many of this motor's properties. We find that ATP binding induces a ratchet-like docking of the neck linker and simultaneous, parallel docking of the N-terminal cover strand. Loop L5, the binding site for allosteric inhibitors of kinesin-5, also undergoes a dramatic reorientation when ATP binds, suggesting that it is directly involved in controlling nucleotide binding. Our structures indicate that allosteric inhibitors of human kinesin-5, which are being developed as anti-cancer therapeutics, bind to a motor conformation that occurs in the course of normal function. However, due to evolutionarily defined sequence variations in L5, this conformation is not adopted by invertebrate kinesin-5s, explaining their resistance to drug inhibition. Together, our data reveal the precision with which the molecular mechanism of kinesin-5 motors has evolved for force generation.	[Goulet, Adeline; Moores, Carolyn A.] Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Behnke-Parks, William M.] Columbia Univ, Dept Biol, New York, NY 10035 USA; [Sindelar, Charles V.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Major, Jennifer; Rosenfeld, Steven S.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	University of London; Birkbeck University London; Columbia University; Yale University; Cleveland Clinic Foundation	Moores, CA (corresponding author), Birkbeck Coll, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	c.moores@mail.cryst.bbk.ac.uk		Goulet, Adeline/0000-0002-5971-9488	National Institutes of Health [GM102875]; Biotechnology and Biological Sciences Research Council [BB/H005137/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102875] Funding Source: NIH RePORTER; BBSRC [BB/H005137/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102875. This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/H005137/1	Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; Duselder A, 2012, J MOL BIOL, V423, P159, DOI 10.1016/j.jmb.2012.06.043; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geoghegan KF, 2000, BIOCONJUGATE CHEM, V11, P71, DOI 10.1021/bc9900845; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Harrington TD, 2011, J THEOR BIOL, V289, P107, DOI 10.1016/j.jtbi.2011.08.017; Hirose K, 2000, EMBO J, V19, P5308, DOI 10.1093/emboj/19.20.5308; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Kalchishkova N, 2008, J MOL BIOL, V382, P127, DOI 10.1016/j.jmb.2008.06.092; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kikkawa M, 2008, TRENDS CELL BIOL, V18, P128, DOI 10.1016/j.tcb.2008.01.002; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Li MH, 2012, BIOCHEMISTRY-US, V51, P5022, DOI 10.1021/bi300362a; Liu LQ, 2011, J BIOL CHEM, V286, P6201, DOI 10.1074/jbc.M110.154989; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCINTOSH JR, 1969, NATURE, V224, P659, DOI 10.1038/224659a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pandurangan AP, 2012, J STRUCT BIOL, V177, P520, DOI 10.1016/j.jsb.2011.10.011; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pylypenko O, 2011, J BIOL CHEM, V286, P11716, DOI 10.1074/jbc.M110.200626; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Safer D, 1999, J STRUCT BIOL, V127, P101, DOI 10.1006/jsbi.1999.4110; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Sheth PR, 2009, BIOCHEMISTRY-US, V48, P11045, DOI 10.1021/bi900946r; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar Charles V, 2011, Biophys Rev, V3, P85, DOI 10.1007/s12551-011-0049-4; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Waitzman JS, 2011, BIOPHYS J, V101, P2760, DOI 10.1016/j.bpj.2011.10.032; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Zhao YC, 2010, J BIOL CHEM, V285, P25213, DOI 10.1074/jbc.M110.123067	63	58	60	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44654	44666		10.1074/jbc.M112.404228	http://dx.doi.org/10.1074/jbc.M112.404228			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23135273	Green Published, hybrid			2022-12-25	WOS:000312938600061
J	Yates, LA; Lumb, CN; Brahme, NN; Zalyte, R; Bird, LE; De Colibus, L; Owens, RJ; Calderwood, DA; Sansom, MSP; Gilbert, RJC				Yates, Luke A.; Lumb, Craig N.; Brahme, Nina N.; Zalyte, Ruta; Bird, Louise E.; De Colibus, Luigi; Owens, Raymond J.; Calderwood, David A.; Sansom, Mark S. P.; Gilbert, Robert J. C.			Structural and Functional Characterization of the Kindlin-1 Pleckstrin Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; INTEGRIN ACTIVATION; CRYSTAL-STRUCTURE; FORCE-FIELD; PH DOMAIN; PHOSPHOINOSITIDE-BINDING; SPECIFICITY DETERMINANTS; RESOLUTION STRUCTURE; INOSITOL PHOSPHATES; LEUKOCYTE ADHESION	Inside-out activation of integrins is mediated via the binding of talin and kindlin to integrin beta-subunit cytoplasmic tails. The kindlin FERM domain is interrupted by a pleckstrin homology (PH) domain within its F2 subdomain. Here, we present data confirming the importance of the kindlin-1 PH domain for integrin activation and its x-ray crystal structure at a resolution of 2.1 angstrom revealing a C-terminal second alpha-helix integral to the domain but found only in the kindlin protein family. An isoform-specific salt bridge occludes the canonical phosphoinositide binding site, but molecular dynamics simulations display transient switching to an alternative open conformer. Molecular docking reveals that the opening of the pocket would enable potential ligands to bind within it. Although lipid overlay assays suggested the PH domain binds inositol monophosphates, surface plasmon resonance demonstrated weak affinities for inositol 3,4,5-triphosphate (Ins(3,4,5)P-3; K-D similar to 100 mu M) and no monophosphate binding. Removing the salt bridge by site-directed mutagenesis increases the PH domain affinity for Ins(3,4,5)P-3 as measured by surface plasmon resonance and enables it to bind PtdIns(3,5)P-2 on a dot-blot. Structural comparison with other PH domains suggests that the phosphate binding pocket in the kindlin-1 PH domain is more occluded than in kindlins-2 and -3 due to its salt bridge. In addition, the apparent affinity for Ins(3,4,5)P-3 is affected by the presence of PO4 ions in the buffer. We suggest the physiological ligand of the kindlin-1 PH domain is most likely not an inositol phosphate but another phosphorylated species.	[Yates, Luke A.; Zalyte, Ruta; Bird, Louise E.; De Colibus, Luigi; Owens, Raymond J.; Gilbert, Robert J. C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Lumb, Craig N.; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Bird, Louise E.; Owens, Raymond J.] Oxford Prot Prod Facil United Kingdom, Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Yale University; Yale University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Gilbert, RJC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	gilbert@strubi.ox.ac.uk	Sansom, Mark S.P./C-5157-2009; Calderwood, David A/AAC-6954-2019	Sansom, Mark S.P./0000-0001-6360-7959; Calderwood, David A/0000-0002-0791-4142; Bird, Louise/0000-0002-9846-5716; Yates, Luke/0000-0002-5023-0803; Gilbert, Robert/0000-0001-9336-5604; Owens, Ray/0000-0002-3705-2993	National Institutes of Health [R01GM088240, R01 GM068600, T32 GM007223]; Biotechnology and Biological Sciences Research Council (United Kingdom); Wellcome Trust; Medical Research Council (UK); Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust [090532/Z/09/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088240, T32GM007223, R01GM068600] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BEP17032, BBS/B/16011, B19456, BB/I019855/1, BB/H000267/1] Funding Source: researchfish; Medical Research Council [G1100525, G0701506] Funding Source: researchfish; BBSRC [BB/H000267/1, BB/I019855/1] Funding Source: UKRI; MRC [G0701506] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM088240, R01 GM068600, and T32 GM007223 (to D. A. C. and N. N. B.). This work was also supported by the Biotechnology and Biological Sciences Research Council (United Kingdom) and the Wellcome Trust (to M. S. P. S.).; Supported by the Medical Research Council (UK) for financial support.; The Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust Core Award Grant number 090532/Z/09/Z. We gratefully acknowledge the technical support of David Staunton and Marcus Bridge and the use of the SPR equipment in the Biophysical Facility of the Department of Biochemistry, University of Oxford, and the Sir William Dunn School of Pathology, University of Oxford.	Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowling JJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-36; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kern J S, 2007, J Pathol, V213, P462, DOI 10.1002/path.2253; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li CL, 2004, J MED CHEM, V47, P6681, DOI 10.1021/jm049504o; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Liu Y, 2012, PROTEIN CELL, V3, P434, DOI 10.1007/s13238-012-2046-1; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Riffel N, 2002, STRUCTURE, V10, P1627, DOI 10.1016/S0969-2126(02)00896-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Worthylake DK, 2004, STRUCTURE, V12, P1079, DOI 10.1016/j.str.2004.03.021; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639	82	23	23	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43246	43261		10.1074/jbc.M112.422089	http://dx.doi.org/10.1074/jbc.M112.422089			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132860	Green Published, hybrid			2022-12-25	WOS:000312940800006
J	Engelen, M; Vanna, R; Bellei, C; Zucca, FA; Wakamatsu, K; Monzani, E; Ito, S; Casella, L; Zecca, L				Engelen, Mireille; Vanna, Renzo; Bellei, Chiara; Zucca, Fabio A.; Wakamatsu, Kazumasa; Monzani, Enrico; Ito, Shosuke; Casella, Luigi; Zecca, Luigi			Neuromelanins of Human Brain Have Soluble and Insoluble Components with Dolichols Attached to the Melanic Structure	PLOS ONE			English	Article							HUMAN SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; NMR-SPECTROSCOPY; CHEMICAL CHARACTERIZATION; RESONANCE-SPECTROSCOPY; IRON; LIPIDS; PHEOMELANIN; EUMELANIN; OXIDATION	Neuromelanins (NMs) are neuronal pigments of melanic-lipidic type which accumulate during aging. They are involved in protective and degenerative mechanisms depending on the cellular context, however their structures are still poorly understood. NMs from nine human brain areas were analyzed in detail. Elemental analysis led to identification of three types of NM, while infrared spectroscopy showed that NMs from neurons of substantia nigra and locus coeruleus, which selectively degenerate in Parkinson's disease, have similar structure but different from NMs from brain regions not targeted by the disease. Synthetic melanins containing Fe and bovine serum albumin were prepared to model the natural product and help clarifying the structure of NMs. Extensive nuclear magnetic resonance spectroscopy studies showed the presence of dolichols both in the soluble and insoluble parts of NM. Diffusion measurements demonstrated that the dimethyl sulfoxide soluble components consist of oligomeric precursors with MWs in the range 1.4-52 kDa, while the insoluble part contains polymers of larger size but with a similar composition. These data suggest that the selective vulnerability of neurons of substantia nigra and locus coeruleus in Parkinson's disease might depend on the structure of the pigment. Moreover, they allow to propose a pathway for NM biosynthesis in human brain.	[Engelen, Mireille; Vanna, Renzo; Bellei, Chiara; Zucca, Fabio A.; Zecca, Luigi] Natl Res Council Italy, Inst Biomed Technol, Milan, Italy; [Wakamatsu, Kazumasa; Ito, Shosuke] Fujita Hlth Univ, Dept Chem, Sch Hlth Sci, Toyoake, Aichi, Japan; [Monzani, Enrico; Casella, Luigi] Univ Pavia, Dept Gen Chem, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Fujita Health University; University of Pavia	Zecca, L (corresponding author), Natl Res Council Italy, Inst Biomed Technol, Milan, Italy.	luigi.zecca@itb.cnr.it	Wakamatsu, Kazumasa/AAZ-5877-2020; Vanna, Renzo/K-4670-2016; Zucca, Fabio A./O-4368-2015	Wakamatsu, Kazumasa/0000-0003-1748-9001; Vanna, Renzo/0000-0001-6218-8393; Zucca, Fabio A./0000-0003-1230-1129; MONZANI, ENRICO/0000-0002-8791-6446; Ito, Shosuke/0000-0001-9182-5144	Italian Ministry of Education, University, and Research (MIUR) - Research Projects of National Interest (PRIN) [20085SYP79]; MIUR - Medical Research in Italy (MERIT) [RBNE08ZZN7]; Japan Society for the promotion of Science (JSPS) [21500358]	Italian Ministry of Education, University, and Research (MIUR) - Research Projects of National Interest (PRIN)(Ministry of Education, Universities and Research (MIUR)); MIUR - Medical Research in Italy (MERIT); Japan Society for the promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Italian Ministry of Education, University, and Research (MIUR) - Research Projects of National Interest (PRIN) Project 20085SYP79 (Metal ions, neuromelanin, and oxidative stress in Parkinson's disease) and MIUR - Medical Research in Italy (MERIT) Project RBNE08ZZN7, and, in part, by a Japan Society for the promotion of Science (JSPS) grant (No. 21500358) given to KW and SI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIME S, 1994, J NEUROCHEM, V62, P369; Aime S, 2000, MOVEMENT DISORD, V15, P977, DOI 10.1002/1531-8257(200009)15:5<977::AID-MDS1032>3.0.CO;2-Q; Bridelli MG, 1999, FEBS LETT, V457, P18, DOI 10.1016/S0014-5793(99)01001-7; Bush WD, 2006, P NATL ACAD SCI USA, V103, P14785, DOI 10.1073/pnas.0604010103; CHEDEKEL MR, 1992, PIGM CELL RES, V5, P143, DOI 10.1111/j.1600-0749.1992.tb00010.x; Dreissig I, 2009, SPECTROCHIM ACTA A, V71, P2069, DOI 10.1016/j.saa.2008.08.008; Fedorow H, 2005, J NEUROCHEM, V92, P990, DOI 10.1111/j.1471-4159.2004.02975.x; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; ITO S, 1988, BIOCHIM BIOPHYS ACTA, V964, P1, DOI 10.1016/0304-4165(88)90060-8; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; KARLIN S, 1992, PROTEIN ENG, V5, P729, DOI 10.1093/protein/5.8.729; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; Nikonenko NA, 2000, BIOPOLYMERS, V57, P257, DOI 10.1002/1097-0282(2000)57:4<257::AID-BIP7>3.0.CO;2-3; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; RIBONI L, 1986, J BIOL CHEM, V261, P8514; ROSSENEUMOTREFF M, 1970, J BIOCHEM, V68, P369, DOI 10.1093/oxfordjournals.jbchem.a129367; Sacco A, 1997, J SOLUTION CHEM, V26, P527, DOI 10.1007/BF02767604; SCHEIDER W, 1970, BIOCHIM BIOPHYS ACTA, V221, P376, DOI 10.1016/0005-2795(70)90280-1; Shima T, 1997, FREE RADICAL BIO MED, V23, P110, DOI 10.1016/S0891-5849(96)00623-5; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Szczerbowska-Boruchowska M, 2007, ARCH BIOCHEM BIOPHYS, V459, P241, DOI 10.1016/j.abb.2006.12.027; TANAKA Y, 1987, BIOCHEM J, V243, P481, DOI 10.1042/bj2430481; THATHACHARI YT, 1969, BIOPHYS J, V9, P77, DOI 10.1016/S0006-3495(69)86370-8; Wakamatsu K, 2003, J NEUROCHEM, V86, P1015, DOI 10.1046/j.1471-4159.2003.01917.x; Wakamatsu K, 2009, PIGM CELL MELANOMA R, V22, P474, DOI 10.1111/j.1755-148X.2009.00580.x; Ward WC, 2009, ARCH BIOCHEM BIOPHYS, V484, P94, DOI 10.1016/j.abb.2009.01.013; Zecca L, 1996, NEUROSCIENCE, V73, P407, DOI 10.1016/0306-4522(96)00047-4; ZECCA L, 1992, BIOCHIM BIOPHYS ACTA, V1138, P6, DOI 10.1016/0925-4439(92)90144-C; Zecca L, 2000, J NEUROCHEM, V74, P1758, DOI 10.1046/j.1471-4159.2000.0741758.x; Zecca L, 2002, FEBS LETT, V510, P216, DOI 10.1016/S0014-5793(01)03269-0; Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105; Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x	37	45	45	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48490	10.1371/journal.pone.0048490	http://dx.doi.org/10.1371/journal.pone.0048490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139786	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400049
J	Fladeby, C; Vik, ES; Laerdahl, JK; Neurauter, CG; Heggelund, JE; Thorgaard, E; Strom-Andersen, P; Bjoras, M; Dalhus, B; Alseth, I				Fladeby, Cathrine; Vik, Erik Sebastian; Laerdahl, Jon K.; Neurauter, Christine Gran; Heggelund, Julie E.; Thorgaard, Eirik; Strom-Andersen, Pernille; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun			The Human Homolog of Escherichia coli Endonuclease V Is a Nucleolar Protein with Affinity for Branched DNA Structures	PLOS ONE			English	Article							HOLLIDAY JUNCTION RESOLVASE; DEOXYINOSINE 3-ENDONUCLEASE; NITROUS-ACID; HYPOXANTHINE; RESIDUES; DEAMINATION; CLEAVAGE; EXCISION; GENOME; ENZYME	Loss of amino groups from adenines in DNA results in the formation of hypoxanthine (Hx) bases with miscoding properties. The primary enzyme in Escherichia coli for DNA repair initiation at deaminated adenine is endonuclease V (endoV), encoded by the nfi gene, which cleaves the second phosphodiester bond 39 of an Hx lesion. Endonuclease V orthologs are widespread in nature and belong to a family of highly conserved proteins. Whereas prokaryotic endoV enzymes are well characterized, the function of the eukaryotic homologs remains obscure. Here we describe the human endoV ortholog and show with bioinformatics and experimental analysis that a large number of transcript variants exist for the human endonuclease V gene (ENDOV), many of which are unlikely to be translated into functional protein. Full-length ENDOV is encoded by 8 evolutionary conserved exons covering the core region of the enzyme, in addition to one or more 39-exons encoding an unstructured and poorly conserved C-terminus. In contrast to the E. coli enzyme, we find recombinant ENDOV neither to incise nor bind Hx-containing DNA. While both enzymes have strong affinity for several branched DNA substrates, cleavage is observed only with E. coli endoV. We find that ENDOV is localized in the cytoplasm and nucleoli of human cells. As nucleoli harbor the rRNA genes, this may suggest a role for the protein in rRNA gene transactions such as DNA replication or RNA transcription.	[Fladeby, Cathrine; Vik, Erik Sebastian; Laerdahl, Jon K.; Neurauter, Christine Gran; Thorgaard, Eirik; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun] Oslo Univ Hosp HF, Dept Microbiol, Oslo, Norway; [Fladeby, Cathrine; Vik, Erik Sebastian; Laerdahl, Jon K.; Neurauter, Christine Gran; Heggelund, Julie E.; Thorgaard, Eirik; Strom-Andersen, Pernille; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun] Univ Oslo, Rikshosp, N-0027 Oslo, Norway; [Vik, Erik Sebastian; Heggelund, Julie E.; Strom-Andersen, Pernille; Dalhus, Bjorn] Oslo Univ Hosp HF, Dept Med Biochem, Oslo, Norway; [Fladeby, Cathrine; Vik, Erik Sebastian; Laerdahl, Jon K.; Neurauter, Christine Gran; Heggelund, Julie E.; Thorgaard, Eirik; Strom-Andersen, Pernille; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun] Oslo Univ Hosp HF, CMBN, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Alseth, I (corresponding author), Oslo Univ Hosp HF, Dept Microbiol, Oslo, Norway.	ingrun.alseth@rr-research.no	Dalhus, Bjørn/AAK-2895-2020; Bjørås, Magnar/N-9286-2017	Laerdahl, Jon Kristen/0000-0002-0826-9464	The Norwegian Research Council; The Norwegian Cancer Society	The Norwegian Research Council(Research Council of Norway); The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission)	The study was supported by The Norwegian Research Council and The Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Budke B, 2006, J BACTERIOL, V188, P6553, DOI 10.1128/JB.00447-06; CHEN H, 1993, BIOCHEMISTRY-US, V32, P3535, DOI 10.1021/bi00065a003; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Feng H, 2005, BIOCHEMISTRY-US, V44, P675, DOI 10.1021/bi048752j; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; GATES FT, 1977, J BIOL CHEM, V252, P1647; GATES FT, 1977, J BIOL CHEM, V252, P2802; GREEN M, 1957, J BIOL CHEM, V228, P621; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guo GM, 1997, J BACTERIOL, V179, P310, DOI 10.1128/jb.179.2.310-316.1997; He B, 2000, MUTAT RES-DNA REPAIR, V459, P109, DOI 10.1016/S0921-8777(99)00063-4; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang JM, 2002, BIOCHEMISTRY-US, V41, P8342, DOI 10.1021/bi015960s; Huang JM, 2001, BIOCHEMISTRY-US, V40, P8738, DOI 10.1021/bi010183h; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kanugula S, 2005, P NATL ACAD SCI USA, V102, P3617, DOI 10.1073/pnas.0408719102; KARRAN P, 1980, BIOCHEMISTRY-US, V19, P6005, DOI 10.1021/bi00567a010; Kobayashi T, 2006, GENES GENET SYST, V81, P155, DOI 10.1266/ggs.81.155; Lee CC, 2010, DNA REPAIR, V9, P1073, DOI 10.1016/j.dnarep.2010.07.007; Lee DH, 2003, J BIOL CHEM, V278, P10314, DOI 10.1074/jbc.M212696200; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Liu J, 2000, MUTAT RES-DNA REPAIR, V461, P169, DOI 10.1016/S0921-8777(00)00054-9; Mi RJ, 2012, MUTAT RES-FUND MOL M, V735, P12, DOI 10.1016/j.mrfmmm.2012.05.003; Mi RJ, 2011, NUCLEIC ACIDS RES, V39, P536, DOI 10.1093/nar/gkq791; Moe A, 2003, NUCLEIC ACIDS RES, V31, P3893, DOI 10.1093/nar/gkg472; Mullen JR, 2001, GENETICS, V157, P103; MYRNES B, 1982, NUCLEIC ACIDS RES, V10, P3693, DOI 10.1093/nar/10.12.3693; Pang B, 2012, P NATL ACAD SCI USA, V109, P2319, DOI 10.1073/pnas.1118455109; PARK CH, 1995, J BIOL CHEM, V270, P22657, DOI 10.1074/jbc.270.39.22657; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schouten KA, 1999, MUTAT RES-DNA REPAIR, V435, P245, DOI 10.1016/S0921-8777(99)00049-X; SHAPIRO R, 1968, BIOCHEMISTRY-US, V7, P448, DOI 10.1021/bi00841a057; SHAPIRO R, 1969, BIOCHIM BIOPHYS ACTA, V174, P403, DOI 10.1016/0005-2787(69)90268-8; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Yao M, 1997, J BIOL CHEM, V272, P30774, DOI 10.1074/jbc.272.49.30774; Yao M, 1996, J BIOL CHEM, V271, P30672, DOI 10.1074/jbc.271.48.30672; YAO M, 1994, J BIOL CHEM, V269, P31390; YAO M, 1994, J BIOL CHEM, V269, P16260	50	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47466	10.1371/journal.pone.0047466	http://dx.doi.org/10.1371/journal.pone.0047466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139746	Green Published, gold			2022-12-25	WOS:000310741400023
J	Hopp, CS; Flueck, C; Solyakov, L; Tobin, A; Baker, DA				Hopp, Christine S.; Flueck, Christian; Solyakov, Lev; Tobin, Andrew; Baker, David A.			Spatiotemporal and Functional Characterisation of the Plasmodium falciparum cGMP-Dependent Protein Kinase	PLOS ONE			English	Article							MALARIA PARASITE; ENDOPLASMIC-RETICULUM; LIFE-CYCLE; STAGE; IDENTIFICATION; INVASION; TRANSCRIPTOME; ERYTHROCYTES; PURIFICATION; DISRUPTION	Signalling by 3'-5'-cyclic guanosine monophosphate (cGMP) exists in virtually all eukaryotes. In the apicomplexan parasite Plasmodium, the cGMP-dependent protein kinase (PKG) has previously been reported to play a critical role in four key stages of the life cycle. The Plasmodium falciparum isoform (PfPKG) is essential for the initiation of gametogenesis and for blood stage schizont rupture and work on the orthologue from the rodent malaria parasite P. berghei (PbPKG) has shown additional roles in ookinete differentiation and motility as well as liver stage schizont development. In the present study, PfPKG expression and subcellular location in asexual blood stages was investigated using transgenic epitope-tagged PfPKG-expressing P. falciparum parasites. In Western blotting experiments and immunofluorescence analysis (IFA), maximal PfPKG expression was detected at the late schizont stage. While IFA suggested a cytosolic location, a degree of overlap with markers of the endoplasmic reticulum (ER) was found and subcellular fractionation showed some association with the peripheral membrane fraction. This broad localisation is consistent with the notion that PfPKG, as with the mammalian orthologue, has numerous cellular substrates. This idea is further supported by the global protein phosphorylation pattern of schizonts which was substantially changed following PfPKG inhibition, suggesting a complex role for PfPKG during schizogony.	[Hopp, Christine S.; Flueck, Christian; Baker, David A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Solyakov, Lev; Tobin, Andrew] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of London; London School of Hygiene & Tropical Medicine; University of Leicester	Baker, DA (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	David.Baker@lshtm.ac.uk		Hopp, Christine/0000-0002-0528-9531; Baker, David/0000-0002-5490-8933; Flueck, Christian/0000-0001-9145-9324	European Commission [223044]; Wellcome Trust [094752]	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the European Commission FP7 (http://cordis.europa.eu/fp7/home_en.html) project, 'MALSIG' (Ref 223044) and a Wellcome Trust (http://www.wellcome.ac.uk/) Project Grant (Ref 094752) to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Bannister L, 2003, TRENDS PARASITOL, V19, P209, DOI 10.1016/S1471-4922(03)00086-2; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; Deng WS, 2003, BIOCHEM J, V374, P559, DOI 10.1042/BJ20030474; Deng WS, 2002, MOL MICROBIOL, V44, P1141, DOI 10.1046/j.1365-2958.2002.02948.x; Diaz CA, 2006, MOL BIOCHEM PARASIT, V146, P78, DOI 10.1016/j.molbiopara.2005.10.020; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; Falae A, 2010, J BIOL CHEM, V285, P3282, DOI 10.1074/jbc.M109.070367; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Fritsch E.F., 1989, MOL CLONING LAB MANU; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Haase S, 2008, INFECT IMMUN, V76, P879, DOI 10.1128/IAI.00144-07; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Janse CJ, 2007, CELL, V131, P1036, DOI 10.1016/j.cell.2007.11.026; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; MANDERS EMM, 1992, J CELL SCI, V103, P857; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Panchal D, 2010, ANTIMICROB AGENTS CH, V54, P4269, DOI 10.1128/AAC.00420-10; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Taylor CJ, 2008, MOL MICROBIOL, V69, P110, DOI 10.1111/j.1365-2958.2008.06267.x; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; TRAGER W, 1977, B WORLD HEALTH ORGAN, V55, P363; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Waterkeyn JG, 1999, INT J PARASITOL, V29, P945, DOI 10.1016/S0020-7519(99)00047-8; Westenberger SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000653; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10	40	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48206	10.1371/journal.pone.0048206	http://dx.doi.org/10.1371/journal.pone.0048206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139764	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000310741400041
J	Vossfeldt, H; Butzlaff, M; Prussing, K; Charthaigh, RAN; Karsten, P; Lankes, A; Hamm, S; Simons, M; Adryan, B; Schulz, JB; Voigt, A				Vossfeldt, Hannes; Butzlaff, Malte; Pruessing, Katja; Charthaigh, Roisin-Ana Ni; Karsten, Peter; Lankes, Anne; Hamm, Sabine; Simons, Mikael; Adryan, Boris; Schulz, Joerg B.; Voigt, Aaron			Large-Scale Screen for Modifiers of Ataxin-3-Derived Polyglutamine-Induced Toxicity in Drosophila	PLOS ONE			English	Article							RNA INTERFERENCE SCREEN; INTRANUCLEAR INCLUSIONS; PROTEIN AGGREGATION; HUNTINGTONS-DISEASE; NUCLEAR-LOCALIZATION; REPEAT EXPANSION; TRANSGENIC MICE; NEURODEGENERATION; PROTEASOME; GENE	Polyglutamine (polyQ) diseases represent a neuropathologically heterogeneous group of disorders. The common theme of these disorders is an elongated polyQ tract in otherwise unrelated proteins. So far, only symptomatic treatment can be applied to patients suffering from polyQ diseases. Despite extensive research, the molecular mechanisms underlying polyQ-induced toxicity are largely unknown. To gain insight into polyQ pathology, we performed a large-scale RNAi screen in Drosophila to identify modifiers of toxicity induced by expression of truncated Ataxin-3 containing a disease-causing polyQ expansion. We identified various unknown modifiers of polyQ toxicity. Large-scale analysis indicated a dissociation of polyQ aggregation and toxicity.	[Vossfeldt, Hannes; Butzlaff, Malte; Pruessing, Katja; Charthaigh, Roisin-Ana Ni; Karsten, Peter; Lankes, Anne; Hamm, Sabine; Schulz, Joerg B.; Voigt, Aaron] Rhein Westfal TH Aachen, Dept Neurol, Univ Med Ctr, Aachen, Germany; [Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Simons, Mikael] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Charthaigh, Roisin-Ana Ni; Adryan, Boris] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Schulz, Joerg B.] Julich Aachen Res Alliance JARA Brain Translat Br, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Max Planck Society; University of Gottingen; University of Cambridge	Voigt, A (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Univ Med Ctr, Aachen, Germany.	avoigt@ukaachen.de	Schulz, Jörg B/D-9786-2012; Ní Chárthaigh, Róisín-Ana/J-7529-2017	Schulz, Jörg B/0000-0002-8903-0593; Ní Chárthaigh, Róisín-Ana/0000-0002-5688-3530; Butzlaff, Malte/0000-0001-6365-419X; Simons, Mikael/0000-0001-5329-192X; Adryan, Boris/0000-0003-4588-7867	Bundesministerium fur Bildung und Forschung [01GS08137/01GS08137-6a]; "Kompetenznetz Degenerative Demenzen" (KNDD) [01GI0703/01GI1005C]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); "Kompetenznetz Degenerative Demenzen" (KNDD)	This work is/was funded by the "Bundesministerium fur Bildung und Forschung" ("Nationales Genomforschungsnetz (NGFN+): 01GS08137/01GS08137-6a to AV and JBS and "Kompetenznetz Degenerative Demenzen" (KNDD): 01GI0703/01GI1005C to JBS). BA is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambegaokar SS, 2011, HUM MOL GENET, V20, P4947, DOI 10.1093/hmg/ddr432; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Breuer P, 2010, J BIOL CHEM, V285, P6532, DOI 10.1074/jbc.M109.036335; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chan WM, 2011, HUM MOL GENET, V20, P1738, DOI 10.1093/hmg/ddr049; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lessing D, 2008, PLOS BIOL, V6, P266, DOI 10.1371/journal.pbio.0060029; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Mallik M, 2010, GENETICS, V184, P927, DOI 10.1534/genetics.109.113696; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Proud CG, 2004, DNA REPAIR, V3, P927, DOI 10.1016/j.dnarep.2004.03.012; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Shulman JM, 2003, GENETICS, V165, P1233; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wong SLA, 2008, FASEB J, V22, P3348, DOI 10.1096/fj.07-103887; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	56	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47452	10.1371/journal.pone.0047452	http://dx.doi.org/10.1371/journal.pone.0047452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139745	Green Published, gold			2022-12-25	WOS:000310741400022
J	Cain, SA; McGovern, A; Baldwin, AK; Baldock, C; Kielty, CM				Cain, Stuart A.; McGovern, Amanda; Baldwin, Andrew K.; Baldock, Clair; Kielty, Cay M.			Fibrillin-1 Mutations Causing Weill-Marchesani Syndrome and Acromicric and Geleophysic Dysplasias Disrupt Heparan Sulfate Interactions	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; CELL-ADHESION; INTEGRIN BINDING; MARFAN-SYNDROME; DOMAIN; MACROMOLECULES; PROTEOGLYCANS; MICROFIBRILS; ORGANIZATION; DEPOSITION	The extracellular glycoprotein fibrillin-1 forms microfibrils that act as the template for elastic fibers. Most mutations in fibrillin-1 cause Marfan syndrome with severe cardiovascular and ocular symptoms, and tall stature. This is in contrast to mutations within a heparin-binding TB domain (TB5), which is downstream of the arg-gly-asp cell adhesion domain, which can cause Weill-Marchesani syndrome (WMS) or Acromicric (AD) and Geleophysic Dysplasias (GD). WMS is characterized by short limbs, joint stiffness and ocular defects, whilst fibrillin-1 AD and GD have severe short stature, joint defects and thickened skin. We previously showed that TB5 binds heparin. Here, we show that the corresponding region of fibrillin-2 binds heparin very poorly, highlighting a novel functional difference between the two isoforms. This finding enabled us to map heparin/heparan sulfate binding to two sites on fibrillin-1 TB5 using a mutagenesis approach. Once these sites were mapped, we were able to investigate whether disease-causing mutations in this domain disrupt binding to HS. We show that a WMS deletion mutant, and five AD and GD point mutants all have disrupted heparin binding to TB5. These data provide insights into the biology of fibrillins and the pathologies of WMS, AD and GD.	[Cain, Stuart A.; McGovern, Amanda; Baldwin, Andrew K.; Baldock, Clair; Kielty, Cay M.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	University of Manchester	Cain, SA (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	stuart.a.cain@manchester.ac.uk	Cain, Stuart A/G-2836-2017	Baldwin, Andrew/0000-0002-8331-6769; Baldock, Clair/0000-0003-3497-1959; McGovern, Amanda/0000-0001-7727-3283; Cain, Stuart/0000-0001-8417-1058	Medical Research Council, UK [G0801787]; MRC [G0801787] Funding Source: UKRI; Medical Research Council [G0801787] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK (G0801787). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Berry A, 2003, NUCL INSTRUM METH A, V513, P260, DOI 10.1016/j.nima.2003.08.043; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, J BIOL CHEM, V283, P27017, DOI 10.1074/jbc.M803373200; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kutz WE, 2011, J BIOL CHEM, V286, P17156, DOI 10.1074/jbc.M111.231571; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Lewis RA, 1997, NUCL INSTRUM METH A, V392, P32, DOI 10.1016/S0168-9002(97)00211-8; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Rhys NH, 2011, J SYNCHROTRON RADIAT, V18, P79, DOI 10.1107/S0909049510034977; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sengle G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002425; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	39	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48634	10.1371/journal.pone.0048634	http://dx.doi.org/10.1371/journal.pone.0048634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133647	gold, Green Submitted, Green Published			2022-12-25	WOS:000310702400040
J	Zhang, XF; Wu, XJ; Su, P; Gao, YS; Meng, B; Sun, YL; Li, L; Zhou, ZQ; Zhou, GY				Zhang, Xiaofang; Wu, Xiaojuan; Su, Peng; Gao, Yongsheng; Meng, Bin; Sun, Yanlin; Li, Li; Zhou, Zhiqiang; Zhou, Gengyin			Doxorubicin Influences the Expression of Glucosylceramide Synthase in Invasive Ductal Breast Cancer	PLOS ONE			English	Article							ADRIAMYCIN RESISTANCE; DRUG-RESISTANCE; CERAMIDE; CELLS; CHEMOTHERAPY; CARCINOMA	Introduction: Glucosylceramide synthase (GCS) is one enzyme that provides a major route for ceramide clearance. Recent evidence has indicated an important role for GCS in multidrug resistance (MDR) tumors. Doxorubicin (DOX)can modulate the expression of GCS in leukemia and ovary cell lines. However, few studies have investigated their relationship in breast cancer; Methods: We collected 84 excision biopsies from patients with invasive ductal breast cancer of whom 33 patients had undergone preoperative chemotherapy. Immunohistochemistry was used to analyze the expression of GCS protein and significantly showed that the expression of GCS was higher in the samples from patients treated with preoperative chemotherapy(p = 0.018). In order to investigate the underlying mechanism, breast cancer cell lines were cultured with different concentrations of DOX, and mRNA and protein levels of GCS were then detected; Results: DOX significantly upregulated the expression of GCS at both the mRNA and protein level in ERa-positive MCF-7 cells. We then block down the Sp1 site of GCS promoter, which inhibited the DOX-mediated increase in GCS expression; and after Era was inhibited in MCF-7 cells, the up-regulation of GCS by DOX also been inhibited. Conclusions: In conclusion, our data demonstrated the novel finding that DOX could modulate the expression of GCS through the Sp1 site of GCS promoter in ERa-positive breast cancer cells.	[Zhang, Xiaofang; Wu, Xiaojuan; Su, Peng; Meng, Bin; Sun, Yanlin; Li, Li; Zhou, Zhiqiang; Zhou, Gengyin] Shandong Univ, Dept Pathol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Gao, Yongsheng] Acad Tumor Treatment & Prevent, Dept Pathol, Jinan, Shandong, Peoples R China	Shandong University	Zhou, GY (corresponding author), Shandong Univ, Dept Pathol, Sch Med, Jinan 250100, Shandong, Peoples R China.	zhougy@sdu.edu.cn			National Natural Science Foundation of China [30901456]; Postdoctor Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctor Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901456) and the Postdoctor Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1996, BBA-LIPID LIPID MET, V1299, P333, DOI 10.1016/0005-2760(95)00217-0; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Gouaze V, 2004, MOL CANCER THER, V3, P633; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Kaszubiak A, 2007, INT J ONCOL, V31, P419; Lidcovitch M, 2007, CANC LETT, V245, P350; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Liu YY, 2000, J BIOL CHEM, V275, P7138, DOI 10.1074/jbc.275.10.7138; Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140; Ozben T, 2006, FEBS LETT, V580, P2903, DOI 10.1016/j.febslet.2006.02.020; Ruckhaberle E, 2009, J CANCER RES CLIN, V135, P81, DOI 10.1007/s00432-008-0436-9; Rudas M, 2003, BREAST CANCER RES TR, V81, P149, DOI 10.1023/A:1025751631115; Sun YL, 2010, BREAST CANCER RES TR, V121, P591, DOI 10.1007/s10549-009-0513-z; Uchida Y, 2004, CANCER RES, V64, P6271, DOI 10.1158/0008-5472.CAN-03-1476; Uchida Y, 2002, J LIPID RES, V43, P1293, DOI 10.1194/jlr.M100442-JLR200; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Yamashita T, 2000, SEIKAGAKU, V72, P1420; Zhang XF, 2009, CANCER BIOL THER, V8, P1117, DOI 10.4161/cbt.8.12.8374	19	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48492	10.1371/journal.pone.0048492	http://dx.doi.org/10.1371/journal.pone.0048492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133636	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400036
J	Xia, X; Babcock, JP; Blaber, SI; Harper, KM; Blaber, M				Xia, Xue; Babcock, Joseph P.; Blaber, Sachiko I.; Harper, Kathleen M.; Blaber, Michael			Pharmacokinetic Properties of 2nd-Generation Fibroblast Growth Factor-1 Mutants for Therapeutic Application	PLOS ONE			English	Article							CHRONIC MYOCARDIAL-ISCHEMIA; DIABETIC MOUSE; RABBIT MODEL; GENE-THERAPY; BETA-TREFOIL; ANGIOGENESIS; PROTEIN; STABILITY; SEQUENCE; HEPARIN	Fibroblast growth factor-1 (FGF-1) is an angiogenic factor with therapeutic potential for the treatment of ischemic disease. FGF-1 has low intrinsic thermostability and is characteristically formulated with heparin as a stabilizing agent. Heparin, however, adds a number of undesirable properties that negatively impact safety and cost. Mutations that increase the thermostability of FGF-1 may obviate the need for heparin in formulation and may prove to be useful "2nd-generation" forms for therapeutic use. We report a pharmacokinetic (PK) study in rabbits of human FGF-1 in the presence and absence of heparin, as well as three mutant forms having differential effects upon thermostability, buried reactive thiols, and heparin affinity. The results support the hypothesis that heparan sulfate proteoglycan (HSPG) in the vasculature of liver, kidney and spleen serves as the principle peripheral compartment in the distribution kinetics. The addition of heparin to FGF-1 is shown to increase endocrine-like properties of distribution. Mutant forms of FGF-1 that enhance thermostability or eliminate buried reactive thiols demonstrate a shorter distribution half-life, a longer elimination half-life, and a longer mean residence time (MRT) in comparison to wild-type FGF-1. The results show how such mutations can produce useful 2nd-generation forms with tailored PK profiles for specific therapeutic application.	[Xia, Xue; Babcock, Joseph P.; Blaber, Sachiko I.; Blaber, Michael] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Harper, Kathleen M.] Florida State Univ, Biomed Res Lab Anim Resources, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Blaber, M (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.	michael.blaber@med.fsu.edu	Blaber, Michael/N-1083-2019; Blaber, Michael/E-7478-2011; Blaber, Michael/ABA-5031-2021	Blaber, Michael/0000-0002-6856-1643; 	Florida Department of Health [1KF03]	Florida Department of Health	Florida Department of Health Grant 1KF03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsenaidy MA, 2012, PROTEIN SCI, V21, P418, DOI 10.1002/pro.2008; [Anonymous], 2009, ANIMAL CLIN CHEM PRA; BAFFOUR R, 1992, J VASC SURG, V16, P181, DOI 10.1016/0741-5214(92)90106-I; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bing M, 2007, WOUND REPAIR REGEN, V15, P795, DOI 10.1111/j.1524-475X.2007.00307.x; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; Blaber SI, 1999, BIOPHYS J, V77, P470, DOI 10.1016/S0006-3495(99)76904-3; BROWN RL, 1994, J SURG RES, V56, P562, DOI 10.1006/jsre.1994.1090; Brych SR, 2004, J MOL BIOL, V344, P769, DOI 10.1016/j.jmb.2004.09.060; Brych SR, 2003, PROTEIN SCI, V12, P2704, DOI 10.1110/ps.03374903; Brych SR, 2001, PROTEIN SCI, V10, P2587, DOI 10.1110/ps.ps.34701; COPELAND RA, 1991, ARCH BIOCHEM BIOPHYS, V289, P53, DOI 10.1016/0003-9861(91)90441-K; Dubey VK, 2007, J MOL BIOL, V371, P256, DOI 10.1016/j.jmb.2007.05.065; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V128, P611; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hedman M, 2003, CIRCULATION, V107, P2677, DOI 10.1161/01.CIR.0000070540.80780.92; HEWITT CD, 1989, CLIN CHEM, V35, P1777; HGASHIYAMA A, 1995, CIRCULATION, V92, P3094, DOI 10.1161/01.CIR.92.10.3094; HONDERMARCK H, 1990, EXPERIENTIA, V46, P973, DOI 10.1007/BF01939392; HOOBER JK, 1967, BIOCHIM BIOPHYS ACTA, V138, P347, DOI 10.1016/0005-2787(67)90495-9; Ioli V, 1992, 5 ANN S ADV WOUND CA, P150; Jimenez PA, 1999, J SURG RES, V81, P238, DOI 10.1006/jsre.1998.5501; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kurtzman AL, 2001, CURR OPIN BIOTECH, V12, P361, DOI 10.1016/S0958-1669(00)00228-7; Laham RJ, 2000, J PHARMACOL EXP THER, V292, P795; LANDAU C, 1995, AM HEART J, V129, P924, DOI 10.1016/0002-8703(95)90113-2; Lee J, 2011, J MOL BIOL, V407, P744, DOI 10.1016/j.jmb.2011.02.002; Lee J, 2009, J MOL BIOL, V393, P113, DOI 10.1016/j.jmb.2009.08.026; LEVIMONTALCINI R, 1964, ANN NY ACAD SCI, V118, P149, DOI 10.1111/j.1749-6632.1964.tb33978.x; LITTLE RA, 1969, POSTGRAD MED J, V45, P559, DOI 10.1136/pgmj.45.526.559; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Marti Guy P., 2008, V423, P383, DOI 10.1007/978-1-59745-194-9_30; MATUSZEWSKA B, 1994, PHARM RES-DORDR, V11, P65, DOI 10.1023/A:1018993610801; MCLACHLAN AD, 1979, J MOL BIOL, V133, P557, DOI 10.1016/0022-2836(79)90408-X; Mellin TN, 1992, GROWTH FACTORS, V7, P1, DOI 10.3109/08977199209023933; MELLIN TN, 1995, J INVEST DERMATOL, V104, P850, DOI 10.1111/1523-1747.ep12607026; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403; Prechel M, 2012, SEMIN THROMB HEMOST, V38, P483, DOI 10.1055/s-0032-1306432; Preckel B, 2002, BRIT J ANAESTH, V88, P264, DOI 10.1093/bja/88.2.264; Pu L Q, 1994, J Invest Surg, V7, P49, DOI 10.3109/08941939409018282; PU LQ, 1993, CIRCULATION, V88, P208, DOI 10.1161/01.CIR.88.1.208; Reiche M, 2010, HORM METAB RES, V42, P178, DOI 10.1055/s-0029-1243249; Rosenbaum S., 2011, BASIC PHARMACOKINETI, V1st ed.; Rosengart TK, 1999, CIRCULATION, V100, P468, DOI 10.1161/01.CIR.100.5.468; ROSENGART TK, 1989, CIRC RES, V64, P227, DOI 10.1161/01.RES.64.2.227; RUDLAND PS, 1974, P NATL ACAD SCI USA, V71, P2600, DOI 10.1073/pnas.71.7.2600; Ryden M, 2009, CELL MOL LIFE SCI, V66, P2067, DOI 10.1007/s00018-009-0003-9; SCHENKEIN I, 1968, SCIENCE, V159, P640, DOI 10.1126/science.159.3815.640; Schumacher B, 1998, J CARDIOVASC SURG, V39, P783; Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645; Seitz Cornelia S, 2008, Dermatol Online J, V14, P4; STEGMANN TJ, 2000, CARDIAC VASCULAR REG, V1, P5; THRALL M.A., 2004, VET HEMATOLOGY CLIN; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; TSAI PK, 1993, PHARMACEUT RES, V10, P649, DOI 10.1023/A:1018939228201; Wagoner LE, 2007, CIRCULATION, V116, P443; Wang W, 2008, LIFE SCI, V82, P190, DOI 10.1016/j.lfs.2007.11.009; Willard MD, 2007, SMALL ANIMAL CLIN DI; ZAZO M, 1992, GENE, V113, P231, DOI 10.1016/0378-1119(92)90400-J; Zinn KR, 2000, NUCL MED BIOL, V27, P407, DOI 10.1016/S0969-8051(00)00090-1	64	20	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48210	10.1371/journal.pone.0048210	http://dx.doi.org/10.1371/journal.pone.0048210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133616	Green Published, Green Submitted, gold			2022-12-25	WOS:000310601300005
J	Magrach, A; Larrinaga, AR; Santamaria, L				Magrach, Ainhoa; Larrinaga, Asier R.; Santamaria, Luis			Internal Habitat Quality Determines the Effects of Fragmentation on Austral Forest Climbing and Epiphytic Angiosperms	PLOS ONE			English	Article							TEMPERATE RAIN-FORESTS; SEED DISPERSAL; REPRODUCTIVE SUCCESS; SPECIES RICHNESS; CHILOE ISLAND; DIVERSITY; PLANT; CONSEQUENCES; BIODIVERSITY; POLLINATORS	Habitat fragmentation has become one of the major threats to biodiversity worldwide, particularly in the case of forests, which have suffered enormous losses during the past decades. We analyzed how changes in patch configuration and habitat quality derived from the fragmentation of austral temperate rainforests affect the distribution of six species of forest-dwelling climbing and epiphytic angiosperms. Epiphyte and vine abundance is primarily affected by the internal characteristics of patches (such as tree size, the presence of logging gaps or the proximity to patch edges) rather than patch and landscape features (such as patch size, shape or connectivity). These responses were intimately related to speciesspecific characteristics such as drought- or shade-tolerance. Our study therefore suggests that plant responses to fragmentation are contingent on both the species' ecology and the specific pathways through which the study area is being fragmented, (i.e. extensive logging that shaped the boundaries of current forest patches plus recent, unregulated logging that creates gaps within patches). Management practices in fragmented landscapes should therefore consider habitat quality within patches together with other spatial attributes at landscape or patch scales.	[Magrach, Ainhoa; Larrinaga, Asier R.; Santamaria, Luis] Mediterranean Inst Adv Studies, Lab Spatial Ecol, Mallorca, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Magrach, A (corresponding author), Mediterranean Inst Adv Studies, Lab Spatial Ecol, Mallorca, Balearic Island, Spain.	ainhoamagrach@hotmail.com	Larrinaga, Asier/B-3826-2013; Magrach, Ainhoa/B-1038-2012; Santamaria, Luis/C-1438-2012	Larrinaga, Asier/0000-0001-6813-8784; Magrach, Ainhoa/0000-0003-2155-7556; Santamaria, Luis/0000-0002-5072-2912	Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (project DOSEL); Basque Country Government; JAEDOC program of the Spanish Research Council (CSIC)	Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (project DOSEL); Basque Country Government(Basque Government); JAEDOC program of the Spanish Research Council (CSIC)	Funding by the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (project DOSEL) and the Basque Country Government (pre-doctoral fellowship for A.M.) are gratefully acknowledged. A.R.L. received funding from the JAEDOC program of the Spanish Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2003, ECOLOGY, V84, P2613, DOI 10.1890/02-0521; AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; Amico G, 2000, NATURE, V408, P929, DOI 10.1038/35050170; ARMESTO JJ, 1987, REV CHIL HIST NAT, V60, P321; ARMESTO JJ, 1989, J BIOGEOGR, V16, P219, DOI 10.2307/2845258; ARMESTO JJ, 1987, J BIOGEOGR, V14, P367, DOI 10.2307/2844944; Armesto JJ, 1996, ECOLOGIA BOSQUES NAT, P23; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Benzing D.H., 1990, VASCULAR EPIPHYTES; Braschler B, 2009, ECOL ENTOMOL, V34, P321, DOI 10.1111/j.1365-2311.2008.01080.x; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Bunnell FL, 1999, WILDLIFE MANAGEMENT, pvii; Burnham KM, 2010, BIOL INVASIONS, V12, P1509, DOI 10.1007/s10530-009-9563-8; Echeverria C, 2008, ECOL MODEL, V212, P439, DOI 10.1016/j.ecolmodel.2007.10.045; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Exeler N, 2008, CONSERV GENET, V9, P1233, DOI 10.1007/s10592-007-9450-8; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Salinas MF, 2010, ANN MO BOT GARD, V97, P117, DOI 10.3417/2006210; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Gonzalez M, 2010, FOREST ECOL MANAG, V259, P266, DOI 10.1016/j.foreco.2009.10.010; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; HANSKI I, 1997, METAPOPULATION ECOLO; Hanski Ilkka, 2004, P3, DOI 10.1016/B978-012323448-3/50003-9; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Kanowski J, 2005, FOREST ECOL MANAG, V208, P359, DOI 10.1016/j.foreco.2005.01.018; Koster N, 2009, CONSERV BIOL, V23, P911, DOI 10.1111/j.1523-1739.2008.01164.x; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Lang S., 2003, P 18 ESRI EUR US C I; Lara A, 2002, INFORM PAIS ESTADO M, P131; Laurance WF, 1998, CONSERV BIOL, V12, P460, DOI 10.1046/j.1523-1739.1998.97175.x; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Lienert Judit, 2004, Journal for Nature Conservation (Jena), V12, P53, DOI 10.1016/j.jnc.2003.07.002; Magrach A, 2012, AUSTRAL ECOL, V37, P600, DOI 10.1111/j.1442-9993.2011.02320.x; Magrach A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021596; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Meyer CFJ, 2009, BIOTROPICA, V41, P95, DOI 10.1111/j.1744-7429.2008.00443.x; MITCHELL B, 2007, FRAGSTATSBATCH ARCGI; Munoz AA, 2003, AUST J BOT, V51, P381, DOI 10.1071/BT02070; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Parkes David, 2003, Ecological Management & Restoration, V4, pS29, DOI 10.1046/j.1442-8903.4.s.4.x; Paschke M, 2002, AM J BOT, V89, P1250, DOI 10.3732/ajb.89.8.1250; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rodriguez-Cabal MA, 2007, BIOL CONSERV, V139, P195, DOI 10.1016/j.biocon.2007.06.014; Ruiz-Guerra B, 2010, OIKOS, V119, P317, DOI 10.1111/j.1600-0706.2009.17614.x; Salinas M. F., 2008, THESIS U CHILE SANTI; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; Smith-Ramirez C, 2005, BOT J LINN SOC, V147, P399, DOI 10.1111/j.1095-8339.2005.00388.x; SMITHRAMIREZ C, 1993, REV CHIL HIST NAT, V66, P65; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stiles A, 2010, J BIOGEOGR, V37, P1721, DOI 10.1111/j.1365-2699.2010.02333.x; THOMAS L., 2006, DISTANCE 5 0 RELEASE; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tsaliki M, 2010, PLANT BIOLOGY, V12, P622, DOI 10.1111/j.1438-8677.2009.00266.x; Wilcove D.S., 1986, P237; Wilson TL, 2009, LANDSCAPE ECOL, V24, P351, DOI 10.1007/s10980-008-9309-5; WU JG, 1991, ECOL MODEL, V58, P249, DOI 10.1016/0304-3800(91)90039-4; Zizka G, 1999, BOT J LINN SOC, V129, P315, DOI 10.1006/bojl.1998.0223	63	9	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48743	10.1371/journal.pone.0048743	http://dx.doi.org/10.1371/journal.pone.0048743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119096	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500203
J	Bartolini, RM; Winkler, JL; Penny, ME; LaMontagne, DS				Bartolini, Rosario M.; Winkler, Jennifer L.; Penny, Mary E.; LaMontagne, D. Scott			Parental Acceptance of HPV Vaccine in Peru: A Decision Framework	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; DEVELOPING-COUNTRIES; ACCEPTABILITY; WOMEN; STRATEGIES; INFECTION; ATTITUDES; CANCER	Objective and Method: Cervical cancer is the third most common cancer affecting women worldwide and it is an important cause of death, especially in developing countries. Cervical cancer is caused by human papillomavirus (HPV) and can be prevented by HPV vaccine. The challenge is to expand vaccine availability to countries where it is most needed. In 2008 Peru's Ministry of Health implemented a demonstration project involving 5th grade girls in primary schools in the Piura region. We designed and conducted a qualitative study of the decision-making process among parents of girls, and developed a conceptual model describing the process of HPV vaccine acceptance. Results: We found a nonlinear HPV decision-making process that evolved over time. Initially, the vaccine's newness, the requirement of written consent, and provision of information were important. If information was sufficient and provided by credible sources, many parents accepted the vaccine. Later, after obtaining additional information from teachers, health personnel, and other trusted sources, more parents accepted vaccination. An understanding of the issues surrounding the vaccine developed, parents overcome fears and rumors, and engaged in family negotiations-including hearing the girl's voice in the decision-making process. The concept of prevention (cancer as danger, future health, and trust in vaccines) combined with pragmatic factors (no cost, available at school) and the credibility of the offer (information in the media, recommendation of respected authority figure) were central to motivations that led parents to decide to vaccinate their daughters. A lack of confidence in the health system was the primary inhibitor of vaccine acceptance. Conclusions: Health personnel and teachers are credible sources of information and can provide important support to HPV vaccination campaigns.	[Winkler, Jennifer L.; LaMontagne, D. Scott] PATH, Seattle, WA USA; [Bartolini, Rosario M.; Penny, Mary E.] Inst Invest Nutr, Lima, Peru; [LaMontagne, D. Scott] Univ Washington, Harborview Med Ctr, Dept Global Hlth, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	LaMontagne, DS (corresponding author), PATH, Seattle, WA USA.	Slamontagne@path.org	Penny, Mary/J-2286-2017	Penny, Mary/0000-0001-5501-9399	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded in whole by a grant to PATH from the Bill & Melinda Gates Foundation. The views expressed herein are solely those of the authors and do not necessarily reflect the views of the Foundation. Quadrivalent (Guardasil (R)) HPV vaccine was donated to PATH by Merck & Co. (United States of America) for use in the demonstration project in Peru. Merck & Co. was not involved in the study design, data collection and analysis, or writing of this paper.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Brabin L, 2009, BRIT J CANCER, V101, P1502, DOI 10.1038/sj.bjc.6605362; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Dahlstrom LA, 2010, INT J CANCER, V126, P500, DOI 10.1002/ijc.24712; Dempsey AF, 2008, CURR OPIN OBSTET GYN, V20, P447, DOI 10.1097/GCO.0b013e3283086719; Fazekas KI, 2008, J WOMENS HEALTH, V17, P539, DOI 10.1089/jwh.2007.0489; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; Ferris DG, 2010, J LOW GENIT TRACT DI, V14, P179, DOI 10.1097/LGT.0b013e3181d41806; Flick U., 2002, INTRO QUALITATIVE RE, V2nd; Katahoire A, 2012, INT J CHILD IN PRESS; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Munira SL, 2007, SOC SCI MED, V65, P1751, DOI 10.1016/j.socscimed.2007.05.054; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Pan American Health Organization, 2007, PER HLTH AM; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Penny M, 2011, VACCINE, V29, P5022, DOI 10.1016/j.vaccine.2011.04.078; Robbins SCC, 2010, HEALTH PSYCHOL, V29, P618, DOI 10.1037/a0021449; Robbins SCC, 2010, SEX HEALTH, V7, P271, DOI 10.1071/SH09140; Sam IC, 2009, J ADOLESCENT HEALTH, V44, P610, DOI 10.1016/j.jadohealth.2008.11.014; Scarinci IC, 2007, J WOMENS HEALTH, V16, P1224, DOI 10.1089/jwh.2006.0175; Schiffman M, 2012, LANCET ONCOL, V13, P10, DOI 10.1016/S1470-2045(11)70324-2; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wenger JD, 1999, VACCINE, V18, P736, DOI 10.1016/S0264-410X(99)00269-8; Zimet GD, 2006, VACCINE, V24, P201, DOI 10.1016/j.vaccine.2006.06.017	29	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48017	10.1371/journal.pone.0048017	http://dx.doi.org/10.1371/journal.pone.0048017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032HH	23144719	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300030
J	Chen, A; Raule, N; Chomyn, A; Attardi, G				Chen, Ai; Raule, Nicola; Chomyn, Anne; Attardi, Giuseppe			Decreased Reactive Oxygen Species Production in Cells with Mitochondrial Haplogroups Associated with Longevity	PLOS ONE			English	Article							HUMAN MTDNA; REPLICATION ORIGIN; CYTOCHROME BC(1); CONTROL REGION; DNA; SEQUENCE; GENOME; CENTENARIANS; POLYMORPHISM; POPULATION	Mitochondrial DNA (mtDNA) is highly polymorphic, and its variations in humans may contribute to individual differences in function. Zhang and colleagues found a strikingly higher frequency of a C150T transition in the D-loop of mtDNA from centenarians and twins of an Italian population, and also demonstrated that this base substitution causes a remodeling of the mtDNA 151 replication origin in human leukocytes and fibroblasts [1]. The C150T transition is a polymorphism associated with several haplogroups. To determine whether haplogroups that carry the C150T transition display any phenotype that may be advantageous for longevity, we analyzed cybrids carrying or not the C150T transition. These cybrids were obtained by fusing cytoplasts derived from human fibroblasts with human mtDNA-less cells (rho(0) cells). We chose for cybrid construction and analysis haplogroup-matched pairs of fibroblast strains containing or not the C150T transition. In particular, we used, as one pair of mtDNA donors, a fibroblast strain of the U3a haplogroup, carrying the C150T transition and a strain of the U-K2 haplogroup, without the C150T transition, and as another pair, fibroblasts of the J2b haplogroup, carrying the C150T transition and of the J1c haplogroup, without the C150T transition. We have found no association of respiratory capacity, mtDNA level, mitochondrial gene expression level, or growth rate with the presence of the C150T transition. However, we have found that the cybrids with haplogroups that include the C150T transition have in common a lower reactive oxygen species (ROS) production rate than the haplogroup-matched cybrids without that transition. Thus, the lower ROS production rate may be a factor in the increased longevity associated with the U and the J2 haplogroups. Of further interest, we found that cybrids with the U3a haplogroup exhibited a higher respiration rate than the other cybrids examined.	[Chen, Ai; Raule, Nicola; Chomyn, Anne; Attardi, Giuseppe] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Chen, A (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	chenainy@hotmail.com; chomyn@caltech.edu			National Institutes of Health [R01 AG012117]; Ellison Foundation; Grace C. Steele Foundation; NATIONAL INSTITUTE ON AGING [R01AG012117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); Grace C. Steele Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was support by National Institutes of Health grant R01 AG012117 and the Ellison Foundation Senior Scholar Award, both to Guiseppe Attardi. The Grace C. Steele Foundation also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0; De Benedictis G, 2000, ANN NY ACAD SCI, V908, P208; Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077; Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Harman D, 1973, Triangle, V12, P153; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Ivanova R, 1998, GERONTOLOGY, V44, P349, DOI 10.1159/000022041; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; *MITOMAP, 2006, HUM MIT GEN DAT; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Torroni A, 1996, GENETICS, V144, P1835; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2002, HUM GENET, V111, P462, DOI 10.1007/s00439-002-0826-z; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	33	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e46473	10.1371/journal.pone.0046473	http://dx.doi.org/10.1371/journal.pone.0046473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144696	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000310705300007
J	Liu, F; Chen, ZF; Gu, YQ; Wang, Q; Cui, WD; Fan, WM				Liu, Feng; Chen, Zhefeng; Gu, Yanqing; Wang, Qing; Cui, Weiding; Fan, Weimin			Deformation of the Durom Acetabular Component and Its Impact on Tribology in a Cadaveric Model-A Simulator Study	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; METALLIC RESURFACING CUPS; WEAR PARTICLES; ION LEVELS; FAILURE; INCLINATION; REPLACEMENT; CHROMIUM; BEARING; DEBRIS	Background: Recent studies have shown that the acetabular component frequently becomes deformed during press-fit insertion. The aim of this study was to explore the deformation of the Durom cup after implantation and to clarify the impact of deformation on wear and ion release of the Durom large head metal-on-metal (MOM) total hips in simulators. Methods: Six Durom cups impacted into reamed acetabula of fresh cadavers were used as the experimental group and another 6 size-paired intact Durom cups constituted the control group. All 12 Durom MOM total hips were put through a 3 million cycle (MC) wear test in simulators. Results: The 6 cups in the experimental group were all deformed, with a mean deformation of 41.78 +/- 8.86 mu m. The average volumetric wear rate in the experimental group and in the control group in the first million cycle was 6.65 +/- 0.29 mm(3)/MC and 0.89 +/- 0.04 mm(3)/MC (t = 48.43, p = 0.000). The ion levels of Cr and Co in the experimental group were also higher than those in the control group before 2.0 MC. However there was no difference in the ion levels between 2.0 and 3.0 MC. Conclusions: This finding implies that the non-modular acetabular component of Durom total hip prosthesis is likely to become deformed during press-fit insertion, and that the deformation will result in increased volumetric wear and increased ion release.	[Liu, Feng; Chen, Zhefeng; Gu, Yanqing; Wang, Qing; Cui, Weiding; Fan, Weimin] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Fan, WM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing, Jiangsu, Peoples R China.	fanweimin@vip.sina.com						Berton C, 2010, J BONE JOINT SURG BR, V92B, P202, DOI 10.1302/0301-620X.92B2.22653; Brodner W, 2004, J ARTHROPLASTY, V19, P66, DOI 10.1016/j.arth.2004.09.003; Brown C, 2007, J MATER SCI-MATER M, V18, P819, DOI 10.1007/s10856-006-0015-z; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; De Haan R, 2008, J BONE JOINT SURG BR, V90B, P1291, DOI 10.1302/0301-620X.90B10.20533; De Haan R, 2008, J BONE JOINT SURG BR, V90B, P1158, DOI 10.1302/0301-620X.90B9.19891; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P738, DOI 10.1302/0301-620X.91B6.21682; Illgen RL, 2010, J ARTHROPLASTY, V25, P26, DOI 10.1016/j.arth.2010.04.005; Imanishi T, 2010, ARCH ORTHOP TRAUM SU, V130, P1447, DOI 10.1007/s00402-010-1056-9; Jin ZM, 2006, P I MECH ENG H, V220, P299, DOI 10.1243/095441105X69150; Kim RH, 2008, J ARTHROPLASTY, V23, P44, DOI 10.1016/j.arth.2008.06.007; Kroeber M, 2002, J ARTHROPLASTY, V17, P349, DOI 10.1054/arth.2002.30412; Langton DJ, 2008, J BONE JOINT SURG BR, V90B, P1143, DOI 10.1302/0301-620X.90B9.20785; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Leslie I, 2008, J BIOMED MATER RES B, V87B, P163, DOI 10.1002/jbm.b.31087; MacDonald SJ, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000150309.48474.8b; Maezawa K, 2010, J ARTHROPLASTY, V25, P1196, DOI 10.1016/j.arth.2009.08.016; Markel D, 2011, INT ORTHOP, V35, P1131, DOI 10.1007/s00264-010-1077-6; McMinn DJW, 2008, J BONE JOINT SURG BR, V90B, P715, DOI 10.1302/0301-620X.90B6.19875; Morlock MM, 2008, J BONE JOINT SURG AM, V90A, P89, DOI 10.2106/JBJS.H.00621; Ollivere B, 2009, J BONE JOINT SURG BR, V91B, P1025, DOI 10.1302/0301-620X.91B8.21701; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Saikko V, 2005, P I MECH ENG H, V219, P437, DOI 10.1243/095441105X34419; Saito S, 2006, J ARTHROPLASTY, V21, P1105, DOI 10.1016/j.arth.2005.11.011; Squire M, 2006, J ARTHROPLASTY, V21, P72, DOI 10.1016/j.arth.2006.04.016; Stuchin SA, 2008, J BONE JOINT SURG AM, V90A, P52, DOI 10.2106/JBJS.H.00690; Whittingham-Jones PM, 2008, J ARTHROPLASTY, V23, P1212, DOI 10.1016/j.arth.2007.10.015; Yew A, 2006, P I MECH ENG H, V220, P311, DOI 10.1243/095441105X69105	30	11	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e45786	10.1371/journal.pone.0045786	http://dx.doi.org/10.1371/journal.pone.0045786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144694	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300005
J	Yang, YW; Wu, CH; Ko, WJ; Wu, VC; Chen, JS; Chou, NK; Lai, HS				Yang, Ya-Wen; Wu, Che-Hsiung; Ko, Wen-Je; Wu, Vin-Cent; Chen, Jin-Shing; Chou, Nai-Kuan; Lai, Hong-Shiee			Prevalence of Acute Kidney Injury and Prognostic Significance in Patients with Acute Myocarditis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; RENAL REPLACEMENT THERAPY; FAILURE ASSESSMENT SCORE; RIFLE CRITERIA; MORTALITY PREDICTION; HEART-FAILURE; OUTCOMES; SOFA; CLASSIFICATION; SURGERY	Objective: Myocarditis is an inflammation of the myocardium. The condition is commonly associated with rapid disease progression and often results in profound shock. Impaired renal function is the result of impairment in end-organ perfusion and is highly prevalent among critically ill patients. The aim of this study was to evaluate the incidence of acute kidney injury (AKI) and identify the relationship between AKI and the prognosis of patients with acute myocarditis. Design, Measurements and Main Results: This retrospective study reviewed the medical records of 101 patients suffering from acute myocarditis between 1996 and 2011. Sixty of these patients (59%) developed AKI within 48 hours of being hospitalized. AKI defined as AKIN stage 3 (p=0.007) and SOFA score (p=0.03) were identified as predictors of in-hospital mortality in multivariate analysis. The conditional effect plot of the estimated risk against SOFA score upon admission categorized according to the AKIN stages showed that the risk of in-hospital mortality was highest among patients in AKIN stage 3 with a high SOFA score. Conclusions: Among patients with acute myocarditis, AKI defined as AKIN stage 3 and elevated SOFA score were associated with unfavorable outcomes. AKIN classification is a simple, reproducible, and easily applied evaluation tool capable of providing objective information related to the clinical prognosis of patients with acute myocarditis.	[Yang, Ya-Wen; Ko, Wen-Je; Chen, Jin-Shing; Chou, Nai-Kuan; Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wu, Che-Hsiung] Tzu Chi Gen Hosp, Div Nephrol, Dept Med, Taipei Branch, New Taipei City, Taiwan; [Wu, Vin-Cent] Natl Taiwan Univ Hosp, Dept Med, Div Nephrol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital; National Taiwan University; National Taiwan University Hospital	Lai, HS (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan.	paipai0127@gmail.com		YANG, YA-WEN/0000-0003-0412-584X; Wu, Che-Hsiung/0000-0001-6164-6655; WU, VIN-CENT/0000-0001-7935-0991; Lai, Hong-Shiee/0000-0002-7958-2183; Chou, Nai-Kuan/0000-0001-5494-7708; CHEN, JIN-SHING/0000-0001-5077-4483				ARETZ HT, 1987, HUM PATHOL, V18, P619; Badreldin AMA, 2012, THORAC CARDIOV SURG, V60, P35, DOI 10.1055/s-0030-1270943; Barrantes F, 2008, CRIT CARE MED, V36, P1397, DOI 10.1097/CCM.0b013e318168fbe0; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Caforio ALP, 2007, EUR HEART J, V28, P1326, DOI 10.1093/eurheartj/ehm076; Chen YS, 2001, J HEART LUNG TRANSPL, V20, P850, DOI 10.1016/S1053-2498(01)00267-4; Clec'h C, 2011, CRIT CARE, V15, DOI 10.1186/cc10241; Cruz DN, 2009, CRIT CARE, V13, DOI 10.1186/cc7759; Dennen P, 2010, CRIT CARE MED, V38, P261, DOI 10.1097/CCM.0b013e3181bfb0b5; Hata N, 2010, EUR J HEART FAIL, V12, P32, DOI 10.1093/eurjhf/hfp169; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Houel R, 1999, ANN THORAC SURG, V68, P2177, DOI 10.1016/S0003-4975(99)00839-5; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li SY, 2011, EUR J CARDIO-THORAC, V39, P323, DOI 10.1016/j.ejcts.2010.07.010; LIEBERMAN EB, 1991, J AM COLL CARDIOL, V18, P1617, DOI 10.1016/0735-1097(91)90493-S; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Morgan D, 2008, NEPHROL DIAL TRANSPL, V23, P4072, DOI 10.1093/ndt/gfn390; Olimulder MAGM, 2009, NETH HEART J, V17, P481, DOI 10.1007/BF03086308; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7123; Shiao CC, 2009, CRIT CARE, V13, DOI 10.1186/cc8147; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Toma T, 2007, J BIOMED INFORM, V40, P649, DOI 10.1016/j.jbi.2007.03.007; Toyozaki T, 1998, AM J CARDIOL, V82, P246, DOI 10.1016/S0002-9149(98)00300-2; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x; Wu VC, 2007, J AM COLL SURGEONS, V205, P266, DOI 10.1016/j.jamcollsurg.2007.04.006; Wu VC, 2010, AM J SURG, V199, P466, DOI 10.1016/j.amjsurg.2009.01.007	30	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48055	10.1371/journal.pone.0048055	http://dx.doi.org/10.1371/journal.pone.0048055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144725	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300035
J	Qin, L; Guo, YX; Chen, LY; Liang, RK; Gu, MA; Xu, GH; Zhao, J; Walk, T; Liao, H				Qin, Lu; Guo, Yongxiang; Chen, Liyu; Liang, Ruikang; Gu, Mian; Xu, Guohua; Zhao, Jing; Walk, Thomas; Liao, Hong			Functional Characterization of 14 Pht1 Family Genes in Yeast and Their Expressions in Response to Nutrient Starvation in Soybean	PLOS ONE			English	Article							PHOSPHATE TRANSPORTER GENE; ARBUSCULAR MYCORRHIZAL; KINETIC-PROPERTIES; GLYCINE-MAX; ARABIDOPSIS; PHOSPHORUS; PATTERNS; IRON; HOMEOSTASIS; MEMBERS	Background: Phosphorus (P) is essential for plant growth and development. Phosphate (Pi) transporter genes in the Pht1 family play important roles in Pi uptake and translocation in plants. Although Pht1 family genes have been well studied in model plants, little is known about their functions in soybean, an important legume crop worldwide. Principal Findings: We identified and isolated a complete set of 14 Pi transporter genes (GmPT1-14) in the soybean genome and categorized them into two subfamilies based on phylogenetic analysis. Then, an experiment to elucidate Pi transport activity of the GmPTs was carried out using a yeast mutant defective in high-affinity Pi transport. Results showed that 12 of the 14 GmPTs were able to complement Pi uptake of the yeast mutant with Km values ranging from 25.7 to 116.3 mu M, demonstrating that most of the GmPTs are high-affinity Pi transporters. Further results from qRT-PCR showed that the expressions of the 14 GmPTs differed not only in response to P availability in different tissues, but also to other nutrient stresses, including N, K and Fe deficiency, suggesting that besides functioning in Pi uptake and translocation, GmPTs might be involved in synergistic regulation of mineral nutrient homeostasis in soybean. Conclusions: The comprehensive analysis of Pi transporter function in yeast and expression responses to nutrition starvation of Pht1 family genes in soybean revealed their involvement in other nutrient homeostasis besides P, which could help to better understand the regulation network among ion homeostasis in plants.	[Qin, Lu; Guo, Yongxiang; Chen, Liyu; Liang, Ruikang; Zhao, Jing; Liao, Hong] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China; [Gu, Mian; Xu, Guohua] Nanjing Agr Univ, Coll Resources & Environm Sci, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Walk, Thomas] USDA ARS, US Pacific Basin Agr Res Ctr, Hilo, HI USA	South China Agricultural University; Nanjing Agricultural University; United States Department of Agriculture (USDA)	Zhao, J (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Root Biol Ctr, Guangzhou, Guangdong, Peoples R China.	jzhao@scau.edu.cn	Xu, Guohua/J-1840-2012; Chen, Liyu/HGD-6881-2022	Xu, Guohua/0000-0002-3283-2392; Chen, Liyu/0000-0002-9897-3294	National Natural Science Foundation of China [30890131]; National Key Basic Research Special Funds of China [2011CB100301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Special Funds of China(National Basic Research Program of China)	This work was jointly supported by the grants from the National Natural Science Foundation of China (Grant No. 30890131) and National Key Basic Research Special Funds of China (2011CB100301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai P, 2009, P INT PLANT NUTR C 1; Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; BUREAU MF, 1953, AGRON J, V45, P150, DOI 10.2134/agronj1953.00021962004500040005x; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Coello P, 1999, PLANT SCI, V143, P211, DOI 10.1016/S0168-9452(99)00033-3; DALTON CC, 1983, PHYSIOL PLANTARUM, V57, P472, DOI 10.1111/j.1399-3054.1983.tb02771.x; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Grossman A, 2001, ANNU REV PLANT PHYS, V52, P163, DOI 10.1146/annurev.arplant.52.1.163; Grunwald U, 2009, PLANTA, V229, P1023, DOI 10.1007/s00425-008-0877-z; Guo B, 2008, NEW PHYTOL, V177, P889, DOI 10.1111/j.1469-8137.2007.02331.x; Hammond JP, 2003, PLANT PHYSIOL, V132, P578, DOI 10.1104/pp.103.020941; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Kant S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002021; Karandashov V, 2005, TRENDS PLANT SCI, V10, P22, DOI 10.1016/j.tplants.2004.12.003; Karthikeyan AS, 2002, PLANT PHYSIOL, V130, P221, DOI 10.1104/pp.020007; Knappe S, 2003, PLANT PHYSIOL, V131, P1178, DOI 10.1104/pp.016519; Kobae Y, 2010, PLANT CELL PHYSIOL, V51, P341, DOI 10.1093/pcp/pcq013; Kochian L.V., 2000, BIOCH MOL BIOL PLANT, V20, P1204; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Liu JY, 2008, J BIOL CHEM, V283, P24673, DOI 10.1074/jbc.M802695200; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Maeda D, 2006, PLANT CELL PHYSIOL, V47, P807, DOI 10.1093/pcp/pcj069; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Miller AJ, 2000, BBA-BIOMEMBRANES, V1465, P343, DOI 10.1016/S0005-2736(00)00148-6; Mimura T, 1999, INT REV CYTOL, V191, P149, DOI 10.1016/S0074-7696(08)60159-X; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Mitsukawa N, 1997, P NATL ACAD SCI USA, V94, P7098, DOI 10.1073/pnas.94.13.7098; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nacry P, 2005, PLANT PHYSIOL, V138, P2061, DOI 10.1104/pp.105.060061; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; Nagy R, 2009, NEW PHYTOL, V181, P950, DOI 10.1111/j.1469-8137.2008.02721.x; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Rae AL, 2003, PLANT MOL BIOL, V53, P27, DOI 10.1023/B:PLAN.0000009259.75314.15; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Sanchez-Calderon L, 2010, PLANT CELL MONOGR, V17, P173, DOI 10.1007/978-3-642-10613-2_8; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Schmidt W, 2001, PLANT PHYSIOL, V125, P2078, DOI 10.1104/pp.125.4.2078; Schunmann PHD, 2004, PLANT PHYSIOL, V136, P4205, DOI 10.1104/pp.104.045823; Schunmann PHD, 2004, J EXP BOT, V55, P855, DOI 10.1093/jxb/erh103; Secco D, 2010, PLANT PHYSIOL, V152, P1693, DOI 10.1104/pp.109.149872; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Smith F. W., 1999, Plant nutrition - molecular biology and genetics. Proceedings of the Sixth International Symposium on Genetics and Molecular Biology of Plant Nutrition, Elsinore, Denmark, 17-21 August 1998., P145; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ULLRICHEBERIUS CI, 1981, PLANT PHYSIOL, V67, P797, DOI 10.1104/pp.67.4.797; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Wasaki J, 2003, PLANT CELL ENVIRON, V26, P1515, DOI 10.1046/j.1365-3040.2003.01074.x; Woody JL, 2011, GENOME, V54, P10, DOI 10.1139/G10-090; Wu ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019752; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021	67	45	56	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47726	10.1371/journal.pone.0047726	http://dx.doi.org/10.1371/journal.pone.0047726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133521	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800014
J	Gokirmak, T; Campanale, JP; Shipp, LE; Moy, GW; Tao, HC; Hamdoun, A				Goekirmak, Tufan; Campanale, Joseph P.; Shipp, Lauren E.; Moy, Gary W.; Tao, Houchao; Hamdoun, Amro			Localization and Substrate Selectivity of Sea Urchin Multidrug (MDR) Efflux Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN; STRONGYLOCENTROTUS-PURPURATUS; CAENORHABDITIS-ELEGANS; RESISTANCE PROTEINS; BINDING; GENE; EXPRESSION; FAMILY; ABCG2; ABCB1	In this study, we cloned, expressed and functionally characterized Stronglycentrotus purpuratus (Sp) ATP-binding cassette (ABC) transporters. This screen identified three multidrug resistance (MDR) transporters with functional homology to the major types of MDR transporters found in humans. When overexpressed in embryos, the apical transporters Sp-ABCB1a, ABCB4a, and ABCG2a can account for as much as 87% of the observed efflux activity, providing a robust assay for their substrate selectivity. Using this assay, we found that sea urchin MDR transporters export canonical MDR susbtrates such as calcein-AM, bodipy-verapamil, bodipy-vinblastine, and mitoxantrone. In addition, we characterized the impact of nonconservative substitutions in the primary sequences of drug binding domains of sea urchin versus murine ABCB1 by mutation of Sp-ABCB1a and treatment of embryos with stereoisomeric cyclic peptide inhibitors (QZ59 compounds). The results indicated that two substitutions in transmembrane helix 6 reverse stereoselectivity of Sp-ABCB1a for QZ59 enantiomers compared with mouse ABCB1a. This suggests that subtle changes in the primary sequence of transporter drug binding domains could fine-tune substrate specificity through evolution.	[Goekirmak, Tufan; Campanale, Joseph P.; Shipp, Lauren E.; Moy, Gary W.; Hamdoun, Amro] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Tao, Houchao] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Scripps Research Institute	Hamdoun, A (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, 9500 Gilman Dr 0202, La Jolla, CA 92093 USA.	hamdoun@ucsd.edu	Campanale, Joseph/A-9409-2011; Tao, Houchao/N-7042-2013; Tao, Houchao/E-7436-2013; Hamdoun, Amro/AAE-1905-2021	Hamdoun, Amro/0000-0003-2568-048X; Campanale, Joseph/0000-0003-1902-7708	National Institutes of Health Grant [HD058070]; Krinsk Research Advancement Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD058070, R00HD058070] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Krinsk Research Advancement Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD058070 (to A. H.). This work was also supported by Krinsk Research Advancement Initiative (to A. H.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bosnjak I, 2009, ENVIRON SCI TECHNOL, V43, P8374, DOI 10.1021/es901677r; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Caminada D, 2008, AQUAT TOXICOL, V90, P214, DOI 10.1016/j.aquatox.2008.08.013; Campanale JP, 2012, DEVELOPMENT, V139, P783, DOI 10.1242/dev.076752; Cheers MS, 2004, METHOD CELL BIOL, V74, P287; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Crivellato E, 2002, J HISTOCHEM CYTOCHEM, V50, P731, DOI 10.1177/002215540205000514; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Dean M, 2001, J LIPID RES, V42, P1007; DEPABLO F, 1988, DEV BIOL, V130, P304, DOI 10.1016/0012-1606(88)90436-8; Essodaigui M, 1998, BIOCHEMISTRY-US, V37, P2243, DOI 10.1021/bi9718043; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hamdoun AM, 2004, DEV BIOL, V276, P452, DOI 10.1016/j.ydbio.2004.09.013; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kimchi-Sarfaty C, 2002, MOL PHARMACOL, V62, P1, DOI 10.1124/mol.62.1.1; Klepsch F, 2010, MOL INFORM, V29, P276, DOI 10.1002/minf.201000017; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Litman T, 2000, J CELL SCI, V113, P2011; Luckenbach T, 2008, AM J PHYSIOL-REG I, V294, pR1919, DOI 10.1152/ajpregu.00563.2007; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Orban TI, 2008, BIOCHEM BIOPH RES CO, V367, P667, DOI 10.1016/j.bbrc.2007.12.172; Pajeva IK, 2009, FEBS J, V276, P7016, DOI 10.1111/j.1742-4658.2009.07415.x; Prasad KVSK, 2012, SCIENCE, V337, P1081, DOI 10.1126/science.1221636; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Shipp LE, 2012, DEV DYNAM, V241, P1111, DOI 10.1002/dvdy.23786; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Tao HC, 2011, CHEMBIOCHEM, V12, P868, DOI 10.1002/cbic.201100048; Tarnay JN, 2004, INSECT MOL BIOL, V13, P539, DOI 10.1111/j.0962-1075.2004.00512.x; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vache C, 2007, ENVIRON TOXICOL CHEM, V26, P1418, DOI 10.1897/06-552R.1; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Whalen K, 2012, MOL BIOL CELL, V23, P3663, DOI 10.1091/mbc.E12-06-0438; Wirgin I, 2011, SCIENCE, V331, P1322, DOI 10.1126/science.1197296; Zaja R, 2008, AQUAT TOXICOL, V90, P322, DOI 10.1016/j.aquatox.2008.09.012	43	46	46	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43876	43883		10.1074/jbc.M112.424879	http://dx.doi.org/10.1074/jbc.M112.424879			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23124201	hybrid, Green Published			2022-12-25	WOS:000312940800064
J	Paci, A; Liu, XH; Huang, H; Lim, A; Houry, WA; Zhao, RM				Paci, Alexandr; Liu, Xiao Hu; Huang, Hao; Lim, Abelyn; Houry, Walid A.; Zhao, Rongmin			The Stability of the Small Nucleolar Ribonucleoprotein (snoRNP) Assembly Protein Pih1 in Saccharomyces cerevisiae Is Modulated by Its C Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; SECONDARY STRUCTURE; HSP90 CHAPERONE; 20S PROTEASOME; R2TP COMPLEX; SEQUENCES; COCHAPERONE; PREDICTION; HELICASES; BINDING	Pih1 is an unstable protein and a subunit of the R2TP complex that, in yeast Saccharomyces cerevisiae, also contains the helicases Rvb1, Rvb2, and the Hsp90 cofactor Tah1. Pih1 and the R2TP complex are required for the box C/D small nucleolar ribonucleoprotein (snoRNP) assembly and ribosomal RNA processing. Purified Pih1 tends to aggregate in vitro. Molecular chaperone Hsp90 and its cochaperone Tah1 are required for the stability of Pih1 in vivo. We had shown earlier that the C terminus of Pih1 destabilizes the protein and that the C terminus of Tah1 binds to the Pih1 C terminus to form a stable complex. Here, we analyzed the secondary structure of the Pih1 C terminus and identified two intrinsically disordered regions and five hydrophobic clusters. Site-directed mutagenesis indicated that one predicted intrinsically disordered region IDR2 is involved in Tah1 binding, and that the C terminus of Pih1 contains multiple destabilization or degron elements. Additionally, the Pih1 N-terminal domain, Pih1(1-230), was found to be able to complement the physiological role of full-length Pih1 at 37 degrees C. Pih1(1-230) as well as a shorter Pih1 N-terminal fragment Pih1(1-195) is able to bind Rvb1/Rvb2 heterocomplex. However, the sequence between the two disordered regions in Pih1 significantly enhances the Pih1 N-terminal domain binding to Rvb1/Rvb2. Based on these data, a model of protein-protein interactions within the R2TP complex is proposed.	[Paci, Alexandr; Liu, Xiao Hu; Huang, Hao; Lim, Abelyn; Zhao, Rongmin] Univ Toronto Scarborough, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada; [Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Scarborough; University of Toronto	Zhao, RM (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada.	r.zhao@utsc.utoronto.ca		Zhao, Rongmin/0000-0003-1300-5882; Huang, Hao/0000-0002-1188-9760	University of Toronto Connaught New Stuff Matching-Fund [487199]; NSERC Discovery Grant [371789-2009]; Canadian Institutes of Health Research [MOP-93778]; Canadian Institutes of Health Research Strategic Training Program in Protein Folding and Interaction Dynamics [TGF-53910]; NSERC Undergraduate Student Research Award	University of Toronto Connaught New Stuff Matching-Fund; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Strategic Training Program in Protein Folding and Interaction Dynamics(Canadian Institutes of Health Research (CIHR)); NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a University of Toronto Connaught New Stuff Matching-Fund (487199) and NSERC Discovery Grant 371789-2009 (to R. Z.) and by Grant MOP-93778 from the Canadian Institutes of Health Research (to W. A. H.).; Supported by the Canadian Institutes of Health Research Strategic Training Program in Protein Folding and Interaction Dynamics (TGF-53910).; Supported by an NSERC Undergraduate Student Research Award.	Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Inoue M, 2010, BIOCHEM BIOPH RES CO, V403, P340, DOI 10.1016/j.bbrc.2010.11.031; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jimenez B, 2012, J BIOL CHEM, V287, P5698, DOI 10.1074/jbc.M111.287458; Kakihara Y., BIOCH BIOPHYS ACTA, V1823, P101; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lijnzaad P, 1997, PROTEINS, V28, P333; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Tsvetkov P, 2012, MOL BIOSYST, V8, P368, DOI 10.1039/c1mb05283g; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhai N., J MOL CELL BIOL; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	36	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43205	43214		10.1074/jbc.M112.408849	http://dx.doi.org/10.1074/jbc.M112.408849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23139418	Green Published, hybrid			2022-12-25	WOS:000312940800002
J	Wenk, M; Ba, QR; Erichsen, V; MacInnes, K; Wiese, H; Warscheid, B; Koch, HG				Wenk, Meike; Ba, Qiaorui; Erichsen, Veronika; MacInnes, Katherine; Wiese, Heike; Warscheid, Bettina; Koch, Hans-Georg			A Universally Conserved ATPase Regulates the Oxidative Stress Response in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYR TRANSCRIPTION FACTOR; TRANSFER-RNA HYDROLASE; GTP-BINDING PROTEINS; OBG-LIKE ATPASE; HYDROGEN-PEROXIDE; DNA-BINDING; OXIDASE ACTIVITY; CATALASE; IRON; IDENTIFICATION	YchF is an evolutionarily conserved ATPase of unknown function. In humans, the YchF homologue hOla1 appears to influence cell proliferation and was found to be up-regulated in many tumors. A possible involvement in regulating the oxidative stress response was also suggested, but details on the underlying mechanism are lacking. For gaining insight into YchF function, we used Escherichia coli as a model organism and found that YchF overexpression resulted in H2O2 hypersensitivity. This was not caused by transcriptional or translational down-regulation of H2O2-scavenging enzymes. Instead, we observed YchF-dependent inhibition of catalase activity and a direct interaction with the major E. coli catalase KatG. KatG inhibition was dependent on the ATPase activity of YchF and was regulated by post-translational modifications, most likely including an H2O2-dependent dephosphorylation. We furthermore showed that YchF expression is repressed by the transcription factor OxyR and further post-translationally modified in response to H2O2. In summary, our data show that YchF functions as a novel negative regulator of the oxidative stress response in E. coli. Considering the available data on hOla1, YchF/Ola1 most likely execute similar functions in bacteria and humans, and their up-regulation inhibits the ability of the cells to scavenge damaging reactive oxygen species.	[Koch, Hans-Georg] ZBMZ, Fac Med, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Wenk, Meike; Ba, Qiaorui; Wiese, Heike; Warscheid, Bettina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Koch, HG (corresponding author), ZBMZ, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Hans-Georg.Koch@biochemie.uni-freiburg.de		Wiese, Heike/0000-0002-8941-3762; Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft [DFG-FOR 967, IRTG1478, FOR1352]; Excellence Initiative of the German Federal Government [GSC-4]; Excellence Initiative of the German State Government [GSC-4]; China Scholarship Council;  [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; China Scholarship Council(China Scholarship Council); 	This work was supported in part by Deutsche Forschungsgemeinschaft Grants DFG-FOR 967 and IRTG1478 (to H. G. K.) and FOR1352 (to B. W.) and the Excellence Initiative of the German Federal and State Governments (Grant GSC-4, Spemann Graduate School for Biology and Medicine (to H. G. K.) and Grant EXC 294 BIOSS (to B. W.)).; Supported by a China Scholarship Council Ph.D. scholarship.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; ATHERLY AG, 1972, NATURE-NEW BIOL, V240, P245, DOI 10.1038/newbio240245a0; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chen YC, 2011, INT J MED MICROBIOL, V301, P469, DOI 10.1016/j.ijmm.2011.02.002; Cheung MY, 2010, J BIOL CHEM, V285, P37359, DOI 10.1074/jbc.M110.172080; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CUZIN F, 1967, P NATL ACAD SCI USA, V58, P2079, DOI 10.1073/pnas.58.5.2079; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Fernebro J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-65; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gradia DF, 2009, INT J PARASITOL, V39, P49, DOI 10.1016/j.ijpara.2008.05.019; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kira Y, 2008, CELL MOL BIOL LETT, V13, P570, DOI 10.2478/s11658-008-0023-8; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; MULVEY MR, 1990, J BACTERIOL, V172, P6713, DOI 10.1128/jb.172.12.6713-6720.1990; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; RADI R, 1991, J BIOL CHEM, V266, P22028; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Schembri MA, 2003, J BACTERIOL, V185, P2236, DOI 10.1128/JB.185.7.2236-2242.2003; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Sun H, 2010, MOL CANCER RES, V8, P57, DOI 10.1158/1541-7786.MCR-09-0278; Teplyakov A, 2003, J BACTERIOL, V185, P4031, DOI 10.1128/JB.185.14.4031-4037.2003; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tomar SK, 2011, BIOCHEM BIOPH RES CO, V408, P459, DOI 10.1016/j.bbrc.2011.04.052; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Vetrano AM, 2005, J BIOL CHEM, V280, P35372, DOI 10.1074/jbc.M503991200; Wallecha A, 2003, J BACTERIOL, V185, P2203, DOI 10.1128/JB.185.7.2203-2209.2003; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zhang JW, 2009, J ZHEJIANG UNIV-SC B, V10, P796, DOI 10.1631/jzus.B0910009; Zhang J, 2009, P NATL ACAD SCI USA, V106, P15356, DOI 10.1073/pnas.0907213106; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	59	23	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43585	43598		10.1074/jbc.M112.413070	http://dx.doi.org/10.1074/jbc.M112.413070			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23139412	Green Published, hybrid			2022-12-25	WOS:000312940800039
J	Perez-Gonzalez, R; Gauthier, SA; Kumar, A; Levy, E				Perez-Gonzalez, Rocio; Gauthier, Sebastien A.; Kumar, Asok; Levy, Efrat			The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MEMORY DEFICITS; MULTIVESICULAR BODIES; TRANSGENIC MICE; BETA PEPTIDE; MOUSE MODEL; ASSOCIATION; INHIBITION; VESICLES; BIOGENESIS	In vitro studies have shown that neuronal cell cultures secrete exosomes containing amyloid-beta precursor protein (APP) and the APP-processing products, C-terminal fragments (CTFs) and amyloid-beta (A beta). We investigated the secretion of full-length APP (flAPP) and APP CTFs via the exosome secretory pathway in vivo. To this end, we developed a novel protocol designed to isolate exosomes secreted into mouse brain extracellular space. Exosomes with typical morphology were isolated from freshly removed mouse brains and from frozen mouse and human brain tissues, demonstrating that exosomes can be isolated from postmortem tissue frozen for long periods of time. flAPP, APPCTFs, and enzymes that cleave both flAPP and APP CTFs were identified in brain exosomes. Although higher levels of both flAPP and APP CTFs were observed in exosomes isolated from the brains of transgenic mice overexpressing human APP (Tg2576) compared with wild-type control mice, there was no difference in the number of secreted brain exosomes. These data indicate that the levels of flAPP and APP CTFs associated with exosomes mirror the cellular levels of flAPP and APP CTFs. Interestingly, exosomes isolated from the brains of both Tg2576 and wild-type mice are enriched with APP CTFs relative to flAPP. Thus, we hypothesize that the exosome secretory pathway plays a pleiotropic role in the brain: exosome secretion is beneficial to the cell, acting as a specific releasing system of neurotoxic APP CTFs and A beta, but the secretion of exosomes enriched with APP CTFs, neurotoxic proteins that are also a source of secreted A beta, is harmful to the brain.	[Perez-Gonzalez, Rocio; Gauthier, Sebastien A.; Kumar, Asok; Levy, Efrat] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Perez-Gonzalez, Rocio] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Levy, Efrat] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Levy, Efrat] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Levy, E (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	elevy@nki.rfmh.org	Perez-Gonzalez, Rocio/GQH-7068-2022	Perez-Gonzalez, Rocio/0000-0002-0641-2001; Gauthier, Sebastien/0000-0002-5692-9260	National Institutes of Health [AG017617]; Alzheimer's Association [ZEN-10-172559]; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG017617. This work was also supported by Alzheimer's Association Grant ZEN-10-172559.	Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Clayton A., 2006, CURR PROTOC CELL BIO; Deyts C, 2012, J NEUROSCI, V32, P1714, DOI 10.1523/JNEUROSCI.5433-11.2012; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Grant R, 2011, J IMMUNOL METHODS, V371, P143, DOI 10.1016/j.jim.2011.06.024; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Savina A, 2002, J CELL SCI, V115, P2505; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Tasaki M, 2010, BIOCHEM BIOPH RES CO, V400, P559, DOI 10.1016/j.bbrc.2010.08.101; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yamazaki T, 1996, J CELL SCI, V109, P999; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	51	255	260	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43108	43115		10.1074/jbc.M112.404467	http://dx.doi.org/10.1074/jbc.M112.404467			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23129776	hybrid, Green Published			2022-12-25	WOS:000312501600066
J	Hendrickson, ML; Ling, CY; Kalil, RE				Hendrickson, Michael L.; Ling, Changying; Kalil, Ronald E.			Degeneration of Axotomized Projection Neurons in the Rat dLGN: Temporal Progression of Events and Their Mitigation by a Single Administration of FGF2	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; LATERAL GENICULATE-NUCLEUS; CENTRAL-NERVOUS-SYSTEM; GLUTAMATE-RECEPTOR ACTIVATION; RETINAL GANGLION-CELLS; MPTP-TREATED MICE; BRAIN-INJURY; OPTIC-NERVE; IN-VIVO; CHOLINERGIC NEURONS	Removal of visual cortex in the rat axotomizes projection neurons in the dorsal lateral geniculate nucleus (dLGN), leading to cytological and structural changes and apoptosis. Biotinylated dextran amine was injected into the visual cortex to label dLGN projection neurons retrogradely prior to removing the cortex in order to quantify the changes in the dendritic morphology of these neurons that precede cell death. At 12 hours after axotomy we observed a loss of appendages and the formation of varicosities in the dendrites of projection neurons. During the next 7 days, the total number of dendrites and the cross-sectional areas of the dendritic arbors of projection neurons declined to about 40% and 20% of normal, respectively. The response of dLGN projection neurons to axotomy was asynchronous, but the sequence of structural changes in individual neurons was similar; namely, disruption of dendrites began within hours followed by cell soma atrophy and nuclear condensation that commenced after the loss of secondary dendrites had occurred. However, a single administration of fibroblast growth factor-2 (FGF2), which mitigates injury-induced neuronal cell death in the dLGN when given at the time of axotomy, markedly reduced the dendritic degeneration of projection neurons. At 3 and 7 days after axotomy the number of surviving dendrites of dLGN projection neurons in FGF-2 treated rats was approximately 50% greater than in untreated rats, and the cross-sectional areas of dendritic arbors were approximately 60% and 50% larger. Caspase-3 activity in axotomized dLGN projection neurons was determined by immunostaining for fractin (fractin-IR), an actin cleavage product produced exclusively by activated caspase-3. Fractin-IR was seen in some dLGN projection neurons at 36 hours survival, and it increased slightly by 3 days. A marked increase in reactivity was seen by 7 days, with the entire dLGN filled with dense fractin-IR in neuronal cell somas and dendrites.	[Kalil, Ronald E.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Ling, Changying] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Hendrickson, Michael L.] Univ Wisconsin, WM Keck Lab Biol Imaging, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kalil, RE (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rekalil@wisc.edu		Hendrickson, Michael/0000-0002-4555-765X	NSF [IBN-9809905]	NSF(National Science Foundation (NSF))	This work was supported by a grant from the NSF (IBN-9809905) to REK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, DEV BRAIN RES, V122, P81, DOI 10.1016/S0165-3806(00)00054-7; Abe K, 2001, PHARMACOL RES, V43, P307, DOI 10.1006/phrs.2000.0794; Agarwala S, 1998, J COMP NEUROL, V392, P264; Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5; Al-Abdulla NA, 2002, NEUROSCIENCE, V115, P7, DOI 10.1016/S0306-4522(02)00363-9; Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; Barron KD, 2004, J NEUROL SCI, V220, P119, DOI 10.1016/j.jns.2004.03.009; BARRON KD, 1973, J NEUROPATH EXP NEUR, V32, P218, DOI 10.1097/00005072-197304000-00004; Boxer PA, 1997, DRUG DISCOV TODAY, V2, P219, DOI 10.1016/S1359-6446(97)01045-3; Chadi G, 1998, BRAZ J MED BIOL RES, V31, P231, DOI 10.1590/S0100-879X1998000200007; CHADI G, 1993, EXP BRAIN RES, V97, P145; Choi JS, 2003, INVEST OPHTH VIS SCI, V44, P1747, DOI 10.1167/iovs.01-0886; Combs CM, 1949, J COMP NEUROL, V93, P373; CUMMINGS BJ, 1992, BRAIN RES, V591, P271, DOI 10.1016/0006-8993(92)91707-L; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; DATE I, 1993, BRAIN RES, V621, P150, DOI 10.1016/0006-8993(93)90312-B; Datta SR, 1998, HORM SIGNALING, V1, P257; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; EMMETT CJ, 1995, BRAIN RES, V673, P199, DOI 10.1016/0006-8993(94)01414-D; Faddis BT, 1997, J NEUROSCI, V17, P951; Forgie ML, 2003, BEHAV NEUROSCI, V117, P257, DOI 10.1037/0735-7044.117.2.257; FRIM DM, 1993, NEUROREPORT, V4, P367, DOI 10.1097/00001756-199304000-00006; Furutani R, 2012, J NEUROTRAUM, V29, P1266, DOI 10.1089/neu.2010.1630; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Grothe C, 1989, EXS, V57, P251; Grothe C, 1996, INT J DEV BIOL, V40, P403; HAMBURGER V, 1993, J NEUROBIOL, V24, P893, DOI 10.1002/neu.480240702; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; HSU M, 1993, J NEUROSCI, V13, P3964; HUGHES HC, 1977, J COMP NEUROL, V175, P311, DOI 10.1002/cne.901750306; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; KIRSCHNER PB, 1995, J CEREBR BLOOD F MET, V15, P619, DOI 10.1038/jcbfm.1995.76; Koliatsos VE, 1996, BRAIN PATHOL, V6, P447, DOI 10.1111/j.1750-3639.1996.tb00875.x; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Krantic S, 2005, TRENDS NEUROSCI, V28, P670, DOI 10.1016/j.tins.2005.09.011; KRIEG WJS, 1946, J COMP NEUROL, V84, P221, DOI 10.1002/cne.900840205; KWEI S, 1993, BRAIN RES, V620, P203, DOI 10.1016/0006-8993(93)90157-I; Lashley KS, 1941, J COMP NEUROL, V75, P67, DOI 10.1002/cne.900750105; Lemaire C, 1998, FEBS LETT, V425, P266, DOI 10.1016/S0014-5793(98)00252-X; Levi-Montalcini, 1987, BIOSCIENCE REP, V7, P681; LIEBERMAN AR, 1974, J NEUROCYTOL, V3, P677, DOI 10.1007/BF01097191; Ling C, 2012, PLOS ONE IN PRESS; Longthorne VL, 1997, EMBO J, V16, P3805, DOI 10.1093/emboj/16.13.3805; Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011; Martin LJ, 2003, J NEUROCHEM, V85, P234, DOI 10.1046/j.1471-4159.2003.01659.x; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; McCarthy MJ, 1997, J CELL SCI, V110, P2165; MONTERO VM, 1968, J COMP NEUROL, V134, P211, DOI 10.1002/cne.901340208; Muessel MJ, 2002, MOL BRAIN RES, V103, P12, DOI 10.1016/S0169-328X(02)00158-4; Natale JE, 2002, NEUROSCIENCE, V112, P665, DOI 10.1016/S0306-4522(02)00098-2; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Ohta T, 1997, J BIOL CHEM, V272, P23111, DOI 10.1074/jbc.272.37.23111; OTTO D, 1989, J NEUROSCI RES, V22, P83, DOI 10.1002/jnr.490220111; OTTO D, 1993, EUR J NEUROSCI, V5, P927, DOI 10.1111/j.1460-9568.1993.tb00943.x; OTTO D, 1990, J NEUROSCI, V10, P1912; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Pascual A, 2011, J MOL ENDOCRINOL, V46, pR83, DOI 10.1530/JME-10-0125; Peng PH, 2010, EXP EYE RES, V90, P528, DOI 10.1016/j.exer.2010.01.007; PEREZNAVARRO E, 1994, EUR J NEUROSCI, V6, P706, DOI 10.1111/j.1460-9568.1994.tb00982.x; Peterson DA, 1996, J NEUROSCI, V16, P886; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Repici M, 2003, NEUROSCIENCE, V117, P859, DOI 10.1016/S0306-4522(02)00968-5; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; RIBAK CE, 1975, BRAIN RES, V92, P341, DOI 10.1016/0006-8993(75)90322-4; Rios-Munoz W, 2005, J NEUROCHEM, V93, P1422, DOI 10.1111/j.1471-4159.2005.03129.x; Rossiter JP, 2000, NEUROPATH APPL NEURO, V26, P342, DOI 10.1046/j.1365-2990.2000.00252.x; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Schulz R, 2009, GLIA, V57, P1619, DOI 10.1002/glia.20875; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Springer JE, 2001, CLIN CHEM LAB MED, V39, P299, DOI 10.1515/CCLM.2001.046; Troy CM, 2011, PROG MOL BIOL TRANSL, V99, P265, DOI 10.1016/S1877-1173(11)99007-3; Tseng GF, 1996, ACTA ANAT, V155, P184; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Yang F, 1998, AM J PATHOL, V152, P329; Zacharaki T, 2010, BRAIN RES, V1344, P62, DOI 10.1016/j.brainres.2010.05.021; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	91	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e46918	10.1371/journal.pone.0046918	http://dx.doi.org/10.1371/journal.pone.0046918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144793	gold, Green Submitted, Green Published			2022-12-25	WOS:000310741400012
J	Nakajima, T; Kudo, T; Ohmura, R; Takeya, S; Mori, YH				Nakajima, Takahiro; Kudo, Taisuke; Ohmura, Ryo; Takeya, Satoshi; Mori, Yasuhiko H.			Molecular Storage of Ozone in a Clathrate Hydrate: An Attempt at Preserving Ozone at High Concentrations	PLOS ONE			English	Article							CARBON-TETRACHLORIDE	This paper reports an experimental study of the formation of a mixed O-3+ O-2+ CO2 hydrate and its frozen storage under atmospheric pressure, which aimed to establish a hydrate-based technology for preserving ozone (O-3), a chemically unstable substance, for various industrial, medical and consumer uses. By improving the experimental technique that we recently devised for forming an O-3+ O-2+ CO2 hydrate, we succeeded in significantly increasing the fraction of ozone contained in the hydrate. For a hydrate formed at a system pressure of 3.0 MPa, the mass fraction of ozone was initially about 0.9%; and even after a 20-day storage at -25 degrees C and atmospheric pressure, it was still about 0.6%. These results support the prospect of establishing an economical, safe, and easy-to-handle ozone-preservation technology of practical use.	[Nakajima, Takahiro; Kudo, Taisuke; Ohmura, Ryo; Mori, Yasuhiko H.] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan; [Takeya, Satoshi] Natl Inst Adv Ind Sci & Technol, Res Inst Instrumentat Frontier, Tsukuba, Ibaraki, Japan	Keio University; National Institute of Advanced Industrial Science & Technology (AIST)	Mori, YH (corresponding author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan.	yhmori@mech.keio.ac.jp	Ohmura, Ryo/D-6035-2014; TAKEYA, Satoshi/L-2108-2018	TAKEYA, Satoshi/0000-0002-7240-2899	Ministry of Education, Culture, Sport and Technology, Japan; JKA promotion fund from Keirin racing	Ministry of Education, Culture, Sport and Technology, Japan; JKA promotion fund from Keirin racing	This study was supported by a Grant-in-Aid for the Global COE Program for the "Center for Education and Research of Symbiotic, Safe and Secure System Design" from the Ministry of Education, Culture, Sport and Technology, Japan, and by a JKA promotion fund from Keirin racing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Koike K, 2005, J LOSS PREVENT PROC, V18, P465, DOI 10.1016/j.jlp.2005.07.020; Masaoka T., 2007, Jpn. Patent, Patent No. [2007-210881, 2007210881]; MCTURK G, 1964, NATURE, V202, P1107, DOI 10.1038/2021107a0; MITSUDA H, 1990, P JPN ACAD B-PHYS, V66, P68, DOI 10.2183/pjab.66.68; Muromachi S, 2012, J CHEM THERMODYN, V49, P1, DOI 10.1016/j.jct.2012.01.009; Muromachi S, 2011, FLUID PHASE EQUILIBR, V305, P145, DOI 10.1016/j.fluid.2011.03.020; Muromachi S, 2010, J PHYS CHEM B, V114, P11430, DOI 10.1021/jp105031n; Nakajima T, 2011, ANGEW CHEM INT EDIT, V50, P10340, DOI 10.1002/anie.201104660; Sloan ED, 2008, CLATHRATE HYDRATES N, P266; Waller JG, 1964, U.K. Patent Specification, Patent No. 961115	10	18	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48563	10.1371/journal.pone.0048563	http://dx.doi.org/10.1371/journal.pone.0048563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139794	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400052
J	Husseiny, MI; Kuroda, A; Kaye, AN; Nair, I; Kandeel, F; Ferreri, K				Husseiny, Mohamed I.; Kuroda, Akio; Kaye, Alexander N.; Nair, Indu; Kandeel, Fouad; Ferreri, Kevin			Development of a Quantitative Methylation-Specific Polymerase Chain Reaction Method for Monitoring Beta Cell Death in Type 1 Diabetes	PLOS ONE			English	Article							CIRCULATING NUCLEIC-ACIDS; TIME RT-PCR; DNA METHYLATION; CANCER-PATIENTS; GASTRIC-CANCER; PATHOGENESIS; EXPRESSION; BIOMARKERS; PLASMA; MOUSE	DNA methylation is a mechanism by which cells control gene expression, and cell-specific genes often exhibit unique patterns of DNA methylation. We previously reported that the mouse insulin-2 gene (Ins2) promoter has three potential methylation (CpG) sites, all of which are unmethylated in insulin-producing cells but methylated in other tissues. In this study we examined Ins2 exon 2 and found a similar tissue-specific methylation pattern. These methylation patterns can differentiate between DNA from insulin-producing beta cells and other tissues. We hypothesized that damaged beta cells release their DNA into circulation at the onset of type 1 diabetes mellitus (T1DM) and sought to develop a quantitative methylation-specific polymerase chain reaction (qMSP) assay for circulating beta cell DNA to monitor the loss of beta cells. Methylation-specific primers were designed to interrogate two or more CpG in the same assay. The cloned mouse Ins2 gene was methylated in vitro and used for development of the qMSP assay. We found the qMSP method to be sensitive and specific to differentiate between insulin-producing cells and other tissues with a detection limit of 10 copies in the presence of non-specific genomic DNA background. We also compared different methods for data analysis and found that the Relative Expression Ratio method is the most robust method since it incorporates both a reference value to normalize day-to-day variability as well as PCR reaction efficiencies to normalize between the methylation-specific and bisulfite-specific components of the calculations. The assay was applied in the streptozotocin-treated diabetic mouse model and detected a significant increase in circulating beta cell DNA before the rise in blood glucose level. These results demonstrate that this qMSP assay can be used for monitoring circulating DNA from insulin-producing cells, which will provide the basis for development of assays to detect beta cell destruction in early T1DM.	[Husseiny, Mohamed I.; Kaye, Alexander N.; Nair, Indu; Kandeel, Fouad; Ferreri, Kevin] Beckman Res Inst City Hope, Dept Diabet & Metab Dis Res, Duarte, CA USA; [Kuroda, Akio] Univ Tokushima, Diabet Therapeut & Res Ctr, Tokushima 770, Japan	City of Hope; Beckman Research Institute of City of Hope; Tokushima University	Ferreri, K (corresponding author), Beckman Res Inst City Hope, Dept Diabet & Metab Dis Res, Duarte, CA USA.	kferreri@coh.org		Elsayed, Mohamed Ibrahim Husseiny/0000-0002-3470-2858; Ferreri, Kevin/0000-0003-0379-0389	Juvenile Diabetes Research Foundation (JDRF) [1-2008-1009, 5-2007-1010]	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation)	This work was funded by the Juvenile Diabetes Research Foundation (JDRF #1-2008-1009 and JDRF #5-2007-1010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Baschal EE, 2011, DIABETOLOGIA, V54, P1702, DOI 10.1007/s00125-011-2161-1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dai YD, 2005, CELL MOL IMMUNOL, V2, P169; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; Galm Oliver, 2005, V113, P279, DOI 10.1385/1-59259-916-8:279; Garner BC, 2007, VET CLIN PATH, V36, P240, DOI 10.1111/j.1939-165X.2007.tb00218.x; Herbach N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022814; Huang HH, 2012, ACTA DIABETOL; Knip M, 2010, DIABETES CARE, V33, P1206, DOI 10.2337/dc09-1040; Koike H, 2004, J SURG ONCOL, V87, P182, DOI 10.1002/jso.20106; Kristensen LS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn113; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lo YMD, 2001, ANN NY ACAD SCI, V945, P1; Long AE, 2012, DIABETES, V61, P683, DOI 10.2337/db11-0962; Meier JJ, 2012, DIABETOLOGIA; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Purohit S, 2008, INT J CLIN EXP MED, V1, P98; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shi H, 2007, EXPERT REV MOL DIAGN, V7, P519, DOI 10.1586/14737159.7.5.519; Silveira PA, 2006, TRENDS ENDOCRIN MET, V17, P128, DOI 10.1016/j.tem.2006.03.006; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Tani N, 2007, ANTICANCER RES, V27, P1207; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; Tsang JCH, 2007, PATHOLOGY, V39, P197, DOI 10.1080/00313020701230831; VACHA J, 1975, PHYSIOL BOHEMOSLOV, V24, P413; Volle R, 2012, J VIROL METHODS, V185, P142, DOI 10.1016/j.jviromet.2012.06.019; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	35	47	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47942	10.1371/journal.pone.0047942	http://dx.doi.org/10.1371/journal.pone.0047942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144715	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300026
J	Port, JA; Wallace, JC; Griffith, WC; Faustman, EM				Port, Jesse A.; Wallace, James C.; Griffith, William C.; Faustman, Elaine M.			Metagenomic Profiling of Microbial Composition and Antibiotic Resistance Determinants in Puget Sound	PLOS ONE			English	Article							WATER TREATMENT-PLANT; FUNCTIONAL METAGENOMICS; BACTERIAL COMMUNITIES; PHYLOGENETIC ANALYSIS; HUMAN HEALTH; GENES; EVOLUTION; OCEANS; URBAN; IDENTIFICATION	Human-health relevant impacts on marine ecosystems are increasing on both spatial and temporal scales. Traditional indicators for environmental health monitoring and microbial risk assessment have relied primarily on single species analyses and have provided only limited spatial and temporal information. More high-throughput, broad-scale approaches to evaluate these impacts are therefore needed to provide a platform for informing public health. This study uses shotgun metagenomics to survey the taxonomic composition and antibiotic resistance determinant content of surface water bacterial communities in the Puget Sound estuary. Metagenomic DNA was collected at six sites in Puget Sound in addition to one wastewater treatment plant (WWTP) that discharges into the Sound and pyrosequenced. A total of similar to 550 Mbp (1.4 million reads) were obtained, 22 Mbp of which could be assembled into contigs. While the taxonomic and resistance determinant profiles across the open Sound samples were similar, unique signatures were identified when comparing these profiles across the open Sound, a nearshore marina and WWTP effluent. The open Sound was dominated by alpha-Proteobacteria (in particular Rhodobacterales sp.), gamma-Proteobacteria and Bacteroidetes while the marina and effluent had increased abundances of Actinobacteria, beta-Proteobacteria and Firmicutes. There was a significant increase in the antibiotic resistance gene signal from the open Sound to marina to WWTP effluent, suggestive of a potential link to human impacts. Mobile genetic elements associated with environmental and pathogenic bacteria were also differentially abundant across the samples. This study is the first comparative metagenomic survey of Puget Sound and provides baseline data for further assessments of community composition and antibiotic resistance determinants in the environment using next generation sequencing technologies. In addition, these genomic signals of potential human impact can be used to guide initial public health monitoring as well as more targeted and functionally-based investigations.	[Port, Jesse A.; Wallace, James C.; Griffith, William C.; Faustman, Elaine M.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Port, Jesse A.; Wallace, James C.; Griffith, William C.; Faustman, Elaine M.] Univ Washington, Sch Publ Hlth, Inst Risk Anal & Risk Commun, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Faustman, EM (corresponding author), Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	faustman@uw.edu		Faustman, Elaine/0000-0002-3085-6403	National Institute of Environmental Health Sciences [NIEHS 3P50ES012762-05S1]; National Oceanic and Atmospheric Administration [UCAR S08-67883]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012762] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (NIEHS 3P50ES012762-05S1). J.A. Port was partially supported as a fellow through the National Oceanic and Atmospheric Administration (UCAR S08-67883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo-Ferretjans MM, 2008, SYST APPL MICROBIOL, V31, P231, DOI 10.1016/j.syapm.2008.04.003; Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Babson AL, 2006, ATMOS OCEAN, V44, P29, DOI 10.3137/ao.440103; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cook KL, 2010, ANAEROBE, V16, P74, DOI 10.1016/j.anaerobe.2009.06.003; County King, 2011, WAST TREATM PROC WAS; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; Fleming LE, 2006, MAR POLLUT BULL, V53, P545, DOI 10.1016/j.marpolbul.2006.08.012; Furushita M, 2011, MICROBES ENVIRON, V26, P84, DOI 10.1264/jsme2.ME10160; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Jencova V, 2008, RES MICROBIOL, V159, P118, DOI 10.1016/j.resmic.2007.11.018; Kelly KM, 2001, FEMS MICROBIOL ECOL, V35, P85, DOI 10.1016/S0168-6496(00)00115-X; Kite-Powell HL, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S6; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Laws EA, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S1; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Monchy S, 2007, J BACTERIOL, V189, P7417, DOI 10.1128/JB.00375-07; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; National Research Council, 1999, MONS MICR UND OC ROL; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Newton RJ, 2011, APPL ENVIRON MICROB, V77, P6972, DOI 10.1128/AEM.05480-11; Nogales B, 2007, ENVIRON MICROBIOL, V9, P1913, DOI 10.1111/j.1462-2920.2007.01308.x; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sajjaphan K, 2004, APPL ENVIRON MICROB, V70, P4402, DOI 10.1128/AEM.70.7.4402-4407.2004; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Salyers AA, 1997, ANTIMICROB AGENTS CH, V41, P2321, DOI 10.1128/AAC.41.11.2321; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Schluter A, 2007, APPL ENVIRON MICROB, V73, P6345, DOI 10.1128/AEM.01177-07; Soge OO, 2009, J ANTIMICROB CHEMOTH, V64, P1148, DOI 10.1093/jac/dkp368; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P1947, DOI 10.1021/es902893f; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Torres-Cortes G, 2011, ENVIRON MICROBIOL, V13, P1101, DOI 10.1111/j.1462-2920.2010.02422.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; United Nations Environment Programme, 2006, MAR COAST EC HUM WEL; Uyaguari MI, 2011, APPL ENVIRON MICROB, V77, P8226, DOI 10.1128/AEM.02732-10; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Washington State Department of Ecology and Herrera Environmental Consultants Inc., 2010, PHAS 3 LOAD TOX CHEM; Washington State Department of Health, 2012, 2011 ANN REP COMM RE; Wu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011285; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041; Zhang YL, 2009, SCI TOTAL ENVIRON, V407, P3702, DOI 10.1016/j.scitotenv.2009.02.013; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	82	36	38	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48000	10.1371/journal.pone.0048000	http://dx.doi.org/10.1371/journal.pone.0048000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144718	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300029
J	Wang, RW; Solomon, MJ				Wang, Ruiwen; Solomon, Mark J.			Identification of She3 as an SCFGrr1 Substrate in Budding Yeast	PLOS ONE			English	Article							ASH1 MESSENGER-RNA; UBIQUITIN-DEPENDENT DEGRADATION; ANAPHASE-PROMOTING COMPLEX; SACCHAROMYCES-CEREVISIAE; F-BOX; PSEUDOSUBSTRATE INHIBITOR; PHOSPHORYLATION SITES; GLUCOSE REPRESSION; CELL-DIVISION; MYOSIN MYO4P	The highly orchestrated progression of the cell cycle depends on the degradation of many regulatory proteins at different cell cycle stages. One of the key cell cycle ubiquitin ligases is the Skp1-cullin-F-box (SCF) complex. Acting in concert with the substrate-binding F-box protein Grr1, SCFGrr1 promotes the degradation of cell cycle regulators as well as various metabolic enzymes. Using a yeast two-hybrid assay with a Grr1 derivative as the bait, we identified She3, which is an adaptor protein in the asymmetric mRNA transport system, as a novel Grr1 substrate. We generated stabilized She3 mutants, which no longer bound to Grr1, and found that the degradation of She3 is not required for regulating asymmetric mRNA transport. However, She3 stabilization leads to slower growth compared to wild-type cells in a co-culture assay, demonstrating that the degradation of She3 by Grr1 is required for optimal cell growth.	[Wang, Ruiwen; Solomon, Mark J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Solomon, MJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	Mark.Solomon@yale.edu			National Institutes of Health [GM76200, GM88272]; American Heart Association [09GRNT2370047]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076200, R01GM088272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM76200 and GM88272 and by American Heart Association Founders Affiliate grant 09GRNT2370047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon A, 1996, CELL, V84, P651, DOI 10.1016/S0092-8674(00)81041-7; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAILEY RB, 1984, MOL GEN GENET, V193, P507, DOI 10.1007/BF00382091; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; FLICK JS, 1991, MOL CELL BIOL, V11, P5101, DOI 10.1128/MCB.11.10.5101; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; James P, 1996, GENETICS, V144, P1425; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kruse C, 2002, J CELL BIOL, V159, P971, DOI 10.1083/jcb.200207101; Landers SM, 2009, EUKARYOT CELL, V8, P1072, DOI 10.1128/EC.00084-09; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Ostapenko D, 2011, MOL BIOL CELL, V22, P2175, DOI 10.1091/mbc.E11-01-0031; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; STRATHERN JN, 1979, CELL, V17, P371, DOI 10.1016/0092-8674(79)90163-6; Tang WG, 2003, J BIOL CHEM, V278, P48942, DOI 10.1074/jbc.M307962200	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48020	10.1371/journal.pone.0048020	http://dx.doi.org/10.1371/journal.pone.0048020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144720	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300031
J	Knaster, P; Estlander, AM; Karlsson, H; Kaprio, J; Kalso, E				Knaster, Peter; Estlander, Ann-Mari; Karlsson, Hasse; Kaprio, Jaakko; Kalso, Eija			Temperament Traits and Chronic Pain: The Association of Harm Avoidance and Pain-Related Anxiety	PLOS ONE			English	Article							CHARACTER INVENTORY TCI; BECK DEPRESSION INVENTORY; PERSONALITY-TRAITS; NORMATIVE DATA; NEGATIVE AFFECTIVITY; GENERAL-POPULATION; MAJOR DEPRESSION; FEAR-AVOIDANCE; SOCIAL PHOBIA; SYMPTOMS	Objective: Anxiety symptoms are common in chronic pain patients. High levels of anxiety are associated with increased pain experience and disability. Proneness to anxiety has a large interindividual variation. The aim of the study was to determine whether the anxiety-related temperament trait Harm Avoidance (HA), is associated with pain-related anxiety. Methods: One hundred chronic pain patients in a multidisciplinary pain clinic participated in the study. The patients were assessed using the HA scale of the Temperament and Character Inventory (TCI) of Cloninger and Pain Anxiety Symptoms Scale-20 (PASS-20). Both the HA total score and the four subscales of HA were analyzed. Current pain intensity was measured using the Visual Analogue Scale (VAS). The Beck Depression Inventory (BDI) was used to control for the influence of depression on the personality measurement. Results: The HA total score was associated with PASS-20, but the association became non-significant after controlling for depression. The HA4 Fatigability subscale was associated with the PASS scales. Depression did not influence this association. Pain intensity was not correlated with HA or the PASS scales. However, the association between HA4 Fatigability and PASS was influenced by pain intensity. Higher pain intensity was associated with stronger association between the scales. Conclusion: Harm Avoidance, representing temperament and trait-related anxiety, has relevance in pain-related anxiety. Assessing personality and temperament may deepen the clinician's understanding of the pain experience and behavior in chronic pain patients.	[Knaster, Peter; Karlsson, Hasse] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland; [Estlander, Ann-Mari; Kalso, Eija] Univ Helsinki, Cent Hosp, Pain Clin, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Knaster, P (corresponding author), Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland.	peter.knaster@dr.com	Kaprio, Jaakko/A-1820-2008	Kaprio, Jaakko/0000-0002-3716-2455; Kalso, Eija/0000-0002-4899-605X	Signe and Ane Gyllenberg Foundation; Foundation for Psychiatric Research; Wilhelm and Else Stockmann Foundation (HELSINKI); Finnish Association for the Study of Pain; Helsinki University Central Hospital	Signe and Ane Gyllenberg Foundation; Foundation for Psychiatric Research; Wilhelm and Else Stockmann Foundation (HELSINKI); Finnish Association for the Study of Pain; Helsinki University Central Hospital	This study was supported by grants from the Signe and Ane Gyllenberg Foundation (stiftel-sen@gyllenbergs.fi), the Foundation for Psychiatric Research (psykiatrian.tutkimussaatio@psy.fi), the Wilhelm and Else Stockmann Foundation (TEMPELGATAN 1 A 17/STOCKMANN KARL, 00100 HELSINKI tel: +358 9 1215802), the Finnish Association for the Study of Pain (http://www.suomenkivuntutkimusyhdistys.fi/), and the Helsinki University Central Hospital Research funds (http://www.hyksinstituutti.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boz C, 2004, PSYCHIAT CLIN NEUROS, V58, P536, DOI 10.1111/j.1440-1819.2004.01297.x; Brandstrom S, 1998, COMPR PSYCHIAT, V39, P122, DOI 10.1016/S0010-440X(98)90070-0; Brandstrom S, 2001, PSYCHOL REP, V89, P747, DOI 10.2466/PR0.89.7.747-758; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Conrad R, 2007, PAIN, V133, P197, DOI 10.1016/j.pain.2007.07.024; Coons MJ, 2004, EUR J PAIN, V8, P511, DOI 10.1016/j.ejpain.2003.11.018; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; Elovainio M, 2004, J AFFECT DISORDERS, V83, P227, DOI 10.1016/j.jad.2004.06.005; Estlander AM, UNPUB; Ettelt S, 2008, J AFFECT DISORDERS, V107, P265, DOI 10.1016/j.jad.2007.08.017; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Farmer A, 2002, BRIT J PSYCHIAT, V181, P118; Farmer RF, 2009, DEPRESS ANXIETY, V26, P371, DOI 10.1002/da.20459; Faytout M, 2007, EUR PSYCHIAT, V22, P75, DOI 10.1016/j.eurpsy.2005.07.009; Fishbain DA, 2006, PAIN MED, V7, P509, DOI 10.1111/j.1526-4637.2006.00239.x; Goubert L, 2004, PAIN, V107, P234, DOI 10.1016/j.pain.2003.11.005; Granot M, 2005, J PAIN, V6, P168, DOI 10.1016/j.jpain.2004.11.010; Hansenne M, 1999, J PSYCHIATR RES, V33, P31, DOI 10.1016/S0022-3956(98)00036-3; Hathaway SR, 2001, AM PSYCHIAT ASS HDB, P89; Jiang N, 2003, J PSYCHOSOM RES, V55, P493, DOI 10.1016/S0022-3999(03)00021-7; Jylha P, 2006, EUR PSYCHIAT, V21, P389, DOI 10.1016/j.eurpsy.2005.09.003; Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167; KEARNS NP, 1982, BRIT J PSYCHIAT, V141, P45, DOI 10.1192/bjp.141.1.45; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Malmgren-Olsson EB, 2006, CLIN J PAIN, V22, P625, DOI 10.1097/01.ajp.0000210907.65170.a3; Marteinsdottir I, 2003, NORD J PSYCHIAT, V57, P29, DOI 10.1080/08039480310000239; Matsudaira T, 2006, J CLIN PSYCHOL, V62, P97, DOI 10.1002/jclp.20215; McCracken Lance M, 2002, Pain Res Manag, V7, P45; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; Miettunen J, 2004, ACTA PSYCHIAT SCAND, V110, P150, DOI 10.1111/j.1600-0047.2004.00344.x; Mongini Franco, 2005, J Headache Pain, V6, P247, DOI 10.1007/s10194-005-0198-6; Morley S, 2002, PAIN, V99, P289, DOI 10.1016/S0304-3959(02)00137-9; Muris P, 2007, CHILD PSYCHIAT HUM D, V38, P171, DOI 10.1007/s10578-007-0054-9; Naito M, 2000, J CLIN PSYCHOL, V56, P1579, DOI 10.1002/1097-4679(200012)56:12<1579::AID-8>3.0.CO;2-K; Nery FG, 2009, DEPRESS ANXIETY, V26, P382, DOI 10.1002/da.20478; Pelissolo A, 2000, PSYCHIAT RES, V94, P67, DOI 10.1016/S0165-1781(00)00127-X; Pincus T, 1999, J PSYCHOSOM RES, V47, P211, DOI 10.1016/S0022-3999(99)00045-8; Pud D, 2004, EUR J PAIN, V8, P31, DOI 10.1016/S1090-3801(03)00065-X; Ramirez-Maestre C, 2004, J BEHAV MED, V27, P147, DOI 10.1023/B:JOBM.0000019849.21524.70; Reiss S, 1985, THEORETICAL ISSUES B; Richter J, 2000, EUR ARCH PSY CLIN N, V250, P40, DOI 10.1007/PL00007538; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; SVRAKIC DM, 1992, J AFFECT DISORDERS, V24, P217, DOI 10.1016/0165-0327(92)90106-G; Van der Does W, 2003, PSYCHOTHER PSYCHOSOM, V72, P217, DOI 10.1159/000070786; Varjonen J, 1997, NORD J PSYCHIAT, V51, P331, DOI 10.3109/08039489709090727; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Zvolensky MJ, 2001, BEHAV RES THER, V39, P683, DOI 10.1016/S0005-7967(00)00049-8	55	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e45672	10.1371/journal.pone.0045672	http://dx.doi.org/10.1371/journal.pone.0045672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026GE	23133510	Green Submitted, gold, Green Published			2022-12-25	WOS:000310261800003
J	Najand, N; Ryu, JR; Brook, WJ				Najand, Nima; Ryu, Jae-Ryeon; Brook, William J.			In Vitro Site Selection of a Consensus Binding Site for the Drosophila melanogaster Tbx20 Homolog Midline	PLOS ONE			English	Article							T-BOX PROTEINS; TRANSCRIPTION FACTOR; DNA-BINDING; TBX20-RELATED GENES; SEGMENT POLARITY; BRACHYURY; EXPRESSION; DOMAIN; SPECIFICITY; WINGLESS	We employed in vitro site selection to identify a consensus binding sequence for the Drosophila melanogaster Tbx20 T-box transcription factor homolog Midline. We purified a bacterially expressed T-box DNA binding domain of Midline, and used it in four rounds of precipitation and polymerase-chain-reaction based amplification. We cloned and sequenced 54 random oligonucleotides selected by Midline. Electromobility shift-assays confirmed that 27 of these could bind the Midline T-box. Sequence alignment of these 27 clones suggests that Midline binds as a monomer to a consensus sequence that contains an AGGTGT core. Thus, the Midline consensus binding site we define in this study is similar to that defined for vertebrate Tbx20, but differs from a previously reported Midline binding sequence derived through site selection.	[Najand, Nima; Ryu, Jae-Ryeon; Brook, William J.] Univ Calgary, Genes & Dev Res Grp, Alberta Childrens Hosp Res Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary	Brook, WJ (corresponding author), Univ Calgary, Genes & Dev Res Grp, Alberta Childrens Hosp Res Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada.	brook@ucalgary.ca			CIHR (Canadian Institutes of Health Research)	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	This work was funded by the CIHR (Canadian Institutes of Health Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Buescher M, 2006, DEV BIOL, V292, P418, DOI 10.1016/j.ydbio.2006.01.016; Buescher M, 2004, CURR BIOL, V14, P1694, DOI 10.1016/j.cub.2004.09.048; Cao Y, 2007, EMBO J, V26, P2942, DOI 10.1038/sj.emboj.7601736; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Coll M, 2002, STRUCTURE, V10, P343, DOI 10.1016/S0969-2126(02)00722-0; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Formaz-Preston A, 2012, DEV BIOL, V369, P319, DOI 10.1016/j.ydbio.2012.07.004; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Leal SM, 2009, DEV BIOL, V325, P138, DOI 10.1016/j.ydbio.2008.10.006; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Liu QX, 2009, GENE DEV, V23, P1165, DOI 10.1101/gad.1774209; Macindoe I, 2009, J MOL BIOL, V389, P606, DOI 10.1016/j.jmb.2009.04.056; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Miskolczi-McCallum CM, 2005, DEV BIOL, V278, P459, DOI 10.1016/j.ydbio.2004.11.026; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Papapetrou C, 1997, FEBS LETT, V409, P201, DOI 10.1016/S0014-5793(97)00506-1; Papapetrou C, 1999, GENOMICS, V55, P238, DOI 10.1006/geno.1998.5646; Qian L, 2005, DEV BIOL, V279, P509, DOI 10.1016/j.ydbio.2005.01.013; Reim I, 2005, MECH DEVELOP, V122, P1056, DOI 10.1016/j.mod.2005.04.006; Ryu JR, 2011, DEV DYNAM, V240, P86, DOI 10.1002/dvdy.22495; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Sinha S, 2000, GENE, V258, P15, DOI 10.1016/S0378-1119(00)00417-0; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Stirnimann CU, 2010, J MOL BIOL, V400, P71, DOI 10.1016/j.jmb.2010.04.052; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48176	10.1371/journal.pone.0048176	http://dx.doi.org/10.1371/journal.pone.0048176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133562	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800052
J	Zhao, J; Zhang, J; Yu, M; Xie, Y; Huang, Y; Wolff, DW; Abel, PW; Tu, Y				Zhao, J.; Zhang, J.; Yu, M.; Xie, Y.; Huang, Y.; Wolff, D. W.; Abel, P. W.; Tu, Y.			Mitochondrial dynamics regulates migration and invasion of breast cancer cells	ONCOGENE			English	Article						breast cancer; metastasis; lamellipodia; Drp1; mitochondrial dynamics; fission and fusion	ENDOPLASMIC-RETICULUM; FUSION; INHIBITION; ACTIN; PHOSPHORYLATION; CYTOSKELETON; CHEMOTAXIS; FISSION; ROLES	Mitochondria are highly dynamic and undergo constant fusion and fission that are essential for maintaining physiological functions of cells. Although dysfunction of mitochondria has been implicated in tumorigenesis, little is known about the roles of mitochondrial dynamics in metastasis, the major cause of cancer death. In the present study, we found a marked upregulation of mitochondrial fission protein dynamin-related protein 1 (Drp1) expression in human invasive breast carcinoma and metastases to lymph nodes. Compared with non-metastatic breast cancer cells, mitochondria also were more fragmented in metastatic breast cancer cells that express higher levels of total and active Drp1 and less mitochondrial fusion protein 1 (Mfn1). Silencing Drp1 or overexpression of Mfn1 resulted in mitochondria elongation or clusters, respectively, and significantly suppressed metastatic abilities of breast cancer cells. In contrast, silencing Mfn proteins led to mitochondrial fragmentation and enhanced metastatic abilities of breast cancer cells. Interestingly, these manipulations of mitochondrial dynamics altered the subcellular distribution of mitochondria in breast cancer cells. For example, silencing Drp1 or overexpression of Mfn1 inhibited lamellipodia formation, a key step for cancer metastasis, and suppressed chemoattractant-induced recruitment of mitochondria to lamellipodial regions. Conversely, silencing Mfn proteins resulted in more cell spreading and lamellipodia formation, causing accumulation of more mitochondria in lamellipodia regions. More importantly, treatment with a mitochondrial uncoupling agent or adenosine triphosphate synthesis inhibitor reduced lamellipodia formation and decreased breast cancer cell migration and invasion, suggesting a functional importance of mitochondria in breast cancer metastasis. Together, our findings show a new role and mechanism for regulation of cancer cell migration and invasion by mitochondrial dynamics. Thus targeting dysregulated Drp1-dependent mitochondrial fission may provide a novel strategy for suppressing breast cancer metastasis.	[Zhao, J.; Zhang, J.; Yu, M.; Huang, Y.] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhao, J.; Xie, Y.; Wolff, D. W.; Abel, P. W.; Tu, Y.] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Creighton University	Tu, Y (corresponding author), Creighton Univ, Sch Med, Dept Pharmacol, 2500 Calif Plaza,551 Criss III, Omaha, NE 68178 USA.	yapingtu@creighton.edu	Yu, Meifang/O-3728-2017; Wolff, Dennis W/E-3013-2015; Yu, Meifang/N-6026-2017	Abel, Peter/0000-0002-6588-1676; Yu, Meifang/0000-0002-1878-307X	National Institutes of Health [CA125661]; Nebraska LB595 program; National Basic Research Program of China [2010CB833701, 2012CB934003]; National Natural Science Foundation of China [31100973]; NATIONAL CANCER INSTITUTE [R01CA125661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska LB595 program; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Professors Fuyu Yang and Quan Chen for their valuable suggestions. This work was supported by the National Institutes of Health (CA125661), Nebraska LB595 program and the National Basic Research Program of China (2010CB833701, 2012CB934003). Dr Juan Zhang is a grant recipient of the National Natural Science Foundation of China (31100973).	Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; BERTINA RM, 1974, BIOCHIM BIOPHYS ACTA, V368, P279, DOI 10.1016/0005-2728(74)90175-3; Biswas S, 1998, FEBS LETT, V425, P411, DOI 10.1016/S0014-5793(98)00273-7; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, DEV CELL, V11, P592, DOI 10.1016/j.devcel.2006.10.009; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Condeelis JS, 2001, SEMIN CANCER BIOL, V11, P119, DOI 10.1006/scbi.2000.0363; Conklin MW, 2005, DEV BIOL, V287, P201, DOI 10.1016/j.ydbio.2005.09.006; COUCHMAN JR, 1982, EUR J CELL BIOL, V27, P47; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Platet N, 1998, INT J CANCER, V75, P750, DOI 10.1002/(SICI)1097-0215(19980302)75:5<750::AID-IJC14>3.0.CO;2-A; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; VONJAGOW G, 1980, ANGEW CHEM INT EDIT, V19, P659, DOI 10.1002/anie.198006593; WERTH JL, 1994, J NEUROSCI, V14, P348; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zhang JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1099	44	447	461	1	64	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4814	4824		10.1038/onc.2012.494	http://dx.doi.org/10.1038/onc.2012.494			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23128392	Green Accepted			2022-12-25	WOS:000325274700010
J	Mishra, AK; Alves, JE; Krumbach, K; Nigou, J; Castro, AG; Geurtsen, J; Eggeling, L; Saraiva, M; Besra, GS				Mishra, Arun K.; Alves, Joana E.; Krumbach, Karin; Nigou, Jerome; Castro, Antonio G.; Geurtsen, Jeroen; Eggeling, Lothar; Saraiva, Margarida; Besra, Gurdyal S.			Differential Arabinan Capping of Lipoarabinomannan Modulates Innate Immune Responses and Impacts T Helper Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CORYNEBACTERIUM-GLUTAMICUM; BIOSYNTHESIS; IDENTIFICATION; INFECTION; TLR2; RECOGNITION; LIPOMANNANS; LIPOGLYCANS; MICE	Toll-like receptors (TLRs) recognize pathogens by interacting with pathogen-associated molecular patterns, such as the phosphatidylinositol-based lipoglycans, lipomannan (LM) and lipoarabinomannan (LAM). Such structures are present in several pathogens, including Mycobacterium tuberculosis, being important for the initiation of immune responses. It is well established that the interaction of LM and LAM with TLR2 is a process dependent on the structure of the ligands. However, the implications of structural variations on TLR2 ligands for the development of T helper (Th) cell responses or in the context of in vivo responses are less studied. Herein, we used Corynebacterium glutamicum as a source of lipoglycan intermediates for host interaction studies. In this study, we have deleted a putative glycosyltransferase, NCgl2096, from C. glutamicum and found that it encodes for a novel alpha(1 -> 2) arabinofuranosyltransferase, AftE. Biochemical analysis of the lipoglycans obtained in the presence (wild type) or absence of NCgl2096 showed that AftE is involved in the biosynthesis of singular arabinans of LAM. In its absence, the resulting molecule is a hypermannosylated (hLM) form of LAM. Both LAM and hLM were recognized by dendritic cells, mainly via TLR2, and triggered the production of several cytokines. hLM was a stronger stimulus for in vitro cytokine production and, as a result, a more potent inducer of Th17 responses. In vivo data confirmed hLM as a stronger inducer of cytokine responses and suggested the involvement of pattern recognition receptors other than TLR2 as sensors for lipoglycans.	[Mishra, Arun K.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Alves, Joana E.; Castro, Antonio G.; Saraiva, Margarida; Besra, Gurdyal S.] Univ Minho, Life & Hlth & Sci Res Inst, P-4710057 Braga, Portugal; [Alves, Joana E.; Castro, Antonio G.; Saraiva, Margarida; Besra, Gurdyal S.] ICVS 3Bs PT Govt Associate Lab, P-4710057 Braga, Portugal; [Krumbach, Karin; Eggeling, Lothar] Res Ctr Juelich, Inst Biotechnol 1, D-52425 Julich, Germany; [Nigou, Jerome] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Nigou, Jerome] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Geurtsen, Jeroen] VU, Med Ctr, Dept Med Microbiol & Infect Control, NL-1081 BT Amsterdam, Netherlands	University of Birmingham; Universidade do Minho; Helmholtz Association; Research Center Julich; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Vrije Universiteit Amsterdam	Saraiva, M (corresponding author), Univ Minho, Life & Hlth & Sci Res Inst, P-4710057 Braga, Portugal.	msaraiva@ecsaude.uminho.pt; g.besra@bham.ac.uk	Castro, Gil/T-7584-2018; Alves, Joana EV/J-6866-2013; Nigou, Jérôme/D-6802-2019; Saraiva, Margarida/E-8781-2011	Castro, Gil/0000-0002-4684-4183; Alves, Joana EV/0000-0003-3131-9834; Nigou, Jérôme/0000-0002-6233-2487; Besra, Gurdyal/0000-0002-5605-0395; Saraiva, Margarida/0000-0002-8180-1293	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/SAU-MII/101977/2008, PTDC/BIA-BCM/102776/2008]; Netherlands Organization for Scientific Research (NWO) [016.101.001]; Personal Research Chair from James Bardrick; Royal Society Wolfson Research Merit Award; Lister Institute-Jenner research fellowship; Medical Research Council; Wellcome Trust Grant [081569/Z/06/Z]; Medical Research Council [G0901690] Funding Source: researchfish; MRC [G0901690] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Personal Research Chair from James Bardrick; Royal Society Wolfson Research Merit Award(Royal Society of London); Lister Institute-Jenner research fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal, Personal Grant PTDC/SAU-MII/101977/2008.; Supported by the Netherlands Organization for Scientific Research (NWO) through a VENI research grant (016.101.001).; Supported by FCT, Portugal, Project Grant PTDC/BIA-BCM/102776/2008. A Ciencia 2007 fellow.; Supported by a Personal Research Chair from James Bardrick, a Royal Society Wolfson Research Merit Award, a Lister Institute-Jenner research fellowship, the Medical Research Council, and Wellcome Trust Grant 081569/Z/06/Z.	Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Alderwick LJ, 2006, GLYCOBIOLOGY, V16, P1073, DOI 10.1093/glycob/cwl030; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Birch HL, 2010, P NATL ACAD SCI USA, V107, P2634, DOI 10.1073/pnas.0915082107; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jang S, 2004, J IMMUNOL, V173, P3392, DOI 10.4049/jimmunol.173.5.3392; Jankute M, 2012, FUTURE MICROBIOL, V7, P129, DOI [10.2217/fmb.11.123, 10.2217/FMB.11.123]; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kirschner DE, 2010, CURR OPIN BIOTECH, V21, P524, DOI 10.1016/j.copbio.2010.06.002; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Krishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028476; Mazzoni A, 2004, J LEUKOCYTE BIOL, V75, P721, DOI 10.1189/jlb.1003482; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, MOL MICROBIOL, V80, P1241, DOI 10.1111/j.1365-2958.2011.07640.x; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; O'Garra A, 2004, ADV IMMUNOL, V83, P133; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Pitarque S, 2008, TUBERCULOSIS, V88, P560, DOI 10.1016/j.tube.2008.04.002; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Tatituri RVV, 2007, MICROBIOL-SGM, V153, P2621, DOI 10.1099/mic.0.2007/008078-0; Teixeira-Coelho M, 2011, INT IMMUNOL, V23, P89, DOI 10.1093/intimm/dxq459; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Torrelles JB, 2011, J BIOL CHEM, V286, P35438, DOI 10.1074/jbc.M111.232587; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014	53	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44173	44183		10.1074/jbc.M112.402396	http://dx.doi.org/10.1074/jbc.M112.402396			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144457	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000312938600016
J	Sukumaran, P; Lof, C; Kemppainen, K; Kankaanpaa, P; Pulli, I; Nasman, J; Viitanen, T; Tornquist, K				Sukumaran, Pramod; Lof, Christoffer; Kemppainen, Kati; Kankaanpaa, Pasi; Pulli, Ilari; Nasman, Johnny; Viitanen, Tero; Tornquist, Kid			Canonical Transient Receptor Potential Channel 2 (TRPC2) as a Major Regulator of Calcium Homeostasis in Rat Thyroid FRTL-5 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CATION CHANNEL; PATCH-CLAMP; CA2+ ENTRY; STIM1; THYROTROPIN; MECHANISM; STIMULATION; RETICULUM; BINDING	Mammalian non-selective transient receptor potential cation channels (TRPCs) are important in the regulation of cellular calcium homeostasis. In thyroid cells, including rat thyroid FRTL-5 cells, calcium regulates a multitude of processes. RT-PCR screening of FRTL-5 cells revealed the presence of TRPC2 channels only. Knockdown of TRPC2 using shRNA (shTRPC2) resulted in decreased ATP-evoked calcium peak amplitude and inward current. In calcium-free buffer, there was no difference in the ATP-evoked calcium peak amplitude between control cells and shTRPC2 cells. Store-operated calcium entry was indistinguishable between the two cell lines. Basal calcium entry was enhanced in shTRPC2 cells, whereas the level of PKC beta 1 andPKC delta, the activity of sarco/endoplasmic reticulum Ca2+-ATPase, and the calcium content in the endoplasmic reticulum were decreased. Stromal interaction molecule (STIM) 2, but not STIM1, was arranged in puncta in resting shTRPC2 cells but not in control cells. Phosphorylation site Orai1 S27A/S30A mutant and non-functional Orai1 R91W attenuated basal calcium entry in shTRPC2 cells. Knockdown of PKC delta with siRNA increased STIM2 punctum formation and enhanced basal calcium entry but decreased sarco/endoplasmic reticulum Ca2+-ATPase activity in wild-type cells. Transfection of a truncated, non-conducting mutant of TRPC2 evoked similar results. Thus, TRPC2 functions as a major regulator of calcium homeostasis in rat thyroid cells.	[Sukumaran, Pramod; Lof, Christoffer; Kemppainen, Kati; Pulli, Ilari; Nasman, Johnny; Tornquist, Kid] Abo Akad Univ, Dept Biosci, FIN-20520 Turku, Finland; [Lof, Christoffer] Turku Doctoral Programme Biomed Sci, Turku 20520, Finland; [Kankaanpaa, Pasi] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland; [Viitanen, Tero] Univ Helsinki, Inst Biomed Physiol, FIN-00014 Helsinki, Finland; [Viitanen, Tero; Tornquist, Kid] Biomedicum Helsinki, Minerva Fdn Inst Med Res, Helsinki 00270, Finland	Abo Akademi University; University of Turku; University of Helsinki; University of Helsinki	Tornquist, K (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6A, FIN-20520 Turku, Finland.	ktornqvi@abo.fi		Pulli, Ilari/0000-0002-4785-8253; Sukumaran, Pramod/0000-0002-4781-3389; Lof, Christoffer/0000-0002-7149-5528; Kemppainen, Kati/0000-0003-3785-2269	Academy of Finland; Sigrid Juselius Foundation; Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); Magnus Ehrnrooth Foundation; Receptor Research Program (Abo Akademi University and University of Turku)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University); Magnus Ehrnrooth Foundation; Receptor Research Program (Abo Akademi University and University of Turku)	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Centre of Excellence in Cell Stress and Molecular Ageing (Abo Akademi University), the Magnus Ehrnrooth Foundation, and the Receptor Research Program (Abo Akademi University and University of Turku).	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Alvarez J, 2008, AM J PHYSIOL-HEART C, V295, pH21, DOI 10.1152/ajpheart.00135.2008; Arruda AP, 2007, BBA-BIOMEMBRANES, V1768, P1498, DOI 10.1016/j.bbamem.2007.03.016; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BERMAN MI, 1987, MOL CELL ENDOCRINOL, V54, P151, DOI 10.1016/0303-7207(87)90152-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; CORDA D, 1985, J BIOL CHEM, V260, P9230; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Di Jeso B, 1998, EUR J BIOCHEM, V252, P583, DOI 10.1046/j.1432-1327.1998.2520583.x; Dietrich A, 2005, N-S ARCH PHARMACOL, V371, P257, DOI 10.1007/s00210-005-1052-8; Ekokoski E, 2001, J CELL PHYSIOL, V187, P166, DOI 10.1002/jcp.1070; Grasberger H, 2007, J CLIN ENDOCR METAB, V92, P2816, DOI 10.1210/jc.2007-0366; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Larsen AH, 2001, BMC BIOCHEM, V2; Larsson KP, 2005, J BIOL CHEM, V280, P1771, DOI 10.1074/jbc.M406073200; Liman ER, 2003, J PHYSIOL-LONDON, V548, P777, DOI 10.1113/jphysiol.2002.037119; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Lof C, 2008, J CELL PHYSIOL, V216, P245, DOI 10.1002/jcp.21396; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Mast TG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-61; McCollum AT, 2004, J NEUROSCI RES, V76, P104, DOI 10.1002/jnr.20059; OKAJIMA F, 1987, J BIOL CHEM, V262, P13483; Okajima F, 1997, ENDOCRINOLOGY, V138, P220, DOI 10.1210/en.138.1.220; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; RASPE E, 1991, MOL CELL ENDOCRINOL, V81, P175, DOI 10.1016/0303-7207(91)90216-F; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; SAJI M, 1991, BIOCHEM BIOPH RES CO, V176, P94, DOI 10.1016/0006-291X(91)90894-D; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; SHO K, 1991, J BIOL CHEM, V266, P12180; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stiber JA, 2008, MOL CELL BIOL, V28, P2637, DOI 10.1128/MCB.01601-07; Sukumaran P., 2012, MOL ENDOCRI IN PRESS; Sutton KA, 2004, DEV BIOL, V274, P426, DOI 10.1016/j.ydbio.2004.07.031; Tong Q, 2004, AM J PHYSIOL-CELL PH, V287, pC1667, DOI 10.1152/ajpcell.00265.2004; TORNQUIST K, 1993, BIOCHEM J, V290, P443; Tornquist K, 1997, ENDOCRINOLOGY, V138, P4049, DOI 10.1210/en.138.10.4049; Tornquist K, 1996, J CELL PHYSIOL, V166, P241; TORNQUIST K, 1992, J CELL PHYSIOL, V150, P90, DOI 10.1002/jcp.1041500113; Villereal ML, 2006, SEMIN CELL DEV BIOL, V17, P618, DOI 10.1016/j.semcdb.2006.10.010; Wang L, 2011, MOL CANCER THER, V10, P461, DOI 10.1158/1535-7163.MCT-10-0812; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Yildirim E, 2003, P NATL ACAD SCI USA, V100, P2220, DOI 10.1073/pnas.0438036100; Yildirim E., 2007, V179, P53; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	59	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44345	44360		10.1074/jbc.M112.374348	http://dx.doi.org/10.1074/jbc.M112.374348			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144458	Green Published, hybrid			2022-12-25	WOS:000312938600032
J	Borau, C; Kim, T; Bidone, T; Garcia-Aznar, JM; Kamm, RD				Borau, Carlos; Kim, Taeyoon; Bidone, Tamara; Manuel Garcia-Aznar, Jose; Kamm, Roger D.			Dynamic Mechanisms of Cell Rigidity Sensing: Insights from a Computational Model of Actomyosin Networks	PLOS ONE			English	Article							SUBSTRATE STIFFNESS; TRACTION FORCES; FOCAL ADHESIONS; SOFT MEDIA; MYOSIN-II; MUSCLE; ELASTICITY; ORGANIZATION; DEPENDENCE; MOLECULES	Cells modulate themselves in response to the surrounding environment like substrate elasticity, exhibiting structural reorganization driven by the contractility of cytoskeleton. The cytoskeleton is the scaffolding structure of eukaryotic cells, playing a central role in many mechanical and biological functions. It is composed of a network of actins, actin cross-linking proteins (ACPs), and molecular motors. The motors generate contractile forces by sliding couples of actin filaments in a polar fashion, and the contractile response of the cytoskeleton network is known to be modulated also by external stimuli, such as substrate stiffness. This implies an important role of actomyosin contractility in the cell mechano-sensing. However, how cells sense matrix stiffness via the contractility remains an open question. Here, we present a 3-D Brownian dynamics computational model of a cross-linked actin network including the dynamics of molecular motors and ACPs. The mechano-sensing properties of this active network are investigated by evaluating contraction and stress in response to different substrate stiffness. Results demonstrate two mechanisms that act to limit internal stress: (i) In stiff substrates, motors walk until they exert their maximum force, leading to a plateau stress that is independent of substrate stiffness, whereas (ii) in soft substrates, motors walk until they become blocked by other motors or ACPs, leading to submaximal stress levels. Therefore, this study provides new insights into the role of molecular motors in the contraction and rigidity sensing of cells.	[Borau, Carlos; Kamm, Roger D.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Borau, Carlos; Kamm, Roger D.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Borau, Carlos; Manuel Garcia-Aznar, Jose] Univ Zaragoza, Dept Mech Engn, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Kim, Taeyoon] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Bidone, Tamara] Politecn Torino, Dept Mech, Turin, Italy	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Zaragoza; University of Chicago; Polytechnic University of Turin	Kamm, RD (corresponding author), MIT, Dept Biol Engn, Cambridge, MA 02139 USA.	rdkamm@mit.edu	Garcia-Aznar, Jose Manuel/F-8256-2010; Borau, Carlos/A-7688-2018; Kamm, Roger D/I-7630-2012	Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Borau, Carlos/0000-0002-3784-1140; /0000-0002-7232-304X	Spanish Ministry of Science and Innovation [DPI 2009-14115-CO3-01]; FPI [BES-2010-029927]; European Union, European Regional Development Fund; United States National Institutes of Health; Computation Institute and the Biological Sciences Division of the University of Chicago and Argonne National Laboratory [S10 RR029030-01]; Singapore-MIT Alliance for Research and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029030] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPI(Spanish Government); European Union, European Regional Development Fund(European Commission); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Computation Institute and the Biological Sciences Division of the University of Chicago and Argonne National Laboratory; Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Spanish Ministry of Science and Innovation (DPI 2009-14115-CO3-01) and the FPI grant (BES-2010-029927) (Project Part Financed by the European Union, European Regional Development Fund). In addition, this research was supported in part by the United States National Institutes of Health through resources provided by the Computation Institute and the Biological Sciences Division of the University of Chicago and Argonne National Laboratory, under grant S10 RR029030-01, and also by the Singapore-MIT Alliance for Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrom JA, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051913; Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Bordeleau F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038780; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dou Y, 2007, AM J PHYSIOL-CELL PH, V293, pC1148, DOI 10.1152/ajpcell.00551.2006; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Kim T, 2009, EXP MECH, V49, P91, DOI 10.1007/s11340-007-9091-3; Kim T, 2011, BIOPHYS J, V101, P1597, DOI 10.1016/j.bpj.2011.08.033; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Marcq P, 2011, BIOPHYS J, V101, pL33, DOI 10.1016/j.bpj.2011.08.023; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; McMahon T, 1985, PERCEPT MOTOR SKILL, V60, P679; Mitrossilis D, 2010, P NATL ACAD SCI USA, V107, P16518, DOI 10.1073/pnas.1007940107; Mitrossilis D, 2009, P NATL ACAD SCI USA, V106, P18243, DOI 10.1073/pnas.0903994106; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rassier DE, 1999, J APPL PHYSIOL, V86, P1445, DOI 10.1152/jappl.1999.86.5.1445; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023; Ruegg C, 2002, NEWS PHYSIOL SCI, V17, P213, DOI 10.1152/nips.01389.2002; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Schwarz US, 2005, MED ENG PHYS, V27, P763, DOI 10.1016/j.medengphy.2005.04.007; Silver Frederick H, 2003, Crit Rev Biomed Eng, V31, P255, DOI 10.1615/CritRevBiomedEng.v31.i4.10; Sung CH, 2011, COMPUT ANAL SYNTH DE, P177; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Webster KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017807; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P13897, DOI 10.1073/pnas.0606087103; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zemel A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194110	43	51	52	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49174	10.1371/journal.pone.0049174	http://dx.doi.org/10.1371/journal.pone.0049174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139838	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400070
J	Korencic, A; Bordyugov, G; Kosir, R; Rozman, D; Golicnik, M; Herzel, H				Korencic, Anja; Bordyugov, Grigory; Kosir, Rok; Rozman, Damjana; Golicnik, Marko; Herzel, Hanspeter			The Interplay of cis-Regulatory Elements Rules Circadian Rhythms in Mouse Liver	PLOS ONE			English	Article							CASEIN KINASE 1; NEGATIVE FEEDBACK; GENE-EXPRESSION; PERIPHERAL-TISSUES; CLOCK GENES; TRANSCRIPTION; MODEL; MECHANISMS; IDENTIFICATION; OSCILLATION	The mammalian circadian clock is driven by cell-autonomous transcriptional feedback loops that involve E-boxes, D-boxes, and ROR-elements. In peripheral organs, circadian rhythms are additionally affected by systemic factors. We show that intrinsic combinatorial gene regulation governs the liver clock. With a temporal resolution of 2 h, we measured the expression of 21 clock genes in mouse liver under constant darkness and equinoctial light-dark cycles. Based on these data and known transcription factor binding sites, we develop a six-variable gene regulatory network. The transcriptional feedback loops are represented by equations with time-delayed variables, which substantially simplifies modelling of intermediate protein dynamics. Our model accurately reproduces measured phases, amplitudes, and waveforms of clock genes. Analysis of the network reveals properties of the clock: overcritical delays generate oscillations; synergy of inhibition and activation enhances amplitudes; and combinatorial modulation of transcription controls the phases. The agreement of measurements and simulations suggests that the intrinsic gene regulatory network primarily determines the circadian clock in liver, whereas systemic cues such as light-dark cycles serve to fine-tune the rhythms.	[Bordyugov, Grigory; Herzel, Hanspeter] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; [Korencic, Anja; Kosir, Rok; Rozman, Damjana; Golicnik, Marko] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia; [Kosir, Rok; Rozman, Damjana] Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Ljubljana, Slovenia	Humboldt University of Berlin; University of Ljubljana; University of Ljubljana	Herzel, H (corresponding author), Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany.	h.herzel@biologie.hu-berlin.de	Kosir, Rok/AAT-2901-2020	Kosir, Rok/0000-0002-1197-9627; Rozman, Damjana/0000-0002-6501-2163	Slovene Research Agency; Slovene Research Agency [P1-170, P1-104]; Deutsche Forschungsgemeinschaft [SFB 618]	Slovene Research Agency(Slovenian Research Agency - Slovenia); Slovene Research Agency(Slovenian Research Agency - Slovenia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	A.K. and R. K. thank the Slovene Research Agency for Young Researcher Fellowships. A. K. is also indebted to the Slovene Human Resources Development and Scholarship Fund, and to Federation of European Biochemical Societies (FEBS) for FEBS Collaborative Experimental Scholarship. This work was financially supported by the Slovene Research Agency (grants P1-170 to M. G. and P1-104 to D. R.) and the Deutsche Forschungsgemeinschaft (SFB 618, SPP InKomBio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase SO, 2008, J MATH BIOL, V56, P279, DOI 10.1007/s00285-007-0115-5; Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Atwood A, 2011, P NATL ACAD SCI USA, V108, P18560, DOI 10.1073/pnas.1115753108; Bernard S, 2006, PHILOS T R SOC A, V364, P1155, DOI 10.1098/rsta.2006.1761; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jacobshagen S, 2008, J BIOL RHYTHM, V23, P511, DOI 10.1177/0748730408325753; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kurosawa G, 2002, J THEOR BIOL, V216, P193, DOI 10.1006/jtbi.2002.2546; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu S, 2007, CHRONOBIOL INT, V24, P793, DOI 10.1080/07420520701672556; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramsey KM, 2007, ANNU REV NUTR, V27, P219, DOI 10.1146/annurev.nutr.27.061406.093546; Relogio A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002309; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Scheer FAJL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000721; Scheper TO, 1999, J NEUROSCI, V19, P40, DOI 10.1523/JNEUROSCI.19-01-00040.1999; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wilkins AK, 2007, PLOS COMPUT BIOL, V3, P2476, DOI 10.1371/journal.pcbi.0030242; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yamajuku D, 2010, NUCLEIC ACIDS RES, V38, P7964, DOI 10.1093/nar/gkq678; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	57	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e46835	10.1371/journal.pone.0046835	http://dx.doi.org/10.1371/journal.pone.0046835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144788	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400009
J	Vierra-Green, C; Roe, D; Hou, LH; Hurley, CK; Rajalingam, R; Reed, E; Lebedeva, T; Yu, N; Stewart, M; Noreen, H; Hollenbach, JA; Guethlein, LA; Wang, T; Spellman, S; Maiers, M				Vierra-Green, Cynthia; Roe, David; Hou, Lihua; Hurley, Carolyn Katovich; Rajalingam, Raja; Reed, Elaine; Lebedeva, Tatiana; Yu, Neng; Stewart, Mary; Noreen, Harriet; Hollenbach, Jill A.; Guethlein, Lisbeth A.; Wang, Tao; Spellman, Stephen; Maiers, Martin			Allele-Level Haplotype Frequencies and Pairwise Linkage Disequilibrium for 14 KIR Loci in 506 European-American Individuals	PLOS ONE			English	Article							MARROW TRANSPLANT POPULATION; INHIBITORY RECEPTOR GENES; B-HAPLOTYPES; DIVERSITY; HLA; POLYMORPHISM; FAMILIES; KIR2DL5; ORGANIZATION; RECOMBINATION	The immune responses of natural killer cells are regulated, in part, by killer cell immunoglobulin-like receptors (KIR). The 16 closely-related genes in the KIR gene system have been diversified by gene duplication and unequal crossing over, thereby generating haplotypes with variation in gene copy number. Allelic variation also contributes to diversity within the complex. In this study, we estimated allele-level haplotype frequencies and pairwise linkage disequilibrium statistics for 14 KIR loci. The typing utilized multiple methodologies by four laboratories to provide at least 2x coverage for each allele. The computational methods generated maximum-likelihood estimates of allele-level haplotypes. Our results indicate the most extensive allele diversity was observed for the KIR framework genes and for the genes localized to the telomeric region of the KIR A haplotype. Particular alleles of the stimulatory loci appear to be nearly fixed on specific, common haplotypes while many of the less frequent alleles of the inhibitory loci appeared on multiple haplotypes, some with common haplotype structures. Haplotype structures cA01 and/or tA01 predominate in this cohort, as has been observed in most populations worldwide. Linkage disequilibrium is high within the centromeric and telomeric haplotype regions but not between them and is particularly strong between centromeric gene pairs KIR2DL5 similar to KIR2DS3S5 and KIR2DS3S5 similar to KIR2DL1, and telomeric KIR3DL1 similar to KIR2DS4. Although 93% of the individuals have unique pairs of full-length allelic haplotypes, large genomic blocks sharing specific sets of alleles are seen in the most frequent haplotypes. These high-resolution, high-quality haplotypes extend our basic knowledge of the KIR gene system and may be used to support clinical studies beyond single gene analysis.	[Roe, David; Hollenbach, Jill A.; Maiers, Martin] Natl Marrow Donor Program, Minneapolis, MN USA; [Vierra-Green, Cynthia; Spellman, Stephen] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Hou, Lihua; Hurley, Carolyn Katovich] Georgetown Univ, Dept Oncol, Washington, DC USA; [Hou, Lihua; Hurley, Carolyn Katovich] Georgetown Univ, Dept Pediat, Washington, DC 20057 USA; [Rajalingam, Raja; Reed, Elaine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, UCLA Immunogenet Ctr, Los Angeles, CA 90095 USA; [Lebedeva, Tatiana; Yu, Neng] Amer Red Cross, HLA Lab, Dedham, MA USA; [Stewart, Mary; Noreen, Harriet] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA; [Hollenbach, Jill A.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Guethlein, Lisbeth A.] Stanford Univ, Stanford, CA 94305 USA; [Wang, Tao] Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI USA	National Marrow Donor Program; Center for International Blood & Marrow Transplant Research; Georgetown University; Georgetown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; American Red Cross; University of Minnesota System; University of Minnesota Twin Cities; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Stanford University; Center for International Blood & Marrow Transplant Research	Maiers, M (corresponding author), Natl Marrow Donor Program, Minneapolis, MN USA.	mmaiers@nmdp.org		Maiers, Martin/0000-0002-0198-2064	Office of Naval Research [ONR N00014-08-1-1207, ONR N00014-10-0199]	Office of Naval Research(Office of Naval Research)	This study was supported by funding from Office of Naval Research grants ONR N00014-08-1-1207 and ONR N00014-10-0199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashouri E, 2009, IMMUNOGENETICS, V61, P483, DOI 10.1007/s00251-009-0378-7; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Belle I, 2008, TISSUE ANTIGENS, V71, P434, DOI 10.1111/j.1399-0039.2008.01017.x; Cooley S, 2010, BLOOD; Cramer H., 1946, MATH MODELS STAT; Do CB, 2008, NAT BIOTECHNOL, V26, P897, DOI 10.1038/nbt1406; Du Z, 2008, GENES IMMUN, V9, P470, DOI 10.1038/gene.2008.39; Du ZY, 2007, IMMUNOGENETICS, V59, P1, DOI 10.1007/s00251-006-0168-4; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gedil MA, 2007, TISSUE ANTIGENS, V70, P228, DOI 10.1111/j.1399-0039.2007.00880.x; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gomez-Lozano N, 2005, EUR J IMMUNOL, V35, P16, DOI 10.1002/eji.200425493; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gonzalez A, 2008, TISSUE ANTIGENS, V72, P11, DOI 10.1111/j.1399-0039.2008.01050.x; Gourraud PA, 2010, IMMUNOGENETICS, V62, P729, DOI 10.1007/s00251-010-0478-4; Grzywacz B, 2008, BEST PRACT RES CL HA, V21, P467, DOI 10.1016/j.beha.2008.07.008; Hollenbach J A, 2010, Tissue Antigens, V76, P9, DOI 10.1111/j.1399-0039.2010.01459.x; Hou L, 2007, TISSUE ANTIGENS, V70, P449, DOI 10.1111/j.1399-0039.2007.00930.x; Hou L, 2011, GENES IMMUN; Hou LH, 2007, TISSUE ANTIGENS, V69, P250, DOI 10.1111/j.1399-0039.2006.00793.x; Hou L, 2008, HUM IMMUNOL, V69, P174, DOI 10.1016/j.humimm.2008.01.009; Hou LH, 2010, IMMUNOGENETICS, V62, P491, DOI 10.1007/s00251-010-0458-8; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jiang K, 2005, TISSUE ANTIGENS, V65, P556, DOI 10.1111/j.1399-0039.2005.00412.x; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; KLITZ W, 1995, AM J HUM GENET, V57, P1436; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lebedeva TV, 2007, HUM IMMUNOL, V68, P789, DOI 10.1016/j.humimm.2007.07.002; Levinson RD, 2008, GENES IMMUN, V9, P249, DOI 10.1038/gene.2008.13; LEWONTIN RC, 1964, GENETICS, V50, P757; Luo LH, 2007, IMMUNOGENETICS, V59, P779, DOI 10.1007/s00251-007-0239-1; Majorczyk E, 2008, INT J IMMUNOGENET, V35, P405, DOI 10.1111/j.1744-313X.2008.00792.x; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; Martin MP, 2008, IMMUNOGENETICS, V60, P767, DOI 10.1007/s00251-008-0334-y; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; Middleton D, 2007, IMMUNOGENETICS, V59, P145, DOI 10.1007/s00251-006-0181-7; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Moffett A, 2006, PLACENTA, V27, pS54, DOI 10.1016/j.placenta.2006.01.021; Norman PJ, 2009, GENOME RES, V19, P757, DOI 10.1101/gr.085738.108; Norman PJ, 2002, GENES IMMUN, V3, P86, DOI 10.1038/sj.gene.6363836; Ordonez D, 2008, GENES IMMUN, V9, P431, DOI 10.1038/gene.2008.34; Ordonez D, 2011, GENES IMMUN, V12, P544, DOI 10.1038/gene.2011.35; Parham P, 2008, SEMIN IMMUNOL, V20, P311, DOI 10.1016/j.smim.2008.10.002; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Robinson J, 2010, NUCLEIC ACIDS RES, V38, pD863, DOI 10.1093/nar/gkp879; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; Shilling HG, 2002, J IMMUNOL, V168, P2307, DOI 10.4049/jimmunol.168.5.2307; Shulse C, 2007, TISSUE ANTIGENS, V70, P157, DOI 10.1111/j.1399-0039.2007.00864.x; Single RM, 2008, IMMUNOGENETICS, V60, P711, DOI 10.1007/s00251-008-0331-1; THOMSON G, 1987, GENETICS, V116, P623; Traherne JA, 2010, HUM MOL GENET, V19, P737, DOI 10.1093/hmg/ddp538; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Velickovic M, 2009, TISSUE ANTIGENS, V73, P9, DOI 10.1111/j.1399-0039.2008.01149.x; Vilches C, 2000, TISSUE ANTIGENS, V56, P453, DOI 10.1034/j.1399-0039.2000.560510.x; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; WATTERSON GA, 1978, GENETICS, V88, P405; Williams F, 2003, HUM IMMUNOL, V64, P729, DOI 10.1016/S0198-8859(03)00089-2; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Witt CS, 2009, CURR OPIN IMMUNOL, V21, P531, DOI 10.1016/j.coi.2009.08.004; Yawata M, 2002, IMMUNOGENETICS, V54, P543, DOI 10.1007/s00251-002-0497-x; Yoo YJ, 2007, BIOINFORMATICS, V23, P2399, DOI 10.1093/bioinformatics/btm371	66	69	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47491	10.1371/journal.pone.0047491	http://dx.doi.org/10.1371/journal.pone.0047491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139747	Green Published, gold			2022-12-25	WOS:000310741400024
J	Johnston, L; Miller, MW; Baums, IB				Johnston, Lyza; Miller, Margaret W.; Baums, Iliana B.			Assessment of Host-Associated Genetic Differentiation among Phenotypically Divergent Populations of a Coral-Eating Gastropod across the Caribbean	PLOS ONE			English	Article							2 SCLERACTINIAN HOSTS; CORALLIOPHILA-ABBREVIATA; CORALLIVOROUS GASTROPOD; SYMPATRIC SPECIATION; BIODIVERSITY HOTSPOTS; TROPICAL ATLANTIC; ACROPORA-PALMATA; REEF DEVELOPMENT; CONNECTIVITY; DIVERSITY	Host-associated adaptation is emerging as a potential driver of population differentiation and speciation for marine organisms with major implications for ecosystem structure and function. Coralliophila abbreviata are corallivorous gastropods that live and feed on most of the reef-building corals in the tropical western Atlantic and Caribbean. Populations of C. abbreviata associated with the threatened acroporid corals, Acropora palmata and A. cervicornis, display different behavioral, morphological, demographic, and life-history characteristics than those that inhabit other coral host taxa, indicating that host-specific selective forces may be acting on C. abbreviata. Here, we used newly developed polymorphic microsatellite loci and mitochondrial cytochrome b sequence data to assess the population genetic structure, connectivity, and demographic history of C. abbreviata populations from three coral host taxa (A. palmata, Montastraea spp., Mycetophyllia spp.) and six geographic locations across the Caribbean. Analysis of molecular variance provided some evidence of weak and possibly geographically variable host-associated differentiation but no evidence of differentiation among sampling locations or major oceanographic regions, suggesting high gene flow across the Caribbean. Phylogenetic network and Bayesian clustering analyses supported a hypothesis of a single panmictic population as individuals failed to cluster by host or sampling location. Demographic analyses consistently supported a scenario of population expansion during the Pleistocene, a time of major carbonate reef development in the region. Although further study is needed to fully elucidate the interactive effects of host-associated selection and high gene flow in this system, our results have implications for local and regional community interactions and impact of predation on declining coral populations.	[Johnston, Lyza] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Miller, Margaret W.] SE Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, Miami, FL USA; [Baums, Iliana B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Johnston, L (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	ljohnston@rsmas.miami.edu	Baums, Iliana Brigitta/G-6435-2010	Baums, Iliana Brigitta/0000-0001-6463-7308	NOAA Coral Reef Conservation Program via the Southeast Fisheries Science Center [NA07NMF4630096]; NSF [OCE 0550294]; Directorate For Geosciences [0825979] Funding Source: National Science Foundation	NOAA Coral Reef Conservation Program via the Southeast Fisheries Science Center; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was funded by the NOAA Coral Reef Conservation Program via the Southeast Fisheries Science Center and grants NA07NMF4630096 to LJ and NSF OCE 0550294 to IBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EVOLUTIONARY ECOLOGY; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise J.C., 2004, MOL MARKERS NATURAL; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2003, MAR BIOL, V142, P1093, DOI 10.1007/s00227-003-1053-4; Baums IB, 2003, MAR BIOL, V142, P1083, DOI 10.1007/s00227-003-1024-9; Benzie JAH, 1999, AM ZOOL, V39, P131; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Bruckner R.J., 1997, P627; Budd AF, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P295; Budd AF, 2001, J PALEONTOL, V75, P527, DOI 10.1666/0022-3360(2001)075<0527:TOAEEO>2.0.CO;2; Budd Ann F., 1996, P168; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Diaz-Ferguson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012675; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Faucci A, 2007, P ROY SOC B-BIOL SCI, V274, P111, DOI 10.1098/rspb.2006.3685; Fu YX, 1997, GENETICS, V147, P915; Gagnaire PA, 2012, GENETICS, V190, P725, DOI 10.1534/genetics.111.134825; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gittenberger A, 2011, ORG DIVERS EVOL, V11, P21, DOI 10.1007/s13127-011-0039-1; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Glynn P.W., 1990, P365; Glynn PW, 2004, ECOSYSTEMS, V7, P358, DOI 10.1007/s10021-004-0184-x; Grober-Dunsmore R, 2006, MAR ECOL PROG SER, V321, P123, DOI 10.3354/meps321123; Haney RA, 2007, HEREDITY, V98, P294, DOI 10.1038/sj.hdy.6800940; Hart MW, 2010, INTEGR COMP BIOL, V50, P643, DOI 10.1093/icb/icq068; HAYES JA, 1990, J EXP MAR BIOL ECOL, V142, P25, DOI 10.1016/0022-0981(90)90135-Y; HEDRICK PW, 1976, ANNU REV ECOL SYST, V7, P1, DOI 10.1146/annurev.es.07.110176.000245; Hollander J, 2008, EVOLUTION, V62, P1381, DOI 10.1111/j.1558-5646.2008.00365.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Johnson KG, 2008, SCIENCE, V319, P1521, DOI 10.1126/science.1152197; Johnson KG, 2007, PALEOBIOLOGY, V33, P24, DOI 10.1666/06022.1; JOHNSON KG, 1995, PALEOBIOLOGY, V21, P52, DOI 10.1017/S0094837300013075; Johnston L, 2007, MAR BIOL, V150, P1215, DOI 10.1007/s00227-006-0422-1; Kawecki TJ, 1997, EVOLUTION, V51, P1751, DOI 10.1111/j.1558-5646.1997.tb05099.x; KIMURA M, 1969, GENETICS, V61, P763; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Knowlton N, 1990, SMITHSON CONTR MAR S, V31, P1, DOI DOI 10.5479/SI.01960768.31.1; Kool JT, 2010, ECOGRAPHY, V33, P597, DOI 10.1111/j.1600-0587.2009.06012.x; Krug PJ, 2011, AM MALACOL BULL, V29, P169, DOI 10.4003/006.029.0210; Marko PB, 2002, MOL BIOL EVOL, V19, P2005, DOI 10.1093/oxfordjournals.molbev.a004024; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; MCMILLAN WO, 1995, P ROY SOC B-BIOL SCI, V260, P229, DOI 10.1098/rspb.1995.0085; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; MILLER AC, 1981, B MAR SCI, V31, P932; MITTON JB, 1989, BIOL BULL-US, V177, P356, DOI 10.2307/1541595; Mokady O, 2001, MOL BIOL EVOL, V18, P975, DOI 10.1093/oxfordjournals.molbev.a003898; Munday PL, 2004, CURR BIOL, V14, P1498, DOI 10.1016/j.cub.2004.08.029; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Oliverio M, 2001, J MOLLUS STUD, V67, P243, DOI 10.1093/mollus/67.2.243; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Pigliucci M, 2003, EVOLUTION, V57, P1455; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ravago-Gotanco RG, 2010, MOL ECOL, V19, P4520, DOI 10.1111/j.1365-294X.2010.04803.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha LA, 2007, CORAL REEFS, V26, P501, DOI 10.1007/s00338-007-0261-7; Rocha LA, 2005, MOL ECOL, V14, P3921, DOI 10.1111/j.1365-294X.2005.02698.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohfritsch A, 2005, HEREDITY, V95, P315, DOI 10.1038/sj.hdy.6800727; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schneider S, 1999, GENETICS, V152, P1079; Shulzitski K, 2009, FISH B-NOAA, V107, P501; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Sotka EE, 2005, ECOL LETT, V8, P448, DOI 10.1111/j.1461-0248.2004.00719.x; STEVENS PM, 1990, J EXP MAR BIOL ECOL, V141, P195, DOI 10.1016/0022-0981(90)90224-Z; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; TAJIMA F, 1989, GENETICS, V123, P597; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Tsang LM, 2009, MOL ECOL, V18, P1463, DOI 10.1111/j.1365-294X.2009.04090.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; vansTienderen PHV, 1991, EVOLUTION, V45, P1317, DOI DOI 10.2307/2409882; VERMEIJ GJ, 1993, AM MALACOL BULL, V10, P181; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Williams DE, 2012, CORAL REEFS, V31, P369, DOI 10.1007/s00338-011-0847-y	94	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47630	10.1371/journal.pone.0047630	http://dx.doi.org/10.1371/journal.pone.0047630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133600	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400012
J	Tang, DJ; Lam, YM; Siu, YL; Lam, CH; Chu, SL; Peiris, JSM; Buchy, P; Nal, B; Bruzzone, R				Tang, Dong-Jiang; Lam, Yuen-Man; Siu, Yu-Lam; Lam, Chi-Hong; Chu, Shui-Ling; Peiris, J. S. Malik; Buchy, Philippe; Nal, Beatrice; Bruzzone, Roberto			A Single Residue Substitution in the Receptor-Binding Domain of H5N1 Hemagglutinin Is Critical for Packaging into Pseudotyped Lentiviral Particles	PLOS ONE			English	Article							INFLUENZA-VIRUS; PATHOGENICITY; NEURAMINIDASE; INFECTION; MEMBRANES; PROTEINS; CLEAVAGE	Background: Serological studies for influenza infection and vaccine response often involve microneutralization and hemagglutination inhibition assays to evaluate neutralizing antibodies against human and avian influenza viruses, including H5N1. We have previously characterized lentiviral particles pseudotyped with H5-HA (H5pp) and validated an H5pp-based assay as a safe alternative for high-throughput serological studies in BSL-2 facilities. Here we show that H5-HAs from different clades do not always give rise to efficient production of H5pp and the underlying mechanisms are addressed. Methodology/Findings: We have carried out mutational analysis to delineate the molecular determinants responsible for efficient packaging of HA from A/Cambodia/40808/2005 (H5Cam) and A/Anhui/1/2005 (H5Anh) into H5pp. Our results demonstrate that a single A134V mutation in the 130-loop of the receptor binding domain is sufficient to render H5Anh the ability to generate H5Anh-pp efficiently, whereas the reverse V134A mutation greatly hampers production of H5Cam-pp. Although protein expression in total cell lysates is similar for H5Anh and H5Cam, cell surface expression of H5Cam is detected at a significantly higher level than that of H5Anh. We further demonstrate by several independent lines of evidence that the behaviour of H5Anh can be explained by a stronger binding to sialic acid receptors implicating residue 134. Conclusions: We have identified a single A134V mutation as the molecular determinant in H5-HA for efficient incorporation into H5pp envelope and delineated the underlying mechanism. The reduced binding to sialic acid receptors as a result of the A134V mutation not only exerts a critical influence in pseudotyping efficiency of H5-HA, but has also an impact at the whole virus level. Because A134V substitution has been reported as a naturally occurring mutation in human host, our results may have implications for the understanding of human host adaptation of avian influenza H5N1 viruses.	[Tang, Dong-Jiang; Lam, Yuen-Man; Siu, Yu-Lam; Lam, Chi-Hong; Chu, Shui-Ling; Peiris, J. S. Malik; Nal, Beatrice; Bruzzone, Roberto] Univ Hong Kong, HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Nal, Beatrice] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Buchy, Philippe] Inst Pasteur Cambodia, Virol Unit, Phnom Penh, Cambodia; [Bruzzone, Roberto] Inst Pasteur, Dept Cell Biol & Infect, Paris, France	University of Hong Kong; University of Hong Kong; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tang, DJ (corresponding author), Guangzhou Med Univ, Sch Basic Sci, Guangzhou, Guangdong, Peoples R China.	tangd@hkucc.hku.hk	NAL, Beatrice/GYU-8888-2022; Bruzzone, Roberto/C-4719-2009; Bruzzone, Roberto/G-9355-2017; Peiris, Joseph Sriyal Malik/C-4380-2009	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; BUCHY, Philippe/0000-0003-1372-3008; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Nal, Beatrice/0000-0003-3452-7524	Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID) [08070972]; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region, China [AoE/M-12/-06]; French Ministry of Health; RESPARI project of the Institut Pasteur International Network	Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID); Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region, China; French Ministry of Health; RESPARI project of the Institut Pasteur International Network	This work was supported by grants from the Research Fund for the Control of Infectious Diseases of Hong Kong (RFCID#08070972), the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/-06 of the Hong Kong Special Administrative Region, China), the French Ministry of Health, and the RESPARI project of the Institut Pasteur International Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; Ao ZJ, 2008, ANTIVIR RES, V79, P12, DOI 10.1016/j.antiviral.2008.02.001; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Barman S, 2001, VIRUS RES, V77, P61, DOI 10.1016/S0168-1702(01)00266-0; Benaroch P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-29; Bosch V, 2001, J GEN VIROL, V82, P2485, DOI 10.1099/0022-1317-82-10-2485; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Garcia JM, 2011, EXPERT REV ANTI-INFE, V9, P443, DOI [10.1586/eri.11.25, 10.1586/ERI.11.25]; Garcia JM, 2010, J CLIN VIROL, V47, P29, DOI 10.1016/j.jcv.2009.10.009; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Houzet L, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-12; Imai H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001106; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McKay T, 2006, GENE THER, V13, P715, DOI 10.1038/sj.gt.3302715; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Szecsi J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-70; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Wang SY, 2009, J BIOMOL SCREEN, V14, P294, DOI 10.1177/1087057108330786; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	42	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e43596	10.1371/journal.pone.0043596	http://dx.doi.org/10.1371/journal.pone.0043596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133587	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400001
J	Zhao, H; Zhao, LQ; Sun, Y; Qian, Y; Liu, LY; Jia, LP; Zhang, Y; Dong, HJ				Zhao, Hui; Zhao, Linqing; Sun, Yu; Qian, Yuan; Liu, Liying; Jia, Liping; Zhang, You; Dong, Huijin			Detection of a Bocavirus Circular Genome in Fecal Specimens from Children with Acute Diarrhea in Beijing, China	PLOS ONE			English	Article							VIRUS; INFECTIONS; PARVOVIRUS; HAIRPIN; CLONING; SAMPLES	To determine if human bocavirus 2 (HBoV2) has a circular genome similar to the head-to-tail sequence of HBoV1 and the episomal form of HBoV3, 15 HBoV2 positive samples identified from 553 stool specimens from children with acute diarrhea were tested for a head-to-tail sequence using TaqMan-based real-time PCR. A circular genome with a head-to-tail sequence was identified in one (BJQ435) out of 15 samples tested by nested PCR. The complete circular genome of HBoV2-C1 (BJQ435) was 5307 nt in length and was flanked with a 520 nt-long terminal non-coding region (NCR). The secondary structure of HBoV2 -C1 had some differences compared to HBoV3-E1 (JN086998). Our study indicates that the HBoV genome exists in the form of a head-to-tail monomer and provides more information for understanding the HBoV replication mechanism.	[Zhao, Hui; Qian, Yuan] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhao, Hui; Zhao, Linqing; Sun, Yu; Qian, Yuan; Liu, Liying; Jia, Liping; Zhang, You; Dong, Huijin] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Institute of Pediatrics (CIP)	Qian, Y (corresponding author), Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China.	yqianbjc@263.net	li, jia/GVT-7587-2022; Jia, li/GPW-8015-2022		National Natural Science Foundation of China [30872153]; Beijing Natural Science Foundation [7112021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 30872153, http://159.226.244.22/portal/ProjectDblDetail.asp? flag = true&name = %C7%AE%D4%A8&orgcode = 10002003&organization = %CA%D7%B6%BC%B6%F9%BF%C6%D1%D0%BE%BF%CB%F9), and Beijing Natural Science Foundation (No. 7112021, http://www.bjnsf.org:8081/search/search_simp_p.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bohmer A, 2009, J VIROL METHODS, V158, P199, DOI 10.1016/j.jviromet.2009.02.010; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; COSTELLO E, 1995, J VIROL, V69, P7489, DOI 10.1128/JVI.69.12.7489-7496.1995; COTMORE SF, 1987, ADV VIRUS RES, V33, P91, DOI 10.1016/S0065-3527(08)60317-6; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Heydari H, 2011, J MED VIROL, V83, P1762, DOI 10.1002/jmv.22149; Huang QF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002899; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Jin Y, 2011, J CLIN VIROL, V52, P251, DOI 10.1016/j.jcv.2011.07.012; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Koseki N, 2012, J CLIN MICROBIOL, V50, P2118, DOI 10.1128/JCM.00098-12; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Schildgen O, 2012, FUTURE VIROL, V7, P31, DOI 10.2217/FVL.11.136; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Song JR, 2010, EMERG INFECT DIS, V16, P324, DOI 10.3201/eid1602.090553; Streiter M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-417; Yang CC, 1997, J VIROL, V71, P9231, DOI 10.1128/JVI.71.12.9231-9247.1997	22	35	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48980	10.1371/journal.pone.0048980	http://dx.doi.org/10.1371/journal.pone.0048980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133667	Green Submitted, Green Published, gold			2022-12-25	WOS:000310702400052
J	Prasad, A; Kuzontkoski, PM; Shrivastava, A; Zhu, WQ; Li, DY; Groopman, JE				Prasad, Anil; Kuzontkoski, Paula M.; Shrivastava, Ashutosh; Zhu, Weiquan; Li, Dean Y.; Groopman, Jerome E.			Slit2N/Robo1 Inhibit HIV-gp120-Induced Migration and Podosome Formation in Immature Dendritic Cells by Sequestering LSP1 and WASp	PLOS ONE			English	Article							SLIT; PROTEIN; CHEMOTAXIS; RECEPTORS; HIV; GUIDANCE; ANGIOGENESIS; REPELLENT; MIDLINE; ROBO	Cell-mediated transmission and dissemination of sexually-acquired human immunodeficiency virus 1 (HIV-1) in the host involves the migration of immature dendritic cells (iDCs). iDCs migrate in response to the HIV-1 envelope protein, gp120, and inhibiting such migration may limit the mucosal transmission of HIV-1. In this study, we elucidated the mechanism of HIV-1-gp120-induced transendothelial migration of iDCs. We found that gp120 enhanced the binding of Wiskott-Aldrich Syndrome protein (WASp) and the Actin-Related Protein 2/3 (Arp2/3) complex with beta-actin, an interaction essential for the proper formation of podosomes, specialized adhesion structures required for the migration of iDCs through different tissues. We further identified Leukocyte-Specific Protein 1 (LSP1) as a novel component of the WASp-Arp2/3-beta-actin complex. Pretreating iDCs with an active fragment of the secretory glycoprotein Slit2 (Slit2N) inhibited HIV-1-gp120-mediated migration and podosome formation, by inducing the cognate receptor Roundabout 1 (Robo1) to bind to and sequester WASp and LSP1 from beta-actin. Slit2N treatment also inhibited Src signaling and the activation of several downstream molecules, including Rac1, Pyk2, paxillin, and CDC42, a major regulator of podosome formation. Taken together, our results support a novel mechanism by which Slit2/Robo1 may inhibit the HIV-1-gp120-induced migration of iDCs, thereby restricting dissemination of HIV-1 from mucosal surfaces in the host.	[Prasad, Anil; Kuzontkoski, Paula M.; Shrivastava, Ashutosh; Groopman, Jerome E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA; [Zhu, Weiquan; Li, Dean Y.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Zhu, Weiquan; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Groopman, JE (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA.	jgroopma@bidmc.harvard.edu	SHRIVASTAVA, ASHUTOSH/ABH-5605-2020		National Institutes of Health (National Institute on Drug Abuse) [5DP1DA026197]; NHLBI; Department of Defense; Juvenile Diabetes Foundation; Rocky Mountain Center of Excellence for Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026197] Funding Source: NIH RePORTER	National Institutes of Health (National Institute on Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Defense(United States Department of Defense); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Rocky Mountain Center of Excellence for Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (National Institute on Drug Abuse) Grant 5DP1DA026197. DYL and WZ were supported by grants from NHLBI, Department of Defense, Juvenile Diabetes Foundation, and the Rocky Mountain Center of Excellence for Biodefense and Emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Chedotal A, 2007, ADV EXP MED BIOL, V621, P65, DOI 10.1007/978-0-387-76715-4_5; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Dovas A, 2011, CELL SIGNAL, V23, P1225, DOI 10.1016/j.cellsig.2011.02.004; Guan HB, 2003, J IMMUNOL, V171, P6519, DOI 10.4049/jimmunol.171.12.6519; Hannigan M, 2001, J LEUKOCYTE BIOL, V69, P497; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Hohenester E, 2008, BIOCHEM SOC T, V36, P251, DOI 10.1042/BST0360251; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lekkerkerker AN, 2006, CURR HIV RES, V4, P169, DOI 10.2174/157016206776055020; LI Y, 1995, J IMMUNOL, V155, P3563; Lin CL, 2000, J EXP MED, V192, P587, DOI 10.1084/jem.192.4.587; Linder S, 2000, J CELL SCI, V113, P4165; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Liu D, 2006, CIRC RES, V98, P480, DOI 10.1161/01.RES.0000205764.85931.4b; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; Monypenny J, 2011, EUR J CELL BIOL, V90, P198, DOI 10.1016/j.ejcb.2010.05.009; Ning YY, 2011, TOXICOLOGY, V283, P32, DOI 10.1016/j.tox.2011.01.026; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Piguet V, 2002, J INVEST DERMATOL, V119, P365, DOI 10.1046/j.1523-1747.2002.01840.x; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Tole S, 2009, J LEUKOCYTE BIOL, V86, P1403, DOI 10.1189/jlb.0609391; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; Ye BQ, 2010, J IMMUNOL, V185, P6294, DOI 10.4049/jimmunol.1001648; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zhang XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002461	51	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48854	10.1371/journal.pone.0048854	http://dx.doi.org/10.1371/journal.pone.0048854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119100	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500207
J	Doshi, BS; Gangadharan, B; Doering, CB; Meeks, SL				Doshi, Bhavya S.; Gangadharan, Bagirath; Doering, Christopher B.; Meeks, Shannon L.			Potentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition	PLOS ONE			English	Article							RECOMBINANT FACTOR-VIII; PREVIOUSLY UNTREATED PATIENTS; DESTROY FACTOR-VIII; DOMAIN ANTIBODIES; COMPLEX; EFFICACY; SAFETY; INACTIVATION; EPITOPE; MODE	Development of inhibitory antibodies to coagulation factor VIII (fVIII) is the primary obstacle to the treatment of hemophilia A in the developed world. This adverse reaction occurs in 20-30% of persons with severe hemophilia A treated with fVIII-replacement products and is characterized by the development of a humoral and neutralizing immune response to fVIII. Patients with inhibitory anti-fVIII antibodies are treated with bypassing agents including recombinant factor VIIa (rfVIIa). However, some patients display poor hemostatic response to bypass therapy and improved treatment options are needed. Recently, we demonstrated that fVIII inhibitors display widely variable kinetics of inhibition that correlate with their respective target epitopes. Thus, it was hypothesized that for antibodies that display slow rates of inhibition, supplementation of rfVIIa with fVIII would result in improved thrombin generation and be predictive of clinical responses to this novel treatment regimen. In order to test this hypothesis, 10 murine monoclonal antibodies (MAbs) with non-overlapping epitopes spanning fVIII, differential inhibition titers, and inhibition kinetics were studied using a thrombin generation assay. Of the 3 MAbs with high inhibitory titers, only the one with fast and complete (classically defined as "type I") kinetics displayed significant inhibition of thrombin generation with no improvement upon supplementation of rfVIIa with fVIII. The other two MAbs that displayed incomplete (classically defined as "type II") inhibition did not suppress the potentiation of thrombin generation by fVIII. All antibodies that did not completely inhibit fVIII activity demonstrated potentiation of thrombin generation by the addition of fVIII as compared to rfVIIa alone. In conclusion, fVIII alone or in combination with rfVIIa corrects the thrombin generation defect produced by the majority of anti-fVIII MAbs better than single agent rfVIIa. Therefore, combined fVIII/rfVIIa therapy may provide better hemostatic control than current therapy in some patients with anti-fVIII inhibitors.	[Gangadharan, Bagirath; Doering, Christopher B.; Meeks, Shannon L.] Childrens Healthcare Atlanta, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Gangadharan, Bagirath; Doering, Christopher B.; Meeks, Shannon L.] Childrens Healthcare Atlanta, Blood Disorders Serv, Atlanta, GA 30322 USA; [Doshi, Bhavya S.] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Children's Healthcare of Atlanta (CHOA); Children's Healthcare of Atlanta (CHOA); Emory University	Meeks, SL (corresponding author), Childrens Healthcare Atlanta, Aflac Canc Ctr, Atlanta, GA 30322 USA.	shannon.meeks@choa.org	Doshi, Bhavya/AAT-5816-2020; Doering, Christopher/W-2064-2019	Doshi, Bhavya/0000-0001-7578-4231; Meeks, Shannon/0000-0002-3683-8644	National Institutes of Health [K08HL102262, 5R01HL092179, U54HL112309]; Hemophilia of Georgia, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092179, U54HL112309, K08HL102262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hemophilia of Georgia, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was funded by National Institutes of Health grants K08HL102262 (SLM), 5R01HL092179 (CBD), U54HL112309 (SLM, CBD) and Hemophilia of Georgia, Inc. (SLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astermark J, 2003, SEMIN THROMB HEMOST, V29, P77, DOI 10.1055/s-2003-37972; Barrow RT, 2006, J THROMB HAEMOST, V4, P2223, DOI 10.1111/j.1538-7836.2006.02135.x; BIGGS R, 1972, BRIT J HAEMATOL, V23, P125, DOI 10.1111/j.1365-2141.1972.tb03467.x; BIGGS R, 1972, BRIT J HAEMATOL, V23, P137, DOI 10.1111/j.1365-2141.1972.tb03468.x; BRAY GL, 1994, BLOOD, V83, P2428; Brummel-Ziedins KE, 2009, HAEMOPHILIA, V15, P1118, DOI 10.1111/j.1365-2516.2009.01994.x; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; GAWRYL MS, 1982, BLOOD, V60, P1103; Hay CRM, 2006, BRIT J HAEMATOL, V133, P591, DOI 10.1111/j.1365-2141.2006.06087.x; Healey JF, 2007, J THROMB HAEMOST, V5, P512, DOI 10.1111/j.1538-7836.2007.02373.x; HEALEY JF, 1995, J BIOL CHEM, V270, P14505, DOI 10.1074/jbc.270.24.14505; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P869; Klintman J, 2010, BRIT J HAEMATOL, V151, P381, DOI 10.1111/j.1365-2141.2010.08378.x; Kreuz W, 2002, SEMIN THROMB HEMOST, V28, P285, DOI 10.1055/s-2002-32664; Lollar P, 1997, THROMB HAEMOSTASIS, V78, P647; LOSSING TS, 1977, BLOOD, V49, P793; Lusher JM, 2003, HAEMOPHILIA, V9, P38, DOI 10.1046/j.1365-2516.2003.00708.x; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; Meeks SL, 2009, J THROMB HAEMOST, V7, P658, DOI 10.1111/j.1538-7836.2009.03299.x; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Millet A, 2011, BRIT J HAEMATOL, V153, P136, DOI 10.1111/j.1365-2141.2010.08517.x; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; SCANDELLA D, 1992, THROMB HAEMOSTASIS, V67, P665; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Turecek PL, 2003, PATHOPHYSIOL HAEMO T, V33, P16, DOI 10.1159/000071637; Varadi K, 2004, HAEMOPHILIA, V10, P17, DOI 10.1111/j.1365-2516.2004.00936.x	27	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48172	10.1371/journal.pone.0048172	http://dx.doi.org/10.1371/journal.pone.0048172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144741	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300051
J	Pitts, AC; Tuck, LR; Faulds-Pain, A; Lewis, RJ; Marles-Wright, J				Pitts, Alison C.; Tuck, Laura R.; Faulds-Pain, Alexandra; Lewis, Richard J.; Marles-Wright, Jon			Structural Insight into the Clostridium difficile Ethanolamine Utilisation Microcompartment	PLOS ONE			English	Article							SALMONELLA-ENTERICA; ESCHERICHIA-COLI; BACTERIAL MICROCOMPARTMENTS; PROTEIN SHELL; CARBOXYSOME; ENZYME; TYPHIMURIUM; ORGANELLES; SEQUENCE; GENE	Bacterial microcompartments form a protective proteinaceous barrier around metabolic enzymes that process unstable or toxic chemical intermediates. The genome of the virulent, multidrug-resistant Clostridium difficile 630 strain contains an operon, eut, encoding a bacterial microcompartment with genes for the breakdown of ethanolamine and its utilisation as a source of reduced nitrogen and carbon. The C. difficile eut operon displays regulatory genetic elements and protein encoding regions in common with homologous loci found in the genomes of other bacteria, including the enteric pathogens Salmonella enterica and Enterococcus faecalis. The crystal structures of two microcompartment shell proteins, CD1908 and CD1918, and an uncharacterised protein with potential enzymatic activity, CD1925, were determined by X-ray crystallography. CD1908 and CD1918 display the same protein fold, though the order of secondary structure elements is permuted in CD1908 and this protein displays an N-terminal beta-strand extension. These proteins form hexamers with molecules related by crystallographic and non-crystallographic symmetry. The structure of CD1925 has a cupin beta-barrel fold and a putative active site that is distinct from the metal-ion dependent catalytic cupins. Thin-section transmission electron microscopy of Escherichia coli over-expressing eut proteins indicates that CD1918 is capable of self-association into arrays, suggesting an organisational role for CD1918 in the formation of this microcompartment. The work presented provides the basis for further study of the architecture and function of the C. difficile eut microcompartment, its role in metabolism and the wider consequences of intestinal colonisation and virulence in this pathogen.	[Pitts, Alison C.; Tuck, Laura R.; Lewis, Richard J.; Marles-Wright, Jon] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Faulds-Pain, Alexandra] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Marles-Wright, Jon] Univ Edinburgh, Inst Struct & Mol Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Newcastle University - UK; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh	Marles-Wright, J (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jon.marles-wright@ed.ac.uk		lewis, richard/0000-0003-2641-8643; Marles-Wright, Jon/0000-0002-9156-3284; Tuck, Laura/0000-0001-8708-2480	University Vacation Studentship by Newcastle University; Faculty Development Fellowship by Newcastle University	University Vacation Studentship by Newcastle University; Faculty Development Fellowship by Newcastle University	This research was supported by a University Vacation Studentship awarded by Newcastle University (ACP) and by a Faculty Development Fellowship awarded by Newcastle University (JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; BRADBEER C, 1965, J BIOL CHEM, V240, P4675; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Brinsmade SR, 2004, J BACTERIOL, V186, P1890, DOI 10.1128/JB.186.6.1890-1892.2004; CHANG GW, 1975, NATURE, V254, P150, DOI 10.1038/254150a0; Chen HD, 2005, FEMS MICROBIOL REV, V29, P83, DOI 10.1016/j.femsre.2004.07.002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; Del Papa MF, 2008, J BACTERIOL, V190, P7147, DOI 10.1128/JB.00952-08; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dineen SS, 2010, J BACTERIOL, V192, P5350, DOI 10.1128/JB.00341-10; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Elliott B, 2007, INTERN MED J, V37, P561, DOI 10.1111/j.1445-5994.2007.01403.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Harvey PC, 2011, INFECT IMMUN, V79, P4105, DOI 10.1128/IAI.01390-10; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Jaroszewski L, 2004, PROTEINS, V56, P611, DOI 10.1002/prot.20130; Just VJ, 2007, BIOCHEM J, V407, P397, DOI 10.1042/BJ20070708; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAWAI K, 1974, BIOCHIM BIOPHYS ACTA, V369, P222; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Marles-Wright J, 2011, PROTEINS, V79, P2015, DOI 10.1002/prot.23028; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monot M, 2011, J MED MICROBIOL, V60, P1193, DOI 10.1099/jmm.0.030452-0; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; RANDLE CL, 1969, BIOCHIM BIOPHYS ACTA, V187, P214, DOI 10.1016/0005-2760(69)90030-7; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; ROOF DM, 1989, J BACTERIOL, V171, P3316, DOI 10.1128/jb.171.6.3316-3323.1989; ROOF DM, 1988, J BACTERIOL, V170, P3855, DOI 10.1128/jb.170.9.3855-3863.1988; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takenoya M, 2010, J BACTERIOL, V192, P6056, DOI 10.1128/JB.00652-10; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Tsoy O, 2009, J BACTERIOL, V191, P7157, DOI 10.1128/JB.00838-09; van Staalduinen LM, 2010, J MOL BIOL, V401, P866, DOI 10.1016/j.jmb.2010.06.063; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Yeates TO, 2007, BIOCHEM SOC T, V35, P508, DOI 10.1042/BST0350508; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	69	38	41	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48360	10.1371/journal.pone.0048360	http://dx.doi.org/10.1371/journal.pone.0048360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144756	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000310705300066
J	Tacutu, R; Shore, DE; Budovsky, A; de Magalhaes, JP; Ruvkun, G; Fraifeld, VE; Curran, SP				Tacutu, Robi; Shore, David E.; Budovsky, Arie; de Magalhaes, Joao Pedro; Ruvkun, Gary; Fraifeld, Vadim E.; Curran, Sean P.			Prediction of C. elegans Longevity Genes by Human and Worm Longevity Networks	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EXTENDS LIFE-SPAN; DIETARY RESTRICTION; MESSENGER-RNA; STRESS; INHIBITION; RESISTANCE; MUTATIONS; RESPONSES; GENOMES	Intricate and interconnected pathways modulate longevity, but screens to identify the components of these pathways have not been saturating. Because biological processes are often executed by protein complexes and fine-tuned by regulatory factors, the first-order protein-protein interactors of known longevity genes are likely to participate in the regulation of longevity. Data-rich maps of protein interactions have been established for many cardinal organisms such as yeast, worms, and humans. We propose that these interaction maps could be mined for the identification of new putative regulators of longevity. For this purpose, we have constructed longevity networks in both humans and worms. We reasoned that the essential first-order interactors of known longevity-associated genes in these networks are more likely to have longevity phenotypes than randomly chosen genes. We have used C. elegans to determine whether post-developmental inactivation of these essential genes modulates lifespan. Our results suggest that the worm and human longevity networks are functionally relevant and possess a high predictive power for identifying new longevity regulators.	[Tacutu, Robi; Budovsky, Arie; Fraifeld, Vadim E.] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, Ctr Multidisciplinary Res Aging, IL-84105 Beer Sheva, Israel; [Shore, David E.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Shore, David E.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [de Magalhaes, Joao Pedro] Univ Liverpool, Inst Integrat Biol, Integrat Genom Ageing Grp, Liverpool L69 3BX, Merseyside, England; [Curran, Sean P.] Univ So Calif, Div Biogerontol, Davis Sch Gerontol, Los Angeles, CA USA; [Curran, Sean P.] Univ So Calif, Dept Mol & Computat Biol, Dornsife Coll Letters Arts & Sci, Los Angeles, CA USA; [Curran, Sean P.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	Ben Gurion University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Liverpool; University of Southern California; University of Southern California; University of Southern California	Fraifeld, VE (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, Ctr Multidisciplinary Res Aging, IL-84105 Beer Sheva, Israel.	vadim.fraifeld@gmail.com; spcurran@usc.edu	de Magalhaes, Joao Pedro/B-4741-2010; Tacutu, Robi/J-3146-2012	de Magalhaes, Joao Pedro/0000-0002-6363-2465; Tacutu, Robi/0000-0001-5853-2470	NIH [AG032308, AG16636]; Wellcome Trust [ME050495MES]; Marie Curie International Reintegration Grant within EC-FP7; European Commission [HEALTH-F4-2008-202047]; NATIONAL INSTITUTE ON AGING [K99AG032308, R00AG032308, R01AG016636] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie International Reintegration Grant within EC-FP7; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research in this study was supported by NIH AG032308 to SPC and AG16636 (NIA NIH HHS/United State) to GR. JPM is grateful for support from the Wellcome Trust (ME050495MES) and from a Marie Curie International Reintegration Grant within EC-FP7. VM was partly funded by the European Commission FP7 Health Research Grant number HEALTH-F4-2008-202047. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Budovsky A, 2007, MECH AGEING DEV, V128, P117, DOI 10.1016/j.mad.2006.11.018; Budovsky A, 2009, MECH AGEING DEV, V130, P33, DOI 10.1016/j.mad.2008.04.002; Chautard E, 2010, BIOGERONTOLOGY, V11, P463, DOI 10.1007/s10522-010-9268-5; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; de Magalhaes JP, 2005, PHYSIOLOGY, V20, P252, DOI 10.1152/physiol.00010.2005; de Magalhaes JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/j.febslet.2004.07.006; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fassio CA, 2010, GENETICS, V185, P199, DOI 10.1534/genetics.110.115584; FROLKIS VV, 1991, FIZIOL ZH SSSR, V37, P3; FROLKIS VV, 1991, MECH AGEING DEV, V60, P55, DOI 10.1016/0047-6374(91)90109-D; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2007, WESTERN HUM REV, V61, P6; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee SS, 2006, EXP GERONTOL, V41, P968, DOI 10.1016/j.exger.2006.06.048; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lui JC, 2010, MECH AGEING DEV, V131, P641, DOI 10.1016/j.mad.2010.08.010; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Rohl C, 2006, MOL BIOTECHNOL, V34, P69, DOI 10.1385/MB:34:1:69; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Tacutu R, 2011, AGING-US, V3, P1178, DOI 10.18632/aging.100413; Tacutu R, 2010, BIOGERONTOLOGY, V11, P513, DOI 10.1007/s10522-010-9265-8; Tacutu R, 2010, REJUV RES, V13, P373, DOI 10.1089/rej.2009.0980; Takasugi M, 2011, MECH AGEING DEV, V132, P65, DOI 10.1016/j.mad.2010.12.003; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954	51	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48282	10.1371/journal.pone.0048282	http://dx.doi.org/10.1371/journal.pone.0048282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144747	Green Published, gold			2022-12-25	WOS:000310705300057
J	Berthelot, K; Lecomte, S; Estevez, Y; Coulary-Salin, B; Bentaleb, A; Cullin, C; Deffieux, A; Peruch, F				Berthelot, Karine; Lecomte, Sophie; Estevez, Yannick; Coulary-Salin, Benedicte; Bentaleb, Ahmed; Cullin, Christophe; Deffieux, Alain; Peruch, Frederic			Rubber Elongation Factor (REF), a Major Allergen Component in Hevea brasiliensis Latex Has Amyloid Properties	PLOS ONE			English	Article							SPINA-BIFIDA; B 3; TRANSCRIPTOME ANALYSIS; PARTHENIUM-ARGENTATUM; MOLECULAR-CLONING; PARTICLE PROTEIN; FACTOR GENE; BIOSYNTHESIS; AGGREGATION; SEQUENCE	REF (Hevb1) and SRPP (Hevb3) are two major components of Hevea brasiliensis latex, well known for their allergenic properties. They are obviously taking part in the biosynthesis of natural rubber, but their exact function is still unclear. They could be involved in defense/stress mechanisms after tapping or directly acting on the isoprenoid biosynthetic pathway. The structure of these two proteins is still not described. In this work, it was discovered that REF has amyloid properties, contrary to SRPP. We investigated their structure by CD, TEM, ATR-FTIR and WAXS and neatly showed the presence of beta-sheet organized aggregates for REF, whereas SRPP mainly fold as a helical protein. Both proteins are highly hydrophobic but differ in their interaction with lipid monolayers used to mimic the monomembrane surrounding the rubber particles. Ellipsometry experiments showed that REF seems to penetrate deeply into the monolayer and SRPP only binds to the lipid surface. These results could therefore clarify the role of these two paralogous proteins in latex production, either in the coagulation of natural rubber or in stress-related responses. To our knowledge, this is the first report of an amyloid formed from a plant protein. This suggests also the presence of functional amyloid in the plant kingdom.	[Berthelot, Karine; Estevez, Yannick; Deffieux, Alain; Peruch, Frederic] CNRS, LCPO, UMR 5629, Pessac, France; [Lecomte, Sophie] CNRS, CBMN, UMR 5248, Pessac, France; [Coulary-Salin, Benedicte; Cullin, Christophe] Univ Bordeaux 2, CNRS, IBGC, UMR 5095, F-33076 Bordeaux, France; [Bentaleb, Ahmed] CNRS, CRPP, UPR 8641, Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Berthelot, K (corresponding author), CNRS, LCPO, UMR 5629, Pessac, France.	kberthelot@enscbp.fr; peruch@enscbp.fr	cullin, christophe/AAM-2179-2020; BERTHELOT, Karine V.J./A-5546-2011; PERUCH, Frederic/E-1765-2015	cullin, christophe/0000-0003-4110-4677; BERTHELOT, Karine V.J./0000-0003-0809-4921; PERUCH, Frederic/0000-0003-1891-5877	ANR Polyterp (French Research Ministry); "Agence Nationale pour la Recherche" (ANR Polyterp) [ANR-10-CD2I-08]	ANR Polyterp (French Research Ministry)(French National Research Agency (ANR)); "Agence Nationale pour la Recherche" (ANR Polyterp)(French National Research Agency (ANR))	This work was funded by ANR Polyterp (French Research Ministry). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KB and YE acknowledge the "Agence Nationale pour la Recherche" for their Post-Doctoral Researcher Fellowship (ANR Polyterp; ANR-10-CD2I-08). We are grateful to Michelin (Clermont-Ferrand, France) for providing latex samples from Brazil. We thank Pr Ioan Lascu (IBGC) for help with CD and many valuable discussions.	AKASAWA A, 1995, J ALLERGY CLIN IMMUN, V95, P1196, DOI 10.1016/S0091-6749(95)70076-5; Alenius H, 1996, INT ARCH ALLERGY IMM, V109, P362, DOI 10.1159/000237264; ARCHER BL, 1963, BIOCHEM J, V89, P565, DOI 10.1042/bj0890565; ATTANYAKA DPSTG, 1991, PLANT MOL BIOL, V16, P1079, DOI 10.1007/BF00016080; AUDLEY BG, 1966, BIOCHEM J, V98, P335, DOI 10.1042/bj0980335; Banerjee B, 2000, MOL IMMUNOL, V37, P789, DOI 10.1016/S0161-5890(00)00095-X; Berthelot K, 2012, BIOCHIMIE, V94, P1621, DOI 10.1016/j.biochi.2012.03.021; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chow KS, 2007, J EXP BOT, V58, P2429, DOI 10.1093/jxb/erm093; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Chrestin H, 1989, PHYSL RUBBER TREE LA, P59; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Couthouis J, 2010, PRION, V4, P283, DOI 10.4161/pri.4.4.13126; CZUPPON AB, 1993, J ALLERGY CLIN IMMUN, V92, P690, DOI 10.1016/0091-6749(93)90012-5; d'Auzac J., 1989, PHYSL RUBBER TREE LA; DENNIS MS, 1989, J BIOL CHEM, V264, P18618; DENNIS MS, 1989, J BIOL CHEM, V264, P18608; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; GOMEZ JB, 1975, J ULTRA MOL STRUCT R, V52, P76, DOI 10.1016/S0022-5320(75)80023-2; Goormaghtigh E, 1994, Subcell Biochem, V23, P363; GOYVAERTS E, 1991, PLANT PHYSIOL, V97, P317, DOI 10.1104/pp.97.1.317; Ta HP, 2011, LANGMUIR, V27, P4797, DOI 10.1021/la103788r; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Han KH, 2000, TREE PHYSIOL, V20, P503; HASMA H, 1986, Journal of Natural Rubber Research, V1, P30; Hasma H., 1991, Journal of Natural Rubber Research, V6, P105; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; JACOB JL, 1993, CLIN REV ALLERG, V11, P325; Kim IJ, 2004, J EXP BOT, V55, P377, DOI 10.1093/jxb/erh039; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Ko JH, 2003, PLANT MOL BIOL, V53, P479, DOI 10.1023/B:PLAN.0000019119.66643.5d; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liengprayoon S, 2011, PHYTOCHEMISTRY, V72, P1902, DOI 10.1016/j.phytochem.2011.04.023; LU LJ, 1995, J IMMUNOL, V155, P2721; Morris VK, 2011, J BIOL CHEM, V286, P15955, DOI 10.1074/jbc.M110.214197; Oh SK, 1999, J BIOL CHEM, V274, P17132, DOI 10.1074/jbc.274.24.17132; Ohya N., 2000, Journal of Rubber Research, V3, P214; Priya P, 2007, PLANT CELL REP, V26, P1833, DOI 10.1007/s00299-007-0402-z; Priya P, 2006, PLANT SCI, V171, P470, DOI 10.1016/j.plantsci.2006.05.009; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Sando T, 2009, PLANTA, V230, P215, DOI 10.1007/s00425-009-0936-0; Scheiner O, 1999, INT ARCH ALLERGY IMM, V118, P311, DOI 10.1159/000024113; Seo SG, 2010, GENES GENOM, V32, P544, DOI 10.1007/s13258-010-0093-7; Shamsul Bahri A., 1996, J RUBBER RES, V11, P88; Siler DJ, 1997, PLANT PHYSIOL BIOCH, V35, P881; Singh AP, 2003, J EXP BOT, V54, P985, DOI 10.1093/jxb/erg107; SLATER JE, 1992, J ALLERGY CLIN IMMUN, V89, P673, DOI 10.1016/0091-6749(92)90373-A; Sookmark U, 2002, PLANT CELL PHYSIOL, V43, P1323, DOI 10.1093/pcp/pcf161; Sunderasan E., 1994, Journal of Natural Rubber Research, V9, P127; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian WM, 2003, ACTA BOT SIN, V45, P127; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Wagner B, 1999, J ALLERGY CLIN IMMUN, V104, P1084, DOI 10.1016/S0091-6749(99)70093-X; Wititsuwannakul R, 2008, PHYTOCHEMISTRY, V69, P1111, DOI 10.1016/j.phytochem.2007.12.007; Wood DF, 2000, INT J PLANT SCI, V161, P435, DOI 10.1086/314269; Yeang HY, 1996, J ALLERGY CLIN IMMUN, V98, P628, DOI 10.1016/S0091-6749(96)70097-0; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	65	58	67	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48065	10.1371/journal.pone.0048065	http://dx.doi.org/10.1371/journal.pone.0048065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133547	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800037
J	Lin, T; Gao, LH; Zhang, CH; Odeh, E; Jacobs, MB; Coutte, L; Chaconas, G; Philipp, MT; Norris, SJ				Lin, Tao; Gao, Lihui; Zhang, Chuhua; Odeh, Evelyn; Jacobs, Mary B.; Coutte, Loic; Chaconas, George; Philipp, Mario T.; Norris, Steven J.			Analysis of an Ordered, Comprehensive STM Mutant Library in Infectious Borrelia burgdorferi: Insights into the Genes Required for Mouse Infectivity	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; SIGNATURE-TAGGED MUTAGENESIS; OUTER SURFACE-PROTEINS; LINEAR PLASMIDS 1P25; TRANSPOSON MUTAGENESIS; ANTIGENIC VARIATION; BINDING PROTEIN; MAMMALIAN HOST; LUXS GENE; IDENTIFICATION	The identification of genes important in the pathogenesis of Lyme disease Borrelia has been hampered by exceedingly low transformation rates in low-passage, infectious organisms. Using the infectious, moderately transformable B. burgdorferi derivative 5A18NP1 and signature-tagged versions of the Himar1 transposon vector pGKT, we have constructed a defined transposon library for the efficient genome-wide investigation of genes required for wild-type pathogenesis, in vitro growth, physiology, morphology, and plasmid replication. To facilitate analysis, the insertion sites of 4,479 transposon mutants were determined by sequencing. The transposon insertions were widely distributed across the entire B. burgdorferi genome, with an average of 2.68 unique insertion sites per kb DNA. The 10 linear plasmids and 9 circular plasmids had insertions in 33 to 100 percent of their predicted genes. In contrast, only 35% of genes in the 910 kb linear chromosome had incapacitating insertions; therefore, the remaining 601 chromosomal genes may represent essential gene candidates. In initial signature-tagged mutagenesis (STM) analyses, 434 mutants were examined at multiple tissue sites for infectivity in mice using a semi-quantitative, Luminex-based DNA detection method. Examples of genes found to be important in mouse infectivity included those involved in motility, chemotaxis, the phosphoenolpyruvate phosphotransferase system, and other transporters, as well as putative plasmid maintenance genes. Availability of this ordered STM library and a high-throughput screening method is expected to lead to efficient assessment of the roles of B. burgdorferi genes in the infectious cycle and pathogenesis of Lyme disease.	[Lin, Tao; Gao, Lihui; Zhang, Chuhua; Odeh, Evelyn; Coutte, Loic; Norris, Steven J.] Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Sch Med, Houston, TX USA; [Norris, Steven J.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Sch Med, Houston, TX USA; [Jacobs, Mary B.; Philipp, Mario T.] Tulane Univ, Hlth Sci Ctr, Dept Parasitol, Tulane Reg Primate Res Ctr, Covington, LA USA; [Chaconas, George] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Chaconas, George] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Tulane University; University of Calgary; University of Calgary	Lin, T (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Sch Med, Houston, TX USA.	Tao.Lin@uth.tmc.edu	Coutte, Loïc/G-4379-2012; Norris, Steven James/K-6586-2019; coutte, loic/B-2566-2019	Coutte, Loïc/0000-0002-8626-8109; Norris, Steven James/0000-0002-2501-8034; coutte, loic/0000-0002-8626-8109; Lin, Tao/0000-0001-7440-4954	National Institute of Allergy and Infectious Diseases [R01 AI59048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059048] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Number R01 AI59048 (to S.J.N. and T. L.) from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autret N, 2005, FEMS MICROBIOL REV, V29, P703, DOI 10.1016/j.femsre.2004.10.006; Babb K, 2005, J BACTERIOL, V187, P3079, DOI 10.1128/JB.187.9.3079-3087.2005; Bankhead T, 2007, MOL MICROBIOL, V65, P1547, DOI 10.1111/j.1365-2958.2007.05895.x; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barthold SW, 2006, INFECT IMMUN, V74, P4817, DOI 10.1128/IAI.00469-06; Beaurepaire C, 2005, MOL MICROBIOL, V57, P132, DOI 10.1111/j.1365-2958.2005.04688.x; Blevins JS, 2004, INFECT IMMUN, V72, P4864, DOI 10.1128/IAI.72.8.4864-4867.2004; Botkin D.J., 2006, MOL BIOL SPIROCHETES, P13; Botkin DJ, 2006, INFECT IMMUN, V74, P6690, DOI 10.1128/IAI.00993-06; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chaconas G, 2010, BORRELIA MOL BIOL HO, P55; Chaconas G, 2010, ANNU REV MICROBIOL, V64, P185, DOI 10.1146/annurev.micro.112408.134037; Deneke J, 2008, J BACTERIOL, V190, P3992, DOI 10.1128/JB.00057-08; Eggers CH, 2002, MOL MICROBIOL, V43, P281, DOI 10.1046/j.1365-2958.2002.02758.x; Escalante A, 2012, APPL MICROBIOL BIOT, V94, P1483, DOI 10.1007/s00253-012-4101-5; Feng SL, 2000, INFECT IMMUN, V68, P4169, DOI 10.1128/IAI.68.7.4169-4173.2000; Feng SL, 2003, INFECT IMMUN, V71, P7211, DOI 10.1128/IAI.71.12.7211-7214.2003; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; Grimm D, 2003, INFECT IMMUN, V71, P3138, DOI 10.1128/IAI.71.6.3138-3145.2003; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hagman KE, 2000, INFECT IMMUN, V68, P4759, DOI 10.1128/IAI.68.8.4759-4764.2000; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hubner A, 2003, INFECT IMMUN, V71, P2892, DOI 10.1128/IAI.71.5.2892-2896.2003; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Indest KJ, 2001, INFECT IMMUN, V69, P7083, DOI 10.1128/IAI.69.11.7083-7090.2001; Jewett MW, 2007, MOL MICROBIOL, V66, P975, DOI 10.1111/j.1365-2958.2007.05969.x; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; Jewett MW, 2011, MICROBIOL-SGM, V157, P2831, DOI 10.1099/mic.0.051706-0; Judson N, 2000, TRENDS MICROBIOL, V8, P521, DOI 10.1016/S0966-842X(00)01865-5; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lawrenz MB, 2002, INFECT IMMUN, V70, P4798, DOI 10.1128/IAI.70.9.4798-4804.2002; Lehoux DE, 1999, BIOTECHNIQUES, V26, P473, DOI 10.2144/99263st02; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Li X, 2006, INFECT IMMUN, V74, P3305, DOI 10.1128/IAI.02035-05; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; Liu J, 2012, P NATL ACAD IN PRESS; Miller JC, 2004, INT J MED MICROBIOL, V293, P120, DOI 10.1016/S1433-1128(04)80020-2; Motaleb MA, 2011, J BACTERIOL, V193, P3332, DOI 10.1128/JB.00362-11; Mulay V, 2007, J BACTERIOL, V189, P2063, DOI 10.1128/JB.01239-06; Mulay VB, 2009, J BACTERIOL, V191, P2783, DOI 10.1128/JB.01802-08; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Norris S. J., 2010, BORRELIA MOL BIOL HO, P299; NORRIS SJ, 1995, INFECT IMMUN, V63, P2206, DOI 10.1128/IAI.63.6.2206-2212.1995; Norris SJ, 2011, APPL ENVIRON MICROB, V77, P1483, DOI 10.1128/AEM.01877-10; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Revel AT, 2005, P NATL ACAD SCI USA, V102, P6972, DOI 10.1073/pnas.0502565102; Rhodes RG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-21; Rosa PA, 2005, NAT REV MICROBIOL, V3, P129, DOI 10.1038/nrmicro1086; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Samuels D S, 1995, Methods Mol Biol, V47, P253; Samuels D.S., 2010, BORRELIA MOL BIOL HO; Schwan TG, 2003, BIOCHEM SOC T, V31, P108, DOI 10.1042/BST0310108; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Skare JT, 1996, J BACTERIOL, V178, P4909, DOI 10.1128/jb.178.16.4909-4918.1996; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Stevenson B, 2003, MICROBES INFECT, V5, P991, DOI 10.1016/S1286-4579(03)00184-9; Stevenson B, 2002, INFECT IMMUN, V70, P4099, DOI 10.1128/IAI.70.8.4099-4105.2002; Stewart PE, 2001, MOL MICROBIOL, V39, P714, DOI 10.1046/j.1365-2958.2001.02256.x; Stewart PE, 2004, APPL ENVIRON MICROB, V70, P5973, DOI 10.1128/AEM.70.10.5973-5979.2004; Stewart PE, 2003, J BACTERIOL, V185, P3202, DOI 10.1128/JB.185.10.3202-3209.2003; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Stewart Philip E., 2008, V431, P85; Strother KO, 2005, VECTOR-BORNE ZOONOT, V5, P237, DOI 10.1089/vbz.2005.5.237; Sze CW, 2012, INFECT IMMUN, V80, P2485, DOI 10.1128/IAI.00145-12; Sze CW, 2012, INFECT IMMUN; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Tilly K, 2001, J BACTERIOL, V183, P5544, DOI 10.1128/JB.183.19.5544-5553.2001; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tilly K, 2012, PLASMID, V68, P1, DOI 10.1016/j.plasmid.2012.01.009; Tilly K, 2009, INFECT IMMUN, V77, P2672, DOI 10.1128/IAI.01193-08; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; von Lackum K, 2006, INT J MED MICROBIOL, V296, P92, DOI 10.1016/j.ijmm.2005.12.011; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhang L, 2012, PLOS PATHOG, V7, DOI DOI 10.1371/JOURNAL.PPAT.1002079	91	91	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47532	10.1371/journal.pone.0047532	http://dx.doi.org/10.1371/journal.pone.0047532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133514	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800007
J	Rye, MS; Warrington, NM; Scaman, ESH; Vijayasekaran, S; Coates, HL; Anderson, D; Pennell, CE; Blackwell, JM; Jamieson, SE				Rye, Marie S.; Warrington, Nicole M.; Scaman, Elizabeth S. H.; Vijayasekaran, Shyan; Coates, Harvey L.; Anderson, Denise; Pennell, Craig E.; Blackwell, Jenefer M.; Jamieson, Sarra E.			Genome-Wide Association Study to Identify the Genetic Determinants of Otitis Media Susceptibility in Childhood	PLOS ONE			English	Article							BETA PATHWAY; HERITABILITY; LINKAGE; SCAN; IDENTIFICATION; VISUALIZATION; ACTIVATION; PROTEINS; GENOTYPE; EFFUSION	Background: Otitis media (OM) is a common childhood disease characterised by middle ear inflammation and effusion. Susceptibility to recurrent acute OM (rAOM; >= 3 episodes of AOM in 6 months) and chronic OM with effusion (COME; MEE >= 3 months) is 40-70% heritable. Few underlying genes have been identified to date, and no genome-wide association study (GWAS) of OM has been reported. Methods and Findings: Data for 2,524,817 single nucleotide polymorphisms (SNPs; 535,544 quality-controlled SNPs genotyped by Illumina 660W-Quad; 1,989,273 by imputation) were analysed for association with OM in 416 cases and 1,075 controls from the Western Australian Pregnancy Cohort (Raine) Study. Logistic regression analyses under an additive model undertaken in GenABEL/ProbABEL adjusting for population substructure using principal components identified SNPs at CAPN14 (rs6755194: OR = 1.90; 95%CI 1.47-2.45;Padj-PCA = 8.3 x 10(-7)) on chromosome 2p23.1 as the top hit, with independent effects (rs1862981: OR = 1.60; 95%CI 1.29-1.99; Padj-PCA = 2.2 x 10(-5)) observed at the adjacent GALNT14 gene. In a gene-based analysis in VEGAS, BPIFA3 (P-Gene = 2 x 10(-5)) and BPIFA1 (P-Gene = 1.07 x 10(-4)) in the BPIFA gene cluster on chromosome 20q11.21 were the top hits. In all, 32 genomic regions show evidence of association (Padj-PCA < 10(-5)) in this GWAS, with pathway analysis showing a connection between top candidates and the TGF beta pathway. However, top and tag-SNP analysis for seven selected candidate genes in this pathway did not replicate in 645 families (793 affected individuals) from the Western Australian Family Study of Otitis Media (WAFSOM). Lack of replication may be explained by sample size, difference in OM disease severity between primary and replication cohorts or due to type I error in the primary GWAS. Conclusions: This first discovery GWAS for an OM phenotype has identified CAPN14 and GALNT14 on chromosome 2p23.1 and the BPIFA gene cluster on chromosome 20q11.21 as novel candidate genes which warrant further analysis in cohorts matched more precisely for clinical phenotypes.	[Rye, Marie S.; Scaman, Elizabeth S. H.; Anderson, Denise; Blackwell, Jenefer M.; Jamieson, Sarra E.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Warrington, Nicole M.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Vijayasekaran, Shyan; Coates, Harvey L.] Princess Margaret Hosp Children, Dept Otolaryngol Head & Neck Surg, Perth, WA, Australia; [Vijayasekaran, Shyan; Coates, Harvey L.] Univ Western Australia, Dept Otolaryngol Head & Neck Surg, Nedlands, WA 6009, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Rye, MS (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia.	mrye@ichr.uwa.edu.au; sjamieson@ichr.uwa.edu.au	Study, Raine/G-9547-2015; Pennell, Craig/ABD-6902-2020; vijayasekaran, shyan/AAB-7538-2022; Warrington, Nicole/P-4868-2014; Coates, Harvey Larry Charles/AAR-2846-2020; Blackwell, Jenefer M/H-3015-2015; Study, Raine/K-4517-2013	Pennell, Craig/0000-0002-0937-6165; vijayasekaran, shyan/0000-0001-7990-6742; Warrington, Nicole/0000-0003-4195-775X; Anderson, Denise/0000-0003-0643-4136; Rye, Marie/0000-0003-2727-5728	Brightspark Foundation Fellowship; Raine Medical Research Foundation Priming Grant; Stan Perron Foundation; University of Western Australia (UWA); Western Australian State Government; Australian Post Graduate Scholarship; National Health and Medical Research Council; Raine Medical Research Foundation at UWA; UWA Faculty of Medicine, Dentistry and Health Sciences; Telethon Institute for Child Health Research; Women and Infants Research Foundation; Curtin University; National Health and Medical Research Council [572613]	Brightspark Foundation Fellowship; Raine Medical Research Foundation Priming Grant; Stan Perron Foundation; University of Western Australia (UWA); Western Australian State Government; Australian Post Graduate Scholarship(Australian Government); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Raine Medical Research Foundation at UWA; UWA Faculty of Medicine, Dentistry and Health Sciences; Telethon Institute for Child Health Research; Women and Infants Research Foundation; Curtin University; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funds to SEJ from a Brightspark Foundation Fellowship, a Raine Medical Research Foundation Priming Grant to SEJ, and core funds to JMB from The Stan Perron Foundation, the University of Western Australia (UWA) and the Western Australian State Government. MSR is supported by an Australian Post Graduate Scholarship. The Raine Study has been supported by the National Health and Medical Research Council over the last 20 years with funding for Core Management provided by UWA, The Raine Medical Research Foundation at UWA, the UWA Faculty of Medicine, Dentistry and Health Sciences, the Telethon Institute for Child Health Research, the Women and Infants Research Foundation and Curtin University. Raine Study Illumina 660W-Quad Beadchip Data was supported by the National Health and Medical Research Council (ID 572613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar MS, 1996, J LARYNGOL OTOL, V110, P534, DOI 10.1017/S002221510013419X; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Bingle CD, 2011, BIOCHEM SOC T, V39, P977, DOI 10.1042/BST0390977; BROOKS DN, 1979, ANN OTO RHINOL LARYN, V88, P29, DOI 10.1177/00034894790880S504; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chen WM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-124; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Daly KA, 2010, INT J PEDIATR OTORHI, V74, P231, DOI 10.1016/j.ijporl.2009.09.006; Dear TN, 2001, GENE, V274, P245, DOI 10.1016/S0378-1119(01)00599-6; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Kirkeby S, 2011, MICROB PATHOGENESIS, V51, P48, DOI 10.1016/j.micpath.2011.03.008; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; Kong K, 2009, MED J AUSTRALIA, V191, pS39; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Kvaerner KJ, 1997, ANN OTO RHINOL LARYN, V106, P624, DOI 10.1177/000348949710600802; Lee YW, 2011, ANN OTO RHINOL LARYN, V120, P204, DOI 10.1177/000348941112000310; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; O'Connell JR, 1997, AM J HUM GENET, V61, pA288; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Rye MS, 2011, GENES IMMUN, V12, P352, DOI 10.1038/gene.2011.2; Rye MS, 2012, LARYNGOSCOPE, V122, P665, DOI 10.1002/lary.22506; Rye MS, 2011, MAMM GENOME, V22, P66, DOI 10.1007/s00335-010-9295-1; Segade F, 2006, ARCH OTOLARYNGOL, V132, P729, DOI 10.1001/archotol.132.7.729; Soong G, 2012, J INFECT DIS, V205, P1571, DOI 10.1093/infdis/jis244; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; StataCorp, 2007, STAT STAT SOFTW REL; Tateossian Hilda, 2009, Pathogenetics, V2, P5, DOI 10.1186/1755-8417-2-5; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Ueta M, 2010, BRIT J OPHTHALMOL, V94, P1239, DOI 10.1136/bjo.2009.173419; Wang H, 2003, BIOCHEM BIOPH RES CO, V300, P738, DOI 10.1016/S0006-291X(02)02908-X; Williams CJ, 2009, MED J AUSTRALIA, V191, pS69	47	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48215	10.1371/journal.pone.0048215	http://dx.doi.org/10.1371/journal.pone.0048215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133572	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800062
J	Tong, XJ; Xia, ZD; Zu, Y; Telfer, H; Hu, J; Yu, JY; Liu, H; Zhang, Q; Sodmergen; Lin, S; Zhang, B				Tong, Xiangjun; Xia, Zhidan; Zu, Yao; Telfer, Helena; Hu, Jing; Yu, Jingyi; Liu, Huan; Zhang, Quan; Sodmergen; Lin, Shuo; Zhang, Bo			ngs (Notochord Granular Surface) Gene Encodes a Novel Type of Intermediate Filament Family Protein Essential for Notochord Maintenance in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; MUTATIONS; DISEASE; EMBRYO; CELLS; GFAP	The notochord is an important organ involved in embryonic patterning and locomotion. In zebrafish, the mature notochord consists of a single stack of fully differentiated, large vacuolated cells called chordocytes, surrounded by a single layer of less differentiated notochordal epithelial cells called chordoblasts. Through genetic analysis of zebrafish lines carrying pseudo-typed retroviral insertions, a mutant exhibiting a defective notochord with a granular appearance was isolated, and the corresponding gene was identified as ngs (notochord granular surface), which was specifically expressed in the notochord. In the mutants, the notochord started to degenerate from 32 hours post-fertilization, and the chordocytes were then gradually replaced by smaller cells derived from chordoblasts. The granular notochord phenotype was alleviated by anesthetizing the mutant embryos with tricaine to prevent muscle contraction and locomotion. Phylogenetic analysis showed that ngs encodes a new type of intermediate filament (IF) family protein, which we named chordostatin based on its function. Under the transmission electron microcopy, bundles of 10-nm-thick IF-like filaments were enriched in the chordocytes of wild-type zebrafish embryos, whereas the chordocytes in ngs mutants lacked IF-like structures. Furthermore, chordostatin-enhanced GFP (EGFP) fusion protein assembled into a filamentous network specifically in chordocytes. Taken together, our work demonstrates that ngs encodes a novel type of IF protein and functions to maintain notochord integrity for larval development and locomotion. Our work sheds light on the mechanisms of notochord structural maintenance, as well as the evolution and biological function of IF family proteins.	[Tong, Xiangjun; Xia, Zhidan; Zu, Yao; Hu, Jing; Yu, Jingyi; Liu, Huan; Zhang, Quan; Sodmergen; Zhang, Bo] Peking Univ, Coll Life Sci, Ctr Dev Biol & Genet, Minist Educ,Key Lab Cell Proliferat & Differentia, Beijing 100871, Peoples R China; [Zu, Yao] Hebei Univ, Coll Life Sci, Baoding 071002, Hebei Province, Peoples R China; [Telfer, Helena] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Peking University; Hebei University; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Zhang, B (corresponding author), Peking Univ, Coll Life Sci, Ctr Dev Biol & Genet, Minist Educ,Key Lab Cell Proliferat & Differentia, Yiheyuan Rd 5, Beijing 100871, Peoples R China.	bzhang@pku.edu.cn		Zu, Yao/0000-0001-8081-9136	National Natural Science Foundation of China [30871418, 31110103904, 30730056]; 973 Program [2012CB945101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30871418, 31110103904, and 30730056 and 973 Program Grant 2012CB945101.	ADAMS DS, 1990, DEVELOPMENT, V110, P115; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Bartels H, 1998, J ELECTRON MICROSC, V47, P627, DOI 10.1093/oxfordjournals.jmicro.a023636; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Erber A, 1998, J MOL EVOL, V47, P751, DOI 10.1007/PL00006434; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Goldstein AM, 1998, DEV BIOL, V201, P247, DOI 10.1006/dbio.1998.8976; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Grotmol S, 2005, J ANAT, V206, P427, DOI 10.1111/j.1469-7580.2005.00408.x; Grotmol S, 2006, J ANAT, V209, P339, DOI 10.1111/j.1469-7580.2006.00618.x; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Li R, 2002, INT J DEV NEUROSCI, V20, P259, DOI 10.1016/S0736-5748(02)00019-9; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL, P7; Odenthal J, 1996, DEVELOPMENT, V123, P103; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Platz F, 2006, ANN ANAT, V188, P289, DOI 10.1016/j.aanat.2006.01.009; Schmitz RJ, 1998, J MORPHOL, V236, P105, DOI 10.1002/(SICI)1097-4687(199805)236:2<105::AID-JMOR2>3.0.CO;2-4; Schmitz RJ, 1998, J MORPHOL, V236, P75, DOI 10.1002/(SICI)1097-4687(199805)236:2<75::AID-JMOR1>3.0.CO;2-N; Stehr CM, 2006, TOXICOL SCI, V92, P270, DOI 10.1093/toxsci/kfj185; Stemple DL, 2004, CURR BIOL, V14, pR873, DOI 10.1016/j.cub.2004.09.065; Stemple DL, 1996, DEVELOPMENT, V123, P117; Tada M, 2005, CURR BIOL, V15, pR14, DOI 10.1016/j.cub.2004.12.011; VENETIANER A, 1983, NATURE, V305, P730, DOI 10.1038/305730a0; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE	36	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2711	2720		10.1074/jbc.M112.379172	http://dx.doi.org/10.1074/jbc.M112.379172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23132861	Green Published, hybrid			2022-12-25	WOS:000314211500055
J	Moreno, JL; Muguruza, C; Umali, A; Mortillo, S; Holloway, T; Pilar-Cuellar, F; Mocci, G; Seto, J; Callado, LF; Neve, RL; Milligan, G; Sealfon, SC; Lopez-Gimenez, JF; Meana, JJ; Benson, DL; Gonzalez-Maeso, J				Moreno, Jose L.; Muguruza, Carolina; Umali, Adrienne; Mortillo, Steven; Holloway, Terrell; Pilar-Cuellar, Fuencisla; Mocci, Giuseppe; Seto, Jeremy; Callado, Luis F.; Neve, Rachael L.; Milligan, Graeme; Sealfon, Stuart C.; Lopez-Gimenez, Juan F.; Javier Meana, J.; Benson, Deanna L.; Gonzalez-Maeso, Javier			Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A.mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; CLASS-A; GPCR; RHODOPSIN; COMPLEX; MODELS; OLIGOMERIZATION; ORGANIZATION; PHARMACOLOGY	Serotonin and glutamate G protein-coupled receptor (GPCR) neurotransmission affects cognition and perception in humans and rodents. GPCRs are capable of forming heteromeric complexes that differentially alter cell signaling, but the role of this structural arrangement in modulating behavior remains unknown. Here, we identified three residues located at the intracellular end of transmembrane domain four that are necessary for the metabotropic glutamate 2 (mGlu2) receptor to be assembled as a GPCR heteromer with the serotonin 5-hydroxytryptamine 2A (5-HT2A) receptor in the mouse frontal cortex. Substitution of these residues (Ala-677(4.40), Ala-681(4.44), and Ala-685(4.48)) leads to absence of 5-HT2A.mGlu2 receptor complex formation, an effect that is associated with a decrease in their heteromeric ligand binding interaction. Disruption of heteromeric expression with mGlu2 attenuates the psychosis-like effects induced in mice by hallucinogenic 5-HT2A agonists. Furthermore, the ligand binding interaction between the components of the 5-HT2A.mGlu2 receptor heterocomplex is up-regulated in the frontal cortex of schizophrenic subjects as compared with controls. Together, these findings provide structural evidence for the unique behavioral function of a GPCR heteromer.	[Moreno, Jose L.; Umali, Adrienne; Holloway, Terrell; Pilar-Cuellar, Fuencisla; Mocci, Giuseppe; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Seto, Jeremy; Sealfon, Stuart C.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Mortillo, Steven; Sealfon, Stuart C.; Benson, Deanna L.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; [Sealfon, Stuart C.; Benson, Deanna L.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Muguruza, Carolina; Callado, Luis F.; Javier Meana, J.] Univ Pais Vasco Euskal Herriko Unibertsitatea, Univ Basque Country, Dept Pharmacol, E-48490 Leioa, Bizkaia, Spain; [Umali, Adrienne; Callado, Luis F.; Javier Meana, J.] Univ Pais Vasco Euskal Herriko Unibertsitatea, Univ Basque Country, Ctr Invest Biomed Red Salud Mental, E-48490 Leioa, Bizkaia, Spain; [Lopez-Gimenez, Juan F.] Fac Med, Inst Biomed Biotecnol Cantabria, E-39011 Santander, Spain; [Milligan, Graeme; Lopez-Gimenez, Juan F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of Glasgow; Massachusetts Institute of Technology (MIT)	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1425 Madison Ave,Box 1229, New York, NY 10029 USA.	Javier.Maeso@mssm.edu	Pilar-Cuellar, Fuencisla/L-2983-2014; Callado, Luis F./A-7024-2008; Lopez-Gimenez, Juan/K-5823-2014; Milligan, Graeme/F-9426-2011; Moreno, Jose L/L-8981-2017; Muguruza, Carolina/B-8986-2013	Pilar-Cuellar, Fuencisla/0000-0003-1229-001X; Callado, Luis F./0000-0001-9941-012X; Lopez-Gimenez, Juan/0000-0003-3021-6200; Milligan, Graeme/0000-0002-6946-3519; Muguruza, Carolina/0000-0002-0477-5757; Benson, Deanna/0000-0001-7037-1147; MEANA, JOSE JAVIER/0000-0002-7913-6714; SEALFON, Stuart/0000-0001-5791-1217; CALLADO HERNANDO, LUIS FELIPE/0000-0002-5564-3447	National Institutes of Health [R01 MH084894, R01 NS37731, P01 DA12923]; Dainippon Sumi-tomo Pharma; National Alliance for Research on Schizophrenia and Depression; Mortimer D. Sackler Foundation; Ministerio de Ciencia e Innovacion Grant [SAF2009-084609]; Basque Government [IT-199-07]; Consejo Superior de Investigaciones Cientificas Grants [PA1003176, 200980I110]; Medical Research Council United Kingdom [G0900050]; University of the Basque Country, Spain; Fundacion Alicia Koplowitz, Spain; Consejo Superior de Investigaciones Cientificas, Spain; Medical Research Council [G0900050] Funding Source: researchfish; MRC [G0900050] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dainippon Sumi-tomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); National Alliance for Research on Schizophrenia and Depression(NARSAD); Mortimer D. Sackler Foundation; Ministerio de Ciencia e Innovacion Grant(Spanish Government); Basque Government(Basque Government); Consejo Superior de Investigaciones Cientificas Grants; Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of the Basque Country, Spain; Fundacion Alicia Koplowitz, Spain; Consejo Superior de Investigaciones Cientificas, Spain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH084894 (to J. G. M.), R01 NS37731 (to D. L. B.), and P01 DA12923 (to S. C. S.). This work was also supported by Dainippon Sumi-tomo Pharma (to J. G. M.), National Alliance for Research on Schizophrenia and Depression (to J. G. M.), The Mortimer D. Sackler Foundation (to J. G. M.), Ministerio de Ciencia e Innovacion Grant SAF2009-084609 (to J. J. M.), Basque Government Grant IT-199-07 (to J. J. M.), Consejo Superior de Investigaciones Cientificas Grants PA1003176 and 200980I110 (to J. F. L.-G.), and Medical Research Council United Kingdom Grant G0900050 (to G. M.).; Recipient of a predoctoral fellowship from University of the Basque Country, Spain.; Recipient of a postdoctoral fellowship from Fundacion Alicia Koplowitz, Spain.; Recipient of a predoctoral fellowship from Consejo Superior de Investigaciones Cientificas, Spain.	Aghajanian GK, 2009, PSYCHOPHARMACOLOGY, V206, P575, DOI 10.1007/s00213-009-1484-9; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Beique JC, 2007, P NATL ACAD SCI USA, V104, P9870, DOI 10.1073/pnas.0700436104; Belichenko P. V., 2000, COMP CYTOARCHITECTON, P129; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Carhart-Harris RL, 2012, P NATL ACAD SCI USA, V109, P2138, DOI 10.1073/pnas.1119598109; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Celada P, 2008, BIOL PSYCHIAT, V64, P392, DOI 10.1016/j.biopsych.2008.03.013; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Filizola M, 2005, CURR OPIN DRUG DISC, V8, P577; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Garcia-Sevilla JA, 2010, EUR NEUROPSYCHOPHARM, V20, P721, DOI 10.1016/j.euroneuro.2010.04.008; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jakab RL, 1998, P NATL ACAD SCI USA, V95, P735, DOI 10.1073/pnas.95.2.735; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Marek GJ, 2000, J PHARMACOL EXP THER, V292, P76; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Mortillo S, 2012, J COMP NEUROL, V520, P2041, DOI 10.1002/cne.23027; Muguruza C., 2012, EUR NEUROPS IN PRESS; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Ohishi H, 1998, NEUROSCI RES, V30, P65, DOI 10.1016/S0168-0102(97)00120-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perez DM, 2003, MOL PHARMACOL, V63, P1202, DOI 10.1124/mol.63.6.1202; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vollenweider FX, 1997, NEUROPSYCHOPHARMACOL, V16, P357, DOI 10.1016/S0893-133X(96)00246-1; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wright R. A., 2012, NEUROPHARMACOLOGY; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645	63	86	89	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44301	44319		10.1074/jbc.M112.413161	http://dx.doi.org/10.1074/jbc.M112.413161			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129762	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000312938600028
J	Raymond, F; Wang, L; Moser, M; Metairon, S; Mansourian, R; Zwahlen, MC; Kussmann, M; Fuerholz, A; Mace, K; Chou, CJ				Raymond, Frederic; Wang, Long; Moser, Mireille; Metairon, Sylviane; Mansourian, Robert; Zwahlen, Marie-Camille; Kussmann, Martin; Fuerholz, Andreas; Mace, Katherine; Chou, Chieh Jason			Consequences of Exchanging Carbohydrates for Proteins in the Cholesterol Metabolism of Mice Fed a High-fat Diet	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; BILE-ACID BIOSYNTHESIS; RANDOMIZED-TRIAL; WEIGHT-LOSS; 7-ALPHA-HYDROXYLASE GENE; MICROARRAY DATA; ADIPOSE-TISSUE; SEVERE OBESITY; INSULIN ACTION; MESSENGER-RNA	Consumption of low-carbohydrate, high-protein, high-fat diets lead to rapid weight loss but the cardioprotective effects of these diets have been questioned. We examined the impact of high-protein and high-fat diets on cholesterol metabolism by comparing the plasma cholesterol and the expression of cholesterol biosynthesis genes in the liver of mice fed a high-fat (HF) diet that has a high (H) or a low (L) protein-to-carbohydrate (P/C) ratio. H-P/C-HF feeding, compared with L-P/C-HF feeding, decreased plasma total cholesterol and increased HDL cholesterol concentrations at 4-wk. Interestingly, the expression of genes involved in hepatic steroid biosynthesis responded to an increased dietary P/C ratio by first down-regulation (2-d) followed by later up-regulation at 4-wk, and the temporal gene expression patterns were connected to the putative activity of SREBF1 and 2. In contrast, Cyp7a1, the gene responsible for the conversion of cholesterol to bile acids, was consistently up-regulated in the H-P/C-HF liver regardless of feeding duration. Over expression of Cyp7a1 after 2-d and 4-wk H-P/C-HF feeding was connected to two unique sets of transcription regulators. At both time points, up-regulation of the Cyp7a1 gene could be explained by enhanced activations and reduced suppressions of multiple transcription regulators. In conclusion, we demonstrated that the hypocholesterolemic effect of H-P/C-HF feeding coincided with orchestrated changes of gene expressions in lipid metabolic pathways in the liver of mice. Based on these results, we hypothesize that the cholesterol lowering effect of high-protein feeding is associated with enhanced bile acid production but clinical validation is warranted. (246 words)	[Mace, Katherine; Chou, Chieh Jason] Nestle Res Ctr, Nutr & Hlth Dept, CH-1000 Lausanne, Switzerland; [Raymond, Frederic; Moser, Mireille; Metairon, Sylviane; Mansourian, Robert; Zwahlen, Marie-Camille; Fuerholz, Andreas] Nestle Res Ctr, Bioanalyt Sci Dept, CH-1000 Lausanne, Switzerland; [Wang, Long] Syracuse Univ, Dept Nutr Sci & Dietet, Syracuse, NY USA; [Kussmann, Martin] Nestle Res Ctr, Prote & Metabon Core, CH-1000 Lausanne, Switzerland; [Kussmann, Martin] Aarhus Univ, Fac Sci, Aarhus, Denmark; [Kussmann, Martin] Swiss Fed Inst Technol, Fac Life Sci, CH-1015 Lausanne, Switzerland	Nestle SA; Nestle SA; Syracuse University; Nestle SA; Aarhus University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Chou, CJ (corresponding author), Nestle Res Ctr, Nutr & Hlth Dept, CH-1000 Lausanne, Switzerland.	chieh-jason.chou@rd.nestle.com	Kussmann, Martin/AAB-7453-2022	Kussmann, Martin/0000-0002-0966-2313; Raymond, Frederic/0000-0002-6148-6898				Ascencio C, 2004, J NUTR, V134, P522, DOI 10.1093/jn/134.3.522; Bommer GT, 2011, CELL METAB, V13, P241, DOI 10.1016/j.cmet.2011.02.004; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Brehm BJ, 2005, J CLIN ENDOCR METAB, V90, P1475, DOI 10.1210/jc.2004-1540; Brinkworth GD, 2009, AM J CLIN NUTR, V90, P23, DOI 10.3945/ajcn.2008.27326; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Endo Y, 2002, J NUTR, V132, P3632, DOI 10.1093/jn/132.12.3632; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foo SY, 2009, P NATL ACAD SCI USA, V106, P15418, DOI 10.1073/pnas.0907995106; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gannon MC, 2004, DIABETES, V53, P2375, DOI 10.2337/diabetes.53.9.2375; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2002, BIOCHEM BIOPH RES CO, V293, P338, DOI 10.1016/S0006-291X(02)00229-2; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kim HJ, 2004, J BIOL CHEM, V279, P28122, DOI 10.1074/jbc.M313302200; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Linn T, 2000, DIABETOLOGIA, V43, P1257, DOI 10.1007/s001250051521; LIU ZQ, 1994, BIOCHEM BIOPH RES CO, V205, P680, DOI 10.1006/bbrc.1994.2719; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mansourian R, 2004, BIOINFORMATICS, V20, P2726, DOI 10.1093/bioinformatics/bth319; Miyake JH, 2002, ARTERIOSCL THROM VAS, V22, P121, DOI 10.1161/hq0102.102588; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Petzke KJ, 2005, EUR J NUTR, V44, P414, DOI 10.1007/s00394-004-0545-4; Phillips BE, 2012, CURR OPIN CLIN NUTR, V15, P58, DOI 10.1097/MCO.0b013e32834d19bc; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Ratnayake WMN, 1997, BRIT J NUTR, V78, P459, DOI 10.1079/BJN19970163; ROSSETTI L, 1989, AM J PHYSIOL, V257, pE212, DOI 10.1152/ajpendo.1989.257.2.E212; Rossi M, 2009, SURG OBES RELAT DIS, V5, P11, DOI 10.1016/j.soard.2008.08.002; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Seshadri P, 2004, AM J MED, V117, P398, DOI 10.1016/j.amjmed.2004.04.009; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Stroup D, 2000, J LIPID RES, V41, P1; Tappy L, 1996, REPROD NUTR DEV, V36, P391, DOI 10.1051/rnd:19960405; Torre-Villalvazo I, 2008, J NUTR, V138, P462, DOI 10.1093/jn/138.3.462; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wang MH, 2004, HEPATOLOGY, V40, P600, DOI 10.1002/hep.20349; Westerterp KR, 1999, INT J OBESITY, V23, P287, DOI 10.1038/sj.ijo.0800810	52	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e49058	10.1371/journal.pone.0049058	http://dx.doi.org/10.1371/journal.pone.0049058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139832	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300069
J	Rodriguez-Flores, JL; Fuller, J; Hackett, NR; Salit, J; Malek, JA; Al-Dous, E; Chouchane, L; Zirie, M; Jayoussi, A; Mahmoud, MA; Crystal, RG; Mezey, JG				Rodriguez-Flores, Juan L.; Fuller, Jennifer; Hackett, Neil R.; Salit, Jacqueline; Malek, Joel A.; Al-Dous, Eman; Chouchane, Lotfi; Zirie, Mahmoud; Jayoussi, Amin; Mahmoud, Mai A.; Crystal, Ronald G.; Mezey, Jason G.			Exome Sequencing of Only Seven Qataris Identifies Potentially Deleterious Variants in the Qatari Population	PLOS ONE			English	Article							ASSOCIATION; DISCOVERY; MUTATION	The Qatari population, located at the Arabian migration crossroads of African and Eurasia, is comprised of Bedouin, Persian and African genetic subgroups. By deep exome sequencing of only 7 Qataris, including individuals in each subgroup, we identified 2,750 nonsynonymous SNPs predicted to be deleterious, many of which are linked to human health, or are in genes linked to human health. Many of these SNPs were at significantly elevated deleterious allele frequency in Qataris compared to other populations worldwide. Despite the small sample size, SNP allele frequency was highly correlated with a larger Qatari sample. Together, the data demonstrate that exome sequencing of only a small number of individuals can reveal genetic variations with potential health consequences in understudied populations.	[Rodriguez-Flores, Juan L.; Fuller, Jennifer; Hackett, Neil R.; Salit, Jacqueline; Crystal, Ronald G.; Mezey, Jason G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Malek, Joel A.; Al-Dous, Eman; Chouchane, Lotfi] Weill Cornell Med Coll Qatar, Dept Med Genet, Doha, Qatar; [Zirie, Mahmoud; Jayoussi, Amin] Hamad Med Corp, Doha, Qatar; [Zirie, Mahmoud; Mahmoud, Mai A.] Weill Cornell Med Coll Qatar, Dept Med, Doha, Qatar; [Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Cornell University	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.	geneticmedicine@med.cornell.edu	Rodriguez-Flores, Juan L/AAJ-7565-2020; Chouchane, Lotfi/ABF-1360-2020	Rodriguez-Flores, Juan L/0000-0002-0394-8062; 	Qatar Foundation; Weill Cornell Medical College in Qatar; National Science Foundation [0922432]; National Institutes of Health NIH [T32 HL09428]	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported, in part, by the Qatar Foundation and Weill Cornell Medical College in Qatar, and by the National Science Foundation (#0922432). JLRF is supported, in part, by National Institutes of Health NIH T32 HL09428. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bener A, 2006, J BIOSOC SCI, V38, P239, DOI 10.1017/S0021932004007060; Bener A, 2010, ANN HLTH REPORT; BERKSON J, 1978, J STAT PLAN INFER, V2, P27, DOI 10.1016/0378-3758(78)90019-8; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hamad AI, 2004, SAUDI MED J, V25, P79; Hartl D., 2007, PRINCIPLES POPULATIO; Hiller M, 2006, AM J HUM GENET, V78, P291, DOI 10.1086/500151; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; IDF Diabetes Atlas, 2011, IDF DIAB ATL; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li JX, 2005, BIOCHEM BIOPH RES CO, V337, P179, DOI 10.1016/j.bbrc.2005.09.029; Li MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007055; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Mackay J, 2004, ATLAS HEART DIS STRO; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McEvoy BP, 2010, AM J HUM GENET, V87, P297, DOI 10.1016/j.ajhg.2010.07.008; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Perez-Miranda AM, 2006, HUM HERED, V61, P67, DOI 10.1159/000092648; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Qatar Statistics Authority, 2010, RES 2010 CEN POP HOU; Saccone SF, 2008, BIOINFORMATICS, V24, P1805, DOI 10.1093/bioinformatics/btn315; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47614	10.1371/journal.pone.0047614	http://dx.doi.org/10.1371/journal.pone.0047614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139751	gold, Green Published, Green Submitted			2022-12-25	WOS:000311315300011
J	Dobler, CC; Marks, GB				Dobler, Claudia C.; Marks, Guy B.			Completion of Treatment for Latent Tuberculosis Infection with Monthly Drug Dispensation Directly through the Tuberculosis Clinic	PLOS ONE			English	Article							UNITED-STATES; RANDOMIZED-TRIAL; ARKANSAS METHOD; ADHERENCE; PREDICTORS; ACCEPTANCE; RIFAMPIN; CONTACTS; THERAPY; FAILURE	Setting: An Australian metropolitan TB clinic where treatment for latent tuberculosis infection (LTBI) comprises six months of isoniazid, self-administered but dispensed monthly by the clinic. Objective: To determine the proportion of patients who complete treatment for LTBI and to identify factors associated with non-completion. Methods: Clinical files of all patients receiving treatment for LTBI between 01/2000 and 12/2010 were reviewed. The study population comprised all patients who were commenced on isoniazid as treatment for LTBI. Odds ratios (OR) for completing treatment were estimated by logistic regression. Results: Of 216 patients who commenced isoniazid treatment for LTBI, 16 (75% )completed six months treatment. Fifty-three percent of the 53 patients who did not complete treatment dropped out after three months treatment. The mean (SD) age of the patients was 27 (16) years and 123 (57%) were female. The majority of patients (59%) were born overseas and 69% received treatment for LTBI because they were contacts of patients with TB. Patients' sex, age, country of birth, time since immigration for overseas born people, health care worker status, TST conversion status, chest x-ray findings, language, employment status and the indication for which treatment of LTBI was prescribed were not significantly related to treatment completion. Conclusion: In a setting where isoniazid is dispensed monthly by the TB clinic, a relatively high proportion of patients who commence treatment for LTBI complete the six month scheduled course of treatment. The study did not identify any patient characteristics that predicted treatment completion. Interventions to improve completion rates should extend over the whole duration of treatment.	[Dobler, Claudia C.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Dobler, Claudia C.; Marks, Guy B.] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Dobler, Claudia C.; Marks, Guy B.] Liverpool Hosp, Dept Resp Med, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Liverpool Hospital	Dobler, CC (corresponding author), Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia.	cdobler@med.usyd.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Dobler, Claudia/0000-0002-5460-0189	University of Sydney Australian Postgraduate Award	University of Sydney Australian Postgraduate Award(University of Sydney)	Claudia Dobler was supported by a University of Sydney Australian Postgraduate Award. The funders of the research scholarship had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anibarro L, 2010, INT J TUBERC LUNG D, V14, P701; [Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; Codecasa LR, 1998, INT J TUBERC LUNG D, V2, P208; Coly A, 2004, INT J TUBERC LUNG D, V8, P703; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow- up in the IUAT trial, 1982, B WORLD HEALTH ORGAN, V60, P555; Felton Charles P., 2005, ADH TREATM LAT TUB I; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Goswami ND, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-468; Guerra RL, 2010, RESP MED, V104, P754, DOI 10.1016/j.rmed.2010.02.001; Hanifa Y, 2007, INT J TUBERC LUNG D, V11, P1232; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2010, INT J TUBERC LUNG D, V14, P1104; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Kwara A, 2008, CHEST, V133, P862, DOI 10.1378/chest.07-2024; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Menzies D, 2005, INT J TUBERC LUNG D, V9, P1343; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; NSW Department of Health, 2009, POL DIR TUB SKIN TES; Nyamathi AM, 2006, INT J TUBERC LUNG D, V10, P775; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Parsyan AE, 2007, J INFECTION, V54, P262, DOI 10.1016/j.jinf.2006.04.010; Reichler MR, 2002, SOUTH MED J, V95, P414, DOI 10.1097/00007611-200295040-00009; San Sebastian M, 2000, RESP MED, V94, P648, DOI 10.1053/rmed.1999.0877; Shieh FK, 2006, AM J RESP CRIT CARE, V174, P717, DOI 10.1164/rccm.200510-1667OC; Shukla SJ, 2002, CHEST, V122, P1609, DOI 10.1378/chest.122.5.1609; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Trajman A, 2010, INT J TUBERC LUNG D, V14, P551; Trauer JM, 2011, MED J AUSTRALIA, V194, P579, DOI 10.5694/j.1326-5377.2011.tb03108.x; Watkins RE, 2004, INT J TUBERC LUNG D, V8, P218	31	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48900	10.1371/journal.pone.0048900	http://dx.doi.org/10.1371/journal.pone.0048900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139824	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400063
J	Jami, SK; Clark, GB; Ayele, BT; Ashe, P; Kirti, PB				Jami, Sravan Kumar; Clark, Greg B.; Ayele, Belay T.; Ashe, Paula; Kirti, Pulugurtha Bharadwaja			Genome-wide Comparative Analysis of Annexin Superfamily in Plants	PLOS ONE			English	Article							BINDING PROTEINS; GENE FAMILY; BRASSICA-JUNCEA; ARABIDOPSIS; EXPRESSION; IDENTIFICATION; EVOLUTION; SEQUENCE; STRESS; DUPLICATIONS	Most annexins are calcium-dependent, phospholipid-binding proteins with suggested functions in response to environmental stresses and signaling during plant growth and development. They have previously been identified and characterized in Arabidopsis and rice, and constitute a multigene family in plants. In this study, we performed a comparative analysis of annexin gene families in the sequenced genomes of Viridiplantae ranging from unicellular green algae to multicellular plants, and identified 149 genes. Phylogenetic studies of these deduced annexins classified them into nine different arbitrary groups. The occurrence and distribution of bona fide type II calcium binding sites within the four annexin domains were found to be different in each of these groups. Analysis of chromosomal distribution of annexin genes in rice, Arabidopsis and poplar revealed their localization on various chromosomes with some members also found on duplicated chromosomal segments leading to gene family expansion. Analysis of gene structure suggests sequential or differential loss of introns during the evolution of land plant annexin genes. Intron positions and phases are well conserved in annexin genes from representative genomes ranging from Physcomitrella to higher plants. The occurrence of alternative motifs such as K/R/HGD was found to be overlapping or at the mutated regions of the type II calcium binding sites indicating potential functional divergence in certain plant annexins. This study provides a basis for further functional analysis and characterization of annexin multigene families in the plant lineage.	[Jami, Sravan Kumar; Ayele, Belay T.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Clark, Greg B.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Jami, Sravan Kumar; Ashe, Paula] Natl Res Council Canada, Saskatoon, SK, Canada; [Kirti, Pulugurtha Bharadwaja] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Manitoba; University of Texas System; University of Texas Austin; National Research Council Canada; University of Hyderabad	Jami, SK (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada.	jami@cc.umanitoba.ca	Kirti, P.B./R-1504-2019					Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Battey NH, 1996, PLANT PHYSIOL, V112, P1391, DOI 10.1104/pp.112.3.1391; BLACKBOURN HD, 1991, PLANTA, V184, P67, DOI 10.1007/BF00208238; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Braun EL, 1998, J MOL EVOL, V47, P531, DOI 10.1007/PL00006409; Breton G, 2000, PLANT CELL PHYSIOL, V41, P177, DOI 10.1093/pcp/41.2.177; Cantero A, 2006, PLANT PHYSIOL BIOCH, V44, P13, DOI 10.1016/j.plaphy.2006.02.002; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Clark GB, 2001, PLANT PHYSIOL, V126, P1072, DOI 10.1104/pp.126.3.1072; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Divya K, 2010, PLANT MOL BIOL, V73, P293, DOI 10.1007/s11103-010-9615-6; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Fernandez MP, 2003, MOL B INT U, P21; GEISOW MJ, 1986, NATURE, V320, P636, DOI 10.1038/320636a0; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gorecka KM, 2005, BIOCHEM BIOPH RES CO, V336, P868, DOI 10.1016/j.bbrc.2005.08.181; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Hofmann A, 2000, J BIOL CHEM, V275, P8072, DOI 10.1074/jbc.275.11.8072; Hoshino D, 2004, PLANTA, V219, P867, DOI 10.1007/s00425-004-1285-7; Hu NJ, 2008, J BIOL CHEM, V283, P18314, DOI 10.1074/jbc.M801051200; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huh SM, 2010, PLANT CELL PHYSIOL, V51, P1499, DOI 10.1093/pcp/pcq111; Jami SK, 2012, PLANT CELL REP, V31, P813, DOI 10.1007/s00299-011-1201-0; Jami SK, 2010, PLANT SIGNAL BEHAV, V5, P618, DOI 10.4161/psb.11506; Jami SK, 2009, PLANT PHYSIOL BIOCH, V47, P977, DOI 10.1016/j.plaphy.2009.08.005; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Kaetzel MA, 1998, BIOCHIM BIOPHYS ACTA, V1223, P368; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Konopka-Postupolska D, 2011, PLANT SCI, V181, P230, DOI 10.1016/j.plantsci.2011.05.013; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Laval V, 1999, BBA-PROTEIN STRUCT M, V1435, P61, DOI 10.1016/S0005-2728(99)00087-0; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Lu YG, 2012, GENE, V499, P14, DOI 10.1016/j.gene.2012.03.026; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MAGENDZO K, 1991, J BIOL CHEM, V266, P3228; Misumi O, 2008, J PLANT RES, V121, P3, DOI 10.1007/s10265-007-0133-9; Morgan RO, 2006, BBA-MOL CELL RES, V1763, P1238, DOI 10.1016/j.bbamcr.2006.09.028; MORGAN RO, 1995, MOL BIOL EVOL, V12, P967; Morgan RO, 2004, BBA-MOL CELL RES, V1742, P133, DOI 10.1016/j.bbamcr.2004.09.010; Morgan RO, 1997, CELL MOL LIFE SCI, V53, P508, DOI 10.1007/s000180050064; Mortimer JC, 2008, J EXP BOT, V59, P533, DOI 10.1093/jxb/erm344; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Nagpal P, 1999, GENE, V230, P33, DOI 10.1016/S0378-1119(99)00068-2; Palmer JD, 2004, AM J BOT, V91, P1437, DOI 10.3732/ajb.91.10.1437; Peers G, 2008, PLANT CELL, V20, P502, DOI 10.1105/tpc.107.056556; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Proust J, 1999, PLANT MOL BIOL, V39, P361, DOI 10.1023/A:1006199814795; Proust J, 1996, FEBS LETT, V383, P208, DOI 10.1016/0014-5793(96)00252-9; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; Roy SW, 2007, MOL BIOL EVOL, V24, P171, DOI 10.1093/molbev/msl159; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Simoes I, 2005, FEBS J, V272, P5786, DOI 10.1111/j.1742-4658.2005.04967.x; SMITH PD, 1994, TRENDS GENET, V10, P241, DOI 10.1016/0168-9525(94)90171-6; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Sudo T, 1996, BIOCHEM BIOPH RES CO, V223, P706, DOI 10.1006/bbrc.1996.0967; Sudo T, 1998, J BIOL CHEM, V273, P6351, DOI 10.1074/jbc.273.11.6351; Sun Y, 2000, PLANT CELL PHYSIOL, V41, P1136, DOI 10.1093/pcp/pcd039; Suzuki H, 2009, BIOCHEM SOC T, V37, P190, DOI 10.1042/BST0370190; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wagner A, 2002, GENOME BIOL, V3; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038	72	46	52	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e47801	10.1371/journal.pone.0047801	http://dx.doi.org/10.1371/journal.pone.0047801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133603	Green Published, gold			2022-12-25	WOS:000310702400015
J	Schiavon, G; Ruggiero, A; Schoffski, P; van der Holt, B; Bekers, DJ; Eechoute, K; Vandecaveye, V; Krestin, GP; Verweij, J; Sleijfer, S; Mathijssen, RHJ				Schiavon, Gaia; Ruggiero, Alessandro; Schoeffski, Patrick; van der Holt, Bronno; Bekers, Dave J.; Eechoute, Karel; Vandecaveye, Vincent; Krestin, Gabriel P.; Verweij, Jaap; Sleijfer, Stefan; Mathijssen, Ron H. J.			Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; LYMPH-NODE METASTASES; COMPUTED-TOMOGRAPHY; SOLID TUMORS; SEMIAUTOMATED MEASUREMENT; EVALUATION CRITERIA; PULMONARY NODULES; RECIST; CT; SURVIVAL	Background: Assessment of tumor size changes is crucial in clinical trials and patient care. We compared imatinib-induced volume changes of liver metastases (LM) from gastro-intestinal stromal tumors (GIST) to RECIST and Choi criteria and their association with overall survival (OS). Methods: LM from 84 GIST patients (training and validation set) were evaluated using manual and semi-automated Computed Tomography measurements at baseline, after 3, 6 and 12 months of imatinib. The ability of uni-dimensional (1D) and three-dimensional (3D) measurements to detect size changes (increase/decrease) >= 20% was evaluated. Volumetric response cut-offs were derived from minimally relevant changes (+20/230%) by RECIST, considering lesions as spherical or ellipsoidal. Results: 3D measurements detected size changes >= 20% more frequently than 1D at every time-point (P <= 0.008). 3D and Choi criteria registered more responses than RECIST at 3 and 6 months for 3D-spheres (P <= 0.03) and at all time-points for 3D-ellipsoids and Choi criteria (P<0.001). Progressive disease by 3D criteria seems to better correlate to OS at late time-points than other criteria. Conclusion: Volume criteria (especially ellipsoids) classify a higher number of patients as imatinib-responders than RECIST. Volume discriminates size changes better than diameter in GIST and constitutes a feasible and robust method to evaluate response and predict patient benefit.	[Schiavon, Gaia; Eechoute, Karel; Verweij, Jaap; Sleijfer, Stefan; Mathijssen, Ron H. J.] Erasmus Univ, Med Ctr, Dept Med Oncol, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands; [Schoeffski, Patrick] Catholic Univ Louvain, Dept Gen Med Oncol, Univ Hosp Leuven, Leuven Canc Inst, B-3000 Louvain, Belgium; [Ruggiero, Alessandro; Krestin, Gabriel P.] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [van der Holt, Bronno] Erasmus Univ, Med Ctr, Daniel den Hoed Canc Ctr, Dept Trials & Stat, Rotterdam, Netherlands; [Bekers, Dave J.] TNO Tech Sci, The Hague, Netherlands; [Vandecaveye, Vincent] Catholic Univ Louvain, Univ Hosp Leuven, Dept Radiol, Louvain, Belgium; [Schiavon, Gaia] Royal Marsden Hosp, Breast Unit, London SW3 6JJ, England	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Netherlands Organization Applied Science Research; KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Royal Marsden NHS Foundation Trust	Schiavon, G (corresponding author), Erasmus Univ, Med Ctr, Dept Med Oncol, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands.	g.schiavon@erasmusmc.nl		van der Holt, Bronno/0000-0001-6414-2671	Siemens AG	Siemens AG(Siemens AG)	Gabriel P. Krestin has served as a consultant or has been on the Advisory Board for GEHC-Europe, and has received research funding from Siemens AG. The other co-authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anderson JR, 2008, J CLIN ONCOL, V26, P3913, DOI 10.1200/JCO.2008.16.1000; Benjamin RS, 2007, J CLIN ONCOL, V25, P1760, DOI 10.1200/JCO.2006.07.3411; Beyer F, 2010, NUKLEARMED-NUCL MED, V49, P41, DOI 10.3413/nukmed-0277; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Choi H, 2004, AM J ROENTGENOL, V183, P1619, DOI 10.2214/ajr.183.6.01831619; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Dudeck O, 2011, ANN ONCOL, V22, P1828, DOI 10.1093/annonc/mdq696; Eechoute K, 2011, CLIN PHARMACOL THER, V89, P816, DOI 10.1038/clpt.2011.42; Eechoute K, 2012, CLIN CANCER RES, V18, P5780, DOI 10.1158/1078-0432.CCR-12-0490; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fabel M, 2008, EUR RADIOL, V18, P1114, DOI 10.1007/s00330-008-0866-4; Gilles EM, 2012, J CLIN ONCOL, V30, P116, DOI 10.1200/JCO.2011.39.1284; Higgins LJ, 2011, SEMIN ONCOL, V38, P3, DOI 10.1053/j.seminoncol.2010.11.010; James K, 1999, J NATL CANCER I, V91, P523, DOI 10.1093/jnci/91.6.523; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keil S, 2009, ROFO-FORTSCHR RONTG, V181, P888, DOI 10.1055/s-0028-1109509; Keil S, 2008, EUR RADIOL, V18, P2456, DOI 10.1007/s00330-008-1050-6; Keil S, 2009, INVEST RADIOL, V44, P82, DOI 10.1097/RLI.0b013e3181911ffa; Kuhnigk JM, 2006, IEEE T MED IMAGING, V25, P417, DOI 10.1109/TMI.2006.871547; Le Cesne A, 2009, J CLIN ONCOL, V27, P3969, DOI 10.1200/JCO.2008.21.3330; Levine ZH, 2010, OPT EXPRESS, V18, P8151, DOI 10.1364/OE.18.008151; Liu F, 2010, J THORAC ONCOL, V5, P879, DOI 10.1097/JTO.0b013e3181dd0ef1; Machin D, 2007, SURVIVAL ANAL PRACTI, P40; Marten K, 2006, EUR RADIOL, V16, P781, DOI 10.1007/s00330-005-0036-x; MOERTEL CG, 1976, CANCER, V38, P388, DOI 10.1002/1097-0142(197607)38:1<388::AID-CNCR2820380156>3.0.CO;2-A; Mozley PD, 2010, ANN ONCOL, V21, P1751, DOI 10.1093/annonc/mdq051; Oxnard GR, 2011, J CLIN ONCOL, V29, P3114, DOI 10.1200/JCO.2010.33.7071; Padhani AR, 2001, BRIT J RADIOL, V74, P983, DOI 10.1259/bjr.74.887.740983; Pietanza M, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.14562; Prasad SR, 2002, RADIOLOGY, V225, P416, DOI 10.1148/radiol.2252011604; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schiavon G, 2012, J CLIN ONCOL S, V30; Schuetze SM, 2008, ONCOLOGIST, V13, P32, DOI 10.1634/theoncologist.13-S2-32; Schwartz LH, 2007, J CLIN ONCOL, V25; Sekine I, 2002, ANN ONCOL, V13, P1300, DOI 10.1093/annonc/mdf202; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tran LN, 2004, ACAD RADIOL, V11, P1355, DOI 10.1016/j.acra.2004.09.004; van der Vorst JR, 2010, WORLD J SURG, V34, P2426, DOI 10.1007/s00268-010-0663-5; Van Glabbeke M, 2005, J CLIN ONCOL, V23, P5795, DOI 10.1200/JCO.2005.11.601; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Zhao BS, 2006, RADIOLOGY, V241, P892, DOI 10.1148/radiol.2413051887	45	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48372	10.1371/journal.pone.0048372	http://dx.doi.org/10.1371/journal.pone.0048372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133631	gold, Green Published			2022-12-25	WOS:000310702400034
J	Chechlacz, M; Rotshtein, P; Roberts, KL; Bickerton, WL; Lau, JKL; Humphreys, GW				Chechlacz, Magdalena; Rotshtein, Pia; Roberts, Katherine L.; Bickerton, Wai-Ling; Lau, Johnny K. L.; Humphreys, Glyn W.			The Prognosis of Allocentric and Egocentric Neglect: Evidence from Clinical Scans	PLOS ONE			English	Article							RIGHT-HEMISPHERE STROKE; UNILATERAL VISUAL NEGLECT; ANATOMY UNDERLYING ACUTE; CHRONIC SPATIAL NEGLECT; OBJECT-BASED NEGLECT; HEMISPATIAL NEGLECT; VISUOSPATIAL NEGLECT; WHITE-MATTER; UNIFIED SEGMENTATION; EYE-MOVEMENTS	We contrasted the neuroanatomical substrates of sub-acute and chronic visuospatial deficits associated with different aspects of unilateral neglect using computed tomography scans acquired as part of routine clinical diagnosis. Voxel-wise statistical analyses were conducted on a group of 160 stroke patients scanned at a sub-acute stage. Lesion-deficit relationships were assessed across the whole brain, separately for grey and white matter. We assessed lesions that were associated with behavioural performance (i) at a sub-acute stage (within 3 months of the stroke) and (ii) at a chronic stage (after 9 months post stroke). Allocentric and egocentric neglect symptoms at the sub-acute stage were associated with lesions to dissociated regions within the frontal lobe, amongst other regions. However the frontal lesions were not associated with neglect at the chronic stage. On the other hand, lesions in the angular gyrus were associated with persistent allocentric neglect. In contrast, lesions within the superior temporal gyrus extending into the supramarginal gyrus, as well as lesions within the basal ganglia and insula, were associated with persistent egocentric neglect. Damage within the temporoparietal junction was associated with both types of neglect at the sub-acute stage and 9 months later. Furthermore, white matter disconnections resulting from damage along the superior longitudinal fasciculus were associated with both types of neglect and critically related to both sub-acute and chronic deficits. Finally, there was a significant difference in the lesion volume between patients who recovered from neglect and patients with chronic deficits. The findings presented provide evidence that (i) the lesion location and lesion size can be used to successfully predict the outcome of neglect based on clinical CT scans, (ii) lesion location alone can serve as a critical predictor for persistent neglect symptoms, (iii) wide spread lesions are associated with neglect symptoms at the sub-acute stage but only some of these are critical for predicting whether neglect will become a chronic disorder and (iv) the severity of behavioural symptoms can be a useful predictor of recovery in the absence of neuroimaging findings on clinical scans. We discuss the implications for understanding the symptoms of the neglect syndrome, the recovery of function and the use of clinical scans to predict outcome.	[Chechlacz, Magdalena; Humphreys, Glyn W.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Chechlacz, Magdalena; Rotshtein, Pia; Roberts, Katherine L.; Bickerton, Wai-Ling; Lau, Johnny K. L.; Humphreys, Glyn W.] Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England	University of Oxford; University of Birmingham	Chechlacz, M (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	magdalena.chechlacz@psy.ox.ac.uk	Lau, Johnny King L/P-9638-2015; Chechlacz, Magdalena/ABB-6360-2021; Roberts, Katherine/B-9709-2014	Lau, Johnny King L/0000-0002-3958-5582; Chechlacz, Magdalena/0000-0003-1811-3946; Roberts, Katherine/0000-0002-8735-2249; Rotshtein, Pia/0000-0002-0301-9511	Stroke Association	Stroke Association	This work was supported by grant from the Stroke Association awarded to Professor Glyn Humphreys for Birmingham University Cognitive Screen. http://www.stroke.org.uk/research/index.html; http://bucs.bham.ac.uk/main.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J., 2003, HUMAN BRAIN FUNCTION, P655; Bartolomeo P, 2007, CEREB CORTEX, V17, P2479, DOI 10.1093/cercor/bhl181; Bickerton WL, 2011, NEUROPSYCHOLOGY, V25, P567, DOI 10.1037/a0023501; Bird CM, 2006, J NEUROL NEUROSUR PS, V77, P1008, DOI 10.1136/jnnp.2006.094417; Butcher K, 2003, STROKE, V34, P2159, DOI 10.1161/01.STR.0000086529.83878.A2; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; CAMPBELL DC, 1976, CORTEX, V12, P303, DOI 10.1016/S0010-9452(76)80034-2; Cassidy TP, 1999, AGE AGEING, V28, P257, DOI 10.1093/ageing/28.3.257; Chechlacz M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00230; Chechlacz M, 2010, COGN NEUROPSYCHOL, V27, P277, DOI 10.1080/02643294.2010.519699; Cherney LR, 2001, ARCH PHYS MED REHAB, V82, P322, DOI 10.1053/apmr.2001.21511; Cherney LR, 2001, BRAIN INJURY, V15, P585, DOI 10.1080/02699050010009090; Committeri G, 2007, BRAIN, V130, P431, DOI 10.1093/brain/awl265; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Delis D C, 1983, Int Rehabil Med, V5, P132; DENES G, 1982, BRAIN, V105, P543, DOI 10.1093/brain/105.3.543; Doricchi F, 2003, NEUROREPORT, V14, P2239, DOI 10.1097/00001756-200312020-00021; Doricchi F, 2000, CORTEX, V36, P337, DOI 10.1016/S0010-9452(08)70845-1; Driver J, 2000, J COGNITIVE NEUROSCI, V12, P542, DOI 10.1162/089892900562192; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Farne A, 2004, J NEUROL NEUROSUR PS, V75, P1401, DOI 10.1136/jnnp.2002.003095; Gaffan D, 1997, BRAIN, V120, P1647, DOI 10.1093/brain/120.9.1647; Gandola M, 2011, CORTEX; Gottesman RF, 2008, NEUROLOGY, V71, P1439, DOI 10.1212/01.wnl.0000327888.48230.d2; HALLIGAN PW, 1994, NEUROPSYCHOLOGIA, V32, P13, DOI 10.1016/0028-3932(94)90065-5; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; HEILMAN KM, 1979, ANN NEUROL, V5, P166, DOI 10.1002/ana.410050210; Heinke D, 2003, PSYCHOL REV, V110, P29, DOI 10.1037//0033-295X.110.1.29; Hillis AE, 2000, NEUROLOGY, V55, P782, DOI 10.1212/WNL.55.6.782; Hillis AE, 2005, J NEUROSCI, V25, P3161, DOI 10.1523/JNEUROSCI.4468-04.2005; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Humphreys G. W., 2012, BIRMINGHAM COGNITIVE; Humphreys GW, 1998, PHILOS T R SOC B, V353, P1341, DOI 10.1098/rstb.1998.0288; HUMPHREYS GW, 1994, COGNITIVE NEUROPSYCH, V11, P207, DOI 10.1080/02643299408251974; HUMPHREYS GW, 1995, COGNITIVE NEUROPSYCH, V12, P283, DOI 10.1080/02643299508252000; Jehkonen M, 1998, LANCET, V351, P727, DOI 10.1016/S0140-6736(05)78497-X; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Karnath HO, 2011, BRAIN, V134, P903, DOI 10.1093/brain/awq355; Karnath HO, 2009, CEREB CORTEX, V19, P2331, DOI 10.1093/cercor/bhn250; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Karnath HO, 2005, BRAIN, V128, P2462, DOI 10.1093/brain/awh629; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; KERTESZ A, 1981, Journal of Clinical Neuropsychology, V3, P283, DOI 10.1080/01688638108403133; Khurshid S, 2011, CORTEX; Kiebel S., 2003, HUMAN BRAIN FUNCTION, P725; Kleinman JT, 2007, BRAIN COGNITION, V64, P50, DOI 10.1016/j.bandc.2006.10.005; Kortte K, 2009, CURR NEUROL NEUROSCI, V9, P459, DOI 10.1007/s11910-009-0068-8; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; LEVINE DN, 1986, NEUROLOGY, V36, P362, DOI 10.1212/WNL.36.3.362; Luaute J, 2006, NEUROSCI BIOBEHAV R, V30, P961, DOI 10.1016/j.neubiorev.2006.03.001; Maguire AM, 2002, NEUROPSYCHOLOGIA, V40, P879, DOI 10.1016/S0028-3932(01)00169-5; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marsh EB, 2008, CORTEX, V44, P1215, DOI 10.1016/j.cortex.2006.02.002; Medina J, 2009, J COGNITIVE NEUROSCI, V21, P2073, DOI 10.1162/jocn.2008.21160; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Olson CR, 2003, ANNU REV NEUROSCI, V26, P331, DOI 10.1146/annurev.neuro.26.041002.131405; Ota H, 2001, NEUROLOGY, V57, P2064, DOI 10.1212/WNL.57.11.2064; Petrides M, 2006, J COMP NEUROL, V498, P227, DOI 10.1002/cne.21048; Riddoch MJ, 2010, ANN NY ACAD SCI, V1191, P156, DOI 10.1111/j.1749-6632.2010.05448.x; RIDDOCH MJ, 1983, NEUROPSYCHOLOGIA, V21, P589, DOI 10.1016/0028-3932(83)90056-8; RIDDOCH MJ, 1995, COGNITIVE NEUROPSYCH, V12, P569, DOI 10.1080/02643299508252008; Rivers CS, 2006, STROKE, V37, P1418, DOI 10.1161/01.STR.0000221294.90068.c4; Saj A, 2012, BRAIN, V135, DOI 10.1093/brain/awr227; Samuelsson H, 1997, CORTEX, V33, P271, DOI 10.1016/S0010-9452(08)70004-2; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN, Vxviii, P654; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Silvetti M, 2007, NEUROPSYCHOLOGIA, V45, P2553, DOI 10.1016/j.neuropsychologia.2007.03.012; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; STONE SP, 1992, J NEUROL NEUROSUR PS, V55, P431, DOI 10.1136/jnnp.55.6.431; Thiebaut de Schotten M, 2008, CORTEX, V44, P1097, DOI 10.1016/j.cortex.2008.02.003; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Ticini LF, 2010, J COGNITIVE NEUROSCI, V22, P2141, DOI 10.1162/jocn.2009.21315; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Vallar Giuseppe, 2003, Adv Neurol, V93, P293; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; Vuilleumier P, 1998, ANN NEUROL, V43, P406, DOI 10.1002/ana.410430324; Walker R, 1996, CORTEX, V32, P279, DOI 10.1016/S0010-9452(96)80051-7; Walker R, 1996, COGNITIVE NEUROPSYCH, V13, P569; Wardlaw JM, 2004, BRIT MED J, V328, P655, DOI 10.1136/bmj.328.7441.655; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Worsley K. J., 2003, HUMAN BRAIN FUNCTION, P881	91	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e47821	10.1371/journal.pone.0047821	http://dx.doi.org/10.1371/journal.pone.0047821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133604	Green Published, gold, Green Submitted			2022-12-25	WOS:000310601300003
J	O'Farrell, B; Haase, JK; Velayudhan, V; Murphy, RA; Achtman, M				O'Farrell, Brian; Haase, Jana K.; Velayudhan, Vimalkumar; Murphy, Ronan A.; Achtman, Mark			Transforming Microbial Genotyping: A Robotic Pipeline for Genotyping Bacterial Strains	PLOS ONE			English	Article							INFORMATION-MANAGEMENT-SYSTEM; AUTOMATION; LIMS; DNA; PURIFICATION; WORKFLOWS	Microbial genotyping increasingly deals with large numbers of samples, and data are commonly evaluated by unstructured approaches, such as spread-sheets. The efficiency, reliability and throughput of genotyping would benefit from the automation of manual manipulations within the context of sophisticated data storage. We developed a medium-throughput genotyping pipeline for MultiLocus Sequence Typing (MLST) of bacterial pathogens. This pipeline was implemented through a combination of four automated liquid handling systems, a Laboratory Information Management System (LIMS) consisting of a variety of dedicated commercial operating systems and programs, including a Sample Management System, plus numerous PYTHON scripts. All tubes and microwell racks were bar-coded and their locations and status were recorded in the LIMS. We also created a hierarchical set of items that could be used to represent bacterial species, their products and experiments. The LIMS allowed reliable, semi-automated, traceable bacterial genotyping from initial single colony isolation and sub-cultivation through DNA extraction and normalization to PCRs, sequencing and MLST sequence trace evaluation. We also describe robotic sequencing to facilitate cherrypicking of sequence dropouts. This pipeline is user-friendly, with a throughput of 96 strains within 10 working days at a total cost of < (sic)25 per strain. Since developing this pipeline, >200,000 items were processed by two to three people. Our sophisticated automated pipeline can be implemented by a small microbiology group without extensive external support, and provides a general framework for semi-automated bacterial genotyping of large numbers of samples at low cost.	[O'Farrell, Brian; Haase, Jana K.; Velayudhan, Vimalkumar; Murphy, Ronan A.; Achtman, Mark] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland	University College Cork	O'Farrell, B (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland.	b.ofarrell@ucc.ie; j.haase@ucc.ie; m.achtman@ucc.ie		Achtman, Mark/0000-0001-6815-0070; Murphy, Ronan/0000-0001-7274-6563; Velayudhan, Vimalkumar/0000-0002-3307-2938	Science Foundation Ireland [05/FE1/B882]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Science Foundation Ireland (grant number 05/FE1/B882 to MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Anderson NR, 2007, J AM MED INFORM ASSN, V14, P478, DOI 10.1197/jamia.M2114; Andre G, 2010, J DAIRY SCI, V93, P942, DOI 10.3168/jds.2009-2373; Blow N, 2008, NAT METHODS, V5, P109, DOI 10.1038/nmeth0108-109; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Clarke SC, 2002, BIOESSAYS, V24, P858, DOI 10.1002/bies.10142; Clarke SC, 2002, MOL BIOTECHNOL, V21, P221, DOI 10.1385/MB:21:3:221; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Greub G, 2011, CLIN MICROBIOL INFEC, V17, P655, DOI 10.1111/j.1469-0691.2011.03513.x; Haase JK, 2011, ENVIRON MICROBIOL, V13, P3163, DOI 10.1111/j.1462-2920.2011.02610.x; Huang YW, 2011, BIOINFORMATICS, V27, P437, DOI 10.1093/bioinformatics/btq676; Jayashree B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-383; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; McGrath TF, 2012, ANAL BIOANAL CHEM, V403, P75, DOI 10.1007/s00216-011-5685-9; Meldrum D, 2000, GENOME RES, V10, P1081, DOI 10.1101/gr.101400; Milisavljevic M, 2010, MAMM GENOME, V21, P224, DOI 10.1007/s00335-010-9258-6; Morris JA, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-4; *R DEV COR TEAM, R LANG ENV STAT COMP; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Russom D, 2012, CYTOTHERAPY, V14, P114, DOI 10.3109/14653249.2011.619007; Soldatova LN, 2006, BIOINFORMATICS, V22, pE464, DOI 10.1093/bioinformatics/btl207; Song YJ, 2010, J ANTIMICROB CHEMOTH, V65, P1631, DOI 10.1093/jac/dkq175; Sparkes A, 2012, BIOINFORMATICS, V28, P1390, DOI 10.1093/bioinformatics/bts140; Sullivan CB, 2006, MOL BIOTECHNOL, V32, P219, DOI 10.1385/MB:32:3:219; Szymanski P, 2012, INT J MOL SCI, V13, P427, DOI 10.3390/ijms13010427; Vu TD, 2012, INTEGR BIOL-UK, V4, P744, DOI 10.1039/c2ib00146b; Tolopko AN, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-260; Troshin Peter V, 2011, BMC Res Notes, V4, P48, DOI 10.1186/1756-0500-4-48; Voegele C, 2007, BIOINFORMATICS, V23, P2504, DOI 10.1093/bioinformatics/btm365; Voegele C, 2010, BIOINFORMATICS, V26, P2798, DOI 10.1093/bioinformatics/btq502; Wurdemann HA, 2011, TRENDS FOOD SCI TECH, V22, P14, DOI 10.1016/j.tifs.2010.10.003; Zolnai Zsolt, 2003, Journal of Structural and Functional Genomics, V4, P11, DOI 10.1023/A:1024684404761	35	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48022	10.1371/journal.pone.0048022	http://dx.doi.org/10.1371/journal.pone.0048022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144721	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300032
J	Russo, D; Cistrone, L; Jones, G				Russo, Danilo; Cistrone, Luca; Jones, Gareth			Sensory Ecology of Water Detection by Bats: A Field Experiment	PLOS ONE			English	Article							BROWN BATS; ECHOLOCATION; CHIROPTERA; BEHAVIOR; VISION; ENERGY; WINTER	Bats face a great risk of dehydration, so sensory mechanisms for water recognition are crucial for their survival. In the laboratory, bats recognized any smooth horizontal surface as water because these provide analogous reflections of echolocation calls. We tested whether bats also approach smooth horizontal surfaces other than water to drink in nature by partly covering watering troughs used by hundreds of bats with a Perspex layer mimicking water. We aimed 1) to confirm that under natural conditions too bats mistake any horizontal smooth surface for water by testing this on large numbers of individuals from a range of species and 2) to assess the occurrence of learning effects. Eleven bat species mistook Perspex for water relying chiefly on echoacoustic information. Using black instead of transparent Perspex did not deter bats from attempting to drink. In Barbastella barbastellus no echolocation differences occurred between bats approaching the water and the Perspex surfaces respectively, confirming that bats perceive water and Perspex to be acoustically similar. The drinking attempt rates at the fake surface were often lower than those recorded in the laboratory: bats then either left the site or moved to the control water surface. This suggests that bats modified their behaviour as soon as the lack of drinking reward had overridden the influence of echoacoustic information. Regardless of which of two adjoining surfaces was covered, bats preferentially approached and attempted to drink from the first surface encountered, probably because they followed a common route, involving spatial memory and perhaps social coordination. Overall, although acoustic recognition itself is stereotyped and its importance in the drinking process overwhelming, our findings point at the role of experience in increasing behavioural flexibility under natural conditions.	[Russo, Danilo] Univ Napoli Federico II Portici, Dipartimento Ar Bo Pa Ve, Lab Ecol Applicata, Fac Agr, Naples, Italy; [Russo, Danilo; Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Naples Federico II; University of Bristol	Russo, D (corresponding author), Univ Napoli Federico II Portici, Dipartimento Ar Bo Pa Ve, Lab Ecol Applicata, Fac Agr, Naples, Italy.	danrusso@unina.it	Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Russo, Danilo/0000-0002-1934-7130	Abruzzo, Lazio and Molise National Park [168 12]	Abruzzo, Lazio and Molise National Park	DR was funded by the Abruzzo, Lazio and Molise National Park (Project: Bats and Forestry, contract n 168 12 April 2010). www.parcoabruzzo.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2002, ACTA CHIROPTEROL, V4, P195, DOI 10.3161/001.004.0211; Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; BARCLAY RMR, 1994, AM NAT, V144, P1021, DOI 10.1086/285723; BELL GP, 1986, ANIM BEHAV, V34, P409, DOI 10.1016/S0003-3472(86)80110-5; Bernard RTF, 1996, S AFR J ZOOL, V31, P218; Boyles JG, 2006, MAMMAL REV, V36, P267, DOI 10.1111/j.1365-2907.2006.00095.x; Bravo A, 2010, J TROP ECOL, V26, P173, DOI 10.1017/S0266467409990472; CHEW ROBERT M., 1960, JOUR MAMMAL, V41, P452, DOI 10.2307/1377532; Denzinger A, 2001, J COMP PHYSIOL A, V187, P521, DOI 10.1007/s003590100223; Eklof J, 2003, ANIM BEHAV, V66, P949, DOI 10.1006/anbe.2003.2272; Eklof J., 2003, THESIS GOTEBORG U; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Goerlitz HR, 2012, BEHAV PROCESS, V89, P61, DOI 10.1016/j.beproc.2011.10.018; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Holland RA, 2007, BEHAVIOUR, V144, P1053, DOI 10.1163/156853907781871842; Huitema BE, 1980, ANAL COVARIANCE ITS; KALKO EKV, 1989, BEHAV ECOL SOCIOBIOL, V24, P225, DOI 10.1007/BF00295202; KWIECINSKI GG, 1987, AM J ANAT, V178, P410, DOI 10.1002/aja.1001780410; Munoz-Garcia A, 2012, COMP BIOCHEM PHYS A, V161, P208, DOI 10.1016/j.cbpa.2011.10.025; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; Orbach DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013912; QUADE D, 1982, BIOMETRICS, V38, P597, DOI 10.2307/2530042; Rainho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019227; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Rydell J, 2003, NATURWISSENSCHAFTEN, V90, P481, DOI 10.1007/s00114-003-0464-x; SCHMIDT S, 1988, NATURE, V331, P617, DOI 10.1038/331617a0; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Siemers Bjoern M., 2009, P373; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SPEAKMAN JR, 1989, J ANIM ECOL, V58, P797, DOI 10.2307/5125; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; SUTHERS RA, 1966, SCIENCE, V152, P1102, DOI 10.1126/science.152.3725.1102; THOMAS DW, 1992, PHYSIOL ZOOL, V65, P443, DOI 10.1086/physzool.65.2.30158262; Vaughan Nancy, 1997, Bioacoustics, V7, P189; Voigt CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002011; Wolff JO, 2003, BIOSCIENCE, V53, P421, DOI 10.1641/0006-3568(2003)053[0421:LSWRFO]2.0.CO;2	38	32	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48144	10.1371/journal.pone.0048144	http://dx.doi.org/10.1371/journal.pone.0048144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133558	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800048
J	Yadav, V; Sultana, S; Yadav, J; Saini, N				Yadav, Vikas; Sultana, Sarwat; Yadav, Jyoti; Saini, Neeru			Gatifloxacin Induces S and G(2)-Phase Cell Cycle Arrest in Pancreatic Cancer Cells via p21/p27/p53	PLOS ONE			English	Article							TGF-BETA; SMAD PROTEINS; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS; CIPROFLOXACIN; CARCINOMA; APOPTOSIS; GROWTH; LINE; MOXIFLOXACIN	Pancreatic cancer, despite being the most dreadful among gastrointestinal cancers, is poorly diagnosed, and further, the situation has been aggravated owing to acquired drug resistance against the single known drug therapy. While previous studies have highlighted the growth inhibitory effects of older generation fluoroquinolones, the current study aims to evaluate the growth inhibitory effects of newer generation fluoroquinolone, Gatifloxacin, on pancreatic cancer cell lines MIA PaCa-2 and Panc-1 as well as to elucidate the underlying molecular mechanisms. Herein, we report that Gatifloxacin suppresses the proliferation of MIA PaCa-2 and Panc-1 cells by causing S and G(2)-phase cell cycle arrest without induction of apoptosis. Blockade in S-phase of the cell cycle was associated with increased TGF-beta 1 expression and translocation of Smad3-4 complex to the nucleus with subsequent activation of p21 in MIA PaCa-2 cells, whereas TGF-beta signalling attenuated Panc-1 cells showed S-phase arrest by direct activation of p27. However, Gatifloxacin mediated G(2)-phase cell cycle arrest was found to be p53 dependent in both the cell lines. Our study is of interest because fluoroquinolones have the ability to penetrate pancreatic tissue which can be very effective in combating pancreatic cancers that are usually associated with loss or downregulation of CDK inhibitors p21/p27 as well as mutational inactivation of p53. Additionally, Gatifloxacin was also found to synergize the effect of Gemcitabine, the only known drug against pancreatic cancer, as well as the broad spectrum anticancer drug cisplatin. Taken together our results suggest that Gatifloxacin possesses anticancer activities against pancreatic cancer and is a promising candidate to be repositioned from broad spectrum antibiotics to anticancer agent.	[Yadav, Vikas; Yadav, Jyoti; Saini, Neeru] Inst Genom & Integrat Biol CSIR, Delhi, India; [Yadav, Vikas; Sultana, Sarwat] Jamia Hamdard, Dept Med Elementol & Toxicol, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Jamia Hamdard University	Yadav, J (corresponding author), Inst Genom & Integrat Biol CSIR, Mall Rd, Delhi, India.	j.yadav@igib.res.in; nsaini@igib.in	yadav, vikas/AAZ-7364-2021	yadav, vikas/0000-0003-4353-3731	Council of Scientific and Industrial Research (CSIR), India [NWP-13, EXP0011]; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants (NWP-13 and EXP0011) from the Council of Scientific and Industrial Research (CSIR), India. VY was supported with Senior Research Fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam U, 2001, INFECTION, V29, P326, DOI 10.1007/s15010-001-1158-y; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Aranha O, 2000, CLIN CANCER RES, V6, P891; Aranha O, 2003, INT J ONCOL, V22, P787; Bao PQ, 2011, 3 ERRATUM PHASE 2 ST; BARTON CM, 1991, BRIT J CANCER, V64, P1076, DOI 10.1038/bjc.1991.467; Bourikas LA, 2009, BRIT J PHARMACOL, V157, P362, DOI 10.1111/j.1476-5381.2009.00161.x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Colucci G, 2002, CANCER, V94, P902, DOI 10.1002/cncr.10323.abs; Drlica K, 1999, CURR OPIN MICROBIOL, V2, P504, DOI 10.1016/S1369-5274(99)00008-9; Duffy John P, 2003, Mol Cancer, V2, P12, DOI 10.1186/1476-4598-2-12; Fabian I, 2006, BRIT J CANCER, V95, P1038, DOI 10.1038/sj.bjc.6603355; Fahy BN, 2003, BRIT J CANCER, V89, P391, DOI 10.1038/sj.bjc.6601037; Goel A, 2007, FEBS LETT, V581, P2447, DOI 10.1016/j.febslet.2007.04.052; Goel A, 2009, CHEM-BIOL INTERACT, V179, P363, DOI 10.1016/j.cbi.2008.10.060; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; GRANA X, 1995, ONCOGENE, V11, P211; Hahm KB, 2000, J CLIN INVEST, V105, P1057, DOI 10.1172/JCI8337; Heinemann V, 2000, ANN ONCOL, V11, P1399, DOI 10.1023/A:1026595525977; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Herold C, 2002, BRIT J CANCER, V86, P443, DOI 10.1038/sj.bjc.6600079; Jin YH, 2003, CARCINOGENESIS, V24, P1767, DOI 10.1093/carcin/bgg097; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Jun YT, 2003, ANTIMICROB AGENTS CH, V47, P1161, DOI 10.1128/AAC.47.3.1161-1164.2003; Khan AA, 2001, ANTIMICROB AGENTS CH, V45, P48, DOI 10.1128/AAC.45.1.48-51.2001; KHODURSKY AB, 1995, P NATL ACAD SCI USA, V92, P11801, DOI 10.1073/pnas.92.25.11801; Kim MP, 2008, CLIN CANCER RES, V14, P1284, DOI 10.1158/1078-0432.CCR-07-2247; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LILLEMOE KD, 1995, ANN SURG, V221, P133, DOI 10.1097/00000658-199502000-00003; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Maeda SI, 2007, INT J UROL, V14, P422, DOI 10.1111/j.1442-2042.2007.01750.x; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Mondal E R, 2004, Asian Pac J Cancer Prev, V5, P196; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; PALMER KR, 1994, BRIT J SURG, V81, P882, DOI 10.1002/bjs.1800810629; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piercy T, 2005, J ANTIMICROB CHEMOTH, V56, P1069, DOI 10.1093/jac/dki359; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reuveni D, 2010, INT J ONCOL, V37, P463, DOI 10.3892/ijo_00000695; Reuveni D, 2010, BIOCHEM PHARMACOL, V79, P1100, DOI 10.1016/j.bcp.2009.12.001; Riall TS, 2006, SURGERY, V140, P764, DOI 10.1016/j.surg.2006.04.006; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; SHEN LL, 1989, BIOCHEMISTRY-US, V28, P3879, DOI 10.1021/bi00435a038; Takeyama K, 2007, ANTIMICROB AGENTS CH, V51, P162, DOI 10.1128/AAC.00395-06; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wagner M, 1998, INT J CANCER, V78, P255, DOI 10.1002/(SICI)1097-0215(19981005)78:2<255::AID-IJC21>3.0.CO;2-8	54	65	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47796	10.1371/journal.pone.0047796	http://dx.doi.org/10.1371/journal.pone.0047796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133524	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800017
J	Quizi, JL; Baron, K; Al-Zahrani, KN; O'Reilly, P; Sriram, RK; Conway, J; Laurin, AA; Sabourin, LA				Quizi, J. L.; Baron, K.; Al-Zahrani, K. N.; O'Reilly, P.; Sriram, R. K.; Conway, J.; Laurin, A-A; Sabourin, L. A.			SLK-mediated phosphorylation of paxillin is required for focal adhesion turnover and cell migration	ONCOGENE			English	Article						Ste20; kinase; paxillin; phosphorylation; migration	STE20-LIKE KINASE SLK; EARLY MOLECULAR EVENTS; MICROTUBULE CATASTROPHES; REGULATES ADHESION; ASSOCIATION; ACTIVATION; COMPLEX	Focal adhesion turnover is a complex process required for cell migration. We have previously shown that the Ste20-like kinase (SLK) is required for cell migration and efficient focal adhesion (FA) turnover in a FA kinase (FAK)-dependent manner. However, the role of SLK in this process remains unclear. Using a candidate substrate approach, we show that SLK phosphorylates the adhesion adapter protein paxillin on serine 250. Serine 250 phosphorylation is required for paxillin redistribution and cell motility. Mutation of paxillin serine 250 prevents its phosphorylation by SLK in vitro and results in impaired migration in vivo as evidenced by an accumulation of phospho-FAK-Tyr397 and altered FA turnover rates. Together, our data suggest that SLK phosphorylation of paxillin on serine 250 is required for FAK-dependent FA dynamics.	[Quizi, J. L.; Baron, K.; Al-Zahrani, K. N.; O'Reilly, P.; Sriram, R. K.; Sabourin, L. A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Quizi, J. L.; Baron, K.; Al-Zahrani, K. N.; Sriram, R. K.; Conway, J.; Laurin, A-A; Sabourin, L. A.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON K1H 8L6, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Sabourin, LA (corresponding author), Ottawa Hosp Res Inst, Canc Therapeut Program, 501 Smyth Rd,Box 926, Ottawa, ON K1H 8L6, Canada.	lsabourin@ohri.ca		, Jillian/0000-0003-4354-0026; Baron, Kyla/0000-0002-8859-9251	Canadian Institute for Health Research; Canadian Breast Cancer Foundation; OGSST	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); OGSST	This work was supported by the Canadian Institute for Health Research and the Canadian Breast Cancer Foundation. JLQ, KB and KNA-Z are the recipient of a Canadian Breast Cancer Foundation scholar award. LAS is the recipient of a CIHR scholar award. PO is the recipient of an OGSST studentship.	Abou Zeid Nancy, 2006, Cell Commun Signal, V4, P8, DOI 10.1186/1478-811X-4-8; Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Brown MC, 2002, INT J BIOCHEM CELL B, V34, P855, DOI 10.1016/S1357-2725(01)00154-6; Canas Benito, 2006, Briefings in Functional Genomics & Proteomics, V4, P295, DOI 10.1093/bfgp/eli002; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; Efimov A, 2009, CELL ADHES MIGR, V3, P285, DOI 10.4161/cam.3.3.8858; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Loyet KM, 2005, MOL CELL PROTEOMICS, V4, P235, DOI 10.1074/mcp.R400011-MCP200; Manes S, 2000, IUBMB LIFE, V49, P89; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Roovers K, 2009, ONCOGENE, V28, P2839, DOI 10.1038/onc.2009.146; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Storbeck CJ, 2009, MOL BIOL CELL, V20, P4174, DOI 10.1091/mbc.E08-07-0707; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Wagner S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001868; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb DJ, 2005, J CELL SCI, V118, P4925, DOI 10.1242/jcs.02563; Wu Hsin-Yi, 2008, Chang Gung Med J, V31, P217; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	36	28	29	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2013	32	39					4656	4663		10.1038/onc.2012.488	http://dx.doi.org/10.1038/onc.2012.488			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23128389	Green Submitted			2022-12-25	WOS:000325072200007
J	Valentin-Hansen, L; Holst, B; Frimurer, TM; Schwartz, TW				Valentin-Hansen, Louise; Holst, Birgitte; Frimurer, Thomas M.; Schwartz, Thue W.			PheVI:09 (Phe6.44) as a Sliding Microswitch in Seven-transmembrane (7TM) G Protein-coupled Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING-SITES; GLYCINE 121; DRY MOTIF; SWITCH; RHODOPSIN; IDENTIFICATION; MECHANISM; RESIDUES; TMVI	In seven-transmembrane (7TM), G protein-coupled receptors, highly conserved residues function as microswitches, which alternate between different conformations and interaction partners in an extended allosteric interface between the transmembrane segments performing the large scale conformational changes upon receptor activation. Computational analysis using x-ray structures of the beta(2)-adrenergic receptor demonstrated that PheVI:09 (6.44), which in the inactive state is locked between the backbone and two hydrophobic residues in transmembrane (TM)-III, upon activation slides similar to 2 angstrom toward TM-V into a tight pocket generated by five hydrophobic residues protruding from TM-III and TM-V. Of these, the residue in position III:16 (3.40) (often an Ile or Val) appears to function as a barrier or gate for the transition between inactive and active conformation. Mutational analysis showed that PheVI:09 is essential for the constitutive and/or agonist-induced signaling of the ghrelin receptor, GPR119, the beta(2)-adrenergic receptor, and the neurokinin-1 receptor. Substitution of the residues constituting the hydrophobic pocket between TM-III and TM-V in the ghrelin receptor in four of five positions impaired receptor signaling. In GPR39, representing the 12% of 7TM receptors lacking an aromatic residue at position VI:09, unchanged agonist-induced signaling was observed upon Ala substitution of LeuVI:09 despite reduced cell surface expression of the mutant receptor. It is concluded that PheVI:09 constitutes an aromatic microswitch that stabilizes the active, outward tilted conformation of TM-VI relative to TM-III by sliding into a tight hydrophobic pocket between TM-III and TM-V and that the hydrophobic residue in position III:16 constitutes a gate for this transition.	[Valentin-Hansen, Louise; Holst, Birgitte; Schwartz, Thue W.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Panum Inst, DK-2200 Copenhagen, Denmark; [Valentin-Hansen, Louise; Holst, Birgitte; Frimurer, Thomas M.; Schwartz, Thue W.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Schwartz, TW (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Panum Inst, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	tws@sund.ku.dk		Holst, Birgitte/0000-0001-7432-097X; Frimruer, Thomas/0000-0002-9682-8245; Schwartz, Thue W./0000-0002-0261-6904	Novo Nordisk Foundation; Faculty of Health Sciences at the University of Copenhagen	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Faculty of Health Sciences at the University of Copenhagen	The Novo Nordisk Foundation Center for Basic Metabolic Research is supported by an unconditional grant from the Novo Nordisk Foundation to the Faculty of Health Sciences at the University of Copenhagen.; Recipient of a Ph.D. scholarship from the Faculty of Health Sciences at the University of Copenhagen.	Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen SH, 2002, BIOCHEMISTRY-US, V41, P6045, DOI 10.1021/bi012189c; Chen SH, 2002, BIOCHEMISTRY-US, V41, P588, DOI 10.1021/bi011868k; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jagerschmidt A, 1998, MOL PHARMACOL, V53, P878; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seibold A, 1998, RECEPTOR CHANNEL, V5, P375; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P31973, DOI 10.1074/jbc.M112.348565; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	34	27	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43516	43526		10.1074/jbc.M112.395137	http://dx.doi.org/10.1074/jbc.M112.395137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135271	Green Published, hybrid			2022-12-25	WOS:000312940800032
J	Bychkov, E; Zurkovsky, L; Garret, MB; Ahmed, MR; Gurevich, EV				Bychkov, Evgeny; Zurkovsky, Lilia; Garret, Mika B.; Ahmed, Mohamed R.; Gurevich, Eugenia V.			Distinct Cellular and Subcellular Distributions of G Protein-Coupled Receptor Kinase and Arrestin Isoforms in the Striatum	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; BETA-ARRESTINS; SELECTIVE REGULATION; HOMOLOGY DOMAIN; 2 GRK2; EXPRESSION; LOCALIZATION; DESENSITIZATION; D1; SUPERSENSITIVITY	G protein-coupled receptor kinases (GRKs) and arrestins mediate desensitization of G protein-coupled receptors (GPCR). Arrestins also mediate G protein-independent signaling via GPCRs. Since GRK and arrestins demonstrate no strict receptor specificity, their functions in the brain may depend on their cellular complement, expression level, and subcellular targeting. However, cellular expression and subcellular distribution of GRKs and arrestins in the brain is largely unknown. We show that GRK isoforms GRK2 and GRK5 are similarly expressed in direct and indirect pathway neurons in the rat striatum. Arrestin-2 and arrestin-3 are also expressed in neurons of both pathways. Cholinergic interneurons are enriched in GRK2, arrestin-3, and GRK5. Parvalbumin-positive interneurons express more of GRK2 and less of arrestin-2 than medium spiny neurons. The GRK5 subcellular distribution in the human striatal neurons is altered by its phosphorylation: unphosphorylated enzyme preferentially localizes to synaptic membranes, whereas phosphorylated GRK5 is found in plasma membrane and cytosolic fractions. Both GRK isoforms are abundant in the nucleus of human striatal neurons, whereas the proportion of both arrestins in the nucleus was equally low. However, overall higher expression of arrestin-2 yields high enough concentration in the nucleus to mediate nuclear functions. These data suggest cell type-and subcellular compartment-dependent differences in GRK/arrestin-mediated desensitization and signaling.	[Bychkov, Evgeny; Zurkovsky, Lilia; Garret, Mika B.; Ahmed, Mohamed R.; Gurevich, Eugenia V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, EV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	Eugenia.Gurevich@vanderbilt.edu	Bychkov, Evgenii/AAH-1890-2021	Bychkov, Evgenii/0000-0002-8911-6805	National Institute of Health [NS065868, DA030103, MH068855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030103] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute of Health grants NS065868 and DA030103 (to EVG) and MH068855 (funding for Harvard Brain Tissue Resource Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2008, J NEUROCHEM, V104, P1622, DOI 10.1111/j.1471-4159.2007.05104.x; Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; ARRIZA JL, 1992, J NEUROSCI, V12, P4045; BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bezard E, 2005, NEUROBIOL DIS, V18, P323, DOI 10.1016/j.nbd.2004.10.005; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2003, J NEUROSCI, V23, P10265; Bordet R, 1997, P NATL ACAD SCI USA, V94, P3363, DOI 10.1073/pnas.94.7.3363; Bychkov ER, 2008, NEUROBIOL AGING, V29, P379, DOI 10.1016/j.neurobiolaging.2006.10.012; Bychkov ER, 2011, NEUROBIOL DIS, V44, P248, DOI 10.1016/j.nbd.2011.07.009; Bychkov E, 2011, INT J NEUROPSYCHOPH, V14, P1, DOI 10.1017/S1461145710000118; Cai XJ, 2009, MOL PHARMACOL, V75, P626, DOI 10.1124/mol.108.050278; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; CHUANG TT, 1995, J BIOL CHEM, V270, P18660, DOI 10.1074/jbc.270.31.18660; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Daigle TL, 2012, J NEUROSCI, V32, P11461, DOI 10.1523/JNEUROSCI.2234-12.2012; Day PW, 2003, BIOCHEMISTRY-US, V42, P9176, DOI 10.1021/bi034442+; Deep-Soboslay A, 2011, BIOL PSYCHIAT, V69, P104, DOI 10.1016/j.biopsych.2010.05.025; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Gerfen CR, 1995, J NEUROSCI, V15, P8167; Gerfen CR, 2000, ANN NEUROL, V47, pS42; Gurevich E.V., 2011, PHARMACOL THERAPEUT, V133, P40; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2010, RECEPT SER, P525, DOI 10.1007/978-1-60327-333-6_18; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Hoeppner CZ, 2012, J BIOL CHEM, V287, P8932, DOI 10.1074/jbc.M111.294058; Iaccarino G, 1998, AM J PHYSIOL-HEART C, V275, pH1298, DOI 10.1152/ajpheart.1998.275.4.H1298; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Macey TA, 2005, J NEUROCHEM, V93, P128, DOI 10.1111/j.1471-4159.2004.02998.x; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Mo W, 2008, MOL CELL, V31, P695, DOI 10.1016/j.molcel.2008.06.017; Picascia A, 2004, METHOD ENZYMOL, V390, P337; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Raehal KM, 2009, DRUG ALCOHOL DEPEN, V104, P187, DOI 10.1016/j.drugalcdep.2009.04.011; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Terman GW, 2004, BRIT J PHARMACOL, V141, P55, DOI 10.1038/sj.bjp.0705595; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P901, DOI 10.1189/jlb.0403136; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P698, DOI 10.1189/jlb.0703320; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Winstel R, 1996, P NATL ACAD SCI USA, V93, P2105, DOI 10.1073/pnas.93.5.2105	66	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48912	10.1371/journal.pone.0048912	http://dx.doi.org/10.1371/journal.pone.0048912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139825	gold, Green Published, Green Submitted			2022-12-25	WOS:000311315300063
J	Lhotakova, Y; Plistil, L; Moravkova, A; Kubat, P; Lang, K; Forstova, J; Mosinger, J				Lhotakova, Yveta; Plistil, Lukas; Moravkova, Alena; Kubat, Pavel; Lang, Kamil; Forstova, Jitka; Mosinger, Jiri			Virucidal Nanofiber Textiles Based on Photosensitized Production of Singlet Oxygen	PLOS ONE			English	Article							AMINO-ACIDS; POLYOMAVIRUS; POLYMER; INACTIVATION; NANOFABRICS; REACTIVITY; PORPHYRIN; MEMBRANE	Novel biomaterials based on hydrophilic polycaprolactone and polyurethane (Tecophilic (R)) nanofibers with an encapsulated 5,10,5,20-tetraphenylporphyrin photosensitizer were prepared by electrospinning. The doped nanofiber textiles efficiently photo-generate O-2((1)Delta(g)), which oxidize external chemical and biological substrates/targets. Strong photo-virucidal effects toward non-enveloped polyomaviruses and enveloped baculoviruses were observed on the surface of these textiles. The photo-virucidal effect was confirmed by a decrease in virus infectivity. In contrast, no virucidal effect was detected in the absence of light and/or the encapsulated photosensitizer.	[Lhotakova, Yveta; Plistil, Lukas; Moravkova, Alena; Forstova, Jitka; Mosinger, Jiri] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Kubat, Pavel] Acad Sci Czech Republ, Vvi, J Heyrovsky Inst Phys Chem, Prague, Czech Republic; [Lang, Kamil; Mosinger, Jiri] Acad Sci Czech Republ, Inst Inorgan Chem, Vvi, CZ-25068 Rez, Czech Republic; [Plistil, Lukas] Elmarco Sro, Liberec, Czech Republic	Charles University Prague; Czech Academy of Sciences; J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Inorganic Chemistry of the Czech Academy of Sciences	Forstova, J (corresponding author), Charles Univ Prague, Fac Sci, Prague, Czech Republic.	jitkaf@natur.cuni.cz; mosinger@natur.cuni.cz	Forstová, Jitka/L-7328-2017; Lang, Kamil/D-3050-2014; Kubat, Pavel/H-3655-2011; Mosinger, Jiri/F-7531-2011	Forstová, Jitka/0000-0003-0219-506X; Lang, Kamil/0000-0002-4151-8805; Kubat, Pavel/0000-0002-7861-9212; Mosinger, Jiri/0000-0001-5173-2744	Czech Science Foundation [P208/10/1678]; Ministry of Health [IGA NS/10093]; Ministry of Education, Youth and Sports of the Czech Republic [MSM 0021620857, 0021620858, LC545]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Health; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Czech Science Foundation (no. P208/10/1678), by the Ministry of Health (IGA NS/10093) and by the Ministry of Education, Youth and Sports of the Czech Republic (MSM 0021620857, 0021620858 and LC545). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atiyeh Bishara S., 2002, Current Pharmaceutical Biotechnology, V3, P179, DOI 10.2174/1389201023378283; Aubry JM, 2003, ACCOUNTS CHEM RES, V36, P668, DOI 10.1021/ar010086g; Babakir-Mina M, 2011, NEW MICROBIOL, V34, P1; BONNETT R, 1995, CHEM SOC REV, V24, P19, DOI 10.1039/cs9952400019; Brew BJ, 2010, NAT REV NEUROL, V6, P667, DOI 10.1038/nrneurol.2010.164; Cho M, 2010, ENVIRON SCI TECHNOL, V44, P6685, DOI 10.1021/es1014967; Dai T, 2009, PHOTODIAGN PHOTODYN, V6, P170, DOI 10.1016/j.pdpdt.2009.10.008; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038; DILWORTH SM, 1982, P NATL ACAD SCI-BIOL, V79, P1059, DOI 10.1073/pnas.79.4.1059; Dong SC, 2010, J VIROL, V84, P5351, DOI 10.1128/JVI.02517-09; Duan YY, 2007, J APPL POLYM SCI, V106, P1208, DOI 10.1002/app.26786; EGOROV SY, 1989, CHEM PHYS LETT, V163, P421, DOI 10.1016/0009-2614(89)85161-9; FORSTOVA J, 1993, J VIROL, V67, P1405; Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; HINK WF, 1970, NATURE, V226, P466, DOI 10.1038/226466b0; Hirsch HH, 2002, AM J TRANSPLANT, V2, P25, DOI 10.1034/j.1600-6143.2002.020106.x; Jesenska S, 2011, J BIOMED MATER RES A, V99A, P676, DOI 10.1002/jbm.a.33218; Jirsak O., 2005, WO Pat, Patent No. [WO/2005/024101, 2005024101, WO 2005/024101]; Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081; Korytowski W, 1999, PHOTOCHEM PHOTOBIOL, V70, P484; Lang K, 2004, COORDIN CHEM REV, V248, P321, DOI 10.1016/j.ccr.2004.02.004; Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719; Li ZF, 2009, J VIROL, V83, P10993, DOI 10.1128/JVI.01085-09; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Martins A, 2009, J TISSUE ENG REGEN M, V3, P37, DOI 10.1002/term.132; MICHAELI A, 1994, PHOTOCHEM PHOTOBIOL, V59, P284, DOI 10.1111/j.1751-1097.1994.tb05035.x; Mosinger J, 2007, J MATER CHEM, V17, P164, DOI 10.1039/b614617a; Mosinger J, 2010, J PHYS CHEM B, V114, P15773, DOI 10.1021/jp105789p; Mosinger J, 2010, LANGMUIR, V26, P10050, DOI 10.1021/la1001607; Mosinger J, 2009, J FLUORESC, V19, P705, DOI 10.1007/s10895-009-0464-0; Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d; Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; STRAIGHT R, 1978, PHOTOCHEM PHOTOBIOL, V27, P565, DOI 10.1111/j.1751-1097.1978.tb07647.x; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Triesscheijn M, 2006, ONCOLOGIST, V11, P1034, DOI 10.1634/theoncologist.11-9-1034; Turler H, 1985, VIROLOGY PRACTICAL A, P169; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Wang JP, 2011, ACS APPL MATER INTER, V3, P67, DOI 10.1021/am100862h; Wen WH, 2009, J MED CHEM, V52, P4903, DOI 10.1021/jm900515g; WILKINSON F, 1993, J PHYS CHEM REF DATA, V22, P113, DOI 10.1063/1.555934; Yarin AL, 2007, J MATER CHEM, V17, P2585, DOI 10.1039/b618508h	45	38	38	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e49226	10.1371/journal.pone.0049226	http://dx.doi.org/10.1371/journal.pone.0049226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139839	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300072
J	Huang, HB; Liu, NN; Guo, HP; Liao, SY; Li, XF; Yang, CS; Liu, ST; Song, WB; Liu, CJ; Guan, LX; Li, B; Xu, L; Zhang, CG; Wang, XJ; Dou, QP; Liu, JB				Huang, Hongbiao; Liu, Ningning; Guo, Haiping; Liao, Siyan; Li, Xiaofen; Yang, Changshan; Liu, Shouting; Song, Wenbin; Liu, Chunjiao; Guan, Lixia; Li, Bing; Xu, Li; Zhang, Change; Wang, Xuejun; Dou, Q. Ping; Liu, Jinbao			L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITORS; LYSINE ACETYLATION; ANTITUMOR-ACTIVITY; PHOSPHORYLATION; APOPTOSIS; SUPPLEMENTATION; UBIQUITINATION; DEGRADATION; CROSSTALK	L-carnitine (LC) is generally believed to transport long-chain acyl groups from fatty acids into the mitochondrial matrix for ATP generation via the citric acid cycle. Based on Warburg's theory that most cancer cells mainly depend on glycolysis for ATP generation, we hypothesize that, LC treatment would lead to disturbance of cellular metabolism and cytotoxicity in cancer cells. In this study, Human hepatoma HepG2, SMMC-7721 cell lines, primary cultured thymocytes and mice bearing HepG2 tumor were used. ATP content was detected by HPLC assay. Cell cycle, cell death and cell viability were assayed by flow cytometry and MTS respectively. Gene, mRNA expression and protein level were detected by gene microarray, Real-time PCR and Western blot respectively. HDAC activities and histone acetylation were detected both in test tube and in cultured cells. A molecular docking study was carried out with CDOCKER protocol of Discovery Studio 2.0 to predict the molecular interaction between L-carnitine and HDAC. Here we found that (1) LC treatment selectively inhibited cancer cell growth in vivo and in vitro; (2) LC treatment selectively induces the expression of p21(cip1) gene, mRNA and protein in cancer cells but not p27(kip1); (4) LC increases histone acetylation and induces accumulation of acetylated histones both in normal thymocytes and cancer cells; (5) LC directly inhibits HDAC I/II activities via binding to the active sites of HDAC and induces histone acetylation and lysine-acetylation accumulation in vitro; (6) LC treatment induces accumulation of acetylated histones in chromatin associated with the p21(cip1) gene but not p27(kip1) detected by ChIP assay. These data support that LC, besides transporting acyl group, works as an endogenous HDAC inhibitor in the cell, which would be of physiological and pathological importance.	[Huang, Hongbiao; Liu, Ningning; Guo, Haiping; Liao, Siyan; Li, Xiaofen; Yang, Changshan; Liu, Shouting; Song, Wenbin; Liu, Chunjiao; Guan, Lixia; Xu, Li; Zhang, Change; Dou, Q. Ping; Liu, Jinbao] Guangzhou Med Univ, Prot Modificat & Degradat Lab, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Li, Bing] Guangzhou Med Univ, Expt Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Xu, Li] Peoples Hosp Guangxi Autonomous Reg, Dept Hematol, Nanning, Guangxi, Peoples R China; [Wang, Xuejun] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Guangzhou Medical University; Guangzhou Medical University; University of South Dakota; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University	Dou, QP (corresponding author), Guangzhou Med Univ, Prot Modificat & Degradat Lab, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	doup@karmanos.org; Liujinbao1@yahoo.com.cn	Wang, Xuejun/K-8874-2013; Wang, Xuejun/AAT-9490-2021	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; Dou, Qingping/0000-0002-6465-1473; Liu, Ningning/0000-0002-9587-2332	National High Technology Research and Development Program of China [2006AA02Z4B5]; National Natural Science Foundation of China [81070033, 30770835, 81170608, 81072091]; Guangdong Province Natural Science Foundation [9251018201002, 94510018201003604]; Guangzhou Municipal Education Commission [10A 057S, 08A 108]; National Institutes of Health [R01HL072166, R01HL085629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085629, R01HL072166] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou Municipal Education Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National High Technology Research and Development Program of China (Project 2006AA02Z4B5), National Natural Science Foundation of China (Projects 81070033, 30770835, 81170608, 81072091); Projects (9251018201002, 94510018201003604) of Guangdong Province Natural Science Foundation and projects from Guangzhou Municipal Education Commission (10A 057S, 08A 108) (to JL, HH and CZ). This study is in part supported by National Institutes of Health grant R01HL072166 and R01HL085629 (to XW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rejaie SS, 2009, WORLD J GASTROENTERO, V15, P1373, DOI 10.3748/wjg.15.1373; Atadja PW, 2011, PROG DRUG RES, V67, P175, DOI 10.1007/978-3-7643-8989-5_9; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Burgess AJ, 2001, MOL PHARMACOL, V60, P828; Butler LM, 2000, CANCER RES, V60, P5165; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chai F, 2000, CARCINOGENESIS, V21, P7, DOI 10.1093/carcin/21.1.7; Chang BJ, 2005, INT J CANCER, V113, P719, DOI 10.1002/ijc.20636; Chang J, 2011, BRIT J CANCER, V106, P116; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cruciani RA, 2006, J PAIN SYMPTOM MANAG, V32, P551, DOI 10.1016/j.jpainsymman.2006.09.001; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Faye A, 2007, J BIOL CHEM, V282, P26908, DOI 10.1074/jbc.M705418200; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Grarnignano G, 2006, NUTRITION, V22, P136, DOI 10.1016/j.nut.2005.06.003; Huang Hongbiao, 2011, Front Biosci (Elite Ed), V3, P1315; Huang HB, 2011, CANCER LETT, V301, P221, DOI 10.1016/j.canlet.2010.12.015; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Karlic H, 2004, NUTRITION, V20, P709, DOI 10.1016/j.nut.2004.04.003; Kim JS, 2001, BIOCHEM BIOPH RES CO, V281, P866, DOI 10.1006/bbrc.2001.4434; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; RAMSAY RR, 1975, FEBS LETT, V54, P21, DOI 10.1016/0014-5793(75)81059-3; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Richon VM, 2002, CLIN CANCER RES, V8, P662; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Vrana JA, 1999, ONCOGENE, V18, P7016, DOI 10.1038/sj.onc.1203176; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	57	59	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49062	10.1371/journal.pone.0049062	http://dx.doi.org/10.1371/journal.pone.0049062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139833	Green Submitted, Green Published, gold			2022-12-25	WOS:000310741400066
J	Girish, VM; Kumar, S; Joseph, L; Jobichen, C; Kini, RM; Sivaraman, J				Girish, Vallerinteavide Mavelli; Kumar, Sundramurthy; Joseph, Lissa; Jobichen, Chacko; Kini, R. Manjunatha; Sivaraman, J.			Identification and Structural Characterization of a New Three-Finger Toxin Hemachatoxin from Hemachatus haemachatus Venom	PLOS ONE			English	Article							MEMBRANE-BINDING MOTIF; NAJA-NIGRICOLLIS VENOM; AMINO-ACID-SEQUENCE; X-RAY-STRUCTURE; SNAKE-VENOM; CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTOR; ALPHA-BUNGAROTOXIN; COBRA CARDIOTOXIN; CURAREMIMETIC TOXINS	Snake venoms are rich sources of biologically active proteins and polypeptides. Three-finger toxins are non-enzymatic proteins present in elapid (cobras, kraits, mambas and sea snakes) and colubrid venoms. These proteins contain four conserved disulfide bonds in the core to maintain the three-finger folds. Although all three-finger toxins have similar fold, their biological activities are different. A new three-finger toxin (hemachatoxin) was isolated from Hemachatus haemachatus (Ringhals cobra) venom. Its amino acid sequence was elucidated, and crystal structure was determined at 2.43 A resolution. The overall fold is similar to other three-finger toxins. The structure and sequence analysis revealed that the fold is maintained by four highly conserved disulfide bonds. It exhibited highest similarity to particularly P-type cardiotoxins that are known to associate and perturb the membrane surface with their lipid binding sites. Also, the increased B value of hemachotoxin loop II suggests that loop II is flexible and may remain flexible until its interaction with membrane phospholipids. Based on the analysis, we predict hemachatoxin to be cardiotoxic/cytotoxic and our future experiments will be directed to characterize the activity of hemachatoxin.	[Girish, Vallerinteavide Mavelli; Kumar, Sundramurthy; Joseph, Lissa; Jobichen, Chacko; Kini, R. Manjunatha; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem, Richmond, VA 23298 USA	National University of Singapore; Virginia Commonwealth University	Kini, RM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore.	dbskinim@nus.edu.sg; dbsjayar@nus.edu.sg	Jobichen, Chacko/AAR-7637-2020; Jobichen, Chacko/D-1978-2014; Mavelli, Girish Vallerinteavide/S-6109-2019	Jobichen, Chacko/0000-0001-5927-1815; Mavelli, Girish Vallerinteavide/0000-0003-1512-1203; Kini, Manjunatha/0000-0002-6100-3251; J, Sivaraman/0000-0001-9781-5326	Academic Research Fund [R154000438112]; Bio-Medical Research Council (BMRC - A*STAR)	Academic Research Fund(Ministry of Education, Singapore); Bio-Medical Research Council (BMRC - A*STAR)(Agency for Science Technology & Research (A*STAR))	JS acknowledges the funding support from Academic Research Fund (R154000438112). RMK was supported by Bio-Medical Research Council (BMRC - A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBRAND JP, 1995, BIOCHEMISTRY-US, V34, P5923, DOI 10.1021/bi00017a022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; BILWES A, 1994, J MOL BIOL, V239, P122, DOI 10.1006/jmbi.1994.1357; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Carsi JM, 2000, TOXICON, V38, P187, DOI 10.1016/S0041-0101(99)00141-5; Chen TS, 2005, BIOCHEMISTRY-US, V44, P7414, DOI 10.1021/bi050172e; CHIEN KY, 1994, J BIOL CHEM, V269, P14473; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; CORFIELD PWR, 1989, J BIOL CHEM, V264, P9239; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dementieva DV, 1999, EUR J BIOCHEM, V263, P152, DOI 10.1046/j.1432-1327.1999.00478.x; DEWAN JC, 1994, BIOCHEMISTRY-US, V33, P13147, DOI 10.1021/bi00248a026; DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437; Dubovskii PV, 2003, EUR J BIOCHEM, V270, P2038, DOI 10.1046/j.1432-1033.2003.03580.x; Dubovskii PV, 2001, J MOL BIOL, V305, P137, DOI 10.1006/jmbi.2000.4283; DUFTON MJ, 1988, PHARMACOL THERAPEUT, V36, P1, DOI 10.1016/0163-7258(88)90111-8; DUFTON MJ, 1983, CRC CR REV BIOCH MOL, V14, P113, DOI 10.3109/10409238309102792; DUFTON MJ, 1993, ENDEAVOUR, V17, P138, DOI 10.1016/0160-9327(93)90104-B; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo T., 1991, P165; Fernandez J, 2011, J PROTEOME RES, V10, P1816, DOI 10.1021/pr101091a; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Fruchart-Gaillard C, 2008, MOL PHARMACOL, V74, P1554, DOI 10.1124/mol.108.050773; FRYKLUND L, 1973, BIOCHEMISTRY-US, V12, P661, DOI 10.1021/bi00728a015; Gaucher JF, 2000, EUR J BIOCHEM, V267, P1323, DOI 10.1046/j.1432-1327.2000.01099.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grant GA, 1997, BIOCHEMISTRY-US, V36, P3353, DOI 10.1021/bi9629687; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hou XM, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-29; Joseph JS, 1999, BLOOD, V94, P621, DOI 10.1182/blood.V94.2.621.414k25_621_631; JOUBERT FJ, 1977, EUR J BIOCHEM, V74, P387, DOI 10.1111/j.1432-1033.1977.tb11403.x; Junqueira-de-Azevedo ILM, 2006, GENETICS, V173, P877, DOI 10.1534/genetics.106.056515; Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x; Karlsson E, 2000, BIOCHIMIE, V82, P793, DOI 10.1016/S0300-9084(00)01176-7; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; KINI RM, 1989, INT J PEPT PROT RES, V34, P277; KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; KOLBE HVJ, 1993, J BIOL CHEM, V268, P16458; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LeDu MH, 1996, ACTA CRYSTALLOGR D, V52, P87, DOI 10.1107/S0907444995007517; Lee SC, 2005, J BIOL CHEM, V280, P9567, DOI 10.1074/jbc.M412398200; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; LOVE RA, 1986, PROTEIN ENG, V1, P37, DOI 10.1093/protein/1.1.37; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; Nau F, 2003, POULTRY SCI, V82, P242, DOI 10.1093/ps/82.2.242; Nirthanan S, 2003, BRIT J PHARMACOL, V139, P832, DOI 10.1038/sj.bjp.0705299; Ogawa T, 2005, TOXICON, V45, P1, DOI 10.1016/j.toxicon.2004.07.028; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; Osipov AV, 2012, J BIOL CHEM, V287, P6725, DOI 10.1074/jbc.M111.322313; OSWALD RE, 1991, BIOCHEMISTRY-US, V30, P4901, DOI 10.1021/bi00234a010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pahari S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-175; Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200; Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Quinton L, 2010, BRIT J PHARMACOL, V159, P316, DOI 10.1111/j.1476-5381.2009.00532.x; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; REES B, 1990, J MOL BIOL, V214, P281, DOI 10.1016/0022-2836(90)90161-E; Ricciardi A, 2000, J BIOL CHEM, V275, P18302, DOI 10.1074/jbc.275.24.18302; Rosenthal JA, 1999, BIOCHEMISTRY-US, V38, P7847, DOI 10.1021/bi990045g; Rouget C, 2010, BRIT J PHARMACOL, V161, P1361, DOI 10.1111/j.1476-5381.2010.00966.x; Roy A, 2010, J BIOL CHEM, V285, P8302, DOI 10.1074/jbc.M109.074161; RUAN KH, 1991, BIOCHEM J, V274, P849, DOI 10.1042/bj2740849; Servent D, 1997, J BIOL CHEM, V272, P24279, DOI 10.1074/jbc.272.39.24279; Servent D, 2000, EUR J PHARMACOL, V393, P197, DOI 10.1016/S0014-2999(00)00095-9; Sun YJ, 1997, BIOCHEMISTRY-US, V36, P2403, DOI 10.1021/bi962594h; SUTCLIFFE MJ, 1994, NAT STRUCT BIOL, V1, P802, DOI 10.1038/nsb1194-802; Teixeira-Clerc F, 2002, J BIOL CHEM, V277, P25741, DOI 10.1074/jbc.M200534200; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Yasuda Osamu, 1994, Artery, V21, P287; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	87	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48112	10.1371/journal.pone.0048112	http://dx.doi.org/10.1371/journal.pone.0048112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144733	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300043
J	Nongkhlaw, M; Kumar, R; Acharya, C; Joshi, SR				Nongkhlaw, Macmillan; Kumar, Rakshak; Acharya, Celin; Joshi, Santa Ram			Occurrence of Horizontal Gene Transfer of P-IB-type ATPase Genes among Bacteria Isolated from an Uranium Rich Deposit of Domiasiat in North East India	PLOS ONE			English	Article							METAL HOMEOSTASIS GENES; STAPHYLOCOCCUS-AUREUS; RESISTANCE GENES; EVOLUTION; CADMIUM; SOIL; TRANSPORT; DATABASE; ISLANDS; CADA	Uranium (U) tolerant aerobic heterotrophs were isolated from the subsurface soils of one of the pre-mined U-rich deposits at Domiasiat located in the north-eastern part of India. On screening of genomic DNA from 62 isolates exhibiting superior U and heavy metal tolerance, 32 isolates were found to be positive for P-IB-type ATPase genes. Phylogenetic incongruence and anomalous DNA base compositions revealed the acquisition of P-IB-type ATPase genes by six isolates through horizontal gene transfer (HGT). Three of these instances of HGT appeared to have occurred at inter-phylum level and the other three instances indicated to have taken place at intra-phylum level. This study provides an insight into one of the possible survival strategies that bacteria might employ to adapt to environments rich in uranium and heavy metals.	[Nongkhlaw, Macmillan; Kumar, Rakshak; Joshi, Santa Ram] NE Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong 793014, Meghalaya, India; [Acharya, Celin] Bhabha Atom Res Ctr, Div Mol Biol, Mumbai 400085, Maharashtra, India	North Eastern Hill University; Bhabha Atomic Research Center (BARC)	Joshi, SR (corresponding author), NE Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong 793014, Meghalaya, India.	srjoshi2006@yahoo.co.in	Joshi/F-2097-2015; asif, huma/C-1441-2012; Kumar, Rakshak/AAP-8704-2020	Kumar, Rakshak/0000-0002-6982-2454; Joshi, Santa Ram/0000-0001-8080-484X	Bhabha Atomic Research Centre (BARC) Board of Research in Nuclear Sciences (BRNS), Mumbai, Department of Atomic Energy, Government of India; Department of Biotechnology (DBT), Government of India	Bhabha Atomic Research Centre (BARC) Board of Research in Nuclear Sciences (BRNS), Mumbai, Department of Atomic Energy, Government of India; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	RK and SRJ acknowledge financial support received from Bhabha Atomic Research Centre (BARC) Board of Research in Nuclear Sciences (BRNS), Mumbai, Department of Atomic Energy, Government of India; and MN acknowledges the financial support received from Department of Biotechnology (DBT), Government of India, for carrying out the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shanab RAI, 2007, CHEMOSPHERE, V68, P360, DOI 10.1016/j.chemosphere.2006.12.051; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Coombs JM, 2005, APPL ENVIRON MICROB, V71, P7083, DOI 10.1128/AEM.71.11.7083-7091.2005; Coombs JM, 2004, APPL ENVIRON MICROB, V70, P1698, DOI 10.1128/AEM.70.3.1698-1707.2004; DeLong EF, 2002, CURR OPIN MICROBIOL, V5, P520, DOI 10.1016/S1369-5274(02)00353-3; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hoda SQ., 2004, P 13 NAT S ENV SHILL, P33; Keller M, 2009, MICROBIOL MOL BIOL R, V73, P62, DOI 10.1128/MMBR.00028-08; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Koch A. L., 1981, MANUAL METHODS GENER, P179; Kumar R, 2011, J MICROBIOL, V49, P568, DOI 10.1007/s12275-011-0366-0; Lacerda Carla M. R., 2009, Briefings in Functional Genomics & Proteomics, V8, P75, DOI 10.1093/bfgp/elp005; Larbig KD, 2002, J BACTERIOL, V184, P6665, DOI 10.1128/JB.184.23.6665-6680.2002; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; LEBRUN M, 1994, J BACTERIOL, V176, P3040, DOI 10.1128/JB.176.10.3040-3048.1994; Lenka P, 2009, J ENVIRON RADIOACTIV, V100, P509, DOI 10.1016/j.jenvrad.2009.03.015; Liles MR, 2003, APPL ENVIRON MICROB, V69, P2684, DOI 10.1128/AEM.69.5.2684-2691.2003; LIM CK, 1993, J BACTERIOL, V175, P4492, DOI 10.1128/JB.175.14.4492-4498.1993; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Martinez RJ, 2006, APPL ENVIRON MICROB, V72, P3111, DOI 10.1128/AEM.72.5.3111-3118.2006; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Nedelkova M, 2007, FEMS MICROBIOL ECOL, V59, P694, DOI 10.1111/j.1574-6941.2006.00261.x; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; O'Sullivan D, 2001, APPL ENVIRON MICROB, V67, P929, DOI 10.1128/AEM.67.2.929-937.2001; Palleroni N., 1984, BERGEYS MANUAL SYSTE, VVolume 1, P141; POOLE RK, 1989, J GEN MICROBIOL, V135, P1865; Ragan MA, 2001, CURR OPIN GENET DEV, V11, P620, DOI 10.1016/S0959-437X(00)00244-6; Raju D, 1989, EXPL RES ATOM MINERA, V2, P1; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Ron Eliora Z., 1992, Biodegradation, V3, P161, DOI 10.1007/BF00129081; Rossbach S, 2000, ENVIRON MICROBIOL, V2, P373, DOI 10.1046/j.1462-2920.2000.00117.x; Shida O, 1997, INT J SYST BACTERIOL, V47, P299, DOI 10.1099/00207713-47-2-299; Slepecky RA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P530, DOI 10.1007/0-387-30744-3_16; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TREVORS JT, 1986, CAN J MICROBIOL, V32, P447, DOI 10.1139/m86-085; Yoo SH, 2007, INT J SYST EVOL MICR, V57, P1590, DOI 10.1099/ijs.0.64948-0	45	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48199	10.1371/journal.pone.0048199	http://dx.doi.org/10.1371/journal.pone.0048199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133569	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800059
J	Norring, SA; Ednie, AR; Schwetz, TA; Du, DP; Yang, H; Bennett, ES				Norring, Sarah A.; Ednie, Andrew R.; Schwetz, Tara A.; Du, Dongping; Yang, Hui; Bennett, Eric S.			Channel sialic acids limit hERG channel activity during the ventricular action potential	FASEB JOURNAL			English	Article						cardiac; voltage-gated potassium channel; arrhythmias; N-glycosylation; ion channel; sialylation	I-KR CHANNELS; CONGENITAL DISORDERS; POTASSIUM CHANNEL; N-GLYCOSYLATION; CELLULAR MECHANISMS; CARDIAC-ARRHYTHMIA; K+ CHANNELS; QT SYNDROME; CARDIOMYOPATHY; INACTIVATION	Activity of human ether-a-go-go-related gene (hERG) 1 voltage-gated K+ channels is responsible for portions of phase 2 and phase 3 repolarization of the human ventricular action potential. Here, we questioned whether and how physiologically and pathophysiologically relevant changes in surface N-glycosylation modified hERG channel function. Voltage-dependent hERG channel gating and activity were evaluated as expressed in a set of Chinese hamster ovary (CHO) cell lines under conditions of full glycosylation, no sialylation, no complex N-glycans, and following enzymatic deglycosylation of surface N-glycans. For each condition of reduced glycosylation, hERG channel steady-state activation and inactivation relationships were shifted linearly by significant depolarizing similar to 9 and similar to 18 mV, respectively. The hERG window current increased significantly by 50-150%, and the peak shifted by a depolarizing similar to 10 mV. There was no significant change in maximum hERG current density. Deglycosylated channels were significantly more active (20-80%) than glycosylated controls during phases 2 and 3 of action potential clamp protocols. Simulations of hERG current and ventricular action potentials corroborated experimental data and predicted reduced sialylation leads to a 50-70-ms decrease in action potential duration. The data describe a novel mechanism by which hERG channel gating is modulated through physiologically and pathophysiologically relevant changes in N-glycosylation; reduced channel sialylation increases hERG channel activity during the action potential, thereby increasing the rate of action potential repolarization.-Norring, S. A., Ednie, A. R., Schwetz, T. A., Du, D., Yang, H., Bennett, E. S. Channel sialic acids limit hERG channel activity during the ventricular action potential. FASEB J. 27, 622-631 (2013). www.fasebj.org	[Norring, Sarah A.; Ednie, Andrew R.; Schwetz, Tara A.; Bennett, Eric S.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Bennett, Eric S.] Univ S Florida, Morsani Coll Med, Program Neurosci, Tampa, FL USA; [Bennett, Eric S.] Univ S Florida, Morsani Coll Med, Program Cardiovasc Sci, Tampa, FL USA; [Du, Dongping; Yang, Hui] Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Bennett, ES (corresponding author), MDC 8,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	esbennet@health.usf.edu		Yang, Hui/0000-0001-5997-6823	American Heart Association; James and Esther King Florida Biomedical Research Program; U.S. National Science Foundation; Division Of Integrative Organismal Systems [1146882] Funding Source: National Science Foundation	American Heart Association(American Heart Association); James and Esther King Florida Biomedical Research Program; U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank Dr. Gail Robertson (University of Wisconsin, Madison, WI., USA) for generously supplying the hERG1A cDNA. This work was supported by an American Heart Association predoctoral fellowship (S.A.N.), bridge and challenge grants from the James and Esther King Florida Biomedical Research Program (E. S. B.), and a grant from the U.S. National Science Foundation (E. S. B., H.Y.). The authors declare no conflicts of interest.	Al-Owain M, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-7; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Bennett ES, 2002, J PHYSIOL-LONDON, V538, P675, DOI 10.1113/jphysiol.2001.013285; Bertaso F, 2002, BASIC RES CARDIOL, V97, P424, DOI 10.1007/s00395-002-0377-4; Cordeiro JM, 2005, CARDIOVASC RES, V67, P498, DOI 10.1016/j.cardiores.2005.02.018; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Drici MD, 2000, THERAPIE, V55, P185; Du DP, 2011, IEEE ENG MED BIO, P104, DOI 10.1109/IEMBS.2011.6089907; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Footitt EJ, 2009, J INHERIT METAB DIS, V32, pS313, DOI 10.1007/s10545-009-1262-1; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gehrmann J, 2003, CARDIOL YOUNG, V13, P345, DOI 10.1017/S1047951103000702; Gintant G, 2011, PHARMACOL THERAPEUT, V129, P109, DOI 10.1016/j.pharmthera.2010.08.008; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Hayashi K, 2011, J MOL CELL CARDIOL, V50, P50, DOI 10.1016/j.yjmcc.2010.10.007; Hong K, 2005, J CARDIOVASC ELECTR, V16, P394, DOI 10.1046/j.1540-8167.2005.40621.x; Jaeken J, 2004, CURR OPIN PEDIATR, V16, P434, DOI 10.1097/01.mop.0000133636.56790.4a; Jaeken J, 2004, J Inherit Metab Dis, V27, P423, DOI 10.1023/B:BOLI.0000031221.44647.9e; Jaeken J, 2003, J INHERIT METAB DIS, V26, P99, DOI 10.1023/A:1024431131208; Jo SH, 2009, PHARMACOL RES, V60, P429, DOI 10.1016/j.phrs.2009.05.008; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; Johnson D, 2006, J BIOL CHEM, V281, P25875, DOI 10.1074/jbc.M605060200; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Krasemann T, 2010, CLIN RES CARDIOL, V99, P309, DOI 10.1007/s00392-010-0120-3; Leroy JG, 2006, PEDIATR RES, V60, P643, DOI 10.1203/01.pdr.0000246802.57692.ea; Liengme BV., 2002, GUIDE MICROSOFT EXCE; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Nakajima T, 2007, J BIOL CHEM, V282, P5506, DOI 10.1074/jbc.M605976200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Park KH, 2003, FASEB J, V17, DOI 10.1096/fj.03-0577fje; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Pond AL, 2001, TRENDS CARDIOVAS MED, V11, P286, DOI 10.1016/S1050-1738(01)00127-X; Priest BT, 2008, CHANNELS, V2, P87, DOI 10.4161/chan.2.2.6004; Roden DM, 1999, CARDIOVASC RES, V44, P242, DOI 10.1016/S0008-6363(99)00224-2; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Schwetz TA, 2010, BBA-BIOMEMBRANES, V1798, P367, DOI 10.1016/j.bbamem.2009.11.018; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Taubel J, 2010, BRIT J CLIN PHARMACO, V69, P391, DOI 10.1111/j.1365-2125.2009.03595.x; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Ufret-Vincenty CA, 2001, AM J PHYSIOL-CELL PH, V281, pC464, DOI 10.1152/ajpcell.2001.281.2.C464; Vargas Hugo M., 2008, Journal of Pharmacological and Toxicological Methods, V58, P72, DOI 10.1016/j.vascn.2008.04.001; Wang HZ, 1999, AM J PHYSIOL-HEART C, V277, pH1081, DOI 10.1152/ajpheart.1999.277.3.H1081; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Watanabe I., 2003, J PHYSL, V550, P51; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Witchel HJ, 2011, CARDIOVASC THER, V29, P251, DOI 10.1111/j.1755-5922.2010.00154.x; Zhu I, 2009, BRAIN RES, V1251, P16, DOI 10.1016/j.brainres.2008.11.033	60	14	14	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					622	631		10.1096/fj.12-214387	http://dx.doi.org/10.1096/fj.12-214387			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23139156				2022-12-25	WOS:000314358000021
J	Ninkina, N; Peters, OM; Connor-Robson, N; Lytkina, O; Sharfeddin, E; Buchman, VL				Ninkina, Natalia; Peters, Owen M.; Connor-Robson, Natalie; Lytkina, Olga; Sharfeddin, Essam; Buchman, Vladimir L.			Contrasting Effects of alpha-Synuclein and gamma-Synuclein on the Phenotype of Cysteine String Protein alpha (CSP alpha) Null Mutant Mice Suggest Distinct Function of these Proteins in Neuronal Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; EXPRESSION; BINDING; SNARE; NEURODEGENERATION; IDENTIFICATION; CHAPERONE; DYNAMICS; GLAUCOMA; PATTERN	In neuronal synapses, neurotransmitter-loaded vesicles fuse with presynaptic plasma membrane in a complex sequence of tightly regulated events. The assembly of specialized SNARE complexes plays a pivotal role in this process. The function of the chaperone cysteine string protein alpha (CSP alpha) is important for synaptic SNARE complex formation, and mice lacking this protein develop severe synaptic dysfunction and neurodegeneration that lead to their death within 3 months after birth. Another presynaptic protein, alpha-synuclein, also potentiates SNARE complex formation, and its overexpression rescues the phenotype of CSP alpha null mutant mice, although these two proteins use different mechanisms to achieve this effect. alpha-synuclein is a member of a family of three related proteins whose structural similarity suggests functional redundancy. Here, we assessed whether gamma-synuclein shares the ability of alpha-synuclein to bind synaptic vesicles and ameliorate neurodegeneration caused by CSP alpha deficiency in vivo. Although the N-terminal lipid-binding domains of the two synucleins showed similar affinity for purified synaptic vesicles, the C-terminal domain of gamma-synuclein was not able to interact with synaptobrevin-2/VAMP2. Consequently, overexpression of gamma-synuclein did not have any noticeable effect on the phenotype of CSP alpha null mutant mice. Our data suggest that the functions of alpha- and gamma-synucleins in presynaptic terminals are not fully redundant.	[Ninkina, Natalia; Peters, Owen M.; Connor-Robson, Natalie; Sharfeddin, Essam; Buchman, Vladimir L.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Lytkina, Olga] Russian Acad Sci, Inst Physiologically Act Cpds, Chernogolovka 142432, Moscow Region, Russia	Cardiff University; Russian Academy of Sciences; Institute of Physiologically Active Compounds of the Russian Academy of Sciences	Buchman, VL (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	buchmanvl@cf.ac.uk	Lytkina, Olga/H-3118-2014; Ninkina, Natalia N/A-1732-2011; Buchman, Vladimir L/A-4814-2010	Lytkina, Olga/0000-0003-3015-6447; Buchman, Vladimir L/0000-0002-7631-8352; Peters, Owen/0000-0002-6824-0663; Connor-Robson, Natalie/0000-0001-8350-6928	Parkinson's UK [G-1006]; Wellcome Trust [075615/Z/04/z]; ERA.Net RUS [STProjects-065]; Parkinson&quot;s UK [G-1006] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); Wellcome Trust(Wellcome TrustEuropean Commission); ERA.Net RUS; Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by Parkinson's UK Grant G-1006 and Programme Grant 075615/Z/04/z from The Wellcome Trust (to V. L. B.) and STProjects-065 (ERA.Net RUS) (to N. N.).	Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Buchman VL, 1998, J NEUROSCI, V18, P9335; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ninkina N., 2012, P NATL ACAD IN PRESS; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Ninkina NN, 1998, HUM MOL GENET, V7, P1417, DOI 10.1093/hmg/7.9.1417; Oort PJ, 2008, J NUTR, V138, P841, DOI 10.1093/jn/138.5.841; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Peters OM, 2012, NEUROBIOL DIS, V48, P124, DOI 10.1016/j.nbd.2012.06.016; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; TOLL L, 1978, BIOCHEMISTRY-US, V17, P2517, DOI 10.1021/bi00606a010; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029	37	19	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44471	44477		10.1074/jbc.M112.422402	http://dx.doi.org/10.1074/jbc.M112.422402			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129765	hybrid, Green Published			2022-12-25	WOS:000312938600043
J	Tanabe, C; Maeda, T; Zou, K; Liu, JJ; Liu, SY; Nakajima, T; Komano, H				Tanabe, Chiaki; Maeda, Tomoji; Zou, Kun; Liu, Junjun; Liu, Shuyu; Nakajima, Toshihiro; Komano, Hiroto			The Ubiquitin Ligase Synoviolin Up-regulates Amyloid beta Production by Targeting a Negative Regulator of gamma-Secretase, Rer1, for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED-DEGRADATION; ER-ASSOCIATED DEGRADATION; MEMBRANE-PROTEINS; RETRIEVAL RECEPTOR; ALZHEIMERS-DISEASE; GOLGI-APPARATUS; NICASTRIN; COMPLEX; TRAFFICKING; MATURATION	Alzheimer's disease is characterized by the deposition of A beta, which is generated from the amyloid precursor protein through its cleavage by beta- and gamma-secretases. The gamma-secretase complex component nicastrin (NCT) plays significant roles in the assembly and proper trafficking of the gamma-secretase complex and in the recognition of amyloid precursor protein. NCT is incorporated into the gamma-secretase complex in the endoplasmic reticulum (ER) and glycosylated in the Golgi. In contrast, unassembled NCT is retrieved or retained in the ER by the protein Retention in endoplasmic reticulum 1 (Rer1). We reported previously that synoviolin (Syvn), an E3 ubiquitin ligase, degrades NCT and affects the generation of A beta. Here, we examined in more detail the effect of Syvn on the generation of A beta. We found that overexpression of a dominant negative form of Syvn (C307A mutant) and a Syvn-RNAi decreased the generation of A beta. These results indicate that the ubiquitin ligase activity of Syvn up-regulates the generation of A beta. We hypothesized, therefore, that Syvn regulates the assembly or localization of the gamma-secretase complex by ubiquitinating Rer1, resulting in its subsequent degradation. Our findings that the level of Rer1 was increased in Syvn knockout fibroblasts because of inhibition of its degradation support this hypothesis. Moreover, we found that Rer1 interacts with Syvn in the ER, is ubiquitinated by Syvn, and is then degraded via the proteasome or lysosomal pathways. Finally, we showed that localization of mature NCT to the plasma membrane as well as gamma-secretase complex levels are decreased in fibroblasts of Syvn knockout mice. Thus, it is likely that Syvn regulates the assembly of the gamma-secretase complex via the degradation of Rer1, which results in the generation of A beta.	[Tanabe, Chiaki; Maeda, Tomoji; Zou, Kun; Liu, Junjun; Liu, Shuyu; Komano, Hiroto] Iwate Med Univ, Sch Pharm, Dept Neurosci, Shiwa, Iwate 0283694, Japan; [Nakajima, Toshihiro] Tokyo Med Univ, Inst Med Sci, Tokyo 1608402, Japan	Iwate Medical University; Tokyo Medical University	Maeda, T (corresponding author), Iwate Med Univ, Sch Pharm, Dept Neurosci, 2-1-1 Nishitokuta, Shiwa, Iwate 0283694, Japan.	maedato@iwate-med.ac.jp; hkomano@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation;  [23700425];  [23590110]; Grants-in-Aid for Scientific Research [23590110, 24700383, 23659176] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Young Scientists (B) 23700425 (to C.T.); Grant-in-Aid for Scientific Research (C) 23590110 (to T.M.); by a Grant-in-Aid for Strategic Medical Science Research Center (The MIAST Project) (to H.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a grant from the Takeda Science Foundation (to T.M.).	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Capell A, 2003, J BIOL CHEM, V278, P52519, DOI 10.1074/jbc.C300435200; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fullekrug J, 1997, EUR J CELL BIOL, V74, P31; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200; Komano H, 2002, J BIOL CHEM, V277, P39627, DOI 10.1074/jbc.M205255200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Maeda T, 2009, FEBS J, V276, P5832, DOI 10.1111/j.1742-4658.2009.07264.x; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schwappach B, 2008, MOL MEMBR BIOL, V25, P270, DOI 10.1080/09687680801960998; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	31	16	16	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44203	44211		10.1074/jbc.M112.365296	http://dx.doi.org/10.1074/jbc.M112.365296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23129766	hybrid, Green Published			2022-12-25	WOS:000312938600019
J	Flach, K; Hilbrich, I; Schiffmann, A; Gartner, U; Kruger, M; Leonhardt, M; Waschipky, H; Wick, L; Arendt, T; Holzer, M				Flach, Katharina; Hilbrich, Isabel; Schiffmann, Andrea; Gaertner, Ulrich; Krueger, Martin; Leonhardt, Marion; Waschipky, Hanka; Wick, Lukas; Arendt, Thomas; Holzer, Max			Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOFIBRILLAR ALPHA-SYNUCLEIN; PROTEIN MISFOLDING DISEASES; SOLUBLE AMYLOID OLIGOMERS; PAIRED HELICAL FILAMENTS; BETA-SHEET STRUCTURE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; IN-VITRO; NEURODEGENERATIVE DISEASES; VESICLE PERMEABILIZATION	The microtubule-associated protein Tau is mainly expressed in neurons, where it binds and stabilizes microtubules. In Alzheimer disease and other tauopathies, Tau protein has a reduced affinity toward microtubules. As a consequence, Tau protein detaches from microtubules and eventually aggregates into beta-sheet-containing filaments. The fibrillization of monomeric Tau to filaments is a multistep process that involves the formation of various aggregates, including spherical and protofibrillar oligomers. Previous concepts, primarily developed for A beta and alpha-synuclein, propose these oligomeric intermediates as the primary cytotoxic species mediating their deleterious effects through membrane permeabilization. In the present study, we thus analyzed whether this concept can also be applied to Tau protein. To this end, viability and membrane integrity were assessed on SH-SY5Y neuroblastoma cells and artificial phospholipid vesicles, treated with Tau monomers, Tau aggregation intermediates, or Tau fibrils. Our findings suggest that oligomeric Tau aggregation intermediates are the most toxic compounds of Tau fibrillogenesis, which effectively decrease cell viability and increase phospholipid vesicle leakage. Our data integrate Tau protein into the class of amyloidogenic proteins and enforce the hypothesis of a common toxicity-mediating mechanism for amyloidogenic proteins.	[Flach, Katharina; Hilbrich, Isabel; Schiffmann, Andrea; Gaertner, Ulrich; Leonhardt, Marion; Arendt, Thomas; Holzer, Max] Univ Leipzig, Fac Med, Dept Mol & Cellular Mech Neurodegenerat, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Krueger, Martin] Inst Anat, D-04103 Leipzig, Germany; [Waschipky, Hanka] Inst Med Phys & Biophys, D-04107 Leipzig, Germany; [Wick, Lukas] Helmholtz Ctr Environm Res, Dept Environm Microbiol, D-04318 Leipzig, Germany	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Holzer, M (corresponding author), Univ Leipzig, Fac Med, Dept Mol & Cellular Mech Neurodegenerat, Paul Flechsig Inst Brain Res, Jahnallee 59, D-04109 Leipzig, Germany.	holm@medizin.uni-leipzig.de	Holzer, Max/A-1729-2008; Arendt, Thomas/C-8747-2012; Wick, Lukas Y/AAH-3221-2020	Holzer, Max/0000-0003-1754-9932; Wick, Lukas Y/0000-0001-7296-865X; Arendt, Thomas/0000-0003-4553-1625	Deutsche Forschungsgemeinschaft Grant [HO2368-4/1]; Alzheimer Forschung Initiative Project [06825]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Alzheimer Forschung Initiative Project	This work was supported, in part, by Deutsche Forschungsgemeinschaft Grant HO2368-4/1 and by Alzheimer Forschung Initiative Project 06825.	Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; ARISPE N, 1994, MOL CELL BIOCHEM, V140, P119, DOI 10.1007/BF00926750; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1993, J BIOL CHEM, V268, P3414; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; Goedert M, 1999, PHILOS T ROY SOC B, V354, P1101, DOI 10.1098/rstb.1999.0466; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; HOLZER M, 1994, NEUROSCIENCE, V63, P499, DOI 10.1016/0306-4522(94)90546-0; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kourie JI, 2001, J NEUROSCI RES, V66, P214, DOI 10.1002/jnr.1213; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Monoi H, 2000, BIOPHYS J, V78, P2892, DOI 10.1016/S0006-3495(00)76830-5; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pountney DL, 2005, NEUROTOX RES, V7, P59, DOI 10.1007/BF03033776; PRICE DL, 1987, CIBA F SYMP, V126, P30; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Yoshida H, 2002, BIOCHEMISTRY-US, V41, P15203, DOI 10.1021/bi026464m; Zschornig O, 2005, COLLOID SURFACE B, V42, P69, DOI 10.1016/j.colsurfb.2005.01.008	70	131	131	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43223	43233		10.1074/jbc.M112.396176	http://dx.doi.org/10.1074/jbc.M112.396176			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129775	Green Published, hybrid			2022-12-25	WOS:000312940800004
J	Chen, C; DeClerck, G; Tian, F; Spooner, W; McCouch, S; Buckler, E				Chen, Charles; DeClerck, Genevieve; Tian, Feng; Spooner, William; McCouch, Susan; Buckler, Edward			PICARA, an Analytical Pipeline Providing Probabilistic Inference about A Priori Candidates Genes Underlying Genome-Wide Association QTL in Plants	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ENRICHMENT ANALYSIS; LINKAGE DISEQUILIBRIUM; POSITIONAL CLONING; COMPLEX TRAITS; ARABIDOPSIS; MAIZE; RICE; GENETICS; ARCHITECTURE	PICARA is an analytical pipeline designed to systematically summarize observed SNP/trait associations identified by genome wide association studies (GWAS) and to identify candidate genes involved in the regulation of complex trait variation. The pipeline provides probabilistic inference about a priori candidate genes using integrated information derived from genome-wide association signals, gene homology, and curated gene sets embedded in pathway descriptions. In this paper, we demonstrate the performance of PICARA using data for flowering time variation in maize - a key trait for geographical and seasonal adaption of plants. Among 406 curated flowering time-related genes from Arabidopsis, we identify 61 orthologs in maize that are significantly enriched for GWAS SNP signals, including key regulators such as FT (Flowering Locus T) and GI (GIGANTEA), and genes centered in the Arabidopsis circadian pathway, including TOC1 (Timing of CAB Expression 1) and LHY (Late Elongated Hypocotyl). In addition, we discover a regulatory feature that is characteristic of these a priori flowering time candidates in maize. This new probabilistic analytical pipeline helps researchers infer the functional significance of candidate genes associated with complex traits and helps guide future experiments by providing statistical support for gene candidates based on the integration of heterogeneous biological information.	[Chen, Charles; DeClerck, Genevieve; McCouch, Susan; Buckler, Edward] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14853 USA; [Tian, Feng] China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China; [Spooner, William] Eagle Genom Ltd, Cambridge, England; [Buckler, Edward] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Buckler, Edward] ARS, USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Cornell University; China Agricultural University; Cornell University; United States Department of Agriculture (USDA)	Chen, C (corresponding author), Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14853 USA.	cc859@cornell.edu	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Buckler, Edward/0000-0002-3100-371X	National Science Foundation (NSF) [0703908]; NSF [1026555]; Division Of Integrative Organismal Systems [1026555] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is supported by the National Science Foundation (NSF) Plant Genome Research Grant 0703908. SM is also funded by NSF Plant Genome Research Grant 1026555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2002, PLANT MOL BIOL, V48, P99, DOI 10.1023/A:1013734019946; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Avraham S, 2008, NUCLEIC ACIDS RES, V36, pD449, DOI 10.1093/nar/gkm908; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen M, 1997, P NATL ACAD SCI USA, V94, P3431, DOI 10.1073/pnas.94.7.3431; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Cho YC, 2003, TREAT CROP RES, V4, P19; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Devos KM, 1999, GENOME RES, V9, P825, DOI 10.1101/gr.9.9.825; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Feuillet C, 1999, P NATL ACAD SCI USA, V96, P8265, DOI 10.1073/pnas.96.14.8265; Fisher RA, 1930, GENETICAL THEORY NAU; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jiang SY, 2010, INT J BIOL SCI, V6, P228; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Kimura MA, 1985, NEUTRAL THEORY MOL E; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lipkin E, 2009, GENETICS, V181, P691, DOI 10.1534/genetics.108.097402; McMullen MD, 2001, GENOME, V44, P667, DOI 10.1139/gen-44-4-667; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Olsen LT, 2008, J EXP BOT, V59, P3753, DOI 10.1093/jxb/ern228; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002; Peterson ME, 2009, PROTEIN SCI, V18, P1306, DOI 10.1002/pro.143; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Ramakrishna W, 2003, METH MOL B, V236, P109; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Singh LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002345; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tian Q, 2007, PLANT CELL, V19, P3127, DOI 10.1105/tpc.106.048868; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Weil CF, 2009, PLANT PHYSIOL, V149, P158, DOI 10.1104/pp.108.128785; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99; Wullschleger SD, 2003, COMP FUNCT GENOM, V4, P216, DOI 10.1002/cfg.277; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148; Youens-Clark K, 2009, BIOINFORMATICS, V25, P3040, DOI 10.1093/bioinformatics/btp458; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu XH, 2010, PLANT PHYSIOL, V153, P1074, DOI 10.1104/pp.110.158386; Zhao J, 2010, DIABETOLOGIA, V53, P2340, DOI 10.1007/s00125-010-1852-3; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	70	19	21	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e46596	10.1371/journal.pone.0046596	http://dx.doi.org/10.1371/journal.pone.0046596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144785	Green Published, gold, Green Submitted			2022-12-25	WOS:000311935800007
J	Baysan, M; Bozdag, S; Cam, MC; Kotliarova, S; Ahn, S; Walling, J; Killian, JK; Stevenson, H; Meltzer, P; Fine, HA				Baysan, Mehmet; Bozdag, Serdar; Cam, Margaret C.; Kotliarova, Svetlana; Ahn, Susie; Walling, Jennifer; Killian, Jonathan K.; Stevenson, Holly; Meltzer, Paul; Fine, Howard A.			G-Cimp Status Prediction Of Glioblastoma Samples Using mRNA Expression Data	PLOS ONE			English	Article							VALIDATION; MICROARRAY; SUBTYPES	Glioblastoma Multiforme (GBM) is a tumor with high mortality and no known cure. The dramatic molecular and clinical heterogeneity seen in this tumor has led to attempts to define genetically similar subgroups of GBM with the hope of developing tumor specific therapies targeted to the unique biology within each of these subgroups. Recently, a subset of relatively favorable prognosis GBMs has been identified. These glioma CpG island methylator phenotype, or G-CIMP tumors, have distinct genomic copy number aberrations, DNA methylation patterns, and (mRNA) expression profiles compared to other GBMs. While the standard method for identifying G-CIMP tumors is based on genome-wide DNA methylation data, such data is often not available compared to the more widely available gene expression data. In this study, we have developed and evaluated a method to predict the G-CIMP status of GBM samples based solely on gene expression data.	[Baysan, Mehmet; Cam, Margaret C.; Kotliarova, Svetlana; Ahn, Susie; Walling, Jennifer; Fine, Howard A.] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA; [Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Killian, Jonathan K.; Stevenson, Holly; Meltzer, Paul] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Fine, Howard A.] NYU, Inst Canc, Langone Med Ctr, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Marquette University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; NYU Langone Medical Center	Fine, HA (corresponding author), NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA.	Howard.Fine@nyumc.org	baysan, mehmet/O-1710-2018	baysan, mehmet/0000-0001-7359-2965	National Institutes of Health Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC011091] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded through the National Institutes of Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2011, GENOMICS; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Huse JT, 2011, GLIA; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Malzkorn B, 2011, BRAIN PATHOL, V21, P619, DOI 10.1111/j.1750-3639.2011.00536.x; Marko NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020826; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rechache NS, 2012, J CLIN ENDOCRINOLOGY; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Turcan S, 2012, NATURE; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020	17	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47839	10.1371/journal.pone.0047839	http://dx.doi.org/10.1371/journal.pone.0047839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139755	Green Published, gold, Green Submitted			2022-12-25	WOS:000311315300013
J	Klein-Hennig, M; Dietz, M; Klinge-Strahl, A; Klump, G; Hohmann, V				Klein-Hennig, Martin; Dietz, Mathias; Klinge-Strahl, Astrid; Klump, Georg; Hohmann, Volker			Effect of Mistuning on the Detection of a Tone Masked by a Harmonic Tone Complex	PLOS ONE			English	Article							THRESHOLDS; HEARING; PITCH	The human auditory system is sensitive in detecting "mistuned" components in a harmonic complex, which do not match the frequency pattern defined by the fundamental frequency of the complex. Depending on the frequency configuration, the mistuned component may be perceptually segregated from the complex and may be heard as a separate tone. In the context of a masking experiment, mistuning a single component decreases its masked threshold. In this study we propose to quantify the ability to detect a single component for fixed amounts of mistuning by adaptively varying its level. This method produces masking release by mistuning that can be compared to other masking release effects. Detection thresholds were obtained for various frequency configurations where the target component was resolved or unresolved in the auditory system. The results from 6 normal-hearing listeners show a significant decrease of masked thresholds between harmonic and mistuned conditions in all configurations and provide evidence for the employment of different detection strategies for resolved and unresolved components. The data suggest that across-frequency processing is involved in the release from masking. The results emphasize the ability of this method to assess integrative aspects of pitch and harmonicity perception.	[Klein-Hennig, Martin; Dietz, Mathias; Klinge-Strahl, Astrid; Klump, Georg; Hohmann, Volker] Carl von Ossietzky Univ Oldenburg, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Klein-Hennig, M (corresponding author), Carl von Ossietzky Univ Oldenburg, D-2900 Oldenburg, Germany.	martin.klein.hennig@uni-oldenburg.de	Dietz, Mathias/N-2358-2017	Dietz, Mathias/0000-0002-1830-469X	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich SFB/TRR31]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) within the Sonderforschungsbereich SFB/TRR31 "The Active Auditory System". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bregman A.S., 1994, AUDITORY SCENE ANAL; Darwin CJ, 1995, AUDITORY GROUPING HE, VSecond, P387; GOLDSTEIN JL, 1967, J ACOUST SOC AM, V41, P676, DOI 10.1121/1.1910396; HALL JW, 1984, J ACOUST SOC AM, V76, P50, DOI 10.1121/1.391005; HARTMANN WM, 1990, J ACOUST SOC AM, V88, P1712, DOI 10.1121/1.400246; Hartmann WM, 1996, J ACOUST SOC AM, V99, P567, DOI 10.1121/1.414514; HOUTSMA AJM, 1990, J ACOUST SOC AM, V87, P304, DOI 10.1121/1.399297; Klinge A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026124; Levitt H., 1971, J ACOUSTICAL SOC S2, V49, P467; LICKLIDER JCR, 1948, J ACOUST SOC AM, V20, P150, DOI 10.1121/1.1906358; MOORE BCJ, 1986, J ACOUST SOC AM, V80, P479, DOI 10.1121/1.394043; Moore BCJ, 1996, ACUSTICA, V82, P335; MOORE BCJ, 1985, J ACOUST SOC AM, V77, P1861, DOI 10.1121/1.391937; Oh EL, 2000, J ACOUST SOC AM, V108, P706, DOI 10.1121/1.429603; Plack CJ, 2005, SPR HDB AUD, V24, P7	15	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48419	10.1371/journal.pone.0048419	http://dx.doi.org/10.1371/journal.pone.0048419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139782	Green Submitted, gold, Green Published			2022-12-25	WOS:000310741400048
J	Lind, M; van der Nest, M; Olson, A; Brandstrom-Durling, M; Stenlid, J				Lind, Marten; van der Nest, Magriet; Olson, Ake; Brandstrom-Durling, Mikael; Stenlid, Jan			A 2nd Generation Linkage Map of Heterobasidion annosum s.l. Based on In Silico Anchoring of AFLP Markers	PLOS ONE			English	Article							GENETIC-LINKAGE; SOMATIC INCOMPATIBILITY; PHLEBIOPSIS-GIGANTEA; GENOME SEQUENCE; PHYSICAL MAPS; PATHOGEN; INTERSTERILITY; POLYMORPHISM; IDENTIFICATION; CHROMOSOME	In this study, we present a 2nd generation genetic linkage map of a cross between the North American species Heterobasidion irregulare and H. occidentale, based on the alignment of the previously published 1st generation map to the parental genomes. We anchored 216 of the original 308 AFLP markers to their respective restriction sites using an in silico-approach. The map resolution was improved by adding 146 sequence-tagged microsatellite markers and 39 sequenced gene markers. The new markers confirmed the positions of the anchored AFLP markers, fused the original 39 linkage groups together into 17, and fully expanded 12 of these to single groups covering entire chromosomes. Map coverage of the genome increased from 55.3% to 92.8%, with 96.3% of 430 markers collinearly aligned with the genome sequence. The anchored map also improved the H. irregulare assembly considerably. It identified several errors in scaffold arrangements and assisted in reducing the total number of major scaffolds from 18 to 15. This denser, more comprehensive map allowed sequence-based mapping of three intersterility loci and one mating type locus. This demonstrates the possibility to utilize an in silico procedure to convert anonymous markers into sequence-tagged ones, as well as the power of a sequence-anchored linkage map and its usefulness in the assembly of a whole genome sequence.	[Lind, Marten; van der Nest, Magriet; Olson, Ake; Brandstrom-Durling, Mikael; Stenlid, Jan] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Lind, M (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	marten.lind@slu.se	Stenlid, Jan/K-5909-2019; Brandström Durling, Mikael/C-1213-2008	Brandström Durling, Mikael/0000-0001-6485-197X; Stenlid, Jan/0000-0002-5344-2094; Lind, Marten/0000-0002-3817-2823; van der Nest, Magriet/0000-0001-6914-8343	Swedish Foundation for Strategic Research [RBb08-0011]; Carl Tryggers Foundation [CTS 07:271]; Nilsson-Ehle donations [2008-11-12]; Anna; Nils Hakanssons Stiftelse [2007-04-12]; CF Lundstroms Stiftelse [1347]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Tryggers Foundation; Nilsson-Ehle donations; Anna; Nils Hakanssons Stiftelse; CF Lundstroms Stiftelse	This project was funded by the Swedish Foundation for Strategic Research (grant RBb08-0011), Carl Tryggers Foundation (grant CTS 07:271), the Nilsson-Ehle donations (grant 2008-11-12), Anna and Nils Hakanssons Stiftelse (grant 2007-04-12) and CF Lundstroms Stiftelse (grant 1347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomas A, 2006, FEMS MICROBIOL ECOL, V57, P26, DOI 10.1111/j.1574-6941.2006.00094.x; Anderson M, 1993, P 8 INT C ROOT BUTT, P303; Lopez-Lavalle LAB, 2011, GENOME, V54, P779, DOI [10.1139/G11-037, 10.1139/g11-037]; Brugmans B, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng055; CHAKRAVARTI A, 1991, GENOMICS, V11, P219, DOI 10.1016/0888-7543(91)90123-V; Chang SW, 2008, GENOME, V51, P128, DOI [10.1139/G07-097, 10.1139/g07-097]; CHASE TE, 1990, MYCOLOGIA, V82, P73, DOI 10.2307/3759965; CHASE TE, 1983, MYCOLOGIA, V75, P825, DOI 10.2307/3792773; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Foulongne-Oriol M, 2011, CURR GENET, V57, P39, DOI 10.1007/s00294-010-0325-z; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gallegos A, 2000, GENETICS, V154, P623; Gardes M, 1996, SPECIES DIAGNOSTICS; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hsueh YP, 2006, PLOS GENET, V2, P1702, DOI 10.1371/journal.pgen.0020184; Hutchison E, 2009, MICROBIOL-SGM, V155, P3957, DOI 10.1099/mic.0.032284-0; Iakovlev A, 2004, FEMS MICROBIOL LETT, V241, P79, DOI 10.1016/j.femsle.2004.10.007; Karlsson M, 2003, FUNGAL GENET BIOL, V39, P51, DOI 10.1016/S1087-1845(02)00586-8; Kema GHJ, 2002, GENETICS, V161, P1497; Korhonen K, 1978, 94 COMM I FOR FENN, V94; Labbe J, 2008, NEW PHYTOL, V180, P316, DOI 10.1111/j.1469-8137.2008.02614.x; Lee J, 2008, APPL ENVIRON MICROB, V74, P2349, DOI 10.1128/AEM.01866-07; Li YD, 2010, J INTEGR PLANT BIOL, V52, P1036, DOI 10.1111/j.1744-7909.2010.01001.x; Lim S, 2004, FUNGAL GENET BIOL, V41, P1025, DOI 10.1016/j.fgb.2004.08.004; Lind M, 2005, FUNGAL GENET BIOL, V42, P519, DOI 10.1016/j.fgb.2005.03.005; Lind M, 2007, FUNGAL GENET BIOL, V44, P1242, DOI 10.1016/j.fgb.2007.04.013; Lind M, 2007, CURR GENET, V52, P35, DOI 10.1007/s00294-007-0137-y; Miao H, 2011, EUPHYTICA, V182, P167, DOI 10.1007/s10681-011-0410-5; Niemela T, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P27; Olson A, 2005, FOREST PATHOL, V35, P321, DOI 10.1111/j.1439-0329.2005.00412.x; Olson A, 2001, NATURE, V411, P438, DOI 10.1038/35078147; Olson A, 2012, NEW PHYTOLOGIST; Olson A, 2006, MYCOL RES, V110, P979, DOI 10.1016/j.mycres.2006.05.009; Otrosina WJ, 2010, FUNGAL BIOL-UK, V114, P16, DOI 10.1016/j.mycres.2009.09.001; Petro D, 2011, EUPHYTICA, V179, P405, DOI 10.1007/s10681-010-0338-1; Rombauts S, 2003, BIOINFORMATICS, V19, P776, DOI 10.1093/bioinformatics/btg090; Samils N, 2008, BIOL CONTROL, V45, P419, DOI 10.1016/j.biocontrol.2008.03.010; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; STENLID J, 1985, CAN J BOT, V63, P2268, DOI 10.1139/b85-322; Terashima K, 2002, MYCOL RES, V106, P911, DOI 10.1017/S0953756202006275; Ueng P, 2009, PHYTOPATHOLOGY, V99, pS132; van der Nest MA, 2011, FUNGAL GENET BIOL, V48, P1034, DOI 10.1016/j.fgb.2011.08.001; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Woodward S, 1998, BIOL ECOLOGY IMPACT; Xu DH, 2004, GENOME, V47, P660, DOI [10.1139/g04-022, 10.1139/G04-022]; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	50	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48347	10.1371/journal.pone.0048347	http://dx.doi.org/10.1371/journal.pone.0048347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139779	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400046
J	Hata, T; Tazawa, S; Ohta, S; Rhyu, MR; Misaka, T; Ichihara, K				Hata, Taketoshi; Tazawa, Shigemi; Ohta, Shozo; Rhyu, Mee-Ra; Misaka, Takumi; Ichihara, Kenji			Artepillin C, a Major Ingredient of Brazilian Propolis, Induces a Pungent Taste by Activating TRPA1 Channels	PLOS ONE			English	Article							PLANT-ORIGIN; ION-CHANNEL; COVALENT MODIFICATION; CHEMICAL-COMPOSITION; TUMOR-CELLS; RECEPTOR; GROWTH; TOXICITY; IDENTIFICATION; ANTIBACTERIAL	Brazilian green propolis is a popular health supplement because of its various biological properties. The ethanol extract of Brazilian green propolis (EEBP) is characteristic for its herb-like smell and unique pungent taste. However, the ingredients responsible for its pungency have not yet been identified. This study provides the first evidence that artepillin C is the main pungent ingredient in EEBP and that it potently activates human transient receptor potential ankyrin 1 (TRPA1) channels. EEBP was fractionated using column chromatography with a step gradient elution of an ethanol-water solution, and the fractions having the pungent taste were determined by sensory tests. HPLC analysis revealed that the pungent fraction was composed primarily of artepillin C, a prenylated derivative of cinnamic acid. Artepillin C was also identified as the pungent compound of EEBP by organoleptic examiners. Furthermore, the effects of artepillin C and other cinnamic acids found in EEBP on TRPA1 channels were examined by calcium imaging and plate reader-based assays in human TRPA1-expressing cells to investigate the molecular mechanisms underlying their pungent tastes. Artepillin C and baccharin activated the TRPA1 channel strongly, whereas drupanin caused a slight activation and p-coumaric acid showed no activation. Because the EC50 values of artepillin C, baccharin, and allyl isothiocyanate were 1.8 mu M, 15.5 mu M, and 6.2 mu M, respectively, artepillin C was more potent than the typical TRPA1 agonist allyl isothiocyanate. These findings strongly indicate that artepillin C is the main pungent ingredient in EEBP and stimulates a pungent taste by activating TRPA1 channels.	[Hata, Taketoshi; Tazawa, Shigemi; Ohta, Shozo; Ichihara, Kenji] API Co Ltd, Nagaragawa Res Ctr, Gifu, Japan; [Rhyu, Mee-Ra] Korea Food Res Inst, Funct Food Technol Res Grp, Songnam, Gyeonggi Do, South Korea; [Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	Korea Food Research Institute (KFRI); University of Tokyo	Ichihara, K (corresponding author), API Co Ltd, Nagaragawa Res Ctr, Gifu, Japan.	ichihara-kenji@api3838.co.jp		Misaka, Takumi/0000-0002-9547-5767				AGA H, 1994, BIOSCI BIOTECH BIOCH, V58, P945, DOI 10.1271/bbb.58.945; Akao Y, 2003, BIOL PHARM BULL, V26, P1057, DOI 10.1248/bpb.26.1057; Aso K, 2004, BIOL PHARM BULL, V27, P727, DOI 10.1248/bpb.27.727; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BANKOVA V, 1995, Z NATURFORSCH C, V50, P167; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Choi SS, 2011, BIOCHEM PHARMACOL, V81, P925, DOI 10.1016/j.bcp.2011.01.002; des Gachons CP, 2011, J NEUROSCI, V31, P999, DOI 10.1523/JNEUROSCI.1374-10.2011; Drago L, 2000, J CHEMOTHERAPY, V12, P390, DOI 10.1179/joc.2000.12.5.390; GREENAWAY W, 1991, Z NATURFORSCH C, V46, P111; GRUNBERGER D, 1988, EXPERIENTIA, V44, P230, DOI 10.1007/BF01941717; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kimoto T, 1998, CANCER DETECT PREV, V22, P506, DOI 10.1046/j.1525-1500.1998.00020.x; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Kumazawa S, 2003, CHEM PHARM BULL, V51, P740, DOI 10.1248/cpb.51.740; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Matsuno T, 1997, ANTICANCER RES, V17, P3565; Mishima S, 2005, J ETHNOPHARMACOL, V99, P5, DOI 10.1016/j.jep.2005.02.005; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Paulino N, 2008, EUR J PHARMACOL, V587, P296, DOI 10.1016/j.ejphar.2008.02.067; Penuelas A, 2007, EUR J PHARMACOL, V576, P143, DOI 10.1016/j.ejphar.2007.08.015; SCHELLER S, 1989, Z NATURFORSCH C, V44, P1063; Shimizu K, 2004, ARCH BIOCHEM BIOPHYS, V424, P181, DOI 10.1016/j.abb.2004.02.021; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Teixeira EW, 2005, EVID-BASED COMPL ALT, V2, P85, DOI 10.1093/ecam/neh055; Uto Y, 2006, BIOORGAN MED CHEM, V14, P5721, DOI 10.1016/j.bmc.2006.04.015	33	53	54	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48072	10.1371/journal.pone.0048072	http://dx.doi.org/10.1371/journal.pone.0048072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133611	Green Submitted, Green Published, gold			2022-12-25	WOS:000310702400021
J	Metzner, M; Jack, HM; Wabl, M				Metzner, Mirjam; Jaeck, Hans-Martin; Wabl, Matthias			LINE-1 Retroelements Complexed and Inhibited by Activation Induced Cytidine Deaminase	PLOS ONE			English	Article							HYPER-IGM SYNDROME; L1 RETROTRANSPOSITION; AUTOIMMUNE-DISEASE; DEFICIENCY CAUSES; DNA DEAMINATION; AID; RNA; EXPRESSION; PROTEIN; GENOME	LINE-1 (abbreviated L1) is a major class of retroelements in humans and mice. If unrestricted, retroelements accumulate in the cytoplasm and insert their DNA into the host genome, with the potential to cause autoimmune disease and cancer. Retroviruses and other retroelements are inhibited by proteins of the APOBEC family, of which activation-induced cytidine deaminase (AID) is a member. Although AID is mainly known for being a DNA mutator shaping the antibody repertoire in B lymphocytes, we found that AID also restricts de novo L1 integrations in B-and non-B-cell lines. It does so by decreasing the protein level of open reading frame 1 (ORF1) of both exogenous and endogenous L1. In activated B lymphocytes, AID deficiency increased L1 mRNA 1.6-fold and murine leukemia virus (MLV) mRNA 2.7-fold. In cell lines and activated B lymphocytes, AID forms cytoplasmic high-molecular-mass complexes with L1 mRNA, which may contribute to L1 restriction. Because AID-deficient activated B lymphocytes do not express ORF1 protein, we suggest that ORF1 protein expression is inhibited by additional restriction factors in these cells. The greater increase in MLV compared to L1 mRNA in AID-deficient activated B lymphocytes may indicate less strict surveillance of retrovirus.	[Metzner, Mirjam; Wabl, Matthias] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Metzner, Mirjam; Jaeck, Hans-Martin] Univ Erlangen Nurnberg, Dept Internal Med 3, Nikolaus Fiebiger Ctr, Div Mol Immunol, D-91054 Erlangen, Germany	University of California System; University of California San Francisco; University of Erlangen Nuremberg	Metzner, M (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	mmetzner@molmed.uni-erlangen.de		Jack, Hans-Martin/0000-0002-6332-8463	National Institutes of Health [R01AI041570]; Lupus Research Institute; Deutsche Forschungsgemeinschaft [FOR832, GRK1660]; IZKF Erlangen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Erlangen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health [R01AI041570] and the Lupus Research Institute to MW; and the Deutsche Forschungsgemeinschaft [FOR832, GRK1660] and the IZKF Erlangen to H-MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Beck-Engeser GB, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-91; Beck-Engeser GB, 2009, P NATL ACAD SCI USA, V106, P20865, DOI 10.1073/pnas.0908074106; Belancio VP, 2009, GENOME MED, V1, DOI 10.1186/gm97; Benihoud K, 2002, ONCOGENE, V21, P5593, DOI 10.1038/sj.onc.1205730; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chen L, 2010, CLIN EXP IMMUNOL, V159, P169, DOI 10.1111/j.1365-2249.2009.04058.x; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Dobigny G, 2004, CHROMOSOME RES, V12, P787, DOI 10.1007/s10577-005-5265-y; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Durandy A, 2003, CURR OPIN ALLERGY CL, V3, P421, DOI 10.1097/01.all.0000104450.09202.0e; Ergun S, 2004, J BIOL CHEM, V279, P27753, DOI 10.1074/jbc.M312985200; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; Hasler J, 2011, P NATL ACAD SCI USA, V108, P18366, DOI 10.1073/pnas.1106729108; Hase K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003033; Hayashi S, 2003, BIOL REPROD, V69, P1170, DOI 10.1095/biolreprod.103.016832; Innerarity TL, 1996, J BIOL CHEM, V271, P2353, DOI 10.1074/jbc.271.5.2353; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Krueger C, 2006, J GENE MED, V8, P1037, DOI 10.1002/jgm.932; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; Lotscher M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001158; Lorens JB, 2000, VIROLOGY, V272, P7, DOI 10.1006/viro.2000.0353; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; MARTIN SL, 1993, MOL CELL BIOL, V13, P5383, DOI 10.1128/MCB.13.9.5383; Metzner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008883; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3; Nonaka T, 2009, P NATL ACAD SCI USA, V106, P2747, DOI 10.1073/pnas.0812957106; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Prak NL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/37049; Prochnow C, 2009, SCI CHINA SER C, V52, P893, DOI 10.1007/s11427-009-0133-1; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Schreck S, 2006, J PATHOL, V210, P26, DOI 10.1002/path.2014; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Suto A, 2002, BLOOD, V100, P4565, DOI 10.1182/blood-2002-04-1115; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41	68	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e49358	10.1371/journal.pone.0049358	http://dx.doi.org/10.1371/journal.pone.0049358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133680	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400059
J	Saha, R; Verseput, AT; Berla, BM; Mueller, TJ; Pakrasi, HB; Maranas, CD				Saha, Rajib; Verseput, Alex T.; Berla, Bertram M.; Mueller, Thomas J.; Pakrasi, Himadri B.; Maranas, Costas D.			Reconstruction and Comparison of the Metabolic Potential of Cyanobacteria Cyanothece sp ATCC 51142 and Synechocystis sp PCC 6803	PLOS ONE			English	Article							BLUE-GREEN-ALGAE; SP PCC-6803; PHOTOSYSTEM-I; PHOTOSYNTHETIC PRODUCTION; INSERTIONAL INACTIVATION; DELETION MUTAGENESIS; CYTOCHROME C-550; CHLOROPHYLL-A; GENE; PROTEIN	Cyanobacteria are an important group of photoautotrophic organisms that can synthesize valuable bio-products by harnessing solar energy. They are endowed with high photosynthetic efficiencies and diverse metabolic capabilities that confer the ability to convert solar energy into a variety of biofuels and their precursors. However, less well studied are the similarities and differences in metabolism of different species of cyanobacteria as they pertain to their suitability as microbial production chassis. Here we assemble, update and compare genome-scale models (iCyt773 and iSyn731) for two phylogenetically related cyanobacterial species, namely Cyanothece sp. ATCC 51142 and Synechocystis sp. PCC 6803. All reactions are elementally and charge balanced and localized into four different intracellular compartments (i.e., periplasm, cytosol, carboxysome and thylakoid lumen) and biomass descriptions are derived based on experimental measurements. Newly added reactions absent in earlier models (266 and 322, respectively) span most metabolic pathways with an emphasis on lipid biosynthesis. All thermodynamically infeasible loops are identified and eliminated from both models. Comparisons of model predictions against gene essentiality data reveal a specificity of 0.94 (94/100) and a sensitivity of 1 (19/19) for the Synechocystis iSyn731 model. The diurnal rhythm of Cyanothece 51142 metabolism is modeled by constructing separate (light/dark) biomass equations and introducing regulatory restrictions over light and dark phases. Specific metabolic pathway differences between the two cyanobacteria alluding to different bio-production potentials are reflected in both models.	[Saha, Rajib; Verseput, Alex T.; Mueller, Thomas J.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Berla, Bertram M.; Pakrasi, Himadri B.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO USA; [Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Washington University (WUSTL); Washington University (WUSTL)	Maranas, CD (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Saha, Rajib/0000-0002-2974-0243	United States Department of Energy, Biological and Environmental Research (DOE-BER) [DE-SC0006870]	United States Department of Energy, Biological and Environmental Research (DOE-BER)(United States Department of Energy (DOE))	This study was supported by a grant from the United States Department of Energy, Biological and Environmental Research (DOE-BER), grant DE-SC0006870. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdiyeva Y, 2011, J BIOL CHEM, V286, P24007, DOI 10.1074/jbc.M111.223289; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Antal TK, 2005, J APPL MICROBIOL, V98, P114, DOI 10.1111/j.1365-2672.2004.02431.x; ARNON DI, 1974, BIOCHIM BIOPHYS ACTA, V357, P231, DOI 10.1016/0005-2728(74)90063-2; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Bandyopadhyay A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1139; Bentley FK, 2012, BIOTECHNOL BIOENG, V109, P100, DOI 10.1002/bit.23298; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; BURNAP RL, 1991, BIOCHEMISTRY-US, V30, P440, DOI 10.1021/bi00216a020; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; CHITNIS PR, 1989, J BIOL CHEM, V264, P18374; CHITNIS PR, 1989, J BIOL CHEM, V264, P18381; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Connor MR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541698; Dahnhardt D, 2002, FEBS LETT, V523, P177, DOI 10.1016/S0014-5793(02)02978-2; DELORIMIER R, 1990, BIOCHIM BIOPHYS ACTA, V1019, P29, DOI 10.1016/0005-2728(90)90121-J; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; FernandezGonzalez B, 1997, J BIOL CHEM, V272, P9728; Fu PC, 2009, J CHEM TECHNOL BIOT, V84, P473, DOI 10.1002/jctb.2065; Gao QQ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-17; GLAZER AN, 1977, MOL CELL BIOCHEM, V18, P125, DOI 10.1007/BF00280278; Hong SJ, 2007, BIOTECHNOL BIOPROC E, V12, P165, DOI 10.1007/BF03028644; Jallet D, 2012, BBA-BIOENERGETICS, V1817, P1418, DOI 10.1016/j.bbabio.2011.11.020; JANSSON C, 1987, PLANT PHYSIOL, V85, P1021, DOI 10.1104/pp.85.4.1021; Jensen PA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-147; Kaneko T, 1996, DNA Res, V3, P109; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; Kumar VS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-28; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Liu XY, 2009, P NATL ACAD SCI USA, V106, P21550, DOI 10.1073/pnas.0911953106; Mahadevan RE, 2003, BIOPHYS J, V83, P1331; Manna P, 1997, PLANT MOL BIOL, V35, P407, DOI 10.1023/A:1005875124387; McHugh K., 2005, HYDROGEN PRODUCTION; Min HT, 2010, APPL ENVIRON MICROB, V76, P4293, DOI 10.1128/AEM.00146-10; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Montagud A, 2011, BIOTECHNOL J, V6, P330, DOI 10.1002/biot.201000109; Montagud A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-156; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MuroPastor MI, 1996, J BACTERIOL, V178, P4070, DOI 10.1128/jb.178.14.4070-4076.1996; Nakamoto H, 1995, PLANT CELL PHYSIOL, V36, P1579; Nakamura Y, 1999, NUCLEIC ACIDS RES, V27, P66, DOI 10.1093/nar/27.1.66; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Navarro E, 2009, INT J HYDROGEN ENERG, V34, P8828, DOI 10.1016/j.ijhydene.2009.08.036; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; OGAWA T, 1994, J BACTERIOL, V176, P2374, DOI 10.1128/JB.176.8.2374-2378.1994; PAERL HW, 1984, OECOLOGIA, V61, P143, DOI 10.1007/BF00396752; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Popa R, 2007, ISME J, V1, P354, DOI 10.1038/ismej.2007.44; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Poutanen EL, 2001, AMBIO, V30, P179, DOI 10.1639/0044-7447(2001)030[0179:CPATOC]2.0.CO;2; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Quintero MJ, 2000, J BACTERIOL, V182, P1008, DOI 10.1128/JB.182.4.1008-1015.2000; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Sakuragi Y, 2002, BIOCHEMISTRY-US, V41, P394, DOI 10.1021/bi011297w; Savage DF, 2008, ACS CHEM BIOL, V3, P13, DOI 10.1021/cb700259j; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schopf JW., 2000, ECOLOGY CYANOBACTERI, P13; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; Shen JR, 1997, J BIOL CHEM, V272, P17821, DOI 10.1074/jbc.272.28.17821; SHEN JR, 1995, J BIOL CHEM, V270, P6901, DOI 10.1074/jbc.270.12.6901; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; Solomon CM, 2010, AQUAT MICROB ECOL, V59, P67, DOI 10.3354/ame01390; Steiger S, 1999, J PHOTOCH PHOTOBIO B, V52, P14, DOI 10.1016/S1011-1344(99)00094-9; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Stockel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016680; Taiz L, 2002, PLANT PHYSILOGY; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Tredici MR, 1986, P 1986 INT C REN EN, V1, P191; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Turner J, 2008, INT J ENERG RES, V32, P379, DOI 10.1002/er.1372; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Vu TT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002460; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Wu B, 2010, MICROBIOL-SGM, V156, P596, DOI 10.1099/mic.0.031799-0; Wu GF, 2001, J CHEM ENG JPN, V34, P1187, DOI 10.1252/jcej.34.1187; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zahalak M, 2004, MOL MICROBIOL, V51, P539, DOI 10.1046/j.1365-2958.2003.03851.x; Zehr JP, 2005, NATO SERIES BOOK PRE, P337; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858	98	74	75	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48285	10.1371/journal.pone.0048285	http://dx.doi.org/10.1371/journal.pone.0048285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23133581	Green Published, gold			2022-12-25	WOS:000310600500090
J	Berge, T; Gronningsaeter, IHB; Lorvik, KB; Abrahamsen, G; Granum, S; Sundvold-Gjerstad, V; Corthay, A; Bogen, B; Spurkland, A				Berge, Tone; Gronningsaeter, Ingrid Helene Bo; Lorvik, Kristina Berg; Abrahamsen, Greger; Granum, Stine; Sundvold-Gjerstad, Vibeke; Corthay, Alexandre; Bogen, Bjarne; Spurkland, Anne			SH2D2A Modulates T Cell Mediated Protection to a B Cell Derived Tumor in Transgenic Mice	PLOS ONE			English	Article							ADAPTER PROTEIN TSAD; COMPLEX CLASS-II; CLONAL DELETION; LCK; IMMUNOGLOBULIN; IMMUNOSURVEILLANCE; THYMOCYTES; RECEPTOR; ACTIVATION; RESISTANCE	Background: T cell specific adapter protein (TSAd), encoded by the SH2D2A gene, modulates signaling downstream of the T cell receptor (TCR). Young, unchallenged SH2D2A-deficient C57BL/6 mice exhibit a relatively normal immune phenotype. To address whether SH2D2A regulates physiologic immune responses, SH2D2A-deficient TCR-transgenic BALB/c mice were generated. The transgenic TCR recognizes a myeloma-derived idiotypic (Id) peptide in the context of the major histocompatibility complex (MHC) class II molecule I-E-d, and confers T cell mediated resistance to transplanted multiple myeloma development in vivo. Principal Findings: The immune phenotype of SH2D2A-deficient C57BL/6 and BALB/c mice did not reveal major differences compared to the corresponding wild type mice. When challenged with myeloma cells, Id-specific TCR-transgenic BALB/c mice lacking SH2D2A displayed increased resistance towards tumor development. Tumor free TCR-transgenic SH2D2-Adeficient mice had higher numbers of Id-specific single positive CD4+ thymocytes compared to TCR-transgenic wild-type mice. Conclusion: Our results suggest a modulatory role for SH2D2A in T cell mediated immune surveillance of cancer. However, it remains to be established whether its effect is T-cell intrinsic. Further studies are required to determine whether targeting SH2D2A function in T cells may be a potential adjuvant in cancer immunotherapy.	[Berge, Tone; Gronningsaeter, Ingrid Helene Bo; Abrahamsen, Greger; Granum, Stine; Sundvold-Gjerstad, Vibeke; Spurkland, Anne] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Lorvik, Kristina Berg; Corthay, Alexandre; Bogen, Bjarne] Oslo Univ Hosp, Rikshosp, Ctr Immune Regulat, Dept Immunol, Oslo, Norway; [Berge, Tone] Univ Oslo, Ulleval Hosp, Dept Neurol, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Berge, T (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.	tone.berge@medisin.uio.no	Spurkland, Anne/L-3369-2019; Lorvik, Kristina Berg/J-5849-2019; Corthay, Alexandre/M-5289-2013; Corthay, Alexandre/M-5289-2013	Spurkland, Anne/0000-0003-4421-0766; Lorvik, Kristina Berg/0000-0001-8593-8054; Corthay, Alexandre/0000-0003-1152-0549; Corthay, Alexandre/0000-0001-9519-5725	Norwegian Research Council [177789/V40, 196386]; Norwegian Cancer Society [HS01-0330, 420042 71237-PR-2006-0303]; Novo Nordisk; Vitenskapsradet; Oslo University Hospital Ulleval; Legatet til kreftens bekjempelse; Anders Jahres Research Fund; South-Eastern Norway Regional Health Authority; Helse sorost	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Novo Nordisk(Novo Nordisk); Vitenskapsradet; Oslo University Hospital Ulleval; Legatet til kreftens bekjempelse; Anders Jahres Research Fund; South-Eastern Norway Regional Health Authority; Helse sorost	This study was supported by the Norwegian Research Council (grant 177789/V40 and grant 196386, www.forskningsradet.no), the Norwegian Cancer Society (grant HS01-0330 and 420042 71237-PR-2006-0303, www.kreftforeningen.no), Novo Nordisk (www.novonordiskfonden.dk), Vitenskapsradet (http://www.oslo-universitetssykehus.no), Oslo University Hospital Ulleval, Legatet til kreftens bekjempelse (www.unifor.no), Anders Jahres Research Fund (www.unifor.no), South-Eastern Norway Regional Health Authority, Helse sorost (www.helse-sorost.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berge T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009761; BOGEN B, 1993, EMBO J, V12, P357, DOI 10.1002/j.1460-2075.1993.tb05664.x; BOGEN B, 1990, EUR J IMMUNOL, V20, P2359, DOI 10.1002/eji.1830201030; BOGEN B, 1995, EUR J IMMUNOL, V25, P3079, DOI 10.1002/eji.1830251114; BOGEN B, 1992, EUR J IMMUNOL, V22, P703, DOI 10.1002/eji.1830220313; Bogen B, 1996, EUR J IMMUNOL, V26, P2671, DOI 10.1002/eji.1830261119; BOGEN B, 1986, EUR J IMMUNOL, V16, P1373, DOI 10.1002/eji.1830161110; Caserta S, 2010, J IMMUNOL, V185, P6545, DOI 10.4049/jimmunol.1001867; Choi YB, 1999, J IMMUNOL, V163, P5242; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Corthay A, 2009, CANCER RES, V69, P5901, DOI 10.1158/0008-5472.CAN-08-4816; Drappa J, 2003, J EXP MED, V198, P809, DOI 10.1084/jem.20021358; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Granum S, 2008, J BIOL CHEM, V283, P21909, DOI 10.1074/jbc.M800871200; Granum S, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-15; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; LAURITZSEN GF, 1993, CELL IMMUNOL, V148, P177, DOI 10.1006/cimm.1993.1100; LAURITZSEN GF, 1994, P NATL ACAD SCI USA, V91, P5700, DOI 10.1073/pnas.91.12.5700; Lauritzsen GF, 1998, INT J CANCER, V78, P216, DOI 10.1002/(SICI)1097-0215(19981005)78:2<216::AID-IJC16>3.3.CO;2-E; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Lorvik KB, 2012, BLOOD, V119, P2176, DOI 10.1182/blood-2011-10-388892; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marti F, 2006, J EXP MED, V203, P281, DOI 10.1084/jem.20051637; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Perchonock CE, 2007, J IMMUNOL, V179, P1768, DOI 10.4049/jimmunol.179.3.1768; Rajagopal K, 1999, J EXP MED, V190, P1657, DOI 10.1084/jem.190.11.1657; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sundvold V, 2000, J IMMUNOL, V165, P2927, DOI 10.4049/jimmunol.165.6.2927; Sundvold-Gjerstad V, 2005, EUR J IMMUNOL, V35, P1612, DOI 10.1002/eji.200425638; SUNDVOLDGJERSTA.V, 2007, LYMPHOCYTE ACTIVATIO, P211; Wallace PK, 2008, CYTOM PART A, V73A, P1019, DOI 10.1002/cyto.a.20619; WEISS S, 1989, P NATL ACAD SCI USA, V86, P282, DOI 10.1073/pnas.86.1.282; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wu LW, 2000, J BIOL CHEM, V275, P6059, DOI 10.1074/jbc.275.9.6059	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48239	10.1371/journal.pone.0048239	http://dx.doi.org/10.1371/journal.pone.0048239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144743	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300053
J	Kickler, K; Choileain, SN; Williams, A; Richards, A; Astier, AL				Kickler, Karoline; Choileain, Siobhan Ni; Williams, Anna; Richards, Anna; Astier, Anne L.			Calcitriol Modulates the CD46 Pathway in T Cells	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; COMPLEMENT-REGULATORY PROTEINS; MULTIPLE-SCLEROSIS; VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; INTERLEUKIN-10 PRODUCTION; ASTHMA PATIENTS; ACTIVATION; RECEPTOR; INHIBITION	The complement regulator CD46 is a costimulatory molecule for human T cells that induces a regulatory Tr1 phenotype, characterized by large amounts of IL-10 secretion. Secretion of IL-10 upon CD46 costimulation is largely impaired in T cells from patients with multiple sclerosis (MS). Vitamin D can exert a direct effect on T cells, and may be beneficial in several pathologies, including MS. In this pilot study, we examined whether active vitamin D (1,25(OH)(2)D-3 or calcitriol) could modulate the CD46 pathway and restore IL-10 production by CD46-costimulated CD4+ T cells from patients with MS. In healthy T cells, calcitriol profoundly affects the phenotype of CD46-costimulated CD4+ T cells, by increasing the expression of CD28, CD25, CTLA-4 and Foxp3 while it concomitantly decreased CD46 expression. Similar trends were observed in MS CD4+ T cells except for CD25 for which a striking opposite effect was observed: while CD25 was normally induced on MS T cells by CD46 costimulation, addition of calcitriol consistently inhibited its induction. Despite the aberrant effect on CD25 expression, calcitriol increased the IL-10:IFN gamma ratio, characteristic of the CD46-induced Tr1 phenotype, in both T cells from healthy donors and patients with MS. Hence, we show that calcitriol affects the CD46 pathway, and that it promotes anti-inflammatory responses mediated by CD46. Moreover, it might be beneficial for T cell responses in MS.	[Kickler, Karoline; Choileain, Siobhan Ni; Richards, Anna; Astier, Anne L.] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Choileain, Siobhan Ni; Williams, Anna; Astier, Anne L.] Univ Edinburgh, MRC Ctr Regenerat Med, Multiple Sclerosis Res Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Astier, AL (corresponding author), Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	a.astier@ed.ac.uk	Astier, Anne L/A-1641-2008; Richards, Anna/E-8337-2013	Astier, Anne L/0000-0002-0144-3431; Williams, Anna/0000-0002-6329-382X	MS Society [859/07]	MS Society	This work was supported by a research grant from the MS Society to ALA (859/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; ALROY I, 1995, MOL CELL BIOL, V15, P5789; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Baeke F, 2011, J IMMUNOL, V186, P132, DOI 10.4049/jimmunol.1000695; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bartels LE, 2007, INT IMMUNOPHARMACOL, V7, P1755, DOI 10.1016/j.intimp.2007.09.016; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Choileain SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016287; Christmas SE, 2006, IMMUNOLOGY, V119, P522, DOI 10.1111/j.1365-2567.2006.02467.x; Cole DS, 2006, MOL IMMUNOL, V43, P1953, DOI 10.1016/j.molimm.2005.11.015; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Coussens AK, 2009, IMMUNOLOGY, V127, P539, DOI 10.1111/j.1365-2567.2008.03024.x; Devereux G, 2009, AM J RESP CRIT CARE, V179, P739, DOI 10.1164/rccm.200901-0145ED; Dimeloe S, 2010, J STEROID BIOCHEM, V120, P86, DOI 10.1016/j.jsbmb.2010.02.029; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hakulinen J, 2006, J BIOL CHEM, V281, P21369, DOI 10.1074/jbc.M602053200; Huotari A, 2008, INT J CIRCUMPOL HEAL, V67, P164, DOI 10.3402/ijch.v67i2-3.18258; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Khoo AL, 2011, IMMUNOLOGY, V134, P459, DOI 10.1111/j.1365-2567.2011.03507.x; Kickler K, 2012, J IMMUNOL IN PRESS; LUBLIN DM, 1988, J EXP MED, V168, P181, DOI 10.1084/jem.168.1.181; Ma AL, 2009, INT IMMUNOPHARMACOL, V9, P599, DOI 10.1016/j.intimp.2009.01.034; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Martin R, 2012, CLIN IMMUNOL, V142, P9, DOI 10.1016/j.clim.2011.10.008; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; Mayne CG, 2011, EUR J IMMUNOL, V41, P822, DOI 10.1002/eji.201040632; Ni Choileain S, 2011, IMMUNOBIOLOGY; Oliaro J, 2006, P NATL ACAD SCI USA, V103, P18685, DOI 10.1073/pnas.0602458103; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; Ramagopalan SV, 2011, ANN NEUROL, V70, P881, DOI 10.1002/ana.22678; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; RIGBY WFC, 1987, J CLIN INVEST, V79, P1659, DOI 10.1172/JCI113004; RIGBY WFC, 1987, EUR J IMMUNOL, V17, P563, DOI 10.1002/eji.1830170420; Schmitz JP, 1996, J CELL PHYSIOL, V168, P570, DOI 10.1002/(SICI)1097-4652(199609)168:3<570::AID-JCP9>3.3.CO;2-S; Smolders J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015235; Soilu-Hanninen M, 2012, J NEUROL NEUROSURG P; Spach KM, 2006, J IMMUNOL, V177, P6030, DOI 10.4049/jimmunol.177.9.6030; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; TAGA K, 1992, J IMMUNOL, V148, P1143; Urry Z, 2009, J CLIN INVEST, V119, P387, DOI 10.1172/JCI32354; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Xu YQ, 2010, J ASTHMA, V47, P367, DOI 10.3109/02770903.2010.481340; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Zaffran Y, 2001, J IMMUNOL, V167, P6780, DOI 10.4049/jimmunol.167.12.6780	56	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48486	10.1371/journal.pone.0048486	http://dx.doi.org/10.1371/journal.pone.0048486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144765	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300075
J	Miller, SC; Miyata, K; Brown, SJ; Tomoyasu, Y				Miller, Sherry C.; Miyata, Keita; Brown, Susan J.; Tomoyasu, Yoshinori			Dissecting Systemic RNA Interference in the Red Flour Beetle Tribolium castaneum: Parameters Affecting the Efficiency of RNAi	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GERM-LINE DEVELOPMENT; SMALL TEMPORAL RNAS; C-ELEGANS; CAENORHABDITIS-ELEGANS; AEDES-AEGYPTI; LARVAL RNAI; CELL-LINES; GENE; SIRNA	The phenomenon of RNAi, in which the introduction of dsRNA into a cell triggers the destruction of the corresponding mRNA resulting in a gene silencing effect, is conserved across a wide array of plant and animal phyla. However, the mechanism by which the dsRNA enters a cell, allowing the RNAi effect to occur throughout a multicellular organism (systemic RNAi), has only been studied extensively in certain plants and the nematode Caenorhabditis elegans. In recent years, RNAi has become a popular reverse genetic technique for gene silencing in many organisms. Although many RNAi techniques in non-traditional model organisms rely on the systemic nature of RNAi, little has been done to analyze the parameters required to obtain a robust systemic RNAi response. The data provided here show that the concentration and length of dsRNA have profound effects on the efficacy of the RNAi response both in regard to initial efficiency and duration of the effect in Tribolium castaneum. In addition, our analyses using a series of short dsRNAs and chimeric dsRNA provide evidence that dsRNA cellular uptake (and not the RNAi response itself) is the major step affected by dsRNA size in Tribolium. We also demonstrate that competitive inhibition of dsRNA can occur when multiple dsRNAs are injected together, influencing the effectiveness of RNAi. These data provide specific information essential to the design and implementation of RNAi based studies, and may provide insight into the molecular basis of the systemic RNAi response in insects.	[Miyata, Keita; Tomoyasu, Yoshinori] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Miller, Sherry C.; Brown, Susan J.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Miller, Sherry C.; Brown, Susan J.] Kansas State Univ, K State Arthropod Genom Ctr, Manhattan, KS 66506 USA	University System of Ohio; Miami University; Kansas State University; Kansas State University	Tomoyasu, Y (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	tomoyay@muohio.edu	Tomoyasu, Yoshinori/D-3061-2017	Tomoyasu, Yoshinori/0000-0001-9824-3454; Brown, Susan/0000-0002-7984-0445	KINBRE from the National Center for Research Resources [P20 RR016475]; National Institutes of Health [HD29594]; Miami University; National Science Foundation [IOS 0950964]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029594] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	KINBRE from the National Center for Research Resources; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami University; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	SCM received a STAR-trainee award from KINBRE, Award Number P20 RR016475 from the National Center for Research Resources. This work was supported by the National Institutes of Health (SJB: HD29594), Miami University start-up grant (YT), and National Science Foundation (YT: IOS 0950964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Barik S, 2006, NAT BIOTECHNOL, V24, P796, DOI 10.1038/nbt0706-796; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Formstecher E, 2006, OLIGONUCLEOTIDES, V16, P387, DOI 10.1089/oli.2006.16.387; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Isoe J, 2007, INSECT MOL BIOL, V16, P83, DOI 10.1111/j.1365-2583.2006.00704.x; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Khila A, 2007, DEV GENES EVOL, V217, P241, DOI 10.1007/s00427-007-0132-9; Klahre U, 2002, P NATL ACAD SCI USA, V99, P11981, DOI 10.1073/pnas.182204199; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Koller E, 2006, NUCLEIC ACIDS RES, V34, P4467, DOI 10.1093/nar/gkl589; Kurreck J, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/83757; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; McManus MT, 2002, J IMMUNOL, V169, P5754, DOI 10.4049/jimmunol.169.10.5754; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Mutti NS, 2006, J INS SCI, V6; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Philip BN, 2011, METHODS MOL BIOL, V772, P471, DOI 10.1007/978-1-61779-228-1_28; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Siebert KS, 2008, INSECT BIOCHEM MOLEC, V38, P749, DOI 10.1016/j.ibmb.2008.04.007; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stierle V, 2007, BIOCHIMIE, V89, P1033, DOI 10.1016/j.biochi.2007.03.011; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tomoyasu Y, 2009, CURR BIOL, V19, P2057, DOI 10.1016/j.cub.2009.11.014; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Vienne A, 2003, IMMUNOGENETICS, V55, P429, DOI 10.1007/s00251-003-0601-x; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yoo JW, 2008, BIOCHEM BIOPH RES CO, V367, P78, DOI 10.1016/j.bbrc.2007.12.099; Zawadzki JL, 2006, TRENDS PARASITOL, V22, P495, DOI 10.1016/j.pt.2006.08.015; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100	70	134	137	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47431	10.1371/journal.pone.0047431	http://dx.doi.org/10.1371/journal.pone.0047431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133513	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800006
J	Shi, S; Carattino, MD; Kleyman, TR				Shi, Shujie; Carattino, Marcelo D.; Kleyman, Thomas R.			Role of the Wrist Domain in the Response of the Epithelial Sodium Channel to External Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; POTASSIUM SECRETION; K+ SECRETION; FLOW-RATE; ENAC; INHIBITION; TRANSPORT; FINGER; TUBULE; FLUID	The epithelial Na+ channel (ENaC) is regulated by a variety of external factors that alter channel activity by inducing conformational changes within its large extracellular region that are transmitted to the gate. The wrist domain consists of small linkers connecting the extracellular region to the transmembrane domains, where the channel pore and gate reside. We employed site-directed mutagenesis combined with two-electrode voltage clamp to investigate the role of the wrist domain in channel gating in response to extracellular factors. Channel inhibition by external Na+ was reduced by selected mutations within the wrist domain of the alpha subunit, likely reflecting an increase in channel open probability. The most robust changes were observed when Cys was introduced at alpha Pro-138 and alpha Ser-568, sites immediately adjacent to the palm domain. In addition, one of these Cys mutants exhibited an enhanced response to shear stress. In the context of channels that have a low open probability due to retention of an inhibitory tract, the response to external Na+ was reduced by Cys substitutions at both alpha Pro-138 and alpha Ser-568. We observed a significant correlation between changes in channel inhibition by external Na+ and the relative response to shear stress for the alpha subunit mutants that were examined. Mutants that exhibited reduced inhibition by external Na+ also showed an enhanced response to shear stress. Together, our data suggest that the wrist domain has a role in modulating the channel's response to external stimuli.	[Shi, Shujie; Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Shi, Shujie/D-4999-2012		National Institutes of Health [R37 DK051391, R01 DK084060, P30 DK079307]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK051391, R37DK051391, R01DK084060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part by National Institutes of Health Grants R37 DK051391, R01 DK084060, and P30 DK079307.; Supported by a postdoctoral fellowship award from the American Heart Association.	Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; ENGBRETSON BG, 1987, AM J PHYSIOL, V253, pF896, DOI 10.1152/ajprenal.1987.253.5.F896; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; GOOD DW, 1979, AM J PHYSIOL, V236, pF192, DOI 10.1152/ajprenal.1979.236.2.F192; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; KHURI RN, 1975, AM J PHYSIOL, V228, P1249, DOI 10.1152/ajplegacy.1975.228.4.1249; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KUNAU RT, 1974, J CLIN INVEST, V54, P1488, DOI 10.1172/JCI107897; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; MALNIC G, 1989, AM J PHYSIOL, V256, pF932, DOI 10.1152/ajprenal.1989.256.5.F932; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Shi SJ, 2012, J BIOL CHEM, V287, P15439, DOI 10.1074/jbc.M112.346551; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786	31	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44027	44035		10.1074/jbc.M112.421743	http://dx.doi.org/10.1074/jbc.M112.421743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144453	hybrid, Green Published			2022-12-25	WOS:000312938600002
J	Santolla, MF; Lappano, R; De Marco, P; Pupo, M; Vivacqua, A; Sisci, D; Abonante, S; Iacopetta, D; Cappello, AR; Dolce, V; Maggiolini, M				Santolla, Maria Francesca; Lappano, Rosamaria; De Marco, Paola; Pupo, Marco; Vivacqua, Adele; Sisci, Diego; Abonante, Sergio; Iacopetta, Domenico; Cappello, Anna Rita; Dolce, Vincenza; Maggiolini, Marcello			G Protein-coupled Estrogen Receptor Mediates the Up-regulation of Fatty Acid Synthase Induced by 17 beta-Estradiol in Cancer Cells and Cancer-associated Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION CHANGES; STROMAL FIBROBLASTS; PROSTATE-CANCER; COLON-CANCER; TUMOR MICROENVIRONMENT; HORMONE-RECEPTORS; BREAST; GPR30; GROWTH; PROLIFERATION	Activation of lipid metabolism is an early event in carcinogenesis and a central hallmark of many tumors. Fatty acid synthase (FASN) is a key lipogenic enzyme catalyzing the terminal steps in the de novo biogenesis of fatty acids. In cancer cells, FASN may act as a metabolic oncogene, given that it confers growth and survival advantages to these cells, whereas its inhibition effectively and selectively kills tumor cells. Hormones such as estrogens and growth factors contribute to the transcriptional regulation of FASN expression also through the activation of downstream signaling and a cross-talk among diverse transduction pathways. In this study, we demonstrate for the first time that 17 beta-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts. In addition, the proliferative effects induced by E2 and G-1 in these cells involved FASN as the inhibitor of its activity, named cerulenin, abolished the growth response to both ligands. Our data suggest that GPER may be included among the transduction mediators involved by estrogens in regulating FASN expression and activity in cancer cells and cancer-associated fibroblasts that strongly contribute to cancer progression.	[Santolla, Maria Francesca; Lappano, Rosamaria; De Marco, Paola; Pupo, Marco; Vivacqua, Adele; Sisci, Diego; Iacopetta, Domenico; Cappello, Anna Rita; Dolce, Vincenza; Maggiolini, Marcello] Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy; [Abonante, Sergio] Reg Hosp, I-87100 Cosenza, Italy	University of Calabria	Maggiolini, M (corresponding author), Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy.	marcellomaggiolini@yahoo.it	Lappano, Rosamaria/Z-4857-2019; Iacopetta, Domenico/H-4242-2014; Cappello, Anna Rita/AAE-2766-2020; vivacqua, adele/I-2771-2015; Maggiolini, Marcello/Z-4729-2019; /AAD-9701-2019; Santolla, Maria Francesca/AAH-5481-2020	Iacopetta, Domenico/0000-0001-5179-7118; vivacqua, adele/0000-0001-5333-8396; /0000-0001-6577-1541; Maggiolini, Marcello/0000-0002-7485-854X; Dolce, Vincenza/0000-0003-2966-4866; Abonante, Sergio/0000-0003-4686-6961; Santolla, Maria Francesca/0000-0002-4838-5953; cappello, anna rita/0000-0001-7824-3561; Lappano, Rosamaria/0000-0002-9374-9701	Associazione Italiana per la Ricerca sul Cancro [12849/2012]; Associazione Italiana per la Ricerca sul Cancro Project Calabria; Fondazione Cassa di Risparmio di Calabria e Lucania	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro Project Calabria(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Calabria e Lucania	This work was supported by Associazione Italiana per la Ricerca sul Cancro (Project 12849/2012), Associazione Italiana per la Ricerca sul Cancro Project Calabria 2011, and Fondazione Cassa di Risparmio di Calabria e Lucania.	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Chimento A, 2010, MOL CELL ENDOCRINOL, V320, P136, DOI 10.1016/j.mce.2010.01.035; De Marco P, 2013, ONCOGENE, V32, P678, DOI 10.1038/onc.2012.97; DIMANCHEBOITREL MT, 1994, INT J CANCER, V56, P512, DOI 10.1002/ijc.2910560410; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filice E, 2009, J PHYSIOL PHARMACOL, V60, P3; Gerdes MJ, 2006, CANCER RES, V66, P7578, DOI 10.1158/0008-5472.CAN-06-1247; IKUTA K, 1986, VIROLOGY, V154, P207, DOI 10.1016/0042-6822(86)90442-3; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Lacasa D, 2001, J BIOL CHEM, V276, P11512, DOI 10.1074/jbc.M008556200; Lafkas D, 2008, INT J CANCER, V123, P967, DOI 10.1002/ijc.23546; Lappano R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3096; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lappano R, 2010, MOL CELL ENDOCRINOL, V320, P162, DOI 10.1016/j.mce.2010.02.006; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Lupu R, 2006, ENDOCRINOLOGY, V147, P4056, DOI 10.1210/en.2006-0486; Madeo A, 2010, ONCOGENE, V29, P978, DOI 10.1038/onc.2009.400; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Maggiolini M, 1999, BIOL CHEM, V380, P695, DOI 10.1515/BC.1999.086; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Menendez JA, 2005, INT J ONCOL, V26, P1507; Menendez JA, 2005, MED HYPOTHESES, V64, P997, DOI 10.1016/j.mehy.2004.09.027; Menendez JA, 2005, MED HYPOTHESES, V64, P342, DOI 10.1016/j.mehy.2004.07.022; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Murata S, 2010, CANCER SCI, V101, P1861, DOI 10.1111/j.1349-7006.2010.01596.x; Ollila S, 2007, J PHYS CHEM B, V111, P3139, DOI 10.1021/jp065424f; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Panno ML, 1996, J CANCER RES CLIN, V122, P745, DOI 10.1007/BF01209122; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Pizer ES, 1998, CANCER-AM CANCER SOC, V83, P528, DOI 10.1002/(SICI)1097-0142(19980801)83:3<528::AID-CNCR22>3.0.CO;2-X; Pizer ES, 1996, CANCER RES, V56, P2745; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Recchia AG, 2011, J BIOL CHEM, V286, P10773, DOI 10.1074/jbc.M110.172247; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Sirianni R, 2008, ENDOCRINOLOGY, V149, P5043, DOI 10.1210/en.2007-1593; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Swinnen JV, 1997, CANCER RES, V57, P1086; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; Van de Sande T, 2002, CANCER RES, V62, P642; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Vivacqua A, 2009, MOL ENDOCRINOL, V23, P1815, DOI 10.1210/me.2009-0120; Wang Young Y, 2004, J Exp Ther Oncol, V4, P101; Wortman MD, 2003, NAT MED, V9, P483, DOI 10.1038/nm0503-483; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yamaguchi Y, 2009, ENDOCR J, V56, P1, DOI 10.1507/endocrj.K08E-099; Yoon S, 2007, J BIOL CHEM, V282, P26122, DOI 10.1074/jbc.M702854200; Zhan Y, 2008, CLIN CANCER RES, V14, P5735, DOI 10.1158/1078-0432.CCR-07-5074	64	76	77	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43234	43245		10.1074/jbc.M112.417303	http://dx.doi.org/10.1074/jbc.M112.417303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135268	Green Published, hybrid			2022-12-25	WOS:000312940800005
J	Clifford, RJ; Milillo, M; Prestwood, J; Quintero, R; Zurawski, DV; Kwak, YI; Waterman, PE; Lesho, EP; Mc Gann, P				Clifford, Robert J.; Milillo, Michael; Prestwood, Jackson; Quintero, Reyes; Zurawski, Daniel V.; Kwak, Yoon I.; Waterman, Paige E.; Lesho, Emil P.; Mc Gann, Patrick			Detection of Bacterial 16S rRNA and Identification of Four Clinically Important Bacteria by Real-Time PCR	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; ACINETOBACTER-BAUMANNII; MULTIPLEX PCR; VITEK 2; ENTEROBACTERIACEAE; GENES; DNA	Within the paradigm of clinical infectious disease research, Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa represent the four most clinically relevant, and hence most extensively studied bacteria. Current culture-based methods for identifying these organisms are slow and cumbersome, and there is increasing need for more rapid and accurate molecular detection methods. Using bioinformatic tools, 962,279 bacterial 16S rRNA gene sequences were aligned, and regions of homology were selected to generate a set of real-time PCR primers that target 93.6% of all bacterial 16S rRNA sequences published to date. A set of four species-specific real-time PCR primer pairs were also designed, capable of detecting less than 100 genome copies of A. baumannii, E. coli, K. pneumoniae, and P. aeruginosa. All primers were tested for specificity in vitro against 50 species of Gram-positive and -negative bacteria. Additionally, the species-specific primers were tested against a panel of 200 clinical isolates of each species, randomly selected from a large repository of clinical isolates from diverse areas and sources. A comparison of culture and real-time PCR demonstrated 100% concordance. The primers were incorporated into a rapid assay capable of positive identification from plate or broth cultures in less than 90 minutes. Furthermore, our data demonstrate that current targets, such as the uidA gene in E. coli, are not suitable as species-specific genes due to sequence variation. The assay described herein is rapid, cost-effective and accurate, and can be easily incorporated into any research laboratory capable of real-time PCR.	[Clifford, Robert J.; Milillo, Michael; Prestwood, Jackson; Quintero, Reyes; Kwak, Yoon I.; Waterman, Paige E.; Lesho, Emil P.; Mc Gann, Patrick] Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD 20910 USA; [Zurawski, Daniel V.] Walter Reed Army Inst Res, Dept Wound Infect, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Mc Gann, P (corresponding author), Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD 20910 USA.	patrick.mcgann@amedd.army.mil	Zurawski, Daniel V./B-6578-2009	Zurawski, Daniel V./0000-0002-7920-5601; Mc Gann, Patrick/0000-0003-1548-9438; Clifford, Robert/0000-0001-8888-897X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anklam KS, 2012, J FOOD PROTECT, V75, P643, DOI 10.4315/0362-028X.JFP-11-392; Anuj SN, 2009, DIAGN MICR INFEC DIS, V63, P127, DOI 10.1016/j.diagmicrobio.2008.09.018; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Cattoir V, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-21; Chen L, 2012, ANTIMICROB AGENTS CH, V56, P3444, DOI 10.1128/AAC.00316-12; Chern EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/j.1472-765X.2010.03001.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Donhauser SC, 2009, ANAL SCI, V25, P669, DOI 10.2116/analsci.25.669; Frahm E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1; Hartman LJ, 2009, J MOL DIAGN, V11, P464, DOI 10.2353/jmoldx.2009.080136; Hillenbrand ME, 2011, INT J OPHTHALMOL-CHI, V4, P262, DOI 10.3980/j.issn.2222-3959.2011.03.10; Jin WY, 2011, DIAGN MICR INFEC DIS, V70, P442, DOI 10.1016/j.diagmicrobio.2011.04.013; Lavenir R, 2007, J MICROBIOL METH, V70, P20, DOI 10.1016/j.mimet.2007.03.008; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Maurer JJ, 2011, ANNU REV FOOD SCI T, V2, P259, DOI 10.1146/annurev.food.080708.100730; McConnell MJ, 2012, J CLIN MICROBIOL, V50, P1412, DOI 10.1128/JCM.06566-11; McGann P, 2011, INFECT CONT HOSP EP, V32, P1116, DOI 10.1086/662380; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P411, DOI 10.1111/j.1469-0691.2012.03795.x; O'Leary J, 2009, J CLIN MICROBIOL, V47, P3449, DOI 10.1128/JCM.01026-09; Pavlovic M, 2011, J APPL MICROBIOL, V110, P1245, DOI 10.1111/j.1365-2672.2011.04973.x; Penel S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3; Stenger DA, 2002, CURR OPIN BIOTECH, V13, P208, DOI 10.1016/S0958-1669(02)00321-X; Thong KL, 2011, TROP BIOMED, V28, P21; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Winstanley T, 2011, CLIN MICROBIOL REV, V24, P515, DOI 10.1128/CMR.00061-10; Woodford N, 2010, J CLIN MICROBIOL, V48, P2999, DOI 10.1128/JCM.00341-10	32	162	173	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48558	10.1371/journal.pone.0048558	http://dx.doi.org/10.1371/journal.pone.0048558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139793	gold, Green Published, Green Submitted			2022-12-25	WOS:000311315300038
J	Robb, GN; Woodborne, S; Bennett, NC				Robb, Gillian N.; Woodborne, Stephan; Bennett, Nigel C.			Subterranean Sympatry: An Investigation into Diet Using Stable Isotope Analysis	PLOS ONE			English	Article							COMMON MOLE-RAT; POCKET GOPHER; CRYPTOMYS-HOTTENTOTUS; ECOLOGY; NICHE; RODENT; ENERGY; FOOD; PREFERENCES; POPULATIONS	In the Western Cape three species of mole-rat occur in sympatry, however, little is known about differences in their dietary preferences. Dietary composition of the three species; the common mole-rat (Cryptomys hottentotus hottentotus), the Cape mole-rat (Georychus capensis) and the Cape dune mole-rat (Bathyergus suillus) were examined using stable isotope analysis. Blood, fur and claw samples were collected from 70 mole-rats, in addition to several potential food items, to assess food selection of the three species under natural conditions. Overall there was a significant difference in the isotopic composition (delta C-13 and delta N-15) between all three species and significant differences in their diet composition. There were also significant differences between tissues in all three species suggesting temporal variation in diet. The small size and colonial lifestyle of C. h. hottentotus allows it to feed almost 100% on bulbs, while the solitary and larger species G. capensis and B. suillus fed to a greater extent on other resources such as grasses and clover. B. suillus, the largest of the species, had the most generalized diet. However, overall all species relied most heavily upon geophytes and consumed the same species suggesting competition for resources could exist. We also showed a high level of individual variation in diet choices. This was most pronounced in B. suillus and G. capensis and less so in C. h. hottentotus. We demonstrate that stable isotope analysis can successfully be applied to examine dietary patterns in subterranean mammals and provide insights into foraging patterns and dietary variation at both the inter and intra population level.	[Robb, Gillian N.; Bennett, Nigel C.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Woodborne, Stephan] CSIR, Nat Resources & Environm, ZA-0001 Pretoria, South Africa	University of Pretoria; Council for Scientific & Industrial Research (CSIR) - South Africa	Robb, GN (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	gnrobb@zoology.up.ac.za	Bennett, Nigel/E-4238-2010	Bennett, Nigel/0000-0001-9748-2947	University of Pretoria; Department of Science and Technology and National Research Foundation SARChI Chair of Mammal Behavioural Ecology and Physiology	University of Pretoria; Department of Science and Technology and National Research Foundation SARChI Chair of Mammal Behavioural Ecology and Physiology	G. Robb was funded by a University of Pretoria Post-doctoral fellowship. N. Bennett and fieldwork costs were funded through the Department of Science and Technology and National Research Foundation SARChI Chair of Mammal Behavioural Ecology and Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT I, 1977, ECOL MONOGR, V47, P151, DOI 10.2307/1942615; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; BenDavid M, 1996, OIKOS, V75, P41, DOI 10.2307/3546319; BENNETT NC, 1995, J ZOOL, V236, P189, DOI 10.1111/j.1469-7998.1995.tb04487.x; BENNETT NC, 1989, J ZOOL, V219, P45, DOI 10.1111/j.1469-7998.1989.tb02564.x; Bennett NC, 2000, AFRICAN MOLE RATS EC, P53; Beviss-Challinor M, 1980, THESIS CAPE TOWN U C; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; COMPARATORE VM, 1995, REV CHIL HIST NAT, V68, P197; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; DAVIES KC, 1986, J ZOOL, V209, P125, DOI 10.1111/j.1469-7998.1986.tb03570.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; GODWIN KO, 1959, J NUTR, V69, P121, DOI 10.1093/jn/69.2.121; HETH G, 1989, OECOLOGIA, V79, P496, DOI 10.1007/BF00378667; HICKMAN GC, 1979, S AFR J ZOOL, V14, P9; HUTTO RL, 1978, OECOLOGIA, V33, P115, DOI 10.1007/BF00377000; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kronfeld-Schor N, 2001, J THERM BIOL, V26, P139, DOI 10.1016/S0306-4565(00)00034-6; Kurle CM, 2009, FUNCT ECOL, V23, P733, DOI 10.1111/j.1365-2435.2009.01553.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LOVEGROVE B G, 1986, Cimbebasia Series A, V8, P79; MacAvoy SE, 2006, OECOLOGIA, V150, P190, DOI 10.1007/s00442-006-0522-0; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Norris JJ, 1943, ECOLOGY, V24, P244, DOI 10.2307/1929703; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; REICHMAN OJ, 1989, J MAMMAL, V70, P763, DOI 10.2307/1381710; RUITERS C, 1994, ANN BOT-LONDON, V74, P633, DOI 10.1006/anbo.1994.1165; Skliba J, 2011, ECOL RES, V26, P1081, DOI 10.1007/s11284-011-0860-1; SPENCER SR, 1985, OECOLOGIA, V66, P111, DOI 10.1007/BF00378561; Spinks AC, 1999, J ZOOL, V249, P143; Spinks AC, 2000, OECOLOGIA, V125, P341, DOI 10.1007/s004420000460; Stewart KM, 2003, ECOSCIENCE, V10, P297, DOI 10.1080/11956860.2003.11682777; TIESZEN LL, 1993, PREHISTORIC HUMAN BO, P127; VLECK D, 1979, PHYSIOL ZOOL, V52, P122, DOI 10.1086/physzool.52.2.30152558; WILLIAMS LR, 1986, J MAMMAL, V67, P489, DOI 10.2307/1381280	40	16	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48572	10.1371/journal.pone.0048572	http://dx.doi.org/10.1371/journal.pone.0048572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139795	Green Published, gold			2022-12-25	WOS:000310741400053
J	Li, QC; Li, XM; Guo, ZL; Xu, F; Xia, JY; Liu, ZM; Ren, T				Li, Qinchuan; Li, Xiaoman; Guo, Zhongliang; Xu, Feng; Xia, Jingyan; Liu, Zhongmin; Ren, Tao			MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CELLS; EXPRESSION; CHES1; DIFFERENTIATION; METASTASIS; CARCINOMA; GENES	Accumulating data suggested that functional expression of Toll-like receptors (TLRs) in tumor cells was involved in tumor progression. Our previous study demonstrated that TLR9 signaling could enhance the tumor progression of human lung cancer cells in vitro and in vivo. We further showed that miR-574-5p was the mostly up-regulated miRNA in human lung cancer cells under TLR9 signaling by miRNA array analysis. Here we characterized the potential role of miRNA-574-5p in enhanced tumor progression induced by TLR9 signaling in human lung cancer. We confirmed that TLR9 signaling effectively elevated the expression of miR-574-5p in human lung cancer cells. Notably, we found that down-regulation of miRNA-5745p using miR-574-5p inhibitor in vitro or miR-574-5p sponge in vivo significantly abrogated the enhanced tumor progression induced by TLR9 signaling. Further studies showed that miR-574-5p was an important player associated with enhanced tumor progression of human lung cancer cells. Notably, we identified checkpoint suppressor 1 (Ches1) as the dominant direct target for miRNA-574-5p to confer the TLR9 signaling enhanced tumor progression. We revealed that overexpression of Ches1 significantly inhibited the cell cycle entry of human lung cancer cells. Finally, we revealed that the expression of miR-574-5p was positively correlated with TLR9 and reversely correlated with Ches1 in lung cancer patients. Our findings not only facilitated the further understanding of the crosstalk between miRNAs and TLRs in tumor biology, but also provided novel potential candidates for treatment of cancer.	[Guo, Zhongliang; Ren, Tao] Tongji Univ, Sch Med, East Hosp, Dept Resp Med, Shanghai 200092, Peoples R China; [Li, Qinchuan; Liu, Zhongmin] Tongji Univ, Sch Med, East Hosp, Dept Cardiothorac Surg, Shanghai 200092, Peoples R China; [Li, Xiaoman] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Clin Lab, Shanghai 200030, Peoples R China; [Xu, Feng] Zhejiang Univ, Sch Med, Dept Resp Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Jingyan] Zhejiang Univ, Sch Med, Dept Radiat Therapy, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Tongji University; Tongji University; Shanghai Jiao Tong University; Zhejiang University; Zhejiang University	Ren, T (corresponding author), Tongji Univ, Sch Med, East Hosp, Dept Resp Med, Shanghai 200092, Peoples R China.	rentaosh@126.com	xia, jingyan/GVS-5716-2022		Fund of Science and Technology Department of Pudong New Area [PKJ2011-Y33]; National Natural Science Foundation of China [81071744]; Shanghai Pudong New Area Academic Leader in Health System [PWRd2010-01]; Basic Research Program; Shanghai Committee of Science and Technology [11JC1410900]; Qianjiang Talent Project of Science and Technology Department of Zhejiang Province [2010R10080]	Fund of Science and Technology Department of Pudong New Area; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pudong New Area Academic Leader in Health System; Basic Research Program; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Qianjiang Talent Project of Science and Technology Department of Zhejiang Province	This work was supported by Fund of Science and Technology Department of Pudong New Area (PKJ2011-Y33), National Natural Science Foundation of China (81071744), Shanghai Pudong New Area Academic Leader in Health System (PWRd2010-01), Basic Research Program supported by the Shanghai Committee of Science and Technology (11JC1410900), and Qianjiang Talent Project of Science and Technology Department of Zhejiang Province (2010R10080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Busygina V, 2006, CANCER RES, V66, P8397, DOI 10.1158/0008-5472.CAN-06-0061; Chang JT, 2005, INT J CANCER, V114, P942, DOI 10.1002/ijc.20663; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Chen YJ, 2011, HEAD NECK-J SCI SPEC, V33, P257, DOI 10.1002/hed.21442; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Gao W, 2011, EXPERT REV RESP MED, V5, P699, DOI [10.1586/ers.11.55, 10.1586/ERS.11.55]; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huang ZH, 2011, CANCER RES, V71, P2582, DOI 10.1158/0008-5472.CAN-10-3032; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Markowski J, 2009, J PHYSIOL PHARMACOL, V60, P57; Markowski J, 2009, EUR ARCH OTO-RHINO-L, V266, P1501, DOI 10.1007/s00405-009-1019-3; Pati D, 1997, MOL CELL BIOL, V17, P3037, DOI 10.1128/MCB.17.6.3037; Ren T, 2011, SCI RES ESSAYS, V6, P2519; Ren T, 2007, CANCER BIOL THER, V6, P1704, DOI 10.4161/cbt.6.11.4826; Ren T, 2009, PATHOL ONCOL RES, V15, P623, DOI 10.1007/s12253-009-9162-0; Sun Y, 2012, IMMUNOL LET IN PRESS; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wang C, 2012, CANC BIOL T IN PRESS; Xu L, 2010, IMMUNOL LETT, V127, P93, DOI 10.1016/j.imlet.2009.10.002; Xu L, 2009, BIOCHEM BIOPH RES CO, V382, P571, DOI 10.1016/j.bbrc.2009.03.072	30	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48278	10.1371/journal.pone.0048278	http://dx.doi.org/10.1371/journal.pone.0048278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133627	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400031
J	De Smet, L; Ravoet, J; de Miranda, JR; Wenseleers, T; Mueller, MY; Moritz, RFA; de Graaf, DC				De Smet, Lina; Ravoet, Jorgen; de Miranda, Joachim R.; Wenseleers, Tom; Mueller, Matthias Y.; Moritz, Robin F. A.; de Graaf, Dirk C.			BeeDoctor, a Versatile MLPA-Based Diagnostic Tool for Screening Bee Viruses	PLOS ONE			English	Article							DEFORMED-WING VIRUS; DEPENDENT PROBE AMPLIFICATION; PICORNA-LIKE VIRUS; APIS-MELLIFERA L.; COMPLETE GENOME SEQUENCE; QUEEN-CELL-VIRUS; HONEY-BEE; PARALYSIS-VIRUS; RT-PCR; RELATIVE QUANTIFICATION	The long-term decline of managed honeybee hives in the world has drawn significant attention to the scientific community and bee-keeping industry. A high pathogen load is believed to play a crucial role in this phenomenon, with the bee viruses being key players. Most of the currently characterized honeybee viruses (around twenty) are positive stranded RNA viruses. Techniques based on RNA signatures are widely used to determine the viral load in honeybee colonies. High throughput screening for viral loads necessitates the development of a multiplex polymerase chain reaction approach in which different viruses can be targeted simultaneously. A new multiparameter assay, called "BeeDoctor", was developed based on multiplex-ligation probe dependent amplification (MLPA) technology. This assay detects 10 honeybee viruses in one reaction. "BeeDoctor" is also able to screen selectively for either the positive strand of the targeted RNA bee viruses or the negative strand, which is indicative for active viral replication. Due to its sensitivity and specificity, the MLPA assay is a useful tool for rapid diagnosis, pathogen characterization, and epidemiology of viruses in honeybee populations. "BeeDoctor" was used for screening 363 samples from apiaries located throughout Flanders; the northern half of Belgium. Using the "BeeDoctor", virus infections were detected in almost eighty percent of the colonies, with deformed wing virus by far the most frequently detected virus and multiple virus infections were found in 26 percent of the colonies.	[De Smet, Lina; Ravoet, Jorgen; de Graaf, Dirk C.] Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium; [de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Wenseleers, Tom] Katholieke Univ Leuven, Lab Socioecol & Social Evolut, Louvain, Belgium; [Mueller, Matthias Y.; Moritz, Robin F. A.] Univ Halle Wittenberg, Inst Biol, Halle, Germany	Ghent University; Swedish University of Agricultural Sciences; KU Leuven; Martin Luther University Halle Wittenberg	De Smet, L (corresponding author), Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium.	Lina.desmet@ugent.be	de Graaf, Dirk C./HGD-4017-2022; Moritz, Robin FA/K-6053-2012; Wenseleers, Tom/J-3960-2013; De Smet, Lina/A-7354-2013	Moritz, Robin FA/0000-0003-0791-887X; Wenseleers, Tom/0000-0002-1434-861X; ravoet, Jorgen/0000-0002-2904-7342; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	European Commission [FP7-KBBE-2009-3 244956 CP-FP]; Research Foundation-Flanders (FWO) [G.0628.11]	European Commission(European CommissionEuropean Commission Joint Research Centre); Research Foundation-Flanders (FWO)(FWO)	This work was supported by the European Commission through the 7th framework collaborative project BEE DOC (Bees in Europe and the Decline of Honeybee Colonies; EU contract number: FP7-KBBE-2009-3 244956 CP-FP) and by the Research Foundation-Flanders (FWO, research grant G.0628.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Antunez K, 2012, RES VET SCI, V93, P1441, DOI 10.1016/j.rvsc.2012.03.006; Antunez K, 2006, J INVERTEBR PATHOL, V93, P67, DOI 10.1016/j.jip.2006.05.009; Aubert M., 2008, VIROLOGY HONEY BEE, P233; Bailey L, 1991, HONEYBEE PATHOLOGY, P113; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Bergal IL, 2008, J CLIN MICROBIOL, V46, P689, DOI 10.1128/JCM.01821-07; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Boncristiani HF, 2009, J VIROL METHODS, V161, P147, DOI 10.1016/j.jviromet.2009.06.006; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Bos MM, 2007, ECOL APPL, V17, P1841, DOI 10.1890/06-1763.1; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2011, J VIROL METHODS, V174, P150, DOI 10.1016/j.jviromet.2011.03.029; de Miranda J.R., 2008, VIROLOGY HONEY BEE, P121; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; de Miranda JR, 2012, CONTEMP TOP ENTOMOL, P71; de Miranda JR, 2010, J GEN VIROL, V91, P2524, DOI 10.1099/vir.0.022434-0; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Forgach P, 2008, J INVERTEBR PATHOL, V98, P235, DOI 10.1016/j.jip.2007.11.002; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; Grabensteiner E, 2007, J INVERTEBR PATHOL, V94, P222, DOI 10.1016/j.jip.2006.11.006; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; Mayo M A, 2002, Arch Virol, V147, P1071, DOI 10.1007/s007050200036; Meeus I, 2010, J INVERTEBR PATHOL, V105, P200, DOI 10.1016/j.jip.2010.06.012; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Reijans M, 2008, J CLIN MICROBIOL, V46, P1232, DOI 10.1128/JCM.02294-07; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Stern RF, 2004, BIOTECHNIQUES, V37, P399, DOI 10.2144/04373ST04; Sun JF, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-98; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Terefework Z, 2008, J MICROBIOL METH, V75, P558, DOI 10.1016/j.mimet.2008.08.012; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wolffs PFG, 2009, J CLIN MICROBIOL, V47, P2620, DOI 10.1128/JCM.02436-08; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Zhang JM, 2011, J MICROBIOL METH, V85, P33, DOI 10.1016/j.mimet.2011.01.022	50	42	46	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47953	10.1371/journal.pone.0047953	http://dx.doi.org/10.1371/journal.pone.0047953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144717	Green Published, gold			2022-12-25	WOS:000310705300028
J	Madhira, SL; Challa, SS; Chalasani, M; Nappanveethl, G; Bhonde, RR; Ajumeera, R; Venkatesan, V				Madhira, Soundarya L.; Challa, Satya S.; Chalasani, Maniprabha; Nappanveethl, Giridharan; Bhonde, Ramesh R.; Ajumeera, Rajanna; Venkatesan, Vijayalakshmi			Promise(s) of Mesenchymal Stem Cells as an In Vitro Model System to Depict Pre-Diabetic/Diabetic Milieu in WNIN/GR-Ob Mutant Rats	PLOS ONE			English	Article							MUSCLE INSULIN-RESISTANCE; BONE-MARROW; DIABETES-MELLITUS; OXIDATIVE STRESS; METABOLIC SYNDROME; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; ABDOMINAL OBESITY; STROMAL CELLS; MICROENVIRONMENT	Background: Development of model systems have helped to a large extent, in bridging gap to understand the mechanism(s) of disease including diabetes. Interestingly, WNIN/GR-Ob rats (Mutants), established at National Centre for Laboratory Animals (NCLAS) of National Institute of Nutrition (NIN), form a suitable model system to study obesity with Type 2 diabetes (T2D) demonstrating several secondary complications (cataract, cardiovascular complications, infertility, nephropathy etc). The present study has been carried out to explore the potent application(s) of multipotent stem cells such as bone marrow mesenchymal stem cells (BM-MSCs), to portray features of pre-diabetic/T2D vis-a-vis featuring obesity, with impaired glucose tolerance (IGT), hyperinsulinemia (HI) and insulin resistance (IR) seen with Mutant rats akin to human situation. Methodology/Principal Findings: Primary cultures of BM-MSCs (third passage) from Mutants, its lean littermate (Lean) and parental control (Control) were characterized for: proliferation markers, disease memory to mark obesity/T2D/HI/IR which included phased gene expression studies for adipogenic/pancreatic lineages, inflammatory markers and differentiation ability to form mature adipocytes/Insulin-like cellular aggregates (ILCAs). The data showed that BM-MSCs from Mutant demonstrated a state of disease memory, depicted by an upregulated expression of inflammatory markers (IL-6, TNF alpha); increased stem cell recruitment (Oct-4, Sox-2) and proliferation rates (CD90+/CD29+, PDA, 'S' phase of cell cycle by FACS and BrdU incorporation); accelerated preadipocyte induction (Dact-1, PPAR gamma 2) with a quantitative increase in mature adipocyte formation (Leptin); ILCAs, which were non-responsive to high glucose did confer the Obese/T2D memory in Mutants. Further, these observations were in compliance with the anthropometric data. Conclusions: Given the ease of accessibility and availability of MSCs, the present study form the basis to report for the first time, application of BM-MSCs as a feasible in vitro model system to portray the disease memory of pre-clinical/T2D with IR a major metabolic disorder of global concern.	[Madhira, Soundarya L.; Challa, Satya S.; Chalasani, Maniprabha; Ajumeera, Rajanna; Venkatesan, Vijayalakshmi] Natl Inst Nutr, Dept Biochem Stem Cell Res, Hyderabad 500007, Andhra Pradesh, India; [Nappanveethl, Giridharan] Natl Inst Nutr, Natl Ctr Lab Anim Sci, Hyderabad 500007, Andhra Pradesh, India; [Bhonde, Ramesh R.] Manipal Inst Regenerat Med, Bangalore, Karnataka, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Indian Council of Medical Research (ICMR); ICMR - National Animal Resource Facility for Biomedical Research (NARFBR); ICMR - National Institute of Nutrition (NIN); Manipal Academy of Higher Education (MAHE)	Venkatesan, V (corresponding author), Natl Inst Nutr, Dept Biochem Stem Cell Res, Hyderabad 500007, Andhra Pradesh, India.	v.venkateshan@gmail.com		Venkatesan, Vijayalakhsmi/0000-0002-3142-9657	Department of Biotechnology (DBT) [BT/PR7950/MED/14/1192/2006]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	National Institue of Nutrition provided the required infrastructure, consumables and fellowship towards manpower. This work has been supported by Department of Biotechnology (DBT)(BT/PR7950/MED/14/1192/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Al Rayes MH, 2005, BLOOD, V105, P4895; Atli T, 2004, ARCH GERONTOL GERIAT, V39, P269, DOI 10.1016/j.archger.2004.04.065; Awad O, 2005, STEM CELLS, V23, P575, DOI 10.1634/stemcells.2004-0185; BALASUBRAMANIAN KA, 1988, BIOCHIM BIOPHYS ACTA, V962, P51, DOI 10.1016/0005-2760(88)90094-X; Bandaru P, 2011, ISRN ENDOCRINOLOGY, V2011, DOI [10.5402/2011/980105, DOI 10.5402/2011/980105]; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Brun RP, 1996, CURR OPIN CELL BIOL, V8, P826, DOI 10.1016/S0955-0674(96)80084-6; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Challa SS, 2011, TISSUE CELL, V43, P266, DOI 10.1016/j.tice.2011.03.007; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; Coe LM, 2011, J CELL PHYSIOL, V226, P477, DOI 10.1002/jcp.22357; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; DESPRES JP, 1993, NUTRITION, V9, P452; Drewa T, 2008, TRANSPL P, V40, P1668, DOI 10.1016/j.transproceed.2008.03.141; ELAHI D, 1982, NEW ENGL J MED, V306, P1196, DOI 10.1056/NEJM198205203062002; Ferrero I, 2008, CELL TRANSPLANT, V17, P255, DOI 10.3727/096368908784153940; Gambacciani M, 2001, MATURITAS, V39, P125, DOI 10.1016/S0378-5122(01)00194-3; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Griffith JF, 2006, RADIOLOGY, V241, P831, DOI 10.1148/radiol.2413051858; Haffner SM, 2006, EUR HEART J SUPPL, V8, pB20, DOI 10.1093/eurheartj/sul004; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Harishankar N, 2011, INDIAN J MED RES, V134, P320; Herrero C, 2010, BRAZ J MED BIOL RES, V43, P425, DOI 10.1590/S0100-879X2010007500033; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsieh CH, 2006, INDIAN J MED RES, V124, P527; Javazon EH, 2001, STEM CELLS, V19, P219, DOI 10.1634/stemcells.19-3-219; Kangralkar VA, 2011, INT J PHARM APPL, V1, P38; Karalis KP, 2009, FEBS J, V276, P5747, DOI 10.1111/j.1742-4658.2009.07304.x; Kastrinaki MC, 2009, CURR STEM CELL RES T, V4, P61, DOI 10.2174/157488809787169084; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kiran SG, 2011, EXP BIOL MED, V236, P456, DOI 10.1258/ebm.2011.010361; Kopelman PG, 1997, BRIT MED BULL, V53, P322, DOI 10.1093/oxfordjournals.bmb.a011616; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Li N, 2009, CANCER-AM CANCER SOC, V115, P4795, DOI 10.1002/cncr.24519; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; Madhira SL, 2011, MOL CELL BIOCHEM, V357, P217, DOI 10.1007/s11010-011-0892-4; Majka SM, 2011, STEM CELLS, V29, P1034, DOI 10.1002/stem.653; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Memisogullari R, 2003, CELL BIOCHEM FUNCT, V21, P291, DOI 10.1002/cbf.1025; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Phadnis Smruti M, 2009, Rev Diabet Stud, V6, P260, DOI 10.1900/RDS.2009.6.260; Ramulu P, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000140; Reddy PY, 2012, MOL VIS, V18, P495; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Ridray S, 1999, INT J OBESITY, V1, pS39; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Salazar KD, 2009, AM J PHYSIOL-LUNG C, V297, pL1002, DOI 10.1152/ajplung.90347.2008; Stefanec T, 2004, MED HYPOTHESES, V62, P247, DOI 10.1016/S0306-9877(03)00327-X; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Sun Y, 2007, CHINESE MED J-PEKING, V120, P771, DOI 10.1097/00029330-200705010-00007; Tran TT, 2006, ENDOCRINOLOGY, V147, P1830, DOI 10.1210/en.2005-1012; Venkatesan V, 2012, CYTOTECHNOLOGY, V64, P139, DOI 10.1007/s10616-011-9409-y; Victor VM, 2011, CURR PHARM DESIGN, V17, P3947, DOI 10.2174/138161211798764915; von Soosten D, 2011, J DAIRY SCI, V94, P2859, DOI 10.3168/jds.2010-3851; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Yaccoby S, 2004, CANCER RES, V64, P2016, DOI 10.1158/0008-5472.CAN-03-1131; Yang H, 2011, CLIN CHEM LAB MED, V49, P1773, DOI 10.1515/CCLM.2011.250; Zhao ZG, 2007, STEM CELLS DEV, V16, P637, DOI 10.1089/scd.2007.0008	62	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48061	10.1371/journal.pone.0048061	http://dx.doi.org/10.1371/journal.pone.0048061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144726	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300036
J	Miremba, P; Kalyango, JN; Worodria, W; Mugerwa, H; Nakakawa, E; Asiimwe, BB				Miremba, Penelope; Kalyango, Joan N.; Worodria, William; Mugerwa, Henry; Nakakawa, Ethel; Asiimwe, Benon B.			Performance of Frontloading for Smear Microscopy in the Diagnosis of Pulmonary Tuberculosis: A Cross-Sectional Study at a Referral Hospital in Uganda	PLOS ONE			English	Article							SPUTUM	Objective: To compare the performance of frontloading and the standard WHO method for diagnosis of pulmonary TB at Mulago Hospital in order to validate the technique in this setting. Methods: This was a cross-sectional study in which 229 adult (>= 18 years) TB suspects were consecutively enrolled. Suspects submitted three sputum samples as follows: at initial presentation, one hour after the first sample, and the next morning. The first and next morning samples formed the standard WHO method, while the first and the one hour later samples formed the frontloading method. Sample processing was by the standard N-acetyl L-cystein (NALC)-NaOH method, and fluorescent microscopy was done for both methods, while cultures of the first sample on Lowenstein-Jensen slants acted as a gold standard. The sensitivity, specificity and predictive values for the WHO standard and frontloading methods were compared. Results: The sensitivity of both the frontloading and standard schemes was 91.1% while their specificities were 86.2% and 91.7% respectively. There was excellent agreement between the diagnostic capacity of the two methods (kappa statistic =0.87, P<0.0001). The positive predictive value for the frontloading scheme was 87.2% and that for the standard approach was 91.9%, while the negative predictive values were 90.4% and 90.9%, respectively. Among the HIV positive patients, frontloading identified 59/79 (74.7%) culture positive samples while the standard approach identified 55/79 (69.6%). In the HIV sero-negative category, on the other hand, front-loading identified 48/110 (43.6%) culture positive samples compared to 45/110 (40.9%) by the standard approach. Conclusion: Frontloading based on smear examination of two same-day sputum samples has a similar performance to the current standard method and would not be associated with any significant missed diagnosis. It may therefore be advocated for use in our setting so as to reduce time to completion of diagnosis and patient loss to follow-up.	[Nakakawa, Ethel; Asiimwe, Benon B.] Makerere Univ, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Miremba, Penelope; Kalyango, Joan N.; Mugerwa, Henry] Makerere Univ, Coll Hlth Sci, Clin Epidemiol Unit, Kampala, Uganda; [Kalyango, Joan N.] Makerere Univ, Dept Pharm, Coll Hlth Sci, Kampala, Uganda; [Worodria, William] Mulago Hosp Complex, Dept Med, Kampala, Uganda	Makerere University; Makerere University; Makerere University; Mulago National Referral Hospital	Asiimwe, BB (corresponding author), Makerere Univ, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda.	basiimwe@chs.mak.ac.ug						[Anonymous], 2011, WHO POL STAT; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Cambanis A, 2006, INT J TUBERC LUNG D, V10, P230; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000443; Hirao S, 2007, TROP MED INT HEALTH, V12, P1459, DOI 10.1111/j.1365-3156.2007.01952.x; Kent PT, 1985, GUIDE LEVEL 3 LAB; NTLP, 2011, NAT TUB LEPR PROGR G; Ramsay A, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/398767; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; WHO, 2007, WHO POL STAT	11	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48531	10.1371/journal.pone.0048531	http://dx.doi.org/10.1371/journal.pone.0048531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144768	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300078
J	Al Ain, S; Belin, L; Patris, B; Schaal, B				Al Ain, Syrina; Belin, Laurine; Patris, Bruno; Schaal, Benoist			An Odor Timer in Milk? Synchrony in the Odor of Milk Effluvium and Neonatal Chemosensation in the Mouse	PLOS ONE			English	Article							IN-HOUSE MICE; MATERNAL-CARE; MUS-MUSCULUS; LACTATION; NEWBORN; BEHAVIOR; FAT; CONSTITUENTS; OXYTOCIN; PATTERN	Mammalian newborns exhibit avid responsiveness to odor compounds emanating from conspecific milk. Milk is however developmentally heterogeneous in composition as a function of both evolved constraints and offspring demand. The present study aimed to verify whether milk odor attractivity for neonates is equally distributed along lactation in Mus musculus (Balb-c strain). Therefore, we exposed pups varying in age to milk samples collected from females in different lactational stages. The pups were assayed at postnatal days 2 (P2), 6 (P6) and 15 (P15) in a series of paired-choice tests opposing either murine milk and a blank (water), or two samples of milk collected in different stages of lactation [lactation days 2 (L2), 6 (L6), and 15 L15)]. Pups of any age were able to detect, and were attracted to, the odor of the different milk. When milk from different lactational stages were simultaneously presented, P2 pups oriented for a similar duration to the odors of L2 and of L6 milk, but significantly less to the odor of L15 milk. Next, P6 pups roamed equivalently over L2 and L6 milk odors, but still less over the odor of L15 milk. Finally, P15 pups explored as much L15 milk odor as the odors of both L2 and L6 milk. This developmental shift in milk attractivity is discussed in terms of changing chemosensory properties of milk and of shifting chemosensory abilities/experience of pups.	[Al Ain, Syrina; Belin, Laurine; Patris, Bruno; Schaal, Benoist] Univ Bourgogne, CNRS UMR 6265, Ctr Smell Taste & Food Sci, Dev Ethol & Cognit Psychol Grp, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne	Schaal, B (corresponding author), Univ Bourgogne, CNRS UMR 6265, Ctr Smell Taste & Food Sci, Dev Ethol & Cognit Psychol Grp, Dijon, France.	Benoist.Schaal@u-bourgogne.fr			CNRS, Paris; Regional Council of Burgundy, Dijon; CNRS; Regional Council of Burgundy	CNRS, Paris(Centre National de la Recherche Scientifique (CNRS)); Regional Council of Burgundy, Dijon(Region Bourgogne-Franche-Comte); CNRS(Centre National de la Recherche Scientifique (CNRS)); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This research was funded by the CNRS, Paris, and the Regional Council of Burgundy, Dijon (grant PARI to BS and BP). SAA was supported by a doctoral grant from CNRS and the Regional Council of Burgundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JC, 1990, J DAIRY SCI, V73, P975, DOI 10.3168/jds.S0022-0302(90)78755-3; Armstrong CM, 2006, CHEM SENSES, V31, P343, DOI 10.1093/chemse/bjj038; ATKINSON SA, 1981, J PEDIATR-US, V99, P617, DOI 10.1016/S0022-3476(81)80275-2; Bernt KM, 1999, ACTA PAEDIATR, V88, P27; Bouslama M, 2005, BEHAV BRAIN RES, V161, P102, DOI 10.1016/j.bbr.2005.01.010; Branchi I, 2009, NEUROSCI BIOBEHAV R, V33, P551, DOI 10.1016/j.neubiorev.2008.03.011; Buettner A, 2007, FLAVOUR FRAG J, V22, P465, DOI 10.1002/ffj.1822; Chraiti A, DEV PSYCHOB IN PRESS; Coureaud G, 2001, ANIM BEHAV, V61, P153, DOI 10.1006/anbe.2000.1563; Coureaud G, 2008, CHEMOECOLOGY, V18, P53, DOI 10.1007/s00049-007-0392-x; Coureaud G, 2006, CHEMOECOLOGY, V16, P169, DOI 10.1007/s00049-006-0345-9; DePeters EJ, 2009, J MAMMARY GLAND BIOL, V14, P397, DOI 10.1007/s10911-009-9158-0; DEVINOY E, 1995, EXP CELL RES, V221, P272, DOI 10.1006/excr.1995.1375; DREWETT RF, 1982, EARLY HUM DEV, V6, P161, DOI 10.1016/0378-3782(82)90103-7; Druaux C, 1997, TRENDS FOOD SCI TECH, V8, P364, DOI 10.1016/S0924-2244(97)01095-9; Durand E, 2003, J APPL PHYSIOL, V94, P812, DOI 10.1152/japplphysiol.00488.2002; German JB, 2002, CURR OPIN CLIN NUTR, V5, P653, DOI 10.1097/00075197-200211000-00007; Gors S, 2009, J DAIRY SCI, V92, P632, DOI 10.3168/jds.2008-1563; GOREWIT RC, 1984, J DAIRY SCI, V67, P2050, DOI 10.3168/jds.S0022-0302(84)81543-X; GRUETERS A, 1985, PEDIATR RES, V19, P934, DOI 10.1203/00006450-198509000-00014; HALL B, 1975, LANCET, V1, P779; Hameed A, 2010, PAK J AGR SCI, V47, P147; Hamosh M, 2001, PEDIATR CLIN N AM, V48, P69, DOI 10.1016/S0031-3955(05)70286-8; Hansen AP, 1997, ADV EXP MED BIOL, V415, P67; Heiman H, 2006, EARLY HUM DEV, V82, P781, DOI 10.1016/j.earlhumdev.2006.09.009; HEPPER PG, 1988, ANIM BEHAV, V36, P935, DOI 10.1016/S0003-3472(88)80177-5; HOLLOWAY WR, 1978, BEHAV BIOL, V24, P428, DOI 10.1016/S0091-6773(78)90743-5; Jensen RG, 1995, HDB MILK COMPOSITION; KEIL W, 1990, PHYSIOL BEHAV, V47, P525, DOI 10.1016/0031-9384(90)90120-S; KNIGHT CH, 1986, COMP BIOCHEM PHYS A, V84, P127, DOI 10.1016/0300-9629(86)90054-X; KONIG B, 1994, ANIM BEHAV, V48, P1449, DOI 10.1006/anbe.1994.1381; KONIG B, 1987, BEHAV ECOL SOCIOBIOL, V20, P1, DOI 10.1007/BF00292161; KONIG B, 1988, J ZOOL, V216, P195; Macfarlane A, 1975, Ciba Found Symp, P103; MAINARDI DANILO, 1965, ATTI SOC ITAL SCI NATUR MUS CIVICO STORIA NATUR MILANO, V104, P325; Marlier L, 1997, CR ACAD SCI III-VIE, V320, P999, DOI 10.1016/S0764-4469(97)82473-0; Marlier L, 2005, CHILD DEV, V76, P155, DOI 10.1111/j.1467-8624.2005.00836.x; Miettinen SM, 2004, J AGR FOOD CHEM, V52, P8111, DOI 10.1021/jf040218v; Mizuno K, 2004, EARLY HUM DEV, V76, P83, DOI 10.1016/j.earlhumdev.2003.10.003; Moio L, 1996, J DAIRY SCI, V79, P1322, DOI 10.3168/jds.S0022-0302(96)76488-3; Moltz H, 1983, SYMBIOSIS PARENT OFF, P45; Nusser KD, 2001, ADV EXP MED BIOL, V501, P71; NYSENBAUM AN, 1982, EARLY HUM DEV, V6, P205, DOI 10.1016/0378-3782(82)90108-6; Oftedal O. T., 1995, HDB MILK COMPOSITION, P749; Peaker M, 1998, BIOCHEM SOC T, V26, P103, DOI 10.1042/bst0260103; Putter J., 1973, Veterinary Medical Review, P145; RAGUENEAU S, 1987, PHYSIOL BEHAV, V40, P431, DOI 10.1016/0031-9384(87)90027-8; RICHARDS RC, 1984, EXPERIENTIA, V40, P757, DOI 10.1007/BF01949764; Rijnkels M, 1997, MAMM GENOME, V8, P9, DOI 10.1007/s003359900338; Riley LG, 2006, J ANIM SCI, V84, P2118, DOI 10.2527/jas.2005-609; Rimbault M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-572; SCHAAL B, 1995, BIOL NEONATE, V67, P397; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Schaal B, 2005, PRENATAL DEV POSTNAT, P51; Schaal B, 2010, VITAM HORM, V83, P83, DOI 10.1016/S0083-6729(10)83004-3; Schanler RJ, 2011, SEMIN PERINATOL, V35, P29, DOI 10.1053/j.semperi.2010.10.005; Sellers G, 2010, J VET PHARMACOL THER, V33, P480, DOI 10.1111/j.1365-2885.2010.01159.x; Shimoda M, 2000, J FAC AGR KYUSHU U, V45, P199; Sun CQ, 2002, CHEM-BIOL INTERACT, V140, P185, DOI 10.1016/S0009-2797(02)00016-9; Veloso C, 2003, COMP BIOCHEM PHYS A, V134, P387, DOI 10.1016/S1095-6433(02)00286-6; Weber EM, 2008, APPL ANIM BEHAV SCI, V114, P1, DOI 10.1016/j.applanim.2008.06.006; WILLIAMS E, 1953, BEHAVIOUR, V6, P35, DOI 10.1163/156853954X00031; Yoneda M, 2001, J DAIRY SCI, V84, P1851, DOI 10.3168/jds.S0022-0302(01)74625-5	63	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47228	10.1371/journal.pone.0047228	http://dx.doi.org/10.1371/journal.pone.0047228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133511	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800004
J	Pagliuca, A; Valvo, C; Fabrizi, E; di Martino, S; Biffoni, M; Runci, D; Forte, S; De Maria, R; Ricci-Vitiani, L				Pagliuca, A.; Valvo, C.; Fabrizi, E.; di Martino, S.; Biffoni, M.; Runci, D.; Forte, S.; De Maria, R.; Ricci-Vitiani, L.			Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression	ONCOGENE			English	Article						RAS/MAPK; signaling pathway; miRNA; microarray; colorectal cancer	MESSENGER-RNAS; MICRORNA-143; EXPRESSION; TARGETS; SYSTEM; KRAS; CLUSTER; GROWTH	MicroRNAs (miRNAs) from the gene cluster miR-143-145 are diminished in cells of colorectal tumor origin when compared with normal colon epithelia. Until now, no report has addressed the coordinate action of these miRNAs in colorectal cancer (CRC). In this study, we performed a comprehensive molecular and functional analysis of the miRNA cluster regulatory network. First, we evaluated proliferation, migration, anchorage-independent growth and chemoresistance in the colon tumor cell lines after miR-143 and miR-145 restoration. Then, we assessed the contribution of single genes targeted by miR-143 and miR-145 by reinforcing their expression and checking functional recovery. Restoring miR-143 and miR-145 in colon cancer cells decreases proliferation, migration and chemoresistance. We identified cluster of differentiation 44 (CD44), Kruppel-like factor 5 (KLF5), Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) and v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as proteins targeted by miR-143 and miR145. Their re-expression can partially revert a decrease in transformation properties caused by the overexpression of miR-143 and miR145. In addition, we determined a set of mRNAs that are diminished after reinforcing miR-143 and miR-145 expression. The whole transcriptome analysis ascertained that downregulated transcripts are enriched in predicted target genes in a statistically significant manner. A number of additional genes, whose expression decreases as a direct or indirect consequence of miR-143 and miR-145, reveals a complex regulatory network that affects cell signaling pathways involved in transformation. In conclusion, we identified a coordinated program of gene repression by miR-143 and miR-145, in CRC, where either of the two miRNAs share a target transcript, or where the target transcripts share a common signaling pathway. Major mediators of the oncosuppression by miR-143 and miR-145 are genes belonging to the growth factor receptor-mitogen-activated protein kinase network and to the p53 signaling pathway.	[Pagliuca, A.; Fabrizi, E.; di Martino, S.; Biffoni, M.; Runci, D.; Ricci-Vitiani, L.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Valvo, C.; De Maria, R.] Italian Natl Canc Inst Regina Elena, Rome, Italy; [Forte, S.] IOM Ric Srl, Viagrande, CT, Italy	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR)	Pagliuca, A (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	alfredo.pagliuca@iss.it; lriccivitiani@yahoo.it	Ricci Vitiani, Lucia/J-8320-2016; Pagliuca, Alfredo/AAI-3689-2020; Biffoni, Mauro/J-8318-2016; De Maria, Ruggero/S-6385-2019; di Martino, Simona SdM/K-9304-2016; Forte, Stefano/D-3645-2013	Ricci Vitiani, Lucia/0000-0001-7336-5615; Biffoni, Mauro/0000-0002-1304-9060; De Maria, Ruggero/0000-0003-2255-0583; di Martino, Simona SdM/0000-0003-4533-3776; Forte, Stefano/0000-0001-5746-7451; pagliuca, alfredo/0000-0002-8703-2077	Associazione Italiana per la Ricerca sul Cancro, AIRC [6326]	Associazione Italiana per la Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grant from Associazione Italiana per la Ricerca sul Cancro, AIRC (Start-up 6326 to LR-V and Regional Fellowship to CV). We thank Tania Merlino for contribution in editing the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; Batliner J, 2012, LEUKEMIA RES, V36, P237, DOI 10.1016/j.leukres.2011.10.006; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kent OA, 2013, ONCOGENE, V32, P2576, DOI 10.1038/onc.2012.266; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Ricci-Vitiani L, 2010, FASEB J, V24, P4291, DOI 10.1096/fj.10-159970; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Villadsen SB, 2012, BRIT J CANCER, V106, P366, DOI 10.1038/bjc.2011.520; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531	35	151	159	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4806	4813		10.1038/onc.2012.495	http://dx.doi.org/10.1038/onc.2012.495			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23128394				2022-12-25	WOS:000325274700009
J	Bonacci, G; Baker, PRS; Salvatore, SR; Shores, D; Khoo, NKH; Koenitzer, JR; Vitturi, DA; Woodcock, SR; Golin-Bisello, F; Cole, MP; Watkins, S; Croix, CS; Batthyany, CI; Freeman, BA; Schopfer, FJ				Bonacci, Gustavo; Baker, Paul R. S.; Salvatore, Sonia R.; Shores, Darla; Khoo, Nicholas K. H.; Koenitzer, Jeffrey R.; Vitturi, Dario A.; Woodcock, Steven R.; Golin-Bisello, Franca; Cole, Marsha P.; Watkins, Simon; Croix, Claudette St.; Batthyany, Carlos I.; Freeman, Bruce A.; Schopfer, Francisco J.			Conjugated Linoleic Acid Is a Preferential Substrate for Fatty Acid Nitration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; NITROGEN-DIOXIDE; HUMAN BLOOD; ISCHEMIA; INFLAMMATION; NITROALKENE; GENERATION; MYELOPEROXIDASE; PEROXYNITRITE; REPERFUSION	The oxidation and nitration of unsaturated fatty acids by oxides of nitrogen yield electrophilic derivatives that can modulate protein function via post-translational protein modifications. The biological mechanisms accounting for fatty acid nitration and the specific structural characteristics of products remain to be defined. Herein, conjugated linoleic acid (CLA) is identified as the primary endogenous substrate for fatty acid nitration in vitro and in vivo, yielding up to 10(5) greater extent of nitration products as compared with bis-allylic linoleic acid. Multiple enzymatic and cellular mechanisms account for CLA nitration, including reactions catalyzed by mitochondria, activated macrophages, and gastric acidification. Nitroalkene derivatives of CLA and their metabolites are detected in the plasma of healthy humans and are increased in tissues undergoing episodes of ischemia reperfusion. Dietary CLA and nitrite supplementation in rodents elevates NO2-CLA levels in plasma, urine, and tissues, which in turn induces heme oxygenase-1 (HO-1) expression in the colonic epithelium. These results affirm that metabolic and inflammatory reactions yield electrophilic products that can modulate adaptive cell signaling mechanisms.	[Bonacci, Gustavo; Baker, Paul R. S.; Salvatore, Sonia R.; Khoo, Nicholas K. H.; Koenitzer, Jeffrey R.; Vitturi, Dario A.; Woodcock, Steven R.; Golin-Bisello, Franca; Cole, Marsha P.; Freeman, Bruce A.; Schopfer, Francisco J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Shores, Darla] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA; [Watkins, Simon; Croix, Claudette St.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Batthyany, Carlos I.] Inst Pasteur, Montevideo 11400, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Thomas E Starzl Biomed Sci Tower E1340,200 Lothro, Pittsburgh, PA 15213 USA.	freerad@pitt.edu; fjs2@pitt.edu	Woodcock, Steven/AAE-9199-2020; Schopfer, Francisco Jose/AAE-8125-2020; Watkins, Simon/ABG-2590-2021; Vitturi, Dario/Z-3469-2019; Schopfer, Francisco/AAW-6505-2021; Shores, Darla/GXH-2652-2022	Schopfer, Francisco Jose/0000-0001-9526-695X; Watkins, Simon/0000-0003-4092-1552; Batthyany, Carlos/0000-0002-0627-1982; Vitturi, Dario/0000-0003-0354-4567; Bonacci, Gustavo/0000-0002-9830-1850; Salvatore, Sonia/0000-0002-9942-3905	National Institutes of Health [R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455, R01 AT006822-01]; National Center for Complementary & Integrative Health [R01AT006822] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, P01HL103455, R00HL095769, R01HL064937, K99HL095769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455 (to B.A.F.), and R01 AT006822-01 (to F.J.S.). B.A.F. and F.J.S. acknowledge financial interest in Complexa, Inc.	Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; ATKINSON R, 1984, INT J CHEM KINET, V16, P697, DOI 10.1002/kin.550160607; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Baldus S, 2001, J CLIN INVEST, V108, P1759; Bates DJP, 2011, BIOCHEMISTRY-US, V50, P7765, DOI 10.1021/bi2005784; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Bonacci G, 2011, J AM SOC MASS SPECTR, V22, P1534, DOI 10.1007/s13361-011-0185-x; Borniquel S, 2010, FREE RADICAL BIO MED, V48, P499, DOI 10.1016/j.freeradbiomed.2009.11.014; Claridge RP, 1998, J CHEM SOC PERK T 1, P3523, DOI 10.1039/a806451b; Cole MP, 2009, CIRC RES, V105, P965, DOI 10.1161/CIRCRESAHA.109.199075; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; DENNIS SC, 1991, J MOL CELL CARDIOL, V23, P1077, DOI 10.1016/0022-2828(91)91642-5; Dezfulian C, 2009, CIRCULATION, V120, P897, DOI 10.1161/CIRCULATIONAHA.109.853267; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Evans NP, 2010, J NUTR, V140, P515, DOI 10.3945/jn.109.115642; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; GIAMALVA DH, 1987, J AM CHEM SOC, V109, P7059, DOI 10.1021/ja00257a025; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; HUYSER ES, 1966, J ORG CHEM, V31, P2437, DOI 10.1021/jo01346a002; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; LINDSAY T, 1988, AM J PHYSIOL, V254, pH578, DOI 10.1152/ajpheart.1988.254.3.H578; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2011, CARDIOVASC RES, V89, P525, DOI 10.1093/cvr/cvq325; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Napolitano A, 2002, TETRAHEDRON, V58, P5061, DOI 10.1016/S0040-4020(02)00460-X; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/NCHEMBIO.1018, 10.1038/nchembio.1018]; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Pannala AS, 2006, FREE RADICAL BIO MED, V41, P896, DOI 10.1016/j.freeradbiomed.2006.05.010; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, CIRC RES, V105, P511, DOI 10.1161/CIRCRESAHA.109.202077; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shiva S, 2009, BASIC RES CARDIOL, V104, P113, DOI 10.1007/s00395-009-0009-3; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; Turpeinen AM, 2002, AM J CLIN NUTR, V76, P504, DOI 10.1093/ajcn/76.3.504; Wright MM, 2009, BIOCHEM J, V422, P353, DOI 10.1042/BJ20090339; Zlatanos SN, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-34; Zulet MA, 2005, J PHYSIOL BIOCHEM, V61, P483, DOI 10.1007/BF03168454	55	103	107	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44071	44082		10.1074/jbc.M112.401356	http://dx.doi.org/10.1074/jbc.M112.401356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144452	Green Published, hybrid			2022-12-25	WOS:000312938600006
J	Kabil, O; Banerjee, R				Kabil, Omer; Banerjee, Ruma			Characterization of Patient Mutations in Human Persulfide Dioxygenase (ETHE1) Involved in H2S Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYOXALASE-II; HYDROGEN-SULFIDE; OXIDATION; ENCEPHALOPATHY; BINDING; GENE; ZINC	Hydrogen sulfide (H2S) is a recently described endogenously produced gaseous signaling molecule that influences various cellular processes in the central nervous system, cardiovascular system, and gastrointestinal tract. The biogenesis of H2S involves the cytoplasmic transsulfuration enzymes, cystathionine beta-synthase and gamma-cystathionase, whereas its catabolism occurs in the mitochondrion and couples to the energy-yielding electron transfer chain. Low steady-state levels of H2S appear to be controlled primarily by efficient oxygen-dependent catabolism via sulfide quinone oxidoreductase, persulfide dioxygenase (ETHE1), rhodanese, and sulfite oxidase. Mutations in the persulfide dioxgenase, i.e. ETHE1, result in ethylmalonic encephalopathy, an inborn error of metabolism. In this study, we report the biochemical characterization and kinetic properties of human persulfide dioxygenase and describe the biochemical penalties associated with two patient mutations, T152I and D196N. Steady-state kinetic analysis reveals that the T152I mutation results in a 3-fold lower activity, which is correlated with a 3-fold lower iron content compared with the wild-type enzyme. The D196N mutation results in a 2-fold higher K-m for the substrate, glutathione persulfide.	[Kabil, Omer; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kabil, Omer/AAJ-1435-2020		National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; BURLINA AB, 1991, LANCET, V338, P1522, DOI 10.1016/0140-6736(91)92338-3; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; Crowder MW, 1997, FEBS LETT, V418, P351, DOI 10.1016/S0014-5793(97)01416-6; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GARCIASILVA MT, 1994, J PEDIATR-US, V125, P843, DOI 10.1016/S0022-3476(06)80197-6; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Holdorf MM, 2008, J INORG BIOCHEM, V102, P1825, DOI 10.1016/j.jinorgbio.2008.06.003; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; KOJ A, 1967, BIOCHEM J, V103, P791, DOI 10.1042/bj1030791; Leschelle X, 2005, BBA-GEN SUBJECTS, V1725, P201, DOI 10.1016/j.bbagen.2005.06.002; Levitt MD, 2011, ANTIOXID REDOX SIGN, V15, P373, DOI 10.1089/ars.2010.3525; Marasinghe GPK, 2005, J BIOL CHEM, V280, P40668, DOI 10.1074/jbc.M509748200; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Mineri R, 2008, J MED GENET, V45, P473, DOI 10.1136/jmg.2008.058271; Olson KR, 2006, J EXP BIOL, V209, P4011, DOI 10.1242/jeb.02480; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; SHAW L, 1987, BIOCHIM BIOPHYS ACTA, V919, P171, DOI 10.1016/0005-2760(87)90204-9; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wenzel NF, 2004, J BIOL INORG CHEM, V9, P429, DOI 10.1007/s00775-004-0535-2; WILLIAMSON G, 1982, J BIOL CHEM, V257, P4314; WOOD JL, 1987, METHOD ENZYMOL, V143, P25; Zang TM, 2001, J BIOL CHEM, V276, P4788, DOI 10.1074/jbc.M005090200	28	92	95	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44561	44567		10.1074/jbc.M112.407411	http://dx.doi.org/10.1074/jbc.M112.407411			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144459	Green Published, hybrid			2022-12-25	WOS:000312938600052
J	Tamura, Y; Onguka, O; Itoh, K; Endo, T; Iijima, M; Claypool, SM; Sesaki, H				Tamura, Yasushi; Onguka, Ouma; Itoh, Kie; Endo, Toshiya; Iijima, Miho; Claypool, Steven M.; Sesaki, Hiromi			Phosphatidylethanolamine Biosynthesis in Mitochondria PHOSPHATIDYLSERINE (PS) TRAFFICKING IS INDEPENDENT OF A PS DECARBOXYLASE AND INTERMEMBRANE SPACE PROTEINS UPS1P AND UPS2P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CARDIOLIPIN BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; INNER MEMBRANE; YEAST; GENE; MAINTENANCE; COMPLEX; FUSION; IDENTIFICATION	Phosphatidylethanolamine (PE) plays important roles for the structure and function of mitochondria and other intracellular organelles. In yeast, the majority of PE is produced from phosphatidylserine (PS) by a mitochondrion-located PS decarboxylase, Psd1p. Because PS is synthesized in the endoplasmic reticulum (ER), PS is transported from the ER to mitochondria and converted to PE. After its synthesis, a portion of PE moves back to the ER. Two mitochondrial proteins located in the intermembrane space, Ups1p and Ups2p, have been shown to regulate PE metabolism by controlling the export of PE. It remains to be determined where PS is decarboxylated in mitochondria and whether decarboxylation is coupled to trafficking of PS. Here, using fluorescent PS as a substrate in an in vitro assay for Psd1p-dependent PE production in isolated mitochondria, we show that PS is transferred from the mitochondrial outer membrane to the inner membrane independently of Psd1p, Ups1p, and Ups2p and decarboxylated to PE by Psd1p in the inner membrane. Interestingly, Ups1p is required for the maintenance of Psd1p and therefore PE production. Restoration of Psd1p levels rescued PE production defects in ups1 Delta mitochondria. Our data provide novel mechanistic insight into PE biogenesis in mitochondria.	[Tamura, Yasushi; Itoh, Kie; Iijima, Miho; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Onguka, Ouma; Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Nagoya, Aichi 4648602, Japan	Johns Hopkins University; Johns Hopkins University; Nagoya University	Tamura, Y (corresponding author), Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan.	tamura@chem.nagoya-u.ac.jp; sclaypo1@jhmi.edu; hsesaki@jhmi.edu	Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017; Tamura, Yasushi/A-9997-2013	Tamura, Yasushi/0000-0002-8462-0607; Claypool, Steven/0000-0001-5316-1623	National Institutes of Health [GM084015, GM089853]; Japan Society for the Promotion of Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in whole or in part, by National Institutes of Health Grants GM084015 (to M. I.) and GM089853 (to H. S.). This work was also supported by a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science (to Y. T.).	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Brachmann CB, 1998, YEAST, V14, P115; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Choi JY, 2005, ANAL BIOCHEM, V347, P165, DOI 10.1016/j.ab.2005.03.017; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; de Kroon AIPM, 1999, MOL MEMBR BIOL, V16, P205; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Federovitch CM, 2008, MOL BIOL CELL, V19, P4506, DOI 10.1091/mbc.E07-11-1188; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Harada Y, 2010, BIOCHEM BIOPH RES CO, V392, P228, DOI 10.1016/j.bbrc.2010.01.024; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; SIMBENI R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P1, DOI 10.1016/0005-2736(93)90374-9; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wu WI, 2004, J BIOL CHEM, V279, P6635, DOI 10.1074/jbc.M311570200; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	58	33	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43961	43971		10.1074/jbc.M112.390997	http://dx.doi.org/10.1074/jbc.M112.390997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23124206	Green Published, hybrid			2022-12-25	WOS:000312940800071
J	Okuda, T; Osawa, C; Yamada, H; Hayashi, K; Nishikawa, S; Ushio, T; Kubo, Y; Satou, M; Ogawa, H; Haga, T				Okuda, Takashi; Osawa, Chieko; Yamada, Haruhiko; Hayashi, Kengo; Nishikawa, Shizue; Ushio, Tomoko; Kubo, Yuji; Satou, Motoyasu; Ogawa, Haruo; Haga, Tatsuya			Transmembrane Topology and Oligomeric Structure of the High-affinity Choline Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLES; RADIATION-INACTIVATION; MEMBRANE TOPOLOGY; FUNCTIONAL UNIT; COTRANSPORTER; GLUCOSE; MODEL; IDENTIFICATION; LOCALIZATION; ENDOCYTOSIS	The high-affinity choline transporter CHT1 mediates choline uptake essential for acetylcholine synthesis in cholinergic nerve terminals. CHT1 belongs to the Na+/glucose cotransporter family (SLC5), which is postulated to have a common 13-transmembrane domain core; however, no direct experimental evidence for CHT1 transmembrane topology has yet been reported. We examined the transmembrane topology of human CHT1 using cysteine-scanning analysis. Single cysteine residues were introduced into the putative extra- and intracellular loops and probed for external accessibility for labeling with a membrane-impermeable, sulfhydryl-specific biotinylating reagent in intact cells expressing these mutants. The results provide experimental evidence for a topological model of a 13-transmembrane domain protein with an extracellular amino terminus and an intracellular carboxyl terminus. We also constructed a three-dimensional homology model of CHT1 based on the crystal structure of the bacterial Na+/galactose cotransporter, which supports our conclusion of CHT1 transmembrane topology. Furthermore, we examined whether CHT1 exists as a monomer or oligomer. Chemical cross-linking induces the formation of a higher molecular weight form of CHT1 on the cell surface in HEK293 cells. Two different epitope-tagged CHT1 proteins expressed in the same cells can be co-immunoprecipitated. Moreover, co-expression of an inactive mutant I89A with the wild type induces a dominant-negative effect on the overall choline uptake activity. These results indicate that CHT1 forms a homo-oligomer on the cell surface in cultured cells.	[Okuda, Takashi] Keio Univ, Fac Pharm, Dept Pharmacol, Minato Ku, Tokyo 1058512, Japan; [Okuda, Takashi; Osawa, Chieko; Yamada, Haruhiko; Hayashi, Kengo; Nishikawa, Shizue; Ushio, Tomoko; Kubo, Yuji; Satou, Motoyasu; Haga, Tatsuya] Gakushuin Univ, Fac Sci, Dept Life Sci, Toshima Ku, Tokyo 1718588, Japan; [Ogawa, Haruo] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Keio University; Gakushuin University; University of Tokyo	Okuda, T (corresponding author), Keio Univ, Fac Pharm, Dept Pharmacol, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	okuda-tk@pha.keio.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BELIVEAU R, 1988, BIOCHEM J, V252, P807, DOI 10.1042/bj2520807; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English BA, 2009, J NEURODEV DISORD, V1, P252, DOI 10.1007/s11689-009-9033-8; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Ferguson SM, 2004, MOL INTERV, V4, P22, DOI 10.1124/mi.4.1.22; Ferguson SM, 2003, J NEUROSCI, V23, P9697; Hahn MK, 2008, GENES BRAIN BEHAV, V7, P487, DOI 10.1111/j.1601-183X.2007.00384.x; Hahn MK, 2003, J NEUROSCI, V23, P4470; Hou ZJ, 2010, J BIOL CHEM, V285, P4732, DOI 10.1074/jbc.M109.086033; Iwamoto H, 2006, J NEUROSCI, V26, P9851, DOI 10.1523/JNEUROSCI.1862-06.2006; Jette M, 1997, BBA-BIOMEMBRANES, V1327, P242, DOI 10.1016/S0005-2736(97)00069-2; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; KOEPSELL H, 1994, J MEMBRANE BIOL, V138, P1; Kohler K, 2000, J BIOL CHEM, V275, P26113, DOI 10.1074/jbc.M003564200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; LIN JT, 1984, BIOCHIM BIOPHYS ACTA, V777, P201, DOI 10.1016/0005-2736(84)90421-8; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Nakata K, 2004, SYNAPSE, V53, P53, DOI 10.1002/syn.20029; Okuda T, 2000, FEBS LETT, V484, P92, DOI 10.1016/S0014-5793(00)02134-7; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Okuda T, 2003, NEUROCHEM RES, V28, P483, DOI 10.1023/A:1022809003997; Okuda T, 2002, J BIOL CHEM, V277, P45315, DOI 10.1074/jbc.M207742200; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Okuda T, 2011, J NEUROSCI, V31, P14989, DOI 10.1523/JNEUROSCI.2983-11.2011; Ribeiro FM, 2006, J NEUROCHEM, V97, P1, DOI 10.1111/j.1471-4159.2006.03695.x; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Ribeiro FM, 2003, J NEUROCHEM, V87, P136, DOI 10.1046/j.1471-4159.2003.01974.x; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; STEVENS BR, 1990, P NATL ACAD SCI USA, V87, P1456, DOI 10.1073/pnas.87.4.1456; TAKAHASHI M, 1985, J BIOL CHEM, V260, P551; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Turk E, 1997, J MEMBRANE BIOL, V159, P1, DOI 10.1007/s002329900264; Turk E, 1996, J BIOL CHEM, V271, P1925, DOI 10.1074/jbc.271.4.1925; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6	41	22	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42826	42834		10.1074/jbc.M112.405027	http://dx.doi.org/10.1074/jbc.M112.405027			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23132865	Green Published, hybrid			2022-12-25	WOS:000312501600041
J	Appleby, SL; Cockshell, MP; Pippal, JB; Thompson, EJ; Barrett, JM; Tooley, K; Sen, S; Sun, WY; Grose, R; Nicholson, I; Levina, V; Cooke, I; Talbo, G; Lopez, AF; Bonder, CS				Appleby, Sarah L.; Cockshell, Michaelia P.; Pippal, Jyotsna B.; Thompson, Emma J.; Barrett, Jeffrey M.; Tooley, Katie; Sen, Shaundeep; Sun, Wai Yan; Grose, Randall; Nicholson, Ian; Levina, Vitalina; Cooke, Ira; Talbo, Gert; Lopez, Angel F.; Bonder, Claudine S.			Characterization of a Distinct Population of Circulating Human Non-Adherent Endothelial Forming Cells and Their Recruitment via Intercellular Adhesion Molecule-3	PLOS ONE			English	Article							PROGENITOR CELLS; STATISTICAL-MODEL; ANALYSIS REVEALS; PRECURSOR CELLS; CLONAL ANALYSIS; E-SELECTIN; DC-SIGN; EXPRESSION; ICAM-3; ANGIOGENESIS	Circulating vascular progenitor cells contribute to the pathological vasculogenesis of cancer whilst on the other hand offer much promise in therapeutic revascularization in post-occlusion intervention in cardiovascular disease. However, their characterization has been hampered by the many variables to produce them as well as their described phenotypic and functional heterogeneity. Herein we have isolated, enriched for and then characterized a human umbilical cord blood derived CD133(+) population of non-adherent endothelial forming cells (naEFCs) which expressed the hematopoietic progenitor cell markers (CD133, CD34, CD117, CD90 and CD38) together with mature endothelial cell markers (VEGFR2, CD144 and CD31). These cells also expressed low levels of CD45 but did not express the lymphoid markers (CD3, CD4, CD8) or myeloid markers (CD11b and CD14) which distinguishes them from 'early' endothelial progenitor cells (EPCs). Functional studies demonstrated that these naEFCs (i) bound Ulex europaeus lectin, (ii) demonstrated acetylated-low density lipoprotein uptake, (iii) increased vascular cell adhesion molecule (VCAM-1) surface expression in response to tumor necrosis factor and (iv) in co-culture with mature endothelial cells increased the number of tubes, tubule branching and loops in a 3-dimensional in vitro matrix. More importantly, naEFCs placed in vivo generated new lumen containing vasculature lined by CD144 expressing human endothelial cells (ECs). Extensive genomic and proteomic analyses of the naEFCs showed that intercellular adhesion molecule (ICAM)-3 is expressed on their cell surface but not on mature endothelial cells. Furthermore, functional analysis demonstrated that ICAM-3 mediated the rolling and adhesive events of the naEFCs under shear stress. We suggest that the distinct population of naEFCs identified and characterized here represents a new valuable therapeutic target to control aberrant vasculogenesis.	[Appleby, Sarah L.; Cockshell, Michaelia P.; Pippal, Jyotsna B.; Thompson, Emma J.; Barrett, Jeffrey M.; Tooley, Katie; Sun, Wai Yan; Lopez, Angel F.; Bonder, Claudine S.] S Australian Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Appleby, Sarah L.; Cockshell, Michaelia P.; Pippal, Jyotsna B.; Thompson, Emma J.; Barrett, Jeffrey M.; Tooley, Katie; Sun, Wai Yan; Grose, Randall; Nicholson, Ian; Levina, Vitalina; Cooke, Ira; Talbo, Gert; Lopez, Angel F.; Bonder, Claudine S.] La Trobe Univ, Cooperat Res Ctr Biomarker Translat, Melbourne, Vic, Australia; [Sen, Shaundeep; Sun, Wai Yan; Lopez, Angel F.; Bonder, Claudine S.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Grose, Randall; Nicholson, Ian] Womens & Childrens Hlth Res Inst, Leukocyte Biol Lab, Adelaide, SA, Australia; [Levina, Vitalina; Cooke, Ira; Talbo, Gert] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic, Australia	Centre for Cancer Biology; La Trobe University; University of Adelaide; Womens & Childrens Hospital Australia; La Trobe University	Bonder, CS (corresponding author), S Australian Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	claudine.bonder@health.sa.gov.au	Cooke, Ira R/B-4409-2008	Lopez, Angel F/0000-0001-7430-0135; Cooke, Ira/0000-0001-6520-1397; Bonder, Claudine S./0000-0001-9875-967X; Cockshell, Michaelia/0000-0002-1350-2988	National Health and Medical Research Council (NHMRC) of Australia; Co-operative Research Centre for Biomarker Translation (Transbio Limited); La Trobe University, Melbourne, Victoria, Australia; Cancer Council of South Australia; Australian Government grant under the Co-operative Research Centre (CRC) Research	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Co-operative Research Centre for Biomarker Translation (Transbio Limited); La Trobe University, Melbourne, Victoria, Australia; Cancer Council of South Australia(Cancer Council South Australia); Australian Government grant under the Co-operative Research Centre (CRC) Research(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia, Co-operative Research Centre for Biomarker Translation (Transbio Limited), La Trobe University, Melbourne, Victoria, Australia and the Cancer Council of South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TransBio Limited is the management company of an Australian Government grant under the Co-operative Research Centre (CRC) Research funding program. SLA, JBP, MPC, EJT, KT, JMB, SS, WYS, RG, IN, VL, IC, GT, AFL and CSB have no commercial associations which might create a conflict of interest in connection with the submitted manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 2011, STEM CELLS; Bonder CS, 2009, BLOOD, V113, P2108, DOI 10.1182/blood-2008-07-166942; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; CORDELL JL, 1994, J CLIN PATHOL, V47, P143, DOI 10.1136/jcp.47.2.143; DOUSSISANAGNOSTOPOULOU I, 1993, AM J PATHOL, V143, P1040; Estes ML, 2010, CURR PROTOC CYTOM, V33, P31, DOI DOI 10.1002/0471142956.CY0933S52; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; FOX SB, 1995, J PATHOL, V177, P369, DOI 10.1002/path.1711770407; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Hagensen MK, 2012, CARDIOVASC RES, V95, P281, DOI 10.1093/cvr/cvs182; Han KA, 2011, DIABETES-METAB RES, V27, P354, DOI 10.1002/dmrr.1183; Hoenig MR, 2008, CURR MOL MED, V8, P754, DOI 10.2174/156652408786733685; Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X; Igreja C, 2008, EXP HEMATOL, V36, P193, DOI 10.1016/j.exphem.2007.09.001; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Kawamoto A, 2001, CIRCULATION, V103, P634; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim I, 2000, BIOCHEM BIOPH RES CO, V269, P361, DOI 10.1006/bbrc.2000.2296; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Leeb T, 2004, GENE, V343, P239, DOI 10.1016/j.gene.2004.10.002; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Litwin M, 1997, J CELL BIOL, V139, P219, DOI 10.1083/jcb.139.1.219; Loomans CJM, 2009, MOL MED, V15, P152, DOI 10.2119/molmed.2009.00032; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Oostendorp RAJ, 1997, EXP HEMATOL, V25, P345; Pacilli A, 2010, ANN VASC SURG, V24, P258, DOI 10.1016/j.avsg.2008.12.003; Patenaude A, 2010, MICROVASC RES; Patey N, 1996, AM J PATHOL, V148, P465; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Ramos AL, 2010, CIRC RES, V107, P1460, DOI 10.1161/CIRCRESAHA.110.223669; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Searle J, 2011, ARTERIOSCL THROM VAS, V31, P2972, DOI 10.1161/ATVBAHA.111.237784; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Sieveking DP, 2009, VASC MED, V14, P153, DOI 10.1177/1358863X08098698; Suarez Y, 2007, J IMMUNOL, V179, P7488, DOI 10.4049/jimmunol.179.11.7488; Sun WY, 2010, AM J PATHOL, V177, P436, DOI 10.2353/ajpath.2010.091016; Szczepanski M, 2012, ORAL DIS, V18, P280, DOI 10.1111/j.1601-0825.2011.01873.x; SZEKANECZ Z, 1994, ARTHRITIS RHEUM, V37, P221, DOI 10.1002/art.1780370211; Taverna D, 2001, CANCER RES, V61, P5255; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Terol MJ, 1996, TISSUE ANTIGENS, V48, P271, DOI 10.1111/j.1399-0039.1996.tb02645.x; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; van Buul JD, 2004, J VASC RES, V41, P28, DOI 10.1159/000076126; Verkarre V, 1999, J CUTAN PATHOL, V26, P17, DOI 10.1111/j.1600-0560.1999.tb01785.x; Verloop RE, 2009, EUR CYTOKINE NETW, V20, P207, DOI 10.1684/ecn.2009.0174; WALL RT, 1978, J CELL PHYSIOL, V96, P203, DOI 10.1002/jcp.1040960209; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635	67	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e46996	10.1371/journal.pone.0046996	http://dx.doi.org/10.1371/journal.pone.0046996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144795	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000311935800011
J	Ishikawa, S; Tateya, I; Hayasaka, T; Masaki, N; Takizawa, Y; Ohno, S; Kojima, T; Kitani, Y; Kitamura, M; Hirano, S; Setou, M; Ito, J				Ishikawa, Seiji; Tateya, Ichiro; Hayasaka, Takahiro; Masaki, Noritaka; Takizawa, Yoshinori; Ohno, Satoshi; Kojima, Tsuyoshi; Kitani, Yoshiharu; Kitamura, Morimasa; Hirano, Shigeru; Setou, Mitsutoshi; Ito, Juichi			Increased Expression of Phosphatidylcholine (16:0/18:1) and (16:0/18:2) in Thyroid Papillary Cancer	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; SQUAMOUS-CELL CARCINOMA; FATTY-ACID-COMPOSITION; PROTEIN EXPRESSION; TISSUE; BREAST; PHOSPHOLIPIDS; DISCOVERY	A good prognosis can be expected for most, but not all, cases of thyroid papillary cancer. Numerous molecular studies have demonstrated beneficial treatment and prognostic factors in various molecular markers. Whereas most previous reports have focused on genomics and proteomics, few have focused on lipidomics. With the advent of mass spectrometry (MS), it has become possible to identify many types of molecules, and this analytical tool has become critical in the field of omics. Recently, imaging mass spectrometry (IMS) was developed. After a simple pretreatment process, IMS can be used to examine tissue sections on glass slides with location information. Here, we conducted an IMS analysis of seven cases of thyroid papillary cancer by comparison of cancerous with normal tissues, focusing on the distribution of phospholipids. We identified that phosphatidylcholine (16:0/18:1) and (16:0/18:2) and sphingomyelin (d18:0/16:1) are significantly higher in thyroid papillary cancer than in normal thyroid tissue as determined by tandem mass (MS/MS) analysis. These distributional differences may be associated with the biological behavior of thyroid papillary cancer.	[Ishikawa, Seiji; Tateya, Ichiro; Ohno, Satoshi; Kojima, Tsuyoshi; Kitani, Yoshiharu; Kitamura, Morimasa; Hirano, Shigeru; Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Hayasaka, Takahiro; Masaki, Noritaka; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Takizawa, Yoshinori] Hamamatsu Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Hamamatsu, Shizuoka 4313192, Japan	Kyoto University; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Tateya, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan.	tateya@ent.kuhp.kyoto-u.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan;  [WAKATE-S: 20670004]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported by a SENTAN grant from the Japan Science and Technology Agency to MS (http://www.jst.go.jp/sentan/en/); a Grant-in-Aid for Scientific Research to MS (WAKATE-S: 20670004, http://www.jsps.go.jp); and a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan to IT and MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2010, J LIPID RES, V51, P2143, DOI 10.1194/jlr.M004762; Al-Saad KA, 2003, J AM SOC MASS SPECTR, V14, P373, DOI 10.1016/S1044-0305(03)00068-0; Bojunga J, 2004, CLIN ENDOCRINOL, V61, P523, DOI 10.1111/j.1365-2265.2004.02131.x; Brown LM, 2006, MOL CARCINOGEN, V45, P613, DOI 10.1002/mc.20193; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Carpi A, 2010, J CELL PHYSIOL, V224, P612, DOI 10.1002/jcp.22187; Cazares LH, 2011, ANAL BIOANAL CHEM, V401, P17, DOI 10.1007/s00216-011-5003-6; CHAJES V, 1992, INT J CANCER, V50, P405, DOI 10.1002/ijc.2910500314; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cullis P.R., 1996, BIOCH LIPIDS LIPOPRO; Enomoto H, 2011, ANAL BIOANAL CHEM, V400, P1913, DOI 10.1007/s00216-011-4924-4; Falvella FS, 2002, CARCINOGENESIS, V23, P1933, DOI 10.1093/carcin/23.11.1933; Gschwind A, 2002, CANCER RES, V62, P6329; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Linkous A, 2010, CELL MICROBIOL; Doria ML, 2012, BREAST CANCER RES TR, V133, P635, DOI 10.1007/s10549-011-1823-5; MANN EA, 1994, ARCH OTOLARYNGOL, V120, P763; Netea-Maier RT, 2008, CANCER RES, V68, P1572, DOI 10.1158/0008-5472.CAN-07-5020; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Schwamborn K, 2007, INT J MOL MED, V20, P155; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Sipos JA, 2010, CLIN ONCOL-UK, V22, P395, DOI 10.1016/j.clon.2010.05.004; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Stoeckli M, 1999, J AM SOC MASS SPECTR, V10, P67, DOI 10.1016/S1044-0305(98)00126-3; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Sugiura Y, 2009, RAPID COMMUN MASS SP, V23, P3269, DOI 10.1002/rcm.4242; Thiery G, 2007, RAPID COMMUN MASS SP, V21, P823, DOI 10.1002/rcm.2895; WILLIAMS CM, 1993, EUR J CLIN NUTR, V47, P260	31	62	66	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48873	10.1371/journal.pone.0048873	http://dx.doi.org/10.1371/journal.pone.0048873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139822	Green Submitted, gold, Green Published			2022-12-25	WOS:000311315300061
J	Kane, MJ; Angoa-Perez, M; Briggs, DI; Sykes, CE; Francescutti, DM; Rosenberg, DR; Kuhn, DM				Kane, Michael J.; Angoa-Perez, Mariana; Briggs, Denise I.; Sykes, Catherine E.; Francescutti, Dina M.; Rosenberg, David R.; Kuhn, Donald M.			Mice Genetically Depleted of Brain Serotonin Display Social Impairments, Communication Deficits and Repetitive Behaviors: Possible Relevance to Autism	PLOS ONE			English	Article							FAMILY-BASED ASSOCIATION; COPY-NUMBER VARIATION; RARE DE-NOVO; MOUSE MODEL; ULTRASONIC VOCALIZATIONS; SPECTRUM DISORDERS; REUPTAKE INHIBITORS; TASKS RELEVANT; SCENT MARKING; FEMALE MICE	Autism is a complex neurodevelopmental disorder characterized by impaired reciprocal social interaction, communication deficits and repetitive behaviors. A very large number of genes have been linked to autism, many of which encode proteins involved in the development and function of synaptic circuitry. However, the manner in which these mutated genes might participate, either individually or together, to cause autism is not understood. One factor known to exert extremely broad influence on brain development and network formation, and which has been linked to autism, is the neurotransmitter serotonin. Unfortunately, very little is known about how alterations in serotonin neuronal function might contribute to autism. To test the hypothesis that serotonin dysfunction can contribute to the core symptoms of autism, we analyzed mice lacking brain serotonin (via a null mutation in the gene for tryptophan hydroxylase 2 (TPH2)) for behaviors that are relevant to this disorder. Mice lacking brain serotonin (TPH2-/-) showed substantial deficits in numerous validated tests of social interaction and communication. These mice also display highly repetitive and compulsive behaviors. Newborn TPH2-/- mutant mice show delays in the expression of key developmental milestones and their diminished preference for maternal scents over the scent of an unrelated female is a forerunner of more severe socialization deficits that emerge in weanlings and persist into adulthood. Taken together, these results indicate that a hypo-serotonin condition can lead to behavioral traits that are highly characteristic of autism. Our findings should stimulate new studies that focus on determining how brain hyposerotonemia during critical neurodevelopmental periods can alter the maturation of synaptic circuits known to be mis-wired in autism and how prevention of such deficits might prevent this disorder.	[Kane, Michael J.; Angoa-Perez, Mariana; Briggs, Denise I.; Sykes, Catherine E.; Francescutti, Dina M.; Kuhn, Donald M.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI USA; [Kane, Michael J.; Angoa-Perez, Mariana; Briggs, Denise I.; Sykes, Catherine E.; Francescutti, Dina M.; Rosenberg, David R.; Kuhn, Donald M.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI USA	Wayne State University	Kuhn, DM (corresponding author), John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI USA.	donald.kuhn@wayne.edu		Briggs, Denise/0000-0002-4824-3947	Department of Veterans Affairs; Veterans Affairs [I01RX000458] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Angoa-Perez M, 2012, J NEUROCHEM, V121, P974, DOI 10.1111/j.1471-4159.2012.07739.x; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bonnin A, 2011, NEUROSCIENCE, V197, P1, DOI 10.1016/j.neuroscience.2011.10.005; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Boylan CB, 2007, BEHAV BRAIN RES, V176, P94, DOI 10.1016/j.bbr.2006.08.026; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; Buitelaar J K, 2000, Paediatr Drugs, V2, P67; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Chadman KK, 2011, PHARMACOL BIOCHEM BE, V97, P586, DOI 10.1016/j.pbb.2010.09.012; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Chou-Green JM, 2003, PHYSIOL BEHAV, V78, P641, DOI 10.1016/S0031-9384(03)00047-7; Chugani DC, 2002, MOL PSYCHIATR, V7, pS16, DOI 10.1038/sj.mp.4001167; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; Chugani DC, 1997, ANN NEUROL, V42, P666, DOI 10.1002/ana.410420420; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Coon H, 2005, AM J MED GENET B, V135B, P42, DOI 10.1002/ajmg.b.30168; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; DeLorey TM, 2008, BEHAV BRAIN RES, V187, P207, DOI 10.1016/j.bbr.2007.09.009; Delorme R, 2006, BIOL PSYCHIAT, V60, P202, DOI 10.1016/j.biopsych.2005.12.014; Egawa J, 2012, PSYCHIAT RES, V196, P320, DOI 10.1016/j.psychres.2011.09.001; Fairless AH, 2011, ANAT REC, V294, P1713, DOI 10.1002/ar.21318; Flurkey K, 2007, FACULTY RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gould GG, 2011, J NEUROCHEM, V116, P291, DOI 10.1111/j.1471-4159.2010.07104.x; Gould GG, 2012, PROG NEUROPSYCHOPHAR, DOI [10.1016/j.pnpbh.2012.04.011, DOI 10.1016/J.PNPBH.2012.04.011]; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hollander E, 2003, LANCET, V362, P732, DOI 10.1016/S0140-6736(03)14236-5; Jacob S, 2009, AUTISM RES, V2, P293, DOI 10.1002/aur.108; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Kolevzon A, 2006, J CLIN PSYCHIAT, V67, P407, DOI 10.4088/JCP.v67n0311; Kriegebaum C, 2010, NEUROCHEM INT, V57, P512, DOI 10.1016/j.neuint.2010.06.015; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LAUDER JM, 1978, DEV NEUROSCI-BASEL, V1, P15, DOI 10.1159/000112549; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lim MA, 2008, INT J DEV NEUROSCI, V26, P423, DOI 10.1016/j.ijdevneu.2008.03.002; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; Liu Y, 2011, NATURE, V472, P95, DOI 10.1038/nature09822; McCracken JT, 2002, NEW ENGL J MED, V347, P314, DOI 10.1056/NEJMoa013171; McDougle CJ, 1996, ARCH GEN PSYCHIAT, V53, P993; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Osorio NS, 2009, GENES BRAIN BEHAV, V8, P337, DOI 10.1111/j.1601-183X.2009.00478.x; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pobbe RLH, 2012, HORM BEHAV, V61, P436, DOI 10.1016/j.yhbeh.2011.10.010; Popova NK, 2006, BIOESSAYS, V28, P495, DOI 10.1002/bies.20412; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Posey David J, 2002, Curr Opin Investig Drugs, V3, P1212; Posey DJ, 2006, J CHILD ADOL PSYCHOP, V16, P181, DOI 10.1089/cap.2006.16.181; Qiu SF, 2012, DEV NEUROSCI-BASEL, V34, P88, DOI 10.1159/000336644; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Ramoz N, 2006, AM J MED GENET B, V141B, P861, DOI 10.1002/ajmg.b.30356; Sacco R, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-11; Salinger WL, 2003, BEHAV NEUROSCI, V117, P1257, DOI 10.1037/0735-7044.117.6.1257; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Scearce-Levie K, 2008, GENES BRAIN BEHAV, V7, P344, DOI 10.1111/j.1601-183X.2007.00357.x; Schaaf CP, 2011, NEURON, V70, P806, DOI 10.1016/j.neuron.2011.05.025; SCHAIN RJ, 1961, J PEDIATR-US, V58, P315, DOI 10.1016/S0022-3476(61)80261-8; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Spiker MA, 2012, AUTISM, V16, P306, DOI 10.1177/1362361311401763; Tamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015126; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Thomas DM, 2010, J NEUROCHEM, V115, P595, DOI 10.1111/j.1471-4159.2010.06950.x; Veenstra-VanderWeele J, 2012, P NATL ACAD SCI USA, V109, P5469, DOI 10.1073/pnas.1112345109; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Volkmar FR, 2009, ARCH GEN PSYCHIAT, V66, P581, DOI 10.1001/archgenpsychiatry.2009.42; Wang ZS, 2011, NEUROPSYCHOPHARMACOL, V36, P772, DOI 10.1038/npp.2010.211; Weber T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028283; Winslow JT, 2003, CURR PROTOC NEUROSCI, V8; Witkin JM, 2008, CURR PROTOC NEUROSCI, V30, P1, DOI DOI 10.1002/0471142301.NS0930S45; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yan QJ, 2004, GENES BRAIN BEHAV, V3, P337, DOI 10.1111/j.1601-183X.2004.00087.x; Yang SY, 2012, NEUROSCI RES, V73, P333, DOI 10.1016/j.neures.2012.05.012; Zafeiriou DI, 2009, CURR NEUROPHARMACOL, V7, P150, DOI 10.2174/157015909788848848; Zhang X, 2006, CELL MOL LIFE SCI, V63, P6, DOI 10.1007/s00018-005-5417-4; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	106	91	92	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48975	10.1371/journal.pone.0048975	http://dx.doi.org/10.1371/journal.pone.0048975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139830	Green Published, Green Submitted, gold			2022-12-25	WOS:000311315300066
J	Miwa, JM; Walz, A				Miwa, Julie M.; Walz, Andreas			Enhancement in Motor Learning through Genetic Manipulation of the Lynx1 Gene	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SYNAPTIC PLASTICITY; CEREBELLUM; PROTOTOXIN; PROTEINS; MULTIPLE; MEMBER; MICE; IDENTIFICATION; LOCALIZATION	The cholinergic system is a neuromodulatory neurotransmitter system involved in a variety of brain processes, including learning and memory, attention, and motor processes, among others. The influence of nicotinic acetylcholine receptors of the cholinergic system are moderated by lynx proteins, which are GPI-anchored membrane proteins forming tight associations with nicotinic receptors. Previous studies indicate lynx1 inhibits nicotinic receptor function and limits neuronal plasticity. We sought to investigate the mechanism of action of lynx1 on nicotinic receptor function, through the generation of lynx mouse models, expressing a soluble version of lynx and comparing results to the full length overexpression. Using rotarod as a test for motor learning, we found that expressing a secreted variant of lynx leads to motor learning enhancements whereas overexpression of full-length lynx had no effect. Further, adult lynx1KO mice demonstrated comparable motor learning enhancements as the soluble transgenic lines, whereas previously, aged lynx1KO mice showed performance augmentation only with nicotine treatment. From this we conclude the motor learning is more sensitive to loss of lynx function, and that the GPI anchor plays a role in the normal function of the lynx protein. In addition, our data suggests that the lynx gene plays a modulatory role in the brain during aging, and that a soluble version of lynx has potential as a tool for adjusting cholinergic-dependent plasticity and learning mechanisms in the brain.	[Miwa, Julie M.] CALTECH, Pasadena, CA 91125 USA; [Walz, Andreas] Ophidion Inc, Pasadena, CA USA	California Institute of Technology	Miwa, JM (corresponding author), CALTECH, Pasadena, CA 91125 USA.	miwaj@caltech.edu		Miwa, Julie/0000-0002-4418-3756	Tobacco-Related Disease Research Program [TRDRP 19KT-0032]; Croll Research Foundation on Autism; National Institutes of Health, The National Institute of Mental Health [R43MH083416-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH083416] Funding Source: NIH RePORTER	Tobacco-Related Disease Research Program(University of California System); Croll Research Foundation on Autism; National Institutes of Health, The National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Tobacco-Related Disease Research Program grant TRDRP 19KT-0032 (http://www.trdrp.org/), and Croll Research Foundation on Autism to JMM, and National Institutes of Health, The National Institute of Mental Health grant R43MH083416-02 to AW (http://www.nimh.nih.gov/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Caruncho HJ, 1997, NEUROREPORT, V8, P1431, DOI 10.1097/00001756-199704140-00021; Cendelin J, 2008, BEHAV BRAIN RES, V189, P65, DOI 10.1016/j.bbr.2007.12.013; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; COLLINS AC, 1988, PHARMACOL BIOCHEM BE, V29, P365, DOI 10.1016/0091-3057(88)90170-0; COURT JA, 1993, DEV BRAIN RES, V74, P73, DOI 10.1016/0165-3806(93)90085-O; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Darvas M, 2009, EUR NEUROPSYCHOPHARM, V19, P670, DOI 10.1016/j.euroneuro.2009.03.007; Davis JA, 2007, J NEUROSCI, V27, P10870, DOI 10.1523/JNEUROSCI.3242-07.2007; De Filippi G, 2005, PROG BRAIN RES, V148, P309, DOI 10.1016/S0079-6123(04)48024-8; De Filippi G, 2001, PHARMACOL BIOCHEM BE, V70, P447, DOI 10.1016/S0091-3057(01)00653-0; DECKER MW, 1993, PHARMACOL BIOCHEM BE, V45, P571, DOI 10.1016/0091-3057(93)90508-Q; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Dizon MJ, 2011, J NEUROSCI, V31, P10463, DOI 10.1523/JNEUROSCI.1350-11.2011; FRIEDMAN S, 1990, IMMUNOGENETICS, V31, P104, DOI 10.1007/BF00661220; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jaarsma D, 1997, PROG BRAIN RES, V114, P67; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Levitin F, 2008, J BIOL CHEM, V283, P16928, DOI 10.1074/jbc.M801454200; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Lisberger SG, 1996, J PHYSIOLOGY-PARIS, V90, P381, DOI 10.1016/S0928-4257(97)87923-5; Liu SJ, 2008, CEREBELLUM, V7, P559, DOI 10.1007/s12311-008-0057-5; LUETJE CW, 1990, J NEUROCHEM, V55, P632, DOI 10.1111/j.1471-4159.1990.tb04180.x; Lyukmanova E.N., 2011, J BIOL CHEM, DOI 10,1074/jbc.M110.189100; Middleton SJ, 2008, NEURON, V58, P763, DOI 10.1016/j.neuron.2008.03.030; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nakayama H, 1997, NEUROSCI RES, V29, P233, DOI 10.1016/S0168-0102(97)00100-4; Nirthanan S, 2004, J PHARMACOL SCI, V94, P1, DOI 10.1254/jphs.94.1; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Reno LAC, 2004, NEUROSCIENCE, V124, P647, DOI 10.1016/j.neuroscience.2003.12.023; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Sher E, 2004, CURR TOP MED CHEM, V4, P283, DOI 10.2174/1568026043451393; SOCCI DJ, 1995, NEUROBIOL AGING, V16, P857, DOI 10.1016/0197-4580(95)00091-R; Taslim N, 2011, BEHAV BRAIN RES, V217, P282, DOI 10.1016/j.bbr.2010.10.026; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Thompson RF, 2009, NEUROSCIENCE, V162, P732, DOI 10.1016/j.neuroscience.2009.01.041; Tsetlin V, 2009, BIOCHEM PHARMACOL, V78, P720, DOI 10.1016/j.bcp.2009.05.032; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; Turner JR, 2005, J NEUROSCI, V25, P9258, DOI 10.1523/JNEUROSCI.2112-05.2005; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Zheng N, 2010, CEREBELLUM, V9, P56, DOI 10.1007/s12311-009-0140-6	57	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e43302	10.1371/journal.pone.0043302	http://dx.doi.org/10.1371/journal.pone.0043302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139735	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000310741400001
J	Raheel, H; Karim, MS; Saleem, S; Bharwani, S				Raheel, Hina; Karim, Mehtab S.; Saleem, Sarah; Bharwani, Sulaiman			Knowledge, Attitudes and Practices of Contraception among Afghan Refugee Women in Pakistan: A Cross-Sectional Study	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; RESETTLEMENT; ACCESS; CARE	Background: During the 1980s, approximately three million people migrated from Afghanistan to Pakistan and sought refuge in several cities including the city of Karachi. After the initial settlement of the refugees, the international organizations transitioned the health care of these refugees to the two local non-profit service agencies in Karachi. One of these agencies subsidized health care to the refugees under their care and the other agency encouraged the refugees under their care to utilize governmental and non-governmental private health resources at the disposal of general public. Our objective was to measure the effect of health subsidy on the uptake of contraception among Afghan refugee women and compare them to the group of Afghan women without such a subsidy. Methodology/Principal Findings: A randomly selected group of 650 married Afghan women-325 women in each group-participated in a detailed survey regarding the knowledge, attitude and practices of family planning and contraceptive use. 90 percent of the women in the health subsidy group had had heard of family planning, compared to the 45 percent in the non-subsidized group. The use of contraceptives was greater than two-fold in the former versus the latter. Results of logistic regression analysis revealed that the refugee women who had had access to subsidized healthcare were significantly more likely to use the contraceptive methods with advancing age as compared to the women in the non-health subsidy group. The difference remained significant after adjusting for other variables. Conclusions/Significance: Refugee women who are provided subsidized healthcare are more inclined to use contraceptives. It is therefore important that Afghan refugee women living elsewhere in Pakistan be provided healthcare subsidy, whereby their reproductive health indicators could improve with reduced fertility. We strongly encourage facilities introducing such subsidies to refugees in resource poor settings to assess the impact through similar inquiry.	[Bharwani, Sulaiman] UAE Univ, Dept Pediat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Raheel, Hina] UAE Univ, Fac Med & Hlth Sci, Dept Obstet & Gynecol, Al Ain, U Arab Emirates; [Karim, Mehtab S.] George Mason Univ, Sch Publ Policy, Arlington, VA USA; [Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	United Arab Emirates University; United Arab Emirates University; George Mason University; Aga Khan University	Bharwani, S (corresponding author), UAE Univ, Dept Pediat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	sulaiman_bharwani@uaeu.ac.ae		Bharwani, Sulaiman/0000-0002-2651-2640				Afghanistan Research and Evaluation Unit, 2005, AFGH KAR MIGR SETTL; [Anonymous], 2007, REPR HLTH ASS TOOLK; [Anonymous], 1997, POPUL TODAY, V25, P5; [Anonymous], 2011, POP COUNC ANN REP; Badshah S, 2011, J PAK MED ASSOC, V61, P161; Balsara ZP, 2010, J HEALTH POPUL NUTR, V28, P501; Barnes DM, 2004, JOGNN-J OBST GYN NEO, V33, P723, DOI 10.1177/0884217504270668; Dennis A, 2012, CONTRACEPTION, V85, P166, DOI 10.1016/j.contraception.2011.06.003; Haider S, 2009, HEALTH CARE WOMEN IN, V30, P935, DOI 10.1080/07399330903052129; Howard Natasha, 2008, Confl Health, V2, P12, DOI 10.1186/1752-1505-2-12; Hynes M, 2002, JAMA-J AM MED ASSOC, V288, P595, DOI 10.1001/jama.288.5.595; Institute of Policy Studies, 2008, AFGH PAK PROTR REF S; Khanani MR, 2010, J INFECTION, V61, P434, DOI 10.1016/j.jinf.2010.08.009; Kottegoda S, 2008, REPROD HEALTH MATTER, V16, P75, DOI 10.1016/S0968-8080(08)31359-7; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Leete R, 1991, Popul Res Leads, P1; Marie Stopes International, 2009, KEY STAT AFGH AFGH; Morris K, 2009, LANCET INFECT DIS, V9, P212, DOI 10.1016/S1473-3099(09)70096-9; Otsea K, 1999, Initiat Reprod Health Policy, V3, P1; PAKISTAN BUREAU OF STATISTICS, 2007, PAK DEM SURV; Ponsar F, 2011, HLTH POLICY PLANN S2, V26, pii72; ROSS J, 1995, STUD FAMILY PLANN, V26, P241, DOI 10.2307/2137849; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Sulaiman-Hill CMR, 2012, AUST NZ J PUBL HEAL, V36, P126, DOI 10.1111/j.1753-6405.2011.00778.x; Todd CS, 2008, CONTRACEPTION, V78, P249, DOI 10.1016/j.contraception.2008.05.005; UNHCR, 2005, PAK CENS AFGH PROV 1; van der Gaag J, 2012, HEALTH ECON, V21, P55, DOI 10.1002/hec.1811; Wali S, 1994, Migr World Mag, V22, P26	28	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48760	10.1371/journal.pone.0048760	http://dx.doi.org/10.1371/journal.pone.0048760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032GO	23133658	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400047
J	Ng, V; Sargeant, JM				Ng, Victoria; Sargeant, Jan M.			A Quantitative and Novel Approach to the Prioritization of Zoonotic Diseases in North America: A Public Perspective	PLOS ONE			English	Article							CONJOINT-ANALYSIS; INFECTIOUS-DISEASES; UNITED-STATES; HEALTH; SURVEILLANCE	Background: Zoonoses account for over half of all communicable diseases causing illness in humans. As there are limited resources available for the control and prevention of zoonotic diseases, a framework for their prioritization is necessary to ensure resources are directed into those of highest importance. Although zoonotic outbreaks are a significant burden of disease in North America, the systematic prioritization of zoonoses in this region has not been previously evaluated. Methodology/Principal Findings: This study describes the novel use of a well-established quantitative method, conjoint analysis (CA), to identify the relative importance of 21 key characteristics of zoonotic diseases that can be used for their prioritization in Canada and the US. Relative importance weights from the CA were used to develop a point-scoring system to derive a recommended list of zoonoses for prioritization in Canada and the US. Over 1,500 participants from the general public were recruited to complete the online survey (761 from Canada and 778 from the US). Hierarchical Bayes models were fitted to the survey data to derive CA-weighted scores. Scores were applied to 62 zoonotic diseases of public health importance in Canada and the US to rank diseases in order of priority. Conclusions/Significance: This was the first study to describe a systematic and quantitative approach to the prioritization of zoonoses in North America involving public participants. We found individuals with no prior knowledge or experience in prioritizing zoonoses were capable of producing meaningful results using CA as a novel quantitative approach to prioritization. More similarities than differences were observed between countries suggesting general agreement in disease prioritization between Canadians and Americans. We demonstrate CA as a potential tool for the prioritization of zoonoses; other prioritization exercises may also consider this approach.	[Ng, Victoria; Sargeant, Jan M.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada	University of Guelph	Ng, V (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada.	vng03@uoguelph.ca		Ng, Victoria/0000-0002-7619-541X	Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada Applied Public Health Research Chair	Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada Applied Public Health Research Chair(Canadian Institutes of Health Research (CIHR))	Funding was provided from a Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada Applied Public Health Research Chair awarded to JMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha P.N., 2003, ZOONOSES COMMUNICABL; [Anonymous], 2002, EMERG INFECT DIS; [Anonymous], COMMUN DIS REP CDR S; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Chrzan K, 2010, INT J MARKET RES, V52, P827, DOI 10.2501/S1470785310201673; Doherty J A, 2000, Can J Infect Dis, V11, P21; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; Gilsdorf A, 2011, EUROSURVEILLANCE, V16, P15; GREEN PE, 1978, J CONSUM RES, V5, P103, DOI 10.1086/208721; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Heymann DL, 2008, CONTROL COMMUNICABLE; Horby P, 2001, Commun Dis Public Health, V4, P8; Howell J., 2009, CBC HB BEGINNERS; InVS, 2010, DEF PRIOR DOM ZOON N; InVS, 2002, DEF PRIOR DOM ZOON N; Kahn C, 2010, MERCK VET MANUAL; Kermode-Scott B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2746; Krause G, 2009, EUROSURVEILLANCE, V14, P5; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mangen MJJ, 2010, RISK ANAL, V30, P782, DOI 10.1111/j.1539-6924.2009.01291.x; Mele NL, 2008, NURS RES, V57, P220, DOI 10.1097/01.NNR.0000319499.52122.d2; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029752; Orme BK., 2019, GETTING STARTED CONJ, V4th; Patterson M., 2004, 10 SAWT SOFTW C P SA, V1, P173; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sampietro-Colom L, 2008, MED DECIS MAKING, V28, P554, DOI 10.1177/0272989X08315235; Sargeant J, 2011, ECOHEALTH, V7, pS34; Sawtooth, 2009, CBC HB VERS 5 0 TECH; Sawtooth Software, 2008, CBC V6 0 TECHN PAP C; StatsCan, 2011, AG SEX HIGHL TABL 20; StatsCan, 2006, POP 15 YEARS HIGH CE; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; U.S. Census Bureau, 2010, 2010 CENS DAT; USCB, 2010, ED ATT US 2010 DET T; WHO, 2012, NEGL ZOON DIS; World Health Organization, 2003, WHO M BUCH ROM 21 23	40	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48519	10.1371/journal.pone.0048519	http://dx.doi.org/10.1371/journal.pone.0048519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133639	Green Published, gold			2022-12-25	WOS:000310601300017
J	Schottker, B; Jansen, EHJM; Haug, U; Schomburg, L; Kohrle, J; Brenner, H				Schoettker, Ben; Jansen, Eugene H. J. M.; Haug, Ulrike; Schomburg, Lutz; Koehrle, Josef; Brenner, Hermann			Standardization of Misleading Immunoassay Based 25-Hydroxyvitamin D Levels with Liquid Chromatography Tandem-Mass Spectrometry in a Large Cohort Study	PLOS ONE			English	Article							VITAMIN-D STATUS; D ASSAYS; SERUM; D-3; CALCIUM; RISK	Background: The interest in vitamin D measurement has strongly increased in recent years. The best indicator for circulating vitamin D levels is 25-hydroxy-vitamin D (25(OH)D) which is often measured by different immunoassays. We demonstrate problems in comparability of measures by different immunoassays and the need for standardization in the context of a large population-based cohort study. Methods: 25(OH)D was measured with the immunoassays Diasorin Liaison in 2006 in 5,386 women and in the context of another project with IDS-iSYS in 4,199 men in 2009-2010 (when the Diasorin Liaison was no longer available in the version utilized in 2006). Standardization was performed by re-measuring of 25(OH)D levels in 97 men and 97 women with liquid chromatography tandem-mass spectrometry (LC-MS/MS) to obtain linear regression conversion equations. Results: Applying a 30 nmol/L cut-off value for vitamin D deficiency would have resulted in 48.3% of women and 12.1% of men with vitamin D deficiency ahead of standardization. The large gender difference was strongly attenuated after standardization of the assays with only 15.7% of women and 14.3% of men with vitamin D deficiency. Standardization on average increased the 25(OH)D levels by 10.3 nmol/L in women and decreased 25(OH)D levels by 2.9 nmol/L in men. Conclusion: The standardization with LC-MS/MS revealed that much of the observed gender difference was only assay-driven and the extremely high proportion of 48.3% vitamin D deficient women proved to be an exaggeration of the old version of the Diasorin-Liaison immunoassay. Standardization of 25(OH)D immunoassay results by LC-MS/MS is recommended to improve their accuracy and comparability, provided the LC-MS/MS method itself is adequately validated and standardized.	[Schoettker, Ben; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany; [Jansen, Eugene H. J. M.] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Haug, Ulrike] German Canc Res Ctr, Div Prevent Oncol, D-6900 Heidelberg, Germany; [Schomburg, Lutz; Koehrle, Josef] Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Netherlands National Institute for Public Health & the Environment; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schottker, B (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany.	b.schoettker@dkfz.de	Schöttker, Ben/F-8183-2014; Köhrle, Josef/AAH-6438-2020; Schomburg, Lutz/D-8096-2013; Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Schöttker, Ben/0000-0002-1217-4521; Köhrle, Josef/0000-0002-9187-9078; Schomburg, Lutz/0000-0001-9445-1555; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Haug, Ulrike/0000-0002-1886-2923	DG-RESEARCH in the European Commission; German Cancer Aid [108250, 108426]; Baden-Wurttemberg State Ministry of Science, Research and Arts (Stuttgart, Germany)	DG-RESEARCH in the European Commission; German Cancer Aid(Deutsche Krebshilfe); Baden-Wurttemberg State Ministry of Science, Research and Arts (Stuttgart, Germany)	This study was conducted in the context of the CHANCES project funded in the FP7 framework programme of DG-RESEARCH in the European Commission and the German Cancer Aid project number 108250 and 108426. The CHANCES project is coordinated by the Hellenic Health Foundation, Greece. The ESTHER study was funded by the Baden-Wurttemberg State Ministry of Science, Research and Arts (Stuttgart, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binkley N, 2004, J CLIN ENDOCR METAB, V89, P3152, DOI 10.1210/jc.2003-031979; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Carter GD, 2009, CLIN CHEM, V55, P1300, DOI 10.1373/clinchem.2009.125906; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Farrell CJL, 2012, CLIN CHEM, V58, P531, DOI 10.1373/clinchem.2011.172155; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Grant WB, 2009, DERM-ENDOCRINOL, V1, P17, DOI 10.4161/derm.1.1.7388; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Low M, 2004, DEUT MED WOCHENSCHR, V129, P2643, DOI 10.1055/s-2004-836089; NHANES, 2010, REV AN NOT NHANES 20; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Raum E, 2007, EUR J CARDIOV PREV R, V14, P809, DOI 10.1097/HJR.0b013e3282eeb308; Ross C. A., 2011, COMMITTEE REV DIETAR; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Schottker Ben, 2009, GMS Health Technol Assess, V5, pDoc09, DOI 10.3205/hta000071; Seamans KM, 2009, AM J CLIN NUTR, V89, p1997S, DOI 10.3945/ajcn.2009.27230D; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Shah I, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-46; Slomski A, 2011, JAMA-J AM MED ASSOC, V305, P453, DOI 10.1001/jama.2011.50; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Stepman HCM, 2011, CLIN CHEM LAB MED, V49, P253, DOI 10.1515/CCLM.2011.050; Stepman HCM, 2011, CLIN CHEM, V57, P441, DOI 10.1373/clinchem.2010.152553; Tai SSC, 2010, ANAL CHEM, V82, P1942, DOI 10.1021/ac9026862; van den Ouweland JMW, 2010, J CHROMATOGR B, V878, P1163, DOI 10.1016/j.jchromb.2010.03.035; Wallace AM, 2010, STEROIDS, V75, P477, DOI 10.1016/j.steroids.2010.02.012; Wootton Andrew M, 2005, Clin Biochem Rev, V26, P33; Yetley EA, 2010, J NUTR, V140, p2030S, DOI 10.3945/jn.110.121483	28	45	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48774	10.1371/journal.pone.0048774	http://dx.doi.org/10.1371/journal.pone.0048774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133659	Green Published, gold, Green Submitted			2022-12-25	WOS:000310601300026
J	Wahome, PG; Ahlawat, S; Mantis, NJ				Wahome, Paul G.; Ahlawat, Sarita; Mantis, Nicholas J.			Identification of Small Molecules That Suppress Ricin-Induced Stress-Activated Signaling Pathways	PLOS ONE			English	Article							N-GLYCOSIDASE ACTIVITY; RIBOSOMAL-RNA; A-CHAIN; ENDOPLASMIC-RETICULUM; EUKARYOTIC RIBOSOMES; TOXIN; INHIBITORS; CELLS; APOPTOSIS; P38	Ricin is a member of the ribosome-inactivating protein (RIP) family of plant and bacterial toxins. In this study we used a high-throughput, cell-based assay to screen more than 118,000 compounds from diverse chemical libraries for molecules that reduced ricin-induced cell death. We describe three compounds, PW66, PW69, and PW72 that at micromolar concentrations significantly delayed ricin-induced cell death. None of the compounds had any demonstrable effect on ricin's ability to arrest protein synthesis in cells or on ricin's enzymatic activity as assessed in vitro. Instead, all three compounds appear to function by blocking downstream stress-induced signaling pathways associated with the toxin-mediated apoptosis. PW66 virtually eliminated ricin-induced TNF-alpha secretion by J774A.1 macrophages and concomitantly blocked activation of the p38 MAPK and JNK signaling pathways. PW72 suppressed ricin-induced TNF-alpha secretion, but not p38 MAPK and JNK signaling. PW69 suppressed activity of the executioner caspases 3/7 in ricin toxin- and Shiga toxin 2-treated cells. While the actual molecular targets of the three compounds have yet to be identified, these data nevertheless underscore the potential of small molecules to down-regulate inflammatory signaling pathways associated with exposure to the RIP family of toxins.	[Wahome, Paul G.; Ahlawat, Sarita; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA; [Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY USA.	nmantis@wadsworth.org		Mantis, Nicholas/0000-0002-5083-8640	National Institute of Allergy and Infectious Diseases (NIAID) [5U01 AI075509, U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, U01AI075509] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) grants 5U01 AI075509 and U54 AI057159. (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Bai Y, 2010, TOXICON, V56, P526, DOI 10.1016/j.toxicon.2010.05.009; Bai Y, 2009, ARCH BIOCHEM BIOPHYS, V483, P23, DOI 10.1016/j.abb.2008.12.013; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Higuchi S, 2003, J BIOCHEM, V134, P927, DOI 10.1093/jb/mvg224; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Jandhyala DM, 2008, CELL MICROBIOL, V10, P1468, DOI 10.1111/j.1462-5822.2008.01139.x; Jandhyala DM, 2012, CURR TOP MICROBIOL, V357, P41, DOI 10.1007/82_2011_181; Korcheva V, 2005, AM J PATHOL, V166, P323, DOI 10.1016/S0002-9440(10)62256-0; Korcheva V, 2007, MOL IMMUNOL, V44, P2761, DOI 10.1016/j.molimm.2006.10.025; Leyva-Illades D, 2012, INFECT IMMUN; Lindauer M, 2010, TOXINS, V2, P1500, DOI 10.3390/toxins2061500; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; Park JG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00631; Pruet JM, 2011, EUR J MED CHEM, V46, P3608, DOI 10.1016/j.ejmech.2011.05.025; Redmann V, 2011, J BIOL CHEM, V286, P21231, DOI 10.1074/jbc.M111.234708; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sauter K. A., 2010, CANCER BIOL THER, V10, P258, DOI DOI 10.4161/CBT.10.3.12367; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Smith WE, 2003, INFECT IMMUN, V71, P1497, DOI 10.1128/IAI.71.3.1497-1504.2003; Sokolowska I, 2011, BIOCHEM J, V436, P371, DOI 10.1042/BJ20101493; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Wahome PG, 2012, CURR TOP MICROBIOL, V357, P179, DOI 10.1007/82_2011_177; Wahome PG, 2010, TOXICON, V56, P313, DOI 10.1016/j.toxicon.2010.03.016; Wang XS, 2005, J BIOL CHEM, V280, P19298, DOI 10.1074/jbc.M413059200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yan XJ, 1997, J MOL BIOL, V266, P1043, DOI 10.1006/jmbi.1996.0865; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; Yoder JM, 2007, INFECT IMMUN, V75, P1745, DOI 10.1128/IAI.01528-06; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	37	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e49075	10.1371/journal.pone.0049075	http://dx.doi.org/10.1371/journal.pone.0049075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133670	gold, Green Published, Green Submitted			2022-12-25	WOS:000310601300030
J	Biermann, D; Heilmann, A; Didie, M; Schlossarek, S; Wahab, A; Grimm, M; Romer, M; Reichenspurner, H; Sultan, KR; Steenpass, A; Ergun, S; Donzelli, S; Carrier, L; Ehmke, H; Zimmermann, WH; Hein, L; Boger, RH; Benndorf, RA				Biermann, Daniel; Heilmann, Andreas; Didie, Michael; Schlossarek, Saskia; Wahab, Azadeh; Grimm, Michael; Roemer, Maria; Reichenspurner, Hermann; Sultan, Karim R.; Steenpass, Anna; Erguen, Sueleyman; Donzelli, Sonia; Carrier, Lucie; Ehmke, Heimo; Zimmermann, Wolfram H.; Hein, Lutz; Boeger, Rainer H.; Benndorf, Ralf A.			Impact of AT2 Receptor Deficiency on Postnatal Cardiovascular Development	PLOS ONE			English	Article							II TYPE-2 RECEPTOR; CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-II; IN-VITRO; TUBE FORMATION; GROWTH; ANGIOGENESIS; EXPRESSION; GENE; INHIBITION	Background: The angiotensin II receptor subtype 2 (AT2 receptor) is ubiquitously and highly expressed in early postnatal life. However, its role in postnatal cardiac development remained unclear. Methodology/Principal Findings: Hearts from 1, 7, 14 and 56 days old wild-type (WT) and AT2 receptor-deficient (KO) mice were extracted for histomorphometrical analysis as well as analysis of cardiac signaling and gene expression. Furthermore, heart and body weights of examined animals were recorded and echocardiographic analysis of cardiac function as well as telemetric blood pressure measurements were performed. Moreover, gene expression, sarcomere shortening and calcium transients were examined in ventricular cardiomyocytes isolated from both genotypes. KO mice exhibited an accelerated body weight gain and a reduced heart to body weight ratio as compared to WT mice in the postnatal period. However, in adult KO mice the heart to body weight ratio was significantly increased most likely due to elevated systemic blood pressure. At postnatal day 7 ventricular capillarization index and the density of alpha-smooth muscle cell actin-positive blood vessels were higher in KO mice as compared to WT mice but normalized during adolescence. Echocardiographic assessment of cardiac systolic function at postnatal day 7 revealed decreased contractility of KO hearts in response to beta-adrenergic stimulation. Moreover, cardiomyocytes from KO mice showed a decreased sarcomere shortening and an increased peak Ca2+ transient in response to isoprenaline when stimulated concomitantly with angiotensin II. Conclusion: The AT2 receptor affects postnatal cardiac growth possibly via reducing body weight gain and systemic blood pressure. Moreover, it moderately attenuates postnatal vascularization of the heart and modulates the beta adrenergic response of the neonatal heart. These AT2 receptor-mediated effects may be implicated in the physiological maturation process of the heart.	[Erguen, Sueleyman; Benndorf, Ralf A.] Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany; [Biermann, Daniel; Reichenspurner, Hermann] Univ Heart Ctr, Dept Cardiovasc Surg, Hamburg, Germany; [Heilmann, Andreas; Wahab, Azadeh; Steenpass, Anna; Boeger, Rainer H.] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Didie, Michael; Zimmermann, Wolfram H.] Univ Gottingen, Dept Pharmacol, Gottingen, Germany; [Didie, Michael; Zimmermann, Wolfram H.] Univ Gottingen, Heart Res Ctr Gottingen, Gottingen, Germany; [Schlossarek, Saskia; Grimm, Michael; Sultan, Karim R.; Donzelli, Sonia; Carrier, Lucie] Univ Med Ctr Hamburg Eppendorf, Inst Expt Pharmacol & Toxicol, Hamburg, Germany; [Grimm, Michael] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Sultan, Karim R.] Lab Pharmacol & Toxicol, Hamburg, Germany; [Roemer, Maria; Ehmke, Heimo] Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, Hamburg, Germany; [Donzelli, Sonia] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Hein, Lutz] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79106 Freiburg, Germany; [Benndorf, Ralf A.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmacol Toxicol & Clin Pharm, D-38106 Braunschweig, Germany	University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of California System; University of California San Diego; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; Braunschweig University of Technology	Benndorf, RA (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany.	ralf.benndorf@uni-wuerzburg.de	Hein, Lutz/GRJ-8644-2022; Zimmermann, Wolfram-Hubertus H/I-6838-2012	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040	FFM of the University Medical Center Hamburg-Eppendorf [F-141]; Werner Otto Foundation [Be-6/70]	FFM of the University Medical Center Hamburg-Eppendorf; Werner Otto Foundation	This study was supported by a grant (F-141) from the FFM of the University Medical Center Hamburg-Eppendorf to RAB and a grant (Be-6/70) from the Werner Otto Foundation to RAB and WHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avkiran M, 2003, CARDIOVASC RES, V57, P942, DOI 10.1016/S0008-6363(02)00782-4; BEINLICH CJ, 1991, J MOL CELL CARDIOL, V23, P1031, DOI 10.1016/0022-2828(91)91638-8; Benndorf R, 2003, CIRC RES, V93, P438, DOI 10.1161/01.RES.0000088358.99466.04; Benndorf RA, 2008, CIRC RES, V103, P1037, DOI 10.1161/CIRCRESAHA.108.184036; Benndorf RA, 2009, KIDNEY INT, V75, P1039, DOI 10.1038/ki.2009.2; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Falcon BL, 2005, HYPERTENSION, V45, P692, DOI 10.1161/01.HYP.0000154254.89733.29; Galle J, 2008, NAT CLIN PRACT CARD, V5, pS36, DOI 10.1038/ncpcardio0806; Gao LE, 2011, CURR OPIN PHARMACOL, V11, P124, DOI 10.1016/j.coph.2010.11.004; Gross V, 2000, J HYPERTENS, V18, P955, DOI 10.1097/00004872-200018070-00018; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Horiuchi M, 1998, ENDOCR RES, V24, P307, DOI 10.3109/07435809809032610; Hutchinson HG, 1999, CARDIOVASC RES, V41, P689, DOI 10.1016/S0008-6363(98)00267-3; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Kou BJ, 2007, VASC PHARMACOL, V47, P199, DOI 10.1016/j.vph.2007.06.011; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; Lamparter S, 1999, CARDIOVASC RES, V43, P165, DOI 10.1016/S0008-6363(99)00111-X; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Llambi HG, 1996, HYPERTENSION, V27, P704, DOI 10.1161/01.HYP.27.3.704; Madsen K, 2010, J AM SOC NEPHROL, V21, P448, DOI 10.1681/ASN.2009010045; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Munk VC, 2007, HYPERTENSION, V49, P1178, DOI 10.1161/HYPERTENSIONAHA.106.080242; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Price RL, 1997, DEV BIOL, V192, P572, DOI 10.1006/dbio.1997.8764; Sanchez SI, 2008, EUR J PHARMACOL, V588, P114, DOI 10.1016/j.ejphar.2008.04.014; Schutz S, 1996, AM J PATHOL, V149, P2067; SECHI LA, 1992, CIRC RES, V71, P1482, DOI 10.1161/01.RES.71.6.1482; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Shanmugam S, 1996, HYPERTENSION, V28, P91, DOI 10.1161/01.HYP.28.1.91; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Silvestre JS, 2002, CIRC RES, V90, P1072, DOI 10.1161/01.RES.0000019892.41157.24; van Esch JHM, 2010, CARDIOVASC RES, V86, P401, DOI 10.1093/cvr/cvq004; Velazquez-Armenta EY, 2007, HYPERTENS PREGNANCY, V26, P51, DOI 10.1080/10641950601147937; YAMAZAKI T, 1994, J HYPERTENS, V12, pS153; Yang ZQ, 2002, CIRCULATION, V106, P106, DOI 10.1161/01.CIR.0000020014.14176.6D	42	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47916	10.1371/journal.pone.0047916	http://dx.doi.org/10.1371/journal.pone.0047916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144713	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705300024
J	Viennet, E; Garros, C; Rakotoarivony, I; Allene, X; Gardes, L; Lhoir, J; Fuentes, I; Venail, R; Crochet, D; Lancelot, R; Riou, M; Moulia, C; Baldet, T; Balenghien, T				Viennet, Elvina; Garros, Claire; Rakotoarivony, Ignace; Allene, Xavier; Gardes, Laetitia; Lhoir, Jonathan; Fuentes, Ivanna; Venail, Roger; Crochet, Didier; Lancelot, Renaud; Riou, Mickael; Moulia, Catherine; Baldet, Thierry; Balenghien, Thomas			Host-Seeking Activity of Bluetongue Virus Vectors: Endo/Exophagy and Circadian Rhythm of Culicoides in Western Europe	PLOS ONE			English	Article							MIDGES DIPTERA-CERATOPOGONIDAE; BITING MIDGES; FURENS POEY; CATTLE; DIEL; OBSOLETUS; POPULATION; LIVESTOCK; HABITS; INDOOR	Feeding success of free-living hematophagous insects depends on their ability to be active when hosts are available and to reach places where hosts are accessible. When the hematophagous insect is a vector of pathogens, determining the components of host-seeking behavior is of primary interest for the assessment of transmission risk. Our aim was to describe endo/exophagy and circadian host-seeking activity of Palaearctic Culicoides species, which are major biting pests and arbovirus vectors, using drop traps and suction traps baited with four sheep, as bluetongue virus hosts. Collections were carried out in the field, a largely-open stable and an enclosed stable during six collection periods of 24 hours in April/May, in late June and in September/October 2010 in western France. A total of 986 Culicoides belonging to 13 species, mainly C. brunnicans and C. obsoletus, was collected on animal baits. Culicoides brunnicans was clearly exophagic, whereas C. obsoletus was able to enter stables. Culicoides brunnicans exhibited a bimodal pattern of host-seeking activity with peaks just after sunrise and sunset. Culicoides obsoletus was active before sunset in spring and autumn and after sunset in summer, thus illustrating influence of other parameters than light, especially temperature. Description of host-seeking behaviors allowed us to discuss control strategies for transmission of Culicoides-borne pathogens, such as bluetongue virus. However, practical vector-control recommendations are difficult to provide because of the variation in the degree of endophagy and time of host-seeking activity.	[Viennet, Elvina; Garros, Claire; Rakotoarivony, Ignace; Allene, Xavier; Gardes, Laetitia; Lhoir, Jonathan; Fuentes, Ivanna; Lancelot, Renaud; Baldet, Thierry; Balenghien, Thomas] CIRAD, UMR Controle Malad, Montpellier, France; [Venail, Roger] EID Mediterranee, Montpellier, France; [Crochet, Didier; Riou, Mickael] INRA, PFIE UE1277, F-37380 Nouzilly, France; [Moulia, Catherine] Univ Montpellier 2, ISEM Equipe Genom Interact, Montpellier, France	CIRAD; INRAE; Universite de Montpellier	Viennet, E (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Coll Med Biol & Environm, Canberra, ACT, Australia.	elvina.viennet@anu.edu.au; thomas.balenghien@cirad.fr	Garros, Claire/C-2715-2011; Viennet, Elvina/M-5818-2019; Lancelot, Renaud/HGE-1086-2022; Viennet, Elvina/D-9032-2017	Viennet, Elvina/0000-0002-1418-1426; Lancelot, Renaud/0000-0002-5826-5242; Viennet, Elvina/0000-0002-1418-1426	CIRAD; Ministere de l'agriculture, de l'alimentation, de la peche, de la ruraliteet de l'amenagement du terroire; EU [261504]	CIRAD; Ministere de l'agriculture, de l'alimentation, de la peche, de la ruraliteet de l'amenagement du terroire; EU(European Commission)	This study was funded by CIRAD, by the Ministere de l'agriculture, de l'alimentation, de la peche, de la ruraliteet de l'amenagement du terroire and by the EU FP7-HEALTH-2010-single-stage grant 261504 EDENext. This paper is catalogued by the EDENext Steering Committee as EDENext032 (http://www.edenext.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ANDERSON GS, 1993, CAN ENTOMOL, V125, P439, DOI 10.4039/Ent125439-3; Baldet T, 2008, PREV VET MED, V87, P84, DOI 10.1016/j.prevetmed.2008.06.014; Balenghien T, 2008, VET REC, V162, P323, DOI 10.1136/vr.162.10.323-b; Barnard BJH, 1997, ONDERSTEPOORT J VET, V64, P227; BARNARD DR, 1980, ENVIRON ENTOMOL, V9, P446, DOI 10.1093/ee/9.4.446; Baylis M, 2010, MED VET ENTOMOL, V24, P38, DOI 10.1111/j.1365-2915.2009.00842.x; Blackwell A, 1997, MED VET ENTOMOL, V11, P361, DOI 10.1111/j.1365-2915.1997.tb00423.x; Calvete C, 2009, MED VET ENTOMOL, V23, P202, DOI 10.1111/j.1365-2915.2009.00801.x; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Clements A. N., 1999, BIOL MOSQUITOES SENS; Combes C, 2010, ART ETRE PARASITE AS; Combes Claude, 2000, Journal de la Societe de Biologie, V194, P19; Delecolle J. C., 1985, THESIS U L PASTEUR S; DYCE A L, 1969, Journal of the Australian Entomological Society, V8, P11; European Food Safety Authority (EFSA), 2008, EFSA J, V735, P1, DOI DOI 10.2903/J.EFSA.2008.735; Garcia-Saenz A, 2011, MED VET ENTOMOL, V25, P113, DOI 10.1111/j.1365-2915.2010.00904.x; Gerry AC, 2009, J MED ENTOMOL, V46, P615, DOI 10.1603/033.046.0329; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Kettle DS, 1998, MED VET ENTOMOL, V12, P367, DOI 10.1046/j.1365-2915.1998.00119.x; KETTLE DS, 1969, B ENTOMOL RES, V59, P21, DOI 10.1017/S0007485300002996; KETTLE DS, 1969, B ENTOMOL RES, V59, P241, DOI 10.1017/S0007485300003187; LILLIE TH, 1987, J MED ENTOMOL, V24, P503, DOI 10.1093/jmedent/24.4.503; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Meiswinkel R, 2000, B ENTOMOL RES, V90, P509, DOI 10.1017/S0007485300000626; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MURRAY MD, 1987, AUST J ZOOL, V35, P559, DOI 10.1071/ZO9870559; NIELSEN BO, 1975, NORD VET MED, V27, P365; Ninio C, 2011, VET PARASITOL, V183, P125, DOI 10.1016/j.vetpar.2011.07.020; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Sanders CJ, 2012, J MED ENTOMOL, V49, P757, DOI 10.1603/ME11259; Solano P, 1997, ACTA TROP, V65, P175, DOI 10.1016/S0001-706X(97)00663-3; TAUBER CA, 1981, ANNU REV ECOL SYST, V12, P281, DOI 10.1146/annurev.es.12.110181.001433; Tsutsui T, 2011, PARASITOL RES, V108, P1575, DOI 10.1007/s00436-010-2048-y; van der Rijt R, 2008, VET J, V178, P91, DOI 10.1016/j.tvjl.2007.07.005; Velthuis AGJ, 2009, PREVENTIVE VET MED, V11; Venables W.N., 2019, INTRO R NOTES R PROG; Viennet E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-119; Votypka J, 2009, MED VET ENTOMOL, V23, P277, DOI 10.1111/j.1365-2915.2009.00800.x; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Zimmer JY, 2010, EMERG INFECT DIS, V16, P575, DOI 10.3201/eid1603.091311	40	32	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48120	10.1371/journal.pone.0048120	http://dx.doi.org/10.1371/journal.pone.0048120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144735	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705300045
J	Johnston, CE; Hartley, C; Salisbury, AM; Wigley, P				Johnston, Claire E.; Hartley, Catherine; Salisbury, Anne-Marie; Wigley, Paul			Immunological Changes at Point-of-Lay Increase Susceptibility to Salmonella enterica Serovar Enteritidis Infection in Vaccinated Chickens	PLOS ONE			English	Article							REPRODUCTIVE-TRACT; EGG CONTAMINATION; PHAGE TYPE-4; COLONIZATION; EXPRESSION; PROTECTION; CHALLENGE; LOCALIZATION; TYPHIMURIUM; MACROPHAGES	Chicken eggs are the main source of human Salmonella enterica serovar Enteritidis infection. S. Enteritidis infects the oviduct and ovary of the chicken leading to infection of developing eggs. Therefore, control in poultry production is a major public health priority. Vaccination of hens has proved successful in control strategies in United Kingdom leading to a 70% drop in human cases since introduced. However, as hens reach sexual maturity they become immunosuppressed and it has been postulated this leads to increased susceptibility to Salmonella infection. In this study we define the changes to the systemic and reproductive tract-associated immune system of hens throughout sexual development by flow cytometry and histology and determine changes in susceptibility to experimental S. Enteritidis challenge in naive and vaccinated hens. Changes to both systemic and local immune systems occur in chickens at sexual development around 140 days of age. The population of several leukocyte classes drop, with the greatest fall in CD4+ lymphocyte numbers. Within the developing reproductive tract there an organised structure of lymphocytic aggregates with gamma delta-T lymphocytes associated with the mucosa. At point-of-lay, this organised structure disappears and only scattered lymphocytes remain. Protection against Salmonella challenge is significantly reduced in vaccinated birds at point-of-lay, coinciding with the drop in CD4+ lymphocytes. Susceptibility to reproductive tract infection by Salmonella increased in vaccinated and naive animals at 140 and 148 days of age. We hypothesise that the drop in gamma delta-T lymphocytes in the tract leads to decreased innate protection of the mucosa to infection. These findings indicate that systemic and local changes to the immune system increase the susceptibility of hens to S. Enteritidis infection. The loss of protective immunity in vaccinated birds demonstrates that Salmonella control should not rely on vaccination alone, but as part of an integrated control strategy including biosecurity and improved animal welfare.	[Wigley, Paul] Univ Liverpool, Inst Infect & Global Hlth, Zoonot Infect Pigs & Poultry Grp, Neston, England; Univ Liverpool, Sch Vet Sci, Neston, England	University of Liverpool; University of Liverpool	Wigley, P (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Zoonot Infect Pigs & Poultry Grp, Leahurst Campus, Neston, England.	paul.wigley@liv.ac.uk		Wigley, Paul/0000-0001-6563-0773	UK Biotechnology and Biological Sciences Research Council [BB/D007542/1]; Biotechnology and Biological Sciences Research Council [BB/D007542/1] Funding Source: researchfish; BBSRC [BB/D007542/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council, www.bbsrc.ac.uk, Grant Number BB/D007542/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow PA, 2007, AVIAN PATHOL, V36, P1, DOI 10.1080/03079450601113167; Beal RK, 2006, INFECT IMMUN, V74, P1442, DOI 10.1128/IAI.74.2.1442-1444.2006; Berchieri A, 2001, AVIAN PATHOL, V30, P297, DOI 10.1080/03079450120066304; Berndt A, 2006, INFECT IMMUN, V74, P3967, DOI 10.1128/IAI.01128-05; BISWAL G, 1954, POULTRY SCI, V33, P843, DOI 10.3382/ps.0330843; *CDC, 2010, INV UPD MULT OUTBR H; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; Clayton DJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-228; Cogan TA, 2003, J APPL MICROBIOL, V94, p114S, DOI 10.1046/j.1365-2672.94.s1.13.x; Davies R, 2003, VET REC, V153, P673, DOI 10.1136/vr.153.22.673; Davies R, 2003, AVIAN PATHOL, V32, P227, DOI 10.1080/0307945031000097822; DEFRA (Department for Environment Food and Rural Affairs), 2011, ZOON REP UK 2010; Desin TS, 2011, VET MICROBIOL, V148, P298, DOI 10.1016/j.vetmic.2010.09.006; Gantois I, 2006, VACCINE, V24, P6250, DOI 10.1016/j.vaccine.2006.05.070; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Gast RK, 2007, AVIAN DIS, V51, P40, DOI 10.1637/0005-2086(2007)051[0040:COSROT]2.0.CO;2; Gillespie I, 2005, EUROSURVEILLANCE, V10; Gillespie IA, 2005, EPIDEMIOL INFECT, V133, P795, DOI 10.1017/S0950268805004474; Guard-Petter J, 2001, ENVIRON MICROBIOL, V3, P421, DOI 10.1046/j.1462-2920.2001.00213.x; Hartley C, 2012, AVIAN PATHOL, V41, P77, DOI 10.1080/03079457.2011.640305; He HQ, 2005, FEMS IMMUNOL MED MIC, V43, P81, DOI 10.1016/j.femsim.2004.07.009; Iqbal M, 2005, INFECT IMMUN, V73, P2344, DOI 10.1128/IAI.73.4.2344-2350.2005; Jawale CV, 2012, INFECT IMMUN, V80, P1502, DOI 10.1128/IAI.06264-11; Kogut MH, 2005, J INTERF CYTOK RES, V25, P73, DOI 10.1089/jir.2005.25.73; MacKinnon KM, 2009, VET IMMUNOL IMMUNOP, V127, P371, DOI 10.1016/j.vetimm.2008.10.001; Methner U, 2011, VACCINE, V29, P3248, DOI 10.1016/j.vaccine.2011.02.030; Nandre RM, 2011, VET IMMUNOL IMMUNOP, V144, P299, DOI 10.1016/j.vetimm.2011.08.015; Olah I, 2008, AVIAN IMMUNOLOGY, P13, DOI 10.1016/B978-012370634-8.50005-6; Peng W, 2011, IMMUNOBIOLOGY, V216, P558, DOI 10.1016/j.imbio.2010.10.001; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Toyota-Hanatani Y, 2009, VACCINE, V27, P1680, DOI 10.1016/j.vaccine.2009.01.024; Van Immerseel F, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-23; Wigley P, 2005, INFECT IMMUN, V73, P2986, DOI 10.1128/IAI.73.5.2986-2990.2005; Wigley P, 2001, INFECT IMMUN, V69, P7873, DOI 10.1128/IAI.69.12.7873-7879.2001; Wigley P, 2008, AVIAN IMMUNOLOGY, P289, DOI 10.1016/B978-012370634-8.50018-4; Withanage GSK, 2005, INFECT IMMUN, V73, P5173, DOI 10.1128/IAI.73.8.5173-5182.2005; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; Withanage GSK, 1997, POULTRY SCI, V76, P671, DOI 10.1093/ps/76.5.671; Woodward MJ, 2000, J MED MICROBIOL, V49, P481, DOI 10.1099/0022-1317-49-5-481; Zheng WM, 1999, POULTRY SCI, V78, P1014, DOI 10.1093/ps/78.7.1014	40	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48195	10.1371/journal.pone.0048195	http://dx.doi.org/10.1371/journal.pone.0048195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133568	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800058
J	Marinkovic, M; de Leeuw, WC; de Jong, M; Kraak, MHS; Admiraal, W; Breit, TM; Jonker, MJ				Marinkovic, Marino; de Leeuw, Wim C.; de Jong, Mark; Kraak, Michiel H. S.; Admiraal, Wim; Breit, Timo M.; Jonker, Martijs J.			Combining Next-Generation Sequencing and Microarray Technology into a Transcriptomics Approach for the Non-Model Organism Chironomus riparius	PLOS ONE			English	Article							LIFE-CYCLE RESPONSES; EXPRESSION; ANNOTATION; BLAST2GO; GENOME; TOOL	Whole-transcriptome gene-expression analyses are commonly performed in species that have a sequenced genome and for which microarrays are commercially available. To do such analyses in species with no or limited genome data, i.e. non-model organisms, necessary transcriptomics resources, i.e. an annotated transcriptome and a validated gene-expression microarray, must first be developed. The aim of the present study was to establish an advanced approach for developing transcriptomics resources for non-model organisms by combining next-generation sequencing (NGS) and microarray technology. We applied our approach to the non-biting midge Chironomus riparius, an ecologically relevant species that is widely used in sediment ecotoxicity testing. We sampled extensively covering all C. riparius developmental stages as well as toxicant exposed larvae and obtained from a normalized cDNA library 1.5 M NGS reads totalling 501 Mbp. Using the NGS data we developed transcriptomics resources in several steps. First, we designed 844 k probes directly on the NGS reads, as well as 76 k probes targeting expressed sequence tags of related species. These probes were tested for their affinity to C. riparius DNA and mRNA, by performing two biological experiments with a 1 M probe-selection microarray that contained the entire probe-library. Subsequently, the 1.5 M NGS reads were assembled into 23,709 isotigs and 135,082 singletons, which were associated to similar to 55 k, respectively, similar to 61 k gene ontology terms and which corresponded together to 22,593 unique protein accessions. An algorithm was developed that took the assembly and the probe affinities to DNA and mRNA into account, what resulted in 59 k highly-reliable probes that targeted uniquely 95% of the isotigs and 18% of the singletons. Concluding, our approach allowed the development of high-quality transcriptomics resources for C. riparius, and is applicable to any non-model organism. It is expected, that these resources will advance ecotoxicity testing with C. riparius as whole-transcriptome gene-expression analysis are now possible with this species.	[Marinkovic, Marino; de Leeuw, Wim C.; de Jong, Mark; Breit, Timo M.; Jonker, Martijs J.] Univ Amsterdam, Microarray Dept, SILS, Amsterdam, Netherlands; [Marinkovic, Marino; de Leeuw, Wim C.; de Jong, Mark; Breit, Timo M.; Jonker, Martijs J.] Univ Amsterdam, SILS, Integrat Bioinformat Unit, Amsterdam, Netherlands; [Marinkovic, Marino; Kraak, Michiel H. S.; Admiraal, Wim] Univ Amsterdam, IBED, Dept Aquat Ecol & Ecotoxicol, Amsterdam, Netherlands; [de Leeuw, Wim C.; de Jong, Mark; Breit, Timo M.; Jonker, Martijs J.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Jonker, MJ (corresponding author), Univ Amsterdam, Microarray Dept, SILS, Amsterdam, Netherlands.	M.J.Jonker@uva.nl	Kraak, Michiel/K-6928-2012		Netherlands Organization for Scientific Research (NWO) [017.004.014]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was financially supported by Mozaiek grant 017.004.014 of The Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; Armitage P.D., 1995, THE CHIRONOMIDAE; ARMITAGE PD, 1983, WATER RES, V17, P333, DOI 10.1016/0043-1354(83)90188-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bass C, 2012, INSECT SCI, V19, P1, DOI 10.1111/j.1744-7917.2011.01440.x; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Boonstra Michelle, 2009, Proceedings of the Netherlands Entomological Society Meeting, V20, P9; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-252; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Gabriels W, 2010, LIMNOLOGICA, V40, P199, DOI 10.1016/j.limno.2009.10.001; Garcia-Reyero N, 2008, J FISH BIOL, V72, P2354, DOI 10.1111/j.1095-8649.2008.01904.x; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gong P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014266; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marinkovic M, 2011, ENVIRON SCI TECHNOL, V45, P1645, DOI 10.1021/es102904y; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Nair Prakash M Gopalakrishnan, 2011, Environ Health Toxicol, V26, pe2011010, DOI 10.5620/eht.2011.26.e2011010; Neumann NF, 2002, BIOTECHNOL ADV, V20, P391, DOI 10.1016/S0734-9750(02)00025-3; OECD, 2004, GUID TEST CHEM 219 S; OECD, 2011, GUID TEST CHEM 235 C; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Paumen ML, 2008, ENVIRON POLLUT, V152, P225, DOI 10.1016/j.envpol.2007.04.027; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Severson DW, 2012, ANNU REV ENTOMOL, V57, P143, DOI 10.1146/annurev-ento-120710-100651; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Steiner G, 2004, ENVIRON HEALTH PERSP, V112, P1236, DOI 10.1289/txg.7036; Swain S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-32; Traas T. P., 2007, RISK ASSESSMENT CHEM, P281; van Straalen NM, 2012, ENVIRON SCI TECHNOL, V46, P3, DOI 10.1021/es2034153; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x	45	29	29	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48096	10.1371/journal.pone.0048096	http://dx.doi.org/10.1371/journal.pone.0048096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133553	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800043
J	Zdobnova, TA; Stremovskiy, OA; Lebedenko, EN; Deyev, SM				Zdobnova, Tatiana A.; Stremovskiy, Oleg A.; Lebedenko, Ekaterina N.; Deyev, Sergey M.			Self-Assembling Complexes of Quantum Dots and scFv Antibodies for Cancer Cell Targeting and Imaging	PLOS ONE			English	Article							IN-VIVO; BINDING; BARNASE; FUSION; RIBONUCLEASE; BARSTAR; NANOPARTICLES; MULTIVALENT; EXPRESSION; APOPTOSIS	Semiconductor quantum dots represent a novel class of fluorophores with unique physical and chemical properties which could enable a remarkable broadening of the current applications of fluorescent imaging and optical diagnostics. Complexes of quantum dots and antibodies are promising visualising agents for fluorescent detection of selective biomarkers overexpressed in tumor tissues. Here we describe the construction of self-assembling fluorescent complexes of quantum dots and anti-HER1 or anti-HER2/neu scFv antibodies and their interactions with cultured tumor cells. A binding strategy based on a very specific non-covalent interaction between two proteins, barnase and barstar, was used to connect quantum dots and the targeting antibodies. Such a strategy allows combining the targeting and visualization functions simply by varying the corresponding modules of the fluorescent complex.	[Zdobnova, Tatiana A.; Stremovskiy, Oleg A.; Lebedenko, Ekaterina N.; Deyev, Sergey M.] Russian Acad Sci, Inst Bioorgan Chem, Moscow, Russia; [Zdobnova, Tatiana A.] Lobachevsky State Univ Nizhny Novgorod, Dept Biol, Nizhnii Novgorod, Russia; [Deyev, Sergey M.] Nizhny Novgorod State Med Acad, Res Inst Appl & Fundamental Med, Nizhnii Novgorod, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lobachevsky State University of Nizhni Novgorod; Privolzhsky Research Medical University	Zdobnova, TA (corresponding author), Russian Acad Sci, Inst Bioorgan Chem, Moscow, Russia.	t.zdobnova@mail.ru	Zdobnova, Tatiana/AAE-8638-2022; Deyev, Sergey M/F-8191-2014	Deyev, Sergey M/0000-0002-3952-0631	Russian Foundation for Basic Research [12-04-00757-a, 11-04-12091-ofi-m-2011, 10-04-01506]; Presidium of Russian Academy of Sciences (Molecular & Cellular Biology and Nanotechnologies Nanomaterials); Ministry of Education and Science of the Russian Federation [16.740.11.0497, 14.740.11.0253, 16.512.11.2053, 11.G 34. 31.0017]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of Russian Academy of Sciences (Molecular & Cellular Biology and Nanotechnologies Nanomaterials); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This research was supported by the Russian Foundation for Basic Research (project nos. 12-04-00757-a, 11-04-12091-ofi-m-2011, and 10-04-01506), Presidium of Russian Academy of Sciences (Molecular & Cellular Biology and Nanotechnologies & Nanomaterials) and the Ministry of Education and Science of the Russian Federation (project nos. 16.740.11.0497, 14.740.11.0253, 16.512.11.2053 and 11.G 34. 31.0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balandin TG, 2011, INVEST NEW DRUG, V29, P22, DOI 10.1007/s10637-009-9329-2; Bentzen EL, 2005, BIOCONJUGATE CHEM, V16, P1488, DOI 10.1021/bc0502006; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Dean GS, 1998, CLIN CANCER RES, V4, P2545; Deyev SM, 2008, BIOESSAYS, V30, P904, DOI 10.1002/bies.20805; Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916; Diagaradjane P, 2008, CLIN CANCER RES, V14, P731, DOI 10.1158/1078-0432.CCR-07-1958; Duan HW, 2007, J AM CHEM SOC, V129, P3333, DOI 10.1021/ja068158s; Edelweiss E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002434; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Hanash S, 2004, NAT REV CANCER, V4, P638, DOI 10.1038/nrc1414; HARTLEY RW, 1972, PREP BIOCHEM, V2, P229; Ilinskaya ON, 2007, BIOCHEM BIOPH RES CO, V361, P1000, DOI 10.1016/j.bbrc.2007.07.143; Jinno H, 1996, CANCER CHEMOTH PHARM, V38, P303, DOI 10.1007/s002800050487; Kairdolf BA, 2008, ANAL CHEM, V80, P3029, DOI 10.1021/ac800068q; Kawashima N, 2010, CHEM-EUR J, V16, P1186, DOI 10.1002/chem.200902963; Kelf TA, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/28/285105; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lidke DS, 2004, METHOD MOL BIOL, V374, P69; Liu W, 2008, J AM CHEM SOC, V130, P1274, DOI 10.1021/ja076069p; Martsev SP, 2004, PROTEIN ENG DES SEL, V17, P85, DOI 10.1093/protein/gzh011; Muller KM, 1998, FEBS LETT, V422, P259, DOI 10.1016/S0014-5793(98)00021-0; Nikitin MP, 2010, P NATL ACAD SCI USA, V107, P5827, DOI 10.1073/pnas.1001142107; Nobs L, 2006, BIOCONJUGATE CHEM, V17, P139, DOI 10.1021/bc050137k; Pathak S, 2001, J AM CHEM SOC, V123, P4103, DOI 10.1021/ja0058334; Pathak S, 2007, NANO LETT, V7, P1839, DOI 10.1021/nl062706i; Pelley JL, 2009, TOXICOL SCI, V112, P276, DOI 10.1093/toxsci/kfp188; Polanovski OL, 2012, BIOCHEMISTRY-MOSCOW+, V77, P227, DOI 10.1134/S0006297912030029; PRIOR TI, 1991, CANCER RES, V51, P174; RUSHIZKY GW, 1963, BIOCHEMISTRY-US, V2, P787, DOI 10.1021/bi00904a028; Schreiber G, 2000, METH MOL B, V160, P213; Semenyuk EG, 2007, BIOCHIMIE, V89, P31, DOI 10.1016/j.biochi.2006.07.012; Serebrovskaya EO, 2009, P NATL ACAD SCI USA, V106, P9221, DOI 10.1073/pnas.0904140106; Tada H, 2007, CANCER RES, V67, P1138, DOI 10.1158/0008-5472.CAN-06-1185; Takeda M, 2008, BREAST CANCER-TOKYO, V15, P145, DOI 10.1007/s12282-008-0037-0; Weng KC, 2008, NANO LETT, V8, P2851, DOI 10.1021/nl801488u; Willuda J, 1999, CANCER RES, V59, P5758; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Yang LL, 2009, SMALL, V5, P235, DOI 10.1002/smll.200800714; Yezhelyev MV, 2007, ADV MATER, V19, P3146, DOI 10.1002/adma.200701983; Zdobnova TA, 2011, ACTA NATURAE, V3, P29, DOI 10.32607/20758251-2011-3-1-29-47	43	25	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48248	10.1371/journal.pone.0048248	http://dx.doi.org/10.1371/journal.pone.0048248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133578	gold, Green Published, Green Submitted			2022-12-25	WOS:000310261800068
J	Chapman-Rothe, N; Curry, E; Zeller, C; Liber, D; Stronach, E; Gabra, H; Ghaem-Maghami, S; Brown, R				Chapman-Rothe, N.; Curry, E.; Zeller, C.; Liber, D.; Stronach, E.; Gabra, H.; Ghaem-Maghami, S.; Brown, R.			Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells	ONCOGENE			English	Article						bivalent genes; ChIPseq; tumor sustaining cells; chemo-resistant cells; ovarian cancer	EMBRYONIC STEM-CELLS; MANAGEMENT; POLYCOMB; CHIP; IDENTIFICATION; CHEMOTHERAPY; STRATEGIES; PATHWAY; GENOME; MEMORY	In embryonic stem (ES) cells, bivalent chromatin domains containing H3K4me3 and H3K27me3 marks silence developmental genes, while keeping them poised for activation following differentiation. We have identified gene sets associated with H3K27me3 and H3K4me3 marks at transcription start sites in a high-grade ovarian serous tumour and examined their association with epigenetic silencing and malignant progression. This revealed novel silenced bivalent marked genes, not described previously for ES cells, which are significantly enriched for the PI3K (P < 10(-7)) and TGF-beta signalling pathways (P < 10(-5)). We matched histone marked gene sets to gene expression sets of eight normal fallopian tubes and 499 high-grade serous malignant ovarian samples. This revealed a significant decrease in gene expression for the H3K27me3 and bivalent gene sets in malignant tissue. We then correlated H3K27me3 and bivalent gene sets to gene expression data of ovarian tumour 'stem cell-like' sustaining cells versus non-sustaining cells. This showed a significantly lower expression for the H3K27me3 and bivalent gene sets in the tumour-sustaining cells. Similarly, comparison of matched chemo-sensitive and chemo-resistant ovarian cell lines showed a significantly lower expression of H3K27me3/bivalent marked genes in the chemo-resistant compared with the chemo-sensitive cell line. Our analysis supports the hypothesis that bivalent marks are associated with epigenetic silencing in ovarian cancer. However it also suggests that additional tumour specific bivalent marks, to those known in ES cells, are present in tumours and may potentially influence the subsequent development of drug resistance and tumour progression.	[Chapman-Rothe, N.; Zeller, C.; Liber, D.; Ghaem-Maghami, S.; Brown, R.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Epigenet Unit, London W12 0NN, England; [Curry, E.; Liber, D.; Stronach, E.; Gabra, H.; Brown, R.] Univ London Imperial Coll Sci Technol & Med, Ovarian Canc Act Res Ctr, London W12 0NN, England	Imperial College London; Imperial College London	Brown, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, IRDB 4th Floor,Hammersmith Hosp Campus,Cane Rd, London W12 0NN, England.	b.brown@imperial.ac.uk		Curry, Edward/0000-0002-5603-6956; Ghaem-Maghami, Sadaf/0000-0002-7369-5080; Gabra, Hani/0000-0002-3322-4399; Brown, Robert/0000-0001-7960-5755	Ovarian Cancer Action; Cancer Research UK; Imperial Experimental Cancer Research and Biomedical Research Centres; Cancer Research UK [13086] Funding Source: researchfish; Ovarian Cancer Action [OCA3] Funding Source: researchfish	Ovarian Cancer Action(Ovarian Cancer Action); Cancer Research UK(Cancer Research UK); Imperial Experimental Cancer Research and Biomedical Research Centres; Cancer Research UK(Cancer Research UK); Ovarian Cancer Action(Ovarian Cancer Action)	This work was supported by funding from Ovarian Cancer Action; and Cancer Research UK; as well as the Imperial Experimental Cancer Research and Biomedical Research Centres. We are grateful for help from the Gynaecological Oncology team at Hammersmith Hospital and members of the Ovarian Cancer Action Research Centre, in particular Elham Shamsaei, Nona Rama, and Kay Dawson from Dept Pathology. We thank Prof Edison T Liu, Genome Institute of Singapore, and the Agency for Science Technology and Research of Singapore for supporting the microarray expression data on the ovarian tumour and benign samples. Gene expression data generated by The Cancer Genome Atlas (TCGA) Pilot Project established by the NCI and NHGRI were used in the study.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Aletti GD, 2007, MAYO CLIN PROC, V82, P751; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berkenblit A, 2005, J REPROD MED, V50, P426; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Ho JWK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-134; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; LANGDON SP, 1988, CANCER RES, V48, P6166; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Matsumura N, 2011, GENOME RES, V21, P74, DOI 10.1101/gr.108803.110; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rizzo S, 2011, MOL CANCER THER, V10, P325, DOI 10.1158/1535-7163.MCT-10-0788; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhang HY, 2009, EUR J OBSTET GYN R B, V146, P81, DOI 10.1016/j.ejogrb.2009.04.035; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	32	55	57	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4586	4592		10.1038/onc.2012.477	http://dx.doi.org/10.1038/onc.2012.477			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23128397				2022-12-25	WOS:000324831300015
J	Deng, ZQ; Du, WW; Fang, L; Shan, SW; Qian, J; Lin, J; Qian, W; Ma, JC; Rutnam, ZJ; Yang, BB				Deng, Zhaoqun; Du, William W.; Fang, Ling; Shan, Sze Wan; Qian, Jun; Lin, Jiang; Qian, Wei; Ma, Jichun; Rutnam, Zina Jeyapalan; Yang, Burton B.			The Intermediate Filament Vimentin Mediates MicroRNA miR-378 Function in Cellular Self-renewal by Regulating the Expression of the Sox2 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; PROMOTES TUMOR-GROWTH; NUCLEAR EXPORT; HUMAN CANCER; PROLIFERATION; BINDING; OCT4; ANGIOGENESIS; MULTIPOTENT; GENERATION	MicroRNAs are short noncoding RNAs that are implicated in cell self-renewal and cancer development. We show that miR-378 is up-regulated in human cancers and found that tumor cells transfected with miR-378 acquired properties of tumor stem cells, including cell self-renewal. Overexpression of miR-378 enhanced cell survival and colony formation. Isolated from a single-cell colony, the miR-378-expressing cells formed tumors in nude mice at low cell densities. These cells expressed higher levels of miR-378 and formed more and larger spheres and colonies. We found that the miR-378-expressing cells contained a large number of side population cells and could undergo differentiation. Cells transfected with miR-378 expressed increased levels of Sox2. Expression of miR-378 and Sox2 was found correlated significantly in cancer cell lines and in cancer patient specimens. We also observed opposite levels of vimentin in the cancer cell lines and human breast carcinoma specimens. We further demonstrated that vimentin is a target of miR-378, and ectopic transfection of vimentin inhibited Sox2 expression, resulting in decreased cell survival. Silencing vimentin promoted Sox2 expression and cell survival. Our study demonstrates that miR-378 is a regulator of stem cell marker Sox2 by targeting vimentin, which may serve as a new tool in studying the role of stem cells in tumorigenesis.	[Deng, Zhaoqun; Du, William W.; Fang, Ling; Shan, Sze Wan; Rutnam, Zina Jeyapalan; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Qian, Jun; Lin, Jiang; Qian, Wei; Ma, Jichun] Jiangsu Univ, Affiliated Peoples Hosp, Zhenjiang City 212000, Peoples R China; [Deng, Zhaoqun; Du, William W.; Fang, Ling; Shan, Sze Wan; Rutnam, Zina Jeyapalan; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Jiangsu University; University of Toronto	Yang, BB (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca		SHAN, SW/0000-0001-6876-9914	Canadian Institutes of Health Research [MOP-102635, MOP-111171]; Heart and Stroke Foundation of Ontario [CI 7418]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from Canadian Institutes of Health Research (MOP-102635, MOP-111171) to B. B. Y., who is the recipient of a Career Investigator Award (CI 7418) from the Heart and Stroke Foundation of Ontario.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Collins RE, 2005, FEBS LETT, V579, P5841, DOI 10.1016/j.febslet.2005.07.072; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fang L., 2012, CELL CYCLE, V30, P23; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Giorgetti A, 2010, NAT PROTOC, V5, P811, DOI 10.1038/nprot.2010.16; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Laguette MJ, 2011, MATRIX BIOL, V30, P338, DOI 10.1016/j.matbio.2011.05.001; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mello CC, 2004, NAT MED, V10, P1297, DOI 10.1038/nm1204-1297; Mergui X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-473; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rutnam ZJ, 2012, HISTOL HISTOPATHOL, V27, P1263, DOI 10.14670/HH-27.1263; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tanaka Y, 2000, INT J ONCOL, V16, P725; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang Weining, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P140; Yang XL, 2012, CELL CYCLE, V11, P3097, DOI 10.4161/cc.21503; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	54	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					319	331		10.1074/jbc.M112.418830	http://dx.doi.org/10.1074/jbc.M112.418830			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23135265	Green Published, hybrid			2022-12-25	WOS:000313197200034
J	Herrmann, S; Ninkovic, M; Kohl, T; Lorinczi, EV; Pardo, LA				Herrmann, Solveig; Ninkovic, Milena; Kohl, Tobias; Loerinczi, Eva; Pardo, Luis A.			Cortactin Controls Surface Expression of the Voltage-gated Potassium Channel K(V)10.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GO-GO; HUMAN ETHER; FUNCTIONAL EXPRESSION; ACTIN CYTOSKELETON; CELL-CYCLE; HUMAN EAG1; PHOSPHORYLATION; ADHESION; IDENTIFICATION; ACTIVATION	K(V)10.1 is a voltage-gated potassium channel aberrantly expressed in many cases of cancer, and participates in cancer initiation and tumor progression. Its action as an oncoprotein can be inhibited by a functional monoclonal antibody, indicating a role for channels located at the plasma membrane, accessible to the antibody. Cortactin is an actin-interacting protein implicated in cytoskeletal architecture and often amplified in several types of cancer. In this study, we describe a physical and functional interaction between cortactin and K(V)10.1. Binding of these two proteins occurs between the Cterminus of K(V)10.1 and the proline-rich domain of cortactin, regions targeted by many post-translational modifications. This interaction is specific for K(V)10.1 and does not occur with K(V)10.2. Cortactin controls the abundance of K(V)10.1 at the plasma membrane and is required for functional expression of K(V)10.1 channels.	[Ninkovic, Milena; Kohl, Tobias; Loerinczi, Eva] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37975 Gottingen, Germany; [Herrmann, Solveig; Pardo, Luis A.] Max Planck Inst Expt Med, Oncophysiol Grp, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Pardo, LA (corresponding author), Max Planck Inst Expt Med, AG Onkophysiol, Hermann Rein Str 3, D-37975 Gottingen, Germany.	pardo@em.mpg.de	Pardo, Luis/C-5066-2013	Pardo, Luis/0000-0003-1375-4349				Agarwal JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-18; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Arcangeli A, 2004, BIOCHEM SOC T, V32, P826, DOI 10.1042/BST0320826; Borowiec AS, 2007, J CELL PHYSIOL, V212, P690, DOI 10.1002/jcp.21065; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Camacho J, 2000, PFLUG ARCH EUR J PHY, V441, P167, DOI 10.1007/s004240000420; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chen IH, 2011, J BIOL CHEM, V286, P27183, DOI 10.1074/jbc.M111.233825; Chen L, 2006, ACTA BIOCH BIOPH SIN, V38, P95, DOI 10.1111/j.1745-7270.2006.00141.x; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hofmann G, 2001, J BIOL CHEM, V276, P4923, DOI 10.1074/jbc.M005682200; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Kohl T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026329; Lin HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020362; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; SCHUURING E, 1992, ONCOGENE, V7, P355; Stuhmer W, 1998, METHOD ENZYMOL, V293, P280; Tian L, 2008, J BIOL CHEM, V283, P3067, DOI 10.1074/jbc.M706826200; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Toral C, 2007, LIFE SCI, V81, P255, DOI 10.1016/j.lfs.2007.05.014; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Zahradka P, 2009, CAN J PHYSIOL PHARM, V87, P805, DOI 10.1139/Y09-052	44	23	27	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44151	44163		10.1074/jbc.M112.372540	http://dx.doi.org/10.1074/jbc.M112.372540			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144454	Green Published, hybrid			2022-12-25	WOS:000312938600014
J	Bradtmoller, M; Hartmann, C; Zietsch, J; Jaschke, S; Mautner, VF; Kurtz, A; Park, SJ; Baier, M; Harder, A; Reuss, D; von Deimling, A; Heppner, FL; Holtkamp, N				Bradtmoeller, Maren; Hartmann, Christian; Zietsch, Jan; Jaeschke, Sebastian; Mautner, Victor-F; Kurtz, Andreas; Park, Su-Jin; Baier, Michael; Harder, Anja; Reuss, David; von Deimling, Andreas; Heppner, Frank L.; Holtkamp, Nikola			Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours	PLOS ONE			English	Article							SUPPRESSOR GENE; MAMMALIAN TARGET; MOUSE MODEL; SOMA SIZE; INHIBITION; MUTATION; RAPAMYCIN; EGFR; NF1; DEFICIENT	Malignant peripheral nerve sheath tumours (MPNST) are aggressive sarcomas that develop in about 10% of patients with the genetic disease neurofibromatosis type 1 (NF1). Molecular alterations contributing to MPNST formation have only partially been resolved. Here we examined the role of Pten, a key regulator of the Pi3k/Akt/mTOR pathway, in human MPNST and benign neurofibromas. Immunohistochemistry showed that Pten expression was significantly lower in MPNST (n = 16) than in neurofibromas (n = 16) and normal nervous tissue. To elucidate potential mechanisms for Pten down-regulation or Akt/mTOR activation in MPNST we performed further experiments. Mutation analysis revealed absence of somatic mutations in PTEN (n = 31) and PIK3CA (n = 38). However, we found frequent PTEN promotor methylation in primary MPNST (11/26) and MPNST cell lines (7/8) but not in benign nerve sheath tumours. PTEN methylation was significantly associated with early metastasis. Moreover, we detected an inverse correlation of Pten-regulating miR-21 and Pten protein levels in MPNST cell lines. The examination of NF1-/- and NF1+/+ Schwann cells and fibroblasts showed that Pten expression is not regulated by NF1. To determine the significance of Pten status for treatment with the mTOR inhibitor rapamycin we treated 5 MPNST cell lines with rapamycin. All cell lines were sensitive to rapamycin without a significant correlation to Pten levels. When rapamycin was combined with simvastatin a synergistic anti-proliferative effect was achieved. Taken together we show frequent loss/reduction of Pten expression in MPNST and provide evidence for the involvement of multiple Pten regulating mechanisms.	[Bradtmoeller, Maren; Zietsch, Jan; Jaeschke, Sebastian; Heppner, Frank L.; Holtkamp, Nikola] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [Hartmann, Christian; Reuss, David; von Deimling, Andreas] Heidelberg Univ, Inst Pathol, Dept Neuropathol, D-6900 Heidelberg, Germany; [Hartmann, Christian; Reuss, David; von Deimling, Andreas] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-6900 Heidelberg, Germany; [Mautner, Victor-F] Univ Hosp Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany; [Kurtz, Andreas; Park, Su-Jin; Holtkamp, Nikola] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Kurtz, Andreas] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea; [Baier, Michael] Robert Koch Inst, Project Neurodegenerat Dis, Berlin, Germany; [Harder, Anja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Seoul National University (SNU); Robert Koch Institute; University of Munster	Holtkamp, N (corresponding author), Charite, Dept Neuropathol, D-13353 Berlin, Germany.	nikola.holtkamp@charite.de	Heppner, Frank/ABH-8393-2020; von Deimling, Andreas/F-7774-2013; Hartmann, Christian/D-1882-2010	Heppner, Frank/0000-0001-9816-8917; von Deimling, Andreas/0000-0002-5863-540X; Harder, nee Klose, Anja/0000-0002-3045-2222; Kurtz, Andreas/0000-0003-3301-6546	Bundesministerium fur Bildung und Forschung (BMBF) [01GM0841]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) program "rare diseases'', NF1 consortium (grant 01GM0841), http://www.bmbf.de/de/1109.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bhola P, 2010, INT J CANCER, V126, P563, DOI 10.1002/ijc.24783; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; DAHLBERG WK, 1993, INT J RADIAT BIOL, V63, P191, DOI 10.1080/09553009314550251; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Frahm S, 2004, NEUROBIOL DIS, V16, P85, DOI 10.1016/j.nbd.2004.01.006; GLOVER TW, 1991, GENE CHROMOSOME CANC, V3, P62, DOI 10.1002/gcc.2870030111; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Gregorian C, 2009, P NATL ACAD SCI USA, V106, P19479, DOI 10.1073/pnas.0910398106; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hartmann C, 2006, NEUROPATH APPL NEURO, V32, P209, DOI 10.1111/j.1365-2990.2006.00700.x; Hartmann C, 2004, INT J CANCER, V108, P839, DOI 10.1002/ijc.11638; Holtkamp N, 2006, CARCINOGENESIS, V27, P664, DOI 10.1093/carcin/bgi273; Holtkamp N, 2008, NEURO-ONCOLOGY, V10, P946, DOI 10.1215/15228517-2008-053; Huson S. M., 1994, P160; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johansson G, 2008, MOL CANCER THER, V7, P1237, DOI 10.1158/1535-7163.MCT-07-2335; Khanzada UK, 2006, ONCOGENE, V25, P877, DOI 10.1038/sj.onc.1209117; Kolanczyk M, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-21; Kourea HP, 1999, AM J PATHOL, V155, P1855, DOI 10.1016/S0002-9440(10)65504-6; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; LEGIUS E, 1994, GENE CHROMOSOME CANC, V10, P250, DOI 10.1002/gcc.2870100405; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Mawrin C, 2002, VIRCHOWS ARCH, V440, P610, DOI 10.1007/s00428-001-0550-4; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; Mo HB, 2004, EXP BIOL MED, V229, P567, DOI 10.1177/153537020422900701; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Perrone F, 2009, NEURO-ONCOLOGY, V11, P725, DOI 10.1215/15228517-2009-003; Perry A, 2002, J NEUROPATH EXP NEUR, V61, P702, DOI 10.1093/jnen/61.8.702; Reifenberger G, 2004, J MOL MED, V82, P656, DOI 10.1007/s00109-004-0564-x; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sane KM, 2010, J PHARMACOL EXP THER, V333, P23, DOI 10.1124/jpet.109.160192; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Zietsch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011858	42	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47595	10.1371/journal.pone.0047595	http://dx.doi.org/10.1371/journal.pone.0047595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139750	gold, Green Published, Green Submitted			2022-12-25	WOS:000311315300010
J	Chen, YH; Wu, KL; Chen, CH				Chen, Yun-Hsiang; Wu, Kuang-Lun; Chen, Chia-Hsiang			Methamphetamine Reduces Human Influenza A Virus Replication	PLOS ONE			English	Article							EPITHELIAL-CELLS; INFECTION; AMPHETAMINE; INTERFERONS; CHLOROQUINE; MECHANISMS; RESISTANCE; INHIBITION; INDUCTION; DISEASES	Methamphetamine (meth) is a highly addictive psychostimulant that is among the most widely abused illicit drugs, with an estimated over 35 million users in the world. Several lines of evidence suggest that chronic meth abuse is a major factor for increased risk of infections with human immunodeficiency virus and possibly other pathogens, due to its immunosuppressive property. Influenza A virus infections frequently cause epidemics and pandemics of respiratory diseases among human populations. However, little is known about whether meth has the ability to enhance influenza A virus replication, thus increasing severity of influenza illness in meth abusers. Herein, we investigated the effects of meth on influenza A virus replication in human lung epithelial A549 cells. The cells were exposed to meth and infected with human influenza A/WSN/33 (H1N1) virus. The viral progenies were titrated by plaque assays, and the expression of viral proteins and cellular proteins involved in interferon responses was examined by Western blotting and immunofluorescence staining. We report the first evidence that meth significantly reduces, rather than increases, virus propagation and the susceptibility to influenza infection in the human lung epithelial cell line, consistent with a decrease in viral protein synthesis. These effects were apparently not caused by meth's effects on enhancing virus-induced interferon responses in the host cells, reducing viral biological activities, or reducing cell viability. Our results suggest that meth might not be a great risk factor for influenza A virus infection among meth abusers. Although the underlying mechanism responsible for the action of meth on attenuating virus replication requires further investigation, these findings prompt the study to examine whether other structurally similar compounds could be used as anti-influenza agents.	[Chen, Yun-Hsiang; Wu, Kuang-Lun; Chen, Chia-Hsiang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Mental Hlth & Addict Med, Zhunan, Taiwan; [Chen, Chia-Hsiang] Chang Gung Mem Hosp Linkou, Dept Psychiat, Tao Yuan, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan	National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Chen, CH (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Mental Hlth & Addict Med, Zhunan, Taiwan.	cchen@nhri.org.tw	Chen, Chia-Hsiang/E-3939-2010		National Health Research Institutes	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	Source of funding: National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faress S, 2008, VIRUS RES, V132, P33, DOI 10.1016/j.virusres.2007.10.007; Albertson TE, 1999, WESTERN J MED, V170, P214; ATKINSON WL, 1986, ARCH INTERN MED, V146, P1751, DOI 10.1001/archinte.146.9.1751; Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301; Beck MA, 1998, NUTR REV, V56, pS140; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Colfax Grant, 2005, Curr HIV/AIDS Rep, V2, P194, DOI 10.1007/s11904-005-0016-4; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gavrilin MA, 2002, J NEUROVIROL, V8, P240, DOI 10.1080/13550280290049660; Gonzales R, 2006, J SUBST ABUSE TREAT, V31, P195, DOI 10.1016/j.jsat.2006.04.006; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; HALL CB, 1987, PEDIATRICS, V80, P275; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; HORISBERGER MA, 1995, AM J RESP CRIT CARE, V152, pS67, DOI 10.1164/ajrccm/152.4_Pt_2.S67; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jaspers I, 2005, TOXICOL SCI, V85, P990, DOI 10.1093/toxsci/kfi141; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Kitler ME, 2002, VACCINE, V20, pS5, DOI 10.1016/S0264-410X(02)00121-4; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Michaelis M, 2009, MED MICROBIOL IMMUN, V198, P175, DOI 10.1007/s00430-009-0118-5; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Noda T, 2010, REV MED VIROL, V20, P380, DOI 10.1002/rmv.666; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39; Pendyala G, 2011, AIDS RES HUM RETROV, V27, P179, DOI 10.1089/aid.2010.0090; Peterhans E, 1997, J NUTR, V127, pS962, DOI 10.1093/jn/127.5.962S; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; RICAURTE GA, 1980, BRAIN RES, V193, P153, DOI 10.1016/0006-8993(80)90952-X; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Scholtissek C, 1995, VIRUS GENES, V11, P209, DOI 10.1007/BF01728660; Suliman HB, 2001, AM J PHYSIOL-LUNG C, V280, pL69, DOI 10.1152/ajplung.2001.280.1.L69; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; WOOLVERTON WL, 1989, BRAIN RES, V486, P73, DOI 10.1016/0006-8993(89)91279-1; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x; Ye L, 2008, J VIRAL HEPATITIS, V15, P261, DOI 10.1111/j.1365-2893.2007.00940.x	49	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48335	10.1371/journal.pone.0048335	http://dx.doi.org/10.1371/journal.pone.0048335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139774	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300025
J	De Biasio, A; Campos-Olivas, R; Sanchez, R; Lopez-Alonso, JP; Pantoja-Uceda, D; Merino, N; Villate, M; Martin-Garcia, JM; Castillo, F; Luque, I; Blanco, FJ				De Biasio, Alfredo; Campos-Olivas, Ramon; Sanchez, Ricardo; Lopez-Alonso, Jorge P.; Pantoja-Uceda, David; Merino, Nekane; Villate, Maider; Martin-Garcia, Jose M.; Castillo, Francisco; Luque, Irene; Blanco, Francisco J.			Proliferating Cell Nuclear Antigen (PCNA) Interactions in Solution Studied by NMR	PLOS ONE			English	Article							DNA-REPLICATION; FLAP ENDONUCLEASE-1; CRYSTAL-STRUCTURE; INHIBITOR DESIGN; PROTEIN-KINASES; IN-VITRO; PIP-BOX; BINDING; RECOGNITION; RELAXATION	PCNA is an essential factor for DNA replication and repair. It forms a ring shaped structure of 86 kDa by the symmetric association of three identical protomers. The ring encircles the DNA and acts as a docking platform for other proteins, most of them containing the PCNA Interaction Protein sequence (PIP-box). We have used NMR to characterize the interactions of PCNA with several other proteins and fragments in solution. The binding of the PIP-box peptide of the cell cycle inhibitor p21 to PCNA is consistent with the crystal structure of the complex. A shorter p21 peptide binds with reduced affinity but retains most of the molecular recognition determinants. However the binding of the corresponding peptide of the tumor suppressor ING1 is extremely weak, indicating that slight deviations from the consensus PIP-box sequence dramatically reduce the affinity for PCNA, in contrast with a proposed less stringent PIP-box sequence requirement. We could not detect any binding between PCNA and the MCL-1 or the CDK2 protein, reported to interact with PCNA in biochemical assays. This suggests that they do not bind directly to PCNA, or they do but very weakly, with additional unidentified factors stabilizing the interactions in the cell. Backbone dynamics measurements show three PCNA regions with high relative flexibility, including the interdomain connector loop (IDCL) and the C-terminus, both of them involved in the interaction with the PIP-box. Our work provides the basis for high resolution studies of direct ligand binding to PCNA in solution.	[Campos-Olivas, Ramon; Lopez-Alonso, Jorge P.] Ctr Nacl Invest Oncol, Spect & NMR Unit, Madrid, Spain; [De Biasio, Alfredo; Sanchez, Ricardo; Merino, Nekane; Villate, Maider; Blanco, Francisco J.] CIC bioGUNE, Struct Biol Unit, Derio, Spain; [Pantoja-Uceda, David] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Martin-Garcia, Jose M.; Castillo, Francisco; Luque, Irene] Univ Granada, Dept Phys Chem, Granada, Spain; [Martin-Garcia, Jose M.; Castillo, Francisco; Luque, Irene] Univ Granada, Inst Biotechnol, Granada, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	CIC bioGUNE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Granada; University of Granada; Basque Foundation for Science	Campos-Olivas, R (corresponding author), Ctr Nacl Invest Oncol, Spect & NMR Unit, Madrid, Spain.	rcampos@cnio.es; fblanco@cicbiogune.es	Blanco, Francisco J/D-4401-2009; MARTIN GARCIA, JOSE MANUEL/GQA-3160-2022; MARTIN GARCIA, JOSE MANUEL/AAB-6838-2020; Luque, Inmaculada/K-9464-2014; Luque, Irene/K-4758-2012; cancer, biogune/H-7276-2012; Sánchez, Ricardo/AAB-1516-2019; Merino, Nekane/L-8203-2014; López-Alonso, Jorge Pedro/U-5551-2018; Pantoja-Uceda, David/J-8097-2014; Campos-Olivas, Ramón/L-9173-2014; Garcia, Jose Manuel Martin/V-2043-2018	Blanco, Francisco J/0000-0003-2545-4319; MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; Luque, Inmaculada/0000-0003-1838-2636; Luque, Irene/0000-0003-2757-4779; Merino, Nekane/0000-0003-0721-4813; López-Alonso, Jorge Pedro/0000-0003-2081-2607; Campos-Olivas, Ramón/0000-0002-5743-2221; Garcia, Jose Manuel Martin/0000-0002-4558-3858; Castillo Correa, Francisco Jose/0000-0001-5587-9612; De Biasio, Alfredo/0000-0003-2139-2958; Pantoja-Uceda, David/0000-0003-4390-6972	Spanish Ministry of Economic Affairs and Competitiveness [CTQ2011-28680, BIO2009-13265-CO2-01]; BIPEDD-CM from Comunidad Autonoma de Madrid [P-BIO-0214-2006]	Spanish Ministry of Economic Affairs and Competitiveness(Spanish Government); BIPEDD-CM from Comunidad Autonoma de Madrid	This work was supported by the Spanish Ministry of Economic Affairs and Competitiveness (www.mineco.gob.es) grants CTQ2011-28680 to FJB and BIO2009-13265-CO2-01 to IL, and by the grant BIPEDD-CM (P-BIO-0214-2006) from Comunidad Autonoma de Madrid (www.madrid.org) to RCO. ADB was supported by a Juan de la Cierva contract from the Spanish Ministry of Economic Affairs and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2011, AGING CELL, V10, P158, DOI 10.1111/j.1474-9726.2010.00651.x; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bernado P, 2002, J BIOMOL NMR, V23, P139, DOI 10.1023/A:1016359412284; Blanco FJ, 2011, FEBS J, V278, P1643, DOI 10.1111/j.1742-4658.2011.08095.x; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Chen JJ, 1996, NUCLEIC ACIDS RES, V24, P1727, DOI 10.1093/nar/24.9.1727; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; De Biasio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016600; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Germain M, 2007, J BIOL CHEM, V282, P32233, DOI 10.1074/jbc.M706408200; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hajduk PJ, 1999, J MED CHEM, V42, P2315, DOI 10.1021/jm9901475; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Heathcote DA, 2010, J MED CHEM, V53, P8508, DOI 10.1021/jm100732t; Hingorani MM, 2000, NAT REV MOL CELL BIO, V1, P22, DOI 10.1038/35036044; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kontopidis G, 2003, STRUCTURE, V11, P1537, DOI 10.1016/j.str.2003.11.006; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Koundrioukoff S, 2000, J BIOL CHEM, V275, P22882, DOI 10.1074/jbc.M001850200; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Pantoja-Uceda D, 2008, BIOCHEMISTRY-US, V47, P7066, DOI 10.1021/bi800403m; Punchihewa C, 2012, J BIOL CHEM, V287, P14289, DOI 10.1074/jbc.M112.353201; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Riva F, 2004, EXP CELL RES, V293, P357, DOI 10.1016/j.yexcr.2003.10.025; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sanchez R, 2007, BIOMOL NMR ASSIGN, V1, P245, DOI 10.1007/s12104-007-9068-2; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Schurtenberger P, 1998, J MOL BIOL, V275, P123, DOI 10.1006/jmbi.1997.1435; Scott M, 2001, J CELL SCI, V114, P3455; Shah S, 2009, BIOCHEM CELL BIOL, V87, P117, DOI 10.1139/O08-107; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Warbrick E, 1998, NUCLEIC ACIDS RES, V26, P3925, DOI 10.1093/nar/26.17.3925; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	59	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48390	10.1371/journal.pone.0048390	http://dx.doi.org/10.1371/journal.pone.0048390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139781	gold, Green Published, Green Submitted			2022-12-25	WOS:000311315300030
J	Parajuli, N; Campbell, LH; Marine, A; Brockbank, KGM; MacMillan-Crow, LA				Parajuli, Nirmala; Campbell, Lia H.; Marine, Akira; Brockbank, Kelvin G. M.; MacMillan-Crow, Lee Ann			MitoQ Blunts Mitochondrial and Renal Damage during Cold Preservation of Porcine Kidneys	PLOS ONE			English	Article							CYTOCHROME BC(1) COMPLEX; PROXIMAL TUBULAR CELLS; MACHINE PERFUSION; TARGETED ANTIOXIDANTS; RESPIRATORY-CHAIN; OXIDATIVE STRESS; MUSCLE-FIBERS; Q(O) SITE; STORAGE; ISCHEMIA	Cold preservation has greatly facilitated the use of cadaveric kidneys for transplantation but damage occurs during the preservation episode. It is well established that oxidant production increases during cold renal preservation and mitochondria are a key target for injury. Our laboratory has demonstrated that cold storage of renal cells and rat kidneys leads to increased mitochondrial superoxide levels and mitochondrial electron transport chain damage, and that addition of Mitoquinone (MitoQ) to the preservation solutions blunted this injury. In order to better translate animal studies, the inclusion of large animal models is necessary to develop safe preclinical protocols. Therefore, we tested the hypothesis that addition of MitoQ to cold storage solution preserves mitochondrial function by decreasing oxidative stress, leading to less renal tubular damage during cold preservation of porcine kidneys employing a standard criteria donor model. Results showed that cold storage significantly induced oxidative stress (nitrotyrosine), renal tubular damage, and cell death. Using High Resolution Respirometry and fresh porcine kidney biopsies to assess mitochondrial function we showed that MitoQ significantly improved complex II/III respiration of the electron transport chain following 24 hours of cold storage. In addition, MitoQ blunted oxidative stress, renal tubular damage, and cell death after 48 hours. These results suggested that MitoQ decreased oxidative stress, tubular damage and cell death by improving mitochondrial function during cold storage. Therefore this compound should be considered as an integral part of organ preservation solution prior to transplantation.	[Parajuli, Nirmala; Marine, Akira; MacMillan-Crow, Lee Ann] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Campbell, Lia H.; Brockbank, Kelvin G. M.] Cell & Tissue Syst Inc, N Charleston, SC USA; [Brockbank, Kelvin G. M.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Brockbank, Kelvin G. M.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC USA	University of Arkansas System; University of Arkansas Medical Sciences; University System of Georgia; Georgia Institute of Technology; Medical University of South Carolina	MacMillan-Crow, LA (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.	lmcrow@uams.edu	Parajuli, Nirmala/V-9901-2019; Brockbank, Kelvin/GWV-4265-2022	Parajuli, Nirmala/0000-0003-3994-5338; Campbell, Lia/0000-0002-6501-9875	US Public Health Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R43DK089659]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK089659] Funding Source: NIH RePORTER	US Public Health Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by a US Public Health Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant #R43DK089659, to KGMB/LAMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK or the National Institutes of Health.	Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Bon D, 2012, NAT REV NEPHROL, V8, P339, DOI 10.1038/nrneph.2012.83; Bruton JD, 2010, J PHYSIOL-LONDON, V588, P4275, DOI 10.1113/jphysiol.2010.198598; Chacko BK, 2011, HEPATOLOGY, V54, P153, DOI 10.1002/hep.24377; Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Gnaiger E, 2000, LIFE IN THE COLD, P431; Hauet T, 1998, J PHARMACOL EXP THER, V285, P1061; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Klingenspor M, 1996, BIOCHEM J, V316, P607, DOI 10.1042/bj3160607; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lowes DA, 2008, FREE RADICAL BIO MED, V45, P1559, DOI 10.1016/j.freeradbiomed.2008.09.003; Lu C, 2008, ANTIOXID REDOX SIGN, V10, P651, DOI 10.1089/ars.2007.1865; McAnulty JF, 2010, CRYOBIOLOGY, V60, pS13, DOI 10.1016/j.cryobiol.2009.06.004; Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026; Mitchell T, 2011, J PHARMACOL EXP THER, V336, P682, DOI 10.1124/jpet.110.176743; Mitchell T, 2010, FREE RADICAL BIO MED, V49, P1273, DOI 10.1016/j.freeradbiomed.2010.07.012; Moers C, 2012, NEW ENGL J MED, V366, P770, DOI 10.1056/NEJMc1111038; Moers C, 2010, TRANSPLANTATION, V90, P966, DOI 10.1097/TP.0b013e3181f5c40c; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Monton S, 1999, TRANSPLANT P, V31, P2350, DOI 10.1016/S0041-1345(99)00374-7; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V53, P1123, DOI 10.1016/j.freeradbiomed.2012.05.036; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Nicholson ML, 2004, TRANSPLANTATION, V78, P333, DOI 10.1097/01.TP.0000128634.03233.15; Parajuli N, 2011, FREE RADICAL BIO MED, V51, P406, DOI 10.1016/j.freeradbiomed.2011.04.024; Peters SMA, 1998, TRANSPLANTATION, V65, P625, DOI 10.1097/00007890-199803150-00005; PLOEG RJ, 1988, TRANSPLANTATION, V46, P191, DOI 10.1097/00007890-198808000-00002; Saba H, 2008, RENAL FAILURE, V30, P125, DOI 10.1080/08860220701813327; Salahudeen A K, 1999, Saudi J Kidney Dis Transpl, V10, P137; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Salahudeen AK, 2001, TRANSPLANTATION, V72, P798, DOI 10.1097/00007890-200109150-00010; Salahudeen AK, 2000, TRANSPLANTATION, V70, P1424, DOI 10.1097/00007890-200011270-00005; Schnuelle P, 1998, J AM SOC NEPHROL, V9, P2135; Skulachev VP, 2005, IUBMB LIFE, V57, P305, DOI 10.1080/15216540500092161; Stubenitsky BM, 2001, TRANSPLANT INT, V14, P256, DOI 10.1111/j.1432-2277.2001.tb00054.x; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Treckmann J, 2011, TRANSPL INT, V24, P548, DOI 10.1111/j.1432-2277.2011.01232.x; Turkmen K, 2011, TRANSPLANTATION, V91, P1192, DOI 10.1097/TP.0b013e31821ab9c8; Watson CJE, 2010, AM J TRANSPLANT, V10, P1991, DOI 10.1111/j.1600-6143.2010.03165.x; Yoboue ED, 2012, INT J CELL BIOL	49	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48590	10.1371/journal.pone.0048590	http://dx.doi.org/10.1371/journal.pone.0048590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139796	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300039
J	Latour, G; Kowalczuk, L; Savoldelli, M; Bourges, JL; Plamann, K; Behar-Cohen, F; Schanne-Klein, MC				Latour, Gael; Kowalczuk, Laura; Savoldelli, Michele; Bourges, Jean-Louis; Plamann, Karsten; Behar-Cohen, Francine; Schanne-Klein, Marie-Claire			Hyperglycemia-Induced Abnormalities in Rat and Human Corneas: The Potential of Second Harmonic Generation Microscopy	PLOS ONE			English	Article							DESCEMETS-MEMBRANE; COLLAGEN; AUTOFLUORESCENCE; FLUORESCENCE; DYSTROPHY	Background: Second Harmonic Generation (SHG) microscopy recently appeared as an efficient optical imaging technique to probe unstained collagen-rich tissues like cornea. Moreover, corneal remodeling occurs in many diseases and precise characterization requires overcoming the limitations of conventional techniques. In this work, we focus on diabetes, which affects hundreds of million people worldwide and most often leads to diabetic retinopathy, with no early diagnostic tool. This study then aims to establish the potential of SHG microscopy for in situ detection and characterization of hyperglycemia-induced abnormalities in the Descemet's membrane, in the posterior cornea. Methodology/Principal Findings: We studied corneas from age-matched control and Goto-Kakizaki rats, a spontaneous model of type 2 diabetes, and corneas from human donors with type 2 diabetes and without any diabetes. SHG imaging was compared to confocal microscopy, to histology characterization using conventional staining and transmitted light microscopy and to transmission electron microscopy. SHG imaging revealed collagen deposits in the Descemet's membrane of unstained corneas in a unique way compared to these gold standard techniques in ophthalmology. It provided background-free images of the three-dimensional interwoven distribution of the collagen deposits, with improved contrast compared to confocal microscopy. It also provided structural capability in intact corneas because of its high specificity to fibrillar collagen, with substantially larger field of view than transmission electron microscopy. Moreover, in vivo SHG imaging was demonstrated in Goto-Kakizaki rats. Conclusions/Significance: Our study shows unambiguously the high potential of SHG microscopy for three-dimensional characterization of structural abnormalities in unstained corneas. Furthermore, our demonstration of in vivo SHG imaging opens the way to long-term dynamical studies. This method should be easily generalized to other structural remodeling of the cornea and SHG microscopy should prove to be invaluable for in vivo corneal pathological studies.	[Latour, Gael; Schanne-Klein, Marie-Claire] Ecole Polytech, CNRS, Lab Opt & Biosci, INSERM,U696, F-91128 Palaiseau, France; [Kowalczuk, Laura; Plamann, Karsten] Ecole Polytech, CNRS, ENSTA ParisTech, Lab Appl Opt, F-91128 Palaiseau, France; [Kowalczuk, Laura; Behar-Cohen, Francine] INSERM UMRS 872, Physiopathol Ocular Dis Team17, Paris, France; [Kowalczuk, Laura; Behar-Cohen, Francine] Univ Paris 06, Ctr Rech Cordeliers, Paris, France; [Kowalczuk, Laura; Savoldelli, Michele; Bourges, Jean-Louis; Behar-Cohen, Francine] Paris Descartes Univ, AP HP Hotel Dieu, Dept Ophthalmol, Fac Med, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Schanne-Klein, MC (corresponding author), Ecole Polytech, CNRS, Lab Opt & Biosci, INSERM,U696, F-91128 Palaiseau, France.	marie-claire.schanne-klein@polytechnique.edu	Schanne-Klein, Marie-Claire/E-6490-2011; Latour, Gaël/R-6629-2017; Kowalczuk, Laura/AAF-6230-2020	Schanne-Klein, Marie-Claire/0000-0003-3026-8932; Latour, Gaël/0000-0002-6244-6556; BOURGES, Jean-Louis/0000-0002-7016-9819; Kowalczuk, Laura/0000-0003-0268-9430	Bourse Berther Fouassier - Fondation de France; Agence Nationale de la Recherche NOUGAT (Nouvel OUtil pour la chirurgie du Glaucome Assistee par laser femto-seconde et Tomographie par coherence optique) [ANR-08-TecSan-012]	Bourse Berther Fouassier - Fondation de France(Fondation de France); Agence Nationale de la Recherche NOUGAT (Nouvel OUtil pour la chirurgie du Glaucome Assistee par laser femto-seconde et Tomographie par coherence optique)(French National Research Agency (ANR))	GL was supported by "Bourse Berther Fouassier - Fondation de France" and LK was supported by Agence Nationale de la Recherche NOUGAT (Nouvel OUtil pour la chirurgie du Glaucome Assistee par laser femto-seconde et Tomographie par coherence optique) ANR-08-TecSan-012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Y, 2008, EXP DIABETES RES, DOI 10.1155/2008/818341; Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586; AZAR DT, 1992, ARCH OPHTHALMOL-CHIC, V110, P537, DOI 10.1001/archopht.1992.01080160115045; Bancelin S, 2012, BIOMED OPT EXPRESS, V3, P1446, DOI 10.1364/BOE.3.001446; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chang PY, 2006, AM J OPHTHALMOL, V142, P488, DOI 10.1016/j.ajo.2006.04.033; Deniset-Besseau A, 2009, J PHYS CHEM B, V113, P13437, DOI 10.1021/jp9046837; Directory EEBA, 2010, DIR EEBA; Erie JC, 2009, AM J OPHTHALMOL, V148, P639, DOI 10.1016/j.ajo.2009.06.022; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P4504, DOI 10.1167/iovs.05-0497; Guthoff RF, 2009, CLIN EXP OPHTHALMOL, V37, P100, DOI 10.1111/j.1442-9071.2009.02016.x; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; Hao M, 2010, EXP EYE RES, V91, P308, DOI 10.1016/j.exer.2010.06.007; Huang D, 2008, BIOL MED PHYS BIOMED, P961, DOI 10.1007/978-3-540-77550-8_31; Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654; Kim J, 2011, GRAEF ARCH CLIN EXP, V249, P529, DOI 10.1007/s00417-010-1573-9; Latour G, 2012, BIOMED OPT EXPRESS, V3, P1, DOI 10.1364/BOE.3.000001; Latour G, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3486544; LEVY SG, 1995, EXP EYE RES, V61, P323, DOI 10.1016/S0014-4835(05)80127-7; Levy SG, 1996, CURR EYE RES, V15, P45, DOI 10.3109/02713689609017610; Morishige N, 2007, INVEST OPHTH VIS SCI, V48, P1087, DOI 10.1167/iovs.06-1177; Pena AM, 2005, J AM CHEM SOC, V127, P10314, DOI 10.1021/ja0520969; Piston D. W., 1995, Journal of Microscopy, V178, P20, DOI 10.1111/j.1365-2818.1995.tb03576.x; Rehany U, 2000, CORNEA, V19, P534, DOI 10.1097/00003226-200007000-00026; Rehany U, 2000, CORNEA, V19, P390, DOI 10.1097/00003226-200005000-00026; Schultz R O, 1981, Trans Am Ophthalmol Soc, V79, P180; Steven P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026253; Steven P, 2010, J CATARACT REFR SURG, V36, P2150, DOI 10.1016/j.jcrs.2010.06.068; Strupler M, 2007, OPT EXPRESS, V15, P4054, DOI 10.1364/OE.15.004054; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; Wang Z, 2007, OPHTHALMOLOGY, V114, P1453, DOI 10.1016/j.ophtha.2006.10.049; Yadav R, 2011, BIOMED OPT EXPRESS, V2, P3037, DOI 10.1364/BOE.2.003037; Yeh AT, 2002, OPT LETT, V27, P2082, DOI 10.1364/OL.27.002082; Yin J, 2011, INVEST OPHTH VIS SCI, V52, P6589, DOI 10.1167/iovs.11-7709; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	36	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e48388	10.1371/journal.pone.0048388	http://dx.doi.org/10.1371/journal.pone.0048388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139780	Green Published, Green Submitted, gold			2022-12-25	WOS:000310741400047
J	Farooq, SM; Ashour, HM				Farooq, Shukkur M.; Ashour, Hossam M.			Type II Collagen Induces Peripheral Tolerance in BALB/c Mice via the Generation of CD8(+) T Regulatory Cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE DEVIATION ACAID; GROWTH-FACTOR-BETA; ANTERIOR-CHAMBER; B-CELLS; RHEUMATOID-ARTHRITIS; SUPPRESSOR-CELLS; PRIVILEGE; ANTIGEN; EYE	Antigens introduced into the anterior chamber (AC) of the eye induce a potent form of antigen-specific peripheral immune tolerance termed AC-associated immune deviation (ACAID), which prevents inflammatory immune responses and is characterized by impaired delayed-type hypersensitivity (DTH) responses. Type-II collagen (CII) is a fibrillar protein expressed exclusively in cartilage tissues. Although of its clinical relevance to Rheumatoid arthritis, aging, and osteoarthritis, there have been no studies to date to test if CII has the ability to induce ACAID. We hypothesized that ACAID could be generated via AC injection of CII in BALB/c mice. Using a DTH assay, the hypothesis was supported and led to another hypothesis that CII is capable of inducing specific immune tolerance via CD8(+) T regulatory cells (Tregs). Thus, we performed functional local adoptive transfer (LAT) assays to examine the regulatory roles of spleen cells, T cells, and CD8(+) T cells in the specific immune regulation induced by CII injection into the AC. Results indicated that CII induced ACAID when injected into the AC. Spleen cells of mice injected with CII in the AC significantly suppressed DTH responses. The T cell compartment of the spleen was capable of expressing this suppression. CD8(+) Tregs could solely express this CII-driven suppression and even exerted more noticeable suppression than spleen cells or splenic T cells. This study suggests a crucial role for CD8(+) Tregs in mediating CII-driven ACAID-mediated immune tolerance. This could have therapeutic implications in Rheumatoid arthritis, aging, osteoarthritis, and other diseases in which CII is involved.	[Farooq, Shukkur M.; Ashour, Hossam M.] Wayne State Univ, Dept Pharm Practice, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI 48202 USA; [Ashour, Hossam M.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt	Wayne State University; Egyptian Knowledge Bank (EKB); Cairo University	Ashour, HM (corresponding author), Wayne State Univ, Dept Pharm Practice, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI 48202 USA.	hossamking@mailcity.com		Ashour, Hossam/0000-0002-1256-7368	Wayne State University	Wayne State University	Start-up funds from Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Ashour HM, 2006, J IMMUNOL, V177, P8331, DOI 10.4049/jimmunol.177.12.8331; Ashour HM, 2006, J IMMUNOL, V176, P5950, DOI 10.4049/jimmunol.176.10.5950; Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Cone Robert E., 2008, V94, P138, DOI 10.1159/000154998; Correale J, 2010, ANN NEUROL, V67, P625, DOI 10.1002/ana.21944; Cunnusamy K, 2011, J IMMUNOL, V186, P6737, DOI 10.4049/jimmunol.1100101; Davila E, 2005, J IMMUNOL, V174, P7292, DOI 10.4049/jimmunol.174.11.7292; Faunce DE, 2004, J IMMUNOL, V172, P1991, DOI 10.4049/jimmunol.172.4.1991; Faunce DE, 2001, J IMMUNOL, V166, P313, DOI 10.4049/jimmunol.166.1.313; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Jung S, 2010, EXP MOL MED, V42, P187, DOI 10.3858/emm.2010.42.3.019; Katagiri K, 2002, J IMMUNOL, V169, P84, DOI 10.4049/jimmunol.169.1.84; Konya C, 2009, EXPERT OPIN BIOL TH, V9, P951, DOI 10.1517/14712590903020759; KOSIEWICZ MM, 1994, J IMMUNOL, V153, P2962; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Lu LR, 2008, CELL MOL IMMUNOL, V5, P401, DOI 10.1038/cmi.2008.50; McKenna KC, 2005, OCUL IMMUNOL INFLAMM, V13, P149, DOI 10.1080/09273940590933520; Menager-Marcq I, 2006, GASTROENTEROLOGY, V131, P1775, DOI 10.1053/j.gastro.2006.09.008; Niederkorn Jerry Y, 2007, Chem Immunol Allergy, V92, P131, DOI 10.1159/000099263; Niederkorn Jerry Y, 2007, Chem Immunol Allergy, V92, P27, DOI 10.1159/000099251; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Niederkorn JY, 2002, CRIT REV IMMUNOL, V22, P13; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; Skelsey ME, 2003, IMMUNOLOGY, V110, P18, DOI 10.1046/j.1365-2567.2003.01676.x; Sonoda KH, 2002, EUR J IMMUNOL, V32, P848, DOI 10.1002/1521-4141(200203)32:3<848::AID-IMMU848>3.0.CO;2-I; Stein-Streilein J, 2008, TRENDS IMMUNOL, V29, P548, DOI 10.1016/j.it.2008.08.002; Stein-Streilein Joan, 2002, Int Rev Immunol, V21, P123, DOI 10.1080/08830180212066; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Streilein JW, 1997, HUM IMMUNOL, V52, P138, DOI 10.1016/S0198-8859(96)00288-1; Sugita S, 2007, EXP EYE RES, V85, P626, DOI 10.1016/j.exer.2007.07.015; TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; WILBANKS G A, 1992, Regional Immunology, V4, P130; WILBANKS GA, 1990, IMMUNOLOGY, V71, P383; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; Zhang-Hoover Jie, 2007, Chem Immunol Allergy, V92, P317, DOI 10.1159/000099281	40	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48635	10.1371/journal.pone.0048635	http://dx.doi.org/10.1371/journal.pone.0048635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133648	Green Published, gold, Green Submitted			2022-12-25	WOS:000310702400041
J	Tsuruda, JM; Harris, JW; Bourgeois, L; Danka, RG; Hunt, GJ				Tsuruda, Jennifer M.; Harris, Jeffrey W.; Bourgeois, Lanie; Danka, Robert G.; Hunt, Greg J.			High-Resolution Linkage Analyses to Identify Genes That Influence Varroa Sensitive Hygiene Behavior in Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA-L.; DESTRUCTOR MESOSTIGMATA VARROIDAE; QUANTITATIVE TRAIT LOCI; DEFORMED WING VIRUS; JACOBSONI OUD.; COLONY LOSSES; ECTOPARASITIC MITE; PHOSPHOLIPASE-C; FLUVALINATE RESISTANCE; ACARICIDE RESIDUES	Varroa mites (V. destructor) are a major threat to honey bees (Apis melilfera) and beekeeping worldwide and likely lead to colony decline if colonies are not treated. Most treatments involve chemical control of the mites; however, Varroa has evolved resistance to many of these miticides, leaving beekeepers with a limited number of alternatives. A non-chemical control method is highly desirable for numerous reasons including lack of chemical residues and decreased likelihood of resistance. Varroa sensitive hygiene behavior is one of two behaviors identified that are most important for controlling the growth of Varroa populations in bee hives. To identify genes influencing this trait, a study was conducted to map quantitative trait loci (QTL). Individual workers of a backcross family were observed and evaluated for their VSH behavior in a mite-infested observation hive. Bees that uncapped or removed pupae were identified. The genotypes for 1,340 informative single nucleotide polymorphisms were used to construct a high-resolution genetic map and interval mapping was used to analyze the association of the genotypes with the performance of Varroa sensitive hygiene. We identified one major QTL on chromosome 9 (LOD score = 3.21) and a suggestive QTL on chromosome 1 (LOD = 1.95). The QTL confidence interval on chromosome 9 contains the gene 'no receptor potential A' and a dopamine receptor. 'No receptor potential A' is involved in vision and olfaction in Drosophila, and dopamine signaling has been previously shown to be required for aversive olfactory learning in honey bees, which is probably necessary for identifying mites within brood cells. Further studies on these candidate genes may allow for breeding bees with this trait using marker-assisted selection.	[Tsuruda, Jennifer M.; Hunt, Greg J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Harris, Jeffrey W.; Bourgeois, Lanie; Danka, Robert G.] USDA, ARS, Dept Agr, Honey Bee Breeding Genet & Physiol Res Lab, Baton Rouge, LA USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA)	Tsuruda, JM (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	jmtsuruda@gmail.com			USDA-NRI [2008-35302-18803]; Managed Pollinator Coordinated Agricultural Project [USDA-NIFA 2009-8511805718]	USDA-NRI(United States Department of Agriculture (USDA)); Managed Pollinator Coordinated Agricultural Project	This research was funded by a USDA-NRI award (2008-35302-18803) and the Managed Pollinator Coordinated Agricultural Project (USDA-NIFA 2009-8511805718) to GJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arathi HS, 2000, ETHOLOGY, V106, P365, DOI 10.1046/j.1439-0310.2000.00556.x; Arechavaleta-Velasco ME, 2001, APIDOLOGIE, V32, P157, DOI 10.1051/apido:2001121; Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Aumeier P, 2001, APIDOLOGIE, V32, P253, DOI 10.1051/apido:2001127; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Behrens D, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.17; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Boecking O, 1999, APIDOLOGIE, V30, P141, DOI 10.1051/apido:19990205; Boecking O, 1994, APIDOLOGIE, V25, P433, DOI [10.1051/apido:19940501, DOI 10.1051/APIDO:19940501]; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; Busto GU, 2010, PHYSIOLOGY, V25, P338, DOI 10.1152/physiol.00026.2010; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chouquet B, 2010, CHEM SENSES, V35, P363, DOI 10.1093/chemse/bjq024; CHURCHILL GA, 1994, GENETICS, V138, P963; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Dahle B, 2010, J APICULT RES, V49, P124, DOI 10.3896/IBRA.1.49.1.26; Danka RG, 2012, J ECON ENTOMOL, V105, P313, DOI 10.1603/EC11286; Delaplane KS, 1999, APIDOLOGIE, V30, P383, DOI 10.1051/apido:19990504; Dietemann V, 2012, J APICULT RES, V51, P125, DOI 10.3896/IBRA.1.51.1.15; Dupuis J, 1999, GENETICS, V151, P373; Ellis JD, 2001, AM BEE J, V141, P813; Elzen P, 2004, APIDOLOGIE, V35, P519, DOI 10.1051/apido:2004036; Elzen PJ, 2000, APIDOLOGIE, V31, P437, DOI 10.1051/apido:2000134; Elzen PJ, 2002, AM BEE J, V142, P291; Elzen PJ, 1999, APIDOLOGIE, V30, P13, DOI 10.1051/apido:19990102; Elzen PJ, 1998, AM BEE J, V138, P674; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Gramacho KP, 2003, BEHAV ECOL SOCIOBIOL, V54, P472, DOI 10.1007/s00265-003-0643-y; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Harbo JR, 2009, J APICULT RES, V48, P156, DOI 10.3896/IBRA.1.48.3.02; Harbo JR, 2005, J APICULT RES, V44, P21, DOI 10.1080/00218839.2005.11101141; Harris JW, 2007, J APICULT RES, V46, P134, DOI 10.1080/00218839.2007.11101383; Harris JW, 2012, ANN ENTOMOL SOC AM, V105, P512, DOI 10.1603/AN11188; Harris JW, 2010, ANN ENTOMOL SOC AM, V103, P146, DOI 10.1603/AN09138; HUNT GJ, 1995, GENETICS, V139, P1371; Ibrahim A, 2006, APIDOLOGIE, V37, P31, DOI 10.1051/apido:2005052; Ibrahim A, 2007, APIDOLOGIE, V38, P67, DOI 10.1051/apido:2006065; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kirrane MJ, 2011, J ECON ENTOMOL, V104, P1146, DOI 10.1603/EC11035; KORPELA S, 1992, J APICULT RES, V31, P157, DOI 10.1080/00218839.1992.11101278; LANDER ES, 1989, GENETICS, V121, P185; Le Conte Y, 2011, INSECT MOL BIOL, V20, P399, DOI 10.1111/j.1365-2583.2011.01074.x; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lodesani M, 2005, BEE WORLD, V86, P102, DOI 10.1080/0005772X.2005.11417324; LODESANI M, 1995, APIDOLOGIE, V26, P67, DOI 10.1051/apido:19950109; Lodesani M, 2008, APIDOLOGIE, V39, P324, DOI 10.1051/apido:2008012; Maida R, 2000, NEUROREPORT, V11, P1773, DOI 10.1097/00001756-200006050-00035; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; MARTIN SJ, 1994, EXP APPL ACAROL, V18, P87, DOI 10.1007/BF00055033; Masterman R, 2001, J COMP PHYSIOL A, V187, P441, DOI 10.1007/s003590100216; Mathieu L, 2000, J APICULT RES, V39, P155, DOI 10.1080/00218839.2000.11101036; MEYERTHOLEN EP, 1987, J COMP PHYSIOL A, V161, P793, DOI 10.1007/BF00610221; Milani N, 1999, APIDOLOGIE, V30, P229, DOI 10.1051/apido:19990211; Mustard JA, 2012, HONEYBEE NEUROBIOLOG, P199, DOI DOI 10.1007/978-94-007-2099-2_16; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; Page RE, 2000, J HERED, V91, P474, DOI 10.1093/jhered/91.6.474; Pak WL, 1979, STUDY PHOTORECEPTOR; Parker R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r81; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Peterson M, 2009, J APICULT RES, V48, P145, DOI 10.3896/IBRA.1.48.2.11; Pettis JS, 2004, APIDOLOGIE, V35, P91, DOI 10.1051/apido:2003060; Pollock VP, 2003, J EXP BIOL, V206, P901, DOI 10.1242/jeb.00189; RIESGOESCOVAR J, 1995, P NATL ACAD SCI USA, V92, P2864, DOI 10.1073/pnas.92.7.2864; Rinderer TE, 2010, APIDOLOGIE, V41, P409, DOI 10.1051/apido/2010015; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Rueppell O, 2004, GENETICS, V167, P1767, DOI 10.1534/genetics.103.021949; Sammataro D, 2005, INT J ACAROL, V31, P67, DOI 10.1080/01647950508684419; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Sandoz JC, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00098; SCHNEIDER P, 1987, APIDOLOGIE, V18, P101, DOI 10.1051/apido:19870108; Schoning C, 2012, J EXP BIOL, V215, P264, DOI 10.1242/jeb.062562; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; SCHULZ AE, 1984, APIDOLOGIE, V15, P401, DOI 10.1051/apido:19840404; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Spivak M, 1996, APIDOLOGIE, V27, P245, DOI 10.1051/apido:19960407; Spivak M, 1998, BEE WORLD, V79, P124, DOI 10.1080/0005772X.1998.11099394; Spivak M, 1998, BEE WORLD, V79, P169, DOI 10.1080/0005772X.1998.11099408; Spivak M, 2003, J NEUROBIOL, V55, P341, DOI 10.1002/neu.10219; Spivak M, 2001, J ECON ENTOMOL, V94, P326, DOI 10.1603/0022-0493-94.2.326; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Thakur RK, 1997, AM BEE J, V137, P143; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Villa JD, 2008, ANN ENTOMOL SOC AM, V101, P867, DOI 10.1603/0013-8746(2008)101[867:CIHBHA]2.0.CO;2; Villa JD, 2009, J APICULT RES, V48, P162, DOI 10.3896/IBRA.1.48.3.03; Wallner K, 1999, APIDOLOGIE, V30, P235, DOI 10.1051/apido:19990212; Ward K, 2008, J ECON ENTOMOL, V101, P654, DOI 10.1603/0022-0493(2008)101[654:CPOTMS]2.0.CO;2; Webster T.C., 2001, MITES HONEY BEE; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	107	70	74	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48276	10.1371/journal.pone.0048276	http://dx.doi.org/10.1371/journal.pone.0048276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133626	Green Published, gold			2022-12-25	WOS:000310702400030
J	Zhao, T; Linde, HZVD; Severijnen, LA; Oostra, BA; Willemsen, R; Bonifati, V				Zhao, Tianna; Zondervan-van der Linde, Herma; Severijnen, Lies-Anne; Oostra, Ben A.; Willemsen, Rob; Bonifati, Vincenzo			Dopaminergic Neuronal Loss and Dopamine-Dependent Locomotor Defects in Fbxo7-Deficient Zebrafish	PLOS ONE			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; PINK1 FUNCTION; TRANSPORTER; EXPRESSION; MUTATIONS; LOCALIZATION; TOXICITY; ATP13A2; EMBRYOS	Recessive mutations in the F-box only protein 7 gene (FBXO7) cause PARK15, a Mendelian form of early-onset, levodopa-responsive parkinsonism with severe loss of nigrostriatal dopaminergic neurons. However, the function of the protein encoded by FBXO7, and the pathogenesis of PARK15 remain unknown. No animal models of this disease exist. Here, we report the generation of a vertebrate model of PARK15 in zebrafish. We first show that the zebrafish Fbxo7 homolog protein (zFbxo7) is expressed abundantly in the normal zebrafish brain. Next, we used two zFbxo7-specific morpholinos (targeting protein translation and mRNA splicing, respectively), to knock down the zFbxo7 expression. The injection of either of these zFbxo7-specific morpholinos in the fish embryos induced a marked decrease in the zFbxo7 protein expression, and a range of developmental defects. Furthermore, whole-mount in situ mRNA hybridization showed abnormal patterning and significant decrease in the number of diencephalic tyrosine hydroxylase-expressing neurons, corresponding to the human nigrostriatal or ventral tegmental dopaminergic neurons. Of note, the number of the dopamine transporter-expressing neurons was much more severely depleted, suggesting dopaminergic dysfunctions earlier and larger than those due to neuronal loss. Last, the zFbxo7 morphants displayed severe locomotor disturbances (bradykinesia), which were dramatically improved by the dopaminergic agonist apomorphine. The severity of these morphological and behavioral abnormalities correlated with the severity of zFbxo7 protein deficiency. Moreover, the effects of the co-injection of zFbxo7- and p53-specific morpholinos were similar to those obtained with zFbxo7-specific morpholinos alone, supporting further the contention that the observed phenotypes were specifically due to the knock down of zFbxo7. In conclusion, this novel vertebrate model reproduces pathologic and behavioral hallmarks of human parkinsonism (dopaminergic neuronal loss and dopamine-dependent bradykinesia), representing therefore a valid tool for investigating the mechanisms of selective dopaminergic neuronal death, and screening for modifier genes and therapeutic compounds.	[Zhao, Tianna; Zondervan-van der Linde, Herma; Severijnen, Lies-Anne; Oostra, Ben A.; Willemsen, Rob; Bonifati, Vincenzo] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Bonifati, V (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	v.bonifati@erasmusmc.nl			Netherlands Organization for Scientific Research (NWO) [4600268033]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO, VIDI grant n.4600268033) to VB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607; Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Bai Q, 2009, NEUROSCIENCE, V164, P1138, DOI 10.1016/j.neuroscience.2009.09.014; Bandmann O, 2010, NEUROBIOL DIS, V40, P58, DOI 10.1016/j.nbd.2010.05.017; Baulac S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-12; Bonifati Vincenzo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS4, DOI 10.1016/S1353-8020(11)70004-9; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fett ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011783; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hersch SM, 1997, J COMP NEUROL, V388, P211; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Ibanez CF, 2008, NAT NEUROSCI, V11, P735, DOI 10.1038/nn0708-735; Kabashi E, 2011, BBA-MOL BASIS DIS, V1812, P335, DOI 10.1016/j.bbadis.2010.09.011; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Matsui H, 2010, NEUROSCI RES, V66, P151, DOI 10.1016/j.neures.2009.10.010; Milanese C, 2012, J BIOL CHEM, V287, P2971, DOI 10.1074/jbc.M111.308312; Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221; Ren GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020630; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sallinen V, 2010, NEUROBIOL DIS, V40, P93, DOI 10.1016/j.nbd.2010.06.001; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; Xi YW, 2010, EUR J NEUROSCI, V31, P623, DOI 10.1111/j.1460-9568.2010.07091.x; Zhao TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016983	36	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48911	10.1371/journal.pone.0048911	http://dx.doi.org/10.1371/journal.pone.0048911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133663	Green Published, gold			2022-12-25	WOS:000310702400049
J	Yang, SG; Wang, SW; Zhao, M; Zhang, R; Zhou, WW; Li, YN; Su, YJ; Zhang, H; Yu, XL; Liu, RT				Yang, Shi-gao; Wang, Shao-wei; Zhao, Min; Zhang, Ran; Zhou, Wei-wei; Li, Ya-nan; Su, Ya-jing; Zhang, He; Yu, Xiao-lin; Liu, Rui-tian			A Peptide Binding to the beta-Site of APP Improves Spatial Memory and Attenuates A beta Burden in Alzheimer's Disease Transgenic Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CLEAVING ENZYME-1 BACE1; LONG-TERM POTENTIATION; SINGLE-CHAIN ANTIBODY; GAMMA-SECRETASE; MOUSE MODEL; THERAPEUTIC TARGET; ALPHA-SECRETASE; CELL BIOLOGY; IN-VITRO	Amyloid precursor protein cleaving enzyme 1 (BACE1), an aspartyl protease, initiates processing of the amyloid precursor protein (APP) into beta-amyloid (A beta); the peptide likely contributes to development of Alzheimer's disease (AD). BACE1 is an attractive therapeutic target for AD treatment, but it exhibits other physiological activities and has many other substrates besides APP. Thus, inhibition of BACE1 function may cause adverse side effects. Here, we present a peptide, S1, isolated from a peptide library that selectively inhibits BACE1 hydrolytic activity by binding to the beta-proteolytic site on APP and Ab N-terminal. The S1 peptide significantly reduced A beta levels in vitro and in vivo and inhibited A beta cytotoxicity in SH-SY5Y cells. When applied to APPswe/PS1dE9 double transgenic mice by intracerebroventricular injection, S1 significantly improved the spatial memory as determined by the Morris Water Maze, and also attenuated their Ab burden. These results indicate that the dual-functional peptide S1 may have therapeutic potential for AD by both reducing Ab generation and inhibiting Ab cytotoxicity.	[Wang, Shao-wei; Yu, Xiao-lin; Liu, Rui-tian] Chinese Acad Sci, Natl Key Lab Biochem Engn, Inst Proc Engn, Beijing, Peoples R China; [Yang, Shi-gao; Wang, Shao-wei; Zhao, Min; Zhang, Ran; Zhou, Wei-wei; Li, Ya-nan; Su, Ya-jing; Zhang, He; Liu, Rui-tian] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Ya-nan; Su, Ya-jing] Ningxia Univ, Sch Life Sci, Yinchuan, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Tsinghua University; Ningxia University	Yu, XL (corresponding author), Chinese Acad Sci, Natl Key Lab Biochem Engn, Inst Proc Engn, Beijing, Peoples R China.	yuxiaolin@home.ipe.ac.cn; rtliu@tsinghua.edu.cn	Zhang, Ran/GZG-8709-2022	Yang, Shigao/0000-0003-2717-6914	National Natural Science Foundation of China (NSFC) [30971012, 81171014]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (30971012 and 81171014), the National Science and Technology Major Projects of New Drugs (2012ZX09103301-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbel-Ornath M, 2010, J ALZHEIMERS DIS, V22, P469, DOI 10.3233/JAD-2010-100753; Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; Boddapati S, 2012, J ALZHEIMERS DIS, V28, P961, DOI 10.3233/JAD-2011-111196; Boddapati S, 2011, J MOL BIOL, V405, P436, DOI 10.1016/j.jmb.2010.10.054; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Chang WP, 2011, FASEB J, V25, P775, DOI 10.1096/fj.10-167213; Cole SL, 2007, CURR GENOMICS, V8, P509, DOI 10.2174/138920207783769512; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; De Strooper B, 2000, NATURE, V405, P627, DOI 10.1038/35015193; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Dominguez JL, 2010, BIOCHEMISTRY-US, V49, P7255, DOI 10.1021/bi100637n; Dong YL, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-5; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; FABIAN H, 1994, EUR J BIOCHEM, V221, P959, DOI 10.1111/j.1432-1033.1994.tb18811.x; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Fukuchi KI, 2006, BIOCHEM BIOPH RES CO, V344, P79, DOI 10.1016/j.bbrc.2006.03.145; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Harada H, 2006, NEUROSCI RES, V54, P24, DOI 10.1016/j.neures.2005.10.001; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkins J, 2011, NEURODEGENER DIS, V8, P455, DOI 10.1159/000324511; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hunt CE, 2009, FEBS J, V276, P1845, DOI 10.1111/j.1742-4658.2009.06929.x; Janusz M, 2009, FEBS LETT, V583, P190, DOI 10.1016/j.febslet.2008.11.053; Jo DG, 2010, NEUROBIOL AGING, V31, P917, DOI 10.1016/j.neurobiolaging.2008.07.003; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Legleiter J, 2004, J MOL BIOL, V335, P997, DOI 10.1016/j.jmb.2003.11.019; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Liu R, 2004, BIOCHEMISTRY-US, V43, P9999, DOI 10.1021/bi0492354; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; Ma HF, 2007, P NATL ACAD SCI USA, V104, P8167, DOI 10.1073/pnas.0609521104; Mancini F, 2011, ANAL BIOANAL CHEM, V400, P1979, DOI 10.1007/s00216-011-4963-x; McAllister C, 2010, J NEUROSCI, V30, P7326, DOI 10.1523/JNEUROSCI.1180-10.2010; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Orner BP, 2006, J AM CHEM SOC, V128, P11882, DOI 10.1021/ja0619861; Ortega A, 2011, BIOORG MED CHEM LETT, V21, P2183, DOI 10.1016/j.bmcl.2011.03.023; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Probst GD, 2010, BIOORG MED CHEM LETT, V20, P6034, DOI 10.1016/j.bmcl.2010.08.070; Qahwash I, 2003, J BIOL CHEM, V278, P23187, DOI 10.1074/jbc.M213298200; Quiroz-Baez R, 2009, NEUROCHEM INT, V55, P662, DOI 10.1016/j.neuint.2009.06.012; Rakover I, 2007, NEURODEGENER DIS, V4, P392, DOI 10.1159/000103250; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Solomon B, 2002, CURR MED CHEM, V9, P1737; Townsend M, 2006, ANN NEUROL, V60, P668, DOI 10.1002/ana.21051; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xue D, 2012, NEUROBIOL DIS, V46, P701, DOI 10.1016/j.nbd.2012.03.013; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yang SG, 2010, J ALZHEIMERS DIS, V22, P107, DOI 10.3233/JAD-2010-100621; Yin F, 2011, NEUROCHEM INT, V58, P399, DOI 10.1016/j.neuint.2010.12.017; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou LJ, 2011, J BIOL CHEM, V286, P8677, DOI 10.1074/jbc.M110.194860; Zhu ZY, 2010, J NEUROCHEM, V114, P374, DOI 10.1111/j.1471-4159.2010.06751.x	77	7	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48540	10.1371/journal.pone.0048540	http://dx.doi.org/10.1371/journal.pone.0048540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133641	gold, Green Published, Green Submitted			2022-12-25	WOS:000310601300018
J	Liu, MF; Ferrandez, Y; Bouhsira, E; Monteil, M; Franc, M; Boulouis, HJ; Biville, F				Liu, MaFeng; Ferrandez, Yann; Bouhsira, Emilie; Monteil, Martine; Franc, Michel; Boulouis, Henri-Jean; Biville, Francis			Heme Binding Proteins of Bartonella henselae Are Required when Undergoing Oxidative Stress During Cell and Flea Invasion	PLOS ONE			English	Article							C-TYPE CYTOCHROMES; CONGO RED BINDING; ESCHERICHIA-COLI; SERRATIA-MARCESCENS; YERSINIA-PESTIS; IRON UPTAKE; PROTEOMIC ANALYSIS; ENDOTHELIAL-CELLS; MEMBRANE-PROTEINS; HYDROGEN-PEROXIDE	Bartonella are hemotropic bacteria responsible for emerging zoonoses. These heme auxotroph alphaproteobacteria must import heme for their growth, since they cannot synthesize it. To import exogenous heme, Bartonella genomes encode for a complete heme uptake system enabling transportation of this compound into the cytoplasm and degrading it to release iron. In addition, these bacteria encode for four or five outer membrane heme binding proteins (Hbps). The structural genes of these highly homologous proteins are expressed differently depending on oxygen, temperature and heme concentrations. These proteins were hypothesized as being involved in various cellular processes according to their ability to bind heme and their regulation profile. In this report, we investigated the roles of the four Hbps of Bartonella henselae, responsible for cat scratch disease. We show that Hbps can bind heme in vitro. They are able to enhance the efficiency of heme uptake when co-expressed with a heme transporter in Escherichia coli. Using B. henselae Hbp knockdown mutants, we show that these proteins are involved in defense against the oxidative stress, colonization of human endothelial cell and survival in the flea.	[Liu, MaFeng; Ferrandez, Yann; Monteil, Martine; Boulouis, Henri-Jean; Biville, Francis] UMR BIPAR Univ Paris Est, Ecole Natl Vet Alfort, INRA Anses UPEC ENVA, Maisons Alfort, France; [Liu, MaFeng] Jilin Univ, Key Lab Zoonosis, Minist Educ, Inst Zoonosis, Changchun 130023, Peoples R China; [Bouhsira, Emilie; Franc, Michel] Univ Toulouse, Lab Parasitol, INP, ENVT, Toulouse, France; [Biville, Francis] Inst Pasteur, Dept Microbiol, Paris, France	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Jilin University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Biville, F (corresponding author), UMR BIPAR Univ Paris Est, Ecole Natl Vet Alfort, INRA Anses UPEC ENVA, Maisons Alfort, France.	fbiville@pasteur.fr			Institut Pasteur; Centre National de la Recherche Scientifique [URA2172]; Agence Nationale pour la Recherche [ANR-06-MIME-019-01]; China Scholarship Council; 319 DIM Malinf [dim100103]	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); China Scholarship Council(China Scholarship Council); 319 DIM Malinf	This work was supported by the Institut Pasteur, the Centre National de la Recherche Scientifique (URA2172) and the Agence Nationale pour la Recherche [ANR-06-MIME-019-01]. MaFeng Liu was supported by a grant from the China Scholarship Council. Yann Ferrandez was supported by a grant from 319 DIM Malinf (dim100103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; AMABILECUEVAS CF, 1991, NUCLEIC ACIDS RES, V19, P4479, DOI 10.1093/nar/19.16.4479; Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06; Benevides-Matos N, 2008, J BACTERIOL, V190, P21, DOI 10.1128/JB.01389-07; Benevides-Matos N, 2010, MICROBIOL-SGM, V156, P1749, DOI 10.1099/mic.0.034405-0; Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06; Carroll JA, 2000, INFECT IMMUN, V68, P6750, DOI 10.1128/IAI.68.12.6750-6757.2000; Chang CC, 2011, VET MICROBIOL, V149, P147, DOI 10.1016/j.vetmic.2010.09.033; Chenoweth MR, 2004, INFECT IMMUN, V72, P3097, DOI 10.1128/IAI.72.6.3097-3105.2004; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; Coleman SA, 2003, MICROB PATHOGENESIS, V34, P179, DOI 10.1016/S0882-4010(03)00005-6; Dabo SM, 2006, MICROB PATHOGENESIS, V41, P10, DOI 10.1016/j.micpath.2006.04.003; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209; Eberhardt C, 2009, PROTEOMICS, V9, P1967, DOI 10.1002/pmic.200700670; Edouard S, 2010, MED MALADIES INFECT, V40, P319, DOI 10.1016/j.medmal.2009.11.004; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Gillaspie D, 2009, APPL ENVIRON MICROB, V75, P5434, DOI 10.1128/AEM.00949-09; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Hare JM, 1999, J BACTERIOL, V181, P4896, DOI 10.1128/JB.181.16.4896-4904.1999; Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x; Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x; Klotz SA, 2011, AM FAM PHYSICIAN, V83, P152; Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Li DM, 2011, GENET MOL RES, V10, P1789, DOI 10.4238/vol10-3gmr1153; Liu MF, 2012, MICROBIOL-SGM, V158, P886, DOI 10.1099/mic.0.054619-0; Liu MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037630; Mandle T, 2005, BLOOD, V106, P1215, DOI 10.1182/blood-2004-12-4670; Maniatis T., 1989, MOL CLONING LAB MANU; Mehock JR, 1998, INFECT IMMUN, V66, P3462, DOI 10.1128/IAI.66.7.3462-3466.1998; Miller J.H., 1972, EXPT MOL GENETICS; Minnick MF, 2003, INFECT IMMUN, V71, P814, DOI 10.1128/IAI.71.2.814-821.2003; Minnick MF, 2009, FUTURE MICROBIOL, V4, P743, DOI [10.2217/fmb.09.41, 10.2217/FMB.09.41]; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Nijssen E, 2009, CLIN MICROBIOL INFEC, V15, P118, DOI 10.1111/j.1469-0691.2008.02193.x; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Parrow NL, 2009, INFECT IMMUN, V77, P307, DOI 10.1128/IAI.01194-08; Perrotte-Piquemal M, 1999, BIOCHIMIE, V81, P245, DOI 10.1016/S0300-9084(99)80058-3; Perry RD, 2007, BIOMETALS, V20, P699, DOI 10.1007/s10534-006-9051-x; Reif KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002805; Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933; Riess T, 2003, GENE, V313, P103, DOI 10.1016/S0378-1119(03)00636-X; Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08; Roden JA, 2012, INFECT IMMUN, V80, P929, DOI 10.1128/IAI.05769-11; Rydkina E, INFECT IMMUN, V78, P2599; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38; Sahni SK, 2009, FUTURE MICROBIOL, V4, P323, DOI 10.2217/FMB.09.6; Saisongkorh W, FEMS MICROBIOL LETT, V310, P158; Sander A, 2000, FEMS MICROBIOL LETT, V189, P55, DOI 10.1111/j.1574-6968.2000.tb09205.x; SCHELLHORN HE, 1995, FEMS MICROBIOL LETT, V131, P113, DOI 10.1111/j.1574-6968.1995.tb07764.x; SIMON D, 1992, P NATL ACAD SCI USA, V89, P5512, DOI 10.1073/pnas.89.12.5512; Smalley JW, 2000, FEMS MICROBIOL LETT, V183, P159, DOI 10.1111/j.1574-6968.2000.tb08951.x; STORZ G, 1990, ANTON LEEUW INT J G, V58, P157, DOI 10.1007/BF00548927; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; STUGARD CE, 1989, INFECT IMMUN, V57, P3534, DOI 10.1128/IAI.57.11.3534-3539.1989; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; WEEL JFL, 1991, J EXP MED, V173, P1395, DOI 10.1084/jem.173.6.1395; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Zhou W, J MED ENTOMOL, V49, P364; Zhou W, 2012, J MED ENTOMOL, V49, P364, DOI 10.1603/ME11172; Zimmermann R, 2003, J BACTERIOL, V185, P1739, DOI 10.1128/JB.185.5.1739-1744.2003	74	15	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48408	10.1371/journal.pone.0048408	http://dx.doi.org/10.1371/journal.pone.0048408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144761	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705300071
J	Chen, S; Zhang, Q; Shen, LM; Liu, YH; Xu, FY; Li, DL; Fu, ZK; Yuan, WG; Pang, D; Li, DJ				Chen, Shuang; Zhang, Qing; Shen, Liming; Liu, Yanhong; Xu, Fengyan; Li, Dalin; Fu, Zhenkun; Yuan, Weiguang; Pang, Da; Li, Dianjun			Investigation of CD28 Gene Polymorphisms in Patients with Sporadic Breast Cancer in a Chinese Han Population in Northeast China	PLOS ONE			English	Article							B7 FAMILY; ASSOCIATION; VARIANTS; CTLA-4; ICOS; EXPRESSION; RECEPTOR; RISK	Background: CD28 is one of a number of costimulatory molecules that play crucial roles in immune regulation and homeostasis. Accumulating evidence indicates that immune factors influence breast carcinogenesis. To clarify the relationships between polymorphisms in the CD28 gene and breast carcinogenesis, a case-control study was conducted in women from Heilongjiang Province in northeast of China. Methodology/Principal Findings: Our research subjects consisted of 565 female patients with sporadic breast cancer and 605 age-and sex-matched healthy controls. In total, 12 single nucleotide polymorphisms (SNPs) in the CD28 gene were successfully determined using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The relationship between the CD28 variants and clinical features, including histological grade, tumor size, lymph node metastasis, human epidermal growth factor receptor 2 (C-erbB2), estrogen receptor (ER), progesterone receptor (PR), and tumor protein 53 (P53) status were analyzed. A statistically significant association was observed between rs3116496 and breast cancer risk under different genetic models (additive P = 0.0164, dominant P = 0.0042). Different distributions of the rs3116496 'T' allele were found in patients and controls, which remained significant after correcting the P value for multiple testing using Haploview with 10,000 permutations (corrected P = 0.0384). In addition, significant associations were observed between rs3116487/rs3116494 (D' = 1, r(2) = 0.99) and clinicopathological features such as C-erbB2 and ER status, in breast cancer patients. Conclusions/Significance: Our findings indicate that CD28 gene polymorphisms contribute to sporadic breast cancer risk and have a significant association with clinicopathological features in a northeast Chinese Han population.	[Chen, Shuang; Fu, Zhenkun; Yuan, Weiguang; Pang, Da; Li, Dianjun] Harbin Med Univ, Inst Canc Prevent & Treatment, Dept Tumor Cell Biol, Harbin, Peoples R China; [Chen, Shuang; Zhang, Qing; Shen, Liming; Xu, Fengyan; Yuan, Weiguang; Li, Dianjun] Harbin Med Univ, Dept Immunol, Harbin, Peoples R China; [Li, Dalin; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Surg, Harbin, Peoples R China; [Liu, Yanhong] Harbin Med Univ, Hosp 2, Dept Lab Med, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Pang, D (corresponding author), Harbin Med Univ, Inst Canc Prevent & Treatment, Dept Tumor Cell Biol, Harbin, Peoples R China.	pangdasir@163.com; dianjunli@163.com			National Natural Science Foundation of China [31070780]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (31070780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Boesteanu AC, 2009, SEMIN IMMUNOL, V21, P69, DOI 10.1016/j.smim.2009.02.005; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Cazzaniga M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/985620; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen X, 2011, INT J IMMUNOGENET, V38, P51, DOI 10.1111/j.1744-313X.2010.00969.x; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Deshpande M, 2002, HUM IMMUNOL, V63, P20, DOI 10.1016/S0198-8859(01)00354-8; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Elledge RM, 2000, INT J CANCER, V89, P111, DOI 10.1002/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.3.CO;2-N; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghaderi A, 2011, IRAN J IMMUNOL, V8, P127, DOI IJIv8i3A1; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gunesacar R, 2007, INT J IMMUNOGENET, V34, P45, DOI 10.1111/j.1744-313X.2007.00655.x; Guzman VB, 2008, HUM MOL GENET, V17, P1838, DOI 10.1093/hmg/ddn077; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanawa H, 2002, BLOOD, V99, P2138, DOI 10.1182/blood.V99.6.2138; HILL WG, 1994, AM J HUM GENET, V54, P705; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Idirisinghe PKA, 2010, AM J CLIN PATHOL, V133, P416, DOI 10.1309/AJCPJ57FLLJRXKPV; Ivansson EL, 2010, GYNECOL ONCOL, V116, P544, DOI 10.1016/j.ygyno.2009.10.084; Jarvinen TAH, 2003, BREAST CANCER RES TR, V78, P299, DOI 10.1023/A:1023077507295; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim HJ, 2011, J GENET, V90, P151, DOI 10.1007/s12041-011-0042-5; Korecka Anna, 2007, Postepy Hig Med Dosw (Online), V61, P74; Ledezma-Lozano IY, 2011, DIS MARKERS, V30, P25, DOI [10.1155/2011/620849, 10.3233/DMA-2011-0760]; Lens M, 2008, RECENT PAT ANTI-CANC, V3, P105, DOI 10.2174/157489208784638767; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Magistrelli G, 1999, BIOCHEM BIOPH RES CO, V259, P34, DOI 10.1006/bbrc.1999.0725; Pandolfi F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/894704; Pawlak E, 2010, HUM IMMUNOL, V71, P195, DOI 10.1016/j.humimm.2009.11.006; Rathinam C, 2012, PLOS ONE, V7; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Song M, 2011, MOL CARCINOGEN, V50, P280, DOI 10.1002/mc.20639; Sun T, 2009, CANCER RES, V69, P6011, DOI 10.1158/0008-5472.CAN-09-0176; Suwalska K, 2008, HUM IMMUNOL, V69, P193, DOI 10.1016/j.humimm.2008.01.014; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6	42	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48031	10.1371/journal.pone.0048031	http://dx.doi.org/10.1371/journal.pone.0048031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133541	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800032
J	Lammers, B; Zhao, Y; Foks, AC; Hildebrand, RB; Kuiper, J; Van Berkel, TJC; Van Eck, M				Lammers, Bart; Zhao, Ying; Foks, Amanda C.; Hildebrand, Reeni B.; Kuiper, Johan; Van Berkel, Theo J. C.; Van Eck, Miranda			Leukocyte ABCA1 Remains Atheroprotective in Splenectomized LDL Receptor Knockout Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ATHEROSCLEROTIC LESION DEVELOPMENT; DENSITY-LIPOPROTEIN DEFICIENCY; BONE-MARROW; SPLENIC AUTOTRANSPLANTATION; COMBINED DELETION; LIPID-METABOLISM; FREE-CHOLESTEROL; MACROPHAGES; CELLS	Aim: ATP-binding cassette transporter A1 (ABCA1) is an important mediator of macrophage cholesterol efflux. It mediates the efflux of cellular cholesterol to lipid-poor apolipoprotein A-I. LDL receptor (LDLr) knockout (KO) mice deficient for leukocyte ABCA1 (ABCA1 KO -> LDLr KO) show increased atherosclerosis and splenic lipid accumulation despite largely attenuated serum cholesterol levels. In the present study, we aimed to explore the importance of the spleen for the atheroprotective effects of leukocyte ABCA1. Methods: LDLr KO mice were transplanted with bone marrow from ABCA1 KO mice or wild-type (WT) controls. After 8 weeks recovery, mice were either splenectomized (SP-x) or underwent a sham operation, and were subsequently challenged with a Western-type diet (WTD). Results: In agreement with previous studies, the atherosclerotic lesion area in ABCA1 KO -> LDLr KO sham animals (655 +/- 82x10(3) mu m(2)) was 1.4-fold (p = 0.03) larger compared to sham WT -> LDLr KO mice (459 +/- 33x10(3) mu m(2)) after 8 weeks WTD feeding, despite 1.7-fold (p<0.001) lower serum cholesterol levels. Interestingly, deletion of ABCA1 in leukocytes led to 1.6-fold higher neutrophil content in the spleen in absence of differences in circulating neutrophils. Levels of KC, an important chemoattractant for neutrophils, in serum, however, were increased 2.9-fold (p = 0.07) in ABCA1 KO -> LDLr KO mice. SP-x induced blood neutrophilia as compared to WT -> LDLr KO mice (1.9-fold; p<0.05), but did not evoke differences in serum cholesterol and anti-oxLDL antibody levels. Atherosclerotic lesion development, however, was 1.3-fold induced both in the presence and absence of leukocyte ABCA1 (WT: 614 +/- 106x10(3) mu m(2), ABCA1 KO: 786 +/- 44x10(3) mu m(2)). Two-way ANOVA revealed independent effects on atherosclerosis for both leukocyte ABCA1 deficiency and SP-x (p<0.05). Conclusions: The observed splenic alterations induced by leukocyte ABCA1 deficiency do not play a significant role in the anti-atherogenic effects of leukocyte ABCA1 on lesion development.	[Lammers, Bart; Zhao, Ying; Foks, Amanda C.; Hildebrand, Reeni B.; Kuiper, Johan; Van Berkel, Theo J. C.; Van Eck, Miranda] Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Lammers, B (corresponding author), Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, POB 9502, NL-2300 RA Leiden, Netherlands.	b.lammers@lacdr.leidenuniv.nl	Van Berkel, Theo/ABD-7677-2021; Zhao, Ying/AAS-7970-2021; Zhao, Ying/C-3916-2011	van Eck, Miranda/0000-0003-3936-3194; Foks, Amanda/0000-0002-9747-3458	Netherlands Heart Foundation [2007T056]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by The Netherlands Heart Foundation (Established Investigator Grant number 2007T056 to B.L. and M.V.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Akan AA, 2008, J INVEST SURG, V21, P369, DOI 10.1080/08941930802438898; ASAI K, 1988, ANGIOLOGY, V39, P497, DOI 10.1177/000331978803900602; Barbosa KBF, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-61; Bot I, 2012, ARTERIOSCL THROM VAS, V32, P2197, DOI 10.1161/ATVBAHA.112.252924; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; FATOUROS M, 1995, BRIT J SURG, V82, P1675, DOI 10.1002/bjs.1800821230; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; JONES NCH, 1957, BRIT J HAEMATOL, V3, P125; KING H, 1952, ANN SURG, V136, P239, DOI 10.1097/00000658-195208000-00006; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Lammers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026095; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; MOLAD Y, 1994, BIOCHEM J, V299, P881, DOI 10.1042/bj2990881; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Rezende AB, 2011, J SURG RES, V171, pE231, DOI 10.1016/j.jss.2011.08.010; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Sato Y, 1998, AM J PHYSIOL-LUNG C, V275, pL255, DOI 10.1152/ajplung.1998.275.2.L255; Schmitz G, 1999, PATHOBIOLOGY, V67, P236, DOI 10.1159/000028100; SCHRODER JM, 1989, J IMMUNOL, V142, P244; Shapiro S, 1927, J EXP MED, V45, P595, DOI 10.1084/jem.45.4.595; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Teixeira FM, 2008, CLIN EXP IMMUNOL, V154, P255, DOI 10.1111/j.1365-2249.2008.03728.x; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Zhao Y, 2010, CIRC RES, V107, pE20, DOI 10.1161/CIRCRESAHA.110.226282; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48080	10.1371/journal.pone.0048080	http://dx.doi.org/10.1371/journal.pone.0048080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133551	gold, Green Published			2022-12-25	WOS:000310261800041
J	Mao, YB; Zhang, NN; Xu, JF; Ding, ZJ; Zong, RR; Liu, ZG				Mao, Yubin; Zhang, Nini; Xu, Jinfei; Ding, Zhijie; Zong, Rongrong; Liu, Zuguo			Significance of Heterogeneous Twist2 Expression in Human Breast Cancers	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-METASTASIS; UP-REGULATION; E-CADHERIN; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; PROGRESSION; CELLS; INVASION; SNAIL	Background: Twist2 (Dermo1) has been shown to mediate the epithelial-mesenchymal transition (EMT) to promote tumor invasion and even metastasis. However, the involvement of EMT in breast cancer progression is highly debated, partially due to clinical observations showing that the majority of human breast carcinoma metastases express E-cadherin and maintain their epithelial morphology. The molecular mechanism by which Twist2 participates in EMT of breast cancer in vivo remains poorly understood. Methods: We examined Twist2 expression pattern in human breast carcinomas by western blot and tissue microarray, and analyzed Twist2 cellular localization by confocal microscopy, cell fractionation and other approaches. Results: Twist2 expression was significantly increased in breast cancer. Cytoplasmic Twist2 positive cancer cells expressing E-cadherin on the cellular membrane were mainly located at tumor center of primary carcinomas and lymph metastases, while cancer cells with nuclear Twist2 clearly showed loss of E-cadherin and were detected at the invasive front in ductal breast carcinomas. In addition, ectopically stable-expressed Twist2 was found to localize in the cytoplasm of cancer cells. Collectively, these data indicate that upregulation of cytoplasmic Twist2 is correlated with tumor histological type and tumor metastasis in human breast cancers. Conclusion: The differential cellular distribution of Twist2 may be associated with tumor progression. The cytoplasmic Twist2 in cancer cells at tumor center of primary carcinomas and lymph metastases contributes to the maintenance of epithelial cancer characteristics expressing E-cadherin in a noninvasive state, while the nuclear Twist2 at the cancer invasion front activates EMT to deprive epithelial property of neoplastic cells, thus facilitating invasion and metastasis. These findings suggest that heterogeneous expression of Twist2 in tumors may have a functional link to tumor progression.	[Mao, Yubin; Zhang, Nini; Xu, Jinfei] Xiamen Univ, Dept Pathophysiol Basic Sci, Coll Med, Xiamen, Fujian, Peoples R China; [Ding, Zhijie] Xiamen Univ, Dept Surg, Zhongshan Hosp, Xiamen, Fujian, Peoples R China; [Zong, Rongrong; Liu, Zuguo] Xiamen Univ, Inst Eye, Coll Med, Xiamen, Fujian, Peoples R China; [Zong, Rongrong; Liu, Zuguo] Xiamen Univ, Xiamen Eye Ctr, Coll Med, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Xiamen University	Mao, YB (corresponding author), Xiamen Univ, Dept Pathophysiol Basic Sci, Coll Med, Xiamen, Fujian, Peoples R China.	maoyubin@xmu.edu.cn; zuguoliu@xmu.edu.cn			National Natural Science Foundation of China [30872515]; Fundamental Research Funds for the Central Universities of China [2011121062]; Natural Science Foundation of Fujian Province of China [2012J01417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 30872515), the Fundamental Research Funds for the Central Universities of China (No. 2011121062), and the Natural Science Foundation of Fujian Province of China (No. 2012J01417) to YB Mao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gos Monika, 2009, Postepy Biochem, V55, P121; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Li Y, 2012, GYNECOL ONCOL, V124, P112, DOI 10.1016/j.ygyno.2011.09.003; Mao YB, 2006, CELL BIOL INT, V30, P332, DOI 10.1016/j.cellbi.2005.12.008; Mao YB, 2011, ONCOL REP, V25, P107, DOI 10.3892/or_00001048; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Niu RF, 2007, J EXP CLIN CANC RES, V26, P385; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Sun T, 2010, HEPATOLOGY, V51, P545, DOI 10.1002/hep.23311; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Xia WL, 2011, MOL CANCER THER, V10, P1367, DOI 10.1158/1535-7163.MCT-10-0991; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x; Zhang Z, 2007, HUM PATHOL, V38, P598, DOI 10.1016/j.humpath.2006.10.004	38	22	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48178	10.1371/journal.pone.0048178	http://dx.doi.org/10.1371/journal.pone.0048178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133563	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800053
J	Morra, S; Giraudo, A; Di Nardo, G; King, PW; Gilardi, G; Valetti, F				Morra, Simone; Giraudo, Alberto; Di Nardo, Giovanna; King, Paul W.; Gilardi, Gianfranco; Valetti, Francesca			Site Saturation Mutagenesis Demonstrates a Central Role for Cysteine 298 as Proton Donor to the Catalytic Site in CaHydA [FeFe]-Hydrogenase	PLOS ONE			English	Article							FE-ONLY HYDROGENASES; CLOSTRIDIUM-PASTEURIANUM; DIRECTED EVOLUTION; H-CLUSTER; MECHANISM; ENZYMES; ACTIVATION; MATURATION; PROTEINS; CYCLE	[FeFe]-hydrogenases reversibly catalyse molecular hydrogen evolution by reduction of two protons. Proton supply to the catalytic site (H-cluster) is essential for enzymatic activity. Cysteine 298 is a highly conserved residue in all [FeFe]-hydrogenases; moreover C298 is structurally very close to the H-cluster and it is important for hydrogenase activity. Here, the function of C298 in catalysis was investigated in detail by means of site saturation mutagenesis, simultaneously studying the effect of C298 replacement with all other 19 amino acids and selecting for mutants with high retained activity. We demonstrated that efficient enzymatic turnover was maintained only when C298 was replaced by aspartic acid, despite the structural diversity between the two residues. Purified CaHydA C298D does not show any significant structural difference in terms of secondary structure and iron incorporation, demonstrating that the mutation does not affect the overall protein fold. C298D retains the hydrogen evolution activity with a decrease of k(cat) only by 2-fold at pH 8.0 and it caused a shift of the optimum pH from 8.0 to 7.0. Moreover, the oxygen inactivation rate was not affected demonstrating that the mutation does not influence O-2 diffusion to the active site or its reactivity with the H-cluster. Our results clearly demonstrate that, in order to maintain the catalytic efficiency and the high turnover number typical of [FeFe] hydrogenases, the highly conserved C298 can be replaced only by another ionisable residue with similar steric hindrance, giving evidence of its involvement in the catalytic function of [FeFe]-hydrogenases in agreement with an essential role in proton transfer to the active site.	[Morra, Simone; Giraudo, Alberto; Di Nardo, Giovanna; Gilardi, Gianfranco; Valetti, Francesca] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [King, Paul W.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA	University of Turin; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Valetti, F (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	francesca.valetti@unito.it	Gilardi, Gianfranco/M-3748-2019; Gilardi, Gianfranco/B-4523-2010; Morra, Simone/B-4225-2018; King, Paul W./D-9979-2011	Gilardi, Gianfranco/0000-0002-6559-276X; Gilardi, Gianfranco/0000-0002-6559-276X; Morra, Simone/0000-0003-1341-191X; King, Paul W./0000-0001-5039-654X; Di Nardo, Giovanna/0000-0002-4169-2635; Valetti, Francesca/0000-0002-8380-595X	project BIOH2 Regione Piemonte; Foundation "Compagnia di San Paolo (Torino)"	project BIOH2 Regione Piemonte; Foundation "Compagnia di San Paolo (Torino)"	This work was partially funded by project BIOH2 Regione Piemonte. SM was supported by a PhD fellowship granted by the Foundation "Compagnia di San Paolo (Torino)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1984, J BIOL CHEM, V259, P7045; ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Bingham AS, 2012, INT J HYDROGEN ENERG, V37, P2965, DOI 10.1016/j.ijhydene.2011.02.048; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; CLELAND WW, 1982, METHOD ENZYMOL, V87, P390; Cohen J, 2005, STRUCTURE, V13, P1321, DOI 10.1016/j.str.2005.05.013; Cornish AJ, 2011, J BIOL CHEM, V286, P38341, DOI 10.1074/jbc.M111.254664; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Cukierman S, 2006, BBA-BIOENERGETICS, V1757, P876, DOI 10.1016/j.bbabio.2005.12.001; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Dixon M., 1979, ENZYMES, Vthird; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Greco C, 2007, INORG CHEM, V46, P5911, DOI 10.1021/ic062320a; Gunner MR, 2006, BBA-BIOENERGETICS, V1757, P942, DOI 10.1016/j.bbabio.2006.06.005; Hallenbeck PC, 2009, INT J HYDROGEN ENERG, V34, P7379, DOI 10.1016/j.ijhydene.2008.12.080; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; Hong G, 2011, BBA-BIOENERGETICS, V1807, P510, DOI 10.1016/j.bbabio.2011.01.011; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Knorzer P, 2012, J BIOL CHEM, V286, P38341; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lautier T, 2011, FARADAY DISCUSS, V148, P385, DOI 10.1039/c004099c; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; MULTANI JS, 1972, BIOCHIM BIOPHYS ACTA, V256, P66, DOI 10.1016/0005-2728(72)90163-6; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2010, INT J HYDROGEN ENERG, V35, P10750, DOI 10.1016/j.ijhydene.2010.02.056; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015275; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010554; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r	43	41	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48400	10.1371/journal.pone.0048400	http://dx.doi.org/10.1371/journal.pone.0048400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133586	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800074
J	Namlos, HM; Meza-Zepeda, LA; Baroy, T; Ostensen, IHG; Kresse, SH; Kuijjer, ML; Serra, M; Burger, H; Cleton-Jansen, AM; Myklebost, O				Namlos, Heidi M.; Meza-Zepeda, Leonardo A.; Baroy, Tale; Ostensen, Ingrid H. G.; Kresse, Stine H.; Kuijjer, Marieke L.; Serra, Massimo; Burger, Horst; Cleton-Jansen, Anne-Marie; Myklebost, Ola			Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs	PLOS ONE			English	Article							CELL-LINES; TUMOR-SUPPRESSOR; GENE; CLUSTER; IDENTIFICATION; PROFILES; MIRNA; TUMORIGENICITY; DEREGULATION; SIGNATURE	Background: Osteosarcomas are the most common primary malignant tumors of bone and show multiple and complex genomic aberrations. miRNAs are non-coding RNAs capable of regulating gene expression at the post transcriptional level, and miRNAs and their target genes may represent novel therapeutic targets or biomarkers for osteosarcoma. In order to investigate the involvement of miRNAs in osteosarcoma development, global microarray analyses of a panel of 19 human osteosarcoma cell lines was performed. Principal findings: We identified 177 miRNAs that were differentially expressed in osteosarcoma cell lines relative to normal bone. Among these, miR-126/miR-126*, miR-142-3p, miR-150, miR-223, miR-486-5p and members of the miR-1/miR-133a, miR-144/miR-451, miR-195/miR-497 and miR-206/miR-133b clusters were found to be downregulated in osteosarcoma cell lines. All miRNAs in the paralogous clusters miR-17-92, miR-106b-25 and miR-106a-92 were overexpressed. Furthermore, the upregulated miRNAs included miR-9/miR-9*, miR-21*, miR-31/miR-31*, miR-196a/miR-196b, miR-374a and members of the miR-29 and miR-130/301 families. The most interesting inversely correlated miRNA/mRNA pairs in osteosarcoma cell lines included miR-9/TGFBR2 and miR-29/p85a regulatory subunit of PI3K. PTEN mRNA correlated inversely with miR-92a and members of the miR-17 and miR-130/301 families. Expression profiles of selected miRNAs were confirmed in clinical samples. A set of miRNAs, miR-1, miR-18a, miR-18b, miR-19b, miR-31, miR-126, miR-142-3p, miR-133b, miR-144, miR-195, miR-223, miR-451 and miR-497 was identified with an intermediate expression level in osteosarcoma clinical samples compared to osteoblasts and bone, which may reflect the differentiation level of osteosarcoma relative to the undifferentiated osteoblast and fully differentiated normal bone. Significance: This study provides an integrated analysis of miRNA and mRNA in osteosarcoma, and gives new insight into the complex genetic mechanisms of osteosarcoma development and progression.	[Namlos, Heidi M.; Meza-Zepeda, Leonardo A.; Baroy, Tale; Ostensen, Ingrid H. G.; Kresse, Stine H.; Kuijjer, Marieke L.; Serra, Massimo; Burger, Horst; Cleton-Jansen, Anne-Marie; Myklebost, Ola] Oslo Univ Hosp, EuroBoNet Network Excellence Bone Tumours, Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway; [Namlos, Heidi M.; Meza-Zepeda, Leonardo A.; Baroy, Tale; Kresse, Stine H.; Myklebost, Ola] Oslo Univ Hosp, Dept Tumor Biol, Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway; [Meza-Zepeda, Leonardo A.; Ostensen, Ingrid H. G.; Myklebost, Ola] Univ Oslo, Norwegian Microarray Consortium, Dept Mol Biosci, Oslo, Norway; [Kuijjer, Marieke L.; Cleton-Jansen, Anne-Marie] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Serra, Massimo] Rizzoli Orthopaed Inst, Expt Oncol Lab, Bologna, Italy; [Burger, Horst] Univ Munster, Inst Pathol, Munster, Germany	University of Oslo; University of Oslo; University of Oslo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; IRCCS Istituto Ortopedico Rizzoli; University of Munster	Myklebost, O (corresponding author), Oslo Univ Hosp, EuroBoNet Network Excellence Bone Tumours, Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway.	ola.myklebost@imbv.uio.no	Meza-Zepeda, Leonardo Andres/CAG-5229-2022; Namløs, Heidi Maria/AAB-2843-2021; Myklebost, Ola/E-9335-2010; kuijjer, marieke/AAG-5844-2019; Serra, Massimo/J-4878-2016	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X; Myklebost, Ola/0000-0002-2866-3223; kuijjer, marieke/0000-0001-6280-3130; Serra, Massimo/0000-0003-0742-1177; Baroy, Tale/0000-0002-6796-7959	EuroBoNet, a European Commission granted Network of Excellence [LSHC-CT-2006-018814]; Norwegian Cancer Society	EuroBoNet, a European Commission granted Network of Excellence(European CommissionEuropean Commission Joint Research Centre); Norwegian Cancer Society(Norwegian Cancer Society)	The study was funded by EuroBoNet, a European Commission granted Network of Excellence for studying the pathology and genetics of bone tumors (LSHC-CT-2006-018814), and the Norwegian Cancer Society (Ragnvarda F. Sorvik and Hakon Starheims legacy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, R LANG ENV STAT COMP; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumhoer D, 2012, CANCER GENET-NY, V205, P212, DOI 10.1016/j.cancergen.2012.03.001; Bianchi N, 2012, EPIGENOMICS-UK, V4, P51, DOI [10.2217/EPI.11.104, 10.2217/epi.11.104]; Buddingh EP, 2011, CLIN CANCER RES, V17, P2110, DOI 10.1158/1078-0432.CCR-10-2047; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kobayashi Eisuke, 2012, Sarcoma, V2012, P359739, DOI 10.1155/2012/359739; Kresse SH, 2012, PLOS ONE IN PRESS; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Kuijjer ML, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-66; Kurek KC, 2010, CANCER RES, V70, P5577, DOI 10.1158/0008-5472.CAN-09-4602; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Liao MZ, 2010, MOL BIOSYST, V6, P1863, DOI 10.1039/b926947a; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lulla Rishi R., 2011, Sarcoma, V2011, P732690, DOI 10.1155/2011/732690; Maire G, 2011, CANCER GENET-NY, V204, P138, DOI 10.1016/j.cancergen.2010.12.012; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; PosthumaDeBoer J, 2011, CLIN EXP METASTAS, V28, P493, DOI 10.1007/s10585-011-9384-x; Raymond AK., 2002, WHO CLASSIFICATION T; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sarver AL, 2010, LAB INVEST; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Wang Y, 2008, J CLIN ONCOL, V7, P296; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zhang H, 2010, ONCOL REP, V24, P1363, DOI 10.3892/or_00000994; Ziyan W, 2010, MED ONCOL, V28, P1469	60	232	243	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48086	10.1371/journal.pone.0048086	http://dx.doi.org/10.1371/journal.pone.0048086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133552	Green Submitted, gold, Green Published			2022-12-25	WOS:000310261800042
J	Sulzmaier, FJ; Li, ZW; Nakashige, ML; Fash, DM; Chain, WJ; Ramos, JW				Sulzmaier, Florian J.; Li, Zhenwu; Nakashige, Mika L.; Fash, David M.; Chain, William J.; Ramos, Joe W.			Englerin A Selectively Induces Necrosis in Human Renal Cancer Cells	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; FORMAL SYNTHESIS; PLASMA-MEMBRANE; CARCINOMA; DEATH; APOPTOSIS; AUTOPHAGY; (-)-ENGLERIN; EXPRESSION; INHIBITOR	The number of renal cancers has increased over the last ten years and patient survival in advanced stages remains very poor. Therefore, new therapeutic approaches for renal cancer are essential. Englerin A is a natural product with a very potent and selective cytotoxicity against renal cancer cells. This makes it a promising drug candidate that may improve current treatment standards for patients with renal cancers in all stages. However, little is known about englerin A's mode of action in targeting specifically renal cancer cells. Our study is the first to investigate the biological mechanism of englerin A action in detail. We report that englerin A is specific for renal tumor cells and does not affect normal kidney cells. We find that englerin A treatment induces necrotic cell death in renal cancer cells but not in normal kidney cells. We further show that autophagic and pyroptotic proteins are unaffected by the compound and that necrotic signaling in these cells coincided with production of reactive oxygen species and calcium influx into the cytoplasm. As the first study to analyze the biological effects of englerin A, our work provides an important basis for the evaluation and validation of the compound's use as an anti-tumor drug. It also provides a context in which to identify the specific target or targets of englerin A in renal cancer cells.	[Sulzmaier, Florian J.; Chain, William J.; Ramos, Joe W.] Univ Hawaii Manoa, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA; [Li, Zhenwu; Nakashige, Mika L.; Fash, David M.; Chain, William J.] Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA; [Sulzmaier, Florian J.; Ramos, Joe W.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Ramos, JW (corresponding author), Univ Hawaii Manoa, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA.	jramos@cc.hawaii.edu	Ramos, Joe/G-4074-2010; Chain, William/AAA-3271-2020; Li, Zhenwu/C-2021-2013	Ramos, Joe/0000-0002-9708-2115; Li, Zhenwu/0000-0003-0962-5931	National Institutes of Health, National Institute of General Medicine [R01GM088266]; Victoria S. and Bradley L. Geist Foundation [47030]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088266] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Victoria S. and Bradley L. Geist Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Institute of General Medicine (R01GM088266 to JWR) and the Victoria S. and Bradley L. Geist Foundation (47030 to WJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agle KA, 2010, J BIOL CHEM, V285, P16066, DOI 10.1074/jbc.M109.061416; Akee RK, 2012, J NAT PROD; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Arjumand W, 2012, TUMOR BIOL, V33, P9, DOI 10.1007/s13277-011-0257-3; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Chain WJ, 2011, SYNLETT, P2605, DOI 10.1055/s-0030-1289521; Chan KP, 2011, CHEMMEDCHEM, V6, P420, DOI 10.1002/cmdc.201000544; Cho DC, 2011, HEMATOL ONCOL CLIN N, V25, P917, DOI 10.1016/j.hoc.2011.05.001; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Clarke PG, 2012, AUTOPHAGY, V8; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Kabir J, 2002, BIOCHEM J, V367, P145, DOI 10.1042/BJ20020665; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee J, 2012, ORG LETT; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Li Minghua, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P156; Li ZW, 2011, J AM CHEM SOC, V133, P6553, DOI 10.1021/ja201921j; Lu YY, 2012, CHINESE J ORG CHEM, V32, P1, DOI 10.6023/cjoc1110141; Mancuso A, 2006, CURR OPIN UROL, V16, P337, DOI 10.1097/01.mou.0000240305.78205.77; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Nicolaou KC, 2010, J AM CHEM SOC, V132, P8219, DOI 10.1021/ja102927n; Potti A, 2004, CLIN CANCER RES, V10, p6371S, DOI 10.1158/1078-0432.CCR-050014; Pouwer RH, 2012, CHEM-ASIAN J, V7, P22, DOI 10.1002/asia.201100780; Radtke L, 2011, ANGEW CHEM INT EDIT, V50, P3998, DOI 10.1002/anie.201007790; Ratnayake R, 2009, ORG LETT, V11, P57, DOI 10.1021/ol802339w; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Ushakov DB, 2011, ORG LETT, V13, P2090, DOI 10.1021/ol200499t; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vuky J, 2000, UROL ONCOL, V5, P249, DOI 10.1016/S1078-1439(00)00068-5; Wadhwa S, 2009, INT UROL NEPHROL, V41, P251, DOI 10.1007/s11255-008-9459-z; Wang CL, 2012, SYNLETT, P263, DOI 10.1055/s-0031-1290090; Wang JR, 2008, AUTOPHAGY, V4, P947, DOI 10.4161/auto.6787; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Xu J, 2012, CHEM-ASIAN J, V7, P1052, DOI 10.1002/asia.201101021; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	45	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e48032	10.1371/journal.pone.0048032	http://dx.doi.org/10.1371/journal.pone.0048032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23144724	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400029
J	Gottschalk, AJ; Trivedi, RD; Conaway, JW; Conaway, RC				Gottschalk, Aaron J.; Trivedi, Rushi D.; Conaway, Joan W.; Conaway, Ronald C.			Activation of the SNF2 Family ATPase ALC1 by Poly(ADP-ribose) in a Stable ALC1.PARP1.Nucleosome Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; CHROMATIN; CHD1L; GLYCOHYDROLASE; RIBOSE); PARP-1	The human ALC1/CHD1L oncogene encodes an SNF2 family ATPase with a macrodomain that binds poly(ADP-ribose) (PAR). We and others previously showed that ALC1 possesses a cryptic ATP-dependent nucleosome remodeling activity that is potently activated in the presence of PARP1 and NAD(+), its substrate for PAR synthesis. In this work, we dissected the mechanism by which PARP1 and NAD(+) activate ALC1 nucleosome remodeling. We demonstrate that ALC1 activation depends on the formation of a stable ALC1.PARylated PARP1.nucleosome intermediate. In addition, by exploiting a novel PAR footprinting assay, we obtained evidence that the ALC1 macrodomain remains stably associated with PAR on autoPARylated PARP1 during the course of nucleosome remodeling reactions. Taken together, our findings are consistent with the model that PAR present on PARylated PARP1 acts as an allosteric effector of ALC1 nucleosome remodeling activity.	[Gottschalk, Aaron J.; Trivedi, Rushi D.; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Trivedi, Rushi D.; Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org		Conaway, Joan/0000-0002-2786-0663	National Institutes of Health Grant from NIGMS [GM41628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041628, R37GM041628] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41628 from NIGMS (to J. W. C. and R. C. C.). This work was also supported by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Brockschmidt A, 2012, NEPHROL DIAL TRANSPL, V27, P2355, DOI 10.1093/ndt/gfr649; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006727; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; MIWA M, 1974, J BIOL CHEM, V249, P3475; Owen-Hughes T, 1999, METH MOL B, V119, P319; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664	15	44	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43527	43532		10.1074/jbc.M112.401141	http://dx.doi.org/10.1074/jbc.M112.401141			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23132853	Green Published, hybrid			2022-12-25	WOS:000312940800033
J	Oberg, EA; Nifoussi, SK; Gingras, AC; Strack, S				Oberg, Elizabeth A.; Nifoussi, Shanna K.; Gingras, Anne-Claude; Strack, Stefan			Selective Proteasomal Degradation of the B 'beta Subunit of Protein Phosphatase 2A by the E3 Ubiquitin Ligase Adaptor Kelch-like 15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHATASES; SUBSTRATE ADAPTER; TYROSINE-HYDROXYLASE; REGULATORY SUBUNITS; CRYSTAL-STRUCTURE; CORE ENZYME; HUMAN-CELLS; HOLOENZYME; PP2A; PATHWAY	Protein phosphatase 2A (PP2A), a ubiquitous and pleiotropic regulator of intracellular signaling, is composed of a core dimer (AC) bound to a variable (B) regulatory subunit. PP2A is an enzyme family of dozens of heterotrimers with different subcellular locations and cellular substrates dictated by the B subunit. B'beta is a brain-specific PP2A regulatory subunit that mediates dephosphorylation of Ca2+/calmodulin-dependent protein kinase II and tyrosine hydroxylase. Unbiased proteomic screens for B'beta interactors identified Cullin3 (Cul3), a scaffolding component of E3 ubiquitin ligase complexes, and the previously uncharacterized Kelch-like 15 (KLHL15). KLHL15 is one of similar to 40 Kelch-like proteins, many of which have been identified as adaptors for the recruitment of substrates to Cul3-based E3 ubiquitin ligases. Here, we report that KLHL15-Cul3 specifically targets B'beta to promote turnover of the PP2A subunit by ubiquitylation and proteasomal degradation. Comparison of KLHL15 and B'beta tissue expression profiles suggests that the E3 ligase adaptor contributes to selective expression of the PP2A/B'beta holoenzyme in the brain. We mapped KLHL15 residues critical for homodimerization as well as interaction with Cul3 and B'beta. Explaining PP2A subunit selectivity, the divergent N terminus of B'beta was found necessary and sufficient for KLHL15-mediated degradation, with Tyr-52 having an obligatory role. Although KLHL15 can interact with the PP2A/B'beta heterotrimer, it only degrades B'beta, thus promoting exchange with other regulatory subunits. E3 ligase adaptor-mediated control of PP2A holoenzyme composition thereby adds another layer of regulation to cellular dephosphorylation events.	[Oberg, Elizabeth A.; Nifoussi, Shanna K.; Strack, Stefan] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Gingras, Anne-Claude] Univ Toronto, Samuel Lunenfeld Inst, Toronto, ON M5G 1X5, Canada	University of Iowa; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Strack, S (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, 51 Newton Rd,2-432 BSB, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu	Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [NS043254, NS056244, NS057714]; Canadian Institutes of Health Research [MOP-84314]; American Heart Association Predoctoral Fellowship [0715634Z]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057714, R01NS056244, R56NS056244, R01NS043254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS043254, NS056244, and NS057714 (to S. S.). This work was also supported by the Canadian Institutes of Health Research Grant MOP-84314 (to A.-C. G.) and American Heart Association Predoctoral Fellowship 0715634Z (to S. K. N.).	Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dunham WH, 2011, PROTEOMICS, V11, P2603, DOI 10.1002/pmic.201000571; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Laezza F, 2008, NEUROPHARMACOLOGY, V55, P1131, DOI 10.1016/j.neuropharm.2008.07.021; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Nam S, 2009, J BIOL CHEM, V284, P8192, DOI 10.1074/jbc.M808230200; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Ruediger R, 1999, J VIROL, V73, P839, DOI 10.1128/JVI.73.1.839-842.1999; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Saraf A, 2010, BIOCHEMISTRY-US, V49, P986, DOI 10.1021/bi902160t; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Sumara I, 2007, CELL CYCLE, V6, P3004, DOI 10.4161/cc.6.24.5068; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003; Yatsenko AN, 2006, HUM MOL GENET, V15, P3411, DOI 10.1093/hmg/ddl417; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	45	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43378	43389		10.1074/jbc.M112.420281	http://dx.doi.org/10.1074/jbc.M112.420281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135275	hybrid, Green Published			2022-12-25	WOS:000312940800019
J	Sayed, N; Nonin-Lecomte, S; Rety, S; Felden, B				Sayed, Nour; Nonin-Lecomte, Sylvie; Rety, Stephane; Felden, Brice			Functional and Structural Insights of a Staphylococcus aureus Apoptotic-like Membrane Peptide from a Toxin-Antitoxin Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIA; DYNAMICS; SYSTEMS; RNAS; DISCOVERY; PROTEINS; MODEL	We report a functional type I toxin-antitoxin (TA) module expressed by a human pathogen, Staphylococcus aureus. TA-systems consist of stable toxins and labile antitoxins encoded within small genetic modules widespread in eubacteria and archaea. TA genes provide stress adaptation and protection against DNA loss or invasion. The genes encoding the SprA1 toxic peptide (PepA1) and the SprA1(AS) RNA antitoxin are within a pathogenicity island on opposite strands and possess a 3' overlap. To prevent peptide toxicity during S. aureus growth, PepA1 expression from stable (half-life > 3 h) SprA1 is repressed by elevated amounts of unstable (half-life = similar to 10 mn) SprA1(AS). In vivo, PepA1 localizes at the bacterial membrane and triggers S. aureus death. Based on NMR and CD data, its solution structure was solved and is a long bent, interrupted helix. Molecular dynamics simulations indicate that PepA1 compaction and helical content fluctuate in accordance with its cytoplasm or membrane location. When inserted into the S. aureus membrane, the PepA1 conformation switches to a similar to 7-nm-long continuous helix, presumably forming pores to alter membrane integrity. PepA1 expression is induced upon acidic and oxidative stresses by reducing SprA1(AS) levels. As an altruistic behavior during infection, some cells may induce the expression of that toxin that would facilitate departure from the host immune cells for spreading.	[Nonin-Lecomte, Sylvie; Rety, Stephane] CNRS, UMR 8015, Lab Cristallog & RMN Biol, F-75270 Paris 06, France; [Sayed, Nour; Felden, Brice] Univ Rennes 1, INSERM U835, Upres EA2311, F-35043 Rennes, France; [Nonin-Lecomte, Sylvie; Rety, Stephane] Univ Paris 05, Fac Pharm, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UDICE-French Research Universities; Universite Paris Cite	Nonin-Lecomte, S (corresponding author), CNRS, UMR 8015, Lab Cristallog & RMN Biol, F-75270 Paris 06, France.	snonin@parisdescartes.fr; bfelden@univ-rennes1.fr	Rety, Stephane/L-9870-2019; felden, brice/L-4825-2015	Rety, Stephane/0000-0002-2089-6727; Nonin-Lecomte, Sylvie/0000-0001-5155-8088	Agence Nationale pour la Recherche [ANR-09-MIEN-030-01]; INSERM; CNRS; Brittany; Fondation pour la Recherche Medicale; French Department of Research and Education	Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Brittany; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Department of Research and Education	This work was supported by Grant ANR-09-MIEN-030-01 from the Agence Nationale pour la Recherche (to B. F. and S. N.-L.), funds from the INSERM and the CNRS, a doctoral grant from Brittany (to N. S.), a grant from the Fondation pour la Recherche Medicale (to N. S.), and funds from the French Department of Research and Education.	Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Burkhart BM, 1999, BIOPOLYMERS, V51, P129, DOI 10.1002/(SICI)1097-0282(1999)51:2<129::AID-BIP3>3.0.CO;2-Y; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Fischer J, 1996, J CHROMATOGR B, V681, P3, DOI 10.1016/0378-4347(95)00538-2; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gobl C, 2010, BIOCHEMISTRY-US, V49, P6567, DOI 10.1021/bi1005128; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Kandasamy SK, 2006, BIOPHYS J, V90, P2326, DOI 10.1529/biophysj.105.073395; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Pashkov VS, 1999, FEBS LETT, V457, P117, DOI 10.1016/S0014-5793(99)01023-6; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Romilly C, 2012, RNA BIOL, V9, P402, DOI 10.4161/rna.20103; Sayed N, 2012, NAT STRUCT MOL BIOL, V19, P105, DOI 10.1038/nsmb.2193; Standberg E., 2004, CONCEPTS MAGN REAS A, V23A, P89; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang G., 2008, OPEN MAGN RESON J, V1, P9; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	27	53	54	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43454	43463		10.1074/jbc.M112.402693	http://dx.doi.org/10.1074/jbc.M112.402693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129767	Green Published, hybrid			2022-12-25	WOS:000312940800026
J	Shen, YY; Zhou, WP; Zhou, TC; Zeng, YN; Li, GM; Irwin, DM; Zhang, YP				Shen, Yong-Yi; Zhou, Wei-Ping; Zhou, Tai-Cheng; Zeng, Yan-Ni; Li, Gui-Mei; Irwin, David M.; Zhang, Ya-Ping			Genome-Wide Scan for Bats and Dolphin to Detect Their Genetic Basis for New Locomotive Styles	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; ECHOLOCATING BATS; ENERGY-METABOLISM; FLIGHT; CONVERGENT; ORIGIN	For most mammals, running is their major locomotive style, however, cetaceans and bats are two mammalian groups that have independently developed new locomotive styles (swimming and flying) from their terrestrial ancestors. In this study, we used a genome-wide comparative analysis in an attempt to identify the selective imprint of the development of new locomotive styles by cetaceans and bats to adapt to their new ecological niches. We found that an elevated proportion of mitochondrion-associated genes show evidence of adaptive evolution in cetaceans and on the common ancestral lineage leading to bats, compared to other terrestrial mammals. This result is consistent with the fact that during the independent developments of swimming and flying in these two groups, the changes of energy metabolism ratios would be among the most important factors to overcome elevated energy demands. Furthermore, genes that show evidence of sequence convergence or parallel evolution in these two lineages were overrepresented in the categories of energy metabolism, muscle contraction, heart, and glucose metabolism, genes that perform functions which are essential for locomotion. In conclusion, our analyses showed that on the dolphin and bat lineages, genes associated with locomotion not only both show a greater propensity to adaptively evolve, but also show evidence of sequence convergence, which likely reflects a response to a common requirement during their development of these two drastic locomotive styles.	[Shen, Yong-Yi; Zhou, Wei-Ping; Zeng, Yan-Ni; Li, Gui-Mei; Irwin, David M.; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhou, Wei-Ping] Univ Sci & Technol China, Sch Life Sci, Dept Mol & Cell Biol, Hefei 230026, Anhui, Peoples R China; [Zhou, Tai-Cheng] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Zeng, Yan-Ni; Zhang, Ya-Ping] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Yunnan University; East China Normal University; University of Toronto; University of Toronto	Shen, YY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	shen_yongyi@yahoo.com.cn; zhangyp@mail.kiz.ac.cn	Shen, Yongyi/GWU-8031-2022	Irwin, David/0000-0001-6131-4933	National Basic Research Program of China (973 Program) [2007CB411600]; National Natural Science Foundation of China [31172080]; Bureau of Science and Technology of Yunnan Province and Chinese Academy of Sciences	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province and Chinese Academy of Sciences	This work was supported by grants from the National Basic Research Program of China (973 Program, 2007CB411600), National Natural Science Foundation of China (No. 31172080), Bureau of Science and Technology of Yunnan Province and Chinese Academy of Sciences to Y-PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1977, J COMP PHYSIOL, V119, P141, DOI 10.1007/BF00686562; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; Dejours P., 1987, COMP PHYSL LIFE WATE; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Goodman M, 2009, P NATL ACAD SCI USA, V106, P20824, DOI 10.1073/pnas.0911239106; HARTMAN FRANK A., 1963, OHIO JOUR SCI, V63, P59; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUI CA, 1987, J MAMMAL, V68, P126, DOI 10.2307/1381055; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Maina JN, 2000, J EXP BIOL, V203, P3045; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; OWEN TG, 1974, BIOCHEM J, V143, P541, DOI 10.1042/bj1430541; PASQUIS P, 1970, RESP PHYSIOL, V9, P298, DOI 10.1016/0034-5687(70)90078-2; Polasek LK, 2001, J EXP BIOL, V204, P209; Ridgway, 1972, MAMMALS SEA BIOL MED; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Suarez RK, 2009, COMP BIOCHEM PHYS A, V153, P136, DOI 10.1016/j.cbpa.2009.01.015; THOMAS SP, 1972, J EXP BIOL, V57, P317; THOMAS SP, 1975, J EXP BIOL, V63, P273; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789	27	5	7	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e46455	10.1371/journal.pone.0046455	http://dx.doi.org/10.1371/journal.pone.0046455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139738	gold, Green Submitted, Green Published			2022-12-25	WOS:000311315300004
J	Chen, LL; Lee, D; Fukushima, K; Fukushima, J				Chen, Lewis L.; Lee, Daeyeol; Fukushima, Kikuro; Fukushima, Junko			Submovement Composition of Head Movement	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; KINEMATIC PROPERTIES; ARM MOVEMENTS; EYE FIELD; MONKEY; MODEL; GAZE; DECOMPOSITIONS; QUANTIZATION; GENERATION	Limb movement is smooth and corrections of movement trajectory and amplitude are barely noticeable midflight. This suggests that skeletomuscular motor commands are smooth in transition, such that the rate of change of acceleration (or jerk) is minimized. Here we applied the methodology of minimum-jerk submovement decomposition to a member of the skeletomuscular family, the head movement. We examined the submovement composition of three types of horizontal head movements generated by nonhuman primates: head-alone tracking, head-gaze pursuit, and eye-head combined gaze shifts. The first two types of head movements tracked a moving target, whereas the last type oriented the head with rapid gaze shifts toward a target fixed in space. During head tracking, the head movement was composed of a series of episodes, each consisting of a distinct, bell-shaped velocity profile (submovement) that rarely overlapped with each other. There was no specific magnitude order in the peak velocities of these submovements. In contrast, during eye-head combined gaze shifts, the head movement was often comprised of overlapping submovements, in which the peak velocity of the primary submovement was always higher than that of the subsequent submovement, consistent with the two-component strategy observed in goal-directed limb movements. These results extend the previous submovement composition studies from limb to head movements, suggesting that submovement composition provides a biologically plausible approach to characterizing the head motor recruitment that can vary depending on task demand.	[Chen, Lewis L.] Univ Mississippi, Med Ctr, Dept Otolaryngol Neurobiol & Anat Sci, Jackson, MS 39216 USA; [Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Fukushima, Kikuro] Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido 060, Japan; [Fukushima, Junko] Hokkaido Univ, Sch Med, Dept Hlth Sci, Sapporo, Hokkaido 060, Japan	University of Mississippi; University of Mississippi Medical Center; Yale University; Hokkaido University; Hokkaido University	Chen, LL (corresponding author), Univ Mississippi, Med Ctr, Dept Otolaryngol Neurobiol & Anat Sci, Jackson, MS 39216 USA.	lchen2@umc.edu			 [EY016710];  [MH059216];  [17022001];  [18300130]; Grants-in-Aid for Scientific Research [23500577] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R21EY016710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059216] Funding Source: NIH RePORTER	; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by EY016710 (LC), MH059216 (DL), and Grants-in-aid for Scientific Research on Priority Areas, Japan (17022001 and 18300130) (JF and KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck S, 2007, BRAIN RES, V1179, P51, DOI 10.1016/j.brainres.2007.08.048; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Burdet E, 1998, BIOL CYBERN, V78, P307, DOI 10.1007/s004220050435; Chen LL, 2007, EUR J NEUROSCI, V25, P1253, DOI 10.1111/j.1460-9568.2007.05392.x; Chen LLT, 2006, J NEUROPHYSIOL, V95, P3528, DOI 10.1152/jn.01320.2005; Chen LLT, 2005, J NEUROPHYSIOL, V94, P4502, DOI 10.1152/jn.00510.2005; Dipietro L, 2009, CORTEX, V45, P318, DOI 10.1016/j.cortex.2008.02.008; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Fishbach A, 2005, EXP BRAIN RES, V164, P442, DOI 10.1007/s00221-005-2264-3; Fishbach A, 2007, EXP BRAIN RES, V177, P45, DOI 10.1007/s00221-006-0652-y; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fukushima K, 2009, CEREB CORTEX, V19, P263, DOI 10.1093/cercor/bhn079; Green AM, 2003, J NEUROSCI, V23, P9265; HOGAN N, 1984, J NEUROSCI, V4, P2745; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; King WM, 2011, ANN NY ACAD SCI, V1233, P219, DOI 10.1111/j.1749-6632.2011.06165.x; Krebs HI, 1999, P NATL ACAD SCI USA, V96, P4645, DOI 10.1073/pnas.96.8.4645; Lee D, 1997, EXP BRAIN RES, V116, P421, DOI 10.1007/PL00005770; MILNER TE, 1992, NEUROSCIENCE, V49, P487, DOI 10.1016/0306-4522(92)90113-G; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Novak KE, 2000, EXP BRAIN RES, V132, P419, DOI 10.1007/s002210000366; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Perez MA, 2009, CORTEX, V45, P1065, DOI 10.1016/j.cortex.2008.12.006; Quinet J, 2007, J NEUROPHYSIOL, V98, P3269, DOI 10.1152/jn.00741.2007; Quinet J, 2009, J NEUROPHYSIOL, V102, P320, DOI 10.1152/jn.90716.2008; Richmond F.J., 1988, CONTROL HEAD MOVEMEN, P1; Rohrer B, 2006, BIOL CYBERN, V94, P409, DOI 10.1007/s00422-006-0055-y; Rohrer B, 2004, MOTOR CONTROL, V8, P472, DOI 10.1123/mcj.8.4.472; Rohrer B, 2003, BIOL CYBERN, V89, P190, DOI 10.1007/s00422-003-0428-4; Sparks DL, 2001, VISION RES, V41, P3295, DOI 10.1016/S0042-6989(01)00063-3; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; Zhou W, 2011, SOC NEUR ABSTR	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e47565	10.1371/journal.pone.0047565	http://dx.doi.org/10.1371/journal.pone.0047565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139749	Green Published, gold			2022-12-25	WOS:000310741400026
J	Ling, CY; Hendrickson, ML; Kalil, RE				Ling, Changying; Hendrickson, Michael L.; Kalil, Ronald E.			Resolving the Detailed Structure of Cortical and Thalamic Neurons in the Adult Rat Brain with Refined Biotinylated Dextran Amine Labeling	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; WHEAT-GERM-AGGLUTININ; PRIMARY VISUAL-CORTEX; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; CENTRAL-NERVOUS-SYSTEM; HORSERADISH-PEROXIDASE; ANTEROGRADE TRACER; VERSATILE ANTEROGRADE; SYNAPTIC ACTIVITY; AXONAL-TRANSPORT	Biotinylated dextran amine (BDA) has been used frequently for both anterograde and retrograde pathway tracing in the central nervous system. Typically, BDA labels axons and cell somas in sufficient detail to identify their topographical location accurately. However, BDA labeling often has proved to be inadequate to resolve the fine structural details of axon arbors or the dendrites of neurons at a distance from the site of BDA injection. To overcome this limitation, we varied several experimental parameters associated with the BDA labeling of neurons in the adult rat brain in order to improve the sensitivity of the method. Specifically, we compared the effect on labeling sensitivity of: (a) using 3,000 or 10,000 MW BDA; (b) injecting different volumes of BDA; (c) co-injecting BDA with NMDA; and (d) employing various post-injection survival times. Following the extracellular injection of BDA into the visual cortex, labeled cells and axons were observed in both cortical and thalamic areas of all animals studied. However, the detailed morphology of axon arbors and distal dendrites was evident only under optimal conditions for BDA labeling that take into account the: molecular weight of the BDA used, concentration and volume of BDA injected, post-injection survival time, and toning of the resolved BDA with gold and silver. In these instances, anterogradely labeled axons and retrogradely labeled dendrites were resolved in fine detail, approximating that which can be achieved with intracellularly injected compounds such as biocytin or fluorescent dyes.	[Kalil, Ronald E.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hendrickson, Michael L.] Univ Wisconsin, WM Keck Lab Biol Imaging, Sch Med & Publ Hlth, Madison, WI USA; [Ling, Changying] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kalil, RE (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rekalil@wisc.edu		Hendrickson, Michael/0000-0002-4555-765X	NSF [IBN-9809905]	NSF(National Science Foundation (NSF))	This work was supported by a grant from the NSF (IBN-9809905) to REK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTERMARK B, 1990, EXP BRAIN RES, V80, P83, DOI 10.1007/BF00228850; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Bielschowsky M, 1908, JB PSYCHOL NEUROL, V12, P135; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; BRANDT HM, 1992, J NEUROSCI METH, V45, P35, DOI 10.1016/0165-0270(92)90041-B; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CROSSLAND WJ, 1985, BRAIN RES, V347, P11, DOI 10.1016/0006-8993(85)90884-4; CRUNELLI V, 1987, J PHYSIOL-LONDON, V384, P587, DOI 10.1113/jphysiol.1987.sp016471; CURRIE SN, 1994, BRAIN RES, V662, P103, DOI 10.1016/0006-8993(94)90801-X; DING SL, 1995, J NEUROSCI METH, V57, P67, DOI 10.1016/0165-0270(94)00127-3; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; FINK ROBERT P., 1967, BRAIN RES, V4, P369, DOI 10.1016/0006-8993(67)90166-7; FRITZSCH B, 1993, J NEUROSCI METH, V50, P95, DOI 10.1016/0165-0270(93)90060-5; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P311; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Golgi C., 1875, RIV SPERIMENTALE FRE, V1, P405; GROSSMAN A, 1973, J COMP NEUROL, V150, P441, DOI 10.1002/cne.901500404; Hendrickson A, 1978, METHODS PSYSIOLOGICA, V2, P241; Holzman E, 1971, SCIENCE, V173, P733; HUGHES HC, 1977, J COMP NEUROL, V175, P311, DOI 10.1002/cne.901750306; IZZO PN, 1991, J NEUROSCI METH, V36, P155, DOI 10.1016/0165-0270(91)90041-W; JANKOWSKA E, 1985, BRAIN RES, V341, P403, DOI 10.1016/0006-8993(85)91084-4; JIANG XP, 1993, J NEUROSCI METH, V50, P45, DOI 10.1016/0165-0270(93)90055-V; JOHNSON RR, 1992, EXP BRAIN RES, V89, P20; Johnson RR, 1996, J COMP NEUROL, V368, P335, DOI 10.1002/(SICI)1096-9861(19960506)368:3<335::AID-CNE2>3.0.CO;2-6; KING MA, 1989, BRAIN RES, V497, P361, DOI 10.1016/0006-8993(89)90281-3; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; KRIEBEL RM, 1975, J COMP NEUROL, V159, P45, DOI 10.1002/cne.901590105; KRIEG WJS, 1946, J COMP NEUROL, V84, P221, DOI 10.1002/cne.900840205; Lanciego JL, 2011, J CHEM NEUROANAT, V42, P157, DOI 10.1016/j.jchemneu.2011.07.001; Ling C, 1998, VISUAL NEUROSCI, V15, P1; Ling C, 2012, PLOS ONE IN PRESS; Ling CY, 1997, J COMP NEUROL, V388, P467; Lozsadi DA, 1996, EUR J NEUROSCI, V8, P2416, DOI 10.1111/j.1460-9568.1996.tb01205.x; MANTYH PW, 1983, J NEUROSCI METH, V7, P117, DOI 10.1016/0165-0270(83)90074-2; MARTINEZGARCIA F, 1994, J COMP NEUROL, V350, P439, DOI 10.1002/cne.903500308; MCDONALD CT, 1993, J NEUROSCI, V13, P768; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; MIKKELSEN JD, 1992, BRAIN RES BULL, V28, P619, DOI 10.1016/0361-9230(92)90112-B; Mobbs P., 1994, MICROELECTRODE TECHN, V2nd, P361; NAUTA WJH, 1954, STAIN TECHNOL, V29, P91, DOI 10.3109/10520295409115448; Nowicka D, 1996, J NEUROSCI RES, V44, P471, DOI 10.1002/(SICI)1097-4547(19960601)44:5<471::AID-JNR7>3.0.CO;2-C; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; PETERS A, 1985, J COMP NEUROL, V238, P263, DOI 10.1002/cne.902380303; PETERS A, 1981, J NEUROCYTOL, V10, P921, DOI 10.1007/BF01258522; PETERS A, 1987, J COMP NEUROL, V260, P573, DOI 10.1002/cne.902600410; PEYRONNARD JM, 1983, BRAIN RES, V275, P203, DOI 10.1016/0006-8993(83)90983-6; POPOV S, 1992, J NEUROSCI, V12, P77; RAJAKUMAR N, 1993, BRAIN RES, V607, P47, DOI 10.1016/0006-8993(93)91488-E; Raju DV, 2006, CURR PROTOC NEUROSCI, V1; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; RIBAK CE, 1975, BRAIN RES, V92, P341, DOI 10.1016/0006-8993(75)90322-4; Rosoklija G, 2003, J NEUROSCI METH, V131, P1, DOI 10.1016/j.jneumeth.2003.06.001; RUDA M, 1982, BRAIN RES, V249, P237, DOI 10.1016/0006-8993(82)90057-9; SINGER W, 1977, BRAIN RES, V120, P133, DOI 10.1016/0006-8993(77)90502-9; TODOROVA N, 1995, J NEUROSCI METH, V61, P145, DOI 10.1016/0165-0270(95)00036-T; Uchihara T, 2007, ACTA NEUROPATHOL, V113, P483, DOI 10.1007/s00401-007-0200-2; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; WEBSTER MJ, 1984, EXP BRAIN RES, V56, P468; WERNER L, 1982, Z MIKROSK ANAT FORSC, V96, P433; Williams SR, 1996, J PHYSL, V490, P120; WOUTERLOOD FG, 1993, J NEUROSCI METH, V48, P75, DOI 10.1016/S0165-0270(05)80009-3; Yasukawa T, 2004, J COMP NEUROL, V471, P153, DOI 10.1002/cne.20029; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	67	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e45886	10.1371/journal.pone.0045886	http://dx.doi.org/10.1371/journal.pone.0045886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23144777	Green Published, gold, Green Submitted			2022-12-25	WOS:000310741400005
J	van Gestel, AJR; Clarenbach, CF; Stowhas, AC; Rossi, VA; Sievi, NA; Camen, G; Russi, EW; Kohler, M				van Gestel, Arnoldus J. R.; Clarenbach, Christian F.; Stoewhas, Anne C.; Rossi, Valentina A.; Sievi, Noriane A.; Camen, Giovanni; Russi, Erich W.; Kohler, Malcolm			Predicting Daily Physical Activity in Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							6-MIN WALK DISTANCE; ENERGY-EXPENDITURE; DAILY-LIFE; MUSCLE STRENGTH; COPD; HEALTH; RELIABILITY; MORTALITY; VALIDITY	Background: Objectively measuring daily physical activity (PA) using an accelerometer is a relatively expensive and time-consuming undertaking. In routine clinical practice it would be useful to estimate PA in patients with chronic obstructive pulmonary disease (COPD) with more simple methods. Objectives: To evaluate whether PA can be estimated by simple tests commonly used in clinical practice in patients with COPD. Methods: The average number of steps per day was measured for 7 days with a SenseWear Pro (TM) accelerometer and used as gold standard for PA. A physical activity level (PAL) of <1.4 was considered very inactive. Univariate and multivariate analyses were used to examine the relationship between the 6-minute walking distance (6MWD), the number of stands in the Sit-to-Stand Test (STST), hand-grip strength and the total energy expenditure as assessed by the Zutphen Physical Activity Questionnaire (TEEZPAQ). ROC curve analysis was used to identify patients with an extremely inactive lifestyle (PAL<1.4). Results: In 70 patients with COPD (21 females) with a mean [SD] FEV1 of 43.0 [22.0] % predicted, PA was found to be significantly and independently associated with the 6MWD (r = 0.69, 95% CI 0.54 to 0.80, p<0.001), STST (r = 0.51, 95% CI 0.31 to 0.66, p = 0.001) and TEEZPAQ (r = 0.50, 95% CI 0.30 to 0.66, p<0.001) but not with hand-grip strength. However, ROC curve analysis demonstrated that these tests cannot be used to reliably identify patients with an extremely inactive lifestyle. Conclusions: In patients with COPD simple tests such as the 6-Minute Walk Test, the Sit-to-Stand Test and the Zutphen Physical Activity Questionnaire cannot be used to reliably predict physical inactivity.	[van Gestel, Arnoldus J. R.; Clarenbach, Christian F.; Stoewhas, Anne C.; Rossi, Valentina A.; Sievi, Noriane A.; Camen, Giovanni; Russi, Erich W.; Kohler, Malcolm] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland; [van Gestel, Arnoldus J. R.] Zurich Univ Appl Sci, Dept Hlth, Winterthur, Switzerland; [Russi, Erich W.; Kohler, Malcolm] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Zurich University of Applied Sciences; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	van Gestel, AJR (corresponding author), Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland.	vrns@zhaw.ch	Russi, Erich/AGN-8387-2022					Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; [Anonymous], 2008, Z GERONTOL GERIATR, V41, P208; BARANOWSKI T, 1984, RES Q EXERCISE SPORT, V55, P309, DOI 10.1080/02701367.1984.10608408; Black AE, 1996, EUR J CLIN NUTR, V50, P72; Bossenbroek L, 2011, COPD, V8, P306, DOI 10.3109/15412555.2011.578601; Bourbeau J, 2009, COPD, V6, P192, DOI 10.1080/15412550902902638; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Canuto F F, 2010, Electromyogr Clin Neurophysiol, V50, P47; Cavalheri V, 2011, RESP MED, V105, P922, DOI 10.1016/j.rmed.2011.01.004; Coronado Marcos, 2003, J Cardiopulm Rehabil, V23, P357, DOI 10.1097/00008483-200309000-00006; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Rocco CCD, 2011, CLINICS, V66, P125, DOI 10.1590/S1807-59322011000100022; Decramer M, 1997, EUR RESPIR J, V10, P417, DOI 10.1183/09031936.97.10020417; Donaldson GC, 2005, AM J RESP CRIT CARE, V171, P446, DOI 10.1164/rccm.200408-1054OC; Dourado VZ, 2006, CHEST, V129, P551, DOI 10.1378/chest.129.3.551; Durnin J., 1967, ENERGY WORK LEISURE; FOLSOM AR, 1986, J CHRON DIS, V39, P505, DOI 10.1016/0021-9681(86)90195-5; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garcia-Aymerich J, 2003, THORAX, V58, P100, DOI 10.1136/thorax.58.2.100; Giantomaso T, 2003, CLIN REHABIL, V17, P394, DOI 10.1191/0269215503cr626oa; Global Initiative for Chronic Obstructive Lung Disease, 2004, COPD, V1, P103; Global Initiative for Chronic Obstructive Lung Disease, 2004, COPD, V1, P105; Gross MM, 1998, GAIT POSTURE, V8, P175, DOI 10.1016/S0966-6362(98)00033-2; Jacobs D. R., 1997, MED SCI SPORTS EXERC, V29, P62; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; Kapella MC, 2006, NURS RES, V55, P10, DOI 10.1097/00006199-200601000-00002; Kocks JWH, 2011, PRIM CARE RESP J, V20, P269, DOI 10.4104/pcrj.2011.00031; LIGHT RW, 1985, CHEST, V87, P35, DOI 10.1378/chest.87.1.35; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montoye HJ, 2000, MED SCI SPORT EXER, V32, pS439, DOI 10.1097/00005768-200009001-00001; Ozalevli S, 2007, RESP MED, V101, P286, DOI 10.1016/j.rmed.2006.05.007; Patel Sanjay A, 2007, COPD, V4, P107, DOI 10.1080/15412550701246658; Pitta F, 2006, EUR RESPIR J, V27, P1040, DOI 10.1183/09031936.06.00064105; Pitta F, 2005, ARCH PHYS MED REHAB, V86, P1979, DOI 10.1016/j.apmr.2005.04.016; Pitta F, 2008, RESP MED, V102, P1203, DOI 10.1016/j.rmed.2008.03.004; Poulain M, 2003, CHEST, V123, P1401, DOI 10.1378/chest.123.5.1401; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Slinde F, 2003, CLIN NUTR, V22, P159, DOI 10.1054/clnu.2002.0618; Steele BG, 2000, CHEST, V117, P1359, DOI 10.1378/chest.117.5.1359; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Troosters T, 2010, RESP MED, V104, P1005, DOI 10.1016/j.rmed.2010.01.012; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Watz H, 2008, AM J RESP CRIT CARE, V177, P743, DOI 10.1164/rccm.200707-1011OC	46	51	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48081	10.1371/journal.pone.0048081	http://dx.doi.org/10.1371/journal.pone.0048081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133612	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000310702400022
J	Chen, WT; Zhong, YG; Qin, YN; Sun, SS; Li, Z				Chen, Wentian; Zhong, Yaogang; Qin, Yannan; Sun, Shisheng; Li, Zheng			The Evolutionary Pattern of Glycosylation Sites in Influenza Virus (H5N1) Hemagglutinin and Neuraminidase	PLOS ONE			English	Article							A VIRUS; ENDOPLASMIC-RETICULUM; ANTIGENIC SITES; MOLECULAR-BASIS; HONG-KONG; VIRULENCE; OUTBREAK; PROTEIN; RESISTANT; INFECTION	Two glycoproteins, hemagglutinin (HA) and neuraminidase (NA), on the surface of influenza viruses play crucial roles in transfaunation, membrane fusion and the release of progeny virions. To explore the distribution of N-glycosylation sites (glycosites) in these two glycoproteins, we collected and aligned the amino acid sequences of all the HA and NA subtypes. Two glycosites were located at HA0 cleavage sites and fusion peptides and were strikingly conserved in all HA subtypes, while the remaining glycosites were unique to their subtypes. Two to four conserved glycosites were found in the stalk domain of NA, but these are affected by the deletion of specific stalk domain sequences. Another highly conserved glycosite appeared at the top center of tetrameric global domain, while the others glycosites were distributed around the global domain. Here we present a detailed investigation of the distribution and the evolutionary pattern of the glycosites in the envelope glycoproteins of IVs, and further focus on the H5N1 virus and conclude that the glycosites in H5N1 have become more complicated in HA and less influential in NA in the last five years.	[Chen, Wentian; Zhong, Yaogang; Qin, Yannan; Li, Zheng] NW Univ Xian, Coll Life Sci, Lab Funct Glyc, Xian 710069, Peoples R China; [Sun, Shisheng] Johns Hopkins Univ, Dept Pathol, Div Clin Chem, Baltimore, MD USA	Northwest University Xi'an; Johns Hopkins University	Li, Z (corresponding author), NW Univ Xian, Coll Life Sci, Lab Funct Glyc, Xian 710069, Peoples R China.	zhengli@nwu.edu.cn	Zhong, Yaogang/L-8599-2015; Sun, Shisheng/P-5027-2019	Zhong, Yaogang/0000-0003-0254-2797; Sun, Shisheng/0000-0002-7242-7164	International S&T (Science and Technology) Cooperation Program of the Shaanxi Province of China [2009DFA32730]; Key Science and Technology Program of the Shaanxi Province of China [2010K12- 02(5)]	International S&T (Science and Technology) Cooperation Program of the Shaanxi Province of China; Key Science and Technology Program of the Shaanxi Province of China	This work was supported by the International S&T (Science and Technology) Cooperation Program (2009DFA32730) and the Key Science and Technology Program (2010K12- 02(5)) of the Shaanxi Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Bohne A, 2002, Pac Symp Biocomput, P285; Bragstad K, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-40; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Centers for Disease Control and Prevention, 2012, SEAS INFL FLU; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chavas LMG, 2010, J MED CHEM, V53, P2998, DOI 10.1021/jm100078r; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Chen W, 2000, MOL BIOL CELL, V11, P765, DOI 10.1091/mbc.11.2.765; Chen WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038794; Cherry Joshua L, 2009, PLoS Curr, V1, pRRN1001; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; DuBois RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002398; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilyushina NA, 2005, VIROLOGY, V341, P102, DOI 10.1016/j.virol.2005.07.003; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; KILBOURNE ED, 1990, P NATL ACAD SCI USA, V87, P786, DOI 10.1073/pnas.87.2.786; Kobayashi Y, 2012, J VIROL, V86, P3446, DOI 10.1128/JVI.06147-11; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; LI SQ, 1993, J VIROL, V67, P6667, DOI 10.1128/JVI.67.11.6667-6673.1993; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-80; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; LUO GX, 1993, VIRUS RES, V29, P141; Lynch JP, 2007, SEMIN RESP CRIT CARE, V28, P144, DOI 10.1055/s-2007-976487; Markus A, 2009, TRENDS BIOCHEM SCI, V35, P274; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Nayak D, 2006, VIRUS RES, V106, P147; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Ni J, 2010, VACCINE, V28, P6891, DOI 10.1016/j.vaccine.2010.08.011; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Parker BL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006833; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sammalkorpi M, 2007, BBA-BIOMEMBRANES, V1768, P30, DOI 10.1016/j.bbamem.2006.08.008; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stoll V, 2003, BIOCHEMISTRY-US, V42, P718, DOI 10.1021/bi0205449; Sun SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032119; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Suzuki Y, 2011, GENES GENET SYST, V86, P287, DOI 10.1266/ggs.86.287; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tong SX, 2012, PNAS; Tsai KN, 2011, MICROBES INFECT, V13, P479, DOI 10.1016/j.micinf.2011.01.013; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Viswanathan K, 2010, PLOS ONE, V5; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; Wagner R, 2001, INT CONGR SER, V1219, P375, DOI 10.1016/S0531-5131(01)00347-8; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; WHO, 2012, CUM NUMB CONF HUM CA; WHO/OIE/FAO H5N1 Evolution Working Group, 2008, Emerg Infect Dis, V14, pe1, DOI 10.3201/eid1407.071681; WHO/OIE/FAO H5N1 Evolution Working Group, 2011, UPD UN NOM SYST HIGH; Wu ZLL, 2009, BIOCHEM BIOPH RES CO, V379, P749, DOI 10.1016/j.bbrc.2008.12.139; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	76	28	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e49224	10.1371/journal.pone.0049224	http://dx.doi.org/10.1371/journal.pone.0049224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133677	gold, Green Published, Green Submitted			2022-12-25	WOS:000310601300034
J	Yin, LN; Hu, QZ; Hartmann, RW				Yin, Lina; Hu, Qingzhong; Hartmann, Rolf W.			3-Pyridyl Substituted Aliphatic Cycles as CYP11B2 Inhibitors: Aromaticity Abolishment of the Core Significantly Increased Selectivity over CYP1A2	PLOS ONE			English	Article							ALDOSTERONE SYNTHASE INHIBITORS; HUMAN 17-ALPHA-HYDROXYLASE-17,20-LYASE CYP17; STRUCTURALLY MODIFIED DERIVATIVES; CONGESTIVE-HEART-FAILURE; BIOLOGICAL EVALUATION; AROMATASE INHIBITORS; PROSTATE-CANCER; FLUORINE SUBSTITUTION; MYOCARDIAL FIBROSIS; ANGIOTENSIN-II	Aldosterone synthase (CYP11B2) is a promising therapeutic target for the treatment of cardiovascular diseases related to abnormally high aldosterone levels. On the basis of our previously identified lead compounds I-III, a series of 3-pyridinyl substituted aliphatic cycles were designed, synthesized and tested as CYP11B2 inhibitors. Aromaticity abolishment of the core was successfully applied to overcome the undesired CYP1A2 inhibition. This study resulted in a series of potent and selective CYP11B2 inhibitors, with compound 12 (IC50 = 21 nM, SF = 50) as the most promising one, which shows no inhibition toward CYP1A2 at 2 mu M. The design conception demonstrated in this study can be helpful in the optimization of CYP inhibitor drugs regarding CYP1A2 selectivity.	[Yin, Lina; Hu, Qingzhong; Hartmann, Rolf W.] Univ Saarland, D-6600 Saarbrucken, Germany; [Yin, Lina; Hu, Qingzhong; Hartmann, Rolf W.] Helmholtz Inst Pharmaceut Res Saarland HIPS, D-6600 Saarbrucken, Germany; [Yin, Lina] ElexoPharm GmbH, Saarbrucken, Germany	Saarland University; Helmholtz Association	Hu, QZ (corresponding author), Univ Saarland, D-6600 Saarbrucken, Germany.	q.hu@mx.uni-saarland.de; rolf.hartmann@helmholtz-hzi.de	Hu, Qingzhong/O-5244-2018	Yin, Lina/0000-0002-6734-521X; Hu, Qingzhong/0000-0002-8880-4948				Abadi AH, 2012, MEDCHEMCOMM, V3, P663, DOI 10.1039/c2md20072d; Al-Soud YA, 2011, TETRAHEDRON LETT, V52, P6372, DOI 10.1016/j.tetlet.2011.09.049; Cavalli A, 2005, J MED CHEM, V48, P7282, DOI 10.1021/jm058042r; Chai WX, 2005, HYPERTENSION, V46, P701, DOI 10.1161/01.HYP.0000182661.98259.4f; Ehmer PB, 2002, J STEROID BIOCHEM, V81, P173, DOI 10.1016/S0960-0760(02)00056-0; Fiebeler A, 2005, CIRCULATION, V111, P3087, DOI 10.1161/CIRCULATIONAHA.104.521625; Gobbi S, 2007, J MED CHEM, V50, P3420, DOI 10.1021/jm0702938; Gobbi S, 2006, J MED CHEM, V49, P4777, DOI 10.1021/jm060186y; Haidar S, 2003, J STEROID BIOCHEM, V84, P555, DOI 10.1016/S0960-0760(03)00070-0; HARTMANN RW, 1994, EUR J PHARM SCI, V2, P15, DOI 10.1016/0928-0987(94)90052-3; HARTMANN RW, 1994, J MED CHEM, V37, P1275, DOI 10.1021/jm00035a007; Hartmann RW, 1996, ARCH PHARM, V329, P251, DOI 10.1002/ardp.19963290506; Heim R, 2008, J MED CHEM, V51, P5064, DOI 10.1021/jm800377h; Hille UE, 2011, ACS MED CHEM LETT, V2, P2, DOI 10.1021/ml100071J; Hille UE, 2009, CR CHIM, V12, P1117, DOI 10.1016/j.crci.2009.03.007; Hille UE, 2009, EUR J MED CHEM, V44, P2765, DOI 10.1016/j.ejmech.2009.01.002; Hu QZ, 2008, BIOORGAN MED CHEM, V16, P7715, DOI 10.1016/j.bmc.2008.07.011; Hu QZ, 2012, J MED CHEM, V55, P7080, DOI 10.1021/jm3004637; Hu QZ, 2010, J MED CHEM, V53, P5749, DOI 10.1021/jm100317b; Hu QZ, 2010, J MED CHEM, V53, P5049, DOI 10.1021/jm100400a; Hu QZ, 2010, CHEMMEDCHEM, V5, P899, DOI 10.1002/cmdc.201000065; Jagusch C, 2008, BIOORGAN MED CHEM, V16, P1992, DOI 10.1016/j.bmc.2007.10.094; KAWAMOTO T, 1992, P NATL ACAD SCI USA, V89, P1458, DOI 10.1073/pnas.89.4.1458; Korhonen LE, 2005, J MED CHEM, V48, P3808, DOI 10.1021/jm0489713; Leroux F, 2003, HELV CHIM ACTA, V86, P2671, DOI 10.1002/hlca.200390217; Leze MP, 2006, BIOORG MED CHEM LETT, V16, P1134, DOI 10.1016/j.bmcl.2005.11.099; Lijnen P, 2000, J MOL CELL CARDIOL, V32, P865, DOI 10.1006/jmcc.2000.1129; Lucas S, 2008, J MED CHEM, V51, P6138, DOI 10.1021/jm800683c; Lucas S, 2011, J MED CHEM, V54, P2307, DOI 10.1021/jm101470k; Lucas S, 2008, J MED CHEM, V51, P8077, DOI 10.1021/jm800888q; Marchand P, 2003, BIOORG MED CHEM LETT, V13, P1553, DOI 10.1016/S0960-894X(03)00182-3; Mendieta MAEPB, 2008, ARCH PHARM, V341, P597, DOI 10.1002/ardp.200700251; Mendieta MAEPB, 2008, J MED CHEM, V51, P5009, DOI 10.1021/jm800355c; Mulder P, 2008, EUR HEART J, V29, P2171, DOI 10.1093/eurheartj/ehn277; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Roumen L, 2010, J MED CHEM, V53, P1712, DOI 10.1021/jm901356d; Sato A, 2001, J INT MED RES, V29, P13, DOI 10.1177/147323000102900103; Ulmschneider S, 2005, J MED CHEM, V48, P1796, DOI 10.1021/jm049600p; Ulmschneider S, 2005, J MED CHEM, V48, P1563, DOI 10.1021/jm0492397; Voets M, 2006, J MED CHEM, V49, P2222, DOI 10.1021/jm060055x; Voets M, 2005, J MED CHEM, V48, P6632, DOI 10.1021/jm0503704; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Yin LN, 2012, J MED CHEM, V55, P6629, DOI 10.1021/jm3003872	44	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48048	10.1371/journal.pone.0048048	http://dx.doi.org/10.1371/journal.pone.0048048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133610	Green Published, gold, Green Submitted			2022-12-25	WOS:000310601300004
J	Noutoshi, Y; Ikeda, M; Shirasu, K				Noutoshi, Yoshiteru; Ikeda, Mika; Shirasu, Ken			Diuretics Prime Plant Immunity in Arabidopsis thaliana	PLOS ONE			English	Article							CATION-CHLORIDE COTRANSPORTERS; SYSTEMIC ACQUIRED-RESISTANCE; OF-FUNCTION MUTATION; DISEASE RESISTANCE; SALICYLIC-ACID; DEFENSE RESPONSES; ACTIVATION; IDENTIFICATION; MECHANISMS; HORMONE	Plant activators are agrochemicals that activate the plant immune system, thereby enhancing disease resistance. Due to their prophylactic and durable effects on a wide spectrum of diseases, plant activators can provide synergistic crop protection when used in combination with traditional pest controls. Although plant activators have achieved great success in wet-rice farming practices in Asia, their use is still limited. To isolate novel plant activators applicable to other crops, we screened a chemical library using a method that can selectively identify immune-priming compounds. Here, we report the isolation and characterization of three diuretics, bumetanide, bendroflumethiazide and clopamide, as immune-priming compounds. These drugs upregulate the immunity-related cell death of Arabidopsis suspension-cultured cells induced with an avirulent strain of Pseudomonas syringae pv. tomato in a concentration-dependent manner. The application of these compounds to Arabidopsis plants confers disease resistance to not only the avirulent but also a virulent strain of the pathogen. Unlike salicylic acid, an endogenous phytohormone that governs disease resistance in response to biotrophic pathogens, the three diuretic compounds analyzed here do not induce PR1 or inhibit plant growth, showing potential as lead compounds in a practical application.	[Noutoshi, Yoshiteru; Ikeda, Mika] Okayama Univ, RCIS, Kita Ku, Okayama 7008530, Japan; [Shirasu, Ken] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	Okayama University; RIKEN	Noutoshi, Y (corresponding author), Okayama Univ, RCIS, Kita Ku, Okayama 7008530, Japan.	noutoshi@cc.okayama-u.ac.jp	Shirasu, Ken/ABF-5306-2020; NOUTOSHI, Yoshiteru/B-2421-2011; Noutoshi, Yoshiteru/R-6353-2019; Shirasu, Ken/A-4455-2010	Shirasu, Ken/0000-0002-0349-3870; Noutoshi, Yoshiteru/0000-0001-8140-3722; Shirasu, Ken/0000-0002-0349-3870	KAKENHI [22780036, 24228008]; Special Coordination Fund for Promoting Sciences and Technology of MEXT; Sumitomo Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Ryobi Teien Memory Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Special Coordination Fund for Promoting Sciences and Technology of MEXT; Sumitomo Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation)	This work was supported in part by KAKENHI (no. 22780036 to Y.N and 24228008 to K.S.) and the Special Coordination Fund for Promoting Sciences and Technology of MEXT to Y.N. This work was also partly supported by grants from The Sumitomo Foundation, The Kurata Memorial Hitachi Science and Technology Foundation and The Ryobi Teien Memory Foundation to Y.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G., 2004, PLANT PATHOLOGY; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gilbert P, 2010, MENT HEALTH RELIG CU, V13, P531, DOI 10.1080/13674676.2010.488415; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Healy R, 2007, J FAM PRACTICE, V56, P488; Knoth C, 2009, PLANT PHYSIOL, V150, P333, DOI 10.1104/pp.108.133678; Maor R, 2007, MOL CELL PROTEOMICS, V6, P601, DOI 10.1074/mcp.M600408-MCP200; Menges M, 2002, PLANT J, V30, P203, DOI 10.1046/j.1365-313X.2002.01274.x; Nakashita H, 2002, PHYSIOL MOL PLANT P, V61, P197, DOI 10.1006/pmpp.2002.0426; Noutoshi Y, 2005, PLANT J, V43, P873, DOI 10.1111/j.1365-313X.2005.02500.x; Noutoshi Y, 2012, PLANT CELL, V24, P3795, DOI 10.1105/tpc.112.098343; Oostendorp M, 2001, EUR J PLANT PATHOL, V107, P19, DOI 10.1023/A:1008760518772; OWEN NE, 1985, J BIOL CHEM, V260, P1445; Plant L, 2003, CLIN MED, V3, P517, DOI 10.7861/clinmedicine.3-6-517; Schreiber K, 2008, PLANT J, V54, P522, DOI 10.1111/j.1365-313X.2008.03425.x; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; WATANABE T, 1977, J PESTIC SCI, V2, P291; Weigel D., 2002, ARABIDOPSIS LAB MANU; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842	23	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48443	10.1371/journal.pone.0048443	http://dx.doi.org/10.1371/journal.pone.0048443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144763	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705300073
J	Hammarsten, P; Cipriano, M; Josefsson, A; Stattin, P; Egevad, L; Granfors, T; Fowler, CJ				Hammarsten, Peter; Cipriano, Mariateresa; Josefsson, Andreas; Stattin, Par; Egevad, Lars; Granfors, Torvald; Fowler, Christopher J.			Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RADICAL PROSTATECTOMY; GLEASON SCORE; PATHWAYS; TARGET	Background: In the present study, we have investigated the prognostic usefulness of phosphorylated Akt immunoreactivity (pAkt-IR) in prostate cancer using a well-characterised tissue microarray from men who had undergone transurethral resection due to lower urinary tract symptoms. Methodology/Principal Findings: pAkt-IR in prostate epithelial and tumour cells was assessed using a monoclonal anti-pAkt (Ser(473)) antibody. Immunoreactive intensity was determined for 282 (tumour) and 240 (non-mlignant tissue) cases. Tumour pAkt-IR scores correlated with Gleason score, tumour Ki67-IR (a marker of cell proliferation) and tumour phosphorylated epidermal growth factor receptor (pEGFR)-IR. For cases followed with expectancy, a high tumour pAkt-IR was associated with a poor disease-specific survival, and the prognostic information provided by this biomarker was additive to that provided by either (but not both) tumour pEFGR-IR or Ki67-IR. Upon division of the cases with respect to their Gleason scores, the prognostic value of pAkt-IR was seen for patients with Gleason score 8-10, but not for patients with Gleason score 6-7. Conclusions/Significance: Tumour pAkt-IR is associated with both disease severity and disease-specific survival. However, its clinical use as a biomarker is limited, since it does not provide prognostic information in patients with Gleason scores 6-7.	[Cipriano, Mariateresa; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Hammarsten, Peter; Josefsson, Andreas] Umea Univ, Dept Med Biosci, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Egevad, Lars] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Granfors, Torvald] Cent Hosp Vasteras, Dept Urol, Vasteras, Sweden	Umea University; Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital; Vasteras Central Hospital	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019; Josefsson, Andreas/T-2311-2019	Fowler, Christopher J./0000-0002-6658-7874; Egevad, Lars/0000-0001-8531-222X; Cipriano, Mariateresa/0000-0001-6644-7137; Josefsson, Andreas/0000-0002-2013-0887	Swedish Research Council [12158]; Swedish Cancer Society [CAN2010/437]; Lion's Cancer Research Foundation, Umea University; Cancer Research Foundation in Northern Sweden; Research Funds of the Medical Faculty, Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation, Umea University; Cancer Research Foundation in Northern Sweden; Research Funds of the Medical Faculty, Umea University	The authors thank the Swedish Research Council (Grant no. 12158, medicine, C.J. Fowler); the Swedish Cancer Society (Grant no. CAN2010/437, C.J. Fowler); Lion's Cancer Research Foundation, Umea University (P. Hammarsten & C.J. Fowler); the Cancer Research Foundation in Northern Sweden (P. Hammarsten), and the Research Funds of the Medical Faculty, Umea University (C.J. Fowler) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Board R, 2005, DRUG RESIST UPDATE, V8, P75, DOI 10.1016/j.drup.2005.03.004; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; delPeso L, 1997, SCIENCE, V278, P687; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Fang J, 2007, CARCINOGENESIS, V28, P713, DOI 10.1093/carcin/bgl189; Fowler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015205; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Hammarsten P, 2007, PROSTATE, V67, P573, DOI 10.1002/pros.20529; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Koumakpayi IH, 2010, BRIT J CANCER, V102, P1163, DOI 10.1038/sj.bjc.6605571; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Le Page C, 2006, BRIT J CANCER, V94, P1906, DOI 10.1038/sj.bjc.6603184; Lehmann R., 1977, BIOMETRICAL J, V19, P229; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Malik SN, 2002, CLIN CANCER RES, V8, P1168; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Mimeault M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031919; Mimeault M, 2011, MOL MED, V17, P949, DOI 10.2119/molmed.2011.00115; Nauseef JT, 2011, NAT REV UROL, V8, P428, DOI 10.1038/nrurol.2011.85	29	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47994	10.1371/journal.pone.0047994	http://dx.doi.org/10.1371/journal.pone.0047994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133535	Green Published, gold, Green Submitted			2022-12-25	WOS:000310261800027
J	Shao, JW; Lin, MM; Li, YQ; Li, X; Liu, JX; Liang, JP; Yao, HL				Shao, Jingwei; Lin, Manman; Li, Yongqing; Li, Xue; Liu, Junxian; Liang, Jianpin; Yao, Huilu			In Vivo Blood Glucose Quantification Using Raman Spectroscopy	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; SENSORS; SERUM	We here propose a novel Raman spectroscopy method that permits the noninvasive measurement of blood glucose concentration. To reduce the effects of the strong background signals produced by surrounding tissue and to obtain the fingerprint Raman lines formed by blood analytes, a laser was focused on the blood in vessels in the skin. The Raman spectra were collected transcutaneously. Characteristic peaks of glucose (1125 cm(-1)) and hemoglobin (1549 cm(-1)) were observed. Hemoglobin concentration served as an internal standard, and the ratio of the peaks that appeared at 1125 cm(-1) and 1549 cm(-1) peaks was used to calculate the concentration of blood glucose. We studied three mouse subjects whose blood glucose levels became elevated over a period of 2 hours using a glucose test assay. During the test, 25 Raman spectra were collected transcutaneously and glucose reference values were provided by a blood glucose meter. Results clearly showed the relationship between Raman intensity and concentration. The release curves were approximately linear with a correlation coefficient of 0.91. This noninvasive methodology may be useful for the study of blood glucose in vivo.	[Lin, Manman; Li, Xue; Liang, Jianpin; Yao, Huilu] Guangxi Acad Sci, Biophys Lab, Nanning, Peoples R China; [Shao, Jingwei] Fuzhou Univ, Coll Chem & Chem Engn, Fuzhou 350002, Peoples R China; [Lin, Manman; Li, Xue; Liu, Junxian] Guangxi Normal Univ, Coll Phys & Technol, Guilin, Peoples R China; [Li, Yongqing] E Carolina Univ, Dept Phys, Greenville, NC 27858 USA	Fuzhou University; Guangxi Normal University; University of North Carolina; East Carolina University	Yao, HL (corresponding author), Guangxi Acad Sci, Biophys Lab, Nanning, Peoples R China.	huiluy@gmail.com	邵, 敬伟/G-1412-2013; Yao, Huilu/GVT-0884-2022		National Natural Science Funds [60868002]; Guangxi Science Funds [2011GXNSFA018143, 2012GXNSFFA060008]; China Postdoctoral Science Foundation [2012M510959]; Foundation of Fuzhou University [600565]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Guangxi Science Funds; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Fuzhou University	This work was supported by the grants from National Natural Science Funds (60868002), Guangxi Science Funds (No. 2011GXNSFA018143; No. 2012GXNSFFA060008), China Postdoctoral Science Foundation (No. 2012M510959) and Foundation of Fuzhou University (No. 600565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano RR, 2008, DETECTION GLUCOSE LE; Barman I, 2010, ANAL CHEM, V82, P6104, DOI 10.1021/ac100810e; Bruulsema JT, 1996, C BIOM OPT SPECTR DI; Chaiken J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922147; CHRISTISON GB, 1993, MED BIOL ENG COMPUT, V31, P284, DOI 10.1007/BF02458048; Chuah ZM, 2010, CHEMOMETR INTELL LAB, V104, P347, DOI 10.1016/j.chemolab.2010.08.015; Davidson M.B., 1991, DIABETES MELLITUS DI; Enejder AMK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1920212; Enejder AMK, 2002, OPT LETT, V27, P2004, DOI 10.1364/OL.27.002004; Esenaliev RO, 2001, OPT LETT, V26, P992, DOI 10.1364/OL.26.000992; HEISE HM, 1989, ANAL CHEM, V61, P2009, DOI 10.1021/ac00193a004; Hori Y, 2006, OPT REV, V13, P29, DOI 10.1007/s10043-006-0029-2; Hori Y, 2005, OPT REV, V12, P202, DOI 10.1007/s10043-005-0202-z; Kasemsumran S, 2006, CHEMOMETR INTELL LAB, V82, P97, DOI 10.1016/j.chemolab.2005.08.014; Kinnunen M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2904957; Koschinsky T, 2001, DIABETES-METAB RES, V17, P113, DOI 10.1002/dmrr.188; Lam SCH, 2010, SPECTROSC-INT J, V24, P629, DOI 10.1155/2010/929506; Larin KV, 2007, LASER PHYS LETT, V4, P312, DOI 10.1002/lapl.200610111; Lyandres O, 2008, DIABETES TECHNOL THE, V10, P257, DOI 10.1089/dia.2007.0288; MANSOURI S, 1984, BIO-TECHNOL, V2, P885, DOI 10.1038/nbt1084-885; McNichols RJ, 2000, J BIOMED OPT, V5, P5, DOI 10.1117/1.429962; Oliver NS, 2009, DIABETIC MED, V26, P197, DOI 10.1111/j.1464-5491.2008.02642.x; Qu JNY, 1999, APPL OPTICS, V38, P5491, DOI 10.1364/AO.38.005491; QUAN KM, 1993, PHYS MED BIOL, V38, P1911, DOI 10.1088/0031-9155/38/12/014; Rohleder D, 2004, ANALYST, V129, P906, DOI 10.1039/b408927h; Russell RJ, 1999, ANAL CHEM, V71, P3126, DOI 10.1021/ac990060r; Sapozhnikova VV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2909671; Sierra JF, 2000, ANAL CHIM ACTA, V414, P33, DOI 10.1016/S0003-2670(00)00831-X; Tamada JA, 1999, JAMA-J AM MED ASSOC, V282, P1839, DOI 10.1001/jama.282.19.1839; WANG SY, 1993, APPL OPTICS, V32, P925, DOI 10.1364/AO.32.000925; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang X, 2012, ANAL BIOANAL CHEM, V402, P687, DOI 10.1007/s00216-011-5575-1; Yao HL, 2009, VIB SPECTROSC, V50, P193, DOI 10.1016/j.vibspec.2008.11.003; ZALEVSKY Z, 2007, Patent No. 184868	34	93	103	3	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48127	10.1371/journal.pone.0048127	http://dx.doi.org/10.1371/journal.pone.0048127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133555	Green Submitted, gold, Green Published			2022-12-25	WOS:000310261800045
J	Saunders, PO; Weiss, J; Welschinger, R; Baraz, R; Bradstock, KF; Bendall, LJ				Saunders, P. O.; Weiss, J.; Welschinger, R.; Baraz, R.; Bradstock, K. F.; Bendall, L. J.			RAD001 (everolimus) induces dose-dependent changes to cell cycle regulation and modifies the cell cycle response to vincristine	ONCOGENE			English	Article						acute lymphoblastic leukemia; RAD001; mTOR inhibitors; chemotherapy; checkpoint regulation; mitosis	ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-DAMAGE RESPONSE; MAMMALIAN TARGET; MITOTIC CATASTROPHE; AURORA-B; PROGRESSION; INHIBITORS; APOPTOSIS; MTOR; ACTIVATION	More than 50% of adults and similar to 20% of children with pre-B acute lymphoblastic leukemia (ALL) relapse following treatment. Dismal outcomes for patients with relapsed or refractory disease mandate novel approaches to therapy. We have previously shown that the combination of the mTOR inhibitor RAD001 (everolimus) and the chemotherapeutic agent vincristine increases the survival of non-obese diabetic/severe combined immuno-deficient (NOD/SCID) mice bearing human ALL xenografts. We have also shown that 16 mu M RAD001 synergized with agents that cause DNA damage or microtubule disruption in pre-B ALL cells in vitro. Here, we demonstrate that RAD001 has dose-dependent effects on the cell cycle in ALL cells, with 1.5 mu M RAD001 inhibiting pRb, Ki67 and PCNA expression and increasing G(0/1) cell cycle arrest, whereas 16 mu M RAD001 increases pRb, cyclin D1, Ki67 and PCNA, with no evidence of an accumulation of cells in G(0/1). Transition from G(2) into mitosis was promoted by 16 mu M RAD001 with reduced phosphorylation of cdc2 in cells with 4N DNA content. However, 16 mu M RAD001 preferentially induced cell death in cells undergoing mitosis. When combined with vincristine, 16 mu M RAD001 reduced the vincristine-induced accumulation of cells in mitosis, probably as a result of increased death in this population. Although 16 mu M RAD001 weakly activated Chk1 and Chk2, it suppressed strong vincristine-induced activation of these cell cycle checkpoint regulators. We conclude that RAD001 enhances chemosensitivity at least in part through suppression of cell cycle checkpoint regulation in response to vincristine and increased progression from G(2) into mitosis.	[Saunders, P. O.; Weiss, J.; Welschinger, R.; Baraz, R.; Bradstock, K. F.; Bendall, L. J.] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Bendall, LJ (corresponding author), Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, POB 412 Darcy Rd, Westmead, NSW 2145, Australia.	linda_bendall@wmi.usyd.edu.au			University of Sydney; NHMRC CDA2 [511965]; NHMRC [352326]; Leukemia and Lymphoma Society Translational Program [6105-08]	University of Sydney(University of Sydney); NHMRC CDA2(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society Translational Program(Leukemia and Lymphoma Society)	RAD001 (everolimus) was kindly provided by Novartis. This work was supported by a University of Sydney Postgraduate Award (PS), NHMRC CDA2 No. 511965 (LB) and project grant no. 352326 (RB, JW), and the Leukemia and Lymphoma Society Translational Program grant no. 6105-08 (RW).	Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; BENDALL LJ, 1993, BLOOD, V82, P3125; Blajeski AL, 2002, J CLIN INVEST, V110, P91, DOI 10.1172/JCI200213275; Bradstock K, 1996, LEUKEMIA, V10, P813; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Crazzolara R, 2009, AUTOPHAGY, V5, P727, DOI 10.4161/auto.5.5.8507; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Ehrhardt H, 2011, BLOOD, V118, P6123, DOI 10.1182/blood-2010-02-269811; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gokbuget N, 2009, SEMIN HEMATOL, V46, P64, DOI 10.1053/j.seminhematol.2008.09.003; Grunwald V, 2002, CANCER RES, V62, P6141; Haritunians T, 2007, LEUKEMIA, V21, P333, DOI 10.1038/sj.leu.2404471; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hawkins DS, 1996, CANCER RES, V56, P892; Ito D, 2010, ADV EXP MED BIOL, V676, P15; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Law M, 2006, CANCER RES, V66, P1070, DOI 10.1158/0008-5472.CAN-05-1672; Mabuchi S, 2007, CLIN CANCER RES, V13, P4261, DOI 10.1158/1078-0432.CCR-06-2770; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; MORICE WG, 1993, J BIOL CHEM, V268, P3734; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Peponi E, 2006, AM J PATHOL, V169, P2171, DOI 10.2353/ajpath.2006.051078; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Saunders P, 2011, HAEMATOL-HEMATOL J, V96, P69, DOI 10.3324/haematol.2010.026997; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Silverman LB, 2010, LEUKEMIA, V24, P320, DOI 10.1038/leu.2009.253; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Su WC, 2009, FEBS LETT, V583, P2793, DOI 10.1016/j.febslet.2009.07.027; Tavernier E, 2007, LEUKEMIA, V21, P1907, DOI 10.1038/sj.leu.2404824; Teachey DT, 2008, BLOOD, V112, P2020, DOI 10.1182/blood-2008-02-137141; Wanner K, 2006, BRIT J HAEMATOL, V134, P475, DOI 10.1111/j.1365-2141.2006.06210.x; Wu MYW, 2007, EMBO J, V26, P371, DOI 10.1038/sj.emboj.7601487; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016	38	18	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4789	4797		10.1038/onc.2012.498	http://dx.doi.org/10.1038/onc.2012.498			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23128395				2022-12-25	WOS:000325274700007
J	Hershko, K; Simhadri, VL; Blaisdell, A; Hunt, RC; Newell, J; Tseng, SC; Hershko, AY; Choi, JW; Sauna, ZE; Wu, A; Bram, RJ; Komar, AA; Kimchi-Sarfaty, C				Hershko, Klilah; Simhadri, Vijaya L.; Blaisdell, Adam; Hunt, Ryan C.; Newell, Jordan; Tseng, Sandra C.; Hershko, Alon Y.; Choi, Jae Won; Sauna, Zuben E.; Wu, Andrew; Bram, Richard J.; Komar, Anton A.; Kimchi-Sarfaty, Chava			Cyclosporin A Impairs the Secretion and Activity of ADAMTS13 (A Disintegrin and Metalloprotease with Thrombospondin Type 1 Repeat)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; VON-WILLEBRAND-FACTOR; HEMOLYTIC-UREMIC SYNDROME; FACTOR-CLEAVING PROTEASE; PLASMA-EXCHANGE; SURFACE EXPRESSION; CYCLOPHILIN-B; IN-VIVO; TRANSPLANTATION; ISOMERASES	The protease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat) cleaves multimers of von Willebrand factor, thus regulating platelet aggregation. ADAMTS13 deficiency leads to the fatal disorder thrombotic thrombocytopenic purpura (TTP). It has been observed that cyclosporin A (CsA) treatment, particularly in transplant patients, may sometimes be linked to the development of TTP. Until now, the reason for such a link was unclear. Here we provide evidence demonstrating that cyclophilin B (CypB) activity plays an important role in the secretion of active ADAMTS13. We found that CsA, an inhibitor of CypB, reduces the secretion of ADAMTS13 and leads to conformational changes in the protein resulting in diminished ADAMTS13 proteolytic activity. A direct, functional interaction between CypB (which possesses peptidyl-prolyl cis-trans isomerase (PPIase) and chaperone functions) and ADAMTS13 is demonstrated using immunoprecipitation and siRNA knockdown of CypB. Finally, CypB knockout mice were found to have reduced ADAMTS13 levels. Taken together, our findings indicate that cyclophilin-mediated activity is an important factor affecting secretion and activity of ADAMTS13. The large number of proline residues in ADAMTS13 is consistent with the important role of cis-trans isomerization in the proper folding of this protein. These results altogether provide a novel mechanistic explanation for CsA-induced TTP in transplant patients.	[Hershko, Klilah; Simhadri, Vijaya L.; Blaisdell, Adam; Hunt, Ryan C.; Newell, Jordan; Tseng, Sandra C.; Sauna, Zuben E.; Wu, Andrew; Kimchi-Sarfaty, Chava] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20982 USA; [Choi, Jae Won; Bram, Richard J.] Mayo Clin, Dept Pediat Hematol Oncol, Rochester, MN 55905 USA; [Hershko, Alon Y.] Meir Med Ctr, Dept Med, IL-44281 Kefar Sava, Israel; [Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	US Food & Drug Administration (FDA); Mayo Clinic; Tel Aviv University; Sackler Faculty of Medicine; University System of Ohio; Cleveland State University	Kimchi-Sarfaty, C (corresponding author), 29 Lincoln Dr, Bethesda, MD 20892 USA.	Chava.kimchi-sarfaty@fda.hhs.gov	Sauna, Zuben E./AAA-7149-2019	Kimchi-Sarfaty, Chava/0000-0002-9355-8585; Komar, Anton/0000-0003-4188-0633	United States Food and Drug Administration; National American Heart Association [0730120N]	United States Food and Drug Administration; National American Heart Association(American Heart Association)	This work was supported by the United States Food and Drug Administration and National American Heart Association Grant 0730120N (to A. A. K.).	Allford SL, 2002, LEUKEMIA LYMPHOMA, V43, P1921, DOI 10.1080/1042819021000015862; Arai S, 2001, Hematol J, V2, P292, DOI 10.1038/sj.thj.6200127; Batts ED, 2007, BONE MARROW TRANSPL, V40, P709, DOI 10.1038/sj.bmt.1705758; BONSER RS, 1984, LANCET, V2, P1337; Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Cataland SR, 2007, BRIT J HAEMATOL, V139, P486, DOI 10.1111/j.1365-2141.2007.06819.x; Cataland SR, 2007, BRIT J HAEMATOL, V136, P146, DOI 10.1111/j.1365-2141.2006.06384.x; Cataland SR, 2008, AM J HEMATOL, V83, P911, DOI 10.1002/ajh.21281; Cataland SR, 2006, J THROMB HAEMOST, V4, P1162, DOI 10.1111/j.1538-7836.2006.01909.x; Cattaneo D, 2004, TRANSPL P, V36, p234S, DOI 10.1016/j.transproceed.2004.01.011; Chen H, 1998, FEBS LETT, V422, P307, DOI 10.1016/S0014-5793(98)00028-3; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; Claus RA, 2005, THROMB HAEMOSTASIS, V94, P41; Donadelli R, 2006, THROMB HAEMOSTASIS, V96, P454, DOI 10.1160/TH06-05-0236; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Elliott MA, 2003, MAYO CLIN PROC, V78, P421, DOI 10.4065/78.4.421; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Geetha S, 2009, CYTOM PART A, V75A, P675, DOI 10.1002/cyto.a.20748; George JN, 2004, TRANSFUSION, V44, P1384, DOI 10.1111/j.1537-2995.2004.03412.x; George JN, 2004, TRANSFUSION, V44, P294, DOI 10.1111/j.1537-2995.2004.00700.x; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hachem RR, 2006, TRANSPLANTATION, V81, P57, DOI 10.1097/01.tp.0000188140.50673.63; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hommais A, 2007, THROMB HAEMOSTASIS, V98, P593, DOI 10.1160/TH07-01-0059; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Hunter T, 1998, CELL, V92, P141, DOI 10.1016/S0092-8674(00)80906-X; Ivery MTG, 2000, MED RES REV, V20, P452, DOI 10.1002/1098-1128(200011)20:6<452::AID-MED2>3.0.CO;2-6; Kahan BD, 2009, TRANSPL P, V41, P3011, DOI 10.1016/j.transproceed.2009.07.104; Kentouche K, 2006, SEMIN THROMB HEMOST, V32, P98, DOI 10.1055/s-2006-939765; Kimchi-Sarfaty C, 2002, J BIOL CHEM, V277, P2505, DOI 10.1074/jbc.M109154200; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Lane-Guermonprez L, 2005, J NEUROCHEM, V93, P1401, DOI 10.1111/j.1471-4159.2005.03125.x; Lee CH, 2008, TRANSPL P, V40, P2554, DOI 10.1016/j.transproceed.2008.07.011; Levy G A, 2002, Gastroenterol Hepatol, V25, P289; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Luban J, 1996, CELL, V87, P1157, DOI 10.1016/S0092-8674(00)81811-5; Manea M, 2009, PEDIATR NEPHROL, V24, P447, DOI 10.1007/s00467-008-0986-8; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Peyvandi F, 2006, BRIT J HAEMATOL, V134, P187, DOI 10.1111/j.1365-2141.2006.06126.x; Pimanda JE, 2004, BLOOD, V103, P627, DOI 10.1182/blood-2003-04-1346; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; Rahamimoff H, 2007, ANN NY ACAD SCI, V1099, P204, DOI 10.1196/annals.1387.046; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sauna ZE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006506; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shitrit D, 2003, TRANSPLANT P, V35, P627, DOI 10.1016/S0041-1345(03)00015-0; Soejima K, 2006, J BIOCHEM, V139, P147, DOI 10.1093/jb/mvj013; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Sternberg MJE, 1999, CURR OPIN STRUC BIOL, V9, P368, DOI 10.1016/S0959-440X(99)80050-5; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Tran TT, 2000, J BIOL CHEM, V275, P35708, DOI 10.1074/jbc.M005636200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai HM, 2006, ANNU REV MED, V57, P419, DOI 10.1146/annurev.med.57.061804.084505; van der Plas RM, 1999, BLOOD, V93, P3798, DOI 10.1182/blood.V93.11.3798.411k07_3798_3802; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; WAINBERG MA, 1988, BLOOD, V72, P1904; WALSH CT, 1992, J BIOL CHEM, V267, P13115; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663; Zhou WH, 2009, BLOOD, V113, P929, DOI 10.1182/blood-2008-07-167775	67	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44361	44371		10.1074/jbc.M112.383968	http://dx.doi.org/10.1074/jbc.M112.383968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23144461	hybrid, Green Published			2022-12-25	WOS:000312938600033
J	Ganguly, A; Yang, HL; Sharma, R; Patel, KD; Cabral, F				Ganguly, Anutosh; Yang, Hailing; Sharma, Ritu; Patel, Kamala D.; Cabral, Fernando			The Role of Microtubules and Their Dynamics in Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; BETA-TUBULIN; LIVING CELLS; ALPHA-TUBULIN; MOTILITY; VINBLASTINE; PACLITAXEL; RESISTANCE; DRUGS; NOCODAZOLE	Although microtubules have long been implicated in cell locomotion, the mechanism of their involvement remains controversial. Most studies have concluded that microtubules play a positive role by regulating actin polymerization, transporting membrane vesicles to the leading edge, and/or facilitating the turnover of adhesion plaques. Here we used wild-type and mutant CHO cell lines with alterations in tubulin to demonstrate that microtubules can also act to restrain cell motility. Tubulin mutations or low concentrations of drugs that suppress microtubule dynamics without affecting the amount of microtubule polymer inhibited the rate of migration by preventing microtubule reorganization in the trailing portion of the cells where the more dynamic microtubules are normally found. Under these conditions, cells along the edge of a wound still extended lamellipodia and elongated toward the wound but were inhibited in their ability to retract their tails, thus retarding forward progress. The idea that microtubules normally act to restrain cell locomotion was confirmed by treating cells with high concentrations of nocodazole to depolymerize the microtubule network. In the absence of microtubules, wild-type CHO and HeLa cells could still move at near normal speeds, but the movement became more random. We conclude that microtubules act both to restrain cell movement and to establish directionality.	[Ganguly, Anutosh; Cabral, Fernando] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Ganguly, Anutosh; Sharma, Ritu; Patel, Kamala D.] Univ Calgary, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Yang, Hailing] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Calgary; University of Texas System; UTMD Anderson Cancer Center	Cabral, F (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	fernando.r.cabral@uth.tmc.edu	Patel, Kamala D/AAX-1245-2021	Ganguly, Anutosh/0000-0002-7228-7827	National Institutes of Health [CA 85935]; Canadian Institute for Health Research [MOP-14180]; NATIONAL CANCER INSTITUTE [R01CA085935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA 85935 (to F. C.) and Canadian Institute for Health Research Grant MOP-14180 (to K. P.).	BARLOW S, 1994, J CELL BIOL, V126, P1017, DOI 10.1083/jcb.126.4.1017; Belotti D, 1996, CLIN CANCER RES, V2, P1843; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brown RA, 1996, J CELL PHYSIOL, V169, P439, DOI 10.1002/(SICI)1097-4652(199612)169:3<439::AID-JCP4>3.0.CO;2-P; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F., 2000, DRUG RESIST UPDATE, V3, P1; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; DZIEZANOWSKI MA, 1980, J CELL SCI, V42, P379; EDELSON PJ, 1973, INFECT IMMUN, V8, P127, DOI 10.1128/IAI.8.1.127-129.1973; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Ganguly A, 2011, CELL CYCLE, V10, P2614, DOI 10.4161/cc.10.16.16593; Ganguly A, 2011, ONCOTARGET, V2, P368, DOI 10.18632/oncotarget.250; Ganguly A, 2010, MOL CANCER THER, V9, P2914, DOI 10.1158/1535-7163.MCT-10-0552; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Hari M, 2003, MOL CANCER THER, V2, P597; Huzil JT, 2007, CANCER INFORM, V3, P159; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; KELLER HU, 1984, EXP CELL RES, V153, P173, DOI 10.1016/0014-4827(84)90459-2; LIAO GJ, 1995, J CELL SCI, V108, P3473; Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Samant RS, 2011, ONCOTARGET, V2, P122; SCHIBLER MJ, 1989, FASEB J, V3, P163, DOI 10.1096/fasebj.3.2.2563346; SCHIBLER MJ, 1986, J CELL BIOL, V102, P1522, DOI 10.1083/jcb.102.4.1522; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; SPOONER BS, 1971, J CELL BIOL, V49, P595, DOI 10.1083/jcb.49.3.595; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Vacca A, 1999, BLOOD, V94, P4143, DOI 10.1182/blood.V94.12.4143.424k26_4143_4155; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wang XM, 1996, J CELL BIOL, V132, P345, DOI 10.1083/jcb.132.3.345; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820; Yin SH, 2012, PHARM RES-DORDR, V29, P2994, DOI 10.1007/s11095-012-0794-5; Zhang DH, 2000, J MUSCLE RES CELL M, V21, P293, DOI 10.1023/A:1005600118157	41	91	91	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43359	43369		10.1074/jbc.M112.423905	http://dx.doi.org/10.1074/jbc.M112.423905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23135278	Green Published, hybrid			2022-12-25	WOS:000312940800017
J	Sugiura, N; Shioiri, T; Chiba, M; Sato, T; Narimatsu, H; Kimata, K; Watanabe, H				Sugiura, Nobuo; Shioiri, Tatsumasa; Chiba, Mie; Sato, Takashi; Narimatsu, Hisashi; Kimata, Koji; Watanabe, Hideto			Construction of a Chondroitin Sulfate Library with Defined Structures and Analysis of Molecular Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; MONOCLONAL-ANTIBODY; ESCHERICHIA-COLI; POLYMERIZING FACTOR; CLONING; EXPRESSION; BINDING; 6-SULFOTRANSFERASE; POLYMERASE; TISSUES	Chondroitin sulfate (CS) is a linear acidic polysaccharide, composed of repeating disaccharide units of glucuronic acid and N-acetyl-D-galactosamine and modified with sulfate residues at different positions, which plays various roles in development and disease. Here, we chemo-enzymatically synthesized various CS species with defined lengths and defined sulfate compositions, from chondroitin hexasaccharide conjugated with hexamethylenediamine at the reducing ends, using bacterial chondroitin polymerase and recombinant CS sulfotransferases, including chondroitin-4-sulfotransferase 1 (C4ST-1), chondroitin-6-sulfotransferase 1 (C6ST-1), N-acetylgalactosamine 4-sulfate 6-sulfotransferase (GalNAc4S-6ST), and uronosyl 2-sulfotransferase (UA2ST). Sequential modifications of CS with a series of CS sulfotransferases revealed their distinct features, including their substrate specificities. Reactions with chondroitin polymerase generated non-sulfated chondroitin, and those with C4ST-1 and C6ST-1 generated uniformly sulfated CS containing >95% 4S and 6S units, respectively. GalNAc4S-6ST and UA2ST generated highly sulfated CS possessing similar to 90% corresponding disulfated disaccharide units. Sequential reactions with UA2ST and GalNAc4S-6ST generated further highly sulfated CS containing a mixed structure of disulfated units. Surprisingly, sequential reactions with GalNAc4S-6ST and UA2ST generated a novel CS molecule containing similar to 29% trisulfated disaccharide units. Enzyme-linked immunosorbent assay and surface plasmon resonance analysis using the CS library and natural CS products modified with biotin at the reducing ends, revealed details of the interactions of CS species with anti-CS antibodies, and with CS-binding molecules such as midkine and pleiotrophin. Chemo-enzymatic synthesis enables the generation of CS chains of the desired lengths, compositions, and distinct structures, and the resulting library will be a useful tool for studies of CS functions.	[Sugiura, Nobuo; Shioiri, Tatsumasa; Chiba, Mie; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan; [Sato, Takashi; Narimatsu, Hisashi] Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	Aichi Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Sugiura, N (corresponding author), Aichi Med Univ, Inst Mol Sci Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	nsugiura@aichi-med-u.ac.jp	Narimatsu, Hisashi/M-4757-2018; Sato, Takashi/M-2577-2018	Narimatsu, Hisashi/0000-0002-8402-133X; Sato, Takashi/0000-0002-9973-8923; Watanabe, Hideto/0000-0001-5291-0696	New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science, and technology in Japan (MEXT) [S1101027]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [23570176] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO), a Ministry of Education, Culture, Sports, Science, and technology in Japan (MEXT)-supported Program for the Strategic Research Foundation at Private Universities 2011-2015 (S1101027), and grants-in-aid for scientific research (to N. S. and H. W.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; HABUCHI O, 1993, J BIOL CHEM, V268, P21968; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; Mascellani G, 1996, THROMB RES, V84, P21, DOI 10.1016/0049-3848(96)00158-2; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Myette JR, 2002, BIOCHEM BIOPH RES CO, V290, P1206, DOI 10.1006/bbrc.2001.6268; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; Numakura M, 2010, GLYCOCONJUGATE J, V27, P479, DOI 10.1007/s10719-010-9293-2; Ogawa H, 2010, J BIOL CHEM, V285, P34155, DOI 10.1074/jbc.M110.109553; Ohtake S, 2005, J BIOL CHEM, V280, P39115, DOI 10.1074/jbc.M508816200; Ohtake S, 2003, J BIOL CHEM, V278, P38443, DOI 10.1074/jbc.M306132200; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Okuda T, 2000, J BIOCHEM, V128, P763, DOI 10.1093/oxfordjournals.jbchem.a022813; OOHIRA A, 1994, NEUROSCIENCE, V60, P145, DOI 10.1016/0306-4522(94)90210-0; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Pothacharoen P, 2007, J BIOL CHEM, V282, P35232, DOI 10.1074/jbc.M702255200; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; SUGIURA N, 1993, J BIOL CHEM, V268, P15779; Sugiura N, 2008, GLYCOCONJUGATE J, V25, P521, DOI 10.1007/s10719-008-9105-0; Sugiura N, 2007, ANAL BIOCHEM, V365, P62, DOI 10.1016/j.ab.2007.02.023; Sugiura N, 2011, J BIOL CHEM, V286, P29026, DOI 10.1074/jbc.M111.251157; TOYODA H, 1988, ANAL SCI, V4, P381, DOI 10.2116/analsci.4.381; UENO Y, 1988, CHEM PHARM BULL, V36, P4971; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Xu D, 2007, J BIOL CHEM, V282, P8356, DOI 10.1074/jbc.M608062200; YADA T, 1992, J BIOL CHEM, V267, P9391; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146	37	42	43	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43390	43400		10.1074/jbc.M112.412676	http://dx.doi.org/10.1074/jbc.M112.412676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23129769	hybrid, Green Published			2022-12-25	WOS:000312940800020
J	Abdeladhim, M; Jochim, RC; Ben Ahmed, M; Zhioua, E; Chelbi, I; Cherni, S; Louzir, H; Ribeiro, JMC; Valenzuela, JG				Abdeladhim, Maha; Jochim, Ryan C.; Ben Ahmed, Melika; Zhioua, Elyes; Chelbi, Ifhem; Cherni, Saifedine; Louzir, Hechmi; Ribeiro, Jose M. C.; Valenzuela, Jesus G.			Updating the Salivary Gland Transcriptome of Phlebotomus papatasi (Tunisian Strain): The Search for Sand Fly-Secreted Immunogenic Proteins for Humans	PLOS ONE			English	Article							GLOSSINA-MORSITANS-MORSITANS; DELAYED-TYPE HYPERSENSITIVITY; LUTZOMYIA-LONGIPALPIS; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; CIMEX-LECTULARIUS; ANTIBODY-RESPONSE; IMMUNE-RESPONSE; TSETSE-FLY; BED BUG	Introduction: Sand fly saliva plays an important role in both blood feeding and outcome of Leishmania infection. A cellular immune response against a Phlebotomus papatasi salivary protein was shown to protect rodents against Leishmania major infection. In humans, P. papatasi salivary proteins induce a systemic cellular immune response as well as a specific antisaliva humoral immune response, making these salivary proteins attractive targets as markers of exposure for this Leishmania vector. Surprisingly, the repertoire of salivary proteins reported for P. papatasi-a model sand fly for Leishmania-vector-host molecular interactions-is very limited compared with other sand fly species. We hypothesize that a more comprehensive study of the transcripts present in the salivary glands of P. papatasi will provide better knowledge of the repertoire of proteins of this important vector and will aid in selection of potential immunogenic proteins for humans and of those proteins that are highly conserved between different sand fly strains. Methods and Findings: A cDNA library from P. papatasi (Tunisian strain) salivary glands was constructed, and randomly selected transcripts were sequenced and analyzed. The most abundant transcripts encoding secreted proteins were identified and compared with previously reported sequences. Importantly, we identified salivary proteins not described before in this sand fly species. Conclusions: Comparative analysis between the salivary proteins of P. papatasi from Tunisia and Israel strains shows a high level of identity, suggesting these proteins as potential common targets for markers of vector exposure or inducers of cellular immune responses in humans for different geographic areas.	[Jochim, Ryan C.; Valenzuela, Jesus G.] NIAID, Vector Mol Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Abdeladhim, Maha; Ben Ahmed, Melika; Louzir, Hechmi] Pasteur Inst Tunis, Lab Transmiss Control & Immunobiol Infect Dis, Tunis, Tunisia; [Ben Ahmed, Melika; Louzir, Hechmi] Tunis El Manar Univ, Fac Med Tunis, Tunis, Tunisia; [Zhioua, Elyes; Chelbi, Ifhem; Cherni, Saifedine] Pasteur Inst Tunis, Lab Vector Ecol, Tunis, Tunisia; [Ribeiro, Jose M. C.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Valenzuela, JG (corresponding author), NIAID, Vector Mol Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	jvalenzuela@niaid.nih.gov	Ribeiro, Jose/J-7011-2015; Jochim, Ryan/C-6756-2013	Ben Ahmed, Melika/0000-0002-3179-1648; Ribeiro, Jose/0000-0002-9107-0818; Chelbi, Ifhem/0000-0002-0336-0146	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000932, ZIAAI000810] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeladhim M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001345; Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Andersen JF, 2009, J PROTEOME RES, V8, P1474, DOI 10.1021/pr8008429; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Attardo GM, 2006, INSECT MOL BIOL, V15, P411, DOI 10.1111/j.1365-2583.2006.00649.x; Attardo GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-160; Bahia D, 2007, PARASITOL RES, V100, P449, DOI 10.1007/s00436-006-0307-8; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Belkaid Y, 2000, P NATL ACAD SCI USA, V97, P6704, DOI 10.1073/pnas.97.12.6704; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Chelbi I, 2009, J MED ENTOMOL, V46, P400, DOI 10.1603/033.046.0229; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; Collin N, 2012, ARTERIOSCL THROM VAS, V32, P2185, DOI 10.1161/ATVBAHA.112.253906; Francischetti IMB, 2010, J PROTEOME RES, V9, P3820, DOI 10.1021/pr1000169; GEYER PK, 1986, EMBO J, V5, P2657, DOI 10.1002/j.1460-2075.1986.tb04548.x; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; Grespan R, 2012, INT IMMUNOPHARMACOL, V12, P603, DOI 10.1016/j.intimp.2012.02.004; Hekmat-Scafe DS, 2000, GENETICS, V155, P117; Hostomska J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-282; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002; Jacobson RL, 2001, ACTA TROP, V78, P41, DOI 10.1016/S0001-706X(00)00164-9; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; Kamhawi S, 2000, MICROBES INFECT, V2, P1765, DOI 10.1016/S1286-4579(00)01331-9; Kato H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-226; Marzouki S, 2011, AM J TROP MED HYG, V84, P653, DOI 10.4269/ajtmh.2011.10-0598; Mencke N, 2003, PARASITOL RES, V90, pS108, DOI 10.1007/s00436-003-0905-7; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226; Ramalho-Ortigao M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-300; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; Ribeiro JMC, 2000, INSECT BIOCHEM MOLEC, V30, P271, DOI 10.1016/S0965-1748(99)00119-8; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Valenzuela JG, 1998, J BIOL CHEM, V273, P30583, DOI 10.1074/jbc.273.46.30583; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331; Xu XQ, 2011, J BIOL CHEM, V286, P32383, DOI 10.1074/jbc.M111.268904	48	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e47347	10.1371/journal.pone.0047347	http://dx.doi.org/10.1371/journal.pone.0047347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139741	Green Submitted, Green Published, gold			2022-12-25	WOS:000311315300007
J	Baggett, HC; Chittaganpitch, M; Thamthitiwat, S; Prapasiri, P; Naorat, S; Sawatwong, P; Ditsungnoen, D; Olsen, SJ; Simmerman, JM; Srisaengchai, P; Chantra, S; Peruski, LF; Sawanpanyalert, P; Maloney, SA; Akarasewi, P				Baggett, Henry C.; Chittaganpitch, Malinee; Thamthitiwat, Somsak; Prapasiri, Prabda; Naorat, Sathapana; Sawatwong, Pongpun; Ditsungnoen, Darunee; Olsen, Sonja J.; Simmerman, James M.; Srisaengchai, Prasong; Chantra, Somrak; Peruski, Leonard F.; Sawanpanyalert, Pathom; Maloney, Susan A.; Akarasewi, Pasakorn			Incidence and Epidemiology of Hospitalized Influenza Cases in Rural Thailand during the Influenza A (H1N1) pdm09 Pandemic, 2009-2010	PLOS ONE			English	Article							UNITED-STATES; VIRUS-INFECTION; PNEUMONIA; BURDEN; SURVEILLANCE; IMPACT	Background: Data on the burden of the 2009 influenza pandemic in Asia are limited. Influenza A(H1N1)pdm09 was first reported in Thailand in May 2009. We assessed incidence and epidemiology of influenza-associated hospitalizations during 2009-2010. Methods: We conducted active, population-based surveillance for hospitalized cases of acute lower respiratory infection (ALRI) in all 20 hospitals in two rural provinces. ALRI patients were sampled 1: 2 for participation in an etiology study in which nasopharyngeal swabs were collected for influenza virus testing by PCR. Results: Of 7,207 patients tested, 902 (12.5%) were influenza-positive, including 190 (7.8%) of 2,436 children aged,5 years; 86% were influenza A virus (46% A(H1N1) pdm09, 30% H3N2, 6.5% H1N1, 3.5% not subtyped) and 13% were influenza B virus. Cases of influenza A(H1N1) pdm09 first peaked in August 2009 when 17% of tested patients were positive. Subsequent peaks during 2009 and 2010 represented a mix of influenza A(H1N1) pdm09, H3N2, and influenza B viruses. The estimated annual incidence of hospitalized influenza cases was 136 per 100,000, highest in ages <5 years (477 per 100,000) and >75 years (407 per 100,000). The incidence of influenza A(H1N1) pdm09 was 62 per 100,000 (214 per 100,000 in children <5 years). Eleven influenza-infected patients required mechanical ventilation, and four patients died, all adults with influenza A(H1N1) pdm09 (1) or H3N2 (3). Conclusions: Influenza-associated hospitalization rates in Thailand during 2009-10 were substantial and exceeded rates described in western countries. Influenza A(H1N1) pdm09 predominated, but H3N2 also caused notable morbidity. Expanded influenza vaccination coverage could have considerable public health impact, especially in young children.	[Baggett, Henry C.; Thamthitiwat, Somsak; Prapasiri, Prabda; Naorat, Sathapana; Sawatwong, Pongpun; Olsen, Sonja J.; Simmerman, James M.; Srisaengchai, Prasong; Peruski, Leonard F.; Maloney, Susan A.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth MOPH, Int Emerging Infect Program, Nonthaburi, Thailand; [Baggett, Henry C.; Peruski, Leonard F.; Maloney, Susan A.] Ctr Dis Control & Prevent, Global Dis Detect Branch, Global Dis Detect & Emergency Response Div, Atlanta, GA USA; [Chittaganpitch, Malinee; Sawanpanyalert, Pathom] MOPH, Natl Inst Hlth, Nonthaburi, Thailand; [Ditsungnoen, Darunee] Nakhon Phanom Prov Hlth Off, Nakhon Phanom, Thailand; [Olsen, Sonja J.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Chantra, Somrak] MOPH, Sa Kaeo Prov Hlth Off, Sa Kaeo, Thailand; [Akarasewi, Pasakorn] MOPH, Bur Epidemiol, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Baggett, HC (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth MOPH, Int Emerging Infect Program, Nonthaburi, Thailand.	hbaggett@cdc.gov			U.S. Centers for Disease Control and Prevention	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by the U.S. Centers for Disease Control and Prevention. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baggett HC, 2009, CLIN INFECT DIS, V48, pS65, DOI 10.1086/596484; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Champunot R, 2010, JPN J INFECT DIS, V63, P251; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Grijalva CG, 2007, EPIDEMIOL INFECT, V135, P951, DOI 10.1017/S095026880600762X; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ismail HIM, 2011, EMERG INFECT DIS, V17, P708, DOI 10.3201/eid1704.101212; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; Koon K, 2010, EMERG INFECT DIS, V16, P1976, DOI 10.3201/eid1612.091697; Lindblade KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015826; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Mustaquim D., 2010, Morbidity and Mortality Weekly Report, V59, P901; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Reyes L, 2010, INFLUENZA OTHER RESP, V4, P129, DOI 10.1111/j.1750-2659.2010.00138.x; Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Thailand National Economic and Social Development Board, 2006, POP PROJ THAIL 2000; Thailand National Statistics Office, 2011, PER CAP INC POP REG; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; World Health Organization, 2009, CDC PROT REALT RTPCR	30	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48609	10.1371/journal.pone.0048609	http://dx.doi.org/10.1371/journal.pone.0048609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23139802	gold, Green Submitted, Green Published			2022-12-25	WOS:000311315300044
J	Thomas, GD; Ye, JF; De Nardi, C; Monopoli, A; Ongini, E; Victor, RG				Thomas, Gail D.; Ye, Jianfeng; De Nardi, Claudio; Monopoli, Angela; Ongini, Ennio; Victor, Ronald G.			Treatment with a Nitric Oxide-Donating NSAID Alleviates Functional Muscle Ischemia in the Mouse Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							SYMPATHETIC NEURAL-CONTROL; DEFICIENT SKELETAL-MUSCLE; L-ARGININE; IN-VITRO; SYNTHASE; RAT; NO; SARCOLEMMA; THERAPY; NNOS	In patients with Duchenne muscular dystrophy (DMD) and the standard mdx mouse model of DMD, dystrophin deficiency causes loss of neuronal nitric oxide synthase (nNOS mu) from the sarcolemma, producing functional ischemia when the muscles are exercised. We asked if functional muscle ischemia would be eliminated and normal blood flow regulation restored by treatment with an exogenous nitric oxide (NO)-donating drug. Beginning at 8 weeks of age, mdx mice were fed a standard diet supplemented with 1% soybean oil alone or in combination with a low (15 mg/kg) or high (45 mg/kg) dose of HCT 1026, a NO-donating nonsteroidal anti-inflammatory agent which has previously been shown to slow disease progression in the mdx model. After 1 month of treatment, vasoconstrictor responses to intra-arterial norepinephrine (NE) were compared in resting and contracting hindlimbs. In untreated mdx mice, the usual effect of muscle contraction to attenuate NE-mediated vasoconstriction was impaired, resulting in functional ischemia: NE evoked similar decreases in femoral blood flow velocity and femoral vascular conductance (FVC) in the contracting compared to resting hindlimbs (Delta FVC contraction/Delta FVC rest = 0.88 +/- 0.03). NE-induced functional ischemia was unaffected by low dose HCT 1026 (Delta FVC ratio = 0.92 +/- 0.04; P>0.05 vs untreated), but was alleviated by the high dose of the drug (Delta FVC ratio = 0.22 +/- 0.03; P<0.05 vs untreated or low dose). The beneficial effect of high dose HCT 1026 was maintained with treatment up to 3 months. The effect of the NO-donating drug HCT 1026 to normalize blood flow regulation in contracting mdx mouse hindlimb muscles suggests a putative novel treatment for DMD. Further translational research is warranted.	[Thomas, Gail D.; Victor, Ronald G.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Thomas, Gail D.; Ye, Jianfeng; Victor, Ronald G.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [De Nardi, Claudio; Monopoli, Angela; Ongini, Ennio] NicOx Res Inst, Bresso, Italy	Cedars Sinai Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Thomas, GD (corresponding author), Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA.	gail.thomas@cshs.org		Thomas, Gail/0000-0003-2731-6788	NicOx Research Institute; United States National Institutes of Health (NIH) [R01 AR051034]; UCLA Muscular Dystrophy Core Center [NIH 5P30AR05723]; National Center for Advancing Translational Sciences through UCLA CTSI Grant [UL1TR000124]; NicOx Research Institute [HCT 1026]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051034, P30AR057230] Funding Source: NIH RePORTER	NicOx Research Institute; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Muscular Dystrophy Core Center; National Center for Advancing Translational Sciences through UCLA CTSI Grant; NicOx Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a research grant from NicOx Research Institute, United States National Institutes of Health (NIH) R01 AR051034 (GDT), UCLA Muscular Dystrophy Core Center Grant NIH 5P30AR05723, and the National Center for Advancing Translational Sciences through UCLA CTSI Grant UL1TR000124 (RGV). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. With the exception of the contributions of the authors employed by NicOx Research Institute, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Three of the authors of the manuscript, Claudio De Nardi, Angela Monopoli, and Ennio Ongini, were affiliated with NicOx Research Intsitute at the time the study was performed. NicOx Research Institute provided the drug (HCT 1026) used in the study and partial funding for the study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. There are no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products.	Adami A, 1996, PHARMACOL RES, V33, P239, DOI 10.1006/phrs.1996.0033; Adamo CM, 2010, P NATL ACAD SCI USA, V107, P19079, DOI 10.1073/pnas.1013077107; Aldini G, 2002, LIFE SCI, V71, P1487, DOI 10.1016/S0024-3205(02)01915-X; Archer JD, 2006, FASEB J, V20, P738, DOI 10.1096/fj.05-4821fje; Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bertrand V, 1998, EUR J PHARMACOL, V356, P245, DOI 10.1016/S0014-2999(98)00550-0; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Carini M, 2001, J PHARMACEUT BIOMED, V26, P509, DOI 10.1016/S0731-7085(01)00478-2; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Chavoshan B, 2002, J PHYSIOL-LONDON, V540, P377, DOI 10.1113/jphysiol.2001.013153; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; D'Angelo MG, 2012, PHARMACOL RES, V65, P472, DOI 10.1016/j.phrs.2012.01.006; Fadel PJ, 2012, J PHYSIOL-LONDON, V590, P395, DOI 10.1113/jphysiol.2011.218917; Furlan R, 2004, J NEUROIMMUNOL, V150, P10, DOI 10.1016/j.jneuroim.2004.01.004; Govoni M, 2006, J PHARMACOL EXP THER, V317, P752, DOI 10.1124/jpet.105.097469; Guerron AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011220; Hansen J, 1996, J CLIN INVEST, V98, P584, DOI 10.1172/JCI118826; Hedderick ELF, 2011, NEUROLOGY, V76, P960, DOI 10.1212/WNL.0b013e31821043c8; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Karlsson J, 2009, J RHEUMATOL, V36, P1290, DOI 10.3899/jrheum.081011; Keeble J, 2001, BRIT J PHARMACOL, V133, P1023, DOI 10.1038/sj.bjp.0704161; Keeble JE, 2002, BRIT J PHARMACOL, V137, P295, DOI 10.1038/sj.bjp.0704876; Khairallah M, 2008, P NATL ACAD SCI USA, V105, P7028, DOI 10.1073/pnas.0710595105; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Li DJ, 2011, J PATHOL, V223, P88, DOI 10.1002/path.2799; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Maffia P, 2002, ARTERIOSCL THROM VAS, V22, P263, DOI 10.1161/hq0202.104064; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Munzel T, 2011, CIRCULATION, V123, P2132, DOI 10.1161/CIRCULATIONAHA.110.981407; Muscara MN, 2000, AM J PHYSIOL-HEART C, V279, pH528, DOI 10.1152/ajpheart.2000.279.2.H528; Percival JM, 2012, J PATHOL, V228, P77, DOI 10.1002/path.4054; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Prosperi C, 2001, JPN J PHARMACOL, V86, P230, DOI 10.1254/jjp.86.230; Rando TA, 2001, MICROSC RES TECHNIQ, V55, P223, DOI 10.1002/jemt.1172; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Sciorati C, 2011, PHARMACOL RES, V64, P210, DOI 10.1016/j.phrs.2011.05.003; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Thomas GD, 1998, J PHYSIOL-LONDON, V506, P817, DOI 10.1111/j.1469-7793.1998.817bv.x; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Wallace JL, 2009, TRENDS PHARMACOL SCI, V30, P112, DOI 10.1016/j.tips.2009.01.001; White WB, 2009, AM J CARDIOL, V104, P840, DOI 10.1016/j.amjcard.2009.05.014; Zacharowski P, 2004, CLIN PHARMACOL THER, V76, P350, DOI 10.1016/j.clpt.2004.05.008; Zweier JL, 2010, NITRIC OXIDE-BIOL CH, V22, P83, DOI 10.1016/j.niox.2009.12.004	55	26	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49350	10.1371/journal.pone.0049350	http://dx.doi.org/10.1371/journal.pone.0049350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23139842	gold, Green Published, Green Submitted			2022-12-25	WOS:000310741400072
J	Kumar, S; Lefevre, SD; Veenhuis, M; van der Klei, IJ				Kumar, Sanjeev; Lefevre, Sophie D.; Veenhuis, Marten; van der Klei, Ida J.			Extension of Yeast Chronological Lifespan by Methylamine	PLOS ONE			English	Article							CALORIC RESTRICTION; CANDIDA-BOIDINII; OLEIC-ACID; PEROXISOMES; AUTOPHAGY; LONGEVITY; METHANOL; CELLS; SPERMIDINE; TISSUES	Background: Chronological aging of yeast cells is commonly used as a model for aging of human post-mitotic cells. The yeast Saccharomyces cerevisiae grown on glucose in the presence of ammonium sulphate is mainly used in yeast aging research. We have analyzed chronological aging of the yeast Hansenula polymorpha grown at conditions that require primary peroxisome metabolism for growth. Methodology/Principal Findings: The chronological lifespan of H. polymorpha is strongly enhanced when cells are grown on methanol or ethanol, metabolized by peroxisome enzymes, relative to growth on glucose that does not require peroxisomes. The short lifespan of H. polymorpha on glucose is mainly due to medium acidification, whereas most likely ROS do not play an important role. Growth of cells on methanol/methylamine instead of methanol/ammonium sulphate resulted in further lifespan enhancement. This was unrelated to medium acidification. We show that oxidation of methylamine by peroxisomal amine oxidase at carbon starvation conditions is responsible for lifespan extension. The methylamine oxidation product formaldehyde is further oxidized resulting in NADH generation, which contributes to increased ATP generation and reduction of ROS levels in the stationary phase. Conclusion/Significance: We conclude that primary peroxisome metabolism enhanced chronological lifespan of H. polymorpha. Moreover, the possibility to generate NADH at carbon starvation conditions by an organic nitrogen source supports further extension of the lifespan of the cell. Consequently, the interpretation of CLS analyses in yeast should include possible effects on the energy status of the cell.	[Kumar, Sanjeev; Lefevre, Sophie D.; Veenhuis, Marten; van der Klei, Ida J.] Univ Groningen, Kluyver Ctr Genom Ind Fermentat, Groningen Biomol Sci & Biotechnol Inst GBB, Groningen, Netherlands	University of Groningen	van der Klei, IJ (corresponding author), Univ Groningen, Kluyver Ctr Genom Ind Fermentat, Groningen Biomol Sci & Biotechnol Inst GBB, Groningen, Netherlands.	i.j.van.der.klei@rug.nl	van der Klei, Ida J/D-1919-2012; Lefevre, Sophie D./AAO-2773-2020; Lefevre, Sophie D/G-7713-2015	Lefevre, Sophie D/0000-0002-7504-1881; Kumar, Sanjeev/0000-0003-2685-9940; Van der Klei, Ida J./0000-0001-7165-9679	Netherlands Organisation for Scientific Research (NWO); Dutch Science Foundation (NWO) within the research program of the Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative and NWO	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Science Foundation (NWO) within the research program of the Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative and NWO	SK and SL are supported by the Netherlands Organisation for Scientific Research (NWO). This project was carried out within the research program of the Systems Biology Centre for Metabolism and Aging (SBC-EMA), which is one of three national systems biology centers funded by the Dutch Science Foundation (NWO) and within the research program of the Kluyver Centre for Genomics of Industrial Fermentation, which is part of the Netherlands Genomics Initiative and NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Hipkiss AR, 2010, ADV CLIN CHEM, V50, P123, DOI 10.1016/S0065-2423(10)50007-6; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kennedy BK, 2008, J INTERN MED, V263, P142, DOI 10.1111/j.1365-2796.2007.01903.x; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Komduur JA, 2003, FEMS YEAST RES, V3, P27, DOI 10.1016/S1567-1356(02)00135-6; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; MacLean M, 2001, YEAST, V18, P499, DOI 10.1002/yea.701; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Piper PW, 2012, SUBCELL BIOCHEM, V57, P145, DOI 10.1007/978-94-007-2561-4_7; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; Santos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037090; Saraya R, 2012, FEMS YEAST RES, V12, P271, DOI 10.1111/j.1567-1364.2011.00772.x; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; SULTER GJ, 1990, ARCH MICROBIOL, V153, P485, DOI 10.1007/BF00248431; VANDIJKEN JP, 1975, ARCH MICROBIOL, V105, P261, DOI 10.1007/BF00447145; VANDIJKEN JP, 1976, ARCH MICROBIOL, V111, P137; VANDIJKEN JP, 1978, FEMS MICROBIOL LETT, V4, P97, DOI 10.1016/0378-1097(78)90095-2; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; WATERHAM HR, 1992, J BACTERIOL, V174, P4057, DOI 10.1128/jb.174.12.4057-4063.1992; ZWART K, 1980, ARCH MICROBIOL, V126, P117, DOI 10.1007/BF00511216	29	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48982	10.1371/journal.pone.0048982	http://dx.doi.org/10.1371/journal.pone.0048982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133668	Green Published, Green Submitted, gold			2022-12-25	WOS:000310702400053
J	Pan, B; Ma, YJ; Ren, H; He, YB; Wang, YY; Lv, XF; Liu, DH; Ji, L; Yu, BQ; Wang, YH; Chen, YE; Pennathur, S; Smith, JD; Liu, G; Zheng, LM				Pan, Bing; Ma, Yijing; Ren, Hui; He, Yubin; Wang, Yongyu; Lv, Xiaofeng; Liu, Donghui; Ji, Liang; Yu, Baoqi; Wang, Yuhui; Chen, Y. Eugene; Pennathur, Subramaniam; Smith, Jonathan D.; Liu, George; Zheng, Lemin			Diabetic HDL Is Dysfunctional in Stimulating Endothelial Cell Migration and Proliferation Due to Down Regulation of SR-BI Expression	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; SCAVENGER RECEPTOR BI; PROGENITOR CELLS; SPHINGOSINE 1-PHOSPHATE; CHOLESTEROL EFFLUX; MACROPHAGES; LIPOPROTEINS; GLYCATION; CAPACITY; VITRO	Background: Diabetic HDL had diminished capacity to stimulate endothelial cell (EC) proliferation, migration, and adhesion to extracellular matrix. The mechanism of such dysfunction is poorly understood and we therefore sought to determine the mechanistic features of diabetic HDL dysfunction. Methodology/Principal Findings: We found that the dysfunction of diabetic HDL on human umbilical vein endothelial cells (HUVECs) was associated with the down regulation of the HDL receptor protein, SR-BI. Akt-phosphorylation in HUVECs was induced in a biphasic manner by normal HDL. While diabetic HDL induced Akt phosphorylation normally after 20 minutes, the phosphorylation observed 24 hours after diabetic HDL treatment was reduced. To determine the role of SR-BI down regulation on diminished EC responses of diabetic HDL, Mouse aortic endothelial cells (MAECs) were isolated from wild type and SR-BI (-/-) mice, and treated with normal and diabetic HDL. The proliferative and migratory effects of normal HDL on wild type MAECs were greatly diminished in SR-BI (-/-) cells. In contrast, response to diabetic HDL was impaired in both types suggesting diminished effectiveness of diabetic HDL on EC proliferation and migration might be due to the down regulation of SR-BI. Additionally, SR-BI down regulation diminishes diabetic HDL's capacity to activate Akt chronically. Conclusions/Significance: Diabetic HDL was dysfunctional in promoting EC proliferation, migration, and adhesion to matrix which was associated with the down-regulation of SR-BI. Additionally, SR-BI down regulation diminishes diabetic HDL's capacity to activate Akt chronically.	[Pan, Bing; Ma, Yijing; Ren, Hui; Liu, Donghui; Ji, Liang; Yu, Baoqi; Wang, Yuhui; Liu, George; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Inst Cardiovasc Sci,Minist Educ,Minist Hlth, Beijing 100871, Peoples R China; [Pan, Bing; Zheng, Lemin] Peking Univ, Hlth Sci Ctr,Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Inst Syst Biomed,Minist Educ,Sch Biomed Sci, Beijing 100871, Peoples R China; [Pan, Bing; Ma, Yijing; Ren, Hui; Liu, Donghui; Ji, Liang; Yu, Baoqi; Wang, Yuhui; Liu, George; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Key Lab Mol Cardiovasc Sci,Minist Educ,Minist Hlt, Beijing 100871, Peoples R China; [He, Yubin; Lv, Xiaofeng] Mil Gen Hosp Beijing, Beijing, Peoples R China; [Wang, Yongyu] Shantou Univ, Dept Pathol, Coll Med, Shantou, Guangdong, Peoples R China; [Chen, Y. Eugene; Pennathur, Subramaniam] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Smith, Jonathan D.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44106 USA	Peking University; Peking University; Peking University; Shantou University; University of Michigan System; University of Michigan; Cleveland Clinic Foundation	Liu, G (corresponding author), Peking Univ, Hlth Sci Ctr, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Inst Cardiovasc Sci,Minist Educ,Minist Hlth, Beijing 100871, Peoples R China.	georgeliu@bjmu.edu.cn; zhengl@bjmu.edu.cn	王, 宇慧/GXZ-7548-2022; Wang, Yongyu/F-9039-2011; Smith, Jonathan D./H-9723-2013	Wang, Yongyu/0000-0002-8804-3472; Donghui, Liu/0000-0001-6568-5424; Smith, Jonathan D./0000-0002-0415-386X; Ren, Hui/0000-0002-0166-8614; Wang, Yongyu/0000-0002-6088-8887	"973" National ST Major Project [2010CB912504, 2011CB503900]; National Natural Science Foundation of China [30900595, 30821001, 81172500, 81170101]; Natural Science Foundation of Beijing [7102104, 7122106]; Natural Science Foundation of Fujian [2009J01112]; State Education Ministry of China [20090001120039, 20100001120034]; United States National Institutes of Health [HL098055]; Doris Duke Foundation Clinical Scientist Development Award; American College of Rheumatology Within Our Reach Award; University of Michigan-Peking University Health Science Center Joint Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	"973" National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province); State Education Ministry of China(Ministry of Education, China); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Foundation Clinical Scientist Development Award; American College of Rheumatology Within Our Reach Award; University of Michigan-Peking University Health Science Center Joint Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Grant 2010CB912504, and 2011CB503900 from "973" National S&T Major Project; by Grant 30900595, 30821001, 81172500, 81170101 from the National Natural Science Foundation of China; by Grant 7102104, 7122106 from the Natural Science Foundation of Beijing; and by Grant 2009J01112 from the Natural Science Foundation of Fujian. This project was sponsored by Grant 20090001120039 and 20100001120034, State Education Ministry of China. Additional support to JDS was from United States National Institutes of Health grant HL098055. SP acknowledges support from The Doris Duke Foundation Clinical Scientist Development Award and American College of Rheumatology Within Our Reach Award. This project is also supported by the University of Michigan-Peking University Health Science Center Joint Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; CHUNG BH, 1980, J LIPID RES, V21, P284; de Carvalho F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027707; Giannotti G, 2010, HYPERTENSION, V55, P1389, DOI 10.1161/HYPERTENSIONAHA.109.141614; Hedrick CC, 2000, DIABETOLOGIA, V43, P312, DOI 10.1007/s001250050049; Kawamoto A, 2008, TRENDS CARDIOVAS MED, V18, P33, DOI 10.1016/j.tcm.2007.11.004; Kimura T, 2006, CELL SIGNAL, V18, P841, DOI 10.1016/j.cellsig.2005.07.011; Kimura T, 2003, ARTERIOSCL THROM VAS, V23, P1283, DOI 10.1161/01.ATV.0000079011.67194.5A; Laight DW, 1999, DIABETES-METAB RES, V15, P274, DOI 10.1002/(SICI)1520-7560(199907/08)15:4<274::AID-DMRR46>3.0.CO;2-G; Lam MCW, 2004, ATHEROSCLEROSIS, V177, P313, DOI 10.1016/j.atherosclerosis.2004.08.003; Matsunaga T, 2003, METABOLISM, V52, P42, DOI 10.1053/meta.2003.50013; MURUGESAN G, 1994, CIRC RES, V74, P1149, DOI 10.1161/01.RES.74.6.1149; Nobecourt E, 2008, DIABETOLOGIA, V51, P1008, DOI 10.1007/s00125-008-0986-z; Nobecourt E, 2005, DIABETOLOGIA, V48, P529, DOI 10.1007/s00125-004-1655-5; Pan B, 2011, INT J CANC; Pan B, 2012, CLIN CANC RES; Passarelli M, 2005, DIABETES, V54, P2198, DOI 10.2337/diabetes.54.7.2198; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; Tamagaki T, 1996, ATHEROSCLEROSIS, V123, P73, DOI 10.1016/0021-9150(95)05774-9; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Valiyaveettil M, 2008, BLOOD, V111, P1962, DOI 10.1182/blood-2007-08-107813; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; van Oostrom O, 2007, ARTERIOSCL THROM VAS, V27, P1864, DOI 10.1161/ATVBAHA.107.143875; Xu QB, 2009, TRENDS CARDIOVAS MED, V19, P191, DOI 10.1016/j.tcm.2009.12.002; Xu W, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-94; Yamamoto S, 2011, CIRCULATION, V124, P1382, DOI 10.1161/CIRCULATIONAHA.110.009704; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	34	36	37	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2012	7	11							e48530	10.1371/journal.pone.0048530	http://dx.doi.org/10.1371/journal.pone.0048530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032GO	23133640	Green Submitted, Green Published, gold			2022-12-25	WOS:000310702400037
J	Kato, Y; Kaneko, N; Sawada, M; Ito, K; Arakawa, S; Murakami, S; Sawamoto, K				Kato, Yasuko; Kaneko, Naoko; Sawada, Masato; Ito, Keishi; Arakawa, Sousuke; Murakami, Shingo; Sawamoto, Kazunobu			A Subtype-Specific Critical Period for Neurogenesis in the Postnatal Development of Mouse Olfactory Glomeruli	PLOS ONE			English	Article							EXPERIENCE-DEPENDENT SURVIVAL; NEWLY-GENERATED NEURONS; ADULT BRAIN; SENSORY DEPRIVATION; SUBVENTRICULAR ZONE; VISUAL DEPRIVATION; OCULAR DOMINANCE; NEWBORN NEURONS; BULB; CELLS	Sensory input is essential for the normal development of sensory centers in the brain, such as the somatosensory, visual, auditory, and olfactory systems. Visual deprivation during a specific developmental stage, called the critical period, results in severe and irreversible functional impairments in the primary visual cortex. Olfactory deprivation in the early postnatal period also causes significant developmental defects in the olfactory bulb, the primary center for olfaction. Olfactory bulb interneurons are continuously generated from neural stem cells in the ventricular-subventricular zone, suggesting that the olfactory system has plasticity even in adulthood. Here, we investigated the effect of transient neonatal olfactory deprivation on the addition of interneurons to the glomerular layer of the adult mouse olfactory bulb. We found that the addition of one subtype of interneurons was persistently inhibited even after reopening the naris. BrdU pulse-chase experiments revealed that the neonatal olfactory deprivation predominantly affected an early phase in the maturation of this neuronal subtype in the olfactory bulb. Subjecting the mice to odor stimulation for 6 weeks after naris reopening resulted in significant recovery from the histological and functional defects caused by the olfactory deprivation. These results suggest that a subtype-specific critical period exists for olfactory bulb neurogenesis, but that this period is less strict and more plastic compared with the critical periods for other systems. This study provides new insights into the mechanisms of postnatal neurogenesis and a biological basis for the therapeutic effect of olfactory training.	[Kato, Yasuko; Kaneko, Naoko; Sawada, Masato; Ito, Keishi; Arakawa, Sousuke; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi, Japan; [Kato, Yasuko; Murakami, Shingo] Nagoya City Univ, Grad Sch Med Sci, Dpartment Neurootolaryngol, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University	Sawamoto, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi, Japan.	sawamoto@med.nagoya-cu.ac.jp	Kaneko, Naoko/P-2054-2019	Sawada, Masato/0000-0002-8694-8526; Kaneko, Naoko/0000-0003-3121-7117; Sawamoto, Kazunobu/0000-0003-1984-5129	Funding Program for Next Generation World-Leading Researchers (Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research [23680041] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers (Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Program for Next Generation World-Leading Researchers (Japan Society for the Promotion of Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Bastien-Dionne PO, 2010, J COMP NEUROL, V518, P1847, DOI 10.1002/cne.22307; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Belnoue L, 2011, J NEUROSCI, V31, P1010, DOI 10.1523/JNEUROSCI.3941-10.2011; Bovetti S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006359; BRUNJES PC, 1985, DEV BRAIN RES, V22, P1, DOI 10.1016/0165-3806(85)90063-X; Carvell GE, 1996, J NEUROSCI, V16, P2750; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Cummings DM, 1997, J NEUROSCI, V17, P7433; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Fiske BK, 2000, NEUROSCIENCE, V96, P807, DOI 10.1016/S0306-4522(99)00601-6; Fiske BK, 2001, J COMP NEUROL, V431, P311; Frasnelli J, 2011, PROG BRAIN RES, V191, P233, DOI 10.1016/B978-0-444-53752-2.00002-3; GARCIA CM, 1991, HISTOL HISTOPATHOL, V6, P235; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; Guerin D, 2008, BEHAV NEUROSCI, V122, P816, DOI 10.1037/a0012522; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Johnston R, 2002, ANIM BEHAV, V45, P1061; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Kosaka K, 2007, BRAIN RES, V1167, P42, DOI 10.1016/j.brainres.2007.04.087; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Li XS, 2011, J NEUROSCI, V31, P8450, DOI 10.1523/JNEUROSCI.0939-11.2011; Lim JH, 1999, NEUROSCIENCE, V93, P371, DOI 10.1016/S0306-4522(99)00093-7; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; Matsutani S, 2000, J COMP NEUROL, V418, P402; McLean JH, 2001, DEV BRAIN RES, V128, P17, DOI 10.1016/S0165-3806(01)00144-4; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; MITCHELL DE, 1988, J PHYSIOL-LONDON, V395, P639, DOI 10.1113/jphysiol.1988.sp016939; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; NAJBAUER J, 1995, BRAIN RES, V674, P245, DOI 10.1016/0006-8993(94)01448-Q; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Oboti L, 2009, EUR J NEUROSCI, V29, P679, DOI 10.1111/j.1460-9568.2009.06614.x; OLSON CR, 1980, EXP BRAIN RES, V39, P17; Petreanu L, 2002, J NEUROSCI, V22, P6106; Philpot BD, 1997, J COMP NEUROL, V387, P12; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sawada M, 2011, J NEUROSCI, V31, P11587, DOI 10.1523/JNEUROSCI.0614-11.2011; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Semjildsuren GU, 2008, OTOLARYNG HEAD NECK, V138, P648, DOI 10.1016/j.otohns.2007.12.036; Shepherd GM, 2004, OLFACTORY BULB SYNAP, P165; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Xu H, 2007, J NEUROSCI, V27, P9417, DOI 10.1523/JNEUROSCI.1992-07.2007; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yoshihara S, 2012, J NEUROSCI, V32, P2217, DOI 10.1523/JNEUROSCI.5907-11.2012	55	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48431	10.1371/journal.pone.0048431	http://dx.doi.org/10.1371/journal.pone.0048431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133633	gold, Green Published, Green Submitted			2022-12-25	WOS:000310601300013
J	Rai, E; Sharma, S; Kaul, S; Jain, K; Matharoo, K; Bhanwer, AS; Bamezai, RNK				Rai, Ekta; Sharma, Swarkar; Kaul, Surabhi; Jain, Kamal; Matharoo, Kawaljit; Bhanwer, Amarjit S.; Bamezai, Rameshwar N. K.			The Interactive Effect of SIRT1 Promoter Region Polymorphism on Type 2 Diabetes Susceptibility in the North Indian Population	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN-SECRETION; CALORIE RESTRICTION; THRIFTY GENOTYPE; UNCOUPLING PROTEIN-2; BREAST-CANCER; GLUCOSE; HYPOTHESIS; VARIANTS; PGC-1-ALPHA	Our previous studies have implicated genes mainly involved in the activity of pancreatic beta cells in type 2 diabetes (T2D) susceptibility in the North Indian population. Recent literature on the role of SIRT1 as a potential master switch modulating insulin secretion and regulating gene expression in pancreatic b cells has warranted an evaluation of SIRT1 promoter region polymorphisms in the North Indian population, which is the main focus of the present study. 1542 samples (692 T2D patients and 850 controls) were sequenced for the 1.46 kb region upstream the translation start site of the SIRT1 gene. We performed a functional characterization of the SIRT1 promoter region polymorphisms using luciferase assay and observed a single-nucleotide polymorphism (SNP), rs12778366, in association with SIRT1 expression. We propose that TT, the high-expressing genotype of SNP rs12778366 in the SIRT1 promoter region and present in >80% of the North Indian population, was favored under conditions of feast-famine cycles in evolution, which has turned out to be a cause of concern in the present sedentary lifestyle under ad libitum conditions. Case-control association analysis did not implicate rs12778366 in T2DM per se in the studied population. However, our earlier reported risk genotype combinations of mt-ND3, PGC1 alpha, and UCP2-866, when compared with the protective genotype combinations, in the background of the high-expressing TT genotype of SIRT1 SNP rs12778366, showed a very high additive risk [ corrected odd ratio (OR) = 8.91; p = 6.5x10(-11)]. The risk level was considerably low in the genotype backgrounds of TX (OR = 6.68; p = 2.71x10(-12)) and CX (OR = 3.74; p = 4.0x10(-3)). In addition, we screened other reported T2D-associated polymorphisms: PIK3R1 rs3730089, IRS1 rs1801278, and PPP1R3 rs1799999, which did not show any significant association in North Indian population. The present paper emphasizes the importance of gene interactions in the biological pathways of T2D, a complex lifestyle disease.	[Rai, Ekta; Sharma, Swarkar; Kaul, Surabhi; Jain, Kamal; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Rai, Ekta] UT SW Med Ctr, Dept Immunol, Dallas, TX USA; [Sharma, Swarkar] Texas Scottish Rite Hosp Children, Dept Res, Dallas, TX 75219 USA; [Matharoo, Kawaljit; Bhanwer, Amarjit S.] Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India	Jawaharlal Nehru University, New Delhi; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Scottish Rite Hospital for Children; Guru Nanak Dev University	Sharma, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	sawerkar@hotmail.com; bamezai@ncahg.org	SHARMA, SWARKAR/B-8096-2008	SHARMA, SWARKAR/0000-0001-8857-5906; RAI, EKTA/0000-0002-4579-1788; Bamezai, R.N.K/0000-0002-5128-2859; Bhanwer, AJS/0000-0001-5181-9268	DBT; AJSB (GNDU Amritsar) under the DBT multi center project [BT/PR/8846/MED/12/327/2007]; UGC, India	DBT(Department of Biotechnology (DBT) India); AJSB (GNDU Amritsar) under the DBT multi center project; UGC, India(University Grants Commission, India)	DBT Grant to RNKB (NCAHG) and AJSB (GNDU Amritsar) under the DBT multi center project (BT/PR/8846/MED/12/327/2007). UGC, India grant to the National Centre of Applied Human Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerx Johan, 2003, Nucl Recept Signal, V1, pe006; Bhat A, 2007, HUM GENET, V120, P821, DOI 10.1007/s00439-006-0272-4; Bhat A, 2007, HUM GENET, V121, P609, DOI 10.1007/s00439-007-0352-0; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dong Y, 2011, MOL GENET METAB, V104, P661, DOI 10.1016/j.ymgme.2011.08.001; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gochhait S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1780; Gomez-Cabrera MC, 2007, TRENDS ENDOCRIN MET, V18, P91, DOI 10.1016/j.tem.2007.02.008; Leibiger IB, 2005, CELL METAB, V2, P80, DOI 10.1016/j.cmet.2005.07.006; Liang HY, 2007, ANN NY ACAD SCI, V1100, P264, DOI 10.1196/annals.1395.028; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; NEEL JV, 1962, AM J HUM GENET, V14, P353; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Oberkofler H, 2006, ENDOCRINOLOGY, V147, P966, DOI 10.1210/en.2005-0817; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rai E, 2007, HUM GENET, V122, P535, DOI 10.1007/s00439-007-0421-4; Reaven GM, 1998, DIABETOLOGIA, V41, P482, DOI 10.1007/s001250050933; Riedel MJ, 2005, HUM GENET, V116, P133, DOI 10.1007/s00439-004-1216-5; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rozen S, 2000, Methods Mol Biol, V132, P365; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Summermatter S, 2007, FASEB J; Swinburn BA, 1996, DIABETIC MED, V13, P695, DOI 10.1002/(SICI)1096-9136(199608)13:8<695::AID-DIA170>3.0.CO;2-#; Watve MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-61; Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	35	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48621	10.1371/journal.pone.0048621	http://dx.doi.org/10.1371/journal.pone.0048621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133645	gold, Green Published, Green Submitted			2022-12-25	WOS:000310601300020
J	Zhou, H; Chen, X; Zhang, WM; Zhu, LP; Cheng, L				Zhou, Han; Chen, Xi; Zhang, Wei-Ming; Zhu, Lu-Ping; Cheng, Lei			HIF-1 alpha Inhibition Reduces Nasal Inflammation in a Murine Allergic Rhinitis Model	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; ENDOTHELIAL GROWTH-FACTOR; FACTOR 1-ALPHA; EXPRESSION; CELLS; SUPPRESSION; ASTHMA; VEGF; HIF; HYDROXYLATION	Background: Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is an important regulator of immune and inflammatory responses. We hypothesized that nasal allergic inflammation is attenuated by HIF-1 alpha inhibition and strengthened by HIF-1 alpha a stabilization. Objective: To elucidate the role of HIF-1 alpha in a murine model of allergic rhinitis (AR). Methods: Mice were pretreated with the HIF-1 alpha inhibitor 2-methoxyestradiol (2ME2) or the HIF-1 alpha inducer cobalt chloride (CoCl2) in an established AR murine model using ovalbumin (OVA)-sensitized BALB/c mice. HIF-1 alpha and vascular endothelial growth factor (VEGF) expression in nasal mucosa was measured and multiple parameters of allergic responses were evaluated. Results: HIF-1 alpha and VEGF levels were locally up-regulated in nasal mucosa during AR. Inflammatory responses to OVA challenge, including nasal symptoms, inflammatory cell infiltration, eosinophil recruitment, up-regulation of T-helper type 2 cytokines in nasal lavage fluid, and serum OVA-specific IgE levels were present in the OVA-challenged mice. 2ME2 effectively inhibited HIF-1 alpha and VEGF expression and attenuated the inflammatory responses. Stabilization of HIF-1 alpha by CoCl2 facilitated nasal allergic inflammation. HIF-1 alpha protein levels in nasal airways correlated with the severity of AR in mice. Conclusions: HIF-1 alpha is intimately involved in the pathogenesis of nasal allergies, and the inhibition of HIF-1 alpha may be useful as a novel therapeutic approach for AR.	[Zhou, Han; Chen, Xi; Zhu, Lu-Ping; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Zhang, Wei-Ming] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Cheng, Lei] Nanjing Med Univ, Int Ctr Allergy Res, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Cheng, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China.	jspent@126.com	Cheng, Lei/AAT-2690-2021; Zhou, Han/AAV-2874-2021	Cheng, Lei/0000-0001-6541-7702; 	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Innovative Research Project [CXZZ11_0728]; Health Promotion Project of Jiangsu Province [XK200719, RC2007065, RC2011071]; National Natural Science Foundation of China [81200729]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Innovative Research Project; Health Promotion Project of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Innovative Research Project (CXZZ11_0728) and the Health Promotion Project (XK200719, RC2007065 and RC2011071) of Jiangsu Province, and the National Natural Science Foundation of China (81200729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2008, B-ENT, V4, P253; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; Clauss M, 2000, SEMIN THROMB HEMOST, V26, P561, DOI 10.1055/s-2000-13213; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Feldser D, 1999, CANCER RES, V59, P3915; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gao N, 2002, J BIOL CHEM, V277, P31963, DOI 10.1074/jbc.M200082200; Gibbs BF, 2012, INT J BIOCHEM CELL B, V44, P1739, DOI 10.1016/j.biocel.2012.06.019; Grimmer C, 2007, ARTHRITIS RHEUM, V56, P4084, DOI 10.1002/art.23136; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Huerta-Yepez S, 2008, CLIN IMMUNOL, V129, P313, DOI 10.1016/j.clim.2008.07.023; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Ikeda Y, 2002, JPN J PHARMACOL, V90, P328, DOI 10.1254/jjp.90.328; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee KS, 2008, AM J RESP CRIT CARE, V178, P787, DOI 10.1164/rccm.200801-008OC; Lee YM, 2003, BIOCHEM BIOPH RES CO, V300, P241, DOI 10.1016/S0006-291X(02)02787-0; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Nicholas SA, 2010, IMMUNOL CELL BIOL, V88, P180, DOI 10.1038/icb.2009.76; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Salama SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007356; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; SHAPIRA SK, 1991, P NATL ACAD SCI USA, V88, P7528, DOI 10.1073/pnas.88.17.7528; Sumbayev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034259; Sumbayev VV, 2010, ARCH IMMUNOL THER EX, V58, P287, DOI 10.1007/s00005-010-0083-0; Sumbayev VV, 2009, EUR J IMMUNOL, V39, P3511, DOI 10.1002/eji.200939370; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zarember KA, 2005, J CLIN INVEST, V115, P1702, DOI 10.1172/JCI25740; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	35	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2012	7	11							e48618	10.1371/journal.pone.0048618	http://dx.doi.org/10.1371/journal.pone.0048618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WR	23133644	Green Published, gold, Green Submitted			2022-12-25	WOS:000310601300019
J	Kwong, EK; Kim, KM; Penalosa, PJ; Chan, JY				Kwong, Eric K.; Kim, Kyung-Mi; Penalosa, Patrick J.; Chan, Jefferson Y.			Characterization of Nrf1b, a Novel Isoform of the Nuclear Factor-Erythroid-2 Related Transcription Factor-1 That Activates Antioxidant Response Element-Regulated Genes	PLOS ONE			English	Article							FACTOR E2-RELATED FACTOR-1; ENDOPLASMIC-RETICULUM; ALTERNATIVE PROMOTERS; FACTOR TCF11; NEGATIVE REGULATION; EXPRESSION; MECHANISMS; PATHWAY; PROTEIN; CELLS	Nuclear factor E2-related factor 1 (Nrf1) is a basic leucine zipper transcription factor that plays an important role in the activation of cytoprotective genes through the antioxidant response elements. The previously characterized long isoform of Nrf1 (Nrf1a) is targeted to the endoplasmic reticulum and accumulates in the nucleus in response to activating signals. Here we characterized a novel Nrf1 protein isoform (Nrf1b) generated through an alternative promoter and first exon that lacks the ER targeting domain of Nrf1a. The 5'-flanking region of Nrf1b directed high levels of luciferase reporter expression in cells. RT-PCR and Western blotting showed Nrf1b is widely expressed in various cell lines and mouse tissues. Immunoblot analysis of subcellular fractions and imaging of green fluorescence protein (GFP)-tagged Nrf1b demonstrate Nrf1b is constitutively localized to the nucleus. Nrf1b can activate GAL4-dependent transcription when fused to the heterologous GAL4 DNA-binding domain. Gel-shift and coimmunoprecipitation experiments demonstrate that Nrf1b forms a complex with MafG, and expression of Nrf1b activates the expression of antioxidant response element containing reporters and genes in cells. These results suggest Nrf1b is targeted to the nucleus where it activates ARE-driven genes and may play a role in modulating antioxidant response elements.	[Kwong, Eric K.; Kim, Kyung-Mi; Penalosa, Patrick J.; Chan, Jefferson Y.] Univ Calif Irvine, Dept Lab Med & Pathol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Chan, JY (corresponding author), Univ Calif Irvine, Dept Lab Med & Pathol, Irvine, CA 92717 USA.	jchan@uci.edu	Chan, Julia Y/C-5392-2008	Chan, Julia Y/0000-0003-4434-2160; Kwong, Eric/0000-0002-9466-3627	National Institutes of Health [CA091907, NS065223]; NATIONAL CANCER INSTITUTE [R01CA091907, R56CA091907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by grants from the National Institutes of Health (CA091907, NS065223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Berg DT, 2007, J BIOL CHEM, V282, P36837, DOI 10.1074/jbc.M706909200; Biswas M, 2011, J BIOL CHEM, V286, P39282, DOI 10.1074/jbc.M111.253807; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; CIANETTI L, 1990, NUCLEIC ACIDS RES, V18, P4361, DOI 10.1093/nar/18.15.4361; Gascard P, 2004, BBA-GENE STRUCT EXPR, V1680, P71, DOI 10.1016/j.bbaexp.2004.08.006; Husberg C, 2003, BBA-MOL CELL RES, V1640, P143, DOI 10.1016/S0167-4889(03)00041-7; Husberg C, 2001, J BIOL CHEM, V276, P17641, DOI 10.1074/jbc.M007951200; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Li J, 2002, J BIOL CHEM, V277, P388, DOI 10.1074/jbc.M109380200; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; Narayanan K, 2004, J BIOL CHEM, V279, P45423, DOI 10.1074/jbc.M405031200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Xing WR, 2007, J BIOL CHEM, V282, P22052, DOI 10.1074/jbc.M702614200; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304	37	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e48404	10.1371/journal.pone.0048404	http://dx.doi.org/10.1371/journal.pone.0048404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144760	Green Published, gold			2022-12-25	WOS:000310705300070
J	Loscher, M; Schosserer, M; Dausse, E; Lee, K; Ajuh, P; Grillari-Voglauer, R; Lamond, AI; Toulme, JJ; Grillari, J				Loescher, Marlies; Schosserer, Markus; Dausse, Eric; Lee, Kiseok; Ajuh, Paul; Grillari-Voglauer, Regina; Lamond, Angus I.; Toulme, Jean-Jacques; Grillari, Johannes			Inhibition of Pre-mRNA Splicing by a Synthetic Blom7 alpha-Interacting Small RNA	PLOS ONE			English	Article							IN-VITRO SELECTION; DNA-REPAIR; KH DOMAIN; BINDING; PROTEINS; SNEV; COMPLEX; CDC5L; PSO4	Originally the novel protein Blom7 alpha was identified as novel pre-mRNA splicing factor that interacts with SNEVPrp19/Pso4, an essential protein involved in extension of human endothelial cell life span, DNA damage repair, the ubiquitin-proteasome system, and pre-mRNA splicing. Blom7 alpha belongs to the heteronuclear ribonucleoprotein K homology (KH) protein family, displaying 2 KH domains, a well conserved and widespread RNA-binding motif. In order to identify specific sequence binding motifs, we here used Systematic Evolution of Ligands by Exponential Enrichment (SELEX) with a synthetic RNA library. Besides sequence motifs like (U/A)(1-4) C2-6 (U/A)(1-5), we identified an AC-rich RNA-aptamer that we termed AK48 (Aptamer KH-binding 48), binding to Blom7 alpha with high affinity. Addition of AK48 to pre-mRNA splicing reactions in vitro inhibited the formation of mature spliced mRNA and led to a slight accumulation of the H complex of the spliceosome. These results suggest that the RNA binding activity of Blom7 alpha might be required for pre-mRNA splicing catalysis. The inhibition of in-vitro splicing by the small RNA AK48 indicates the potential use of small RNA molecules in targeting the spliceosome complex as a novel target for drug development.	[Loescher, Marlies; Schosserer, Markus; Lee, Kiseok; Grillari-Voglauer, Regina; Grillari, Johannes] BOKU Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Dausse, Eric; Toulme, Jean-Jacques] European Inst Chem & Biol, INSERM, U869, Pessac, France; [Dausse, Eric; Toulme, Jean-Jacques] Univ Bordeaux, Bordeaux, France; [Ajuh, Paul; Lamond, Angus I.] Univ Dundee, Sch Life Sci, Welcome Trust Bioctr, Dundee, Scotland; [Grillari-Voglauer, Regina] ACIB, Vienna, Austria; [Grillari-Voglauer, Regina] Evercyte GmbH, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Dundee; Austrian Centre of Industrial Biotechnology	Grillari, J (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria.	johannes.grillari@boku.ac.at	Schosserer, Markus/A-5966-2010; Grillari, Johannes/B-2967-2011	Schosserer, Markus/0000-0003-2025-0739; Grillari, Johannes/0000-0001-5474-6332; Grillari, Regina/0000-0002-5487-2838; Lamond, Angus/0000-0001-6204-6045; Toulme, Jean-jacques/0000-0002-8432-5034	Austrian Science Fund FWF [P24498-B20]; Genome Research Austria GEN-AU [820982]; Herzfelder'sche Familienstiftung; C.E.R.I.E.S; OeFG; CERIES, Chanel company; Austrian Science Fund (FWF) [P 24498] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Genome Research Austria GEN-AU; Herzfelder'sche Familienstiftung; C.E.R.I.E.S; OeFG; CERIES, Chanel company; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF [P24498-B20]; Genome Research Austria GEN-AU [Project 820982 "Non-coding RNAs"]; and grants by the Herzfelder'sche Familienstiftung and C.E.R.I.E.S to Johannes Grillari. We are grateful to OeFG for supporting research work at the IECB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JG and RGV are co-founders and employees of Evercyte GmbH. RGV is also affiliated to ACIB GmbH. This study was partly funded by CERIES, part of the Chanel company. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Ajuh P, 2001, J BIOL CHEM, V276, P42370, DOI 10.1074/jbc.M105453200; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Dausse Eric, 2005, V288, P391; Dausse E, 2009, CURR OPIN PHARMACOL, V9, P602, DOI 10.1016/j.coph.2009.07.006; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ellis JJ, 2008, PROTEINS, V70, P1518, DOI 10.1002/prot.21647; Fortschegger K, 2007, MOL CELL BIOL, V27, P3123, DOI 10.1128/MCB.01188-06; Gomes Sonia Da Rocha, 2010, Expert Opin Med Diagn, V4, P511, DOI 10.1517/17530059.2010.516248; Grillari J, 2000, EXP GERONTOL, V35, P187, DOI 10.1016/S0531-5565(00)00080-2; Grillari J, 2005, NUCLEIC ACIDS RES, V33, P6868, DOI 10.1093/nar/gki986; Grillari J, 2009, J BIOL CHEM, V284, P29193, DOI 10.1074/jbc.M109.036632; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; Loscher M, 2005, BIOCHEM J, V388, P593, DOI 10.1042/BJ20041517; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; Messias AC, 2004, ACCOUNTS CHEM RES, V37, P279, DOI 10.1021/ar030034m; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Soontornworajit B, 2011, ANAL BIOANAL CHEM, V399, P1591, DOI 10.1007/s00216-010-4559-x; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Syed MA, 2010, OLIGONUCLEOTIDES, V20, P215, DOI 10.1089/oli.2010.0234; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Voglauer R, 2006, EXP CELL RES, V312, P746, DOI 10.1016/j.yexcr.2005.11.025; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200	37	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e47497	10.1371/journal.pone.0047497	http://dx.doi.org/10.1371/journal.pone.0047497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144703	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705300014
J	Peleg, AY; de Breij, A; Adams, MD; Cerqueira, GM; Mocali, S; Galardini, M; Nibbering, PH; Earl, AM; Ward, DV; Paterson, DL; Seifert, H; Dijkshoorn, L				Peleg, Anton Y.; de Breij, Anna; Adams, Mark D.; Cerqueira, Gustavo M.; Mocali, Stefano; Galardini, Marco; Nibbering, Peter H.; Earl, Ashlee M.; Ward, Doyle V.; Paterson, David L.; Seifert, Harald; Dijkshoorn, Lenie			The Success of Acinetobacter Species; Genetic, Metabolic and Virulence Attributes	PLOS ONE			English	Article							HUMAN SKIN EQUIVALENT; MOLECULAR CHARACTERIZATION; BAUMANNII COMPLEX; BIOFILM FORMATION; GENOME SEQUENCE; IDENTIFICATION; SIDEROPHORE; ACQUISITION; EVOLUTION; ADHERENCE	An understanding of why certain Acinetobacter species are more successful in causing nosocomial infections, transmission and epidemic spread in healthcare institutions compared with other species is lacking. We used genomic, phenotypic and virulence studies to identify differences between Acinetobacter species. Fourteen strains representing nine species were examined. Genomic analysis of six strains showed that the A. baumannii core genome contains many genes important for diverse metabolism and survival in the host. Most of the A. baumannii core genes were also present in one or more of the less clinically successful species. In contrast, when the accessory genome of an individual A. baumannii strain was compared to a strain of a less successful species (A. calcoaceticus RUH2202), many operons with putative virulence function were found to be present only in the A. baumannii strain, including the csu operon, the acinetobactin chromosomal cluster, and bacterial defence mechanisms. Phenotype microarray analysis showed that compared to A. calcoaceticus (RUH2202), A. baumannii ATCC 19606(T) was able to utilise nitrogen sources more effectively and was more tolerant to pH, osmotic and antimicrobial stress. Virulence differences were also observed, with A. baumannii ATCC 19606(T), A. pittii SH024, and A. nosocomialis RUH2624 persisting and forming larger biofilms on human skin than A. calcoaceticus. A. baumannii ATCC 19606 T and A. pittii SH024 were also able to survive in a murine thigh infection model, whereas the other two species were eradicated. The current study provides important insights into the elucidation of differences in clinical relevance among Acinetobacter species.	[Peleg, Anton Y.; Cerqueira, Gustavo M.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Peleg, Anton Y.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Peleg, Anton Y.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [de Breij, Anna; Nibbering, Peter H.; Dijkshoorn, Lenie] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [Adams, Mark D.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Adams, Mark D.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Mocali, Stefano] Agr Res Council CRA ABP, Agrobiol & Pedol Ctr, Florence, Italy; [Galardini, Marco] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Earl, Ashlee M.; Ward, Doyle V.] Broad Inst, Cambridge, MA USA; [Paterson, David L.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Seifert, Harald] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany	Monash University; Florey Institute of Neuroscience & Mental Health; Harvard University; Beth Israel Deaconess Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Case Western Reserve University; Case Western Reserve University; University of Florence; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Queensland; University of Cologne	Peleg, AY (corresponding author), Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia.	anton.peleg@monash.edu	Paterson, David L/A-9258-2010; Mocali, Stefano/ABE-2918-2020; Cerqueira, Gustavo/B-7180-2015; Galardini, Marco/H-6413-2019	Cerqueira, Gustavo/0000-0002-3029-6899; Galardini, Marco/0000-0003-2018-8242; Paterson, David/0000-0003-2079-4437; Earl, Ashlee/0000-0001-7857-9145; Mocali, Stefano/0000-0002-1173-7206; Peleg, Anton/0000-0002-2296-2126	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under the HMP Jumpstart Initiative; Australian National Health and Medical Research Council (NHMRC) [APP1010114]; NHMRC [APP606961]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094403] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under the HMP Jumpstart Initiative; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under the HMP Jumpstart Initiative. The authors also acknowledge support from the Australian National Health and Medical Research Council (NHMRC) project grant (APP1010114) and an NHMRC Biomedical Fellowship to A.Y.P (APP606961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Biondi EG, 2009, APPL ENVIRON MICROB, V75, P5396, DOI 10.1128/AEM.00196-09; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Cerqueira GM, 2011, IUBMB LIFE, V63, P1055, DOI 10.1002/iub.533; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chiang MC, 2012, INFECTION, V40, P19, DOI 10.1007/s15010-011-0187-4; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; de Breij A, 2012, ANTIMICROB AGENTS CH, V56, P2459, DOI 10.1128/AAC.05975-11; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002; Dijkshoorn L, 2004, ANTIMICROB AGENTS CH, V48, P4919, DOI 10.1128/AAC.48.12.4919-4921.2004; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Dorsey CW, 2003, J CLIN MICROBIOL, V41, P4188, DOI 10.1128/JCM.41.9.4188-4193.2003; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; El Ghalbzouri A, 2009, BIOMATERIALS, V30, P71, DOI 10.1016/j.biomaterials.2008.09.002; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hubbard BK, 1998, BIOCHEMISTRY-US, V37, P14369, DOI 10.1021/bi981124f; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Koh TH, 2012, EPIDEMIOL INFECT, P1; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lamichhane-Khadka R, 2011, J BACTERIOL, V193, P5824, DOI 10.1128/JB.05456-11; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Luke NR, 2010, INFECT IMMUN, V78, P2017, DOI 10.1128/IAI.00016-10; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; PIECHAUD D, 1951, ANN I PASTEUR PARIS, V80, P97; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; van den Broek PJ, 2009, J CLIN MICROBIOL, V47, P3593, DOI 10.1128/JCM.00967-09; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Wang LS, 2004, NUCLEIC ACIDS RES, V32, P3689, DOI 10.1093/nar/gkh694; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/BF00301846; Yum JH, 2002, J ANTIMICROB CHEMOTH, V49, P837, DOI 10.1093/jac/dkf043	55	114	121	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2012	7	10							e46984	10.1371/journal.pone.0046984	http://dx.doi.org/10.1371/journal.pone.0046984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HH	23144699	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000310705300010
J	Anuar, TS; Al-Mekhlafi, HM; Ghani, MKA; Osman, E; Yasin, AM; Nordin, A; Azreen, SN; Salleh, FM; Ghazali, N; Bernadus, M; Moktar, N				Anuar, Tengku Shahrul; Al-Mekhlafi, Hesham M.; Ghani, Mohamed Kamel Abdul; Osman, Emelia; Yasin, Azlin Mohd; Nordin, Anisah; Azreen, Siti Nor; Salleh, Fatmah Md; Ghazali, Nuraffini; Bernadus, Mekadina; Moktar, Norhayati			Prevalence and Risk Factors Associated with Entamoeba histolytica/dispar/moshkovskii Infection among Three Orang Asli Ethnic Groups in Malaysia	PLOS ONE			English	Article							HISTOLYTICA INFECTION; INTESTINAL PARASITISM; DISPAR; MOSHKOVSKII; AMEBIASIS; DIARRHEA; CHILDREN; ABORIGINES; DIAGNOSIS; OVA	Background: Entamoeba histolytica/Entamoeba dispar/Entamoeba moshkovskii infection is still prevalent in rural Malaysia especially among Orang Asli communities. Currently, information on prevalence of this infection among different ethnic groups of Orang Asli is unavailable in Malaysia. To contribute to a better comprehension of the epidemiology of this infection, a cross-sectional study aimed at providing the first documented data on the prevalence and risk factors associated with E. histolytica/E. dispar/E. moshkovskii infection was carried out among three Orang Asli ethnic groups (Proto-Malay, Negrito, and Senoi) in selected villages in Negeri Sembilan, Perak, and Pahang states, Malaysia. Methods/Findings: Faecal samples were examined by formalin-ether sedimentation and trichrome staining techniques. Of 500 individuals, 8.7% (13/150) of Proto-Malay, 29.5% (41/139) of Negrito, and 18.5% (39/211) of Senoi were positive for E. histolytica/E. dispar/E. moshkovskii, respectively. The prevalence of this infection showed an age-dependency relationship, with higher rates observed among those aged less than 15 years in all ethnic groups studied. Multivariate analysis confirmed that not washing hands after playing with soils or gardening and presence of other family members infected with E. histolytica/E. dispar/E. moshkovskii were significant risk factors of infection among all ethnic groups. However, eating with hands, the consumption of raw vegetables, and close contact with domestic animals were identified as significant risk factors in Senoi. Conclusions: Essentially, the findings highlighted that E. histolytica/E. dispar/E. moshkovskii parasites are still prevalent in Malaysia. Further studies using molecular approaches to distinguish the morphologically identical species of pathogenic, E. histolytica from the non-pathogenic, E. dispar and E. moshkovskii are needed. The establishment of such data will be beneficial for the public health authorities in the planning and implementation of specific prevention and control strategies of this infection in different Orang Asli ethnic groups in Malaysia.	[Anuar, Tengku Shahrul; Osman, Emelia; Yasin, Azlin Mohd; Nordin, Anisah; Azreen, Siti Nor; Salleh, Fatmah Md; Ghazali, Nuraffini; Bernadus, Mekadina; Moktar, Norhayati] Univ Kebangsaan Malaysia, Fac Med, Dept Parasitol & Med Entomol, Kuala Lumpur, Malaysia; [Al-Mekhlafi, Hesham M.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Ghani, Mohamed Kamel Abdul] Univ Kebangsaan Malaysia, Sch Diagnost & Appl Hlth Sci, Programme Biomed Sci, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya; Universiti Kebangsaan Malaysia	Moktar, N (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Parasitol & Med Entomol, Kuala Lumpur, Malaysia.	syahbasree@yahoo.com	Tengku, Shahrul Anuar/E-4975-2014; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016	Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410	UKMMC Fundamental Research Grant [FF-165-2011]; Special Research University Grant [UKM-GUP-2011-316]; Geran Galakan Penyelidik Muda [GGPM-2011-080]	UKMMC Fundamental Research Grant; Special Research University Grant; Geran Galakan Penyelidik Muda	This work was supported by UKMMC Fundamental Research Grant (FF-165-2011), Special Research University Grant (UKM-GUP-2011-316), and Geran Galakan Penyelidik Muda (GGPM-2011-080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeba Gebertsadik, 2004, Ethiopian Journal of Health Development, V18, P121; [Anonymous], 1997, Wkly Epidemiol Rec, V72, P97; Anuar TS, 2012, INT J PARASITOL, V42, P871, DOI 10.1016/j.ijpara.2012.07.003; Azian MYN, 2006, TROP BIOMED, V23, P31; Beck DL, 2008, ACTA TROP, V107, P48, DOI 10.1016/j.actatropica.2008.03.013; Benetton MLFN, 2005, T ROY SOC TROP MED H, V99, P532, DOI 10.1016/j.trstmh.2004.11.015; Cartwright CP, 1999, J CLIN MICROBIOL, V37, P2408, DOI 10.1128/JCM.37.8.2408-2411.1999; Department of Orang Asli Development (JAKOA), 2011, RES DEV DIV INF DAT; Department of Orang Asli Development (JAKOA), 2011, RES DEV DIV INF DAT; DUNN FL, 1972, B WORLD HEALTH ORGAN, V46, P99; Fleck S. L., 1993, DIAGNOSTIC TECHNIQUE, P10; Fotedar R, 2008, EUR J CLIN MICROBIOL, V27, P133, DOI 10.1007/s10096-007-0399-9; Gasem MH, 2001, TROP MED INT HEALTH, V6, P484, DOI 10.1046/j.1365-3156.2001.00734.x; GHANI BMC, 1991, COLLECTED PAPERS CON, V5, P64; HAN AM, 1989, T ROY SOC TROP MED H, V83, P128, DOI 10.1016/0035-9203(89)90737-2; Haque R, 2006, INFECT IMMUN, V74, P904, DOI 10.1128/IAI.74.2.904-909.2006; Haque Rashidul, 1998, Parasitology International, V47, P201, DOI 10.1016/S1383-5769(98)00020-8; Hartini Y., 2009, MAL J HLTH SC, V7, P59; Hoque BA, 1999, PUBLIC HEALTH, V113, P57, DOI 10.1016/S0033-3506(99)00119-5; Hung CC, 2008, HIV MED, V9, P787, DOI 10.1111/j.1468-1293.2008.00609.x; Kish L, 1968, SURVEY SAMPLING; KNIGHT SM, 1992, INT J EPIDEMIOL, V21, P812, DOI 10.1093/ije/21.4.812; Leiva B, 2006, ARCH MED RES, V37, P529, DOI 10.1016/j.arcmed.2005.10.009; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Malaysia Meteorological Department, 2012, MIN SCI TECHN INN DA; Markell E.D., 1999, MED PARASITOLOGY; MARTI H, 1993, J CLIN MICROBIOL, V31, P3044, DOI 10.1128/JCM.31.11.3044-3045.1993; Matthys B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-195; Naelah A.A., 2011, PLOS ONE, V7; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Nor Aza A., 2003, ASEAN REV BIODIV JAN; Nyarango RM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-237; Okeke IN, 2003, J CLIN MICROBIOL, V41, P4525, DOI 10.1128/JCM.41.10.4525-4530.2003; Parija SC, 2005, J HEALTH POPUL NUTR, V23, P292; Duc PP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-102; Ramos F, 2005, AM J TROP MED HYG, V73, P87, DOI 10.4269/ajtmh.2005.73.87; Rinne S, 2005, T ROY SOC TROP MED H, V99, P585, DOI 10.1016/j.trstmh.2005.01.003; RUIZPALACIOS GM, 1992, ARCHIVES OF MEDICAL RESEARCH, VOL 23, NO 2, P289; Salleh FM, 2012, J MICROBIOL METH, V91, P174, DOI 10.1016/j.mimet.2012.08.004; Shahnazi M, 2010, FOODBORNE PATHOG DIS, V7, P1025, DOI 10.1089/fpd.2009.0477; Solaymani-Mohammadi S, 2006, J CLIN MICROBIOL, V44, P2258, DOI 10.1128/JCM.00530-06; SPENCER HC, 1981, AM J TROP MED HYG, V30, P63, DOI 10.4269/ajtmh.1981.30.63; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Tanyuksel M, 2007, AM J TROP MED HYG, V76, P723, DOI 10.4269/ajtmh.2007.76.723; Tengku SA, 2011, TROP BIOMED, V28, P194; Verweij JJ, 2003, TROP MED INT HEALTH, V8, P1153, DOI 10.1046/j.1360-2276.2003.01145.x; WALSH JA, 1986, REV INFECT DIS, V8, P228; WITTNICH C, 1976, CAN VET J, V17, P259	48	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48165	10.1371/journal.pone.0048165	http://dx.doi.org/10.1371/journal.pone.0048165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133561	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800051
J	de Sousa, EM; da Costa, AC; Trentini, MM; de Araujo, JA; Kipnis, A; Junqueira-Kipnis, AP				de Sousa, Eduardo Martins; da Costa, Adeliane Castro; Trentini, Monalisa Martins; de Araujo Filho, Joao Alves; Kipnis, Andre; Junqueira-Kipnis, Ana Paula			Immunogenicity of a Fusion Protein Containing Immunodominant Epitopes of Ag85C, MPT51, and HspX from Mycobacterium tuberculosis in Mice and Active TB Infection	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; VACCINE; ANTIGENS; PROTECTION; RECOGNITION; IMMUNOLOGY; DIAGNOSIS; STRAINS; CULTURE; GROWTH	Tuberculosis (TB) remains a major global health problem. The only vaccine against tuberculosis, attenuated Mycobacterium bovis Bacillus Calmette-Guerin (BCG), has demonstrated relatively low efficacy and does not provide satisfactory protection against the disease in adults. More effective vaccines and better therapies are urgently needed to reduce the global spread of TB. This study evaluated the immunogenicity of a recombinant M. tuberculosis Ag85C-MPT51-HspX fusion protein (CMX) in mice and individuals with active tuberculosis. BALB/c mice were immunized with the CMX protein liposome-encapsulated with CpG DNA or with CpGDNA liposome-encapsulated, liposome or saline as negative controls. The immunization produced high levels of anti-CMX -specific IgG1 and IgG2a antibodies and induced an increase in the relative and absolute numbers of specific TCD4 IFN-gamma(+) and TNF-alpha(+) cells in the spleen. Sera from a cohort of individuals with active tuberculosis contained higher levels of IgG and IgM that recognized CMX when compared to healthy individuals. In conclusion, this protein was shown to be immunogenic both in mice and humans.	[de Sousa, Eduardo Martins; da Costa, Adeliane Castro; Trentini, Monalisa Martins; de Araujo Filho, Joao Alves; Kipnis, Andre; Junqueira-Kipnis, Ana Paula] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil	Universidade Federal de Goias	Junqueira-Kipnis, AP (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.	apkipnis@gmail.com	Castro da Costa, Adeliane/G-3848-2015; Kipnis, Andre/M-7485-2017; Kipnis, Andre/ABG-5707-2020; Filho, João Alves Araújo/V-5279-2019; Junqueira-Kipnis, Ana Paula/I-5534-2012; Trentini, Monalisa M/P-7092-2017; de Sousa, Eduardo Martins/AAT-9294-2020	Castro da Costa, Adeliane/0000-0002-5440-8613; Kipnis, Andre/0000-0001-5950-106X; Kipnis, Andre/0000-0001-5950-106X; Filho, João Alves Araújo/0000-0002-8810-6998; Trentini, Monalisa M/0000-0002-3207-8967; de Sousa, Eduardo Martins/0000-0002-2506-169X	CNPq [472909/2011-8, 301976/2011-2, 561004/2010-2, 301198/2009-8]; CAPES [5015/10-3]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by following CNPq grants: 472909/2011-8, 301976/2011-2, 561004/2010-2, 301198/2009-8 and EDM received a graduate fellowship from CAPES (No 5015/10-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036046; Andrews JR, 2012, AIDS; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; Bendelac A, 2002, J EXP MED, V195, pF19, DOI 10.1084/jem.20020073; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Bodmer T, 2012, JOVE-J VIS EXP, DOI 10.3791/3547; Caccamo N, 2006, J IMMUNOL, V177, P1780, DOI 10.4049/jimmunol.177.3.1780; Almeida CM, 2008, CLIN VACCINE IMMUNOL, V15, P579, DOI 10.1128/CVI.00359-07; Chen CH, 2012, INT J NANOMED, V7, P607, DOI 10.2147/IJN.S28097; Connell DW, 2011, UPDATE TUBERCULOSIS; Cristina M, 2011, BRAZ J INFECT DIS, V15, P617, DOI 10.1590/S1413-86702011000600022; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; de Araujo JA, 2008, TUBERCULOSIS, V88, P474, DOI 10.1016/j.tube.2008.06.002; Delogu G, 2009, J INFECT DEV COUNTR, V3, P5, DOI 10.3855/jidc.99; Feng L, 2011, EUR J IMMUNOL, V41, P3261, DOI 10.1002/eji.201141625; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fundacao Nacional de Saude-Ministerio da Saude Brasil, 2002, TUB GUIA VIG EP; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; dos Reis MCG, 2009, BRAZ J INFECT DIS, V13, P417, DOI 10.1590/S1413-86702009000600006; Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3; Jeon BY, 2011, MICROBES INFECT, V13, P284, DOI 10.1016/j.micinf.2010.11.002; Joshi MD, 2012, J CONTROL RELEASE; Kashyap RS, 2010, BIOMARK INSIGHTS, V5, P87; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kumar G, 2008, SCAND J IMMUNOL, V68, P177, DOI 10.1111/j.1365-3083.2008.02133.x; Li Q, 2011, SCAND J IMMUNOL, V73, P568, DOI 10.1111/j.1365-3083.2011.02531.x; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Lourembam SD, 2012, VACCINE, V30, P767, DOI 10.1016/j.vaccine.2011.11.069; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Margotto P. R., 2010, CURVA ROC COMO FAZER; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Menzies Dick, 2012, Evid Based Med, V17, P58, DOI 10.1136/ebmed.2011.100291; Niu HX, 2011, VACCINE, V29, P9451, DOI 10.1016/j.vaccine.2011.10.032; Olsen AW, 2003, IMMUNOL LETT, V85, P207, DOI 10.1016/S0165-2478(02)00232-8; Orme IM, 2011, FUTURE MICROBIOL, V6, P161, DOI 10.2217/FMB.10.168; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Samanich KM, 2000, CLIN DIAGN LAB IMMUN, V7, P662, DOI 10.1128/CDLI.7.4.662-668.2000; Scanga CA, 2001, INFECT IMMUN, V69, P7711, DOI 10.1128/IAI.69.12.7711-7717.2001; Secretaria de Vigilancia em Saude - Ministerio da Saude Brasil, 2012, B EP ESP TUB; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Shi CW, 2010, VACCINE, V28, P5237, DOI 10.1016/j.vaccine.2010.05.063; Shin AR, 2008, CLIN VACCINE IMMUNOL, V15, P1788, DOI 10.1128/CVI.00231-08; Thakurdas SM, 2004, CLIN EXP IMMUNOL, V136, P320, DOI 10.1111/j.1365-2249.2004.02459.x; Torrado E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002196; Tortoli E, 2012, EUR RESP J; Uto T, 2011, FEMS IMMUNOL MED MIC, V61, P189, DOI 10.1111/j.1574-695X.2010.00762.x; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2011, TUB SER TESTS POL ST; Wu L, 2011, J INT MED RES, V39, P514, DOI 10.1177/147323001103900219; Wu XQ, 2010, CLIN VACCINE IMMUNOL, V17, P372, DOI [10.1128/CVI.00287-09, 10.3785/j.issn.1006-754X.2010.05.011]; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	54	28	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47781	10.1371/journal.pone.0047781	http://dx.doi.org/10.1371/journal.pone.0047781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133523	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800016
J	McDowell, EN; Kisielewski, AE; Pike, JW; Franco, HL; Yao, HHC; Johnson, KJ				McDowell, Erin N.; Kisielewski, Anne E.; Pike, Jack W.; Franco, Heather L.; Yao, Humphrey H. -C.; Johnson, Kamin J.			A Transcriptome-Wide Screen for mRNAs Enriched in Fetal Leydig Cells: CRHR1 Agonism Stimulates Rat and Mouse Fetal Testis Steroidogenesis	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; IMPAIRED STRESS-RESPONSE; GENE-EXPRESSION; FACTOR RECEPTORS; HORMONE; DISRUPTION; UROCORTIN; ROLES; SEX; MECHANISMS	Fetal testis steroidogenesis plays an important role in the reproductive development of the male fetus. While regulators of certain aspects of steroidogenesis are known, the initial driver of steroidogenesis in the human and rodent fetal testis is unclear. Through comparative analysis of rodent fetal testis microarray datasets, 54 candidate fetal Leydig cell-specific genes were identified. Fetal mouse testis interstitial expression of a subset of these genes with unknown expression (Crhr1, Gramd1b, Itih5, Vgll3, and Vsnl1) was verified by whole-mount in situ hybridization. Among the candidate fetal Leydig cell-specific factors, three receptors (CRHR1, PRLR, and PROKR2) were tested for a steroidogenic function using ex vivo fetal testes treated with receptor agonists (CRH, PRL, and PROK2). While PRL and PROK2 had no effect, CRH, at low (approximately 1 to 10) nM concentration, increased expression of the steroidogenic genes Cyp11a1, Cyp17a1, Scarb1, and Star in GD15 mouse and GD17 rat testes, and in conjunction, testosterone production was increased. Exposure of GD15 fetal mouse testis to a specific CRHR1 antagonist blunted the CRH-induced steroidogenic gene expression and testosterone responses. Similar to ex vivo rodent fetal testes, >= 10 nM CRH exposure of MA-10 Leydig cells increased steroidogenic pathway mRNA and progesterone levels, showing CRH can enhance steroidogenesis by directly targeting Leydig cells. Crh mRNA expression was observed in rodent fetal hypothalamus, and CRH peptide was detected in rodent amniotic fluid. Together, these data provide a resource for discovering factors controlling fetal Leydig cell biology and suggest that CRHR1 activation by CRH stimulates rat and mouse fetal Leydig cell steroidogenesis in vivo.	[McDowell, Erin N.; Kisielewski, Anne E.; Pike, Jack W.; Johnson, Kamin J.] Alfred I Dupont Hosp Children, Wilmington, DE USA; [Franco, Heather L.; Yao, Humphrey H. -C.] NIEHS, NIH, Reprod Dev Biol Grp, Lab Reprod & Dev Toxicol, Res Triangle Pk, NC 27709 USA	Nemours Alfred I. duPont Hospital for Children; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Johnson, KJ (corresponding author), Alfred I Dupont Hosp Children, Wilmington, DE USA.	johnson@nemoursresearch.org	Yao, Hung-Chang Humphrey/B-4795-2010	Yao, Hung-Chang Humphrey/0000-0003-2944-8469; Johnson, Kamin/0000-0003-4550-5566	National Institutes of Health [P20 RR020173]; National Institute of Environmental and Health Sciences branch of the National Institutes of Health; Eunice Kennedy Shriver NICHD/NIH (SCCPIR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental and Health Sciences branch of the National Institutes of Health; Eunice Kennedy Shriver NICHD/NIH (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the National Institutes of Health grant P20 RR020173 and in part by the Intramural Research Program of the National Institute of Environmental and Health Sciences branch of the National Institutes of Health. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Lab is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLAND JF, 1986, J ENDOCRINOL, V108, P171, DOI 10.1677/joe.0.1080171; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; BARAM TZ, 1991, INT J DEV NEUROSCI, V9, P473, DOI 10.1016/0736-5748(91)90033-I; BARKEY RJ, 1987, MOL CELL ENDOCRINOL, V52, P71, DOI 10.1016/0303-7207(87)90098-0; Barsoum I, 2011, BIOL REPROD, V84, P894, DOI 10.1095/biolreprod.110.088997; Barsoum IB, 2010, J ANDROL, V31, P11, DOI 10.2164/jandrol.109.008318; Barthold JS, 2008, J ANDROL, V29, P352, DOI 10.2164/jandrol.107.003970; Braunewell KH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00020; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; DeFalco T, 2011, DEV BIOL, V352, P14, DOI 10.1016/j.ydbio.2011.01.011; Donaldson CJ, 1996, ENDOCRINOLOGY, V137, P2167, DOI 10.1210/en.137.5.2167; Ferraz-de-Souza B, 2011, J CLIN ENDOCR METAB, V96, pE663, DOI 10.1210/jc.2010-2021; Franco HL, 2012, CHROMOSOME RES, V20, P247, DOI 10.1007/s10577-011-9254-z; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRINO M, 1989, ENDOCRINOLOGY, V124, P60, DOI 10.1210/endo-124-1-60; Heinrich N, 1998, ENDOCRINOLOGY, V139, P651, DOI 10.1210/en.139.2.651; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; HUANG BM, 1995, BIOL REPROD, V53, P620, DOI 10.1095/biolreprod53.3.620; Huang BM, 1997, BIOL REPROD, V57, P547, DOI 10.1095/biolreprod57.3.547; Huang BM, 1997, J ANDROL, V18, P528; Huang WJ, 1999, J CELL BIOCHEM, V74, P111, DOI 10.1002/(SICI)1097-4644(19990701)74:1<111::AID-JCB12>3.3.CO;2-9; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V252, P126, DOI 10.1016/j.mce.2006.03.026; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jadhav U, 2011, ENDOCRINOLOGY, V152, P2870, DOI 10.1210/en.2011-0219; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Johnson KJ, 2007, BIOL REPROD, V77, P978, DOI 10.1095/biolreprod.107.062950; Johnson KJ, 2011, TOXICOL SCI, V120, P460, DOI 10.1093/toxsci/kfr020; Kent J, 1996, DEVELOPMENT, V122, P2813; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; Lambrot R, 2006, J CLIN ENDOCR METAB, V91, P2696, DOI 10.1210/jc.2005-2113; Martin LJ, 2010, BIOL REPROD, V83, P3, DOI 10.1095/biolreprod.110.083824; Mastorakos G, 2003, ANN NY ACAD SCI, V997, P136, DOI 10.1196/annals.1290.016; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Menon R, 2008, REPROD SCI, V15, P477, DOI 10.1177/1933719108315300; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Reis FM, 2002, PLACENTA, V23, P522, DOI 10.1053/plac.2002.0831; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020263; Rivier CL, 2008, ENDOCRINOLOGY, V149, P6425, DOI 10.1210/en.2008-0417; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STALLA GK, 1989, GYNECOL ENDOCRINOL, V3, P1, DOI 10.3109/09513598909152447; Tang H, 2008, DEVELOPMENT, V135, P3745, DOI 10.1242/dev.024786; Team R. D. C, 2011, R LANG ENV STAT COMP; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; UDELSMAN R, 1986, NATURE, V319, P147, DOI 10.1038/319147a0; ULISSE S, 1990, J BIOL CHEM, V265, P1964; ULISSE S, 1989, J BIOL CHEM, V264, P2156; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037064; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Walterhouse DO, 2003, BIOL REPROD, V69, P8, DOI 10.1095/biolreprod.103.015941; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; WYNN PC, 1984, PEPTIDES, V5, P1077, DOI 10.1016/0196-9781(84)90174-8; Zhijin W, 2004, J AM STAT ASSOC, V99, P909	60	25	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e47359	10.1371/journal.pone.0047359	http://dx.doi.org/10.1371/journal.pone.0047359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GE	23133512	Green Submitted, Green Published, gold			2022-12-25	WOS:000310261800005
J	Parr, J; Lindeboom, W; Khanam, M; Sanders, J; Koehlmoos, TP				Parr, John; Lindeboom, Wietze; Khanam, Masuma; Sanders, James; Koehlmoos, Tracey Perez			Informal Allopathic Provider Knowledge and Practice Regarding Hypertension in Urban and Rural Bangladesh	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; HUMAN-RESOURCES; HEALTH-CARE; DISEASE; PHARMACIES; MANAGEMENT; PAKISTAN	Objectives: Describe informal allopathic practitioner (IAP) knowledge and practice about management of hypertension and identify gaps in IAP knowledge and practice amenable to interventions. Methods: A cross sectional descriptive survey of 642 IAPs in Kamalapur (urban) and Mirsarai (rural) Bangladesh was conducted from March to April, 2011. Using a structured, pre-tested questionnaire sociodemographic, training, knowledge and practice data about management of hypertension was collected. Comparative statistics were preformed to show differences between urban and rural practitioners using SAS 8.0. Findings: 99.4% of IAPs were male, mean age was 37.5 (12.5 SD) years. Greater than 65% correctly identified the upper limit of normal blood pressure. 50.2% underestimated lower limit of systolic hypertension. 79.8% allowed age to affect their treatment approach. As blood pressure increased, willingness to treat with medication decreased and tendency to refer increased. Sedative/sleeping pills, antidepressants, and beta blockers were the most commonly prescribed medications for prehypertension (58.7%, 50.3% and 53.7% respectively), stage I hypertension (55.0%, 38.6%, 49.8% respectively) and stage II hypertension (42.4%, 23.7%, and 28.8% respectively). Rural IAPs were more likely than urban IAPs to treat (84.7% vs 77.7%), order tests (27.1% vs 6.0%) and write prescriptions (60.4% vs 18.7%). Conclusion: While IAPs are crucial to Bangladesh's pluralistic healthcare system, gaps in knowledge and practice could cause unnecessary harm. To include IAPs in the public sector's fight against the chronic disease epidemic, interventions aimed at standardizing IAPs knowledge and practice will be essential. Successfully utilizing IAPs will have beneficial implications not only for Bangladesh, but for all developing countries.	[Parr, John; Lindeboom, Wietze; Khanam, Masuma; Koehlmoos, Tracey Perez] Int Ctr Diarrheal Dis Res, Hlth Syst & Infect Dis Div, Dhaka, Bangladesh; [Parr, John] Contra Costa Cty Reg Med Ctr, Martinez, CA USA; [Sanders, James] Med Coll Wisconsin, Dept Family Med, Milwaukee, WI 53226 USA; [Koehlmoos, Tracey Perez] George Mason Univ, Coll Hlth & Human Serv, Dept Hlth Adm & Policy, Fairfax, VA 22030 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Medical College of Wisconsin; George Mason University	Parr, J (corresponding author), Int Ctr Diarrheal Dis Res, Hlth Syst & Infect Dis Div, Dhaka, Bangladesh.	jparr@ccfamilymed.com			National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; National Cancer Center; National Eye Institute; National Heart, Blood, and Lung Institute; National Institute of Dental & Craniofacial Research; National Institute On Drug Abuse, National Institute of Mental Health; National Institute of Allergy and Infectious Diseases Health; NIH Office of Women's Health and Research through the International Clinical Research Fellows Program at Vanderbilt University [R24 TW007988]; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Center; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Drug Abuse, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute on Drug Abuse (NIDA)); National Institute of Allergy and Infectious Diseases Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Office of Women's Health and Research through the International Clinical Research Fellows Program at Vanderbilt University; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was supported by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental & Craniofacial Research, National Institute On Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases Health, and NIH Office of Women's Health and Research through the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988), and the American Relief and Recovery Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ager A, 2005, HEALTH POLICY PLANN, V20, P176, DOI 10.1093/heapol/czi021; Ahmed SM, 2007, HEALTH POLICY, V84, P332, DOI 10.1016/j.healthpol.2007.05.011; Ahmed SM, 2009, HEALTH POLICY PLANN, V24, P467, DOI 10.1093/heapol/czp037; Ahsan Karar Z, 2009, GLOB HLTH ACTION; [Anonymous], 2011, JNC 7 FULL REP; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; ASHRAF A, 1982, SOC SCI MED, V16, P2041, DOI 10.1016/0277-9536(82)90160-5; Banerjee A, 2004, INT J TUBERC LUNG D, V8, P1260; Bangladesh Health Watch, 2007, STAT HLTH BANGL 2O06; Bangladesh Health Watch, 2008, HLTH WORKF BANGL WHO; Bhuiya A., 2009, HLTH RURAL MASSES IN; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Butt ZA, 2005, INT J QUAL HEALTH C, V17, P307, DOI 10.1093/intqhc/mzi049; Chalker J, 2000, SEX TRANSM INFECT, V76, P299, DOI 10.1136/sti.76.4.299; Chaudhury N., 2003, GHOST DOCTORS ABSENT; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Haider Sohail, 1995, JPMA (Journal of the Pakistan Medical Association), V45, P297; Iqbal M, 2009, CHARACTERISTICS VILL, P39; Jafar TH, 2005, CIRCULATION, V111, P1278, DOI 10.1161/01.CIR.0000157698.78949.D7; Lawes CMM, 2006, J HYPERTENS, V24, P423, DOI 10.1097/01.hjh.0000209973.67746.f0; Lindeboom W, 2011, HLTH DEMOGRAPHIC SUR; Lindeboom W, 2008, KAMALAPUR 2005 2007; Mayhew S, 2001, HEALTH POLICY PLANN, V16, P152, DOI 10.1093/heapol/16.2.152; Morabia A, 2006, SOZ PRAVENTIV MED, V51, P74, DOI 10.1007/s00038-005-0015-7; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Pakenham-Walsh N, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-30; Parfitt B, 2009, COLLEGIAN, V16, P35, DOI 10.1016/j.colegn.2009.01.002; Parr JD, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-309; Rahman M, 2008, Tanzan J Health Res, V10, P246; Rahman M, 2008, INTERNET J HLTH, V8; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Strong K, 2005, J MED SCREEN, V12, P12, DOI 10.1258/0969141053279086; Syhakhang L, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-3; United States Central Intelligence Agency, 2011, WORLD FACT BOOK; Vidt DG, 2003, CLEV CLIN J MED, V70, P263, DOI 10.3949/ccjm.70.3.263; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WOLFFERS I, 1987, SOC SCI MED, V25, P319, DOI 10.1016/0277-9536(87)90234-6; World Bank, 2003, BANGL PRIV SECT ASS; Zaman MM, 2004, J EPIDEMIOL, V14, P63, DOI 10.2188/jea.14.63; Zaman MM, 2009, PREVENTION EARLY DET	44	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2012	7	10							e48056	10.1371/journal.pone.0048056	http://dx.doi.org/10.1371/journal.pone.0048056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026GE	23133546	Green Published, Green Submitted, gold			2022-12-25	WOS:000310261800036
J	Lam, NSN; Arenas, H; Pace, K; LeSage, J; Campanella, R				Lam, Nina S. N.; Arenas, Helbert; Pace, Kelley; LeSage, James; Campanella, Richard			Predictors of Business Return in New Orleans after Hurricane Katrina	PLOS ONE			English	Article							RECOVERY; RECONSTRUCTION; VULNERABILITY	We analyzed the business reopening process in New Orleans after Hurricane Katrina, which hit the region on August 29, 2005, to better understand what the major predictors were and how their impacts changed through time. A telephone survey of businesses in New Orleans was conducted in October 2007, 26 months after Hurricane Katrina. The data were analyzed using a modified spatial probit regression model to evaluate the importance of each predictor variable through time. The results suggest that the two most important reopening predictors throughout all time periods were the flood depth at the business location and business size as represented by its wages in a logarithmic form. Flood depth was a significant negative predictor and had the largest marginal effects on the reopening probabilities. Smaller businesses had lower reopening probabilities than larger ones. However, the nonlinear response of business size to the reopening probability suggests that recovery aid would be most effective for smaller businesses than for larger ones. The spatial spillovers effect was a significant positive predictor but only for the first nine months. The findings show clearly that flood protection is the overarching issue for New Orleans. A flood protection plan that reduces the vulnerability and length of flooding would be the first and foremost step to mitigate the negative effects from climate-related hazards and enable speedy recovery. The findings cast doubt on the current coastal protection efforts and add to the current debate of whether coastal Louisiana will be sustainable or too costly to protect from further land loss and flooding given the threat of sea-level rise. Finally, a plan to help small businesses to return would also be an effective strategy for recovery, and the temporal window of opportunity that generates the greatest impacts would be the first 6,9 months after the disaster.	[Lam, Nina S. N.; Arenas, Helbert] Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA; [Arenas, Helbert] Louisiana State Univ, Dept Geog & Anthropol, Baton Rouge, LA 70803 USA; [Pace, Kelley] Louisiana State Univ, Dept Finance, Baton Rouge, LA 70803 USA; [LeSage, James; Campanella, Richard] Texas State Univ, Dept Finance & Econ, San Marcos, TX USA; [Campanella, Richard] Tulane Univ, Tulane Sch Architecture, New Orleans, LA 70118 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Texas State University System; Texas State University San Marcos; Tulane University	Lam, NSN (corresponding author), Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA.	nlam@lsu.edu	Lam, Nina/AAQ-1097-2020; Arenas, Helbert/K-3037-2014		National Science Foundation (NSF) [0554937, 1212112, 0729259]; National Oceanic and Atmospheric Administration (NOAA)'s Gulf of Mexico Regional Sea Grant Program; Direct For Social, Behav & Economic Scie [1212112] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration (NOAA)'s Gulf of Mexico Regional Sea Grant Program; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	The authors acknowledge the support of this research by National Science Foundation (NSF awards: #0554937, #0729259, #1212112) and National Oceanic and Atmospheric Administration (NOAA)'s Gulf of Mexico Regional Sea Grant Program (2008). The statements, findings, conclusions, and recommendations are those of the authors and do not necessarily reflect the views of the National Science Foundation, the National Oceanic and Atmospheric Administration, or the Department of Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER EJ, 1995, PROF GEOGR, V47, P137, DOI 10.1111/j.0033-0124.1995.00137.x; Bronson JW, 2006, PSYCHOL REP, V99, P960, DOI 10.2466/PRO.99.3.960-962; CHANG S, 1984, GROWTH CHANGE, V15, P24, DOI 10.1111/j.1468-2257.1984.tb00748.x; Chang SE, 2003, ENV HAZARDS, V4, P59; Corey CM, 2011, J CONTING CRISIS MAN, V19, P169, DOI 10.1111/j.1468-5973.2011.00642.x; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Dahlhamer JM, 1998, SOCIOL SPECTRUM, V18, P121, DOI 10.1080/02732173.1998.9982189; Dietch EA, 2011, MANAG RES REV, V34, P311, DOI 10.1108/01409171111116321; Kates RW, 2006, P NATL ACAD SCI USA, V103, P14653, DOI 10.1073/pnas.0605726103; Lam NSN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006765; LeSage J, 2009, STAT TEXTB MONOGR, P1; LeSage JP, 2011, J R STAT SOC A STAT, V174, P1007, DOI 10.1111/j.1467-985X.2011.00712.x; Liu X., 2011, SIGNIFICANCE, V8, P160, DOI [DOI 10.1111/J.1740-9713.2011.00520.X, 10.1111/j.1740-9713.2011.00520.x]; Palm R, 1993, NATURAL HAZARDS APPL, V56; Plyer A, 2011, NEW ORLEANS INDEX 6; Singer A., 2007, RESETTLING NEW ORLEA; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Waugh WL, 2006, ECON DEV Q, V20, P211, DOI 10.1177/0891242406289287; Webb G.R., 2002, ENV HAZARDS, V4, P45, DOI [10.1016/s1464-2867(03)00005-6, DOI 10.1016/S1464-2867(03)00005-6, https://doi.org/10.1016/S1464-2867(03)00005-6]; Zhang Y, 2009, DISASTERS, V33, P38, DOI 10.1111/j.1467-7717.2008.01061.x	20	33	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47935	10.1371/journal.pone.0047935	http://dx.doi.org/10.1371/journal.pone.0047935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026VC	23133530	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200113
J	Han, YL; Li, YL; Jia, LX; Cheng, JZ; Qi, YF; Zhang, HJ; Du, J				Han, Ya-lei; Li, Yu-lin; Jia, Li-xin; Cheng, Ji-zhong; Qi, Yong-fen; Zhang, Hong-jia; Du, Jie			Reciprocal Interaction between Macrophages and T cells Stimulates IFN-gamma and MCP-1 Production in Ang II-induced Cardiac Inflammation and Fibrosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; ANGIOTENSIN-II; INTERFERON-GAMMA; FIBROBLAST PRECURSORS; CYTOKINE PROFILES; MYOCARDITIS; HYPERTENSION; EXPRESSION; SYSTEM	Background: The inflammatory response plays a critical role in hypertension-induced cardiac remodeling. We aimed to study how interaction among inflammatory cells causes inflammatory responses in the process of hypertensive cardiac fibrosis. Methodology/Principal Findings: Infusion of angiotensin II (Ang II, 1500 ng/kg/min) in mice rapidly induced the expression of interferon gamma (IFN-gamma) and leukocytes infiltration into the heart. To determine the role of IFN-gamma on cardiac inflammation and remodeling, both wild-type (WT) and IFN-gamma-knockout (KO) mice were infused Ang II for 7 days, and were found an equal blood pressure increase. However, knockout of IFN-gamma prevented Ang II-induced: 1) infiltration of macrophages and T cells into cardiac tissue; 2) expression of tumor necrosis factor a and monocyte chemoattractant protein 1 (MCP-1), and 3) cardiac fibrosis, including the expression of alpha-smooth muscle actin and collagen I (all p<0.05). Cultured T cells or macrophages alone expressed very low level of IFN-gamma, however, co-culture of T cells and macrophages increased IFN-gamma expression by 19.860.95 folds ( vs. WT macrophage, p<0.001) and 20.9 +/- 2.09 folds (vs. WT T cells, p<0.001). In vitro co-culture studies using T cells and macrophages from WT or IFN-gamma KO mice demonstrated that T cells were primary source for IFN-gamma production. Co-culture of WT macrophages with WT T cells, but not with IFN-gamma-knockout T cells, increased IFN-gamma production (p<0.01). Moreover, IFN-gamma produced by T cells amplified MCP-1 expression in macrophages and stimulated macrophage migration. Conclusions/Significance: Reciprocal interaction between macrophages and T cells in heart stimulates IFN-gamma expression, leading to increased MCP-1 expression in macrophages, which results a forward-feed recruitment of macrophages, thus contributing to Ang II-induced cardiac inflammation and fibrosis.	[Han, Ya-lei; Li, Yu-lin; Jia, Li-xin; Cheng, Ji-zhong; Qi, Yong-fen; Zhang, Hong-jia; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China; [Qi, Yong-fen; Zhang, Hong-jia; Du, Jie] Inst Heart Lung & Blood Vessel Dis, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University	Han, YL (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China.	jdu@bcm.edu	Li, yulin/AGZ-5611-2022	Han, Ying/0000-0001-8591-7894; Zhu, Guo-Qing/0000-0002-3132-9592	Chinese Ministry of Science and Technology [2012CB517802, 2012CB945104]; National Science Foundation of China [30888004, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the Chinese Ministry of Science and Technology (2012CB517802 and 2012CB945104) and from the National Science Foundation of China (30888004 and 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva M, 2005, P NATL ACAD SCI USA, V102, P180, DOI 10.1073/pnas.0408241102; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Brands MW, 2010, HYPERTENSION, V56, P879, DOI 10.1161/HYPERTENSIONAHA.110.158071; Cheng JZ, 2007, ARTERIOSCL THROM VAS, V27, P1744, DOI 10.1161/ATVBAHA.107.147371; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Coelho PS, 2002, J LEUKOCYTE BIOL, V71, P837; Fairweather D, 2004, AM J PATHOL, V165, P1883, DOI 10.1016/S0002-9440(10)63241-5; Fairweather D, 2003, J IMMUNOL, V170, P4731, DOI 10.4049/jimmunol.170.9.4731; Fauvel JP, 2003, HYPERTENSION, V42, P1112, DOI 10.1161/01.HYP.0000102862.93418.EE; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Hilgers KF, 2000, KIDNEY INT, V58, P2408, DOI 10.1046/j.1523-1755.2000.00424.x; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kawai C, 1999, CIRCULATION, V99, P1091, DOI 10.1161/01.CIR.99.8.1091; Lin AA, 2009, J VIROL, V83, P8604, DOI 10.1128/JVI.02477-08; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Mazzolai L, 2004, HYPERTENSION, V44, P277, DOI 10.1161/01.HYP.0000140269.55873.7b; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Ponomarev ED, 2004, J IMMUNOL, V173, P1587, DOI 10.4049/jimmunol.173.3.1587; Pore D, 2012, J BIOL CHEM IN PRESS; Puddu P, 1997, J IMMUNOL, V159, P3490; Qi GM, 2011, CARDIOVASC TOXICOL, V11, P157, DOI 10.1007/s12012-011-9109-z; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Sturgis LC, 2009, AM J PHYSIOL-REG I, V297, pR1742, DOI 10.1152/ajpregu.90995.2008; Takahashi M, 2008, AM J PHYSIOL-HEART C, V294, pH2879, DOI 10.1152/ajpheart.91406.2007; Tang PCY, 2005, FASEB J, V19, P1528, DOI 10.1096/fj.05-3671fje; Valentincic NV, 2011, MOL VIS, V17, P2003; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	43	83	87	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35506	10.1371/journal.pone.0035506	http://dx.doi.org/10.1371/journal.pone.0035506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567105	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341500023
J	Higginson, IJ; Gao, W; Saleem, TZ; Chaudhuri, KR; Burman, R; McCrone, P; Leigh, PN				Higginson, Irene J.; Gao, Wei; Saleem, Tariq Zaffer; Chaudhuri, K. Ray; Burman, Rachel; McCrone, Paul; Leigh, Peter Nigel			Symptoms and Quality of Life in Late Stage Parkinson Syndromes: A Longitudinal Community Study of Predictive Factors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PALLIATIVE CARE; ADVANCED CANCER; PEOPLE; QUESTIONNAIRE; PREVALENCE; TRAJECTORIES; PROGRESSION; VALIDATION; DISABILITY	Background: Palliative care is increasingly offered earlier in the cancer trajectory but rarely in Idiopathic Parkinson's Disease(IPD), Progressive Supranuclear Palsy(PSP) or Multiple System Atrophy(MSA). There is little longitudinal data of people with late stage disease to understand levels of need. We aimed to determine how symptoms and quality of life of these patients change over time; and what demographic and clinical factors predicted changes. Methods: We recruited 82 patients into a longitudinal study, consenting patients with a diagnosis of IPD, MSA or PSP, stages 3-5 Hoehn and Yahr(H&Y). At baseline and then on up to 3 occasions over one year, we collected self-reported demographic, clinical, symptom, palliative and quality of life data, using Parkinson's specific and generic validated scales, including the Palliative care Outcome Scale (POS). We tested for predictors using multivariable analysis, adjusting for confounders. Findings: Over two thirds of patients had severe disability, over one third being wheelchair-bound/bedridden. Symptoms were highly prevalent in all conditions - mean (SD) of 10.6(4.0) symptoms. More than 50% of the MSA and PSP patients died over the year. Over the year, half of the patients showed either an upward (worsening, 24/60) or fluctuant (8/60) trajectory for POS and symptoms. The strongest predictors of higher levels of symptoms at the end of follow-up were initial scores on POS (AOR 1.30; 95% CI: 1.05-1.60) and being male (AOR 5.18; 95% CI 1.17 to 22.92), both were more predictive than initial H&Y scores. Interpretation: The findings point to profound and complex mix of non-motor and motor symptoms in patients with late stage IPD, MSA and PSP. Symptoms are not resolved and half of the patients deteriorate. Palliative problems are predictive of future symptoms, suggesting that an early palliative assessment might help screen for those in need of earlier intervention.	[Higginson, Irene J.; Gao, Wei; Saleem, Tariq Zaffer; Burman, Rachel] Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England; [Chaudhuri, K. Ray; McCrone, Paul; Leigh, Peter Nigel] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Chaudhuri, K. Ray] Kings Coll Hosp London, Natl Parkinson Fdn Int Ctr Excellence, London, England	University of London; King's College London; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Higginson, IJ (corresponding author), Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England.	irene.higginson@kcl.ac.uk; wei.gao@kcl.ac.uk	Gao, Wei/E-8505-2013; Leigh, Peter/AAD-5638-2019; Gao, Wei/G-8653-2011; Higginson, Irene Julie/C-7309-2012	Gao, Wei/0000-0001-7836-2851; Gao, Wei/0000-0001-8298-3415; Higginson, Irene Julie/0000-0002-3687-1313; Ray Chaudhuri, K/0000-0003-2815-0505; McCrone, Paul/0000-0001-7001-4502	UK Department of Health Research Initiative [05/Q0703/196 URL]	UK Department of Health Research Initiative	UK Department of Health Research Initiative for Long Term Neurological Conditions; Grant number: 05/Q0703/196 URL: http://www.ltnc.org.uk/. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bausewein C, 2011, PALLIATIVE MED, V25, P304, DOI 10.1177/0269216310395984; Bausewein C, 2010, PALLIATIVE MED, V24, P777, DOI 10.1177/0269216310378785; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Brandt HE, 2005, PALLIATIVE MED, V19, P334, DOI 10.1191/0269216305pm1018oa; Brown RG, 2010, BRAIN, V133, P2382, DOI 10.1093/brain/awq158; Buecken R, 2012, PATIENT EDUC COUNS, V88, P318, DOI 10.1016/j.pec.2012.03.010; Chaudhuri KR, 2010, MOVEMENT DISORD, V25, P704, DOI 10.1002/mds.22868; Cheung YB, 2008, QUAL LIFE RES, V17, P1173, DOI 10.1007/s11136-008-9392-8; de Boer AGEM, 1999, MOVEMENT DISORD, V14, P772, DOI 10.1002/1531-8257(199909)14:5<772::AID-MDS1009>3.0.CO;2-S; Dibble LE, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-110; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Grosset D, 2007, J NEUROL NEUROSUR PS, V78, P465, DOI 10.1136/jnnp.2006.098327; Hanratty Barbara, 2007, J Health Serv Res Policy, V12, P90, DOI 10.1258/135581907780279585; Hearn J, 1999, QUAL HEALTH CARE, V8, P219, DOI 10.1136/qshc.8.4.219; Higginson IJ, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-42; Higginson IJ, 2006, J PALLIATIVE CARE, V22, P158, DOI 10.1177/082585970602200306; Higginson IJ, 2011, POSTGRAD MED J, V87, P769, DOI 10.1136/postgradmedj-2011-130290; Higginson IJ, 2009, J PAIN SYMPTOM MANAG, V38, P816, DOI 10.1016/j.jpainsymman.2009.07.002; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Huang TT, 2011, QUAL LIFE RES, V20, P499, DOI 10.1007/s11136-010-9777-3; Forjaz MJ, 2009, MOVEMENT DISORD, V24, P526, DOI 10.1002/mds.22409; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Katsarou Z, 2004, MOVEMENT DISORD, V19, P308, DOI 10.1002/mds.10678; Luo N, 2010, QUAL LIFE RES, V19, P565, DOI 10.1007/s11136-010-9615-7; Marinus J, 2002, J NEUROL NEUROSUR PS, V72, P241, DOI 10.1136/jnnp.72.2.241; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; McCrone P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024369; Menza M, 2009, MOVEMENT DISORD, V24, P1325, DOI 10.1002/mds.22586; Mitchell SL, 2007, J PAIN SYMPTOM MANAG, V34, P7, DOI 10.1016/j.jpainsymman.2007.01.003; Mitchell SL, 2012, ANN INTERN MED, V156, P45, DOI 10.7326/0003-4819-156-1-201201030-00008; Mitsumoto H, 2007, JAMA-J AM MED ASSOC, V298, P207, DOI 10.1001/jama.298.2.207; Murtagh FEM, 2011, CLIN J AM SOC NEPHRO, V6, P1580, DOI 10.2215/CJN.09021010; Payan CAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022293; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Rodriguez-Blazquez C, 2009, MOVEMENT DISORD, V24, P519, DOI 10.1002/mds.22321; Rolls L, 2011, PALLIATIVE MED, V25, P650, DOI 10.1177/0269216310373165; Saleem T, 2007, J PALLIAT CARE, V23, P291, DOI 10.1177/082585970702300408; Schenkman M, 2001, PARKINSONISM RELAT D, V8, P41, DOI 10.1016/S1353-8020(00)00079-1; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P67, DOI 10.1136/jnnp.69.1.67; Schrag A, 2009, MOVEMENT DISORD, V24, P813, DOI 10.1002/mds.22438; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Siegert RJ, 2010, J PAIN SYMPTOM MANAG, V40, P67, DOI 10.1016/j.jpainsymman.2009.11.326; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Stefanova N, 2009, LANCET NEUROL, V8, P1172, DOI 10.1016/S1474-4422(09)70288-1; Visser M, 2009, VALUE HEALTH, V12, P392, DOI 10.1111/j.1524-4733.2008.00430.x; Voltz R, 1997, J NEUROL, V244, pS2, DOI 10.1007/PL00007721; Wenning GK, 2009, J NEUROL, V256, P1791, DOI 10.1007/s00415-009-5173-8	48	85	86	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e46327	10.1371/journal.pone.0046327	http://dx.doi.org/10.1371/journal.pone.0046327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048TK	23209815	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000311935800003
J	Li, HF; Zou, Y; Ding, GQ				Li, Haifeng; Zou, Yan; Ding, Gangqiang			Dietary Factors Associated with Dental Erosion: A Meta-Analysis	PLOS ONE			English	Article							TOOTH WEAR; PREVALENCE; CHILDREN; ADOLESCENTS; SCHOOLCHILDREN	Background: Some diet factors are risk factors for dental erosion. Methods: We performed computer searches of PubMed, Cochrane Library, EBSCO, CALIS, et al., to search for studies investigating risk factors for dental erosion. For risk factors investigated in a comparative way, we computed pooled odds ratios (ORs) using the Mantel and Haenszel method. Results: A total of 9 studies met the inclusion criteria, and 6 risk factors were considered, including soft drinks, sports drinks, juice, vitamin C, milk, and yoghourt. The following associations were found for soft drinks (OR = 2.41, 95% CI = 2.03-2.85) and vitamin C (OR = 1.16, 95% CI = 1.10-1.22). While juice (OR = 0.90, 95% CI = 0.25-3.24), sports drinks (OR = 1.58, 95% CI = 0.88-2.85), milk (OR = 0.67, 95% CI = 0.11-4.01), and yoghourt products (OR = 1.05, 95% CI = 0.28-3.96) were not associated with dental erosion. Conclusions: This meta-analysis provides comprehensive evidence-based assessment of diet-related factors for dental erosion. Preventive strategies should be taken to reduce dental erosion.	[Li, Haifeng] Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zou, Yan; Ding, Gangqiang] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Li, HF (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	zouyan0573@163.com	ding, gangqiang/AHD-5012-2022	Zhang, Bang-Le/0000-0001-9008-5391; Qiu, Peng-cheng/0000-0002-4826-4094				Bartlett DW, 1998, BRIT DENT J, V184, P125, DOI 10.1038/sj.bdj.4809560; Chadwick R G, 2005, J Clin Pediatr Dent, V29, P157; Chen Ya-gang, 2009, Hua Xi Kou Qiang Yi Xue Za Zhi, V27, P565; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dugmore CR, 2004, BRIT DENT J, V196, P283, DOI 10.1038/sj.bdj.4811041; El Aidi H, 2011, J DENT, V39, P558, DOI 10.1016/j.jdent.2011.06.001; El Kanim IA, 2007, COMMUNITY DENT HLTH, V24, P176; Eriksson J H, 1986, Tandlakartidningen, V78, P541; Ganss C, 2006, MG ORAL SCI, V20, P9, DOI 10.1159/000093344; Gatou T, 2012, CLIN ORAL INVEST, V16, P923, DOI 10.1007/s00784-011-0586-z; Gurgel CV, 2011, INT J PAEDIATR DENT, V21, P50, DOI 10.1111/j.1365-263X.2010.01090.x; Hasselkvist A, 2010, SWED DENT J, V34, P187; Holbrook WP, 2009, J DENT RES, V88, P422, DOI 10.1177/0022034509336530; Jager DHJ, 2008, CARIES RES, V42, P98, DOI 10.1159/000116118; Kreulen CM, 2010, CARIES RES, V44, P151, DOI 10.1159/000308567; Luo Y, 2005, J DENT, V33, P115, DOI 10.1016/j.jdent.2004.08.007; Lussi A., 2004, Caries Research, V38, P34, DOI 10.1159/000074360; Milosevic A, 1997, Community Dent Health, V14, P143; Milosevic A, 2004, BRIT DENT J, V197, P475, DOI 10.1038/sj.bdj.4811747; Milosevic A, 2004, BR DENT J, V197, P3; MILOSEVIC A, 2004, BR DENT J, V197, P505, DOI DOI 10.1038/SJ.BDJ.4811747.505; Correa MSNP, 2011, INT J PAEDIATR DENT, V21, P451, DOI 10.1111/j.1365-263X.2011.01150.x; Piangprach T, 2009, J AM DENT ASSOC, V140, P1137, DOI 10.14219/jada.archive.2009.0341; Ratnayake N, 2010, CARIES RES, V44, P14, DOI 10.1159/000271592; Sutton AJAK, 2000, METHODS METAANALYSIS; Waterhouse PJ, 2008, INT J PAEDIATR DENT, V18, P353, DOI 10.1111/j.1365-263X.2008.00919.x; Williams D, 1999, INT DENT J, V49, P211, DOI 10.1111/j.1875-595X.1999.tb00524.x; Yamaguchi K, 2006, J DENT, V34, P230, DOI 10.1016/j.jdent.2005.06.005; Zero DT, 1996, EUR J ORAL SCI, V104, P162, DOI 10.1111/j.1600-0722.1996.tb00065.x	29	82	84	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e42626	10.1371/journal.pone.0042626	http://dx.doi.org/10.1371/journal.pone.0042626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	23139821	Green Submitted, Green Published, gold			2022-12-25	WOS:000308221300008
J	Gao, W; Zhang, CM; Feng, Y; Chen, GG; Wen, SX; Hui, HF; Wang, BQ				Gao, Wei; Zhang, Chunming; Feng, Yan; Chen, Ganggang; Wen, Shuxin; Hui Huangfu; Wang, Binquan			Fascin-1, Ezrin and Paxillin Contribute to the Malignant Progression and Are Predictors of Clinical Prognosis in Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							LUNG-CANCER; EXPRESSION; ADHESION; PROTEIN; ACTIN; STAGE; OVEREXPRESSION; INVASION; MOTILITY; GROWTH	Aims: Fascin-1, ezrin and paxillin, cytoskeleton-associated proteins, have been implicated in several human cancers, but their role in laryngeal squamous cell carcinoma (LSCC) is unknown. We investigated the association of their expression and clinicopathologic factors and their prognostic value in LSCC. Materials and Methods: Quantitative RT-PCR and western blot analyses were used to examine mRNA and protein levels in 10 fresh LSCC specimens and 10 corresponding adjacent normal margin (ANM) tissues from patients undergoing surgery in 2012. We used immunohistochemistry to retrospectively study 216 paraffin blocks of LSCC samples from patients (193 men) who had undergone surgery between 2000 and 2006 and had not received special treatment before the diagnosis. Univariate analysis of patient survival involved the Kaplan-Meier method. Multivariate analyses involved the Cox proportional hazards model. Results: The relative mRNA and protein levels of fascin-1, ezrin and paxillin were significantly greater in LSCC than ANM tissue (P<0.05). The high expression of fascin-1, ezrin or paxillin was positively correlated with poor tumor differentiation, cervical lymph node metastasis (N+), and advanced clinical stage (III+IV) (P<0.05) but not sex or metastasis. In addition, a high expression of fascin-1 (P = 0.007) or ezrin (P = 0.047) was associated with advanced tumor stage (T3+T4). The expression of fascin-1 was higher in smokers than non-smokers (P = 0.019). A high expression of fascin-1, ezrin or paxillin was associated with poor prognosis. Conclusions: Fascin-1, ezrin and paxillin may be prognostic of poor outcome with LSCC after surgery. Our study may lead to establishing new molecular therapeutic targets and/or prognostic biomarkers in LSCC.	[Gao, Wei; Zhang, Chunming; Feng, Yan; Chen, Ganggang; Wen, Shuxin; Hui Huangfu; Wang, Binquan] Shanxi Med Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Taiyuan, Shanxi, Peoples R China; [Gao, Wei; Zhang, Chunming; Feng, Yan; Wen, Shuxin; Hui Huangfu; Wang, Binquan] Key Inst & Lab Otolaryngol Shanxi Prov, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University	Wang, BQ (corresponding author), Shanxi Med Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Taiyuan, Shanxi, Peoples R China.	wbq_xy@yahoo.com.cn	Gao, Wei/E-8505-2013; Leigh, Peter/AAD-5638-2019; Gao, Wei/G-8653-2011; Higginson, Irene Julie/C-7309-2012	Gao, Wei/0000-0001-7836-2851; Gao, Wei/0000-0001-8298-3415; Higginson, Irene Julie/0000-0002-3687-1313; Ray Chaudhuri, K/0000-0003-2815-0505; McCrone, Paul/0000-0001-7001-4502	National Natural Science Foundation of China [81172584]; innovative research project of Shanxi Province, China [20103055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); innovative research project of Shanxi Province, China	This study was funded by the National Natural Science Foundation of China (No. 81172584)(http://www.nsfc.gov.cn) and the innovative research project of Shanxi Province, China (No. 20103055) (http://sxxw.tyut.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisawa N, 1999, BIOCHEM BIOPH RES CO, V258, P395, DOI 10.1006/bbrc.1999.0653; Al-Alwan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027339; Athanasopoulou A, 2011, UROL ONCOL IN PRESS; Benitez-King G, 2009, HISTOL HISTOPATHOL, V24, P789, DOI 10.14670/HH-24.789; Birner P, 2000, CANCER RES, V60, P4693; Buda A, 2004, INT J BIOCHEM CELL B, V36, P759, DOI 10.1016/j.biocel.2003.09.004; Cai HX, 2012, MOL MED REP, V5, P469, DOI 10.3892/mmr.2011.664; Chen ZC, 2001, CANCER-AM CANCER SOC, V92, P3068, DOI 10.1002/1097-0142(20011215)92:12<3068::AID-CNCR10149>3.0.CO;2-5; Chu EA, 2008, OTOLARYNG CLIN N AM, V41, P673, DOI 10.1016/j.otc.2008.01.016; Conway WC, 2006, J CELL BIOCHEM, V98, P1507, DOI 10.1002/jcb.20819; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Dai YM, 2010, INT J CANCER, V126, P611, DOI 10.1002/ijc.24791; Deng XY, 2007, CLIN EXP METASTAS, V24, P107, DOI 10.1007/s10585-007-9059-9; Durmaz A, 2010, J LARYNGOL OTOL, V124, P194, DOI 10.1017/S0022215109991630; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Goncharuk VN, 2002, J CUTAN PATHOL, V29, P430, DOI 10.1034/j.1600-0560.2002.290708.x; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hermans R, 2006, EUR RADIOL, V16, P2386, DOI 10.1007/s00330-006-0301-7; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; Ji WY, 2008, ACTA OTO-LARYNGOL, V128, P574, DOI 10.1080/00016480701596104; Jiang LZ, 2011, HUM PATHOL, V42, P1185, DOI 10.1016/j.humpath.2010.06.017; Kim SJ, 2010, GASTROENTEROLOGY, V138, P1035, DOI 10.1053/j.gastro.2009.09.061; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; Lee TK, 2007, CANCER LETT, V254, P308, DOI 10.1016/j.canlet.2007.03.017; Li BZ, 2008, J INT MED RES, V36, P273, DOI 10.1177/147323000803600209; Li HG, 2005, WORLD J GASTROENTERO, V11, P1445; Li LD, 2002, B CHIN CANC, V11, P497, DOI [10.3969/j.issn.1004-0242.2002.09.001, DOI 10.3969/J.I]; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033987; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Mackinnon AC, 2011, J CLIN PATHOL, V64, P16, DOI 10.1136/jcp.2010.075853; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Mhawech-Fauceglia P, 2007, J CLIN PATHOL, V60, P185, DOI 10.1136/jcp.2006.036624; Nowak JM, 2009, POSTEP HIG MED DOSW, V63, P1; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; Pelosi G, 2003, BRIT J CANCER, V88, P537, DOI 10.1038/sj.bjc.6600731; Sarrio D, 2006, BREAST CANCER RES TR, V98, P71, DOI 10.1007/s10549-005-9133-4; Sattler M, 2000, CRIT REV ONCOGENESIS, V11, P63; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; SCHENK P, 1977, HNO, V25, P413; Shi JN, 2010, J ORAL PATHOL MED, V39, P548, DOI 10.1111/j.1600-0714.2009.00859.x; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Wang L, 2011, TUMOR BIOL, V32, P707, DOI 10.1007/s13277-011-0171-8; Wang YY, 2011, ORAL SURG ORAL MED O, V112, P96, DOI 10.1016/j.tripleo.2011.02.018; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Xie JJ, 2011, J SURG ONCOL, V104, P538, DOI 10.1002/jso.21909; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yeh CN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-233; Zhang XQ, 2012, CLIN LUNG CANCER, V13, P196, DOI 10.1016/j.cllc.2011.04.002; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023; Zou J, 2010, EUR J CANCER PREV, V19, P11, DOI 10.1097/CEJ.0b013e32832f9aa6	59	85	86	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50710	10.1371/journal.pone.0050710	http://dx.doi.org/10.1371/journal.pone.0050710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209815	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800095
J	Wang, YS; Chou, WW; Chen, KC; Cheng, HY; Lin, RT; Juo, SHH				Wang, Yung-Song; Chou, Wen-Wen; Chen, Ku-Chung; Cheng, Hsin-Yun; Lin, Ruey-Tay; Juo, Suh-Hang Hank			microRNA-152 Mediates DNMT1-Regulated DNA Methylation in the Estrogen Receptor alpha Gene	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; ATHEROSCLEROSIS; EXPRESSION; HYPOMETHYLATION; INHIBITION; DISEASE; INFLAMMATION; MECHANISMS; MIGRATION; DNMT3B	Background: Estrogen receptor alpha (ER alpha) has been shown to protect against atherosclerosis. Methylation of the ER alpha gene can reduce ER alpha expression leading to a higher risk for cardiovascular disease. Recently, microRNAs have been found to regulate DNA methyltransferases (DNMTs) and thus control methylation status in several genes. We first searched for microRNAs involved in DNMT-associated DNA methylation in the ER alpha gene. We also tested whether statin and a traditional Chinese medicine (San-Huang-Xie-Xin-Tang, SHXXT) could exert a therapeutic effect on microRNA, DNMT and ER alpha methylation. Methodology/Principal Findings: The ER alpha expression was decreased and ER alpha methylation was increased in LPS-treated human aortic smooth muscle cells (HASMCs) and the aorta from rats under a high-fat diet. microRNA-152 was found to be down regulated in the LPS-treated HASMCs. We validated that microRNA-152 can knock down DNMT1 in HASMCs leading to hypermethylation of the ER alpha gene. Statin had no effect on microRNA-152, DNMT1 or ER alpha expression. On the contrary, SHXXT could restore microRNA-152, decrease DNMT1 and increase ER alpha expression in both cellular and animal studies. Conclusions/Significance: The present study showed that microRNA-152 decreases under the pro-atherosclerotic conditions. The reduced microRNA-152 can lose an inhibitory effect on DNA methyltransferase, which leads to hypermethylation of the ER alpha gene and a decrease of ER alpha level. Although statin can not reverse these cascade proatherosclerotic changes, the SHXXT shows a promising effect to inhibit this unwanted signaling pathway.	[Wang, Yung-Song; Chou, Wen-Wen; Chen, Ku-Chung; Cheng, Hsin-Yun; Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ, Dept Neurol, Kaohsiung, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wang, YS (corresponding author), Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan.	tay@kmu.edu.tw; hjuo@kmu.edu.tw	Juo, Suh-Hang/C-9545-2009; Liu, Xingyue/A-3019-2013	Gao, Yanzheng/0000-0002-3814-3555; Liu, Xingyue/0000-0002-9168-0659	Ministry of Economic Affairs (Taiwan, R.O.C.) [98-EC-17-A-20-S1-134]; National Science Council (Taiwan, R.O.C.) [NSC 99-2628-B-037-037-MY3]; National Health Research Institutes (Taiwan, R.O.C.) [NHRI-Ex96-9607PI]; Department of Health, Executive Yuan (Taiwan, R.O.C.) [DOH99-TD-C-111-002]; Kaohsiung Medical University Hospital [KMUH98-8I11, KMUH99-9M19]	Ministry of Economic Affairs (Taiwan, R.O.C.)(Ministry of Economic Affairs, Taiwan); National Science Council (Taiwan, R.O.C.)(Ministry of Science and Technology, Taiwan); National Health Research Institutes (Taiwan, R.O.C.)(National Health Research Institutes - Taiwan); Department of Health, Executive Yuan (Taiwan, R.O.C.); Kaohsiung Medical University Hospital	This work was supported by the following grants: No. 98-EC-17-A-20-S1-134 from the Ministry of Economic Affairs (Taiwan, R.O.C., Website: www.moea.gov.tw), NSC 99-2628-B-037-037-MY3 from the National Science Council (Taiwan, R.O.C., Website: web1.nsc.gov.tw), NHRI-Ex96-9607PI from the National Health Research Institutes (Taiwan, R.O.C., Website: www.nhri.org.tw), Excellence for Cancer Research Center Grant (DOH99-TD-C-111-002) from the Department of Health, Executive Yuan (Taiwan, R.O.C., Website: www.doh.gov.tw), and Kaohsiung Medical University Hospital intramural grants (KMUH98-8I11 and KMUH99-9M19; Website: www.kmuh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen KC, 2011, FASEB J; Christian RC, 2006, J CLIN ENDOCR METAB, V91, P2713, DOI 10.1210/jc.2005-2672; Diomede L, 2001, ARTERIOSCL THROM VAS, V21, P1327, DOI 10.1161/hq0801.094222; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farmer J A, 2000, Curr Atheroscler Rep, V2, P208, DOI 10.1007/s11883-000-0022-3; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Hiltunen MO, 2003, ARTERIOSCL THROM VAS, V23, P1750, DOI 10.1161/01.ATV.0000092871.30563.41; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Jiang YD, 2007, DNA CELL BIOL, V26, P603, DOI 10.1089/dna.2007.0584; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Laukkanen MO, 1999, ARTERIOSCL THROM VAS, V19, P2171, DOI 10.1161/01.ATV.19.9.2171; Lee ME, 1999, TRENDS CARDIOVAS MED, V9, P49, DOI 10.1016/S1050-1738(99)00002-X; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; Newman PE, 1999, MED HYPOTHESES, V53, P421, DOI 10.1054/mehy.1998.0794; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okubo T, 2000, ENDOCR J, V47, P205, DOI 10.1507/endocrj.47.205; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubanyi GM, 2002, VASC PHARMACOL, V38, P81, DOI 10.1016/S0306-3623(02)00130-1; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Seeger H, 2001, MENOPAUSE, V8, P5, DOI 10.1097/00042192-200101000-00003; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Wang YS, 2011, J ETHNOPHARMACOL, V133, P442, DOI 10.1016/j.jep.2010.10.018; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Ying AK, 2000, CARDIOVASC RES, V46, P172, DOI 10.1016/S0008-6363(00)00004-3	42	139	154	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2012	7	1							e30635	10.1371/journal.pone.0030635	http://dx.doi.org/10.1371/journal.pone.0030635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910ME	23139811	Green Submitted, Green Published, gold			2022-12-25	WOS:000301640600043
